DDI-DrugBank.d678.s0|0-4|Drugs|drug
DDI-DrugBank.d678.s0|6-14|affecting|drug
DDI-DrugBank.d678.s0|16-24|pituitary|drug
DDI-DrugBank.d678.s0|26-27|or|drug
DDI-DrugBank.d678.s0|29-42|adrenocortical|drug
DDI-DrugBank.d678.s0|44-51|function|drug
DDI-DrugBank.d678.s0|52-52|,|drug
DDI-DrugBank.d678.s0|54-62|including|drug
DDI-DrugBank.d678.s0|64-66|all|drug
DDI-DrugBank.d678.s0|68-81|corticosteroid|drug
DDI-DrugBank.d678.s0|83-89|therapy|drug
DDI-DrugBank.d678.s0|90-90|,|drug
DDI-DrugBank.d678.s0|92-95|must|drug
DDI-DrugBank.d678.s0|97-98|be|drug
DDI-DrugBank.d678.s0|100-111|discontinued|drug
DDI-DrugBank.d678.s0|113-117|prior|drug
DDI-DrugBank.d678.s0|119-120|to|drug
DDI-DrugBank.d678.s0|122-124|and|drug
DDI-DrugBank.d678.s0|126-131|during|drug
DDI-DrugBank.d678.s0|133-139|testing|drug
DDI-DrugBank.d678.s0|141-144|with|drug
DDI-DrugBank.d678.s0|146-155|Metopirone|drug
DDI-DrugBank.d678.s0|156-156|.|drug
DDI-DrugBank.d678.s1|0-2|The|drug
DDI-DrugBank.d678.s1|4-13|metabolism|drug
DDI-DrugBank.d678.s1|15-16|of|drug
DDI-DrugBank.d678.s1|18-27|Metopirone|drug
DDI-DrugBank.d678.s1|29-30|is|drug
DDI-DrugBank.d678.s1|32-42|accelerated|drug
DDI-DrugBank.d678.s1|44-45|by|drug
DDI-DrugBank.d678.s1|47-55|phenytoin|drug
DDI-DrugBank.d678.s1|56-56|;|drug
DDI-DrugBank.d678.s2|0-8|therefore|drug
DDI-DrugBank.d678.s2|9-9|,|drug
DDI-DrugBank.d678.s2|11-17|results|drug
DDI-DrugBank.d678.s2|19-20|of|drug
DDI-DrugBank.d678.s2|22-24|the|drug
DDI-DrugBank.d678.s2|26-29|test|drug
DDI-DrugBank.d678.s2|31-33|may|drug
DDI-DrugBank.d678.s2|35-36|be|drug
DDI-DrugBank.d678.s2|38-47|inaccurate|drug
DDI-DrugBank.d678.s2|49-50|in|drug
DDI-DrugBank.d678.s2|52-59|patients|drug
DDI-DrugBank.d678.s2|61-66|taking|drug
DDI-DrugBank.d678.s2|68-76|phenytoin|drug
DDI-DrugBank.d678.s2|78-83|within|drug
DDI-DrugBank.d678.s2|85-87|two|drug
DDI-DrugBank.d678.s2|89-93|weeks|drug
DDI-DrugBank.d678.s2|95-100|before|drug
DDI-DrugBank.d678.s2|101-101|.|drug
DDI-DrugBank.d678.s3|0-9|Asubnormal|drug
DDI-DrugBank.d678.s3|11-18|response|drug
DDI-DrugBank.d678.s3|20-22|may|drug
DDI-DrugBank.d678.s3|24-28|occur|drug
DDI-DrugBank.d678.s3|30-31|in|drug
DDI-DrugBank.d678.s3|33-40|patients|drug
DDI-DrugBank.d678.s3|42-43|on|drug
DDI-DrugBank.d678.s3|45-52|estrogen|drug
DDI-DrugBank.d678.s3|54-60|therapy|drug
DDI-DrugBank.d678.s3|61-61|.|drug
DDI-DrugBank.d678.s4|0-9|Metopirone|drug
DDI-DrugBank.d678.s4|11-18|inhibits|drug
DDI-DrugBank.d678.s4|20-22|the|drug
DDI-DrugBank.d678.s4|24-38|glucuronidation|drug
DDI-DrugBank.d678.s4|40-41|of|drug
DDI-DrugBank.d678.s4|43-55|acetaminophen|drug
DDI-DrugBank.d678.s4|57-59|and|drug
DDI-DrugBank.d678.s4|61-65|could|drug
DDI-DrugBank.d678.s4|67-74|possibly|drug
DDI-DrugBank.d678.s4|76-85|potentiate|drug
DDI-DrugBank.d678.s4|87-99|acetaminophen|drug
DDI-DrugBank.d678.s4|101-108|toxicity|drug
DDI-DrugBank.d678.s4|109-109|.|drug
DDI-DrugBank.d12.s0|0-6|Caution|drug
DDI-DrugBank.d12.s0|8-13|should|drug
DDI-DrugBank.d12.s0|15-16|be|drug
DDI-DrugBank.d12.s0|18-26|exercised|drug
DDI-DrugBank.d12.s0|28-31|when|drug
DDI-DrugBank.d12.s0|33-46|anticoagulants|drug
DDI-DrugBank.d12.s0|48-50|are|drug
DDI-DrugBank.d12.s0|52-56|given|drug
DDI-DrugBank.d12.s0|58-59|in|drug
DDI-DrugBank.d12.s0|61-71|conjunction|drug
DDI-DrugBank.d12.s0|73-76|with|drug
DDI-DrugBank.d12.s0|78-86|Atromid-S|drug
DDI-DrugBank.d12.s0|87-87|.|drug
DDI-DrugBank.d12.s1|0-6|Usually|drug
DDI-DrugBank.d12.s1|7-7|,|drug
DDI-DrugBank.d12.s1|9-11|the|drug
DDI-DrugBank.d12.s1|13-18|dosage|drug
DDI-DrugBank.d12.s1|20-21|of|drug
DDI-DrugBank.d12.s1|23-25|the|drug
DDI-DrugBank.d12.s1|27-39|anticoagulant|drug
DDI-DrugBank.d12.s1|41-46|should|drug
DDI-DrugBank.d12.s1|48-49|be|drug
DDI-DrugBank.d12.s1|51-57|reduced|drug
DDI-DrugBank.d12.s1|59-60|by|drug
DDI-DrugBank.d12.s1|62-69|one-half|drug
DDI-DrugBank.d12.s1|71-71|(|drug
DDI-DrugBank.d12.s1|72-80|depending|drug
DDI-DrugBank.d12.s1|82-83|on|drug
DDI-DrugBank.d12.s1|85-87|the|drug
DDI-DrugBank.d12.s1|89-98|individual|drug
DDI-DrugBank.d12.s1|100-103|case|drug
DDI-DrugBank.d12.s1|104-104|)|drug
DDI-DrugBank.d12.s1|106-107|to|drug
DDI-DrugBank.d12.s1|109-116|maintain|drug
DDI-DrugBank.d12.s1|118-120|the|drug
DDI-DrugBank.d12.s1|122-132|prothrombin|drug
DDI-DrugBank.d12.s1|134-137|time|drug
DDI-DrugBank.d12.s1|139-140|at|drug
DDI-DrugBank.d12.s1|142-144|the|drug
DDI-DrugBank.d12.s1|146-152|desired|drug
DDI-DrugBank.d12.s1|154-158|level|drug
DDI-DrugBank.d12.s1|160-161|to|drug
DDI-DrugBank.d12.s1|163-169|prevent|drug
DDI-DrugBank.d12.s1|171-178|bleeding|drug
DDI-DrugBank.d12.s1|180-192|complications|drug
DDI-DrugBank.d12.s1|193-193|.|drug
DDI-DrugBank.d12.s2|0-7|Frequent|drug
DDI-DrugBank.d12.s2|9-19|prothrombin|drug
DDI-DrugBank.d12.s2|21-34|determinations|drug
DDI-DrugBank.d12.s2|36-38|are|drug
DDI-DrugBank.d12.s2|40-48|advisable|drug
DDI-DrugBank.d12.s2|50-54|until|drug
DDI-DrugBank.d12.s2|56-57|it|drug
DDI-DrugBank.d12.s2|59-61|has|drug
DDI-DrugBank.d12.s2|63-66|been|drug
DDI-DrugBank.d12.s2|68-77|determined|drug
DDI-DrugBank.d12.s2|79-88|definitely|drug
DDI-DrugBank.d12.s2|90-93|that|drug
DDI-DrugBank.d12.s2|95-97|the|drug
DDI-DrugBank.d12.s2|99-109|prothrombin|drug
DDI-DrugBank.d12.s2|111-115|level|drug
DDI-DrugBank.d12.s2|117-119|has|drug
DDI-DrugBank.d12.s2|121-124|been|drug
DDI-DrugBank.d12.s2|126-135|stabilized|drug
DDI-DrugBank.d12.s2|136-136|.|drug
DDI-DrugBank.d12.s3|0-8|Atromid-S|drug
DDI-DrugBank.d12.s3|10-12|may|drug
DDI-DrugBank.d12.s3|14-21|displace|drug
DDI-DrugBank.d12.s3|23-28|acidic|drug
DDI-DrugBank.d12.s3|30-34|drugs|drug
DDI-DrugBank.d12.s3|36-39|such|drug
DDI-DrugBank.d12.s3|41-42|as|drug
DDI-DrugBank.d12.s3|44-52|phenytoin|drug
DDI-DrugBank.d12.s3|54-55|or|drug
DDI-DrugBank.d12.s3|57-67|tolbutamide|drug
DDI-DrugBank.d12.s3|69-72|from|drug
DDI-DrugBank.d12.s3|74-78|their|drug
DDI-DrugBank.d12.s3|80-86|binding|drug
DDI-DrugBank.d12.s3|88-92|sites|drug
DDI-DrugBank.d12.s3|93-93|.|drug
DDI-DrugBank.d12.s4|0-6|Caution|drug
DDI-DrugBank.d12.s4|8-13|should|drug
DDI-DrugBank.d12.s4|15-16|be|drug
DDI-DrugBank.d12.s4|18-26|exercised|drug
DDI-DrugBank.d12.s4|28-31|when|drug
DDI-DrugBank.d12.s4|33-40|treating|drug
DDI-DrugBank.d12.s4|42-49|patients|drug
DDI-DrugBank.d12.s4|51-54|with|drug
DDI-DrugBank.d12.s4|56-61|either|drug
DDI-DrugBank.d12.s4|63-64|of|drug
DDI-DrugBank.d12.s4|66-70|these|drug
DDI-DrugBank.d12.s4|72-76|drugs|drug
DDI-DrugBank.d12.s4|78-79|or|drug
DDI-DrugBank.d12.s4|81-85|other|drug
DDI-DrugBank.d12.s4|87-92|highly|drug
DDI-DrugBank.d12.s4|94-106|protein-bound|drug
DDI-DrugBank.d12.s4|108-112|drugs|drug
DDI-DrugBank.d12.s4|114-116|and|drug
DDI-DrugBank.d12.s4|118-126|Atromid-S|drug
DDI-DrugBank.d12.s4|127-127|.|drug
DDI-DrugBank.d12.s5|0-2|The|drug
DDI-DrugBank.d12.s5|4-15|hypoglycemic|drug
DDI-DrugBank.d12.s5|17-22|effect|drug
DDI-DrugBank.d12.s5|24-25|of|drug
DDI-DrugBank.d12.s5|27-37|tolbutamide|drug
DDI-DrugBank.d12.s5|39-41|has|drug
DDI-DrugBank.d12.s5|43-46|been|drug
DDI-DrugBank.d12.s5|48-55|reported|drug
DDI-DrugBank.d12.s5|57-58|to|drug
DDI-DrugBank.d12.s5|60-67|increase|drug
DDI-DrugBank.d12.s5|69-72|when|drug
DDI-DrugBank.d12.s5|74-82|Atromid-S|drug
DDI-DrugBank.d12.s5|84-85|is|drug
DDI-DrugBank.d12.s5|87-91|given|drug
DDI-DrugBank.d12.s5|93-104|concurrently|drug
DDI-DrugBank.d12.s5|105-105|.|drug
DDI-DrugBank.d12.s6|0-8|Fulminant|drug
DDI-DrugBank.d12.s6|10-23|rhabdomyolysis|drug
DDI-DrugBank.d12.s6|25-27|has|drug
DDI-DrugBank.d12.s6|29-32|been|drug
DDI-DrugBank.d12.s6|34-37|seen|drug
DDI-DrugBank.d12.s6|39-40|as|drug
DDI-DrugBank.d12.s6|42-46|early|drug
DDI-DrugBank.d12.s6|48-49|as|drug
DDI-DrugBank.d12.s6|51-55|three|drug
DDI-DrugBank.d12.s6|57-61|weeks|drug
DDI-DrugBank.d12.s6|63-67|after|drug
DDI-DrugBank.d12.s6|69-78|initiation|drug
DDI-DrugBank.d12.s6|80-81|of|drug
DDI-DrugBank.d12.s6|83-90|combined|drug
DDI-DrugBank.d12.s6|92-98|therapy|drug
DDI-DrugBank.d12.s6|100-103|with|drug
DDI-DrugBank.d12.s6|105-111|another|drug
DDI-DrugBank.d12.s6|113-119|fibrate|drug
DDI-DrugBank.d12.s6|121-123|and|drug
DDI-DrugBank.d12.s6|125-134|lovastatin|drug
DDI-DrugBank.d12.s6|136-138|but|drug
DDI-DrugBank.d12.s6|140-142|may|drug
DDI-DrugBank.d12.s6|144-145|be|drug
DDI-DrugBank.d12.s6|147-150|seen|drug
DDI-DrugBank.d12.s6|152-156|after|drug
DDI-DrugBank.d12.s6|158-164|several|drug
DDI-DrugBank.d12.s6|166-171|months|drug
DDI-DrugBank.d12.s6|172-172|.|drug
DDI-DrugBank.d12.s7|0-2|For|drug
DDI-DrugBank.d12.s7|4-8|these|drug
DDI-DrugBank.d12.s7|10-16|reasons|drug
DDI-DrugBank.d12.s7|17-17|,|drug
DDI-DrugBank.d12.s7|19-20|it|drug
DDI-DrugBank.d12.s7|22-23|is|drug
DDI-DrugBank.d12.s7|25-28|felt|drug
DDI-DrugBank.d12.s7|30-33|that|drug
DDI-DrugBank.d12.s7|34-34|,|drug
DDI-DrugBank.d12.s7|36-37|in|drug
DDI-DrugBank.d12.s7|39-42|most|drug
DDI-DrugBank.d12.s7|44-51|subjects|drug
DDI-DrugBank.d12.s7|53-55|who|drug
DDI-DrugBank.d12.s7|57-60|have|drug
DDI-DrugBank.d12.s7|62-64|had|drug
DDI-DrugBank.d12.s7|66-67|an|drug
DDI-DrugBank.d12.s7|69-82|unsatisfactory|drug
DDI-DrugBank.d12.s7|84-88|lipid|drug
DDI-DrugBank.d12.s7|90-97|response|drug
DDI-DrugBank.d12.s7|99-100|to|drug
DDI-DrugBank.d12.s7|102-107|either|drug
DDI-DrugBank.d12.s7|109-112|drug|drug
DDI-DrugBank.d12.s7|114-118|alone|drug
DDI-DrugBank.d12.s7|119-119|,|drug
DDI-DrugBank.d12.s7|121-123|the|drug
DDI-DrugBank.d12.s7|125-132|possible|drug
DDI-DrugBank.d12.s7|134-141|benefits|drug
DDI-DrugBank.d12.s7|143-144|of|drug
DDI-DrugBank.d12.s7|146-153|combined|drug
DDI-DrugBank.d12.s7|155-161|therapy|drug
DDI-DrugBank.d12.s7|163-166|with|drug
DDI-DrugBank.d12.s7|168-177|lovastatin|drug
DDI-DrugBank.d12.s7|179-181|and|drug
DDI-DrugBank.d12.s7|183-183|a|drug
DDI-DrugBank.d12.s7|185-191|fibrate|drug
DDI-DrugBank.d12.s7|193-194|do|drug
DDI-DrugBank.d12.s7|196-198|not|drug
DDI-DrugBank.d12.s7|200-207|outweigh|drug
DDI-DrugBank.d12.s7|209-211|the|drug
DDI-DrugBank.d12.s7|213-217|risks|drug
DDI-DrugBank.d12.s7|219-220|of|drug
DDI-DrugBank.d12.s7|222-227|severe|drug
DDI-DrugBank.d12.s7|229-236|myopathy|drug
DDI-DrugBank.d12.s7|237-237|,|drug
DDI-DrugBank.d12.s7|239-252|rhabdomyolysis|drug
DDI-DrugBank.d12.s7|253-253|,|drug
DDI-DrugBank.d12.s7|255-257|and|drug
DDI-DrugBank.d12.s7|259-263|acute|drug
DDI-DrugBank.d12.s7|265-269|renal|drug
DDI-DrugBank.d12.s7|271-277|failure|drug
DDI-DrugBank.d12.s7|278-278|.|drug
DDI-DrugBank.d12.s8|0-4|While|drug
DDI-DrugBank.d12.s8|6-7|it|drug
DDI-DrugBank.d12.s8|9-10|is|drug
DDI-DrugBank.d12.s8|12-14|not|drug
DDI-DrugBank.d12.s8|16-20|known|drug
DDI-DrugBank.d12.s8|22-28|whether|drug
DDI-DrugBank.d12.s8|30-33|this|drug
DDI-DrugBank.d12.s8|35-45|interaction|drug
DDI-DrugBank.d12.s8|47-52|occurs|drug
DDI-DrugBank.d12.s8|54-57|with|drug
DDI-DrugBank.d12.s8|59-66|fibrates|drug
DDI-DrugBank.d12.s8|68-72|other|drug
DDI-DrugBank.d12.s8|74-77|than|drug
DDI-DrugBank.d12.s8|79-89|gemfibrozil|drug
DDI-DrugBank.d12.s8|90-90|,|drug
DDI-DrugBank.d12.s8|92-99|myopathy|drug
DDI-DrugBank.d12.s8|101-103|and|drug
DDI-DrugBank.d12.s8|105-118|rhabdomyolysis|drug
DDI-DrugBank.d12.s8|120-123|have|drug
DDI-DrugBank.d12.s8|125-136|occasionally|drug
DDI-DrugBank.d12.s8|138-141|been|drug
DDI-DrugBank.d12.s8|143-152|associated|drug
DDI-DrugBank.d12.s8|154-157|with|drug
DDI-DrugBank.d12.s8|159-161|the|drug
DDI-DrugBank.d12.s8|163-165|use|drug
DDI-DrugBank.d12.s8|167-168|of|drug
DDI-DrugBank.d12.s8|170-177|fibrates|drug
DDI-DrugBank.d12.s8|179-183|alone|drug
DDI-DrugBank.d12.s8|184-184|,|drug
DDI-DrugBank.d12.s8|186-194|including|drug
DDI-DrugBank.d12.s8|196-205|clofibrate|drug
DDI-DrugBank.d12.s8|206-206|.|drug
DDI-DrugBank.d12.s9|0-8|Therefore|drug
DDI-DrugBank.d12.s9|9-9|,|drug
DDI-DrugBank.d12.s9|11-13|the|drug
DDI-DrugBank.d12.s9|15-22|combined|drug
DDI-DrugBank.d12.s9|24-26|use|drug
DDI-DrugBank.d12.s9|28-29|of|drug
DDI-DrugBank.d12.s9|31-40|lovastatin|drug
DDI-DrugBank.d12.s9|42-45|with|drug
DDI-DrugBank.d12.s9|47-54|fibrates|drug
DDI-DrugBank.d12.s9|56-61|should|drug
DDI-DrugBank.d12.s9|63-71|generally|drug
DDI-DrugBank.d12.s9|73-74|be|drug
DDI-DrugBank.d12.s9|76-82|avoided|drug
DDI-DrugBank.d12.s9|83-83|.|drug
DDI-DrugBank.d721.s0|0-2|The|drug
DDI-DrugBank.d721.s0|4-18|bioavailability|drug
DDI-DrugBank.d721.s0|20-21|of|drug
DDI-DrugBank.d721.s0|23-28|SKELID|drug
DDI-DrugBank.d721.s0|30-31|is|drug
DDI-DrugBank.d721.s0|33-41|decreased|drug
DDI-DrugBank.d721.s0|43-44|80|drug
DDI-DrugBank.d721.s0|45-45|%|drug
DDI-DrugBank.d721.s0|47-48|by|drug
DDI-DrugBank.d721.s0|50-56|calcium|drug
DDI-DrugBank.d721.s0|57-57|,|drug
DDI-DrugBank.d721.s0|59-62|when|drug
DDI-DrugBank.d721.s0|64-70|calcium|drug
DDI-DrugBank.d721.s0|72-74|and|drug
DDI-DrugBank.d721.s0|76-81|SKELID|drug
DDI-DrugBank.d721.s0|83-85|are|drug
DDI-DrugBank.d721.s0|87-98|administered|drug
DDI-DrugBank.d721.s0|100-101|at|drug
DDI-DrugBank.d721.s0|103-105|the|drug
DDI-DrugBank.d721.s0|107-110|same|drug
DDI-DrugBank.d721.s0|112-115|time|drug
DDI-DrugBank.d721.s0|116-116|,|drug
DDI-DrugBank.d721.s0|118-120|and|drug
DDI-DrugBank.d721.s0|122-123|60|drug
DDI-DrugBank.d721.s0|124-124|%|drug
DDI-DrugBank.d721.s0|126-127|by|drug
DDI-DrugBank.d721.s0|129-132|some|drug
DDI-DrugBank.d721.s0|134-142|aluminum-|drug
DDI-DrugBank.d721.s0|144-145|or|drug
DDI-DrugBank.d721.s0|147-166|magnesium-containing|drug
DDI-DrugBank.d721.s0|168-175|antacids|drug
DDI-DrugBank.d721.s0|176-176|,|drug
DDI-DrugBank.d721.s0|178-181|when|drug
DDI-DrugBank.d721.s0|183-194|administered|drug
DDI-DrugBank.d721.s0|196-196|1|drug
DDI-DrugBank.d721.s0|198-201|hour|drug
DDI-DrugBank.d721.s0|203-208|before|drug
DDI-DrugBank.d721.s0|210-215|SKELID|drug
DDI-DrugBank.d721.s0|216-216|.|drug
DDI-DrugBank.d721.s1|0-6|Aspirin|drug
DDI-DrugBank.d721.s1|8-10|may|drug
DDI-DrugBank.d721.s1|12-19|decrease|drug
DDI-DrugBank.d721.s1|21-35|bioavailability|drug
DDI-DrugBank.d721.s1|37-38|of|drug
DDI-DrugBank.d721.s1|40-45|SKELID|drug
DDI-DrugBank.d721.s1|47-48|by|drug
DDI-DrugBank.d721.s1|50-51|up|drug
DDI-DrugBank.d721.s1|53-54|to|drug
DDI-DrugBank.d721.s1|56-57|50|drug
DDI-DrugBank.d721.s1|58-58|%|drug
DDI-DrugBank.d721.s1|60-63|when|drug
DDI-DrugBank.d721.s1|65-69|taken|drug
DDI-DrugBank.d721.s1|71-71|2|drug
DDI-DrugBank.d721.s1|73-77|hours|drug
DDI-DrugBank.d721.s1|79-83|after|drug
DDI-DrugBank.d721.s1|85-90|SKELID|drug
DDI-DrugBank.d721.s1|91-91|.|drug
DDI-DrugBank.d721.s2|0-2|The|drug
DDI-DrugBank.d721.s2|4-18|bioavailability|drug
DDI-DrugBank.d721.s2|20-21|of|drug
DDI-DrugBank.d721.s2|23-28|SKELID|drug
DDI-DrugBank.d721.s2|30-31|is|drug
DDI-DrugBank.d721.s2|33-41|increased|drug
DDI-DrugBank.d721.s2|43-45|2-4|drug
DDI-DrugBank.d721.s2|47-50|fold|drug
DDI-DrugBank.d721.s2|52-53|by|drug
DDI-DrugBank.d721.s2|55-66|indomethacin|drug
DDI-DrugBank.d721.s2|68-70|but|drug
DDI-DrugBank.d721.s2|72-73|is|drug
DDI-DrugBank.d721.s2|75-77|not|drug
DDI-DrugBank.d721.s2|79-91|significantly|drug
DDI-DrugBank.d721.s2|93-99|altered|drug
DDI-DrugBank.d721.s2|101-102|by|drug
DDI-DrugBank.d721.s2|104-119|coadministration|drug
DDI-DrugBank.d721.s2|121-122|of|drug
DDI-DrugBank.d721.s2|124-133|diclofenac|drug
DDI-DrugBank.d721.s2|134-134|.|drug
DDI-DrugBank.d721.s3|0-2|The|drug
DDI-DrugBank.d721.s3|4-18|pharmacokinetic|drug
DDI-DrugBank.d721.s3|20-29|parameters|drug
DDI-DrugBank.d721.s3|31-32|of|drug
DDI-DrugBank.d721.s3|34-40|digoxin|drug
DDI-DrugBank.d721.s3|42-44|are|drug
DDI-DrugBank.d721.s3|46-48|not|drug
DDI-DrugBank.d721.s3|50-62|significantly|drug
DDI-DrugBank.d721.s3|64-71|modified|drug
DDI-DrugBank.d721.s3|73-74|by|drug
DDI-DrugBank.d721.s3|76-81|SKELID|drug
DDI-DrugBank.d721.s3|83-98|coadministration|drug
DDI-DrugBank.d721.s3|99-99|.|drug
DDI-DrugBank.d721.s4|0-1|In|drug
DDI-DrugBank.d721.s4|3-7|vitro|drug
DDI-DrugBank.d721.s4|9-15|studies|drug
DDI-DrugBank.d721.s4|17-20|show|drug
DDI-DrugBank.d721.s4|22-25|that|drug
DDI-DrugBank.d721.s4|27-37|tiludronate|drug
DDI-DrugBank.d721.s4|39-42|does|drug
DDI-DrugBank.d721.s4|44-46|not|drug
DDI-DrugBank.d721.s4|48-55|displace|drug
DDI-DrugBank.d721.s4|57-64|warfarin|drug
DDI-DrugBank.d721.s4|66-69|from|drug
DDI-DrugBank.d721.s4|71-73|its|drug
DDI-DrugBank.d721.s4|75-81|binding|drug
DDI-DrugBank.d721.s4|83-86|site|drug
DDI-DrugBank.d721.s4|88-89|on|drug
DDI-DrugBank.d721.s4|91-97|protein|drug
DDI-DrugBank.d721.s4|98-98|.|drug
DDI-DrugBank.d415.s0|0-12|Coumarin-Type|drug
DDI-DrugBank.d415.s0|14-27|Anticoagulants|drug
DDI-DrugBank.d415.s0|28-28|:|drug
DDI-DrugBank.d415.s0|30-36|Several|drug
DDI-DrugBank.d415.s0|38-47|short-term|drug
DDI-DrugBank.d415.s0|49-58|controlled|drug
DDI-DrugBank.d415.s0|60-66|studies|drug
DDI-DrugBank.d415.s0|68-73|failed|drug
DDI-DrugBank.d415.s0|75-76|to|drug
DDI-DrugBank.d415.s0|78-82|wshow|drug
DDI-DrugBank.d415.s0|84-87|that|drug
DDI-DrugBank.d415.s0|89-97|ibuprofen|drug
DDI-DrugBank.d415.s0|99-111|significantly|drug
DDI-DrugBank.d415.s0|113-120|affected|drug
DDI-DrugBank.d415.s0|122-132|prothrombin|drug
DDI-DrugBank.d415.s0|134-138|times|drug
DDI-DrugBank.d415.s0|140-141|or|drug
DDI-DrugBank.d415.s0|143-143|a|drug
DDI-DrugBank.d415.s0|145-151|variety|drug
DDI-DrugBank.d415.s0|153-154|of|drug
DDI-DrugBank.d415.s0|156-160|other|drug
DDI-DrugBank.d415.s0|162-169|clotting|drug
DDI-DrugBank.d415.s0|171-177|factors|drug
DDI-DrugBank.d415.s0|179-182|when|drug
DDI-DrugBank.d415.s0|184-195|administered|drug
DDI-DrugBank.d415.s0|197-198|to|drug
DDI-DrugBank.d415.s0|200-210|individuals|drug
DDI-DrugBank.d415.s0|212-213|on|drug
DDI-DrugBank.d415.s0|215-227|coumarin-type|drug
DDI-DrugBank.d415.s0|229-242|anticoagulants|drug
DDI-DrugBank.d415.s0|243-243|.|drug
DDI-DrugBank.d415.s1|0-6|However|drug
DDI-DrugBank.d415.s1|7-7|,|drug
DDI-DrugBank.d415.s1|9-15|because|drug
DDI-DrugBank.d415.s1|17-24|bleeding|drug
DDI-DrugBank.d415.s1|26-28|has|drug
DDI-DrugBank.d415.s1|30-33|been|drug
DDI-DrugBank.d415.s1|35-42|reported|drug
DDI-DrugBank.d415.s1|44-47|when|drug
DDI-DrugBank.d415.s1|49-57|ibuprofen|drug
DDI-DrugBank.d415.s1|59-61|and|drug
DDI-DrugBank.d415.s1|63-67|other|drug
DDI-DrugBank.d415.s1|69-80|nonsteroidal|drug
DDI-DrugBank.d415.s1|82-98|anti-inflammatory|drug
DDI-DrugBank.d415.s1|100-105|agents|drug
DDI-DrugBank.d415.s1|107-110|have|drug
DDI-DrugBank.d415.s1|112-115|been|drug
DDI-DrugBank.d415.s1|117-128|administered|drug
DDI-DrugBank.d415.s1|130-131|to|drug
DDI-DrugBank.d415.s1|133-140|patients|drug
DDI-DrugBank.d415.s1|142-143|on|drug
DDI-DrugBank.d415.s1|145-157|coumarin-type|drug
DDI-DrugBank.d415.s1|159-172|anticoagulants|drug
DDI-DrugBank.d415.s1|173-173|,|drug
DDI-DrugBank.d415.s1|175-177|the|drug
DDI-DrugBank.d415.s1|179-187|physician|drug
DDI-DrugBank.d415.s1|189-194|should|drug
DDI-DrugBank.d415.s1|196-197|be|drug
DDI-DrugBank.d415.s1|199-206|cautious|drug
DDI-DrugBank.d415.s1|208-211|when|drug
DDI-DrugBank.d415.s1|213-225|administering|drug
DDI-DrugBank.d415.s1|227-235|ibuprofen|drug
DDI-DrugBank.d415.s1|237-238|to|drug
DDI-DrugBank.d415.s1|240-247|patients|drug
DDI-DrugBank.d415.s1|249-250|on|drug
DDI-DrugBank.d415.s1|252-265|anticoagulants|drug
DDI-DrugBank.d415.s1|266-266|.|drug
DDI-DrugBank.d415.s2|0-6|Aspirin|drug
DDI-DrugBank.d415.s2|7-7|:|drug
DDI-DrugBank.d415.s2|9-14|Animal|drug
DDI-DrugBank.d415.s2|16-22|studies|drug
DDI-DrugBank.d415.s2|24-28|wshow|drug
DDI-DrugBank.d415.s2|30-33|that|drug
DDI-DrugBank.d415.s2|35-41|aspirin|drug
DDI-DrugBank.d415.s2|43-47|given|drug
DDI-DrugBank.d415.s2|49-52|with|drug
DDI-DrugBank.d415.s2|54-65|nonsteroidal|drug
DDI-DrugBank.d415.s2|67-83|anti-inflammatory|drug
DDI-DrugBank.d415.s2|85-90|agents|drug
DDI-DrugBank.d415.s2|91-91|,|drug
DDI-DrugBank.d415.s2|93-101|including|drug
DDI-DrugBank.d415.s2|103-111|ibuprofen|drug
DDI-DrugBank.d415.s2|112-112|,|drug
DDI-DrugBank.d415.s2|114-119|yields|drug
DDI-DrugBank.d415.s2|121-121|a|drug
DDI-DrugBank.d415.s2|123-125|net|drug
DDI-DrugBank.d415.s2|127-134|decrease|drug
DDI-DrugBank.d415.s2|136-137|in|drug
DDI-DrugBank.d415.s2|139-155|anti-inflammatory|drug
DDI-DrugBank.d415.s2|157-164|activity|drug
DDI-DrugBank.d415.s2|166-169|with|drug
DDI-DrugBank.d415.s2|171-177|lowered|drug
DDI-DrugBank.d415.s2|179-183|blood|drug
DDI-DrugBank.d415.s2|185-190|levels|drug
DDI-DrugBank.d415.s2|192-193|of|drug
DDI-DrugBank.d415.s2|195-197|the|drug
DDI-DrugBank.d415.s2|199-209|non-aspirin|drug
DDI-DrugBank.d415.s2|211-214|drug|drug
DDI-DrugBank.d415.s2|215-215|.|drug
DDI-DrugBank.d415.s3|0-5|Single|drug
DDI-DrugBank.d415.s3|7-10|dose|drug
DDI-DrugBank.d415.s3|12-26|bioavailability|drug
DDI-DrugBank.d415.s3|28-34|studies|drug
DDI-DrugBank.d415.s3|36-37|in|drug
DDI-DrugBank.d415.s3|39-44|normal|drug
DDI-DrugBank.d415.s3|46-55|volunteers|drug
DDI-DrugBank.d415.s3|57-60|have|drug
DDI-DrugBank.d415.s3|62-67|failed|drug
DDI-DrugBank.d415.s3|69-70|to|drug
DDI-DrugBank.d415.s3|72-76|wshow|drug
DDI-DrugBank.d415.s3|78-79|an|drug
DDI-DrugBank.d415.s3|81-86|effect|drug
DDI-DrugBank.d415.s3|88-89|of|drug
DDI-DrugBank.d415.s3|91-97|aspirin|drug
DDI-DrugBank.d415.s3|99-100|on|drug
DDI-DrugBank.d415.s3|102-110|ibuprofen|drug
DDI-DrugBank.d415.s3|112-116|blood|drug
DDI-DrugBank.d415.s3|118-123|levels|drug
DDI-DrugBank.d415.s3|124-124|.|drug
DDI-DrugBank.d415.s4|0-10|Correlative|drug
DDI-DrugBank.d415.s4|12-19|clinical|drug
DDI-DrugBank.d415.s4|21-27|studies|drug
DDI-DrugBank.d415.s4|29-32|have|drug
DDI-DrugBank.d415.s4|34-36|not|drug
DDI-DrugBank.d415.s4|38-41|been|drug
DDI-DrugBank.d415.s4|43-51|performed|drug
DDI-DrugBank.d415.s4|52-52|.|drug
DDI-DrugBank.d415.s5|0-11|Methotrexate|drug
DDI-DrugBank.d415.s5|12-12|:|drug
DDI-DrugBank.d415.s5|14-22|Ibuprofen|drug
DDI-DrugBank.d415.s5|23-23|,|drug
DDI-DrugBank.d415.s5|25-26|as|drug
DDI-DrugBank.d415.s5|28-31|well|drug
DDI-DrugBank.d415.s5|33-34|as|drug
DDI-DrugBank.d415.s5|36-40|other|drug
DDI-DrugBank.d415.s5|42-53|nonsteroidal|drug
DDI-DrugBank.d415.s5|55-71|anti-inflammatory|drug
DDI-DrugBank.d415.s5|73-77|drugs|drug
DDI-DrugBank.d415.s5|78-78|,|drug
DDI-DrugBank.d415.s5|80-87|probably|drug
DDI-DrugBank.d415.s5|89-95|reduces|drug
DDI-DrugBank.d415.s5|97-99|the|drug
DDI-DrugBank.d415.s5|101-107|tubular|drug
DDI-DrugBank.d415.s5|109-117|secretion|drug
DDI-DrugBank.d415.s5|119-120|of|drug
DDI-DrugBank.d415.s5|122-133|methotrexate|drug
DDI-DrugBank.d415.s5|135-139|based|drug
DDI-DrugBank.d415.s5|141-142|on|drug
DDI-DrugBank.d415.s5|144-145|in|drug
DDI-DrugBank.d415.s5|147-151|vitro|drug
DDI-DrugBank.d415.s5|153-159|studies|drug
DDI-DrugBank.d415.s5|161-162|in|drug
DDI-DrugBank.d415.s5|164-169|rabbit|drug
DDI-DrugBank.d415.s5|171-176|kidney|drug
DDI-DrugBank.d415.s5|178-183|slices|drug
DDI-DrugBank.d415.s5|184-184|.|drug
DDI-DrugBank.d415.s6|0-3|This|drug
DDI-DrugBank.d415.s6|5-7|may|drug
DDI-DrugBank.d415.s6|9-16|indicate|drug
DDI-DrugBank.d415.s6|18-21|that|drug
DDI-DrugBank.d415.s6|23-31|ibuprofen|drug
DDI-DrugBank.d415.s6|33-37|could|drug
DDI-DrugBank.d415.s6|39-45|enhance|drug
DDI-DrugBank.d415.s6|47-49|the|drug
DDI-DrugBank.d415.s6|51-58|toxicity|drug
DDI-DrugBank.d415.s6|60-61|of|drug
DDI-DrugBank.d415.s6|63-74|methotrexate|drug
DDI-DrugBank.d415.s6|75-75|.|drug
DDI-DrugBank.d415.s7|0-6|Caution|drug
DDI-DrugBank.d415.s7|8-13|should|drug
DDI-DrugBank.d415.s7|15-16|be|drug
DDI-DrugBank.d415.s7|18-21|used|drug
DDI-DrugBank.d415.s7|23-24|if|drug
DDI-DrugBank.d415.s7|26-34|ibuprofen|drug
DDI-DrugBank.d415.s7|36-37|is|drug
DDI-DrugBank.d415.s7|39-50|administered|drug
DDI-DrugBank.d415.s7|52-64|concomitantly|drug
DDI-DrugBank.d415.s7|66-69|with|drug
DDI-DrugBank.d415.s7|71-82|methotrexate|drug
DDI-DrugBank.d415.s7|83-83|.|drug
DDI-DrugBank.d415.s8|0-2|H-2|drug
DDI-DrugBank.d415.s8|4-14|Antagonists|drug
DDI-DrugBank.d415.s8|15-15|:|drug
DDI-DrugBank.d415.s8|17-18|In|drug
DDI-DrugBank.d415.s8|20-26|studies|drug
DDI-DrugBank.d415.s8|28-31|with|drug
DDI-DrugBank.d415.s8|33-37|human|drug
DDI-DrugBank.d415.s8|39-48|volunteers|drug
DDI-DrugBank.d415.s8|49-49|,|drug
DDI-DrugBank.d415.s8|51-67|co-administration|drug
DDI-DrugBank.d415.s8|69-70|of|drug
DDI-DrugBank.d415.s8|72-81|cimetidine|drug
DDI-DrugBank.d415.s8|83-84|or|drug
DDI-DrugBank.d415.s8|86-95|ranitidine|drug
DDI-DrugBank.d415.s8|97-100|with|drug
DDI-DrugBank.d415.s8|102-110|ibuprofen|drug
DDI-DrugBank.d415.s8|112-114|had|drug
DDI-DrugBank.d415.s8|116-117|no|drug
DDI-DrugBank.d415.s8|119-129|substantive|drug
DDI-DrugBank.d415.s8|131-136|effect|drug
DDI-DrugBank.d415.s8|138-139|on|drug
DDI-DrugBank.d415.s8|141-149|ibuprofen|drug
DDI-DrugBank.d415.s8|151-155|serum|drug
DDI-DrugBank.d415.s8|157-170|concentrations|drug
DDI-DrugBank.d415.s8|171-171|.|drug
DDI-DrugBank.d415.s9|0-9|Furosemide|drug
DDI-DrugBank.d415.s9|10-10|:|drug
DDI-DrugBank.d415.s9|12-19|Clinical|drug
DDI-DrugBank.d415.s9|21-27|studies|drug
DDI-DrugBank.d415.s9|28-28|,|drug
DDI-DrugBank.d415.s9|30-31|as|drug
DDI-DrugBank.d415.s9|33-36|well|drug
DDI-DrugBank.d415.s9|38-39|as|drug
DDI-DrugBank.d415.s9|41-46|random|drug
DDI-DrugBank.d415.s9|48-59|observations|drug
DDI-DrugBank.d415.s9|60-60|,|drug
DDI-DrugBank.d415.s9|62-65|have|drug
DDI-DrugBank.d415.s9|67-71|shown|drug
DDI-DrugBank.d415.s9|73-76|that|drug
DDI-DrugBank.d415.s9|78-86|ibuprofen|drug
DDI-DrugBank.d415.s9|88-90|can|drug
DDI-DrugBank.d415.s9|92-97|reduce|drug
DDI-DrugBank.d415.s9|99-101|the|drug
DDI-DrugBank.d415.s9|103-113|natriuretic|drug
DDI-DrugBank.d415.s9|115-120|effect|drug
DDI-DrugBank.d415.s9|122-123|of|drug
DDI-DrugBank.d415.s9|125-134|furosemide|drug
DDI-DrugBank.d415.s9|136-138|and|drug
DDI-DrugBank.d415.s9|140-148|thiazides|drug
DDI-DrugBank.d415.s9|150-151|in|drug
DDI-DrugBank.d415.s9|153-156|some|drug
DDI-DrugBank.d415.s9|158-165|patients|drug
DDI-DrugBank.d415.s9|166-166|.|drug
DDI-DrugBank.d415.s10|0-3|This|drug
DDI-DrugBank.d415.s10|5-12|response|drug
DDI-DrugBank.d415.s10|14-16|has|drug
DDI-DrugBank.d415.s10|18-21|been|drug
DDI-DrugBank.d415.s10|23-32|attributed|drug
DDI-DrugBank.d415.s10|34-35|to|drug
DDI-DrugBank.d415.s10|37-46|inhibition|drug
DDI-DrugBank.d415.s10|48-49|of|drug
DDI-DrugBank.d415.s10|51-55|renal|drug
DDI-DrugBank.d415.s10|57-69|prostaglandin|drug
DDI-DrugBank.d415.s10|71-79|synthesis|drug
DDI-DrugBank.d415.s10|80-80|.|drug
DDI-DrugBank.d415.s11|0-5|During|drug
DDI-DrugBank.d415.s11|7-17|concomitant|drug
DDI-DrugBank.d415.s11|19-25|therapy|drug
DDI-DrugBank.d415.s11|27-30|with|drug
DDI-DrugBank.d415.s11|32-40|ibuprofen|drug
DDI-DrugBank.d415.s11|41-41|,|drug
DDI-DrugBank.d415.s11|43-45|the|drug
DDI-DrugBank.d415.s11|47-53|patient|drug
DDI-DrugBank.d415.s11|55-60|should|drug
DDI-DrugBank.d415.s11|62-63|be|drug
DDI-DrugBank.d415.s11|65-72|observed|drug
DDI-DrugBank.d415.s11|74-80|closely|drug
DDI-DrugBank.d415.s11|82-84|for|drug
DDI-DrugBank.d415.s11|86-90|signs|drug
DDI-DrugBank.d415.s11|92-93|of|drug
DDI-DrugBank.d415.s11|95-99|renal|drug
DDI-DrugBank.d415.s11|101-107|failure|drug
DDI-DrugBank.d415.s11|108-108|,|drug
DDI-DrugBank.d415.s11|110-111|as|drug
DDI-DrugBank.d415.s11|113-116|well|drug
DDI-DrugBank.d415.s11|118-119|as|drug
DDI-DrugBank.d415.s11|121-122|to|drug
DDI-DrugBank.d415.s11|124-129|assure|drug
DDI-DrugBank.d415.s11|131-138|diuretic|drug
DDI-DrugBank.d415.s11|140-147|efficacy|drug
DDI-DrugBank.d415.s11|148-148|.|drug
DDI-DrugBank.d415.s12|0-6|Lithium|drug
DDI-DrugBank.d415.s12|7-7|:|drug
DDI-DrugBank.d415.s12|9-17|Ibuprofen|drug
DDI-DrugBank.d415.s12|19-26|produced|drug
DDI-DrugBank.d415.s12|28-29|an|drug
DDI-DrugBank.d415.s12|31-39|elevation|drug
DDI-DrugBank.d415.s12|41-42|of|drug
DDI-DrugBank.d415.s12|44-49|plasma|drug
DDI-DrugBank.d415.s12|51-57|lithium|drug
DDI-DrugBank.d415.s12|59-64|levels|drug
DDI-DrugBank.d415.s12|66-68|and|drug
DDI-DrugBank.d415.s12|70-70|a|drug
DDI-DrugBank.d415.s12|72-80|reduction|drug
DDI-DrugBank.d415.s12|82-83|in|drug
DDI-DrugBank.d415.s12|85-89|renal|drug
DDI-DrugBank.d415.s12|91-97|lithium|drug
DDI-DrugBank.d415.s12|99-107|clearance|drug
DDI-DrugBank.d415.s12|109-110|in|drug
DDI-DrugBank.d415.s12|112-112|a|drug
DDI-DrugBank.d415.s12|114-118|study|drug
DDI-DrugBank.d415.s12|120-121|of|drug
DDI-DrugBank.d415.s12|123-128|eleven|drug
DDI-DrugBank.d415.s12|130-135|normal|drug
DDI-DrugBank.d415.s12|137-146|volunteers|drug
DDI-DrugBank.d415.s12|147-147|.|drug
DDI-DrugBank.d415.s13|0-2|The|drug
DDI-DrugBank.d415.s13|4-7|mean|drug
DDI-DrugBank.d415.s13|9-15|minimum|drug
DDI-DrugBank.d415.s13|17-23|lithium|drug
DDI-DrugBank.d415.s13|25-37|concentration|drug
DDI-DrugBank.d415.s13|39-47|increased|drug
DDI-DrugBank.d415.s13|49-50|15|drug
DDI-DrugBank.d415.s13|51-51|%|drug
DDI-DrugBank.d415.s13|53-55|and|drug
DDI-DrugBank.d415.s13|57-59|the|drug
DDI-DrugBank.d415.s13|61-65|renal|drug
DDI-DrugBank.d415.s13|67-75|clearance|drug
DDI-DrugBank.d415.s13|77-78|of|drug
DDI-DrugBank.d415.s13|80-86|lithium|drug
DDI-DrugBank.d415.s13|88-90|was|drug
DDI-DrugBank.d415.s13|92-100|decreased|drug
DDI-DrugBank.d415.s13|102-103|by|drug
DDI-DrugBank.d415.s13|105-106|19|drug
DDI-DrugBank.d415.s13|107-107|%|drug
DDI-DrugBank.d415.s13|109-114|during|drug
DDI-DrugBank.d415.s13|116-119|this|drug
DDI-DrugBank.d415.s13|121-126|period|drug
DDI-DrugBank.d415.s13|128-129|of|drug
DDI-DrugBank.d415.s13|131-141|concomitant|drug
DDI-DrugBank.d415.s13|143-146|drug|drug
DDI-DrugBank.d415.s13|148-161|administration|drug
DDI-DrugBank.d415.s13|162-162|.|drug
DDI-DrugBank.d415.s14|0-3|This|drug
DDI-DrugBank.d415.s14|5-10|effect|drug
DDI-DrugBank.d415.s14|12-14|has|drug
DDI-DrugBank.d415.s14|16-19|been|drug
DDI-DrugBank.d415.s14|21-30|attributed|drug
DDI-DrugBank.d415.s14|32-33|to|drug
DDI-DrugBank.d415.s14|35-44|inhibition|drug
DDI-DrugBank.d415.s14|46-47|of|drug
DDI-DrugBank.d415.s14|49-53|renal|drug
DDI-DrugBank.d415.s14|55-67|prostaglandin|drug
DDI-DrugBank.d415.s14|69-77|synthesis|drug
DDI-DrugBank.d415.s14|79-80|by|drug
DDI-DrugBank.d415.s14|82-90|ibuprofen|drug
DDI-DrugBank.d415.s14|91-91|.|drug
DDI-DrugBank.d415.s15|0-3|Thus|drug
DDI-DrugBank.d415.s15|4-4|,|drug
DDI-DrugBank.d415.s15|6-9|when|drug
DDI-DrugBank.d415.s15|11-19|ibuprofen|drug
DDI-DrugBank.d415.s15|21-23|and|drug
DDI-DrugBank.d415.s15|25-31|lithium|drug
DDI-DrugBank.d415.s15|33-35|are|drug
DDI-DrugBank.d415.s15|37-48|administered|drug
DDI-DrugBank.d415.s15|50-61|concurrently|drug
DDI-DrugBank.d415.s15|62-62|,|drug
DDI-DrugBank.d415.s15|64-71|subjects|drug
DDI-DrugBank.d415.s15|73-78|should|drug
DDI-DrugBank.d415.s15|80-81|be|drug
DDI-DrugBank.d415.s15|83-90|observed|drug
DDI-DrugBank.d415.s15|92-100|carefully|drug
DDI-DrugBank.d415.s15|102-104|for|drug
DDI-DrugBank.d415.s15|106-110|signs|drug
DDI-DrugBank.d415.s15|112-113|of|drug
DDI-DrugBank.d415.s15|115-121|lithium|drug
DDI-DrugBank.d415.s15|123-130|toxicity|drug
DDI-DrugBank.d415.s15|131-131|.|drug
DDI-DrugBank.d415.s16|0-0|(|drug
DDI-DrugBank.d415.s16|1-4|Read|drug
DDI-DrugBank.d415.s16|6-14|circulars|drug
DDI-DrugBank.d415.s16|16-18|for|drug
DDI-DrugBank.d415.s16|20-26|lithium|drug
DDI-DrugBank.d415.s16|28-38|preparation|drug
DDI-DrugBank.d415.s16|40-45|before|drug
DDI-DrugBank.d415.s16|47-49|use|drug
DDI-DrugBank.d415.s16|51-52|of|drug
DDI-DrugBank.d415.s16|54-57|such|drug
DDI-DrugBank.d415.s16|59-68|concurrent|drug
DDI-DrugBank.d415.s16|70-76|therapy|drug
DDI-DrugBank.d415.s16|77-77|)|drug
DDI-DrugBank.d415.s16|78-78|.|drug
DDI-DrugBank.d529.s0|0-7|Antacids|drug
DDI-DrugBank.d529.s0|8-8|:|drug
DDI-DrugBank.d529.s0|10-23|Administration|drug
DDI-DrugBank.d529.s0|25-26|of|drug
DDI-DrugBank.d529.s0|28-39|flurbiprofen|drug
DDI-DrugBank.d529.s0|41-42|to|drug
DDI-DrugBank.d529.s0|44-53|volunteers|drug
DDI-DrugBank.d529.s0|55-59|under|drug
DDI-DrugBank.d529.s0|61-67|fasting|drug
DDI-DrugBank.d529.s0|69-78|conditions|drug
DDI-DrugBank.d529.s0|79-79|,|drug
DDI-DrugBank.d529.s0|81-82|or|drug
DDI-DrugBank.d529.s0|84-87|with|drug
DDI-DrugBank.d529.s0|89-95|antacid|drug
DDI-DrugBank.d529.s0|97-106|suspension|drug
DDI-DrugBank.d529.s0|108-114|yielded|drug
DDI-DrugBank.d529.s0|116-122|similar|drug
DDI-DrugBank.d529.s0|124-128|serum|drug
DDI-DrugBank.d529.s0|130-141|flurbiprofen|drug
DDI-DrugBank.d529.s0|143-146|time|drug
DDI-DrugBank.d529.s0|148-155|profiles|drug
DDI-DrugBank.d529.s0|157-158|in|drug
DDI-DrugBank.d529.s0|160-164|young|drug
DDI-DrugBank.d529.s0|166-173|subjects|drug
DDI-DrugBank.d529.s0|175-175|(|drug
DDI-DrugBank.d529.s0|176-179|n=12|drug
DDI-DrugBank.d529.s0|180-180|)|drug
DDI-DrugBank.d529.s0|181-181|.|drug
DDI-DrugBank.d529.s1|0-1|In|drug
DDI-DrugBank.d529.s1|3-11|geriatric|drug
DDI-DrugBank.d529.s1|13-20|subjects|drug
DDI-DrugBank.d529.s1|22-22|(|drug
DDI-DrugBank.d529.s1|23-25|n=7|drug
DDI-DrugBank.d529.s1|26-26|)|drug
DDI-DrugBank.d529.s1|28-32|there|drug
DDI-DrugBank.d529.s1|34-36|was|drug
DDI-DrugBank.d529.s1|38-38|a|drug
DDI-DrugBank.d529.s1|40-48|reduction|drug
DDI-DrugBank.d529.s1|50-51|in|drug
DDI-DrugBank.d529.s1|53-55|the|drug
DDI-DrugBank.d529.s1|57-60|rate|drug
DDI-DrugBank.d529.s1|62-64|but|drug
DDI-DrugBank.d529.s1|66-68|not|drug
DDI-DrugBank.d529.s1|70-72|the|drug
DDI-DrugBank.d529.s1|74-79|extent|drug
DDI-DrugBank.d529.s1|81-82|of|drug
DDI-DrugBank.d529.s1|84-95|flurbiprofen|drug
DDI-DrugBank.d529.s1|97-106|absorption|drug
DDI-DrugBank.d529.s1|107-107|.|drug
DDI-DrugBank.d529.s2|0-13|Anticoagulants|drug
DDI-DrugBank.d529.s2|14-14|:|drug
DDI-DrugBank.d529.s2|16-27|Flurbiprofen|drug
DDI-DrugBank.d529.s2|29-32|like|drug
DDI-DrugBank.d529.s2|34-38|other|drug
DDI-DrugBank.d529.s2|40-51|nonsteroidal|drug
DDI-DrugBank.d529.s2|53-69|anti-inflammatory|drug
DDI-DrugBank.d529.s2|71-75|drugs|drug
DDI-DrugBank.d529.s2|76-76|,|drug
DDI-DrugBank.d529.s2|78-80|has|drug
DDI-DrugBank.d529.s2|82-85|been|drug
DDI-DrugBank.d529.s2|87-91|shown|drug
DDI-DrugBank.d529.s2|93-94|to|drug
DDI-DrugBank.d529.s2|96-101|affect|drug
DDI-DrugBank.d529.s2|103-110|bleeding|drug
DDI-DrugBank.d529.s2|112-121|parameters|drug
DDI-DrugBank.d529.s2|123-124|in|drug
DDI-DrugBank.d529.s2|126-133|patients|drug
DDI-DrugBank.d529.s2|135-143|receiving|drug
DDI-DrugBank.d529.s2|145-159|anti-coagulants|drug
DDI-DrugBank.d529.s2|160-160|,|drug
DDI-DrugBank.d529.s2|162-164|and|drug
DDI-DrugBank.d529.s2|166-172|serious|drug
DDI-DrugBank.d529.s2|174-181|clinical|drug
DDI-DrugBank.d529.s2|183-190|bleeding|drug
DDI-DrugBank.d529.s2|192-194|has|drug
DDI-DrugBank.d529.s2|196-199|been|drug
DDI-DrugBank.d529.s2|201-208|reported|drug
DDI-DrugBank.d529.s2|209-209|.|drug
DDI-DrugBank.d529.s3|0-2|The|drug
DDI-DrugBank.d529.s3|4-12|physician|drug
DDI-DrugBank.d529.s3|14-19|should|drug
DDI-DrugBank.d529.s3|21-22|be|drug
DDI-DrugBank.d529.s3|24-31|cautious|drug
DDI-DrugBank.d529.s3|33-36|when|drug
DDI-DrugBank.d529.s3|38-50|administering|drug
DDI-DrugBank.d529.s3|52-63|flurbiprofen|drug
DDI-DrugBank.d529.s3|65-66|to|drug
DDI-DrugBank.d529.s3|68-75|patients|drug
DDI-DrugBank.d529.s3|77-82|taking|drug
DDI-DrugBank.d529.s3|84-97|anticoagulants|drug
DDI-DrugBank.d529.s3|98-98|.|drug
DDI-DrugBank.d529.s4|0-6|Aspirin|drug
DDI-DrugBank.d529.s4|7-7|:|drug
DDI-DrugBank.d529.s4|9-18|Concurrent|drug
DDI-DrugBank.d529.s4|20-33|administration|drug
DDI-DrugBank.d529.s4|35-36|of|drug
DDI-DrugBank.d529.s4|38-44|aspirin|drug
DDI-DrugBank.d529.s4|46-48|and|drug
DDI-DrugBank.d529.s4|50-61|flurbiprofen|drug
DDI-DrugBank.d529.s4|63-70|resulted|drug
DDI-DrugBank.d529.s4|72-73|in|drug
DDI-DrugBank.d529.s4|75-76|50|drug
DDI-DrugBank.d529.s4|77-77|%|drug
DDI-DrugBank.d529.s4|79-83|lower|drug
DDI-DrugBank.d529.s4|85-89|serum|drug
DDI-DrugBank.d529.s4|91-102|flurbiprofen|drug
DDI-DrugBank.d529.s4|104-117|concentrations|drug
DDI-DrugBank.d529.s4|118-118|.|drug
DDI-DrugBank.d529.s5|0-3|This|drug
DDI-DrugBank.d529.s5|5-10|effect|drug
DDI-DrugBank.d529.s5|12-13|of|drug
DDI-DrugBank.d529.s5|15-21|aspirin|drug
DDI-DrugBank.d529.s5|23-23|(|drug
DDI-DrugBank.d529.s5|24-28|which|drug
DDI-DrugBank.d529.s5|30-33|also|drug
DDI-DrugBank.d529.s5|35-40|lowers|drug
DDI-DrugBank.d529.s5|42-46|serum|drug
DDI-DrugBank.d529.s5|48-61|concentrations|drug
DDI-DrugBank.d529.s5|63-64|of|drug
DDI-DrugBank.d529.s5|66-70|other|drug
DDI-DrugBank.d529.s5|72-83|nonsteroidal|drug
DDI-DrugBank.d529.s5|85-101|anti-inflammatory|drug
DDI-DrugBank.d529.s5|103-107|drugs|drug
DDI-DrugBank.d529.s5|109-113|given|drug
DDI-DrugBank.d529.s5|115-118|with|drug
DDI-DrugBank.d529.s5|120-121|it|drug
DDI-DrugBank.d529.s5|122-122|)|drug
DDI-DrugBank.d529.s5|124-126|has|drug
DDI-DrugBank.d529.s5|128-131|been|drug
DDI-DrugBank.d529.s5|133-144|demonstrated|drug
DDI-DrugBank.d529.s5|146-147|in|drug
DDI-DrugBank.d529.s5|149-156|patients|drug
DDI-DrugBank.d529.s5|158-161|with|drug
DDI-DrugBank.d529.s5|163-172|rheumatoid|drug
DDI-DrugBank.d529.s5|174-182|arthritis|drug
DDI-DrugBank.d529.s5|184-184|(|drug
DDI-DrugBank.d529.s5|185-186|n=|drug
DDI-DrugBank.d529.s5|188-189|15|drug
DDI-DrugBank.d529.s5|190-190|)|drug
DDI-DrugBank.d529.s5|192-193|as|drug
DDI-DrugBank.d529.s5|195-198|well|drug
DDI-DrugBank.d529.s5|200-201|as|drug
DDI-DrugBank.d529.s5|203-208|normal|drug
DDI-DrugBank.d529.s5|210-219|volunteers|drug
DDI-DrugBank.d529.s5|221-221|(|drug
DDI-DrugBank.d529.s5|222-223|n=|drug
DDI-DrugBank.d529.s5|225-226|16|drug
DDI-DrugBank.d529.s5|227-227|)|drug
DDI-DrugBank.d529.s5|228-228|.|drug
DDI-DrugBank.d529.s6|0-9|Concurrent|drug
DDI-DrugBank.d529.s6|11-13|use|drug
DDI-DrugBank.d529.s6|15-16|of|drug
DDI-DrugBank.d529.s6|18-29|flurbiprofen|drug
DDI-DrugBank.d529.s6|31-33|and|drug
DDI-DrugBank.d529.s6|35-41|aspirin|drug
DDI-DrugBank.d529.s6|43-44|is|drug
DDI-DrugBank.d529.s6|46-54|therefore|drug
DDI-DrugBank.d529.s6|56-58|not|drug
DDI-DrugBank.d529.s6|60-70|recommended|drug
DDI-DrugBank.d529.s6|71-71|.|drug
DDI-DrugBank.d529.s7|0-14|Beta-adrenergic|drug
DDI-DrugBank.d529.s7|16-23|Blocking|drug
DDI-DrugBank.d529.s7|25-30|Agents|drug
DDI-DrugBank.d529.s7|31-31|:|drug
DDI-DrugBank.d529.s7|33-35|The|drug
DDI-DrugBank.d529.s7|37-42|effect|drug
DDI-DrugBank.d529.s7|44-45|of|drug
DDI-DrugBank.d529.s7|47-58|flurbiprofen|drug
DDI-DrugBank.d529.s7|60-61|on|drug
DDI-DrugBank.d529.s7|63-67|blood|drug
DDI-DrugBank.d529.s7|69-76|pressure|drug
DDI-DrugBank.d529.s7|78-85|response|drug
DDI-DrugBank.d529.s7|87-88|to|drug
DDI-DrugBank.d529.s7|90-100|propranolol|drug
DDI-DrugBank.d529.s7|102-104|and|drug
DDI-DrugBank.d529.s7|106-113|atenolol|drug
DDI-DrugBank.d529.s7|115-117|was|drug
DDI-DrugBank.d529.s7|119-127|evaluated|drug
DDI-DrugBank.d529.s7|129-130|in|drug
DDI-DrugBank.d529.s7|132-134|men|drug
DDI-DrugBank.d529.s7|136-139|with|drug
DDI-DrugBank.d529.s7|141-144|mild|drug
DDI-DrugBank.d529.s7|146-158|uncomplicated|drug
DDI-DrugBank.d529.s7|160-171|hypertension|drug
DDI-DrugBank.d529.s7|173-173|(|drug
DDI-DrugBank.d529.s7|174-174|n|drug
DDI-DrugBank.d529.s7|176-176|=|drug
DDI-DrugBank.d529.s7|178-179|10|drug
DDI-DrugBank.d529.s7|180-180|)|drug
DDI-DrugBank.d529.s7|181-181|.|drug
DDI-DrugBank.d529.s8|0-11|Flurbiprofen|drug
DDI-DrugBank.d529.s8|13-24|pretreatment|drug
DDI-DrugBank.d529.s8|26-35|attenuated|drug
DDI-DrugBank.d529.s8|37-39|the|drug
DDI-DrugBank.d529.s8|41-51|hypotensive|drug
DDI-DrugBank.d529.s8|53-58|effect|drug
DDI-DrugBank.d529.s8|60-61|of|drug
DDI-DrugBank.d529.s8|63-63|a|drug
DDI-DrugBank.d529.s8|65-70|single|drug
DDI-DrugBank.d529.s8|72-75|dose|drug
DDI-DrugBank.d529.s8|77-78|of|drug
DDI-DrugBank.d529.s8|80-90|propranolol|drug
DDI-DrugBank.d529.s8|92-94|but|drug
DDI-DrugBank.d529.s8|96-98|not|drug
DDI-DrugBank.d529.s8|100-107|atenolol|drug
DDI-DrugBank.d529.s8|108-108|.|drug
DDI-DrugBank.d529.s9|0-11|Flurbiprofen|drug
DDI-DrugBank.d529.s9|13-15|did|drug
DDI-DrugBank.d529.s9|17-19|not|drug
DDI-DrugBank.d529.s9|21-26|appear|drug
DDI-DrugBank.d529.s9|28-29|to|drug
DDI-DrugBank.d529.s9|31-36|affect|drug
DDI-DrugBank.d529.s9|38-40|the|drug
DDI-DrugBank.d529.s9|42-62|beta-blocker-mediated|drug
DDI-DrugBank.d529.s9|64-72|reduction|drug
DDI-DrugBank.d529.s9|74-75|in|drug
DDI-DrugBank.d529.s9|77-81|heart|drug
DDI-DrugBank.d529.s9|83-86|rate|drug
DDI-DrugBank.d529.s9|87-87|.|drug
DDI-DrugBank.d529.s10|0-11|Flurbiprofen|drug
DDI-DrugBank.d529.s10|13-15|did|drug
DDI-DrugBank.d529.s10|17-19|not|drug
DDI-DrugBank.d529.s10|21-26|affect|drug
DDI-DrugBank.d529.s10|28-30|the|drug
DDI-DrugBank.d529.s10|32-46|pharmacokinetic|drug
DDI-DrugBank.d529.s10|48-54|profile|drug
DDI-DrugBank.d529.s10|56-57|of|drug
DDI-DrugBank.d529.s10|59-64|either|drug
DDI-DrugBank.d529.s10|66-69|drug|drug
DDI-DrugBank.d529.s10|70-70|,|drug
DDI-DrugBank.d529.s10|72-74|and|drug
DDI-DrugBank.d529.s10|76-78|the|drug
DDI-DrugBank.d529.s10|80-88|mechanism|drug
DDI-DrugBank.d529.s10|90-94|under|drug
DDI-DrugBank.d529.s10|96-100|lying|drug
DDI-DrugBank.d529.s10|102-104|the|drug
DDI-DrugBank.d529.s10|106-117|interference|drug
DDI-DrugBank.d529.s10|119-122|with|drug
DDI-DrugBank.d529.s10|124-135|propranolols|drug
DDI-DrugBank.d529.s10|137-147|hypotensive|drug
DDI-DrugBank.d529.s10|149-154|effect|drug
DDI-DrugBank.d529.s10|156-157|is|drug
DDI-DrugBank.d529.s10|159-165|unknown|drug
DDI-DrugBank.d529.s10|166-166|.|drug
DDI-DrugBank.d529.s11|0-7|Patients|drug
DDI-DrugBank.d529.s11|9-14|taking|drug
DDI-DrugBank.d529.s11|16-19|both|drug
DDI-DrugBank.d529.s11|21-32|flurbiprofen|drug
DDI-DrugBank.d529.s11|34-36|and|drug
DDI-DrugBank.d529.s11|38-38|a|drug
DDI-DrugBank.d529.s11|40-51|beta-blocker|drug
DDI-DrugBank.d529.s11|53-58|should|drug
DDI-DrugBank.d529.s11|60-61|be|drug
DDI-DrugBank.d529.s11|63-71|monitored|drug
DDI-DrugBank.d529.s11|73-74|to|drug
DDI-DrugBank.d529.s11|76-81|ensure|drug
DDI-DrugBank.d529.s11|83-86|that|drug
DDI-DrugBank.d529.s11|88-88|a|drug
DDI-DrugBank.d529.s11|90-101|satisfactory|drug
DDI-DrugBank.d529.s11|103-113|hypotensive|drug
DDI-DrugBank.d529.s11|115-120|effect|drug
DDI-DrugBank.d529.s11|122-123|is|drug
DDI-DrugBank.d529.s11|125-132|achieved|drug
DDI-DrugBank.d529.s11|133-133|.|drug
DDI-DrugBank.d529.s12|0-9|Cimetidine|drug
DDI-DrugBank.d529.s12|10-10|,|drug
DDI-DrugBank.d529.s12|12-21|Ranitidine|drug
DDI-DrugBank.d529.s12|22-22|:|drug
DDI-DrugBank.d529.s12|24-25|In|drug
DDI-DrugBank.d529.s12|27-32|normal|drug
DDI-DrugBank.d529.s12|34-43|volunteers|drug
DDI-DrugBank.d529.s12|45-45|(|drug
DDI-DrugBank.d529.s12|46-48|n=9|drug
DDI-DrugBank.d529.s12|49-49|)|drug
DDI-DrugBank.d529.s12|50-50|,|drug
DDI-DrugBank.d529.s12|52-63|pretreatment|drug
DDI-DrugBank.d529.s12|65-68|with|drug
DDI-DrugBank.d529.s12|70-79|cimetidine|drug
DDI-DrugBank.d529.s12|81-82|or|drug
DDI-DrugBank.d529.s12|84-93|ranitidine|drug
DDI-DrugBank.d529.s12|95-97|did|drug
DDI-DrugBank.d529.s12|99-101|not|drug
DDI-DrugBank.d529.s12|103-108|affect|drug
DDI-DrugBank.d529.s12|110-121|flurbiprofen|drug
DDI-DrugBank.d529.s12|123-138|pharmacokinetics|drug
DDI-DrugBank.d529.s12|140-145|except|drug
DDI-DrugBank.d529.s12|147-150|that|drug
DDI-DrugBank.d529.s12|152-152|a|drug
DDI-DrugBank.d529.s12|154-158|small|drug
DDI-DrugBank.d529.s12|160-160|(|drug
DDI-DrugBank.d529.s12|161-162|13|drug
DDI-DrugBank.d529.s12|164-164|%|drug
DDI-DrugBank.d529.s12|165-165|)|drug
DDI-DrugBank.d529.s12|167-169|but|drug
DDI-DrugBank.d529.s12|171-183|statistically|drug
DDI-DrugBank.d529.s12|185-195|significant|drug
DDI-DrugBank.d529.s12|197-204|increase|drug
DDI-DrugBank.d529.s12|206-207|in|drug
DDI-DrugBank.d529.s12|209-211|the|drug
DDI-DrugBank.d529.s12|213-216|area|drug
DDI-DrugBank.d529.s12|218-222|under|drug
DDI-DrugBank.d529.s12|224-226|the|drug
DDI-DrugBank.d529.s12|228-232|serum|drug
DDI-DrugBank.d529.s12|234-246|concentration|drug
DDI-DrugBank.d529.s12|248-252|curve|drug
DDI-DrugBank.d529.s12|254-255|of|drug
DDI-DrugBank.d529.s12|257-268|flurbiprofen|drug
DDI-DrugBank.d529.s12|270-277|resulted|drug
DDI-DrugBank.d529.s12|279-282|with|drug
DDI-DrugBank.d529.s12|284-293|cimetidine|drug
DDI-DrugBank.d529.s12|294-294|.|drug
DDI-DrugBank.d529.s13|0-6|Digoxin|drug
DDI-DrugBank.d529.s13|7-7|:|drug
DDI-DrugBank.d529.s13|9-15|Studies|drug
DDI-DrugBank.d529.s13|17-18|of|drug
DDI-DrugBank.d529.s13|20-30|concomitant|drug
DDI-DrugBank.d529.s13|32-45|administration|drug
DDI-DrugBank.d529.s13|47-48|of|drug
DDI-DrugBank.d529.s13|50-61|flurbiprofen|drug
DDI-DrugBank.d529.s13|63-65|and|drug
DDI-DrugBank.d529.s13|67-73|digoxin|drug
DDI-DrugBank.d529.s13|75-76|to|drug
DDI-DrugBank.d529.s13|78-84|healthy|drug
DDI-DrugBank.d529.s13|86-88|men|drug
DDI-DrugBank.d529.s13|90-90|(|drug
DDI-DrugBank.d529.s13|91-92|n=|drug
DDI-DrugBank.d529.s13|94-95|14|drug
DDI-DrugBank.d529.s13|96-96|)|drug
DDI-DrugBank.d529.s13|98-100|did|drug
DDI-DrugBank.d529.s13|102-104|not|drug
DDI-DrugBank.d529.s13|106-109|show|drug
DDI-DrugBank.d529.s13|111-111|a|drug
DDI-DrugBank.d529.s13|113-118|change|drug
DDI-DrugBank.d529.s13|120-121|in|drug
DDI-DrugBank.d529.s13|123-125|the|drug
DDI-DrugBank.d529.s13|127-132|steady|drug
DDI-DrugBank.d529.s13|134-138|state|drug
DDI-DrugBank.d529.s13|140-144|serum|drug
DDI-DrugBank.d529.s13|146-151|levels|drug
DDI-DrugBank.d529.s13|153-154|of|drug
DDI-DrugBank.d529.s13|156-161|either|drug
DDI-DrugBank.d529.s13|163-166|drug|drug
DDI-DrugBank.d529.s13|167-167|.|drug
DDI-DrugBank.d529.s14|0-8|Diuretics|drug
DDI-DrugBank.d529.s14|9-9|:|drug
DDI-DrugBank.d529.s14|11-17|Studies|drug
DDI-DrugBank.d529.s14|19-20|in|drug
DDI-DrugBank.d529.s14|22-27|normal|drug
DDI-DrugBank.d529.s14|29-38|volunteers|drug
DDI-DrugBank.d529.s14|40-43|have|drug
DDI-DrugBank.d529.s14|45-49|shown|drug
DDI-DrugBank.d529.s14|51-54|that|drug
DDI-DrugBank.d529.s14|56-67|flurbiprofen|drug
DDI-DrugBank.d529.s14|69-72|like|drug
DDI-DrugBank.d529.s14|74-78|other|drug
DDI-DrugBank.d529.s14|80-91|nonsteroidal|drug
DDI-DrugBank.d529.s14|93-109|anti-inflammatory|drug
DDI-DrugBank.d529.s14|111-115|drugs|drug
DDI-DrugBank.d529.s14|116-116|,|drug
DDI-DrugBank.d529.s14|118-120|can|drug
DDI-DrugBank.d529.s14|122-130|interfere|drug
DDI-DrugBank.d529.s14|132-135|with|drug
DDI-DrugBank.d529.s14|137-139|the|drug
DDI-DrugBank.d529.s14|141-147|effects|drug
DDI-DrugBank.d529.s14|149-150|of|drug
DDI-DrugBank.d529.s14|152-161|furosemide|drug
DDI-DrugBank.d529.s14|162-162|.|drug
DDI-DrugBank.d529.s15|0-7|Although|drug
DDI-DrugBank.d529.s15|9-15|results|drug
DDI-DrugBank.d529.s15|17-20|have|drug
DDI-DrugBank.d529.s15|22-27|varied|drug
DDI-DrugBank.d529.s15|29-32|from|drug
DDI-DrugBank.d529.s15|34-38|study|drug
DDI-DrugBank.d529.s15|40-41|to|drug
DDI-DrugBank.d529.s15|43-47|study|drug
DDI-DrugBank.d529.s15|48-48|,|drug
DDI-DrugBank.d529.s15|50-56|effects|drug
DDI-DrugBank.d529.s15|58-61|have|drug
DDI-DrugBank.d529.s15|63-66|been|drug
DDI-DrugBank.d529.s15|68-72|shown|drug
DDI-DrugBank.d529.s15|74-75|on|drug
DDI-DrugBank.d529.s15|77-97|furosemide-stimulated|drug
DDI-DrugBank.d529.s15|99-106|diuresis|drug
DDI-DrugBank.d529.s15|107-107|,|drug
DDI-DrugBank.d529.s15|109-119|natriuresis|drug
DDI-DrugBank.d529.s15|120-120|,|drug
DDI-DrugBank.d529.s15|122-124|and|drug
DDI-DrugBank.d529.s15|126-135|kaliuresis|drug
DDI-DrugBank.d529.s15|136-136|.|drug
DDI-DrugBank.d529.s16|0-4|Other|drug
DDI-DrugBank.d529.s16|6-17|nonsteroidal|drug
DDI-DrugBank.d529.s16|19-35|anti-inflammatory|drug
DDI-DrugBank.d529.s16|37-41|drugs|drug
DDI-DrugBank.d529.s16|43-46|that|drug
DDI-DrugBank.d529.s16|48-54|inhibit|drug
DDI-DrugBank.d529.s16|56-68|prostaglandin|drug
DDI-DrugBank.d529.s16|70-78|synthesis|drug
DDI-DrugBank.d529.s16|80-83|have|drug
DDI-DrugBank.d529.s16|85-88|been|drug
DDI-DrugBank.d529.s16|90-94|shown|drug
DDI-DrugBank.d529.s16|96-97|to|drug
DDI-DrugBank.d529.s16|99-107|interfere|drug
DDI-DrugBank.d529.s16|109-112|with|drug
DDI-DrugBank.d529.s16|114-121|thiazide|drug
DDI-DrugBank.d529.s16|123-131|diuretics|drug
DDI-DrugBank.d529.s16|133-134|in|drug
DDI-DrugBank.d529.s16|136-139|some|drug
DDI-DrugBank.d529.s16|141-147|studies|drug
DDI-DrugBank.d529.s16|149-151|and|drug
DDI-DrugBank.d529.s16|153-156|with|drug
DDI-DrugBank.d529.s16|158-174|potassium-sparing|drug
DDI-DrugBank.d529.s16|176-184|diuretics|drug
DDI-DrugBank.d529.s16|185-185|.|drug
DDI-DrugBank.d529.s17|0-7|Patients|drug
DDI-DrugBank.d529.s17|9-17|receiving|drug
DDI-DrugBank.d529.s17|19-30|flurbiprofen|drug
DDI-DrugBank.d529.s17|32-34|and|drug
DDI-DrugBank.d529.s17|36-45|furosemide|drug
DDI-DrugBank.d529.s17|47-48|or|drug
DDI-DrugBank.d529.s17|50-54|other|drug
DDI-DrugBank.d529.s17|56-64|diuretics|drug
DDI-DrugBank.d529.s17|66-71|should|drug
DDI-DrugBank.d529.s17|73-74|be|drug
DDI-DrugBank.d529.s17|76-83|observed|drug
DDI-DrugBank.d529.s17|85-91|closely|drug
DDI-DrugBank.d529.s17|93-94|to|drug
DDI-DrugBank.d529.s17|96-104|determine|drug
DDI-DrugBank.d529.s17|106-107|if|drug
DDI-DrugBank.d529.s17|109-111|the|drug
DDI-DrugBank.d529.s17|113-119|desired|drug
DDI-DrugBank.d529.s17|121-126|effect|drug
DDI-DrugBank.d529.s17|128-129|is|drug
DDI-DrugBank.d529.s17|131-138|obtained|drug
DDI-DrugBank.d529.s17|139-139|.|drug
DDI-DrugBank.d529.s18|0-3|Oral|drug
DDI-DrugBank.d529.s18|5-16|Hypoglycemic|drug
DDI-DrugBank.d529.s18|18-23|Agents|drug
DDI-DrugBank.d529.s18|24-24|:|drug
DDI-DrugBank.d529.s18|26-27|In|drug
DDI-DrugBank.d529.s18|29-31|one|drug
DDI-DrugBank.d529.s18|33-37|study|drug
DDI-DrugBank.d529.s18|38-38|,|drug
DDI-DrugBank.d529.s18|40-51|flurbiprofen|drug
DDI-DrugBank.d529.s18|53-55|was|drug
DDI-DrugBank.d529.s18|57-61|given|drug
DDI-DrugBank.d529.s18|63-64|to|drug
DDI-DrugBank.d529.s18|66-70|adult|drug
DDI-DrugBank.d529.s18|72-80|diabetics|drug
DDI-DrugBank.d529.s18|82-84|who|drug
DDI-DrugBank.d529.s18|86-89|were|drug
DDI-DrugBank.d529.s18|91-97|already|drug
DDI-DrugBank.d529.s18|99-107|receiving|drug
DDI-DrugBank.d529.s18|109-117|glyburide|drug
DDI-DrugBank.d529.s18|119-119|(|drug
DDI-DrugBank.d529.s18|120-122|n=4|drug
DDI-DrugBank.d529.s18|123-123|)|drug
DDI-DrugBank.d529.s18|124-124|,|drug
DDI-DrugBank.d529.s18|126-134|metformin|drug
DDI-DrugBank.d529.s18|136-136|(|drug
DDI-DrugBank.d529.s18|137-139|n=2|drug
DDI-DrugBank.d529.s18|140-140|)|drug
DDI-DrugBank.d529.s18|142-155|chlorpropamide|drug
DDI-DrugBank.d529.s18|157-160|with|drug
DDI-DrugBank.d529.s18|162-171|phenformin|drug
DDI-DrugBank.d529.s18|173-173|(|drug
DDI-DrugBank.d529.s18|174-175|n=|drug
DDI-DrugBank.d529.s18|177-177|3|drug
DDI-DrugBank.d529.s18|178-178|)|drug
DDI-DrugBank.d529.s18|180-181|or|drug
DDI-DrugBank.d529.s18|183-191|glyburide|drug
DDI-DrugBank.d529.s18|193-196|with|drug
DDI-DrugBank.d529.s18|198-207|phenformin|drug
DDI-DrugBank.d529.s18|209-209|(|drug
DDI-DrugBank.d529.s18|210-212|n=6|drug
DDI-DrugBank.d529.s18|213-213|)|drug
DDI-DrugBank.d529.s18|214-214|.|drug
DDI-DrugBank.d529.s19|0-7|Although|drug
DDI-DrugBank.d529.s19|9-13|there|drug
DDI-DrugBank.d529.s19|15-17|was|drug
DDI-DrugBank.d529.s19|19-19|a|drug
DDI-DrugBank.d529.s19|21-26|slight|drug
DDI-DrugBank.d529.s19|28-36|reduction|drug
DDI-DrugBank.d529.s19|38-39|in|drug
DDI-DrugBank.d529.s19|41-45|blood|drug
DDI-DrugBank.d529.s19|47-51|sugar|drug
DDI-DrugBank.d529.s19|53-66|concentrations|drug
DDI-DrugBank.d529.s19|68-73|during|drug
DDI-DrugBank.d529.s19|75-85|concomitant|drug
DDI-DrugBank.d529.s19|87-100|administration|drug
DDI-DrugBank.d529.s19|102-103|of|drug
DDI-DrugBank.d529.s19|105-116|flurbiprofen|drug
DDI-DrugBank.d529.s19|118-120|and|drug
DDI-DrugBank.d529.s19|122-133|hypoglycemic|drug
DDI-DrugBank.d529.s19|135-140|agents|drug
DDI-DrugBank.d529.s19|141-141|,|drug
DDI-DrugBank.d529.s19|143-147|there|drug
DDI-DrugBank.d529.s19|149-152|were|drug
DDI-DrugBank.d529.s19|154-155|no|drug
DDI-DrugBank.d529.s19|157-161|signs|drug
DDI-DrugBank.d529.s19|163-164|or|drug
DDI-DrugBank.d529.s19|166-173|symptoms|drug
DDI-DrugBank.d529.s19|175-176|of|drug
DDI-DrugBank.d529.s19|178-189|hypoglycemia|drug
DDI-DrugBank.d529.s19|190-190|.|drug
DDI-DrugBank.d511.s0|0-0|A|drug
DDI-DrugBank.d511.s0|2-9|possible|drug
DDI-DrugBank.d511.s0|11-14|drug|drug
DDI-DrugBank.d511.s0|16-26|interaction|drug
DDI-DrugBank.d511.s0|28-29|of|drug
DDI-DrugBank.d511.s0|31-38|FOSCAVIR|drug
DDI-DrugBank.d511.s0|40-42|and|drug
DDI-DrugBank.d511.s0|44-54|intravenous|drug
DDI-DrugBank.d511.s0|56-66|pentamidine|drug
DDI-DrugBank.d511.s0|68-70|has|drug
DDI-DrugBank.d511.s0|72-75|been|drug
DDI-DrugBank.d511.s0|77-85|described|drug
DDI-DrugBank.d511.s0|86-86|.|drug
DDI-DrugBank.d511.s1|0-10|Concomitant|drug
DDI-DrugBank.d511.s1|12-20|treatment|drug
DDI-DrugBank.d511.s1|22-23|of|drug
DDI-DrugBank.d511.s1|25-28|four|drug
DDI-DrugBank.d511.s1|30-37|patients|drug
DDI-DrugBank.d511.s1|39-40|in|drug
DDI-DrugBank.d511.s1|42-44|the|drug
DDI-DrugBank.d511.s1|46-51|United|drug
DDI-DrugBank.d511.s1|53-59|Kingdom|drug
DDI-DrugBank.d511.s1|61-64|with|drug
DDI-DrugBank.d511.s1|66-73|FOSCAVIR|drug
DDI-DrugBank.d511.s1|75-77|and|drug
DDI-DrugBank.d511.s1|79-89|intravenous|drug
DDI-DrugBank.d511.s1|91-101|pentamidine|drug
DDI-DrugBank.d511.s1|103-105|may|drug
DDI-DrugBank.d511.s1|107-110|have|drug
DDI-DrugBank.d511.s1|112-117|caused|drug
DDI-DrugBank.d511.s1|119-130|hypocalcemia|drug
DDI-DrugBank.d511.s1|131-131|;|drug
DDI-DrugBank.d511.s2|0-2|one|drug
DDI-DrugBank.d511.s2|4-10|patient|drug
DDI-DrugBank.d511.s2|12-15|died|drug
DDI-DrugBank.d511.s2|17-20|with|drug
DDI-DrugBank.d511.s2|22-27|severe|drug
DDI-DrugBank.d511.s2|29-40|hypocalcemia|drug
DDI-DrugBank.d511.s2|41-41|.|drug
DDI-DrugBank.d511.s3|0-7|Toxicity|drug
DDI-DrugBank.d511.s3|9-18|associated|drug
DDI-DrugBank.d511.s3|20-23|with|drug
DDI-DrugBank.d511.s3|25-35|concomitant|drug
DDI-DrugBank.d511.s3|37-39|use|drug
DDI-DrugBank.d511.s3|41-42|of|drug
DDI-DrugBank.d511.s3|44-54|aerosolized|drug
DDI-DrugBank.d511.s3|56-66|pentamidine|drug
DDI-DrugBank.d511.s3|68-70|has|drug
DDI-DrugBank.d511.s3|72-74|not|drug
DDI-DrugBank.d511.s3|76-79|been|drug
DDI-DrugBank.d511.s3|81-88|reported|drug
DDI-DrugBank.d511.s3|89-89|.|drug
DDI-DrugBank.d511.s4|0-6|Because|drug
DDI-DrugBank.d511.s4|8-9|of|drug
DDI-DrugBank.d511.s4|11-20|foscarnets|drug
DDI-DrugBank.d511.s4|22-29|tendency|drug
DDI-DrugBank.d511.s4|31-32|to|drug
DDI-DrugBank.d511.s4|34-38|cause|drug
DDI-DrugBank.d511.s4|40-44|renal|drug
DDI-DrugBank.d511.s4|46-55|impairment|drug
DDI-DrugBank.d511.s4|56-56|,|drug
DDI-DrugBank.d511.s4|58-60|the|drug
DDI-DrugBank.d511.s4|62-64|use|drug
DDI-DrugBank.d511.s4|66-67|of|drug
DDI-DrugBank.d511.s4|69-76|FOSCAVIR|drug
DDI-DrugBank.d511.s4|78-83|should|drug
DDI-DrugBank.d511.s4|85-86|be|drug
DDI-DrugBank.d511.s4|88-94|avoided|drug
DDI-DrugBank.d511.s4|96-97|in|drug
DDI-DrugBank.d511.s4|99-109|combination|drug
DDI-DrugBank.d511.s4|111-114|with|drug
DDI-DrugBank.d511.s4|116-126|potentially|drug
DDI-DrugBank.d511.s4|128-138|nephrotoxic|drug
DDI-DrugBank.d511.s4|140-144|drugs|drug
DDI-DrugBank.d511.s4|146-149|such|drug
DDI-DrugBank.d511.s4|151-152|as|drug
DDI-DrugBank.d511.s4|154-168|aminoglycosides|drug
DDI-DrugBank.d511.s4|169-169|,|drug
DDI-DrugBank.d511.s4|171-182|amphotericin|drug
DDI-DrugBank.d511.s4|184-184|B|drug
DDI-DrugBank.d511.s4|186-188|and|drug
DDI-DrugBank.d511.s4|190-200|intravenous|drug
DDI-DrugBank.d511.s4|202-212|pentamidine|drug
DDI-DrugBank.d511.s4|214-219|unless|drug
DDI-DrugBank.d511.s4|221-223|the|drug
DDI-DrugBank.d511.s4|225-233|potential|drug
DDI-DrugBank.d511.s4|235-242|benefits|drug
DDI-DrugBank.d511.s4|244-251|outweigh|drug
DDI-DrugBank.d511.s4|253-255|the|drug
DDI-DrugBank.d511.s4|257-261|risks|drug
DDI-DrugBank.d511.s4|263-264|to|drug
DDI-DrugBank.d511.s4|266-268|the|drug
DDI-DrugBank.d511.s4|270-276|patient|drug
DDI-DrugBank.d511.s4|277-277|.|drug
DDI-DrugBank.d511.s5|0-4|Since|drug
DDI-DrugBank.d511.s5|6-13|FOSCAVIR|drug
DDI-DrugBank.d511.s5|15-23|decreases|drug
DDI-DrugBank.d511.s5|25-29|serum|drug
DDI-DrugBank.d511.s5|31-44|concentrations|drug
DDI-DrugBank.d511.s5|46-47|of|drug
DDI-DrugBank.d511.s5|49-55|ionized|drug
DDI-DrugBank.d511.s5|57-63|calcium|drug
DDI-DrugBank.d511.s5|64-64|,|drug
DDI-DrugBank.d511.s5|66-75|concurrent|drug
DDI-DrugBank.d511.s5|77-85|treatment|drug
DDI-DrugBank.d511.s5|87-90|with|drug
DDI-DrugBank.d511.s5|92-96|other|drug
DDI-DrugBank.d511.s5|98-102|drugs|drug
DDI-DrugBank.d511.s5|104-108|known|drug
DDI-DrugBank.d511.s5|110-111|to|drug
DDI-DrugBank.d511.s5|113-121|influence|drug
DDI-DrugBank.d511.s5|123-127|serum|drug
DDI-DrugBank.d511.s5|129-135|calcium|drug
DDI-DrugBank.d511.s5|137-150|concentrations|drug
DDI-DrugBank.d511.s5|152-157|should|drug
DDI-DrugBank.d511.s5|159-160|be|drug
DDI-DrugBank.d511.s5|162-165|used|drug
DDI-DrugBank.d511.s5|167-170|with|drug
DDI-DrugBank.d511.s5|172-181|particular|drug
DDI-DrugBank.d511.s5|183-189|caution|drug
DDI-DrugBank.d511.s5|190-190|.|drug
DDI-DrugBank.d511.s6|0-10|Ganciclovir|drug
DDI-DrugBank.d511.s6|11-11|:|drug
DDI-DrugBank.d511.s6|13-15|The|drug
DDI-DrugBank.d511.s6|17-32|pharmacokinetics|drug
DDI-DrugBank.d511.s6|34-35|of|drug
DDI-DrugBank.d511.s6|37-45|foscarnet|drug
DDI-DrugBank.d511.s6|47-49|and|drug
DDI-DrugBank.d511.s6|51-61|ganciclovir|drug
DDI-DrugBank.d511.s6|63-66|were|drug
DDI-DrugBank.d511.s6|68-70|not|drug
DDI-DrugBank.d511.s6|72-78|altered|drug
DDI-DrugBank.d511.s6|80-81|in|drug
DDI-DrugBank.d511.s6|83-84|13|drug
DDI-DrugBank.d511.s6|86-93|patients|drug
DDI-DrugBank.d511.s6|95-103|receiving|drug
DDI-DrugBank.d511.s6|105-110|either|drug
DDI-DrugBank.d511.s6|112-122|concomitant|drug
DDI-DrugBank.d511.s6|124-130|therapy|drug
DDI-DrugBank.d511.s6|132-133|or|drug
DDI-DrugBank.d511.s6|135-139|daily|drug
DDI-DrugBank.d511.s6|141-151|alternating|drug
DDI-DrugBank.d511.s6|153-159|therapy|drug
DDI-DrugBank.d511.s6|161-163|for|drug
DDI-DrugBank.d511.s6|165-175|maintenance|drug
DDI-DrugBank.d511.s6|177-178|of|drug
DDI-DrugBank.d511.s6|180-182|CMV|drug
DDI-DrugBank.d511.s6|184-190|disease|drug
DDI-DrugBank.d511.s6|191-191|.|drug
DDI-DrugBank.d573.s0|0-10|Interaction|drug
DDI-DrugBank.d573.s0|12-15|with|drug
DDI-DrugBank.d573.s0|17-28|Guanethidine|drug
DDI-DrugBank.d573.s0|29-29|:|drug
DDI-DrugBank.d573.s0|31-38|Although|drug
DDI-DrugBank.d573.s0|40-48|minoxidil|drug
DDI-DrugBank.d573.s0|50-53|does|drug
DDI-DrugBank.d573.s0|55-57|not|drug
DDI-DrugBank.d573.s0|59-64|itself|drug
DDI-DrugBank.d573.s0|66-70|cause|drug
DDI-DrugBank.d573.s0|72-82|orthostatic|drug
DDI-DrugBank.d573.s0|84-94|hypotension|drug
DDI-DrugBank.d573.s0|95-95|,|drug
DDI-DrugBank.d573.s0|97-99|its|drug
DDI-DrugBank.d573.s0|101-114|administration|drug
DDI-DrugBank.d573.s0|116-117|to|drug
DDI-DrugBank.d573.s0|119-126|patients|drug
DDI-DrugBank.d573.s0|128-134|already|drug
DDI-DrugBank.d573.s0|136-144|receiving|drug
DDI-DrugBank.d573.s0|146-157|guanethidine|drug
DDI-DrugBank.d573.s0|159-161|can|drug
DDI-DrugBank.d573.s0|163-168|result|drug
DDI-DrugBank.d573.s0|170-171|in|drug
DDI-DrugBank.d573.s0|173-180|profound|drug
DDI-DrugBank.d573.s0|182-192|orthostatic|drug
DDI-DrugBank.d573.s0|194-200|effects|drug
DDI-DrugBank.d573.s0|201-201|.|drug
DDI-DrugBank.d573.s1|0-1|If|drug
DDI-DrugBank.d573.s1|3-4|at|drug
DDI-DrugBank.d573.s1|6-8|all|drug
DDI-DrugBank.d573.s1|10-17|possible|drug
DDI-DrugBank.d573.s1|19-30|guanethidine|drug
DDI-DrugBank.d573.s1|32-37|should|drug
DDI-DrugBank.d573.s1|39-40|be|drug
DDI-DrugBank.d573.s1|42-53|discontinued|drug
DDI-DrugBank.d573.s1|55-58|well|drug
DDI-DrugBank.d573.s1|60-65|before|drug
DDI-DrugBank.d573.s1|67-75|minoxidil|drug
DDI-DrugBank.d573.s1|77-78|is|drug
DDI-DrugBank.d573.s1|80-84|begun|drug
DDI-DrugBank.d573.s1|85-85|.|drug
DDI-DrugBank.d573.s2|0-4|Where|drug
DDI-DrugBank.d573.s2|6-9|this|drug
DDI-DrugBank.d573.s2|11-12|is|drug
DDI-DrugBank.d573.s2|14-16|not|drug
DDI-DrugBank.d573.s2|18-25|possible|drug
DDI-DrugBank.d573.s2|26-26|,|drug
DDI-DrugBank.d573.s2|28-36|minoxidil|drug
DDI-DrugBank.d573.s2|38-44|therapy|drug
DDI-DrugBank.d573.s2|46-51|should|drug
DDI-DrugBank.d573.s2|53-54|be|drug
DDI-DrugBank.d573.s2|56-62|started|drug
DDI-DrugBank.d573.s2|64-65|in|drug
DDI-DrugBank.d573.s2|67-69|the|drug
DDI-DrugBank.d573.s2|71-78|hospital|drug
DDI-DrugBank.d573.s2|80-82|and|drug
DDI-DrugBank.d573.s2|84-86|the|drug
DDI-DrugBank.d573.s2|88-94|patient|drug
DDI-DrugBank.d573.s2|96-101|should|drug
DDI-DrugBank.d573.s2|103-108|remain|drug
DDI-DrugBank.d573.s2|110-126|institutionalized|drug
DDI-DrugBank.d573.s2|128-132|until|drug
DDI-DrugBank.d573.s2|134-139|severe|drug
DDI-DrugBank.d573.s2|141-151|orthostatic|drug
DDI-DrugBank.d573.s2|153-159|effects|drug
DDI-DrugBank.d573.s2|161-163|are|drug
DDI-DrugBank.d573.s2|165-166|no|drug
DDI-DrugBank.d573.s2|168-173|longer|drug
DDI-DrugBank.d573.s2|175-181|present|drug
DDI-DrugBank.d573.s2|183-184|or|drug
DDI-DrugBank.d573.s2|186-188|the|drug
DDI-DrugBank.d573.s2|190-196|patient|drug
DDI-DrugBank.d573.s2|198-200|has|drug
DDI-DrugBank.d573.s2|202-208|learned|drug
DDI-DrugBank.d573.s2|210-211|to|drug
DDI-DrugBank.d573.s2|213-217|avoid|drug
DDI-DrugBank.d573.s2|219-228|activities|drug
DDI-DrugBank.d573.s2|230-233|that|drug
DDI-DrugBank.d573.s2|235-241|provoke|drug
DDI-DrugBank.d573.s2|243-246|them|drug
DDI-DrugBank.d573.s2|247-247|.|drug
DDI-MedLine.d85.s0|0-11|Misonidazole|drug
DDI-MedLine.d85.s0|13-20|protects|drug
DDI-MedLine.d85.s0|22-26|mouse|drug
DDI-MedLine.d85.s0|28-33|tumour|drug
DDI-MedLine.d85.s0|35-37|and|drug
DDI-MedLine.d85.s0|39-44|normal|drug
DDI-MedLine.d85.s0|46-52|tissues|drug
DDI-MedLine.d85.s0|54-57|from|drug
DDI-MedLine.d85.s0|59-61|the|drug
DDI-MedLine.d85.s0|63-70|toxicity|drug
DDI-MedLine.d85.s0|72-73|of|drug
DDI-MedLine.d85.s0|75-78|oral|drug
DDI-MedLine.d85.s0|80-83|CCNU|drug
DDI-MedLine.d85.s0|84-84|.|drug
DDI-MedLine.d85.s1|0-6|Because|drug
DDI-MedLine.d85.s1|8-10|the|drug
DDI-MedLine.d85.s1|12-22|nitrosourea|drug
DDI-MedLine.d85.s1|24-27|CCNU|drug
DDI-MedLine.d85.s1|29-30|is|drug
DDI-MedLine.d85.s1|32-36|given|drug
DDI-MedLine.d85.s1|38-48|exclusively|drug
DDI-MedLine.d85.s1|50-51|by|drug
DDI-MedLine.d85.s1|53-55|the|drug
DDI-MedLine.d85.s1|57-60|oral|drug
DDI-MedLine.d85.s1|62-66|route|drug
DDI-MedLine.d85.s1|68-69|in|drug
DDI-MedLine.d85.s1|71-73|man|drug
DDI-MedLine.d85.s1|74-74|,|drug
DDI-MedLine.d85.s1|76-77|we|drug
DDI-MedLine.d85.s1|79-82|have|drug
DDI-MedLine.d85.s1|84-90|carried|drug
DDI-MedLine.d85.s1|92-94|out|drug
DDI-MedLine.d85.s1|96-102|studies|drug
DDI-MedLine.d85.s1|104-105|in|drug
DDI-MedLine.d85.s1|107-110|mice|drug
DDI-MedLine.d85.s1|112-113|on|drug
DDI-MedLine.d85.s1|115-117|the|drug
DDI-MedLine.d85.s1|119-128|antitumour|drug
DDI-MedLine.d85.s1|130-137|activity|drug
DDI-MedLine.d85.s1|138-138|,|drug
DDI-MedLine.d85.s1|140-144|acute|drug
DDI-MedLine.d85.s1|146-153|toxicity|drug
DDI-MedLine.d85.s1|155-157|and|drug
DDI-MedLine.d85.s1|159-174|pharmacokinetics|drug
DDI-MedLine.d85.s1|176-177|of|drug
DDI-MedLine.d85.s1|179-182|oral|drug
DDI-MedLine.d85.s1|184-187|CCNU|drug
DDI-MedLine.d85.s1|188-188|,|drug
DDI-MedLine.d85.s1|190-195|either|drug
DDI-MedLine.d85.s1|197-201|alone|drug
DDI-MedLine.d85.s1|203-204|or|drug
DDI-MedLine.d85.s1|206-207|in|drug
DDI-MedLine.d85.s1|209-219|combination|drug
DDI-MedLine.d85.s1|221-224|with|drug
DDI-MedLine.d85.s1|226-228|the|drug
DDI-MedLine.d85.s1|230-244|chemosensitizer|drug
DDI-MedLine.d85.s1|246-257|misonidazole|drug
DDI-MedLine.d85.s1|258-258|.|drug
DDI-MedLine.d85.s2|0-1|In|drug
DDI-MedLine.d85.s2|3-6|both|drug
DDI-MedLine.d85.s2|8-13|plasma|drug
DDI-MedLine.d85.s2|15-17|and|drug
DDI-MedLine.d85.s2|19-21|KHT|drug
DDI-MedLine.d85.s2|23-28|tumour|drug
DDI-MedLine.d85.s2|30-32|the|drug
DDI-MedLine.d85.s2|34-37|peak|drug
DDI-MedLine.d85.s2|39-51|concentration|drug
DDI-MedLine.d85.s2|53-55|and|drug
DDI-MedLine.d85.s2|57-57|``|drug
DDI-MedLine.d85.s2|58-62|early|drug
DDI-MedLine.d85.s2|63-63|''|drug
DDI-MedLine.d85.s3|0-2|AUC|drug
DDI-MedLine.d85.s3|4-6|for|drug
DDI-MedLine.d85.s3|8-12|total|drug
DDI-MedLine.d85.s3|14-25|nitrosoureas|drug
DDI-MedLine.d85.s3|27-30|were|drug
DDI-MedLine.d85.s3|32-36|about|drug
DDI-MedLine.d85.s3|38-44|1.4-1.5|drug
DDI-MedLine.d85.s3|46-49|fold|drug
DDI-MedLine.d85.s3|51-57|greater|drug
DDI-MedLine.d85.s3|59-61|for|drug
DDI-MedLine.d85.s3|63-65|the|drug
DDI-MedLine.d85.s3|67-70|oral|drug
DDI-MedLine.d85.s3|72-79|compared|drug
DDI-MedLine.d85.s3|81-82|to|drug
DDI-MedLine.d85.s3|84-86|the|drug
DDI-MedLine.d85.s3|88-90|i.p|drug
DDI-MedLine.d85.s3|91-91|.|drug
DDI-MedLine.d85.s4|0-4|route|drug
DDI-MedLine.d85.s4|5-5|.|drug
DDI-MedLine.d85.s5|0-4|These|drug
DDI-MedLine.d85.s5|6-16|differences|drug
DDI-MedLine.d85.s5|18-21|were|drug
DDI-MedLine.d85.s5|23-31|reflected|drug
DDI-MedLine.d85.s5|33-34|in|drug
DDI-MedLine.d85.s5|36-38|the|drug
DDI-MedLine.d85.s5|40-46|roughly|drug
DDI-MedLine.d85.s5|48-54|twofold|drug
DDI-MedLine.d85.s5|56-62|greater|drug
DDI-MedLine.d85.s5|64-73|antitumour|drug
DDI-MedLine.d85.s5|75-82|activity|drug
DDI-MedLine.d85.s5|84-86|for|drug
DDI-MedLine.d85.s5|88-90|the|drug
DDI-MedLine.d85.s5|92-95|oral|drug
DDI-MedLine.d85.s5|97-101|route|drug
DDI-MedLine.d85.s5|102-102|.|drug
DDI-MedLine.d85.s6|0-1|In|drug
DDI-MedLine.d85.s6|3-10|contrast|drug
DDI-MedLine.d85.s6|11-11|,|drug
DDI-MedLine.d85.s6|13-17|acute|drug
DDI-MedLine.d85.s6|19-26|toxicity|drug
DDI-MedLine.d85.s6|28-32|tests|drug
DDI-MedLine.d85.s6|34-39|showed|drug
DDI-MedLine.d85.s6|41-44|that|drug
DDI-MedLine.d85.s6|46-49|oral|drug
DDI-MedLine.d85.s6|51-54|CCNU|drug
DDI-MedLine.d85.s6|56-58|was|drug
DDI-MedLine.d85.s6|60-63|1.45|drug
DDI-MedLine.d85.s6|65-69|times|drug
DDI-MedLine.d85.s6|71-74|less|drug
DDI-MedLine.d85.s6|76-80|toxic|drug
DDI-MedLine.d85.s6|82-83|to|drug
DDI-MedLine.d85.s6|85-90|normal|drug
DDI-MedLine.d85.s6|92-97|tissue|drug
DDI-MedLine.d85.s6|98-98|,|drug
DDI-MedLine.d85.s6|100-107|although|drug
DDI-MedLine.d85.s6|109-111|the|drug
DDI-MedLine.d85.s6|113-125|dose-limiting|drug
DDI-MedLine.d85.s6|127-131|organ|drug
DDI-MedLine.d85.s6|133-135|may|drug
DDI-MedLine.d85.s6|137-138|be|drug
DDI-MedLine.d85.s6|140-148|different|drug
DDI-MedLine.d85.s6|150-152|for|drug
DDI-MedLine.d85.s6|154-156|the|drug
DDI-MedLine.d85.s6|158-160|two|drug
DDI-MedLine.d85.s6|162-167|routes|drug
DDI-MedLine.d85.s6|168-168|.|drug
DDI-MedLine.d85.s7|0-11|Misonidazole|drug
DDI-MedLine.d85.s7|13-19|reduced|drug
DDI-MedLine.d85.s7|21-23|the|drug
DDI-MedLine.d85.s7|25-34|antitumour|drug
DDI-MedLine.d85.s7|36-43|activity|drug
DDI-MedLine.d85.s7|45-46|of|drug
DDI-MedLine.d85.s7|48-51|oral|drug
DDI-MedLine.d85.s7|53-56|CCNU|drug
DDI-MedLine.d85.s7|58-59|by|drug
DDI-MedLine.d85.s7|61-64|dose|drug
DDI-MedLine.d85.s7|66-74|modifying|drug
DDI-MedLine.d85.s7|76-82|factors|drug
DDI-MedLine.d85.s7|84-84|(|drug
DDI-MedLine.d85.s7|85-87|DMF|drug
DDI-MedLine.d85.s7|88-88|)|drug
DDI-MedLine.d85.s7|90-91|of|drug
DDI-MedLine.d85.s7|93-101|0.58-0.71|drug
DDI-MedLine.d85.s7|102-102|.|drug
DDI-MedLine.d85.s8|0-8|Similarly|drug
DDI-MedLine.d85.s8|9-9|,|drug
DDI-MedLine.d85.s8|11-13|the|drug
DDI-MedLine.d85.s8|15-19|acute|drug
DDI-MedLine.d85.s8|21-28|toxicity|drug
DDI-MedLine.d85.s8|30-32|was|drug
DDI-MedLine.d85.s8|34-37|also|drug
DDI-MedLine.d85.s8|39-48|diminished|drug
DDI-MedLine.d85.s8|50-51|by|drug
DDI-MedLine.d85.s8|53-53|a|drug
DDI-MedLine.d85.s8|55-57|DMF|drug
DDI-MedLine.d85.s8|59-60|of|drug
DDI-MedLine.d85.s8|62-65|0.74|drug
DDI-MedLine.d85.s8|66-66|.|drug
DDI-MedLine.d85.s9|0-11|Misonidazole|drug
DDI-MedLine.d85.s9|13-15|has|drug
DDI-MedLine.d85.s9|17-17|a|drug
DDI-MedLine.d85.s9|19-25|complex|drug
DDI-MedLine.d85.s9|27-32|effect|drug
DDI-MedLine.d85.s9|34-35|on|drug
DDI-MedLine.d85.s9|37-40|oral|drug
DDI-MedLine.d85.s9|42-45|CCNU|drug
DDI-MedLine.d85.s9|47-62|pharmacokinetics|drug
DDI-MedLine.d85.s9|63-63|.|drug
DDI-MedLine.d85.s10|0-2|The|drug
DDI-MedLine.d85.s10|4-9|plasma|drug
DDI-MedLine.d85.s10|11-13|and|drug
DDI-MedLine.d85.s10|15-20|tumour|drug
DDI-MedLine.d85.s10|22-26|total|drug
DDI-MedLine.d85.s10|28-38|nitrosourea|drug
DDI-MedLine.d85.s10|40-43|peak|drug
DDI-MedLine.d85.s10|45-58|concentrations|drug
DDI-MedLine.d85.s10|60-63|were|drug
DDI-MedLine.d85.s10|65-71|reduced|drug
DDI-MedLine.d85.s10|73-74|by|drug
DDI-MedLine.d85.s10|76-78|1.5|drug
DDI-MedLine.d85.s10|80-82|and|drug
DDI-MedLine.d85.s10|84-86|1.7|drug
DDI-MedLine.d85.s10|88-91|fold|drug
DDI-MedLine.d85.s10|93-104|respectively|drug
DDI-MedLine.d85.s10|105-105|.|drug
DDI-MedLine.d85.s11|0-11|Misonidazole|drug
DDI-MedLine.d85.s11|13-16|also|drug
DDI-MedLine.d85.s11|18-24|reduced|drug
DDI-MedLine.d85.s11|26-28|the|drug
DDI-MedLine.d85.s11|30-30|``|drug
DDI-MedLine.d85.s11|31-35|early|drug
DDI-MedLine.d85.s11|36-36|''|drug
DDI-MedLine.d85.s12|0-10|nitrosourea|drug
DDI-MedLine.d85.s12|12-14|AUC|drug
DDI-MedLine.d85.s12|15-15|,|drug
DDI-MedLine.d85.s12|17-20|with|drug
DDI-MedLine.d85.s12|22-24|the|drug
DDI-MedLine.d85.s12|26-31|extent|drug
DDI-MedLine.d85.s12|33-34|of|drug
DDI-MedLine.d85.s12|36-38|the|drug
DDI-MedLine.d85.s12|40-48|reduction|drug
DDI-MedLine.d85.s12|50-58|depending|drug
DDI-MedLine.d85.s12|60-61|on|drug
DDI-MedLine.d85.s12|63-65|the|drug
DDI-MedLine.d85.s12|67-73|minimum|drug
DDI-MedLine.d85.s12|75-83|effective|drug
DDI-MedLine.d85.s12|85-97|concentration|drug
DDI-MedLine.d85.s12|99-99|(|drug
DDI-MedLine.d85.s12|100-102|MEC|drug
DDI-MedLine.d85.s12|103-103|)|drug
DDI-MedLine.d85.s12|105-110|chosen|drug
DDI-MedLine.d85.s12|111-111|.|drug
DDI-MedLine.d85.s13|0-2|For|drug
DDI-MedLine.d85.s13|4-10|example|drug
DDI-MedLine.d85.s13|11-11|,|drug
DDI-MedLine.d85.s13|13-15|the|drug
DDI-MedLine.d85.s13|17-22|plasma|drug
DDI-MedLine.d85.s13|24-34|nitrosourea|drug
DDI-MedLine.d85.s13|36-38|AUC|drug
DDI-MedLine.d85.s13|40-42|was|drug
DDI-MedLine.d85.s13|44-50|reduced|drug
DDI-MedLine.d85.s13|52-53|by|drug
DDI-MedLine.d85.s13|55-61|factors|drug
DDI-MedLine.d85.s13|63-64|of|drug
DDI-MedLine.d85.s13|66-69|1.05|drug
DDI-MedLine.d85.s13|71-73|and|drug
DDI-MedLine.d85.s13|75-77|9.6|drug
DDI-MedLine.d85.s13|79-81|for|drug
DDI-MedLine.d85.s13|83-85|MEC|drug
DDI-MedLine.d85.s13|87-92|values|drug
DDI-MedLine.d85.s13|94-95|of|drug
DDI-MedLine.d85.s13|97-97|1|drug
DDI-MedLine.d85.s13|99-101|and|drug
DDI-MedLine.d85.s13|103-103|2|drug
DDI-MedLine.d85.s13|105-114|micrograms|drug
DDI-MedLine.d85.s13|116-119|ml-1|drug
DDI-MedLine.d85.s13|121-132|respectively|drug
DDI-MedLine.d85.s13|133-133|.|drug
DDI-MedLine.d85.s14|0-1|We|drug
DDI-MedLine.d85.s14|3-9|propose|drug
DDI-MedLine.d85.s14|11-15|these|drug
DDI-MedLine.d85.s14|17-31|pharmacokinetic|drug
DDI-MedLine.d85.s14|33-39|changes|drug
DDI-MedLine.d85.s14|41-42|to|drug
DDI-MedLine.d85.s14|44-45|be|drug
DDI-MedLine.d85.s14|47-49|the|drug
DDI-MedLine.d85.s14|51-60|underlying|drug
DDI-MedLine.d85.s14|62-70|mechanism|drug
DDI-MedLine.d85.s14|72-74|for|drug
DDI-MedLine.d85.s14|76-78|the|drug
DDI-MedLine.d85.s14|80-88|reduction|drug
DDI-MedLine.d85.s14|90-91|of|drug
DDI-MedLine.d85.s14|93-96|oral|drug
DDI-MedLine.d85.s14|98-101|CCNU|drug
DDI-MedLine.d85.s14|103-114|cytotoxicity|drug
DDI-MedLine.d85.s14|116-117|by|drug
DDI-MedLine.d85.s14|119-130|misonidazole|drug
DDI-MedLine.d85.s14|131-131|.|drug
DDI-MedLine.d85.s15|0-7|Clinical|drug
DDI-MedLine.d85.s15|9-14|trials|drug
DDI-MedLine.d85.s15|16-17|of|drug
DDI-MedLine.d85.s15|19-22|such|drug
DDI-MedLine.d85.s15|24-35|combinations|drug
DDI-MedLine.d85.s15|37-42|should|drug
DDI-MedLine.d85.s15|44-45|be|drug
DDI-MedLine.d85.s15|47-57|accompanied|drug
DDI-MedLine.d85.s15|59-60|by|drug
DDI-MedLine.d85.s15|62-69|detailed|drug
DDI-MedLine.d85.s15|71-85|pharmacokinetic|drug
DDI-MedLine.d85.s15|87-96|evaluation|drug
DDI-MedLine.d85.s15|97-97|.|drug
DDI-DrugBank.d506.s0|0-1|If|drug
DDI-DrugBank.d506.s0|3-11|phenytoin|drug
DDI-DrugBank.d506.s0|13-14|or|drug
DDI-DrugBank.d506.s0|16-20|other|drug
DDI-DrugBank.d506.s0|22-28|hepatic|drug
DDI-DrugBank.d506.s0|30-35|enzyme|drug
DDI-DrugBank.d506.s0|37-44|inducers|drug
DDI-DrugBank.d506.s0|46-48|are|drug
DDI-DrugBank.d506.s0|50-54|taken|drug
DDI-DrugBank.d506.s0|56-67|concurrently|drug
DDI-DrugBank.d506.s0|69-72|with|drug
DDI-DrugBank.d506.s0|74-80|Norpace|drug
DDI-DrugBank.d506.s0|82-83|or|drug
DDI-DrugBank.d506.s0|85-91|Norpace|drug
DDI-DrugBank.d506.s0|93-94|CR|drug
DDI-DrugBank.d506.s0|95-95|,|drug
DDI-DrugBank.d506.s0|97-101|lower|drug
DDI-DrugBank.d506.s0|103-108|plasma|drug
DDI-DrugBank.d506.s0|110-115|levels|drug
DDI-DrugBank.d506.s0|117-118|of|drug
DDI-DrugBank.d506.s0|120-131|disopyramide|drug
DDI-DrugBank.d506.s0|133-135|may|drug
DDI-DrugBank.d506.s0|137-141|occur|drug
DDI-DrugBank.d506.s0|142-142|.|drug
DDI-DrugBank.d506.s1|0-9|Monitoring|drug
DDI-DrugBank.d506.s1|11-12|of|drug
DDI-DrugBank.d506.s1|14-25|disopyramide|drug
DDI-DrugBank.d506.s1|27-32|plasma|drug
DDI-DrugBank.d506.s1|34-39|levels|drug
DDI-DrugBank.d506.s1|41-42|is|drug
DDI-DrugBank.d506.s1|44-54|recommended|drug
DDI-DrugBank.d506.s1|56-57|in|drug
DDI-DrugBank.d506.s1|59-62|such|drug
DDI-DrugBank.d506.s1|64-73|concurrent|drug
DDI-DrugBank.d506.s1|75-77|use|drug
DDI-DrugBank.d506.s1|79-80|to|drug
DDI-DrugBank.d506.s1|82-86|avoid|drug
DDI-DrugBank.d506.s1|88-98|ineffective|drug
DDI-DrugBank.d506.s1|100-106|therapy|drug
DDI-DrugBank.d506.s1|107-107|.|drug
DDI-DrugBank.d506.s2|0-4|Other|drug
DDI-DrugBank.d506.s2|6-19|antiarrhythmic|drug
DDI-DrugBank.d506.s2|21-25|drugs|drug
DDI-DrugBank.d506.s2|27-27|(|drug
DDI-DrugBank.d506.s2|28-29|eg|drug
DDI-DrugBank.d506.s2|30-30|,|drug
DDI-DrugBank.d506.s2|32-40|quinidine|drug
DDI-DrugBank.d506.s2|41-41|,|drug
DDI-DrugBank.d506.s2|43-54|procainamide|drug
DDI-DrugBank.d506.s2|55-55|,|drug
DDI-DrugBank.d506.s2|57-65|lidocaine|drug
DDI-DrugBank.d506.s2|66-66|,|drug
DDI-DrugBank.d506.s2|68-78|propranolol|drug
DDI-DrugBank.d506.s2|79-79|)|drug
DDI-DrugBank.d506.s2|81-84|have|drug
DDI-DrugBank.d506.s2|86-97|occasionally|drug
DDI-DrugBank.d506.s2|99-102|been|drug
DDI-DrugBank.d506.s2|104-107|used|drug
DDI-DrugBank.d506.s2|109-120|concurrently|drug
DDI-DrugBank.d506.s2|122-125|with|drug
DDI-DrugBank.d506.s2|127-133|Norpace|drug
DDI-DrugBank.d506.s2|134-134|.|drug
DDI-DrugBank.d506.s3|0-8|Excessive|drug
DDI-DrugBank.d506.s3|10-17|widening|drug
DDI-DrugBank.d506.s3|19-20|of|drug
DDI-DrugBank.d506.s3|22-24|the|drug
DDI-DrugBank.d506.s3|26-28|QRS|drug
DDI-DrugBank.d506.s3|30-36|complex|drug
DDI-DrugBank.d506.s3|38-43|and/or|drug
DDI-DrugBank.d506.s3|45-56|prolongation|drug
DDI-DrugBank.d506.s3|58-59|of|drug
DDI-DrugBank.d506.s3|61-63|the|drug
DDI-DrugBank.d506.s3|65-67|Q-T|drug
DDI-DrugBank.d506.s3|69-76|interval|drug
DDI-DrugBank.d506.s3|78-80|may|drug
DDI-DrugBank.d506.s3|82-86|occur|drug
DDI-DrugBank.d506.s3|88-89|in|drug
DDI-DrugBank.d506.s3|91-95|these|drug
DDI-DrugBank.d506.s3|97-106|situations|drug
DDI-DrugBank.d506.s3|107-107|.|drug
DDI-DrugBank.d506.s4|0-1|In|drug
DDI-DrugBank.d506.s4|3-9|healthy|drug
DDI-DrugBank.d506.s4|11-18|subjects|drug
DDI-DrugBank.d506.s4|19-19|,|drug
DDI-DrugBank.d506.s4|21-22|no|drug
DDI-DrugBank.d506.s4|24-34|significant|drug
DDI-DrugBank.d506.s4|36-44|drug-drug|drug
DDI-DrugBank.d506.s4|46-56|interaction|drug
DDI-DrugBank.d506.s4|58-60|was|drug
DDI-DrugBank.d506.s4|62-69|observed|drug
DDI-DrugBank.d506.s4|71-74|when|drug
DDI-DrugBank.d506.s4|76-82|Norpace|drug
DDI-DrugBank.d506.s4|84-86|was|drug
DDI-DrugBank.d506.s4|88-101|coadministered|drug
DDI-DrugBank.d506.s4|103-106|with|drug
DDI-DrugBank.d506.s4|108-113|either|drug
DDI-DrugBank.d506.s4|115-125|propranolol|drug
DDI-DrugBank.d506.s4|127-128|or|drug
DDI-DrugBank.d506.s4|130-137|diazepam|drug
DDI-DrugBank.d506.s4|138-138|.|drug
DDI-DrugBank.d506.s5|0-10|Concomitant|drug
DDI-DrugBank.d506.s5|12-25|administration|drug
DDI-DrugBank.d506.s5|27-28|of|drug
DDI-DrugBank.d506.s5|30-36|Norpace|drug
DDI-DrugBank.d506.s5|38-40|and|drug
DDI-DrugBank.d506.s5|42-50|quinidine|drug
DDI-DrugBank.d506.s5|52-59|resulted|drug
DDI-DrugBank.d506.s5|61-62|in|drug
DDI-DrugBank.d506.s5|64-69|slight|drug
DDI-DrugBank.d506.s5|71-79|increases|drug
DDI-DrugBank.d506.s5|81-82|in|drug
DDI-DrugBank.d506.s5|84-89|plasma|drug
DDI-DrugBank.d506.s5|91-102|disopyramide|drug
DDI-DrugBank.d506.s5|104-109|levels|drug
DDI-DrugBank.d506.s5|111-113|and|drug
DDI-DrugBank.d506.s5|115-120|slight|drug
DDI-DrugBank.d506.s5|122-130|decreases|drug
DDI-DrugBank.d506.s5|132-133|in|drug
DDI-DrugBank.d506.s5|135-140|plasma|drug
DDI-DrugBank.d506.s5|142-150|quinidine|drug
DDI-DrugBank.d506.s5|152-157|levels|drug
DDI-DrugBank.d506.s5|158-158|.|drug
DDI-DrugBank.d506.s6|0-6|Norpace|drug
DDI-DrugBank.d506.s6|8-11|does|drug
DDI-DrugBank.d506.s6|13-15|not|drug
DDI-DrugBank.d506.s6|17-24|increase|drug
DDI-DrugBank.d506.s6|26-30|serum|drug
DDI-DrugBank.d506.s6|32-38|digoxin|drug
DDI-DrugBank.d506.s6|40-45|levels|drug
DDI-DrugBank.d506.s6|46-46|.|drug
DDI-DrugBank.d506.s7|0-7|Patients|drug
DDI-DrugBank.d506.s7|9-14|taking|drug
DDI-DrugBank.d506.s7|16-27|disopyramide|drug
DDI-DrugBank.d506.s7|29-37|phosphate|drug
DDI-DrugBank.d506.s7|39-41|and|drug
DDI-DrugBank.d506.s7|43-54|erythromycin|drug
DDI-DrugBank.d506.s7|56-68|concomitantly|drug
DDI-DrugBank.d506.s7|70-72|may|drug
DDI-DrugBank.d506.s7|74-80|develop|drug
DDI-DrugBank.d506.s7|82-90|increased|drug
DDI-DrugBank.d506.s7|92-96|serum|drug
DDI-DrugBank.d506.s7|98-111|concentrations|drug
DDI-DrugBank.d506.s7|113-114|of|drug
DDI-DrugBank.d506.s7|116-127|disopyramide|drug
DDI-DrugBank.d506.s7|129-137|resulting|drug
DDI-DrugBank.d506.s7|139-140|in|drug
DDI-DrugBank.d506.s7|142-150|excessive|drug
DDI-DrugBank.d506.s7|152-159|widening|drug
DDI-DrugBank.d506.s7|161-162|of|drug
DDI-DrugBank.d506.s7|164-166|the|drug
DDI-DrugBank.d506.s7|168-170|QRS|drug
DDI-DrugBank.d506.s7|172-178|complex|drug
DDI-DrugBank.d506.s7|180-185|and/or|drug
DDI-DrugBank.d506.s7|187-198|prolongation|drug
DDI-DrugBank.d506.s7|200-201|of|drug
DDI-DrugBank.d506.s7|203-205|the|drug
DDI-DrugBank.d506.s7|207-209|Q-T|drug
DDI-DrugBank.d506.s7|211-218|interval|drug
DDI-DrugBank.d506.s7|219-219|.|drug
DDI-DrugBank.d506.s8|0-7|Patients|drug
DDI-DrugBank.d506.s8|9-14|taking|drug
DDI-DrugBank.d506.s8|16-27|disopyramide|drug
DDI-DrugBank.d506.s8|29-37|phosphate|drug
DDI-DrugBank.d506.s8|39-41|and|drug
DDI-DrugBank.d506.s8|43-49|hepatic|drug
DDI-DrugBank.d506.s8|51-56|enzyme|drug
DDI-DrugBank.d506.s8|58-67|inhibitors|drug
DDI-DrugBank.d506.s8|69-81|concomitantly|drug
DDI-DrugBank.d506.s8|83-88|should|drug
DDI-DrugBank.d506.s8|90-91|be|drug
DDI-DrugBank.d506.s8|93-99|closely|drug
DDI-DrugBank.d506.s8|101-109|monitored|drug
DDI-DrugBank.d506.s8|110-110|.|drug
DDI-DrugBank.d506.s9|0-4|Until|drug
DDI-DrugBank.d506.s9|6-9|data|drug
DDI-DrugBank.d506.s9|11-12|on|drug
DDI-DrugBank.d506.s9|14-21|possible|drug
DDI-DrugBank.d506.s9|23-34|interactions|drug
DDI-DrugBank.d506.s9|36-42|between|drug
DDI-DrugBank.d506.s9|44-52|verapamil|drug
DDI-DrugBank.d506.s9|54-56|and|drug
DDI-DrugBank.d506.s9|58-69|disopyramide|drug
DDI-DrugBank.d506.s9|71-79|phosphate|drug
DDI-DrugBank.d506.s9|81-83|are|drug
DDI-DrugBank.d506.s9|85-92|obtained|drug
DDI-DrugBank.d506.s9|93-93|,|drug
DDI-DrugBank.d506.s9|95-106|disopyramide|drug
DDI-DrugBank.d506.s9|108-113|should|drug
DDI-DrugBank.d506.s9|115-117|not|drug
DDI-DrugBank.d506.s9|119-120|be|drug
DDI-DrugBank.d506.s9|122-133|administered|drug
DDI-DrugBank.d506.s9|135-140|within|drug
DDI-DrugBank.d506.s9|142-143|48|drug
DDI-DrugBank.d506.s9|145-149|hours|drug
DDI-DrugBank.d506.s9|151-156|before|drug
DDI-DrugBank.d506.s9|158-159|or|drug
DDI-DrugBank.d506.s9|161-162|24|drug
DDI-DrugBank.d506.s9|164-168|hours|drug
DDI-DrugBank.d506.s9|170-174|after|drug
DDI-DrugBank.d506.s9|176-184|verapamil|drug
DDI-DrugBank.d506.s9|186-199|administration|drug
DDI-DrugBank.d506.s9|200-200|.|drug
DDI-MedLine.d216.s0|0-7|Exposure|drug
DDI-MedLine.d216.s0|9-10|to|drug
DDI-MedLine.d216.s0|12-15|oral|drug
DDI-MedLine.d216.s0|17-26|S-ketamine|drug
DDI-MedLine.d216.s0|28-29|is|drug
DDI-MedLine.d216.s0|31-40|unaffected|drug
DDI-MedLine.d216.s0|42-43|by|drug
DDI-MedLine.d216.s0|45-56|itraconazole|drug
DDI-MedLine.d216.s0|58-60|but|drug
DDI-MedLine.d216.s0|62-68|greatly|drug
DDI-MedLine.d216.s0|70-78|increased|drug
DDI-MedLine.d216.s0|80-81|by|drug
DDI-MedLine.d216.s0|83-93|ticlopidine|drug
DDI-MedLine.d216.s0|94-94|.|drug
DDI-MedLine.d216.s1|0-3|This|drug
DDI-MedLine.d216.s1|5-9|study|drug
DDI-MedLine.d216.s1|11-18|examined|drug
DDI-MedLine.d216.s1|20-28|drug-drug|drug
DDI-MedLine.d216.s1|30-41|interactions|drug
DDI-MedLine.d216.s1|43-44|of|drug
DDI-MedLine.d216.s1|46-49|oral|drug
DDI-MedLine.d216.s1|51-60|S-ketamine|drug
DDI-MedLine.d216.s1|62-65|with|drug
DDI-MedLine.d216.s1|67-69|the|drug
DDI-MedLine.d216.s1|71-80|cytochrome|drug
DDI-MedLine.d216.s1|82-85|P450|drug
DDI-MedLine.d216.s1|87-87|(|drug
DDI-MedLine.d216.s1|88-90|CYP|drug
DDI-MedLine.d216.s1|91-91|)|drug
DDI-MedLine.d216.s1|93-95|2B6|drug
DDI-MedLine.d216.s1|97-105|inhibitor|drug
DDI-MedLine.d216.s1|107-117|ticlopidine|drug
DDI-MedLine.d216.s1|119-121|and|drug
DDI-MedLine.d216.s1|123-125|the|drug
DDI-MedLine.d216.s1|127-131|CYP3A|drug
DDI-MedLine.d216.s1|133-141|inhibitor|drug
DDI-MedLine.d216.s1|143-154|itraconazole|drug
DDI-MedLine.d216.s1|155-155|.|drug
DDI-MedLine.d216.s2|0-1|In|drug
DDI-MedLine.d216.s2|3-6|this|drug
DDI-MedLine.d216.s2|8-17|randomized|drug
DDI-MedLine.d216.s2|18-18|,|drug
DDI-MedLine.d216.s2|20-26|blinded|drug
DDI-MedLine.d216.s2|27-27|,|drug
DDI-MedLine.d216.s2|29-37|crossover|drug
DDI-MedLine.d216.s2|39-43|study|drug
DDI-MedLine.d216.s2|44-44|,|drug
DDI-MedLine.d216.s2|46-47|11|drug
DDI-MedLine.d216.s2|49-55|healthy|drug
DDI-MedLine.d216.s2|57-66|volunteers|drug
DDI-MedLine.d216.s2|68-75|ingested|drug
DDI-MedLine.d216.s2|77-79|0.2|drug
DDI-MedLine.d216.s2|81-85|mg/kg|drug
DDI-MedLine.d216.s2|87-96|S-ketamine|drug
DDI-MedLine.d216.s2|98-102|after|drug
DDI-MedLine.d216.s2|104-116|pretreatments|drug
DDI-MedLine.d216.s2|118-121|with|drug
DDI-MedLine.d216.s2|123-126|oral|drug
DDI-MedLine.d216.s2|128-138|ticlopidine|drug
DDI-MedLine.d216.s2|140-140|(|drug
DDI-MedLine.d216.s2|141-143|250|drug
DDI-MedLine.d216.s2|145-146|mg|drug
DDI-MedLine.d216.s2|148-152|twice|drug
DDI-MedLine.d216.s2|154-158|daily|drug
DDI-MedLine.d216.s2|159-159|)|drug
DDI-MedLine.d216.s2|160-160|,|drug
DDI-MedLine.d216.s2|162-173|itraconazole|drug
DDI-MedLine.d216.s2|175-175|(|drug
DDI-MedLine.d216.s2|176-178|200|drug
DDI-MedLine.d216.s2|180-181|mg|drug
DDI-MedLine.d216.s2|183-186|once|drug
DDI-MedLine.d216.s2|188-192|daily|drug
DDI-MedLine.d216.s2|193-193|)|drug
DDI-MedLine.d216.s2|194-194|,|drug
DDI-MedLine.d216.s2|196-197|or|drug
DDI-MedLine.d216.s2|199-205|placebo|drug
DDI-MedLine.d216.s2|207-208|in|drug
DDI-MedLine.d216.s2|210-214|6-day|drug
DDI-MedLine.d216.s2|216-224|treatment|drug
DDI-MedLine.d216.s2|226-232|periods|drug
DDI-MedLine.d216.s2|234-235|at|drug
DDI-MedLine.d216.s2|237-245|intervals|drug
DDI-MedLine.d216.s2|247-248|of|drug
DDI-MedLine.d216.s2|250-250|4|drug
DDI-MedLine.d216.s2|252-256|weeks|drug
DDI-MedLine.d216.s2|257-257|.|drug
DDI-MedLine.d216.s3|0-10|Ticlopidine|drug
DDI-MedLine.d216.s3|12-20|treatment|drug
DDI-MedLine.d216.s3|22-30|increased|drug
DDI-MedLine.d216.s3|32-34|the|drug
DDI-MedLine.d216.s3|36-39|mean|drug
DDI-MedLine.d216.s3|41-44|area|drug
DDI-MedLine.d216.s3|46-50|under|drug
DDI-MedLine.d216.s3|52-54|the|drug
DDI-MedLine.d216.s3|56-61|plasma|drug
DDI-MedLine.d216.s3|63-80|concentration-time|drug
DDI-MedLine.d216.s3|82-86|curve|drug
DDI-MedLine.d216.s3|88-99|extrapolated|drug
DDI-MedLine.d216.s3|101-102|to|drug
DDI-MedLine.d216.s3|104-111|infinity|drug
DDI-MedLine.d216.s3|113-113|(|drug
DDI-MedLine.d216.s3|114-116|AUC|drug
DDI-MedLine.d216.s3|117-117|(|drug
DDI-MedLine.d216.s3|118-119|0-|drug
DDI-MedLine.d216.s3|123-123|)|drug
DDI-MedLine.d216.s3|124-124|)|drug
DDI-MedLine.d216.s3|126-127|of|drug
DDI-MedLine.d216.s3|129-132|oral|drug
DDI-MedLine.d216.s3|134-141|ketamine|drug
DDI-MedLine.d216.s3|143-144|by|drug
DDI-MedLine.d216.s3|146-153|2.4-fold|drug
DDI-MedLine.d216.s3|154-154|,|drug
DDI-MedLine.d216.s3|156-162|whereas|drug
DDI-MedLine.d216.s3|164-175|itraconazole|drug
DDI-MedLine.d216.s3|177-185|treatment|drug
DDI-MedLine.d216.s3|187-189|did|drug
DDI-MedLine.d216.s3|191-193|not|drug
DDI-MedLine.d216.s3|195-202|increase|drug
DDI-MedLine.d216.s3|204-206|the|drug
DDI-MedLine.d216.s3|208-215|exposure|drug
DDI-MedLine.d216.s3|217-218|to|drug
DDI-MedLine.d216.s3|220-229|S-ketamine|drug
DDI-MedLine.d216.s3|230-230|.|drug
DDI-MedLine.d216.s4|0-2|The|drug
DDI-MedLine.d216.s4|4-8|ratio|drug
DDI-MedLine.d216.s4|10-11|of|drug
DDI-MedLine.d216.s4|13-23|norketamine|drug
DDI-MedLine.d216.s4|25-27|AUC|drug
DDI-MedLine.d216.s4|28-28|(|drug
DDI-MedLine.d216.s4|29-30|0-|drug
DDI-MedLine.d216.s4|34-34|)|drug
DDI-MedLine.d216.s4|36-37|to|drug
DDI-MedLine.d216.s4|39-46|ketamine|drug
DDI-MedLine.d216.s4|48-50|AUC|drug
DDI-MedLine.d216.s4|51-51|(|drug
DDI-MedLine.d216.s4|52-53|0-|drug
DDI-MedLine.d216.s4|57-57|)|drug
DDI-MedLine.d216.s4|59-61|was|drug
DDI-MedLine.d216.s4|63-75|significantly|drug
DDI-MedLine.d216.s4|77-85|decreased|drug
DDI-MedLine.d216.s4|87-88|in|drug
DDI-MedLine.d216.s4|90-92|the|drug
DDI-MedLine.d216.s4|94-104|ticlopidine|drug
DDI-MedLine.d216.s4|106-106|(|drug
DDI-MedLine.d216.s4|107-107|P|drug
DDI-MedLine.d216.s4|109-109|&|drug
DDI-MedLine.d216.s4|110-111|lt|drug
DDI-MedLine.d216.s4|112-112|;|drug
DDI-MedLine.d216.s4|114-118|0.001|drug
DDI-MedLine.d216.s4|119-119|)|drug
DDI-MedLine.d216.s4|121-123|and|drug
DDI-MedLine.d216.s4|125-136|itraconazole|drug
DDI-MedLine.d216.s4|138-143|phases|drug
DDI-MedLine.d216.s4|145-145|(|drug
DDI-MedLine.d216.s4|146-146|P|drug
DDI-MedLine.d216.s4|148-148|=|drug
DDI-MedLine.d216.s4|150-154|0.006|drug
DDI-MedLine.d216.s4|155-155|)|drug
DDI-MedLine.d216.s4|157-158|as|drug
DDI-MedLine.d216.s4|160-167|compared|drug
DDI-MedLine.d216.s4|169-170|to|drug
DDI-MedLine.d216.s4|172-178|placebo|drug
DDI-MedLine.d216.s4|179-179|.|drug
DDI-MedLine.d216.s5|0-1|In|drug
DDI-MedLine.d216.s5|3-5|the|drug
DDI-MedLine.d216.s5|7-17|ticlopidine|drug
DDI-MedLine.d216.s5|19-21|and|drug
DDI-MedLine.d216.s5|23-34|itraconazole|drug
DDI-MedLine.d216.s5|36-41|phases|drug
DDI-MedLine.d216.s5|42-42|,|drug
DDI-MedLine.d216.s5|44-46|the|drug
DDI-MedLine.d216.s5|48-52|areas|drug
DDI-MedLine.d216.s5|54-58|under|drug
DDI-MedLine.d216.s5|60-62|the|drug
DDI-MedLine.d216.s5|64-74|effect-time|drug
DDI-MedLine.d216.s5|76-81|curves|drug
DDI-MedLine.d216.s5|83-83|(|drug
DDI-MedLine.d216.s5|84-96|self-reported|drug
DDI-MedLine.d216.s5|98-107|drowsiness|drug
DDI-MedLine.d216.s5|109-111|and|drug
DDI-MedLine.d216.s5|113-123|performance|drug
DDI-MedLine.d216.s5|124-124|)|drug
DDI-MedLine.d216.s5|126-129|were|drug
DDI-MedLine.d216.s5|131-143|significantly|drug
DDI-MedLine.d216.s5|145-150|higher|drug
DDI-MedLine.d216.s5|152-155|than|drug
DDI-MedLine.d216.s5|157-161|those|drug
DDI-MedLine.d216.s5|163-164|in|drug
DDI-MedLine.d216.s5|166-168|the|drug
DDI-MedLine.d216.s5|170-176|placebo|drug
DDI-MedLine.d216.s5|178-182|phase|drug
DDI-MedLine.d216.s5|184-184|(|drug
DDI-MedLine.d216.s5|185-185|P|drug
DDI-MedLine.d216.s5|187-187|<|drug
DDI-MedLine.d216.s5|189-192|0.05|drug
DDI-MedLine.d216.s5|193-193|)|drug
DDI-MedLine.d216.s5|194-194|.|drug
DDI-MedLine.d216.s6|0-2|The|drug
DDI-MedLine.d216.s6|4-11|findings|drug
DDI-MedLine.d216.s6|13-19|suggest|drug
DDI-MedLine.d216.s6|21-24|that|drug
DDI-MedLine.d216.s6|26-28|the|drug
DDI-MedLine.d216.s6|30-35|dosage|drug
DDI-MedLine.d216.s6|37-38|of|drug
DDI-MedLine.d216.s6|40-49|S-ketamine|drug
DDI-MedLine.d216.s6|51-56|should|drug
DDI-MedLine.d216.s6|58-59|be|drug
DDI-MedLine.d216.s6|61-67|reduced|drug
DDI-MedLine.d216.s6|69-70|in|drug
DDI-MedLine.d216.s6|72-79|patients|drug
DDI-MedLine.d216.s6|81-89|receiving|drug
DDI-MedLine.d216.s6|91-101|ticlopidine|drug
DDI-MedLine.d216.s6|102-102|.|drug
DDI-MedLine.d143.s0|0-0|[|drug
DDI-MedLine.d143.s0|1-11|Interaction|drug
DDI-MedLine.d143.s0|13-19|between|drug
DDI-MedLine.d143.s0|21-31|clopidogrel|drug
DDI-MedLine.d143.s0|33-35|and|drug
DDI-MedLine.d143.s0|37-42|proton|drug
DDI-MedLine.d143.s0|44-47|pump|drug
DDI-MedLine.d143.s0|49-58|inhibitors|drug
DDI-MedLine.d143.s0|59-59|]|drug
DDI-MedLine.d143.s0|60-60|.|drug
DDI-MedLine.d143.s1|0-2|The|drug
DDI-MedLine.d143.s1|4-7|drug|drug
DDI-MedLine.d143.s1|9-19|interaction|drug
DDI-MedLine.d143.s1|21-27|between|drug
DDI-MedLine.d143.s1|29-34|proton|drug
DDI-MedLine.d143.s1|36-39|pump|drug
DDI-MedLine.d143.s1|41-50|inhibitors|drug
DDI-MedLine.d143.s1|52-54|and|drug
DDI-MedLine.d143.s1|56-66|clopidogrel|drug
DDI-MedLine.d143.s1|68-70|has|drug
DDI-MedLine.d143.s1|72-75|been|drug
DDI-MedLine.d143.s1|77-79|the|drug
DDI-MedLine.d143.s1|81-87|subject|drug
DDI-MedLine.d143.s1|89-90|of|drug
DDI-MedLine.d143.s1|92-95|much|drug
DDI-MedLine.d143.s1|97-101|study|drug
DDI-MedLine.d143.s1|103-104|in|drug
DDI-MedLine.d143.s1|106-111|recent|drug
DDI-MedLine.d143.s1|113-117|years|drug
DDI-MedLine.d143.s1|118-118|.|drug
DDI-MedLine.d143.s2|0-12|Contradictory|drug
DDI-MedLine.d143.s2|14-20|results|drug
DDI-MedLine.d143.s2|22-30|regarding|drug
DDI-MedLine.d143.s2|32-34|the|drug
DDI-MedLine.d143.s2|36-41|effect|drug
DDI-MedLine.d143.s2|43-44|of|drug
DDI-MedLine.d143.s2|46-51|proton|drug
DDI-MedLine.d143.s2|53-56|pump|drug
DDI-MedLine.d143.s2|58-67|inhibitors|drug
DDI-MedLine.d143.s2|69-70|on|drug
DDI-MedLine.d143.s2|72-79|platelet|drug
DDI-MedLine.d143.s2|81-90|reactivity|drug
DDI-MedLine.d143.s2|92-94|and|drug
DDI-MedLine.d143.s2|96-97|on|drug
DDI-MedLine.d143.s2|99-106|clinical|drug
DDI-MedLine.d143.s2|108-114|outcome|drug
DDI-MedLine.d143.s2|116-117|in|drug
DDI-MedLine.d143.s2|119-137|clopidogrel-treated|drug
DDI-MedLine.d143.s2|139-146|patients|drug
DDI-MedLine.d143.s2|148-151|have|drug
DDI-MedLine.d143.s2|153-156|been|drug
DDI-MedLine.d143.s2|158-165|reported|drug
DDI-MedLine.d143.s2|167-168|in|drug
DDI-MedLine.d143.s2|170-179|literature|drug
DDI-MedLine.d143.s2|180-180|.|drug
DDI-MedLine.d143.s3|0-10|Concomitant|drug
DDI-MedLine.d143.s3|12-14|use|drug
DDI-MedLine.d143.s3|16-17|of|drug
DDI-MedLine.d143.s3|19-28|omeprazole|drug
DDI-MedLine.d143.s3|30-32|and|drug
DDI-MedLine.d143.s3|34-44|clopidogrel|drug
DDI-MedLine.d143.s3|46-48|was|drug
DDI-MedLine.d143.s3|50-54|found|drug
DDI-MedLine.d143.s3|56-57|to|drug
DDI-MedLine.d143.s3|59-66|decrease|drug
DDI-MedLine.d143.s3|68-70|the|drug
DDI-MedLine.d143.s3|72-79|exposure|drug
DDI-MedLine.d143.s3|81-81|(|drug
DDI-MedLine.d143.s3|82-84|AUC|drug
DDI-MedLine.d143.s3|85-85|)|drug
DDI-MedLine.d143.s3|87-88|to|drug
DDI-MedLine.d143.s3|90-100|clopidogrel|drug
DDI-MedLine.d143.s3|101-102|'s|drug
DDI-MedLine.d143.s3|104-109|active|drug
DDI-MedLine.d143.s3|111-120|metabolite|drug
DDI-MedLine.d143.s3|122-123|by|drug
DDI-MedLine.d143.s3|125-126|50|drug
DDI-MedLine.d143.s3|127-127|%|drug
DDI-MedLine.d143.s3|129-131|and|drug
DDI-MedLine.d143.s3|133-134|to|drug
DDI-MedLine.d143.s3|136-142|sharply|drug
DDI-MedLine.d143.s3|144-151|increase|drug
DDI-MedLine.d143.s3|153-160|platelet|drug
DDI-MedLine.d143.s3|162-171|reactivity|drug
DDI-MedLine.d143.s3|172-172|,|drug
DDI-MedLine.d143.s3|174-175|as|drug
DDI-MedLine.d143.s3|177-177|a|drug
DDI-MedLine.d143.s3|179-184|result|drug
DDI-MedLine.d143.s3|186-187|of|drug
DDI-MedLine.d143.s3|189-198|inhibition|drug
DDI-MedLine.d143.s3|200-201|by|drug
DDI-MedLine.d143.s3|203-212|omeprazole|drug
DDI-MedLine.d143.s3|214-215|of|drug
DDI-MedLine.d143.s3|217-223|CYP2C19|drug
DDI-MedLine.d143.s3|224-224|,|drug
DDI-MedLine.d143.s3|226-226|a|drug
DDI-MedLine.d143.s3|228-237|cytochrome|drug
DDI-MedLine.d143.s3|239-242|P450|drug
DDI-MedLine.d143.s3|244-244|(|drug
DDI-MedLine.d143.s3|245-247|CYP|drug
DDI-MedLine.d143.s3|248-248|)|drug
DDI-MedLine.d143.s3|250-255|enzyme|drug
DDI-MedLine.d143.s3|256-256|.|drug
DDI-MedLine.d143.s4|0-11|Pantoprazole|drug
DDI-MedLine.d143.s4|13-15|has|drug
DDI-MedLine.d143.s4|17-17|a|drug
DDI-MedLine.d143.s4|19-22|much|drug
DDI-MedLine.d143.s4|24-29|weaker|drug
DDI-MedLine.d143.s4|31-36|effect|drug
DDI-MedLine.d143.s4|38-39|on|drug
DDI-MedLine.d143.s4|41-51|clopidogrel|drug
DDI-MedLine.d143.s4|52-53|'s|drug
DDI-MedLine.d143.s4|55-70|pharmacokinetics|drug
DDI-MedLine.d143.s4|72-74|and|drug
DDI-MedLine.d143.s4|76-77|on|drug
DDI-MedLine.d143.s4|79-86|platelet|drug
DDI-MedLine.d143.s4|88-97|reactivity|drug
DDI-MedLine.d143.s4|99-104|during|drug
DDI-MedLine.d143.s4|106-116|concomitant|drug
DDI-MedLine.d143.s4|118-120|use|drug
DDI-MedLine.d143.s4|121-121|.|drug
DDI-MedLine.d143.s5|0-2|The|drug
DDI-MedLine.d143.s5|4-12|influence|drug
DDI-MedLine.d143.s5|14-15|of|drug
DDI-MedLine.d143.s5|17-19|the|drug
DDI-MedLine.d143.s5|21-25|other|drug
DDI-MedLine.d143.s5|27-32|proton|drug
DDI-MedLine.d143.s5|34-37|pump|drug
DDI-MedLine.d143.s5|39-48|inhibitors|drug
DDI-MedLine.d143.s5|50-53|when|drug
DDI-MedLine.d143.s5|55-58|used|drug
DDI-MedLine.d143.s5|60-73|simultaneously|drug
DDI-MedLine.d143.s5|75-78|with|drug
DDI-MedLine.d143.s5|80-90|clopidogrel|drug
DDI-MedLine.d143.s5|92-94|has|drug
DDI-MedLine.d143.s5|96-98|not|drug
DDI-MedLine.d143.s5|100-102|yet|drug
DDI-MedLine.d143.s5|104-107|been|drug
DDI-MedLine.d143.s5|109-120|investigated|drug
DDI-MedLine.d143.s5|122-123|in|drug
DDI-MedLine.d143.s5|125-134|adequately|drug
DDI-MedLine.d143.s5|136-145|randomized|drug
DDI-MedLine.d143.s5|147-153|studies|drug
DDI-MedLine.d143.s5|154-154|.|drug
DDI-MedLine.d143.s6|0-9|Regulatory|drug
DDI-MedLine.d143.s6|11-18|agencies|drug
DDI-MedLine.d143.s6|20-24|state|drug
DDI-MedLine.d143.s6|26-29|that|drug
DDI-MedLine.d143.s6|31-33|the|drug
DDI-MedLine.d143.s6|35-45|combination|drug
DDI-MedLine.d143.s6|47-48|of|drug
DDI-MedLine.d143.s6|50-60|clopidogrel|drug
DDI-MedLine.d143.s6|62-64|and|drug
DDI-MedLine.d143.s6|66-68|the|drug
DDI-MedLine.d143.s6|70-76|CYP2C19|drug
DDI-MedLine.d143.s6|78-87|inhibitors|drug
DDI-MedLine.d143.s6|89-98|omeprazole|drug
DDI-MedLine.d143.s6|100-102|and|drug
DDI-MedLine.d143.s6|104-115|esomeprazole|drug
DDI-MedLine.d143.s6|117-122|should|drug
DDI-MedLine.d143.s6|124-125|be|drug
DDI-MedLine.d143.s6|127-133|avoided|drug
DDI-MedLine.d143.s6|134-134|.|drug
DDI-MedLine.d143.s7|0-1|To|drug
DDI-MedLine.d143.s7|3-6|date|drug
DDI-MedLine.d143.s7|7-7|,|drug
DDI-MedLine.d143.s7|9-13|there|drug
DDI-MedLine.d143.s7|15-16|is|drug
DDI-MedLine.d143.s7|18-19|no|drug
DDI-MedLine.d143.s7|21-30|conclusive|drug
DDI-MedLine.d143.s7|32-39|evidence|drug
DDI-MedLine.d143.s7|41-42|of|drug
DDI-MedLine.d143.s7|44-44|a|drug
DDI-MedLine.d143.s7|46-64|clinically-relevant|drug
DDI-MedLine.d143.s7|66-76|interaction|drug
DDI-MedLine.d143.s7|78-84|between|drug
DDI-MedLine.d143.s7|86-88|any|drug
DDI-MedLine.d143.s7|90-91|of|drug
DDI-MedLine.d143.s7|93-95|the|drug
DDI-MedLine.d143.s7|97-102|proton|drug
DDI-MedLine.d143.s7|104-107|pump|drug
DDI-MedLine.d143.s7|109-118|inhibitors|drug
DDI-MedLine.d143.s7|120-122|and|drug
DDI-MedLine.d143.s7|124-134|clopidogrel|drug
DDI-MedLine.d143.s7|135-135|.|drug
DDI-DrugBank.d665.s0|0-9|Concurrent|drug
DDI-DrugBank.d665.s0|11-24|administration|drug
DDI-DrugBank.d665.s0|26-27|of|drug
DDI-DrugBank.d665.s0|29-42|bacteriostatic|drug
DDI-DrugBank.d665.s0|44-54|antibiotics|drug
DDI-DrugBank.d665.s0|56-56|(|drug
DDI-DrugBank.d665.s0|57-60|e.g.|drug
DDI-DrugBank.d665.s0|61-61|,|drug
DDI-DrugBank.d665.s0|63-74|erythromycin|drug
DDI-DrugBank.d665.s0|75-75|,|drug
DDI-DrugBank.d665.s0|77-88|tetracycline|drug
DDI-DrugBank.d665.s0|89-89|)|drug
DDI-DrugBank.d665.s0|91-93|may|drug
DDI-DrugBank.d665.s0|95-102|diminish|drug
DDI-DrugBank.d665.s0|104-106|the|drug
DDI-DrugBank.d665.s0|108-119|bactericidal|drug
DDI-DrugBank.d665.s0|121-127|effects|drug
DDI-DrugBank.d665.s0|129-130|of|drug
DDI-DrugBank.d665.s0|132-142|penicillins|drug
DDI-DrugBank.d665.s0|144-145|by|drug
DDI-DrugBank.d665.s0|147-153|slowing|drug
DDI-DrugBank.d665.s0|155-157|the|drug
DDI-DrugBank.d665.s0|159-162|rate|drug
DDI-DrugBank.d665.s0|164-165|of|drug
DDI-DrugBank.d665.s0|167-175|bacterial|drug
DDI-DrugBank.d665.s0|177-182|growth|drug
DDI-DrugBank.d665.s0|183-183|.|drug
DDI-DrugBank.d665.s1|0-11|Bactericidal|drug
DDI-DrugBank.d665.s1|13-18|agents|drug
DDI-DrugBank.d665.s1|20-23|work|drug
DDI-DrugBank.d665.s1|25-28|most|drug
DDI-DrugBank.d665.s1|30-40|effectively|drug
DDI-DrugBank.d665.s1|42-48|against|drug
DDI-DrugBank.d665.s1|50-52|the|drug
DDI-DrugBank.d665.s1|54-61|immature|drug
DDI-DrugBank.d665.s1|63-66|cell|drug
DDI-DrugBank.d665.s1|68-71|wall|drug
DDI-DrugBank.d665.s1|73-74|of|drug
DDI-DrugBank.d665.s1|76-82|rapidly|drug
DDI-DrugBank.d665.s1|84-96|proliferating|drug
DDI-DrugBank.d665.s1|98-111|microorganisms|drug
DDI-DrugBank.d665.s1|112-112|.|drug
DDI-DrugBank.d665.s2|0-3|This|drug
DDI-DrugBank.d665.s2|5-7|has|drug
DDI-DrugBank.d665.s2|9-12|been|drug
DDI-DrugBank.d665.s2|14-25|demonstrated|drug
DDI-DrugBank.d665.s2|27-28|in|drug
DDI-DrugBank.d665.s2|30-34|vitro|drug
DDI-DrugBank.d665.s2|35-35|;|drug
DDI-DrugBank.d665.s3|0-6|however|drug
DDI-DrugBank.d665.s3|7-7|,|drug
DDI-DrugBank.d665.s3|9-11|the|drug
DDI-DrugBank.d665.s3|13-20|clinical|drug
DDI-DrugBank.d665.s3|22-33|significance|drug
DDI-DrugBank.d665.s3|35-36|of|drug
DDI-DrugBank.d665.s3|38-41|this|drug
DDI-DrugBank.d665.s3|43-53|interaction|drug
DDI-DrugBank.d665.s3|55-56|is|drug
DDI-DrugBank.d665.s3|58-60|not|drug
DDI-DrugBank.d665.s3|62-65|well|drug
DDI-DrugBank.d665.s3|67-76|documented|drug
DDI-DrugBank.d665.s3|77-77|.|drug
DDI-DrugBank.d665.s4|0-4|There|drug
DDI-DrugBank.d665.s4|6-8|are|drug
DDI-DrugBank.d665.s4|10-12|few|drug
DDI-DrugBank.d665.s4|14-21|clinical|drug
DDI-DrugBank.d665.s4|23-32|situations|drug
DDI-DrugBank.d665.s4|34-35|in|drug
DDI-DrugBank.d665.s4|37-41|which|drug
DDI-DrugBank.d665.s4|43-45|the|drug
DDI-DrugBank.d665.s4|47-56|concurrent|drug
DDI-DrugBank.d665.s4|58-60|use|drug
DDI-DrugBank.d665.s4|62-63|of|drug
DDI-DrugBank.d665.s4|65-66|``|drug
DDI-DrugBank.d665.s4|67-72|static|drug
DDI-DrugBank.d665.s4|73-74|''|drug
DDI-DrugBank.d665.s4|76-78|and|drug
DDI-DrugBank.d665.s4|80-81|``|drug
DDI-DrugBank.d665.s4|82-86|cidal|drug
DDI-DrugBank.d665.s4|88-89|``|drug
DDI-DrugBank.d665.s4|91-101|antibiotics|drug
DDI-DrugBank.d665.s4|103-105|are|drug
DDI-DrugBank.d665.s4|107-115|indicated|drug
DDI-DrugBank.d665.s4|116-116|.|drug
DDI-DrugBank.d665.s5|0-6|However|drug
DDI-DrugBank.d665.s5|7-7|,|drug
DDI-DrugBank.d665.s5|9-10|in|drug
DDI-DrugBank.d665.s5|12-19|selected|drug
DDI-DrugBank.d665.s5|21-33|circumstances|drug
DDI-DrugBank.d665.s5|35-36|in|drug
DDI-DrugBank.d665.s5|38-42|which|drug
DDI-DrugBank.d665.s5|44-47|such|drug
DDI-DrugBank.d665.s5|49-55|therapy|drug
DDI-DrugBank.d665.s5|57-58|is|drug
DDI-DrugBank.d665.s5|60-70|appropriate|drug
DDI-DrugBank.d665.s5|71-71|,|drug
DDI-DrugBank.d665.s5|73-77|using|drug
DDI-DrugBank.d665.s5|79-86|adequate|drug
DDI-DrugBank.d665.s5|88-92|doses|drug
DDI-DrugBank.d665.s5|94-95|of|drug
DDI-DrugBank.d665.s5|97-109|antibacterial|drug
DDI-DrugBank.d665.s5|111-116|agents|drug
DDI-DrugBank.d665.s5|118-120|and|drug
DDI-DrugBank.d665.s5|122-130|beginning|drug
DDI-DrugBank.d665.s5|132-141|penicillin|drug
DDI-DrugBank.d665.s5|143-149|therapy|drug
DDI-DrugBank.d665.s5|151-155|first|drug
DDI-DrugBank.d665.s5|156-156|,|drug
DDI-DrugBank.d665.s5|158-163|should|drug
DDI-DrugBank.d665.s5|165-172|minimize|drug
DDI-DrugBank.d665.s5|174-176|the|drug
DDI-DrugBank.d665.s5|178-186|potential|drug
DDI-DrugBank.d665.s5|188-190|for|drug
DDI-DrugBank.d665.s5|192-202|interaction|drug
DDI-DrugBank.d665.s5|203-203|.|drug
DDI-DrugBank.d665.s6|0-9|Penicillin|drug
DDI-DrugBank.d665.s6|11-15|blood|drug
DDI-DrugBank.d665.s6|17-22|levels|drug
DDI-DrugBank.d665.s6|24-26|may|drug
DDI-DrugBank.d665.s6|28-29|be|drug
DDI-DrugBank.d665.s6|31-39|prolonged|drug
DDI-DrugBank.d665.s6|41-42|by|drug
DDI-DrugBank.d665.s6|44-53|concurrent|drug
DDI-DrugBank.d665.s6|55-68|administration|drug
DDI-DrugBank.d665.s6|70-71|of|drug
DDI-DrugBank.d665.s6|73-82|probenecid|drug
DDI-DrugBank.d665.s6|84-88|which|drug
DDI-DrugBank.d665.s6|90-95|blocks|drug
DDI-DrugBank.d665.s6|97-99|the|drug
DDI-DrugBank.d665.s6|101-105|renal|drug
DDI-DrugBank.d665.s6|107-113|tubular|drug
DDI-DrugBank.d665.s6|115-123|secretion|drug
DDI-DrugBank.d665.s6|125-126|of|drug
DDI-DrugBank.d665.s6|128-138|penicillins|drug
DDI-DrugBank.d665.s6|139-139|.|drug
DDI-DrugBank.d665.s7|0-11|Displacement|drug
DDI-DrugBank.d665.s7|13-14|of|drug
DDI-DrugBank.d665.s7|16-25|penicillin|drug
DDI-DrugBank.d665.s7|27-30|from|drug
DDI-DrugBank.d665.s7|32-37|plasma|drug
DDI-DrugBank.d665.s7|39-45|protein|drug
DDI-DrugBank.d665.s7|47-53|binding|drug
DDI-DrugBank.d665.s7|55-59|sites|drug
DDI-DrugBank.d665.s7|61-64|will|drug
DDI-DrugBank.d665.s7|66-72|elevate|drug
DDI-DrugBank.d665.s7|74-76|the|drug
DDI-DrugBank.d665.s7|78-82|level|drug
DDI-DrugBank.d665.s7|84-85|of|drug
DDI-DrugBank.d665.s7|87-90|free|drug
DDI-DrugBank.d665.s7|92-101|penicillin|drug
DDI-DrugBank.d665.s7|103-104|in|drug
DDI-DrugBank.d665.s7|106-108|the|drug
DDI-DrugBank.d665.s7|110-114|serum|drug
DDI-DrugBank.d665.s7|115-115|.|drug
DDI-DrugBank.d728.s0|0-1|No|drug
DDI-DrugBank.d728.s0|3-10|specific|drug
DDI-DrugBank.d728.s0|12-21|cytochrome|drug
DDI-DrugBank.d728.s0|23-32|P450-based|drug
DDI-DrugBank.d728.s0|34-37|drug|drug
DDI-DrugBank.d728.s0|39-49|interaction|drug
DDI-DrugBank.d728.s0|51-57|studies|drug
DDI-DrugBank.d728.s0|59-62|have|drug
DDI-DrugBank.d728.s0|64-67|been|drug
DDI-DrugBank.d728.s0|69-77|conducted|drug
DDI-DrugBank.d728.s0|78-78|.|drug
DDI-DrugBank.d728.s1|0-1|No|drug
DDI-DrugBank.d728.s1|3-17|pharmacokinetic|drug
DDI-DrugBank.d728.s1|19-29|interaction|drug
DDI-DrugBank.d728.s1|31-37|between|drug
DDI-DrugBank.d728.s1|39-40|85|drug
DDI-DrugBank.d728.s1|42-46|mg/m2|drug
DDI-DrugBank.d728.s1|48-55|ELOXATIN|drug
DDI-DrugBank.d728.s1|57-59|and|drug
DDI-DrugBank.d728.s1|61-70|infusional|drug
DDI-DrugBank.d728.s1|72-75|5-FU|drug
DDI-DrugBank.d728.s1|77-79|has|drug
DDI-DrugBank.d728.s1|81-84|been|drug
DDI-DrugBank.d728.s1|86-93|observed|drug
DDI-DrugBank.d728.s1|95-96|in|drug
DDI-DrugBank.d728.s1|98-105|patients|drug
DDI-DrugBank.d728.s1|107-113|treated|drug
DDI-DrugBank.d728.s1|115-119|every|drug
DDI-DrugBank.d728.s1|121-121|2|drug
DDI-DrugBank.d728.s1|123-127|weeks|drug
DDI-DrugBank.d728.s1|128-128|.|drug
DDI-DrugBank.d728.s2|0-8|Increases|drug
DDI-DrugBank.d728.s2|10-11|of|drug
DDI-DrugBank.d728.s2|13-16|5-FU|drug
DDI-DrugBank.d728.s2|18-23|plasma|drug
DDI-DrugBank.d728.s2|25-38|concentrations|drug
DDI-DrugBank.d728.s2|40-41|by|drug
DDI-DrugBank.d728.s2|43-55|approximately|drug
DDI-DrugBank.d728.s2|57-58|20|drug
DDI-DrugBank.d728.s2|59-59|%|drug
DDI-DrugBank.d728.s2|61-64|have|drug
DDI-DrugBank.d728.s2|66-69|been|drug
DDI-DrugBank.d728.s2|71-78|observed|drug
DDI-DrugBank.d728.s2|80-83|with|drug
DDI-DrugBank.d728.s2|85-89|doses|drug
DDI-DrugBank.d728.s2|91-92|of|drug
DDI-DrugBank.d728.s2|94-96|130|drug
DDI-DrugBank.d728.s2|98-102|mg/m2|drug
DDI-DrugBank.d728.s2|104-111|ELOXATIN|drug
DDI-DrugBank.d728.s2|113-117|dosed|drug
DDI-DrugBank.d728.s2|119-123|every|drug
DDI-DrugBank.d728.s2|125-125|3|drug
DDI-DrugBank.d728.s2|127-131|weeks|drug
DDI-DrugBank.d728.s2|132-132|.|drug
DDI-DrugBank.d728.s3|0-4|Since|drug
DDI-DrugBank.d728.s3|6-13|platinum|drug
DDI-DrugBank.d728.s3|15-24|containing|drug
DDI-DrugBank.d728.s3|26-32|species|drug
DDI-DrugBank.d728.s3|34-36|are|drug
DDI-DrugBank.d728.s3|38-47|eliminated|drug
DDI-DrugBank.d728.s3|49-57|primarily|drug
DDI-DrugBank.d728.s3|59-65|through|drug
DDI-DrugBank.d728.s3|67-69|the|drug
DDI-DrugBank.d728.s3|71-76|kidney|drug
DDI-DrugBank.d728.s3|77-77|,|drug
DDI-DrugBank.d728.s3|79-87|clearance|drug
DDI-DrugBank.d728.s3|89-90|of|drug
DDI-DrugBank.d728.s3|92-96|these|drug
DDI-DrugBank.d728.s3|98-105|products|drug
DDI-DrugBank.d728.s3|107-109|may|drug
DDI-DrugBank.d728.s3|111-112|be|drug
DDI-DrugBank.d728.s3|114-122|decreased|drug
DDI-DrugBank.d728.s3|124-125|by|drug
DDI-DrugBank.d728.s3|127-142|coadministration|drug
DDI-DrugBank.d728.s3|144-145|of|drug
DDI-DrugBank.d728.s3|147-157|potentially|drug
DDI-DrugBank.d728.s3|159-169|nephrotoxic|drug
DDI-DrugBank.d728.s3|171-179|compounds|drug
DDI-DrugBank.d728.s3|180-180|;|drug
DDI-DrugBank.d728.s4|0-7|although|drug
DDI-DrugBank.d728.s4|8-8|,|drug
DDI-DrugBank.d728.s4|10-13|this|drug
DDI-DrugBank.d728.s4|15-17|has|drug
DDI-DrugBank.d728.s4|19-21|not|drug
DDI-DrugBank.d728.s4|23-26|been|drug
DDI-DrugBank.d728.s4|28-39|specifically|drug
DDI-DrugBank.d728.s4|41-47|studied|drug
DDI-DrugBank.d728.s4|48-48|.|drug
DDI-DrugBank.d469.s0|0-4|Drugs|drug
DDI-DrugBank.d469.s0|6-10|which|drug
DDI-DrugBank.d469.s0|12-14|may|drug
DDI-DrugBank.d469.s0|16-22|enhance|drug
DDI-DrugBank.d469.s0|24-26|the|drug
DDI-DrugBank.d469.s0|28-40|neuromuscular|drug
DDI-DrugBank.d469.s0|42-49|blocking|drug
DDI-DrugBank.d469.s0|51-56|action|drug
DDI-DrugBank.d469.s0|58-59|of|drug
DDI-DrugBank.d469.s0|61-68|TRACRIUM|drug
DDI-DrugBank.d469.s0|70-76|include|drug
DDI-DrugBank.d469.s0|77-77|:|drug
DDI-DrugBank.d469.s0|79-87|enflurane|drug
DDI-DrugBank.d469.s0|88-88|;|drug
DDI-DrugBank.d469.s1|0-9|isoflurane|drug
DDI-DrugBank.d469.s1|10-10|;|drug
DDI-DrugBank.d469.s2|0-8|halothane|drug
DDI-DrugBank.d469.s2|9-9|;|drug
DDI-DrugBank.d469.s3|0-6|certain|drug
DDI-DrugBank.d469.s3|8-18|antibiotics|drug
DDI-DrugBank.d469.s3|19-19|,|drug
DDI-DrugBank.d469.s3|21-30|especially|drug
DDI-DrugBank.d469.s3|32-34|the|drug
DDI-DrugBank.d469.s3|36-50|aminoglycosides|drug
DDI-DrugBank.d469.s3|52-54|and|drug
DDI-DrugBank.d469.s3|56-65|polymyxins|drug
DDI-DrugBank.d469.s3|66-66|;|drug
DDI-DrugBank.d469.s4|0-6|lithium|drug
DDI-DrugBank.d469.s4|7-7|;|drug
DDI-DrugBank.d469.s5|0-8|magnesium|drug
DDI-DrugBank.d469.s5|10-14|salts|drug
DDI-DrugBank.d469.s5|15-15|;|drug
DDI-DrugBank.d469.s6|0-11|procainamide|drug
DDI-DrugBank.d469.s6|12-12|;|drug
DDI-DrugBank.d469.s7|0-4|Drugs|drug
DDI-DrugBank.d469.s7|6-10|which|drug
DDI-DrugBank.d469.s7|12-14|may|drug
DDI-DrugBank.d469.s7|16-22|enhance|drug
DDI-DrugBank.d469.s7|24-26|the|drug
DDI-DrugBank.d469.s7|28-40|neuromuscular|drug
DDI-DrugBank.d469.s7|42-49|blocking|drug
DDI-DrugBank.d469.s7|51-56|action|drug
DDI-DrugBank.d469.s7|58-59|of|drug
DDI-DrugBank.d469.s7|61-68|TRACRIUM|drug
DDI-DrugBank.d469.s7|70-76|include|drug
DDI-DrugBank.d469.s7|77-77|:|drug
DDI-DrugBank.d469.s7|79-87|enflurane|drug
DDI-DrugBank.d469.s7|88-88|;|drug
DDI-DrugBank.d469.s7|89-98|isoflurane|drug
DDI-DrugBank.d469.s7|99-99|;|drug
DDI-DrugBank.d469.s7|100-108|halothane|drug
DDI-DrugBank.d469.s7|109-109|;|drug
DDI-DrugBank.d469.s7|110-116|certain|drug
DDI-DrugBank.d469.s7|118-128|antibiotics|drug
DDI-DrugBank.d469.s7|129-129|,|drug
DDI-DrugBank.d469.s7|131-140|especially|drug
DDI-DrugBank.d469.s7|142-144|the|drug
DDI-DrugBank.d469.s7|146-160|aminoglycosides|drug
DDI-DrugBank.d469.s7|162-164|and|drug
DDI-DrugBank.d469.s7|166-175|polymyxins|drug
DDI-DrugBank.d469.s7|176-176|;|drug
DDI-DrugBank.d469.s7|177-183|lithium|drug
DDI-DrugBank.d469.s7|184-184|;|drug
DDI-DrugBank.d469.s7|185-193|magnesium|drug
DDI-DrugBank.d469.s7|195-199|salts|drug
DDI-DrugBank.d469.s7|200-200|;|drug
DDI-DrugBank.d469.s7|201-212|procainamide|drug
DDI-DrugBank.d469.s7|213-213|;|drug
DDI-DrugBank.d469.s7|214-216|and|drug
DDI-DrugBank.d469.s7|218-226|quinidine|drug
DDI-DrugBank.d469.s7|227-227|.|drug
DDI-DrugBank.d469.s8|0-1|If|drug
DDI-DrugBank.d469.s8|3-7|other|drug
DDI-DrugBank.d469.s8|9-14|muscle|drug
DDI-DrugBank.d469.s8|16-24|relaxants|drug
DDI-DrugBank.d469.s8|26-28|are|drug
DDI-DrugBank.d469.s8|30-33|used|drug
DDI-DrugBank.d469.s8|35-40|during|drug
DDI-DrugBank.d469.s8|42-44|the|drug
DDI-DrugBank.d469.s8|46-49|same|drug
DDI-DrugBank.d469.s8|51-59|procedure|drug
DDI-DrugBank.d469.s8|60-60|,|drug
DDI-DrugBank.d469.s8|62-64|the|drug
DDI-DrugBank.d469.s8|66-76|possibility|drug
DDI-DrugBank.d469.s8|78-79|of|drug
DDI-DrugBank.d469.s8|81-81|a|drug
DDI-DrugBank.d469.s8|83-93|synergistic|drug
DDI-DrugBank.d469.s8|95-96|or|drug
DDI-DrugBank.d469.s8|98-107|antagonist|drug
DDI-DrugBank.d469.s8|109-114|effect|drug
DDI-DrugBank.d469.s8|116-121|should|drug
DDI-DrugBank.d469.s8|123-124|be|drug
DDI-DrugBank.d469.s8|126-135|considered|drug
DDI-DrugBank.d469.s8|136-136|.|drug
DDI-DrugBank.d469.s9|0-2|The|drug
DDI-DrugBank.d469.s9|4-8|prior|drug
DDI-DrugBank.d469.s9|10-23|administration|drug
DDI-DrugBank.d469.s9|25-26|of|drug
DDI-DrugBank.d469.s9|28-42|succinylcholine|drug
DDI-DrugBank.d469.s9|44-47|does|drug
DDI-DrugBank.d469.s9|49-51|not|drug
DDI-DrugBank.d469.s9|53-59|enhance|drug
DDI-DrugBank.d469.s9|61-63|the|drug
DDI-DrugBank.d469.s9|65-72|duration|drug
DDI-DrugBank.d469.s9|73-73|,|drug
DDI-DrugBank.d469.s9|75-77|but|drug
DDI-DrugBank.d469.s9|79-86|quickens|drug
DDI-DrugBank.d469.s9|88-90|the|drug
DDI-DrugBank.d469.s9|92-96|onset|drug
DDI-DrugBank.d469.s9|98-100|and|drug
DDI-DrugBank.d469.s9|102-104|may|drug
DDI-DrugBank.d469.s9|106-113|increase|drug
DDI-DrugBank.d469.s9|115-117|the|drug
DDI-DrugBank.d469.s9|119-123|depth|drug
DDI-DrugBank.d469.s9|124-124|,|drug
DDI-DrugBank.d469.s9|126-127|of|drug
DDI-DrugBank.d469.s9|129-141|neuromuscular|drug
DDI-DrugBank.d469.s9|143-147|block|drug
DDI-DrugBank.d469.s9|149-155|induced|drug
DDI-DrugBank.d469.s9|157-158|by|drug
DDI-DrugBank.d469.s9|160-167|TRACRIUM|drug
DDI-DrugBank.d469.s9|168-168|.|drug
DDI-DrugBank.d469.s10|0-7|TRACRIUM|drug
DDI-DrugBank.d469.s10|9-14|should|drug
DDI-DrugBank.d469.s10|16-18|not|drug
DDI-DrugBank.d469.s10|20-21|be|drug
DDI-DrugBank.d469.s10|23-34|administered|drug
DDI-DrugBank.d469.s10|36-40|until|drug
DDI-DrugBank.d469.s10|42-42|a|drug
DDI-DrugBank.d469.s10|44-50|patient|drug
DDI-DrugBank.d469.s10|52-54|has|drug
DDI-DrugBank.d469.s10|56-64|recovered|drug
DDI-DrugBank.d469.s10|66-69|from|drug
DDI-DrugBank.d469.s10|71-93|succinylcholine-induced|drug
DDI-DrugBank.d469.s10|95-107|neuromuscular|drug
DDI-DrugBank.d469.s10|109-113|block|drug
DDI-DrugBank.d469.s10|114-114|.|drug
DDI-DrugBank.d11.s0|0-8|Drug-Drug|drug
DDI-DrugBank.d11.s0|10-21|Interactions|drug
DDI-DrugBank.d11.s0|23-31|Albuterol|drug
DDI-DrugBank.d11.s0|33-33|-|drug
DDI-DrugBank.d11.s0|35-43|STRATTERA|drug
DDI-DrugBank.d11.s0|45-50|should|drug
DDI-DrugBank.d11.s0|52-53|be|drug
DDI-DrugBank.d11.s0|55-66|administered|drug
DDI-DrugBank.d11.s0|68-71|with|drug
DDI-DrugBank.d11.s0|73-79|caution|drug
DDI-DrugBank.d11.s0|81-82|to|drug
DDI-DrugBank.d11.s0|84-91|patients|drug
DDI-DrugBank.d11.s0|93-97|being|drug
DDI-DrugBank.d11.s0|99-105|treated|drug
DDI-DrugBank.d11.s0|107-110|with|drug
DDI-DrugBank.d11.s0|112-136|systemically-administered|drug
DDI-DrugBank.d11.s0|138-138|(|drug
DDI-DrugBank.d11.s0|139-142|oral|drug
DDI-DrugBank.d11.s0|144-145|or|drug
DDI-DrugBank.d11.s0|147-157|intravenous|drug
DDI-DrugBank.d11.s0|158-158|)|drug
DDI-DrugBank.d11.s0|160-168|albuterol|drug
DDI-DrugBank.d11.s0|170-170|(|drug
DDI-DrugBank.d11.s0|171-172|or|drug
DDI-DrugBank.d11.s0|174-178|other|drug
DDI-DrugBank.d11.s0|180-184|beta2|drug
DDI-DrugBank.d11.s0|186-193|agonists|drug
DDI-DrugBank.d11.s0|194-194|)|drug
DDI-DrugBank.d11.s0|196-202|because|drug
DDI-DrugBank.d11.s0|204-206|the|drug
DDI-DrugBank.d11.s0|208-213|action|drug
DDI-DrugBank.d11.s0|215-216|of|drug
DDI-DrugBank.d11.s0|218-226|albuterol|drug
DDI-DrugBank.d11.s0|228-229|on|drug
DDI-DrugBank.d11.s0|231-233|the|drug
DDI-DrugBank.d11.s0|235-248|cardiovascular|drug
DDI-DrugBank.d11.s0|250-255|system|drug
DDI-DrugBank.d11.s0|257-259|can|drug
DDI-DrugBank.d11.s0|261-262|be|drug
DDI-DrugBank.d11.s0|264-274|potentiated|drug
DDI-DrugBank.d11.s0|276-284|resulting|drug
DDI-DrugBank.d11.s0|286-287|in|drug
DDI-DrugBank.d11.s0|289-297|increases|drug
DDI-DrugBank.d11.s0|299-300|in|drug
DDI-DrugBank.d11.s0|302-306|heart|drug
DDI-DrugBank.d11.s0|308-311|rate|drug
DDI-DrugBank.d11.s0|313-315|and|drug
DDI-DrugBank.d11.s0|317-321|blood|drug
DDI-DrugBank.d11.s0|323-330|pressure|drug
DDI-DrugBank.d11.s0|331-331|.|drug
DDI-DrugBank.d11.s1|0-5|CYP2D6|drug
DDI-DrugBank.d11.s1|7-16|inhibitors|drug
DDI-DrugBank.d11.s1|18-18|-|drug
DDI-DrugBank.d11.s1|20-30|Atomoxetine|drug
DDI-DrugBank.d11.s1|32-33|is|drug
DDI-DrugBank.d11.s1|35-43|primarily|drug
DDI-DrugBank.d11.s1|45-55|metabolized|drug
DDI-DrugBank.d11.s1|57-58|by|drug
DDI-DrugBank.d11.s1|60-62|the|drug
DDI-DrugBank.d11.s1|64-69|CYP2D6|drug
DDI-DrugBank.d11.s1|71-77|pathway|drug
DDI-DrugBank.d11.s1|79-80|to|drug
DDI-DrugBank.d11.s1|82-101|4-hydroxyatomoxetine|drug
DDI-DrugBank.d11.s1|102-102|.|drug
DDI-DrugBank.d11.s2|0-1|In|drug
DDI-DrugBank.d11.s2|3-5|EMs|drug
DDI-DrugBank.d11.s2|6-6|,|drug
DDI-DrugBank.d11.s2|8-16|selective|drug
DDI-DrugBank.d11.s2|18-27|inhibitors|drug
DDI-DrugBank.d11.s2|29-30|of|drug
DDI-DrugBank.d11.s2|32-37|CYP2D6|drug
DDI-DrugBank.d11.s2|39-46|increase|drug
DDI-DrugBank.d11.s2|48-58|atomoxetine|drug
DDI-DrugBank.d11.s2|60-71|steady-state|drug
DDI-DrugBank.d11.s2|73-78|plasma|drug
DDI-DrugBank.d11.s2|80-93|concentrations|drug
DDI-DrugBank.d11.s2|95-96|to|drug
DDI-DrugBank.d11.s2|98-106|exposures|drug
DDI-DrugBank.d11.s2|108-114|similar|drug
DDI-DrugBank.d11.s2|116-117|to|drug
DDI-DrugBank.d11.s2|119-123|those|drug
DDI-DrugBank.d11.s2|125-132|observed|drug
DDI-DrugBank.d11.s2|134-135|in|drug
DDI-DrugBank.d11.s2|137-139|PMs|drug
DDI-DrugBank.d11.s2|140-140|.|drug
DDI-DrugBank.d11.s3|0-5|Dosage|drug
DDI-DrugBank.d11.s3|7-16|adjustment|drug
DDI-DrugBank.d11.s3|18-19|of|drug
DDI-DrugBank.d11.s3|21-29|STRATTERA|drug
DDI-DrugBank.d11.s3|31-33|may|drug
DDI-DrugBank.d11.s3|35-36|be|drug
DDI-DrugBank.d11.s3|38-46|necessary|drug
DDI-DrugBank.d11.s3|48-51|when|drug
DDI-DrugBank.d11.s3|53-66|coadministered|drug
DDI-DrugBank.d11.s3|68-71|with|drug
DDI-DrugBank.d11.s3|73-78|CYP2D6|drug
DDI-DrugBank.d11.s3|80-89|inhibitors|drug
DDI-DrugBank.d11.s3|90-90|,|drug
DDI-DrugBank.d11.s3|92-95|e.g.|drug
DDI-DrugBank.d11.s3|96-96|,|drug
DDI-DrugBank.d11.s3|98-107|paroxetine|drug
DDI-DrugBank.d11.s3|108-108|,|drug
DDI-DrugBank.d11.s3|110-119|fluoxetine|drug
DDI-DrugBank.d11.s3|120-120|,|drug
DDI-DrugBank.d11.s3|122-124|and|drug
DDI-DrugBank.d11.s3|126-134|quinidine|drug
DDI-DrugBank.d11.s3|135-135|.|drug
DDI-DrugBank.d11.s4|0-1|In|drug
DDI-DrugBank.d11.s4|3-4|EM|drug
DDI-DrugBank.d11.s4|6-16|individuals|drug
DDI-DrugBank.d11.s4|18-24|treated|drug
DDI-DrugBank.d11.s4|26-29|with|drug
DDI-DrugBank.d11.s4|31-40|paroxetine|drug
DDI-DrugBank.d11.s4|42-43|or|drug
DDI-DrugBank.d11.s4|45-54|fluoxetine|drug
DDI-DrugBank.d11.s4|55-55|,|drug
DDI-DrugBank.d11.s4|57-59|the|drug
DDI-DrugBank.d11.s4|61-63|AUC|drug
DDI-DrugBank.d11.s4|65-66|of|drug
DDI-DrugBank.d11.s4|68-78|atomoxetine|drug
DDI-DrugBank.d11.s4|80-81|is|drug
DDI-DrugBank.d11.s4|83-95|approximately|drug
DDI-DrugBank.d11.s4|97-98|6-|drug
DDI-DrugBank.d11.s4|100-101|to|drug
DDI-DrugBank.d11.s4|103-108|8-fold|drug
DDI-DrugBank.d11.s4|110-112|and|drug
DDI-DrugBank.d11.s4|114-116|Css|drug
DDI-DrugBank.d11.s4|117-117|,|drug
DDI-DrugBank.d11.s4|118-120|max|drug
DDI-DrugBank.d11.s4|122-123|is|drug
DDI-DrugBank.d11.s4|125-129|about|drug
DDI-DrugBank.d11.s4|131-132|3-|drug
DDI-DrugBank.d11.s4|134-135|to|drug
DDI-DrugBank.d11.s4|137-142|4-fold|drug
DDI-DrugBank.d11.s4|144-150|greater|drug
DDI-DrugBank.d11.s4|152-155|than|drug
DDI-DrugBank.d11.s4|157-167|atomoxetine|drug
DDI-DrugBank.d11.s4|169-173|alone|drug
DDI-DrugBank.d11.s4|174-174|.|drug
DDI-DrugBank.d11.s5|0-1|In|drug
DDI-DrugBank.d11.s5|3-7|vitro|drug
DDI-DrugBank.d11.s5|9-15|studies|drug
DDI-DrugBank.d11.s5|17-23|suggest|drug
DDI-DrugBank.d11.s5|25-28|that|drug
DDI-DrugBank.d11.s5|30-45|coadministration|drug
DDI-DrugBank.d11.s5|47-48|of|drug
DDI-DrugBank.d11.s5|50-59|cytochrome|drug
DDI-DrugBank.d11.s5|61-64|P450|drug
DDI-DrugBank.d11.s5|66-75|inhibitors|drug
DDI-DrugBank.d11.s5|77-78|to|drug
DDI-DrugBank.d11.s5|80-82|PMs|drug
DDI-DrugBank.d11.s5|84-87|will|drug
DDI-DrugBank.d11.s5|89-91|not|drug
DDI-DrugBank.d11.s5|93-100|increase|drug
DDI-DrugBank.d11.s5|102-104|the|drug
DDI-DrugBank.d11.s5|106-111|plasma|drug
DDI-DrugBank.d11.s5|113-126|concentrations|drug
DDI-DrugBank.d11.s5|128-129|of|drug
DDI-DrugBank.d11.s5|131-141|atomoxetine|drug
DDI-DrugBank.d11.s5|142-142|.|drug
DDI-DrugBank.d11.s6|0-6|Pressor|drug
DDI-DrugBank.d11.s6|8-13|agents|drug
DDI-DrugBank.d11.s6|15-15|-|drug
DDI-DrugBank.d11.s6|17-23|Because|drug
DDI-DrugBank.d11.s6|25-26|of|drug
DDI-DrugBank.d11.s6|28-35|possible|drug
DDI-DrugBank.d11.s6|37-43|effects|drug
DDI-DrugBank.d11.s6|45-46|on|drug
DDI-DrugBank.d11.s6|48-52|blood|drug
DDI-DrugBank.d11.s6|54-61|pressure|drug
DDI-DrugBank.d11.s6|62-62|,|drug
DDI-DrugBank.d11.s6|64-72|STRATTERA|drug
DDI-DrugBank.d11.s6|74-79|should|drug
DDI-DrugBank.d11.s6|81-82|be|drug
DDI-DrugBank.d11.s6|84-87|used|drug
DDI-DrugBank.d11.s6|89-98|cautiously|drug
DDI-DrugBank.d11.s6|100-103|with|drug
DDI-DrugBank.d11.s6|105-111|pressor|drug
DDI-DrugBank.d11.s6|113-118|agents|drug
DDI-DrugBank.d11.s6|119-119|.|drug
DDI-DrugBank.d276.s0|0-7|Antacids|drug
DDI-DrugBank.d276.s0|9-18|containing|drug
DDI-DrugBank.d276.s0|20-28|magnesium|drug
DDI-DrugBank.d276.s0|30-40|trisilicate|drug
DDI-DrugBank.d276.s0|41-41|,|drug
DDI-DrugBank.d276.s0|43-46|when|drug
DDI-DrugBank.d276.s0|48-59|administered|drug
DDI-DrugBank.d276.s0|61-73|concomitantly|drug
DDI-DrugBank.d276.s0|75-78|with|drug
DDI-DrugBank.d276.s0|80-93|nitrofurantoin|drug
DDI-DrugBank.d276.s0|94-94|,|drug
DDI-DrugBank.d276.s0|96-101|reduce|drug
DDI-DrugBank.d276.s0|103-106|both|drug
DDI-DrugBank.d276.s0|108-110|the|drug
DDI-DrugBank.d276.s0|112-115|rate|drug
DDI-DrugBank.d276.s0|117-119|and|drug
DDI-DrugBank.d276.s0|121-126|extent|drug
DDI-DrugBank.d276.s0|128-129|of|drug
DDI-DrugBank.d276.s0|131-140|absorption|drug
DDI-DrugBank.d276.s0|141-141|.|drug
DDI-DrugBank.d276.s1|0-2|The|drug
DDI-DrugBank.d276.s1|4-12|mechanism|drug
DDI-DrugBank.d276.s1|14-16|for|drug
DDI-DrugBank.d276.s1|18-21|this|drug
DDI-DrugBank.d276.s1|23-33|interaction|drug
DDI-DrugBank.d276.s1|35-42|probably|drug
DDI-DrugBank.d276.s1|44-45|is|drug
DDI-DrugBank.d276.s1|47-56|adsorption|drug
DDI-DrugBank.d276.s1|58-59|of|drug
DDI-DrugBank.d276.s1|61-74|nitrofurantoin|drug
DDI-DrugBank.d276.s1|76-79|onto|drug
DDI-DrugBank.d276.s1|81-83|the|drug
DDI-DrugBank.d276.s1|85-91|surface|drug
DDI-DrugBank.d276.s1|93-94|of|drug
DDI-DrugBank.d276.s1|96-104|magnesium|drug
DDI-DrugBank.d276.s1|106-116|trisilicate|drug
DDI-DrugBank.d276.s1|117-117|.|drug
DDI-DrugBank.d276.s2|0-9|Uricosuric|drug
DDI-DrugBank.d276.s2|11-15|drugs|drug
DDI-DrugBank.d276.s2|16-16|,|drug
DDI-DrugBank.d276.s2|18-21|such|drug
DDI-DrugBank.d276.s2|23-24|as|drug
DDI-DrugBank.d276.s2|26-35|probenecid|drug
DDI-DrugBank.d276.s2|37-39|and|drug
DDI-DrugBank.d276.s2|41-54|sulfinpyrazone|drug
DDI-DrugBank.d276.s2|55-55|,|drug
DDI-DrugBank.d276.s2|57-59|can|drug
DDI-DrugBank.d276.s2|61-67|inhibit|drug
DDI-DrugBank.d276.s2|69-73|renal|drug
DDI-DrugBank.d276.s2|75-81|tubular|drug
DDI-DrugBank.d276.s2|83-91|secretion|drug
DDI-DrugBank.d276.s2|93-94|of|drug
DDI-DrugBank.d276.s2|96-109|nitrofurantoin|drug
DDI-DrugBank.d276.s2|110-110|.|drug
DDI-DrugBank.d276.s3|0-2|The|drug
DDI-DrugBank.d276.s3|4-12|resulting|drug
DDI-DrugBank.d276.s3|14-21|increase|drug
DDI-DrugBank.d276.s3|23-24|in|drug
DDI-DrugBank.d276.s3|26-39|nitrofurantoin|drug
DDI-DrugBank.d276.s3|41-45|serum|drug
DDI-DrugBank.d276.s3|47-52|levels|drug
DDI-DrugBank.d276.s3|54-56|may|drug
DDI-DrugBank.d276.s3|58-65|increase|drug
DDI-DrugBank.d276.s3|67-74|toxicity|drug
DDI-DrugBank.d276.s3|75-75|,|drug
DDI-DrugBank.d276.s3|77-79|and|drug
DDI-DrugBank.d276.s3|81-83|the|drug
DDI-DrugBank.d276.s3|85-93|decreased|drug
DDI-DrugBank.d276.s3|95-101|urinary|drug
DDI-DrugBank.d276.s3|103-108|levels|drug
DDI-DrugBank.d276.s3|110-114|could|drug
DDI-DrugBank.d276.s3|116-121|lessen|drug
DDI-DrugBank.d276.s3|123-125|its|drug
DDI-DrugBank.d276.s3|127-134|efficacy|drug
DDI-DrugBank.d276.s3|136-137|as|drug
DDI-DrugBank.d276.s3|139-139|a|drug
DDI-DrugBank.d276.s3|141-147|urinary|drug
DDI-DrugBank.d276.s3|149-153|tract|drug
DDI-DrugBank.d276.s3|155-167|antibacterial|drug
DDI-DrugBank.d276.s3|168-168|.|drug
DDI-DrugBank.d276.s4|0-14|Drug/Laboratory|drug
DDI-DrugBank.d276.s4|16-19|Test|drug
DDI-DrugBank.d276.s4|21-32|Interactions|drug
DDI-DrugBank.d276.s4|34-35|As|drug
DDI-DrugBank.d276.s4|37-37|a|drug
DDI-DrugBank.d276.s4|39-44|result|drug
DDI-DrugBank.d276.s4|46-47|of|drug
DDI-DrugBank.d276.s4|49-51|the|drug
DDI-DrugBank.d276.s4|53-60|presence|drug
DDI-DrugBank.d276.s4|62-63|of|drug
DDI-DrugBank.d276.s4|65-78|nitrofurantoin|drug
DDI-DrugBank.d276.s4|79-79|,|drug
DDI-DrugBank.d276.s4|81-81|a|drug
DDI-DrugBank.d276.s4|83-96|false-positive|drug
DDI-DrugBank.d276.s4|98-105|reaction|drug
DDI-DrugBank.d276.s4|107-109|for|drug
DDI-DrugBank.d276.s4|111-117|glucose|drug
DDI-DrugBank.d276.s4|119-120|in|drug
DDI-DrugBank.d276.s4|122-124|the|drug
DDI-DrugBank.d276.s4|126-130|urine|drug
DDI-DrugBank.d276.s4|132-134|may|drug
DDI-DrugBank.d276.s4|136-140|occur|drug
DDI-DrugBank.d276.s4|141-141|.|drug
DDI-DrugBank.d276.s5|0-3|This|drug
DDI-DrugBank.d276.s5|5-7|has|drug
DDI-DrugBank.d276.s5|9-12|been|drug
DDI-DrugBank.d276.s5|14-21|observed|drug
DDI-DrugBank.d276.s5|23-26|with|drug
DDI-DrugBank.d276.s5|28-35|Benedict|drug
DDI-DrugBank.d276.s5|37-37|s|drug
DDI-DrugBank.d276.s5|39-41|and|drug
DDI-DrugBank.d276.s5|43-49|Fehling|drug
DDI-DrugBank.d276.s5|51-51|s|drug
DDI-DrugBank.d276.s5|53-61|solutions|drug
DDI-DrugBank.d276.s5|63-65|but|drug
DDI-DrugBank.d276.s5|67-69|not|drug
DDI-DrugBank.d276.s5|71-74|with|drug
DDI-DrugBank.d276.s5|76-78|the|drug
DDI-DrugBank.d276.s5|80-86|glucose|drug
DDI-DrugBank.d276.s5|88-96|enzymatic|drug
DDI-DrugBank.d276.s5|98-101|test|drug
DDI-DrugBank.d276.s5|102-102|.|drug
DDI-DrugBank.d552.s0|0-7|Nabilone|drug
DDI-DrugBank.d552.s0|9-14|should|drug
DDI-DrugBank.d552.s0|16-17|be|drug
DDI-DrugBank.d552.s0|19-30|administered|drug
DDI-DrugBank.d552.s0|32-35|with|drug
DDI-DrugBank.d552.s0|37-43|caution|drug
DDI-DrugBank.d552.s0|45-46|to|drug
DDI-DrugBank.d552.s0|48-55|patients|drug
DDI-DrugBank.d552.s0|57-59|who|drug
DDI-DrugBank.d552.s0|61-63|are|drug
DDI-DrugBank.d552.s0|65-70|taking|drug
DDI-DrugBank.d552.s0|72-76|other|drug
DDI-DrugBank.d552.s0|78-89|psychoactive|drug
DDI-DrugBank.d552.s0|91-95|drugs|drug
DDI-DrugBank.d552.s0|97-98|or|drug
DDI-DrugBank.d552.s0|100-102|CNS|drug
DDI-DrugBank.d552.s0|104-114|depressants|drug
DDI-DrugBank.d552.s0|115-115|,|drug
DDI-DrugBank.d552.s0|117-125|including|drug
DDI-DrugBank.d552.s0|127-133|alcohol|drug
DDI-DrugBank.d552.s0|134-134|,|drug
DDI-DrugBank.d552.s0|136-147|barbiturates|drug
DDI-DrugBank.d552.s0|149-151|and|drug
DDI-DrugBank.d552.s0|153-160|narcotic|drug
DDI-DrugBank.d552.s0|162-171|analgesics|drug
DDI-DrugBank.d552.s0|172-172|,|drug
DDI-DrugBank.d552.s0|174-175|or|drug
DDI-DrugBank.d552.s0|177-178|to|drug
DDI-DrugBank.d552.s0|180-184|those|drug
DDI-DrugBank.d552.s0|186-189|with|drug
DDI-DrugBank.d552.s0|191-191|a|drug
DDI-DrugBank.d552.s0|193-199|history|drug
DDI-DrugBank.d552.s0|201-202|of|drug
DDI-DrugBank.d552.s0|204-214|psychiatric|drug
DDI-DrugBank.d552.s0|216-223|disorder|drug
DDI-DrugBank.d552.s0|225-225|(|drug
DDI-DrugBank.d552.s0|226-234|including|drug
DDI-DrugBank.d552.s0|236-251|manic-depressive|drug
DDI-DrugBank.d552.s0|253-259|illness|drug
DDI-DrugBank.d552.s0|261-263|and|drug
DDI-DrugBank.d552.s0|265-277|schizophrenia|drug
DDI-DrugBank.d552.s0|278-278|)|drug
DDI-DrugBank.d552.s0|279-279|.|drug
DDI-DrugBank.d552.s1|0-7|Nabilone|drug
DDI-DrugBank.d552.s1|9-11|has|drug
DDI-DrugBank.d552.s1|13-16|been|drug
DDI-DrugBank.d552.s1|18-22|shown|drug
DDI-DrugBank.d552.s1|24-25|to|drug
DDI-DrugBank.d552.s1|27-30|have|drug
DDI-DrugBank.d552.s1|32-33|an|drug
DDI-DrugBank.d552.s1|35-42|additive|drug
DDI-DrugBank.d552.s1|44-46|CNS|drug
DDI-DrugBank.d552.s1|48-57|depressant|drug
DDI-DrugBank.d552.s1|59-64|effect|drug
DDI-DrugBank.d552.s1|66-69|when|drug
DDI-DrugBank.d552.s1|71-75|given|drug
DDI-DrugBank.d552.s1|77-80|with|drug
DDI-DrugBank.d552.s1|82-87|either|drug
DDI-DrugBank.d552.s1|89-96|diazepam|drug
DDI-DrugBank.d552.s1|97-97|,|drug
DDI-DrugBank.d552.s1|99-111|secobarbitone|drug
DDI-DrugBank.d552.s1|113-118|sodium|drug
DDI-DrugBank.d552.s1|119-119|,|drug
DDI-DrugBank.d552.s1|121-127|alcohol|drug
DDI-DrugBank.d552.s1|129-130|or|drug
DDI-DrugBank.d552.s1|132-138|codeine|drug
DDI-DrugBank.d552.s1|139-139|.|drug
DDI-DrugBank.d51.s0|0-7|ATROVENT|drug
DDI-DrugBank.d51.s0|9-18|Inhalation|drug
DDI-DrugBank.d51.s0|20-26|Aerosol|drug
DDI-DrugBank.d51.s0|28-30|has|drug
DDI-DrugBank.d51.s0|32-35|been|drug
DDI-DrugBank.d51.s0|37-40|used|drug
DDI-DrugBank.d51.s0|42-54|concomitantly|drug
DDI-DrugBank.d51.s0|56-59|with|drug
DDI-DrugBank.d51.s0|61-65|other|drug
DDI-DrugBank.d51.s0|67-71|drugs|drug
DDI-DrugBank.d51.s0|72-72|,|drug
DDI-DrugBank.d51.s0|74-82|including|drug
DDI-DrugBank.d51.s0|84-98|sympathomimetic|drug
DDI-DrugBank.d51.s0|100-114|bronchodilators|drug
DDI-DrugBank.d51.s0|115-115|,|drug
DDI-DrugBank.d51.s0|117-131|methylxanthines|drug
DDI-DrugBank.d51.s0|132-132|,|drug
DDI-DrugBank.d51.s0|134-136|and|drug
DDI-DrugBank.d51.s0|138-145|steroids|drug
DDI-DrugBank.d51.s0|146-146|,|drug
DDI-DrugBank.d51.s0|148-155|commonly|drug
DDI-DrugBank.d51.s0|157-160|used|drug
DDI-DrugBank.d51.s0|162-163|in|drug
DDI-DrugBank.d51.s0|165-167|the|drug
DDI-DrugBank.d51.s0|169-177|treatment|drug
DDI-DrugBank.d51.s0|179-180|of|drug
DDI-DrugBank.d51.s0|182-188|chronic|drug
DDI-DrugBank.d51.s0|190-200|obstructive|drug
DDI-DrugBank.d51.s0|202-210|pulmonary|drug
DDI-DrugBank.d51.s0|212-218|disease|drug
DDI-DrugBank.d51.s0|219-219|.|drug
DDI-DrugBank.d51.s1|0-3|With|drug
DDI-DrugBank.d51.s1|5-7|the|drug
DDI-DrugBank.d51.s1|9-17|exception|drug
DDI-DrugBank.d51.s1|19-20|of|drug
DDI-DrugBank.d51.s1|22-30|albuterol|drug
DDI-DrugBank.d51.s1|31-31|,|drug
DDI-DrugBank.d51.s1|33-37|there|drug
DDI-DrugBank.d51.s1|39-41|are|drug
DDI-DrugBank.d51.s1|43-44|no|drug
DDI-DrugBank.d51.s1|46-51|formal|drug
DDI-DrugBank.d51.s1|53-59|studies|drug
DDI-DrugBank.d51.s1|61-65|fully|drug
DDI-DrugBank.d51.s1|67-76|evaluating|drug
DDI-DrugBank.d51.s1|78-80|the|drug
DDI-DrugBank.d51.s1|82-92|interaction|drug
DDI-DrugBank.d51.s1|94-100|effects|drug
DDI-DrugBank.d51.s1|102-103|of|drug
DDI-DrugBank.d51.s1|105-112|ATROVENT|drug
DDI-DrugBank.d51.s1|114-123|Inhalation|drug
DDI-DrugBank.d51.s1|125-131|Aerosol|drug
DDI-DrugBank.d51.s1|133-135|and|drug
DDI-DrugBank.d51.s1|137-141|these|drug
DDI-DrugBank.d51.s1|143-147|drugs|drug
DDI-DrugBank.d51.s1|149-152|with|drug
DDI-DrugBank.d51.s1|154-160|respect|drug
DDI-DrugBank.d51.s1|162-163|to|drug
DDI-DrugBank.d51.s1|165-177|effectiveness|drug
DDI-DrugBank.d51.s1|178-178|.|drug
DDI-DrugBank.d51.s2|0-14|Anticholinergic|drug
DDI-DrugBank.d51.s2|16-21|agents|drug
DDI-DrugBank.d51.s2|22-22|:|drug
DDI-DrugBank.d51.s2|24-31|Although|drug
DDI-DrugBank.d51.s2|33-43|ipratropium|drug
DDI-DrugBank.d51.s2|45-51|bromide|drug
DDI-DrugBank.d51.s2|53-54|is|drug
DDI-DrugBank.d51.s2|56-64|minimally|drug
DDI-DrugBank.d51.s2|66-73|absorbed|drug
DDI-DrugBank.d51.s2|75-78|into|drug
DDI-DrugBank.d51.s2|80-82|the|drug
DDI-DrugBank.d51.s2|84-91|systemic|drug
DDI-DrugBank.d51.s2|93-103|circulation|drug
DDI-DrugBank.d51.s2|104-104|,|drug
DDI-DrugBank.d51.s2|106-110|there|drug
DDI-DrugBank.d51.s2|112-113|is|drug
DDI-DrugBank.d51.s2|115-118|some|drug
DDI-DrugBank.d51.s2|120-128|potential|drug
DDI-DrugBank.d51.s2|130-132|for|drug
DDI-DrugBank.d51.s2|134-135|an|drug
DDI-DrugBank.d51.s2|137-144|additive|drug
DDI-DrugBank.d51.s2|146-156|interaction|drug
DDI-DrugBank.d51.s2|158-161|with|drug
DDI-DrugBank.d51.s2|163-175|concomitantly|drug
DDI-DrugBank.d51.s2|177-180|used|drug
DDI-DrugBank.d51.s2|182-196|anticholinergic|drug
DDI-DrugBank.d51.s2|198-208|medications|drug
DDI-DrugBank.d51.s2|209-209|.|drug
DDI-DrugBank.d51.s3|0-6|Caution|drug
DDI-DrugBank.d51.s3|8-9|is|drug
DDI-DrugBank.d51.s3|11-19|therefore|drug
DDI-DrugBank.d51.s3|21-27|advised|drug
DDI-DrugBank.d51.s3|29-30|in|drug
DDI-DrugBank.d51.s3|32-34|the|drug
DDI-DrugBank.d51.s3|36-51|coadministration|drug
DDI-DrugBank.d51.s3|53-54|of|drug
DDI-DrugBank.d51.s3|56-63|ATROVENT|drug
DDI-DrugBank.d51.s3|65-74|Inhalation|drug
DDI-DrugBank.d51.s3|76-82|Aerosol|drug
DDI-DrugBank.d51.s3|84-87|with|drug
DDI-DrugBank.d51.s3|89-93|other|drug
DDI-DrugBank.d51.s3|95-120|anticholinergic-containing|drug
DDI-DrugBank.d51.s3|122-126|drugs|drug
DDI-DrugBank.d51.s3|127-127|.|drug
DDI-DrugBank.d146.s0|0-9|Colchicine|drug
DDI-DrugBank.d146.s0|11-12|is|drug
DDI-DrugBank.d146.s0|14-22|inhibited|drug
DDI-DrugBank.d146.s0|24-25|by|drug
DDI-DrugBank.d146.s0|27-36|acidifying|drug
DDI-DrugBank.d146.s0|38-43|agents|drug
DDI-DrugBank.d146.s0|44-44|.|drug
DDI-DrugBank.d146.s1|0-2|The|drug
DDI-DrugBank.d146.s1|4-9|action|drug
DDI-DrugBank.d146.s1|11-12|of|drug
DDI-DrugBank.d146.s1|14-23|colchicine|drug
DDI-DrugBank.d146.s1|25-26|is|drug
DDI-DrugBank.d146.s1|28-38|potentiated|drug
DDI-DrugBank.d146.s1|40-41|by|drug
DDI-DrugBank.d146.s1|43-54|alkalinizing|drug
DDI-DrugBank.d146.s1|56-61|agents|drug
DDI-DrugBank.d146.s1|62-62|.|drug
DDI-DrugBank.d146.s2|0-9|Colchicine|drug
DDI-DrugBank.d146.s2|11-13|may|drug
DDI-DrugBank.d146.s2|15-22|increase|drug
DDI-DrugBank.d146.s2|24-34|sensitivity|drug
DDI-DrugBank.d146.s2|36-37|to|drug
DDI-DrugBank.d146.s2|39-41|the|drug
DDI-DrugBank.d146.s2|43-45|CNS|drug
DDI-DrugBank.d146.s2|47-57|depressants|drug
DDI-DrugBank.d146.s2|58-58|.|drug
DDI-DrugBank.d146.s3|0-7|Response|drug
DDI-DrugBank.d146.s3|9-10|to|drug
DDI-DrugBank.d146.s3|12-26|sympathomimetic|drug
DDI-DrugBank.d146.s3|28-33|agents|drug
DDI-DrugBank.d146.s3|35-37|may|drug
DDI-DrugBank.d146.s3|39-40|be|drug
DDI-DrugBank.d146.s3|42-49|enhanced|drug
DDI-DrugBank.d146.s3|51-52|by|drug
DDI-DrugBank.d146.s3|54-63|colchicine|drug
DDI-DrugBank.d146.s3|64-64|.|drug
DDI-MedLine.d189.s0|0-6|Effects|drug
DDI-MedLine.d189.s0|8-9|of|drug
DDI-MedLine.d189.s0|11-13|CYP|drug
DDI-MedLine.d189.s0|15-24|inhibitors|drug
DDI-MedLine.d189.s0|26-27|on|drug
DDI-MedLine.d189.s0|29-37|precocene|drug
DDI-MedLine.d189.s0|39-39|I|drug
DDI-MedLine.d189.s0|41-50|metabolism|drug
DDI-MedLine.d189.s0|52-54|and|drug
DDI-MedLine.d189.s0|56-63|toxicity|drug
DDI-MedLine.d189.s0|65-66|in|drug
DDI-MedLine.d189.s0|68-70|rat|drug
DDI-MedLine.d189.s0|72-76|liver|drug
DDI-MedLine.d189.s0|78-83|slices|drug
DDI-MedLine.d189.s0|84-84|.|drug
DDI-MedLine.d189.s1|0-1|We|drug
DDI-MedLine.d189.s1|3-9|present|drug
DDI-MedLine.d189.s1|11-11|a|drug
DDI-MedLine.d189.s1|13-25|comprehensive|drug
DDI-MedLine.d189.s1|27-28|in|drug
DDI-MedLine.d189.s1|30-34|vitro|drug
DDI-MedLine.d189.s1|36-43|approach|drug
DDI-MedLine.d189.s1|45-46|to|drug
DDI-MedLine.d189.s1|48-56|assessing|drug
DDI-MedLine.d189.s1|58-76|metabolism-mediated|drug
DDI-MedLine.d189.s1|78-91|hepatotoxicity|drug
DDI-MedLine.d189.s1|93-97|using|drug
DDI-MedLine.d189.s1|99-102|male|drug
DDI-MedLine.d189.s1|104-117|Sprague-Dawley|drug
DDI-MedLine.d189.s1|119-121|rat|drug
DDI-MedLine.d189.s1|123-127|liver|drug
DDI-MedLine.d189.s1|129-134|slices|drug
DDI-MedLine.d189.s1|136-144|incubated|drug
DDI-MedLine.d189.s1|146-149|with|drug
DDI-MedLine.d189.s1|151-153|the|drug
DDI-MedLine.d189.s1|155-158|well|drug
DDI-MedLine.d189.s1|160-172|characterized|drug
DDI-MedLine.d189.s1|174-187|hepatotoxicant|drug
DDI-MedLine.d189.s1|188-188|,|drug
DDI-MedLine.d189.s1|190-198|precocene|drug
DDI-MedLine.d189.s1|200-200|I|drug
DDI-MedLine.d189.s1|201-201|,|drug
DDI-MedLine.d189.s1|203-205|and|drug
DDI-MedLine.d189.s1|207-216|inhibitors|drug
DDI-MedLine.d189.s1|218-219|of|drug
DDI-MedLine.d189.s1|221-230|cytochrome|drug
DDI-MedLine.d189.s1|232-235|P450|drug
DDI-MedLine.d189.s1|237-237|(|drug
DDI-MedLine.d189.s1|238-240|CYP|drug
DDI-MedLine.d189.s1|241-241|)|drug
DDI-MedLine.d189.s1|243-249|enzymes|drug
DDI-MedLine.d189.s1|250-250|.|drug
DDI-MedLine.d189.s2|0-3|This|drug
DDI-MedLine.d189.s2|5-12|approach|drug
DDI-MedLine.d189.s2|14-21|combines|drug
DDI-MedLine.d189.s2|23-28|liquid|drug
DDI-MedLine.d189.s2|30-43|chromatography|drug
DDI-MedLine.d189.s2|45-48|mass|drug
DDI-MedLine.d189.s2|50-61|spectrometry|drug
DDI-MedLine.d189.s2|63-63|(|drug
DDI-MedLine.d189.s2|64-65|LC|drug
DDI-MedLine.d189.s2|67-68|MS|drug
DDI-MedLine.d189.s2|69-69|)|drug
DDI-MedLine.d189.s2|71-79|detection|drug
DDI-MedLine.d189.s2|81-87|methods|drug
DDI-MedLine.d189.s2|89-92|with|drug
DDI-MedLine.d189.s2|94-101|multiple|drug
DDI-MedLine.d189.s2|103-110|toxicity|drug
DDI-MedLine.d189.s2|112-120|endpoints|drug
DDI-MedLine.d189.s2|122-123|to|drug
DDI-MedLine.d189.s2|125-130|enable|drug
DDI-MedLine.d189.s2|132-145|identification|drug
DDI-MedLine.d189.s2|147-148|of|drug
DDI-MedLine.d189.s2|150-157|critical|drug
DDI-MedLine.d189.s2|159-167|metabolic|drug
DDI-MedLine.d189.s2|169-176|pathways|drug
DDI-MedLine.d189.s2|178-180|for|drug
DDI-MedLine.d189.s2|182-195|hepatotoxicity|drug
DDI-MedLine.d189.s2|196-196|.|drug
DDI-MedLine.d189.s3|0-2|The|drug
DDI-MedLine.d189.s3|4-14|incubations|drug
DDI-MedLine.d189.s3|16-19|were|drug
DDI-MedLine.d189.s3|21-29|performed|drug
DDI-MedLine.d189.s3|31-32|in|drug
DDI-MedLine.d189.s3|34-36|the|drug
DDI-MedLine.d189.s3|38-44|absence|drug
DDI-MedLine.d189.s3|46-48|and|drug
DDI-MedLine.d189.s3|50-57|presence|drug
DDI-MedLine.d189.s3|59-60|of|drug
DDI-MedLine.d189.s3|62-64|the|drug
DDI-MedLine.d189.s3|66-77|non-specific|drug
DDI-MedLine.d189.s3|79-81|CYP|drug
DDI-MedLine.d189.s3|83-91|inhibitor|drug
DDI-MedLine.d189.s3|92-92|,|drug
DDI-MedLine.d189.s3|94-113|1-aminobenzotriazole|drug
DDI-MedLine.d189.s3|115-115|(|drug
DDI-MedLine.d189.s3|116-118|ABT|drug
DDI-MedLine.d189.s3|119-119|)|drug
DDI-MedLine.d189.s3|121-123|and|drug
DDI-MedLine.d189.s3|125-140|isoform-specific|drug
DDI-MedLine.d189.s3|142-151|inhibitors|drug
DDI-MedLine.d189.s3|152-152|.|drug
DDI-MedLine.d189.s4|0-2|The|drug
DDI-MedLine.d189.s4|4-13|metabolite|drug
DDI-MedLine.d189.s4|15-21|profile|drug
DDI-MedLine.d189.s4|23-24|of|drug
DDI-MedLine.d189.s4|26-34|precocene|drug
DDI-MedLine.d189.s4|36-36|I|drug
DDI-MedLine.d189.s4|38-39|in|drug
DDI-MedLine.d189.s4|41-43|rat|drug
DDI-MedLine.d189.s4|45-49|liver|drug
DDI-MedLine.d189.s4|51-56|slices|drug
DDI-MedLine.d189.s4|58-63|shares|drug
DDI-MedLine.d189.s4|65-68|some|drug
DDI-MedLine.d189.s4|70-77|features|drug
DDI-MedLine.d189.s4|79-80|of|drug
DDI-MedLine.d189.s4|82-84|the|drug
DDI-MedLine.d189.s4|86-87|in|drug
DDI-MedLine.d189.s4|89-92|vivo|drug
DDI-MedLine.d189.s4|94-100|profile|drug
DDI-MedLine.d189.s4|101-101|,|drug
DDI-MedLine.d189.s4|103-105|but|drug
DDI-MedLine.d189.s4|107-110|also|drug
DDI-MedLine.d189.s4|112-114|had|drug
DDI-MedLine.d189.s4|116-116|a|drug
DDI-MedLine.d189.s4|118-122|major|drug
DDI-MedLine.d189.s4|124-133|difference|drug
DDI-MedLine.d189.s4|135-136|in|drug
DDI-MedLine.d189.s4|138-141|that|drug
DDI-MedLine.d189.s4|143-149|epoxide|drug
DDI-MedLine.d189.s4|151-161|dihydrodiol|drug
DDI-MedLine.d189.s4|163-172|hydrolysis|drug
DDI-MedLine.d189.s4|174-181|products|drug
DDI-MedLine.d189.s4|183-186|were|drug
DDI-MedLine.d189.s4|188-190|not|drug
DDI-MedLine.d189.s4|192-199|observed|drug
DDI-MedLine.d189.s4|201-202|to|drug
DDI-MedLine.d189.s4|204-204|a|drug
DDI-MedLine.d189.s4|206-215|measurable|drug
DDI-MedLine.d189.s4|217-222|extent|drug
DDI-MedLine.d189.s4|223-223|.|drug
DDI-MedLine.d189.s5|0-1|As|drug
DDI-MedLine.d189.s5|3-10|examples|drug
DDI-MedLine.d189.s5|12-13|of|drug
DDI-MedLine.d189.s5|15-17|our|drug
DDI-MedLine.d189.s5|19-23|liver|drug
DDI-MedLine.d189.s5|25-29|slice|drug
DDI-MedLine.d189.s5|31-40|metabolite|drug
DDI-MedLine.d189.s5|42-55|identification|drug
DDI-MedLine.d189.s5|57-65|procedure|drug
DDI-MedLine.d189.s5|66-66|,|drug
DDI-MedLine.d189.s5|68-68|a|drug
DDI-MedLine.d189.s5|70-74|minor|drug
DDI-MedLine.d189.s5|76-86|glutathione|drug
DDI-MedLine.d189.s5|88-93|adduct|drug
DDI-MedLine.d189.s5|95-97|and|drug
DDI-MedLine.d189.s5|99-108|previously|drug
DDI-MedLine.d189.s5|110-119|unreported|drug
DDI-MedLine.d189.s5|121-133|7-O-desmethyl|drug
DDI-MedLine.d189.s5|135-137|and|drug
DDI-MedLine.d189.s5|139-152|glucuronidated|drug
DDI-MedLine.d189.s5|154-164|metabolites|drug
DDI-MedLine.d189.s5|166-167|of|drug
DDI-MedLine.d189.s5|169-177|precocene|drug
DDI-MedLine.d189.s5|179-179|I|drug
DDI-MedLine.d189.s5|181-183|are|drug
DDI-MedLine.d189.s5|185-192|reported|drug
DDI-MedLine.d189.s5|193-193|.|drug
DDI-MedLine.d189.s6|0-8|Precocene|drug
DDI-MedLine.d189.s6|10-10|I|drug
DDI-MedLine.d189.s6|12-18|induced|drug
DDI-MedLine.d189.s6|20-33|hepatocellular|drug
DDI-MedLine.d189.s6|35-42|necrosis|drug
DDI-MedLine.d189.s6|44-45|in|drug
DDI-MedLine.d189.s6|47-47|a|drug
DDI-MedLine.d189.s6|49-53|dose-|drug
DDI-MedLine.d189.s6|55-57|and|drug
DDI-MedLine.d189.s6|59-72|time-dependent|drug
DDI-MedLine.d189.s6|74-79|manner|drug
DDI-MedLine.d189.s6|80-80|.|drug
DDI-MedLine.d189.s7|0-2|ABT|drug
DDI-MedLine.d189.s7|4-12|decreased|drug
DDI-MedLine.d189.s7|14-16|the|drug
DDI-MedLine.d189.s7|18-25|toxicity|drug
DDI-MedLine.d189.s7|27-28|of|drug
DDI-MedLine.d189.s7|30-38|precocene|drug
DDI-MedLine.d189.s7|40-40|I|drug
DDI-MedLine.d189.s7|41-41|,|drug
DDI-MedLine.d189.s7|43-51|increased|drug
DDI-MedLine.d189.s7|53-60|exposure|drug
DDI-MedLine.d189.s7|62-63|to|drug
DDI-MedLine.d189.s7|65-70|parent|drug
DDI-MedLine.d189.s7|72-79|compound|drug
DDI-MedLine.d189.s7|80-80|,|drug
DDI-MedLine.d189.s7|82-84|and|drug
DDI-MedLine.d189.s7|86-94|decreased|drug
DDI-MedLine.d189.s7|96-105|metabolite|drug
DDI-MedLine.d189.s7|107-112|levels|drug
DDI-MedLine.d189.s7|114-115|in|drug
DDI-MedLine.d189.s7|117-117|a|drug
DDI-MedLine.d189.s7|119-132|dose-dependent|drug
DDI-MedLine.d189.s7|134-139|manner|drug
DDI-MedLine.d189.s7|140-140|.|drug
DDI-MedLine.d189.s8|0-1|Of|drug
DDI-MedLine.d189.s8|3-5|the|drug
DDI-MedLine.d189.s8|7-22|isoform-specific|drug
DDI-MedLine.d189.s8|24-26|CYP|drug
DDI-MedLine.d189.s8|28-37|inhibitors|drug
DDI-MedLine.d189.s8|39-44|tested|drug
DDI-MedLine.d189.s8|46-48|for|drug
DDI-MedLine.d189.s8|50-51|an|drug
DDI-MedLine.d189.s8|53-58|effect|drug
DDI-MedLine.d189.s8|60-61|on|drug
DDI-MedLine.d189.s8|63-65|the|drug
DDI-MedLine.d189.s8|67-75|precocene|drug
DDI-MedLine.d189.s8|77-77|I|drug
DDI-MedLine.d189.s8|79-88|metabolite|drug
DDI-MedLine.d189.s8|90-96|profile|drug
DDI-MedLine.d189.s8|97-97|,|drug
DDI-MedLine.d189.s8|99-102|only|drug
DDI-MedLine.d189.s8|104-118|tranylcypromine|drug
DDI-MedLine.d189.s8|120-122|was|drug
DDI-MedLine.d189.s8|124-133|noticeably|drug
DDI-MedLine.d189.s8|135-143|effective|drug
DDI-MedLine.d189.s8|144-144|,|drug
DDI-MedLine.d189.s8|146-155|indicating|drug
DDI-MedLine.d189.s8|157-157|a|drug
DDI-MedLine.d189.s8|159-162|role|drug
DDI-MedLine.d189.s8|164-165|of|drug
DDI-MedLine.d189.s8|167-170|CYPs|drug
DDI-MedLine.d189.s8|172-174|2A6|drug
DDI-MedLine.d189.s8|175-175|,|drug
DDI-MedLine.d189.s8|177-179|2C9|drug
DDI-MedLine.d189.s8|180-180|,|drug
DDI-MedLine.d189.s8|182-185|2Cl9|drug
DDI-MedLine.d189.s8|186-186|,|drug
DDI-MedLine.d189.s8|188-190|and|drug
DDI-MedLine.d189.s8|192-194|2E1|drug
DDI-MedLine.d189.s8|195-195|.|drug
DDI-MedLine.d189.s9|0-3|With|drug
DDI-MedLine.d189.s9|5-11|respect|drug
DDI-MedLine.d189.s9|13-14|to|drug
DDI-MedLine.d189.s9|16-23|toxicity|drug
DDI-MedLine.d189.s9|24-24|,|drug
DDI-MedLine.d189.s9|26-28|the|drug
DDI-MedLine.d189.s9|30-34|order|drug
DDI-MedLine.d189.s9|36-37|of|drug
DDI-MedLine.d189.s9|39-41|CYP|drug
DDI-MedLine.d189.s9|43-51|inhibitor|drug
DDI-MedLine.d189.s9|53-65|effectiveness|drug
DDI-MedLine.d189.s9|67-69|was|drug
DDI-MedLine.d189.s9|71-73|ABT|drug
DDI-MedLine.d189.s9|74-74|>|drug
DDI-MedLine.d189.s9|75-112|diethyldithiocarbamate~tranylcypromine|drug
DDI-MedLine.d189.s9|113-113|>|drug
DDI-MedLine.d189.s9|114-125|ketoconazole|drug
DDI-MedLine.d189.s9|126-126|.|drug
DDI-MedLine.d189.s10|0-10|Furafylline|drug
DDI-MedLine.d189.s10|12-14|and|drug
DDI-MedLine.d189.s10|16-29|sulfaphenazole|drug
DDI-MedLine.d189.s10|31-33|had|drug
DDI-MedLine.d189.s10|35-36|no|drug
DDI-MedLine.d189.s10|38-43|effect|drug
DDI-MedLine.d189.s10|44-44|,|drug
DDI-MedLine.d189.s10|46-50|while|drug
DDI-MedLine.d189.s10|52-60|quinidine|drug
DDI-MedLine.d189.s10|62-69|appeared|drug
DDI-MedLine.d189.s10|71-72|to|drug
DDI-MedLine.d189.s10|74-80|augment|drug
DDI-MedLine.d189.s10|82-90|precocene|drug
DDI-MedLine.d189.s10|92-92|I|drug
DDI-MedLine.d189.s10|94-101|toxicity|drug
DDI-MedLine.d189.s10|102-102|.|drug
DDI-MedLine.d189.s11|0-4|These|drug
DDI-MedLine.d189.s11|6-12|results|drug
DDI-MedLine.d189.s11|14-20|suggest|drug
DDI-MedLine.d189.s11|22-25|that|drug
DDI-MedLine.d189.s11|27-29|rat|drug
DDI-MedLine.d189.s11|31-35|liver|drug
DDI-MedLine.d189.s11|37-42|slices|drug
DDI-MedLine.d189.s11|44-45|do|drug
DDI-MedLine.d189.s11|47-49|not|drug
DDI-MedLine.d189.s11|51-59|reproduce|drug
DDI-MedLine.d189.s11|61-63|the|drug
DDI-MedLine.d189.s11|65-72|reported|drug
DDI-MedLine.d189.s11|74-75|in|drug
DDI-MedLine.d189.s11|77-80|vivo|drug
DDI-MedLine.d189.s11|82-98|biotransformation|drug
DDI-MedLine.d189.s11|100-101|of|drug
DDI-MedLine.d189.s11|103-111|precocene|drug
DDI-MedLine.d189.s11|113-113|I|drug
DDI-MedLine.d189.s11|115-117|and|drug
DDI-MedLine.d189.s11|119-127|therefore|drug
DDI-MedLine.d189.s11|129-131|may|drug
DDI-MedLine.d189.s11|133-135|not|drug
DDI-MedLine.d189.s11|137-138|be|drug
DDI-MedLine.d189.s11|140-141|an|drug
DDI-MedLine.d189.s11|143-153|appropriate|drug
DDI-MedLine.d189.s11|155-159|model|drug
DDI-MedLine.d189.s11|161-163|for|drug
DDI-MedLine.d189.s11|165-173|precocene|drug
DDI-MedLine.d189.s11|175-175|I|drug
DDI-MedLine.d189.s11|177-186|metabolism|drug
DDI-MedLine.d189.s11|187-187|.|drug
DDI-MedLine.d189.s12|0-6|However|drug
DDI-MedLine.d189.s12|7-7|,|drug
DDI-MedLine.d189.s12|9-13|these|drug
DDI-MedLine.d189.s12|15-21|results|drug
DDI-MedLine.d189.s12|23-29|provide|drug
DDI-MedLine.d189.s12|31-32|an|drug
DDI-MedLine.d189.s12|34-40|example|drug
DDI-MedLine.d189.s12|42-43|of|drug
DDI-MedLine.d189.s12|45-47|how|drug
DDI-MedLine.d189.s12|49-53|small|drug
DDI-MedLine.d189.s12|55-62|molecule|drug
DDI-MedLine.d189.s12|64-75|manipulation|drug
DDI-MedLine.d189.s12|77-78|of|drug
DDI-MedLine.d189.s12|80-82|CYP|drug
DDI-MedLine.d189.s12|84-91|activity|drug
DDI-MedLine.d189.s12|93-94|in|drug
DDI-MedLine.d189.s12|96-97|an|drug
DDI-MedLine.d189.s12|99-100|in|drug
DDI-MedLine.d189.s12|102-106|vitro|drug
DDI-MedLine.d189.s12|108-112|model|drug
DDI-MedLine.d189.s12|114-116|can|drug
DDI-MedLine.d189.s12|118-119|be|drug
DDI-MedLine.d189.s12|121-124|used|drug
DDI-MedLine.d189.s12|126-127|to|drug
DDI-MedLine.d189.s12|129-135|confirm|drug
DDI-MedLine.d189.s12|137-155|metabolism-mediated|drug
DDI-MedLine.d189.s12|157-164|toxicity|drug
DDI-MedLine.d189.s12|165-165|.|drug
DDI-DrugBank.d405.s0|0-8|Dicumarol|drug
DDI-DrugBank.d405.s0|10-12|and|drug
DDI-DrugBank.d405.s0|14-21|warfarin|drug
DDI-DrugBank.d405.s0|23-25|may|drug
DDI-DrugBank.d405.s0|27-34|decrease|drug
DDI-DrugBank.d405.s0|36-54|hypoprothrombinemic|drug
DDI-DrugBank.d405.s0|56-61|effect|drug
DDI-DrugBank.d405.s0|62-62|.|drug
DDI-DrugBank.d405.s1|0-4|Other|drug
DDI-DrugBank.d405.s1|6-17|depressasnts|drug
DDI-DrugBank.d405.s1|19-22|such|drug
DDI-DrugBank.d405.s1|24-25|as|drug
DDI-DrugBank.d405.s1|27-33|alcohol|drug
DDI-DrugBank.d405.s1|34-34|,|drug
DDI-DrugBank.d405.s1|36-47|barbiturates|drug
DDI-DrugBank.d405.s1|48-48|,|drug
DDI-DrugBank.d405.s1|50-52|and|drug
DDI-DrugBank.d405.s1|54-58|MAOIs|drug
DDI-DrugBank.d405.s1|60-62|may|drug
DDI-DrugBank.d405.s1|64-70|enhance|drug
DDI-DrugBank.d405.s1|72-74|CNS|drug
DDI-DrugBank.d405.s1|76-85|depression|drug
DDI-DrugBank.d405.s1|87-90|when|drug
DDI-DrugBank.d405.s1|92-103|administered|drug
DDI-DrugBank.d405.s1|105-108|with|drug
DDI-DrugBank.d405.s1|110-122|ethchlorvynol|drug
DDI-DrugBank.d405.s1|123-123|.|drug
DDI-DrugBank.d576.s0|0-10|Salicylates|drug
DDI-DrugBank.d576.s0|12-21|antagonize|drug
DDI-DrugBank.d576.s0|23-25|the|drug
DDI-DrugBank.d576.s0|27-36|uricosuric|drug
DDI-DrugBank.d576.s0|38-43|action|drug
DDI-DrugBank.d576.s0|45-46|of|drug
DDI-DrugBank.d576.s0|48-48|.|drug
DDI-DrugBank.d576.s0|50-54|drugs|drug
DDI-DrugBank.d576.s0|56-59|used|drug
DDI-DrugBank.d576.s0|61-62|to|drug
DDI-DrugBank.d576.s0|64-68|treat|drug
DDI-DrugBank.d576.s0|70-73|gout|drug
DDI-DrugBank.d576.s0|74-74|.|drug
DDI-DrugBank.d576.s1|0-6|ASPIRIN|drug
DDI-DrugBank.d576.s1|8-10|AND|drug
DDI-DrugBank.d576.s1|12-16|OTHER|drug
DDI-DrugBank.d576.s1|18-27|SALICYLATE|drug
DDI-DrugBank.d576.s1|29-33|DRUGS|drug
DDI-DrugBank.d576.s1|35-38|WILL|drug
DDI-DrugBank.d576.s1|40-41|BE|drug
DDI-DrugBank.d576.s1|43-50|ADDITIVE|drug
DDI-DrugBank.d576.s1|52-53|TO|drug
DDI-DrugBank.d576.s1|55-62|DISALCID|drug
DDI-DrugBank.d576.s1|64-66|AND|drug
DDI-DrugBank.d576.s1|68-70|MAY|drug
DDI-DrugBank.d576.s1|72-79|INCREASE|drug
DDI-DrugBank.d576.s1|81-86|PLASMA|drug
DDI-DrugBank.d576.s1|88-101|CONCENTRATIONS|drug
DDI-DrugBank.d576.s1|103-104|OF|drug
DDI-DrugBank.d576.s1|106-114|SALICYLIC|drug
DDI-DrugBank.d576.s1|116-119|ACID|drug
DDI-DrugBank.d576.s1|121-122|TO|drug
DDI-DrugBank.d576.s1|124-128|TOXIC|drug
DDI-DrugBank.d576.s1|130-135|LEVELS|drug
DDI-DrugBank.d576.s1|136-136|.|drug
DDI-DrugBank.d576.s2|0-4|Drugs|drug
DDI-DrugBank.d576.s2|6-8|and|drug
DDI-DrugBank.d576.s2|10-14|foods|drug
DDI-DrugBank.d576.s2|16-19|that|drug
DDI-DrugBank.d576.s2|21-25|raise|drug
DDI-DrugBank.d576.s2|27-31|urine|drug
DDI-DrugBank.d576.s2|33-34|pH|drug
DDI-DrugBank.d576.s2|36-39|will|drug
DDI-DrugBank.d576.s2|41-48|increase|drug
DDI-DrugBank.d576.s2|50-54|renal|drug
DDI-DrugBank.d576.s2|56-64|clearance|drug
DDI-DrugBank.d576.s2|66-68|and|drug
DDI-DrugBank.d576.s2|70-76|urinary|drug
DDI-DrugBank.d576.s2|78-86|excretion|drug
DDI-DrugBank.d576.s2|88-89|of|drug
DDI-DrugBank.d576.s2|91-99|salicylic|drug
DDI-DrugBank.d576.s2|101-104|acid|drug
DDI-DrugBank.d576.s2|105-105|,|drug
DDI-DrugBank.d576.s2|107-110|thus|drug
DDI-DrugBank.d576.s2|112-119|lowering|drug
DDI-DrugBank.d576.s2|121-126|plasma|drug
DDI-DrugBank.d576.s2|128-133|levels|drug
DDI-DrugBank.d576.s2|134-134|;|drug
DDI-DrugBank.d576.s3|0-9|acidifying|drug
DDI-DrugBank.d576.s3|11-15|drugs|drug
DDI-DrugBank.d576.s3|17-18|or|drug
DDI-DrugBank.d576.s3|20-24|foods|drug
DDI-DrugBank.d576.s3|26-29|will|drug
DDI-DrugBank.d576.s3|31-38|decrease|drug
DDI-DrugBank.d576.s3|40-46|urinary|drug
DDI-DrugBank.d576.s3|48-56|excretion|drug
DDI-DrugBank.d576.s3|58-60|and|drug
DDI-DrugBank.d576.s3|62-69|increase|drug
DDI-DrugBank.d576.s3|71-76|plasma|drug
DDI-DrugBank.d576.s3|78-83|levels|drug
DDI-DrugBank.d576.s3|84-84|.|drug
DDI-DrugBank.d576.s4|0-10|Salicylates|drug
DDI-DrugBank.d576.s4|12-16|given|drug
DDI-DrugBank.d576.s4|18-30|concomitantly|drug
DDI-DrugBank.d576.s4|32-35|with|drug
DDI-DrugBank.d576.s4|37-49|anticoagulant|drug
DDI-DrugBank.d576.s4|51-55|drugs|drug
DDI-DrugBank.d576.s4|57-59|may|drug
DDI-DrugBank.d576.s4|61-70|predispose|drug
DDI-DrugBank.d576.s4|72-73|to|drug
DDI-DrugBank.d576.s4|75-82|systemic|drug
DDI-DrugBank.d576.s4|84-91|bleeding|drug
DDI-DrugBank.d576.s4|92-92|.|drug
DDI-DrugBank.d576.s5|0-10|Salicylates|drug
DDI-DrugBank.d576.s5|12-14|may|drug
DDI-DrugBank.d576.s5|16-22|enhance|drug
DDI-DrugBank.d576.s5|24-26|the|drug
DDI-DrugBank.d576.s5|28-39|hypoglycemic|drug
DDI-DrugBank.d576.s5|41-46|effect|drug
DDI-DrugBank.d576.s5|48-49|of|drug
DDI-DrugBank.d576.s5|51-54|oral|drug
DDI-DrugBank.d576.s5|56-67|antidiabetic|drug
DDI-DrugBank.d576.s5|69-73|drugs|drug
DDI-DrugBank.d576.s5|75-76|of|drug
DDI-DrugBank.d576.s5|78-80|the|drug
DDI-DrugBank.d576.s5|82-93|sulfonylurea|drug
DDI-DrugBank.d576.s5|95-99|class|drug
DDI-DrugBank.d576.s5|100-100|.|drug
DDI-DrugBank.d576.s6|0-9|Salicylate|drug
DDI-DrugBank.d576.s6|11-18|competes|drug
DDI-DrugBank.d576.s6|20-23|with|drug
DDI-DrugBank.d576.s6|25-25|a|drug
DDI-DrugBank.d576.s6|27-32|number|drug
DDI-DrugBank.d576.s6|34-35|of|drug
DDI-DrugBank.d576.s6|37-41|drugs|drug
DDI-DrugBank.d576.s6|43-45|for|drug
DDI-DrugBank.d576.s6|47-53|protein|drug
DDI-DrugBank.d576.s6|55-61|binding|drug
DDI-DrugBank.d576.s6|63-67|sites|drug
DDI-DrugBank.d576.s6|68-68|,|drug
DDI-DrugBank.d576.s6|70-76|notably|drug
DDI-DrugBank.d576.s6|78-87|penicillin|drug
DDI-DrugBank.d576.s6|88-88|,|drug
DDI-DrugBank.d576.s6|90-99|thiopental|drug
DDI-DrugBank.d576.s6|100-100|,|drug
DDI-DrugBank.d576.s6|102-110|thyroxine|drug
DDI-DrugBank.d576.s6|111-111|,|drug
DDI-DrugBank.d576.s6|113-128|triiodothyronine|drug
DDI-DrugBank.d576.s6|129-129|,|drug
DDI-DrugBank.d576.s6|131-139|phenytoin|drug
DDI-DrugBank.d576.s6|140-140|,|drug
DDI-DrugBank.d576.s6|142-155|sulfinpyrazone|drug
DDI-DrugBank.d576.s6|156-156|,|drug
DDI-DrugBank.d576.s6|158-165|naproxen|drug
DDI-DrugBank.d576.s6|166-166|,|drug
DDI-DrugBank.d576.s6|168-175|warfarin|drug
DDI-DrugBank.d576.s6|176-176|,|drug
DDI-DrugBank.d576.s6|178-189|methotrexate|drug
DDI-DrugBank.d576.s6|190-190|,|drug
DDI-DrugBank.d576.s6|192-194|and|drug
DDI-DrugBank.d576.s6|196-203|possibly|drug
DDI-DrugBank.d576.s6|205-219|corticosteroids|drug
DDI-DrugBank.d576.s6|220-220|.|drug
DDI-DrugBank.d576.s7|0-4|Drug/|drug
DDI-DrugBank.d576.s7|6-15|Laboratory|drug
DDI-DrugBank.d576.s7|17-20|Test|drug
DDI-DrugBank.d576.s7|22-33|Interactions|drug
DDI-DrugBank.d576.s7|35-44|Salicylate|drug
DDI-DrugBank.d576.s7|46-53|competes|drug
DDI-DrugBank.d576.s7|55-58|with|drug
DDI-DrugBank.d576.s7|60-66|thyroid|drug
DDI-DrugBank.d576.s7|68-74|hormone|drug
DDI-DrugBank.d576.s7|76-78|for|drug
DDI-DrugBank.d576.s7|80-86|binding|drug
DDI-DrugBank.d576.s7|88-89|to|drug
DDI-DrugBank.d576.s7|91-96|plasma|drug
DDI-DrugBank.d576.s7|98-105|proteins|drug
DDI-DrugBank.d576.s7|106-106|,|drug
DDI-DrugBank.d576.s7|108-112|which|drug
DDI-DrugBank.d576.s7|114-116|may|drug
DDI-DrugBank.d576.s7|118-119|be|drug
DDI-DrugBank.d576.s7|121-129|reflected|drug
DDI-DrugBank.d576.s7|131-132|in|drug
DDI-DrugBank.d576.s7|134-134|a|drug
DDI-DrugBank.d576.s7|136-144|depressed|drug
DDI-DrugBank.d576.s7|146-151|plasma|drug
DDI-DrugBank.d576.s7|153-154|T4|drug
DDI-DrugBank.d576.s7|156-160|value|drug
DDI-DrugBank.d576.s7|162-163|in|drug
DDI-DrugBank.d576.s7|165-168|some|drug
DDI-DrugBank.d576.s7|170-177|patients|drug
DDI-DrugBank.d576.s7|178-178|;|drug
DDI-DrugBank.d576.s8|0-6|thyroid|drug
DDI-DrugBank.d576.s8|8-15|function|drug
DDI-DrugBank.d576.s8|17-19|and|drug
DDI-DrugBank.d576.s8|21-25|basal|drug
DDI-DrugBank.d576.s8|27-36|metabolism|drug
DDI-DrugBank.d576.s8|38-40|are|drug
DDI-DrugBank.d576.s8|42-51|unaffected|drug
DDI-DrugBank.d576.s8|52-52|.|drug
DDI-MedLine.d64.s0|0-14|Pharmacological|drug
DDI-MedLine.d64.s0|16-24|treatment|drug
DDI-MedLine.d64.s0|26-27|of|drug
DDI-MedLine.d64.s0|29-38|depression|drug
DDI-MedLine.d64.s0|39-39|:|drug
DDI-MedLine.d64.s0|41-43|the|drug
DDI-MedLine.d64.s0|45-48|role|drug
DDI-MedLine.d64.s0|50-51|of|drug
DDI-MedLine.d64.s0|53-62|paroxetine|drug
DDI-MedLine.d64.s0|63-63|.|drug
DDI-MedLine.d64.s1|0-9|Depression|drug
DDI-MedLine.d64.s1|11-12|is|drug
DDI-MedLine.d64.s1|14-21|reaching|drug
DDI-MedLine.d64.s1|23-30|epidemic|drug
DDI-MedLine.d64.s1|32-42|proportions|drug
DDI-MedLine.d64.s1|44-45|in|drug
DDI-MedLine.d64.s1|47-49|the|drug
DDI-MedLine.d64.s1|51-57|western|drug
DDI-MedLine.d64.s1|59-63|world|drug
DDI-MedLine.d64.s1|64-64|.|drug
DDI-MedLine.d64.s2|0-3|With|drug
DDI-MedLine.d64.s2|5-8|each|drug
DDI-MedLine.d64.s2|10-19|successive|drug
DDI-MedLine.d64.s2|21-30|generation|drug
DDI-MedLine.d64.s2|32-35|more|drug
DDI-MedLine.d64.s2|37-42|people|drug
DDI-MedLine.d64.s2|44-46|are|drug
DDI-MedLine.d64.s2|48-55|becoming|drug
DDI-MedLine.d64.s2|57-60|more|drug
DDI-MedLine.d64.s2|62-69|severely|drug
DDI-MedLine.d64.s2|71-79|depressed|drug
DDI-MedLine.d64.s2|81-82|at|drug
DDI-MedLine.d64.s2|84-84|a|drug
DDI-MedLine.d64.s2|86-92|younger|drug
DDI-MedLine.d64.s2|94-96|age|drug
DDI-MedLine.d64.s2|97-97|.|drug
DDI-DrugBank.d623.s0|0-1|No|drug
DDI-DrugBank.d623.s0|3-11|drug-drug|drug
DDI-DrugBank.d623.s0|13-23|interaction|drug
DDI-DrugBank.d623.s0|25-31|studies|drug
DDI-DrugBank.d623.s0|33-36|have|drug
DDI-DrugBank.d623.s0|38-41|been|drug
DDI-DrugBank.d623.s0|43-51|conducted|drug
DDI-DrugBank.d623.s0|53-56|with|drug
DDI-DrugBank.d623.s0|58-66|depo-subQ|drug
DDI-DrugBank.d623.s0|68-74|provera|drug
DDI-DrugBank.d623.s0|76-78|104|drug
DDI-DrugBank.d623.s0|79-79|.|drug
DDI-DrugBank.d623.s1|0-16|Aminoglutethimide|drug
DDI-DrugBank.d623.s1|18-29|administered|drug
DDI-DrugBank.d623.s1|31-43|concomitantly|drug
DDI-DrugBank.d623.s1|45-48|with|drug
DDI-DrugBank.d623.s1|50-58|depo-subQ|drug
DDI-DrugBank.d623.s1|60-66|provera|drug
DDI-DrugBank.d623.s1|68-70|104|drug
DDI-DrugBank.d623.s1|72-74|may|drug
DDI-DrugBank.d623.s1|76-88|significantly|drug
DDI-DrugBank.d623.s1|90-97|decrease|drug
DDI-DrugBank.d623.s1|99-101|the|drug
DDI-DrugBank.d623.s1|103-107|serum|drug
DDI-DrugBank.d623.s1|109-122|concentrations|drug
DDI-DrugBank.d623.s1|124-125|of|drug
DDI-DrugBank.d623.s1|127-129|MPA|drug
DDI-DrugBank.d623.s1|130-130|.|drug
DDI-DrugBank.d623.s2|0-9|Laboratory|drug
DDI-DrugBank.d623.s2|11-15|Tests|drug
DDI-DrugBank.d623.s2|17-19|The|drug
DDI-DrugBank.d623.s2|21-31|pathologist|drug
DDI-DrugBank.d623.s2|33-38|should|drug
DDI-DrugBank.d623.s2|40-41|be|drug
DDI-DrugBank.d623.s2|43-49|advised|drug
DDI-DrugBank.d623.s2|51-52|of|drug
DDI-DrugBank.d623.s2|54-62|progestin|drug
DDI-DrugBank.d623.s2|64-70|therapy|drug
DDI-DrugBank.d623.s2|72-75|when|drug
DDI-DrugBank.d623.s2|77-84|relevant|drug
DDI-DrugBank.d623.s2|86-94|specimens|drug
DDI-DrugBank.d623.s2|96-98|are|drug
DDI-DrugBank.d623.s2|100-108|submitted|drug
DDI-DrugBank.d623.s2|109-109|.|drug
DDI-DrugBank.d623.s3|0-2|The|drug
DDI-DrugBank.d623.s3|4-12|physician|drug
DDI-DrugBank.d623.s3|14-19|should|drug
DDI-DrugBank.d623.s3|21-22|be|drug
DDI-DrugBank.d623.s3|24-31|informed|drug
DDI-DrugBank.d623.s3|33-36|that|drug
DDI-DrugBank.d623.s3|38-44|certain|drug
DDI-DrugBank.d623.s3|46-54|endocrine|drug
DDI-DrugBank.d623.s3|56-58|and|drug
DDI-DrugBank.d623.s3|60-64|liver|drug
DDI-DrugBank.d623.s3|66-73|function|drug
DDI-DrugBank.d623.s3|75-79|tests|drug
DDI-DrugBank.d623.s3|80-80|,|drug
DDI-DrugBank.d623.s3|82-84|and|drug
DDI-DrugBank.d623.s3|86-90|blood|drug
DDI-DrugBank.d623.s3|92-101|components|drug
DDI-DrugBank.d623.s3|103-105|may|drug
DDI-DrugBank.d623.s3|107-108|be|drug
DDI-DrugBank.d623.s3|110-117|affected|drug
DDI-DrugBank.d623.s3|119-120|by|drug
DDI-DrugBank.d623.s3|122-130|progestin|drug
DDI-DrugBank.d623.s3|132-138|therapy|drug
DDI-DrugBank.d623.s3|139-139|:|drug
DDI-DrugBank.d623.s3|141-141|(|drug
DDI-DrugBank.d623.s3|142-142|a|drug
DDI-DrugBank.d623.s3|143-143|)|drug
DDI-DrugBank.d623.s3|145-150|Plasma|drug
DDI-DrugBank.d623.s3|152-154|and|drug
DDI-DrugBank.d623.s3|156-162|urinary|drug
DDI-DrugBank.d623.s3|164-170|steroid|drug
DDI-DrugBank.d623.s3|172-177|levels|drug
DDI-DrugBank.d623.s3|179-181|are|drug
DDI-DrugBank.d623.s3|183-191|decreased|drug
DDI-DrugBank.d623.s3|193-193|(|drug
DDI-DrugBank.d623.s3|194-197|e.g.|drug
DDI-DrugBank.d623.s3|198-198|,|drug
DDI-DrugBank.d623.s3|200-211|progesterone|drug
DDI-DrugBank.d623.s3|212-212|,|drug
DDI-DrugBank.d623.s3|214-222|estradiol|drug
DDI-DrugBank.d623.s3|223-223|,|drug
DDI-DrugBank.d623.s3|225-236|pregnanediol|drug
DDI-DrugBank.d623.s3|237-237|,|drug
DDI-DrugBank.d623.s3|239-250|testosterone|drug
DDI-DrugBank.d623.s3|251-251|,|drug
DDI-DrugBank.d623.s3|253-260|cortisol|drug
DDI-DrugBank.d623.s3|261-261|)|drug
DDI-DrugBank.d623.s3|262-262|.|drug
DDI-DrugBank.d623.s4|0-0|(|drug
DDI-DrugBank.d623.s4|1-1|b|drug
DDI-DrugBank.d623.s4|2-2|)|drug
DDI-DrugBank.d623.s4|4-9|Plasma|drug
DDI-DrugBank.d623.s4|11-13|and|drug
DDI-DrugBank.d623.s4|15-21|urinary|drug
DDI-DrugBank.d623.s4|23-34|gonadotropin|drug
DDI-DrugBank.d623.s4|36-41|levels|drug
DDI-DrugBank.d623.s4|43-45|are|drug
DDI-DrugBank.d623.s4|47-55|decreased|drug
DDI-DrugBank.d623.s4|57-57|(|drug
DDI-DrugBank.d623.s4|58-61|e.g.|drug
DDI-DrugBank.d623.s4|62-62|,|drug
DDI-DrugBank.d623.s4|64-65|LH|drug
DDI-DrugBank.d623.s4|66-66|,|drug
DDI-DrugBank.d623.s4|68-70|FSH|drug
DDI-DrugBank.d623.s4|71-71|)|drug
DDI-DrugBank.d623.s4|72-72|.|drug
DDI-DrugBank.d623.s5|0-0|(|drug
DDI-DrugBank.d623.s5|1-1|c|drug
DDI-DrugBank.d623.s5|2-2|)|drug
DDI-DrugBank.d623.s5|4-7|SHBG|drug
DDI-DrugBank.d623.s5|9-22|concentrations|drug
DDI-DrugBank.d623.s5|24-26|are|drug
DDI-DrugBank.d623.s5|28-36|decreased|drug
DDI-DrugBank.d623.s5|37-37|.|drug
DDI-DrugBank.d623.s6|0-0|(|drug
DDI-DrugBank.d623.s6|1-1|d|drug
DDI-DrugBank.d623.s6|2-2|)|drug
DDI-DrugBank.d623.s6|4-12|T3-uptake|drug
DDI-DrugBank.d623.s6|14-19|values|drug
DDI-DrugBank.d623.s6|21-23|may|drug
DDI-DrugBank.d623.s6|25-32|decrease|drug
DDI-DrugBank.d623.s6|33-33|.|drug
DDI-DrugBank.d623.s7|0-0|(|drug
DDI-DrugBank.d623.s7|1-1|e|drug
DDI-DrugBank.d623.s7|2-2|)|drug
DDI-DrugBank.d623.s7|4-8|There|drug
DDI-DrugBank.d623.s7|10-12|may|drug
DDI-DrugBank.d623.s7|14-15|be|drug
DDI-DrugBank.d623.s7|17-21|small|drug
DDI-DrugBank.d623.s7|23-29|changes|drug
DDI-DrugBank.d623.s7|31-32|in|drug
DDI-DrugBank.d623.s7|34-44|coagulation|drug
DDI-DrugBank.d623.s7|46-52|factors|drug
DDI-DrugBank.d623.s7|53-53|.|drug
DDI-DrugBank.d623.s8|0-0|(|drug
DDI-DrugBank.d623.s8|1-1|f|drug
DDI-DrugBank.d623.s8|2-2|)|drug
DDI-DrugBank.d623.s8|4-22|Sulfobromophthalein|drug
DDI-DrugBank.d623.s8|24-26|and|drug
DDI-DrugBank.d623.s8|28-32|other|drug
DDI-DrugBank.d623.s8|34-38|liver|drug
DDI-DrugBank.d623.s8|40-47|function|drug
DDI-DrugBank.d623.s8|49-52|test|drug
DDI-DrugBank.d623.s8|54-59|values|drug
DDI-DrugBank.d623.s8|61-63|may|drug
DDI-DrugBank.d623.s8|65-66|be|drug
DDI-DrugBank.d623.s8|68-76|increased|drug
DDI-DrugBank.d623.s8|78-85|slightly|drug
DDI-DrugBank.d623.s8|86-86|.|drug
DDI-DrugBank.d623.s9|0-0|(|drug
DDI-DrugBank.d623.s9|1-1|g|drug
DDI-DrugBank.d623.s9|2-2|)|drug
DDI-DrugBank.d623.s9|4-8|There|drug
DDI-DrugBank.d623.s9|10-12|may|drug
DDI-DrugBank.d623.s9|14-15|be|drug
DDI-DrugBank.d623.s9|17-21|small|drug
DDI-DrugBank.d623.s9|23-29|changes|drug
DDI-DrugBank.d623.s9|31-32|in|drug
DDI-DrugBank.d623.s9|34-38|lipid|drug
DDI-DrugBank.d623.s9|40-47|profiles|drug
DDI-DrugBank.d623.s9|48-48|.|drug
DDI-DrugBank.d603.s0|0-3|When|drug
DDI-DrugBank.d603.s0|5-16|administered|drug
DDI-DrugBank.d603.s0|18-30|concomitantly|drug
DDI-DrugBank.d603.s0|32-35|with|drug
DDI-DrugBank.d603.s0|37-46|ProAmatine|drug
DDI-DrugBank.d603.s0|50-50|,|drug
DDI-DrugBank.d603.s0|52-58|cardiac|drug
DDI-DrugBank.d603.s0|60-69|glycosides|drug
DDI-DrugBank.d603.s0|71-73|may|drug
DDI-DrugBank.d603.s0|75-81|enhance|drug
DDI-DrugBank.d603.s0|83-84|or|drug
DDI-DrugBank.d603.s0|86-96|precipitate|drug
DDI-DrugBank.d603.s0|98-108|bradycardia|drug
DDI-DrugBank.d603.s0|109-109|,|drug
DDI-DrugBank.d603.s0|111-113|A.V|drug
DDI-DrugBank.d603.s0|114-114|.|drug
DDI-DrugBank.d603.s1|0-4|block|drug
DDI-DrugBank.d603.s1|6-7|or|drug
DDI-DrugBank.d603.s1|9-18|arrhythmia|drug
DDI-DrugBank.d603.s1|19-19|.|drug
DDI-DrugBank.d603.s2|0-2|The|drug
DDI-DrugBank.d603.s2|4-6|use|drug
DDI-DrugBank.d603.s2|8-9|of|drug
DDI-DrugBank.d603.s2|11-15|drugs|drug
DDI-DrugBank.d603.s2|17-20|that|drug
DDI-DrugBank.d603.s2|22-30|stimulate|drug
DDI-DrugBank.d603.s2|32-47|alpha-adrenergic|drug
DDI-DrugBank.d603.s2|49-57|receptors|drug
DDI-DrugBank.d603.s2|59-59|(|drug
DDI-DrugBank.d603.s2|60-63|e.g.|drug
DDI-DrugBank.d603.s2|64-64|,|drug
DDI-DrugBank.d603.s2|66-78|phenylephrine|drug
DDI-DrugBank.d603.s2|79-79|,|drug
DDI-DrugBank.d603.s2|81-95|pseudoephedrine|drug
DDI-DrugBank.d603.s2|96-96|,|drug
DDI-DrugBank.d603.s2|98-106|ephedrine|drug
DDI-DrugBank.d603.s2|107-107|,|drug
DDI-DrugBank.d603.s2|109-127|phenylpropanolamine|drug
DDI-DrugBank.d603.s2|129-130|or|drug
DDI-DrugBank.d603.s2|132-148|dihydroergotamine|drug
DDI-DrugBank.d603.s2|149-149|)|drug
DDI-DrugBank.d603.s2|151-153|may|drug
DDI-DrugBank.d603.s2|155-161|enhance|drug
DDI-DrugBank.d603.s2|163-164|or|drug
DDI-DrugBank.d603.s2|166-175|potentiate|drug
DDI-DrugBank.d603.s2|177-179|the|drug
DDI-DrugBank.d603.s2|181-187|pressor|drug
DDI-DrugBank.d603.s2|189-195|effects|drug
DDI-DrugBank.d603.s2|197-198|of|drug
DDI-DrugBank.d603.s2|200-209|ProAmatine|drug
DDI-DrugBank.d603.s2|213-213|.|drug
DDI-DrugBank.d603.s2|215-223|Therefore|drug
DDI-DrugBank.d603.s2|224-224|,|drug
DDI-DrugBank.d603.s2|226-232|caution|drug
DDI-DrugBank.d603.s2|234-239|should|drug
DDI-DrugBank.d603.s2|241-242|be|drug
DDI-DrugBank.d603.s2|244-247|used|drug
DDI-DrugBank.d603.s2|249-252|when|drug
DDI-DrugBank.d603.s2|254-263|ProAmatine|drug
DDI-DrugBank.d603.s2|268-269|is|drug
DDI-DrugBank.d603.s2|271-282|administered|drug
DDI-DrugBank.d603.s2|284-296|concomitantly|drug
DDI-DrugBank.d603.s2|298-301|with|drug
DDI-DrugBank.d603.s2|303-308|agents|drug
DDI-DrugBank.d603.s2|310-313|that|drug
DDI-DrugBank.d603.s2|315-319|cause|drug
DDI-DrugBank.d603.s2|321-336|vasoconstriction|drug
DDI-DrugBank.d603.s2|337-337|.|drug
DDI-DrugBank.d603.s3|0-9|ProAmatine|drug
DDI-DrugBank.d603.s3|14-16|has|drug
DDI-DrugBank.d603.s3|18-21|been|drug
DDI-DrugBank.d603.s3|23-26|used|drug
DDI-DrugBank.d603.s3|28-29|in|drug
DDI-DrugBank.d603.s3|31-38|patients|drug
DDI-DrugBank.d603.s3|40-52|concomitantly|drug
DDI-DrugBank.d603.s3|54-60|treated|drug
DDI-DrugBank.d603.s3|62-65|with|drug
DDI-DrugBank.d603.s3|67-80|salt-retaining|drug
DDI-DrugBank.d603.s3|82-88|steroid|drug
DDI-DrugBank.d603.s3|90-96|therapy|drug
DDI-DrugBank.d603.s3|98-98|(|drug
DDI-DrugBank.d603.s3|99-102|i.e.|drug
DDI-DrugBank.d603.s3|103-103|,|drug
DDI-DrugBank.d603.s3|105-119|fludrocortisone|drug
DDI-DrugBank.d603.s3|121-127|acetate|drug
DDI-DrugBank.d603.s3|128-128|)|drug
DDI-DrugBank.d603.s3|129-129|,|drug
DDI-DrugBank.d603.s3|131-134|with|drug
DDI-DrugBank.d603.s3|136-137|or|drug
DDI-DrugBank.d603.s3|139-145|without|drug
DDI-DrugBank.d603.s3|147-150|salt|drug
DDI-DrugBank.d603.s3|152-166|supplementation|drug
DDI-DrugBank.d603.s3|167-167|.|drug
DDI-DrugBank.d603.s4|0-2|The|drug
DDI-DrugBank.d603.s4|4-12|potential|drug
DDI-DrugBank.d603.s4|14-16|for|drug
DDI-DrugBank.d603.s4|18-23|supine|drug
DDI-DrugBank.d603.s4|25-36|hypertension|drug
DDI-DrugBank.d603.s4|38-43|should|drug
DDI-DrugBank.d603.s4|45-46|be|drug
DDI-DrugBank.d603.s4|48-56|carefully|drug
DDI-DrugBank.d603.s4|58-66|monitored|drug
DDI-DrugBank.d603.s4|68-69|in|drug
DDI-DrugBank.d603.s4|71-75|these|drug
DDI-DrugBank.d603.s4|77-84|patients|drug
DDI-DrugBank.d603.s4|86-88|and|drug
DDI-DrugBank.d603.s4|90-92|may|drug
DDI-DrugBank.d603.s4|94-95|be|drug
DDI-DrugBank.d603.s4|97-105|minimized|drug
DDI-DrugBank.d603.s4|107-108|by|drug
DDI-DrugBank.d603.s4|110-115|either|drug
DDI-DrugBank.d603.s4|117-124|reducing|drug
DDI-DrugBank.d603.s4|126-128|the|drug
DDI-DrugBank.d603.s4|130-133|dose|drug
DDI-DrugBank.d603.s4|135-136|of|drug
DDI-DrugBank.d603.s4|138-152|fludrocortisone|drug
DDI-DrugBank.d603.s4|154-160|acetate|drug
DDI-DrugBank.d603.s4|162-163|or|drug
DDI-DrugBank.d603.s4|165-174|decreasing|drug
DDI-DrugBank.d603.s4|176-178|the|drug
DDI-DrugBank.d603.s4|180-183|salt|drug
DDI-DrugBank.d603.s4|185-190|intake|drug
DDI-DrugBank.d603.s4|192-196|prior|drug
DDI-DrugBank.d603.s4|198-199|to|drug
DDI-DrugBank.d603.s4|201-210|initiation|drug
DDI-DrugBank.d603.s4|212-213|of|drug
DDI-DrugBank.d603.s4|215-223|treatment|drug
DDI-DrugBank.d603.s4|225-228|with|drug
DDI-DrugBank.d603.s4|229-229|.|drug
DDI-DrugBank.d603.s5|0-10|ProAmatine|drug
DDI-DrugBank.d603.s5|12-27|.|drug
DDI-DrugBank.d603.s5|29-36|Alpha-adrenergic|drug
DDI-DrugBank.d603.s5|38-43|blocking|drug
DDI-DrugBank.d603.s5|44-44|agents|drug
DDI-DrugBank.d603.s5|46-49|,|drug
DDI-DrugBank.d603.s5|51-52|such|drug
DDI-DrugBank.d603.s5|54-61|as|drug
DDI-DrugBank.d603.s5|62-62|prazosin|drug
DDI-DrugBank.d603.s5|64-72|,|drug
DDI-DrugBank.d603.s5|73-73|terazosin|drug
DDI-DrugBank.d603.s5|75-77|,|drug
DDI-DrugBank.d603.s5|79-87|and|drug
DDI-DrugBank.d603.s5|88-88|doxazosin|drug
DDI-DrugBank.d603.s5|90-92|,|drug
DDI-DrugBank.d603.s5|94-103|can|drug
DDI-DrugBank.d603.s5|105-107|antagonize|drug
DDI-DrugBank.d603.s5|109-115|the|drug
DDI-DrugBank.d603.s5|117-118|effects|drug
DDI-DrugBank.d603.s5|120-130|of|drug
DDI-DrugBank.d603.s5|132-140|ProAmatine|drug
DDI-DrugBank.d603.s5|142-144|.|drug
DDI-DrugBank.d603.s5|146-149|Potential|drug
DDI-DrugBank.d603.s5|151-162|for|drug
DDI-DrugBank.d603.s5|163-163|Drug|drug
DDI-DrugBank.d603.s5|165-166|Interactions|drug
DDI-DrugBank.d603.s5|168-174|:|drug
DDI-DrugBank.d603.s5|176-183|It|drug
DDI-DrugBank.d603.s5|184-184|appears|drug
DDI-DrugBank.d603.s5|186-193|possible|drug
DDI-DrugBank.d603.s5|195-199|,|drug
DDI-DrugBank.d603.s5|201-202|although|drug
DDI-DrugBank.d603.s5|204-205|there|drug
DDI-DrugBank.d603.s5|207-216|is|drug
DDI-DrugBank.d603.s5|218-229|no|drug
DDI-DrugBank.d603.s5|231-238|supporting|drug
DDI-DrugBank.d603.s5|239-239|experimental|drug
DDI-DrugBank.d603.s5|241-244|evidence|drug
DDI-DrugBank.d603.s5|246-248|,|drug
DDI-DrugBank.d603.s5|250-253|that|drug
DDI-DrugBank.d603.s5|255-259|the|drug
DDI-DrugBank.d603.s5|261-269|high|drug
DDI-DrugBank.d603.s5|271-272|renal|drug
DDI-DrugBank.d603.s5|274-288|clearance|drug
DDI-DrugBank.d603.s5|290-290|of|drug
DDI-DrugBank.d603.s5|291-291|desglymidodrine|drug
DDI-DrugBank.d603.s5|293-296|(|drug
DDI-DrugBank.d603.s5|297-297|a|drug
DDI-DrugBank.d603.s5|299-300|base|drug
DDI-DrugBank.d603.s5|302-304|)|drug
DDI-DrugBank.d603.s5|306-307|is|drug
DDI-DrugBank.d603.s5|309-314|due|drug
DDI-DrugBank.d603.s5|316-322|to|drug
DDI-DrugBank.d603.s5|324-332|active|drug
DDI-DrugBank.d603.s5|334-335|tubular|drug
DDI-DrugBank.d603.s5|337-339|secretion|drug
DDI-DrugBank.d603.s5|341-354|by|drug
DDI-DrugBank.d603.s5|356-361|the|drug
DDI-DrugBank.d603.s5|363-366|base-secreting|drug
DDI-DrugBank.d603.s5|368-378|system|drug
DDI-DrugBank.d603.s5|380-382|also|drug
DDI-DrugBank.d603.s5|384-386|responsible|drug
DDI-DrugBank.d603.s5|388-396|for|drug
DDI-DrugBank.d603.s5|398-399|the|drug
DDI-DrugBank.d603.s5|401-404|secretion|drug
DDI-DrugBank.d603.s5|406-410|of|drug
DDI-DrugBank.d603.s5|412-413|such|drug
DDI-DrugBank.d603.s5|415-423|drugs|drug
DDI-DrugBank.d603.s5|424-424|as|drug
DDI-DrugBank.d603.s5|426-435|metformin|drug
DDI-DrugBank.d603.s5|436-436|,|drug
DDI-DrugBank.d603.s5|438-447|cimetidine|drug
DDI-DrugBank.d603.s5|448-448|,|drug
DDI-DrugBank.d603.s5|450-461|ranitidine|drug
DDI-DrugBank.d603.s5|462-462|,|drug
DDI-DrugBank.d603.s5|464-474|procainamide|drug
DDI-DrugBank.d603.s5|475-475|,|drug
DDI-DrugBank.d603.s5|477-486|triamterene|drug
DDI-DrugBank.d603.s5|487-487|,|drug
DDI-DrugBank.d603.s5|489-491|flecainide|drug
DDI-DrugBank.d603.s5|493-501|,|drug
DDI-DrugBank.d603.s5|502-502|and|drug
DDI-DrugBank.d603.s6|0-3|Thus|drug
DDI-DrugBank.d603.s6|5-9|there|drug
DDI-DrugBank.d603.s6|11-13|may|drug
DDI-DrugBank.d603.s6|15-16|be|drug
DDI-DrugBank.d603.s6|18-18|a|drug
DDI-DrugBank.d603.s6|20-28|potential|drug
DDI-DrugBank.d603.s6|30-32|for|drug
DDI-DrugBank.d603.s6|34-42|drug-drug|drug
DDI-DrugBank.d603.s6|44-55|interactions|drug
DDI-DrugBank.d603.s6|57-60|with|drug
DDI-DrugBank.d603.s6|62-66|these|drug
DDI-DrugBank.d603.s6|68-72|drugs|drug
DDI-DrugBank.d603.s6|73-73|.|drug
DDI-DrugBank.d57.s0|0-1|In|drug
DDI-DrugBank.d57.s0|3-7|vitro|drug
DDI-DrugBank.d57.s0|9-14|mixing|drug
DDI-DrugBank.d57.s0|16-17|of|drug
DDI-DrugBank.d57.s0|19-20|an|drug
DDI-DrugBank.d57.s0|22-35|aminoglycoside|drug
DDI-DrugBank.d57.s0|37-40|with|drug
DDI-DrugBank.d57.s0|42-56|beta-lactamtype|drug
DDI-DrugBank.d57.s0|58-68|antibiotics|drug
DDI-DrugBank.d57.s0|70-70|(|drug
DDI-DrugBank.d57.s0|71-81|penicillins|drug
DDI-DrugBank.d57.s0|83-84|or|drug
DDI-DrugBank.d57.s0|86-99|cephalosporins|drug
DDI-DrugBank.d57.s0|100-100|)|drug
DDI-DrugBank.d57.s0|102-104|may|drug
DDI-DrugBank.d57.s0|106-111|result|drug
DDI-DrugBank.d57.s0|113-114|in|drug
DDI-DrugBank.d57.s0|116-116|a|drug
DDI-DrugBank.d57.s0|118-128|significant|drug
DDI-DrugBank.d57.s0|130-135|mutual|drug
DDI-DrugBank.d57.s0|137-148|inactivation|drug
DDI-DrugBank.d57.s0|149-149|.|drug
DDI-DrugBank.d57.s1|0-3|Even|drug
DDI-DrugBank.d57.s1|5-8|when|drug
DDI-DrugBank.d57.s1|10-11|an|drug
DDI-DrugBank.d57.s1|13-26|aminoglycoside|drug
DDI-DrugBank.d57.s1|28-30|and|drug
DDI-DrugBank.d57.s1|32-32|a|drug
DDI-DrugBank.d57.s1|34-48|penicillin-type|drug
DDI-DrugBank.d57.s1|50-53|drug|drug
DDI-DrugBank.d57.s1|55-57|are|drug
DDI-DrugBank.d57.s1|59-70|administered|drug
DDI-DrugBank.d57.s1|72-81|separately|drug
DDI-DrugBank.d57.s1|83-84|by|drug
DDI-DrugBank.d57.s1|86-94|different|drug
DDI-DrugBank.d57.s1|96-101|routes|drug
DDI-DrugBank.d57.s1|102-102|,|drug
DDI-DrugBank.d57.s1|104-104|a|drug
DDI-DrugBank.d57.s1|106-114|reduction|drug
DDI-DrugBank.d57.s1|116-117|in|drug
DDI-DrugBank.d57.s1|119-132|aminoglycoside|drug
DDI-DrugBank.d57.s1|134-138|serum|drug
DDI-DrugBank.d57.s1|140-148|half-life|drug
DDI-DrugBank.d57.s1|150-151|or|drug
DDI-DrugBank.d57.s1|153-157|serum|drug
DDI-DrugBank.d57.s1|159-164|levels|drug
DDI-DrugBank.d57.s1|166-168|has|drug
DDI-DrugBank.d57.s1|170-173|been|drug
DDI-DrugBank.d57.s1|175-182|reported|drug
DDI-DrugBank.d57.s1|184-185|in|drug
DDI-DrugBank.d57.s1|187-194|patients|drug
DDI-DrugBank.d57.s1|196-199|with|drug
DDI-DrugBank.d57.s1|201-208|impaired|drug
DDI-DrugBank.d57.s1|210-214|renal|drug
DDI-DrugBank.d57.s1|216-223|function|drug
DDI-DrugBank.d57.s1|225-227|and|drug
DDI-DrugBank.d57.s1|229-230|in|drug
DDI-DrugBank.d57.s1|232-235|some|drug
DDI-DrugBank.d57.s1|237-244|patients|drug
DDI-DrugBank.d57.s1|246-249|with|drug
DDI-DrugBank.d57.s1|251-256|normal|drug
DDI-DrugBank.d57.s1|258-262|renal|drug
DDI-DrugBank.d57.s1|264-271|function|drug
DDI-DrugBank.d57.s1|272-272|.|drug
DDI-DrugBank.d57.s2|0-6|Usually|drug
DDI-DrugBank.d57.s2|7-7|,|drug
DDI-DrugBank.d57.s2|9-12|such|drug
DDI-DrugBank.d57.s2|14-25|inactivation|drug
DDI-DrugBank.d57.s2|27-28|of|drug
DDI-DrugBank.d57.s2|30-32|the|drug
DDI-DrugBank.d57.s2|34-47|aminoglycoside|drug
DDI-DrugBank.d57.s2|49-50|is|drug
DDI-DrugBank.d57.s2|52-61|clinically|drug
DDI-DrugBank.d57.s2|63-73|significant|drug
DDI-DrugBank.d57.s2|75-78|only|drug
DDI-DrugBank.d57.s2|80-81|in|drug
DDI-DrugBank.d57.s2|83-90|patients|drug
DDI-DrugBank.d57.s2|92-95|with|drug
DDI-DrugBank.d57.s2|97-104|severely|drug
DDI-DrugBank.d57.s2|106-113|impaired|drug
DDI-DrugBank.d57.s2|115-119|renal|drug
DDI-DrugBank.d57.s2|121-130|function|drug
DDI-DrugBank.d57.s3|0-2|See|drug
DDI-MedLine.d9.s0|0-15|Pharmacokinetics|drug
DDI-MedLine.d9.s0|17-18|of|drug
DDI-MedLine.d9.s0|20-32|calcium-entry|drug
DDI-MedLine.d9.s0|34-41|blockers|drug
DDI-MedLine.d9.s0|42-42|.|drug
DDI-MedLine.d9.s1|0-8|Effective|drug
DDI-MedLine.d9.s1|10-12|use|drug
DDI-MedLine.d9.s1|14-15|of|drug
DDI-MedLine.d9.s1|17-21|drugs|drug
DDI-MedLine.d9.s1|23-24|in|drug
DDI-MedLine.d9.s1|26-32|therapy|drug
DDI-MedLine.d9.s1|34-40|depends|drug
DDI-MedLine.d9.s1|42-44|not|drug
DDI-MedLine.d9.s1|46-49|only|drug
DDI-MedLine.d9.s1|51-52|on|drug
DDI-MedLine.d9.s1|54-61|clinical|drug
DDI-MedLine.d9.s1|63-68|acumen|drug
DDI-MedLine.d9.s1|70-72|but|drug
DDI-MedLine.d9.s1|74-77|also|drug
DDI-MedLine.d9.s1|79-80|on|drug
DDI-MedLine.d9.s1|82-84|the|drug
DDI-MedLine.d9.s1|86-97|availability|drug
DDI-MedLine.d9.s1|99-100|of|drug
DDI-MedLine.d9.s1|102-109|relevant|drug
DDI-MedLine.d9.s1|111-125|pharmacokinetic|drug
DDI-MedLine.d9.s1|127-129|and|drug
DDI-MedLine.d9.s1|131-145|pharmacodynamic|drug
DDI-MedLine.d9.s1|147-150|data|drug
DDI-MedLine.d9.s1|151-151|.|drug
DDI-MedLine.d9.s2|0-3|Such|drug
DDI-MedLine.d9.s2|5-15|information|drug
DDI-MedLine.d9.s2|17-23|assists|drug
DDI-MedLine.d9.s2|25-26|in|drug
DDI-MedLine.d9.s2|28-38|development|drug
DDI-MedLine.d9.s2|40-41|of|drug
DDI-MedLine.d9.s2|43-46|safe|drug
DDI-MedLine.d9.s2|48-53|dosing|drug
DDI-MedLine.d9.s2|55-62|regimens|drug
DDI-MedLine.d9.s2|63-63|,|drug
DDI-MedLine.d9.s2|65-74|prediction|drug
DDI-MedLine.d9.s2|76-77|of|drug
DDI-MedLine.d9.s2|79-86|abnormal|drug
DDI-MedLine.d9.s2|88-95|handling|drug
DDI-MedLine.d9.s2|97-98|of|drug
DDI-MedLine.d9.s2|100-104|drugs|drug
DDI-MedLine.d9.s2|106-107|in|drug
DDI-MedLine.d9.s2|109-114|states|drug
DDI-MedLine.d9.s2|116-117|of|drug
DDI-MedLine.d9.s2|119-125|disease|drug
DDI-MedLine.d9.s2|127-129|and|drug
DDI-MedLine.d9.s2|131-138|disorder|drug
DDI-MedLine.d9.s2|140-142|and|drug
DDI-MedLine.d9.s2|144-155|anticipation|drug
DDI-MedLine.d9.s2|157-158|of|drug
DDI-MedLine.d9.s2|160-163|drug|drug
DDI-MedLine.d9.s2|165-176|interactions|drug
DDI-MedLine.d9.s2|177-177|.|drug
DDI-MedLine.d9.s3|0-2|For|drug
DDI-MedLine.d9.s3|4-6|the|drug
DDI-MedLine.d9.s3|8-20|calcium-entry|drug
DDI-MedLine.d9.s3|22-29|blocking|drug
DDI-MedLine.d9.s3|31-36|agents|drug
DDI-MedLine.d9.s3|38-40|now|drug
DDI-MedLine.d9.s3|42-50|available|drug
DDI-MedLine.d9.s3|52-53|in|drug
DDI-MedLine.d9.s3|55-57|the|drug
DDI-MedLine.d9.s3|59-64|United|drug
DDI-MedLine.d9.s3|66-71|States|drug
DDI-MedLine.d9.s3|73-73|(|drug
DDI-MedLine.d9.s3|74-82|verapamil|drug
DDI-MedLine.d9.s3|83-83|,|drug
DDI-MedLine.d9.s3|85-94|nifedipine|drug
DDI-MedLine.d9.s3|96-98|and|drug
DDI-MedLine.d9.s3|100-108|diltiazem|drug
DDI-MedLine.d9.s3|109-109|)|drug
DDI-MedLine.d9.s3|110-110|,|drug
DDI-MedLine.d9.s3|112-116|these|drug
DDI-MedLine.d9.s3|118-121|data|drug
DDI-MedLine.d9.s3|123-130|appeared|drug
DDI-MedLine.d9.s3|132-135|well|drug
DDI-MedLine.d9.s3|137-141|after|drug
DDI-MedLine.d9.s3|143-150|clinical|drug
DDI-MedLine.d9.s3|152-159|patterns|drug
DDI-MedLine.d9.s3|161-162|of|drug
DDI-MedLine.d9.s3|164-166|use|drug
DDI-MedLine.d9.s3|168-174|evolved|drug
DDI-MedLine.d9.s3|175-175|.|drug
DDI-MedLine.d9.s4|0-10|Nonetheless|drug
DDI-MedLine.d9.s4|11-11|,|drug
DDI-MedLine.d9.s4|13-17|their|drug
DDI-MedLine.d9.s4|19-27|relevance|drug
DDI-MedLine.d9.s4|29-37|continues|drug
DDI-MedLine.d9.s4|39-40|to|drug
DDI-MedLine.d9.s4|42-43|be|drug
DDI-MedLine.d9.s4|45-56|demonstrated|drug
DDI-MedLine.d9.s4|58-59|by|drug
DDI-MedLine.d9.s4|61-63|the|drug
DDI-MedLine.d9.s4|65-74|dependence|drug
DDI-MedLine.d9.s4|76-77|of|drug
DDI-MedLine.d9.s4|79-82|each|drug
DDI-MedLine.d9.s4|84-88|agent|drug
DDI-MedLine.d9.s4|90-91|on|drug
DDI-MedLine.d9.s4|93-98|intact|drug
DDI-MedLine.d9.s4|100-104|liver|drug
DDI-MedLine.d9.s4|106-110|blood|drug
DDI-MedLine.d9.s4|112-115|flow|drug
DDI-MedLine.d9.s4|117-119|and|drug
DDI-MedLine.d9.s4|121-128|function|drug
DDI-MedLine.d9.s4|130-132|for|drug
DDI-MedLine.d9.s4|134-139|normal|drug
DDI-MedLine.d9.s4|141-145|rates|drug
DDI-MedLine.d9.s4|147-148|of|drug
DDI-MedLine.d9.s4|150-160|elimination|drug
DDI-MedLine.d9.s4|161-161|;|drug
DDI-MedLine.d9.s5|0-1|by|drug
DDI-MedLine.d9.s5|3-5|the|drug
DDI-MedLine.d9.s5|7-15|nonlinear|drug
DDI-MedLine.d9.s5|17-23|kinetic|drug
DDI-MedLine.d9.s5|25-39|characteristics|drug
DDI-MedLine.d9.s5|41-43|for|drug
DDI-MedLine.d9.s5|45-53|verapamil|drug
DDI-MedLine.d9.s5|55-57|and|drug
DDI-MedLine.d9.s5|59-67|diltiazem|drug
DDI-MedLine.d9.s5|69-69|(|drug
DDI-MedLine.d9.s5|70-72|and|drug
DDI-MedLine.d9.s5|74-81|probably|drug
DDI-MedLine.d9.s5|83-85|for|drug
DDI-MedLine.d9.s5|87-96|nifedipine|drug
DDI-MedLine.d9.s5|97-97|,|drug
DDI-MedLine.d9.s5|99-100|as|drug
DDI-MedLine.d9.s5|102-105|well|drug
DDI-MedLine.d9.s5|106-106|)|drug
DDI-MedLine.d9.s5|108-110|and|drug
DDI-MedLine.d9.s5|112-114|the|drug
DDI-MedLine.d9.s5|116-125|derivative|drug
DDI-MedLine.d9.s5|127-138|implications|drug
DDI-MedLine.d9.s5|140-142|for|drug
DDI-MedLine.d9.s5|144-152|decreased|drug
DDI-MedLine.d9.s5|154-159|dosing|drug
DDI-MedLine.d9.s5|161-169|frequency|drug
DDI-MedLine.d9.s5|171-182|requirements|drug
DDI-MedLine.d9.s5|183-183|;|drug
DDI-MedLine.d9.s6|0-2|and|drug
DDI-MedLine.d9.s6|4-5|by|drug
DDI-MedLine.d9.s6|7-18|observations|drug
DDI-MedLine.d9.s6|20-22|now|drug
DDI-MedLine.d9.s6|24-32|appearing|drug
DDI-MedLine.d9.s6|34-35|on|drug
DDI-MedLine.d9.s6|37-39|the|drug
DDI-MedLine.d9.s6|41-48|relation|drug
DDI-MedLine.d9.s6|50-56|between|drug
DDI-MedLine.d9.s6|58-63|plasma|drug
DDI-MedLine.d9.s6|65-68|drug|drug
DDI-MedLine.d9.s6|70-75|levels|drug
DDI-MedLine.d9.s6|77-79|and|drug
DDI-MedLine.d9.s6|81-84|drug|drug
DDI-MedLine.d9.s6|86-92|effects|drug
DDI-MedLine.d9.s6|93-93|,|drug
DDI-MedLine.d9.s6|95-98|both|drug
DDI-MedLine.d9.s6|100-110|therapeutic|drug
DDI-MedLine.d9.s6|112-114|and|drug
DDI-MedLine.d9.s6|116-120|toxic|drug
DDI-MedLine.d9.s6|121-121|.|drug
DDI-MedLine.d9.s7|0-3|Such|drug
DDI-MedLine.d9.s7|5-8|data|drug
DDI-MedLine.d9.s7|10-12|are|drug
DDI-MedLine.d9.s7|14-22|discussed|drug
DDI-MedLine.d9.s7|24-29|herein|drug
DDI-MedLine.d9.s7|30-30|,|drug
DDI-MedLine.d9.s7|32-35|with|drug
DDI-MedLine.d9.s7|37-44|emphasis|drug
DDI-MedLine.d9.s7|46-47|on|drug
DDI-MedLine.d9.s7|49-53|those|drug
DDI-MedLine.d9.s7|55-61|aspects|drug
DDI-MedLine.d9.s7|63-66|that|drug
DDI-MedLine.d9.s7|68-73|impact|drug
DDI-MedLine.d9.s7|75-76|on|drug
DDI-MedLine.d9.s7|78-80|the|drug
DDI-MedLine.d9.s7|82-89|clinical|drug
DDI-MedLine.d9.s7|91-93|use|drug
DDI-MedLine.d9.s7|95-96|of|drug
DDI-MedLine.d9.s7|98-100|the|drug
DDI-MedLine.d9.s7|102-114|calcium-entry|drug
DDI-MedLine.d9.s7|116-126|antagonists|drug
DDI-MedLine.d9.s7|127-127|.|drug
DDI-DrugBank.d434.s0|0-2|The|drug
DDI-DrugBank.d434.s0|4-7|drug|drug
DDI-DrugBank.d434.s0|9-19|interaction|drug
DDI-DrugBank.d434.s0|21-24|data|drug
DDI-DrugBank.d434.s0|26-34|described|drug
DDI-DrugBank.d434.s0|36-37|in|drug
DDI-DrugBank.d434.s0|39-42|this|drug
DDI-DrugBank.d434.s0|44-50|section|drug
DDI-DrugBank.d434.s0|52-55|were|drug
DDI-DrugBank.d434.s0|57-64|obtained|drug
DDI-DrugBank.d434.s0|66-69|from|drug
DDI-DrugBank.d434.s0|71-80|controlled|drug
DDI-DrugBank.d434.s0|82-89|clinical|drug
DDI-DrugBank.d434.s0|91-96|trials|drug
DDI-DrugBank.d434.s0|98-100|and|drug
DDI-DrugBank.d434.s0|102-108|studies|drug
DDI-DrugBank.d434.s0|110-118|involving|drug
DDI-DrugBank.d434.s0|120-128|otherwise|drug
DDI-DrugBank.d434.s0|130-136|healthy|drug
DDI-DrugBank.d434.s0|138-143|adults|drug
DDI-DrugBank.d434.s0|145-148|with|drug
DDI-DrugBank.d434.s0|150-157|epilepsy|drug
DDI-DrugBank.d434.s0|158-158|.|drug
DDI-DrugBank.d434.s1|0-2|Use|drug
DDI-DrugBank.d434.s1|4-5|in|drug
DDI-DrugBank.d434.s1|7-17|Conjunction|drug
DDI-DrugBank.d434.s1|19-22|with|drug
DDI-DrugBank.d434.s1|24-28|Other|drug
DDI-DrugBank.d434.s1|30-42|Antiepileptic|drug
DDI-DrugBank.d434.s1|44-48|Drugs|drug
DDI-DrugBank.d434.s1|49-49|:|drug
DDI-DrugBank.d434.s1|51-53|The|drug
DDI-DrugBank.d434.s1|55-62|addition|drug
DDI-DrugBank.d434.s1|64-65|of|drug
DDI-DrugBank.d434.s1|67-74|Felbatol|drug
DDI-DrugBank.d434.s1|77-78|to|drug
DDI-DrugBank.d434.s1|80-92|antiepileptic|drug
DDI-DrugBank.d434.s1|94-98|drugs|drug
DDI-DrugBank.d434.s1|100-100|(|drug
DDI-DrugBank.d434.s1|101-104|AEDs|drug
DDI-DrugBank.d434.s1|105-105|)|drug
DDI-DrugBank.d434.s1|107-113|affects|drug
DDI-DrugBank.d434.s1|115-117|the|drug
DDI-DrugBank.d434.s1|119-130|steady-state|drug
DDI-DrugBank.d434.s1|132-137|plasma|drug
DDI-DrugBank.d434.s1|139-152|concentrations|drug
DDI-DrugBank.d434.s1|154-155|of|drug
DDI-DrugBank.d434.s1|157-160|AEDs|drug
DDI-DrugBank.d434.s1|161-161|.|drug
DDI-DrugBank.d434.s2|0-2|The|drug
DDI-DrugBank.d434.s2|4-6|net|drug
DDI-DrugBank.d434.s2|8-13|effect|drug
DDI-DrugBank.d434.s2|15-16|of|drug
DDI-DrugBank.d434.s2|18-22|these|drug
DDI-DrugBank.d434.s2|24-35|interactions|drug
DDI-DrugBank.d434.s2|37-38|is|drug
DDI-DrugBank.d434.s2|40-49|summarized|drug
DDI-DrugBank.d434.s2|51-52|in|drug
DDI-DrugBank.d434.s2|54-56|the|drug
DDI-DrugBank.d434.s2|58-66|following|drug
DDI-DrugBank.d434.s2|68-72|table|drug
DDI-DrugBank.d434.s2|73-73|:|drug
DDI-DrugBank.d434.s2|75-77|AED|drug
DDI-DrugBank.d434.s2|79-81|AED|drug
DDI-DrugBank.d434.s2|83-90|Felbatol|drug
DDI-DrugBank.d434.s3|0-13|Coadministered|drug
DDI-DrugBank.d434.s3|15-27|Concentration|drug
DDI-DrugBank.d434.s3|29-41|Concentration|drug
DDI-DrugBank.d434.s4|0-8|Phenytoin|drug
DDI-DrugBank.d434.s5|0-8|Valproate|drug
DDI-DrugBank.d434.s5|13-14|*|drug
DDI-DrugBank.d434.s6|0-12|Carbamazepine|drug
DDI-DrugBank.d434.s6|14-14|(|drug
DDI-DrugBank.d434.s6|15-17|CBZ|drug
DDI-DrugBank.d434.s6|18-18|)|drug
DDI-DrugBank.d434.s7|0-3|*|drug
DDI-DrugBank.d434.s7|5-11|CBZ|drug
DDI-DrugBank.d434.s8|0-12|Phenobarbital|drug
DDI-DrugBank.d434.s9|0-3|*|drug
DDI-DrugBank.d434.s9|5-16|Not|drug
DDI-DrugBank.d434.s9|17-17|administered|drug
DDI-DrugBank.d434.s9|19-21|,|drug
DDI-DrugBank.d434.s9|23-24|but|drug
DDI-DrugBank.d434.s9|26-31|an|drug
DDI-DrugBank.d434.s9|33-42|active|drug
DDI-DrugBank.d434.s9|44-45|metabolite|drug
DDI-DrugBank.d434.s9|47-59|of|drug
DDI-DrugBank.d434.s9|60-60|carbamazepine|drug
DDI-DrugBank.d434.s10|0-3|*|drug
DDI-DrugBank.d434.s10|5-15|*|drug
DDI-DrugBank.d434.s10|17-22|No|drug
DDI-DrugBank.d434.s10|23-23|significant|drug
DDI-DrugBank.d434.s11|0-7|Specific|drug
DDI-DrugBank.d434.s11|9-15|Effects|drug
DDI-DrugBank.d434.s11|17-18|of|drug
DDI-DrugBank.d434.s11|20-27|Felbatol|drug
DDI-DrugBank.d434.s11|30-31|on|drug
DDI-DrugBank.d434.s11|33-37|Other|drug
DDI-DrugBank.d434.s11|39-51|Antiepileptic|drug
DDI-DrugBank.d434.s11|53-57|Drugs|drug
DDI-DrugBank.d434.s11|59-67|Phenytoin|drug
DDI-DrugBank.d434.s11|68-68|:|drug
DDI-DrugBank.d434.s11|70-77|Felbatol|drug
DDI-DrugBank.d434.s11|80-85|causes|drug
DDI-DrugBank.d434.s11|87-88|an|drug
DDI-DrugBank.d434.s11|90-97|increase|drug
DDI-DrugBank.d434.s11|99-100|in|drug
DDI-DrugBank.d434.s11|102-113|steady-state|drug
DDI-DrugBank.d434.s11|115-123|phenytoin|drug
DDI-DrugBank.d434.s11|125-130|plasma|drug
DDI-DrugBank.d434.s11|132-145|concentrations|drug
DDI-DrugBank.d434.s11|146-146|.|drug
DDI-DrugBank.d434.s12|0-1|In|drug
DDI-DrugBank.d434.s12|3-4|10|drug
DDI-DrugBank.d434.s12|6-14|otherwise|drug
DDI-DrugBank.d434.s12|16-22|healthy|drug
DDI-DrugBank.d434.s12|24-31|subjects|drug
DDI-DrugBank.d434.s12|33-36|with|drug
DDI-DrugBank.d434.s12|38-45|epilepsy|drug
DDI-DrugBank.d434.s12|47-55|ingesting|drug
DDI-DrugBank.d434.s12|57-65|phenytoin|drug
DDI-DrugBank.d434.s12|66-66|,|drug
DDI-DrugBank.d434.s12|68-70|the|drug
DDI-DrugBank.d434.s12|72-82|steadystate|drug
DDI-DrugBank.d434.s12|84-89|trough|drug
DDI-DrugBank.d434.s12|91-91|(|drug
DDI-DrugBank.d434.s12|92-95|Cmin|drug
DDI-DrugBank.d434.s12|96-96|)|drug
DDI-DrugBank.d434.s12|98-106|phenytoin|drug
DDI-DrugBank.d434.s12|108-113|plasma|drug
DDI-DrugBank.d434.s12|115-127|concentration|drug
DDI-DrugBank.d434.s12|129-131|was|drug
DDI-DrugBank.d434.s12|133-134|17|drug
DDI-DrugBank.d434.s12|136-136|5|drug
DDI-DrugBank.d434.s12|138-150|micrograms/mL|drug
DDI-DrugBank.d434.s12|151-151|.|drug
DDI-DrugBank.d434.s13|0-2|The|drug
DDI-DrugBank.d434.s13|4-15|steady-state|drug
DDI-DrugBank.d434.s13|17-20|Cmin|drug
DDI-DrugBank.d434.s13|22-30|increased|drug
DDI-DrugBank.d434.s13|32-33|to|drug
DDI-DrugBank.d434.s13|35-36|21|drug
DDI-DrugBank.d434.s13|38-38|5|drug
DDI-DrugBank.d434.s13|40-52|micrograms/mL|drug
DDI-DrugBank.d434.s13|54-57|when|drug
DDI-DrugBank.d434.s13|59-62|1200|drug
DDI-DrugBank.d434.s13|64-69|mg/day|drug
DDI-DrugBank.d434.s13|71-72|of|drug
DDI-DrugBank.d434.s13|74-82|felbamate|drug
DDI-DrugBank.d434.s13|84-86|was|drug
DDI-DrugBank.d434.s13|88-101|coadministered|drug
DDI-DrugBank.d434.s13|102-102|.|drug
DDI-DrugBank.d434.s14|0-9|Increasing|drug
DDI-DrugBank.d434.s14|11-13|the|drug
DDI-DrugBank.d434.s14|15-23|felbamate|drug
DDI-DrugBank.d434.s14|25-28|dose|drug
DDI-DrugBank.d434.s14|30-31|to|drug
DDI-DrugBank.d434.s14|33-36|1800|drug
DDI-DrugBank.d434.s14|38-43|mg/day|drug
DDI-DrugBank.d434.s14|45-46|in|drug
DDI-DrugBank.d434.s14|48-50|six|drug
DDI-DrugBank.d434.s14|52-53|of|drug
DDI-DrugBank.d434.s14|55-59|these|drug
DDI-DrugBank.d434.s14|61-68|subjects|drug
DDI-DrugBank.d434.s14|70-78|increased|drug
DDI-DrugBank.d434.s14|80-82|the|drug
DDI-DrugBank.d434.s14|84-95|steady-state|drug
DDI-DrugBank.d434.s14|97-105|phenytoin|drug
DDI-DrugBank.d434.s14|107-110|Cmin|drug
DDI-DrugBank.d434.s14|112-113|to|drug
DDI-DrugBank.d434.s14|115-116|25|drug
DDI-DrugBank.d434.s14|118-118|7|drug
DDI-DrugBank.d434.s14|120-132|micrograms/mL|drug
DDI-DrugBank.d434.s14|133-133|.|drug
DDI-DrugBank.d434.s15|0-1|In|drug
DDI-DrugBank.d434.s15|3-7|order|drug
DDI-DrugBank.d434.s15|9-10|to|drug
DDI-DrugBank.d434.s15|12-19|maintain|drug
DDI-DrugBank.d434.s15|21-29|phenytoin|drug
DDI-DrugBank.d434.s15|31-36|levels|drug
DDI-DrugBank.d434.s15|37-37|,|drug
DDI-DrugBank.d434.s15|39-43|limit|drug
DDI-DrugBank.d434.s15|45-51|adverse|drug
DDI-DrugBank.d434.s15|53-63|experiences|drug
DDI-DrugBank.d434.s15|64-64|,|drug
DDI-DrugBank.d434.s15|66-68|and|drug
DDI-DrugBank.d434.s15|70-76|achieve|drug
DDI-DrugBank.d434.s15|78-80|the|drug
DDI-DrugBank.d434.s15|82-90|felbamate|drug
DDI-DrugBank.d434.s15|92-95|dose|drug
DDI-DrugBank.d434.s15|97-98|of|drug
DDI-DrugBank.d434.s15|100-103|3600|drug
DDI-DrugBank.d434.s15|105-110|mg/day|drug
DDI-DrugBank.d434.s15|111-111|,|drug
DDI-DrugBank.d434.s15|113-113|a|drug
DDI-DrugBank.d434.s15|115-123|phenytoin|drug
DDI-DrugBank.d434.s15|125-128|dose|drug
DDI-DrugBank.d434.s15|130-138|reduction|drug
DDI-DrugBank.d434.s15|140-141|of|drug
DDI-DrugBank.d434.s15|143-155|approximately|drug
DDI-DrugBank.d434.s15|157-158|40|drug
DDI-DrugBank.d434.s15|159-159|%|drug
DDI-DrugBank.d434.s15|161-163|was|drug
DDI-DrugBank.d434.s15|165-173|necessary|drug
DDI-DrugBank.d434.s15|175-177|for|drug
DDI-DrugBank.d434.s15|179-183|eight|drug
DDI-DrugBank.d434.s15|185-186|of|drug
DDI-DrugBank.d434.s15|188-192|these|drug
DDI-DrugBank.d434.s15|194-195|10|drug
DDI-DrugBank.d434.s15|197-204|subjects|drug
DDI-DrugBank.d434.s15|205-205|.|drug
DDI-DrugBank.d434.s16|0-1|In|drug
DDI-DrugBank.d434.s16|3-3|a|drug
DDI-DrugBank.d434.s16|5-14|controlled|drug
DDI-DrugBank.d434.s16|16-23|clinical|drug
DDI-DrugBank.d434.s16|25-29|trial|drug
DDI-DrugBank.d434.s16|30-30|,|drug
DDI-DrugBank.d434.s16|32-32|a|drug
DDI-DrugBank.d434.s16|34-35|20|drug
DDI-DrugBank.d434.s16|36-36|%|drug
DDI-DrugBank.d434.s16|38-46|reduction|drug
DDI-DrugBank.d434.s16|48-49|of|drug
DDI-DrugBank.d434.s16|51-53|the|drug
DDI-DrugBank.d434.s16|55-63|phenytoin|drug
DDI-DrugBank.d434.s16|65-68|dose|drug
DDI-DrugBank.d434.s16|70-71|at|drug
DDI-DrugBank.d434.s16|73-75|the|drug
DDI-DrugBank.d434.s16|77-86|initiation|drug
DDI-DrugBank.d434.s16|88-89|of|drug
DDI-DrugBank.d434.s16|91-98|Felbatol|drug
DDI-DrugBank.d434.s16|101-107|therapy|drug
DDI-DrugBank.d434.s16|109-116|resulted|drug
DDI-DrugBank.d434.s16|118-119|in|drug
DDI-DrugBank.d434.s16|121-129|phenytoin|drug
DDI-DrugBank.d434.s16|131-136|levels|drug
DDI-DrugBank.d434.s16|138-147|comparable|drug
DDI-DrugBank.d434.s16|149-150|to|drug
DDI-DrugBank.d434.s16|152-156|those|drug
DDI-DrugBank.d434.s16|158-162|prior|drug
DDI-DrugBank.d434.s16|164-165|to|drug
DDI-DrugBank.d434.s16|167-174|Felbatol|drug
DDI-DrugBank.d434.s16|177-190|administration|drug
DDI-DrugBank.d434.s16|191-191|.|drug
DDI-DrugBank.d434.s17|0-12|Carbamazepine|drug
DDI-DrugBank.d434.s17|13-13|:|drug
DDI-DrugBank.d434.s17|15-22|Felbatol|drug
DDI-DrugBank.d434.s17|25-30|causes|drug
DDI-DrugBank.d434.s17|32-32|a|drug
DDI-DrugBank.d434.s17|34-41|decrease|drug
DDI-DrugBank.d434.s17|43-44|in|drug
DDI-DrugBank.d434.s17|46-48|the|drug
DDI-DrugBank.d434.s17|50-61|steady-state|drug
DDI-DrugBank.d434.s17|63-75|carbamazepine|drug
DDI-DrugBank.d434.s17|77-82|plasma|drug
DDI-DrugBank.d434.s17|84-97|concentrations|drug
DDI-DrugBank.d434.s17|99-101|and|drug
DDI-DrugBank.d434.s17|103-104|an|drug
DDI-DrugBank.d434.s17|106-113|increase|drug
DDI-DrugBank.d434.s17|115-116|in|drug
DDI-DrugBank.d434.s17|118-120|the|drug
DDI-DrugBank.d434.s17|122-133|steady-state|drug
DDI-DrugBank.d434.s17|135-147|carbamazepine|drug
DDI-DrugBank.d434.s17|149-155|epoxide|drug
DDI-DrugBank.d434.s17|157-162|plasma|drug
DDI-DrugBank.d434.s17|164-176|concentration|drug
DDI-DrugBank.d434.s17|177-177|.|drug
DDI-DrugBank.d434.s18|0-1|In|drug
DDI-DrugBank.d434.s18|3-6|nine|drug
DDI-DrugBank.d434.s18|8-16|otherwise|drug
DDI-DrugBank.d434.s18|18-24|healthy|drug
DDI-DrugBank.d434.s18|26-33|subjects|drug
DDI-DrugBank.d434.s18|35-38|with|drug
DDI-DrugBank.d434.s18|40-47|epilepsy|drug
DDI-DrugBank.d434.s18|49-57|ingesting|drug
DDI-DrugBank.d434.s18|59-71|carbamazepine|drug
DDI-DrugBank.d434.s18|72-72|,|drug
DDI-DrugBank.d434.s18|74-76|the|drug
DDI-DrugBank.d434.s18|78-89|steady-state|drug
DDI-DrugBank.d434.s18|91-96|trough|drug
DDI-DrugBank.d434.s18|98-98|(|drug
DDI-DrugBank.d434.s18|99-102|Cmin|drug
DDI-DrugBank.d434.s18|103-103|)|drug
DDI-DrugBank.d434.s18|105-117|carbamazepine|drug
DDI-DrugBank.d434.s18|119-131|concentration|drug
DDI-DrugBank.d434.s18|133-135|was|drug
DDI-DrugBank.d434.s18|137-137|8|drug
DDI-DrugBank.d434.s18|139-139|2|drug
DDI-DrugBank.d434.s18|141-153|micrograms/mL|drug
DDI-DrugBank.d434.s18|154-154|.|drug
DDI-DrugBank.d434.s19|0-2|The|drug
DDI-DrugBank.d434.s19|4-16|carbamazepine|drug
DDI-DrugBank.d434.s19|18-29|steady-state|drug
DDI-DrugBank.d434.s19|31-34|Cmin|drug
DDI-DrugBank.d434.s19|36-44|decreased|drug
DDI-DrugBank.d434.s19|46-47|31|drug
DDI-DrugBank.d434.s19|48-48|%|drug
DDI-DrugBank.d434.s19|50-51|to|drug
DDI-DrugBank.d434.s19|53-53|5|drug
DDI-DrugBank.d434.s19|55-55|1|drug
DDI-DrugBank.d434.s19|57-69|micrograms/mL|drug
DDI-DrugBank.d434.s19|71-74|when|drug
DDI-DrugBank.d434.s19|76-84|felbamate|drug
DDI-DrugBank.d434.s19|86-86|(|drug
DDI-DrugBank.d434.s19|87-90|3000|drug
DDI-DrugBank.d434.s19|92-97|mg/day|drug
DDI-DrugBank.d434.s19|98-98|,|drug
DDI-DrugBank.d434.s19|100-106|divided|drug
DDI-DrugBank.d434.s19|108-111|into|drug
DDI-DrugBank.d434.s19|113-117|three|drug
DDI-DrugBank.d434.s19|119-123|doses|drug
DDI-DrugBank.d434.s19|124-124|)|drug
DDI-DrugBank.d434.s19|126-128|was|drug
DDI-DrugBank.d434.s19|130-143|coadministered|drug
DDI-DrugBank.d434.s19|144-144|.|drug
DDI-DrugBank.d434.s20|0-12|Carbamazepine|drug
DDI-DrugBank.d434.s20|14-20|epoxide|drug
DDI-DrugBank.d434.s20|22-33|steady-state|drug
DDI-DrugBank.d434.s20|35-38|Cmin|drug
DDI-DrugBank.d434.s20|40-53|concentrations|drug
DDI-DrugBank.d434.s20|55-63|increased|drug
DDI-DrugBank.d434.s20|65-66|57|drug
DDI-DrugBank.d434.s20|67-67|%|drug
DDI-DrugBank.d434.s20|69-72|from|drug
DDI-DrugBank.d434.s20|74-76|1.0|drug
DDI-DrugBank.d434.s20|78-80|0.3|drug
DDI-DrugBank.d434.s20|82-83|to|drug
DDI-DrugBank.d434.s20|85-87|1.6|drug
DDI-DrugBank.d434.s20|89-91|0.4|drug
DDI-DrugBank.d434.s20|93-105|micrograms/mL|drug
DDI-DrugBank.d434.s20|107-110|with|drug
DDI-DrugBank.d434.s20|112-114|the|drug
DDI-DrugBank.d434.s20|116-123|addition|drug
DDI-DrugBank.d434.s20|125-126|of|drug
DDI-DrugBank.d434.s20|128-136|felbamate|drug
DDI-DrugBank.d434.s20|137-137|.|drug
DDI-DrugBank.d434.s21|0-1|In|drug
DDI-DrugBank.d434.s21|3-10|clinical|drug
DDI-DrugBank.d434.s21|12-17|trials|drug
DDI-DrugBank.d434.s21|18-18|,|drug
DDI-DrugBank.d434.s21|20-26|similar|drug
DDI-DrugBank.d434.s21|28-34|changes|drug
DDI-DrugBank.d434.s21|36-37|in|drug
DDI-DrugBank.d434.s21|39-51|carbamazepine|drug
DDI-DrugBank.d434.s21|53-55|and|drug
DDI-DrugBank.d434.s21|57-69|carbamazepine|drug
DDI-DrugBank.d434.s21|71-77|epoxide|drug
DDI-DrugBank.d434.s21|79-82|were|drug
DDI-DrugBank.d434.s21|84-87|seen|drug
DDI-DrugBank.d434.s21|88-88|.|drug
DDI-DrugBank.d434.s22|0-8|Valproate|drug
DDI-DrugBank.d434.s22|9-9|:|drug
DDI-DrugBank.d434.s22|11-18|Felbatol|drug
DDI-DrugBank.d434.s22|21-26|causes|drug
DDI-DrugBank.d434.s22|28-29|an|drug
DDI-DrugBank.d434.s22|31-38|increase|drug
DDI-DrugBank.d434.s22|40-41|in|drug
DDI-DrugBank.d434.s22|43-54|steady-state|drug
DDI-DrugBank.d434.s22|56-64|valproate|drug
DDI-DrugBank.d434.s22|66-79|concentrations|drug
DDI-DrugBank.d434.s22|80-80|.|drug
DDI-DrugBank.d434.s23|0-1|In|drug
DDI-DrugBank.d434.s23|3-6|four|drug
DDI-DrugBank.d434.s23|8-15|subjects|drug
DDI-DrugBank.d434.s23|17-20|with|drug
DDI-DrugBank.d434.s23|22-29|epilepsy|drug
DDI-DrugBank.d434.s23|31-39|ingesting|drug
DDI-DrugBank.d434.s23|41-49|valproate|drug
DDI-DrugBank.d434.s23|50-50|,|drug
DDI-DrugBank.d434.s23|52-54|the|drug
DDI-DrugBank.d434.s23|56-67|steady-state|drug
DDI-DrugBank.d434.s23|69-74|trough|drug
DDI-DrugBank.d434.s23|76-76|(|drug
DDI-DrugBank.d434.s23|77-80|Cmin|drug
DDI-DrugBank.d434.s23|81-81|)|drug
DDI-DrugBank.d434.s23|83-91|valproate|drug
DDI-DrugBank.d434.s23|93-98|plasma|drug
DDI-DrugBank.d434.s23|100-112|concentration|drug
DDI-DrugBank.d434.s23|114-116|was|drug
DDI-DrugBank.d434.s23|118-119|63|drug
DDI-DrugBank.d434.s23|121-122|16|drug
DDI-DrugBank.d434.s23|124-136|micrograms/mL|drug
DDI-DrugBank.d434.s23|137-137|.|drug
DDI-DrugBank.d434.s24|0-2|The|drug
DDI-DrugBank.d434.s24|4-15|steady-state|drug
DDI-DrugBank.d434.s24|17-20|Cmin|drug
DDI-DrugBank.d434.s24|22-30|increased|drug
DDI-DrugBank.d434.s24|32-33|to|drug
DDI-DrugBank.d434.s24|35-36|78|drug
DDI-DrugBank.d434.s24|38-39|14|drug
DDI-DrugBank.d434.s24|41-53|micrograms/mL|drug
DDI-DrugBank.d434.s24|55-58|when|drug
DDI-DrugBank.d434.s24|60-63|1200|drug
DDI-DrugBank.d434.s24|65-70|mg/day|drug
DDI-DrugBank.d434.s24|72-73|of|drug
DDI-DrugBank.d434.s24|75-83|felbamate|drug
DDI-DrugBank.d434.s24|85-87|was|drug
DDI-DrugBank.d434.s24|89-102|coadministered|drug
DDI-DrugBank.d434.s24|103-103|.|drug
DDI-DrugBank.d434.s25|0-9|Increasing|drug
DDI-DrugBank.d434.s25|11-13|the|drug
DDI-DrugBank.d434.s25|15-23|felbamate|drug
DDI-DrugBank.d434.s25|25-28|dose|drug
DDI-DrugBank.d434.s25|30-31|to|drug
DDI-DrugBank.d434.s25|33-36|2400|drug
DDI-DrugBank.d434.s25|38-43|mg/day|drug
DDI-DrugBank.d434.s25|45-53|increased|drug
DDI-DrugBank.d434.s25|55-57|the|drug
DDI-DrugBank.d434.s25|59-69|steadystate|drug
DDI-DrugBank.d434.s25|71-79|valproate|drug
DDI-DrugBank.d434.s25|81-84|Cmin|drug
DDI-DrugBank.d434.s25|86-87|to|drug
DDI-DrugBank.d434.s25|89-90|96|drug
DDI-DrugBank.d434.s25|92-93|25|drug
DDI-DrugBank.d434.s25|95-107|micrograms/mL|drug
DDI-DrugBank.d434.s25|108-108|.|drug
DDI-DrugBank.d434.s26|0-12|Corresponding|drug
DDI-DrugBank.d434.s26|14-19|values|drug
DDI-DrugBank.d434.s26|21-23|for|drug
DDI-DrugBank.d434.s26|25-28|free|drug
DDI-DrugBank.d434.s26|30-38|valproate|drug
DDI-DrugBank.d434.s26|40-43|Cmin|drug
DDI-DrugBank.d434.s26|45-58|concentrations|drug
DDI-DrugBank.d434.s26|60-63|were|drug
DDI-DrugBank.d434.s26|65-65|7|drug
DDI-DrugBank.d434.s26|67-67|3|drug
DDI-DrugBank.d434.s26|68-68|,|drug
DDI-DrugBank.d434.s26|70-70|9|drug
DDI-DrugBank.d434.s26|72-72|4|drug
DDI-DrugBank.d434.s26|73-73|,|drug
DDI-DrugBank.d434.s26|75-77|and|drug
DDI-DrugBank.d434.s26|79-80|11|drug
DDI-DrugBank.d434.s26|82-82|6|drug
DDI-DrugBank.d434.s26|84-96|micrograms/mL|drug
DDI-DrugBank.d434.s26|98-100|for|drug
DDI-DrugBank.d434.s26|102-102|0|drug
DDI-DrugBank.d434.s26|103-103|,|drug
DDI-DrugBank.d434.s26|105-108|1200|drug
DDI-DrugBank.d434.s26|109-109|,|drug
DDI-DrugBank.d434.s26|111-113|and|drug
DDI-DrugBank.d434.s26|115-118|2400|drug
DDI-DrugBank.d434.s26|120-125|mg/day|drug
DDI-DrugBank.d434.s26|127-134|Felbatol|drug
DDI-DrugBank.d434.s26|136-136|,|drug
DDI-DrugBank.d434.s26|138-149|respectively|drug
DDI-DrugBank.d434.s26|150-150|.|drug
DDI-DrugBank.d434.s27|0-2|The|drug
DDI-DrugBank.d434.s27|4-9|ratios|drug
DDI-DrugBank.d434.s27|11-12|of|drug
DDI-DrugBank.d434.s27|14-16|the|drug
DDI-DrugBank.d434.s27|18-21|AUCs|drug
DDI-DrugBank.d434.s27|23-24|of|drug
DDI-DrugBank.d434.s27|26-32|unbound|drug
DDI-DrugBank.d434.s27|34-42|valproate|drug
DDI-DrugBank.d434.s27|44-45|to|drug
DDI-DrugBank.d434.s27|47-49|the|drug
DDI-DrugBank.d434.s27|51-54|AUCs|drug
DDI-DrugBank.d434.s27|56-57|of|drug
DDI-DrugBank.d434.s27|59-61|the|drug
DDI-DrugBank.d434.s27|63-67|total|drug
DDI-DrugBank.d434.s27|69-77|valproate|drug
DDI-DrugBank.d434.s27|79-82|were|drug
DDI-DrugBank.d434.s27|84-87|11.1|drug
DDI-DrugBank.d434.s27|89-89|%|drug
DDI-DrugBank.d434.s27|90-90|,|drug
DDI-DrugBank.d434.s27|92-95|13.0|drug
DDI-DrugBank.d434.s27|96-96|%|drug
DDI-DrugBank.d434.s27|97-97|,|drug
DDI-DrugBank.d434.s27|99-101|and|drug
DDI-DrugBank.d434.s27|103-106|11.5|drug
DDI-DrugBank.d434.s27|107-107|%|drug
DDI-DrugBank.d434.s27|108-108|,|drug
DDI-DrugBank.d434.s27|110-113|with|drug
DDI-DrugBank.d434.s27|115-130|coadministration|drug
DDI-DrugBank.d434.s27|132-133|of|drug
DDI-DrugBank.d434.s27|135-135|0|drug
DDI-DrugBank.d434.s27|136-136|,|drug
DDI-DrugBank.d434.s27|138-141|1200|drug
DDI-DrugBank.d434.s27|142-142|,|drug
DDI-DrugBank.d434.s27|144-146|and|drug
DDI-DrugBank.d434.s27|148-151|2400|drug
DDI-DrugBank.d434.s27|153-158|mg/day|drug
DDI-DrugBank.d434.s27|160-161|of|drug
DDI-DrugBank.d434.s27|163-170|Felbatol|drug
DDI-DrugBank.d434.s27|172-172|,|drug
DDI-DrugBank.d434.s27|174-185|respectively|drug
DDI-DrugBank.d434.s27|186-186|.|drug
DDI-DrugBank.d434.s28|0-12|Phenobarbital|drug
DDI-DrugBank.d434.s28|13-13|:|drug
DDI-DrugBank.d434.s28|15-30|Coadministration|drug
DDI-DrugBank.d434.s28|32-33|of|drug
DDI-DrugBank.d434.s28|35-43|felbamate|drug
DDI-DrugBank.d434.s28|45-48|with|drug
DDI-DrugBank.d434.s28|50-62|phenobarbital|drug
DDI-DrugBank.d434.s28|64-69|causes|drug
DDI-DrugBank.d434.s28|71-72|an|drug
DDI-DrugBank.d434.s28|74-81|increase|drug
DDI-DrugBank.d434.s28|83-84|in|drug
DDI-DrugBank.d434.s28|86-98|phenobarbital|drug
DDI-DrugBank.d434.s28|100-105|plasma|drug
DDI-DrugBank.d434.s28|107-120|concentrations|drug
DDI-DrugBank.d434.s28|121-121|,|drug
DDI-DrugBank.d434.s28|123-124|In|drug
DDI-DrugBank.d434.s28|126-127|12|drug
DDI-DrugBank.d434.s28|129-137|otherwise|drug
DDI-DrugBank.d434.s28|139-145|healthy|drug
DDI-DrugBank.d434.s28|147-150|male|drug
DDI-DrugBank.d434.s28|152-161|volunteers|drug
DDI-DrugBank.d434.s28|163-171|ingesting|drug
DDI-DrugBank.d434.s28|173-185|phenobarbital|drug
DDI-DrugBank.d434.s28|186-186|,|drug
DDI-DrugBank.d434.s28|188-190|the|drug
DDI-DrugBank.d434.s28|192-203|steady-state|drug
DDI-DrugBank.d434.s28|205-210|trough|drug
DDI-DrugBank.d434.s28|212-212|(|drug
DDI-DrugBank.d434.s28|213-216|Cmin|drug
DDI-DrugBank.d434.s28|217-217|)|drug
DDI-DrugBank.d434.s28|219-231|phenobarbital|drug
DDI-DrugBank.d434.s28|233-245|concentration|drug
DDI-DrugBank.d434.s28|247-249|was|drug
DDI-DrugBank.d434.s28|251-254|14.2|drug
DDI-DrugBank.d434.s28|256-268|micrograms/mL|drug
DDI-DrugBank.d434.s28|269-269|.|drug
DDI-DrugBank.d434.s29|0-2|The|drug
DDI-DrugBank.d434.s29|4-15|steady-state|drug
DDI-DrugBank.d434.s29|17-20|Cmin|drug
DDI-DrugBank.d434.s29|22-34|concentration|drug
DDI-DrugBank.d434.s29|36-44|increased|drug
DDI-DrugBank.d434.s29|46-47|to|drug
DDI-DrugBank.d434.s29|49-52|17.8|drug
DDI-DrugBank.d434.s29|54-66|micrograms/mL|drug
DDI-DrugBank.d434.s29|68-71|when|drug
DDI-DrugBank.d434.s29|73-76|2400|drug
DDI-DrugBank.d434.s29|78-83|mg/day|drug
DDI-DrugBank.d434.s29|85-86|of|drug
DDI-DrugBank.d434.s29|88-96|felbamate|drug
DDI-DrugBank.d434.s29|98-100|was|drug
DDI-DrugBank.d434.s29|102-115|coadministered|drug
DDI-DrugBank.d434.s29|117-119|for|drug
DDI-DrugBank.d434.s29|121-123|one|drug
DDI-DrugBank.d434.s29|125-128|week|drug
DDI-DrugBank.d434.s29|129-129|.|drug
DDI-DrugBank.d434.s30|0-6|Effects|drug
DDI-DrugBank.d434.s30|8-9|of|drug
DDI-DrugBank.d434.s30|11-15|Other|drug
DDI-DrugBank.d434.s30|17-29|Antiepileptic|drug
DDI-DrugBank.d434.s30|31-35|Drugs|drug
DDI-DrugBank.d434.s30|37-38|on|drug
DDI-DrugBank.d434.s30|40-47|Felbatol|drug
DDI-DrugBank.d434.s30|50-58|Phenytoin|drug
DDI-DrugBank.d434.s30|59-59|:|drug
DDI-DrugBank.d434.s30|61-69|Phenytoin|drug
DDI-DrugBank.d434.s30|71-76|causes|drug
DDI-DrugBank.d434.s30|78-79|an|drug
DDI-DrugBank.d434.s30|81-91|approximate|drug
DDI-DrugBank.d434.s30|93-100|doubling|drug
DDI-DrugBank.d434.s30|102-103|of|drug
DDI-DrugBank.d434.s30|105-107|the|drug
DDI-DrugBank.d434.s30|109-117|clearance|drug
DDI-DrugBank.d434.s30|119-120|of|drug
DDI-DrugBank.d434.s30|122-129|Felbatol|drug
DDI-DrugBank.d434.s30|132-132|(|drug
DDI-DrugBank.d434.s30|133-141|felbamate|drug
DDI-DrugBank.d434.s30|142-142|)|drug
DDI-DrugBank.d434.s30|144-145|at|drug
DDI-DrugBank.d434.s30|147-152|steady|drug
DDI-DrugBank.d434.s30|154-158|state|drug
DDI-DrugBank.d434.s30|160-162|and|drug
DDI-DrugBank.d434.s30|163-163|,|drug
DDI-DrugBank.d434.s30|165-173|therefore|drug
DDI-DrugBank.d434.s30|174-174|,|drug
DDI-DrugBank.d434.s30|176-178|the|drug
DDI-DrugBank.d434.s30|180-187|addition|drug
DDI-DrugBank.d434.s30|189-190|of|drug
DDI-DrugBank.d434.s30|192-200|phenytoin|drug
DDI-DrugBank.d434.s30|202-207|causes|drug
DDI-DrugBank.d434.s30|209-210|an|drug
DDI-DrugBank.d434.s30|212-222|approximate|drug
DDI-DrugBank.d434.s30|224-225|45|drug
DDI-DrugBank.d434.s30|226-226|%|drug
DDI-DrugBank.d434.s30|228-235|decrease|drug
DDI-DrugBank.d434.s30|237-238|in|drug
DDI-DrugBank.d434.s30|240-242|the|drug
DDI-DrugBank.d434.s30|244-255|steady-state|drug
DDI-DrugBank.d434.s30|257-262|trough|drug
DDI-DrugBank.d434.s30|264-277|concentrations|drug
DDI-DrugBank.d434.s30|279-280|of|drug
DDI-DrugBank.d434.s30|282-289|Felbatol|drug
DDI-DrugBank.d434.s30|292-293|as|drug
DDI-DrugBank.d434.s30|295-302|compared|drug
DDI-DrugBank.d434.s30|304-305|to|drug
DDI-DrugBank.d434.s30|307-309|the|drug
DDI-DrugBank.d434.s30|311-314|same|drug
DDI-DrugBank.d434.s30|316-319|dose|drug
DDI-DrugBank.d434.s30|321-322|of|drug
DDI-DrugBank.d434.s30|324-331|Felbatol|drug
DDI-DrugBank.d434.s30|334-338|given|drug
DDI-DrugBank.d434.s30|340-341|as|drug
DDI-DrugBank.d434.s30|343-353|monotherapy|drug
DDI-DrugBank.d434.s30|354-354|.|drug
DDI-DrugBank.d434.s31|0-12|Carbamazepine|drug
DDI-DrugBank.d434.s31|13-13|:|drug
DDI-DrugBank.d434.s31|15-27|Carbamazepine|drug
DDI-DrugBank.d434.s31|29-34|causes|drug
DDI-DrugBank.d434.s31|36-37|an|drug
DDI-DrugBank.d434.s31|39-49|approximate|drug
DDI-DrugBank.d434.s31|51-52|50|drug
DDI-DrugBank.d434.s31|53-53|%|drug
DDI-DrugBank.d434.s31|55-62|increase|drug
DDI-DrugBank.d434.s31|64-65|in|drug
DDI-DrugBank.d434.s31|67-69|the|drug
DDI-DrugBank.d434.s31|71-79|clearance|drug
DDI-DrugBank.d434.s31|81-82|of|drug
DDI-DrugBank.d434.s31|84-91|Felbatol|drug
DDI-DrugBank.d434.s31|94-95|at|drug
DDI-DrugBank.d434.s31|97-102|steady|drug
DDI-DrugBank.d434.s31|104-108|state|drug
DDI-DrugBank.d434.s31|110-112|and|drug
DDI-DrugBank.d434.s31|113-113|,|drug
DDI-DrugBank.d434.s31|115-123|therefore|drug
DDI-DrugBank.d434.s31|124-124|,|drug
DDI-DrugBank.d434.s31|126-128|the|drug
DDI-DrugBank.d434.s31|130-137|addition|drug
DDI-DrugBank.d434.s31|139-140|of|drug
DDI-DrugBank.d434.s31|142-154|carbamazepine|drug
DDI-DrugBank.d434.s31|156-162|results|drug
DDI-DrugBank.d434.s31|164-165|in|drug
DDI-DrugBank.d434.s31|167-168|an|drug
DDI-DrugBank.d434.s31|170-180|approximate|drug
DDI-DrugBank.d434.s31|182-183|40|drug
DDI-DrugBank.d434.s31|184-184|%|drug
DDI-DrugBank.d434.s31|186-193|decrease|drug
DDI-DrugBank.d434.s31|195-196|in|drug
DDI-DrugBank.d434.s31|198-200|the|drug
DDI-DrugBank.d434.s31|202-213|steady-state|drug
DDI-DrugBank.d434.s31|215-220|trough|drug
DDI-DrugBank.d434.s31|222-235|concentrations|drug
DDI-DrugBank.d434.s31|237-238|of|drug
DDI-DrugBank.d434.s31|240-247|Felbatol|drug
DDI-DrugBank.d434.s31|250-251|as|drug
DDI-DrugBank.d434.s31|253-260|compared|drug
DDI-DrugBank.d434.s31|262-263|to|drug
DDI-DrugBank.d434.s31|265-267|the|drug
DDI-DrugBank.d434.s31|269-272|same|drug
DDI-DrugBank.d434.s31|274-277|dose|drug
DDI-DrugBank.d434.s31|279-280|of|drug
DDI-DrugBank.d434.s31|282-289|Felbatol|drug
DDI-DrugBank.d434.s31|292-296|given|drug
DDI-DrugBank.d434.s31|298-299|as|drug
DDI-DrugBank.d434.s31|301-311|monotherapy|drug
DDI-DrugBank.d434.s31|312-312|.|drug
DDI-DrugBank.d434.s32|0-8|Valproate|drug
DDI-DrugBank.d434.s32|9-9|:|drug
DDI-DrugBank.d434.s32|11-19|Available|drug
DDI-DrugBank.d434.s32|21-24|data|drug
DDI-DrugBank.d434.s32|26-32|suggest|drug
DDI-DrugBank.d434.s32|34-37|that|drug
DDI-DrugBank.d434.s32|39-43|there|drug
DDI-DrugBank.d434.s32|45-46|is|drug
DDI-DrugBank.d434.s32|48-49|no|drug
DDI-DrugBank.d434.s32|51-61|significant|drug
DDI-DrugBank.d434.s32|63-68|effect|drug
DDI-DrugBank.d434.s32|70-71|of|drug
DDI-DrugBank.d434.s32|73-81|valproate|drug
DDI-DrugBank.d434.s32|83-84|on|drug
DDI-DrugBank.d434.s32|86-88|the|drug
DDI-DrugBank.d434.s32|90-98|clearance|drug
DDI-DrugBank.d434.s32|100-101|of|drug
DDI-DrugBank.d434.s32|103-110|Felbatol|drug
DDI-DrugBank.d434.s32|113-114|at|drug
DDI-DrugBank.d434.s32|116-121|steady|drug
DDI-DrugBank.d434.s32|123-127|state|drug
DDI-DrugBank.d434.s32|128-128|,|drug
DDI-DrugBank.d434.s32|130-138|Therefore|drug
DDI-DrugBank.d434.s32|139-139|,|drug
DDI-DrugBank.d434.s32|141-143|the|drug
DDI-DrugBank.d434.s32|145-152|addition|drug
DDI-DrugBank.d434.s32|154-155|of|drug
DDI-DrugBank.d434.s32|157-165|valproate|drug
DDI-DrugBank.d434.s32|167-168|is|drug
DDI-DrugBank.d434.s32|170-172|not|drug
DDI-DrugBank.d434.s32|174-181|expected|drug
DDI-DrugBank.d434.s32|183-184|to|drug
DDI-DrugBank.d434.s32|186-190|cause|drug
DDI-DrugBank.d434.s32|192-192|a|drug
DDI-DrugBank.d434.s32|194-203|clinically|drug
DDI-DrugBank.d434.s32|205-213|important|drug
DDI-DrugBank.d434.s32|215-220|effect|drug
DDI-DrugBank.d434.s32|222-223|on|drug
DDI-DrugBank.d434.s32|225-232|Felbatol|drug
DDI-DrugBank.d434.s32|235-235|(|drug
DDI-DrugBank.d434.s32|236-244|felbamate|drug
DDI-DrugBank.d434.s32|245-245|)|drug
DDI-DrugBank.d434.s32|247-252|plasma|drug
DDI-DrugBank.d434.s32|254-267|concentrations|drug
DDI-DrugBank.d434.s32|268-268|.|drug
DDI-DrugBank.d434.s33|0-12|Phenobarbital|drug
DDI-DrugBank.d434.s33|13-13|:|drug
DDI-DrugBank.d434.s33|15-16|It|drug
DDI-DrugBank.d434.s33|18-24|appears|drug
DDI-DrugBank.d434.s33|26-29|that|drug
DDI-DrugBank.d434.s33|31-43|phenobarbital|drug
DDI-DrugBank.d434.s33|45-47|may|drug
DDI-DrugBank.d434.s33|49-54|reduce|drug
DDI-DrugBank.d434.s33|56-61|plasma|drug
DDI-DrugBank.d434.s33|63-71|felbamate|drug
DDI-DrugBank.d434.s33|73-86|concentrations|drug
DDI-DrugBank.d434.s33|87-87|.|drug
DDI-DrugBank.d434.s34|0-11|Steady-state|drug
DDI-DrugBank.d434.s34|13-18|plasma|drug
DDI-DrugBank.d434.s34|20-28|felbamate|drug
DDI-DrugBank.d434.s34|30-43|concentrations|drug
DDI-DrugBank.d434.s34|45-48|were|drug
DDI-DrugBank.d434.s34|50-54|found|drug
DDI-DrugBank.d434.s34|56-57|to|drug
DDI-DrugBank.d434.s34|59-60|be|drug
DDI-DrugBank.d434.s34|62-63|29|drug
DDI-DrugBank.d434.s34|64-64|%|drug
DDI-DrugBank.d434.s34|66-70|lower|drug
DDI-DrugBank.d434.s34|72-75|than|drug
DDI-DrugBank.d434.s34|77-79|the|drug
DDI-DrugBank.d434.s34|81-84|mean|drug
DDI-DrugBank.d434.s34|86-99|concentrations|drug
DDI-DrugBank.d434.s34|101-102|of|drug
DDI-DrugBank.d434.s34|104-104|a|drug
DDI-DrugBank.d434.s34|106-110|group|drug
DDI-DrugBank.d434.s34|112-113|of|drug
DDI-DrugBank.d434.s34|115-119|newly|drug
DDI-DrugBank.d434.s34|121-129|diagnosed|drug
DDI-DrugBank.d434.s34|131-138|subjects|drug
DDI-DrugBank.d434.s34|140-143|with|drug
DDI-DrugBank.d434.s34|145-152|epilepsy|drug
DDI-DrugBank.d434.s34|154-157|also|drug
DDI-DrugBank.d434.s34|159-167|receiving|drug
DDI-DrugBank.d434.s34|169-172|2400|drug
DDI-DrugBank.d434.s34|174-175|mg|drug
DDI-DrugBank.d434.s34|177-178|of|drug
DDI-DrugBank.d434.s34|180-188|felbamate|drug
DDI-DrugBank.d434.s34|190-190|a|drug
DDI-DrugBank.d434.s34|192-194|day|drug
DDI-DrugBank.d434.s34|195-195|.|drug
DDI-DrugBank.d434.s35|0-6|Effects|drug
DDI-DrugBank.d434.s35|8-9|of|drug
DDI-DrugBank.d434.s35|11-18|Antacids|drug
DDI-DrugBank.d434.s35|20-21|on|drug
DDI-DrugBank.d434.s35|23-30|Felbatol|drug
DDI-DrugBank.d434.s35|33-35|The|drug
DDI-DrugBank.d434.s35|37-40|rate|drug
DDI-DrugBank.d434.s35|42-44|and|drug
DDI-DrugBank.d434.s35|46-51|extent|drug
DDI-DrugBank.d434.s35|53-54|of|drug
DDI-DrugBank.d434.s35|56-65|absorption|drug
DDI-DrugBank.d434.s35|67-68|of|drug
DDI-DrugBank.d434.s35|70-70|a|drug
DDI-DrugBank.d434.s35|72-75|2400|drug
DDI-DrugBank.d434.s35|77-78|mg|drug
DDI-DrugBank.d434.s35|80-83|dose|drug
DDI-DrugBank.d434.s35|85-86|of|drug
DDI-DrugBank.d434.s35|88-95|Felbatol|drug
DDI-DrugBank.d434.s35|98-99|as|drug
DDI-DrugBank.d434.s35|101-111|monotherapy|drug
DDI-DrugBank.d434.s35|113-117|given|drug
DDI-DrugBank.d434.s35|119-120|as|drug
DDI-DrugBank.d434.s35|122-128|tablets|drug
DDI-DrugBank.d434.s35|130-132|was|drug
DDI-DrugBank.d434.s35|134-136|not|drug
DDI-DrugBank.d434.s35|138-145|affected|drug
DDI-DrugBank.d434.s35|147-150|when|drug
DDI-DrugBank.d434.s35|152-165|coadministered|drug
DDI-DrugBank.d434.s35|167-170|with|drug
DDI-DrugBank.d434.s35|172-179|antacids|drug
DDI-DrugBank.d434.s35|180-180|.|drug
DDI-DrugBank.d434.s36|0-6|Effects|drug
DDI-DrugBank.d434.s36|8-9|of|drug
DDI-DrugBank.d434.s36|11-22|Erythromycin|drug
DDI-DrugBank.d434.s36|24-25|on|drug
DDI-DrugBank.d434.s36|27-34|Felbatol|drug
DDI-DrugBank.d434.s36|37-39|The|drug
DDI-DrugBank.d434.s36|41-56|coadministration|drug
DDI-DrugBank.d434.s36|58-59|of|drug
DDI-DrugBank.d434.s36|61-72|erythromycin|drug
DDI-DrugBank.d434.s36|74-74|(|drug
DDI-DrugBank.d434.s36|75-78|1000|drug
DDI-DrugBank.d434.s36|80-85|mg/day|drug
DDI-DrugBank.d434.s36|86-86|)|drug
DDI-DrugBank.d434.s36|88-90|for|drug
DDI-DrugBank.d434.s36|92-93|10|drug
DDI-DrugBank.d434.s36|95-98|days|drug
DDI-DrugBank.d434.s36|100-102|did|drug
DDI-DrugBank.d434.s36|104-106|not|drug
DDI-DrugBank.d434.s36|108-112|alter|drug
DDI-DrugBank.d434.s36|114-116|the|drug
DDI-DrugBank.d434.s36|118-132|pharmacokinetic|drug
DDI-DrugBank.d434.s36|134-143|parameters|drug
DDI-DrugBank.d434.s36|145-146|of|drug
DDI-DrugBank.d434.s36|148-151|Cmax|drug
DDI-DrugBank.d434.s36|152-152|,|drug
DDI-DrugBank.d434.s36|154-157|Cmin|drug
DDI-DrugBank.d434.s36|158-158|,|drug
DDI-DrugBank.d434.s36|160-162|AUC|drug
DDI-DrugBank.d434.s36|163-163|,|drug
DDI-DrugBank.d434.s36|165-169|CI/kg|drug
DDI-DrugBank.d434.s36|171-172|or|drug
DDI-DrugBank.d434.s36|174-177|tmax|drug
DDI-DrugBank.d434.s36|179-180|at|drug
DDI-DrugBank.d434.s36|182-190|felbamate|drug
DDI-DrugBank.d434.s36|192-196|daily|drug
DDI-DrugBank.d434.s36|198-202|doses|drug
DDI-DrugBank.d434.s36|204-205|of|drug
DDI-DrugBank.d434.s36|207-210|3000|drug
DDI-DrugBank.d434.s36|212-213|or|drug
DDI-DrugBank.d434.s36|215-218|3600|drug
DDI-DrugBank.d434.s36|220-225|mg/day|drug
DDI-DrugBank.d434.s36|227-228|in|drug
DDI-DrugBank.d434.s36|230-231|10|drug
DDI-DrugBank.d434.s36|233-241|otherwise|drug
DDI-DrugBank.d434.s36|243-249|healthy|drug
DDI-DrugBank.d434.s36|251-258|subjects|drug
DDI-DrugBank.d434.s36|260-263|with|drug
DDI-DrugBank.d434.s36|265-272|epilepsy|drug
DDI-DrugBank.d434.s36|273-273|.|drug
DDI-DrugBank.d434.s37|0-6|Effects|drug
DDI-DrugBank.d434.s37|8-9|of|drug
DDI-DrugBank.d434.s37|11-18|Felbatol|drug
DDI-DrugBank.d434.s37|21-22|on|drug
DDI-DrugBank.d434.s37|24-31|Low-Dose|drug
DDI-DrugBank.d434.s37|33-43|Combination|drug
DDI-DrugBank.d434.s37|45-48|Oral|drug
DDI-DrugBank.d434.s37|50-63|Contraceptives|drug
DDI-DrugBank.d434.s37|65-65|A|drug
DDI-DrugBank.d434.s37|67-71|group|drug
DDI-DrugBank.d434.s37|73-74|of|drug
DDI-DrugBank.d434.s37|76-77|24|drug
DDI-DrugBank.d434.s37|79-88|nonsmoking|drug
DDI-DrugBank.d434.s37|89-89|,|drug
DDI-DrugBank.d434.s37|91-97|healthy|drug
DDI-DrugBank.d434.s37|99-103|white|drug
DDI-DrugBank.d434.s37|105-110|female|drug
DDI-DrugBank.d434.s37|112-121|volunteers|drug
DDI-DrugBank.d434.s37|123-133|established|drug
DDI-DrugBank.d434.s37|135-136|on|drug
DDI-DrugBank.d434.s37|138-139|an|drug
DDI-DrugBank.d434.s37|141-144|oral|drug
DDI-DrugBank.d434.s37|146-158|contraceptive|drug
DDI-DrugBank.d434.s37|160-166|regimen|drug
DDI-DrugBank.d434.s37|168-177|containing|drug
DDI-DrugBank.d434.s37|179-180|30|drug
DDI-DrugBank.d434.s37|182-183|mg|drug
DDI-DrugBank.d434.s37|185-191|ethinyl|drug
DDI-DrugBank.d434.s37|193-201|estradiol|drug
DDI-DrugBank.d434.s37|203-205|and|drug
DDI-DrugBank.d434.s37|207-208|75|drug
DDI-DrugBank.d434.s37|210-211|mg|drug
DDI-DrugBank.d434.s37|213-221|gestodene|drug
DDI-DrugBank.d434.s37|223-225|for|drug
DDI-DrugBank.d434.s37|227-228|at|drug
DDI-DrugBank.d434.s37|230-234|least|drug
DDI-DrugBank.d434.s37|236-236|3|drug
DDI-DrugBank.d434.s37|238-243|months|drug
DDI-DrugBank.d434.s37|245-252|received|drug
DDI-DrugBank.d434.s37|254-257|2400|drug
DDI-DrugBank.d434.s37|259-264|mg/day|drug
DDI-DrugBank.d434.s37|266-267|of|drug
DDI-DrugBank.d434.s37|269-277|felbamate|drug
DDI-DrugBank.d434.s37|279-282|from|drug
DDI-DrugBank.d434.s37|284-291|midcycle|drug
DDI-DrugBank.d434.s37|293-293|(|drug
DDI-DrugBank.d434.s37|294-296|day|drug
DDI-DrugBank.d434.s37|298-299|15|drug
DDI-DrugBank.d434.s37|300-300|)|drug
DDI-DrugBank.d434.s37|302-303|to|drug
DDI-DrugBank.d434.s37|305-312|midcycle|drug
DDI-DrugBank.d434.s37|314-314|(|drug
DDI-DrugBank.d434.s37|315-317|day|drug
DDI-DrugBank.d434.s37|319-320|14|drug
DDI-DrugBank.d434.s37|321-321|)|drug
DDI-DrugBank.d434.s37|323-324|of|drug
DDI-DrugBank.d434.s37|326-328|two|drug
DDI-DrugBank.d434.s37|330-340|consecutive|drug
DDI-DrugBank.d434.s37|342-345|oral|drug
DDI-DrugBank.d434.s37|347-359|contraceptive|drug
DDI-DrugBank.d434.s37|361-366|cycles|drug
DDI-DrugBank.d434.s37|367-367|.|drug
DDI-DrugBank.d434.s38|0-8|Felbamate|drug
DDI-DrugBank.d434.s38|10-18|treatment|drug
DDI-DrugBank.d434.s38|20-27|resulted|drug
DDI-DrugBank.d434.s38|29-30|in|drug
DDI-DrugBank.d434.s38|32-32|a|drug
DDI-DrugBank.d434.s38|34-35|42|drug
DDI-DrugBank.d434.s38|36-36|%|drug
DDI-DrugBank.d434.s38|38-45|decrease|drug
DDI-DrugBank.d434.s38|47-48|in|drug
DDI-DrugBank.d434.s38|50-52|the|drug
DDI-DrugBank.d434.s38|54-62|gestodene|drug
DDI-DrugBank.d434.s38|64-66|AUC|drug
DDI-DrugBank.d434.s38|68-71|0-24|drug
DDI-DrugBank.d434.s38|72-72|,|drug
DDI-DrugBank.d434.s38|74-76|but|drug
DDI-DrugBank.d434.s38|78-79|no|drug
DDI-DrugBank.d434.s38|81-90|clinically|drug
DDI-DrugBank.d434.s38|92-99|relevant|drug
DDI-DrugBank.d434.s38|101-106|effect|drug
DDI-DrugBank.d434.s38|108-110|was|drug
DDI-DrugBank.d434.s38|112-119|observed|drug
DDI-DrugBank.d434.s38|121-122|on|drug
DDI-DrugBank.d434.s38|124-126|the|drug
DDI-DrugBank.d434.s38|128-142|pharmacokinetic|drug
DDI-DrugBank.d434.s38|144-153|parameters|drug
DDI-DrugBank.d434.s38|155-156|of|drug
DDI-DrugBank.d434.s38|158-164|ethinyl|drug
DDI-DrugBank.d434.s38|166-174|estradiol|drug
DDI-DrugBank.d434.s38|175-175|.|drug
DDI-DrugBank.d434.s39|0-1|No|drug
DDI-DrugBank.d434.s39|3-11|volunteer|drug
DDI-DrugBank.d434.s39|13-18|showed|drug
DDI-DrugBank.d434.s39|20-27|hormonal|drug
DDI-DrugBank.d434.s39|29-36|evidence|drug
DDI-DrugBank.d434.s39|38-39|of|drug
DDI-DrugBank.d434.s39|41-49|ovulation|drug
DDI-DrugBank.d434.s39|50-50|,|drug
DDI-DrugBank.d434.s39|52-54|but|drug
DDI-DrugBank.d434.s39|56-58|one|drug
DDI-DrugBank.d434.s39|60-68|volunteer|drug
DDI-DrugBank.d434.s39|70-77|reported|drug
DDI-DrugBank.d434.s39|79-92|intermenstrual|drug
DDI-DrugBank.d434.s39|94-101|bleeding|drug
DDI-DrugBank.d434.s39|103-108|during|drug
DDI-DrugBank.d434.s39|110-118|felbamate|drug
DDI-DrugBank.d434.s39|120-128|treatment|drug
DDI-DrugBank.d434.s39|129-129|.|drug
DDI-DrugBank.d392.s0|0-7|Patients|drug
DDI-DrugBank.d392.s0|9-11|who|drug
DDI-DrugBank.d392.s0|13-15|are|drug
DDI-DrugBank.d392.s0|17-24|applying|drug
DDI-DrugBank.d392.s0|26-33|Panretin|drug
DDI-DrugBank.d392.s0|35-37|gel|drug
DDI-DrugBank.d392.s0|39-44|should|drug
DDI-DrugBank.d392.s0|46-48|not|drug
DDI-DrugBank.d392.s0|50-61|concurrently|drug
DDI-DrugBank.d392.s0|63-65|use|drug
DDI-DrugBank.d392.s0|67-74|products|drug
DDI-DrugBank.d392.s0|76-79|that|drug
DDI-DrugBank.d392.s0|81-87|contain|drug
DDI-DrugBank.d392.s0|89-92|DEET|drug
DDI-DrugBank.d392.s0|94-94|(|drug
DDI-DrugBank.d392.s0|95-95|N|drug
DDI-DrugBank.d392.s0|96-96|,|drug
DDI-DrugBank.d392.s0|98-118|N-diethyl-m-toluamide|drug
DDI-DrugBank.d392.s0|119-119|)|drug
DDI-DrugBank.d392.s0|120-120|,|drug
DDI-DrugBank.d392.s0|122-122|a|drug
DDI-DrugBank.d392.s0|124-129|common|drug
DDI-DrugBank.d392.s0|131-139|component|drug
DDI-DrugBank.d392.s0|141-142|of|drug
DDI-DrugBank.d392.s0|144-149|insect|drug
DDI-DrugBank.d392.s0|151-159|repellent|drug
DDI-DrugBank.d392.s0|161-168|products|drug
DDI-DrugBank.d392.s0|169-169|.|drug
DDI-DrugBank.d392.s1|0-5|Animal|drug
DDI-DrugBank.d392.s1|7-16|toxicology|drug
DDI-DrugBank.d392.s1|18-24|studies|drug
DDI-DrugBank.d392.s1|26-31|showed|drug
DDI-DrugBank.d392.s1|33-41|increased|drug
DDI-DrugBank.d392.s1|43-46|DEET|drug
DDI-DrugBank.d392.s1|48-55|toxicity|drug
DDI-DrugBank.d392.s1|57-60|when|drug
DDI-DrugBank.d392.s1|62-65|DEET|drug
DDI-DrugBank.d392.s1|67-69|was|drug
DDI-DrugBank.d392.s1|71-78|included|drug
DDI-DrugBank.d392.s1|80-81|as|drug
DDI-DrugBank.d392.s1|83-87|proof|drug
DDI-DrugBank.d392.s1|89-90|of|drug
DDI-DrugBank.d392.s1|92-94|the|drug
DDI-DrugBank.d392.s1|96-106|formulation|drug
DDI-DrugBank.d392.s1|107-107|.|drug
DDI-DrugBank.d392.s2|0-7|Although|drug
DDI-DrugBank.d392.s2|9-13|there|drug
DDI-DrugBank.d392.s2|15-17|was|drug
DDI-DrugBank.d392.s2|19-20|no|drug
DDI-DrugBank.d392.s2|22-29|clinical|drug
DDI-DrugBank.d392.s2|31-38|evidence|drug
DDI-DrugBank.d392.s2|40-41|in|drug
DDI-DrugBank.d392.s2|43-45|the|drug
DDI-DrugBank.d392.s2|47-64|vehicle-controlled|drug
DDI-DrugBank.d392.s2|66-72|studies|drug
DDI-DrugBank.d392.s2|74-75|of|drug
DDI-DrugBank.d392.s2|77-80|drug|drug
DDI-DrugBank.d392.s2|82-93|interactions|drug
DDI-DrugBank.d392.s2|95-98|with|drug
DDI-DrugBank.d392.s2|100-107|systemic|drug
DDI-DrugBank.d392.s2|109-122|antiretroviral|drug
DDI-DrugBank.d392.s2|124-129|agents|drug
DDI-DrugBank.d392.s2|130-130|,|drug
DDI-DrugBank.d392.s2|132-140|including|drug
DDI-DrugBank.d392.s2|142-149|protease|drug
DDI-DrugBank.d392.s2|151-160|inhibitors|drug
DDI-DrugBank.d392.s2|161-161|,|drug
DDI-DrugBank.d392.s2|163-171|macrolide|drug
DDI-DrugBank.d392.s2|173-183|antibiotics|drug
DDI-DrugBank.d392.s2|184-184|,|drug
DDI-DrugBank.d392.s2|186-188|and|drug
DDI-DrugBank.d392.s2|190-194|azole|drug
DDI-DrugBank.d392.s2|196-206|antifungals|drug
DDI-DrugBank.d392.s2|207-207|,|drug
DDI-DrugBank.d392.s2|209-211|the|drug
DDI-DrugBank.d392.s2|213-218|effect|drug
DDI-DrugBank.d392.s2|220-221|of|drug
DDI-DrugBank.d392.s2|223-230|Panretin|drug
DDI-DrugBank.d392.s2|232-234|gel|drug
DDI-DrugBank.d392.s2|236-237|on|drug
DDI-DrugBank.d392.s2|239-241|the|drug
DDI-DrugBank.d392.s2|243-254|steady-state|drug
DDI-DrugBank.d392.s2|256-269|concentrations|drug
DDI-DrugBank.d392.s2|271-272|of|drug
DDI-DrugBank.d392.s2|274-278|these|drug
DDI-DrugBank.d392.s2|280-284|drugs|drug
DDI-DrugBank.d392.s2|286-287|is|drug
DDI-DrugBank.d392.s2|289-291|not|drug
DDI-DrugBank.d392.s2|293-297|known|drug
DDI-DrugBank.d392.s2|298-298|.|drug
DDI-DrugBank.d392.s3|0-1|No|drug
DDI-DrugBank.d392.s3|3-6|drug|drug
DDI-DrugBank.d392.s3|8-18|interaction|drug
DDI-DrugBank.d392.s3|20-23|data|drug
DDI-DrugBank.d392.s3|25-27|are|drug
DDI-DrugBank.d392.s3|29-37|available|drug
DDI-DrugBank.d392.s3|39-40|on|drug
DDI-DrugBank.d392.s3|42-52|concomitant|drug
DDI-DrugBank.d392.s3|54-67|administration|drug
DDI-DrugBank.d392.s3|69-70|of|drug
DDI-DrugBank.d392.s3|72-79|Panretin|drug
DDI-DrugBank.d392.s3|81-83|gel|drug
DDI-DrugBank.d392.s3|85-87|and|drug
DDI-DrugBank.d392.s3|89-96|systemic|drug
DDI-DrugBank.d392.s3|98-104|anti-KS|drug
DDI-DrugBank.d392.s3|106-111|agents|drug
DDI-DrugBank.d392.s3|112-112|.|drug
DDI-DrugBank.d406.s0|0-2|May|drug
DDI-DrugBank.d406.s0|4-11|interact|drug
DDI-DrugBank.d406.s0|13-16|with|drug
DDI-DrugBank.d406.s0|18-28|cefamandole|drug
DDI-DrugBank.d406.s0|30-36|naftate|drug
DDI-DrugBank.d406.s0|37-37|,|drug
DDI-DrugBank.d406.s0|39-49|cephalothin|drug
DDI-DrugBank.d406.s0|51-56|sodium|drug
DDI-DrugBank.d406.s0|57-57|,|drug
DDI-DrugBank.d406.s0|59-67|magnesium|drug
DDI-DrugBank.d406.s0|69-75|sulfate|drug
DDI-DrugBank.d406.s0|76-76|,|drug
DDI-DrugBank.d406.s0|78-89|prednisolone|drug
DDI-DrugBank.d406.s0|91-96|sodium|drug
DDI-DrugBank.d406.s0|98-106|succinate|drug
DDI-DrugBank.d406.s0|107-107|,|drug
DDI-DrugBank.d406.s0|109-111|and|drug
DDI-DrugBank.d406.s0|113-128|prochlorperazine|drug
DDI-DrugBank.d406.s0|130-138|edisylate|drug
DDI-DrugBank.d406.s0|139-139|.|drug
DDI-DrugBank.d217.s0|0-7|Elevated|drug
DDI-DrugBank.d217.s0|9-14|plasma|drug
DDI-DrugBank.d217.s0|16-21|levels|drug
DDI-DrugBank.d217.s0|23-24|of|drug
DDI-DrugBank.d217.s0|26-37|theophylline|drug
DDI-DrugBank.d217.s0|39-42|have|drug
DDI-DrugBank.d217.s0|44-47|been|drug
DDI-DrugBank.d217.s0|49-56|reported|drug
DDI-DrugBank.d217.s0|58-61|with|drug
DDI-DrugBank.d217.s0|63-73|concomitant|drug
DDI-DrugBank.d217.s0|75-83|quinolone|drug
DDI-DrugBank.d217.s0|85-87|use|drug
DDI-DrugBank.d217.s0|88-88|.|drug
DDI-DrugBank.d217.s1|0-4|There|drug
DDI-DrugBank.d217.s1|6-9|have|drug
DDI-DrugBank.d217.s1|11-14|been|drug
DDI-DrugBank.d217.s1|16-22|reports|drug
DDI-DrugBank.d217.s1|24-25|of|drug
DDI-DrugBank.d217.s1|27-46|theophylline-related|drug
DDI-DrugBank.d217.s1|48-51|side|drug
DDI-DrugBank.d217.s1|53-59|effects|drug
DDI-DrugBank.d217.s1|61-62|in|drug
DDI-DrugBank.d217.s1|64-71|patients|drug
DDI-DrugBank.d217.s1|73-74|on|drug
DDI-DrugBank.d217.s1|76-86|concomitant|drug
DDI-DrugBank.d217.s1|88-94|therapy|drug
DDI-DrugBank.d217.s1|96-99|with|drug
DDI-DrugBank.d217.s1|101-111|norfloxacin|drug
DDI-DrugBank.d217.s1|113-115|and|drug
DDI-DrugBank.d217.s1|117-128|theophylline|drug
DDI-DrugBank.d217.s1|129-129|.|drug
DDI-DrugBank.d217.s2|0-8|Therefore|drug
DDI-DrugBank.d217.s2|9-9|,|drug
DDI-DrugBank.d217.s2|11-20|monitoring|drug
DDI-DrugBank.d217.s2|22-23|of|drug
DDI-DrugBank.d217.s2|25-36|theophylline|drug
DDI-DrugBank.d217.s2|38-43|plasma|drug
DDI-DrugBank.d217.s2|45-50|levels|drug
DDI-DrugBank.d217.s2|52-57|should|drug
DDI-DrugBank.d217.s2|59-60|be|drug
DDI-DrugBank.d217.s2|62-71|considered|drug
DDI-DrugBank.d217.s2|73-75|and|drug
DDI-DrugBank.d217.s2|77-82|dosage|drug
DDI-DrugBank.d217.s2|84-85|of|drug
DDI-DrugBank.d217.s2|87-98|theophylline|drug
DDI-DrugBank.d217.s2|100-107|adjusted|drug
DDI-DrugBank.d217.s2|109-110|as|drug
DDI-DrugBank.d217.s2|112-119|required|drug
DDI-DrugBank.d217.s2|120-120|.|drug
DDI-DrugBank.d217.s3|0-7|Elevated|drug
DDI-DrugBank.d217.s3|9-13|serum|drug
DDI-DrugBank.d217.s3|15-20|levels|drug
DDI-DrugBank.d217.s3|22-23|of|drug
DDI-DrugBank.d217.s3|25-36|cyclosporine|drug
DDI-DrugBank.d217.s3|38-41|have|drug
DDI-DrugBank.d217.s3|43-46|been|drug
DDI-DrugBank.d217.s3|48-55|reported|drug
DDI-DrugBank.d217.s3|57-60|with|drug
DDI-DrugBank.d217.s3|62-72|concomitant|drug
DDI-DrugBank.d217.s3|74-76|use|drug
DDI-DrugBank.d217.s3|78-79|of|drug
DDI-DrugBank.d217.s3|81-92|cyclosporine|drug
DDI-DrugBank.d217.s3|94-97|with|drug
DDI-DrugBank.d217.s3|99-109|norfloxacin|drug
DDI-DrugBank.d217.s3|110-110|.|drug
DDI-DrugBank.d217.s4|0-8|Therefore|drug
DDI-DrugBank.d217.s4|9-9|,|drug
DDI-DrugBank.d217.s4|11-22|cyclosporine|drug
DDI-DrugBank.d217.s4|24-28|serum|drug
DDI-DrugBank.d217.s4|30-35|levels|drug
DDI-DrugBank.d217.s4|37-42|should|drug
DDI-DrugBank.d217.s4|44-45|be|drug
DDI-DrugBank.d217.s4|47-55|monitored|drug
DDI-DrugBank.d217.s4|57-59|and|drug
DDI-DrugBank.d217.s4|61-71|appropriate|drug
DDI-DrugBank.d217.s4|73-84|cyclosporine|drug
DDI-DrugBank.d217.s4|86-91|dosage|drug
DDI-DrugBank.d217.s4|93-103|adjustments|drug
DDI-DrugBank.d217.s4|105-108|made|drug
DDI-DrugBank.d217.s4|110-113|when|drug
DDI-DrugBank.d217.s4|115-119|these|drug
DDI-DrugBank.d217.s4|121-125|drugs|drug
DDI-DrugBank.d217.s4|127-129|are|drug
DDI-DrugBank.d217.s4|131-134|used|drug
DDI-DrugBank.d217.s4|136-148|concomitantly|drug
DDI-DrugBank.d217.s4|149-149|.|drug
DDI-DrugBank.d217.s5|0-9|Quinolones|drug
DDI-DrugBank.d217.s5|10-10|,|drug
DDI-DrugBank.d217.s5|12-20|including|drug
DDI-DrugBank.d217.s5|22-32|norfloxacin|drug
DDI-DrugBank.d217.s5|33-33|,|drug
DDI-DrugBank.d217.s5|35-37|may|drug
DDI-DrugBank.d217.s5|39-45|enhance|drug
DDI-DrugBank.d217.s5|47-49|the|drug
DDI-DrugBank.d217.s5|51-57|effects|drug
DDI-DrugBank.d217.s5|59-60|of|drug
DDI-DrugBank.d217.s5|62-65|oral|drug
DDI-DrugBank.d217.s5|67-80|anticoagulants|drug
DDI-DrugBank.d217.s5|81-81|,|drug
DDI-DrugBank.d217.s5|83-91|including|drug
DDI-DrugBank.d217.s5|93-100|warfarin|drug
DDI-DrugBank.d217.s5|102-103|or|drug
DDI-DrugBank.d217.s5|105-107|its|drug
DDI-DrugBank.d217.s5|109-119|derivatives|drug
DDI-DrugBank.d217.s5|121-122|or|drug
DDI-DrugBank.d217.s5|124-130|similar|drug
DDI-DrugBank.d217.s5|132-137|agents|drug
DDI-DrugBank.d217.s5|138-138|.|drug
DDI-DrugBank.d217.s6|0-3|When|drug
DDI-DrugBank.d217.s6|5-9|these|drug
DDI-DrugBank.d217.s6|11-18|products|drug
DDI-DrugBank.d217.s6|20-22|are|drug
DDI-DrugBank.d217.s6|24-35|administered|drug
DDI-DrugBank.d217.s6|37-49|concomitantly|drug
DDI-DrugBank.d217.s6|50-50|,|drug
DDI-DrugBank.d217.s6|52-62|prothrombin|drug
DDI-DrugBank.d217.s6|64-67|time|drug
DDI-DrugBank.d217.s6|69-70|or|drug
DDI-DrugBank.d217.s6|72-76|other|drug
DDI-DrugBank.d217.s6|78-85|suitable|drug
DDI-DrugBank.d217.s6|87-97|coagulation|drug
DDI-DrugBank.d217.s6|99-103|tests|drug
DDI-DrugBank.d217.s6|105-110|should|drug
DDI-DrugBank.d217.s6|112-113|be|drug
DDI-DrugBank.d217.s6|115-121|closely|drug
DDI-DrugBank.d217.s6|123-131|monitored|drug
DDI-DrugBank.d217.s6|132-132|.|drug
DDI-DrugBank.d217.s7|0-2|The|drug
DDI-DrugBank.d217.s7|4-14|concomitant|drug
DDI-DrugBank.d217.s7|16-29|administration|drug
DDI-DrugBank.d217.s7|31-32|of|drug
DDI-DrugBank.d217.s7|34-43|quinolones|drug
DDI-DrugBank.d217.s7|45-53|including|drug
DDI-DrugBank.d217.s7|55-65|norfloxacin|drug
DDI-DrugBank.d217.s7|67-70|with|drug
DDI-DrugBank.d217.s7|72-80|glyburide|drug
DDI-DrugBank.d217.s7|82-82|(|drug
DDI-DrugBank.d217.s7|83-83|a|drug
DDI-DrugBank.d217.s7|85-96|sulfonylurea|drug
DDI-DrugBank.d217.s7|98-102|agent|drug
DDI-DrugBank.d217.s7|103-103|)|drug
DDI-DrugBank.d217.s7|105-107|has|drug
DDI-DrugBank.d217.s7|108-108|,|drug
DDI-DrugBank.d217.s7|110-111|on|drug
DDI-DrugBank.d217.s7|113-116|rare|drug
DDI-DrugBank.d217.s7|118-126|occasions|drug
DDI-DrugBank.d217.s7|127-127|,|drug
DDI-DrugBank.d217.s7|129-136|resulted|drug
DDI-DrugBank.d217.s7|138-139|in|drug
DDI-DrugBank.d217.s7|141-146|severe|drug
DDI-DrugBank.d217.s7|148-159|hypoglycemia|drug
DDI-DrugBank.d217.s7|160-160|.|drug
DDI-DrugBank.d217.s8|0-8|Therefore|drug
DDI-DrugBank.d217.s8|9-9|,|drug
DDI-DrugBank.d217.s8|11-20|monitoring|drug
DDI-DrugBank.d217.s8|22-23|of|drug
DDI-DrugBank.d217.s8|25-29|blood|drug
DDI-DrugBank.d217.s8|31-37|glucose|drug
DDI-DrugBank.d217.s8|39-40|is|drug
DDI-DrugBank.d217.s8|42-52|recommended|drug
DDI-DrugBank.d217.s8|54-57|when|drug
DDI-DrugBank.d217.s8|59-63|these|drug
DDI-DrugBank.d217.s8|65-70|agents|drug
DDI-DrugBank.d217.s8|72-74|are|drug
DDI-DrugBank.d217.s8|76-90|co-administered|drug
DDI-DrugBank.d217.s8|91-91|.|drug
DDI-DrugBank.d217.s9|0-9|Diminished|drug
DDI-DrugBank.d217.s9|11-17|urinary|drug
DDI-DrugBank.d217.s9|19-27|excretion|drug
DDI-DrugBank.d217.s9|29-30|of|drug
DDI-DrugBank.d217.s9|32-42|norfloxacin|drug
DDI-DrugBank.d217.s9|44-46|has|drug
DDI-DrugBank.d217.s9|48-51|been|drug
DDI-DrugBank.d217.s9|53-60|reported|drug
DDI-DrugBank.d217.s9|62-67|during|drug
DDI-DrugBank.d217.s9|69-71|the|drug
DDI-DrugBank.d217.s9|73-83|concomitant|drug
DDI-DrugBank.d217.s9|85-98|administration|drug
DDI-DrugBank.d217.s9|100-101|of|drug
DDI-DrugBank.d217.s9|103-112|probenecid|drug
DDI-DrugBank.d217.s9|114-116|and|drug
DDI-DrugBank.d217.s9|118-128|norfloxacin|drug
DDI-DrugBank.d217.s9|129-129|.|drug
DDI-DrugBank.d217.s10|0-2|The|drug
DDI-DrugBank.d217.s10|4-14|concomitant|drug
DDI-DrugBank.d217.s10|16-18|use|drug
DDI-DrugBank.d217.s10|20-21|of|drug
DDI-DrugBank.d217.s10|23-36|nitrofurantoin|drug
DDI-DrugBank.d217.s10|38-39|is|drug
DDI-DrugBank.d217.s10|41-43|not|drug
DDI-DrugBank.d217.s10|45-55|recommended|drug
DDI-DrugBank.d217.s10|57-61|since|drug
DDI-DrugBank.d217.s10|63-76|nitrofurantoin|drug
DDI-DrugBank.d217.s10|78-80|may|drug
DDI-DrugBank.d217.s10|82-91|antagonize|drug
DDI-DrugBank.d217.s10|93-95|the|drug
DDI-DrugBank.d217.s10|97-109|antibacterial|drug
DDI-DrugBank.d217.s10|111-116|effect|drug
DDI-DrugBank.d217.s10|118-119|of|drug
DDI-DrugBank.d217.s10|121-131|Norfloxacin|drug
DDI-DrugBank.d217.s10|133-134|in|drug
DDI-DrugBank.d217.s10|136-138|the|drug
DDI-DrugBank.d217.s10|140-146|urinary|drug
DDI-DrugBank.d217.s10|148-152|tract|drug
DDI-DrugBank.d217.s10|153-153|.|drug
DDI-DrugBank.d217.s11|0-12|Multivitamins|drug
DDI-DrugBank.d217.s11|13-13|,|drug
DDI-DrugBank.d217.s11|15-16|or|drug
DDI-DrugBank.d217.s11|18-22|other|drug
DDI-DrugBank.d217.s11|24-31|products|drug
DDI-DrugBank.d217.s11|33-42|containing|drug
DDI-DrugBank.d217.s11|44-47|iron|drug
DDI-DrugBank.d217.s11|49-50|or|drug
DDI-DrugBank.d217.s11|52-55|zinc|drug
DDI-DrugBank.d217.s11|56-56|,|drug
DDI-DrugBank.d217.s11|58-65|antacids|drug
DDI-DrugBank.d217.s11|67-68|or|drug
DDI-DrugBank.d217.s11|70-79|sucralfate|drug
DDI-DrugBank.d217.s11|81-86|should|drug
DDI-DrugBank.d217.s11|88-90|not|drug
DDI-DrugBank.d217.s11|92-93|be|drug
DDI-DrugBank.d217.s11|95-106|administered|drug
DDI-DrugBank.d217.s11|108-120|concomitantly|drug
DDI-DrugBank.d217.s11|122-125|with|drug
DDI-DrugBank.d217.s11|126-126|,|drug
DDI-DrugBank.d217.s11|128-129|or|drug
DDI-DrugBank.d217.s11|131-136|within|drug
DDI-DrugBank.d217.s11|138-138|2|drug
DDI-DrugBank.d217.s11|140-144|hours|drug
DDI-DrugBank.d217.s11|146-147|of|drug
DDI-DrugBank.d217.s11|148-148|,|drug
DDI-DrugBank.d217.s11|150-152|the|drug
DDI-DrugBank.d217.s11|154-167|administration|drug
DDI-DrugBank.d217.s11|169-170|of|drug
DDI-DrugBank.d217.s11|172-182|norfloxacin|drug
DDI-DrugBank.d217.s11|183-183|,|drug
DDI-DrugBank.d217.s11|185-191|because|drug
DDI-DrugBank.d217.s11|193-196|they|drug
DDI-DrugBank.d217.s11|198-200|may|drug
DDI-DrugBank.d217.s11|202-210|interfere|drug
DDI-DrugBank.d217.s11|212-215|with|drug
DDI-DrugBank.d217.s11|217-226|absorption|drug
DDI-DrugBank.d217.s11|228-236|resulting|drug
DDI-DrugBank.d217.s11|238-239|in|drug
DDI-DrugBank.d217.s11|241-245|lower|drug
DDI-DrugBank.d217.s11|247-251|serum|drug
DDI-DrugBank.d217.s11|253-255|and|drug
DDI-DrugBank.d217.s11|257-261|urine|drug
DDI-DrugBank.d217.s11|263-268|levels|drug
DDI-DrugBank.d217.s11|270-271|of|drug
DDI-DrugBank.d217.s11|273-283|norfloxacin|drug
DDI-DrugBank.d217.s11|284-284|.|drug
DDI-DrugBank.d217.s12|0-4|Videx|drug
DDI-DrugBank.d217.s12|6-6|(|drug
DDI-DrugBank.d217.s12|7-16|Didanosine|drug
DDI-DrugBank.d217.s12|17-17|)|drug
DDI-DrugBank.d217.s12|19-35|chewable/buffered|drug
DDI-DrugBank.d217.s12|37-43|tablets|drug
DDI-DrugBank.d217.s12|45-46|or|drug
DDI-DrugBank.d217.s12|48-50|the|drug
DDI-DrugBank.d217.s12|52-60|pediatric|drug
DDI-DrugBank.d217.s12|62-67|powder|drug
DDI-DrugBank.d217.s12|69-71|for|drug
DDI-DrugBank.d217.s12|73-76|oral|drug
DDI-DrugBank.d217.s12|78-85|solution|drug
DDI-DrugBank.d217.s12|87-92|should|drug
DDI-DrugBank.d217.s12|94-96|not|drug
DDI-DrugBank.d217.s12|98-99|be|drug
DDI-DrugBank.d217.s12|101-112|administered|drug
DDI-DrugBank.d217.s12|114-126|concomitantly|drug
DDI-DrugBank.d217.s12|128-131|with|drug
DDI-DrugBank.d217.s12|132-132|,|drug
DDI-DrugBank.d217.s12|134-135|or|drug
DDI-DrugBank.d217.s12|137-142|within|drug
DDI-DrugBank.d217.s12|144-144|2|drug
DDI-DrugBank.d217.s12|146-150|hours|drug
DDI-DrugBank.d217.s12|152-153|of|drug
DDI-DrugBank.d217.s12|154-154|,|drug
DDI-DrugBank.d217.s12|156-158|the|drug
DDI-DrugBank.d217.s12|160-173|administration|drug
DDI-DrugBank.d217.s12|175-176|of|drug
DDI-DrugBank.d217.s12|178-188|norfloxacin|drug
DDI-DrugBank.d217.s12|189-189|,|drug
DDI-DrugBank.d217.s12|191-197|because|drug
DDI-DrugBank.d217.s12|199-203|these|drug
DDI-DrugBank.d217.s12|205-212|products|drug
DDI-DrugBank.d217.s12|214-216|may|drug
DDI-DrugBank.d217.s12|218-226|interfere|drug
DDI-DrugBank.d217.s12|228-231|with|drug
DDI-DrugBank.d217.s12|233-242|absorption|drug
DDI-DrugBank.d217.s12|244-252|resulting|drug
DDI-DrugBank.d217.s12|254-255|in|drug
DDI-DrugBank.d217.s12|257-261|lower|drug
DDI-DrugBank.d217.s12|263-267|serum|drug
DDI-DrugBank.d217.s12|269-271|and|drug
DDI-DrugBank.d217.s12|273-277|urine|drug
DDI-DrugBank.d217.s12|279-284|levels|drug
DDI-DrugBank.d217.s12|286-287|of|drug
DDI-DrugBank.d217.s12|289-299|norfloxacin|drug
DDI-DrugBank.d217.s12|300-300|.|drug
DDI-DrugBank.d217.s13|0-3|Some|drug
DDI-DrugBank.d217.s13|5-14|quinolones|drug
DDI-DrugBank.d217.s13|16-19|have|drug
DDI-DrugBank.d217.s13|21-24|also|drug
DDI-DrugBank.d217.s13|26-29|been|drug
DDI-DrugBank.d217.s13|31-35|shown|drug
DDI-DrugBank.d217.s13|37-38|to|drug
DDI-DrugBank.d217.s13|40-48|interfere|drug
DDI-DrugBank.d217.s13|50-53|with|drug
DDI-DrugBank.d217.s13|55-57|the|drug
DDI-DrugBank.d217.s13|59-68|metabolism|drug
DDI-DrugBank.d217.s13|70-71|of|drug
DDI-DrugBank.d217.s13|73-80|caffeine|drug
DDI-DrugBank.d217.s13|81-81|.|drug
DDI-DrugBank.d217.s14|0-3|This|drug
DDI-DrugBank.d217.s14|5-7|may|drug
DDI-DrugBank.d217.s14|9-12|lead|drug
DDI-DrugBank.d217.s14|14-15|to|drug
DDI-DrugBank.d217.s14|17-23|reduced|drug
DDI-DrugBank.d217.s14|25-33|clearance|drug
DDI-DrugBank.d217.s14|35-36|of|drug
DDI-DrugBank.d217.s14|38-45|caffeine|drug
DDI-DrugBank.d217.s14|47-49|and|drug
DDI-DrugBank.d217.s14|51-51|a|drug
DDI-DrugBank.d217.s14|53-64|prolongation|drug
DDI-DrugBank.d217.s14|66-67|of|drug
DDI-DrugBank.d217.s14|69-71|its|drug
DDI-DrugBank.d217.s14|73-78|plasma|drug
DDI-DrugBank.d217.s14|80-88|half-life|drug
DDI-DrugBank.d217.s14|89-89|.|drug
DDI-DrugBank.d89.s0|0-9|Cytochrome|drug
DDI-DrugBank.d89.s0|11-14|P450|drug
DDI-DrugBank.d89.s0|16-18|1A2|drug
DDI-DrugBank.d89.s0|20-20|(|drug
DDI-DrugBank.d89.s0|21-26|CYP1A2|drug
DDI-DrugBank.d89.s0|27-27|)|drug
DDI-DrugBank.d89.s0|29-30|is|drug
DDI-DrugBank.d89.s0|32-36|known|drug
DDI-DrugBank.d89.s0|38-39|to|drug
DDI-DrugBank.d89.s0|41-42|be|drug
DDI-DrugBank.d89.s0|44-46|the|drug
DDI-DrugBank.d89.s0|48-52|major|drug
DDI-DrugBank.d89.s0|54-59|enzyme|drug
DDI-DrugBank.d89.s0|61-68|involved|drug
DDI-DrugBank.d89.s0|70-71|in|drug
DDI-DrugBank.d89.s0|73-75|the|drug
DDI-DrugBank.d89.s0|77-86|metabolism|drug
DDI-DrugBank.d89.s0|88-89|of|drug
DDI-DrugBank.d89.s0|91-98|caffeine|drug
DDI-DrugBank.d89.s0|99-99|.|drug
DDI-DrugBank.d89.s1|0-8|Therefore|drug
DDI-DrugBank.d89.s1|9-9|,|drug
DDI-DrugBank.d89.s1|11-18|caffeine|drug
DDI-DrugBank.d89.s1|20-22|has|drug
DDI-DrugBank.d89.s1|24-26|the|drug
DDI-DrugBank.d89.s1|28-36|potential|drug
DDI-DrugBank.d89.s1|38-39|to|drug
DDI-DrugBank.d89.s1|41-48|interact|drug
DDI-DrugBank.d89.s1|50-53|with|drug
DDI-DrugBank.d89.s1|55-59|drugs|drug
DDI-DrugBank.d89.s1|61-64|that|drug
DDI-DrugBank.d89.s1|66-68|are|drug
DDI-DrugBank.d89.s1|70-79|substrates|drug
DDI-DrugBank.d89.s1|81-83|for|drug
DDI-DrugBank.d89.s1|85-90|CYP1A2|drug
DDI-DrugBank.d89.s1|91-91|,|drug
DDI-DrugBank.d89.s1|93-99|inhibit|drug
DDI-DrugBank.d89.s1|101-106|CYP1A2|drug
DDI-DrugBank.d89.s1|107-107|,|drug
DDI-DrugBank.d89.s1|109-110|or|drug
DDI-DrugBank.d89.s1|112-117|induce|drug
DDI-DrugBank.d89.s1|119-124|CYP1A2|drug
DDI-DrugBank.d89.s1|125-125|.|drug
DDI-DrugBank.d89.s2|0-2|Few|drug
DDI-DrugBank.d89.s2|4-7|data|drug
DDI-DrugBank.d89.s2|9-13|exist|drug
DDI-DrugBank.d89.s2|15-16|on|drug
DDI-DrugBank.d89.s2|18-21|drug|drug
DDI-DrugBank.d89.s2|23-34|interactions|drug
DDI-DrugBank.d89.s2|36-39|with|drug
DDI-DrugBank.d89.s2|41-48|caffeine|drug
DDI-DrugBank.d89.s2|50-51|in|drug
DDI-DrugBank.d89.s2|53-59|preterm|drug
DDI-DrugBank.d89.s2|61-68|neonates|drug
DDI-DrugBank.d89.s2|69-69|.|drug
DDI-DrugBank.d89.s3|0-4|Based|drug
DDI-DrugBank.d89.s3|6-7|on|drug
DDI-DrugBank.d89.s3|9-13|adult|drug
DDI-DrugBank.d89.s3|15-18|data|drug
DDI-DrugBank.d89.s3|19-19|,|drug
DDI-DrugBank.d89.s3|21-25|lower|drug
DDI-DrugBank.d89.s3|27-31|doses|drug
DDI-DrugBank.d89.s3|33-34|of|drug
DDI-DrugBank.d89.s3|36-43|caffeine|drug
DDI-DrugBank.d89.s3|45-47|may|drug
DDI-DrugBank.d89.s3|49-50|be|drug
DDI-DrugBank.d89.s3|52-57|needed|drug
DDI-DrugBank.d89.s3|59-67|following|drug
DDI-DrugBank.d89.s3|69-84|coadministration|drug
DDI-DrugBank.d89.s3|86-87|of|drug
DDI-DrugBank.d89.s3|89-93|drugs|drug
DDI-DrugBank.d89.s3|95-99|which|drug
DDI-DrugBank.d89.s3|101-103|are|drug
DDI-DrugBank.d89.s3|105-112|reported|drug
DDI-DrugBank.d89.s3|114-115|to|drug
DDI-DrugBank.d89.s3|117-124|decrease|drug
DDI-DrugBank.d89.s3|126-133|caffeine|drug
DDI-DrugBank.d89.s3|135-145|elimination|drug
DDI-DrugBank.d89.s3|147-147|(|drug
DDI-DrugBank.d89.s3|148-151|e.g.|drug
DDI-DrugBank.d89.s3|152-152|,|drug
DDI-DrugBank.d89.s3|154-163|cimetidine|drug
DDI-DrugBank.d89.s3|165-167|and|drug
DDI-DrugBank.d89.s3|169-180|ketoconazole|drug
DDI-DrugBank.d89.s3|181-181|)|drug
DDI-DrugBank.d89.s3|183-185|and|drug
DDI-DrugBank.d89.s3|187-192|higher|drug
DDI-DrugBank.d89.s3|194-201|caffeine|drug
DDI-DrugBank.d89.s3|203-207|doses|drug
DDI-DrugBank.d89.s3|209-211|may|drug
DDI-DrugBank.d89.s3|213-214|be|drug
DDI-DrugBank.d89.s3|216-221|needed|drug
DDI-DrugBank.d89.s3|223-231|following|drug
DDI-DrugBank.d89.s3|233-248|coadministration|drug
DDI-DrugBank.d89.s3|250-251|of|drug
DDI-DrugBank.d89.s3|253-257|drugs|drug
DDI-DrugBank.d89.s3|259-262|that|drug
DDI-DrugBank.d89.s3|264-271|increase|drug
DDI-DrugBank.d89.s3|273-280|caffeine|drug
DDI-DrugBank.d89.s3|282-292|elimination|drug
DDI-DrugBank.d89.s3|294-294|(|drug
DDI-DrugBank.d89.s3|295-298|e.g.|drug
DDI-DrugBank.d89.s3|299-299|,|drug
DDI-DrugBank.d89.s3|301-313|phenobarbital|drug
DDI-DrugBank.d89.s3|315-317|and|drug
DDI-DrugBank.d89.s3|319-327|phenytoin|drug
DDI-DrugBank.d89.s3|328-328|)|drug
DDI-DrugBank.d89.s3|329-329|.|drug
DDI-DrugBank.d89.s4|0-7|Caffeine|drug
DDI-DrugBank.d89.s4|9-20|administered|drug
DDI-DrugBank.d89.s4|22-33|concurrently|drug
DDI-DrugBank.d89.s4|35-38|with|drug
DDI-DrugBank.d89.s4|40-49|ketoprofen|drug
DDI-DrugBank.d89.s4|51-57|reduced|drug
DDI-DrugBank.d89.s4|59-61|the|drug
DDI-DrugBank.d89.s4|63-67|urine|drug
DDI-DrugBank.d89.s4|69-74|volume|drug
DDI-DrugBank.d89.s4|76-77|in|drug
DDI-DrugBank.d89.s4|79-79|4|drug
DDI-DrugBank.d89.s4|81-87|healthy|drug
DDI-DrugBank.d89.s4|89-98|volunteers|drug
DDI-DrugBank.d89.s4|99-99|.|drug
DDI-DrugBank.d89.s5|0-2|The|drug
DDI-DrugBank.d89.s5|4-11|clinical|drug
DDI-DrugBank.d89.s5|13-24|significance|drug
DDI-DrugBank.d89.s5|26-27|of|drug
DDI-DrugBank.d89.s5|29-32|this|drug
DDI-DrugBank.d89.s5|34-44|interaction|drug
DDI-DrugBank.d89.s5|46-47|in|drug
DDI-DrugBank.d89.s5|49-55|preterm|drug
DDI-DrugBank.d89.s5|57-64|neonates|drug
DDI-DrugBank.d89.s5|66-67|is|drug
DDI-DrugBank.d89.s5|69-71|not|drug
DDI-DrugBank.d89.s5|73-77|known|drug
DDI-DrugBank.d89.s5|78-78|.|drug
DDI-DrugBank.d89.s6|0-14|Interconversion|drug
DDI-DrugBank.d89.s6|16-22|between|drug
DDI-DrugBank.d89.s6|24-31|caffeine|drug
DDI-DrugBank.d89.s6|33-35|and|drug
DDI-DrugBank.d89.s6|37-48|theophylline|drug
DDI-DrugBank.d89.s6|50-52|has|drug
DDI-DrugBank.d89.s6|54-57|been|drug
DDI-DrugBank.d89.s6|59-66|reported|drug
DDI-DrugBank.d89.s6|68-69|in|drug
DDI-DrugBank.d89.s6|71-77|preterm|drug
DDI-DrugBank.d89.s6|79-86|neonates|drug
DDI-DrugBank.d89.s6|87-87|.|drug
DDI-DrugBank.d89.s7|0-2|The|drug
DDI-DrugBank.d89.s7|4-13|concurrent|drug
DDI-DrugBank.d89.s7|15-17|use|drug
DDI-DrugBank.d89.s7|19-20|of|drug
DDI-DrugBank.d89.s7|22-26|these|drug
DDI-DrugBank.d89.s7|28-32|drugs|drug
DDI-DrugBank.d89.s7|34-35|is|drug
DDI-DrugBank.d89.s7|37-39|not|drug
DDI-DrugBank.d89.s7|41-51|recommended|drug
DDI-DrugBank.d89.s7|52-52|.|drug
DDI-DrugBank.d366.s0|0-2|May|drug
DDI-DrugBank.d366.s0|4-11|interact|drug
DDI-DrugBank.d366.s0|13-16|with|drug
DDI-DrugBank.d366.s0|18-21|skin|drug
DDI-DrugBank.d366.s0|23-30|products|drug
DDI-DrugBank.d366.s0|32-33|or|drug
DDI-DrugBank.d366.s0|35-42|shampoos|drug
DDI-DrugBank.d366.s0|44-46|for|drug
DDI-DrugBank.d366.s0|48-55|dandruff|drug
DDI-DrugBank.d366.s0|57-58|or|drug
DDI-DrugBank.d366.s0|60-68|psoriasis|drug
DDI-DrugBank.d366.s0|69-69|.|drug
DDI-DrugBank.d164.s0|0-1|No|drug
DDI-DrugBank.d164.s0|3-6|drug|drug
DDI-DrugBank.d164.s0|8-18|interaction|drug
DDI-DrugBank.d164.s0|20-26|studies|drug
DDI-DrugBank.d164.s0|28-31|were|drug
DDI-DrugBank.d164.s0|33-41|performed|drug
DDI-DrugBank.d164.s0|42-42|.|drug
DDI-DrugBank.d164.s1|0-1|No|drug
DDI-DrugBank.d164.s1|3-4|in|drug
DDI-DrugBank.d164.s1|6-10|vitro|drug
DDI-DrugBank.d164.s1|12-21|metabolism|drug
DDI-DrugBank.d164.s1|23-29|studies|drug
DDI-DrugBank.d164.s1|31-34|were|drug
DDI-DrugBank.d164.s1|36-44|performed|drug
DDI-DrugBank.d164.s1|45-45|.|drug
DDI-DrugBank.d337.s0|0-7|Warfarin|drug
DDI-DrugBank.d337.s0|8-8|:|drug
DDI-DrugBank.d337.s0|10-20|Concomitant|drug
DDI-DrugBank.d337.s0|22-35|administration|drug
DDI-DrugBank.d337.s0|37-38|of|drug
DDI-DrugBank.d337.s0|40-49|daptomycin|drug
DDI-DrugBank.d337.s0|51-51|(|drug
DDI-DrugBank.d337.s0|52-52|6|drug
DDI-DrugBank.d337.s0|54-58|mg/kg|drug
DDI-DrugBank.d337.s0|60-63|once|drug
DDI-DrugBank.d337.s0|65-69|every|drug
DDI-DrugBank.d337.s0|71-72|24|drug
DDI-DrugBank.d337.s0|74-78|hours|drug
DDI-DrugBank.d337.s0|80-82|for|drug
DDI-DrugBank.d337.s0|84-84|5|drug
DDI-DrugBank.d337.s0|86-89|days|drug
DDI-DrugBank.d337.s0|90-90|)|drug
DDI-DrugBank.d337.s0|92-94|and|drug
DDI-DrugBank.d337.s0|96-103|warfarin|drug
DDI-DrugBank.d337.s0|105-105|(|drug
DDI-DrugBank.d337.s0|106-107|25|drug
DDI-DrugBank.d337.s0|109-110|mg|drug
DDI-DrugBank.d337.s0|112-117|single|drug
DDI-DrugBank.d337.s0|119-122|oral|drug
DDI-DrugBank.d337.s0|124-127|dose|drug
DDI-DrugBank.d337.s0|128-128|)|drug
DDI-DrugBank.d337.s0|130-132|had|drug
DDI-DrugBank.d337.s0|134-135|no|drug
DDI-DrugBank.d337.s0|137-147|significant|drug
DDI-DrugBank.d337.s0|149-154|effect|drug
DDI-DrugBank.d337.s0|156-157|on|drug
DDI-DrugBank.d337.s0|159-161|the|drug
DDI-DrugBank.d337.s0|163-178|pharmacokinetics|drug
DDI-DrugBank.d337.s0|180-181|of|drug
DDI-DrugBank.d337.s0|183-188|either|drug
DDI-DrugBank.d337.s0|190-193|drug|drug
DDI-DrugBank.d337.s0|194-194|,|drug
DDI-DrugBank.d337.s0|196-198|and|drug
DDI-DrugBank.d337.s0|200-202|the|drug
DDI-DrugBank.d337.s0|204-206|INR|drug
DDI-DrugBank.d337.s0|208-210|was|drug
DDI-DrugBank.d337.s0|212-214|not|drug
DDI-DrugBank.d337.s0|216-228|significantly|drug
DDI-DrugBank.d337.s0|230-236|altered|drug
DDI-DrugBank.d337.s0|237-237|.|drug
DDI-DrugBank.d337.s1|0-6|HMG-CoA|drug
DDI-DrugBank.d337.s1|8-16|Reductase|drug
DDI-DrugBank.d337.s1|18-27|Inhibitors|drug
DDI-DrugBank.d337.s1|28-28|:|drug
DDI-DrugBank.d337.s1|30-39|Inhibitors|drug
DDI-DrugBank.d337.s1|41-42|of|drug
DDI-DrugBank.d337.s1|44-50|HMG-CoA|drug
DDI-DrugBank.d337.s1|52-60|reductase|drug
DDI-DrugBank.d337.s1|62-64|may|drug
DDI-DrugBank.d337.s1|66-70|cause|drug
DDI-DrugBank.d337.s1|72-79|myopathy|drug
DDI-DrugBank.d337.s1|80-80|,|drug
DDI-DrugBank.d337.s1|82-86|which|drug
DDI-DrugBank.d337.s1|88-89|is|drug
DDI-DrugBank.d337.s1|91-100|manifested|drug
DDI-DrugBank.d337.s1|102-103|as|drug
DDI-DrugBank.d337.s1|105-110|muscle|drug
DDI-DrugBank.d337.s1|112-115|pain|drug
DDI-DrugBank.d337.s1|117-118|or|drug
DDI-DrugBank.d337.s1|120-127|weakness|drug
DDI-DrugBank.d337.s1|129-138|associated|drug
DDI-DrugBank.d337.s1|140-143|with|drug
DDI-DrugBank.d337.s1|145-152|elevated|drug
DDI-DrugBank.d337.s1|154-159|levels|drug
DDI-DrugBank.d337.s1|161-162|of|drug
DDI-DrugBank.d337.s1|164-166|CPK|drug
DDI-DrugBank.d337.s1|167-167|.|drug
DDI-DrugBank.d337.s2|0-4|There|drug
DDI-DrugBank.d337.s2|6-9|were|drug
DDI-DrugBank.d337.s2|11-12|no|drug
DDI-DrugBank.d337.s2|14-20|reports|drug
DDI-DrugBank.d337.s2|22-23|of|drug
DDI-DrugBank.d337.s2|25-32|skeletal|drug
DDI-DrugBank.d337.s2|34-41|myopathy|drug
DDI-DrugBank.d337.s2|43-44|in|drug
DDI-DrugBank.d337.s2|46-46|a|drug
DDI-DrugBank.d337.s2|48-65|placebo-controlled|drug
DDI-DrugBank.d337.s2|67-71|Phase|drug
DDI-DrugBank.d337.s2|73-73|I|drug
DDI-DrugBank.d337.s2|75-79|trial|drug
DDI-DrugBank.d337.s2|81-82|in|drug
DDI-DrugBank.d337.s2|84-88|which|drug
DDI-DrugBank.d337.s2|90-91|10|drug
DDI-DrugBank.d337.s2|93-99|healthy|drug
DDI-DrugBank.d337.s2|101-108|subjects|drug
DDI-DrugBank.d337.s2|110-111|on|drug
DDI-DrugBank.d337.s2|113-118|stable|drug
DDI-DrugBank.d337.s2|120-130|simvastatin|drug
DDI-DrugBank.d337.s2|132-138|therapy|drug
DDI-DrugBank.d337.s2|140-143|were|drug
DDI-DrugBank.d337.s2|145-151|treated|drug
DDI-DrugBank.d337.s2|153-164|concurrently|drug
DDI-DrugBank.d337.s2|166-169|with|drug
DDI-DrugBank.d337.s2|171-180|daptomycin|drug
DDI-DrugBank.d337.s2|182-182|(|drug
DDI-DrugBank.d337.s2|183-183|4|drug
DDI-DrugBank.d337.s2|185-189|mg/kg|drug
DDI-DrugBank.d337.s2|191-194|once|drug
DDI-DrugBank.d337.s2|196-200|every|drug
DDI-DrugBank.d337.s2|202-203|24|drug
DDI-DrugBank.d337.s2|205-209|hours|drug
DDI-DrugBank.d337.s2|210-210|)|drug
DDI-DrugBank.d337.s2|212-214|for|drug
DDI-DrugBank.d337.s2|216-217|14|drug
DDI-DrugBank.d337.s2|219-222|days|drug
DDI-DrugBank.d337.s2|223-223|.|drug
DDI-DrugBank.d337.s3|0-9|Experience|drug
DDI-DrugBank.d337.s3|11-14|with|drug
DDI-DrugBank.d337.s3|16-32|co-administration|drug
DDI-DrugBank.d337.s3|34-35|of|drug
DDI-DrugBank.d337.s3|37-43|HMG-CoA|drug
DDI-DrugBank.d337.s3|45-53|reductase|drug
DDI-DrugBank.d337.s3|55-64|inhibitors|drug
DDI-DrugBank.d337.s3|66-68|and|drug
DDI-DrugBank.d337.s3|70-77|Fentanyl|drug
DDI-DrugBank.d337.s3|79-80|in|drug
DDI-DrugBank.d337.s3|82-89|patients|drug
DDI-DrugBank.d337.s3|91-92|is|drug
DDI-DrugBank.d337.s3|94-100|limited|drug
DDI-DrugBank.d337.s3|101-101|,|drug
DDI-DrugBank.d337.s3|102-110|therefore|drug
DDI-DrugBank.d337.s3|111-111|,|drug
DDI-DrugBank.d337.s3|112-124|consideration|drug
DDI-DrugBank.d337.s3|126-131|should|drug
DDI-DrugBank.d337.s3|133-134|be|drug
DDI-DrugBank.d337.s3|136-140|given|drug
DDI-DrugBank.d337.s3|142-143|to|drug
DDI-DrugBank.d337.s3|145-155|temporarily|drug
DDI-DrugBank.d337.s3|157-166|suspending|drug
DDI-DrugBank.d337.s3|168-170|use|drug
DDI-DrugBank.d337.s3|172-173|of|drug
DDI-DrugBank.d337.s3|175-181|HMG-CoA|drug
DDI-DrugBank.d337.s3|183-191|reductase|drug
DDI-DrugBank.d337.s3|193-202|inhibitors|drug
DDI-DrugBank.d337.s3|204-205|in|drug
DDI-DrugBank.d337.s3|207-214|patients|drug
DDI-DrugBank.d337.s3|216-224|receiving|drug
DDI-DrugBank.d337.s3|226-233|Fentanyl|drug
DDI-DrugBank.d337.s3|234-234|.|drug
DDI-DrugBank.d337.s4|0-14|Drug-Laboratory|drug
DDI-DrugBank.d337.s4|16-19|Test|drug
DDI-DrugBank.d337.s4|21-32|Interactions|drug
DDI-DrugBank.d337.s4|33-33|:|drug
DDI-DrugBank.d337.s4|35-39|There|drug
DDI-DrugBank.d337.s4|41-43|are|drug
DDI-DrugBank.d337.s4|45-46|no|drug
DDI-DrugBank.d337.s4|48-55|reported|drug
DDI-DrugBank.d337.s4|57-71|drug-laboratory|drug
DDI-DrugBank.d337.s4|73-76|test|drug
DDI-DrugBank.d337.s4|78-89|interactions|drug
DDI-DrugBank.d337.s4|90-90|.|drug
DDI-DrugBank.d774.s0|0-9|Trilostane|drug
DDI-DrugBank.d774.s0|11-13|may|drug
DDI-DrugBank.d774.s0|15-22|interact|drug
DDI-DrugBank.d774.s0|24-27|with|drug
DDI-DrugBank.d774.s0|29-45|aminoglutethimide|drug
DDI-DrugBank.d774.s0|47-48|or|drug
DDI-DrugBank.d774.s0|50-57|mitotane|drug
DDI-DrugBank.d774.s0|59-59|(|drug
DDI-DrugBank.d774.s0|60-66|causing|drug
DDI-DrugBank.d774.s0|68-70|too|drug
DDI-DrugBank.d774.s0|72-76|great|drug
DDI-DrugBank.d774.s0|78-78|a|drug
DDI-DrugBank.d774.s0|80-87|decrease|drug
DDI-DrugBank.d774.s0|89-90|in|drug
DDI-DrugBank.d774.s0|92-98|adrenal|drug
DDI-DrugBank.d774.s0|100-107|function|drug
DDI-DrugBank.d774.s0|108-108|)|drug
DDI-DrugBank.d774.s0|109-109|.|drug
DDI-DrugBank.d345.s0|0-4|Since|drug
DDI-DrugBank.d345.s0|6-15|colestipol|drug
DDI-DrugBank.d345.s0|17-29|hydrochloride|drug
DDI-DrugBank.d345.s0|31-32|is|drug
DDI-DrugBank.d345.s0|34-35|an|drug
DDI-DrugBank.d345.s0|37-41|anion|drug
DDI-DrugBank.d345.s0|43-50|exchange|drug
DDI-DrugBank.d345.s0|52-56|resin|drug
DDI-DrugBank.d345.s0|57-57|,|drug
DDI-DrugBank.d345.s0|59-60|it|drug
DDI-DrugBank.d345.s0|62-64|may|drug
DDI-DrugBank.d345.s0|66-69|have|drug
DDI-DrugBank.d345.s0|71-71|a|drug
DDI-DrugBank.d345.s0|73-78|strong|drug
DDI-DrugBank.d345.s0|80-87|affinity|drug
DDI-DrugBank.d345.s0|89-91|for|drug
DDI-DrugBank.d345.s0|93-98|anions|drug
DDI-DrugBank.d345.s0|100-104|other|drug
DDI-DrugBank.d345.s0|106-109|than|drug
DDI-DrugBank.d345.s0|111-113|the|drug
DDI-DrugBank.d345.s0|115-118|bile|drug
DDI-DrugBank.d345.s0|120-124|acids|drug
DDI-DrugBank.d345.s0|125-125|.|drug
DDI-DrugBank.d345.s1|0-1|In|drug
DDI-DrugBank.d345.s1|3-7|vitro|drug
DDI-DrugBank.d345.s1|9-15|studies|drug
DDI-DrugBank.d345.s1|17-20|have|drug
DDI-DrugBank.d345.s1|22-30|indicated|drug
DDI-DrugBank.d345.s1|32-35|that|drug
DDI-DrugBank.d345.s1|37-46|colestipol|drug
DDI-DrugBank.d345.s1|48-60|hydrochloride|drug
DDI-DrugBank.d345.s1|62-66|binds|drug
DDI-DrugBank.d345.s1|68-68|a|drug
DDI-DrugBank.d345.s1|70-75|number|drug
DDI-DrugBank.d345.s1|77-78|of|drug
DDI-DrugBank.d345.s1|80-84|drugs|drug
DDI-DrugBank.d345.s1|85-85|.|drug
DDI-DrugBank.d345.s2|0-8|Therefore|drug
DDI-DrugBank.d345.s2|9-9|,|drug
DDI-DrugBank.d345.s2|11-18|COLESTlD|drug
DDI-DrugBank.d345.s2|20-26|Tablets|drug
DDI-DrugBank.d345.s2|28-30|may|drug
DDI-DrugBank.d345.s2|32-36|delay|drug
DDI-DrugBank.d345.s2|38-39|or|drug
DDI-DrugBank.d345.s2|41-46|reduce|drug
DDI-DrugBank.d345.s2|48-50|the|drug
DDI-DrugBank.d345.s2|52-61|absorption|drug
DDI-DrugBank.d345.s2|63-64|of|drug
DDI-DrugBank.d345.s2|66-76|concomitant|drug
DDI-DrugBank.d345.s2|78-81|oral|drug
DDI-DrugBank.d345.s2|83-92|medication|drug
DDI-DrugBank.d345.s2|93-93|.|drug
DDI-DrugBank.d345.s3|0-2|The|drug
DDI-DrugBank.d345.s3|4-11|interval|drug
DDI-DrugBank.d345.s3|13-19|between|drug
DDI-DrugBank.d345.s3|21-23|the|drug
DDI-DrugBank.d345.s3|25-38|administration|drug
DDI-DrugBank.d345.s3|40-41|of|drug
DDI-DrugBank.d345.s3|43-50|COLESTID|drug
DDI-DrugBank.d345.s3|52-58|Tablets|drug
DDI-DrugBank.d345.s3|60-62|and|drug
DDI-DrugBank.d345.s3|64-66|any|drug
DDI-DrugBank.d345.s3|68-72|other|drug
DDI-DrugBank.d345.s3|74-83|medication|drug
DDI-DrugBank.d345.s3|85-90|should|drug
DDI-DrugBank.d345.s3|92-93|be|drug
DDI-DrugBank.d345.s3|95-96|as|drug
DDI-DrugBank.d345.s3|98-101|long|drug
DDI-DrugBank.d345.s3|103-104|as|drug
DDI-DrugBank.d345.s3|106-113|possible|drug
DDI-DrugBank.d345.s3|114-114|.|drug
DDI-DrugBank.d345.s4|0-7|Patients|drug
DDI-DrugBank.d345.s4|9-14|should|drug
DDI-DrugBank.d345.s4|16-19|take|drug
DDI-DrugBank.d345.s4|21-25|other|drug
DDI-DrugBank.d345.s4|27-31|drugs|drug
DDI-DrugBank.d345.s4|33-34|at|drug
DDI-DrugBank.d345.s4|36-40|least|drug
DDI-DrugBank.d345.s4|42-44|one|drug
DDI-DrugBank.d345.s4|46-49|hour|drug
DDI-DrugBank.d345.s4|51-56|before|drug
DDI-DrugBank.d345.s4|58-59|or|drug
DDI-DrugBank.d345.s4|61-64|four|drug
DDI-DrugBank.d345.s4|66-70|hours|drug
DDI-DrugBank.d345.s4|72-76|after|drug
DDI-DrugBank.d345.s4|78-85|COLESTID|drug
DDI-DrugBank.d345.s4|87-93|Tablets|drug
DDI-DrugBank.d345.s4|95-96|to|drug
DDI-DrugBank.d345.s4|98-102|avoid|drug
DDI-DrugBank.d345.s4|104-111|impeding|drug
DDI-DrugBank.d345.s4|113-117|their|drug
DDI-DrugBank.d345.s4|119-128|absorption|drug
DDI-DrugBank.d345.s4|129-129|.|drug
DDI-DrugBank.d345.s5|0-7|Repeated|drug
DDI-DrugBank.d345.s5|9-13|doses|drug
DDI-DrugBank.d345.s5|15-16|of|drug
DDI-DrugBank.d345.s5|18-27|colestipol|drug
DDI-DrugBank.d345.s5|29-41|hydrochloride|drug
DDI-DrugBank.d345.s5|43-47|given|drug
DDI-DrugBank.d345.s5|49-53|prior|drug
DDI-DrugBank.d345.s5|55-56|to|drug
DDI-DrugBank.d345.s5|58-58|a|drug
DDI-DrugBank.d345.s5|60-65|single|drug
DDI-DrugBank.d345.s5|67-70|dose|drug
DDI-DrugBank.d345.s5|72-73|of|drug
DDI-DrugBank.d345.s5|75-85|propranolol|drug
DDI-DrugBank.d345.s5|87-88|in|drug
DDI-DrugBank.d345.s5|90-94|human|drug
DDI-DrugBank.d345.s5|96-101|trials|drug
DDI-DrugBank.d345.s5|103-106|have|drug
DDI-DrugBank.d345.s5|108-111|been|drug
DDI-DrugBank.d345.s5|113-120|reported|drug
DDI-DrugBank.d345.s5|122-123|to|drug
DDI-DrugBank.d345.s5|125-132|decrease|drug
DDI-DrugBank.d345.s5|134-144|propranolol|drug
DDI-DrugBank.d345.s5|146-155|absorption|drug
DDI-DrugBank.d345.s5|156-156|.|drug
DDI-DrugBank.d345.s6|0-6|However|drug
DDI-DrugBank.d345.s6|7-7|,|drug
DDI-DrugBank.d345.s6|9-10|in|drug
DDI-DrugBank.d345.s6|12-12|a|drug
DDI-DrugBank.d345.s6|14-22|follow-up|drug
DDI-DrugBank.d345.s6|24-28|study|drug
DDI-DrugBank.d345.s6|30-31|in|drug
DDI-DrugBank.d345.s6|33-38|normal|drug
DDI-DrugBank.d345.s6|40-47|subjects|drug
DDI-DrugBank.d345.s6|48-48|,|drug
DDI-DrugBank.d345.s6|50-60|single-dose|drug
DDI-DrugBank.d345.s6|62-75|administration|drug
DDI-DrugBank.d345.s6|77-78|of|drug
DDI-DrugBank.d345.s6|80-89|colestipol|drug
DDI-DrugBank.d345.s6|91-103|hydrochloride|drug
DDI-DrugBank.d345.s6|105-107|and|drug
DDI-DrugBank.d345.s6|109-119|propranolol|drug
DDI-DrugBank.d345.s6|121-123|and|drug
DDI-DrugBank.d345.s6|125-135|twice-a-day|drug
DDI-DrugBank.d345.s6|137-150|administration|drug
DDI-DrugBank.d345.s6|152-154|for|drug
DDI-DrugBank.d345.s6|156-156|5|drug
DDI-DrugBank.d345.s6|158-161|days|drug
DDI-DrugBank.d345.s6|163-164|of|drug
DDI-DrugBank.d345.s6|166-169|both|drug
DDI-DrugBank.d345.s6|171-176|agents|drug
DDI-DrugBank.d345.s6|178-180|did|drug
DDI-DrugBank.d345.s6|182-184|not|drug
DDI-DrugBank.d345.s6|186-191|affect|drug
DDI-DrugBank.d345.s6|193-195|the|drug
DDI-DrugBank.d345.s6|197-202|extent|drug
DDI-DrugBank.d345.s6|204-205|of|drug
DDI-DrugBank.d345.s6|207-217|propranolol|drug
DDI-DrugBank.d345.s6|219-228|absorption|drug
DDI-DrugBank.d345.s6|229-229|,|drug
DDI-DrugBank.d345.s6|231-233|but|drug
DDI-DrugBank.d345.s6|235-237|had|drug
DDI-DrugBank.d345.s6|239-239|a|drug
DDI-DrugBank.d345.s6|241-245|small|drug
DDI-DrugBank.d345.s6|247-249|yet|drug
DDI-DrugBank.d345.s6|251-263|statistically|drug
DDI-DrugBank.d345.s6|265-275|significant|drug
DDI-DrugBank.d345.s6|277-282|effect|drug
DDI-DrugBank.d345.s6|284-285|on|drug
DDI-DrugBank.d345.s6|287-289|its|drug
DDI-DrugBank.d345.s6|291-294|rate|drug
DDI-DrugBank.d345.s6|296-297|of|drug
DDI-DrugBank.d345.s6|299-308|absorption|drug
DDI-DrugBank.d345.s6|309-309|;|drug
DDI-DrugBank.d345.s7|0-2|the|drug
DDI-DrugBank.d345.s7|4-7|time|drug
DDI-DrugBank.d345.s7|9-10|to|drug
DDI-DrugBank.d345.s7|12-16|reach|drug
DDI-DrugBank.d345.s7|18-24|maximum|drug
DDI-DrugBank.d345.s7|26-38|concentration|drug
DDI-DrugBank.d345.s7|40-42|was|drug
DDI-DrugBank.d345.s7|44-50|delayed|drug
DDI-DrugBank.d345.s7|52-64|approximately|drug
DDI-DrugBank.d345.s7|66-67|30|drug
DDI-DrugBank.d345.s7|69-75|minutes|drug
DDI-DrugBank.d345.s7|76-76|.|drug
DDI-DrugBank.d345.s8|0-6|Effects|drug
DDI-DrugBank.d345.s8|8-9|on|drug
DDI-DrugBank.d345.s8|11-13|the|drug
DDI-DrugBank.d345.s8|15-24|absorption|drug
DDI-DrugBank.d345.s8|26-27|of|drug
DDI-DrugBank.d345.s8|29-33|other|drug
DDI-DrugBank.d345.s8|35-47|beta-blockers|drug
DDI-DrugBank.d345.s8|49-52|have|drug
DDI-DrugBank.d345.s8|54-56|not|drug
DDI-DrugBank.d345.s8|58-61|been|drug
DDI-DrugBank.d345.s8|63-72|determined|drug
DDI-DrugBank.d345.s8|73-73|.|drug
DDI-DrugBank.d345.s9|0-8|Therefore|drug
DDI-DrugBank.d345.s9|9-9|,|drug
DDI-DrugBank.d345.s9|11-18|patients|drug
DDI-DrugBank.d345.s9|20-21|on|drug
DDI-DrugBank.d345.s9|23-33|propranolol|drug
DDI-DrugBank.d345.s9|35-40|should|drug
DDI-DrugBank.d345.s9|42-43|be|drug
DDI-DrugBank.d345.s9|45-52|observed|drug
DDI-DrugBank.d345.s9|54-57|when|drug
DDI-DrugBank.d345.s9|59-66|COLESTID|drug
DDI-DrugBank.d345.s9|68-74|Tablets|drug
DDI-DrugBank.d345.s9|76-78|are|drug
DDI-DrugBank.d345.s9|80-85|either|drug
DDI-DrugBank.d345.s9|87-91|added|drug
DDI-DrugBank.d345.s9|93-94|or|drug
DDI-DrugBank.d345.s9|96-102|deleted|drug
DDI-DrugBank.d345.s9|104-107|from|drug
DDI-DrugBank.d345.s9|109-109|a|drug
DDI-DrugBank.d345.s9|111-121|therapeutic|drug
DDI-DrugBank.d345.s9|123-129|regimen|drug
DDI-DrugBank.d345.s9|130-130|.|drug
DDI-DrugBank.d345.s10|0-6|Studies|drug
DDI-DrugBank.d345.s10|8-9|in|drug
DDI-DrugBank.d345.s10|11-16|humans|drug
DDI-DrugBank.d345.s10|18-21|show|drug
DDI-DrugBank.d345.s10|23-26|that|drug
DDI-DrugBank.d345.s10|28-30|the|drug
DDI-DrugBank.d345.s10|32-41|absorption|drug
DDI-DrugBank.d345.s10|43-44|of|drug
DDI-DrugBank.d345.s10|46-59|chlorothiazide|drug
DDI-DrugBank.d345.s10|61-62|as|drug
DDI-DrugBank.d345.s10|64-72|reflected|drug
DDI-DrugBank.d345.s10|74-75|in|drug
DDI-DrugBank.d345.s10|77-83|urinary|drug
DDI-DrugBank.d345.s10|85-93|excretion|drug
DDI-DrugBank.d345.s10|95-96|is|drug
DDI-DrugBank.d345.s10|98-105|markedly|drug
DDI-DrugBank.d345.s10|107-115|decreased|drug
DDI-DrugBank.d345.s10|117-120|even|drug
DDI-DrugBank.d345.s10|122-125|when|drug
DDI-DrugBank.d345.s10|127-138|administered|drug
DDI-DrugBank.d345.s10|140-142|one|drug
DDI-DrugBank.d345.s10|144-147|hour|drug
DDI-DrugBank.d345.s10|149-154|before|drug
DDI-DrugBank.d345.s10|156-165|colestipol|drug
DDI-DrugBank.d345.s10|167-179|hydrochloride|drug
DDI-DrugBank.d345.s10|180-180|.|drug
DDI-DrugBank.d345.s11|0-2|The|drug
DDI-DrugBank.d345.s11|4-13|absorption|drug
DDI-DrugBank.d345.s11|15-16|of|drug
DDI-DrugBank.d345.s11|18-29|tetracycline|drug
DDI-DrugBank.d345.s11|30-30|,|drug
DDI-DrugBank.d345.s11|32-41|furosemide|drug
DDI-DrugBank.d345.s11|42-42|,|drug
DDI-DrugBank.d345.s11|44-53|penicillin|drug
DDI-DrugBank.d345.s11|55-55|G|drug
DDI-DrugBank.d345.s11|56-56|,|drug
DDI-DrugBank.d345.s11|58-76|hydrochlorothiazide|drug
DDI-DrugBank.d345.s11|77-77|,|drug
DDI-DrugBank.d345.s11|79-81|and|drug
DDI-DrugBank.d345.s11|83-93|gemfibrozil|drug
DDI-DrugBank.d345.s11|95-97|was|drug
DDI-DrugBank.d345.s11|99-111|significantly|drug
DDI-DrugBank.d345.s11|113-121|decreased|drug
DDI-DrugBank.d345.s11|123-126|when|drug
DDI-DrugBank.d345.s11|128-132|given|drug
DDI-DrugBank.d345.s11|134-147|simultaneously|drug
DDI-DrugBank.d345.s11|149-152|with|drug
DDI-DrugBank.d345.s11|154-163|colestipol|drug
DDI-DrugBank.d345.s11|165-177|hydrochloride|drug
DDI-DrugBank.d345.s11|178-178|;|drug
DDI-DrugBank.d345.s12|0-4|these|drug
DDI-DrugBank.d345.s12|6-10|drugs|drug
DDI-DrugBank.d345.s12|12-15|were|drug
DDI-DrugBank.d345.s12|17-19|not|drug
DDI-DrugBank.d345.s12|21-26|tested|drug
DDI-DrugBank.d345.s12|28-29|to|drug
DDI-DrugBank.d345.s12|31-39|determine|drug
DDI-DrugBank.d345.s12|41-43|the|drug
DDI-DrugBank.d345.s12|45-50|effect|drug
DDI-DrugBank.d345.s12|52-53|of|drug
DDI-DrugBank.d345.s12|55-68|administration|drug
DDI-DrugBank.d345.s12|70-72|one|drug
DDI-DrugBank.d345.s12|74-77|hour|drug
DDI-DrugBank.d345.s12|79-84|before|drug
DDI-DrugBank.d345.s12|86-95|colestipol|drug
DDI-DrugBank.d345.s12|97-109|hydrochloride|drug
DDI-DrugBank.d345.s12|110-110|.|drug
DDI-DrugBank.d345.s13|0-1|No|drug
DDI-DrugBank.d345.s13|3-12|depressant|drug
DDI-DrugBank.d345.s13|14-19|effect|drug
DDI-DrugBank.d345.s13|21-22|on|drug
DDI-DrugBank.d345.s13|24-28|blood|drug
DDI-DrugBank.d345.s13|30-35|levels|drug
DDI-DrugBank.d345.s13|37-38|in|drug
DDI-DrugBank.d345.s13|40-45|humans|drug
DDI-DrugBank.d345.s13|47-49|was|drug
DDI-DrugBank.d345.s13|51-55|noted|drug
DDI-DrugBank.d345.s13|57-60|when|drug
DDI-DrugBank.d345.s13|62-71|colestipol|drug
DDI-DrugBank.d345.s13|73-85|hydrochloride|drug
DDI-DrugBank.d345.s13|87-89|was|drug
DDI-DrugBank.d345.s13|91-102|administered|drug
DDI-DrugBank.d345.s13|104-107|with|drug
DDI-DrugBank.d345.s13|109-111|any|drug
DDI-DrugBank.d345.s13|113-114|of|drug
DDI-DrugBank.d345.s13|116-118|the|drug
DDI-DrugBank.d345.s13|120-128|following|drug
DDI-DrugBank.d345.s13|130-134|drugs|drug
DDI-DrugBank.d345.s13|135-135|:|drug
DDI-DrugBank.d345.s13|137-143|aspirin|drug
DDI-DrugBank.d345.s13|144-144|,|drug
DDI-DrugBank.d345.s13|146-156|clindamycin|drug
DDI-DrugBank.d345.s13|157-157|,|drug
DDI-DrugBank.d345.s13|159-168|clofibrate|drug
DDI-DrugBank.d345.s13|169-169|,|drug
DDI-DrugBank.d345.s13|171-180|methyldopa|drug
DDI-DrugBank.d345.s13|181-181|,|drug
DDI-DrugBank.d345.s13|183-191|nicotinic|drug
DDI-DrugBank.d345.s13|193-196|acid|drug
DDI-DrugBank.d345.s13|198-198|(|drug
DDI-DrugBank.d345.s13|199-204|niacin|drug
DDI-DrugBank.d345.s13|205-205|)|drug
DDI-DrugBank.d345.s13|206-206|,|drug
DDI-DrugBank.d345.s13|208-218|tolbutamide|drug
DDI-DrugBank.d345.s13|219-219|,|drug
DDI-DrugBank.d345.s13|221-229|phenytoin|drug
DDI-DrugBank.d345.s13|231-232|or|drug
DDI-DrugBank.d345.s13|234-241|warfarin|drug
DDI-DrugBank.d345.s13|242-242|.|drug
DDI-DrugBank.d345.s14|0-9|Particular|drug
DDI-DrugBank.d345.s14|11-17|caution|drug
DDI-DrugBank.d345.s14|19-24|should|drug
DDI-DrugBank.d345.s14|26-27|be|drug
DDI-DrugBank.d345.s14|29-36|observed|drug
DDI-DrugBank.d345.s14|38-41|with|drug
DDI-DrugBank.d345.s14|43-51|digitalis|drug
DDI-DrugBank.d345.s14|53-64|preparations|drug
DDI-DrugBank.d345.s14|66-70|since|drug
DDI-DrugBank.d345.s14|72-76|there|drug
DDI-DrugBank.d345.s14|78-80|are|drug
DDI-DrugBank.d345.s14|82-92|conflicting|drug
DDI-DrugBank.d345.s14|94-100|results|drug
DDI-DrugBank.d345.s14|102-104|for|drug
DDI-DrugBank.d345.s14|106-108|the|drug
DDI-DrugBank.d345.s14|110-115|effect|drug
DDI-DrugBank.d345.s14|117-118|of|drug
DDI-DrugBank.d345.s14|120-129|colestipol|drug
DDI-DrugBank.d345.s14|131-143|hydrochloride|drug
DDI-DrugBank.d345.s14|145-146|on|drug
DDI-DrugBank.d345.s14|148-150|the|drug
DDI-DrugBank.d345.s14|152-163|availability|drug
DDI-DrugBank.d345.s14|165-166|of|drug
DDI-DrugBank.d345.s14|168-174|digoxin|drug
DDI-DrugBank.d345.s14|176-178|and|drug
DDI-DrugBank.d345.s14|180-188|digitoxin|drug
DDI-DrugBank.d345.s14|189-189|.|drug
DDI-DrugBank.d345.s15|0-2|The|drug
DDI-DrugBank.d345.s15|4-12|potential|drug
DDI-DrugBank.d345.s15|14-16|for|drug
DDI-DrugBank.d345.s15|18-24|binding|drug
DDI-DrugBank.d345.s15|26-27|of|drug
DDI-DrugBank.d345.s15|29-33|these|drug
DDI-DrugBank.d345.s15|35-39|drugs|drug
DDI-DrugBank.d345.s15|41-42|if|drug
DDI-DrugBank.d345.s15|44-48|given|drug
DDI-DrugBank.d345.s15|50-62|concomitantly|drug
DDI-DrugBank.d345.s15|64-65|is|drug
DDI-DrugBank.d345.s15|67-73|present|drug
DDI-DrugBank.d345.s15|74-74|.|drug
DDI-DrugBank.d345.s16|0-12|Discontinuing|drug
DDI-DrugBank.d345.s16|14-23|colestipol|drug
DDI-DrugBank.d345.s16|25-37|hydrochloride|drug
DDI-DrugBank.d345.s16|39-43|could|drug
DDI-DrugBank.d345.s16|45-48|pose|drug
DDI-DrugBank.d345.s16|50-50|a|drug
DDI-DrugBank.d345.s16|52-57|hazard|drug
DDI-DrugBank.d345.s16|59-60|to|drug
DDI-DrugBank.d345.s16|62-67|health|drug
DDI-DrugBank.d345.s16|69-70|if|drug
DDI-DrugBank.d345.s16|72-72|a|drug
DDI-DrugBank.d345.s16|74-84|potentially|drug
DDI-DrugBank.d345.s16|86-90|toxic|drug
DDI-DrugBank.d345.s16|92-95|drug|drug
DDI-DrugBank.d345.s16|97-100|that|drug
DDI-DrugBank.d345.s16|102-103|is|drug
DDI-DrugBank.d345.s16|105-117|significantly|drug
DDI-DrugBank.d345.s16|119-123|bound|drug
DDI-DrugBank.d345.s16|125-126|to|drug
DDI-DrugBank.d345.s16|128-130|the|drug
DDI-DrugBank.d345.s16|132-136|resin|drug
DDI-DrugBank.d345.s16|138-140|has|drug
DDI-DrugBank.d345.s16|142-145|been|drug
DDI-DrugBank.d345.s16|147-154|titrated|drug
DDI-DrugBank.d345.s16|156-157|to|drug
DDI-DrugBank.d345.s16|159-159|a|drug
DDI-DrugBank.d345.s16|161-171|maintenance|drug
DDI-DrugBank.d345.s16|173-177|level|drug
DDI-DrugBank.d345.s16|179-183|while|drug
DDI-DrugBank.d345.s16|185-187|the|drug
DDI-DrugBank.d345.s16|189-195|patient|drug
DDI-DrugBank.d345.s16|197-199|was|drug
DDI-DrugBank.d345.s16|201-206|taking|drug
DDI-DrugBank.d345.s16|208-217|colestipol|drug
DDI-DrugBank.d345.s16|219-231|hydrochloride|drug
DDI-DrugBank.d345.s16|232-232|.|drug
DDI-DrugBank.d345.s17|0-3|Bile|drug
DDI-DrugBank.d345.s17|5-8|acid|drug
DDI-DrugBank.d345.s17|10-16|binding|drug
DDI-DrugBank.d345.s17|18-23|resins|drug
DDI-DrugBank.d345.s17|25-27|may|drug
DDI-DrugBank.d345.s17|29-32|also|drug
DDI-DrugBank.d345.s17|34-42|interfere|drug
DDI-DrugBank.d345.s17|44-47|with|drug
DDI-DrugBank.d345.s17|49-51|the|drug
DDI-DrugBank.d345.s17|53-62|absorption|drug
DDI-DrugBank.d345.s17|64-65|of|drug
DDI-DrugBank.d345.s17|67-70|oral|drug
DDI-DrugBank.d345.s17|72-80|phosphate|drug
DDI-DrugBank.d345.s17|82-92|supplements|drug
DDI-DrugBank.d345.s17|94-96|and|drug
DDI-DrugBank.d345.s17|98-111|hydrocortisone|drug
DDI-DrugBank.d345.s17|112-112|.|drug
DDI-DrugBank.d84.s0|0-2|The|drug
DDI-DrugBank.d84.s0|4-14|concomitant|drug
DDI-DrugBank.d84.s0|16-29|administration|drug
DDI-DrugBank.d84.s0|31-32|of|drug
DDI-DrugBank.d84.s0|34-39|Exjade|drug
DDI-DrugBank.d84.s0|41-43|and|drug
DDI-DrugBank.d84.s0|45-63|aluminum-containing|drug
DDI-DrugBank.d84.s0|65-71|antacid|drug
DDI-DrugBank.d84.s0|73-84|preparations|drug
DDI-DrugBank.d84.s0|86-88|has|drug
DDI-DrugBank.d84.s0|90-92|not|drug
DDI-DrugBank.d84.s0|94-97|been|drug
DDI-DrugBank.d84.s0|99-106|formally|drug
DDI-DrugBank.d84.s0|108-114|studied|drug
DDI-DrugBank.d84.s0|115-115|.|drug
DDI-DrugBank.d84.s1|0-7|Although|drug
DDI-DrugBank.d84.s1|9-19|deferasirox|drug
DDI-DrugBank.d84.s1|21-23|has|drug
DDI-DrugBank.d84.s1|25-25|a|drug
DDI-DrugBank.d84.s1|27-31|lower|drug
DDI-DrugBank.d84.s1|33-40|affinity|drug
DDI-DrugBank.d84.s1|42-44|for|drug
DDI-DrugBank.d84.s1|46-53|aluminum|drug
DDI-DrugBank.d84.s1|55-58|than|drug
DDI-DrugBank.d84.s1|60-62|for|drug
DDI-DrugBank.d84.s1|64-67|iron|drug
DDI-DrugBank.d84.s1|68-68|,|drug
DDI-DrugBank.d84.s1|70-75|Exjade|drug
DDI-DrugBank.d84.s1|77-82|should|drug
DDI-DrugBank.d84.s1|84-86|not|drug
DDI-DrugBank.d84.s1|88-89|be|drug
DDI-DrugBank.d84.s1|91-95|taken|drug
DDI-DrugBank.d84.s1|97-100|with|drug
DDI-DrugBank.d84.s1|102-120|aluminum-containing|drug
DDI-DrugBank.d84.s1|122-128|antacid|drug
DDI-DrugBank.d84.s1|130-141|preparations|drug
DDI-DrugBank.d84.s1|142-142|.|drug
DDI-DrugBank.d84.s2|0-1|In|drug
DDI-DrugBank.d84.s2|3-9|healthy|drug
DDI-DrugBank.d84.s2|11-20|volunteers|drug
DDI-DrugBank.d84.s2|21-21|,|drug
DDI-DrugBank.d84.s2|23-28|Exjade|drug
DDI-DrugBank.d84.s2|30-32|had|drug
DDI-DrugBank.d84.s2|34-35|no|drug
DDI-DrugBank.d84.s2|37-42|effect|drug
DDI-DrugBank.d84.s2|44-45|on|drug
DDI-DrugBank.d84.s2|47-49|the|drug
DDI-DrugBank.d84.s2|51-66|pharmacokinetics|drug
DDI-DrugBank.d84.s2|68-69|of|drug
DDI-DrugBank.d84.s2|71-77|digoxin|drug
DDI-DrugBank.d84.s2|78-78|.|drug
DDI-DrugBank.d84.s3|0-2|The|drug
DDI-DrugBank.d84.s3|4-9|effect|drug
DDI-DrugBank.d84.s3|11-12|of|drug
DDI-DrugBank.d84.s3|14-20|digoxin|drug
DDI-DrugBank.d84.s3|22-23|on|drug
DDI-DrugBank.d84.s3|25-30|Exjade|drug
DDI-DrugBank.d84.s3|32-47|pharmacokinetics|drug
DDI-DrugBank.d84.s3|49-51|has|drug
DDI-DrugBank.d84.s3|53-55|not|drug
DDI-DrugBank.d84.s3|57-60|been|drug
DDI-DrugBank.d84.s3|62-68|studied|drug
DDI-DrugBank.d84.s3|69-69|.|drug
DDI-DrugBank.d84.s4|0-2|The|drug
DDI-DrugBank.d84.s4|4-14|concomitant|drug
DDI-DrugBank.d84.s4|16-29|administration|drug
DDI-DrugBank.d84.s4|31-32|of|drug
DDI-DrugBank.d84.s4|34-39|Exjade|drug
DDI-DrugBank.d84.s4|41-43|and|drug
DDI-DrugBank.d84.s4|45-51|vitamin|drug
DDI-DrugBank.d84.s4|53-53|C|drug
DDI-DrugBank.d84.s4|55-57|has|drug
DDI-DrugBank.d84.s4|59-61|not|drug
DDI-DrugBank.d84.s4|63-66|been|drug
DDI-DrugBank.d84.s4|68-75|formally|drug
DDI-DrugBank.d84.s4|77-83|studied|drug
DDI-DrugBank.d84.s4|84-84|.|drug
DDI-DrugBank.d84.s5|0-4|Doses|drug
DDI-DrugBank.d84.s5|6-7|of|drug
DDI-DrugBank.d84.s5|9-15|vitamin|drug
DDI-DrugBank.d84.s5|17-17|C|drug
DDI-DrugBank.d84.s5|19-20|up|drug
DDI-DrugBank.d84.s5|22-23|to|drug
DDI-DrugBank.d84.s5|25-27|200|drug
DDI-DrugBank.d84.s5|29-30|mg|drug
DDI-DrugBank.d84.s5|32-35|were|drug
DDI-DrugBank.d84.s5|37-43|allowed|drug
DDI-DrugBank.d84.s5|45-46|in|drug
DDI-DrugBank.d84.s5|48-55|clinical|drug
DDI-DrugBank.d84.s5|57-63|studies|drug
DDI-DrugBank.d84.s5|65-71|without|drug
DDI-DrugBank.d84.s5|73-80|negative|drug
DDI-DrugBank.d84.s5|82-93|consequences|drug
DDI-DrugBank.d84.s5|94-94|.|drug
DDI-DrugBank.d84.s6|0-2|The|drug
DDI-DrugBank.d84.s6|4-14|interaction|drug
DDI-DrugBank.d84.s6|16-17|of|drug
DDI-DrugBank.d84.s6|19-24|Exjade|drug
DDI-DrugBank.d84.s6|26-29|with|drug
DDI-DrugBank.d84.s6|31-41|hydroxyurea|drug
DDI-DrugBank.d84.s6|43-45|has|drug
DDI-DrugBank.d84.s6|47-49|not|drug
DDI-DrugBank.d84.s6|51-54|been|drug
DDI-DrugBank.d84.s6|56-63|formally|drug
DDI-DrugBank.d84.s6|65-71|studied|drug
DDI-DrugBank.d84.s6|72-72|.|drug
DDI-DrugBank.d84.s7|0-1|No|drug
DDI-DrugBank.d84.s7|3-12|inhibition|drug
DDI-DrugBank.d84.s7|14-15|of|drug
DDI-DrugBank.d84.s7|17-27|deferasirox|drug
DDI-DrugBank.d84.s7|29-38|metabolism|drug
DDI-DrugBank.d84.s7|40-41|by|drug
DDI-DrugBank.d84.s7|43-53|hydroxyurea|drug
DDI-DrugBank.d84.s7|55-56|is|drug
DDI-DrugBank.d84.s7|58-65|expected|drug
DDI-DrugBank.d84.s7|67-71|based|drug
DDI-DrugBank.d84.s7|73-74|on|drug
DDI-DrugBank.d84.s7|76-78|the|drug
DDI-DrugBank.d84.s7|80-86|results|drug
DDI-DrugBank.d84.s7|88-89|of|drug
DDI-DrugBank.d84.s7|91-92|an|drug
DDI-DrugBank.d84.s7|94-95|in|drug
DDI-DrugBank.d84.s7|97-101|vitro|drug
DDI-DrugBank.d84.s7|103-107|study|drug
DDI-DrugBank.d84.s7|108-108|.|drug
DDI-DrugBank.d84.s8|0-5|Exjade|drug
DDI-DrugBank.d84.s8|7-12|should|drug
DDI-DrugBank.d84.s8|14-16|not|drug
DDI-DrugBank.d84.s8|18-19|be|drug
DDI-DrugBank.d84.s8|21-28|combined|drug
DDI-DrugBank.d84.s8|30-33|with|drug
DDI-DrugBank.d84.s8|35-39|other|drug
DDI-DrugBank.d84.s8|41-44|iron|drug
DDI-DrugBank.d84.s8|46-53|chelator|drug
DDI-DrugBank.d84.s8|55-63|therapies|drug
DDI-DrugBank.d84.s8|64-64|,|drug
DDI-DrugBank.d84.s8|66-67|as|drug
DDI-DrugBank.d84.s8|69-74|safety|drug
DDI-DrugBank.d84.s8|76-77|of|drug
DDI-DrugBank.d84.s8|79-82|such|drug
DDI-DrugBank.d84.s8|84-95|combinations|drug
DDI-DrugBank.d84.s8|97-99|has|drug
DDI-DrugBank.d84.s8|101-103|not|drug
DDI-DrugBank.d84.s8|105-108|been|drug
DDI-DrugBank.d84.s8|110-120|established|drug
DDI-DrugBank.d84.s8|121-121|.|drug
DDI-DrugBank.d84.s9|0-8|Drug/Food|drug
DDI-DrugBank.d84.s9|10-21|Interactions|drug
DDI-DrugBank.d84.s9|23-25|The|drug
DDI-DrugBank.d84.s9|27-41|bioavailability|drug
DDI-DrugBank.d84.s9|43-43|(|drug
DDI-DrugBank.d84.s9|44-46|AUC|drug
DDI-DrugBank.d84.s9|47-47|)|drug
DDI-DrugBank.d84.s9|49-50|of|drug
DDI-DrugBank.d84.s9|52-62|deferasirox|drug
DDI-DrugBank.d84.s9|64-66|was|drug
DDI-DrugBank.d84.s9|68-75|variably|drug
DDI-DrugBank.d84.s9|77-85|increased|drug
DDI-DrugBank.d84.s9|87-90|when|drug
DDI-DrugBank.d84.s9|92-96|taken|drug
DDI-DrugBank.d84.s9|98-101|with|drug
DDI-DrugBank.d84.s9|103-103|a|drug
DDI-DrugBank.d84.s9|105-108|meal|drug
DDI-DrugBank.d84.s9|109-109|.|drug
DDI-DrugBank.d84.s10|0-10|Deferasirox|drug
DDI-DrugBank.d84.s10|12-17|should|drug
DDI-DrugBank.d84.s10|19-20|be|drug
DDI-DrugBank.d84.s10|22-26|taken|drug
DDI-DrugBank.d84.s10|28-29|on|drug
DDI-DrugBank.d84.s10|31-32|an|drug
DDI-DrugBank.d84.s10|34-38|empty|drug
DDI-DrugBank.d84.s10|40-46|stomach|drug
DDI-DrugBank.d84.s10|48-49|30|drug
DDI-DrugBank.d84.s10|51-57|minutes|drug
DDI-DrugBank.d84.s10|59-64|before|drug
DDI-DrugBank.d84.s10|66-71|eating|drug
DDI-DrugBank.d84.s10|72-72|.|drug
DDI-DrugBank.d84.s11|0-5|Exjade|drug
DDI-DrugBank.d84.s11|7-13|tablets|drug
DDI-DrugBank.d84.s11|15-17|for|drug
DDI-DrugBank.d84.s11|19-22|oral|drug
DDI-DrugBank.d84.s11|24-33|suspension|drug
DDI-DrugBank.d84.s11|35-37|can|drug
DDI-DrugBank.d84.s11|39-40|be|drug
DDI-DrugBank.d84.s11|42-50|dispersed|drug
DDI-DrugBank.d84.s11|52-53|in|drug
DDI-DrugBank.d84.s11|55-59|water|drug
DDI-DrugBank.d84.s11|60-60|,|drug
DDI-DrugBank.d84.s11|62-67|orange|drug
DDI-DrugBank.d84.s11|69-73|juice|drug
DDI-DrugBank.d84.s11|74-74|,|drug
DDI-DrugBank.d84.s11|76-77|or|drug
DDI-DrugBank.d84.s11|79-83|apple|drug
DDI-DrugBank.d84.s11|85-89|juice|drug
DDI-DrugBank.d84.s11|90-90|.|drug
DDI-DrugBank.d285.s0|0-6|Reduced|drug
DDI-DrugBank.d285.s0|8-15|efficacy|drug
DDI-DrugBank.d285.s0|17-19|and|drug
DDI-DrugBank.d285.s0|21-29|increased|drug
DDI-DrugBank.d285.s0|31-39|incidence|drug
DDI-DrugBank.d285.s0|41-42|of|drug
DDI-DrugBank.d285.s0|44-55|breakthrough|drug
DDI-DrugBank.d285.s0|57-64|bleeding|drug
DDI-DrugBank.d285.s0|66-68|and|drug
DDI-DrugBank.d285.s0|70-78|menstrual|drug
DDI-DrugBank.d285.s0|80-93|irregularities|drug
DDI-DrugBank.d285.s0|95-98|have|drug
DDI-DrugBank.d285.s0|100-103|been|drug
DDI-DrugBank.d285.s0|105-114|associated|drug
DDI-DrugBank.d285.s0|116-119|with|drug
DDI-DrugBank.d285.s0|121-131|concomitant|drug
DDI-DrugBank.d285.s0|133-135|use|drug
DDI-DrugBank.d285.s0|137-138|of|drug
DDI-DrugBank.d285.s0|140-147|rifampin|drug
DDI-DrugBank.d285.s0|148-148|.|drug
DDI-DrugBank.d285.s1|0-0|A|drug
DDI-DrugBank.d285.s1|2-8|similar|drug
DDI-DrugBank.d285.s1|10-20|association|drug
DDI-DrugBank.d285.s1|21-21|,|drug
DDI-DrugBank.d285.s1|23-28|though|drug
DDI-DrugBank.d285.s1|30-33|less|drug
DDI-DrugBank.d285.s1|35-40|marked|drug
DDI-DrugBank.d285.s1|41-41|,|drug
DDI-DrugBank.d285.s1|43-45|has|drug
DDI-DrugBank.d285.s1|47-50|been|drug
DDI-DrugBank.d285.s1|52-60|suggested|drug
DDI-DrugBank.d285.s1|62-65|with|drug
DDI-DrugBank.d285.s1|67-78|barbiturates|drug
DDI-DrugBank.d285.s1|79-79|,|drug
DDI-DrugBank.d285.s1|81-95|phenyl-butazone|drug
DDI-DrugBank.d285.s1|96-96|,|drug
DDI-DrugBank.d285.s1|98-106|phenytoin|drug
DDI-DrugBank.d285.s1|108-113|sodium|drug
DDI-DrugBank.d285.s1|114-114|,|drug
DDI-DrugBank.d285.s1|116-128|carbamazepine|drug
DDI-DrugBank.d285.s1|130-132|and|drug
DDI-DrugBank.d285.s1|134-141|possibly|drug
DDI-DrugBank.d285.s1|143-146|with|drug
DDI-DrugBank.d285.s1|148-159|griseofulvin|drug
DDI-DrugBank.d285.s1|160-160|,|drug
DDI-DrugBank.d285.s1|162-171|ampicillin|drug
DDI-DrugBank.d285.s1|172-172|,|drug
DDI-DrugBank.d285.s1|174-176|and|drug
DDI-DrugBank.d285.s1|178-190|tetracyclines|drug
DDI-DrugBank.d285.s1|192-192|(|drug
DDI-DrugBank.d285.s1|193-194|72|drug
DDI-DrugBank.d285.s1|195-195|)|drug
DDI-DrugBank.d285.s2|0-0|.|drug
DDI-MedLine.d102.s0|0-8|Influence|drug
DDI-MedLine.d102.s0|10-11|of|drug
DDI-MedLine.d102.s0|13-21|estradiol|drug
DDI-MedLine.d102.s0|23-25|and|drug
DDI-MedLine.d102.s0|27-38|progesterone|drug
DDI-MedLine.d102.s0|40-41|on|drug
DDI-MedLine.d102.s0|43-45|the|drug
DDI-MedLine.d102.s0|47-57|sensitivity|drug
DDI-MedLine.d102.s0|59-60|of|drug
DDI-MedLine.d102.s0|62-64|rat|drug
DDI-MedLine.d102.s0|66-73|thoracic|drug
DDI-MedLine.d102.s0|75-79|aorta|drug
DDI-MedLine.d102.s0|81-82|to|drug
DDI-MedLine.d102.s0|84-96|noradrenaline|drug
DDI-MedLine.d102.s0|97-97|.|drug
DDI-MedLine.d102.s1|0-2|The|drug
DDI-MedLine.d102.s1|4-6|aim|drug
DDI-MedLine.d102.s1|8-9|of|drug
DDI-MedLine.d102.s1|11-14|this|drug
DDI-MedLine.d102.s1|16-20|study|drug
DDI-MedLine.d102.s1|22-24|was|drug
DDI-MedLine.d102.s1|26-27|to|drug
DDI-MedLine.d102.s1|29-39|investigate|drug
DDI-MedLine.d102.s1|41-43|the|drug
DDI-MedLine.d102.s1|45-51|effects|drug
DDI-MedLine.d102.s1|53-54|of|drug
DDI-MedLine.d102.s1|56-58|low|drug
DDI-MedLine.d102.s1|60-62|and|drug
DDI-MedLine.d102.s1|64-67|high|drug
DDI-MedLine.d102.s1|69-73|doses|drug
DDI-MedLine.d102.s1|75-76|of|drug
DDI-MedLine.d102.s1|78-86|estradiol|drug
DDI-MedLine.d102.s1|87-87|,|drug
DDI-MedLine.d102.s1|89-91|and|drug
DDI-MedLine.d102.s1|93-94|of|drug
DDI-MedLine.d102.s1|96-107|progesterone|drug
DDI-MedLine.d102.s1|109-110|on|drug
DDI-MedLine.d102.s1|112-114|the|drug
DDI-MedLine.d102.s1|116-123|response|drug
DDI-MedLine.d102.s1|125-126|to|drug
DDI-MedLine.d102.s1|128-140|noradrenaline|drug
DDI-MedLine.d102.s1|142-143|in|drug
DDI-MedLine.d102.s1|145-147|rat|drug
DDI-MedLine.d102.s1|149-156|thoracic|drug
DDI-MedLine.d102.s1|158-162|aorta|drug
DDI-MedLine.d102.s1|163-163|.|drug
DDI-MedLine.d102.s2|0-2|Two|drug
DDI-MedLine.d102.s2|4-8|weeks|drug
DDI-MedLine.d102.s2|10-14|after|drug
DDI-MedLine.d102.s2|16-24|bilateral|drug
DDI-MedLine.d102.s2|26-36|ovariectomy|drug
DDI-MedLine.d102.s2|37-37|,|drug
DDI-MedLine.d102.s2|39-44|female|drug
DDI-MedLine.d102.s2|46-49|rats|drug
DDI-MedLine.d102.s2|51-58|received|drug
DDI-MedLine.d102.s2|60-60|a|drug
DDI-MedLine.d102.s2|62-64|s.c|drug
DDI-MedLine.d102.s2|65-65|.|drug
DDI-MedLine.d102.s3|0-8|injection|drug
DDI-MedLine.d102.s3|10-11|of|drug
DDI-MedLine.d102.s3|13-19|vehicle|drug
DDI-MedLine.d102.s3|21-21|(|drug
DDI-MedLine.d102.s3|22-25|corn|drug
DDI-MedLine.d102.s3|27-29|oil|drug
DDI-MedLine.d102.s3|30-30|,|drug
DDI-MedLine.d102.s3|32-34|0.1|drug
DDI-MedLine.d102.s3|36-41|mL/day|drug
DDI-MedLine.d102.s3|42-42|)|drug
DDI-MedLine.d102.s3|43-43|,|drug
DDI-MedLine.d102.s3|45-53|estradiol|drug
DDI-MedLine.d102.s3|55-55|(|drug
DDI-MedLine.d102.s3|56-57|10|drug
DDI-MedLine.d102.s3|59-71|microg/kg/day|drug
DDI-MedLine.d102.s3|73-74|or|drug
DDI-MedLine.d102.s3|76-76|4|drug
DDI-MedLine.d102.s3|78-86|mg/kg/day|drug
DDI-MedLine.d102.s3|87-87|)|drug
DDI-MedLine.d102.s3|89-94|and/or|drug
DDI-MedLine.d102.s3|96-107|progesterone|drug
DDI-MedLine.d102.s3|109-109|(|drug
DDI-MedLine.d102.s3|110-111|20|drug
DDI-MedLine.d102.s3|113-121|mg/kg/day|drug
DDI-MedLine.d102.s3|122-122|)|drug
DDI-MedLine.d102.s3|123-123|,|drug
DDI-MedLine.d102.s3|125-127|for|drug
DDI-MedLine.d102.s3|129-133|eight|drug
DDI-MedLine.d102.s3|135-138|days|drug
DDI-MedLine.d102.s3|139-139|.|drug
DDI-MedLine.d102.s4|0-1|On|drug
DDI-MedLine.d102.s4|3-5|the|drug
DDI-MedLine.d102.s4|7-11|ninth|drug
DDI-MedLine.d102.s4|13-15|day|drug
DDI-MedLine.d102.s4|16-16|,|drug
DDI-MedLine.d102.s4|18-20|the|drug
DDI-MedLine.d102.s4|22-25|rats|drug
DDI-MedLine.d102.s4|27-30|were|drug
DDI-MedLine.d102.s4|32-41|sacrificed|drug
DDI-MedLine.d102.s4|43-45|and|drug
DDI-MedLine.d102.s4|47-52|aortic|drug
DDI-MedLine.d102.s4|54-58|rings|drug
DDI-MedLine.d102.s4|59-59|,|drug
DDI-MedLine.d102.s4|61-64|with|drug
DDI-MedLine.d102.s4|66-67|or|drug
DDI-MedLine.d102.s4|69-75|without|drug
DDI-MedLine.d102.s4|77-87|endothelium|drug
DDI-MedLine.d102.s4|88-88|,|drug
DDI-MedLine.d102.s4|90-93|were|drug
DDI-MedLine.d102.s4|95-98|used|drug
DDI-MedLine.d102.s4|100-101|to|drug
DDI-MedLine.d102.s4|103-110|generate|drug
DDI-MedLine.d102.s4|112-133|concentration-response|drug
DDI-MedLine.d102.s4|135-140|curves|drug
DDI-MedLine.d102.s4|142-143|to|drug
DDI-MedLine.d102.s4|145-157|noradrenaline|drug
DDI-MedLine.d102.s4|158-158|.|drug
DDI-MedLine.d102.s5|0-5|Aortic|drug
DDI-MedLine.d102.s5|7-11|rings|drug
DDI-MedLine.d102.s5|13-16|with|drug
DDI-MedLine.d102.s5|18-23|intact|drug
DDI-MedLine.d102.s5|25-35|endothelium|drug
DDI-MedLine.d102.s5|37-40|from|drug
DDI-MedLine.d102.s5|42-44|the|drug
DDI-MedLine.d102.s5|46-54|high-dose|drug
DDI-MedLine.d102.s5|56-56|(|drug
DDI-MedLine.d102.s5|57-57|4|drug
DDI-MedLine.d102.s5|59-67|mg/kg/day|drug
DDI-MedLine.d102.s5|68-68|)|drug
DDI-MedLine.d102.s5|70-78|estradiol|drug
DDI-MedLine.d102.s5|80-84|group|drug
DDI-MedLine.d102.s5|86-89|were|drug
DDI-MedLine.d102.s5|91-104|supersensitive|drug
DDI-MedLine.d102.s5|106-107|to|drug
DDI-MedLine.d102.s5|109-121|noradrenaline|drug
DDI-MedLine.d102.s5|123-130|compared|drug
DDI-MedLine.d102.s5|132-133|to|drug
DDI-MedLine.d102.s5|135-137|the|drug
DDI-MedLine.d102.s5|139-145|vehicle|drug
DDI-MedLine.d102.s5|147-148|or|drug
DDI-MedLine.d102.s5|150-157|low-dose|drug
DDI-MedLine.d102.s5|159-159|(|drug
DDI-MedLine.d102.s5|160-161|10|drug
DDI-MedLine.d102.s5|163-175|microg/kg/day|drug
DDI-MedLine.d102.s5|176-176|)|drug
DDI-MedLine.d102.s5|178-186|estradiol|drug
DDI-MedLine.d102.s5|188-193|groups|drug
DDI-MedLine.d102.s5|195-195|(|drug
DDI-MedLine.d102.s5|196-198|pD2|drug
DDI-MedLine.d102.s5|200-205|values|drug
DDI-MedLine.d102.s5|207-207|=|drug
DDI-MedLine.d102.s5|209-219|7.86+/-0.09|drug
DDI-MedLine.d102.s5|220-220|,|drug
DDI-MedLine.d102.s5|222-232|7.30+/-0.11|drug
DDI-MedLine.d102.s5|234-236|and|drug
DDI-MedLine.d102.s5|238-248|7.35+/-0.04|drug
DDI-MedLine.d102.s5|249-249|,|drug
DDI-MedLine.d102.s5|251-262|respectively|drug
DDI-MedLine.d102.s5|263-263|)|drug
DDI-MedLine.d102.s5|264-264|.|drug
DDI-MedLine.d102.s6|0-17|Endothelium-intact|drug
DDI-MedLine.d102.s6|19-24|aortic|drug
DDI-MedLine.d102.s6|26-30|rings|drug
DDI-MedLine.d102.s6|32-35|from|drug
DDI-MedLine.d102.s6|37-50|high-estradiol|drug
DDI-MedLine.d102.s6|52-55|rats|drug
DDI-MedLine.d102.s6|57-60|were|drug
DDI-MedLine.d102.s6|62-75|supersensitive|drug
DDI-MedLine.d102.s6|77-78|to|drug
DDI-MedLine.d102.s6|80-92|noradrenaline|drug
DDI-MedLine.d102.s6|94-97|when|drug
DDI-MedLine.d102.s6|99-106|compared|drug
DDI-MedLine.d102.s6|108-109|to|drug
DDI-MedLine.d102.s6|111-118|vehicle-|drug
DDI-MedLine.d102.s6|119-119|,|drug
DDI-MedLine.d102.s6|121-133|progesterone-|drug
DDI-MedLine.d102.s6|135-137|and|drug
DDI-MedLine.d102.s6|139-150|progesterone|drug
DDI-MedLine.d102.s6|152-152|+|drug
DDI-MedLine.d102.s6|154-175|high-estradiol-treated|drug
DDI-MedLine.d102.s6|177-180|rats|drug
DDI-MedLine.d102.s6|182-182|(|drug
DDI-MedLine.d102.s6|183-185|pD2|drug
DDI-MedLine.d102.s6|187-192|values|drug
DDI-MedLine.d102.s6|194-194|=|drug
DDI-MedLine.d102.s6|196-206|7.77+/-0.12|drug
DDI-MedLine.d102.s6|207-207|,|drug
DDI-MedLine.d102.s6|209-219|7.21+/-0.13|drug
DDI-MedLine.d102.s6|220-220|,|drug
DDI-MedLine.d102.s6|222-232|6.93+/-0.04|drug
DDI-MedLine.d102.s6|234-236|and|drug
DDI-MedLine.d102.s6|238-248|7.22+/-0.18|drug
DDI-MedLine.d102.s6|249-249|,|drug
DDI-MedLine.d102.s6|251-262|respectively|drug
DDI-MedLine.d102.s6|263-263|)|drug
DDI-MedLine.d102.s6|264-264|.|drug
DDI-MedLine.d102.s7|0-4|There|drug
DDI-MedLine.d102.s7|6-9|were|drug
DDI-MedLine.d102.s7|11-12|no|drug
DDI-MedLine.d102.s7|14-24|significant|drug
DDI-MedLine.d102.s7|26-36|differences|drug
DDI-MedLine.d102.s7|38-42|among|drug
DDI-MedLine.d102.s7|44-46|the|drug
DDI-MedLine.d102.s7|48-50|pD2|drug
DDI-MedLine.d102.s7|52-57|values|drug
DDI-MedLine.d102.s7|59-61|for|drug
DDI-MedLine.d102.s7|63-75|noradrenaline|drug
DDI-MedLine.d102.s7|77-78|in|drug
DDI-MedLine.d102.s7|80-85|aortic|drug
DDI-MedLine.d102.s7|87-91|rings|drug
DDI-MedLine.d102.s7|93-99|without|drug
DDI-MedLine.d102.s7|101-111|endothelium|drug
DDI-MedLine.d102.s7|112-112|.|drug
DDI-MedLine.d102.s8|0-3|Both|drug
DDI-MedLine.d102.s8|5-6|of|drug
DDI-MedLine.d102.s8|8-12|these|drug
DDI-MedLine.d102.s8|14-20|effects|drug
DDI-MedLine.d102.s8|22-25|were|drug
DDI-MedLine.d102.s8|27-47|endothelium-dependent|drug
DDI-MedLine.d102.s8|48-48|.|drug
DDI-DrugBank.d544.s0|0-1|No|drug
DDI-DrugBank.d544.s0|3-6|dose|drug
DDI-DrugBank.d544.s0|8-17|adjustment|drug
DDI-DrugBank.d544.s0|19-20|is|drug
DDI-DrugBank.d544.s0|22-30|necessary|drug
DDI-DrugBank.d544.s0|32-35|when|drug
DDI-DrugBank.d544.s0|37-44|Simulect|drug
DDI-DrugBank.d544.s0|46-47|is|drug
DDI-DrugBank.d544.s0|49-53|added|drug
DDI-DrugBank.d544.s0|55-56|to|drug
DDI-DrugBank.d544.s0|58-81|triple-immunosuppression|drug
DDI-DrugBank.d544.s0|83-90|regimens|drug
DDI-DrugBank.d544.s0|92-100|including|drug
DDI-DrugBank.d544.s0|102-113|cyclosporine|drug
DDI-DrugBank.d544.s0|114-114|,|drug
DDI-DrugBank.d544.s0|116-130|corticosteroids|drug
DDI-DrugBank.d544.s0|131-131|,|drug
DDI-DrugBank.d544.s0|133-135|and|drug
DDI-DrugBank.d544.s0|137-142|either|drug
DDI-DrugBank.d544.s0|144-155|azathioprine|drug
DDI-DrugBank.d544.s0|157-158|or|drug
DDI-DrugBank.d544.s0|160-172|mycophenolate|drug
DDI-DrugBank.d544.s0|174-180|mofetil|drug
DDI-DrugBank.d544.s0|181-181|.|drug
DDI-DrugBank.d544.s1|0-4|Three|drug
DDI-DrugBank.d544.s1|6-13|clinical|drug
DDI-DrugBank.d544.s1|15-20|trials|drug
DDI-DrugBank.d544.s1|22-25|have|drug
DDI-DrugBank.d544.s1|27-38|investigated|drug
DDI-DrugBank.d544.s1|40-47|Simulect|drug
DDI-DrugBank.d544.s1|49-51|use|drug
DDI-DrugBank.d544.s1|53-54|in|drug
DDI-DrugBank.d544.s1|56-66|combination|drug
DDI-DrugBank.d544.s1|68-71|with|drug
DDI-DrugBank.d544.s1|73-86|triple-therapy|drug
DDI-DrugBank.d544.s1|88-95|regimens|drug
DDI-DrugBank.d544.s1|96-96|.|drug
DDI-DrugBank.d544.s2|0-15|Pharmacokinetics|drug
DDI-DrugBank.d544.s2|17-20|were|drug
DDI-DrugBank.d544.s2|22-29|assessed|drug
DDI-DrugBank.d544.s2|31-32|in|drug
DDI-DrugBank.d544.s2|34-36|two|drug
DDI-DrugBank.d544.s2|38-39|of|drug
DDI-DrugBank.d544.s2|41-45|these|drug
DDI-DrugBank.d544.s2|47-52|trials|drug
DDI-DrugBank.d544.s2|53-53|.|drug
DDI-DrugBank.d544.s3|0-4|Total|drug
DDI-DrugBank.d544.s3|6-9|body|drug
DDI-DrugBank.d544.s3|11-19|clearance|drug
DDI-DrugBank.d544.s3|21-22|of|drug
DDI-DrugBank.d544.s3|24-31|Simulect|drug
DDI-DrugBank.d544.s3|33-35|was|drug
DDI-DrugBank.d544.s3|37-43|reduced|drug
DDI-DrugBank.d544.s3|45-46|by|drug
DDI-DrugBank.d544.s3|48-49|an|drug
DDI-DrugBank.d544.s3|51-57|average|drug
DDI-DrugBank.d544.s3|59-60|22|drug
DDI-DrugBank.d544.s3|61-61|%|drug
DDI-DrugBank.d544.s3|63-65|and|drug
DDI-DrugBank.d544.s3|67-68|51|drug
DDI-DrugBank.d544.s3|69-69|%|drug
DDI-DrugBank.d544.s3|71-74|when|drug
DDI-DrugBank.d544.s3|76-87|azathioprine|drug
DDI-DrugBank.d544.s3|89-91|and|drug
DDI-DrugBank.d544.s3|93-105|mycophenolate|drug
DDI-DrugBank.d544.s3|107-113|mofetil|drug
DDI-DrugBank.d544.s3|114-114|,|drug
DDI-DrugBank.d544.s3|116-127|respectively|drug
DDI-DrugBank.d544.s3|128-128|,|drug
DDI-DrugBank.d544.s3|130-133|were|drug
DDI-DrugBank.d544.s3|135-139|added|drug
DDI-DrugBank.d544.s3|141-142|to|drug
DDI-DrugBank.d544.s3|144-144|a|drug
DDI-DrugBank.d544.s3|146-152|regimen|drug
DDI-DrugBank.d544.s3|154-163|consisting|drug
DDI-DrugBank.d544.s3|165-166|of|drug
DDI-DrugBank.d544.s3|168-179|cyclosporine|drug
DDI-DrugBank.d544.s3|180-180|,|drug
DDI-DrugBank.d544.s3|182-184|USP|drug
DDI-DrugBank.d544.s3|186-186|(|drug
DDI-DrugBank.d544.s3|187-194|MODIFIED|drug
DDI-DrugBank.d544.s3|195-195|)|drug
DDI-DrugBank.d544.s3|197-199|and|drug
DDI-DrugBank.d544.s3|201-215|corticosteroids|drug
DDI-DrugBank.d544.s3|216-216|.|drug
DDI-DrugBank.d544.s4|0-10|Nonetheless|drug
DDI-DrugBank.d544.s4|11-11|,|drug
DDI-DrugBank.d544.s4|13-15|the|drug
DDI-DrugBank.d544.s4|17-21|range|drug
DDI-DrugBank.d544.s4|23-24|of|drug
DDI-DrugBank.d544.s4|26-35|individual|drug
DDI-DrugBank.d544.s4|37-44|Simulect|drug
DDI-DrugBank.d544.s4|46-54|clearance|drug
DDI-DrugBank.d544.s4|56-61|values|drug
DDI-DrugBank.d544.s4|63-64|in|drug
DDI-DrugBank.d544.s4|66-68|the|drug
DDI-DrugBank.d544.s4|70-77|presence|drug
DDI-DrugBank.d544.s4|79-80|of|drug
DDI-DrugBank.d544.s4|82-93|azathioprine|drug
DDI-DrugBank.d544.s4|95-95|(|drug
DDI-DrugBank.d544.s4|96-100|12-57|drug
DDI-DrugBank.d544.s4|102-105|mL/h|drug
DDI-DrugBank.d544.s4|106-106|)|drug
DDI-DrugBank.d544.s4|108-109|or|drug
DDI-DrugBank.d544.s4|111-123|mycophenolate|drug
DDI-DrugBank.d544.s4|125-131|mofetil|drug
DDI-DrugBank.d544.s4|133-133|(|drug
DDI-DrugBank.d544.s4|134-137|7-54|drug
DDI-DrugBank.d544.s4|139-142|mL/h|drug
DDI-DrugBank.d544.s4|143-143|)|drug
DDI-DrugBank.d544.s4|145-147|did|drug
DDI-DrugBank.d544.s4|149-151|not|drug
DDI-DrugBank.d544.s4|153-158|extend|drug
DDI-DrugBank.d544.s4|160-166|outside|drug
DDI-DrugBank.d544.s4|168-170|the|drug
DDI-DrugBank.d544.s4|172-176|range|drug
DDI-DrugBank.d544.s4|178-185|observed|drug
DDI-DrugBank.d544.s4|187-190|with|drug
DDI-DrugBank.d544.s4|192-195|dual|drug
DDI-DrugBank.d544.s4|197-203|therapy|drug
DDI-DrugBank.d544.s4|205-205|(|drug
DDI-DrugBank.d544.s4|206-210|10-78|drug
DDI-DrugBank.d544.s4|212-215|mL/h|drug
DDI-DrugBank.d544.s4|216-216|)|drug
DDI-DrugBank.d544.s4|217-217|.|drug
DDI-DrugBank.d544.s5|0-2|The|drug
DDI-DrugBank.d544.s5|4-12|following|drug
DDI-DrugBank.d544.s5|14-24|medications|drug
DDI-DrugBank.d544.s5|26-29|have|drug
DDI-DrugBank.d544.s5|31-34|been|drug
DDI-DrugBank.d544.s5|36-47|administered|drug
DDI-DrugBank.d544.s5|49-50|in|drug
DDI-DrugBank.d544.s5|52-59|clinical|drug
DDI-DrugBank.d544.s5|61-66|trials|drug
DDI-DrugBank.d544.s5|68-71|with|drug
DDI-DrugBank.d544.s5|73-80|Simulect|drug
DDI-DrugBank.d544.s5|82-85|with|drug
DDI-DrugBank.d544.s5|87-88|no|drug
DDI-DrugBank.d544.s5|90-97|increase|drug
DDI-DrugBank.d544.s5|99-100|in|drug
DDI-DrugBank.d544.s5|102-108|adverse|drug
DDI-DrugBank.d544.s5|110-118|reactions|drug
DDI-DrugBank.d544.s5|119-119|:|drug
DDI-DrugBank.d544.s5|121-127|ATG/ALG|drug
DDI-DrugBank.d544.s5|128-128|,|drug
DDI-DrugBank.d544.s5|130-141|azathioprine|drug
DDI-DrugBank.d544.s5|142-142|,|drug
DDI-DrugBank.d544.s5|144-158|corticosteroids|drug
DDI-DrugBank.d544.s5|159-159|,|drug
DDI-DrugBank.d544.s5|161-172|cyclosporine|drug
DDI-DrugBank.d544.s5|173-173|,|drug
DDI-DrugBank.d544.s5|175-187|mycophenolate|drug
DDI-DrugBank.d544.s5|189-195|mofetil|drug
DDI-DrugBank.d544.s5|196-196|,|drug
DDI-DrugBank.d544.s5|198-200|and|drug
DDI-DrugBank.d544.s5|202-214|muromonab-CD3|drug
DDI-DrugBank.d544.s5|215-215|.|drug
DDI-DrugBank.d264.s0|0-1|No|drug
DDI-DrugBank.d264.s0|3-13|Information|drug
DDI-DrugBank.d264.s0|15-22|Provided|drug
DDI-MedLine.d111.s0|0-5|Effect|drug
DDI-MedLine.d111.s0|7-8|of|drug
DDI-MedLine.d111.s0|10-23|coadministered|drug
DDI-MedLine.d111.s0|25-29|drugs|drug
DDI-MedLine.d111.s0|31-33|and|drug
DDI-MedLine.d111.s0|35-41|ethanol|drug
DDI-MedLine.d111.s0|43-44|on|drug
DDI-MedLine.d111.s0|46-48|the|drug
DDI-MedLine.d111.s0|50-56|binding|drug
DDI-MedLine.d111.s0|58-59|of|drug
DDI-MedLine.d111.s0|61-71|therapeutic|drug
DDI-MedLine.d111.s0|73-77|drugs|drug
DDI-MedLine.d111.s0|79-80|to|drug
DDI-MedLine.d111.s0|82-86|human|drug
DDI-MedLine.d111.s0|88-92|serum|drug
DDI-MedLine.d111.s0|94-95|in|drug
DDI-MedLine.d111.s0|97-101|vitro|drug
DDI-MedLine.d111.s0|102-102|.|drug
DDI-MedLine.d111.s1|0-2|The|drug
DDI-MedLine.d111.s1|4-10|effects|drug
DDI-MedLine.d111.s1|12-13|of|drug
DDI-MedLine.d111.s1|15-28|coadministered|drug
DDI-MedLine.d111.s1|30-34|drugs|drug
DDI-MedLine.d111.s1|36-38|and|drug
DDI-MedLine.d111.s1|40-46|ethanol|drug
DDI-MedLine.d111.s1|48-49|on|drug
DDI-MedLine.d111.s1|51-53|the|drug
DDI-MedLine.d111.s1|55-61|binding|drug
DDI-MedLine.d111.s1|63-64|of|drug
DDI-MedLine.d111.s1|66-76|therapeutic|drug
DDI-MedLine.d111.s1|78-82|drugs|drug
DDI-MedLine.d111.s1|84-85|to|drug
DDI-MedLine.d111.s1|87-91|human|drug
DDI-MedLine.d111.s1|93-97|serum|drug
DDI-MedLine.d111.s1|99-100|in|drug
DDI-MedLine.d111.s1|102-106|vitro|drug
DDI-MedLine.d111.s1|108-110|was|drug
DDI-MedLine.d111.s1|112-123|investigated|drug
DDI-MedLine.d111.s1|124-124|.|drug
DDI-MedLine.d111.s2|0-12|Acetaminophen|drug
DDI-MedLine.d111.s2|13-13|,|drug
DDI-MedLine.d111.s2|15-23|lidocaine|drug
DDI-MedLine.d111.s2|24-24|,|drug
DDI-MedLine.d111.s2|26-38|phenobarbital|drug
DDI-MedLine.d111.s2|39-39|,|drug
DDI-MedLine.d111.s2|41-49|quinidine|drug
DDI-MedLine.d111.s2|50-50|,|drug
DDI-MedLine.d111.s2|52-63|theophylline|drug
DDI-MedLine.d111.s2|64-64|,|drug
DDI-MedLine.d111.s2|66-68|and|drug
DDI-MedLine.d111.s2|70-77|valproic|drug
DDI-MedLine.d111.s2|79-82|acid|drug
DDI-MedLine.d111.s2|84-87|were|drug
DDI-MedLine.d111.s2|89-93|added|drug
DDI-MedLine.d111.s2|95-96|to|drug
DDI-MedLine.d111.s2|98-103|pooled|drug
DDI-MedLine.d111.s2|105-109|human|drug
DDI-MedLine.d111.s2|111-115|serum|drug
DDI-MedLine.d111.s2|117-118|at|drug
DDI-MedLine.d111.s2|120-130|therapeutic|drug
DDI-MedLine.d111.s2|132-145|concentrations|drug
DDI-MedLine.d111.s2|146-146|.|drug
DDI-MedLine.d111.s3|0-1|To|drug
DDI-MedLine.d111.s3|3-6|each|drug
DDI-MedLine.d111.s3|8-18|preparation|drug
DDI-MedLine.d111.s3|20-22|was|drug
DDI-MedLine.d111.s3|24-28|added|drug
DDI-MedLine.d111.s3|30-32|one|drug
DDI-MedLine.d111.s3|34-43|additional|drug
DDI-MedLine.d111.s3|45-48|drug|drug
DDI-MedLine.d111.s3|50-51|at|drug
DDI-MedLine.d111.s3|53-57|three|drug
DDI-MedLine.d111.s3|59-72|concentrations|drug
DDI-MedLine.d111.s3|74-80|ranging|drug
DDI-MedLine.d111.s3|82-85|from|drug
DDI-MedLine.d111.s3|87-97|therapeutic|drug
DDI-MedLine.d111.s3|99-100|to|drug
DDI-MedLine.d111.s3|102-106|toxic|drug
DDI-MedLine.d111.s3|107-107|.|drug
DDI-MedLine.d111.s4|0-2|The|drug
DDI-MedLine.d111.s4|4-12|following|drug
DDI-MedLine.d111.s4|14-18|eight|drug
DDI-MedLine.d111.s4|20-25|target|drug
DDI-MedLine.d111.s4|27-36|drug/added|drug
DDI-MedLine.d111.s4|38-41|drug|drug
DDI-MedLine.d111.s4|43-54|combinations|drug
DDI-MedLine.d111.s4|56-59|were|drug
DDI-MedLine.d111.s4|61-67|studied|drug
DDI-MedLine.d111.s4|68-68|:|drug
DDI-MedLine.d111.s4|70-96|acetaminophen/phenobarbital|drug
DDI-MedLine.d111.s4|97-97|.|drug
DDI-MedLine.d111.s5|0-25|acetaminophen/theophylline|drug
DDI-MedLine.d111.s5|26-26|,|drug
DDI-MedLine.d111.s5|28-46|lidocaine/quinidine|drug
DDI-MedLine.d111.s5|47-47|,|drug
DDI-MedLine.d111.s5|49-75|phenobarbital/acetaminophen|drug
DDI-MedLine.d111.s5|76-76|,|drug
DDI-MedLine.d111.s5|78-99|phenobarbital/valproic|drug
DDI-MedLine.d111.s5|101-104|acid|drug
DDI-MedLine.d111.s5|105-105|,|drug
DDI-MedLine.d111.s5|107-125|quinidine/lidocaine|drug
DDI-MedLine.d111.s5|126-126|,|drug
DDI-MedLine.d111.s5|128-153|theophylline/acetaminophen|drug
DDI-MedLine.d111.s5|154-154|,|drug
DDI-MedLine.d111.s5|156-158|and|drug
DDI-MedLine.d111.s5|160-167|valproic|drug
DDI-MedLine.d111.s5|169-186|acid/phenobarbital|drug
DDI-MedLine.d111.s5|187-187|.|drug
DDI-MedLine.d111.s6|0-3|Each|drug
DDI-MedLine.d111.s6|5-9|serum|drug
DDI-MedLine.d111.s6|11-17|without|drug
DDI-MedLine.d111.s6|19-21|the|drug
DDI-MedLine.d111.s6|23-27|other|drug
DDI-MedLine.d111.s6|29-33|added|drug
DDI-MedLine.d111.s6|35-38|drug|drug
DDI-MedLine.d111.s6|40-41|as|drug
DDI-MedLine.d111.s6|43-46|well|drug
DDI-MedLine.d111.s6|48-49|as|drug
DDI-MedLine.d111.s6|51-53|the|drug
DDI-MedLine.d111.s6|55-59|serum|drug
DDI-MedLine.d111.s6|61-72|supplemented|drug
DDI-MedLine.d111.s6|74-77|with|drug
DDI-MedLine.d111.s6|79-81|the|drug
DDI-MedLine.d111.s6|83-87|other|drug
DDI-MedLine.d111.s6|89-92|drug|drug
DDI-MedLine.d111.s6|94-95|at|drug
DDI-MedLine.d111.s6|97-99|the|drug
DDI-MedLine.d111.s6|101-105|three|drug
DDI-MedLine.d111.s6|107-120|concentrations|drug
DDI-MedLine.d111.s6|122-124|was|drug
DDI-MedLine.d111.s6|126-133|dialyzed|drug
DDI-MedLine.d111.s6|135-141|against|drug
DDI-MedLine.d111.s6|143-151|phosphate|drug
DDI-MedLine.d111.s6|153-158|buffer|drug
DDI-MedLine.d111.s6|159-159|.|drug
DDI-MedLine.d111.s7|0-8|Similarly|drug
DDI-MedLine.d111.s7|10-17|dialyzed|drug
DDI-MedLine.d111.s7|19-22|were|drug
DDI-MedLine.d111.s7|24-36|phenobarbital|drug
DDI-MedLine.d111.s7|37-37|,|drug
DDI-MedLine.d111.s7|39-47|quinidine|drug
DDI-MedLine.d111.s7|48-48|,|drug
DDI-MedLine.d111.s7|50-52|and|drug
DDI-MedLine.d111.s7|54-65|theophylline|drug
DDI-MedLine.d111.s7|66-66|,|drug
DDI-MedLine.d111.s7|68-71|both|drug
DDI-MedLine.d111.s7|73-77|alone|drug
DDI-MedLine.d111.s7|79-80|at|drug
DDI-MedLine.d111.s7|82-92|therapeutic|drug
DDI-MedLine.d111.s7|94-107|concentrations|drug
DDI-MedLine.d111.s7|109-110|in|drug
DDI-MedLine.d111.s7|112-116|serum|drug
DDI-MedLine.d111.s7|118-120|and|drug
DDI-MedLine.d111.s7|122-125|with|drug
DDI-MedLine.d111.s7|127-133|ethanol|drug
DDI-MedLine.d111.s7|135-136|at|drug
DDI-MedLine.d111.s7|138-142|three|drug
DDI-MedLine.d111.s7|144-152|different|drug
DDI-MedLine.d111.s7|154-167|concentrations|drug
DDI-MedLine.d111.s7|169-170|in|drug
DDI-MedLine.d111.s7|172-176|serum|drug
DDI-MedLine.d111.s7|177-177|.|drug
DDI-MedLine.d111.s8|0-2|The|drug
DDI-MedLine.d111.s8|4-13|percentage|drug
DDI-MedLine.d111.s8|15-16|of|drug
DDI-MedLine.d111.s8|18-21|drug|drug
DDI-MedLine.d111.s8|23-29|binding|drug
DDI-MedLine.d111.s8|31-32|in|drug
DDI-MedLine.d111.s8|34-37|each|drug
DDI-MedLine.d111.s8|39-49|preparation|drug
DDI-MedLine.d111.s8|51-53|was|drug
DDI-MedLine.d111.s8|55-64|calculated|drug
DDI-MedLine.d111.s8|65-65|.|drug
DDI-MedLine.d111.s9|0-12|Acetaminophen|drug
DDI-MedLine.d111.s9|14-23|diminished|drug
DDI-MedLine.d111.s9|25-27|the|drug
DDI-MedLine.d111.s9|29-35|binding|drug
DDI-MedLine.d111.s9|37-38|of|drug
DDI-MedLine.d111.s9|40-51|theophylline|drug
DDI-MedLine.d111.s9|53-54|to|drug
DDI-MedLine.d111.s9|56-60|human|drug
DDI-MedLine.d111.s9|62-66|serum|drug
DDI-MedLine.d111.s9|68-69|by|drug
DDI-MedLine.d111.s9|71-71|a|drug
DDI-MedLine.d111.s9|73-75|net|drug
DDI-MedLine.d111.s9|77-82|change|drug
DDI-MedLine.d111.s9|84-85|of|drug
DDI-MedLine.d111.s9|87-89|5.7|drug
DDI-MedLine.d111.s9|90-90|%|drug
DDI-MedLine.d111.s9|92-92|(|drug
DDI-MedLine.d111.s9|93-102|percentage|drug
DDI-MedLine.d111.s9|104-111|increase|drug
DDI-MedLine.d111.s9|113-114|in|drug
DDI-MedLine.d111.s9|116-119|free|drug
DDI-MedLine.d111.s9|121-124|drug|drug
DDI-MedLine.d111.s9|126-133|fraction|drug
DDI-MedLine.d111.s9|135-135|[|drug
DDI-MedLine.d111.s9|136-138|FDF|drug
DDI-MedLine.d111.s9|139-139|]|drug
DDI-MedLine.d111.s9|140-140|,|drug
DDI-MedLine.d111.s9|142-145|11.0|drug
DDI-MedLine.d111.s9|146-146|%|drug
DDI-MedLine.d111.s9|147-147|)|drug
DDI-MedLine.d111.s9|149-150|at|drug
DDI-MedLine.d111.s9|152-154|662|drug
DDI-MedLine.d111.s9|156-165|micromol/L|drug
DDI-MedLine.d111.s9|167-169|and|drug
DDI-MedLine.d111.s9|171-172|by|drug
DDI-MedLine.d111.s9|174-174|a|drug
DDI-MedLine.d111.s9|176-178|net|drug
DDI-MedLine.d111.s9|180-185|change|drug
DDI-MedLine.d111.s9|187-188|of|drug
DDI-MedLine.d111.s9|190-192|7.1|drug
DDI-MedLine.d111.s9|193-193|%|drug
DDI-MedLine.d111.s9|195-195|(|drug
DDI-MedLine.d111.s9|196-205|percentage|drug
DDI-MedLine.d111.s9|207-214|increase|drug
DDI-MedLine.d111.s9|216-217|in|drug
DDI-MedLine.d111.s9|219-221|FDF|drug
DDI-MedLine.d111.s9|222-222|,|drug
DDI-MedLine.d111.s9|224-227|13.7|drug
DDI-MedLine.d111.s9|228-228|%|drug
DDI-MedLine.d111.s9|229-229|)|drug
DDI-MedLine.d111.s9|231-232|at|drug
DDI-MedLine.d111.s9|234-237|1324|drug
DDI-MedLine.d111.s9|239-248|micromol/L|drug
DDI-MedLine.d111.s9|249-249|.|drug
DDI-MedLine.d111.s10|0-11|Theophylline|drug
DDI-MedLine.d111.s10|13-21|decreased|drug
DDI-MedLine.d111.s10|23-25|the|drug
DDI-MedLine.d111.s10|27-33|binding|drug
DDI-MedLine.d111.s10|35-36|of|drug
DDI-MedLine.d111.s10|38-50|acetaminophen|drug
DDI-MedLine.d111.s10|52-53|by|drug
DDI-MedLine.d111.s10|55-55|a|drug
DDI-MedLine.d111.s10|57-59|net|drug
DDI-MedLine.d111.s10|61-66|change|drug
DDI-MedLine.d111.s10|68-69|of|drug
DDI-MedLine.d111.s10|71-73|6.8|drug
DDI-MedLine.d111.s10|74-74|%|drug
DDI-MedLine.d111.s10|76-76|(|drug
DDI-MedLine.d111.s10|77-86|percentage|drug
DDI-MedLine.d111.s10|88-95|increase|drug
DDI-MedLine.d111.s10|97-98|in|drug
DDI-MedLine.d111.s10|100-102|FDF|drug
DDI-MedLine.d111.s10|103-103|,|drug
DDI-MedLine.d111.s10|105-107|8.8|drug
DDI-MedLine.d111.s10|108-108|%|drug
DDI-MedLine.d111.s10|109-109|)|drug
DDI-MedLine.d111.s10|111-112|at|drug
DDI-MedLine.d111.s10|114-118|277.5|drug
DDI-MedLine.d111.s10|120-129|micromol/L|drug
DDI-MedLine.d111.s10|130-130|;|drug
DDI-MedLine.d111.s11|0-12|phenobarbital|drug
DDI-MedLine.d111.s11|14-20|reduced|drug
DDI-MedLine.d111.s11|22-23|it|drug
DDI-MedLine.d111.s11|25-26|by|drug
DDI-MedLine.d111.s11|28-28|a|drug
DDI-MedLine.d111.s11|30-32|net|drug
DDI-MedLine.d111.s11|34-39|change|drug
DDI-MedLine.d111.s11|41-42|of|drug
DDI-MedLine.d111.s11|44-46|6.6|drug
DDI-MedLine.d111.s11|47-47|%|drug
DDI-MedLine.d111.s11|49-49|(|drug
DDI-MedLine.d111.s11|50-59|percentage|drug
DDI-MedLine.d111.s11|61-68|increase|drug
DDI-MedLine.d111.s11|70-71|in|drug
DDI-MedLine.d111.s11|73-75|FDF|drug
DDI-MedLine.d111.s11|76-76|,|drug
DDI-MedLine.d111.s11|78-80|8.5|drug
DDI-MedLine.d111.s11|81-81|%|drug
DDI-MedLine.d111.s11|82-82|)|drug
DDI-MedLine.d111.s11|84-85|at|drug
DDI-MedLine.d111.s11|87-89|431|drug
DDI-MedLine.d111.s11|91-100|micromol/L|drug
DDI-MedLine.d111.s11|101-101|.|drug
DDI-MedLine.d111.s12|0-7|Valproic|drug
DDI-MedLine.d111.s12|9-12|acid|drug
DDI-MedLine.d111.s12|14-23|diminished|drug
DDI-MedLine.d111.s12|25-31|binding|drug
DDI-MedLine.d111.s12|33-34|of|drug
DDI-MedLine.d111.s12|36-48|phenobarbital|drug
DDI-MedLine.d111.s12|50-51|by|drug
DDI-MedLine.d111.s12|53-53|a|drug
DDI-MedLine.d111.s12|55-57|net|drug
DDI-MedLine.d111.s12|59-64|change|drug
DDI-MedLine.d111.s12|66-67|of|drug
DDI-MedLine.d111.s12|69-71|9.9|drug
DDI-MedLine.d111.s12|72-72|%|drug
DDI-MedLine.d111.s12|74-74|(|drug
DDI-MedLine.d111.s12|75-84|percentage|drug
DDI-MedLine.d111.s12|86-93|increase|drug
DDI-MedLine.d111.s12|95-96|in|drug
DDI-MedLine.d111.s12|98-100|FDF|drug
DDI-MedLine.d111.s12|101-101|,|drug
DDI-MedLine.d111.s12|103-106|21.2|drug
DDI-MedLine.d111.s12|107-107|%|drug
DDI-MedLine.d111.s12|108-108|)|drug
DDI-MedLine.d111.s12|110-111|at|drug
DDI-MedLine.d111.s12|113-116|1732|drug
DDI-MedLine.d111.s12|118-127|micromol/L|drug
DDI-MedLine.d111.s12|128-128|.|drug
DDI-MedLine.d111.s13|0-1|No|drug
DDI-MedLine.d111.s13|3-13|significant|drug
DDI-MedLine.d111.s13|15-21|effects|drug
DDI-MedLine.d111.s13|23-26|were|drug
DDI-MedLine.d111.s13|28-32|noted|drug
DDI-MedLine.d111.s13|34-37|with|drug
DDI-MedLine.d111.s13|39-43|other|drug
DDI-MedLine.d111.s13|45-48|drug|drug
DDI-MedLine.d111.s13|50-61|combinations|drug
DDI-MedLine.d111.s13|63-64|or|drug
DDI-MedLine.d111.s13|66-69|with|drug
DDI-MedLine.d111.s13|71-73|the|drug
DDI-MedLine.d111.s13|75-82|addition|drug
DDI-MedLine.d111.s13|84-85|of|drug
DDI-MedLine.d111.s13|87-93|ethanol|drug
DDI-MedLine.d111.s13|94-94|.|drug
DDI-MedLine.d111.s14|0-10|Coingestion|drug
DDI-MedLine.d111.s14|12-13|of|drug
DDI-MedLine.d111.s14|15-27|acetaminophen|drug
DDI-MedLine.d111.s14|29-32|with|drug
DDI-MedLine.d111.s14|34-45|theophylline|drug
DDI-MedLine.d111.s14|46-46|,|drug
DDI-MedLine.d111.s14|48-60|phenobarbital|drug
DDI-MedLine.d111.s14|62-65|with|drug
DDI-MedLine.d111.s14|67-79|acetaminophen|drug
DDI-MedLine.d111.s14|80-80|,|drug
DDI-MedLine.d111.s14|82-84|and|drug
DDI-MedLine.d111.s14|86-93|valproic|drug
DDI-MedLine.d111.s14|95-98|acid|drug
DDI-MedLine.d111.s14|100-103|with|drug
DDI-MedLine.d111.s14|105-117|phenobarbital|drug
DDI-MedLine.d111.s14|119-120|at|drug
DDI-MedLine.d111.s14|122-125|high|drug
DDI-MedLine.d111.s14|127-128|to|drug
DDI-MedLine.d111.s14|130-134|toxic|drug
DDI-MedLine.d111.s14|136-149|concentrations|drug
DDI-MedLine.d111.s14|151-159|decreases|drug
DDI-MedLine.d111.s14|161-163|the|drug
DDI-MedLine.d111.s14|165-171|binding|drug
DDI-MedLine.d111.s14|173-174|of|drug
DDI-MedLine.d111.s14|176-178|the|drug
DDI-MedLine.d111.s14|180-185|target|drug
DDI-MedLine.d111.s14|187-190|drug|drug
DDI-MedLine.d111.s14|191-191|.|drug
DDI-MedLine.d111.s15|0-2|The|drug
DDI-MedLine.d111.s15|4-12|resulting|drug
DDI-MedLine.d111.s15|14-21|increase|drug
DDI-MedLine.d111.s15|23-24|in|drug
DDI-MedLine.d111.s15|26-29|free|drug
DDI-MedLine.d111.s15|31-34|drug|drug
DDI-MedLine.d111.s15|36-48|concentration|drug
DDI-MedLine.d111.s15|50-52|may|drug
DDI-MedLine.d111.s15|54-57|lead|drug
DDI-MedLine.d111.s15|59-60|to|drug
DDI-MedLine.d111.s15|62-69|enhanced|drug
DDI-MedLine.d111.s15|71-74|drug|drug
DDI-MedLine.d111.s15|76-81|effect|drug
DDI-MedLine.d111.s15|83-84|in|drug
DDI-MedLine.d111.s15|86-89|vivo|drug
DDI-MedLine.d111.s15|90-90|.|drug
DDI-DrugBank.d322.s0|0-9|Amantadine|drug
DDI-DrugBank.d322.s0|10-10|,|drug
DDI-DrugBank.d322.s0|12-20|tricyclic|drug
DDI-DrugBank.d322.s0|22-36|antidepressants|drug
DDI-DrugBank.d322.s0|37-37|,|drug
DDI-DrugBank.d322.s0|39-41|and|drug
DDI-DrugBank.d322.s0|43-47|MAOIs|drug
DDI-DrugBank.d322.s0|49-51|may|drug
DDI-DrugBank.d322.s0|53-60|increase|drug
DDI-DrugBank.d322.s0|62-76|anticholinergic|drug
DDI-DrugBank.d322.s0|78-83|effect|drug
DDI-DrugBank.d322.s0|85-86|of|drug
DDI-DrugBank.d322.s0|88-96|clidinium|drug
DDI-DrugBank.d322.s0|97-97|.|drug
DDI-DrugBank.d322.s1|0-8|Clidinium|drug
DDI-DrugBank.d322.s1|10-12|may|drug
DDI-DrugBank.d322.s1|14-21|decrease|drug
DDI-DrugBank.d322.s1|23-25|the|drug
DDI-DrugBank.d322.s1|27-32|effect|drug
DDI-DrugBank.d322.s1|34-35|of|drug
DDI-DrugBank.d322.s1|37-50|phenothiazines|drug
DDI-DrugBank.d322.s1|51-51|,|drug
DDI-DrugBank.d322.s1|53-60|levodopa|drug
DDI-DrugBank.d322.s1|61-61|,|drug
DDI-DrugBank.d322.s1|63-65|and|drug
DDI-DrugBank.d322.s1|67-78|ketoconazole|drug
DDI-DrugBank.d322.s1|79-79|.|drug
DDI-DrugBank.d204.s0|0-3|When|drug
DDI-DrugBank.d204.s0|5-16|administered|drug
DDI-DrugBank.d204.s0|18-29|concurrently|drug
DDI-DrugBank.d204.s0|30-30|,|drug
DDI-DrugBank.d204.s0|32-34|the|drug
DDI-DrugBank.d204.s0|36-44|following|drug
DDI-DrugBank.d204.s0|46-50|drugs|drug
DDI-DrugBank.d204.s0|52-54|may|drug
DDI-DrugBank.d204.s0|56-63|interact|drug
DDI-DrugBank.d204.s0|65-68|with|drug
DDI-DrugBank.d204.s0|70-84|beta-adrenergic|drug
DDI-DrugBank.d204.s0|86-93|receptor|drug
DDI-DrugBank.d204.s0|95-102|blocking|drug
DDI-DrugBank.d204.s0|104-109|agents|drug
DDI-DrugBank.d204.s0|110-110|:|drug
DDI-DrugBank.d204.s0|112-122|Anesthetics|drug
DDI-DrugBank.d204.s0|123-123|,|drug
DDI-DrugBank.d204.s0|125-131|general|drug
DDI-DrugBank.d204.s0|132-132|:|drug
DDI-DrugBank.d204.s0|134-145|exaggeration|drug
DDI-DrugBank.d204.s0|147-148|of|drug
DDI-DrugBank.d204.s0|150-152|the|drug
DDI-DrugBank.d204.s0|154-164|hypotension|drug
DDI-DrugBank.d204.s0|166-172|induced|drug
DDI-DrugBank.d204.s0|174-175|by|drug
DDI-DrugBank.d204.s0|177-183|general|drug
DDI-DrugBank.d204.s0|185-195|anesthetics|drug
DDI-DrugBank.d204.s0|196-196|.|drug
DDI-DrugBank.d204.s1|0-11|Antidiabetic|drug
DDI-DrugBank.d204.s1|13-17|drugs|drug
DDI-DrugBank.d204.s1|19-19|(|drug
DDI-DrugBank.d204.s1|20-23|oral|drug
DDI-DrugBank.d204.s1|25-30|agents|drug
DDI-DrugBank.d204.s1|32-34|and|drug
DDI-DrugBank.d204.s1|36-42|insulin|drug
DDI-DrugBank.d204.s1|43-43|)|drug
DDI-DrugBank.d204.s1|44-44|:|drug
DDI-DrugBank.d204.s1|46-57|hypoglycemia|drug
DDI-DrugBank.d204.s1|59-60|or|drug
DDI-DrugBank.d204.s1|62-74|hyperglycemia|drug
DDI-DrugBank.d204.s1|75-75|;|drug
DDI-DrugBank.d204.s2|0-5|adjust|drug
DDI-DrugBank.d204.s2|7-12|dosage|drug
DDI-DrugBank.d204.s2|14-15|of|drug
DDI-DrugBank.d204.s2|17-28|antidiabetic|drug
DDI-DrugBank.d204.s2|30-33|drug|drug
DDI-DrugBank.d204.s2|35-45|accordingly|drug
DDI-DrugBank.d204.s2|46-46|.|drug
DDI-DrugBank.d204.s3|0-22|Catecholamine-depleting|drug
DDI-DrugBank.d204.s3|24-28|drugs|drug
DDI-DrugBank.d204.s3|30-30|(|drug
DDI-DrugBank.d204.s3|31-34|e.g.|drug
DDI-DrugBank.d204.s3|35-35|,|drug
DDI-DrugBank.d204.s3|37-45|reserpine|drug
DDI-DrugBank.d204.s3|46-46|)|drug
DDI-DrugBank.d204.s3|47-47|:|drug
DDI-DrugBank.d204.s3|49-56|additive|drug
DDI-DrugBank.d204.s3|58-63|effect|drug
DDI-DrugBank.d204.s3|64-64|;|drug
DDI-DrugBank.d204.s4|0-6|monitor|drug
DDI-DrugBank.d204.s4|8-14|closely|drug
DDI-DrugBank.d204.s4|16-18|for|drug
DDI-DrugBank.d204.s4|20-27|evidence|drug
DDI-DrugBank.d204.s4|29-30|of|drug
DDI-DrugBank.d204.s4|32-42|hypotension|drug
DDI-DrugBank.d204.s4|44-49|and/or|drug
DDI-DrugBank.d204.s4|51-59|excessive|drug
DDI-DrugBank.d204.s4|61-71|bradycardia|drug
DDI-DrugBank.d204.s4|73-73|(|drug
DDI-DrugBank.d204.s4|74-77|e.g.|drug
DDI-DrugBank.d204.s4|78-78|,|drug
DDI-DrugBank.d204.s4|80-86|vertigo|drug
DDI-DrugBank.d204.s4|87-87|,|drug
DDI-DrugBank.d204.s4|89-95|syncope|drug
DDI-DrugBank.d204.s4|96-96|,|drug
DDI-DrugBank.d204.s4|98-105|postural|drug
DDI-DrugBank.d204.s4|107-117|hypotension|drug
DDI-DrugBank.d204.s4|118-118|)|drug
DDI-DrugBank.d204.s4|119-119|.|drug
DDI-DrugBank.d204.s5|0-7|Response|drug
DDI-DrugBank.d204.s5|9-10|to|drug
DDI-DrugBank.d204.s5|12-20|Treatment|drug
DDI-DrugBank.d204.s5|22-24|for|drug
DDI-DrugBank.d204.s5|26-37|Anaphylactic|drug
DDI-DrugBank.d204.s5|39-46|Reaction|drug
DDI-DrugBank.d204.s5|47-47|:|drug
DDI-DrugBank.d204.s5|49-53|While|drug
DDI-DrugBank.d204.s5|55-60|taking|drug
DDI-DrugBank.d204.s5|62-74|beta-blockers|drug
DDI-DrugBank.d204.s5|75-75|,|drug
DDI-DrugBank.d204.s5|77-84|patients|drug
DDI-DrugBank.d204.s5|86-89|with|drug
DDI-DrugBank.d204.s5|91-91|a|drug
DDI-DrugBank.d204.s5|93-99|history|drug
DDI-DrugBank.d204.s5|101-102|of|drug
DDI-DrugBank.d204.s5|104-109|severe|drug
DDI-DrugBank.d204.s5|111-122|anaphylactic|drug
DDI-DrugBank.d204.s5|124-131|reaction|drug
DDI-DrugBank.d204.s5|133-134|to|drug
DDI-DrugBank.d204.s5|136-136|a|drug
DDI-DrugBank.d204.s5|138-144|variety|drug
DDI-DrugBank.d204.s5|146-147|of|drug
DDI-DrugBank.d204.s5|149-157|allergens|drug
DDI-DrugBank.d204.s5|159-161|may|drug
DDI-DrugBank.d204.s5|163-164|be|drug
DDI-DrugBank.d204.s5|166-169|more|drug
DDI-DrugBank.d204.s5|171-178|reactive|drug
DDI-DrugBank.d204.s5|180-181|to|drug
DDI-DrugBank.d204.s5|183-190|repeated|drug
DDI-DrugBank.d204.s5|192-200|challenge|drug
DDI-DrugBank.d204.s5|201-201|,|drug
DDI-DrugBank.d204.s5|203-208|either|drug
DDI-DrugBank.d204.s5|210-219|accidental|drug
DDI-DrugBank.d204.s5|220-220|,|drug
DDI-DrugBank.d204.s5|222-231|diagnostic|drug
DDI-DrugBank.d204.s5|232-232|,|drug
DDI-DrugBank.d204.s5|234-235|or|drug
DDI-DrugBank.d204.s5|237-247|therapeutic|drug
DDI-DrugBank.d204.s5|248-248|.|drug
DDI-DrugBank.d204.s6|0-3|Such|drug
DDI-DrugBank.d204.s6|5-12|patients|drug
DDI-DrugBank.d204.s6|14-16|may|drug
DDI-DrugBank.d204.s6|18-19|be|drug
DDI-DrugBank.d204.s6|21-32|unresponsive|drug
DDI-DrugBank.d204.s6|34-35|to|drug
DDI-DrugBank.d204.s6|37-39|the|drug
DDI-DrugBank.d204.s6|41-45|usual|drug
DDI-DrugBank.d204.s6|47-51|doses|drug
DDI-DrugBank.d204.s6|53-54|of|drug
DDI-DrugBank.d204.s6|56-66|epinephrine|drug
DDI-DrugBank.d204.s6|68-71|used|drug
DDI-DrugBank.d204.s6|73-74|to|drug
DDI-DrugBank.d204.s6|76-80|treat|drug
DDI-DrugBank.d204.s6|82-89|allergic|drug
DDI-DrugBank.d204.s6|91-98|reaction|drug
DDI-DrugBank.d204.s6|99-99|.|drug
DDI-DrugBank.d330.s0|0-6|Caution|drug
DDI-DrugBank.d330.s0|8-13|should|drug
DDI-DrugBank.d330.s0|15-16|be|drug
DDI-DrugBank.d330.s0|18-22|taken|drug
DDI-DrugBank.d330.s0|24-25|in|drug
DDI-DrugBank.d330.s0|27-36|concurrent|drug
DDI-DrugBank.d330.s0|38-39|or|drug
DDI-DrugBank.d330.s0|41-46|serial|drug
DDI-DrugBank.d330.s0|48-50|use|drug
DDI-DrugBank.d330.s0|52-53|of|drug
DDI-DrugBank.d330.s0|55-59|other|drug
DDI-DrugBank.d330.s0|61-70|neurotoxic|drug
DDI-DrugBank.d330.s0|72-75|and/|drug
DDI-DrugBank.d330.s0|77-78|or|drug
DDI-DrugBank.d330.s0|80-90|nephrotoxic|drug
DDI-DrugBank.d330.s0|92-96|drugs|drug
DDI-DrugBank.d330.s0|98-104|because|drug
DDI-DrugBank.d330.s0|106-107|of|drug
DDI-DrugBank.d330.s0|109-116|possible|drug
DDI-DrugBank.d330.s0|118-128|enhancement|drug
DDI-DrugBank.d330.s0|130-131|of|drug
DDI-DrugBank.d330.s0|133-135|the|drug
DDI-DrugBank.d330.s0|137-150|nephrotoxicity|drug
DDI-DrugBank.d330.s0|152-157|and/or|drug
DDI-DrugBank.d330.s0|159-169|ototoxicity|drug
DDI-DrugBank.d330.s0|171-172|of|drug
DDI-DrugBank.d330.s0|174-181|neomycin|drug
DDI-DrugBank.d330.s0|182-182|.|drug
DDI-DrugBank.d330.s1|0-6|Caution|drug
DDI-DrugBank.d330.s1|8-13|should|drug
DDI-DrugBank.d330.s1|15-18|also|drug
DDI-DrugBank.d330.s1|20-21|be|drug
DDI-DrugBank.d330.s1|23-27|taken|drug
DDI-DrugBank.d330.s1|29-30|in|drug
DDI-DrugBank.d330.s1|32-41|concurrent|drug
DDI-DrugBank.d330.s1|43-44|or|drug
DDI-DrugBank.d330.s1|46-51|serial|drug
DDI-DrugBank.d330.s1|53-55|use|drug
DDI-DrugBank.d330.s1|57-58|of|drug
DDI-DrugBank.d330.s1|60-64|other|drug
DDI-DrugBank.d330.s1|66-80|aminoglycosides|drug
DDI-DrugBank.d330.s1|82-84|and|drug
DDI-DrugBank.d330.s1|86-95|polymyxins|drug
DDI-DrugBank.d330.s1|97-103|because|drug
DDI-DrugBank.d330.s1|105-108|they|drug
DDI-DrugBank.d330.s1|110-112|may|drug
DDI-DrugBank.d330.s1|114-120|enhance|drug
DDI-DrugBank.d330.s1|122-129|neomycin|drug
DDI-DrugBank.d330.s1|131-131|s|drug
DDI-DrugBank.d330.s1|133-146|nephrotoxicity|drug
DDI-DrugBank.d330.s1|148-153|and/or|drug
DDI-DrugBank.d330.s1|155-165|ototoxicity|drug
DDI-DrugBank.d330.s1|167-169|and|drug
DDI-DrugBank.d330.s1|171-180|potentiate|drug
DDI-DrugBank.d330.s1|182-189|neomycin|drug
DDI-DrugBank.d330.s1|191-197|sulfate|drug
DDI-DrugBank.d330.s1|199-211|neuromuscular|drug
DDI-DrugBank.d330.s1|213-220|blocking|drug
DDI-DrugBank.d330.s1|222-228|effects|drug
DDI-DrugBank.d330.s1|229-229|.|drug
DDI-DrugBank.d330.s2|0-3|Oral|drug
DDI-DrugBank.d330.s2|5-12|neomycin|drug
DDI-DrugBank.d330.s2|14-21|inhibits|drug
DDI-DrugBank.d330.s2|23-25|the|drug
DDI-DrugBank.d330.s2|27-42|gastrointestinal|drug
DDI-DrugBank.d330.s2|44-53|absorption|drug
DDI-DrugBank.d330.s2|55-56|of|drug
DDI-DrugBank.d330.s2|58-67|penicillin|drug
DDI-DrugBank.d330.s2|69-69|V|drug
DDI-DrugBank.d330.s2|70-70|,|drug
DDI-DrugBank.d330.s2|72-75|oral|drug
DDI-DrugBank.d330.s2|77-83|vitamin|drug
DDI-DrugBank.d330.s2|85-88|B-12|drug
DDI-DrugBank.d330.s2|89-89|,|drug
DDI-DrugBank.d330.s2|91-102|methotrexate|drug
DDI-DrugBank.d330.s2|104-106|and|drug
DDI-DrugBank.d330.s2|108-121|5-fluorouracil|drug
DDI-DrugBank.d330.s2|122-122|.|drug
DDI-DrugBank.d330.s3|0-2|The|drug
DDI-DrugBank.d330.s3|4-19|gastrointestinal|drug
DDI-DrugBank.d330.s3|21-30|absorption|drug
DDI-DrugBank.d330.s3|32-33|of|drug
DDI-DrugBank.d330.s3|35-41|digoxin|drug
DDI-DrugBank.d330.s3|43-46|also|drug
DDI-DrugBank.d330.s3|48-54|appears|drug
DDI-DrugBank.d330.s3|56-57|to|drug
DDI-DrugBank.d330.s3|59-60|be|drug
DDI-DrugBank.d330.s3|62-70|inhibited|drug
DDI-DrugBank.d330.s3|71-71|.|drug
DDI-DrugBank.d330.s4|0-8|Therefore|drug
DDI-DrugBank.d330.s4|9-9|,|drug
DDI-DrugBank.d330.s4|11-17|digoxin|drug
DDI-DrugBank.d330.s4|19-23|serum|drug
DDI-DrugBank.d330.s4|25-30|levels|drug
DDI-DrugBank.d330.s4|32-37|should|drug
DDI-DrugBank.d330.s4|39-40|be|drug
DDI-DrugBank.d330.s4|42-50|monitored|drug
DDI-DrugBank.d330.s4|51-51|.|drug
DDI-DrugBank.d330.s5|0-3|Oral|drug
DDI-DrugBank.d330.s5|5-12|neomycin|drug
DDI-DrugBank.d330.s5|14-20|sulfate|drug
DDI-DrugBank.d330.s5|22-24|may|drug
DDI-DrugBank.d330.s5|26-32|enhance|drug
DDI-DrugBank.d330.s5|34-36|the|drug
DDI-DrugBank.d330.s5|38-43|effect|drug
DDI-DrugBank.d330.s5|45-46|of|drug
DDI-DrugBank.d330.s5|48-55|coumarin|drug
DDI-DrugBank.d330.s5|57-58|in|drug
DDI-DrugBank.d330.s5|60-73|anticoagulants|drug
DDI-DrugBank.d330.s5|75-76|by|drug
DDI-DrugBank.d330.s5|78-87|decreasing|drug
DDI-DrugBank.d330.s5|89-95|vitamin|drug
DDI-DrugBank.d330.s5|97-97|K|drug
DDI-DrugBank.d330.s5|99-110|availability|drug
DDI-DrugBank.d330.s5|111-111|.|drug
DDI-MedLine.d79.s0|0-1|If|drug
DDI-MedLine.d79.s0|3-7|taken|drug
DDI-MedLine.d79.s0|9-9|1|drug
DDI-MedLine.d79.s0|11-14|hour|drug
DDI-MedLine.d79.s0|16-21|before|drug
DDI-MedLine.d79.s0|23-31|indinavir|drug
DDI-MedLine.d79.s0|33-33|(|drug
DDI-MedLine.d79.s0|34-36|IDV|drug
DDI-MedLine.d79.s0|37-37|)|drug
DDI-MedLine.d79.s0|38-38|,|drug
DDI-MedLine.d79.s0|40-49|didanosine|drug
DDI-MedLine.d79.s0|51-54|does|drug
DDI-MedLine.d79.s0|56-58|not|drug
DDI-MedLine.d79.s0|60-65|affect|drug
DDI-MedLine.d79.s0|67-69|IDV|drug
DDI-MedLine.d79.s0|71-78|exposure|drug
DDI-MedLine.d79.s0|79-79|,|drug
DDI-MedLine.d79.s0|81-87|despite|drug
DDI-MedLine.d79.s0|89-98|persistent|drug
DDI-MedLine.d79.s0|100-108|buffering|drug
DDI-MedLine.d79.s0|110-116|effects|drug
DDI-MedLine.d79.s0|117-117|.|drug
DDI-MedLine.d79.s1|0-9|Concurrent|drug
DDI-MedLine.d79.s1|11-24|administration|drug
DDI-MedLine.d79.s1|26-27|of|drug
DDI-MedLine.d79.s1|29-37|indinavir|drug
DDI-MedLine.d79.s1|39-41|and|drug
DDI-MedLine.d79.s1|43-52|didanosine|drug
DDI-MedLine.d79.s1|54-66|significantly|drug
DDI-MedLine.d79.s1|68-74|reduces|drug
DDI-MedLine.d79.s1|76-78|the|drug
DDI-MedLine.d79.s1|80-84|level|drug
DDI-MedLine.d79.s1|86-87|of|drug
DDI-MedLine.d79.s1|89-96|exposure|drug
DDI-MedLine.d79.s1|98-99|to|drug
DDI-MedLine.d79.s1|101-109|indinavir|drug
DDI-MedLine.d79.s1|110-110|,|drug
DDI-MedLine.d79.s1|112-114|but|drug
DDI-MedLine.d79.s1|116-117|it|drug
DDI-MedLine.d79.s1|119-120|is|drug
DDI-MedLine.d79.s1|122-128|unclear|drug
DDI-MedLine.d79.s1|130-132|how|drug
DDI-MedLine.d79.s1|134-137|soon|drug
DDI-MedLine.d79.s1|139-143|after|drug
DDI-MedLine.d79.s1|145-154|didanosine|drug
DDI-MedLine.d79.s1|156-169|administration|drug
DDI-MedLine.d79.s1|171-179|indinavir|drug
DDI-MedLine.d79.s1|181-183|may|drug
DDI-MedLine.d79.s1|185-186|be|drug
DDI-MedLine.d79.s1|188-192|given|drug
DDI-MedLine.d79.s1|194-199|safely|drug
DDI-MedLine.d79.s1|200-200|.|drug
DDI-MedLine.d79.s2|0-1|We|drug
DDI-MedLine.d79.s2|3-10|compared|drug
DDI-MedLine.d79.s2|12-20|indinavir|drug
DDI-MedLine.d79.s2|22-37|pharmacokinetics|drug
DDI-MedLine.d79.s2|39-41|and|drug
DDI-MedLine.d79.s2|43-49|gastric|drug
DDI-MedLine.d79.s2|51-52|pH|drug
DDI-MedLine.d79.s2|54-55|in|drug
DDI-MedLine.d79.s2|57-58|12|drug
DDI-MedLine.d79.s2|60-64|human|drug
DDI-MedLine.d79.s2|66-81|immunodeficiency|drug
DDI-MedLine.d79.s2|83-96|virus-positive|drug
DDI-MedLine.d79.s2|98-105|patients|drug
DDI-MedLine.d79.s2|107-108|by|drug
DDI-MedLine.d79.s2|110-112|use|drug
DDI-MedLine.d79.s2|114-115|of|drug
DDI-MedLine.d79.s2|117-119|800|drug
DDI-MedLine.d79.s2|121-122|mg|drug
DDI-MedLine.d79.s2|124-125|of|drug
DDI-MedLine.d79.s2|127-135|indinavir|drug
DDI-MedLine.d79.s2|137-141|alone|drug
DDI-MedLine.d79.s2|143-148|versus|drug
DDI-MedLine.d79.s2|150-152|800|drug
DDI-MedLine.d79.s2|154-155|mg|drug
DDI-MedLine.d79.s2|157-158|of|drug
DDI-MedLine.d79.s2|160-168|indinavir|drug
DDI-MedLine.d79.s2|170-181|administered|drug
DDI-MedLine.d79.s2|183-183|1|drug
DDI-MedLine.d79.s2|185-185|h|drug
DDI-MedLine.d79.s2|187-191|after|drug
DDI-MedLine.d79.s2|193-202|didanosine|drug
DDI-MedLine.d79.s2|204-217|administration|drug
DDI-MedLine.d79.s2|218-218|.|drug
DDI-MedLine.d79.s3|0-5|Median|drug
DDI-MedLine.d79.s3|7-13|gastric|drug
DDI-MedLine.d79.s3|15-16|pH|drug
DDI-MedLine.d79.s3|18-20|was|drug
DDI-MedLine.d79.s3|22-34|significantly|drug
DDI-MedLine.d79.s3|36-41|higher|drug
DDI-MedLine.d79.s3|43-46|when|drug
DDI-MedLine.d79.s3|48-56|indinavir|drug
DDI-MedLine.d79.s3|58-60|was|drug
DDI-MedLine.d79.s3|62-66|taken|drug
DDI-MedLine.d79.s3|68-72|after|drug
DDI-MedLine.d79.s3|74-83|didanosine|drug
DDI-MedLine.d79.s3|85-98|administration|drug
DDI-MedLine.d79.s3|99-99|;|drug
DDI-MedLine.d79.s4|0-6|however|drug
DDI-MedLine.d79.s4|7-7|,|drug
DDI-MedLine.d79.s4|9-10|no|drug
DDI-MedLine.d79.s4|12-22|significant|drug
DDI-MedLine.d79.s4|24-33|difference|drug
DDI-MedLine.d79.s4|35-36|in|drug
DDI-MedLine.d79.s4|38-40|the|drug
DDI-MedLine.d79.s4|42-48|maximum|drug
DDI-MedLine.d79.s4|50-62|concentration|drug
DDI-MedLine.d79.s4|64-65|in|drug
DDI-MedLine.d79.s4|67-72|plasma|drug
DDI-MedLine.d79.s4|74-75|or|drug
DDI-MedLine.d79.s4|77-79|the|drug
DDI-MedLine.d79.s4|81-84|area|drug
DDI-MedLine.d79.s4|86-90|under|drug
DDI-MedLine.d79.s4|92-94|the|drug
DDI-MedLine.d79.s4|96-113|concentration-time|drug
DDI-MedLine.d79.s4|115-119|curve|drug
DDI-MedLine.d79.s4|121-124|from|drug
DDI-MedLine.d79.s4|126-129|time|drug
DDI-MedLine.d79.s4|131-134|zero|drug
DDI-MedLine.d79.s4|136-137|to|drug
DDI-MedLine.d79.s4|139-139|8|drug
DDI-MedLine.d79.s4|141-141|h|drug
DDI-MedLine.d79.s4|143-145|was|drug
DDI-MedLine.d79.s4|147-154|observed|drug
DDI-MedLine.d79.s4|155-155|.|drug
DDI-MedLine.d79.s5|0-8|Indinavir|drug
DDI-MedLine.d79.s5|10-12|may|drug
DDI-MedLine.d79.s5|14-15|be|drug
DDI-MedLine.d79.s5|17-21|taken|drug
DDI-MedLine.d79.s5|23-26|with|drug
DDI-MedLine.d79.s5|28-28|a|drug
DDI-MedLine.d79.s5|30-34|light|drug
DDI-MedLine.d79.s5|36-39|meal|drug
DDI-MedLine.d79.s5|41-41|1|drug
DDI-MedLine.d79.s5|43-43|h|drug
DDI-MedLine.d79.s5|45-53|following|drug
DDI-MedLine.d79.s5|55-57|the|drug
DDI-MedLine.d79.s5|59-72|administration|drug
DDI-MedLine.d79.s5|74-75|of|drug
DDI-MedLine.d79.s5|77-79|400|drug
DDI-MedLine.d79.s5|81-82|mg|drug
DDI-MedLine.d79.s5|84-85|of|drug
DDI-MedLine.d79.s5|87-96|didanosine|drug
DDI-MedLine.d79.s5|97-97|.|drug
DDI-DrugBank.d480.s0|0-2|The|drug
DDI-DrugBank.d480.s0|4-8|risks|drug
DDI-DrugBank.d480.s0|10-11|of|drug
DDI-DrugBank.d480.s0|13-17|using|drug
DDI-DrugBank.d480.s0|19-27|Clozapine|drug
DDI-DrugBank.d480.s0|29-30|in|drug
DDI-DrugBank.d480.s0|32-42|combination|drug
DDI-DrugBank.d480.s0|44-47|with|drug
DDI-DrugBank.d480.s0|49-53|other|drug
DDI-DrugBank.d480.s0|55-59|drugs|drug
DDI-DrugBank.d480.s0|61-64|have|drug
DDI-DrugBank.d480.s0|66-68|not|drug
DDI-DrugBank.d480.s0|70-73|been|drug
DDI-DrugBank.d480.s0|75-88|systematically|drug
DDI-DrugBank.d480.s0|90-98|evaluated|drug
DDI-DrugBank.d480.s0|99-99|.|drug
DDI-DrugBank.d480.s1|0-22|Pharmacodynamic-related|drug
DDI-DrugBank.d480.s1|24-35|Interactions|drug
DDI-DrugBank.d480.s1|36-36|:|drug
DDI-DrugBank.d480.s1|38-40|The|drug
DDI-DrugBank.d480.s1|42-50|mechanism|drug
DDI-DrugBank.d480.s1|52-53|of|drug
DDI-DrugBank.d480.s1|55-63|Clozapine|drug
DDI-DrugBank.d480.s1|65-71|induced|drug
DDI-DrugBank.d480.s1|73-87|agranulocytosis|drug
DDI-DrugBank.d480.s1|89-90|is|drug
DDI-DrugBank.d480.s1|92-98|unknown|drug
DDI-DrugBank.d480.s1|99-99|;|drug
DDI-DrugBank.d480.s2|0-10|nonetheless|drug
DDI-DrugBank.d480.s2|11-11|,|drug
DDI-DrugBank.d480.s2|13-15|the|drug
DDI-DrugBank.d480.s2|17-27|possibility|drug
DDI-DrugBank.d480.s2|29-32|that|drug
DDI-DrugBank.d480.s2|34-42|causative|drug
DDI-DrugBank.d480.s2|44-50|factors|drug
DDI-DrugBank.d480.s2|52-54|may|drug
DDI-DrugBank.d480.s2|56-63|interact|drug
DDI-DrugBank.d480.s2|65-79|synergistically|drug
DDI-DrugBank.d480.s2|81-82|to|drug
DDI-DrugBank.d480.s2|84-91|increase|drug
DDI-DrugBank.d480.s2|93-95|the|drug
DDI-DrugBank.d480.s2|97-100|risk|drug
DDI-DrugBank.d480.s2|102-107|and/or|drug
DDI-DrugBank.d480.s2|109-116|severity|drug
DDI-DrugBank.d480.s2|118-119|of|drug
DDI-DrugBank.d480.s2|121-124|bone|drug
DDI-DrugBank.d480.s2|126-131|marrow|drug
DDI-DrugBank.d480.s2|133-143|suppression|drug
DDI-DrugBank.d480.s2|145-152|warrants|drug
DDI-DrugBank.d480.s2|154-166|consideration|drug
DDI-DrugBank.d480.s2|167-167|.|drug
DDI-DrugBank.d480.s3|0-8|Therefore|drug
DDI-DrugBank.d480.s3|9-9|,|drug
DDI-DrugBank.d480.s3|11-19|Clozapine|drug
DDI-DrugBank.d480.s3|21-26|should|drug
DDI-DrugBank.d480.s3|28-30|not|drug
DDI-DrugBank.d480.s3|32-33|be|drug
DDI-DrugBank.d480.s3|35-38|used|drug
DDI-DrugBank.d480.s3|40-43|with|drug
DDI-DrugBank.d480.s3|45-49|other|drug
DDI-DrugBank.d480.s3|51-56|agents|drug
DDI-DrugBank.d480.s3|58-63|having|drug
DDI-DrugBank.d480.s3|65-65|a|drug
DDI-DrugBank.d480.s3|67-76|well-known|drug
DDI-DrugBank.d480.s3|78-86|potential|drug
DDI-DrugBank.d480.s3|88-89|to|drug
DDI-DrugBank.d480.s3|91-98|suppress|drug
DDI-DrugBank.d480.s3|100-103|bone|drug
DDI-DrugBank.d480.s3|105-110|marrow|drug
DDI-DrugBank.d480.s3|112-119|function|drug
DDI-DrugBank.d480.s3|120-120|.|drug
DDI-DrugBank.d480.s4|0-4|Given|drug
DDI-DrugBank.d480.s4|6-8|the|drug
DDI-DrugBank.d480.s4|10-16|primary|drug
DDI-DrugBank.d480.s4|18-20|CNS|drug
DDI-DrugBank.d480.s4|22-28|effects|drug
DDI-DrugBank.d480.s4|30-31|of|drug
DDI-DrugBank.d480.s4|33-41|Clozapine|drug
DDI-DrugBank.d480.s4|42-42|,|drug
DDI-DrugBank.d480.s4|44-50|caution|drug
DDI-DrugBank.d480.s4|52-53|is|drug
DDI-DrugBank.d480.s4|55-61|advised|drug
DDI-DrugBank.d480.s4|63-64|in|drug
DDI-DrugBank.d480.s4|66-70|using|drug
DDI-DrugBank.d480.s4|72-73|it|drug
DDI-DrugBank.d480.s4|75-87|concomitantly|drug
DDI-DrugBank.d480.s4|89-92|with|drug
DDI-DrugBank.d480.s4|94-98|other|drug
DDI-DrugBank.d480.s4|100-109|CNS-active|drug
DDI-DrugBank.d480.s4|111-115|drugs|drug
DDI-DrugBank.d480.s4|117-118|or|drug
DDI-DrugBank.d480.s4|120-126|alcohol|drug
DDI-DrugBank.d480.s4|127-127|.|drug
DDI-DrugBank.d480.s5|0-10|Orthostatic|drug
DDI-DrugBank.d480.s5|12-22|hypotension|drug
DDI-DrugBank.d480.s5|24-25|in|drug
DDI-DrugBank.d480.s5|27-34|patients|drug
DDI-DrugBank.d480.s5|36-41|taking|drug
DDI-DrugBank.d480.s5|43-51|clozapine|drug
DDI-DrugBank.d480.s5|53-55|can|drug
DDI-DrugBank.d480.s5|56-56|,|drug
DDI-DrugBank.d480.s5|58-59|in|drug
DDI-DrugBank.d480.s5|61-64|rare|drug
DDI-DrugBank.d480.s5|66-70|cases|drug
DDI-DrugBank.d480.s5|72-72|(|drug
DDI-DrugBank.d480.s5|73-85|approximately|drug
DDI-DrugBank.d480.s5|87-87|1|drug
DDI-DrugBank.d480.s5|89-92|case|drug
DDI-DrugBank.d480.s5|94-96|per|drug
DDI-DrugBank.d480.s5|98-102|3,000|drug
DDI-DrugBank.d480.s5|104-111|patients|drug
DDI-DrugBank.d480.s5|112-112|)|drug
DDI-DrugBank.d480.s5|113-113|,|drug
DDI-DrugBank.d480.s5|115-116|be|drug
DDI-DrugBank.d480.s5|118-128|accompanied|drug
DDI-DrugBank.d480.s5|130-131|by|drug
DDI-DrugBank.d480.s5|133-140|profound|drug
DDI-DrugBank.d480.s5|142-149|collapse|drug
DDI-DrugBank.d480.s5|151-153|and|drug
DDI-DrugBank.d480.s5|155-165|respiratory|drug
DDI-DrugBank.d480.s5|167-172|and/or|drug
DDI-DrugBank.d480.s5|174-180|cardiac|drug
DDI-DrugBank.d480.s5|182-187|arrest|drug
DDI-DrugBank.d480.s5|188-188|.|drug
DDI-DrugBank.d480.s6|0-3|Some|drug
DDI-DrugBank.d480.s6|5-6|of|drug
DDI-DrugBank.d480.s6|8-10|the|drug
DDI-DrugBank.d480.s6|12-16|cases|drug
DDI-DrugBank.d480.s6|18-19|of|drug
DDI-DrugBank.d480.s6|21-40|collapse/respiratory|drug
DDI-DrugBank.d480.s6|42-55|arrest/cardiac|drug
DDI-DrugBank.d480.s6|57-62|arrest|drug
DDI-DrugBank.d480.s6|64-69|during|drug
DDI-DrugBank.d480.s6|71-77|initial|drug
DDI-DrugBank.d480.s6|79-87|treatment|drug
DDI-DrugBank.d480.s6|89-96|occurred|drug
DDI-DrugBank.d480.s6|98-99|in|drug
DDI-DrugBank.d480.s6|101-108|patients|drug
DDI-DrugBank.d480.s6|110-112|who|drug
DDI-DrugBank.d480.s6|114-117|were|drug
DDI-DrugBank.d480.s6|119-123|being|drug
DDI-DrugBank.d480.s6|125-136|administered|drug
DDI-DrugBank.d480.s6|138-152|benzodiazepines|drug
DDI-DrugBank.d480.s6|153-153|;|drug
DDI-DrugBank.d480.s7|0-6|similar|drug
DDI-DrugBank.d480.s7|8-13|events|drug
DDI-DrugBank.d480.s7|15-18|have|drug
DDI-DrugBank.d480.s7|20-23|been|drug
DDI-DrugBank.d480.s7|25-32|reported|drug
DDI-DrugBank.d480.s7|34-35|in|drug
DDI-DrugBank.d480.s7|37-44|patients|drug
DDI-DrugBank.d480.s7|46-51|taking|drug
DDI-DrugBank.d480.s7|53-57|other|drug
DDI-DrugBank.d480.s7|59-70|psychotropic|drug
DDI-DrugBank.d480.s7|72-76|drugs|drug
DDI-DrugBank.d480.s7|78-79|or|drug
DDI-DrugBank.d480.s7|81-84|even|drug
DDI-DrugBank.d480.s7|86-94|Clozapine|drug
DDI-DrugBank.d480.s7|96-97|by|drug
DDI-DrugBank.d480.s7|99-104|itself|drug
DDI-DrugBank.d480.s7|105-105|.|drug
DDI-DrugBank.d480.s8|0-7|Although|drug
DDI-DrugBank.d480.s8|9-10|it|drug
DDI-DrugBank.d480.s8|12-14|has|drug
DDI-DrugBank.d480.s8|16-18|not|drug
DDI-DrugBank.d480.s8|20-23|been|drug
DDI-DrugBank.d480.s8|25-35|established|drug
DDI-DrugBank.d480.s8|37-40|that|drug
DDI-DrugBank.d480.s8|42-46|there|drug
DDI-DrugBank.d480.s8|48-49|is|drug
DDI-DrugBank.d480.s8|51-52|an|drug
DDI-DrugBank.d480.s8|54-64|interaction|drug
DDI-DrugBank.d480.s8|66-72|between|drug
DDI-DrugBank.d480.s8|74-82|Clozapine|drug
DDI-DrugBank.d480.s8|84-86|and|drug
DDI-DrugBank.d480.s8|88-102|benzodiazepines|drug
DDI-DrugBank.d480.s8|104-105|or|drug
DDI-DrugBank.d480.s8|107-111|other|drug
DDI-DrugBank.d480.s8|113-125|psychotropics|drug
DDI-DrugBank.d480.s8|126-126|,|drug
DDI-DrugBank.d480.s8|128-134|caution|drug
DDI-DrugBank.d480.s8|136-137|is|drug
DDI-DrugBank.d480.s8|139-145|advised|drug
DDI-DrugBank.d480.s8|147-150|when|drug
DDI-DrugBank.d480.s8|152-160|clozapine|drug
DDI-DrugBank.d480.s8|162-163|is|drug
DDI-DrugBank.d480.s8|165-173|initiated|drug
DDI-DrugBank.d480.s8|175-176|in|drug
DDI-DrugBank.d480.s8|178-185|patients|drug
DDI-DrugBank.d480.s8|187-192|taking|drug
DDI-DrugBank.d480.s8|194-194|a|drug
DDI-DrugBank.d480.s8|196-209|benzodiazepine|drug
DDI-DrugBank.d480.s8|211-212|or|drug
DDI-DrugBank.d480.s8|214-216|any|drug
DDI-DrugBank.d480.s8|218-222|other|drug
DDI-DrugBank.d480.s8|224-235|psychotropic|drug
DDI-DrugBank.d480.s8|237-240|drug|drug
DDI-DrugBank.d480.s8|241-241|.|drug
DDI-DrugBank.d480.s9|0-8|Clozapine|drug
DDI-DrugBank.d480.s9|10-12|may|drug
DDI-DrugBank.d480.s9|14-23|potentiate|drug
DDI-DrugBank.d480.s9|25-27|the|drug
DDI-DrugBank.d480.s9|29-39|hypotensive|drug
DDI-DrugBank.d480.s9|41-47|effects|drug
DDI-DrugBank.d480.s9|49-50|of|drug
DDI-DrugBank.d480.s9|52-67|antihypertensive|drug
DDI-DrugBank.d480.s9|69-73|drugs|drug
DDI-DrugBank.d480.s9|75-77|and|drug
DDI-DrugBank.d480.s9|79-81|the|drug
DDI-DrugBank.d480.s9|83-97|anticholinergic|drug
DDI-DrugBank.d480.s9|99-105|effects|drug
DDI-DrugBank.d480.s9|107-108|of|drug
DDI-DrugBank.d480.s9|110-122|atropine-type|drug
DDI-DrugBank.d480.s9|124-128|drugs|drug
DDI-DrugBank.d480.s9|129-129|.|drug
DDI-DrugBank.d480.s10|0-2|The|drug
DDI-DrugBank.d480.s10|4-17|administration|drug
DDI-DrugBank.d480.s10|19-20|of|drug
DDI-DrugBank.d480.s10|22-32|epinephrine|drug
DDI-DrugBank.d480.s10|34-39|should|drug
DDI-DrugBank.d480.s10|41-42|be|drug
DDI-DrugBank.d480.s10|44-50|avoided|drug
DDI-DrugBank.d480.s10|52-53|in|drug
DDI-DrugBank.d480.s10|55-57|the|drug
DDI-DrugBank.d480.s10|59-67|treatment|drug
DDI-DrugBank.d480.s10|69-70|of|drug
DDI-DrugBank.d480.s10|72-75|drug|drug
DDI-DrugBank.d480.s10|77-83|induced|drug
DDI-DrugBank.d480.s10|85-95|hypotension|drug
DDI-DrugBank.d480.s10|97-103|because|drug
DDI-DrugBank.d480.s10|105-106|of|drug
DDI-DrugBank.d480.s10|108-108|a|drug
DDI-DrugBank.d480.s10|110-117|possible|drug
DDI-DrugBank.d480.s10|119-125|reverse|drug
DDI-DrugBank.d480.s10|127-137|epinephrine|drug
DDI-DrugBank.d480.s10|139-144|effect|drug
DDI-DrugBank.d480.s10|145-145|.|drug
DDI-DrugBank.d480.s11|0-22|Pharmacokinetic-related|drug
DDI-DrugBank.d480.s11|24-35|Interactions|drug
DDI-DrugBank.d480.s11|36-36|:|drug
DDI-DrugBank.d480.s11|38-46|Clozapine|drug
DDI-DrugBank.d480.s11|48-49|is|drug
DDI-DrugBank.d480.s11|51-51|a|drug
DDI-DrugBank.d480.s11|53-61|substrate|drug
DDI-DrugBank.d480.s11|63-65|for|drug
DDI-DrugBank.d480.s11|67-70|many|drug
DDI-DrugBank.d480.s11|72-74|CYP|drug
DDI-DrugBank.d480.s11|76-78|450|drug
DDI-DrugBank.d480.s11|80-87|isozymes|drug
DDI-DrugBank.d480.s11|88-88|,|drug
DDI-DrugBank.d480.s11|90-91|in|drug
DDI-DrugBank.d480.s11|93-102|particular|drug
DDI-DrugBank.d480.s11|104-106|1A2|drug
DDI-DrugBank.d480.s11|107-107|,|drug
DDI-DrugBank.d480.s11|109-111|2D6|drug
DDI-DrugBank.d480.s11|112-112|,|drug
DDI-DrugBank.d480.s11|114-116|and|drug
DDI-DrugBank.d480.s11|118-120|3A4|drug
DDI-DrugBank.d480.s11|121-121|.|drug
DDI-DrugBank.d480.s12|0-2|The|drug
DDI-DrugBank.d480.s12|4-7|risk|drug
DDI-DrugBank.d480.s12|9-10|of|drug
DDI-DrugBank.d480.s12|12-20|metabolic|drug
DDI-DrugBank.d480.s12|22-33|interactions|drug
DDI-DrugBank.d480.s12|35-40|caused|drug
DDI-DrugBank.d480.s12|42-43|by|drug
DDI-DrugBank.d480.s12|45-46|an|drug
DDI-DrugBank.d480.s12|48-53|effect|drug
DDI-DrugBank.d480.s12|55-56|on|drug
DDI-DrugBank.d480.s12|58-59|an|drug
DDI-DrugBank.d480.s12|61-70|individual|drug
DDI-DrugBank.d480.s12|72-78|isoform|drug
DDI-DrugBank.d480.s12|80-81|is|drug
DDI-DrugBank.d480.s12|83-91|therefore|drug
DDI-DrugBank.d480.s12|93-101|minimized|drug
DDI-DrugBank.d480.s12|102-102|.|drug
DDI-DrugBank.d480.s13|0-11|Nevertheless|drug
DDI-DrugBank.d480.s13|12-12|,|drug
DDI-DrugBank.d480.s13|14-20|caution|drug
DDI-DrugBank.d480.s13|22-27|should|drug
DDI-DrugBank.d480.s13|29-30|be|drug
DDI-DrugBank.d480.s13|32-35|used|drug
DDI-DrugBank.d480.s13|37-38|in|drug
DDI-DrugBank.d480.s13|40-47|patients|drug
DDI-DrugBank.d480.s13|49-57|receiving|drug
DDI-DrugBank.d480.s13|59-69|concomitant|drug
DDI-DrugBank.d480.s13|71-79|treatment|drug
DDI-DrugBank.d480.s13|81-84|with|drug
DDI-DrugBank.d480.s13|86-90|other|drug
DDI-DrugBank.d480.s13|92-96|drugs|drug
DDI-DrugBank.d480.s13|98-101|that|drug
DDI-DrugBank.d480.s13|103-105|are|drug
DDI-DrugBank.d480.s13|107-112|either|drug
DDI-DrugBank.d480.s13|114-123|inhibitors|drug
DDI-DrugBank.d480.s13|125-126|or|drug
DDI-DrugBank.d480.s13|128-135|inducers|drug
DDI-DrugBank.d480.s13|137-138|of|drug
DDI-DrugBank.d480.s13|140-144|these|drug
DDI-DrugBank.d480.s13|146-152|enzymes|drug
DDI-DrugBank.d480.s13|153-153|.|drug
DDI-DrugBank.d480.s14|0-10|Concomitant|drug
DDI-DrugBank.d480.s14|12-25|administration|drug
DDI-DrugBank.d480.s14|27-28|of|drug
DDI-DrugBank.d480.s14|30-34|drugs|drug
DDI-DrugBank.d480.s14|36-40|known|drug
DDI-DrugBank.d480.s14|42-43|to|drug
DDI-DrugBank.d480.s14|45-50|induce|drug
DDI-DrugBank.d480.s14|52-61|cytochrome|drug
DDI-DrugBank.d480.s14|63-66|P450|drug
DDI-DrugBank.d480.s14|68-74|enzymes|drug
DDI-DrugBank.d480.s14|76-78|may|drug
DDI-DrugBank.d480.s14|80-87|decrease|drug
DDI-DrugBank.d480.s14|89-91|the|drug
DDI-DrugBank.d480.s14|93-98|plasma|drug
DDI-DrugBank.d480.s14|100-105|levels|drug
DDI-DrugBank.d480.s14|107-108|of|drug
DDI-DrugBank.d480.s14|110-118|clozapine|drug
DDI-DrugBank.d480.s14|119-119|.|drug
DDI-DrugBank.d480.s15|0-8|Phenytoin|drug
DDI-DrugBank.d480.s15|9-9|,|drug
DDI-DrugBank.d480.s15|11-18|nicotine|drug
DDI-DrugBank.d480.s15|19-19|,|drug
DDI-DrugBank.d480.s15|21-23|and|drug
DDI-DrugBank.d480.s15|25-32|rifampin|drug
DDI-DrugBank.d480.s15|34-36|may|drug
DDI-DrugBank.d480.s15|38-45|decrease|drug
DDI-DrugBank.d480.s15|47-55|Clozapine|drug
DDI-DrugBank.d480.s15|57-62|plasma|drug
DDI-DrugBank.d480.s15|64-69|levels|drug
DDI-DrugBank.d480.s15|70-70|,|drug
DDI-DrugBank.d480.s15|72-80|resulting|drug
DDI-DrugBank.d480.s15|82-83|in|drug
DDI-DrugBank.d480.s15|85-85|a|drug
DDI-DrugBank.d480.s15|87-94|decrease|drug
DDI-DrugBank.d480.s15|96-97|in|drug
DDI-DrugBank.d480.s15|99-111|effectiveness|drug
DDI-DrugBank.d480.s15|113-114|of|drug
DDI-DrugBank.d480.s15|116-116|a|drug
DDI-DrugBank.d480.s15|118-127|previously|drug
DDI-DrugBank.d480.s15|129-137|effective|drug
DDI-DrugBank.d480.s15|139-147|Clozapine|drug
DDI-DrugBank.d480.s15|149-152|dose|drug
DDI-DrugBank.d480.s15|153-153|.|drug
DDI-DrugBank.d480.s16|0-10|Concomitant|drug
DDI-DrugBank.d480.s16|12-25|administration|drug
DDI-DrugBank.d480.s16|27-28|of|drug
DDI-DrugBank.d480.s16|30-34|drugs|drug
DDI-DrugBank.d480.s16|36-40|known|drug
DDI-DrugBank.d480.s16|42-43|to|drug
DDI-DrugBank.d480.s16|45-51|inhibit|drug
DDI-DrugBank.d480.s16|53-55|the|drug
DDI-DrugBank.d480.s16|57-64|activity|drug
DDI-DrugBank.d480.s16|66-67|of|drug
DDI-DrugBank.d480.s16|69-78|cytochrome|drug
DDI-DrugBank.d480.s16|80-83|P450|drug
DDI-DrugBank.d480.s16|85-92|isozymes|drug
DDI-DrugBank.d480.s16|94-96|may|drug
DDI-DrugBank.d480.s16|98-105|increase|drug
DDI-DrugBank.d480.s16|107-109|the|drug
DDI-DrugBank.d480.s16|111-116|plasma|drug
DDI-DrugBank.d480.s16|118-123|levels|drug
DDI-DrugBank.d480.s16|125-126|of|drug
DDI-DrugBank.d480.s16|128-136|clozapine|drug
DDI-DrugBank.d480.s16|137-137|.|drug
DDI-DrugBank.d480.s17|0-9|Cimetidine|drug
DDI-DrugBank.d480.s17|10-10|,|drug
DDI-DrugBank.d480.s17|12-19|caffeine|drug
DDI-DrugBank.d480.s17|20-20|,|drug
DDI-DrugBank.d480.s17|22-24|and|drug
DDI-DrugBank.d480.s17|26-37|erythromycin|drug
DDI-DrugBank.d480.s17|39-41|may|drug
DDI-DrugBank.d480.s17|43-50|increase|drug
DDI-DrugBank.d480.s17|52-57|plasma|drug
DDI-DrugBank.d480.s17|59-64|levels|drug
DDI-DrugBank.d480.s17|66-67|of|drug
DDI-DrugBank.d480.s17|69-77|Clozapine|drug
DDI-DrugBank.d480.s17|78-78|,|drug
DDI-DrugBank.d480.s17|80-90|potentially|drug
DDI-DrugBank.d480.s17|92-100|resulting|drug
DDI-DrugBank.d480.s17|102-103|in|drug
DDI-DrugBank.d480.s17|105-111|adverse|drug
DDI-DrugBank.d480.s17|113-119|effects|drug
DDI-DrugBank.d480.s17|120-120|.|drug
DDI-DrugBank.d480.s18|0-7|Although|drug
DDI-DrugBank.d480.s18|9-19|concomitant|drug
DDI-DrugBank.d480.s18|21-23|use|drug
DDI-DrugBank.d480.s18|25-26|of|drug
DDI-DrugBank.d480.s18|28-36|Clozapine|drug
DDI-DrugBank.d480.s18|38-40|and|drug
DDI-DrugBank.d480.s18|42-54|carbamazepine|drug
DDI-DrugBank.d480.s18|56-57|is|drug
DDI-DrugBank.d480.s18|59-61|not|drug
DDI-DrugBank.d480.s18|63-73|recommended|drug
DDI-DrugBank.d480.s18|74-74|,|drug
DDI-DrugBank.d480.s18|76-77|it|drug
DDI-DrugBank.d480.s18|79-84|should|drug
DDI-DrugBank.d480.s18|86-87|be|drug
DDI-DrugBank.d480.s18|89-93|noted|drug
DDI-DrugBank.d480.s18|95-98|that|drug
DDI-DrugBank.d480.s18|100-114|discontinuation|drug
DDI-DrugBank.d480.s18|116-117|of|drug
DDI-DrugBank.d480.s18|119-129|concomitant|drug
DDI-DrugBank.d480.s18|131-143|carbamazepine|drug
DDI-DrugBank.d480.s18|145-158|administration|drug
DDI-DrugBank.d480.s18|160-162|may|drug
DDI-DrugBank.d480.s18|164-169|result|drug
DDI-DrugBank.d480.s18|171-172|in|drug
DDI-DrugBank.d480.s18|174-175|an|drug
DDI-DrugBank.d480.s18|177-184|increase|drug
DDI-DrugBank.d480.s18|186-187|in|drug
DDI-DrugBank.d480.s18|189-197|Clozapine|drug
DDI-DrugBank.d480.s18|199-204|plasma|drug
DDI-DrugBank.d480.s18|206-211|levels|drug
DDI-DrugBank.d480.s18|212-212|.|drug
DDI-DrugBank.d480.s19|0-1|In|drug
DDI-DrugBank.d480.s19|3-3|a|drug
DDI-DrugBank.d480.s19|5-9|study|drug
DDI-DrugBank.d480.s19|11-12|of|drug
DDI-DrugBank.d480.s19|14-26|schizophrenic|drug
DDI-DrugBank.d480.s19|28-35|patients|drug
DDI-DrugBank.d480.s19|37-39|who|drug
DDI-DrugBank.d480.s19|41-48|received|drug
DDI-DrugBank.d480.s19|50-58|clozapine|drug
DDI-DrugBank.d480.s19|60-64|under|drug
DDI-DrugBank.d480.s19|66-71|steady|drug
DDI-DrugBank.d480.s19|73-77|state|drug
DDI-DrugBank.d480.s19|79-88|conditions|drug
DDI-DrugBank.d480.s19|89-89|,|drug
DDI-DrugBank.d480.s19|91-101|fluvoxamine|drug
DDI-DrugBank.d480.s19|103-104|or|drug
DDI-DrugBank.d480.s19|106-115|paroxetine|drug
DDI-DrugBank.d480.s19|117-119|was|drug
DDI-DrugBank.d480.s19|121-125|added|drug
DDI-DrugBank.d480.s19|127-128|in|drug
DDI-DrugBank.d480.s19|130-131|16|drug
DDI-DrugBank.d480.s19|133-135|and|drug
DDI-DrugBank.d480.s19|137-138|14|drug
DDI-DrugBank.d480.s19|140-147|patients|drug
DDI-DrugBank.d480.s19|148-148|,|drug
DDI-DrugBank.d480.s19|150-161|respectively|drug
DDI-DrugBank.d480.s19|162-162|.|drug
DDI-DrugBank.d480.s20|0-4|After|drug
DDI-DrugBank.d480.s20|6-7|14|drug
DDI-DrugBank.d480.s20|9-12|days|drug
DDI-DrugBank.d480.s20|14-15|of|drug
DDI-DrugBank.d480.s20|17-33|co-administration|drug
DDI-DrugBank.d480.s20|34-34|,|drug
DDI-DrugBank.d480.s20|36-39|mean|drug
DDI-DrugBank.d480.s20|41-46|trough|drug
DDI-DrugBank.d480.s20|48-61|concentrations|drug
DDI-DrugBank.d480.s20|63-64|of|drug
DDI-DrugBank.d480.s20|66-74|clozapine|drug
DDI-DrugBank.d480.s20|76-78|and|drug
DDI-DrugBank.d480.s20|80-82|its|drug
DDI-DrugBank.d480.s20|84-94|metabolites|drug
DDI-DrugBank.d480.s20|95-95|,|drug
DDI-DrugBank.d480.s20|97-116|N-desmethylclozapine|drug
DDI-DrugBank.d480.s20|118-120|and|drug
DDI-DrugBank.d480.s20|122-130|clozapine|drug
DDI-DrugBank.d480.s20|132-138|N-oxide|drug
DDI-DrugBank.d480.s20|139-139|,|drug
DDI-DrugBank.d480.s20|141-144|were|drug
DDI-DrugBank.d480.s20|146-153|elevated|drug
DDI-DrugBank.d480.s20|155-158|with|drug
DDI-DrugBank.d480.s20|160-170|fluvoxamine|drug
DDI-DrugBank.d480.s20|172-173|by|drug
DDI-DrugBank.d480.s20|175-179|about|drug
DDI-DrugBank.d480.s20|181-190|three-fold|drug
DDI-DrugBank.d480.s20|192-199|compared|drug
DDI-DrugBank.d480.s20|201-202|to|drug
DDI-DrugBank.d480.s20|204-211|baseline|drug
DDI-DrugBank.d480.s20|213-226|concentrations|drug
DDI-DrugBank.d480.s20|227-227|.|drug
DDI-DrugBank.d480.s21|0-9|Paroxetine|drug
DDI-DrugBank.d480.s21|11-18|produced|drug
DDI-DrugBank.d480.s21|20-23|only|drug
DDI-DrugBank.d480.s21|25-29|minor|drug
DDI-DrugBank.d480.s21|31-37|changes|drug
DDI-DrugBank.d480.s21|39-40|in|drug
DDI-DrugBank.d480.s21|42-44|the|drug
DDI-DrugBank.d480.s21|46-51|levels|drug
DDI-DrugBank.d480.s21|53-54|of|drug
DDI-DrugBank.d480.s21|56-64|clozapine|drug
DDI-DrugBank.d480.s21|66-68|and|drug
DDI-DrugBank.d480.s21|70-72|its|drug
DDI-DrugBank.d480.s21|74-84|metabolites|drug
DDI-DrugBank.d480.s21|85-85|.|drug
DDI-DrugBank.d480.s22|0-6|However|drug
DDI-DrugBank.d480.s22|7-7|,|drug
DDI-DrugBank.d480.s22|9-13|other|drug
DDI-DrugBank.d480.s22|15-23|published|drug
DDI-DrugBank.d480.s22|25-31|reports|drug
DDI-DrugBank.d480.s22|33-40|describe|drug
DDI-DrugBank.d480.s22|42-47|modest|drug
DDI-DrugBank.d480.s22|49-58|elevations|drug
DDI-DrugBank.d480.s22|60-60|(|drug
DDI-DrugBank.d480.s22|61-64|less|drug
DDI-DrugBank.d480.s22|66-69|than|drug
DDI-DrugBank.d480.s22|71-78|two-fold|drug
DDI-DrugBank.d480.s22|79-79|)|drug
DDI-DrugBank.d480.s22|81-82|of|drug
DDI-DrugBank.d480.s22|84-92|clozapine|drug
DDI-DrugBank.d480.s22|94-96|and|drug
DDI-DrugBank.d480.s22|98-107|metabolite|drug
DDI-DrugBank.d480.s22|109-122|concentrations|drug
DDI-DrugBank.d480.s22|124-127|when|drug
DDI-DrugBank.d480.s22|129-137|clozapine|drug
DDI-DrugBank.d480.s22|139-141|was|drug
DDI-DrugBank.d480.s22|143-147|taken|drug
DDI-DrugBank.d480.s22|149-152|with|drug
DDI-DrugBank.d480.s22|154-163|paroxetine|drug
DDI-DrugBank.d480.s22|164-164|,|drug
DDI-DrugBank.d480.s22|166-175|fluoxetine|drug
DDI-DrugBank.d480.s22|176-176|,|drug
DDI-DrugBank.d480.s22|178-180|and|drug
DDI-DrugBank.d480.s22|182-191|sertraline|drug
DDI-DrugBank.d480.s22|192-192|.|drug
DDI-DrugBank.d480.s23|0-8|Therefore|drug
DDI-DrugBank.d480.s23|9-9|,|drug
DDI-DrugBank.d480.s23|11-14|such|drug
DDI-DrugBank.d480.s23|16-23|combined|drug
DDI-DrugBank.d480.s23|25-33|treatment|drug
DDI-DrugBank.d480.s23|35-40|should|drug
DDI-DrugBank.d480.s23|42-43|be|drug
DDI-DrugBank.d480.s23|45-54|approached|drug
DDI-DrugBank.d480.s23|56-59|with|drug
DDI-DrugBank.d480.s23|61-67|caution|drug
DDI-DrugBank.d480.s23|69-71|and|drug
DDI-DrugBank.d480.s23|73-80|patients|drug
DDI-DrugBank.d480.s23|82-87|should|drug
DDI-DrugBank.d480.s23|89-90|be|drug
DDI-DrugBank.d480.s23|92-100|monitored|drug
DDI-DrugBank.d480.s23|102-108|closely|drug
DDI-DrugBank.d480.s23|110-113|when|drug
DDI-DrugBank.d480.s23|115-123|Clozapine|drug
DDI-DrugBank.d480.s23|125-126|is|drug
DDI-DrugBank.d480.s23|128-135|combined|drug
DDI-DrugBank.d480.s23|137-140|with|drug
DDI-DrugBank.d480.s23|142-146|these|drug
DDI-DrugBank.d480.s23|148-152|drugs|drug
DDI-DrugBank.d480.s23|153-153|,|drug
DDI-DrugBank.d480.s23|155-166|particularly|drug
DDI-DrugBank.d480.s23|168-171|with|drug
DDI-DrugBank.d480.s23|173-183|fluvoxamine|drug
DDI-DrugBank.d480.s23|184-184|.|drug
DDI-DrugBank.d480.s24|0-0|A|drug
DDI-DrugBank.d480.s24|2-8|reduced|drug
DDI-DrugBank.d480.s24|10-18|Clozapine|drug
DDI-DrugBank.d480.s24|20-23|dose|drug
DDI-DrugBank.d480.s24|25-30|should|drug
DDI-DrugBank.d480.s24|32-33|be|drug
DDI-DrugBank.d480.s24|35-44|considered|drug
DDI-DrugBank.d480.s24|45-45|.|drug
DDI-DrugBank.d480.s25|0-0|A|drug
DDI-DrugBank.d480.s25|2-7|subset|drug
DDI-DrugBank.d480.s25|9-9|(|drug
DDI-DrugBank.d480.s25|10-10|3|drug
DDI-DrugBank.d480.s25|11-11|%|drug
DDI-DrugBank.d480.s25|12-14|-10|drug
DDI-DrugBank.d480.s25|15-15|%|drug
DDI-DrugBank.d480.s25|16-16|)|drug
DDI-DrugBank.d480.s25|18-19|of|drug
DDI-DrugBank.d480.s25|21-23|the|drug
DDI-DrugBank.d480.s25|25-34|population|drug
DDI-DrugBank.d480.s25|36-38|has|drug
DDI-DrugBank.d480.s25|40-46|reduced|drug
DDI-DrugBank.d480.s25|48-55|activity|drug
DDI-DrugBank.d480.s25|57-58|of|drug
DDI-DrugBank.d480.s25|60-66|certain|drug
DDI-DrugBank.d480.s25|68-71|drug|drug
DDI-DrugBank.d480.s25|73-84|metabolizing|drug
DDI-DrugBank.d480.s25|86-92|enzymes|drug
DDI-DrugBank.d480.s25|94-97|such|drug
DDI-DrugBank.d480.s25|99-100|as|drug
DDI-DrugBank.d480.s25|102-104|the|drug
DDI-DrugBank.d480.s25|106-115|cytochrome|drug
DDI-DrugBank.d480.s25|117-120|P450|drug
DDI-DrugBank.d480.s25|122-128|isozyme|drug
DDI-DrugBank.d480.s25|130-133|P450|drug
DDI-DrugBank.d480.s25|135-137|2D6|drug
DDI-DrugBank.d480.s25|138-138|.|drug
DDI-DrugBank.d480.s26|0-3|Such|drug
DDI-DrugBank.d480.s26|5-15|individuals|drug
DDI-DrugBank.d480.s26|17-19|are|drug
DDI-DrugBank.d480.s26|21-28|referred|drug
DDI-DrugBank.d480.s26|30-31|to|drug
DDI-DrugBank.d480.s26|33-34|as|drug
DDI-DrugBank.d480.s26|36-39|poor|drug
DDI-DrugBank.d480.s26|41-52|metabolizers|drug
DDI-DrugBank.d480.s26|54-55|of|drug
DDI-DrugBank.d480.s26|57-61|drugs|drug
DDI-DrugBank.d480.s26|63-66|such|drug
DDI-DrugBank.d480.s26|68-69|as|drug
DDI-DrugBank.d480.s26|71-81|debrisoquin|drug
DDI-DrugBank.d480.s26|82-82|,|drug
DDI-DrugBank.d480.s26|84-99|dextromethorphan|drug
DDI-DrugBank.d480.s26|100-100|,|drug
DDI-DrugBank.d480.s26|102-104|the|drug
DDI-DrugBank.d480.s26|106-114|tricyclic|drug
DDI-DrugBank.d480.s26|116-130|antidepressants|drug
DDI-DrugBank.d480.s26|131-131|,|drug
DDI-DrugBank.d480.s26|133-135|and|drug
DDI-DrugBank.d480.s26|137-145|clozapine|drug
DDI-DrugBank.d480.s26|146-146|.|drug
DDI-DrugBank.d480.s27|0-4|These|drug
DDI-DrugBank.d480.s27|6-16|individuals|drug
DDI-DrugBank.d480.s27|18-20|may|drug
DDI-DrugBank.d480.s27|22-28|develop|drug
DDI-DrugBank.d480.s27|30-35|higher|drug
DDI-DrugBank.d480.s27|37-40|than|drug
DDI-DrugBank.d480.s27|42-49|expected|drug
DDI-DrugBank.d480.s27|51-56|plasma|drug
DDI-DrugBank.d480.s27|58-71|concentrations|drug
DDI-DrugBank.d480.s27|73-74|of|drug
DDI-DrugBank.d480.s27|76-84|clozapine|drug
DDI-DrugBank.d480.s27|86-89|when|drug
DDI-DrugBank.d480.s27|91-95|given|drug
DDI-DrugBank.d480.s27|97-101|usual|drug
DDI-DrugBank.d480.s27|103-107|doses|drug
DDI-DrugBank.d480.s27|108-108|.|drug
DDI-DrugBank.d480.s28|0-1|In|drug
DDI-DrugBank.d480.s28|3-10|addition|drug
DDI-DrugBank.d480.s28|11-11|,|drug
DDI-DrugBank.d480.s28|13-19|certain|drug
DDI-DrugBank.d480.s28|21-25|drugs|drug
DDI-DrugBank.d480.s28|27-30|that|drug
DDI-DrugBank.d480.s28|32-34|are|drug
DDI-DrugBank.d480.s28|36-46|metabolized|drug
DDI-DrugBank.d480.s28|48-49|by|drug
DDI-DrugBank.d480.s28|51-54|this|drug
DDI-DrugBank.d480.s28|56-62|isozyme|drug
DDI-DrugBank.d480.s28|63-63|,|drug
DDI-DrugBank.d480.s28|65-73|including|drug
DDI-DrugBank.d480.s28|75-78|many|drug
DDI-DrugBank.d480.s28|80-94|antidepressants|drug
DDI-DrugBank.d480.s28|96-96|(|drug
DDI-DrugBank.d480.s28|97-105|clozapine|drug
DDI-DrugBank.d480.s28|106-106|,|drug
DDI-DrugBank.d480.s28|108-116|selective|drug
DDI-DrugBank.d480.s28|118-126|serotonin|drug
DDI-DrugBank.d480.s28|128-135|reuptake|drug
DDI-DrugBank.d480.s28|137-146|inhibitors|drug
DDI-DrugBank.d480.s28|147-147|,|drug
DDI-DrugBank.d480.s28|149-151|and|drug
DDI-DrugBank.d480.s28|153-158|others|drug
DDI-DrugBank.d480.s28|159-159|)|drug
DDI-DrugBank.d480.s28|160-160|,|drug
DDI-DrugBank.d480.s28|162-164|may|drug
DDI-DrugBank.d480.s28|166-172|inhibit|drug
DDI-DrugBank.d480.s28|174-176|the|drug
DDI-DrugBank.d480.s28|178-185|activity|drug
DDI-DrugBank.d480.s28|187-188|of|drug
DDI-DrugBank.d480.s28|190-193|this|drug
DDI-DrugBank.d480.s28|195-201|isozyme|drug
DDI-DrugBank.d480.s28|202-202|,|drug
DDI-DrugBank.d480.s28|204-206|and|drug
DDI-DrugBank.d480.s28|208-211|thus|drug
DDI-DrugBank.d480.s28|213-215|may|drug
DDI-DrugBank.d480.s28|217-220|make|drug
DDI-DrugBank.d480.s28|222-227|normal|drug
DDI-DrugBank.d480.s28|229-240|metabolizers|drug
DDI-DrugBank.d480.s28|242-249|resemble|drug
DDI-DrugBank.d480.s28|251-254|poor|drug
DDI-DrugBank.d480.s28|256-267|metabolizers|drug
DDI-DrugBank.d480.s28|269-272|with|drug
DDI-DrugBank.d480.s28|274-279|regard|drug
DDI-DrugBank.d480.s28|281-282|to|drug
DDI-DrugBank.d480.s28|284-294|concomitant|drug
DDI-DrugBank.d480.s28|296-302|therapy|drug
DDI-DrugBank.d480.s28|304-307|with|drug
DDI-DrugBank.d480.s28|309-313|other|drug
DDI-DrugBank.d480.s28|315-319|drugs|drug
DDI-DrugBank.d480.s28|321-331|metabolized|drug
DDI-DrugBank.d480.s28|333-334|by|drug
DDI-DrugBank.d480.s28|336-339|this|drug
DDI-DrugBank.d480.s28|341-346|enzyme|drug
DDI-DrugBank.d480.s28|348-353|system|drug
DDI-DrugBank.d480.s28|354-354|,|drug
DDI-DrugBank.d480.s28|356-362|leading|drug
DDI-DrugBank.d480.s28|364-365|to|drug
DDI-DrugBank.d480.s28|367-370|drug|drug
DDI-DrugBank.d480.s28|372-382|interaction|drug
DDI-DrugBank.d480.s28|383-383|.|drug
DDI-DrugBank.d480.s29|0-10|Concomitant|drug
DDI-DrugBank.d480.s29|12-14|use|drug
DDI-DrugBank.d480.s29|16-17|of|drug
DDI-DrugBank.d480.s29|19-27|clozapine|drug
DDI-DrugBank.d480.s29|29-32|with|drug
DDI-DrugBank.d480.s29|34-38|other|drug
DDI-DrugBank.d480.s29|40-44|drugs|drug
DDI-DrugBank.d480.s29|46-56|metabolized|drug
DDI-DrugBank.d480.s29|58-59|by|drug
DDI-DrugBank.d480.s29|61-70|cytochrome|drug
DDI-DrugBank.d480.s29|72-75|P450|drug
DDI-DrugBank.d480.s29|77-79|2D6|drug
DDI-DrugBank.d480.s29|81-83|may|drug
DDI-DrugBank.d480.s29|85-91|require|drug
DDI-DrugBank.d480.s29|93-97|lower|drug
DDI-DrugBank.d480.s29|99-103|doses|drug
DDI-DrugBank.d480.s29|105-108|than|drug
DDI-DrugBank.d480.s29|110-116|usually|drug
DDI-DrugBank.d480.s29|118-127|prescribed|drug
DDI-DrugBank.d480.s29|129-131|for|drug
DDI-DrugBank.d480.s29|133-138|either|drug
DDI-DrugBank.d480.s29|140-148|clozapine|drug
DDI-DrugBank.d480.s29|150-151|or|drug
DDI-DrugBank.d480.s29|153-155|the|drug
DDI-DrugBank.d480.s29|157-161|other|drug
DDI-DrugBank.d480.s29|163-166|drug|drug
DDI-DrugBank.d480.s29|167-167|.|drug
DDI-DrugBank.d480.s30|0-8|Therefore|drug
DDI-DrugBank.d480.s30|9-9|,|drug
DDI-DrugBank.d480.s30|11-27|co-administration|drug
DDI-DrugBank.d480.s30|29-30|of|drug
DDI-DrugBank.d480.s30|32-40|clozapine|drug
DDI-DrugBank.d480.s30|42-45|with|drug
DDI-DrugBank.d480.s30|47-51|other|drug
DDI-DrugBank.d480.s30|53-57|drugs|drug
DDI-DrugBank.d480.s30|59-62|that|drug
DDI-DrugBank.d480.s30|64-66|are|drug
DDI-DrugBank.d480.s30|68-78|metabolized|drug
DDI-DrugBank.d480.s30|80-81|by|drug
DDI-DrugBank.d480.s30|83-86|this|drug
DDI-DrugBank.d480.s30|88-94|isozyme|drug
DDI-DrugBank.d480.s30|95-95|,|drug
DDI-DrugBank.d480.s30|97-105|including|drug
DDI-DrugBank.d480.s30|107-121|antidepressants|drug
DDI-DrugBank.d480.s30|122-122|,|drug
DDI-DrugBank.d480.s30|124-137|phenothiazines|drug
DDI-DrugBank.d480.s30|138-138|,|drug
DDI-DrugBank.d480.s30|140-152|carbamazepine|drug
DDI-DrugBank.d480.s30|153-153|,|drug
DDI-DrugBank.d480.s30|155-157|and|drug
DDI-DrugBank.d480.s30|159-162|Type|drug
DDI-DrugBank.d480.s30|164-165|1C|drug
DDI-DrugBank.d480.s30|167-181|antiarrhythmics|drug
DDI-DrugBank.d480.s30|183-183|(|drug
DDI-DrugBank.d480.s30|184-187|e.g.|drug
DDI-DrugBank.d480.s30|188-188|,|drug
DDI-DrugBank.d480.s30|190-200|propafenone|drug
DDI-DrugBank.d480.s30|201-201|,|drug
DDI-DrugBank.d480.s30|203-212|flecainide|drug
DDI-DrugBank.d480.s30|214-216|and|drug
DDI-DrugBank.d480.s30|218-226|encainide|drug
DDI-DrugBank.d480.s30|227-227|)|drug
DDI-DrugBank.d480.s30|228-228|,|drug
DDI-DrugBank.d480.s30|230-231|or|drug
DDI-DrugBank.d480.s30|233-236|that|drug
DDI-DrugBank.d480.s30|238-244|inhibit|drug
DDI-DrugBank.d480.s30|246-249|this|drug
DDI-DrugBank.d480.s30|251-256|enzyme|drug
DDI-DrugBank.d480.s30|258-258|(|drug
DDI-DrugBank.d480.s30|259-262|e.g.|drug
DDI-DrugBank.d480.s30|263-263|,|drug
DDI-DrugBank.d480.s30|265-273|quinidine|drug
DDI-DrugBank.d480.s30|274-274|)|drug
DDI-DrugBank.d480.s30|275-275|,|drug
DDI-DrugBank.d480.s30|277-282|should|drug
DDI-DrugBank.d480.s30|284-285|be|drug
DDI-DrugBank.d480.s30|287-296|approached|drug
DDI-DrugBank.d480.s30|298-301|with|drug
DDI-DrugBank.d480.s30|303-309|caution|drug
DDI-DrugBank.d480.s30|310-310|.|drug
DDI-DrugBank.d751.s0|0-8|AGGRASTAT|drug
DDI-DrugBank.d751.s0|10-12|has|drug
DDI-DrugBank.d751.s0|14-17|been|drug
DDI-DrugBank.d751.s0|19-25|studied|drug
DDI-DrugBank.d751.s0|27-28|on|drug
DDI-DrugBank.d751.s0|30-30|a|drug
DDI-DrugBank.d751.s0|32-41|background|drug
DDI-DrugBank.d751.s0|43-44|of|drug
DDI-DrugBank.d751.s0|46-52|aspirin|drug
DDI-DrugBank.d751.s0|54-56|and|drug
DDI-DrugBank.d751.s0|58-64|heparin|drug
DDI-DrugBank.d751.s0|65-65|.|drug
DDI-DrugBank.d751.s1|0-2|The|drug
DDI-DrugBank.d751.s1|4-6|use|drug
DDI-DrugBank.d751.s1|8-9|of|drug
DDI-DrugBank.d751.s1|11-19|AGGRASTAT|drug
DDI-DrugBank.d751.s1|20-20|,|drug
DDI-DrugBank.d751.s1|22-23|in|drug
DDI-DrugBank.d751.s1|25-35|combination|drug
DDI-DrugBank.d751.s1|37-40|with|drug
DDI-DrugBank.d751.s1|42-48|heparin|drug
DDI-DrugBank.d751.s1|50-52|and|drug
DDI-DrugBank.d751.s1|54-60|aspirin|drug
DDI-DrugBank.d751.s1|61-61|,|drug
DDI-DrugBank.d751.s1|63-65|has|drug
DDI-DrugBank.d751.s1|67-70|been|drug
DDI-DrugBank.d751.s1|72-81|associated|drug
DDI-DrugBank.d751.s1|83-86|with|drug
DDI-DrugBank.d751.s1|88-89|an|drug
DDI-DrugBank.d751.s1|91-98|increase|drug
DDI-DrugBank.d751.s1|100-101|in|drug
DDI-DrugBank.d751.s1|103-110|bleeding|drug
DDI-DrugBank.d751.s1|112-119|compared|drug
DDI-DrugBank.d751.s1|121-122|to|drug
DDI-DrugBank.d751.s1|124-130|heparin|drug
DDI-DrugBank.d751.s1|132-134|and|drug
DDI-DrugBank.d751.s1|136-142|aspirin|drug
DDI-DrugBank.d751.s1|144-148|alone|drug
DDI-DrugBank.d751.s1|150-150|(|drug
DDI-DrugBank.d751.s1|151-153|see|drug
DDI-DrugBank.d700.s0|0-7|Antacids|drug
DDI-DrugBank.d700.s0|8-8|:|drug
DDI-DrugBank.d700.s0|10-19|Absorption|drug
DDI-DrugBank.d700.s0|21-22|of|drug
DDI-DrugBank.d700.s0|24-24|a|drug
DDI-DrugBank.d700.s0|26-31|single|drug
DDI-DrugBank.d700.s0|33-36|dose|drug
DDI-DrugBank.d700.s0|38-39|of|drug
DDI-DrugBank.d700.s0|41-48|Myfortic|drug
DDI-DrugBank.d700.s0|50-52|was|drug
DDI-DrugBank.d700.s0|54-62|decreased|drug
DDI-DrugBank.d700.s0|64-67|when|drug
DDI-DrugBank.d700.s0|69-80|administered|drug
DDI-DrugBank.d700.s0|82-83|to|drug
DDI-DrugBank.d700.s0|85-86|12|drug
DDI-DrugBank.d700.s0|88-93|stable|drug
DDI-DrugBank.d700.s0|95-99|renal|drug
DDI-DrugBank.d700.s0|101-110|transplant|drug
DDI-DrugBank.d700.s0|112-119|patients|drug
DDI-DrugBank.d700.s0|121-124|also|drug
DDI-DrugBank.d700.s0|126-131|taking|drug
DDI-DrugBank.d700.s0|133-150|magnesium-aluminum|drug
DDI-DrugBank.d700.s0|152-161|containing|drug
DDI-DrugBank.d700.s0|163-170|antacids|drug
DDI-DrugBank.d700.s0|172-172|(|drug
DDI-DrugBank.d700.s0|173-174|30|drug
DDI-DrugBank.d700.s0|176-177|mL|drug
DDI-DrugBank.d700.s0|178-178|)|drug
DDI-DrugBank.d700.s0|179-179|:|drug
DDI-DrugBank.d700.s0|181-183|the|drug
DDI-DrugBank.d700.s0|185-188|mean|drug
DDI-DrugBank.d700.s0|190-193|Cmax|drug
DDI-DrugBank.d700.s0|195-197|and|drug
DDI-DrugBank.d700.s0|199-201|AUC|drug
DDI-DrugBank.d700.s0|202-202|(|drug
DDI-DrugBank.d700.s0|203-205|0-t|drug
DDI-DrugBank.d700.s0|206-206|)|drug
DDI-DrugBank.d700.s0|208-213|values|drug
DDI-DrugBank.d700.s0|215-217|for|drug
DDI-DrugBank.d700.s0|219-221|MPA|drug
DDI-DrugBank.d700.s0|223-226|were|drug
DDI-DrugBank.d700.s0|228-229|25|drug
DDI-DrugBank.d700.s0|230-230|%|drug
DDI-DrugBank.d700.s0|232-234|and|drug
DDI-DrugBank.d700.s0|236-237|37|drug
DDI-DrugBank.d700.s0|238-238|%|drug
DDI-DrugBank.d700.s0|240-244|lower|drug
DDI-DrugBank.d700.s0|245-245|,|drug
DDI-DrugBank.d700.s0|247-258|respectively|drug
DDI-DrugBank.d700.s0|259-259|,|drug
DDI-DrugBank.d700.s0|261-264|than|drug
DDI-DrugBank.d700.s0|266-269|when|drug
DDI-DrugBank.d700.s0|271-278|Myfortic|drug
DDI-DrugBank.d700.s0|280-282|was|drug
DDI-DrugBank.d700.s0|284-295|administered|drug
DDI-DrugBank.d700.s0|297-301|alone|drug
DDI-DrugBank.d700.s0|303-307|under|drug
DDI-DrugBank.d700.s0|309-315|fasting|drug
DDI-DrugBank.d700.s0|317-326|conditions|drug
DDI-DrugBank.d700.s0|327-327|.|drug
DDI-DrugBank.d700.s1|0-1|It|drug
DDI-DrugBank.d700.s1|3-4|is|drug
DDI-DrugBank.d700.s1|6-16|recommended|drug
DDI-DrugBank.d700.s1|18-21|that|drug
DDI-DrugBank.d700.s1|23-30|Myfortic|drug
DDI-DrugBank.d700.s1|32-34|and|drug
DDI-DrugBank.d700.s1|36-43|antacids|drug
DDI-DrugBank.d700.s1|45-47|not|drug
DDI-DrugBank.d700.s1|49-50|be|drug
DDI-DrugBank.d700.s1|52-63|administered|drug
DDI-DrugBank.d700.s1|65-78|simultaneously|drug
DDI-DrugBank.d700.s1|79-79|.|drug
DDI-DrugBank.d700.s2|0-11|Cyclosporine|drug
DDI-DrugBank.d700.s2|12-12|:|drug
DDI-DrugBank.d700.s2|14-17|When|drug
DDI-DrugBank.d700.s2|19-25|studied|drug
DDI-DrugBank.d700.s2|27-28|in|drug
DDI-DrugBank.d700.s2|30-35|stable|drug
DDI-DrugBank.d700.s2|37-41|renal|drug
DDI-DrugBank.d700.s2|43-52|transplant|drug
DDI-DrugBank.d700.s2|54-61|patients|drug
DDI-DrugBank.d700.s2|62-62|,|drug
DDI-DrugBank.d700.s2|64-75|cyclosporine|drug
DDI-DrugBank.d700.s2|76-76|,|drug
DDI-DrugBank.d700.s2|78-80|USP|drug
DDI-DrugBank.d700.s2|82-82|(|drug
DDI-DrugBank.d700.s2|83-90|MODIFIED|drug
DDI-DrugBank.d700.s2|91-91|)|drug
DDI-DrugBank.d700.s2|93-108|pharmacokinetics|drug
DDI-DrugBank.d700.s2|110-113|were|drug
DDI-DrugBank.d700.s2|115-124|unaffected|drug
DDI-DrugBank.d700.s2|126-127|by|drug
DDI-DrugBank.d700.s2|129-134|steady|drug
DDI-DrugBank.d700.s2|136-140|state|drug
DDI-DrugBank.d700.s2|142-147|dosing|drug
DDI-DrugBank.d700.s2|149-150|of|drug
DDI-DrugBank.d700.s2|152-159|Myfortic|drug
DDI-DrugBank.d700.s2|160-160|.|drug
DDI-DrugBank.d700.s3|0-20|Acyclovir/Ganciclovir|drug
DDI-DrugBank.d700.s3|21-21|:|drug
DDI-DrugBank.d700.s3|23-25|may|drug
DDI-DrugBank.d700.s3|27-28|be|drug
DDI-DrugBank.d700.s3|30-34|taken|drug
DDI-DrugBank.d700.s3|36-39|with|drug
DDI-DrugBank.d700.s3|41-48|Myfortic|drug
DDI-DrugBank.d700.s3|49-49|;|drug
DDI-DrugBank.d700.s4|0-6|however|drug
DDI-DrugBank.d700.s4|7-7|,|drug
DDI-DrugBank.d700.s4|9-14|during|drug
DDI-DrugBank.d700.s4|16-18|the|drug
DDI-DrugBank.d700.s4|20-25|period|drug
DDI-DrugBank.d700.s4|27-28|of|drug
DDI-DrugBank.d700.s4|30-38|treatment|drug
DDI-DrugBank.d700.s4|39-39|,|drug
DDI-DrugBank.d700.s4|41-50|physicians|drug
DDI-DrugBank.d700.s4|52-57|should|drug
DDI-DrugBank.d700.s4|59-65|monitor|drug
DDI-DrugBank.d700.s4|67-71|blood|drug
DDI-DrugBank.d700.s4|73-76|cell|drug
DDI-DrugBank.d700.s4|78-83|counts|drug
DDI-DrugBank.d700.s4|84-84|.|drug
DDI-DrugBank.d700.s5|0-3|Both|drug
DDI-DrugBank.d700.s5|5-25|acyclovir/ganciclovir|drug
DDI-DrugBank.d700.s5|27-29|and|drug
DDI-DrugBank.d700.s5|31-34|MPAG|drug
DDI-DrugBank.d700.s5|36-49|concentrations|drug
DDI-DrugBank.d700.s5|51-53|are|drug
DDI-DrugBank.d700.s5|55-63|increased|drug
DDI-DrugBank.d700.s5|65-66|in|drug
DDI-DrugBank.d700.s5|68-70|the|drug
DDI-DrugBank.d700.s5|72-79|presence|drug
DDI-DrugBank.d700.s5|81-82|of|drug
DDI-DrugBank.d700.s5|84-88|renal|drug
DDI-DrugBank.d700.s5|90-99|impairment|drug
DDI-DrugBank.d700.s5|100-100|,|drug
DDI-DrugBank.d700.s5|102-106|their|drug
DDI-DrugBank.d700.s5|108-118|coexistence|drug
DDI-DrugBank.d700.s5|120-122|may|drug
DDI-DrugBank.d700.s5|124-130|compete|drug
DDI-DrugBank.d700.s5|132-134|for|drug
DDI-DrugBank.d700.s5|136-142|tubular|drug
DDI-DrugBank.d700.s5|144-152|secretion|drug
DDI-DrugBank.d700.s5|154-156|and|drug
DDI-DrugBank.d700.s5|158-164|further|drug
DDI-DrugBank.d700.s5|166-173|increase|drug
DDI-DrugBank.d700.s5|175-176|in|drug
DDI-DrugBank.d700.s5|178-180|the|drug
DDI-DrugBank.d700.s5|182-195|concentrations|drug
DDI-DrugBank.d700.s5|197-198|of|drug
DDI-DrugBank.d700.s5|200-202|the|drug
DDI-DrugBank.d700.s5|204-206|two|drug
DDI-DrugBank.d700.s5|207-207|.|drug
DDI-DrugBank.d700.s6|0-25|Azathioprine/Mycophenolate|drug
DDI-DrugBank.d700.s6|27-33|Mofetil|drug
DDI-DrugBank.d700.s6|34-34|:|drug
DDI-DrugBank.d700.s6|36-40|Given|drug
DDI-DrugBank.d700.s6|42-45|that|drug
DDI-DrugBank.d700.s6|47-58|azathioprine|drug
DDI-DrugBank.d700.s6|60-62|and|drug
DDI-DrugBank.d700.s6|64-76|mycophenolate|drug
DDI-DrugBank.d700.s6|78-84|mofetil|drug
DDI-DrugBank.d700.s6|86-92|inhibit|drug
DDI-DrugBank.d700.s6|94-99|purine|drug
DDI-DrugBank.d700.s6|101-110|metabolism|drug
DDI-DrugBank.d700.s6|111-111|,|drug
DDI-DrugBank.d700.s6|113-114|it|drug
DDI-DrugBank.d700.s6|116-117|is|drug
DDI-DrugBank.d700.s6|119-129|recommended|drug
DDI-DrugBank.d700.s6|131-134|that|drug
DDI-DrugBank.d700.s6|136-143|Myfortic|drug
DDI-DrugBank.d700.s6|145-147|not|drug
DDI-DrugBank.d700.s6|149-150|be|drug
DDI-DrugBank.d700.s6|152-163|administered|drug
DDI-DrugBank.d700.s6|165-177|concomitantly|drug
DDI-DrugBank.d700.s6|179-182|with|drug
DDI-DrugBank.d700.s6|184-195|azathioprine|drug
DDI-DrugBank.d700.s6|197-198|or|drug
DDI-DrugBank.d700.s6|200-212|mycophenolate|drug
DDI-DrugBank.d700.s6|214-220|mofetil|drug
DDI-DrugBank.d700.s6|221-221|.|drug
DDI-DrugBank.d700.s7|0-13|Cholestyramine|drug
DDI-DrugBank.d700.s7|15-17|and|drug
DDI-DrugBank.d700.s7|19-23|Drugs|drug
DDI-DrugBank.d700.s7|25-28|that|drug
DDI-DrugBank.d700.s7|30-33|Bind|drug
DDI-DrugBank.d700.s7|35-38|Bile|drug
DDI-DrugBank.d700.s7|40-44|Acids|drug
DDI-DrugBank.d700.s7|45-45|:|drug
DDI-DrugBank.d700.s7|47-51|These|drug
DDI-DrugBank.d700.s7|53-57|drugs|drug
DDI-DrugBank.d700.s7|59-67|interrupt|drug
DDI-DrugBank.d700.s7|69-81|enterohepatic|drug
DDI-DrugBank.d700.s7|83-95|recirculation|drug
DDI-DrugBank.d700.s7|97-99|and|drug
DDI-DrugBank.d700.s7|101-106|reduce|drug
DDI-DrugBank.d700.s7|108-110|MPA|drug
DDI-DrugBank.d700.s7|112-119|exposure|drug
DDI-DrugBank.d700.s7|121-124|when|drug
DDI-DrugBank.d700.s7|126-139|coadministered|drug
DDI-DrugBank.d700.s7|141-144|with|drug
DDI-DrugBank.d700.s7|146-158|mycophenolate|drug
DDI-DrugBank.d700.s7|160-166|mofetil|drug
DDI-DrugBank.d700.s7|167-167|.|drug
DDI-DrugBank.d700.s8|0-8|Therefore|drug
DDI-DrugBank.d700.s8|9-9|,|drug
DDI-DrugBank.d700.s8|11-12|do|drug
DDI-DrugBank.d700.s8|14-16|not|drug
DDI-DrugBank.d700.s8|18-27|administer|drug
DDI-DrugBank.d700.s8|29-36|Myfortic|drug
DDI-DrugBank.d700.s8|38-41|with|drug
DDI-DrugBank.d700.s8|43-56|cholestyramine|drug
DDI-DrugBank.d700.s8|58-59|or|drug
DDI-DrugBank.d700.s8|61-65|other|drug
DDI-DrugBank.d700.s8|67-72|agents|drug
DDI-DrugBank.d700.s8|74-77|that|drug
DDI-DrugBank.d700.s8|79-81|may|drug
DDI-DrugBank.d700.s8|83-91|interfere|drug
DDI-DrugBank.d700.s8|93-96|with|drug
DDI-DrugBank.d700.s8|98-110|enterohepatic|drug
DDI-DrugBank.d700.s8|112-124|recirculation|drug
DDI-DrugBank.d700.s8|126-127|or|drug
DDI-DrugBank.d700.s8|129-133|drugs|drug
DDI-DrugBank.d700.s8|135-138|that|drug
DDI-DrugBank.d700.s8|140-142|may|drug
DDI-DrugBank.d700.s8|144-147|bind|drug
DDI-DrugBank.d700.s8|149-152|bile|drug
DDI-DrugBank.d700.s8|154-158|acids|drug
DDI-DrugBank.d700.s8|159-159|,|drug
DDI-DrugBank.d700.s8|161-163|for|drug
DDI-DrugBank.d700.s8|165-171|example|drug
DDI-DrugBank.d700.s8|173-176|bile|drug
DDI-DrugBank.d700.s8|178-181|acid|drug
DDI-DrugBank.d700.s8|183-194|sequestrates|drug
DDI-DrugBank.d700.s8|196-197|or|drug
DDI-DrugBank.d700.s8|199-202|oral|drug
DDI-DrugBank.d700.s8|204-212|activated|drug
DDI-DrugBank.d700.s8|214-221|charcoal|drug
DDI-DrugBank.d700.s8|222-222|,|drug
DDI-DrugBank.d700.s8|224-230|because|drug
DDI-DrugBank.d700.s8|232-233|of|drug
DDI-DrugBank.d700.s8|235-237|the|drug
DDI-DrugBank.d700.s8|239-247|potential|drug
DDI-DrugBank.d700.s8|249-250|to|drug
DDI-DrugBank.d700.s8|252-257|reduce|drug
DDI-DrugBank.d700.s8|259-261|the|drug
DDI-DrugBank.d700.s8|263-270|efficacy|drug
DDI-DrugBank.d700.s8|272-273|of|drug
DDI-DrugBank.d700.s8|275-282|Myfortic|drug
DDI-DrugBank.d700.s8|283-283|.|drug
DDI-DrugBank.d700.s9|0-3|Oral|drug
DDI-DrugBank.d700.s9|5-18|Contraceptives|drug
DDI-DrugBank.d700.s9|19-19|:|drug
DDI-DrugBank.d700.s9|21-25|Given|drug
DDI-DrugBank.d700.s9|27-29|the|drug
DDI-DrugBank.d700.s9|31-39|different|drug
DDI-DrugBank.d700.s9|41-50|metabolism|drug
DDI-DrugBank.d700.s9|52-53|of|drug
DDI-DrugBank.d700.s9|55-62|Myfortic|drug
DDI-DrugBank.d700.s9|64-66|and|drug
DDI-DrugBank.d700.s9|68-71|oral|drug
DDI-DrugBank.d700.s9|73-86|contraceptives|drug
DDI-DrugBank.d700.s9|87-87|,|drug
DDI-DrugBank.d700.s9|89-90|no|drug
DDI-DrugBank.d700.s9|92-95|drug|drug
DDI-DrugBank.d700.s9|97-107|interaction|drug
DDI-DrugBank.d700.s9|109-115|between|drug
DDI-DrugBank.d700.s9|117-121|these|drug
DDI-DrugBank.d700.s9|123-125|two|drug
DDI-DrugBank.d700.s9|127-133|classes|drug
DDI-DrugBank.d700.s9|135-136|of|drug
DDI-DrugBank.d700.s9|138-141|drug|drug
DDI-DrugBank.d700.s9|143-144|is|drug
DDI-DrugBank.d700.s9|146-153|expected|drug
DDI-DrugBank.d700.s9|154-154|.|drug
DDI-DrugBank.d700.s10|0-6|However|drug
DDI-DrugBank.d700.s10|7-7|,|drug
DDI-DrugBank.d700.s10|9-10|in|drug
DDI-DrugBank.d700.s10|12-12|a|drug
DDI-DrugBank.d700.s10|14-22|drug-drug|drug
DDI-DrugBank.d700.s10|24-34|interaction|drug
DDI-DrugBank.d700.s10|36-40|study|drug
DDI-DrugBank.d700.s10|41-41|,|drug
DDI-DrugBank.d700.s10|43-46|mean|drug
DDI-DrugBank.d700.s10|48-62|levonorgesterol|drug
DDI-DrugBank.d700.s10|64-66|AUC|drug
DDI-DrugBank.d700.s10|68-70|was|drug
DDI-DrugBank.d700.s10|72-80|decreased|drug
DDI-DrugBank.d700.s10|82-83|by|drug
DDI-DrugBank.d700.s10|85-86|15|drug
DDI-DrugBank.d700.s10|87-87|%|drug
DDI-DrugBank.d700.s10|89-92|when|drug
DDI-DrugBank.d700.s10|94-107|coadministered|drug
DDI-DrugBank.d700.s10|109-112|with|drug
DDI-DrugBank.d700.s10|114-126|mycophenolate|drug
DDI-DrugBank.d700.s10|128-134|mofetil|drug
DDI-DrugBank.d700.s10|135-135|.|drug
DDI-DrugBank.d700.s11|0-8|Therefore|drug
DDI-DrugBank.d700.s11|9-9|,|drug
DDI-DrugBank.d700.s11|11-12|it|drug
DDI-DrugBank.d700.s11|14-15|is|drug
DDI-DrugBank.d700.s11|17-27|recommended|drug
DDI-DrugBank.d700.s11|29-32|that|drug
DDI-DrugBank.d700.s11|34-37|oral|drug
DDI-DrugBank.d700.s11|39-52|contraceptives|drug
DDI-DrugBank.d700.s11|54-56|are|drug
DDI-DrugBank.d700.s11|58-60|co-|drug
DDI-DrugBank.d700.s11|62-73|administered|drug
DDI-DrugBank.d700.s11|75-78|with|drug
DDI-DrugBank.d700.s11|80-87|Myfortic|drug
DDI-DrugBank.d700.s11|89-92|with|drug
DDI-DrugBank.d700.s11|94-100|caution|drug
DDI-DrugBank.d700.s11|102-104|and|drug
DDI-DrugBank.d700.s11|106-115|additional|drug
DDI-DrugBank.d700.s11|117-121|birth|drug
DDI-DrugBank.d700.s11|123-129|control|drug
DDI-DrugBank.d700.s11|131-137|methods|drug
DDI-DrugBank.d700.s11|139-140|be|drug
DDI-DrugBank.d700.s11|142-151|considered|drug
DDI-DrugBank.d700.s11|152-152|.|drug
DDI-DrugBank.d700.s12|0-3|Live|drug
DDI-DrugBank.d700.s12|5-12|Vaccines|drug
DDI-DrugBank.d700.s12|13-13|:|drug
DDI-DrugBank.d700.s12|15-20|During|drug
DDI-DrugBank.d700.s12|22-30|treatment|drug
DDI-DrugBank.d700.s12|32-35|with|drug
DDI-DrugBank.d700.s12|37-44|Myfortic|drug
DDI-DrugBank.d700.s12|45-45|,|drug
DDI-DrugBank.d700.s12|47-49|the|drug
DDI-DrugBank.d700.s12|51-53|use|drug
DDI-DrugBank.d700.s12|55-56|of|drug
DDI-DrugBank.d700.s12|58-61|live|drug
DDI-DrugBank.d700.s12|63-72|attenuated|drug
DDI-DrugBank.d700.s12|74-81|vaccines|drug
DDI-DrugBank.d700.s12|83-88|should|drug
DDI-DrugBank.d700.s12|90-91|be|drug
DDI-DrugBank.d700.s12|93-99|avoided|drug
DDI-DrugBank.d700.s12|101-103|and|drug
DDI-DrugBank.d700.s12|105-112|patients|drug
DDI-DrugBank.d700.s12|114-119|should|drug
DDI-DrugBank.d700.s12|121-122|be|drug
DDI-DrugBank.d700.s12|124-130|advised|drug
DDI-DrugBank.d700.s12|132-135|that|drug
DDI-DrugBank.d700.s12|137-148|vaccinations|drug
DDI-DrugBank.d700.s12|150-152|may|drug
DDI-DrugBank.d700.s12|154-155|be|drug
DDI-DrugBank.d700.s12|157-160|less|drug
DDI-DrugBank.d700.s12|162-170|effective|drug
DDI-DrugBank.d700.s12|171-171|.|drug
DDI-DrugBank.d700.s13|0-8|Influenza|drug
DDI-DrugBank.d700.s13|10-20|vaccination|drug
DDI-DrugBank.d700.s13|22-24|may|drug
DDI-DrugBank.d700.s13|26-27|be|drug
DDI-DrugBank.d700.s13|29-30|of|drug
DDI-DrugBank.d700.s13|32-36|value|drug
DDI-DrugBank.d700.s13|37-37|.|drug
DDI-DrugBank.d700.s14|0-10|Prescribers|drug
DDI-DrugBank.d700.s14|12-17|should|drug
DDI-DrugBank.d700.s14|19-23|refer|drug
DDI-DrugBank.d700.s14|25-26|to|drug
DDI-DrugBank.d700.s14|28-35|national|drug
DDI-DrugBank.d700.s14|37-46|guidelines|drug
DDI-DrugBank.d700.s14|48-50|for|drug
DDI-DrugBank.d700.s14|52-60|influenza|drug
DDI-DrugBank.d700.s14|62-72|vaccination|drug
DDI-DrugBank.d700.s14|73-73|.|drug
DDI-DrugBank.d700.s15|0-4|Drugs|drug
DDI-DrugBank.d700.s15|6-9|that|drug
DDI-DrugBank.d700.s15|11-15|alter|drug
DDI-DrugBank.d700.s15|17-19|the|drug
DDI-DrugBank.d700.s15|21-36|gastrointestinal|drug
DDI-DrugBank.d700.s15|38-42|flora|drug
DDI-DrugBank.d700.s15|44-46|may|drug
DDI-DrugBank.d700.s15|48-55|interact|drug
DDI-DrugBank.d700.s15|57-60|with|drug
DDI-DrugBank.d700.s15|62-69|Myfortic|drug
DDI-DrugBank.d700.s15|71-72|by|drug
DDI-DrugBank.d700.s15|74-83|disrupting|drug
DDI-DrugBank.d700.s15|85-97|enterohepatic|drug
DDI-DrugBank.d700.s15|99-111|recirculation|drug
DDI-DrugBank.d700.s15|112-112|.|drug
DDI-DrugBank.d700.s16|0-11|Interference|drug
DDI-DrugBank.d700.s16|13-14|of|drug
DDI-DrugBank.d700.s16|16-19|MPAG|drug
DDI-DrugBank.d700.s16|21-30|hydrolysis|drug
DDI-DrugBank.d700.s16|32-34|may|drug
DDI-DrugBank.d700.s16|36-39|lead|drug
DDI-DrugBank.d700.s16|41-42|to|drug
DDI-DrugBank.d700.s16|44-47|less|drug
DDI-DrugBank.d700.s16|49-51|MPA|drug
DDI-DrugBank.d700.s16|53-61|available|drug
DDI-DrugBank.d700.s16|63-65|for|drug
DDI-DrugBank.d700.s16|67-76|absorption|drug
DDI-DrugBank.d700.s16|77-77|.|drug
DDI-DrugBank.d323.s0|0-16|Co-administration|drug
DDI-DrugBank.d323.s0|18-19|of|drug
DDI-DrugBank.d323.s0|21-27|MYOBLOC|drug
DDI-DrugBank.d323.s0|29-31|and|drug
DDI-DrugBank.d323.s0|33-47|aminoglycosides|drug
DDI-DrugBank.d323.s0|49-50|or|drug
DDI-DrugBank.d323.s0|52-56|other|drug
DDI-DrugBank.d323.s0|58-63|agents|drug
DDI-DrugBank.d323.s0|65-75|interfering|drug
DDI-DrugBank.d323.s0|77-80|with|drug
DDI-DrugBank.d323.s0|82-94|neuromuscular|drug
DDI-DrugBank.d323.s0|96-107|transmission|drug
DDI-DrugBank.d323.s0|109-109|(|drug
DDI-DrugBank.d323.s0|110-113|e.g.|drug
DDI-DrugBank.d323.s0|114-114|,|drug
DDI-DrugBank.d323.s0|116-126|curare-like|drug
DDI-DrugBank.d323.s0|128-136|compounds|drug
DDI-DrugBank.d323.s0|137-137|)|drug
DDI-DrugBank.d323.s0|139-144|should|drug
DDI-DrugBank.d323.s0|146-149|only|drug
DDI-DrugBank.d323.s0|151-152|be|drug
DDI-DrugBank.d323.s0|154-162|performed|drug
DDI-DrugBank.d323.s0|164-167|with|drug
DDI-DrugBank.d323.s0|169-175|caution|drug
DDI-DrugBank.d323.s0|177-178|as|drug
DDI-DrugBank.d323.s0|180-182|the|drug
DDI-DrugBank.d323.s0|184-189|effect|drug
DDI-DrugBank.d323.s0|191-192|of|drug
DDI-DrugBank.d323.s0|194-196|the|drug
DDI-DrugBank.d323.s0|198-202|toxin|drug
DDI-DrugBank.d323.s0|204-206|may|drug
DDI-DrugBank.d323.s0|208-209|be|drug
DDI-DrugBank.d323.s0|211-221|potentiated|drug
DDI-DrugBank.d323.s0|222-222|.|drug
DDI-DrugBank.d323.s1|0-2|The|drug
DDI-DrugBank.d323.s1|4-9|effect|drug
DDI-DrugBank.d323.s1|11-12|of|drug
DDI-DrugBank.d323.s1|14-26|administering|drug
DDI-DrugBank.d323.s1|28-36|different|drug
DDI-DrugBank.d323.s1|38-46|botulinum|drug
DDI-DrugBank.d323.s1|48-57|neurotoxin|drug
DDI-DrugBank.d323.s1|59-67|serotypes|drug
DDI-DrugBank.d323.s1|69-70|at|drug
DDI-DrugBank.d323.s1|72-74|the|drug
DDI-DrugBank.d323.s1|76-79|same|drug
DDI-DrugBank.d323.s1|81-84|time|drug
DDI-DrugBank.d323.s1|86-87|or|drug
DDI-DrugBank.d323.s1|89-94|within|drug
DDI-DrugBank.d323.s1|96-99|less|drug
DDI-DrugBank.d323.s1|101-104|than|drug
DDI-DrugBank.d323.s1|106-106|4|drug
DDI-DrugBank.d323.s1|108-113|months|drug
DDI-DrugBank.d323.s1|115-116|of|drug
DDI-DrugBank.d323.s1|118-121|each|drug
DDI-DrugBank.d323.s1|123-127|other|drug
DDI-DrugBank.d323.s1|129-130|is|drug
DDI-DrugBank.d323.s1|132-138|unknown|drug
DDI-DrugBank.d323.s1|139-139|.|drug
DDI-DrugBank.d323.s2|0-6|However|drug
DDI-DrugBank.d323.s2|7-7|,|drug
DDI-DrugBank.d323.s2|9-21|neuromuscular|drug
DDI-DrugBank.d323.s2|23-31|paralysis|drug
DDI-DrugBank.d323.s2|33-35|may|drug
DDI-DrugBank.d323.s2|37-38|be|drug
DDI-DrugBank.d323.s2|40-50|potentiated|drug
DDI-DrugBank.d323.s2|52-53|by|drug
DDI-DrugBank.d323.s2|55-71|co-administration|drug
DDI-DrugBank.d323.s2|73-74|or|drug
DDI-DrugBank.d323.s2|76-86|overlapping|drug
DDI-DrugBank.d323.s2|88-101|administration|drug
DDI-DrugBank.d323.s2|103-104|of|drug
DDI-DrugBank.d323.s2|106-114|different|drug
DDI-DrugBank.d323.s2|116-124|botulinum|drug
DDI-DrugBank.d323.s2|126-130|toxin|drug
DDI-DrugBank.d323.s2|132-140|serotypes|drug
DDI-DrugBank.d323.s2|141-141|.|drug
DDI-DrugBank.d443.s0|0-9|Uricosuric|drug
DDI-DrugBank.d443.s0|11-16|Agents|drug
DDI-DrugBank.d443.s0|17-17|:|drug
DDI-DrugBank.d443.s0|19-25|Aspirin|drug
DDI-DrugBank.d443.s0|27-29|may|drug
DDI-DrugBank.d443.s0|31-38|decrease|drug
DDI-DrugBank.d443.s0|40-42|the|drug
DDI-DrugBank.d443.s0|44-50|effects|drug
DDI-DrugBank.d443.s0|52-53|of|drug
DDI-DrugBank.d443.s0|55-64|probenecid|drug
DDI-DrugBank.d443.s0|65-65|,|drug
DDI-DrugBank.d443.s0|67-80|sulfinpyrazone|drug
DDI-DrugBank.d443.s0|81-81|,|drug
DDI-DrugBank.d443.s0|83-85|and|drug
DDI-DrugBank.d443.s0|87-100|phenylbutazone|drug
DDI-DrugBank.d443.s0|101-101|.|drug
DDI-DrugBank.d443.s1|0-6|Alcohol|drug
DDI-DrugBank.d443.s1|7-7|:|drug
DDI-DrugBank.d443.s1|9-11|Has|drug
DDI-DrugBank.d443.s1|13-13|a|drug
DDI-DrugBank.d443.s1|15-25|synergistic|drug
DDI-DrugBank.d443.s1|27-32|effect|drug
DDI-DrugBank.d443.s1|34-37|with|drug
DDI-DrugBank.d443.s1|39-45|aspirin|drug
DDI-DrugBank.d443.s1|47-48|in|drug
DDI-DrugBank.d443.s1|50-56|causing|drug
DDI-DrugBank.d443.s1|58-73|gastrointestinal|drug
DDI-DrugBank.d443.s1|75-82|bleeding|drug
DDI-DrugBank.d443.s1|83-83|.|drug
DDI-DrugBank.d443.s2|0-14|Corticosteroids|drug
DDI-DrugBank.d443.s2|15-15|:|drug
DDI-DrugBank.d443.s2|17-27|Concomitant|drug
DDI-DrugBank.d443.s2|29-42|administration|drug
DDI-DrugBank.d443.s2|44-47|with|drug
DDI-DrugBank.d443.s2|49-55|aspirin|drug
DDI-DrugBank.d443.s2|57-59|may|drug
DDI-DrugBank.d443.s2|61-68|increase|drug
DDI-DrugBank.d443.s2|70-72|the|drug
DDI-DrugBank.d443.s2|74-77|risk|drug
DDI-DrugBank.d443.s2|79-80|of|drug
DDI-DrugBank.d443.s2|82-97|gastrointestinal|drug
DDI-DrugBank.d443.s2|99-108|ulceration|drug
DDI-DrugBank.d443.s2|110-112|and|drug
DDI-DrugBank.d443.s2|114-116|may|drug
DDI-DrugBank.d443.s2|118-123|reduce|drug
DDI-DrugBank.d443.s2|125-129|serum|drug
DDI-DrugBank.d443.s2|131-140|salicylate|drug
DDI-DrugBank.d443.s2|142-147|levels|drug
DDI-DrugBank.d443.s2|148-148|.|drug
DDI-DrugBank.d443.s3|0-9|Pyrazolone|drug
DDI-DrugBank.d443.s3|11-21|Derivatives|drug
DDI-DrugBank.d443.s3|23-23|(|drug
DDI-DrugBank.d443.s3|24-37|phenylbutazone|drug
DDI-DrugBank.d443.s3|38-38|,|drug
DDI-DrugBank.d443.s3|40-54|oxyphenbutazone|drug
DDI-DrugBank.d443.s3|55-55|,|drug
DDI-DrugBank.d443.s3|57-59|and|drug
DDI-DrugBank.d443.s3|61-68|possibly|drug
DDI-DrugBank.d443.s3|70-77|dipyrone|drug
DDI-DrugBank.d443.s3|78-78|)|drug
DDI-DrugBank.d443.s3|79-79|:|drug
DDI-DrugBank.d443.s3|81-91|Concomitant|drug
DDI-DrugBank.d443.s3|93-106|administration|drug
DDI-DrugBank.d443.s3|108-111|with|drug
DDI-DrugBank.d443.s3|113-119|aspirin|drug
DDI-DrugBank.d443.s3|121-123|may|drug
DDI-DrugBank.d443.s3|125-132|increase|drug
DDI-DrugBank.d443.s3|134-136|the|drug
DDI-DrugBank.d443.s3|138-141|risk|drug
DDI-DrugBank.d443.s3|143-144|of|drug
DDI-DrugBank.d443.s3|146-161|gastrointestinal|drug
DDI-DrugBank.d443.s3|163-172|ulceration|drug
DDI-DrugBank.d443.s3|173-173|.|drug
DDI-DrugBank.d443.s4|0-11|Nonsteroidal|drug
DDI-DrugBank.d443.s4|13-28|Antiinflammatory|drug
DDI-DrugBank.d443.s4|30-35|Agents|drug
DDI-DrugBank.d443.s4|36-36|:|drug
DDI-DrugBank.d443.s4|38-44|Aspirin|drug
DDI-DrugBank.d443.s4|46-47|is|drug
DDI-DrugBank.d443.s4|49-63|contraindicated|drug
DDI-DrugBank.d443.s4|65-66|in|drug
DDI-DrugBank.d443.s4|68-75|patients|drug
DDI-DrugBank.d443.s4|77-79|who|drug
DDI-DrugBank.d443.s4|81-83|are|drug
DDI-DrugBank.d443.s4|85-98|hypersensitive|drug
DDI-DrugBank.d443.s4|100-101|to|drug
DDI-DrugBank.d443.s4|103-114|nonsteroidal|drug
DDI-DrugBank.d443.s4|116-132|anti-inflammatory|drug
DDI-DrugBank.d443.s4|134-139|agents|drug
DDI-DrugBank.d443.s4|140-140|.|drug
DDI-DrugBank.d443.s5|0-6|Urinary|drug
DDI-DrugBank.d443.s5|8-19|Alkalinizers|drug
DDI-DrugBank.d443.s5|20-20|:|drug
DDI-DrugBank.d443.s5|22-29|Decrease|drug
DDI-DrugBank.d443.s5|31-37|aspirin|drug
DDI-DrugBank.d443.s5|39-51|effectiveness|drug
DDI-DrugBank.d443.s5|53-54|by|drug
DDI-DrugBank.d443.s5|56-65|increasing|drug
DDI-DrugBank.d443.s5|67-69|the|drug
DDI-DrugBank.d443.s5|71-74|rate|drug
DDI-DrugBank.d443.s5|76-77|of|drug
DDI-DrugBank.d443.s5|79-88|salicylate|drug
DDI-DrugBank.d443.s5|90-94|renal|drug
DDI-DrugBank.d443.s5|96-104|excretion|drug
DDI-DrugBank.d443.s5|105-105|.|drug
DDI-DrugBank.d443.s6|0-12|Phenobarbital|drug
DDI-DrugBank.d443.s6|13-13|:|drug
DDI-DrugBank.d443.s6|15-23|Decreases|drug
DDI-DrugBank.d443.s6|25-31|aspirin|drug
DDI-DrugBank.d443.s6|33-45|effectiveness|drug
DDI-DrugBank.d443.s6|47-48|by|drug
DDI-DrugBank.d443.s6|50-55|enzyme|drug
DDI-DrugBank.d443.s6|57-65|induction|drug
DDI-DrugBank.d443.s6|66-66|.|drug
DDI-DrugBank.d443.s7|0-8|Phenytoin|drug
DDI-DrugBank.d443.s7|9-9|:|drug
DDI-DrugBank.d443.s7|11-15|Serum|drug
DDI-DrugBank.d443.s7|17-25|phenytoin|drug
DDI-DrugBank.d443.s7|27-32|levels|drug
DDI-DrugBank.d443.s7|34-36|may|drug
DDI-DrugBank.d443.s7|38-39|be|drug
DDI-DrugBank.d443.s7|41-49|increased|drug
DDI-DrugBank.d443.s7|51-52|by|drug
DDI-DrugBank.d443.s7|54-60|aspirin|drug
DDI-DrugBank.d443.s7|61-61|.|drug
DDI-DrugBank.d443.s8|0-10|Propranolol|drug
DDI-DrugBank.d443.s8|11-11|:|drug
DDI-DrugBank.d443.s8|13-15|May|drug
DDI-DrugBank.d443.s8|17-24|decrease|drug
DDI-DrugBank.d443.s8|26-33|aspirins|drug
DDI-DrugBank.d443.s8|35-51|anti-inflammatory|drug
DDI-DrugBank.d443.s8|53-58|action|drug
DDI-DrugBank.d443.s8|60-61|by|drug
DDI-DrugBank.d443.s8|63-71|competing|drug
DDI-DrugBank.d443.s8|73-75|for|drug
DDI-DrugBank.d443.s8|77-79|the|drug
DDI-DrugBank.d443.s8|81-84|same|drug
DDI-DrugBank.d443.s8|86-94|receptors|drug
DDI-DrugBank.d443.s8|95-95|.|drug
DDI-DrugBank.d443.s9|0-7|Antacids|drug
DDI-DrugBank.d443.s9|8-8|:|drug
DDI-DrugBank.d443.s9|10-16|Enteric|drug
DDI-DrugBank.d443.s9|18-23|Coated|drug
DDI-DrugBank.d443.s9|25-31|Aspirin|drug
DDI-DrugBank.d443.s9|33-38|should|drug
DDI-DrugBank.d443.s9|40-42|not|drug
DDI-DrugBank.d443.s9|44-45|be|drug
DDI-DrugBank.d443.s9|47-51|given|drug
DDI-DrugBank.d443.s9|53-64|concurrently|drug
DDI-DrugBank.d443.s9|66-69|with|drug
DDI-DrugBank.d443.s9|71-78|antacids|drug
DDI-DrugBank.d443.s9|79-79|,|drug
DDI-DrugBank.d443.s9|81-85|since|drug
DDI-DrugBank.d443.s9|87-88|an|drug
DDI-DrugBank.d443.s9|90-97|increase|drug
DDI-DrugBank.d443.s9|99-100|in|drug
DDI-DrugBank.d443.s9|102-104|the|drug
DDI-DrugBank.d443.s9|106-107|pH|drug
DDI-DrugBank.d443.s9|109-110|of|drug
DDI-DrugBank.d443.s9|112-114|the|drug
DDI-DrugBank.d443.s9|116-122|stomach|drug
DDI-DrugBank.d443.s9|124-126|may|drug
DDI-DrugBank.d443.s9|128-133|effect|drug
DDI-DrugBank.d443.s9|135-137|the|drug
DDI-DrugBank.d443.s9|139-145|enteric|drug
DDI-DrugBank.d443.s9|147-153|coating|drug
DDI-DrugBank.d443.s9|155-156|of|drug
DDI-DrugBank.d443.s9|158-160|the|drug
DDI-DrugBank.d443.s9|162-168|tablets|drug
DDI-DrugBank.d443.s9|169-169|.|drug
DDI-DrugBank.d716.s0|0-2|You|drug
DDI-DrugBank.d716.s0|4-6|can|drug
DDI-DrugBank.d716.s0|7-9|not|drug
DDI-DrugBank.d716.s0|11-14|take|drug
DDI-DrugBank.d716.s0|16-23|mazindol|drug
DDI-DrugBank.d716.s0|25-26|if|drug
DDI-DrugBank.d716.s0|28-30|you|drug
DDI-DrugBank.d716.s0|32-35|have|drug
DDI-DrugBank.d716.s0|37-41|taken|drug
DDI-DrugBank.d716.s0|43-43|a|drug
DDI-DrugBank.d716.s0|45-53|monoamine|drug
DDI-DrugBank.d716.s0|55-61|oxidase|drug
DDI-DrugBank.d716.s0|63-71|inhibitor|drug
DDI-DrugBank.d716.s0|73-73|(|drug
DDI-DrugBank.d716.s0|74-77|MAOI|drug
DDI-DrugBank.d716.s0|78-78|)|drug
DDI-DrugBank.d716.s0|80-83|such|drug
DDI-DrugBank.d716.s0|85-86|as|drug
DDI-DrugBank.d716.s0|88-100|isocarboxazid|drug
DDI-DrugBank.d716.s0|102-102|(|drug
DDI-DrugBank.d716.s0|103-109|Marplan|drug
DDI-DrugBank.d716.s0|110-110|)|drug
DDI-DrugBank.d716.s0|111-111|,|drug
DDI-DrugBank.d716.s0|113-127|tranylcypromine|drug
DDI-DrugBank.d716.s0|129-129|(|drug
DDI-DrugBank.d716.s0|130-136|Parnate|drug
DDI-DrugBank.d716.s0|137-137|)|drug
DDI-DrugBank.d716.s0|138-138|,|drug
DDI-DrugBank.d716.s0|140-141|or|drug
DDI-DrugBank.d716.s0|143-152|phenelzine|drug
DDI-DrugBank.d716.s0|154-154|(|drug
DDI-DrugBank.d716.s0|155-160|Nardil|drug
DDI-DrugBank.d716.s0|161-161|)|drug
DDI-DrugBank.d716.s0|163-164|in|drug
DDI-DrugBank.d716.s0|166-168|the|drug
DDI-DrugBank.d716.s0|170-173|last|drug
DDI-DrugBank.d716.s0|175-176|14|drug
DDI-DrugBank.d716.s0|178-181|days|drug
DDI-DrugBank.d716.s0|182-182|.|drug
DDI-DrugBank.d716.s1|0-6|Changes|drug
DDI-DrugBank.d716.s1|8-9|in|drug
DDI-DrugBank.d716.s1|11-17|insulin|drug
DDI-DrugBank.d716.s1|19-21|and|drug
DDI-DrugBank.d716.s1|23-27|other|drug
DDI-DrugBank.d716.s1|29-36|diabetes|drug
DDI-DrugBank.d716.s1|38-41|drug|drug
DDI-DrugBank.d716.s1|43-51|therapies|drug
DDI-DrugBank.d716.s1|53-55|may|drug
DDI-DrugBank.d716.s1|57-58|be|drug
DDI-DrugBank.d716.s1|60-68|necessary|drug
DDI-DrugBank.d716.s1|70-75|during|drug
DDI-DrugBank.d716.s1|77-85|treatment|drug
DDI-DrugBank.d716.s1|87-90|with|drug
DDI-DrugBank.d716.s1|92-99|mazindol|drug
DDI-DrugBank.d716.s1|100-100|.|drug
DDI-DrugBank.d716.s2|0-7|Mazindol|drug
DDI-DrugBank.d716.s2|9-11|may|drug
DDI-DrugBank.d716.s2|13-18|reduce|drug
DDI-DrugBank.d716.s2|20-22|the|drug
DDI-DrugBank.d716.s2|24-30|effects|drug
DDI-DrugBank.d716.s2|32-33|of|drug
DDI-DrugBank.d716.s2|35-46|guanethidine|drug
DDI-DrugBank.d716.s2|48-48|(|drug
DDI-DrugBank.d716.s2|49-55|Ismelin|drug
DDI-DrugBank.d716.s2|56-56|)|drug
DDI-DrugBank.d716.s2|57-57|.|drug
DDI-DrugBank.d716.s3|0-3|This|drug
DDI-DrugBank.d716.s3|5-9|could|drug
DDI-DrugBank.d716.s3|11-14|lead|drug
DDI-DrugBank.d716.s3|16-17|to|drug
DDI-DrugBank.d716.s3|19-20|an|drug
DDI-DrugBank.d716.s3|22-29|increase|drug
DDI-DrugBank.d716.s3|31-32|in|drug
DDI-DrugBank.d716.s3|34-38|blood|drug
DDI-DrugBank.d716.s3|40-47|pressure|drug
DDI-DrugBank.d716.s3|48-48|.|drug
DDI-DrugBank.d716.s4|0-3|Tell|drug
DDI-DrugBank.d716.s4|5-8|your|drug
DDI-DrugBank.d716.s4|10-15|doctor|drug
DDI-DrugBank.d716.s4|17-18|if|drug
DDI-DrugBank.d716.s4|20-22|you|drug
DDI-DrugBank.d716.s4|24-26|are|drug
DDI-DrugBank.d716.s4|28-33|taking|drug
DDI-DrugBank.d716.s4|35-46|guanethidine|drug
DDI-DrugBank.d716.s4|47-47|.|drug
DDI-DrugBank.d716.s5|0-5|Before|drug
DDI-DrugBank.d716.s5|7-12|taking|drug
DDI-DrugBank.d716.s5|14-17|this|drug
DDI-DrugBank.d716.s5|19-28|medication|drug
DDI-DrugBank.d716.s5|29-29|,|drug
DDI-DrugBank.d716.s5|31-34|tell|drug
DDI-DrugBank.d716.s5|36-39|your|drug
DDI-DrugBank.d716.s5|41-46|doctor|drug
DDI-DrugBank.d716.s5|48-49|if|drug
DDI-DrugBank.d716.s5|51-53|you|drug
DDI-DrugBank.d716.s5|55-57|are|drug
DDI-DrugBank.d716.s5|59-64|taking|drug
DDI-DrugBank.d716.s5|66-66|a|drug
DDI-DrugBank.d716.s5|68-76|tricyclic|drug
DDI-DrugBank.d716.s5|78-91|antidepressant|drug
DDI-DrugBank.d716.s5|93-96|such|drug
DDI-DrugBank.d716.s5|98-99|as|drug
DDI-DrugBank.d716.s5|101-113|amitriptyline|drug
DDI-DrugBank.d716.s5|115-115|(|drug
DDI-DrugBank.d716.s5|116-121|Elavil|drug
DDI-DrugBank.d716.s5|122-122|)|drug
DDI-DrugBank.d716.s5|123-123|,|drug
DDI-DrugBank.d716.s5|125-133|amoxapine|drug
DDI-DrugBank.d716.s5|135-135|(|drug
DDI-DrugBank.d716.s5|136-142|Asendin|drug
DDI-DrugBank.d716.s5|143-143|)|drug
DDI-DrugBank.d716.s5|144-144|,|drug
DDI-DrugBank.d716.s5|146-152|doxepin|drug
DDI-DrugBank.d716.s5|154-154|(|drug
DDI-DrugBank.d716.s5|155-162|Sinequan|drug
DDI-DrugBank.d716.s5|163-163|)|drug
DDI-DrugBank.d716.s5|164-164|,|drug
DDI-DrugBank.d716.s5|166-178|nortriptyline|drug
DDI-DrugBank.d716.s5|180-180|(|drug
DDI-DrugBank.d716.s5|181-187|Pamelor|drug
DDI-DrugBank.d716.s5|188-188|)|drug
DDI-DrugBank.d716.s5|189-189|,|drug
DDI-DrugBank.d716.s5|191-200|imipramine|drug
DDI-DrugBank.d716.s5|202-202|(|drug
DDI-DrugBank.d716.s5|203-210|Tofranil|drug
DDI-DrugBank.d716.s5|211-211|)|drug
DDI-DrugBank.d716.s5|212-212|,|drug
DDI-DrugBank.d716.s5|214-225|clomipramine|drug
DDI-DrugBank.d716.s5|227-227|(|drug
DDI-DrugBank.d716.s5|228-236|Anafranil|drug
DDI-DrugBank.d716.s5|237-237|)|drug
DDI-DrugBank.d716.s5|238-238|,|drug
DDI-DrugBank.d716.s5|240-252|protriptyline|drug
DDI-DrugBank.d716.s5|254-254|(|drug
DDI-DrugBank.d716.s5|255-262|Vivactil|drug
DDI-DrugBank.d716.s5|263-263|)|drug
DDI-DrugBank.d716.s5|264-264|,|drug
DDI-DrugBank.d716.s5|266-267|or|drug
DDI-DrugBank.d716.s5|269-279|desipramine|drug
DDI-DrugBank.d716.s5|281-281|(|drug
DDI-DrugBank.d716.s5|282-290|Norpramin|drug
DDI-DrugBank.d716.s5|291-291|)|drug
DDI-DrugBank.d716.s5|292-292|.|drug
DDI-DrugBank.d716.s6|0-4|These|drug
DDI-DrugBank.d716.s6|6-10|drugs|drug
DDI-DrugBank.d716.s6|12-14|may|drug
DDI-DrugBank.d716.s6|16-23|decrease|drug
DDI-DrugBank.d716.s6|25-27|the|drug
DDI-DrugBank.d716.s6|29-35|effects|drug
DDI-DrugBank.d716.s6|37-38|of|drug
DDI-DrugBank.d716.s6|40-47|mazindol|drug
DDI-DrugBank.d716.s6|48-48|.|drug
DDI-DrugBank.d578.s0|0-2|The|drug
DDI-DrugBank.d578.s0|4-18|pharmacokinetic|drug
DDI-DrugBank.d578.s0|20-31|interactions|drug
DDI-DrugBank.d578.s0|33-38|listed|drug
DDI-DrugBank.d578.s0|40-44|below|drug
DDI-DrugBank.d578.s0|46-48|are|drug
DDI-DrugBank.d578.s0|50-60|potentially|drug
DDI-DrugBank.d578.s0|62-71|clinically|drug
DDI-DrugBank.d578.s0|73-81|important|drug
DDI-DrugBank.d578.s0|82-82|.|drug
DDI-DrugBank.d578.s1|0-5|Mutual|drug
DDI-DrugBank.d578.s1|7-16|inhibition|drug
DDI-DrugBank.d578.s1|18-19|of|drug
DDI-DrugBank.d578.s1|21-30|metabolism|drug
DDI-DrugBank.d578.s1|32-37|occurs|drug
DDI-DrugBank.d578.s1|39-42|with|drug
DDI-DrugBank.d578.s1|44-53|concurrent|drug
DDI-DrugBank.d578.s1|55-57|use|drug
DDI-DrugBank.d578.s1|59-60|of|drug
DDI-DrugBank.d578.s1|62-72|cyclosporin|drug
DDI-DrugBank.d578.s1|74-76|and|drug
DDI-DrugBank.d578.s1|78-95|methylprednisolone|drug
DDI-DrugBank.d578.s1|96-96|;|drug
DDI-DrugBank.d578.s2|0-8|therefore|drug
DDI-DrugBank.d578.s2|9-9|,|drug
DDI-DrugBank.d578.s2|11-12|it|drug
DDI-DrugBank.d578.s2|14-15|is|drug
DDI-DrugBank.d578.s2|17-24|possible|drug
DDI-DrugBank.d578.s2|26-29|that|drug
DDI-DrugBank.d578.s2|31-37|adverse|drug
DDI-DrugBank.d578.s2|39-44|events|drug
DDI-DrugBank.d578.s2|46-55|associated|drug
DDI-DrugBank.d578.s2|57-60|with|drug
DDI-DrugBank.d578.s2|62-64|the|drug
DDI-DrugBank.d578.s2|66-75|individual|drug
DDI-DrugBank.d578.s2|77-79|use|drug
DDI-DrugBank.d578.s2|81-82|of|drug
DDI-DrugBank.d578.s2|84-89|either|drug
DDI-DrugBank.d578.s2|91-94|drug|drug
DDI-DrugBank.d578.s2|96-98|may|drug
DDI-DrugBank.d578.s2|100-101|be|drug
DDI-DrugBank.d578.s2|103-106|more|drug
DDI-DrugBank.d578.s2|108-110|apt|drug
DDI-DrugBank.d578.s2|112-113|to|drug
DDI-DrugBank.d578.s2|115-119|occur|drug
DDI-DrugBank.d578.s2|120-120|.|drug
DDI-DrugBank.d578.s3|0-10|convulsions|drug
DDI-DrugBank.d578.s3|12-15|have|drug
DDI-DrugBank.d578.s3|17-20|been|drug
DDI-DrugBank.d578.s3|22-29|reported|drug
DDI-DrugBank.d578.s3|31-34|with|drug
DDI-DrugBank.d578.s3|36-45|concurrent|drug
DDI-DrugBank.d578.s3|47-49|use|drug
DDI-DrugBank.d578.s3|51-52|of|drug
DDI-DrugBank.d578.s3|54-71|methylprednisolone|drug
DDI-DrugBank.d578.s3|73-75|and|drug
DDI-DrugBank.d578.s3|77-87|cyclosporin|drug
DDI-DrugBank.d578.s3|88-88|.|drug
DDI-DrugBank.d578.s4|0-4|Drugs|drug
DDI-DrugBank.d578.s4|6-9|that|drug
DDI-DrugBank.d578.s4|11-16|induce|drug
DDI-DrugBank.d578.s4|18-24|hepatic|drug
DDI-DrugBank.d578.s4|26-32|enzymes|drug
DDI-DrugBank.d578.s4|34-37|such|drug
DDI-DrugBank.d578.s4|39-40|as|drug
DDI-DrugBank.d578.s4|42-54|phenobarbital|drug
DDI-DrugBank.d578.s4|55-55|,|drug
DDI-DrugBank.d578.s4|57-65|phenytoin|drug
DDI-DrugBank.d578.s4|66-66|,|drug
DDI-DrugBank.d578.s4|68-70|and|drug
DDI-DrugBank.d578.s4|72-79|rifampin|drug
DDI-DrugBank.d578.s4|81-83|may|drug
DDI-DrugBank.d578.s4|85-92|increase|drug
DDI-DrugBank.d578.s4|94-96|the|drug
DDI-DrugBank.d578.s4|98-106|clearance|drug
DDI-DrugBank.d578.s4|108-109|of|drug
DDI-DrugBank.d578.s4|111-128|methylprednisolone|drug
DDI-DrugBank.d578.s4|130-132|and|drug
DDI-DrugBank.d578.s4|134-136|may|drug
DDI-DrugBank.d578.s4|138-144|require|drug
DDI-DrugBank.d578.s4|146-154|increased|drug
DDI-DrugBank.d578.s4|156-157|in|drug
DDI-DrugBank.d578.s4|159-176|methylprednisolone|drug
DDI-DrugBank.d578.s4|178-181|dose|drug
DDI-DrugBank.d578.s4|183-184|to|drug
DDI-DrugBank.d578.s4|186-192|achieve|drug
DDI-DrugBank.d578.s4|194-196|the|drug
DDI-DrugBank.d578.s4|198-204|desired|drug
DDI-DrugBank.d578.s4|206-213|response|drug
DDI-DrugBank.d578.s4|214-214|.|drug
DDI-DrugBank.d578.s5|0-4|Drugs|drug
DDI-DrugBank.d578.s5|6-9|such|drug
DDI-DrugBank.d578.s5|11-12|as|drug
DDI-DrugBank.d578.s5|14-27|troleandomycin|drug
DDI-DrugBank.d578.s5|29-31|and|drug
DDI-DrugBank.d578.s5|33-44|ketoconazole|drug
DDI-DrugBank.d578.s5|46-48|may|drug
DDI-DrugBank.d578.s5|50-56|inhibit|drug
DDI-DrugBank.d578.s5|58-60|the|drug
DDI-DrugBank.d578.s5|62-71|metabolism|drug
DDI-DrugBank.d578.s5|73-74|of|drug
DDI-DrugBank.d578.s5|76-93|methylprednisolone|drug
DDI-DrugBank.d578.s5|95-97|and|drug
DDI-DrugBank.d578.s5|99-102|thus|drug
DDI-DrugBank.d578.s5|104-111|decrease|drug
DDI-DrugBank.d578.s5|113-115|its|drug
DDI-DrugBank.d578.s5|117-125|clearance|drug
DDI-DrugBank.d578.s5|126-126|.|drug
DDI-DrugBank.d578.s6|0-8|Therefore|drug
DDI-DrugBank.d578.s6|9-9|,|drug
DDI-DrugBank.d578.s6|11-13|the|drug
DDI-DrugBank.d578.s6|15-18|dose|drug
DDI-DrugBank.d578.s6|20-21|of|drug
DDI-DrugBank.d578.s6|23-40|methylprednisolone|drug
DDI-DrugBank.d578.s6|42-47|should|drug
DDI-DrugBank.d578.s6|49-50|be|drug
DDI-DrugBank.d578.s6|52-59|titrated|drug
DDI-DrugBank.d578.s6|61-62|to|drug
DDI-DrugBank.d578.s6|64-68|avoid|drug
DDI-DrugBank.d578.s6|70-76|steroid|drug
DDI-DrugBank.d578.s6|78-85|toxicity|drug
DDI-DrugBank.d578.s6|86-86|.|drug
DDI-DrugBank.d578.s7|0-17|Methylprednisolone|drug
DDI-DrugBank.d578.s7|19-21|may|drug
DDI-DrugBank.d578.s7|23-30|increase|drug
DDI-DrugBank.d578.s7|32-34|the|drug
DDI-DrugBank.d578.s7|36-44|clearance|drug
DDI-DrugBank.d578.s7|46-47|of|drug
DDI-DrugBank.d578.s7|49-55|chronic|drug
DDI-DrugBank.d578.s7|57-60|high|drug
DDI-DrugBank.d578.s7|62-65|dose|drug
DDI-DrugBank.d578.s7|67-73|aspirin|drug
DDI-DrugBank.d578.s7|74-74|.|drug
DDI-DrugBank.d578.s8|0-3|This|drug
DDI-DrugBank.d578.s8|5-9|could|drug
DDI-DrugBank.d578.s8|11-14|lead|drug
DDI-DrugBank.d578.s8|16-17|to|drug
DDI-DrugBank.d578.s8|19-27|decreased|drug
DDI-DrugBank.d578.s8|29-38|salicylate|drug
DDI-DrugBank.d578.s8|40-44|serum|drug
DDI-DrugBank.d578.s8|46-51|levels|drug
DDI-DrugBank.d578.s8|53-54|or|drug
DDI-DrugBank.d578.s8|56-63|increase|drug
DDI-DrugBank.d578.s8|65-67|the|drug
DDI-DrugBank.d578.s8|69-72|risk|drug
DDI-DrugBank.d578.s8|74-75|of|drug
DDI-DrugBank.d578.s8|77-86|salicylate|drug
DDI-DrugBank.d578.s8|88-95|toxicity|drug
DDI-DrugBank.d578.s8|97-100|when|drug
DDI-DrugBank.d578.s8|102-119|methylprednisolone|drug
DDI-DrugBank.d578.s8|121-122|is|drug
DDI-DrugBank.d578.s8|124-132|withdrawn|drug
DDI-DrugBank.d578.s8|133-133|.|drug
DDI-DrugBank.d578.s9|0-6|Aspirin|drug
DDI-DrugBank.d578.s9|8-13|should|drug
DDI-DrugBank.d578.s9|15-16|be|drug
DDI-DrugBank.d578.s9|18-21|used|drug
DDI-DrugBank.d578.s9|23-32|cautiously|drug
DDI-DrugBank.d578.s9|34-35|in|drug
DDI-DrugBank.d578.s9|37-47|conjunction|drug
DDI-DrugBank.d578.s9|49-52|with|drug
DDI-DrugBank.d578.s9|54-68|corticosteroids|drug
DDI-DrugBank.d578.s9|70-71|in|drug
DDI-DrugBank.d578.s9|73-80|patients|drug
DDI-DrugBank.d578.s9|82-90|suffering|drug
DDI-DrugBank.d578.s9|92-95|from|drug
DDI-DrugBank.d578.s9|97-115|hypoprothrombinemia|drug
DDI-DrugBank.d578.s9|116-116|.|drug
DDI-DrugBank.d578.s10|0-2|The|drug
DDI-DrugBank.d578.s10|4-9|effect|drug
DDI-DrugBank.d578.s10|11-12|of|drug
DDI-DrugBank.d578.s10|14-31|methylprednisolone|drug
DDI-DrugBank.d578.s10|33-34|on|drug
DDI-DrugBank.d578.s10|36-39|oral|drug
DDI-DrugBank.d578.s10|41-54|anticoagulants|drug
DDI-DrugBank.d578.s10|56-57|is|drug
DDI-DrugBank.d578.s10|59-66|variable|drug
DDI-DrugBank.d578.s10|67-67|.|drug
DDI-DrugBank.d578.s11|0-4|There|drug
DDI-DrugBank.d578.s11|6-8|are|drug
DDI-DrugBank.d578.s11|10-16|reports|drug
DDI-DrugBank.d578.s11|18-19|of|drug
DDI-DrugBank.d578.s11|21-28|enhanced|drug
DDI-DrugBank.d578.s11|30-31|as|drug
DDI-DrugBank.d578.s11|33-36|well|drug
DDI-DrugBank.d578.s11|38-39|as|drug
DDI-DrugBank.d578.s11|41-50|diminished|drug
DDI-DrugBank.d578.s11|52-58|effects|drug
DDI-DrugBank.d578.s11|60-61|of|drug
DDI-DrugBank.d578.s11|63-75|anticoagulant|drug
DDI-DrugBank.d578.s11|77-80|when|drug
DDI-DrugBank.d578.s11|82-86|given|drug
DDI-DrugBank.d578.s11|88-99|concurrently|drug
DDI-DrugBank.d578.s11|101-104|with|drug
DDI-DrugBank.d578.s11|106-120|corticosteroids|drug
DDI-DrugBank.d578.s11|121-121|.|drug
DDI-DrugBank.d578.s12|0-8|Therefore|drug
DDI-DrugBank.d578.s12|9-9|,|drug
DDI-DrugBank.d578.s12|11-21|coagulation|drug
DDI-DrugBank.d578.s12|23-29|indices|drug
DDI-DrugBank.d578.s12|31-36|should|drug
DDI-DrugBank.d578.s12|38-39|be|drug
DDI-DrugBank.d578.s12|41-49|monitored|drug
DDI-DrugBank.d578.s12|51-52|to|drug
DDI-DrugBank.d578.s12|54-61|maintain|drug
DDI-DrugBank.d578.s12|63-65|the|drug
DDI-DrugBank.d578.s12|67-73|desired|drug
DDI-DrugBank.d578.s12|75-87|anticoagulant|drug
DDI-DrugBank.d578.s12|89-94|effect|drug
DDI-DrugBank.d578.s12|95-95|.|drug
DDI-MedLine.d34.s0|0-11|Interactions|drug
DDI-MedLine.d34.s0|13-14|of|drug
DDI-MedLine.d34.s0|16-21|cobalt|drug
DDI-MedLine.d34.s0|23-25|and|drug
DDI-MedLine.d34.s0|27-30|iron|drug
DDI-MedLine.d34.s0|32-33|in|drug
DDI-MedLine.d34.s0|35-44|absorption|drug
DDI-MedLine.d34.s0|46-48|and|drug
DDI-MedLine.d34.s0|50-58|retention|drug
DDI-MedLine.d34.s0|59-59|.|drug
DDI-MedLine.d34.s1|0-2|The|drug
DDI-MedLine.d34.s1|4-10|effects|drug
DDI-MedLine.d34.s1|12-13|of|drug
DDI-MedLine.d34.s1|15-27|supplementary|drug
DDI-MedLine.d34.s1|29-32|oral|drug
DDI-MedLine.d34.s1|34-39|cobalt|drug
DDI-MedLine.d34.s1|41-43|and|drug
DDI-MedLine.d34.s1|45-48|iron|drug
DDI-MedLine.d34.s1|49-49|,|drug
DDI-MedLine.d34.s1|51-52|as|drug
DDI-MedLine.d34.s1|54-57|well|drug
DDI-MedLine.d34.s1|59-60|as|drug
DDI-MedLine.d34.s1|62-64|the|drug
DDI-MedLine.d34.s1|66-76|interaction|drug
DDI-MedLine.d34.s1|78-84|between|drug
DDI-MedLine.d34.s1|86-89|both|drug
DDI-MedLine.d34.s1|91-92|at|drug
DDI-MedLine.d34.s1|94-96|the|drug
DDI-MedLine.d34.s1|98-107|absorption|drug
DDI-MedLine.d34.s1|109-112|site|drug
DDI-MedLine.d34.s1|113-113|,|drug
DDI-MedLine.d34.s1|115-119|fecal|drug
DDI-MedLine.d34.s1|121-123|and|drug
DDI-MedLine.d34.s1|125-131|urinary|drug
DDI-MedLine.d34.s1|133-141|excretion|drug
DDI-MedLine.d34.s1|143-144|as|drug
DDI-MedLine.d34.s1|146-149|well|drug
DDI-MedLine.d34.s1|151-152|as|drug
DDI-MedLine.d34.s1|154-156|the|drug
DDI-MedLine.d34.s1|158-166|retention|drug
DDI-MedLine.d34.s1|168-169|of|drug
DDI-MedLine.d34.s1|171-175|these|drug
DDI-MedLine.d34.s1|177-181|trace|drug
DDI-MedLine.d34.s1|183-190|elements|drug
DDI-MedLine.d34.s1|192-195|were|drug
DDI-MedLine.d34.s1|197-206|determined|drug
DDI-MedLine.d34.s1|208-209|by|drug
DDI-MedLine.d34.s1|211-215|using|drug
DDI-MedLine.d34.s1|217-220|four|drug
DDI-MedLine.d34.s1|222-226|diets|drug
DDI-MedLine.d34.s1|228-237|containing|drug
DDI-MedLine.d34.s1|239-244|either|drug
DDI-MedLine.d34.s1|246-246|9|drug
DDI-MedLine.d34.s1|248-249|or|drug
DDI-MedLine.d34.s1|251-252|63|drug
DDI-MedLine.d34.s1|254-266|micrograms/kg|drug
DDI-MedLine.d34.s1|268-269|of|drug
DDI-MedLine.d34.s1|271-272|Co|drug
DDI-MedLine.d34.s1|274-276|and|drug
DDI-MedLine.d34.s1|278-279|48|drug
DDI-MedLine.d34.s1|281-282|or|drug
DDI-MedLine.d34.s1|284-286|446|drug
DDI-MedLine.d34.s1|288-292|mg/kg|drug
DDI-MedLine.d34.s1|294-295|of|drug
DDI-MedLine.d34.s1|297-298|Fe|drug
DDI-MedLine.d34.s1|300-303|over|drug
DDI-MedLine.d34.s1|305-305|a|drug
DDI-MedLine.d34.s1|307-312|period|drug
DDI-MedLine.d34.s1|314-315|of|drug
DDI-MedLine.d34.s1|317-318|19|drug
DDI-MedLine.d34.s1|320-323|days|drug
DDI-MedLine.d34.s1|325-326|in|drug
DDI-MedLine.d34.s1|328-328|a|drug
DDI-MedLine.d34.s1|330-334|total|drug
DDI-MedLine.d34.s1|336-337|of|drug
DDI-MedLine.d34.s1|339-340|24|drug
DDI-MedLine.d34.s1|342-345|rats|drug
DDI-MedLine.d34.s1|346-346|.|drug
DDI-MedLine.d34.s2|0-8|Retention|drug
DDI-MedLine.d34.s2|10-12|was|drug
DDI-MedLine.d34.s2|14-23|calculated|drug
DDI-MedLine.d34.s2|25-26|by|drug
DDI-MedLine.d34.s2|28-30|the|drug
DDI-MedLine.d34.s2|32-38|balance|drug
DDI-MedLine.d34.s2|40-48|technique|drug
DDI-MedLine.d34.s2|50-52|and|drug
DDI-MedLine.d34.s2|54-55|by|drug
DDI-MedLine.d34.s2|57-59|the|drug
DDI-MedLine.d34.s2|61-71|comparative|drug
DDI-MedLine.d34.s2|73-81|slaughter|drug
DDI-MedLine.d34.s2|83-91|technique|drug
DDI-MedLine.d34.s2|92-92|.|drug
DDI-MedLine.d34.s3|0-4|After|drug
DDI-MedLine.d34.s3|6-8|one|drug
DDI-MedLine.d34.s3|10-12|day|drug
DDI-MedLine.d34.s3|13-13|,|drug
DDI-MedLine.d34.s3|15-19|fecal|drug
DDI-MedLine.d34.s3|21-22|as|drug
DDI-MedLine.d34.s3|24-27|well|drug
DDI-MedLine.d34.s3|29-30|as|drug
DDI-MedLine.d34.s3|32-38|urinary|drug
DDI-MedLine.d34.s3|40-48|excretion|drug
DDI-MedLine.d34.s3|50-51|of|drug
DDI-MedLine.d34.s3|53-56|both|drug
DDI-MedLine.d34.s3|58-65|elements|drug
DDI-MedLine.d34.s3|67-69|had|drug
DDI-MedLine.d34.s3|71-77|already|drug
DDI-MedLine.d34.s3|79-87|responded|drug
DDI-MedLine.d34.s3|89-90|to|drug
DDI-MedLine.d34.s3|92-94|the|drug
DDI-MedLine.d34.s3|96-102|dietary|drug
DDI-MedLine.d34.s3|104-113|treatments|drug
DDI-MedLine.d34.s3|114-114|,|drug
DDI-MedLine.d34.s3|116-119|with|drug
DDI-MedLine.d34.s3|121-128|constant|drug
DDI-MedLine.d34.s3|130-135|values|drug
DDI-MedLine.d34.s3|137-141|being|drug
DDI-MedLine.d34.s3|143-149|reached|drug
DDI-MedLine.d34.s3|151-155|after|drug
DDI-MedLine.d34.s3|157-169|approximately|drug
DDI-MedLine.d34.s3|171-175|three|drug
DDI-MedLine.d34.s3|177-180|days|drug
DDI-MedLine.d34.s3|181-181|.|drug
DDI-MedLine.d34.s4|0-5|Cobalt|drug
DDI-MedLine.d34.s4|7-15|excretion|drug
DDI-MedLine.d34.s4|17-19|was|drug
DDI-MedLine.d34.s4|21-28|enhanced|drug
DDI-MedLine.d34.s4|30-31|by|drug
DDI-MedLine.d34.s4|33-45|supplementary|drug
DDI-MedLine.d34.s4|47-52|cobalt|drug
DDI-MedLine.d34.s4|53-53|;|drug
DDI-MedLine.d34.s5|0-4|fecal|drug
DDI-MedLine.d34.s5|6-14|excretion|drug
DDI-MedLine.d34.s5|15-15|,|drug
DDI-MedLine.d34.s5|17-19|too|drug
DDI-MedLine.d34.s5|20-20|,|drug
DDI-MedLine.d34.s5|22-24|was|drug
DDI-MedLine.d34.s5|26-34|increased|drug
DDI-MedLine.d34.s5|36-37|by|drug
DDI-MedLine.d34.s5|39-51|supplementary|drug
DDI-MedLine.d34.s5|53-56|iron|drug
DDI-MedLine.d34.s5|57-57|;|drug
DDI-MedLine.d34.s6|0-6|whereas|drug
DDI-MedLine.d34.s6|8-14|urinary|drug
DDI-MedLine.d34.s6|16-24|excretion|drug
DDI-MedLine.d34.s6|26-28|was|drug
DDI-MedLine.d34.s6|30-38|decreased|drug
DDI-MedLine.d34.s6|40-41|in|drug
DDI-MedLine.d34.s6|43-46|both|drug
DDI-MedLine.d34.s6|48-52|cases|drug
DDI-MedLine.d34.s6|53-53|.|drug
DDI-MedLine.d34.s7|0-9|Additional|drug
DDI-MedLine.d34.s7|11-14|iron|drug
DDI-MedLine.d34.s7|16-28|significantly|drug
DDI-MedLine.d34.s7|30-38|inhibited|drug
DDI-MedLine.d34.s7|40-42|the|drug
DDI-MedLine.d34.s7|44-53|absorption|drug
DDI-MedLine.d34.s7|55-56|of|drug
DDI-MedLine.d34.s7|58-63|cobalt|drug
DDI-MedLine.d34.s7|65-66|in|drug
DDI-MedLine.d34.s7|68-71|both|drug
DDI-MedLine.d34.s7|73-79|dietary|drug
DDI-MedLine.d34.s7|81-86|cobalt|drug
DDI-MedLine.d34.s7|88-97|treatments|drug
DDI-MedLine.d34.s7|98-98|.|drug
DDI-MedLine.d34.s8|0-2|The|drug
DDI-MedLine.d34.s8|4-8|lower|drug
DDI-MedLine.d34.s8|10-13|rate|drug
DDI-MedLine.d34.s8|15-16|of|drug
DDI-MedLine.d34.s8|18-27|absorption|drug
DDI-MedLine.d34.s8|29-30|in|drug
DDI-MedLine.d34.s8|32-34|the|drug
DDI-MedLine.d34.s8|36-41|groups|drug
DDI-MedLine.d34.s8|43-51|receiving|drug
DDI-MedLine.d34.s8|53-55|446|drug
DDI-MedLine.d34.s8|57-58|mg|drug
DDI-MedLine.d34.s8|60-61|Fe|drug
DDI-MedLine.d34.s8|63-69|instead|drug
DDI-MedLine.d34.s8|71-72|of|drug
DDI-MedLine.d34.s8|74-75|48|drug
DDI-MedLine.d34.s8|77-78|mg|drug
DDI-MedLine.d34.s8|80-81|of|drug
DDI-MedLine.d34.s8|83-84|Fe|drug
DDI-MedLine.d34.s8|86-88|per|drug
DDI-MedLine.d34.s8|90-91|kg|drug
DDI-MedLine.d34.s8|93-96|diet|drug
DDI-MedLine.d34.s8|98-105|resulted|drug
DDI-MedLine.d34.s8|107-108|in|drug
DDI-MedLine.d34.s8|110-110|a|drug
DDI-MedLine.d34.s8|112-120|decreased|drug
DDI-MedLine.d34.s8|122-126|renal|drug
DDI-MedLine.d34.s8|128-136|excretion|drug
DDI-MedLine.d34.s8|138-139|of|drug
DDI-MedLine.d34.s8|141-146|cobalt|drug
DDI-MedLine.d34.s8|147-147|.|drug
DDI-MedLine.d34.s9|0-11|Consequently|drug
DDI-MedLine.d34.s9|12-12|,|drug
DDI-MedLine.d34.s9|14-16|the|drug
DDI-MedLine.d34.s9|18-23|effect|drug
DDI-MedLine.d34.s9|25-26|of|drug
DDI-MedLine.d34.s9|28-31|iron|drug
DDI-MedLine.d34.s9|33-34|on|drug
DDI-MedLine.d34.s9|36-38|the|drug
DDI-MedLine.d34.s9|40-48|retention|drug
DDI-MedLine.d34.s9|50-51|of|drug
DDI-MedLine.d34.s9|53-58|cobalt|drug
DDI-MedLine.d34.s9|60-62|was|drug
DDI-MedLine.d34.s9|64-68|lower|drug
DDI-MedLine.d34.s9|70-73|than|drug
DDI-MedLine.d34.s9|75-76|on|drug
DDI-MedLine.d34.s9|78-87|absorption|drug
DDI-MedLine.d34.s9|88-88|.|drug
DDI-MedLine.d34.s10|0-3|This|drug
DDI-MedLine.d34.s10|5-12|suggests|drug
DDI-MedLine.d34.s10|14-17|that|drug
DDI-MedLine.d34.s10|19-30|interactions|drug
DDI-MedLine.d34.s10|32-38|between|drug
DDI-MedLine.d34.s10|40-42|the|drug
DDI-MedLine.d34.s10|44-46|two|drug
DDI-MedLine.d34.s10|48-55|elements|drug
DDI-MedLine.d34.s10|57-60|only|drug
DDI-MedLine.d34.s10|62-65|take|drug
DDI-MedLine.d34.s10|67-71|place|drug
DDI-MedLine.d34.s10|73-74|at|drug
DDI-MedLine.d34.s10|76-78|the|drug
DDI-MedLine.d34.s10|80-83|site|drug
DDI-MedLine.d34.s10|85-86|of|drug
DDI-MedLine.d34.s10|88-97|absorption|drug
DDI-MedLine.d34.s10|98-98|.|drug
DDI-MedLine.d34.s11|0-6|Because|drug
DDI-MedLine.d34.s11|8-9|of|drug
DDI-MedLine.d34.s11|11-13|the|drug
DDI-MedLine.d34.s11|15-17|low|drug
DDI-MedLine.d34.s11|19-25|dietary|drug
DDI-MedLine.d34.s11|27-32|cobalt|drug
DDI-MedLine.d34.s11|34-46|concentration|drug
DDI-MedLine.d34.s11|48-49|as|drug
DDI-MedLine.d34.s11|51-58|compared|drug
DDI-MedLine.d34.s11|60-61|to|drug
DDI-MedLine.d34.s11|63-65|the|drug
DDI-MedLine.d34.s11|67-70|iron|drug
DDI-MedLine.d34.s11|72-79|contents|drug
DDI-MedLine.d34.s11|81-82|of|drug
DDI-MedLine.d34.s11|84-86|the|drug
DDI-MedLine.d34.s11|88-92|diets|drug
DDI-MedLine.d34.s11|93-93|,|drug
DDI-MedLine.d34.s11|95-96|no|drug
DDI-MedLine.d34.s11|98-103|effect|drug
DDI-MedLine.d34.s11|105-106|of|drug
DDI-MedLine.d34.s11|108-113|cobalt|drug
DDI-MedLine.d34.s11|115-116|on|drug
DDI-MedLine.d34.s11|118-121|iron|drug
DDI-MedLine.d34.s11|123-132|absorption|drug
DDI-MedLine.d34.s11|134-136|and|drug
DDI-MedLine.d34.s11|138-146|excretion|drug
DDI-MedLine.d34.s11|148-155|occurred|drug
DDI-MedLine.d34.s11|156-156|.|drug
DDI-MedLine.d34.s12|0-10|Differences|drug
DDI-MedLine.d34.s12|12-13|in|drug
DDI-MedLine.d34.s12|15-18|iron|drug
DDI-MedLine.d34.s12|20-26|balance|drug
DDI-MedLine.d34.s12|28-31|were|drug
DDI-MedLine.d34.s12|33-36|only|drug
DDI-MedLine.d34.s12|38-45|observed|drug
DDI-MedLine.d34.s12|47-53|between|drug
DDI-MedLine.d34.s12|55-58|both|drug
DDI-MedLine.d34.s12|60-66|dietary|drug
DDI-MedLine.d34.s12|68-81|concentrations|drug
DDI-MedLine.d34.s12|82-82|,|drug
DDI-MedLine.d34.s12|84-90|showing|drug
DDI-MedLine.d34.s12|92-92|a|drug
DDI-MedLine.d34.s12|94-99|higher|drug
DDI-MedLine.d34.s12|101-108|absolute|drug
DDI-MedLine.d34.s12|110-112|but|drug
DDI-MedLine.d34.s12|114-114|a|drug
DDI-MedLine.d34.s12|116-120|lower|drug
DDI-MedLine.d34.s12|122-129|relative|drug
DDI-MedLine.d34.s12|131-140|absorption|drug
DDI-MedLine.d34.s12|142-143|as|drug
DDI-MedLine.d34.s12|145-148|well|drug
DDI-MedLine.d34.s12|150-151|as|drug
DDI-MedLine.d34.s12|153-161|retention|drug
DDI-MedLine.d34.s12|163-164|in|drug
DDI-MedLine.d34.s12|166-168|the|drug
DDI-MedLine.d34.s12|170-175|groups|drug
DDI-MedLine.d34.s12|177-179|fed|drug
DDI-MedLine.d34.s12|181-187|further|drug
DDI-MedLine.d34.s12|189-191|Fe|drug
DDI-MedLine.d34.s12|192-192|.|drug
DDI-MedLine.d34.s12|193-200|(|drug
DDI-MedLine.d34.s12|202-210|ABSTRACT|drug
DDI-MedLine.d34.s12|212-213|TRUNCATED|drug
DDI-MedLine.d34.s12|215-217|AT|drug
DDI-MedLine.d34.s12|219-223|250|drug
DDI-MedLine.d34.s12|224-224|WORDS|drug
DDI-DrugBank.d495.s0|0-5|Tablet|drug
DDI-DrugBank.d495.s0|7-8|If|drug
DDI-DrugBank.d495.s0|10-10|a|drug
DDI-DrugBank.d495.s0|12-18|patient|drug
DDI-DrugBank.d495.s0|20-28|receiving|drug
DDI-DrugBank.d495.s0|30-38|clonidine|drug
DDI-DrugBank.d495.s0|40-52|hydrochloride|drug
DDI-DrugBank.d495.s0|54-55|is|drug
DDI-DrugBank.d495.s0|57-60|also|drug
DDI-DrugBank.d495.s0|62-67|taking|drug
DDI-DrugBank.d495.s0|69-77|tricyclic|drug
DDI-DrugBank.d495.s0|79-93|antidepressants|drug
DDI-DrugBank.d495.s0|94-94|,|drug
DDI-DrugBank.d495.s0|96-98|the|drug
DDI-DrugBank.d495.s0|100-105|effect|drug
DDI-DrugBank.d495.s0|107-108|of|drug
DDI-DrugBank.d495.s0|110-118|clonidine|drug
DDI-DrugBank.d495.s0|120-122|may|drug
DDI-DrugBank.d495.s0|124-125|be|drug
DDI-DrugBank.d495.s0|127-133|reduced|drug
DDI-DrugBank.d495.s0|134-134|,|drug
DDI-DrugBank.d495.s0|136-139|thus|drug
DDI-DrugBank.d495.s0|141-153|necessitating|drug
DDI-DrugBank.d495.s0|155-156|an|drug
DDI-DrugBank.d495.s0|158-165|increase|drug
DDI-DrugBank.d495.s0|167-168|in|drug
DDI-DrugBank.d495.s0|170-175|dosage|drug
DDI-DrugBank.d495.s0|176-176|.|drug
DDI-DrugBank.d495.s1|0-8|Clonidine|drug
DDI-DrugBank.d495.s1|10-22|hydrochloride|drug
DDI-DrugBank.d495.s1|24-26|may|drug
DDI-DrugBank.d495.s1|28-34|enhance|drug
DDI-DrugBank.d495.s1|36-38|the|drug
DDI-DrugBank.d495.s1|40-53|CNS-depressive|drug
DDI-DrugBank.d495.s1|55-61|effects|drug
DDI-DrugBank.d495.s1|63-64|of|drug
DDI-DrugBank.d495.s1|66-72|alcohol|drug
DDI-DrugBank.d495.s1|73-73|,|drug
DDI-DrugBank.d495.s1|75-86|barbiturates|drug
DDI-DrugBank.d495.s1|88-89|or|drug
DDI-DrugBank.d495.s1|91-95|other|drug
DDI-DrugBank.d495.s1|97-105|sedatives|drug
DDI-DrugBank.d495.s1|106-106|.|drug
DDI-DrugBank.d495.s2|0-12|Amitriptyline|drug
DDI-DrugBank.d495.s2|14-15|in|drug
DDI-DrugBank.d495.s2|17-27|combination|drug
DDI-DrugBank.d495.s2|29-32|with|drug
DDI-DrugBank.d495.s2|34-42|clonidine|drug
DDI-DrugBank.d495.s2|44-51|enhances|drug
DDI-DrugBank.d495.s2|53-55|the|drug
DDI-DrugBank.d495.s2|57-69|manifestation|drug
DDI-DrugBank.d495.s2|71-72|of|drug
DDI-DrugBank.d495.s2|74-80|corneal|drug
DDI-DrugBank.d495.s2|82-88|lesions|drug
DDI-DrugBank.d495.s2|90-91|in|drug
DDI-DrugBank.d495.s2|93-96|rats|drug
DDI-DrugBank.d495.s2|98-105|Epidural|drug
DDI-DrugBank.d495.s2|107-115|Injection|drug
DDI-DrugBank.d495.s2|117-125|Clonidine|drug
DDI-DrugBank.d495.s2|127-129|may|drug
DDI-DrugBank.d495.s2|131-140|potentiate|drug
DDI-DrugBank.d495.s2|142-144|the|drug
DDI-DrugBank.d495.s2|146-159|CNS-depressive|drug
DDI-DrugBank.d495.s2|161-166|effect|drug
DDI-DrugBank.d495.s2|168-169|of|drug
DDI-DrugBank.d495.s2|171-177|alcohol|drug
DDI-DrugBank.d495.s2|178-178|,|drug
DDI-DrugBank.d495.s2|180-191|barbiturates|drug
DDI-DrugBank.d495.s2|193-194|or|drug
DDI-DrugBank.d495.s2|196-200|other|drug
DDI-DrugBank.d495.s2|202-209|sedating|drug
DDI-DrugBank.d495.s2|211-215|drugs|drug
DDI-DrugBank.d495.s2|216-216|.|drug
DDI-DrugBank.d495.s3|0-7|Narcotic|drug
DDI-DrugBank.d495.s3|9-18|analgesics|drug
DDI-DrugBank.d495.s3|20-22|may|drug
DDI-DrugBank.d495.s3|24-33|potentiate|drug
DDI-DrugBank.d495.s3|35-37|the|drug
DDI-DrugBank.d495.s3|39-49|hypotensive|drug
DDI-DrugBank.d495.s3|51-57|effects|drug
DDI-DrugBank.d495.s3|59-60|of|drug
DDI-DrugBank.d495.s3|62-70|clonidine|drug
DDI-DrugBank.d495.s3|71-71|.|drug
DDI-DrugBank.d495.s4|0-8|Tricyclic|drug
DDI-DrugBank.d495.s4|10-24|antidepressants|drug
DDI-DrugBank.d495.s4|26-28|may|drug
DDI-DrugBank.d495.s4|30-39|antagonize|drug
DDI-DrugBank.d495.s4|41-43|the|drug
DDI-DrugBank.d495.s4|45-55|hypotensive|drug
DDI-DrugBank.d495.s4|57-63|effects|drug
DDI-DrugBank.d495.s4|65-66|of|drug
DDI-DrugBank.d495.s4|68-76|clonidine|drug
DDI-DrugBank.d495.s4|77-77|.|drug
DDI-DrugBank.d495.s5|0-2|The|drug
DDI-DrugBank.d495.s5|4-10|effects|drug
DDI-DrugBank.d495.s5|12-13|of|drug
DDI-DrugBank.d495.s5|15-23|tricyclic|drug
DDI-DrugBank.d495.s5|25-39|antidepressants|drug
DDI-DrugBank.d495.s5|41-42|on|drug
DDI-DrugBank.d495.s5|44-53|clonidines|drug
DDI-DrugBank.d495.s5|55-63|analgesic|drug
DDI-DrugBank.d495.s5|65-71|actions|drug
DDI-DrugBank.d495.s5|73-75|are|drug
DDI-DrugBank.d495.s5|77-79|not|drug
DDI-DrugBank.d495.s5|81-85|known|drug
DDI-DrugBank.d495.s5|86-86|.|drug
DDI-DrugBank.d495.s6|0-3|Beta|drug
DDI-DrugBank.d495.s6|5-12|blockers|drug
DDI-DrugBank.d495.s6|14-16|may|drug
DDI-DrugBank.d495.s6|18-27|exacerbate|drug
DDI-DrugBank.d495.s6|29-31|the|drug
DDI-DrugBank.d495.s6|33-44|hypertensive|drug
DDI-DrugBank.d495.s6|46-53|response|drug
DDI-DrugBank.d495.s6|55-58|seen|drug
DDI-DrugBank.d495.s6|60-63|with|drug
DDI-DrugBank.d495.s6|65-73|clonidine|drug
DDI-DrugBank.d495.s6|75-83|withdrawl|drug
DDI-DrugBank.d495.s6|84-84|.|drug
DDI-DrugBank.d495.s7|0-3|Also|drug
DDI-DrugBank.d495.s7|4-4|,|drug
DDI-DrugBank.d495.s7|6-8|due|drug
DDI-DrugBank.d495.s7|10-11|to|drug
DDI-DrugBank.d495.s7|13-15|the|drug
DDI-DrugBank.d495.s7|17-25|potential|drug
DDI-DrugBank.d495.s7|27-29|for|drug
DDI-DrugBank.d495.s7|31-38|additive|drug
DDI-DrugBank.d495.s7|40-46|effects|drug
DDI-DrugBank.d495.s7|48-51|such|drug
DDI-DrugBank.d495.s7|53-54|as|drug
DDI-DrugBank.d495.s7|56-66|bradycardia|drug
DDI-DrugBank.d495.s7|68-70|and|drug
DDI-DrugBank.d495.s7|72-73|AV|drug
DDI-DrugBank.d495.s7|75-79|block|drug
DDI-DrugBank.d495.s7|80-80|,|drug
DDI-DrugBank.d495.s7|82-88|caution|drug
DDI-DrugBank.d495.s7|90-91|is|drug
DDI-DrugBank.d495.s7|93-101|warranted|drug
DDI-DrugBank.d495.s7|103-104|in|drug
DDI-DrugBank.d495.s7|106-113|patients|drug
DDI-DrugBank.d495.s7|115-123|receiving|drug
DDI-DrugBank.d495.s7|125-133|clonidine|drug
DDI-DrugBank.d495.s7|135-138|with|drug
DDI-DrugBank.d495.s7|140-145|agents|drug
DDI-DrugBank.d495.s7|147-151|known|drug
DDI-DrugBank.d495.s7|153-154|to|drug
DDI-DrugBank.d495.s7|156-161|affect|drug
DDI-DrugBank.d495.s7|163-167|sinus|drug
DDI-DrugBank.d495.s7|169-172|node|drug
DDI-DrugBank.d495.s7|174-181|function|drug
DDI-DrugBank.d495.s7|183-184|or|drug
DDI-DrugBank.d495.s7|186-187|AV|drug
DDI-DrugBank.d495.s7|189-193|nodal|drug
DDI-DrugBank.d495.s7|195-204|conduction|drug
DDI-DrugBank.d495.s7|206-206|(|drug
DDI-DrugBank.d495.s7|207-210|e.g.|drug
DDI-DrugBank.d495.s7|211-211|,|drug
DDI-DrugBank.d495.s7|213-221|digitalis|drug
DDI-DrugBank.d495.s7|222-222|,|drug
DDI-DrugBank.d495.s7|224-230|calcium|drug
DDI-DrugBank.d495.s7|232-238|channel|drug
DDI-DrugBank.d495.s7|240-247|blockers|drug
DDI-DrugBank.d495.s7|248-248|,|drug
DDI-DrugBank.d495.s7|250-252|and|drug
DDI-DrugBank.d495.s7|254-266|beta-blockers|drug
DDI-DrugBank.d495.s7|267-267|.|drug
DDI-DrugBank.d495.s7|268-268|)|drug
DDI-DrugBank.d495.s8|0-4|There|drug
DDI-DrugBank.d495.s8|6-7|is|drug
DDI-DrugBank.d495.s8|9-11|one|drug
DDI-DrugBank.d495.s8|13-20|reported|drug
DDI-DrugBank.d495.s8|22-25|case|drug
DDI-DrugBank.d495.s8|27-28|of|drug
DDI-DrugBank.d495.s8|30-30|a|drug
DDI-DrugBank.d495.s8|32-38|patient|drug
DDI-DrugBank.d495.s8|40-43|with|drug
DDI-DrugBank.d495.s8|45-49|acute|drug
DDI-DrugBank.d495.s8|51-58|delirium|drug
DDI-DrugBank.d495.s8|60-69|associated|drug
DDI-DrugBank.d495.s8|71-74|with|drug
DDI-DrugBank.d495.s8|76-78|the|drug
DDI-DrugBank.d495.s8|80-91|simultaneous|drug
DDI-DrugBank.d495.s8|93-95|use|drug
DDI-DrugBank.d495.s8|97-98|of|drug
DDI-DrugBank.d495.s8|100-111|fluphenazine|drug
DDI-DrugBank.d495.s8|113-115|and|drug
DDI-DrugBank.d495.s8|117-120|oral|drug
DDI-DrugBank.d495.s8|122-130|clonidine|drug
DDI-DrugBank.d495.s8|131-131|.|drug
DDI-DrugBank.d495.s9|0-7|Symptoms|drug
DDI-DrugBank.d495.s9|9-16|resolved|drug
DDI-DrugBank.d495.s9|18-21|when|drug
DDI-DrugBank.d495.s9|23-31|clonidine|drug
DDI-DrugBank.d495.s9|33-35|was|drug
DDI-DrugBank.d495.s9|37-45|withdrawn|drug
DDI-DrugBank.d495.s9|47-49|and|drug
DDI-DrugBank.d495.s9|51-58|recurred|drug
DDI-DrugBank.d495.s9|60-63|when|drug
DDI-DrugBank.d495.s9|65-67|the|drug
DDI-DrugBank.d495.s9|69-75|patient|drug
DDI-DrugBank.d495.s9|77-79|was|drug
DDI-DrugBank.d495.s9|81-92|rechallenged|drug
DDI-DrugBank.d495.s9|94-97|with|drug
DDI-DrugBank.d495.s9|99-107|clonidine|drug
DDI-DrugBank.d495.s9|108-108|.|drug
DDI-DrugBank.d495.s10|0-7|Epidural|drug
DDI-DrugBank.d495.s10|9-17|clonidine|drug
DDI-DrugBank.d495.s10|19-21|may|drug
DDI-DrugBank.d495.s10|23-29|prolong|drug
DDI-DrugBank.d495.s10|31-33|the|drug
DDI-DrugBank.d495.s10|35-42|duration|drug
DDI-DrugBank.d495.s10|44-45|of|drug
DDI-DrugBank.d495.s10|47-59|pharmacologic|drug
DDI-DrugBank.d495.s10|61-67|effects|drug
DDI-DrugBank.d495.s10|69-70|of|drug
DDI-DrugBank.d495.s10|72-79|epidural|drug
DDI-DrugBank.d495.s10|81-85|local|drug
DDI-DrugBank.d495.s10|87-97|anesthetics|drug
DDI-DrugBank.d495.s10|98-98|,|drug
DDI-DrugBank.d495.s10|100-108|including|drug
DDI-DrugBank.d495.s10|110-113|both|drug
DDI-DrugBank.d495.s10|115-121|sensory|drug
DDI-DrugBank.d495.s10|123-125|and|drug
DDI-DrugBank.d495.s10|127-131|motor|drug
DDI-DrugBank.d495.s10|133-140|blockade|drug
DDI-DrugBank.d495.s10|141-141|.|drug
DDI-MedLine.d61.s0|0-14|Pharmacokinetic|drug
DDI-MedLine.d61.s0|16-25|evaluation|drug
DDI-MedLine.d61.s0|27-28|of|drug
DDI-MedLine.d61.s0|30-32|the|drug
DDI-MedLine.d61.s0|34-51|digoxin-amiodarone|drug
DDI-MedLine.d61.s0|53-63|interaction|drug
DDI-MedLine.d61.s0|64-64|.|drug
DDI-MedLine.d61.s1|0-9|Amiodarone|drug
DDI-MedLine.d61.s1|11-12|is|drug
DDI-MedLine.d61.s1|14-18|known|drug
DDI-MedLine.d61.s1|20-21|to|drug
DDI-MedLine.d61.s1|23-27|raise|drug
DDI-MedLine.d61.s1|29-33|serum|drug
DDI-MedLine.d61.s1|35-41|digoxin|drug
DDI-MedLine.d61.s1|43-48|levels|drug
DDI-MedLine.d61.s1|49-49|.|drug
DDI-MedLine.d61.s2|0-3|This|drug
DDI-MedLine.d61.s2|5-9|study|drug
DDI-MedLine.d61.s2|11-13|was|drug
DDI-MedLine.d61.s2|15-22|designed|drug
DDI-MedLine.d61.s2|24-25|to|drug
DDI-MedLine.d61.s2|27-34|evaluate|drug
DDI-MedLine.d61.s2|36-38|the|drug
DDI-MedLine.d61.s2|40-54|pharmacokinetic|drug
DDI-MedLine.d61.s2|56-60|basis|drug
DDI-MedLine.d61.s2|62-63|of|drug
DDI-MedLine.d61.s2|65-68|this|drug
DDI-MedLine.d61.s2|70-80|interaction|drug
DDI-MedLine.d61.s2|82-83|in|drug
DDI-MedLine.d61.s2|85-86|10|drug
DDI-MedLine.d61.s2|88-93|normal|drug
DDI-MedLine.d61.s2|95-102|subjects|drug
DDI-MedLine.d61.s2|103-103|.|drug
DDI-MedLine.d61.s3|0-2|The|drug
DDI-MedLine.d61.s3|4-18|pharmacokinetic|drug
DDI-MedLine.d61.s3|20-28|variables|drug
DDI-MedLine.d61.s3|30-32|for|drug
DDI-MedLine.d61.s3|34-40|digoxin|drug
DDI-MedLine.d61.s3|42-45|were|drug
DDI-MedLine.d61.s3|47-56|determined|drug
DDI-MedLine.d61.s3|58-62|after|drug
DDI-MedLine.d61.s3|64-64|a|drug
DDI-MedLine.d61.s3|66-68|1.0|drug
DDI-MedLine.d61.s3|70-71|mg|drug
DDI-MedLine.d61.s3|73-83|intravenous|drug
DDI-MedLine.d61.s3|85-88|dose|drug
DDI-MedLine.d61.s3|90-91|of|drug
DDI-MedLine.d61.s3|93-99|digoxin|drug
DDI-MedLine.d61.s3|101-102|in|drug
DDI-MedLine.d61.s3|104-107|each|drug
DDI-MedLine.d61.s3|109-115|subject|drug
DDI-MedLine.d61.s3|116-116|,|drug
DDI-MedLine.d61.s3|118-123|before|drug
DDI-MedLine.d61.s3|125-127|and|drug
DDI-MedLine.d61.s3|129-133|after|drug
DDI-MedLine.d61.s3|135-138|oral|drug
DDI-MedLine.d61.s3|140-149|amiodarone|drug
DDI-MedLine.d61.s3|150-150|,|drug
DDI-MedLine.d61.s3|152-154|400|drug
DDI-MedLine.d61.s3|156-157|mg|drug
DDI-MedLine.d61.s3|159-163|daily|drug
DDI-MedLine.d61.s3|165-167|for|drug
DDI-MedLine.d61.s3|169-169|3|drug
DDI-MedLine.d61.s3|171-175|weeks|drug
DDI-MedLine.d61.s3|176-176|.|drug
DDI-MedLine.d61.s4|0-5|During|drug
DDI-MedLine.d61.s4|7-16|amiodarone|drug
DDI-MedLine.d61.s4|18-31|administration|drug
DDI-MedLine.d61.s4|32-32|,|drug
DDI-MedLine.d61.s4|34-41|systemic|drug
DDI-MedLine.d61.s4|43-51|clearance|drug
DDI-MedLine.d61.s4|53-54|of|drug
DDI-MedLine.d61.s4|56-62|digoxin|drug
DDI-MedLine.d61.s4|64-66|was|drug
DDI-MedLine.d61.s4|68-74|reduced|drug
DDI-MedLine.d61.s4|76-79|from|drug
DDI-MedLine.d61.s4|81-83|234|drug
DDI-MedLine.d61.s4|85-87|+/-|drug
DDI-MedLine.d61.s4|89-90|72|drug
DDI-MedLine.d61.s4|92-97|ml/min|drug
DDI-MedLine.d61.s4|99-99|(|drug
DDI-MedLine.d61.s4|100-103|mean|drug
DDI-MedLine.d61.s4|105-107|+/-|drug
DDI-MedLine.d61.s4|109-116|standard|drug
DDI-MedLine.d61.s4|118-126|deviation|drug
DDI-MedLine.d61.s4|127-127|)|drug
DDI-MedLine.d61.s4|129-130|to|drug
DDI-MedLine.d61.s4|132-134|172|drug
DDI-MedLine.d61.s4|136-138|+/-|drug
DDI-MedLine.d61.s4|140-141|33|drug
DDI-MedLine.d61.s4|143-148|ml/min|drug
DDI-MedLine.d61.s4|150-150|(|drug
DDI-MedLine.d61.s4|151-151|p|drug
DDI-MedLine.d61.s4|153-156|less|drug
DDI-MedLine.d61.s4|158-161|than|drug
DDI-MedLine.d61.s4|163-166|0.01|drug
DDI-MedLine.d61.s4|167-167|)|drug
DDI-MedLine.d61.s4|168-168|.|drug
DDI-MedLine.d61.s5|0-3|This|drug
DDI-MedLine.d61.s5|5-7|was|drug
DDI-MedLine.d61.s5|9-11|due|drug
DDI-MedLine.d61.s5|13-14|to|drug
DDI-MedLine.d61.s5|16-25|reductions|drug
DDI-MedLine.d61.s5|27-28|in|drug
DDI-MedLine.d61.s5|30-33|both|drug
DDI-MedLine.d61.s5|35-39|renal|drug
DDI-MedLine.d61.s5|41-49|clearance|drug
DDI-MedLine.d61.s5|51-51|(|drug
DDI-MedLine.d61.s5|52-55|from|drug
DDI-MedLine.d61.s5|57-59|105|drug
DDI-MedLine.d61.s5|61-63|+/-|drug
DDI-MedLine.d61.s5|65-66|39|drug
DDI-MedLine.d61.s5|68-69|to|drug
DDI-MedLine.d61.s5|71-72|84|drug
DDI-MedLine.d61.s5|74-76|+/-|drug
DDI-MedLine.d61.s5|78-79|15|drug
DDI-MedLine.d61.s5|81-86|ml/min|drug
DDI-MedLine.d61.s5|87-87|)|drug
DDI-MedLine.d61.s5|89-89|(|drug
DDI-MedLine.d61.s5|90-90|p|drug
DDI-MedLine.d61.s5|92-95|less|drug
DDI-MedLine.d61.s5|97-100|than|drug
DDI-MedLine.d61.s5|102-105|0.05|drug
DDI-MedLine.d61.s5|106-106|)|drug
DDI-MedLine.d61.s5|108-110|and|drug
DDI-MedLine.d61.s5|112-119|nonrenal|drug
DDI-MedLine.d61.s5|121-129|clearance|drug
DDI-MedLine.d61.s5|131-131|(|drug
DDI-MedLine.d61.s5|132-135|from|drug
DDI-MedLine.d61.s5|137-139|130|drug
DDI-MedLine.d61.s5|141-143|+/-|drug
DDI-MedLine.d61.s5|145-146|38|drug
DDI-MedLine.d61.s5|148-149|to|drug
DDI-MedLine.d61.s5|151-152|88|drug
DDI-MedLine.d61.s5|154-156|+/-|drug
DDI-MedLine.d61.s5|158-159|20|drug
DDI-MedLine.d61.s5|161-166|ml/min|drug
DDI-MedLine.d61.s5|167-167|)|drug
DDI-MedLine.d61.s5|169-169|(|drug
DDI-MedLine.d61.s5|170-170|p|drug
DDI-MedLine.d61.s5|172-175|less|drug
DDI-MedLine.d61.s5|177-180|than|drug
DDI-MedLine.d61.s5|182-185|0.01|drug
DDI-MedLine.d61.s5|186-186|)|drug
DDI-MedLine.d61.s5|187-187|.|drug
DDI-MedLine.d61.s6|0-6|Digoxin|drug
DDI-MedLine.d61.s6|8-16|half-life|drug
DDI-MedLine.d61.s6|18-19|of|drug
DDI-MedLine.d61.s6|21-31|elimination|drug
DDI-MedLine.d61.s6|33-35|was|drug
DDI-MedLine.d61.s6|37-45|prolonged|drug
DDI-MedLine.d61.s6|47-50|from|drug
DDI-MedLine.d61.s6|52-53|34|drug
DDI-MedLine.d61.s6|55-57|+/-|drug
DDI-MedLine.d61.s6|59-60|13|drug
DDI-MedLine.d61.s6|62-63|to|drug
DDI-MedLine.d61.s6|65-66|40|drug
DDI-MedLine.d61.s6|68-70|+/-|drug
DDI-MedLine.d61.s6|72-73|16|drug
DDI-MedLine.d61.s6|75-79|hours|drug
DDI-MedLine.d61.s6|81-81|(|drug
DDI-MedLine.d61.s6|82-82|p|drug
DDI-MedLine.d61.s6|84-87|less|drug
DDI-MedLine.d61.s6|89-92|than|drug
DDI-MedLine.d61.s6|94-97|0.05|drug
DDI-MedLine.d61.s6|98-98|)|drug
DDI-MedLine.d61.s6|99-99|.|drug
DDI-MedLine.d61.s7|0-6|Digoxin|drug
DDI-MedLine.d61.s7|8-13|volume|drug
DDI-MedLine.d61.s7|15-16|of|drug
DDI-MedLine.d61.s7|18-29|distribution|drug
DDI-MedLine.d61.s7|31-33|was|drug
DDI-MedLine.d61.s7|35-37|not|drug
DDI-MedLine.d61.s7|39-51|significantly|drug
DDI-MedLine.d61.s7|53-59|changed|drug
DDI-MedLine.d61.s7|60-60|.|drug
DDI-MedLine.d61.s8|0-9|Amiodarone|drug
DDI-MedLine.d61.s8|11-16|caused|drug
DDI-MedLine.d61.s8|18-18|a|drug
DDI-MedLine.d61.s8|20-25|three-|drug
DDI-MedLine.d61.s8|27-28|to|drug
DDI-MedLine.d61.s8|30-37|fivefold|drug
DDI-MedLine.d61.s8|39-46|increase|drug
DDI-MedLine.d61.s8|48-49|in|drug
DDI-MedLine.d61.s8|51-55|serum|drug
DDI-MedLine.d61.s8|57-63|reverse|drug
DDI-MedLine.d61.s8|65-80|triiodothyronine|drug
DDI-MedLine.d61.s8|82-87|levels|drug
DDI-MedLine.d61.s8|88-88|,|drug
DDI-MedLine.d61.s8|90-92|but|drug
DDI-MedLine.d61.s8|94-100|changes|drug
DDI-MedLine.d61.s8|102-103|in|drug
DDI-MedLine.d61.s8|105-111|thyroid|drug
DDI-MedLine.d61.s8|113-120|function|drug
DDI-MedLine.d61.s8|122-125|were|drug
DDI-MedLine.d61.s8|127-129|not|drug
DDI-MedLine.d61.s8|131-144|quantitatively|drug
DDI-MedLine.d61.s8|146-152|related|drug
DDI-MedLine.d61.s8|154-155|to|drug
DDI-MedLine.d61.s8|157-159|the|drug
DDI-MedLine.d61.s8|161-167|changes|drug
DDI-MedLine.d61.s8|169-170|in|drug
DDI-MedLine.d61.s8|172-178|digoxin|drug
DDI-MedLine.d61.s8|180-195|pharmacokinetics|drug
DDI-MedLine.d61.s8|196-196|.|drug
DDI-MedLine.d61.s9|0-4|These|drug
DDI-MedLine.d61.s9|6-16|alterations|drug
DDI-MedLine.d61.s9|18-19|in|drug
DDI-MedLine.d61.s9|21-27|digoxin|drug
DDI-MedLine.d61.s9|29-44|pharmacokinetics|drug
DDI-MedLine.d61.s9|46-53|produced|drug
DDI-MedLine.d61.s9|55-56|by|drug
DDI-MedLine.d61.s9|58-67|amiodarone|drug
DDI-MedLine.d61.s9|69-75|explain|drug
DDI-MedLine.d61.s9|77-79|the|drug
DDI-MedLine.d61.s9|81-88|increase|drug
DDI-MedLine.d61.s9|90-91|in|drug
DDI-MedLine.d61.s9|93-97|serum|drug
DDI-MedLine.d61.s9|99-105|digoxin|drug
DDI-MedLine.d61.s9|107-111|level|drug
DDI-MedLine.d61.s9|113-116|that|drug
DDI-MedLine.d61.s9|118-120|has|drug
DDI-MedLine.d61.s9|122-125|been|drug
DDI-MedLine.d61.s9|127-134|observed|drug
DDI-MedLine.d61.s9|136-139|when|drug
DDI-MedLine.d61.s9|141-144|this|drug
DDI-MedLine.d61.s9|146-149|drug|drug
DDI-MedLine.d61.s9|151-161|combination|drug
DDI-MedLine.d61.s9|163-165|has|drug
DDI-MedLine.d61.s9|167-170|been|drug
DDI-MedLine.d61.s9|172-175|used|drug
DDI-MedLine.d61.s9|177-186|clinically|drug
DDI-MedLine.d61.s9|187-187|.|drug
DDI-DrugBank.d158.s0|0-6|Urinary|drug
DDI-DrugBank.d158.s0|8-17|acidifying|drug
DDI-DrugBank.d158.s0|19-24|agents|drug
DDI-DrugBank.d158.s0|26-30|These|drug
DDI-DrugBank.d158.s0|32-37|agents|drug
DDI-DrugBank.d158.s0|39-39|(|drug
DDI-DrugBank.d158.s0|40-47|ammonium|drug
DDI-DrugBank.d158.s0|49-56|chloride|drug
DDI-DrugBank.d158.s0|57-57|,|drug
DDI-DrugBank.d158.s0|59-64|sodium|drug
DDI-DrugBank.d158.s0|66-69|acid|drug
DDI-DrugBank.d158.s0|71-79|phosphate|drug
DDI-DrugBank.d158.s0|80-80|,|drug
DDI-DrugBank.d158.s0|82-85|etc|drug
DDI-DrugBank.d158.s0|86-86|.|drug
DDI-DrugBank.d158.s0|88-95|)|drug
DDI-DrugBank.d158.s0|97-99|increase|drug
DDI-DrugBank.d158.s0|101-113|the|drug
DDI-DrugBank.d158.s0|115-116|concentration|drug
DDI-DrugBank.d158.s0|118-120|of|drug
DDI-DrugBank.d158.s0|122-128|the|drug
DDI-DrugBank.d158.s0|130-136|ionized|drug
DDI-DrugBank.d158.s0|138-139|species|drug
DDI-DrugBank.d158.s0|141-143|of|drug
DDI-DrugBank.d158.s0|145-155|the|drug
DDI-DrugBank.d158.s0|157-164|amphetamine|drug
DDI-DrugBank.d158.s0|165-165|molecule|drug
DDI-DrugBank.d158.s0|167-173|,|drug
DDI-DrugBank.d158.s0|175-184|thereby|drug
DDI-DrugBank.d158.s0|186-192|increasing|drug
DDI-DrugBank.d158.s0|194-202|urinary|drug
DDI-DrugBank.d158.s0|203-203|excretion|drug
DDI-DrugBank.d158.s1|0-3|Both|drug
DDI-DrugBank.d158.s1|5-10|groups|drug
DDI-DrugBank.d158.s1|12-13|of|drug
DDI-DrugBank.d158.s1|15-20|agents|drug
DDI-DrugBank.d158.s1|22-26|lower|drug
DDI-DrugBank.d158.s1|28-32|blood|drug
DDI-DrugBank.d158.s1|34-39|levels|drug
DDI-DrugBank.d158.s1|41-43|and|drug
DDI-DrugBank.d158.s1|45-52|efficacy|drug
DDI-DrugBank.d158.s1|54-55|of|drug
DDI-DrugBank.d158.s1|57-68|amphetamines|drug
DDI-DrugBank.d158.s1|69-69|.|drug
DDI-DrugBank.d158.s2|0-9|Adrenergic|drug
DDI-DrugBank.d158.s2|11-18|blockers|drug
DDI-DrugBank.d158.s2|20-29|Adrenergic|drug
DDI-DrugBank.d158.s2|31-38|blockers|drug
DDI-DrugBank.d158.s2|40-42|are|drug
DDI-DrugBank.d158.s2|44-52|inhibited|drug
DDI-DrugBank.d158.s2|54-55|by|drug
DDI-DrugBank.d158.s2|57-68|amphetamines|drug
DDI-DrugBank.d158.s2|69-69|.|drug
DDI-DrugBank.d158.s3|0-14|Antidepressants|drug
DDI-DrugBank.d158.s3|15-15|,|drug
DDI-DrugBank.d158.s3|17-25|tricyclic|drug
DDI-DrugBank.d158.s3|27-38|Amphetamines|drug
DDI-DrugBank.d158.s3|40-42|may|drug
DDI-DrugBank.d158.s3|44-50|enhance|drug
DDI-DrugBank.d158.s3|52-54|the|drug
DDI-DrugBank.d158.s3|56-63|activity|drug
DDI-DrugBank.d158.s3|65-66|of|drug
DDI-DrugBank.d158.s3|68-76|tricyclic|drug
DDI-DrugBank.d158.s3|78-92|antidepressants|drug
DDI-DrugBank.d158.s3|94-95|or|drug
DDI-DrugBank.d158.s3|97-111|sympathomimetic|drug
DDI-DrugBank.d158.s3|113-118|agents|drug
DDI-DrugBank.d158.s3|119-119|;|drug
DDI-DrugBank.d158.s4|0-12|d-amphetamine|drug
DDI-DrugBank.d158.s4|14-17|with|drug
DDI-DrugBank.d158.s4|19-29|desipramine|drug
DDI-DrugBank.d158.s4|31-32|or|drug
DDI-DrugBank.d158.s4|34-46|protriptyline|drug
DDI-DrugBank.d158.s4|48-50|and|drug
DDI-DrugBank.d158.s4|52-59|possibly|drug
DDI-DrugBank.d158.s4|61-65|other|drug
DDI-DrugBank.d158.s4|67-76|tricyclics|drug
DDI-DrugBank.d158.s4|78-82|cause|drug
DDI-DrugBank.d158.s4|84-91|striking|drug
DDI-DrugBank.d158.s4|93-95|and|drug
DDI-DrugBank.d158.s4|97-105|sustained|drug
DDI-DrugBank.d158.s4|107-115|increases|drug
DDI-DrugBank.d158.s4|117-118|in|drug
DDI-DrugBank.d158.s4|120-122|the|drug
DDI-DrugBank.d158.s4|124-136|concentration|drug
DDI-DrugBank.d158.s4|138-139|of|drug
DDI-DrugBank.d158.s4|141-153|d-amphetamine|drug
DDI-DrugBank.d158.s4|155-156|in|drug
DDI-DrugBank.d158.s4|158-160|the|drug
DDI-DrugBank.d158.s4|162-166|brain|drug
DDI-DrugBank.d158.s4|167-167|;|drug
DDI-DrugBank.d158.s5|0-13|cardiovascular|drug
DDI-DrugBank.d158.s5|15-21|effects|drug
DDI-DrugBank.d158.s5|23-25|can|drug
DDI-DrugBank.d158.s5|27-28|be|drug
DDI-DrugBank.d158.s5|30-40|potentiated|drug
DDI-DrugBank.d158.s5|41-41|.|drug
DDI-DrugBank.d158.s6|0-2|MAO|drug
DDI-DrugBank.d158.s6|4-13|inhibitors|drug
DDI-DrugBank.d158.s6|15-18|MAOI|drug
DDI-DrugBank.d158.s6|20-34|antidepressants|drug
DDI-DrugBank.d158.s6|35-35|,|drug
DDI-DrugBank.d158.s6|37-38|as|drug
DDI-DrugBank.d158.s6|40-43|well|drug
DDI-DrugBank.d158.s6|45-46|as|drug
DDI-DrugBank.d158.s6|48-48|a|drug
DDI-DrugBank.d158.s6|50-59|metabolite|drug
DDI-DrugBank.d158.s6|61-62|of|drug
DDI-DrugBank.d158.s6|64-75|furazolidone|drug
DDI-DrugBank.d158.s6|76-76|,|drug
DDI-DrugBank.d158.s6|78-81|slow|drug
DDI-DrugBank.d158.s6|83-93|amphetamine|drug
DDI-DrugBank.d158.s6|95-104|metabolism|drug
DDI-DrugBank.d158.s6|105-105|.|drug
DDI-DrugBank.d158.s7|0-3|This|drug
DDI-DrugBank.d158.s7|5-11|slowing|drug
DDI-DrugBank.d158.s7|13-23|potentiates|drug
DDI-DrugBank.d158.s7|25-36|amphetamines|drug
DDI-DrugBank.d158.s7|37-37|,|drug
DDI-DrugBank.d158.s7|39-48|increasing|drug
DDI-DrugBank.d158.s7|50-54|their|drug
DDI-DrugBank.d158.s7|56-61|effect|drug
DDI-DrugBank.d158.s7|63-64|on|drug
DDI-DrugBank.d158.s7|66-68|the|drug
DDI-DrugBank.d158.s7|70-76|release|drug
DDI-DrugBank.d158.s7|78-79|of|drug
DDI-DrugBank.d158.s7|81-94|norepinephrine|drug
DDI-DrugBank.d158.s7|96-98|and|drug
DDI-DrugBank.d158.s7|100-104|other|drug
DDI-DrugBank.d158.s7|106-115|monoamines|drug
DDI-DrugBank.d158.s7|117-120|from|drug
DDI-DrugBank.d158.s7|122-131|adrenergic|drug
DDI-DrugBank.d158.s7|133-137|nerve|drug
DDI-DrugBank.d158.s7|139-145|endings|drug
DDI-DrugBank.d158.s7|146-146|;|drug
DDI-DrugBank.d158.s8|0-3|this|drug
DDI-DrugBank.d158.s8|5-7|can|drug
DDI-DrugBank.d158.s8|9-13|cause|drug
DDI-DrugBank.d158.s8|15-23|headaches|drug
DDI-DrugBank.d158.s8|25-27|and|drug
DDI-DrugBank.d158.s8|29-33|other|drug
DDI-DrugBank.d158.s8|35-39|signs|drug
DDI-DrugBank.d158.s8|41-42|of|drug
DDI-DrugBank.d158.s8|44-55|hypertensive|drug
DDI-DrugBank.d158.s8|57-62|crisis|drug
DDI-DrugBank.d158.s8|63-63|.|drug
DDI-DrugBank.d158.s9|0-0|A|drug
DDI-DrugBank.d158.s9|2-8|variety|drug
DDI-DrugBank.d158.s9|10-11|of|drug
DDI-DrugBank.d158.s9|13-17|toxic|drug
DDI-DrugBank.d158.s9|19-30|neurological|drug
DDI-DrugBank.d158.s9|32-38|effects|drug
DDI-DrugBank.d158.s9|40-42|and|drug
DDI-DrugBank.d158.s9|44-52|malignant|drug
DDI-DrugBank.d158.s9|54-65|hyperpyrexia|drug
DDI-DrugBank.d158.s9|67-69|can|drug
DDI-DrugBank.d158.s9|71-75|occur|drug
DDI-DrugBank.d158.s9|76-76|,|drug
DDI-DrugBank.d158.s9|78-86|sometimes|drug
DDI-DrugBank.d158.s9|88-91|with|drug
DDI-DrugBank.d158.s9|93-97|fatal|drug
DDI-DrugBank.d158.s9|99-105|results|drug
DDI-DrugBank.d158.s9|106-106|.|drug
DDI-DrugBank.d158.s10|0-13|Antihistamines|drug
DDI-DrugBank.d158.s10|14-14|:|drug
DDI-DrugBank.d158.s10|16-27|Amphetamines|drug
DDI-DrugBank.d158.s10|29-31|may|drug
DDI-DrugBank.d158.s10|33-42|counteract|drug
DDI-DrugBank.d158.s10|44-46|the|drug
DDI-DrugBank.d158.s10|48-55|sedative|drug
DDI-DrugBank.d158.s10|57-62|effect|drug
DDI-DrugBank.d158.s10|64-65|of|drug
DDI-DrugBank.d158.s10|67-80|antihistamines|drug
DDI-DrugBank.d158.s10|81-81|.|drug
DDI-DrugBank.d158.s11|0-16|Antihypertensives|drug
DDI-DrugBank.d158.s11|17-17|:|drug
DDI-DrugBank.d158.s11|19-30|Amphetamines|drug
DDI-DrugBank.d158.s11|32-34|may|drug
DDI-DrugBank.d158.s11|36-45|antagonize|drug
DDI-DrugBank.d158.s11|47-49|the|drug
DDI-DrugBank.d158.s11|51-61|hypotensive|drug
DDI-DrugBank.d158.s11|63-69|effects|drug
DDI-DrugBank.d158.s11|71-72|of|drug
DDI-DrugBank.d158.s11|74-90|antihypertensives|drug
DDI-DrugBank.d158.s11|91-91|.|drug
DDI-DrugBank.d158.s12|0-13|Chlorpromazine|drug
DDI-DrugBank.d158.s12|14-14|:|drug
DDI-DrugBank.d158.s12|16-29|Chlorpromazine|drug
DDI-DrugBank.d158.s12|31-36|blocks|drug
DDI-DrugBank.d158.s12|38-45|dopamine|drug
DDI-DrugBank.d158.s12|47-49|and|drug
DDI-DrugBank.d158.s12|51-64|norepinephrine|drug
DDI-DrugBank.d158.s12|66-74|receptors|drug
DDI-DrugBank.d158.s12|75-75|,|drug
DDI-DrugBank.d158.s12|77-80|thus|drug
DDI-DrugBank.d158.s12|82-91|inhibiting|drug
DDI-DrugBank.d158.s12|93-95|the|drug
DDI-DrugBank.d158.s12|97-103|central|drug
DDI-DrugBank.d158.s12|105-113|stimulant|drug
DDI-DrugBank.d158.s12|115-121|effects|drug
DDI-DrugBank.d158.s12|123-124|of|drug
DDI-DrugBank.d158.s12|126-137|amphetamines|drug
DDI-DrugBank.d158.s12|139-141|and|drug
DDI-DrugBank.d158.s12|143-145|can|drug
DDI-DrugBank.d158.s12|147-148|be|drug
DDI-DrugBank.d158.s12|150-153|used|drug
DDI-DrugBank.d158.s12|155-156|to|drug
DDI-DrugBank.d158.s12|158-162|treat|drug
DDI-DrugBank.d158.s12|164-174|amphetamine|drug
DDI-DrugBank.d158.s12|176-184|poisoning|drug
DDI-DrugBank.d158.s12|185-185|.|drug
DDI-DrugBank.d158.s13|0-11|Ethosuximide|drug
DDI-DrugBank.d158.s13|12-12|:|drug
DDI-DrugBank.d158.s13|14-25|Amphetamines|drug
DDI-DrugBank.d158.s13|27-29|may|drug
DDI-DrugBank.d158.s13|31-35|delay|drug
DDI-DrugBank.d158.s13|37-46|intestinal|drug
DDI-DrugBank.d158.s13|48-57|absorption|drug
DDI-DrugBank.d158.s13|59-60|of|drug
DDI-DrugBank.d158.s13|62-73|ethosuximide|drug
DDI-DrugBank.d158.s13|74-74|.|drug
DDI-DrugBank.d158.s14|0-10|Haloperidol|drug
DDI-DrugBank.d158.s14|11-11|:|drug
DDI-DrugBank.d158.s14|13-23|Haloperidol|drug
DDI-DrugBank.d158.s14|25-30|blocks|drug
DDI-DrugBank.d158.s14|32-39|dopamine|drug
DDI-DrugBank.d158.s14|41-49|receptors|drug
DDI-DrugBank.d158.s14|50-50|,|drug
DDI-DrugBank.d158.s14|52-55|thus|drug
DDI-DrugBank.d158.s14|57-66|inhibiting|drug
DDI-DrugBank.d158.s14|68-70|the|drug
DDI-DrugBank.d158.s14|72-78|central|drug
DDI-DrugBank.d158.s14|80-88|stimulant|drug
DDI-DrugBank.d158.s14|90-96|effects|drug
DDI-DrugBank.d158.s14|98-99|of|drug
DDI-DrugBank.d158.s14|101-112|amphetamines|drug
DDI-DrugBank.d158.s14|113-113|.|drug
DDI-DrugBank.d158.s15|0-6|Lithium|drug
DDI-DrugBank.d158.s15|8-16|carbonate|drug
DDI-DrugBank.d158.s15|17-17|:|drug
DDI-DrugBank.d158.s15|19-21|The|drug
DDI-DrugBank.d158.s15|23-31|anorectic|drug
DDI-DrugBank.d158.s15|33-35|and|drug
DDI-DrugBank.d158.s15|37-47|stimulatory|drug
DDI-DrugBank.d158.s15|49-55|effects|drug
DDI-DrugBank.d158.s15|57-58|of|drug
DDI-DrugBank.d158.s15|60-71|amphetamines|drug
DDI-DrugBank.d158.s15|73-75|may|drug
DDI-DrugBank.d158.s15|77-78|be|drug
DDI-DrugBank.d158.s15|80-88|inhibited|drug
DDI-DrugBank.d158.s15|90-91|by|drug
DDI-DrugBank.d158.s15|93-99|lithium|drug
DDI-DrugBank.d158.s15|101-109|carbonate|drug
DDI-DrugBank.d158.s15|110-110|.|drug
DDI-DrugBank.d158.s16|0-9|Meperidine|drug
DDI-DrugBank.d158.s16|10-10|:|drug
DDI-DrugBank.d158.s16|12-23|Amphetamines|drug
DDI-DrugBank.d158.s16|25-34|potentiate|drug
DDI-DrugBank.d158.s16|36-38|the|drug
DDI-DrugBank.d158.s16|40-48|analgesic|drug
DDI-DrugBank.d158.s16|50-55|effect|drug
DDI-DrugBank.d158.s16|57-58|of|drug
DDI-DrugBank.d158.s16|60-69|meperidine|drug
DDI-DrugBank.d158.s16|70-70|.|drug
DDI-DrugBank.d158.s17|0-10|Methenamine|drug
DDI-DrugBank.d158.s17|12-18|therapy|drug
DDI-DrugBank.d158.s17|20-26|Urinary|drug
DDI-DrugBank.d158.s17|28-36|excretion|drug
DDI-DrugBank.d158.s17|38-39|of|drug
DDI-DrugBank.d158.s17|41-52|amphetamines|drug
DDI-DrugBank.d158.s17|54-55|is|drug
DDI-DrugBank.d158.s17|57-65|increased|drug
DDI-DrugBank.d158.s17|66-66|,|drug
DDI-DrugBank.d158.s17|68-70|and|drug
DDI-DrugBank.d158.s17|72-79|efficacy|drug
DDI-DrugBank.d158.s17|81-82|is|drug
DDI-DrugBank.d158.s17|84-90|reduced|drug
DDI-DrugBank.d158.s17|92-93|by|drug
DDI-DrugBank.d158.s17|95-104|acidifying|drug
DDI-DrugBank.d158.s17|106-111|agents|drug
DDI-DrugBank.d158.s17|113-116|used|drug
DDI-DrugBank.d158.s17|118-119|in|drug
DDI-DrugBank.d158.s17|121-131|methenamine|drug
DDI-DrugBank.d158.s17|133-139|therapy|drug
DDI-DrugBank.d158.s17|140-140|.|drug
DDI-DrugBank.d158.s18|0-13|Norepinephrine|drug
DDI-DrugBank.d158.s18|14-14|:|drug
DDI-DrugBank.d158.s18|16-27|Amphetamines|drug
DDI-DrugBank.d158.s18|29-35|enhance|drug
DDI-DrugBank.d158.s18|37-39|the|drug
DDI-DrugBank.d158.s18|41-50|adrenergic|drug
DDI-DrugBank.d158.s18|52-57|effect|drug
DDI-DrugBank.d158.s18|59-60|of|drug
DDI-DrugBank.d158.s18|62-75|norepinephrine|drug
DDI-DrugBank.d158.s18|76-76|.|drug
DDI-DrugBank.d158.s19|0-12|Phenobarbital|drug
DDI-DrugBank.d158.s19|13-13|:|drug
DDI-DrugBank.d158.s19|15-26|Amphetamines|drug
DDI-DrugBank.d158.s19|28-30|may|drug
DDI-DrugBank.d158.s19|32-36|delay|drug
DDI-DrugBank.d158.s19|38-47|intestinal|drug
DDI-DrugBank.d158.s19|49-58|absorption|drug
DDI-DrugBank.d158.s19|60-61|of|drug
DDI-DrugBank.d158.s19|63-75|phenobarbital|drug
DDI-DrugBank.d158.s19|76-76|;|drug
DDI-DrugBank.d158.s20|0-16|co-administration|drug
DDI-DrugBank.d158.s20|18-19|of|drug
DDI-DrugBank.d158.s20|21-33|phenobarbital|drug
DDI-DrugBank.d158.s20|35-37|may|drug
DDI-DrugBank.d158.s20|39-45|produce|drug
DDI-DrugBank.d158.s20|47-47|a|drug
DDI-DrugBank.d158.s20|49-59|synergistic|drug
DDI-DrugBank.d158.s20|61-74|anticonvulsant|drug
DDI-DrugBank.d158.s20|76-81|action|drug
DDI-DrugBank.d158.s20|82-82|.|drug
DDI-DrugBank.d158.s21|0-8|Phenytoin|drug
DDI-DrugBank.d158.s21|9-9|:|drug
DDI-DrugBank.d158.s21|11-22|Amphetamines|drug
DDI-DrugBank.d158.s21|24-26|may|drug
DDI-DrugBank.d158.s21|28-32|delay|drug
DDI-DrugBank.d158.s21|34-43|intestinal|drug
DDI-DrugBank.d158.s21|45-54|absorption|drug
DDI-DrugBank.d158.s21|56-57|of|drug
DDI-DrugBank.d158.s21|59-67|phenytoin|drug
DDI-DrugBank.d158.s21|68-68|;|drug
DDI-DrugBank.d158.s22|0-16|co-administration|drug
DDI-DrugBank.d158.s22|18-19|of|drug
DDI-DrugBank.d158.s22|21-29|phenytoin|drug
DDI-DrugBank.d158.s22|31-33|may|drug
DDI-DrugBank.d158.s22|35-41|produce|drug
DDI-DrugBank.d158.s22|43-43|a|drug
DDI-DrugBank.d158.s22|45-55|synergistic|drug
DDI-DrugBank.d158.s22|57-70|anticonvulsant|drug
DDI-DrugBank.d158.s22|72-77|action|drug
DDI-DrugBank.d158.s22|78-78|.|drug
DDI-DrugBank.d158.s23|0-11|Propoxyphene|drug
DDI-DrugBank.d158.s23|12-12|:|drug
DDI-DrugBank.d158.s23|14-15|In|drug
DDI-DrugBank.d158.s23|17-21|cases|drug
DDI-DrugBank.d158.s23|23-24|of|drug
DDI-DrugBank.d158.s23|26-37|propoxyphene|drug
DDI-DrugBank.d158.s23|39-48|overdosage|drug
DDI-DrugBank.d158.s23|49-49|,|drug
DDI-DrugBank.d158.s23|51-61|amphetamine|drug
DDI-DrugBank.d158.s23|63-65|CNS|drug
DDI-DrugBank.d158.s23|67-77|stimulation|drug
DDI-DrugBank.d158.s23|79-80|is|drug
DDI-DrugBank.d158.s23|82-92|potentiated|drug
DDI-DrugBank.d158.s23|94-96|and|drug
DDI-DrugBank.d158.s23|98-102|fatal|drug
DDI-DrugBank.d158.s23|104-114|convulsions|drug
DDI-DrugBank.d158.s23|116-118|can|drug
DDI-DrugBank.d158.s23|120-124|occur|drug
DDI-DrugBank.d158.s23|125-125|.|drug
DDI-DrugBank.d158.s24|0-7|Veratrum|drug
DDI-DrugBank.d158.s24|9-17|alkaloids|drug
DDI-DrugBank.d158.s24|18-18|:|drug
DDI-DrugBank.d158.s24|20-31|Amphetamines|drug
DDI-DrugBank.d158.s24|33-39|inhibit|drug
DDI-DrugBank.d158.s24|41-43|the|drug
DDI-DrugBank.d158.s24|45-55|hypotensive|drug
DDI-DrugBank.d158.s24|57-62|effect|drug
DDI-DrugBank.d158.s24|64-65|of|drug
DDI-DrugBank.d158.s24|67-74|veratrum|drug
DDI-DrugBank.d158.s24|76-84|alkaloids|drug
DDI-DrugBank.d158.s24|85-85|.|drug
DDI-DrugBank.d158.s25|0-14|Drug/Laboratory|drug
DDI-DrugBank.d158.s25|16-19|Test|drug
DDI-DrugBank.d158.s25|21-32|Interactions|drug
DDI-DrugBank.d158.s25|33-33|:|drug
DDI-DrugBank.d158.s25|35-46|Amphetamines|drug
DDI-DrugBank.d158.s25|48-50|can|drug
DDI-DrugBank.d158.s25|52-56|cause|drug
DDI-DrugBank.d158.s25|58-58|a|drug
DDI-DrugBank.d158.s25|60-70|significant|drug
DDI-DrugBank.d158.s25|72-80|elevation|drug
DDI-DrugBank.d158.s25|82-83|in|drug
DDI-DrugBank.d158.s25|85-90|plasma|drug
DDI-DrugBank.d158.s25|92-105|corticosteroid|drug
DDI-DrugBank.d158.s25|107-112|levels|drug
DDI-DrugBank.d158.s25|113-113|.|drug
DDI-DrugBank.d158.s26|0-3|This|drug
DDI-DrugBank.d158.s26|5-12|increase|drug
DDI-DrugBank.d158.s26|14-15|is|drug
DDI-DrugBank.d158.s26|17-24|greatest|drug
DDI-DrugBank.d158.s26|26-27|in|drug
DDI-DrugBank.d158.s26|29-31|the|drug
DDI-DrugBank.d158.s26|33-39|evening|drug
DDI-DrugBank.d158.s26|40-40|.|drug
DDI-DrugBank.d158.s27|0-11|Amphetamines|drug
DDI-DrugBank.d158.s27|13-15|may|drug
DDI-DrugBank.d158.s27|17-25|interfere|drug
DDI-DrugBank.d158.s27|27-30|with|drug
DDI-DrugBank.d158.s27|32-38|urinary|drug
DDI-DrugBank.d158.s27|40-46|steroid|drug
DDI-DrugBank.d158.s27|48-61|determinations|drug
DDI-DrugBank.d158.s27|62-62|.|drug
DDI-MedLine.d184.s0|0-10|Amphetamine|drug
DDI-MedLine.d184.s0|12-20|locomotor|drug
DDI-MedLine.d184.s0|22-34|sensitization|drug
DDI-MedLine.d184.s0|36-38|and|drug
DDI-MedLine.d184.s0|40-50|conditioned|drug
DDI-MedLine.d184.s0|52-56|place|drug
DDI-MedLine.d184.s0|58-67|preference|drug
DDI-MedLine.d184.s0|69-70|in|drug
DDI-MedLine.d184.s0|72-81|adolescent|drug
DDI-MedLine.d184.s0|83-86|male|drug
DDI-MedLine.d184.s0|88-90|and|drug
DDI-MedLine.d184.s0|92-97|female|drug
DDI-MedLine.d184.s0|99-102|rats|drug
DDI-MedLine.d184.s0|104-113|neonatally|drug
DDI-MedLine.d184.s0|115-121|treated|drug
DDI-MedLine.d184.s0|123-126|with|drug
DDI-MedLine.d184.s0|128-137|quinpirole|drug
DDI-MedLine.d184.s0|138-138|.|drug
DDI-MedLine.d184.s1|0-7|Neonatal|drug
DDI-MedLine.d184.s1|9-18|quinpirole|drug
DDI-MedLine.d184.s1|20-28|treatment|drug
DDI-MedLine.d184.s1|30-32|has|drug
DDI-MedLine.d184.s1|34-37|been|drug
DDI-MedLine.d184.s1|39-43|shown|drug
DDI-MedLine.d184.s1|45-46|to|drug
DDI-MedLine.d184.s1|48-54|produce|drug
DDI-MedLine.d184.s1|56-57|an|drug
DDI-MedLine.d184.s1|59-66|increase|drug
DDI-MedLine.d184.s1|68-69|in|drug
DDI-MedLine.d184.s1|71-78|dopamine|drug
DDI-MedLine.d184.s1|80-86|D2-like|drug
DDI-MedLine.d184.s1|88-95|receptor|drug
DDI-MedLine.d184.s1|97-107|sensitivity|drug
DDI-MedLine.d184.s1|109-112|that|drug
DDI-MedLine.d184.s1|114-121|persists|drug
DDI-MedLine.d184.s1|123-132|throughout|drug
DDI-MedLine.d184.s1|134-136|the|drug
DDI-MedLine.d184.s1|138-144|subject|drug
DDI-MedLine.d184.s1|145-146|'s|drug
DDI-MedLine.d184.s1|148-155|lifetime|drug
DDI-MedLine.d184.s1|156-156|.|drug
DDI-MedLine.d184.s2|0-2|The|drug
DDI-MedLine.d184.s2|4-12|objective|drug
DDI-MedLine.d184.s2|14-16|was|drug
DDI-MedLine.d184.s2|18-19|to|drug
DDI-MedLine.d184.s2|21-27|analyze|drug
DDI-MedLine.d184.s2|29-31|the|drug
DDI-MedLine.d184.s2|33-39|effects|drug
DDI-MedLine.d184.s2|41-42|of|drug
DDI-MedLine.d184.s2|44-51|neonatal|drug
DDI-MedLine.d184.s2|53-62|quinpirole|drug
DDI-MedLine.d184.s2|64-72|treatment|drug
DDI-MedLine.d184.s2|74-75|on|drug
DDI-MedLine.d184.s2|77-83|effects|drug
DDI-MedLine.d184.s2|85-86|of|drug
DDI-MedLine.d184.s2|88-98|amphetamine|drug
DDI-MedLine.d184.s2|100-101|in|drug
DDI-MedLine.d184.s2|103-112|adolescent|drug
DDI-MedLine.d184.s2|114-117|rats|drug
DDI-MedLine.d184.s2|119-123|using|drug
DDI-MedLine.d184.s2|125-133|locomotor|drug
DDI-MedLine.d184.s2|135-147|sensitization|drug
DDI-MedLine.d184.s2|149-151|and|drug
DDI-MedLine.d184.s2|153-163|conditioned|drug
DDI-MedLine.d184.s2|165-169|place|drug
DDI-MedLine.d184.s2|171-180|preference|drug
DDI-MedLine.d184.s2|182-191|procedures|drug
DDI-MedLine.d184.s2|192-192|.|drug
DDI-MedLine.d184.s3|0-13|Sprague-Dawley|drug
DDI-MedLine.d184.s3|15-18|rats|drug
DDI-MedLine.d184.s3|20-23|were|drug
DDI-MedLine.d184.s3|25-31|treated|drug
DDI-MedLine.d184.s3|33-36|with|drug
DDI-MedLine.d184.s3|38-47|quinpirole|drug
DDI-MedLine.d184.s3|49-49|(|drug
DDI-MedLine.d184.s3|50-50|1|drug
DDI-MedLine.d184.s3|52-56|mg/kg|drug
DDI-MedLine.d184.s3|57-57|)|drug
DDI-MedLine.d184.s3|59-60|or|drug
DDI-MedLine.d184.s3|62-67|saline|drug
DDI-MedLine.d184.s3|69-72|from|drug
DDI-MedLine.d184.s3|74-82|postnatal|drug
DDI-MedLine.d184.s3|84-87|days|drug
DDI-MedLine.d184.s3|89-89|(|drug
DDI-MedLine.d184.s3|90-90|P|drug
DDI-MedLine.d184.s3|91-91|)|drug
DDI-MedLine.d184.s3|92-92|1|drug
DDI-MedLine.d184.s3|94-95|to|drug
DDI-MedLine.d184.s3|97-99|P11|drug
DDI-MedLine.d184.s3|101-103|and|drug
DDI-MedLine.d184.s3|105-110|raised|drug
DDI-MedLine.d184.s3|112-113|to|drug
DDI-MedLine.d184.s3|115-125|adolescence|drug
DDI-MedLine.d184.s3|126-126|.|drug
DDI-MedLine.d184.s4|0-2|For|drug
DDI-MedLine.d184.s4|4-12|locomotor|drug
DDI-MedLine.d184.s4|14-26|sensitization|drug
DDI-MedLine.d184.s4|27-27|,|drug
DDI-MedLine.d184.s4|29-36|subjects|drug
DDI-MedLine.d184.s4|38-41|were|drug
DDI-MedLine.d184.s4|43-47|given|drug
DDI-MedLine.d184.s4|49-59|amphetamine|drug
DDI-MedLine.d184.s4|61-61|(|drug
DDI-MedLine.d184.s4|62-62|1|drug
DDI-MedLine.d184.s4|64-68|mg/kg|drug
DDI-MedLine.d184.s4|69-69|)|drug
DDI-MedLine.d184.s4|71-72|or|drug
DDI-MedLine.d184.s4|74-79|saline|drug
DDI-MedLine.d184.s4|81-85|every|drug
DDI-MedLine.d184.s4|87-92|second|drug
DDI-MedLine.d184.s4|94-96|day|drug
DDI-MedLine.d184.s4|98-101|from|drug
DDI-MedLine.d184.s4|103-105|P35|drug
DDI-MedLine.d184.s4|107-108|to|drug
DDI-MedLine.d184.s4|110-112|P47|drug
DDI-MedLine.d184.s4|114-116|and|drug
DDI-MedLine.d184.s4|118-121|were|drug
DDI-MedLine.d184.s4|123-128|placed|drug
DDI-MedLine.d184.s4|130-133|into|drug
DDI-MedLine.d184.s4|135-135|a|drug
DDI-MedLine.d184.s4|137-145|locomotor|drug
DDI-MedLine.d184.s4|147-151|arena|drug
DDI-MedLine.d184.s4|152-152|.|drug
DDI-MedLine.d184.s5|0-1|In|drug
DDI-MedLine.d184.s5|3-8|female|drug
DDI-MedLine.d184.s5|10-13|rats|drug
DDI-MedLine.d184.s5|14-14|,|drug
DDI-MedLine.d184.s5|16-23|neonatal|drug
DDI-MedLine.d184.s5|25-34|quinpirole|drug
DDI-MedLine.d184.s5|36-44|treatment|drug
DDI-MedLine.d184.s5|46-53|enhanced|drug
DDI-MedLine.d184.s5|55-65|amphetamine|drug
DDI-MedLine.d184.s5|67-75|locomotor|drug
DDI-MedLine.d184.s5|77-89|sensitization|drug
DDI-MedLine.d184.s5|91-98|compared|drug
DDI-MedLine.d184.s5|100-103|with|drug
DDI-MedLine.d184.s5|105-119|quinpirole-free|drug
DDI-MedLine.d184.s5|121-128|controls|drug
DDI-MedLine.d184.s5|130-139|sensitized|drug
DDI-MedLine.d184.s5|141-142|to|drug
DDI-MedLine.d184.s5|144-154|amphetamine|drug
DDI-MedLine.d184.s5|155-155|.|drug
DDI-MedLine.d184.s6|0-3|Male|drug
DDI-MedLine.d184.s6|5-8|rats|drug
DDI-MedLine.d184.s6|10-21|demonstrated|drug
DDI-MedLine.d184.s6|23-35|sensitization|drug
DDI-MedLine.d184.s6|37-38|to|drug
DDI-MedLine.d184.s6|40-50|amphetamine|drug
DDI-MedLine.d184.s6|51-51|,|drug
DDI-MedLine.d184.s6|53-60|although|drug
DDI-MedLine.d184.s6|62-65|this|drug
DDI-MedLine.d184.s6|67-69|was|drug
DDI-MedLine.d184.s6|71-75|muted|drug
DDI-MedLine.d184.s6|77-84|compared|drug
DDI-MedLine.d184.s6|86-89|with|drug
DDI-MedLine.d184.s6|91-96|female|drug
DDI-MedLine.d184.s6|98-101|rats|drug
DDI-MedLine.d184.s6|102-102|,|drug
DDI-MedLine.d184.s6|104-106|and|drug
DDI-MedLine.d184.s6|108-111|were|drug
DDI-MedLine.d184.s6|113-122|unaffected|drug
DDI-MedLine.d184.s6|124-125|by|drug
DDI-MedLine.d184.s6|127-134|neonatal|drug
DDI-MedLine.d184.s6|136-145|quinpirole|drug
DDI-MedLine.d184.s6|146-146|.|drug
DDI-MedLine.d184.s7|0-2|For|drug
DDI-MedLine.d184.s7|4-14|conditioned|drug
DDI-MedLine.d184.s7|16-20|place|drug
DDI-MedLine.d184.s7|22-31|preference|drug
DDI-MedLine.d184.s7|32-32|,|drug
DDI-MedLine.d184.s7|34-41|subjects|drug
DDI-MedLine.d184.s7|43-46|were|drug
DDI-MedLine.d184.s7|48-58|conditioned|drug
DDI-MedLine.d184.s7|60-62|for|drug
DDI-MedLine.d184.s7|64-64|8|drug
DDI-MedLine.d184.s7|66-76|consecutive|drug
DDI-MedLine.d184.s7|78-81|days|drug
DDI-MedLine.d184.s7|83-83|(|drug
DDI-MedLine.d184.s7|84-89|P32-39|drug
DDI-MedLine.d184.s7|90-90|)|drug
DDI-MedLine.d184.s7|92-95|with|drug
DDI-MedLine.d184.s7|97-107|amphetamine|drug
DDI-MedLine.d184.s7|109-109|(|drug
DDI-MedLine.d184.s7|110-110|1|drug
DDI-MedLine.d184.s7|112-116|mg/kg|drug
DDI-MedLine.d184.s7|117-117|)|drug
DDI-MedLine.d184.s7|119-120|or|drug
DDI-MedLine.d184.s7|122-127|saline|drug
DDI-MedLine.d184.s7|129-131|and|drug
DDI-MedLine.d184.s7|133-133|a|drug
DDI-MedLine.d184.s7|135-143|drug-free|drug
DDI-MedLine.d184.s7|145-154|preference|drug
DDI-MedLine.d184.s7|156-159|test|drug
DDI-MedLine.d184.s7|161-163|was|drug
DDI-MedLine.d184.s7|165-173|conducted|drug
DDI-MedLine.d184.s7|175-176|at|drug
DDI-MedLine.d184.s7|178-180|P40|drug
DDI-MedLine.d184.s7|181-181|.|drug
DDI-MedLine.d184.s8|0-3|Rats|drug
DDI-MedLine.d184.s8|5-11|treated|drug
DDI-MedLine.d184.s8|13-16|with|drug
DDI-MedLine.d184.s8|18-25|neonatal|drug
DDI-MedLine.d184.s8|27-36|quinpirole|drug
DDI-MedLine.d184.s8|38-45|enhanced|drug
DDI-MedLine.d184.s8|47-50|time|drug
DDI-MedLine.d184.s8|52-56|spent|drug
DDI-MedLine.d184.s8|58-59|in|drug
DDI-MedLine.d184.s8|61-63|the|drug
DDI-MedLine.d184.s8|65-82|amphetamine-paired|drug
DDI-MedLine.d184.s8|84-90|context|drug
DDI-MedLine.d184.s8|92-99|compared|drug
DDI-MedLine.d184.s8|101-104|with|drug
DDI-MedLine.d184.s8|106-120|quinpirole-free|drug
DDI-MedLine.d184.s8|122-129|controls|drug
DDI-MedLine.d184.s8|131-141|conditioned|drug
DDI-MedLine.d184.s8|143-146|with|drug
DDI-MedLine.d184.s8|148-158|amphetamine|drug
DDI-MedLine.d184.s8|159-159|,|drug
DDI-MedLine.d184.s8|161-163|but|drug
DDI-MedLine.d184.s8|165-168|only|drug
DDI-MedLine.d184.s8|170-175|female|drug
DDI-MedLine.d184.s8|177-184|controls|drug
DDI-MedLine.d184.s8|186-196|conditioned|drug
DDI-MedLine.d184.s8|198-201|with|drug
DDI-MedLine.d184.s8|203-213|amphetamine|drug
DDI-MedLine.d184.s8|215-219|spent|drug
DDI-MedLine.d184.s8|221-224|more|drug
DDI-MedLine.d184.s8|226-229|time|drug
DDI-MedLine.d184.s8|231-232|in|drug
DDI-MedLine.d184.s8|234-236|the|drug
DDI-MedLine.d184.s8|238-248|drug-paired|drug
DDI-MedLine.d184.s8|250-256|context|drug
DDI-MedLine.d184.s8|258-265|compared|drug
DDI-MedLine.d184.s8|267-270|with|drug
DDI-MedLine.d184.s8|272-285|saline-treated|drug
DDI-MedLine.d184.s8|287-294|controls|drug
DDI-MedLine.d184.s8|295-295|.|drug
DDI-MedLine.d184.s9|0-8|Increased|drug
DDI-MedLine.d184.s9|10-10|D|drug
DDI-MedLine.d184.s9|14-18|-like|drug
DDI-MedLine.d184.s9|20-27|receptor|drug
DDI-MedLine.d184.s9|29-39|sensitivity|drug
DDI-MedLine.d184.s9|41-47|appears|drug
DDI-MedLine.d184.s9|49-50|to|drug
DDI-MedLine.d184.s9|52-55|have|drug
DDI-MedLine.d184.s9|57-64|enhanced|drug
DDI-MedLine.d184.s9|66-68|the|drug
DDI-MedLine.d184.s9|70-79|behavioral|drug
DDI-MedLine.d184.s9|81-87|effects|drug
DDI-MedLine.d184.s9|89-90|of|drug
DDI-MedLine.d184.s9|92-102|amphetamine|drug
DDI-MedLine.d184.s9|103-103|,|drug
DDI-MedLine.d184.s9|105-107|but|drug
DDI-MedLine.d184.s9|109-113|these|drug
DDI-MedLine.d184.s9|115-121|effects|drug
DDI-MedLine.d184.s9|123-126|were|drug
DDI-MedLine.d184.s9|128-131|more|drug
DDI-MedLine.d184.s9|133-141|prevalent|drug
DDI-MedLine.d184.s9|143-144|in|drug
DDI-MedLine.d184.s9|146-155|adolescent|drug
DDI-MedLine.d184.s9|157-162|female|drug
DDI-MedLine.d184.s9|164-167|rats|drug
DDI-MedLine.d184.s9|169-176|compared|drug
DDI-MedLine.d184.s9|178-181|with|drug
DDI-MedLine.d184.s9|183-186|male|drug
DDI-MedLine.d184.s9|188-191|rats|drug
DDI-MedLine.d184.s9|192-192|.|drug
DDI-DrugBank.d66.s0|0-4|Human|drug
DDI-DrugBank.d66.s0|6-11|growth|drug
DDI-DrugBank.d66.s0|13-19|hormone|drug
DDI-DrugBank.d66.s0|21-21|-|drug
DDI-DrugBank.d66.s0|23-33|Concomitant|drug
DDI-DrugBank.d66.s0|35-37|use|drug
DDI-DrugBank.d66.s0|39-40|of|drug
DDI-DrugBank.d66.s0|42-52|L-glutamine|drug
DDI-DrugBank.d66.s0|54-56|and|drug
DDI-DrugBank.d66.s0|58-62|human|drug
DDI-DrugBank.d66.s0|64-69|growth|drug
DDI-DrugBank.d66.s0|71-77|hormone|drug
DDI-DrugBank.d66.s0|79-81|may|drug
DDI-DrugBank.d66.s0|83-89|enhance|drug
DDI-DrugBank.d66.s0|91-98|nutrient|drug
DDI-DrugBank.d66.s0|100-109|absorption|drug
DDI-DrugBank.d66.s0|111-112|in|drug
DDI-DrugBank.d66.s0|114-118|those|drug
DDI-DrugBank.d66.s0|120-123|with|drug
DDI-DrugBank.d66.s0|125-130|severe|drug
DDI-DrugBank.d66.s0|132-136|short|drug
DDI-DrugBank.d66.s0|138-142|bowel|drug
DDI-DrugBank.d66.s0|144-151|syndrome|drug
DDI-DrugBank.d66.s0|152-152|.|drug
DDI-DrugBank.d66.s1|0-10|L-glutamine|drug
DDI-DrugBank.d66.s1|12-14|has|drug
DDI-DrugBank.d66.s1|16-21|orphan|drug
DDI-DrugBank.d66.s1|23-26|drug|drug
DDI-DrugBank.d66.s1|28-33|status|drug
DDI-DrugBank.d66.s1|35-37|for|drug
DDI-DrugBank.d66.s1|39-42|this|drug
DDI-DrugBank.d66.s1|44-53|indication|drug
DDI-DrugBank.d66.s1|54-54|.|drug
DDI-DrugBank.d66.s2|0-11|Indomethacin|drug
DDI-DrugBank.d66.s2|13-13|-|drug
DDI-DrugBank.d66.s2|15-25|Concomitant|drug
DDI-DrugBank.d66.s2|27-29|use|drug
DDI-DrugBank.d66.s2|31-32|of|drug
DDI-DrugBank.d66.s2|34-44|L-glutamine|drug
DDI-DrugBank.d66.s2|46-48|and|drug
DDI-DrugBank.d66.s2|50-61|indomethacin|drug
DDI-DrugBank.d66.s2|63-65|may|drug
DDI-DrugBank.d66.s2|67-76|ameliorate|drug
DDI-DrugBank.d66.s2|78-86|increased|drug
DDI-DrugBank.d66.s2|88-97|intestinal|drug
DDI-DrugBank.d66.s2|99-110|permeability|drug
DDI-DrugBank.d66.s2|112-117|caused|drug
DDI-DrugBank.d66.s2|119-120|by|drug
DDI-DrugBank.d66.s2|122-133|indomethacin|drug
DDI-DrugBank.d66.s2|134-134|.|drug
DDI-DrugBank.d66.s3|0-2|The|drug
DDI-DrugBank.d66.s3|4-11|reported|drug
DDI-DrugBank.d66.s3|13-16|dose|drug
DDI-DrugBank.d66.s3|18-21|used|drug
DDI-DrugBank.d66.s3|23-25|for|drug
DDI-DrugBank.d66.s3|27-37|L-glutamine|drug
DDI-DrugBank.d66.s3|39-41|was|drug
DDI-DrugBank.d66.s3|43-44|21|drug
DDI-DrugBank.d66.s3|46-50|grams|drug
DDI-DrugBank.d66.s3|52-56|daily|drug
DDI-DrugBank.d66.s3|58-62|taken|drug
DDI-DrugBank.d66.s3|64-65|in|drug
DDI-DrugBank.d66.s3|67-73|divided|drug
DDI-DrugBank.d66.s3|75-79|doses|drug
DDI-DrugBank.d66.s3|81-85|three|drug
DDI-DrugBank.d66.s3|87-91|times|drug
DDI-DrugBank.d66.s3|93-93|a|drug
DDI-DrugBank.d66.s3|95-97|day|drug
DDI-DrugBank.d66.s3|98-98|.|drug
DDI-DrugBank.d66.s4|0-6|Further|drug
DDI-DrugBank.d66.s4|7-7|,|drug
DDI-DrugBank.d66.s4|9-19|misoprostol|drug
DDI-DrugBank.d66.s4|21-22|is|drug
DDI-DrugBank.d66.s4|24-31|reported|drug
DDI-DrugBank.d66.s4|33-34|to|drug
DDI-DrugBank.d66.s4|36-39|have|drug
DDI-DrugBank.d66.s4|41-41|a|drug
DDI-DrugBank.d66.s4|43-53|synergistic|drug
DDI-DrugBank.d66.s4|55-60|effect|drug
DDI-DrugBank.d66.s4|62-65|with|drug
DDI-DrugBank.d66.s4|67-70|this|drug
DDI-DrugBank.d66.s4|72-82|combination|drug
DDI-DrugBank.d66.s4|84-85|in|drug
DDI-DrugBank.d66.s4|87-98|ameliorating|drug
DDI-DrugBank.d66.s4|100-109|intestinal|drug
DDI-DrugBank.d66.s4|111-122|permeability|drug
DDI-DrugBank.d66.s4|123-123|.|drug
DDI-DrugBank.d66.s5|0-11|Methotrexate|drug
DDI-DrugBank.d66.s5|13-13|-|drug
DDI-DrugBank.d66.s5|15-19|There|drug
DDI-DrugBank.d66.s5|21-22|is|drug
DDI-DrugBank.d66.s5|24-26|one|drug
DDI-DrugBank.d66.s5|28-33|report|drug
DDI-DrugBank.d66.s5|35-38|that|drug
DDI-DrugBank.d66.s5|40-51|methotrexate|drug
DDI-DrugBank.d66.s5|53-55|may|drug
DDI-DrugBank.d66.s5|57-64|decrease|drug
DDI-DrugBank.d66.s5|66-68|the|drug
DDI-DrugBank.d66.s5|70-77|possible|drug
DDI-DrugBank.d66.s5|79-91|effectiveness|drug
DDI-DrugBank.d66.s5|93-94|of|drug
DDI-DrugBank.d66.s5|96-107|supplemental|drug
DDI-DrugBank.d66.s5|109-119|L-glutamine|drug
DDI-DrugBank.d66.s5|121-123|for|drug
DDI-DrugBank.d66.s5|125-144|chemotherapy-induced|drug
DDI-DrugBank.d66.s5|146-154|mucositis|drug
DDI-DrugBank.d66.s5|155-155|.|drug
DDI-DrugBank.d66.s6|0-1|In|drug
DDI-DrugBank.d66.s6|3-9|another|drug
DDI-DrugBank.d66.s6|11-16|report|drug
DDI-DrugBank.d66.s6|17-17|,|drug
DDI-DrugBank.d66.s6|19-22|nine|drug
DDI-DrugBank.d66.s6|24-31|patients|drug
DDI-DrugBank.d66.s6|33-36|with|drug
DDI-DrugBank.d66.s6|38-43|breast|drug
DDI-DrugBank.d66.s6|45-50|cancer|drug
DDI-DrugBank.d66.s6|52-55|were|drug
DDI-DrugBank.d66.s6|57-64|reported|drug
DDI-DrugBank.d66.s6|66-67|to|drug
DDI-DrugBank.d66.s6|69-72|have|drug
DDI-DrugBank.d66.s6|74-82|decreased|drug
DDI-DrugBank.d66.s6|84-91|symptoms|drug
DDI-DrugBank.d66.s6|93-94|of|drug
DDI-DrugBank.d66.s6|96-115|methotrexate-related|drug
DDI-DrugBank.d66.s6|117-124|toxicity|drug
DDI-DrugBank.d66.s6|126-129|when|drug
DDI-DrugBank.d66.s6|131-135|given|drug
DDI-DrugBank.d66.s6|137-148|supplemental|drug
DDI-DrugBank.d66.s6|150-160|L-glutamine|drug
DDI-DrugBank.d66.s6|162-163|at|drug
DDI-DrugBank.d66.s6|165-165|a|drug
DDI-DrugBank.d66.s6|167-170|dose|drug
DDI-DrugBank.d66.s6|172-173|of|drug
DDI-DrugBank.d66.s6|175-177|0.5|drug
DDI-DrugBank.d66.s6|179-195|gram/kilogram/day|drug
DDI-DrugBank.d66.s6|196-196|.|drug
DDI-DrugBank.d66.s7|0-9|Paclitaxel|drug
DDI-DrugBank.d66.s7|11-11|-|drug
DDI-DrugBank.d66.s7|13-14|In|drug
DDI-DrugBank.d66.s7|16-18|one|drug
DDI-DrugBank.d66.s7|20-25|report|drug
DDI-DrugBank.d66.s7|26-26|,|drug
DDI-DrugBank.d66.s7|28-38|L-glutamine|drug
DDI-DrugBank.d66.s7|40-41|at|drug
DDI-DrugBank.d66.s7|43-43|a|drug
DDI-DrugBank.d66.s7|45-48|dose|drug
DDI-DrugBank.d66.s7|50-51|of|drug
DDI-DrugBank.d66.s7|53-54|10|drug
DDI-DrugBank.d66.s7|56-60|grams|drug
DDI-DrugBank.d66.s7|62-66|three|drug
DDI-DrugBank.d66.s7|68-72|times|drug
DDI-DrugBank.d66.s7|74-78|daily|drug
DDI-DrugBank.d66.s7|79-79|,|drug
DDI-DrugBank.d66.s7|81-85|given|drug
DDI-DrugBank.d66.s7|87-88|24|drug
DDI-DrugBank.d66.s7|90-94|hours|drug
DDI-DrugBank.d66.s7|96-100|after|drug
DDI-DrugBank.d66.s7|102-110|receiving|drug
DDI-DrugBank.d66.s7|112-121|paclitaxel|drug
DDI-DrugBank.d66.s7|122-122|,|drug
DDI-DrugBank.d66.s7|124-131|appeared|drug
DDI-DrugBank.d66.s7|133-134|to|drug
DDI-DrugBank.d66.s7|136-142|prevent|drug
DDI-DrugBank.d66.s7|144-146|the|drug
DDI-DrugBank.d66.s7|148-158|development|drug
DDI-DrugBank.d66.s7|160-161|of|drug
DDI-DrugBank.d66.s7|163-169|myalgia|drug
DDI-DrugBank.d66.s7|171-173|and|drug
DDI-DrugBank.d66.s7|175-184|arthralgia|drug
DDI-DrugBank.d66.s7|185-185|,|drug
DDI-DrugBank.d66.s7|187-193|adverse|drug
DDI-DrugBank.d66.s7|195-203|reactions|drug
DDI-DrugBank.d66.s7|205-206|of|drug
DDI-DrugBank.d66.s7|208-217|paclitaxel|drug
DDI-DrugBank.d66.s7|218-218|.|drug
DDI-MedLine.d27.s0|0-0|[|drug
DDI-MedLine.d27.s0|1-3|The|drug
DDI-MedLine.d27.s0|5-14|GABA-ergic|drug
DDI-MedLine.d27.s0|16-21|system|drug
DDI-MedLine.d27.s0|23-25|and|drug
DDI-MedLine.d27.s0|27-31|brain|drug
DDI-MedLine.d27.s0|33-37|edema|drug
DDI-MedLine.d27.s0|38-38|]|drug
DDI-MedLine.d27.s0|41-42|It|drug
DDI-MedLine.d27.s0|44-46|has|drug
DDI-MedLine.d27.s0|48-51|been|drug
DDI-MedLine.d27.s0|53-57|shown|drug
DDI-MedLine.d27.s0|59-60|in|drug
DDI-MedLine.d27.s0|62-65|rats|drug
DDI-MedLine.d27.s0|67-70|with|drug
DDI-MedLine.d27.s0|72-83|experimental|drug
DDI-MedLine.d27.s0|85-89|toxic|drug
DDI-MedLine.d27.s0|91-93|and|drug
DDI-MedLine.d27.s0|95-103|traumatic|drug
DDI-MedLine.d27.s0|105-110|edemas|drug
DDI-MedLine.d27.s0|112-115|that|drug
DDI-MedLine.d27.s0|117-126|picrotoxin|drug
DDI-MedLine.d27.s0|128-128|(|drug
DDI-MedLine.d27.s0|129-129|1|drug
DDI-MedLine.d27.s0|131-135|mg/kg|drug
DDI-MedLine.d27.s0|136-136|)|drug
DDI-MedLine.d27.s0|138-144|removes|drug
DDI-MedLine.d27.s0|146-148|the|drug
DDI-MedLine.d27.s0|150-162|antiedematous|drug
DDI-MedLine.d27.s0|164-169|action|drug
DDI-MedLine.d27.s0|171-172|of|drug
DDI-MedLine.d27.s0|174-181|diazepam|drug
DDI-MedLine.d27.s0|182-182|,|drug
DDI-MedLine.d27.s0|184-193|phenazepam|drug
DDI-MedLine.d27.s0|194-194|,|drug
DDI-MedLine.d27.s0|196-203|phenibut|drug
DDI-MedLine.d27.s0|205-207|and|drug
DDI-MedLine.d27.s0|209-214|amizyl|drug
DDI-MedLine.d27.s0|216-218|and|drug
DDI-MedLine.d27.s0|220-226|reduces|drug
DDI-MedLine.d27.s0|228-230|the|drug
DDI-MedLine.d27.s0|232-237|action|drug
DDI-MedLine.d27.s0|239-240|of|drug
DDI-MedLine.d27.s0|242-253|phentolamine|drug
DDI-MedLine.d27.s0|254-254|.|drug
DDI-MedLine.d27.s1|0-3|When|drug
DDI-MedLine.d27.s1|5-7|the|drug
DDI-MedLine.d27.s1|9-12|dose|drug
DDI-MedLine.d27.s1|14-15|of|drug
DDI-MedLine.d27.s1|17-26|picrotoxin|drug
DDI-MedLine.d27.s1|28-29|is|drug
DDI-MedLine.d27.s1|31-39|minimized|drug
DDI-MedLine.d27.s1|41-42|to|drug
DDI-MedLine.d27.s1|44-46|0.5|drug
DDI-MedLine.d27.s1|48-52|mg/kg|drug
DDI-MedLine.d27.s1|54-57|such|drug
DDI-MedLine.d27.s1|59-60|an|drug
DDI-MedLine.d27.s1|62-67|effect|drug
DDI-MedLine.d27.s1|69-70|is|drug
DDI-MedLine.d27.s1|72-74|not|drug
DDI-MedLine.d27.s1|76-83|observed|drug
DDI-MedLine.d27.s1|84-84|.|drug
DDI-MedLine.d27.s2|0-8|Prolonged|drug
DDI-MedLine.d27.s2|10-14|daily|drug
DDI-MedLine.d27.s2|16-29|administration|drug
DDI-MedLine.d27.s2|31-32|of|drug
DDI-MedLine.d27.s2|34-43|picrotoxin|drug
DDI-MedLine.d27.s2|45-46|in|drug
DDI-MedLine.d27.s2|48-48|a|drug
DDI-MedLine.d27.s2|50-53|dose|drug
DDI-MedLine.d27.s2|55-56|of|drug
DDI-MedLine.d27.s2|58-58|1|drug
DDI-MedLine.d27.s2|60-64|mg/kg|drug
DDI-MedLine.d27.s2|66-72|results|drug
DDI-MedLine.d27.s2|74-75|in|drug
DDI-MedLine.d27.s2|77-79|the|drug
DDI-MedLine.d27.s2|81-91|development|drug
DDI-MedLine.d27.s2|93-94|of|drug
DDI-MedLine.d27.s2|96-100|brain|drug
DDI-MedLine.d27.s2|102-106|edema|drug
DDI-MedLine.d27.s2|107-107|.|drug
DDI-MedLine.d27.s3|0-1|It|drug
DDI-MedLine.d27.s3|3-4|is|drug
DDI-MedLine.d27.s3|6-16|recommended|drug
DDI-MedLine.d27.s3|18-21|that|drug
DDI-MedLine.d27.s3|23-35|GABA-positive|drug
DDI-MedLine.d27.s3|37-41|drugs|drug
DDI-MedLine.d27.s3|43-44|be|drug
DDI-MedLine.d27.s3|46-53|included|drug
DDI-MedLine.d27.s3|55-58|into|drug
DDI-MedLine.d27.s3|60-60|a|drug
DDI-MedLine.d27.s3|62-68|complex|drug
DDI-MedLine.d27.s3|70-71|of|drug
DDI-MedLine.d27.s3|73-81|treatment|drug
DDI-MedLine.d27.s3|83-90|measures|drug
DDI-MedLine.d27.s3|92-94|for|drug
DDI-MedLine.d27.s3|96-100|edema|drug
DDI-MedLine.d27.s3|101-101|.|drug
DDI-DrugBank.d747.s0|0-11|Tetracycline|drug
DDI-DrugBank.d747.s0|12-12|,|drug
DDI-DrugBank.d747.s0|14-14|a|drug
DDI-DrugBank.d747.s0|16-29|bacteriostatic|drug
DDI-DrugBank.d747.s0|31-40|antibiotic|drug
DDI-DrugBank.d747.s0|41-41|,|drug
DDI-DrugBank.d747.s0|43-45|may|drug
DDI-DrugBank.d747.s0|47-56|antagonize|drug
DDI-DrugBank.d747.s0|58-60|the|drug
DDI-DrugBank.d747.s0|62-73|bactericidal|drug
DDI-DrugBank.d747.s0|75-80|effect|drug
DDI-DrugBank.d747.s0|82-83|of|drug
DDI-DrugBank.d747.s0|85-94|penicillin|drug
DDI-DrugBank.d747.s0|96-98|and|drug
DDI-DrugBank.d747.s0|100-109|concurrent|drug
DDI-DrugBank.d747.s0|111-113|use|drug
DDI-DrugBank.d747.s0|115-116|of|drug
DDI-DrugBank.d747.s0|118-122|these|drug
DDI-DrugBank.d747.s0|124-128|drugs|drug
DDI-DrugBank.d747.s0|130-135|should|drug
DDI-DrugBank.d747.s0|137-138|be|drug
DDI-DrugBank.d747.s0|140-146|avoided|drug
DDI-DrugBank.d747.s0|147-147|.|drug
DDI-DrugBank.d29.s0|0-11|Esomeprazole|drug
DDI-DrugBank.d29.s0|13-14|is|drug
DDI-DrugBank.d29.s0|16-26|extensively|drug
DDI-DrugBank.d29.s0|28-38|metabolized|drug
DDI-DrugBank.d29.s0|40-41|in|drug
DDI-DrugBank.d29.s0|43-45|the|drug
DDI-DrugBank.d29.s0|47-51|liver|drug
DDI-DrugBank.d29.s0|53-54|by|drug
DDI-DrugBank.d29.s0|56-62|CYP2C19|drug
DDI-DrugBank.d29.s0|64-66|and|drug
DDI-DrugBank.d29.s0|68-73|CYP3A4|drug
DDI-DrugBank.d29.s0|74-74|.|drug
DDI-DrugBank.d29.s1|0-1|In|drug
DDI-DrugBank.d29.s1|3-7|vitro|drug
DDI-DrugBank.d29.s1|9-11|and|drug
DDI-DrugBank.d29.s1|13-14|in|drug
DDI-DrugBank.d29.s1|16-19|vivo|drug
DDI-DrugBank.d29.s1|21-27|studies|drug
DDI-DrugBank.d29.s1|29-32|have|drug
DDI-DrugBank.d29.s1|34-38|shown|drug
DDI-DrugBank.d29.s1|40-43|that|drug
DDI-DrugBank.d29.s1|45-56|esomeprazole|drug
DDI-DrugBank.d29.s1|58-59|is|drug
DDI-DrugBank.d29.s1|61-63|not|drug
DDI-DrugBank.d29.s1|65-70|likely|drug
DDI-DrugBank.d29.s1|72-73|to|drug
DDI-DrugBank.d29.s1|75-81|inhibit|drug
DDI-DrugBank.d29.s1|83-86|CYPs|drug
DDI-DrugBank.d29.s1|88-90|1A2|drug
DDI-DrugBank.d29.s1|91-91|,|drug
DDI-DrugBank.d29.s1|93-95|2A6|drug
DDI-DrugBank.d29.s1|96-96|,|drug
DDI-DrugBank.d29.s1|98-100|2C9|drug
DDI-DrugBank.d29.s1|101-101|,|drug
DDI-DrugBank.d29.s1|103-105|2D6|drug
DDI-DrugBank.d29.s1|106-106|,|drug
DDI-DrugBank.d29.s1|108-110|2E1|drug
DDI-DrugBank.d29.s1|112-114|and|drug
DDI-DrugBank.d29.s1|116-118|3A4|drug
DDI-DrugBank.d29.s1|119-119|.|drug
DDI-DrugBank.d29.s2|0-1|No|drug
DDI-DrugBank.d29.s2|3-12|clinically|drug
DDI-DrugBank.d29.s2|14-21|relevant|drug
DDI-DrugBank.d29.s2|23-34|interactions|drug
DDI-DrugBank.d29.s2|36-39|with|drug
DDI-DrugBank.d29.s2|41-45|drugs|drug
DDI-DrugBank.d29.s2|47-57|metabolized|drug
DDI-DrugBank.d29.s2|59-60|by|drug
DDI-DrugBank.d29.s2|62-66|these|drug
DDI-DrugBank.d29.s2|68-70|CYP|drug
DDI-DrugBank.d29.s2|72-78|enzymes|drug
DDI-DrugBank.d29.s2|80-84|would|drug
DDI-DrugBank.d29.s2|86-87|be|drug
DDI-DrugBank.d29.s2|89-96|expected|drug
DDI-DrugBank.d29.s2|97-97|.|drug
DDI-DrugBank.d29.s3|0-3|Drug|drug
DDI-DrugBank.d29.s3|5-15|interaction|drug
DDI-DrugBank.d29.s3|17-23|studies|drug
DDI-DrugBank.d29.s3|25-28|have|drug
DDI-DrugBank.d29.s3|30-34|shown|drug
DDI-DrugBank.d29.s3|36-39|that|drug
DDI-DrugBank.d29.s3|41-52|esomeprazole|drug
DDI-DrugBank.d29.s3|54-57|does|drug
DDI-DrugBank.d29.s3|59-61|not|drug
DDI-DrugBank.d29.s3|63-66|have|drug
DDI-DrugBank.d29.s3|68-70|any|drug
DDI-DrugBank.d29.s3|72-81|clinically|drug
DDI-DrugBank.d29.s3|83-93|significant|drug
DDI-DrugBank.d29.s3|95-106|interactions|drug
DDI-DrugBank.d29.s3|108-111|with|drug
DDI-DrugBank.d29.s3|113-121|phenytoin|drug
DDI-DrugBank.d29.s3|122-122|,|drug
DDI-DrugBank.d29.s3|124-131|warfarin|drug
DDI-DrugBank.d29.s3|132-132|,|drug
DDI-DrugBank.d29.s3|134-142|quinidine|drug
DDI-DrugBank.d29.s3|143-143|,|drug
DDI-DrugBank.d29.s3|145-158|clarithromycin|drug
DDI-DrugBank.d29.s3|160-161|or|drug
DDI-DrugBank.d29.s3|163-173|amoxicillin|drug
DDI-DrugBank.d29.s3|174-174|.|drug
DDI-DrugBank.d29.s4|0-13|Post-marketing|drug
DDI-DrugBank.d29.s4|15-21|reports|drug
DDI-DrugBank.d29.s4|23-24|of|drug
DDI-DrugBank.d29.s4|26-32|changes|drug
DDI-DrugBank.d29.s4|34-35|in|drug
DDI-DrugBank.d29.s4|37-47|prothrombin|drug
DDI-DrugBank.d29.s4|49-56|measures|drug
DDI-DrugBank.d29.s4|58-61|have|drug
DDI-DrugBank.d29.s4|63-66|been|drug
DDI-DrugBank.d29.s4|68-75|received|drug
DDI-DrugBank.d29.s4|77-81|among|drug
DDI-DrugBank.d29.s4|83-90|patients|drug
DDI-DrugBank.d29.s4|92-93|on|drug
DDI-DrugBank.d29.s4|95-105|concomitant|drug
DDI-DrugBank.d29.s4|107-114|warfarin|drug
DDI-DrugBank.d29.s4|116-118|and|drug
DDI-DrugBank.d29.s4|120-131|esomeprazole|drug
DDI-DrugBank.d29.s4|133-139|therapy|drug
DDI-DrugBank.d29.s4|140-140|.|drug
DDI-DrugBank.d29.s5|0-8|Increases|drug
DDI-DrugBank.d29.s5|10-11|in|drug
DDI-DrugBank.d29.s5|13-15|INR|drug
DDI-DrugBank.d29.s5|17-19|and|drug
DDI-DrugBank.d29.s5|21-31|prothrombin|drug
DDI-DrugBank.d29.s5|33-36|time|drug
DDI-DrugBank.d29.s5|38-40|may|drug
DDI-DrugBank.d29.s5|42-45|lead|drug
DDI-DrugBank.d29.s5|47-48|to|drug
DDI-DrugBank.d29.s5|50-57|abnormal|drug
DDI-DrugBank.d29.s5|59-66|bleeding|drug
DDI-DrugBank.d29.s5|68-70|and|drug
DDI-DrugBank.d29.s5|72-75|even|drug
DDI-DrugBank.d29.s5|77-81|death|drug
DDI-DrugBank.d29.s5|82-82|.|drug
DDI-DrugBank.d29.s6|0-7|Patients|drug
DDI-DrugBank.d29.s6|9-15|treated|drug
DDI-DrugBank.d29.s6|17-20|with|drug
DDI-DrugBank.d29.s6|22-27|proton|drug
DDI-DrugBank.d29.s6|29-32|pump|drug
DDI-DrugBank.d29.s6|34-43|inhibitors|drug
DDI-DrugBank.d29.s6|45-47|and|drug
DDI-DrugBank.d29.s6|49-56|warfarin|drug
DDI-DrugBank.d29.s6|58-70|concomitantly|drug
DDI-DrugBank.d29.s6|72-74|may|drug
DDI-DrugBank.d29.s6|76-79|need|drug
DDI-DrugBank.d29.s6|81-82|to|drug
DDI-DrugBank.d29.s6|84-85|be|drug
DDI-DrugBank.d29.s6|87-95|monitored|drug
DDI-DrugBank.d29.s6|97-99|for|drug
DDI-DrugBank.d29.s6|101-109|increases|drug
DDI-DrugBank.d29.s6|111-112|in|drug
DDI-DrugBank.d29.s6|114-116|INR|drug
DDI-DrugBank.d29.s6|118-120|and|drug
DDI-DrugBank.d29.s6|122-132|prothrombin|drug
DDI-DrugBank.d29.s6|134-137|time|drug
DDI-DrugBank.d29.s6|138-138|.|drug
DDI-DrugBank.d29.s7|0-11|Esomeprazole|drug
DDI-DrugBank.d29.s7|13-15|may|drug
DDI-DrugBank.d29.s7|17-27|potentially|drug
DDI-DrugBank.d29.s7|29-37|interfere|drug
DDI-DrugBank.d29.s7|39-42|with|drug
DDI-DrugBank.d29.s7|44-50|CYP2C19|drug
DDI-DrugBank.d29.s7|51-51|,|drug
DDI-DrugBank.d29.s7|53-55|the|drug
DDI-DrugBank.d29.s7|57-61|major|drug
DDI-DrugBank.d29.s7|63-74|esomeprazole|drug
DDI-DrugBank.d29.s7|76-87|metabolizing|drug
DDI-DrugBank.d29.s7|89-94|enzyme|drug
DDI-DrugBank.d29.s7|95-95|.|drug
DDI-DrugBank.d29.s8|0-15|Coadministration|drug
DDI-DrugBank.d29.s8|17-18|of|drug
DDI-DrugBank.d29.s8|20-31|esomeprazole|drug
DDI-DrugBank.d29.s8|33-34|30|drug
DDI-DrugBank.d29.s8|36-37|mg|drug
DDI-DrugBank.d29.s8|39-41|and|drug
DDI-DrugBank.d29.s8|43-50|diazepam|drug
DDI-DrugBank.d29.s8|51-51|,|drug
DDI-DrugBank.d29.s8|53-53|a|drug
DDI-DrugBank.d29.s8|55-61|CYP2C19|drug
DDI-DrugBank.d29.s8|63-71|substrate|drug
DDI-DrugBank.d29.s8|72-72|,|drug
DDI-DrugBank.d29.s8|74-81|resulted|drug
DDI-DrugBank.d29.s8|83-84|in|drug
DDI-DrugBank.d29.s8|86-86|a|drug
DDI-DrugBank.d29.s8|88-89|45|drug
DDI-DrugBank.d29.s8|90-90|%|drug
DDI-DrugBank.d29.s8|92-99|decrease|drug
DDI-DrugBank.d29.s8|101-102|in|drug
DDI-DrugBank.d29.s8|104-112|clearance|drug
DDI-DrugBank.d29.s8|114-115|of|drug
DDI-DrugBank.d29.s8|117-124|diazepam|drug
DDI-DrugBank.d29.s8|125-125|.|drug
DDI-DrugBank.d29.s9|0-8|Increased|drug
DDI-DrugBank.d29.s9|10-15|plasma|drug
DDI-DrugBank.d29.s9|17-22|levels|drug
DDI-DrugBank.d29.s9|24-25|of|drug
DDI-DrugBank.d29.s9|27-34|diazepam|drug
DDI-DrugBank.d29.s9|36-39|were|drug
DDI-DrugBank.d29.s9|41-48|observed|drug
DDI-DrugBank.d29.s9|50-51|12|drug
DDI-DrugBank.d29.s9|53-57|hours|drug
DDI-DrugBank.d29.s9|59-63|after|drug
DDI-DrugBank.d29.s9|65-70|dosing|drug
DDI-DrugBank.d29.s9|72-74|and|drug
DDI-DrugBank.d29.s9|76-82|onwards|drug
DDI-DrugBank.d29.s9|83-83|.|drug
DDI-DrugBank.d29.s10|0-6|However|drug
DDI-DrugBank.d29.s10|7-7|,|drug
DDI-DrugBank.d29.s10|9-10|at|drug
DDI-DrugBank.d29.s10|12-15|that|drug
DDI-DrugBank.d29.s10|17-20|time|drug
DDI-DrugBank.d29.s10|21-21|,|drug
DDI-DrugBank.d29.s10|23-25|the|drug
DDI-DrugBank.d29.s10|27-32|plasma|drug
DDI-DrugBank.d29.s10|34-39|levels|drug
DDI-DrugBank.d29.s10|41-42|of|drug
DDI-DrugBank.d29.s10|44-51|diazepam|drug
DDI-DrugBank.d29.s10|53-56|were|drug
DDI-DrugBank.d29.s10|58-62|below|drug
DDI-DrugBank.d29.s10|64-66|the|drug
DDI-DrugBank.d29.s10|68-78|therapeutic|drug
DDI-DrugBank.d29.s10|80-87|interval|drug
DDI-DrugBank.d29.s10|88-88|,|drug
DDI-DrugBank.d29.s10|90-92|and|drug
DDI-DrugBank.d29.s10|94-97|thus|drug
DDI-DrugBank.d29.s10|99-102|this|drug
DDI-DrugBank.d29.s10|104-114|interaction|drug
DDI-DrugBank.d29.s10|116-117|is|drug
DDI-DrugBank.d29.s10|119-126|unlikely|drug
DDI-DrugBank.d29.s10|128-129|to|drug
DDI-DrugBank.d29.s10|131-132|be|drug
DDI-DrugBank.d29.s10|134-135|of|drug
DDI-DrugBank.d29.s10|137-144|clinical|drug
DDI-DrugBank.d29.s10|146-154|relevance|drug
DDI-DrugBank.d29.s10|155-155|.|drug
DDI-DrugBank.d29.s11|0-11|Esomeprazole|drug
DDI-DrugBank.d29.s11|13-20|inhibits|drug
DDI-DrugBank.d29.s11|22-28|gastric|drug
DDI-DrugBank.d29.s11|30-33|acid|drug
DDI-DrugBank.d29.s11|35-43|secretion|drug
DDI-DrugBank.d29.s11|44-44|.|drug
DDI-DrugBank.d29.s12|0-8|Therefore|drug
DDI-DrugBank.d29.s12|9-9|,|drug
DDI-DrugBank.d29.s12|11-22|esomeprazole|drug
DDI-DrugBank.d29.s12|24-26|may|drug
DDI-DrugBank.d29.s12|28-36|interfere|drug
DDI-DrugBank.d29.s12|38-41|with|drug
DDI-DrugBank.d29.s12|43-45|the|drug
DDI-DrugBank.d29.s12|47-56|absorption|drug
DDI-DrugBank.d29.s12|58-59|of|drug
DDI-DrugBank.d29.s12|61-65|drugs|drug
DDI-DrugBank.d29.s12|67-71|where|drug
DDI-DrugBank.d29.s12|73-79|gastric|drug
DDI-DrugBank.d29.s12|81-82|pH|drug
DDI-DrugBank.d29.s12|84-85|is|drug
DDI-DrugBank.d29.s12|87-88|an|drug
DDI-DrugBank.d29.s12|90-98|important|drug
DDI-DrugBank.d29.s12|100-110|determinant|drug
DDI-DrugBank.d29.s12|112-113|of|drug
DDI-DrugBank.d29.s12|115-129|bioavailability|drug
DDI-DrugBank.d29.s12|131-131|(|drug
DDI-DrugBank.d29.s12|132-133|eg|drug
DDI-DrugBank.d29.s12|134-134|,|drug
DDI-DrugBank.d29.s12|136-147|ketoconazole|drug
DDI-DrugBank.d29.s12|148-148|,|drug
DDI-DrugBank.d29.s12|150-153|iron|drug
DDI-DrugBank.d29.s12|155-159|salts|drug
DDI-DrugBank.d29.s12|161-163|and|drug
DDI-DrugBank.d29.s12|165-171|digoxin|drug
DDI-DrugBank.d29.s12|172-172|)|drug
DDI-DrugBank.d29.s12|173-173|.|drug
DDI-DrugBank.d29.s13|0-15|Coadministration|drug
DDI-DrugBank.d29.s13|17-18|of|drug
DDI-DrugBank.d29.s13|20-23|oral|drug
DDI-DrugBank.d29.s13|25-38|contraceptives|drug
DDI-DrugBank.d29.s13|39-39|,|drug
DDI-DrugBank.d29.s13|41-48|diazepam|drug
DDI-DrugBank.d29.s13|49-49|,|drug
DDI-DrugBank.d29.s13|51-59|phenytoin|drug
DDI-DrugBank.d29.s13|60-60|,|drug
DDI-DrugBank.d29.s13|62-63|or|drug
DDI-DrugBank.d29.s13|65-73|quinidine|drug
DDI-DrugBank.d29.s13|75-77|did|drug
DDI-DrugBank.d29.s13|79-81|not|drug
DDI-DrugBank.d29.s13|83-86|seem|drug
DDI-DrugBank.d29.s13|88-89|to|drug
DDI-DrugBank.d29.s13|91-96|change|drug
DDI-DrugBank.d29.s13|98-100|the|drug
DDI-DrugBank.d29.s13|102-116|pharmacokinetic|drug
DDI-DrugBank.d29.s13|118-124|profile|drug
DDI-DrugBank.d29.s13|126-127|of|drug
DDI-DrugBank.d29.s13|129-140|esomeprazole|drug
DDI-DrugBank.d29.s13|141-141|.|drug
DDI-DrugBank.d29.s14|0-10|Concomitant|drug
DDI-DrugBank.d29.s14|12-25|administration|drug
DDI-DrugBank.d29.s14|27-28|of|drug
DDI-DrugBank.d29.s14|30-43|clarithromycin|drug
DDI-DrugBank.d29.s14|45-48|with|drug
DDI-DrugBank.d29.s14|50-57|pimozide|drug
DDI-DrugBank.d29.s14|59-60|is|drug
DDI-DrugBank.d29.s14|62-76|contraindicated|drug
DDI-DrugBank.d29.s14|77-77|.|drug
DDI-DrugBank.d693.s0|0-6|Reduced|drug
DDI-DrugBank.d693.s0|8-17|absorption|drug
DDI-DrugBank.d693.s0|19-20|of|drug
DDI-DrugBank.d693.s0|22-26|folic|drug
DDI-DrugBank.d693.s0|28-31|acid|drug
DDI-DrugBank.d693.s0|33-35|and|drug
DDI-DrugBank.d693.s0|37-43|digoxin|drug
DDI-DrugBank.d693.s0|45-48|have|drug
DDI-DrugBank.d693.s0|50-53|been|drug
DDI-DrugBank.d693.s0|55-62|reported|drug
DDI-DrugBank.d693.s0|64-67|when|drug
DDI-DrugBank.d693.s0|69-73|those|drug
DDI-DrugBank.d693.s0|75-80|agents|drug
DDI-DrugBank.d693.s0|82-85|were|drug
DDI-DrugBank.d693.s0|87-98|administered|drug
DDI-DrugBank.d693.s0|100-112|concomitantly|drug
DDI-DrugBank.d693.s0|114-117|with|drug
DDI-DrugBank.d693.s0|119-131|sulfasalazine|drug
DDI-DrugBank.d693.s0|132-132|.|drug
DDI-DrugBank.d693.s1|0-3|When|drug
DDI-DrugBank.d693.s1|5-9|daily|drug
DDI-DrugBank.d693.s1|11-15|doses|drug
DDI-DrugBank.d693.s1|17-18|of|drug
DDI-DrugBank.d693.s1|20-32|sulfasalazine|drug
DDI-DrugBank.d693.s1|34-34|2|drug
DDI-DrugBank.d693.s1|36-36|g|drug
DDI-DrugBank.d693.s1|38-40|and|drug
DDI-DrugBank.d693.s1|42-47|weekly|drug
DDI-DrugBank.d693.s1|49-53|doses|drug
DDI-DrugBank.d693.s1|55-56|of|drug
DDI-DrugBank.d693.s1|58-69|methotrexate|drug
DDI-DrugBank.d693.s1|71-73|7.5|drug
DDI-DrugBank.d693.s1|75-76|mg|drug
DDI-DrugBank.d693.s1|78-81|were|drug
DDI-DrugBank.d693.s1|83-96|coadministered|drug
DDI-DrugBank.d693.s1|98-99|to|drug
DDI-DrugBank.d693.s1|101-102|15|drug
DDI-DrugBank.d693.s1|104-113|rheumatoid|drug
DDI-DrugBank.d693.s1|115-123|arthritis|drug
DDI-DrugBank.d693.s1|125-132|patients|drug
DDI-DrugBank.d693.s1|134-135|in|drug
DDI-DrugBank.d693.s1|137-137|a|drug
DDI-DrugBank.d693.s1|139-147|drug-drug|drug
DDI-DrugBank.d693.s1|149-159|interaction|drug
DDI-DrugBank.d693.s1|161-165|study|drug
DDI-DrugBank.d693.s1|166-166|,|drug
DDI-DrugBank.d693.s1|168-170|the|drug
DDI-DrugBank.d693.s1|172-186|pharmacokinetic|drug
DDI-DrugBank.d693.s1|188-198|disposition|drug
DDI-DrugBank.d693.s1|200-201|of|drug
DDI-DrugBank.d693.s1|203-205|the|drug
DDI-DrugBank.d693.s1|207-211|drugs|drug
DDI-DrugBank.d693.s1|213-215|was|drug
DDI-DrugBank.d693.s1|217-219|not|drug
DDI-DrugBank.d693.s1|221-227|altered|drug
DDI-DrugBank.d693.s1|228-228|.|drug
DDI-DrugBank.d693.s2|0-4|Daily|drug
DDI-DrugBank.d693.s2|6-10|doses|drug
DDI-DrugBank.d693.s2|12-13|of|drug
DDI-DrugBank.d693.s2|15-27|sulfasalazine|drug
DDI-DrugBank.d693.s2|29-29|2|drug
DDI-DrugBank.d693.s2|31-31|g|drug
DDI-DrugBank.d693.s2|33-33|(|drug
DDI-DrugBank.d693.s2|34-40|maximum|drug
DDI-DrugBank.d693.s2|42-42|3|drug
DDI-DrugBank.d693.s2|44-44|g|drug
DDI-DrugBank.d693.s2|45-45|)|drug
DDI-DrugBank.d693.s2|47-49|and|drug
DDI-DrugBank.d693.s2|51-56|weekly|drug
DDI-DrugBank.d693.s2|58-62|doses|drug
DDI-DrugBank.d693.s2|64-65|of|drug
DDI-DrugBank.d693.s2|67-78|methotrexate|drug
DDI-DrugBank.d693.s2|80-82|7.5|drug
DDI-DrugBank.d693.s2|84-85|mg|drug
DDI-DrugBank.d693.s2|87-87|(|drug
DDI-DrugBank.d693.s2|88-94|maximum|drug
DDI-DrugBank.d693.s2|96-97|15|drug
DDI-DrugBank.d693.s2|99-100|mg|drug
DDI-DrugBank.d693.s2|101-101|)|drug
DDI-DrugBank.d693.s2|103-106|were|drug
DDI-DrugBank.d693.s2|108-119|administered|drug
DDI-DrugBank.d693.s2|121-125|alone|drug
DDI-DrugBank.d693.s2|127-128|or|drug
DDI-DrugBank.d693.s2|130-131|in|drug
DDI-DrugBank.d693.s2|133-143|combination|drug
DDI-DrugBank.d693.s2|145-146|to|drug
DDI-DrugBank.d693.s2|148-150|310|drug
DDI-DrugBank.d693.s2|152-161|rheumatoid|drug
DDI-DrugBank.d693.s2|163-171|arthritis|drug
DDI-DrugBank.d693.s2|173-180|patients|drug
DDI-DrugBank.d693.s2|182-183|in|drug
DDI-DrugBank.d693.s2|185-187|two|drug
DDI-DrugBank.d693.s2|189-198|controlled|drug
DDI-DrugBank.d693.s2|200-206|52-week|drug
DDI-DrugBank.d693.s2|208-215|clinical|drug
DDI-DrugBank.d693.s2|217-223|studies|drug
DDI-DrugBank.d693.s2|224-224|.|drug
DDI-DrugBank.d693.s3|0-2|The|drug
DDI-DrugBank.d693.s3|4-10|overall|drug
DDI-DrugBank.d693.s3|12-19|toxicity|drug
DDI-DrugBank.d693.s3|21-27|profile|drug
DDI-DrugBank.d693.s3|29-30|of|drug
DDI-DrugBank.d693.s3|32-34|the|drug
DDI-DrugBank.d693.s3|36-46|combination|drug
DDI-DrugBank.d693.s3|48-55|revealed|drug
DDI-DrugBank.d693.s3|57-58|an|drug
DDI-DrugBank.d693.s3|60-68|increased|drug
DDI-DrugBank.d693.s3|70-78|incidence|drug
DDI-DrugBank.d693.s3|80-81|of|drug
DDI-DrugBank.d693.s3|83-98|gastrointestinal|drug
DDI-DrugBank.d693.s3|100-106|adverse|drug
DDI-DrugBank.d693.s3|108-113|events|drug
DDI-DrugBank.d693.s3|114-114|,|drug
DDI-DrugBank.d693.s3|116-125|especially|drug
DDI-DrugBank.d693.s3|127-132|nausea|drug
DDI-DrugBank.d693.s3|133-133|,|drug
DDI-DrugBank.d693.s3|135-138|when|drug
DDI-DrugBank.d693.s3|140-147|compared|drug
DDI-DrugBank.d693.s3|149-150|to|drug
DDI-DrugBank.d693.s3|152-154|the|drug
DDI-DrugBank.d693.s3|156-164|incidence|drug
DDI-DrugBank.d693.s3|166-175|associated|drug
DDI-DrugBank.d693.s3|177-180|with|drug
DDI-DrugBank.d693.s3|182-187|either|drug
DDI-DrugBank.d693.s3|189-192|drug|drug
DDI-DrugBank.d693.s3|194-205|administered|drug
DDI-DrugBank.d693.s3|207-211|alone|drug
DDI-DrugBank.d693.s3|212-212|.|drug
DDI-DrugBank.d693.s4|0-14|Drug/Laboratory|drug
DDI-DrugBank.d693.s4|16-19|Test|drug
DDI-DrugBank.d693.s4|21-32|Interactions|drug
DDI-DrugBank.d693.s4|33-33|:|drug
DDI-DrugBank.d693.s4|35-37|The|drug
DDI-DrugBank.d693.s4|39-46|presence|drug
DDI-DrugBank.d693.s4|48-49|of|drug
DDI-DrugBank.d693.s4|51-63|sulfasalazine|drug
DDI-DrugBank.d693.s4|65-66|or|drug
DDI-DrugBank.d693.s4|68-70|its|drug
DDI-DrugBank.d693.s4|72-82|metabolites|drug
DDI-DrugBank.d693.s4|84-85|in|drug
DDI-DrugBank.d693.s4|87-90|body|drug
DDI-DrugBank.d693.s4|92-97|fluids|drug
DDI-DrugBank.d693.s4|99-101|has|drug
DDI-DrugBank.d693.s4|103-105|not|drug
DDI-DrugBank.d693.s4|107-110|been|drug
DDI-DrugBank.d693.s4|112-119|reported|drug
DDI-DrugBank.d693.s4|121-122|to|drug
DDI-DrugBank.d693.s4|124-132|interfere|drug
DDI-DrugBank.d693.s4|134-137|with|drug
DDI-DrugBank.d693.s4|139-148|laboratory|drug
DDI-DrugBank.d693.s4|150-153|test|drug
DDI-DrugBank.d693.s4|155-164|procedures|drug
DDI-DrugBank.d693.s4|165-165|.|drug
DDI-DrugBank.d693.s5|0-9|REFERENCES|drug
DDI-DrugBank.d693.s5|11-16|7.Farr|drug
DDI-DrugBank.d693.s5|18-18|M|drug
DDI-DrugBank.d693.s5|19-19|,|drug
DDI-DrugBank.d693.s5|21-22|et|drug
DDI-DrugBank.d693.s5|24-25|al|drug
DDI-DrugBank.d693.s5|26-26|.|drug
DDI-DrugBank.d693.s6|0-17|Immunodeficiencies|drug
DDI-DrugBank.d693.s6|19-28|associated|drug
DDI-DrugBank.d693.s6|30-33|with|drug
DDI-DrugBank.d693.s6|35-48|sulphasalazine|drug
DDI-DrugBank.d693.s6|50-56|therapy|drug
DDI-DrugBank.d693.s6|58-59|in|drug
DDI-DrugBank.d693.s6|61-72|inflammatory|drug
DDI-DrugBank.d693.s6|74-82|arthritis|drug
DDI-DrugBank.d693.s6|83-83|.|drug
DDI-DrugBank.d693.s7|0-6|British|drug
DDI-DrugBank.d693.s7|8-10|Jnl|drug
DDI-DrugBank.d693.s7|12-16|Rheum|drug
DDI-DrugBank.d693.s7|18-21|1991|drug
DDI-DrugBank.d693.s7|22-22|;|drug
DDI-DrugBank.d693.s7|23-32|30:413-417|drug
DDI-DrugBank.d693.s7|33-33|.|drug
DDI-DrugBank.d473.s0|0-7|Although|drug
DDI-DrugBank.d473.s0|9-10|no|drug
DDI-DrugBank.d473.s0|12-19|clinical|drug
DDI-DrugBank.d473.s0|21-29|drug-drug|drug
DDI-DrugBank.d473.s0|31-41|interaction|drug
DDI-DrugBank.d473.s0|43-49|studies|drug
DDI-DrugBank.d473.s0|51-54|have|drug
DDI-DrugBank.d473.s0|56-59|been|drug
DDI-DrugBank.d473.s0|61-69|conducted|drug
DDI-DrugBank.d473.s0|71-72|to|drug
DDI-DrugBank.d473.s0|74-77|date|drug
DDI-DrugBank.d473.s0|78-78|,|drug
DDI-DrugBank.d473.s0|80-81|on|drug
DDI-DrugBank.d473.s0|83-85|the|drug
DDI-DrugBank.d473.s0|87-91|basis|drug
DDI-DrugBank.d473.s0|93-94|of|drug
DDI-DrugBank.d473.s0|96-98|the|drug
DDI-DrugBank.d473.s0|100-101|in|drug
DDI-DrugBank.d473.s0|103-107|vitro|drug
DDI-DrugBank.d473.s0|109-115|studies|drug
DDI-DrugBank.d473.s0|116-116|,|drug
DDI-DrugBank.d473.s0|118-127|cytochrome|drug
DDI-DrugBank.d473.s0|129-132|p450|drug
DDI-DrugBank.d473.s0|134-143|inhibitors|drug
DDI-DrugBank.d473.s0|145-147|and|drug
DDI-DrugBank.d473.s0|149-156|inducers|drug
DDI-DrugBank.d473.s0|158-160|are|drug
DDI-DrugBank.d473.s0|162-169|unlikely|drug
DDI-DrugBank.d473.s0|171-172|to|drug
DDI-DrugBank.d473.s0|174-179|affect|drug
DDI-DrugBank.d473.s0|181-183|the|drug
DDI-DrugBank.d473.s0|185-194|metabolism|drug
DDI-DrugBank.d473.s0|196-197|of|drug
DDI-DrugBank.d473.s0|199-209|clofarabine|drug
DDI-DrugBank.d473.s0|210-210|.|drug
DDI-DrugBank.d473.s1|0-2|The|drug
DDI-DrugBank.d473.s1|4-9|effect|drug
DDI-DrugBank.d473.s1|11-12|of|drug
DDI-DrugBank.d473.s1|14-24|clofarabine|drug
DDI-DrugBank.d473.s1|26-27|on|drug
DDI-DrugBank.d473.s1|29-31|the|drug
DDI-DrugBank.d473.s1|33-42|metabolism|drug
DDI-DrugBank.d473.s1|44-45|of|drug
DDI-DrugBank.d473.s1|47-56|cytochrome|drug
DDI-DrugBank.d473.s1|58-61|p450|drug
DDI-DrugBank.d473.s1|63-72|substrates|drug
DDI-DrugBank.d473.s1|74-76|has|drug
DDI-DrugBank.d473.s1|78-80|not|drug
DDI-DrugBank.d473.s1|82-85|been|drug
DDI-DrugBank.d473.s1|87-93|studied|drug
DDI-DrugBank.d473.s1|94-94|.|drug
DDI-DrugBank.d473.s2|0-14|Drug/Laboratory|drug
DDI-DrugBank.d473.s2|16-20|Tests|drug
DDI-DrugBank.d473.s2|22-33|Interactions|drug
DDI-DrugBank.d473.s2|35-39|There|drug
DDI-DrugBank.d473.s2|41-43|are|drug
DDI-DrugBank.d473.s2|45-46|no|drug
DDI-DrugBank.d473.s2|48-52|known|drug
DDI-DrugBank.d473.s2|54-63|clinically|drug
DDI-DrugBank.d473.s2|65-75|significant|drug
DDI-DrugBank.d473.s2|77-88|interactions|drug
DDI-DrugBank.d473.s2|90-91|of|drug
DDI-DrugBank.d473.s2|93-98|CLOLAR|drug
DDI-DrugBank.d473.s2|101-104|with|drug
DDI-DrugBank.d473.s2|106-110|other|drug
DDI-DrugBank.d473.s2|112-122|medications|drug
DDI-DrugBank.d473.s2|124-125|or|drug
DDI-DrugBank.d473.s2|127-136|laboratory|drug
DDI-DrugBank.d473.s2|138-142|tests|drug
DDI-DrugBank.d473.s2|143-143|.|drug
DDI-DrugBank.d473.s3|0-1|No|drug
DDI-DrugBank.d473.s3|3-8|formal|drug
DDI-DrugBank.d473.s3|10-24|drug/laboratory|drug
DDI-DrugBank.d473.s3|26-29|test|drug
DDI-DrugBank.d473.s3|31-41|interaction|drug
DDI-DrugBank.d473.s3|43-49|studies|drug
DDI-DrugBank.d473.s3|51-54|have|drug
DDI-DrugBank.d473.s3|56-59|been|drug
DDI-DrugBank.d473.s3|61-69|conducted|drug
DDI-DrugBank.d473.s3|71-74|with|drug
DDI-DrugBank.d473.s3|76-81|CLOLAR|drug
DDI-DrugBank.d473.s3|84-84|.|drug
DDI-DrugBank.d102.s0|0-1|No|drug
DDI-DrugBank.d102.s0|3-13|information|drug
DDI-DrugBank.d102.s0|15-22|provided|drug
DDI-DrugBank.d487.s0|0-2|The|drug
DDI-DrugBank.d487.s0|4-18|pharmacokinetic|drug
DDI-DrugBank.d487.s0|20-31|interactions|drug
DDI-DrugBank.d487.s0|33-38|listed|drug
DDI-DrugBank.d487.s0|40-44|below|drug
DDI-DrugBank.d487.s0|46-48|are|drug
DDI-DrugBank.d487.s0|50-60|potentially|drug
DDI-DrugBank.d487.s0|62-71|clinically|drug
DDI-DrugBank.d487.s0|73-81|important|drug
DDI-DrugBank.d487.s0|82-82|.|drug
DDI-DrugBank.d487.s1|0-4|Drugs|drug
DDI-DrugBank.d487.s1|6-9|that|drug
DDI-DrugBank.d487.s1|11-16|induce|drug
DDI-DrugBank.d487.s1|18-24|hepatic|drug
DDI-DrugBank.d487.s1|26-32|enzymes|drug
DDI-DrugBank.d487.s1|34-37|such|drug
DDI-DrugBank.d487.s1|39-40|as|drug
DDI-DrugBank.d487.s1|42-54|phenobarbital|drug
DDI-DrugBank.d487.s1|55-55|,|drug
DDI-DrugBank.d487.s1|57-65|phenytoin|drug
DDI-DrugBank.d487.s1|67-69|and|drug
DDI-DrugBank.d487.s1|71-78|rifampin|drug
DDI-DrugBank.d487.s1|80-82|may|drug
DDI-DrugBank.d487.s1|84-91|increase|drug
DDI-DrugBank.d487.s1|93-95|the|drug
DDI-DrugBank.d487.s1|97-105|clearance|drug
DDI-DrugBank.d487.s1|107-108|of|drug
DDI-DrugBank.d487.s1|110-124|corticosteroids|drug
DDI-DrugBank.d487.s1|126-128|and|drug
DDI-DrugBank.d487.s1|130-132|may|drug
DDI-DrugBank.d487.s1|134-140|require|drug
DDI-DrugBank.d487.s1|142-150|increases|drug
DDI-DrugBank.d487.s1|152-153|in|drug
DDI-DrugBank.d487.s1|155-168|corticosteroid|drug
DDI-DrugBank.d487.s1|170-173|dose|drug
DDI-DrugBank.d487.s1|175-176|to|drug
DDI-DrugBank.d487.s1|178-184|achieve|drug
DDI-DrugBank.d487.s1|186-188|the|drug
DDI-DrugBank.d487.s1|190-196|desired|drug
DDI-DrugBank.d487.s1|198-205|response|drug
DDI-DrugBank.d487.s1|206-206|.|drug
DDI-DrugBank.d487.s2|0-4|Drugs|drug
DDI-DrugBank.d487.s2|6-9|such|drug
DDI-DrugBank.d487.s2|11-12|as|drug
DDI-DrugBank.d487.s2|14-27|troleandomycin|drug
DDI-DrugBank.d487.s2|29-31|and|drug
DDI-DrugBank.d487.s2|33-44|ketoconazole|drug
DDI-DrugBank.d487.s2|46-48|may|drug
DDI-DrugBank.d487.s2|50-56|inhibit|drug
DDI-DrugBank.d487.s2|58-60|the|drug
DDI-DrugBank.d487.s2|62-71|metabolism|drug
DDI-DrugBank.d487.s2|73-74|of|drug
DDI-DrugBank.d487.s2|76-90|corticosteroids|drug
DDI-DrugBank.d487.s2|92-94|and|drug
DDI-DrugBank.d487.s2|96-99|thus|drug
DDI-DrugBank.d487.s2|101-108|decrease|drug
DDI-DrugBank.d487.s2|110-114|their|drug
DDI-DrugBank.d487.s2|116-124|clearance|drug
DDI-DrugBank.d487.s2|125-125|.|drug
DDI-DrugBank.d487.s3|0-8|Therefore|drug
DDI-DrugBank.d487.s3|9-9|,|drug
DDI-DrugBank.d487.s3|11-13|the|drug
DDI-DrugBank.d487.s3|15-18|dose|drug
DDI-DrugBank.d487.s3|20-21|of|drug
DDI-DrugBank.d487.s3|23-36|corticosteroid|drug
DDI-DrugBank.d487.s3|38-43|should|drug
DDI-DrugBank.d487.s3|45-46|be|drug
DDI-DrugBank.d487.s3|48-55|titrated|drug
DDI-DrugBank.d487.s3|57-58|to|drug
DDI-DrugBank.d487.s3|60-64|avoid|drug
DDI-DrugBank.d487.s3|66-72|steroid|drug
DDI-DrugBank.d487.s3|74-81|toxicity|drug
DDI-DrugBank.d487.s3|82-82|.|drug
DDI-DrugBank.d487.s4|0-14|Corticosteroids|drug
DDI-DrugBank.d487.s4|16-18|may|drug
DDI-DrugBank.d487.s4|20-27|increase|drug
DDI-DrugBank.d487.s4|29-31|the|drug
DDI-DrugBank.d487.s4|33-41|clearance|drug
DDI-DrugBank.d487.s4|43-44|of|drug
DDI-DrugBank.d487.s4|46-52|chronic|drug
DDI-DrugBank.d487.s4|54-57|high|drug
DDI-DrugBank.d487.s4|59-62|dose|drug
DDI-DrugBank.d487.s4|64-70|aspirin|drug
DDI-DrugBank.d487.s4|71-71|.|drug
DDI-DrugBank.d487.s5|0-3|This|drug
DDI-DrugBank.d487.s5|5-9|could|drug
DDI-DrugBank.d487.s5|11-14|lead|drug
DDI-DrugBank.d487.s5|16-17|to|drug
DDI-DrugBank.d487.s5|19-27|decreased|drug
DDI-DrugBank.d487.s5|29-38|salicylate|drug
DDI-DrugBank.d487.s5|40-44|serum|drug
DDI-DrugBank.d487.s5|46-51|levels|drug
DDI-DrugBank.d487.s5|53-54|or|drug
DDI-DrugBank.d487.s5|56-63|increase|drug
DDI-DrugBank.d487.s5|65-67|the|drug
DDI-DrugBank.d487.s5|69-72|risk|drug
DDI-DrugBank.d487.s5|74-75|of|drug
DDI-DrugBank.d487.s5|77-86|salicylate|drug
DDI-DrugBank.d487.s5|88-95|toxicity|drug
DDI-DrugBank.d487.s5|97-100|when|drug
DDI-DrugBank.d487.s5|102-115|corticosteroid|drug
DDI-DrugBank.d487.s5|117-118|is|drug
DDI-DrugBank.d487.s5|120-128|withdrawn|drug
DDI-DrugBank.d487.s5|129-129|.|drug
DDI-DrugBank.d487.s6|0-6|Aspirin|drug
DDI-DrugBank.d487.s6|8-13|should|drug
DDI-DrugBank.d487.s6|15-16|be|drug
DDI-DrugBank.d487.s6|18-21|used|drug
DDI-DrugBank.d487.s6|23-32|cautiously|drug
DDI-DrugBank.d487.s6|34-35|in|drug
DDI-DrugBank.d487.s6|37-47|conjunction|drug
DDI-DrugBank.d487.s6|49-52|with|drug
DDI-DrugBank.d487.s6|54-69|cortico-steroids|drug
DDI-DrugBank.d487.s6|71-72|in|drug
DDI-DrugBank.d487.s6|74-81|patients|drug
DDI-DrugBank.d487.s6|83-91|suffering|drug
DDI-DrugBank.d487.s6|93-96|from|drug
DDI-DrugBank.d487.s6|98-117|hypopro-thrombinemia|drug
DDI-DrugBank.d487.s6|118-118|.|drug
DDI-DrugBank.d487.s7|0-2|The|drug
DDI-DrugBank.d487.s7|4-9|effect|drug
DDI-DrugBank.d487.s7|11-12|of|drug
DDI-DrugBank.d487.s7|14-28|corticosteroids|drug
DDI-DrugBank.d487.s7|30-31|on|drug
DDI-DrugBank.d487.s7|33-36|oral|drug
DDI-DrugBank.d487.s7|38-51|anticoagulants|drug
DDI-DrugBank.d487.s7|53-54|is|drug
DDI-DrugBank.d487.s7|56-63|variable|drug
DDI-DrugBank.d487.s7|64-64|.|drug
DDI-DrugBank.d487.s8|0-4|There|drug
DDI-DrugBank.d487.s8|6-8|are|drug
DDI-DrugBank.d487.s8|10-16|reports|drug
DDI-DrugBank.d487.s8|18-19|of|drug
DDI-DrugBank.d487.s8|21-28|enhanced|drug
DDI-DrugBank.d487.s8|30-31|as|drug
DDI-DrugBank.d487.s8|33-36|well|drug
DDI-DrugBank.d487.s8|38-39|as|drug
DDI-DrugBank.d487.s8|41-50|diminished|drug
DDI-DrugBank.d487.s8|52-58|effects|drug
DDI-DrugBank.d487.s8|60-61|of|drug
DDI-DrugBank.d487.s8|63-76|anticoagulants|drug
DDI-DrugBank.d487.s8|78-81|when|drug
DDI-DrugBank.d487.s8|83-87|given|drug
DDI-DrugBank.d487.s8|89-100|concurrently|drug
DDI-DrugBank.d487.s8|102-105|with|drug
DDI-DrugBank.d487.s8|107-121|corticosteroids|drug
DDI-DrugBank.d487.s8|122-122|.|drug
DDI-DrugBank.d487.s9|0-8|Therefore|drug
DDI-DrugBank.d487.s9|9-9|,|drug
DDI-DrugBank.d487.s9|11-21|coagulation|drug
DDI-DrugBank.d487.s9|23-29|indices|drug
DDI-DrugBank.d487.s9|31-36|should|drug
DDI-DrugBank.d487.s9|38-39|be|drug
DDI-DrugBank.d487.s9|41-49|monitored|drug
DDI-DrugBank.d487.s9|51-52|to|drug
DDI-DrugBank.d487.s9|54-61|maintain|drug
DDI-DrugBank.d487.s9|63-65|the|drug
DDI-DrugBank.d487.s9|67-73|desired|drug
DDI-DrugBank.d487.s9|75-87|anticoagulant|drug
DDI-DrugBank.d487.s9|89-94|effect|drug
DDI-DrugBank.d487.s9|95-95|.|drug
DDI-DrugBank.d378.s0|0-4|Renal|drug
DDI-DrugBank.d378.s0|6-13|function|drug
DDI-DrugBank.d378.s0|15-20|should|drug
DDI-DrugBank.d378.s0|22-23|be|drug
DDI-DrugBank.d378.s0|25-33|monitored|drug
DDI-DrugBank.d378.s0|35-43|carefully|drug
DDI-DrugBank.d378.s0|45-46|if|drug
DDI-DrugBank.d378.s0|48-51|high|drug
DDI-DrugBank.d378.s0|53-57|doses|drug
DDI-DrugBank.d378.s0|59-60|of|drug
DDI-DrugBank.d378.s0|62-76|aminoglycosides|drug
DDI-DrugBank.d378.s0|78-80|are|drug
DDI-DrugBank.d378.s0|82-83|to|drug
DDI-DrugBank.d378.s0|85-86|be|drug
DDI-DrugBank.d378.s0|88-99|administered|drug
DDI-DrugBank.d378.s0|101-104|with|drug
DDI-DrugBank.d378.s0|106-113|MAXIPIME|drug
DDI-DrugBank.d378.s0|115-121|because|drug
DDI-DrugBank.d378.s0|123-124|of|drug
DDI-DrugBank.d378.s0|126-128|the|drug
DDI-DrugBank.d378.s0|130-138|increased|drug
DDI-DrugBank.d378.s0|140-148|potential|drug
DDI-DrugBank.d378.s0|150-151|of|drug
DDI-DrugBank.d378.s0|153-166|nephrotoxicity|drug
DDI-DrugBank.d378.s0|168-170|and|drug
DDI-DrugBank.d378.s0|172-182|ototoxicity|drug
DDI-DrugBank.d378.s0|184-185|of|drug
DDI-DrugBank.d378.s0|187-200|aminoglycoside|drug
DDI-DrugBank.d378.s0|202-212|antibiotics|drug
DDI-DrugBank.d378.s0|213-213|.|drug
DDI-DrugBank.d378.s1|0-13|Nephrotoxicity|drug
DDI-DrugBank.d378.s1|15-17|has|drug
DDI-DrugBank.d378.s1|19-22|been|drug
DDI-DrugBank.d378.s1|24-31|reported|drug
DDI-DrugBank.d378.s1|33-41|following|drug
DDI-DrugBank.d378.s1|43-53|concomitant|drug
DDI-DrugBank.d378.s1|55-68|administration|drug
DDI-DrugBank.d378.s1|70-71|of|drug
DDI-DrugBank.d378.s1|73-77|other|drug
DDI-DrugBank.d378.s1|79-92|cephalosporins|drug
DDI-DrugBank.d378.s1|94-97|with|drug
DDI-DrugBank.d378.s1|99-104|potent|drug
DDI-DrugBank.d378.s1|106-114|diuretics|drug
DDI-DrugBank.d378.s1|116-119|such|drug
DDI-DrugBank.d378.s1|121-122|as|drug
DDI-DrugBank.d378.s1|124-133|furosemide|drug
DDI-DrugBank.d378.s1|134-134|.|drug
DDI-DrugBank.d378.s2|0-14|Drug/Laboratory|drug
DDI-DrugBank.d378.s2|16-19|Test|drug
DDI-DrugBank.d378.s2|21-32|Interactions|drug
DDI-DrugBank.d378.s2|34-36|The|drug
DDI-DrugBank.d378.s2|38-51|administration|drug
DDI-DrugBank.d378.s2|53-54|of|drug
DDI-DrugBank.d378.s2|56-63|cefepime|drug
DDI-DrugBank.d378.s2|65-67|may|drug
DDI-DrugBank.d378.s2|69-74|result|drug
DDI-DrugBank.d378.s2|76-77|in|drug
DDI-DrugBank.d378.s2|79-79|a|drug
DDI-DrugBank.d378.s2|81-94|false-positive|drug
DDI-DrugBank.d378.s2|96-103|reaction|drug
DDI-DrugBank.d378.s2|105-107|for|drug
DDI-DrugBank.d378.s2|109-115|glucose|drug
DDI-DrugBank.d378.s2|117-118|in|drug
DDI-DrugBank.d378.s2|120-122|the|drug
DDI-DrugBank.d378.s2|124-128|urine|drug
DDI-DrugBank.d378.s2|130-133|when|drug
DDI-DrugBank.d378.s2|135-139|using|drug
DDI-DrugBank.d378.s2|141-149|Clinitest|drug
DDI-DrugBank.d378.s2|152-158|tablets|drug
DDI-DrugBank.d378.s2|159-159|.|drug
DDI-DrugBank.d378.s3|0-1|It|drug
DDI-DrugBank.d378.s3|3-4|is|drug
DDI-DrugBank.d378.s3|6-16|recommended|drug
DDI-DrugBank.d378.s3|18-21|that|drug
DDI-DrugBank.d378.s3|23-29|glucose|drug
DDI-DrugBank.d378.s3|31-35|tests|drug
DDI-DrugBank.d378.s3|37-41|based|drug
DDI-DrugBank.d378.s3|43-44|on|drug
DDI-DrugBank.d378.s3|46-54|enzymatic|drug
DDI-DrugBank.d378.s3|56-62|glucose|drug
DDI-DrugBank.d378.s3|64-70|oxidase|drug
DDI-DrugBank.d378.s3|72-80|reactions|drug
DDI-DrugBank.d378.s3|82-82|(|drug
DDI-DrugBank.d378.s3|83-86|such|drug
DDI-DrugBank.d378.s3|88-89|as|drug
DDI-DrugBank.d378.s3|91-99|Clinistix|drug
DDI-DrugBank.d378.s3|102-103|or|drug
DDI-DrugBank.d378.s3|105-112|Tes-Tape|drug
DDI-DrugBank.d378.s3|115-115|)|drug
DDI-DrugBank.d378.s3|117-118|be|drug
DDI-DrugBank.d378.s3|120-123|used|drug
DDI-DrugBank.d378.s3|124-124|.|drug
DDI-DrugBank.d527.s0|0-0|A|drug
DDI-DrugBank.d527.s0|2-7|number|drug
DDI-DrugBank.d527.s0|9-10|of|drug
DDI-DrugBank.d527.s0|12-21|substances|drug
DDI-DrugBank.d527.s0|23-28|affect|drug
DDI-DrugBank.d527.s0|30-36|glucose|drug
DDI-DrugBank.d527.s0|38-47|metabolism|drug
DDI-DrugBank.d527.s0|49-51|and|drug
DDI-DrugBank.d527.s0|53-55|may|drug
DDI-DrugBank.d527.s0|57-63|require|drug
DDI-DrugBank.d527.s0|65-71|insulin|drug
DDI-DrugBank.d527.s0|73-76|dose|drug
DDI-DrugBank.d527.s0|78-87|adjustment|drug
DDI-DrugBank.d527.s0|89-91|and|drug
DDI-DrugBank.d527.s0|93-104|particularly|drug
DDI-DrugBank.d527.s0|106-110|close|drug
DDI-DrugBank.d527.s0|112-121|monitoring|drug
DDI-DrugBank.d527.s0|122-122|.|drug
DDI-DrugBank.d527.s1|0-2|The|drug
DDI-DrugBank.d527.s1|4-12|following|drug
DDI-DrugBank.d527.s1|14-16|are|drug
DDI-DrugBank.d527.s1|18-25|examples|drug
DDI-DrugBank.d527.s1|27-28|of|drug
DDI-DrugBank.d527.s1|30-39|substances|drug
DDI-DrugBank.d527.s1|41-44|that|drug
DDI-DrugBank.d527.s1|46-48|may|drug
DDI-DrugBank.d527.s1|50-57|increase|drug
DDI-DrugBank.d527.s1|59-61|the|drug
DDI-DrugBank.d527.s1|63-84|blood-glucose-lowering|drug
DDI-DrugBank.d527.s1|86-91|effect|drug
DDI-DrugBank.d527.s1|93-95|and|drug
DDI-DrugBank.d527.s1|97-110|susceptibility|drug
DDI-DrugBank.d527.s1|112-113|to|drug
DDI-DrugBank.d527.s1|115-126|hypoglycemia|drug
DDI-DrugBank.d527.s1|127-127|:|drug
DDI-DrugBank.d527.s1|129-132|oral|drug
DDI-DrugBank.d527.s1|134-145|antidiabetes|drug
DDI-DrugBank.d527.s1|147-154|products|drug
DDI-DrugBank.d527.s1|155-155|,|drug
DDI-DrugBank.d527.s1|157-159|ACE|drug
DDI-DrugBank.d527.s1|161-170|inhibitors|drug
DDI-DrugBank.d527.s1|171-171|,|drug
DDI-DrugBank.d527.s1|173-184|disopyramide|drug
DDI-DrugBank.d527.s1|185-185|,|drug
DDI-DrugBank.d527.s1|187-194|fibrates|drug
DDI-DrugBank.d527.s1|195-195|,|drug
DDI-DrugBank.d527.s1|197-206|fluoxetine|drug
DDI-DrugBank.d527.s1|207-207|,|drug
DDI-DrugBank.d527.s1|209-211|MAO|drug
DDI-DrugBank.d527.s1|213-222|inhibitors|drug
DDI-DrugBank.d527.s1|223-223|,|drug
DDI-DrugBank.d527.s1|225-236|propoxyphene|drug
DDI-DrugBank.d527.s1|237-237|,|drug
DDI-DrugBank.d527.s1|239-249|salicylates|drug
DDI-DrugBank.d527.s1|250-250|,|drug
DDI-DrugBank.d527.s1|252-263|somatostatin|drug
DDI-DrugBank.d527.s1|265-270|analog|drug
DDI-DrugBank.d527.s1|272-272|(|drug
DDI-DrugBank.d527.s1|273-276|e.g.|drug
DDI-DrugBank.d527.s1|277-277|,|drug
DDI-DrugBank.d527.s1|279-288|octreotide|drug
DDI-DrugBank.d527.s1|289-289|)|drug
DDI-DrugBank.d527.s1|290-290|,|drug
DDI-DrugBank.d527.s1|292-302|sulfonamide|drug
DDI-DrugBank.d527.s1|304-314|antibiotics|drug
DDI-DrugBank.d527.s1|315-315|.|drug
DDI-DrugBank.d527.s2|0-2|The|drug
DDI-DrugBank.d527.s2|4-12|following|drug
DDI-DrugBank.d527.s2|14-16|are|drug
DDI-DrugBank.d527.s2|18-25|examples|drug
DDI-DrugBank.d527.s2|27-28|of|drug
DDI-DrugBank.d527.s2|30-39|substances|drug
DDI-DrugBank.d527.s2|41-44|that|drug
DDI-DrugBank.d527.s2|46-48|may|drug
DDI-DrugBank.d527.s2|50-55|reduce|drug
DDI-DrugBank.d527.s2|57-59|the|drug
DDI-DrugBank.d527.s2|61-82|blood-glucose-lowering|drug
DDI-DrugBank.d527.s2|84-89|effect|drug
DDI-DrugBank.d527.s2|91-92|of|drug
DDI-DrugBank.d527.s2|94-100|insulin|drug
DDI-DrugBank.d527.s2|101-101|:|drug
DDI-DrugBank.d527.s2|103-117|corticosteroids|drug
DDI-DrugBank.d527.s2|118-118|,|drug
DDI-DrugBank.d527.s2|120-126|danazol|drug
DDI-DrugBank.d527.s2|127-127|,|drug
DDI-DrugBank.d527.s2|129-137|diuretics|drug
DDI-DrugBank.d527.s2|138-138|,|drug
DDI-DrugBank.d527.s2|140-154|sympathomimetic|drug
DDI-DrugBank.d527.s2|156-161|agents|drug
DDI-DrugBank.d527.s2|163-163|(|drug
DDI-DrugBank.d527.s2|164-167|e.g.|drug
DDI-DrugBank.d527.s2|168-168|,|drug
DDI-DrugBank.d527.s2|170-180|epinephrine|drug
DDI-DrugBank.d527.s2|181-181|,|drug
DDI-DrugBank.d527.s2|183-191|albuterol|drug
DDI-DrugBank.d527.s2|192-192|,|drug
DDI-DrugBank.d527.s2|194-204|terbutaline|drug
DDI-DrugBank.d527.s2|205-205|)|drug
DDI-DrugBank.d527.s2|206-206|,|drug
DDI-DrugBank.d527.s2|208-216|isoniazid|drug
DDI-DrugBank.d527.s2|217-217|,|drug
DDI-DrugBank.d527.s2|219-231|phenothiazine|drug
DDI-DrugBank.d527.s2|233-243|derivatives|drug
DDI-DrugBank.d527.s2|244-244|,|drug
DDI-DrugBank.d527.s2|246-255|somatropin|drug
DDI-DrugBank.d527.s2|256-256|,|drug
DDI-DrugBank.d527.s2|258-264|thyroid|drug
DDI-DrugBank.d527.s2|266-273|hormones|drug
DDI-DrugBank.d527.s2|274-274|,|drug
DDI-DrugBank.d527.s2|276-284|estrogens|drug
DDI-DrugBank.d527.s2|285-285|,|drug
DDI-DrugBank.d527.s2|287-298|progestogens|drug
DDI-DrugBank.d527.s2|300-300|(|drug
DDI-DrugBank.d527.s2|301-304|e.g.|drug
DDI-DrugBank.d527.s2|305-305|,|drug
DDI-DrugBank.d527.s2|307-308|in|drug
DDI-DrugBank.d527.s2|310-313|oral|drug
DDI-DrugBank.d527.s2|315-328|contraceptives|drug
DDI-DrugBank.d527.s2|329-329|)|drug
DDI-DrugBank.d527.s2|330-330|.|drug
DDI-DrugBank.d527.s3|0-12|Beta-blockers|drug
DDI-DrugBank.d527.s3|13-13|,|drug
DDI-DrugBank.d527.s3|15-23|clonidine|drug
DDI-DrugBank.d527.s3|24-24|,|drug
DDI-DrugBank.d527.s3|26-32|lithium|drug
DDI-DrugBank.d527.s3|34-38|salts|drug
DDI-DrugBank.d527.s3|39-39|,|drug
DDI-DrugBank.d527.s3|41-43|and|drug
DDI-DrugBank.d527.s3|45-51|alcohol|drug
DDI-DrugBank.d527.s3|53-55|may|drug
DDI-DrugBank.d527.s3|57-62|either|drug
DDI-DrugBank.d527.s3|64-73|potentiate|drug
DDI-DrugBank.d527.s3|75-76|or|drug
DDI-DrugBank.d527.s3|78-83|weaken|drug
DDI-DrugBank.d527.s3|85-87|the|drug
DDI-DrugBank.d527.s3|89-110|blood-glucose-lowering|drug
DDI-DrugBank.d527.s3|112-117|effect|drug
DDI-DrugBank.d527.s3|119-120|of|drug
DDI-DrugBank.d527.s3|122-128|insulin|drug
DDI-DrugBank.d527.s3|129-129|.|drug
DDI-DrugBank.d527.s4|0-10|Pentamidine|drug
DDI-DrugBank.d527.s4|12-14|may|drug
DDI-DrugBank.d527.s4|16-20|cause|drug
DDI-DrugBank.d527.s4|22-33|hypoglycemia|drug
DDI-DrugBank.d527.s4|34-34|,|drug
DDI-DrugBank.d527.s4|36-40|which|drug
DDI-DrugBank.d527.s4|42-44|may|drug
DDI-DrugBank.d527.s4|46-54|sometimes|drug
DDI-DrugBank.d527.s4|56-57|be|drug
DDI-DrugBank.d527.s4|59-66|followed|drug
DDI-DrugBank.d527.s4|68-69|by|drug
DDI-DrugBank.d527.s4|71-83|hyperglycemia|drug
DDI-DrugBank.d527.s4|84-84|.|drug
DDI-DrugBank.d527.s5|0-1|In|drug
DDI-DrugBank.d527.s5|3-10|addition|drug
DDI-DrugBank.d527.s5|11-11|,|drug
DDI-DrugBank.d527.s5|13-17|under|drug
DDI-DrugBank.d527.s5|19-21|the|drug
DDI-DrugBank.d527.s5|23-31|influence|drug
DDI-DrugBank.d527.s5|33-34|of|drug
DDI-DrugBank.d527.s5|36-48|sympatholytic|drug
DDI-DrugBank.d527.s5|50-58|medicinal|drug
DDI-DrugBank.d527.s5|60-67|products|drug
DDI-DrugBank.d527.s5|69-72|such|drug
DDI-DrugBank.d527.s5|74-75|as|drug
DDI-DrugBank.d527.s5|77-89|beta-blockers|drug
DDI-DrugBank.d527.s5|90-90|,|drug
DDI-DrugBank.d527.s5|92-100|clonidine|drug
DDI-DrugBank.d527.s5|101-101|,|drug
DDI-DrugBank.d527.s5|103-114|guanethidine|drug
DDI-DrugBank.d527.s5|115-115|,|drug
DDI-DrugBank.d527.s5|117-119|and|drug
DDI-DrugBank.d527.s5|121-129|reserpine|drug
DDI-DrugBank.d527.s5|130-130|,|drug
DDI-DrugBank.d527.s5|132-134|the|drug
DDI-DrugBank.d527.s5|136-140|signs|drug
DDI-DrugBank.d527.s5|142-143|of|drug
DDI-DrugBank.d527.s5|145-156|hypoglycemia|drug
DDI-DrugBank.d527.s5|158-160|may|drug
DDI-DrugBank.d527.s5|162-163|be|drug
DDI-DrugBank.d527.s5|165-171|reduced|drug
DDI-DrugBank.d527.s5|173-174|or|drug
DDI-DrugBank.d527.s5|176-181|absent|drug
DDI-DrugBank.d527.s5|182-182|.|drug
DDI-MedLine.d81.s0|0-10|Hypothermia|drug
DDI-MedLine.d81.s0|12-13|as|drug
DDI-MedLine.d81.s0|15-16|an|drug
DDI-MedLine.d81.s0|18-22|index|drug
DDI-MedLine.d81.s0|24-25|of|drug
DDI-MedLine.d81.s0|27-29|the|drug
DDI-MedLine.d81.s0|31-48|disulfiram-ethanol|drug
DDI-MedLine.d81.s0|50-57|reaction|drug
DDI-MedLine.d81.s0|59-60|in|drug
DDI-MedLine.d81.s0|62-64|the|drug
DDI-MedLine.d81.s0|66-68|rat|drug
DDI-MedLine.d81.s0|69-69|.|drug
DDI-MedLine.d81.s1|0-8|Decreased|drug
DDI-MedLine.d81.s1|10-13|core|drug
DDI-MedLine.d81.s1|15-25|temperature|drug
DDI-MedLine.d81.s1|27-28|in|drug
DDI-MedLine.d81.s1|30-35|female|drug
DDI-MedLine.d81.s1|37-40|rats|drug
DDI-MedLine.d81.s1|42-44|was|drug
DDI-MedLine.d81.s1|46-57|investigated|drug
DDI-MedLine.d81.s1|59-60|as|drug
DDI-MedLine.d81.s1|62-64|one|drug
DDI-MedLine.d81.s1|66-73|possible|drug
DDI-MedLine.d81.s1|75-79|index|drug
DDI-MedLine.d81.s1|81-82|of|drug
DDI-MedLine.d81.s1|84-86|the|drug
DDI-MedLine.d81.s1|88-105|disulfiram-ethanol|drug
DDI-MedLine.d81.s1|107-114|reaction|drug
DDI-MedLine.d81.s1|116-116|(|drug
DDI-MedLine.d81.s1|117-119|DER|drug
DDI-MedLine.d81.s1|120-120|)|drug
DDI-MedLine.d81.s1|121-121|.|drug
DDI-MedLine.d81.s2|0-3|Core|drug
DDI-MedLine.d81.s2|5-15|temperature|drug
DDI-MedLine.d81.s2|17-19|was|drug
DDI-MedLine.d81.s2|21-29|decreased|drug
DDI-MedLine.d81.s2|31-32|in|drug
DDI-MedLine.d81.s2|34-37|rats|drug
DDI-MedLine.d81.s2|39-40|in|drug
DDI-MedLine.d81.s2|42-42|a|drug
DDI-MedLine.d81.s2|44-57|dose-dependent|drug
DDI-MedLine.d81.s2|59-64|manner|drug
DDI-MedLine.d81.s2|66-69|when|drug
DDI-MedLine.d81.s2|71-77|ethanol|drug
DDI-MedLine.d81.s2|79-81|was|drug
DDI-MedLine.d81.s2|83-94|administered|drug
DDI-MedLine.d81.s2|96-97|to|drug
DDI-MedLine.d81.s2|99-102|rats|drug
DDI-MedLine.d81.s2|104-110|treated|drug
DDI-MedLine.d81.s2|112-115|with|drug
DDI-MedLine.d81.s2|117-126|disulfiram|drug
DDI-MedLine.d81.s2|128-128|8|drug
DDI-MedLine.d81.s2|130-134|hours|drug
DDI-MedLine.d81.s2|136-141|before|drug
DDI-MedLine.d81.s2|143-145|the|drug
DDI-MedLine.d81.s2|147-153|ethanol|drug
DDI-MedLine.d81.s2|155-163|challenge|drug
DDI-MedLine.d81.s2|164-164|.|drug
DDI-MedLine.d81.s3|0-2|The|drug
DDI-MedLine.d81.s3|4-11|decrease|drug
DDI-MedLine.d81.s3|13-14|in|drug
DDI-MedLine.d81.s3|16-26|temperature|drug
DDI-MedLine.d81.s3|28-32|began|drug
DDI-MedLine.d81.s3|34-39|within|drug
DDI-MedLine.d81.s3|41-42|20|drug
DDI-MedLine.d81.s3|44-50|minutes|drug
DDI-MedLine.d81.s3|52-56|after|drug
DDI-MedLine.d81.s3|58-64|ethanol|drug
DDI-MedLine.d81.s3|66-79|administration|drug
DDI-MedLine.d81.s3|80-80|,|drug
DDI-MedLine.d81.s3|82-89|reaching|drug
DDI-MedLine.d81.s3|91-91|a|drug
DDI-MedLine.d81.s3|93-99|maximal|drug
DDI-MedLine.d81.s3|101-108|decrease|drug
DDI-MedLine.d81.s3|110-116|between|drug
DDI-MedLine.d81.s3|118-119|60|drug
DDI-MedLine.d81.s3|121-123|and|drug
DDI-MedLine.d81.s3|125-127|120|drug
DDI-MedLine.d81.s3|129-135|minutes|drug
DDI-MedLine.d81.s3|137-140|post|drug
DDI-MedLine.d81.s3|142-148|ethanol|drug
DDI-MedLine.d81.s3|149-149|.|drug
DDI-MedLine.d81.s4|0-2|The|drug
DDI-MedLine.d81.s4|4-7|core|drug
DDI-MedLine.d81.s4|9-19|temperature|drug
DDI-MedLine.d81.s4|21-28|returned|drug
DDI-MedLine.d81.s4|30-31|to|drug
DDI-MedLine.d81.s4|33-38|normal|drug
DDI-MedLine.d81.s4|40-42|300|drug
DDI-MedLine.d81.s4|44-50|minutes|drug
DDI-MedLine.d81.s4|52-56|after|drug
DDI-MedLine.d81.s4|58-64|ethanol|drug
DDI-MedLine.d81.s4|65-65|.|drug
DDI-MedLine.d81.s5|0-2|The|drug
DDI-MedLine.d81.s5|4-8|blood|drug
DDI-MedLine.d81.s5|10-17|pressure|drug
DDI-MedLine.d81.s5|19-19|(|drug
DDI-MedLine.d81.s5|20-26|carotid|drug
DDI-MedLine.d81.s5|28-38|cannulation|drug
DDI-MedLine.d81.s5|39-39|)|drug
DDI-MedLine.d81.s5|41-49|decreased|drug
DDI-MedLine.d81.s5|51-55|along|drug
DDI-MedLine.d81.s5|57-60|with|drug
DDI-MedLine.d81.s5|62-64|the|drug
DDI-MedLine.d81.s5|66-69|core|drug
DDI-MedLine.d81.s5|71-81|temperature|drug
DDI-MedLine.d81.s5|82-82|.|drug
DDI-MedLine.d81.s6|0-6|Maximal|drug
DDI-MedLine.d81.s6|8-18|hypotension|drug
DDI-MedLine.d81.s6|20-22|was|drug
DDI-MedLine.d81.s6|24-28|found|drug
DDI-MedLine.d81.s6|30-32|120|drug
DDI-MedLine.d81.s6|34-40|minutes|drug
DDI-MedLine.d81.s6|42-45|post|drug
DDI-MedLine.d81.s6|47-53|ethanol|drug
DDI-MedLine.d81.s6|54-54|,|drug
DDI-MedLine.d81.s6|56-58|and|drug
DDI-MedLine.d81.s6|60-67|returned|drug
DDI-MedLine.d81.s6|69-70|to|drug
DDI-MedLine.d81.s6|72-77|normal|drug
DDI-MedLine.d81.s6|79-81|300|drug
DDI-MedLine.d81.s6|83-89|minutes|drug
DDI-MedLine.d81.s6|91-95|after|drug
DDI-MedLine.d81.s6|97-103|ethanol|drug
DDI-MedLine.d81.s6|104-104|.|drug
DDI-MedLine.d81.s7|0-4|Heart|drug
DDI-MedLine.d81.s7|6-9|rate|drug
DDI-MedLine.d81.s7|11-19|increased|drug
DDI-MedLine.d81.s7|21-29|initially|drug
DDI-MedLine.d81.s7|31-33|and|drug
DDI-MedLine.d81.s7|35-42|returned|drug
DDI-MedLine.d81.s7|44-45|to|drug
DDI-MedLine.d81.s7|47-52|normal|drug
DDI-MedLine.d81.s7|54-55|40|drug
DDI-MedLine.d81.s7|57-63|minutes|drug
DDI-MedLine.d81.s7|65-69|after|drug
DDI-MedLine.d81.s7|71-77|ethanol|drug
DDI-MedLine.d81.s7|79-87|challenge|drug
DDI-MedLine.d81.s7|88-88|.|drug
DDI-DrugBank.d407.s0|0-14|Drug/Laboratory|drug
DDI-DrugBank.d407.s0|16-27|Interactions|drug
DDI-DrugBank.d407.s0|29-30|No|drug
DDI-DrugBank.d407.s0|32-37|formal|drug
DDI-DrugBank.d407.s0|39-42|drug|drug
DDI-DrugBank.d407.s0|44-54|interaction|drug
DDI-DrugBank.d407.s0|56-62|studies|drug
DDI-DrugBank.d407.s0|64-67|have|drug
DDI-DrugBank.d407.s0|69-72|been|drug
DDI-DrugBank.d407.s0|74-82|performed|drug
DDI-DrugBank.d407.s0|84-87|with|drug
DDI-DrugBank.d407.s0|89-95|Campath|drug
DDI-DrugBank.d407.s0|96-96|.|drug
DDI-DrugBank.d407.s1|0-1|An|drug
DDI-DrugBank.d407.s1|3-8|immune|drug
DDI-DrugBank.d407.s1|10-17|response|drug
DDI-DrugBank.d407.s1|19-20|to|drug
DDI-DrugBank.d407.s1|22-28|Campath|drug
DDI-DrugBank.d407.s1|30-32|may|drug
DDI-DrugBank.d407.s1|34-42|interfere|drug
DDI-DrugBank.d407.s1|44-47|with|drug
DDI-DrugBank.d407.s1|49-58|subsequent|drug
DDI-DrugBank.d407.s1|60-69|diagnostic|drug
DDI-DrugBank.d407.s1|71-75|serum|drug
DDI-DrugBank.d407.s1|77-81|tests|drug
DDI-DrugBank.d407.s1|83-86|that|drug
DDI-DrugBank.d407.s1|88-94|utilize|drug
DDI-DrugBank.d407.s1|96-105|antibodies|drug
DDI-DrugBank.d407.s2|0-0|.|drug
DDI-DrugBank.d92.s0|0-1|No|drug
DDI-DrugBank.d92.s0|3-12|well-known|drug
DDI-DrugBank.d92.s0|14-17|drug|drug
DDI-DrugBank.d92.s0|19-30|interactions|drug
DDI-DrugBank.d92.s0|32-35|with|drug
DDI-DrugBank.d92.s0|37-44|glutamic|drug
DDI-DrugBank.d92.s0|46-49|acid|drug
DDI-DrugBank.d258.s0|0-9|Loratadine|drug
DDI-DrugBank.d258.s0|11-11|(|drug
DDI-DrugBank.d258.s0|12-13|10|drug
DDI-DrugBank.d258.s0|15-16|mg|drug
DDI-DrugBank.d258.s0|18-21|once|drug
DDI-DrugBank.d258.s0|23-27|daily|drug
DDI-DrugBank.d258.s0|28-28|)|drug
DDI-DrugBank.d258.s0|30-32|has|drug
DDI-DrugBank.d258.s0|34-37|been|drug
DDI-DrugBank.d258.s0|39-52|coadministered|drug
DDI-DrugBank.d258.s0|54-57|with|drug
DDI-DrugBank.d258.s0|59-69|therapeutic|drug
DDI-DrugBank.d258.s0|71-75|doses|drug
DDI-DrugBank.d258.s0|77-78|of|drug
DDI-DrugBank.d258.s0|80-91|erythromycin|drug
DDI-DrugBank.d258.s0|92-92|,|drug
DDI-DrugBank.d258.s0|94-103|cimetidine|drug
DDI-DrugBank.d258.s0|104-104|,|drug
DDI-DrugBank.d258.s0|106-108|and|drug
DDI-DrugBank.d258.s0|110-121|ketoconazole|drug
DDI-DrugBank.d258.s0|123-124|in|drug
DDI-DrugBank.d258.s0|126-135|controlled|drug
DDI-DrugBank.d258.s0|137-144|clinical|drug
DDI-DrugBank.d258.s0|146-157|pharmacology|drug
DDI-DrugBank.d258.s0|159-165|studies|drug
DDI-DrugBank.d258.s0|167-168|in|drug
DDI-DrugBank.d258.s0|170-174|adult|drug
DDI-DrugBank.d258.s0|176-185|volunteers|drug
DDI-DrugBank.d258.s0|186-186|.|drug
DDI-DrugBank.d258.s1|0-7|Although|drug
DDI-DrugBank.d258.s1|9-17|increased|drug
DDI-DrugBank.d258.s1|19-24|plasma|drug
DDI-DrugBank.d258.s1|26-39|concentrations|drug
DDI-DrugBank.d258.s1|41-41|(|drug
DDI-DrugBank.d258.s1|42-44|AUC|drug
DDI-DrugBank.d258.s1|46-49|0-24|drug
DDI-DrugBank.d258.s1|51-53|hrs|drug
DDI-DrugBank.d258.s1|54-54|)|drug
DDI-DrugBank.d258.s1|56-57|of|drug
DDI-DrugBank.d258.s1|59-68|loratadine|drug
DDI-DrugBank.d258.s1|70-75|and/or|drug
DDI-DrugBank.d258.s1|77-100|descarboethoxyloratadine|drug
DDI-DrugBank.d258.s1|102-105|were|drug
DDI-DrugBank.d258.s1|107-114|observed|drug
DDI-DrugBank.d258.s1|116-124|following|drug
DDI-DrugBank.d258.s1|126-141|coadministration|drug
DDI-DrugBank.d258.s1|143-144|of|drug
DDI-DrugBank.d258.s1|146-155|loratadine|drug
DDI-DrugBank.d258.s1|157-160|with|drug
DDI-DrugBank.d258.s1|162-165|each|drug
DDI-DrugBank.d258.s1|167-168|of|drug
DDI-DrugBank.d258.s1|170-174|these|drug
DDI-DrugBank.d258.s1|176-180|drugs|drug
DDI-DrugBank.d258.s1|182-183|in|drug
DDI-DrugBank.d258.s1|185-190|normal|drug
DDI-DrugBank.d258.s1|192-201|volunteers|drug
DDI-DrugBank.d258.s1|203-203|(|drug
DDI-DrugBank.d258.s1|204-204|n|drug
DDI-DrugBank.d258.s1|206-206|=|drug
DDI-DrugBank.d258.s1|208-209|24|drug
DDI-DrugBank.d258.s1|211-212|in|drug
DDI-DrugBank.d258.s1|214-217|each|drug
DDI-DrugBank.d258.s1|219-223|study|drug
DDI-DrugBank.d258.s1|224-224|)|drug
DDI-DrugBank.d258.s1|225-225|,|drug
DDI-DrugBank.d258.s1|227-231|there|drug
DDI-DrugBank.d258.s1|233-236|were|drug
DDI-DrugBank.d258.s1|238-239|no|drug
DDI-DrugBank.d258.s1|241-250|clinically|drug
DDI-DrugBank.d258.s1|252-259|relevant|drug
DDI-DrugBank.d258.s1|261-267|changes|drug
DDI-DrugBank.d258.s1|269-270|in|drug
DDI-DrugBank.d258.s1|272-274|the|drug
DDI-DrugBank.d258.s1|276-281|safety|drug
DDI-DrugBank.d258.s1|283-289|profile|drug
DDI-DrugBank.d258.s1|291-292|of|drug
DDI-DrugBank.d258.s1|294-303|loratadine|drug
DDI-DrugBank.d258.s1|304-304|,|drug
DDI-DrugBank.d258.s1|306-307|as|drug
DDI-DrugBank.d258.s1|309-316|assessed|drug
DDI-DrugBank.d258.s1|318-319|by|drug
DDI-DrugBank.d258.s1|321-340|electrocardiographic|drug
DDI-DrugBank.d258.s1|342-351|parameters|drug
DDI-DrugBank.d258.s1|352-352|,|drug
DDI-DrugBank.d258.s1|354-361|clinical|drug
DDI-DrugBank.d258.s1|363-372|laboratory|drug
DDI-DrugBank.d258.s1|374-378|tests|drug
DDI-DrugBank.d258.s1|379-379|,|drug
DDI-DrugBank.d258.s1|381-385|vital|drug
DDI-DrugBank.d258.s1|387-391|signs|drug
DDI-DrugBank.d258.s1|392-392|,|drug
DDI-DrugBank.d258.s1|394-396|and|drug
DDI-DrugBank.d258.s1|398-404|adverse|drug
DDI-DrugBank.d258.s1|406-411|events|drug
DDI-DrugBank.d258.s1|412-412|.|drug
DDI-DrugBank.d258.s2|0-4|There|drug
DDI-DrugBank.d258.s2|6-9|were|drug
DDI-DrugBank.d258.s2|11-12|no|drug
DDI-DrugBank.d258.s2|14-24|significant|drug
DDI-DrugBank.d258.s2|26-32|effects|drug
DDI-DrugBank.d258.s2|34-35|on|drug
DDI-DrugBank.d258.s2|37-39|QTc|drug
DDI-DrugBank.d258.s2|41-49|intervals|drug
DDI-DrugBank.d258.s2|50-50|,|drug
DDI-DrugBank.d258.s2|52-54|and|drug
DDI-DrugBank.d258.s2|56-57|no|drug
DDI-DrugBank.d258.s2|59-65|reports|drug
DDI-DrugBank.d258.s2|67-68|of|drug
DDI-DrugBank.d258.s2|70-77|sedation|drug
DDI-DrugBank.d258.s2|79-80|or|drug
DDI-DrugBank.d258.s2|82-88|syncope|drug
DDI-DrugBank.d258.s2|89-89|.|drug
DDI-DrugBank.d258.s3|0-1|No|drug
DDI-DrugBank.d258.s3|3-9|effects|drug
DDI-DrugBank.d258.s3|11-12|on|drug
DDI-DrugBank.d258.s3|14-19|plasma|drug
DDI-DrugBank.d258.s3|21-34|concentrations|drug
DDI-DrugBank.d258.s3|36-37|of|drug
DDI-DrugBank.d258.s3|39-48|cimetidine|drug
DDI-DrugBank.d258.s3|50-51|or|drug
DDI-DrugBank.d258.s3|53-64|ketoconazole|drug
DDI-DrugBank.d258.s3|66-69|were|drug
DDI-DrugBank.d258.s3|71-78|observed|drug
DDI-DrugBank.d258.s3|79-79|.|drug
DDI-DrugBank.d258.s4|0-5|Plasma|drug
DDI-DrugBank.d258.s4|7-20|concentrations|drug
DDI-DrugBank.d258.s4|22-22|(|drug
DDI-DrugBank.d258.s4|23-25|AUC|drug
DDI-DrugBank.d258.s4|27-30|0-24|drug
DDI-DrugBank.d258.s4|32-34|hrs|drug
DDI-DrugBank.d258.s4|35-35|)|drug
DDI-DrugBank.d258.s4|37-38|of|drug
DDI-DrugBank.d258.s4|40-51|erythromycin|drug
DDI-DrugBank.d258.s4|53-61|decreased|drug
DDI-DrugBank.d258.s4|63-64|15|drug
DDI-DrugBank.d258.s4|65-65|%|drug
DDI-DrugBank.d258.s4|67-70|with|drug
DDI-DrugBank.d258.s4|72-87|coadministration|drug
DDI-DrugBank.d258.s4|89-90|of|drug
DDI-DrugBank.d258.s4|92-101|loratadine|drug
DDI-DrugBank.d258.s4|103-110|relative|drug
DDI-DrugBank.d258.s4|112-113|to|drug
DDI-DrugBank.d258.s4|115-118|that|drug
DDI-DrugBank.d258.s4|120-127|observed|drug
DDI-DrugBank.d258.s4|129-132|with|drug
DDI-DrugBank.d258.s4|134-145|erythromycin|drug
DDI-DrugBank.d258.s4|147-151|alone|drug
DDI-DrugBank.d258.s4|152-152|.|drug
DDI-DrugBank.d258.s5|0-2|The|drug
DDI-DrugBank.d258.s5|4-11|clinical|drug
DDI-DrugBank.d258.s5|13-21|relevance|drug
DDI-DrugBank.d258.s5|23-24|of|drug
DDI-DrugBank.d258.s5|26-29|this|drug
DDI-DrugBank.d258.s5|31-40|difference|drug
DDI-DrugBank.d258.s5|42-43|is|drug
DDI-DrugBank.d258.s5|45-51|unknown|drug
DDI-DrugBank.d258.s5|52-52|.|drug
DDI-DrugBank.d258.s6|0-4|These|drug
DDI-DrugBank.d258.s6|6-10|above|drug
DDI-DrugBank.d258.s6|12-19|findings|drug
DDI-DrugBank.d258.s6|21-23|are|drug
DDI-DrugBank.d258.s6|25-34|summarized|drug
DDI-DrugBank.d258.s6|36-37|in|drug
DDI-DrugBank.d258.s6|39-43|TABLE|drug
DDI-DrugBank.d258.s6|45-45|1|drug
DDI-DrugBank.d258.s6|46-46|.|drug
DDI-DrugBank.d258.s7|0-4|TABLE|drug
DDI-DrugBank.d258.s7|6-6|1|drug
DDI-DrugBank.d258.s7|8-14|Effects|drug
DDI-DrugBank.d258.s7|16-17|on|drug
DDI-DrugBank.d258.s7|19-24|Plasma|drug
DDI-DrugBank.d258.s7|26-39|Concentrations|drug
DDI-DrugBank.d258.s7|41-41|(|drug
DDI-DrugBank.d258.s7|42-44|AUC|drug
DDI-DrugBank.d258.s7|46-49|0-24|drug
DDI-DrugBank.d258.s7|51-53|hrs|drug
DDI-DrugBank.d258.s7|54-54|)|drug
DDI-DrugBank.d258.s7|56-57|of|drug
DDI-DrugBank.d258.s7|59-68|Loratadine|drug
DDI-DrugBank.d258.s7|70-72|and|drug
DDI-DrugBank.d258.s7|74-97|Descarboethoxyloratadine|drug
DDI-DrugBank.d258.s7|99-103|After|drug
DDI-DrugBank.d258.s7|105-106|10|drug
DDI-DrugBank.d258.s7|108-111|Days|drug
DDI-DrugBank.d258.s7|113-114|of|drug
DDI-DrugBank.d258.s7|116-131|Coadministration|drug
DDI-DrugBank.d258.s7|133-133|(|drug
DDI-DrugBank.d258.s7|134-143|Loratadine|drug
DDI-DrugBank.d258.s7|145-146|10|drug
DDI-DrugBank.d258.s7|148-149|mg|drug
DDI-DrugBank.d258.s7|150-150|)|drug
DDI-DrugBank.d258.s7|152-153|in|drug
DDI-DrugBank.d258.s7|155-160|Normal|drug
DDI-DrugBank.d258.s7|162-171|Volunteers|drug
DDI-DrugBank.d258.s8|0-9|Loratadine|drug
DDI-DrugBank.d258.s8|11-34|Descarboethoxyloratadine|drug
DDI-DrugBank.d258.s9|0-11|Erythromycin|drug
DDI-DrugBank.d258.s9|13-13|(|drug
DDI-DrugBank.d258.s9|14-16|500|drug
DDI-DrugBank.d258.s9|18-19|mg|drug
DDI-DrugBank.d258.s9|21-23|q8h|drug
DDI-DrugBank.d258.s9|24-24|)|drug
DDI-DrugBank.d258.s9|26-26|+|drug
DDI-DrugBank.d258.s9|28-29|40|drug
DDI-DrugBank.d258.s9|30-30|%|drug
DDI-DrugBank.d258.s9|32-34|+46|drug
DDI-DrugBank.d258.s9|35-35|%|drug
DDI-DrugBank.d258.s10|0-9|Cimetidine|drug
DDI-DrugBank.d258.s10|11-11|(|drug
DDI-DrugBank.d258.s10|12-14|300|drug
DDI-DrugBank.d258.s10|16-17|mg|drug
DDI-DrugBank.d258.s10|19-21|qid|drug
DDI-DrugBank.d258.s10|22-22|)|drug
DDI-DrugBank.d258.s10|24-27|+103|drug
DDI-DrugBank.d258.s10|28-28|%|drug
DDI-DrugBank.d258.s10|30-30|+|drug
DDI-DrugBank.d258.s10|32-32|6|drug
DDI-DrugBank.d258.s10|33-33|%|drug
DDI-DrugBank.d258.s11|0-11|Ketoconazole|drug
DDI-DrugBank.d258.s11|13-13|(|drug
DDI-DrugBank.d258.s11|14-16|200|drug
DDI-DrugBank.d258.s11|18-19|mg|drug
DDI-DrugBank.d258.s11|21-24|q12h|drug
DDI-DrugBank.d258.s11|25-25|)|drug
DDI-DrugBank.d258.s11|27-30|+307|drug
DDI-DrugBank.d258.s11|31-31|%|drug
DDI-DrugBank.d258.s11|33-35|+73|drug
DDI-DrugBank.d258.s11|36-36|%|drug
DDI-DrugBank.d258.s12|0-4|There|drug
DDI-DrugBank.d258.s12|6-9|does|drug
DDI-DrugBank.d258.s12|11-13|not|drug
DDI-DrugBank.d258.s12|15-20|appear|drug
DDI-DrugBank.d258.s12|22-23|to|drug
DDI-DrugBank.d258.s12|25-26|be|drug
DDI-DrugBank.d258.s12|28-29|an|drug
DDI-DrugBank.d258.s12|31-38|increase|drug
DDI-DrugBank.d258.s12|40-41|in|drug
DDI-DrugBank.d258.s12|43-49|adverse|drug
DDI-DrugBank.d258.s12|51-56|events|drug
DDI-DrugBank.d258.s12|58-59|in|drug
DDI-DrugBank.d258.s12|61-68|subjects|drug
DDI-DrugBank.d258.s12|70-72|who|drug
DDI-DrugBank.d258.s12|74-81|received|drug
DDI-DrugBank.d258.s12|83-86|oral|drug
DDI-DrugBank.d258.s12|88-101|contraceptives|drug
DDI-DrugBank.d258.s12|103-105|and|drug
DDI-DrugBank.d258.s12|107-116|loratadine|drug
DDI-DrugBank.d258.s12|117-117|.|drug
DDI-DrugBank.d453.s0|0-7|Cytosine|drug
DDI-DrugBank.d453.s0|9-19|arabinoside|drug
DDI-DrugBank.d453.s0|20-20|,|drug
DDI-DrugBank.d453.s0|22-22|a|drug
DDI-DrugBank.d453.s0|24-33|cytostatic|drug
DDI-DrugBank.d453.s0|35-39|agent|drug
DDI-DrugBank.d453.s0|40-40|,|drug
DDI-DrugBank.d453.s0|42-44|has|drug
DDI-DrugBank.d453.s0|46-49|been|drug
DDI-DrugBank.d453.s0|51-58|reported|drug
DDI-DrugBank.d453.s0|60-61|to|drug
DDI-DrugBank.d453.s0|63-72|inactivate|drug
DDI-DrugBank.d453.s0|74-76|the|drug
DDI-DrugBank.d453.s0|78-87|antifungal|drug
DDI-DrugBank.d453.s0|89-96|activity|drug
DDI-DrugBank.d453.s0|98-99|of|drug
DDI-DrugBank.d453.s0|101-111|flucytosine|drug
DDI-DrugBank.d453.s0|113-114|by|drug
DDI-DrugBank.d453.s0|116-126|competitive|drug
DDI-DrugBank.d453.s0|128-137|inhibition|drug
DDI-DrugBank.d453.s0|138-138|.|drug
DDI-DrugBank.d453.s1|0-4|Drugs|drug
DDI-DrugBank.d453.s1|6-10|which|drug
DDI-DrugBank.d453.s1|12-17|impair|drug
DDI-DrugBank.d453.s1|19-28|glomerular|drug
DDI-DrugBank.d453.s1|30-39|filtration|drug
DDI-DrugBank.d453.s1|41-43|may|drug
DDI-DrugBank.d453.s1|45-51|prolong|drug
DDI-DrugBank.d453.s1|53-55|the|drug
DDI-DrugBank.d453.s1|57-66|biological|drug
DDI-DrugBank.d453.s1|68-76|half-life|drug
DDI-DrugBank.d453.s1|78-79|of|drug
DDI-DrugBank.d453.s1|81-91|flucytosine|drug
DDI-DrugBank.d453.s1|92-92|.|drug
DDI-DrugBank.d453.s2|0-14|Drug/Laboratory|drug
DDI-DrugBank.d453.s2|16-19|Test|drug
DDI-DrugBank.d453.s2|21-32|Interactions|drug
DDI-DrugBank.d453.s2|33-33|:|drug
DDI-DrugBank.d453.s2|35-45|Measurement|drug
DDI-DrugBank.d453.s2|47-48|of|drug
DDI-DrugBank.d453.s2|50-54|serum|drug
DDI-DrugBank.d453.s2|56-65|creatinine|drug
DDI-DrugBank.d453.s2|67-72|levels|drug
DDI-DrugBank.d453.s2|74-79|should|drug
DDI-DrugBank.d453.s2|81-82|be|drug
DDI-DrugBank.d453.s2|84-93|determined|drug
DDI-DrugBank.d453.s2|95-96|by|drug
DDI-DrugBank.d453.s2|98-100|the|drug
DDI-DrugBank.d453.s2|102-106|Jaffe|drug
DDI-DrugBank.d453.s2|108-115|reaction|drug
DDI-DrugBank.d453.s2|116-116|,|drug
DDI-DrugBank.d453.s2|118-122|since|drug
DDI-DrugBank.d453.s2|124-130|Ancobon|drug
DDI-DrugBank.d453.s2|132-135|does|drug
DDI-DrugBank.d453.s2|137-139|not|drug
DDI-DrugBank.d453.s2|141-149|interfere|drug
DDI-DrugBank.d453.s2|151-154|with|drug
DDI-DrugBank.d453.s2|156-158|the|drug
DDI-DrugBank.d453.s2|160-172|determination|drug
DDI-DrugBank.d453.s2|174-175|of|drug
DDI-DrugBank.d453.s2|177-186|creatinine|drug
DDI-DrugBank.d453.s2|188-193|values|drug
DDI-DrugBank.d453.s2|195-196|by|drug
DDI-DrugBank.d453.s2|198-201|this|drug
DDI-DrugBank.d453.s2|203-208|method|drug
DDI-DrugBank.d453.s2|209-209|.|drug
DDI-DrugBank.d453.s3|0-3|Most|drug
DDI-DrugBank.d453.s3|5-13|automated|drug
DDI-DrugBank.d453.s3|15-23|equipment|drug
DDI-DrugBank.d453.s3|25-27|for|drug
DDI-DrugBank.d453.s3|29-39|measurement|drug
DDI-DrugBank.d453.s3|41-42|of|drug
DDI-DrugBank.d453.s3|44-53|creatinine|drug
DDI-DrugBank.d453.s3|55-59|makes|drug
DDI-DrugBank.d453.s3|61-63|use|drug
DDI-DrugBank.d453.s3|65-66|of|drug
DDI-DrugBank.d453.s3|68-70|the|drug
DDI-DrugBank.d453.s3|72-76|Jaffe|drug
DDI-DrugBank.d453.s3|78-85|reaction|drug
DDI-DrugBank.d453.s3|86-86|.|drug
DDI-DrugBank.d356.s0|0-3|When|drug
DDI-DrugBank.d356.s0|5-13|amiloride|drug
DDI-DrugBank.d356.s0|15-17|HCl|drug
DDI-DrugBank.d356.s0|19-20|is|drug
DDI-DrugBank.d356.s0|22-33|administered|drug
DDI-DrugBank.d356.s0|35-47|concomitantly|drug
DDI-DrugBank.d356.s0|49-52|with|drug
DDI-DrugBank.d356.s0|54-55|an|drug
DDI-DrugBank.d356.s0|57-78|angiotensin-converting|drug
DDI-DrugBank.d356.s0|80-85|enzyme|drug
DDI-DrugBank.d356.s0|87-95|inhibitor|drug
DDI-DrugBank.d356.s0|96-96|,|drug
DDI-DrugBank.d356.s0|98-100|the|drug
DDI-DrugBank.d356.s0|102-105|risk|drug
DDI-DrugBank.d356.s0|107-108|of|drug
DDI-DrugBank.d356.s0|110-121|hyperkalemia|drug
DDI-DrugBank.d356.s0|123-125|may|drug
DDI-DrugBank.d356.s0|127-128|be|drug
DDI-DrugBank.d356.s0|130-138|increased|drug
DDI-DrugBank.d356.s0|139-139|.|drug
DDI-DrugBank.d356.s1|0-8|Therefore|drug
DDI-DrugBank.d356.s1|9-9|,|drug
DDI-DrugBank.d356.s1|11-12|if|drug
DDI-DrugBank.d356.s1|14-24|concomitant|drug
DDI-DrugBank.d356.s1|26-28|use|drug
DDI-DrugBank.d356.s1|30-31|of|drug
DDI-DrugBank.d356.s1|33-37|these|drug
DDI-DrugBank.d356.s1|39-44|agents|drug
DDI-DrugBank.d356.s1|46-47|is|drug
DDI-DrugBank.d356.s1|49-57|indicated|drug
DDI-DrugBank.d356.s1|59-65|because|drug
DDI-DrugBank.d356.s1|67-68|of|drug
DDI-DrugBank.d356.s1|70-81|demonstrated|drug
DDI-DrugBank.d356.s1|83-93|hypokalemia|drug
DDI-DrugBank.d356.s1|94-94|,|drug
DDI-DrugBank.d356.s1|96-99|they|drug
DDI-DrugBank.d356.s1|101-106|should|drug
DDI-DrugBank.d356.s1|108-109|be|drug
DDI-DrugBank.d356.s1|111-114|used|drug
DDI-DrugBank.d356.s1|116-119|with|drug
DDI-DrugBank.d356.s1|121-127|caution|drug
DDI-DrugBank.d356.s1|129-131|and|drug
DDI-DrugBank.d356.s1|133-136|with|drug
DDI-DrugBank.d356.s1|138-145|frequent|drug
DDI-DrugBank.d356.s1|147-156|monitoring|drug
DDI-DrugBank.d356.s1|158-159|of|drug
DDI-DrugBank.d356.s1|161-165|serum|drug
DDI-DrugBank.d356.s1|167-175|potassium|drug
DDI-DrugBank.d356.s1|176-176|.|drug
DDI-DrugBank.d356.s2|0-6|Lithium|drug
DDI-DrugBank.d356.s2|8-16|generally|drug
DDI-DrugBank.d356.s2|18-23|should|drug
DDI-DrugBank.d356.s2|25-27|not|drug
DDI-DrugBank.d356.s2|29-30|be|drug
DDI-DrugBank.d356.s2|32-36|given|drug
DDI-DrugBank.d356.s2|38-41|with|drug
DDI-DrugBank.d356.s2|43-51|diuretics|drug
DDI-DrugBank.d356.s2|53-59|because|drug
DDI-DrugBank.d356.s2|61-64|they|drug
DDI-DrugBank.d356.s2|66-71|reduce|drug
DDI-DrugBank.d356.s2|73-75|its|drug
DDI-DrugBank.d356.s2|77-81|renal|drug
DDI-DrugBank.d356.s2|83-91|clearance|drug
DDI-DrugBank.d356.s2|93-95|and|drug
DDI-DrugBank.d356.s2|97-99|add|drug
DDI-DrugBank.d356.s2|101-101|a|drug
DDI-DrugBank.d356.s2|103-106|high|drug
DDI-DrugBank.d356.s2|108-111|risk|drug
DDI-DrugBank.d356.s2|113-114|of|drug
DDI-DrugBank.d356.s2|116-122|lithium|drug
DDI-DrugBank.d356.s2|124-131|toxicity|drug
DDI-DrugBank.d356.s2|132-132|.|drug
DDI-DrugBank.d356.s3|0-3|Read|drug
DDI-DrugBank.d356.s3|5-13|circulars|drug
DDI-DrugBank.d356.s3|15-17|for|drug
DDI-DrugBank.d356.s3|19-25|lithium|drug
DDI-DrugBank.d356.s3|27-38|preparations|drug
DDI-DrugBank.d356.s3|40-45|before|drug
DDI-DrugBank.d356.s3|47-49|use|drug
DDI-DrugBank.d356.s3|51-52|of|drug
DDI-DrugBank.d356.s3|54-57|such|drug
DDI-DrugBank.d356.s3|59-69|concomitant|drug
DDI-DrugBank.d356.s3|71-77|therapy|drug
DDI-DrugBank.d356.s3|78-78|.|drug
DDI-DrugBank.d356.s4|0-1|In|drug
DDI-DrugBank.d356.s4|3-6|some|drug
DDI-DrugBank.d356.s4|8-15|patients|drug
DDI-DrugBank.d356.s4|16-16|,|drug
DDI-DrugBank.d356.s4|18-20|the|drug
DDI-DrugBank.d356.s4|22-35|administration|drug
DDI-DrugBank.d356.s4|37-38|of|drug
DDI-DrugBank.d356.s4|40-40|a|drug
DDI-DrugBank.d356.s4|42-54|non-steroidal|drug
DDI-DrugBank.d356.s4|56-72|anti-inflammatory|drug
DDI-DrugBank.d356.s4|74-78|agent|drug
DDI-DrugBank.d356.s4|80-82|can|drug
DDI-DrugBank.d356.s4|84-89|reduce|drug
DDI-DrugBank.d356.s4|91-93|the|drug
DDI-DrugBank.d356.s4|95-102|diuretic|drug
DDI-DrugBank.d356.s4|103-103|,|drug
DDI-DrugBank.d356.s4|105-115|natriuretic|drug
DDI-DrugBank.d356.s4|116-116|,|drug
DDI-DrugBank.d356.s4|118-120|and|drug
DDI-DrugBank.d356.s4|122-137|antihypertensive|drug
DDI-DrugBank.d356.s4|139-145|effects|drug
DDI-DrugBank.d356.s4|147-148|of|drug
DDI-DrugBank.d356.s4|150-153|loop|drug
DDI-DrugBank.d356.s4|154-154|,|drug
DDI-DrugBank.d356.s4|156-172|potassium-sparing|drug
DDI-DrugBank.d356.s4|174-176|and|drug
DDI-DrugBank.d356.s4|178-185|thiazide|drug
DDI-DrugBank.d356.s4|187-195|diuretics|drug
DDI-DrugBank.d356.s4|196-196|.|drug
DDI-DrugBank.d356.s5|0-8|Therefore|drug
DDI-DrugBank.d356.s5|9-9|,|drug
DDI-DrugBank.d356.s5|11-14|when|drug
DDI-DrugBank.d356.s5|16-22|MIDAMOR|drug
DDI-DrugBank.d356.s5|24-26|and|drug
DDI-DrugBank.d356.s5|28-40|non-steroidal|drug
DDI-DrugBank.d356.s5|42-58|anti-inflammatory|drug
DDI-DrugBank.d356.s5|60-65|agents|drug
DDI-DrugBank.d356.s5|67-69|are|drug
DDI-DrugBank.d356.s5|71-74|used|drug
DDI-DrugBank.d356.s5|76-88|concomitantly|drug
DDI-DrugBank.d356.s5|89-89|,|drug
DDI-DrugBank.d356.s5|91-93|the|drug
DDI-DrugBank.d356.s5|95-101|patient|drug
DDI-DrugBank.d356.s5|103-108|should|drug
DDI-DrugBank.d356.s5|110-111|be|drug
DDI-DrugBank.d356.s5|113-120|observed|drug
DDI-DrugBank.d356.s5|122-128|closely|drug
DDI-DrugBank.d356.s5|130-131|to|drug
DDI-DrugBank.d356.s5|133-141|determine|drug
DDI-DrugBank.d356.s5|143-144|if|drug
DDI-DrugBank.d356.s5|146-148|the|drug
DDI-DrugBank.d356.s5|150-156|desired|drug
DDI-DrugBank.d356.s5|158-163|effect|drug
DDI-DrugBank.d356.s5|165-166|of|drug
DDI-DrugBank.d356.s5|168-170|the|drug
DDI-DrugBank.d356.s5|172-179|diuretic|drug
DDI-DrugBank.d356.s5|181-182|is|drug
DDI-DrugBank.d356.s5|184-191|obtained|drug
DDI-DrugBank.d356.s5|192-192|.|drug
DDI-DrugBank.d356.s6|0-4|Since|drug
DDI-DrugBank.d356.s6|6-17|indomethacin|drug
DDI-DrugBank.d356.s6|19-21|and|drug
DDI-DrugBank.d356.s6|23-39|potassium-sparing|drug
DDI-DrugBank.d356.s6|41-49|diuretics|drug
DDI-DrugBank.d356.s6|50-50|,|drug
DDI-DrugBank.d356.s6|52-60|including|drug
DDI-DrugBank.d356.s6|62-68|MIDAMOR|drug
DDI-DrugBank.d356.s6|69-69|,|drug
DDI-DrugBank.d356.s6|71-73|may|drug
DDI-DrugBank.d356.s6|75-78|each|drug
DDI-DrugBank.d356.s6|80-81|be|drug
DDI-DrugBank.d356.s6|83-92|associated|drug
DDI-DrugBank.d356.s6|94-97|with|drug
DDI-DrugBank.d356.s6|99-107|increased|drug
DDI-DrugBank.d356.s6|109-113|serum|drug
DDI-DrugBank.d356.s6|115-123|potassium|drug
DDI-DrugBank.d356.s6|125-130|levels|drug
DDI-DrugBank.d356.s6|131-131|,|drug
DDI-DrugBank.d356.s6|133-135|the|drug
DDI-DrugBank.d356.s6|137-145|potential|drug
DDI-DrugBank.d356.s6|147-153|effects|drug
DDI-DrugBank.d356.s6|155-156|on|drug
DDI-DrugBank.d356.s6|158-166|potassium|drug
DDI-DrugBank.d356.s6|168-175|kinetics|drug
DDI-DrugBank.d356.s6|177-179|and|drug
DDI-DrugBank.d356.s6|181-185|renal|drug
DDI-DrugBank.d356.s6|187-194|function|drug
DDI-DrugBank.d356.s6|196-201|should|drug
DDI-DrugBank.d356.s6|203-204|be|drug
DDI-DrugBank.d356.s6|206-215|considered|drug
DDI-DrugBank.d356.s6|217-220|when|drug
DDI-DrugBank.d356.s6|222-226|these|drug
DDI-DrugBank.d356.s6|228-233|agents|drug
DDI-DrugBank.d356.s6|235-237|are|drug
DDI-DrugBank.d356.s6|239-250|administered|drug
DDI-DrugBank.d356.s6|252-263|concurrently|drug
DDI-DrugBank.d356.s6|264-264|.|drug
DDI-DrugBank.d189.s0|0-1|No|drug
DDI-DrugBank.d189.s0|3-11|Important|drug
DDI-DrugBank.d189.s0|13-24|Interactions|drug
DDI-DrugBank.d189.s0|26-27|To|drug
DDI-DrugBank.d189.s0|29-32|Date|drug
DDI-DrugBank.d189.s0|34-45|Levosimendan|drug
DDI-DrugBank.d189.s0|47-50|does|drug
DDI-DrugBank.d189.s0|52-54|not|drug
DDI-DrugBank.d189.s0|56-59|have|drug
DDI-DrugBank.d189.s0|61-70|clinically|drug
DDI-DrugBank.d189.s0|72-80|important|drug
DDI-DrugBank.d189.s0|82-96|pharmacokinetic|drug
DDI-DrugBank.d189.s0|98-109|interactions|drug
DDI-DrugBank.d189.s0|111-114|with|drug
DDI-DrugBank.d189.s0|116-124|captopril|drug
DDI-DrugBank.d189.s0|125-125|,|drug
DDI-DrugBank.d189.s0|127-139|beta-blockers|drug
DDI-DrugBank.d189.s0|140-140|,|drug
DDI-DrugBank.d189.s0|142-151|felodipine|drug
DDI-DrugBank.d189.s0|152-152|,|drug
DDI-DrugBank.d189.s0|154-160|digoxin|drug
DDI-DrugBank.d189.s0|161-161|,|drug
DDI-DrugBank.d189.s0|163-170|warfarin|drug
DDI-DrugBank.d189.s0|171-171|,|drug
DDI-DrugBank.d189.s0|173-182|isosorbide|drug
DDI-DrugBank.d189.s0|184-194|mononitrate|drug
DDI-DrugBank.d189.s0|195-195|,|drug
DDI-DrugBank.d189.s0|197-206|carvedilol|drug
DDI-DrugBank.d189.s0|207-207|,|drug
DDI-DrugBank.d189.s0|209-215|ethanol|drug
DDI-DrugBank.d189.s0|217-218|or|drug
DDI-DrugBank.d189.s0|220-231|itraconazole|drug
DDI-DrugBank.d189.s0|232-232|.|drug
DDI-DrugBank.d121.s0|0-13|Nephrotoxicity|drug
DDI-DrugBank.d121.s0|15-17|has|drug
DDI-DrugBank.d121.s0|19-22|been|drug
DDI-DrugBank.d121.s0|24-31|reported|drug
DDI-DrugBank.d121.s0|33-41|following|drug
DDI-DrugBank.d121.s0|43-53|concomitant|drug
DDI-DrugBank.d121.s0|55-68|administration|drug
DDI-DrugBank.d121.s0|70-71|of|drug
DDI-DrugBank.d121.s0|73-86|aminoglycoside|drug
DDI-DrugBank.d121.s0|88-98|antibiotics|drug
DDI-DrugBank.d121.s0|100-102|and|drug
DDI-DrugBank.d121.s0|104-116|cephalosporin|drug
DDI-DrugBank.d121.s0|118-128|antibiotics|drug
DDI-DrugBank.d121.s0|129-129|.|drug
DDI-DrugBank.d121.s1|0-10|Concomitant|drug
DDI-DrugBank.d121.s1|12-25|administration|drug
DDI-DrugBank.d121.s1|27-28|of|drug
DDI-DrugBank.d121.s1|30-39|probenecid|drug
DDI-DrugBank.d121.s1|41-47|doubled|drug
DDI-DrugBank.d121.s1|49-51|the|drug
DDI-DrugBank.d121.s1|53-55|AUC|drug
DDI-DrugBank.d121.s1|57-59|for|drug
DDI-DrugBank.d121.s1|61-69|cefprozil|drug
DDI-DrugBank.d121.s1|70-70|.|drug
DDI-DrugBank.d121.s2|0-2|The|drug
DDI-DrugBank.d121.s2|4-18|bioavailability|drug
DDI-DrugBank.d121.s2|20-21|of|drug
DDI-DrugBank.d121.s2|23-25|the|drug
DDI-DrugBank.d121.s2|27-33|capsule|drug
DDI-DrugBank.d121.s2|35-45|formulation|drug
DDI-DrugBank.d121.s2|47-48|of|drug
DDI-DrugBank.d121.s2|50-58|cefprozil|drug
DDI-DrugBank.d121.s2|60-62|was|drug
DDI-DrugBank.d121.s2|64-66|not|drug
DDI-DrugBank.d121.s2|68-75|affected|drug
DDI-DrugBank.d121.s2|77-80|when|drug
DDI-DrugBank.d121.s2|82-93|administered|drug
DDI-DrugBank.d121.s2|95-95|5|drug
DDI-DrugBank.d121.s2|97-103|minutes|drug
DDI-DrugBank.d121.s2|105-113|following|drug
DDI-DrugBank.d121.s2|115-116|an|drug
DDI-DrugBank.d121.s2|118-124|antacid|drug
DDI-DrugBank.d121.s2|125-125|.|drug
DDI-DrugBank.d231.s0|0-9|Furosemide|drug
DDI-DrugBank.d231.s0|11-13|may|drug
DDI-DrugBank.d231.s0|15-22|increase|drug
DDI-DrugBank.d231.s0|24-26|the|drug
DDI-DrugBank.d231.s0|28-35|ototoxic|drug
DDI-DrugBank.d231.s0|37-45|potential|drug
DDI-DrugBank.d231.s0|47-48|of|drug
DDI-DrugBank.d231.s0|50-63|aminoglycoside|drug
DDI-DrugBank.d231.s0|65-75|antibiotics|drug
DDI-DrugBank.d231.s0|76-76|,|drug
DDI-DrugBank.d231.s0|78-87|especially|drug
DDI-DrugBank.d231.s0|89-90|in|drug
DDI-DrugBank.d231.s0|92-94|the|drug
DDI-DrugBank.d231.s0|96-103|presence|drug
DDI-DrugBank.d231.s0|105-106|of|drug
DDI-DrugBank.d231.s0|108-115|impaired|drug
DDI-DrugBank.d231.s0|117-121|renal|drug
DDI-DrugBank.d231.s0|123-130|function|drug
DDI-DrugBank.d231.s0|131-131|.|drug
DDI-DrugBank.d231.s1|0-5|Except|drug
DDI-DrugBank.d231.s1|7-8|in|drug
DDI-DrugBank.d231.s1|10-25|life-threatening|drug
DDI-DrugBank.d231.s1|27-36|situations|drug
DDI-DrugBank.d231.s1|37-37|,|drug
DDI-DrugBank.d231.s1|39-43|avoid|drug
DDI-DrugBank.d231.s1|45-48|this|drug
DDI-DrugBank.d231.s1|50-60|combination|drug
DDI-DrugBank.d231.s1|61-61|.|drug
DDI-DrugBank.d231.s2|0-9|Furosemide|drug
DDI-DrugBank.d231.s2|11-16|should|drug
DDI-DrugBank.d231.s2|18-20|not|drug
DDI-DrugBank.d231.s2|22-23|be|drug
DDI-DrugBank.d231.s2|25-28|used|drug
DDI-DrugBank.d231.s2|30-42|concomitantly|drug
DDI-DrugBank.d231.s2|44-47|with|drug
DDI-DrugBank.d231.s2|49-58|ethacrynic|drug
DDI-DrugBank.d231.s2|60-63|acid|drug
DDI-DrugBank.d231.s2|65-71|because|drug
DDI-DrugBank.d231.s2|73-74|of|drug
DDI-DrugBank.d231.s2|76-78|the|drug
DDI-DrugBank.d231.s2|80-90|possibility|drug
DDI-DrugBank.d231.s2|92-93|of|drug
DDI-DrugBank.d231.s2|95-105|ototoxicity|drug
DDI-DrugBank.d231.s2|106-106|.|drug
DDI-DrugBank.d231.s3|0-7|Patients|drug
DDI-DrugBank.d231.s3|9-17|receiving|drug
DDI-DrugBank.d231.s3|19-22|high|drug
DDI-DrugBank.d231.s3|24-28|doses|drug
DDI-DrugBank.d231.s3|30-31|of|drug
DDI-DrugBank.d231.s3|33-43|salicylates|drug
DDI-DrugBank.d231.s3|45-57|concomitantly|drug
DDI-DrugBank.d231.s3|59-62|with|drug
DDI-DrugBank.d231.s3|64-73|furosemide|drug
DDI-DrugBank.d231.s3|74-74|,|drug
DDI-DrugBank.d231.s3|76-77|as|drug
DDI-DrugBank.d231.s3|79-80|in|drug
DDI-DrugBank.d231.s3|82-90|rheumatic|drug
DDI-DrugBank.d231.s3|92-98|disease|drug
DDI-DrugBank.d231.s3|99-99|,|drug
DDI-DrugBank.d231.s3|101-103|may|drug
DDI-DrugBank.d231.s3|105-114|experience|drug
DDI-DrugBank.d231.s3|116-125|salicylate|drug
DDI-DrugBank.d231.s3|127-134|toxicity|drug
DDI-DrugBank.d231.s3|136-137|at|drug
DDI-DrugBank.d231.s3|139-143|lower|drug
DDI-DrugBank.d231.s3|145-149|doses|drug
DDI-DrugBank.d231.s3|151-157|because|drug
DDI-DrugBank.d231.s3|159-160|of|drug
DDI-DrugBank.d231.s3|162-172|competitive|drug
DDI-DrugBank.d231.s3|174-178|renal|drug
DDI-DrugBank.d231.s3|180-188|excretory|drug
DDI-DrugBank.d231.s3|190-194|sites|drug
DDI-DrugBank.d231.s3|195-195|.|drug
DDI-DrugBank.d231.s4|0-9|Furosemide|drug
DDI-DrugBank.d231.s4|11-13|has|drug
DDI-DrugBank.d231.s4|15-15|a|drug
DDI-DrugBank.d231.s4|17-24|tendency|drug
DDI-DrugBank.d231.s4|26-27|to|drug
DDI-DrugBank.d231.s4|29-38|antagonize|drug
DDI-DrugBank.d231.s4|40-42|the|drug
DDI-DrugBank.d231.s4|44-51|skeletal|drug
DDI-DrugBank.d231.s4|53-58|muscle|drug
DDI-DrugBank.d231.s4|60-67|relaxing|drug
DDI-DrugBank.d231.s4|69-74|effect|drug
DDI-DrugBank.d231.s4|76-77|of|drug
DDI-DrugBank.d231.s4|79-90|tubocurarine|drug
DDI-DrugBank.d231.s4|92-94|and|drug
DDI-DrugBank.d231.s4|96-98|may|drug
DDI-DrugBank.d231.s4|100-109|potentiate|drug
DDI-DrugBank.d231.s4|111-113|the|drug
DDI-DrugBank.d231.s4|115-120|action|drug
DDI-DrugBank.d231.s4|122-123|of|drug
DDI-DrugBank.d231.s4|125-139|succinylcholine|drug
DDI-DrugBank.d231.s4|140-140|.|drug
DDI-DrugBank.d231.s5|0-6|Lithium|drug
DDI-DrugBank.d231.s5|8-16|generally|drug
DDI-DrugBank.d231.s5|18-23|should|drug
DDI-DrugBank.d231.s5|25-27|not|drug
DDI-DrugBank.d231.s5|29-30|be|drug
DDI-DrugBank.d231.s5|32-36|given|drug
DDI-DrugBank.d231.s5|38-41|with|drug
DDI-DrugBank.d231.s5|43-51|diuretics|drug
DDI-DrugBank.d231.s5|53-59|because|drug
DDI-DrugBank.d231.s5|61-64|they|drug
DDI-DrugBank.d231.s5|66-71|reduce|drug
DDI-DrugBank.d231.s5|73-80|lithiums|drug
DDI-DrugBank.d231.s5|82-86|renal|drug
DDI-DrugBank.d231.s5|88-96|clearance|drug
DDI-DrugBank.d231.s5|98-100|and|drug
DDI-DrugBank.d231.s5|102-104|add|drug
DDI-DrugBank.d231.s5|106-106|a|drug
DDI-DrugBank.d231.s5|108-111|high|drug
DDI-DrugBank.d231.s5|113-116|risk|drug
DDI-DrugBank.d231.s5|118-119|of|drug
DDI-DrugBank.d231.s5|121-127|lithium|drug
DDI-DrugBank.d231.s5|129-136|toxicity|drug
DDI-DrugBank.d231.s5|137-137|.|drug
DDI-DrugBank.d231.s6|0-9|Furosemide|drug
DDI-DrugBank.d231.s6|11-13|may|drug
DDI-DrugBank.d231.s6|15-17|add|drug
DDI-DrugBank.d231.s6|19-20|to|drug
DDI-DrugBank.d231.s6|22-23|or|drug
DDI-DrugBank.d231.s6|25-34|potentiate|drug
DDI-DrugBank.d231.s6|36-38|the|drug
DDI-DrugBank.d231.s6|40-50|therapeutic|drug
DDI-DrugBank.d231.s6|52-57|effect|drug
DDI-DrugBank.d231.s6|59-60|of|drug
DDI-DrugBank.d231.s6|62-66|other|drug
DDI-DrugBank.d231.s6|68-83|antihypertensive|drug
DDI-DrugBank.d231.s6|85-89|drugs|drug
DDI-DrugBank.d231.s6|90-90|.|drug
DDI-DrugBank.d231.s7|0-11|Potentiation|drug
DDI-DrugBank.d231.s7|13-18|occurs|drug
DDI-DrugBank.d231.s7|20-23|with|drug
DDI-DrugBank.d231.s7|25-34|ganglionic|drug
DDI-DrugBank.d231.s7|36-37|or|drug
DDI-DrugBank.d231.s7|39-48|peripheral|drug
DDI-DrugBank.d231.s7|50-59|adrenergic|drug
DDI-DrugBank.d231.s7|61-68|blocking|drug
DDI-DrugBank.d231.s7|70-74|drugs|drug
DDI-DrugBank.d231.s7|75-75|.|drug
DDI-DrugBank.d231.s8|0-9|Furosemide|drug
DDI-DrugBank.d231.s8|11-13|may|drug
DDI-DrugBank.d231.s8|15-22|decrease|drug
DDI-DrugBank.d231.s8|24-31|arterial|drug
DDI-DrugBank.d231.s8|33-46|responsiveness|drug
DDI-DrugBank.d231.s8|48-49|to|drug
DDI-DrugBank.d231.s8|51-64|norepinephrine|drug
DDI-DrugBank.d231.s8|65-65|.|drug
DDI-DrugBank.d231.s9|0-6|However|drug
DDI-DrugBank.d231.s9|7-7|,|drug
DDI-DrugBank.d231.s9|9-22|norepinephrine|drug
DDI-DrugBank.d231.s9|24-26|may|drug
DDI-DrugBank.d231.s9|28-32|still|drug
DDI-DrugBank.d231.s9|34-35|be|drug
DDI-DrugBank.d231.s9|37-40|used|drug
DDI-DrugBank.d231.s9|42-52|effectively|drug
DDI-DrugBank.d231.s9|53-53|.|drug
DDI-DrugBank.d231.s10|0-6|Tablets|drug
DDI-DrugBank.d231.s10|8-19|Simultaneous|drug
DDI-DrugBank.d231.s10|21-34|administration|drug
DDI-DrugBank.d231.s10|36-37|of|drug
DDI-DrugBank.d231.s10|39-48|sucralfate|drug
DDI-DrugBank.d231.s10|50-52|and|drug
DDI-DrugBank.d231.s10|54-63|furosemide|drug
DDI-DrugBank.d231.s10|65-71|tablets|drug
DDI-DrugBank.d231.s10|73-75|may|drug
DDI-DrugBank.d231.s10|77-82|reduce|drug
DDI-DrugBank.d231.s10|84-86|the|drug
DDI-DrugBank.d231.s10|88-98|natriuretic|drug
DDI-DrugBank.d231.s10|100-102|and|drug
DDI-DrugBank.d231.s10|104-119|antihypertensive|drug
DDI-DrugBank.d231.s10|121-127|effects|drug
DDI-DrugBank.d231.s10|129-130|of|drug
DDI-DrugBank.d231.s10|132-141|furosemide|drug
DDI-DrugBank.d231.s10|142-142|.|drug
DDI-DrugBank.d231.s11|0-7|Patients|drug
DDI-DrugBank.d231.s11|9-17|receiving|drug
DDI-DrugBank.d231.s11|19-22|both|drug
DDI-DrugBank.d231.s11|24-28|drugs|drug
DDI-DrugBank.d231.s11|30-35|should|drug
DDI-DrugBank.d231.s11|37-38|be|drug
DDI-DrugBank.d231.s11|40-47|observed|drug
DDI-DrugBank.d231.s11|49-55|closely|drug
DDI-DrugBank.d231.s11|57-58|to|drug
DDI-DrugBank.d231.s11|60-68|determine|drug
DDI-DrugBank.d231.s11|70-71|if|drug
DDI-DrugBank.d231.s11|73-75|the|drug
DDI-DrugBank.d231.s11|77-83|desired|drug
DDI-DrugBank.d231.s11|85-92|diuretic|drug
DDI-DrugBank.d231.s11|94-99|and/or|drug
DDI-DrugBank.d231.s11|101-116|antihypertensive|drug
DDI-DrugBank.d231.s11|118-123|effect|drug
DDI-DrugBank.d231.s11|125-126|of|drug
DDI-DrugBank.d231.s11|128-137|furosemide|drug
DDI-DrugBank.d231.s11|139-140|is|drug
DDI-DrugBank.d231.s11|142-149|achieved|drug
DDI-DrugBank.d231.s11|150-150|.|drug
DDI-DrugBank.d231.s12|0-2|The|drug
DDI-DrugBank.d231.s12|4-9|intake|drug
DDI-DrugBank.d231.s12|11-12|of|drug
DDI-DrugBank.d231.s12|14-23|furosemide|drug
DDI-DrugBank.d231.s12|25-27|and|drug
DDI-DrugBank.d231.s12|29-38|sucralfate|drug
DDI-DrugBank.d231.s12|40-45|should|drug
DDI-DrugBank.d231.s12|47-48|be|drug
DDI-DrugBank.d231.s12|50-58|separated|drug
DDI-DrugBank.d231.s12|60-61|by|drug
DDI-DrugBank.d231.s12|63-64|at|drug
DDI-DrugBank.d231.s12|66-70|least|drug
DDI-DrugBank.d231.s12|72-74|two|drug
DDI-DrugBank.d231.s12|76-80|hours|drug
DDI-DrugBank.d231.s12|81-81|.|drug
DDI-DrugBank.d231.s13|0-6|Tablets|drug
DDI-DrugBank.d231.s13|7-7|,|drug
DDI-DrugBank.d231.s13|9-17|Injection|drug
DDI-DrugBank.d231.s13|18-18|,|drug
DDI-DrugBank.d231.s13|20-22|and|drug
DDI-DrugBank.d231.s13|24-27|Oral|drug
DDI-DrugBank.d231.s13|29-36|Solution|drug
DDI-DrugBank.d231.s13|38-40|One|drug
DDI-DrugBank.d231.s13|42-46|study|drug
DDI-DrugBank.d231.s13|48-49|in|drug
DDI-DrugBank.d231.s13|51-53|six|drug
DDI-DrugBank.d231.s13|55-62|subjects|drug
DDI-DrugBank.d231.s13|64-75|demonstrated|drug
DDI-DrugBank.d231.s13|77-80|that|drug
DDI-DrugBank.d231.s13|82-84|the|drug
DDI-DrugBank.d231.s13|86-96|combination|drug
DDI-DrugBank.d231.s13|98-99|of|drug
DDI-DrugBank.d231.s13|101-110|furosemide|drug
DDI-DrugBank.d231.s13|112-114|and|drug
DDI-DrugBank.d231.s13|116-130|acetylsalicylic|drug
DDI-DrugBank.d231.s13|132-135|acid|drug
DDI-DrugBank.d231.s13|137-147|temporarily|drug
DDI-DrugBank.d231.s13|149-155|reduced|drug
DDI-DrugBank.d231.s13|157-166|creatinine|drug
DDI-DrugBank.d231.s13|168-176|clearance|drug
DDI-DrugBank.d231.s13|178-179|in|drug
DDI-DrugBank.d231.s13|181-188|patients|drug
DDI-DrugBank.d231.s13|190-193|with|drug
DDI-DrugBank.d231.s13|195-201|chronic|drug
DDI-DrugBank.d231.s13|203-207|renal|drug
DDI-DrugBank.d231.s13|209-221|insufficiency|drug
DDI-DrugBank.d231.s13|222-222|.|drug
DDI-DrugBank.d231.s14|0-4|There|drug
DDI-DrugBank.d231.s14|6-8|are|drug
DDI-DrugBank.d231.s14|10-13|case|drug
DDI-DrugBank.d231.s14|15-21|reports|drug
DDI-DrugBank.d231.s14|23-24|of|drug
DDI-DrugBank.d231.s14|26-33|patients|drug
DDI-DrugBank.d231.s14|35-37|who|drug
DDI-DrugBank.d231.s14|39-47|developed|drug
DDI-DrugBank.d231.s14|49-57|increased|drug
DDI-DrugBank.d231.s14|59-61|BUN|drug
DDI-DrugBank.d231.s14|62-62|,|drug
DDI-DrugBank.d231.s14|64-68|serum|drug
DDI-DrugBank.d231.s14|70-79|creatinine|drug
DDI-DrugBank.d231.s14|81-83|and|drug
DDI-DrugBank.d231.s14|85-89|serum|drug
DDI-DrugBank.d231.s14|91-99|potassium|drug
DDI-DrugBank.d231.s14|101-106|levels|drug
DDI-DrugBank.d231.s14|107-107|,|drug
DDI-DrugBank.d231.s14|109-111|and|drug
DDI-DrugBank.d231.s14|113-118|weight|drug
DDI-DrugBank.d231.s14|120-123|gain|drug
DDI-DrugBank.d231.s14|125-128|when|drug
DDI-DrugBank.d231.s14|130-139|furosemide|drug
DDI-DrugBank.d231.s14|141-143|was|drug
DDI-DrugBank.d231.s14|145-148|used|drug
DDI-DrugBank.d231.s14|150-151|in|drug
DDI-DrugBank.d231.s14|153-163|conjunction|drug
DDI-DrugBank.d231.s14|165-168|with|drug
DDI-DrugBank.d231.s14|170-175|NSAIDs|drug
DDI-DrugBank.d231.s14|176-176|.|drug
DDI-DrugBank.d231.s15|0-9|Literature|drug
DDI-DrugBank.d231.s15|11-17|reports|drug
DDI-DrugBank.d231.s15|19-26|indicate|drug
DDI-DrugBank.d231.s15|28-31|that|drug
DDI-DrugBank.d231.s15|33-48|coadministration|drug
DDI-DrugBank.d231.s15|50-51|of|drug
DDI-DrugBank.d231.s15|53-64|indomethacin|drug
DDI-DrugBank.d231.s15|66-68|may|drug
DDI-DrugBank.d231.s15|70-75|reduce|drug
DDI-DrugBank.d231.s15|77-79|the|drug
DDI-DrugBank.d231.s15|81-91|natriuretic|drug
DDI-DrugBank.d231.s15|93-95|and|drug
DDI-DrugBank.d231.s15|97-112|antihypertensive|drug
DDI-DrugBank.d231.s15|114-120|effects|drug
DDI-DrugBank.d231.s15|122-123|of|drug
DDI-DrugBank.d231.s15|125-134|furosemide|drug
DDI-DrugBank.d231.s15|136-137|in|drug
DDI-DrugBank.d231.s15|139-142|some|drug
DDI-DrugBank.d231.s15|144-151|patients|drug
DDI-DrugBank.d231.s15|153-154|by|drug
DDI-DrugBank.d231.s15|156-165|inhibiting|drug
DDI-DrugBank.d231.s15|167-179|prostaglandin|drug
DDI-DrugBank.d231.s15|181-189|synthesis|drug
DDI-DrugBank.d231.s15|190-190|.|drug
DDI-DrugBank.d231.s16|0-11|Indomethacin|drug
DDI-DrugBank.d231.s16|13-15|may|drug
DDI-DrugBank.d231.s16|17-20|also|drug
DDI-DrugBank.d231.s16|22-27|affect|drug
DDI-DrugBank.d231.s16|29-34|plasma|drug
DDI-DrugBank.d231.s16|36-40|renin|drug
DDI-DrugBank.d231.s16|42-47|levels|drug
DDI-DrugBank.d231.s16|48-48|,|drug
DDI-DrugBank.d231.s16|50-60|aldosterone|drug
DDI-DrugBank.d231.s16|62-70|excretion|drug
DDI-DrugBank.d231.s16|71-71|,|drug
DDI-DrugBank.d231.s16|73-75|and|drug
DDI-DrugBank.d231.s16|77-81|renin|drug
DDI-DrugBank.d231.s16|83-89|profile|drug
DDI-DrugBank.d231.s16|91-100|evaluation|drug
DDI-DrugBank.d231.s16|101-101|.|drug
DDI-DrugBank.d231.s17|0-7|Patients|drug
DDI-DrugBank.d231.s17|9-17|receiving|drug
DDI-DrugBank.d231.s17|19-22|both|drug
DDI-DrugBank.d231.s17|24-35|indomethacin|drug
DDI-DrugBank.d231.s17|37-39|and|drug
DDI-DrugBank.d231.s17|41-50|furosemide|drug
DDI-DrugBank.d231.s17|52-57|should|drug
DDI-DrugBank.d231.s17|59-60|be|drug
DDI-DrugBank.d231.s17|62-69|observed|drug
DDI-DrugBank.d231.s17|71-77|closely|drug
DDI-DrugBank.d231.s17|79-80|to|drug
DDI-DrugBank.d231.s17|82-90|determine|drug
DDI-DrugBank.d231.s17|92-93|if|drug
DDI-DrugBank.d231.s17|95-97|the|drug
DDI-DrugBank.d231.s17|99-105|desired|drug
DDI-DrugBank.d231.s17|107-114|diuretic|drug
DDI-DrugBank.d231.s17|116-121|and/or|drug
DDI-DrugBank.d231.s17|123-138|antihypertensive|drug
DDI-DrugBank.d231.s17|140-145|effect|drug
DDI-DrugBank.d231.s17|147-148|of|drug
DDI-DrugBank.d231.s17|150-159|furosemide|drug
DDI-DrugBank.d231.s17|161-162|is|drug
DDI-DrugBank.d231.s17|164-171|achieved|drug
DDI-DrugBank.d231.s17|172-172|.|drug
DDI-MedLine.d195.s0|0-8|Influence|drug
DDI-MedLine.d195.s0|10-11|of|drug
DDI-MedLine.d195.s0|13-20|piperine|drug
DDI-MedLine.d195.s0|22-23|on|drug
DDI-MedLine.d195.s0|25-33|ibuprofen|drug
DDI-MedLine.d195.s0|35-41|induced|drug
DDI-MedLine.d195.s0|43-57|antinociception|drug
DDI-MedLine.d195.s0|59-61|and|drug
DDI-MedLine.d195.s0|63-65|its|drug
DDI-MedLine.d195.s0|67-82|pharmacokinetics|drug
DDI-MedLine.d195.s0|83-83|.|drug
DDI-MedLine.d195.s1|0-7|Piperine|drug
DDI-MedLine.d195.s1|9-9|(|drug
DDI-MedLine.d195.s1|10-12|CAS|drug
DDI-MedLine.d195.s1|14-20|94-62-2|drug
DDI-MedLine.d195.s1|21-21|)|drug
DDI-MedLine.d195.s1|22-22|,|drug
DDI-MedLine.d195.s1|24-25|an|drug
DDI-MedLine.d195.s1|27-34|alkaloid|drug
DDI-MedLine.d195.s1|36-43|obtained|drug
DDI-MedLine.d195.s1|45-48|from|drug
DDI-MedLine.d195.s1|50-54|Piper|drug
DDI-MedLine.d195.s1|56-61|nigrum|drug
DDI-MedLine.d195.s1|63-65|and|drug
DDI-MedLine.d195.s1|67-67|P|drug
DDI-MedLine.d195.s1|68-68|.|drug
DDI-MedLine.d195.s2|0-5|longum|drug
DDI-MedLine.d195.s2|6-6|,|drug
DDI-MedLine.d195.s2|8-9|is|drug
DDI-MedLine.d195.s2|11-11|a|drug
DDI-MedLine.d195.s2|13-17|known|drug
DDI-MedLine.d195.s2|19-27|inhibitor|drug
DDI-MedLine.d195.s2|29-30|of|drug
DDI-MedLine.d195.s2|32-38|various|drug
DDI-MedLine.d195.s2|40-46|enzymes|drug
DDI-MedLine.d195.s2|48-48|(|drug
DDI-MedLine.d195.s2|49-51|CYP|drug
DDI-MedLine.d195.s2|53-60|isozymes|drug
DDI-MedLine.d195.s2|61-61|)|drug
DDI-MedLine.d195.s2|63-73|responsible|drug
DDI-MedLine.d195.s2|75-77|for|drug
DDI-MedLine.d195.s2|79-95|biotransformation|drug
DDI-MedLine.d195.s2|97-98|of|drug
DDI-MedLine.d195.s2|100-104|drugs|drug
DDI-MedLine.d195.s2|105-105|.|drug
DDI-MedLine.d195.s3|0-1|By|drug
DDI-MedLine.d195.s3|3-12|inhibiting|drug
DDI-MedLine.d195.s3|14-16|the|drug
DDI-MedLine.d195.s3|18-27|metabolism|drug
DDI-MedLine.d195.s3|29-30|of|drug
DDI-MedLine.d195.s3|32-36|drugs|drug
DDI-MedLine.d195.s3|37-37|,|drug
DDI-MedLine.d195.s3|39-46|piperine|drug
DDI-MedLine.d195.s3|48-55|improves|drug
DDI-MedLine.d195.s3|57-59|the|drug
DDI-MedLine.d195.s3|61-75|bioavailability|drug
DDI-MedLine.d195.s3|77-78|of|drug
DDI-MedLine.d195.s3|80-84|drugs|drug
DDI-MedLine.d195.s3|85-85|.|drug
DDI-MedLine.d195.s4|0-1|In|drug
DDI-MedLine.d195.s4|3-5|the|drug
DDI-MedLine.d195.s4|7-13|present|drug
DDI-MedLine.d195.s4|15-19|study|drug
DDI-MedLine.d195.s4|21-28|piperine|drug
DDI-MedLine.d195.s4|30-30|(|drug
DDI-MedLine.d195.s4|31-32|10|drug
DDI-MedLine.d195.s4|34-38|mg/kg|drug
DDI-MedLine.d195.s4|39-39|)|drug
DDI-MedLine.d195.s4|41-53|significantly|drug
DDI-MedLine.d195.s4|55-63|increased|drug
DDI-MedLine.d195.s4|65-67|the|drug
DDI-MedLine.d195.s4|69-82|dose-dependent|drug
DDI-MedLine.d195.s4|84-98|antinociceptive|drug
DDI-MedLine.d195.s4|100-107|activity|drug
DDI-MedLine.d195.s4|109-110|of|drug
DDI-MedLine.d195.s4|112-120|ibuprofen|drug
DDI-MedLine.d195.s4|122-130|evaluated|drug
DDI-MedLine.d195.s4|132-133|by|drug
DDI-MedLine.d195.s4|135-138|both|drug
DDI-MedLine.d195.s4|140-145|acetic|drug
DDI-MedLine.d195.s4|147-150|acid|drug
DDI-MedLine.d195.s4|152-159|writhing|drug
DDI-MedLine.d195.s4|161-163|and|drug
DDI-MedLine.d195.s4|165-172|formalin|drug
DDI-MedLine.d195.s4|174-177|test|drug
DDI-MedLine.d195.s4|178-178|,|drug
DDI-MedLine.d195.s4|180-183|when|drug
DDI-MedLine.d195.s4|185-186|it|drug
DDI-MedLine.d195.s4|188-190|was|drug
DDI-MedLine.d195.s4|192-203|administered|drug
DDI-MedLine.d195.s4|205-208|with|drug
DDI-MedLine.d195.s4|210-218|ibuprofen|drug
DDI-MedLine.d195.s4|219-219|.|drug
DDI-MedLine.d195.s5|0-8|Ibuprofen|drug
DDI-MedLine.d195.s5|10-15|plasma|drug
DDI-MedLine.d195.s5|17-29|concentration|drug
DDI-MedLine.d195.s5|31-33|was|drug
DDI-MedLine.d195.s5|35-38|also|drug
DDI-MedLine.d195.s5|40-48|increased|drug
DDI-MedLine.d195.s5|50-53|when|drug
DDI-MedLine.d195.s5|55-56|it|drug
DDI-MedLine.d195.s5|58-60|was|drug
DDI-MedLine.d195.s5|62-73|administered|drug
DDI-MedLine.d195.s5|75-78|with|drug
DDI-MedLine.d195.s5|80-87|piperine|drug
DDI-MedLine.d195.s5|88-88|.|drug
DDI-MedLine.d195.s6|0-2|The|drug
DDI-MedLine.d195.s6|4-14|synergistic|drug
DDI-MedLine.d195.s6|16-30|antinociception|drug
DDI-MedLine.d195.s6|32-39|activity|drug
DDI-MedLine.d195.s6|41-42|of|drug
DDI-MedLine.d195.s6|44-52|ibuprofen|drug
DDI-MedLine.d195.s6|54-57|when|drug
DDI-MedLine.d195.s6|59-70|administered|drug
DDI-MedLine.d195.s6|72-75|with|drug
DDI-MedLine.d195.s6|77-84|piperine|drug
DDI-MedLine.d195.s6|86-88|can|drug
DDI-MedLine.d195.s6|90-91|be|drug
DDI-MedLine.d195.s6|93-102|attributed|drug
DDI-MedLine.d195.s6|104-105|to|drug
DDI-MedLine.d195.s6|107-115|increased|drug
DDI-MedLine.d195.s6|117-122|plasma|drug
DDI-MedLine.d195.s6|124-136|concentration|drug
DDI-MedLine.d195.s6|138-139|of|drug
DDI-MedLine.d195.s6|141-149|ibuprofen|drug
DDI-MedLine.d195.s6|150-150|.|drug
DDI-MedLine.d195.s7|0-3|From|drug
DDI-MedLine.d195.s7|5-8|this|drug
DDI-MedLine.d195.s7|10-14|study|drug
DDI-MedLine.d195.s7|16-17|it|drug
DDI-MedLine.d195.s7|19-21|can|drug
DDI-MedLine.d195.s7|23-24|be|drug
DDI-MedLine.d195.s7|26-34|concluded|drug
DDI-MedLine.d195.s7|36-39|that|drug
DDI-MedLine.d195.s7|41-48|piperine|drug
DDI-MedLine.d195.s7|50-52|can|drug
DDI-MedLine.d195.s7|54-55|be|drug
DDI-MedLine.d195.s7|57-60|used|drug
DDI-MedLine.d195.s7|62-63|as|drug
DDI-MedLine.d195.s7|65-65|a|drug
DDI-MedLine.d195.s7|67-77|bioenhancer|drug
DDI-MedLine.d195.s7|79-83|along|drug
DDI-MedLine.d195.s7|85-88|with|drug
DDI-MedLine.d195.s7|90-98|ibuprofen|drug
DDI-MedLine.d195.s7|99-99|.|drug
DDI-DrugBank.d628.s0|0-2|The|drug
DDI-DrugBank.d628.s0|4-12|induction|drug
DDI-DrugBank.d628.s0|14-17|dose|drug
DDI-DrugBank.d628.s0|19-30|requirements|drug
DDI-DrugBank.d628.s0|32-33|of|drug
DDI-DrugBank.d628.s0|35-42|DIPRIVAN|drug
DDI-DrugBank.d628.s0|44-53|Injectable|drug
DDI-DrugBank.d628.s0|55-62|Emulsion|drug
DDI-DrugBank.d628.s0|64-66|may|drug
DDI-DrugBank.d628.s0|68-69|be|drug
DDI-DrugBank.d628.s0|71-77|reduced|drug
DDI-DrugBank.d628.s0|79-80|in|drug
DDI-DrugBank.d628.s0|82-89|patients|drug
DDI-DrugBank.d628.s0|91-94|with|drug
DDI-DrugBank.d628.s0|96-108|intramuscular|drug
DDI-DrugBank.d628.s0|110-111|or|drug
DDI-DrugBank.d628.s0|113-123|intravenous|drug
DDI-DrugBank.d628.s0|125-137|premedication|drug
DDI-DrugBank.d628.s0|138-138|,|drug
DDI-DrugBank.d628.s0|140-151|particularly|drug
DDI-DrugBank.d628.s0|153-156|with|drug
DDI-DrugBank.d628.s0|158-166|narcotics|drug
DDI-DrugBank.d628.s0|168-168|(|drug
DDI-DrugBank.d628.s0|169-170|eg|drug
DDI-DrugBank.d628.s0|171-171|,|drug
DDI-DrugBank.d628.s0|173-180|morphine|drug
DDI-DrugBank.d628.s0|181-181|,|drug
DDI-DrugBank.d628.s0|183-192|meperidine|drug
DDI-DrugBank.d628.s0|193-193|,|drug
DDI-DrugBank.d628.s0|195-197|and|drug
DDI-DrugBank.d628.s0|199-206|fentanyl|drug
DDI-DrugBank.d628.s0|207-207|,|drug
DDI-DrugBank.d628.s0|209-211|etc|drug
DDI-DrugBank.d628.s0|212-212|.|drug
DDI-DrugBank.d628.s0|213-213|)|drug
DDI-DrugBank.d628.s1|0-2|and|drug
DDI-DrugBank.d628.s1|4-15|combinations|drug
DDI-DrugBank.d628.s1|17-18|of|drug
DDI-DrugBank.d628.s1|20-26|opioids|drug
DDI-DrugBank.d628.s1|28-30|and|drug
DDI-DrugBank.d628.s1|32-40|sedatives|drug
DDI-DrugBank.d628.s1|42-42|(|drug
DDI-DrugBank.d628.s1|43-44|eg|drug
DDI-DrugBank.d628.s1|45-45|,|drug
DDI-DrugBank.d628.s1|47-61|benzodiazepines|drug
DDI-DrugBank.d628.s1|62-62|,|drug
DDI-DrugBank.d628.s1|64-75|barbiturates|drug
DDI-DrugBank.d628.s1|76-76|,|drug
DDI-DrugBank.d628.s1|78-84|chloral|drug
DDI-DrugBank.d628.s1|86-92|hydrate|drug
DDI-DrugBank.d628.s1|93-93|,|drug
DDI-DrugBank.d628.s1|95-104|droperidol|drug
DDI-DrugBank.d628.s1|105-105|,|drug
DDI-DrugBank.d628.s1|107-110|etc|drug
DDI-DrugBank.d628.s1|111-111|.|drug
DDI-DrugBank.d628.s1|112-112|)|drug
DDI-DrugBank.d628.s2|0-4|These|drug
DDI-DrugBank.d628.s2|6-11|agents|drug
DDI-DrugBank.d628.s2|13-15|may|drug
DDI-DrugBank.d628.s2|17-24|increase|drug
DDI-DrugBank.d628.s2|26-28|the|drug
DDI-DrugBank.d628.s2|30-39|anesthetic|drug
DDI-DrugBank.d628.s2|41-42|or|drug
DDI-DrugBank.d628.s2|44-51|sedative|drug
DDI-DrugBank.d628.s2|53-59|effects|drug
DDI-DrugBank.d628.s2|61-62|of|drug
DDI-DrugBank.d628.s2|64-71|DIPRIVAN|drug
DDI-DrugBank.d628.s2|73-82|Injectable|drug
DDI-DrugBank.d628.s2|84-91|Emulsion|drug
DDI-DrugBank.d628.s2|93-95|and|drug
DDI-DrugBank.d628.s2|97-99|may|drug
DDI-DrugBank.d628.s2|101-104|also|drug
DDI-DrugBank.d628.s2|106-111|result|drug
DDI-DrugBank.d628.s2|113-114|in|drug
DDI-DrugBank.d628.s2|116-119|more|drug
DDI-DrugBank.d628.s2|121-130|pronounced|drug
DDI-DrugBank.d628.s2|132-140|decreases|drug
DDI-DrugBank.d628.s2|142-143|in|drug
DDI-DrugBank.d628.s2|145-152|systolic|drug
DDI-DrugBank.d628.s2|153-153|,|drug
DDI-DrugBank.d628.s2|155-163|diastolic|drug
DDI-DrugBank.d628.s2|164-164|,|drug
DDI-DrugBank.d628.s2|166-168|and|drug
DDI-DrugBank.d628.s2|170-173|mean|drug
DDI-DrugBank.d628.s2|175-182|arterial|drug
DDI-DrugBank.d628.s2|184-192|pressures|drug
DDI-DrugBank.d628.s2|194-196|and|drug
DDI-DrugBank.d628.s2|198-204|cardiac|drug
DDI-DrugBank.d628.s2|206-211|output|drug
DDI-DrugBank.d628.s2|212-212|.|drug
DDI-DrugBank.d628.s3|0-5|During|drug
DDI-DrugBank.d628.s3|7-17|maintenance|drug
DDI-DrugBank.d628.s3|19-20|of|drug
DDI-DrugBank.d628.s3|22-31|anesthesia|drug
DDI-DrugBank.d628.s3|33-34|or|drug
DDI-DrugBank.d628.s3|36-43|sedation|drug
DDI-DrugBank.d628.s3|44-44|,|drug
DDI-DrugBank.d628.s3|46-48|the|drug
DDI-DrugBank.d628.s3|50-53|rate|drug
DDI-DrugBank.d628.s3|55-56|of|drug
DDI-DrugBank.d628.s3|58-65|DIPRIVAN|drug
DDI-DrugBank.d628.s3|67-76|Injectable|drug
DDI-DrugBank.d628.s3|78-85|Emulsion|drug
DDI-DrugBank.d628.s3|87-100|administration|drug
DDI-DrugBank.d628.s3|102-107|should|drug
DDI-DrugBank.d628.s3|109-110|be|drug
DDI-DrugBank.d628.s3|112-119|adjusted|drug
DDI-DrugBank.d628.s3|121-129|according|drug
DDI-DrugBank.d628.s3|131-132|to|drug
DDI-DrugBank.d628.s3|134-136|the|drug
DDI-DrugBank.d628.s3|138-144|desired|drug
DDI-DrugBank.d628.s3|146-150|level|drug
DDI-DrugBank.d628.s3|152-153|of|drug
DDI-DrugBank.d628.s3|155-164|anesthesia|drug
DDI-DrugBank.d628.s3|166-167|or|drug
DDI-DrugBank.d628.s3|169-176|sedation|drug
DDI-DrugBank.d628.s3|178-180|and|drug
DDI-DrugBank.d628.s3|182-184|may|drug
DDI-DrugBank.d628.s3|186-187|be|drug
DDI-DrugBank.d628.s3|189-195|reduced|drug
DDI-DrugBank.d628.s3|197-198|in|drug
DDI-DrugBank.d628.s3|200-202|the|drug
DDI-DrugBank.d628.s3|204-211|presence|drug
DDI-DrugBank.d628.s3|213-214|of|drug
DDI-DrugBank.d628.s3|216-227|supplemental|drug
DDI-DrugBank.d628.s3|229-237|analgesic|drug
DDI-DrugBank.d628.s3|239-244|agents|drug
DDI-DrugBank.d628.s3|246-246|(|drug
DDI-DrugBank.d628.s3|247-248|eg|drug
DDI-DrugBank.d628.s3|249-249|,|drug
DDI-DrugBank.d628.s3|251-257|nitrous|drug
DDI-DrugBank.d628.s3|259-263|oxide|drug
DDI-DrugBank.d628.s3|265-266|or|drug
DDI-DrugBank.d628.s3|268-274|opioids|drug
DDI-DrugBank.d628.s3|275-275|)|drug
DDI-DrugBank.d628.s3|276-276|.|drug
DDI-DrugBank.d628.s4|0-2|The|drug
DDI-DrugBank.d628.s4|4-13|concurrent|drug
DDI-DrugBank.d628.s4|15-28|administration|drug
DDI-DrugBank.d628.s4|30-31|of|drug
DDI-DrugBank.d628.s4|33-38|potent|drug
DDI-DrugBank.d628.s4|40-51|inhalational|drug
DDI-DrugBank.d628.s4|53-58|agents|drug
DDI-DrugBank.d628.s4|60-60|(|drug
DDI-DrugBank.d628.s4|61-62|eg|drug
DDI-DrugBank.d628.s4|63-63|,|drug
DDI-DrugBank.d628.s4|65-74|isoflurane|drug
DDI-DrugBank.d628.s4|75-75|,|drug
DDI-DrugBank.d628.s4|77-85|enflurane|drug
DDI-DrugBank.d628.s4|86-86|,|drug
DDI-DrugBank.d628.s4|88-90|and|drug
DDI-DrugBank.d628.s4|92-100|halothane|drug
DDI-DrugBank.d628.s4|101-101|)|drug
DDI-DrugBank.d628.s4|103-108|during|drug
DDI-DrugBank.d628.s4|110-120|maintenance|drug
DDI-DrugBank.d628.s4|122-125|with|drug
DDI-DrugBank.d628.s4|127-134|DIPRIVAN|drug
DDI-DrugBank.d628.s4|136-145|Injectable|drug
DDI-DrugBank.d628.s4|147-154|Emulsion|drug
DDI-DrugBank.d628.s4|156-158|has|drug
DDI-DrugBank.d628.s4|160-162|not|drug
DDI-DrugBank.d628.s4|164-167|been|drug
DDI-DrugBank.d628.s4|169-179|extensively|drug
DDI-DrugBank.d628.s4|181-189|evaluated|drug
DDI-DrugBank.d628.s4|190-190|.|drug
DDI-DrugBank.d628.s5|0-4|These|drug
DDI-DrugBank.d628.s5|6-17|inhalational|drug
DDI-DrugBank.d628.s5|19-24|agents|drug
DDI-DrugBank.d628.s5|26-28|can|drug
DDI-DrugBank.d628.s5|30-33|also|drug
DDI-DrugBank.d628.s5|35-36|be|drug
DDI-DrugBank.d628.s5|38-45|expected|drug
DDI-DrugBank.d628.s5|47-48|to|drug
DDI-DrugBank.d628.s5|50-57|increase|drug
DDI-DrugBank.d628.s5|59-61|the|drug
DDI-DrugBank.d628.s5|63-72|anesthetic|drug
DDI-DrugBank.d628.s5|74-75|or|drug
DDI-DrugBank.d628.s5|77-84|sedative|drug
DDI-DrugBank.d628.s5|86-88|and|drug
DDI-DrugBank.d628.s5|90-106|cardiorespiratory|drug
DDI-DrugBank.d628.s5|108-114|effects|drug
DDI-DrugBank.d628.s5|116-117|of|drug
DDI-DrugBank.d628.s5|119-126|DIPRIVAN|drug
DDI-DrugBank.d628.s5|128-137|Injectable|drug
DDI-DrugBank.d628.s5|139-146|Emulsion|drug
DDI-DrugBank.d628.s5|147-147|.|drug
DDI-DrugBank.d628.s6|0-7|DIPRIVAN|drug
DDI-DrugBank.d628.s6|9-18|Injectable|drug
DDI-DrugBank.d628.s6|20-27|Emulsion|drug
DDI-DrugBank.d628.s6|29-32|does|drug
DDI-DrugBank.d628.s6|34-36|not|drug
DDI-DrugBank.d628.s6|38-42|cause|drug
DDI-DrugBank.d628.s6|44-44|a|drug
DDI-DrugBank.d628.s6|46-55|clinically|drug
DDI-DrugBank.d628.s6|57-67|significant|drug
DDI-DrugBank.d628.s6|69-74|change|drug
DDI-DrugBank.d628.s6|76-77|in|drug
DDI-DrugBank.d628.s6|79-83|onset|drug
DDI-DrugBank.d628.s6|84-84|,|drug
DDI-DrugBank.d628.s6|86-94|intensity|drug
DDI-DrugBank.d628.s6|95-95|,|drug
DDI-DrugBank.d628.s6|97-98|or|drug
DDI-DrugBank.d628.s6|100-107|duration|drug
DDI-DrugBank.d628.s6|109-110|of|drug
DDI-DrugBank.d628.s6|112-117|action|drug
DDI-DrugBank.d628.s6|119-120|of|drug
DDI-DrugBank.d628.s6|122-124|the|drug
DDI-DrugBank.d628.s6|126-133|commonly|drug
DDI-DrugBank.d628.s6|135-138|used|drug
DDI-DrugBank.d628.s6|140-152|neuromuscular|drug
DDI-DrugBank.d628.s6|154-161|blocking|drug
DDI-DrugBank.d628.s6|163-168|agents|drug
DDI-DrugBank.d628.s6|170-170|(|drug
DDI-DrugBank.d628.s6|171-172|eg|drug
DDI-DrugBank.d628.s6|173-173|,|drug
DDI-DrugBank.d628.s6|175-189|succinylcholine|drug
DDI-DrugBank.d628.s6|191-193|and|drug
DDI-DrugBank.d628.s6|195-209|nondepolarizing|drug
DDI-DrugBank.d628.s6|211-216|muscle|drug
DDI-DrugBank.d628.s6|218-226|relaxants|drug
DDI-DrugBank.d628.s6|227-227|)|drug
DDI-DrugBank.d628.s6|228-228|.|drug
DDI-DrugBank.d628.s7|0-1|No|drug
DDI-DrugBank.d628.s7|3-13|significant|drug
DDI-DrugBank.d628.s7|15-21|adverse|drug
DDI-DrugBank.d628.s7|23-34|interactions|drug
DDI-DrugBank.d628.s7|36-39|with|drug
DDI-DrugBank.d628.s7|41-48|commonly|drug
DDI-DrugBank.d628.s7|50-53|used|drug
DDI-DrugBank.d628.s7|55-68|premedications|drug
DDI-DrugBank.d628.s7|70-71|or|drug
DDI-DrugBank.d628.s7|73-77|drugs|drug
DDI-DrugBank.d628.s7|79-82|used|drug
DDI-DrugBank.d628.s7|84-89|during|drug
DDI-DrugBank.d628.s7|91-100|anesthesia|drug
DDI-DrugBank.d628.s7|102-103|or|drug
DDI-DrugBank.d628.s7|105-112|sedation|drug
DDI-DrugBank.d628.s7|114-114|(|drug
DDI-DrugBank.d628.s7|115-123|including|drug
DDI-DrugBank.d628.s7|125-125|a|drug
DDI-DrugBank.d628.s7|127-131|range|drug
DDI-DrugBank.d628.s7|133-134|of|drug
DDI-DrugBank.d628.s7|136-141|muscle|drug
DDI-DrugBank.d628.s7|143-151|relaxants|drug
DDI-DrugBank.d628.s7|152-152|,|drug
DDI-DrugBank.d628.s7|154-165|inhalational|drug
DDI-DrugBank.d628.s7|167-172|agents|drug
DDI-DrugBank.d628.s7|173-173|,|drug
DDI-DrugBank.d628.s7|175-183|analgesic|drug
DDI-DrugBank.d628.s7|185-190|agents|drug
DDI-DrugBank.d628.s7|191-191|,|drug
DDI-DrugBank.d628.s7|193-195|and|drug
DDI-DrugBank.d628.s7|197-201|local|drug
DDI-DrugBank.d628.s7|203-212|anesthetic|drug
DDI-DrugBank.d628.s7|214-219|agents|drug
DDI-DrugBank.d628.s7|220-220|)|drug
DDI-DrugBank.d628.s7|222-225|have|drug
DDI-DrugBank.d628.s7|227-230|been|drug
DDI-DrugBank.d628.s7|232-239|observed|drug
DDI-DrugBank.d628.s7|240-240|.|drug
DDI-DrugBank.d70.s0|0-10|Fulvestrant|drug
DDI-DrugBank.d70.s0|12-13|is|drug
DDI-DrugBank.d70.s0|15-25|metabolized|drug
DDI-DrugBank.d70.s0|27-28|by|drug
DDI-DrugBank.d70.s0|30-32|CYP|drug
DDI-DrugBank.d70.s0|34-36|3A4|drug
DDI-DrugBank.d70.s0|38-39|in|drug
DDI-DrugBank.d70.s0|41-45|vitro|drug
DDI-DrugBank.d70.s0|46-46|.|drug
DDI-DrugBank.d70.s1|0-7|Clinical|drug
DDI-DrugBank.d70.s1|9-15|studies|drug
DDI-DrugBank.d70.s1|17-18|of|drug
DDI-DrugBank.d70.s1|20-22|the|drug
DDI-DrugBank.d70.s1|24-29|effect|drug
DDI-DrugBank.d70.s1|31-32|of|drug
DDI-DrugBank.d70.s1|34-39|strong|drug
DDI-DrugBank.d70.s1|41-43|CYP|drug
DDI-DrugBank.d70.s1|45-47|3A4|drug
DDI-DrugBank.d70.s1|49-58|inhibitors|drug
DDI-DrugBank.d70.s1|60-61|on|drug
DDI-DrugBank.d70.s1|63-65|the|drug
DDI-DrugBank.d70.s1|67-82|pharmacokinetics|drug
DDI-DrugBank.d70.s1|84-85|of|drug
DDI-DrugBank.d70.s1|87-97|fulvestrant|drug
DDI-DrugBank.d70.s1|99-102|have|drug
DDI-DrugBank.d70.s1|104-106|not|drug
DDI-DrugBank.d70.s1|108-111|been|drug
DDI-DrugBank.d70.s1|113-121|performed|drug
DDI-DrugBank.d70.s1|122-122|.|drug
DDI-DrugBank.d70.s2|0-13|Carcinogenesis|drug
DDI-DrugBank.d70.s2|14-14|,|drug
DDI-DrugBank.d70.s2|16-26|Mutagenesis|drug
DDI-DrugBank.d70.s2|28-30|and|drug
DDI-DrugBank.d70.s2|32-41|Impairment|drug
DDI-DrugBank.d70.s2|43-44|of|drug
DDI-DrugBank.d70.s2|46-54|Fertility|drug
DDI-DrugBank.d70.s2|56-56|A|drug
DDI-DrugBank.d70.s2|58-65|two-year|drug
DDI-DrugBank.d70.s2|67-80|carcinogenesis|drug
DDI-DrugBank.d70.s2|82-86|study|drug
DDI-DrugBank.d70.s2|88-90|was|drug
DDI-DrugBank.d70.s2|92-100|conducted|drug
DDI-DrugBank.d70.s2|102-103|in|drug
DDI-DrugBank.d70.s2|105-110|female|drug
DDI-DrugBank.d70.s2|112-114|and|drug
DDI-DrugBank.d70.s2|116-119|male|drug
DDI-DrugBank.d70.s2|121-124|rats|drug
DDI-DrugBank.d70.s2|125-125|,|drug
DDI-DrugBank.d70.s2|127-128|at|drug
DDI-DrugBank.d70.s2|130-142|intramuscular|drug
DDI-DrugBank.d70.s2|144-148|doses|drug
DDI-DrugBank.d70.s2|150-151|of|drug
DDI-DrugBank.d70.s2|153-154|15|drug
DDI-DrugBank.d70.s2|156-163|mg/kg/30|drug
DDI-DrugBank.d70.s2|165-168|days|drug
DDI-DrugBank.d70.s2|169-169|,|drug
DDI-DrugBank.d70.s2|171-172|10|drug
DDI-DrugBank.d70.s2|174-182|mg/rat/30|drug
DDI-DrugBank.d70.s2|184-187|days|drug
DDI-DrugBank.d70.s2|189-191|and|drug
DDI-DrugBank.d70.s2|193-194|10|drug
DDI-DrugBank.d70.s2|196-204|mg/rat/15|drug
DDI-DrugBank.d70.s2|206-209|days|drug
DDI-DrugBank.d70.s2|210-210|.|drug
DDI-DrugBank.d70.s3|0-4|These|drug
DDI-DrugBank.d70.s3|6-10|doses|drug
DDI-DrugBank.d70.s3|12-21|correspond|drug
DDI-DrugBank.d70.s3|23-24|to|drug
DDI-DrugBank.d70.s3|26-38|approximately|drug
DDI-DrugBank.d70.s3|40-41|1-|drug
DDI-DrugBank.d70.s3|42-42|,|drug
DDI-DrugBank.d70.s3|44-45|3-|drug
DDI-DrugBank.d70.s3|46-46|,|drug
DDI-DrugBank.d70.s3|48-50|and|drug
DDI-DrugBank.d70.s3|52-57|5-fold|drug
DDI-DrugBank.d70.s3|59-59|(|drug
DDI-DrugBank.d70.s3|60-61|in|drug
DDI-DrugBank.d70.s3|63-69|females|drug
DDI-DrugBank.d70.s3|70-70|)|drug
DDI-DrugBank.d70.s3|72-74|and|drug
DDI-DrugBank.d70.s3|76-79|1.3-|drug
DDI-DrugBank.d70.s3|80-80|,|drug
DDI-DrugBank.d70.s3|82-85|1.3-|drug
DDI-DrugBank.d70.s3|86-86|,|drug
DDI-DrugBank.d70.s3|88-90|and|drug
DDI-DrugBank.d70.s3|92-99|1.6-fold|drug
DDI-DrugBank.d70.s3|101-101|(|drug
DDI-DrugBank.d70.s3|102-103|in|drug
DDI-DrugBank.d70.s3|105-109|males|drug
DDI-DrugBank.d70.s3|110-110|)|drug
DDI-DrugBank.d70.s3|112-114|the|drug
DDI-DrugBank.d70.s3|116-123|systemic|drug
DDI-DrugBank.d70.s3|125-132|exposure|drug
DDI-DrugBank.d70.s3|134-134|[|drug
DDI-DrugBank.d70.s3|135-141|AUC0-30|drug
DDI-DrugBank.d70.s3|143-146|days|drug
DDI-DrugBank.d70.s3|147-147|]|drug
DDI-DrugBank.d70.s3|148-148|]|drug
DDI-DrugBank.d70.s3|150-157|achieved|drug
DDI-DrugBank.d70.s3|159-160|in|drug
DDI-DrugBank.d70.s3|162-166|women|drug
DDI-DrugBank.d70.s3|168-176|receiving|drug
DDI-DrugBank.d70.s3|178-180|the|drug
DDI-DrugBank.d70.s3|182-192|recommended|drug
DDI-DrugBank.d70.s3|194-197|dose|drug
DDI-DrugBank.d70.s3|199-200|of|drug
DDI-DrugBank.d70.s3|202-204|250|drug
DDI-DrugBank.d70.s3|206-213|mg/month|drug
DDI-DrugBank.d70.s3|214-214|.|drug
DDI-DrugBank.d70.s4|0-1|An|drug
DDI-DrugBank.d70.s4|3-11|increased|drug
DDI-DrugBank.d70.s4|13-21|incidence|drug
DDI-DrugBank.d70.s4|23-24|of|drug
DDI-DrugBank.d70.s4|26-31|benign|drug
DDI-DrugBank.d70.s4|33-39|ovarian|drug
DDI-DrugBank.d70.s4|41-49|granulosa|drug
DDI-DrugBank.d70.s4|51-54|cell|drug
DDI-DrugBank.d70.s4|56-61|tumors|drug
DDI-DrugBank.d70.s4|63-65|and|drug
DDI-DrugBank.d70.s4|67-76|testicular|drug
DDI-DrugBank.d70.s4|78-83|Leydig|drug
DDI-DrugBank.d70.s4|85-88|cell|drug
DDI-DrugBank.d70.s4|90-95|tumors|drug
DDI-DrugBank.d70.s4|97-99|was|drug
DDI-DrugBank.d70.s4|101-107|evident|drug
DDI-DrugBank.d70.s4|108-108|,|drug
DDI-DrugBank.d70.s4|110-111|in|drug
DDI-DrugBank.d70.s4|113-119|females|drug
DDI-DrugBank.d70.s4|121-125|dosed|drug
DDI-DrugBank.d70.s4|127-128|at|drug
DDI-DrugBank.d70.s4|130-131|10|drug
DDI-DrugBank.d70.s4|133-141|mg/rat/15|drug
DDI-DrugBank.d70.s4|143-146|days|drug
DDI-DrugBank.d70.s4|148-150|and|drug
DDI-DrugBank.d70.s4|152-156|males|drug
DDI-DrugBank.d70.s4|158-162|dosed|drug
DDI-DrugBank.d70.s4|164-165|at|drug
DDI-DrugBank.d70.s4|167-168|15|drug
DDI-DrugBank.d70.s4|170-178|mg/rat/30|drug
DDI-DrugBank.d70.s4|180-183|days|drug
DDI-DrugBank.d70.s4|184-184|,|drug
DDI-DrugBank.d70.s4|186-197|respectively|drug
DDI-DrugBank.d70.s4|198-198|.|drug
DDI-DrugBank.d70.s5|0-8|Induction|drug
DDI-DrugBank.d70.s5|10-11|of|drug
DDI-DrugBank.d70.s5|13-16|such|drug
DDI-DrugBank.d70.s5|18-23|tumors|drug
DDI-DrugBank.d70.s5|25-26|is|drug
DDI-DrugBank.d70.s5|28-37|consistent|drug
DDI-DrugBank.d70.s5|39-42|with|drug
DDI-DrugBank.d70.s5|44-46|the|drug
DDI-DrugBank.d70.s5|48-67|pharmacology-related|drug
DDI-DrugBank.d70.s5|69-77|endocrine|drug
DDI-DrugBank.d70.s5|79-86|feedback|drug
DDI-DrugBank.d70.s5|88-98|alterations|drug
DDI-DrugBank.d70.s5|100-101|in|drug
DDI-DrugBank.d70.s5|103-114|gonadotropin|drug
DDI-DrugBank.d70.s5|116-121|levels|drug
DDI-DrugBank.d70.s5|123-128|caused|drug
DDI-DrugBank.d70.s5|130-131|by|drug
DDI-DrugBank.d70.s5|133-134|an|drug
DDI-DrugBank.d70.s5|136-147|antiestrogen|drug
DDI-DrugBank.d70.s5|148-148|.|drug
DDI-DrugBank.d70.s6|0-10|Fulvestrant|drug
DDI-DrugBank.d70.s6|12-14|was|drug
DDI-DrugBank.d70.s6|16-18|not|drug
DDI-DrugBank.d70.s6|20-28|mutagenic|drug
DDI-DrugBank.d70.s6|30-31|or|drug
DDI-DrugBank.d70.s6|33-43|clastogenic|drug
DDI-DrugBank.d70.s6|45-46|in|drug
DDI-DrugBank.d70.s6|48-55|multiple|drug
DDI-DrugBank.d70.s6|57-58|in|drug
DDI-DrugBank.d70.s6|60-64|vitro|drug
DDI-DrugBank.d70.s6|66-70|tests|drug
DDI-DrugBank.d70.s6|72-75|with|drug
DDI-DrugBank.d70.s6|77-79|and|drug
DDI-DrugBank.d70.s6|81-87|without|drug
DDI-DrugBank.d70.s6|89-91|the|drug
DDI-DrugBank.d70.s6|93-100|addition|drug
DDI-DrugBank.d70.s6|102-103|of|drug
DDI-DrugBank.d70.s6|105-105|a|drug
DDI-DrugBank.d70.s6|107-115|mammalian|drug
DDI-DrugBank.d70.s6|117-121|liver|drug
DDI-DrugBank.d70.s6|123-131|metabolic|drug
DDI-DrugBank.d70.s6|133-142|activation|drug
DDI-DrugBank.d70.s6|144-149|factor|drug
DDI-DrugBank.d70.s6|151-151|(|drug
DDI-DrugBank.d70.s6|152-160|bacterial|drug
DDI-DrugBank.d70.s6|162-169|mutation|drug
DDI-DrugBank.d70.s6|171-175|assay|drug
DDI-DrugBank.d70.s6|177-178|in|drug
DDI-DrugBank.d70.s6|180-186|strains|drug
DDI-DrugBank.d70.s6|188-189|of|drug
DDI-DrugBank.d70.s6|191-200|Salmonella|drug
DDI-DrugBank.d70.s6|202-212|typhimurium|drug
DDI-DrugBank.d70.s6|214-216|and|drug
DDI-DrugBank.d70.s6|218-228|Escherichia|drug
DDI-DrugBank.d70.s6|230-233|coli|drug
DDI-DrugBank.d70.s6|234-234|,|drug
DDI-DrugBank.d70.s6|236-237|in|drug
DDI-DrugBank.d70.s6|239-243|vitro|drug
DDI-DrugBank.d70.s6|245-256|cytogenetics|drug
DDI-DrugBank.d70.s6|258-262|study|drug
DDI-DrugBank.d70.s6|264-265|in|drug
DDI-DrugBank.d70.s6|267-271|human|drug
DDI-DrugBank.d70.s6|273-283|lymphocytes|drug
DDI-DrugBank.d70.s6|284-284|,|drug
DDI-DrugBank.d70.s6|286-294|mammalian|drug
DDI-DrugBank.d70.s6|296-299|cell|drug
DDI-DrugBank.d70.s6|301-308|mutation|drug
DDI-DrugBank.d70.s6|310-314|assay|drug
DDI-DrugBank.d70.s6|316-317|in|drug
DDI-DrugBank.d70.s6|319-323|mouse|drug
DDI-DrugBank.d70.s6|325-332|lymphoma|drug
DDI-DrugBank.d70.s6|334-338|cells|drug
DDI-DrugBank.d70.s6|340-342|and|drug
DDI-DrugBank.d70.s6|344-345|in|drug
DDI-DrugBank.d70.s6|347-350|vivo|drug
DDI-DrugBank.d70.s6|352-363|micronucleus|drug
DDI-DrugBank.d70.s6|365-368|test|drug
DDI-DrugBank.d70.s6|370-371|in|drug
DDI-DrugBank.d70.s6|373-375|rat|drug
DDI-DrugBank.d70.s6|376-376|.|drug
DDI-DrugBank.d70.s7|0-1|In|drug
DDI-DrugBank.d70.s7|3-8|female|drug
DDI-DrugBank.d70.s7|10-13|rats|drug
DDI-DrugBank.d70.s7|14-14|,|drug
DDI-DrugBank.d70.s7|16-26|fulvestrant|drug
DDI-DrugBank.d70.s7|28-39|administered|drug
DDI-DrugBank.d70.s7|41-42|at|drug
DDI-DrugBank.d70.s7|44-48|doses|drug
DDI-DrugBank.d70.s7|52-55|0.01|drug
DDI-DrugBank.d70.s7|57-65|mg/kg/day|drug
DDI-DrugBank.d70.s7|67-67|(|drug
DDI-DrugBank.d70.s7|68-80|approximately|drug
DDI-DrugBank.d70.s7|82-94|one-hundredth|drug
DDI-DrugBank.d70.s7|96-97|of|drug
DDI-DrugBank.d70.s7|99-101|the|drug
DDI-DrugBank.d70.s7|103-107|human|drug
DDI-DrugBank.d70.s7|109-119|recommended|drug
DDI-DrugBank.d70.s7|121-124|dose|drug
DDI-DrugBank.d70.s7|126-130|based|drug
DDI-DrugBank.d70.s7|132-133|on|drug
DDI-DrugBank.d70.s7|135-138|body|drug
DDI-DrugBank.d70.s7|140-146|surface|drug
DDI-DrugBank.d70.s7|148-151|area|drug
DDI-DrugBank.d70.s7|153-153|[|drug
DDI-DrugBank.d70.s7|154-156|BSA|drug
DDI-DrugBank.d70.s7|157-157|]|drug
DDI-DrugBank.d70.s7|158-158|,|drug
DDI-DrugBank.d70.s7|160-162|for|drug
DDI-DrugBank.d70.s7|164-164|2|drug
DDI-DrugBank.d70.s7|166-170|weeks|drug
DDI-DrugBank.d70.s7|172-176|prior|drug
DDI-DrugBank.d70.s7|178-179|to|drug
DDI-DrugBank.d70.s7|181-183|and|drug
DDI-DrugBank.d70.s7|185-187|for|drug
DDI-DrugBank.d70.s7|189-189|1|drug
DDI-DrugBank.d70.s7|191-194|week|drug
DDI-DrugBank.d70.s7|196-204|following|drug
DDI-DrugBank.d70.s7|206-211|mating|drug
DDI-DrugBank.d70.s7|212-212|,|drug
DDI-DrugBank.d70.s7|214-219|caused|drug
DDI-DrugBank.d70.s7|221-221|a|drug
DDI-DrugBank.d70.s7|223-231|reduction|drug
DDI-DrugBank.d70.s7|233-234|in|drug
DDI-DrugBank.d70.s7|236-244|fertility|drug
DDI-DrugBank.d70.s7|246-248|and|drug
DDI-DrugBank.d70.s7|250-258|embryonic|drug
DDI-DrugBank.d70.s7|260-267|survival|drug
DDI-DrugBank.d70.s7|268-268|.|drug
DDI-DrugBank.d70.s8|0-1|No|drug
DDI-DrugBank.d70.s8|3-9|adverse|drug
DDI-DrugBank.d70.s8|11-17|effects|drug
DDI-DrugBank.d70.s8|19-20|on|drug
DDI-DrugBank.d70.s8|22-27|female|drug
DDI-DrugBank.d70.s8|29-37|fertility|drug
DDI-DrugBank.d70.s8|39-41|and|drug
DDI-DrugBank.d70.s8|43-51|embryonic|drug
DDI-DrugBank.d70.s8|53-60|survival|drug
DDI-DrugBank.d70.s8|62-65|were|drug
DDI-DrugBank.d70.s8|67-73|evident|drug
DDI-DrugBank.d70.s8|75-76|in|drug
DDI-DrugBank.d70.s8|78-83|female|drug
DDI-DrugBank.d70.s8|85-91|animals|drug
DDI-DrugBank.d70.s8|93-97|dosed|drug
DDI-DrugBank.d70.s8|99-100|at|drug
DDI-DrugBank.d70.s8|102-106|0.001|drug
DDI-DrugBank.d70.s8|108-116|mg/kg/day|drug
DDI-DrugBank.d70.s8|118-118|(|drug
DDI-DrugBank.d70.s8|119-131|approximately|drug
DDI-DrugBank.d70.s8|133-146|one-thousandth|drug
DDI-DrugBank.d70.s8|148-149|of|drug
DDI-DrugBank.d70.s8|151-153|the|drug
DDI-DrugBank.d70.s8|155-159|human|drug
DDI-DrugBank.d70.s8|161-164|dose|drug
DDI-DrugBank.d70.s8|166-170|based|drug
DDI-DrugBank.d70.s8|172-173|on|drug
DDI-DrugBank.d70.s8|175-177|BSA|drug
DDI-DrugBank.d70.s8|178-178|)|drug
DDI-DrugBank.d70.s8|179-179|.|drug
DDI-DrugBank.d70.s9|0-10|Restoration|drug
DDI-DrugBank.d70.s9|12-13|of|drug
DDI-DrugBank.d70.s9|15-20|female|drug
DDI-DrugBank.d70.s9|22-30|fertility|drug
DDI-DrugBank.d70.s9|32-33|to|drug
DDI-DrugBank.d70.s9|35-40|values|drug
DDI-DrugBank.d70.s9|42-48|similar|drug
DDI-DrugBank.d70.s9|50-51|to|drug
DDI-DrugBank.d70.s9|53-60|controls|drug
DDI-DrugBank.d70.s9|62-64|was|drug
DDI-DrugBank.d70.s9|66-72|evident|drug
DDI-DrugBank.d70.s9|74-82|following|drug
DDI-DrugBank.d70.s9|84-84|a|drug
DDI-DrugBank.d70.s9|86-91|29-day|drug
DDI-DrugBank.d70.s9|93-102|withdrawal|drug
DDI-DrugBank.d70.s9|104-109|period|drug
DDI-DrugBank.d70.s9|111-115|after|drug
DDI-DrugBank.d70.s9|117-122|dosing|drug
DDI-DrugBank.d70.s9|124-125|at|drug
DDI-DrugBank.d70.s9|127-127|2|drug
DDI-DrugBank.d70.s9|129-137|mg/kg/day|drug
DDI-DrugBank.d70.s9|139-139|(|drug
DDI-DrugBank.d70.s9|140-144|twice|drug
DDI-DrugBank.d70.s9|146-148|the|drug
DDI-DrugBank.d70.s9|150-154|human|drug
DDI-DrugBank.d70.s9|156-159|dose|drug
DDI-DrugBank.d70.s9|161-165|based|drug
DDI-DrugBank.d70.s9|167-168|on|drug
DDI-DrugBank.d70.s9|170-172|BSA|drug
DDI-DrugBank.d70.s9|173-173|)|drug
DDI-DrugBank.d70.s9|174-174|.|drug
DDI-DrugBank.d70.s10|0-2|The|drug
DDI-DrugBank.d70.s10|4-10|effects|drug
DDI-DrugBank.d70.s10|12-13|of|drug
DDI-DrugBank.d70.s10|15-25|fulvestrant|drug
DDI-DrugBank.d70.s10|27-28|on|drug
DDI-DrugBank.d70.s10|30-32|the|drug
DDI-DrugBank.d70.s10|34-42|fertility|drug
DDI-DrugBank.d70.s10|44-45|of|drug
DDI-DrugBank.d70.s10|47-52|female|drug
DDI-DrugBank.d70.s10|54-57|rats|drug
DDI-DrugBank.d70.s10|59-64|appear|drug
DDI-DrugBank.d70.s10|66-67|to|drug
DDI-DrugBank.d70.s10|69-70|be|drug
DDI-DrugBank.d70.s10|72-81|consistent|drug
DDI-DrugBank.d70.s10|83-86|with|drug
DDI-DrugBank.d70.s10|88-90|its|drug
DDI-DrugBank.d70.s10|92-106|anti-estrogenic|drug
DDI-DrugBank.d70.s10|108-115|activity|drug
DDI-DrugBank.d70.s10|116-116|.|drug
DDI-DrugBank.d70.s11|0-2|The|drug
DDI-DrugBank.d70.s11|4-12|potential|drug
DDI-DrugBank.d70.s11|14-20|effects|drug
DDI-DrugBank.d70.s11|22-23|of|drug
DDI-DrugBank.d70.s11|25-35|fulvestrant|drug
DDI-DrugBank.d70.s11|37-38|on|drug
DDI-DrugBank.d70.s11|40-42|the|drug
DDI-DrugBank.d70.s11|44-52|fertility|drug
DDI-DrugBank.d70.s11|54-55|of|drug
DDI-DrugBank.d70.s11|57-60|male|drug
DDI-DrugBank.d70.s11|62-68|animals|drug
DDI-DrugBank.d70.s11|70-73|were|drug
DDI-DrugBank.d70.s11|75-77|not|drug
DDI-DrugBank.d70.s11|79-85|studied|drug
DDI-DrugBank.d70.s11|87-89|but|drug
DDI-DrugBank.d70.s11|91-92|in|drug
DDI-DrugBank.d70.s11|94-94|a|drug
DDI-DrugBank.d70.s11|96-102|6-month|drug
DDI-DrugBank.d70.s11|104-113|toxicology|drug
DDI-DrugBank.d70.s11|115-119|study|drug
DDI-DrugBank.d70.s11|120-120|,|drug
DDI-DrugBank.d70.s11|122-125|male|drug
DDI-DrugBank.d70.s11|127-130|rats|drug
DDI-DrugBank.d70.s11|132-138|treated|drug
DDI-DrugBank.d70.s11|140-143|with|drug
DDI-DrugBank.d70.s11|145-157|intramuscular|drug
DDI-DrugBank.d70.s11|159-163|doses|drug
DDI-DrugBank.d70.s11|165-166|of|drug
DDI-DrugBank.d70.s11|168-169|15|drug
DDI-DrugBank.d70.s11|171-178|mg/kg/30|drug
DDI-DrugBank.d70.s11|180-183|days|drug
DDI-DrugBank.d70.s11|184-184|,|drug
DDI-DrugBank.d70.s11|186-187|10|drug
DDI-DrugBank.d70.s11|189-197|mg/rat/30|drug
DDI-DrugBank.d70.s11|199-202|days|drug
DDI-DrugBank.d70.s11|203-203|,|drug
DDI-DrugBank.d70.s11|205-206|or|drug
DDI-DrugBank.d70.s11|208-209|10|drug
DDI-DrugBank.d70.s11|211-219|mg/rat/15|drug
DDI-DrugBank.d70.s11|221-224|days|drug
DDI-DrugBank.d70.s11|226-236|fulvestrant|drug
DDI-DrugBank.d70.s11|238-243|showed|drug
DDI-DrugBank.d70.s11|245-245|a|drug
DDI-DrugBank.d70.s11|247-250|loss|drug
DDI-DrugBank.d70.s11|252-253|of|drug
DDI-DrugBank.d70.s11|255-265|spermatozoa|drug
DDI-DrugBank.d70.s11|267-270|from|drug
DDI-DrugBank.d70.s11|272-274|the|drug
DDI-DrugBank.d70.s11|276-287|seminiferous|drug
DDI-DrugBank.d70.s11|289-295|tubules|drug
DDI-DrugBank.d70.s11|296-296|,|drug
DDI-DrugBank.d70.s11|298-309|seminiferous|drug
DDI-DrugBank.d70.s11|311-317|tubular|drug
DDI-DrugBank.d70.s11|319-325|atrophy|drug
DDI-DrugBank.d70.s11|326-326|,|drug
DDI-DrugBank.d70.s11|328-330|and|drug
DDI-DrugBank.d70.s11|332-343|degenerative|drug
DDI-DrugBank.d70.s11|345-351|changes|drug
DDI-DrugBank.d70.s11|353-354|in|drug
DDI-DrugBank.d70.s11|356-358|the|drug
DDI-DrugBank.d70.s11|360-371|epididymides|drug
DDI-DrugBank.d70.s11|372-372|.|drug
DDI-DrugBank.d70.s12|0-6|Changes|drug
DDI-DrugBank.d70.s12|8-9|in|drug
DDI-DrugBank.d70.s12|11-13|the|drug
DDI-DrugBank.d70.s12|15-20|testes|drug
DDI-DrugBank.d70.s12|22-24|and|drug
DDI-DrugBank.d70.s12|26-37|epididymides|drug
DDI-DrugBank.d70.s12|39-41|had|drug
DDI-DrugBank.d70.s12|43-45|not|drug
DDI-DrugBank.d70.s12|47-55|recovered|drug
DDI-DrugBank.d70.s12|57-58|20|drug
DDI-DrugBank.d70.s12|60-64|weeks|drug
DDI-DrugBank.d70.s12|66-70|after|drug
DDI-DrugBank.d70.s12|72-80|cessation|drug
DDI-DrugBank.d70.s12|82-83|of|drug
DDI-DrugBank.d70.s12|85-90|dosing|drug
DDI-DrugBank.d70.s12|91-91|.|drug
DDI-DrugBank.d70.s13|0-4|These|drug
DDI-DrugBank.d70.s13|6-16|fulvestrant|drug
DDI-DrugBank.d70.s13|18-22|doses|drug
DDI-DrugBank.d70.s13|24-33|correspond|drug
DDI-DrugBank.d70.s13|35-36|to|drug
DDI-DrugBank.d70.s13|38-50|approximately|drug
DDI-DrugBank.d70.s13|52-53|2-|drug
DDI-DrugBank.d70.s13|54-54|,|drug
DDI-DrugBank.d70.s13|56-57|3-|drug
DDI-DrugBank.d70.s13|58-58|,|drug
DDI-DrugBank.d70.s13|60-62|and|drug
DDI-DrugBank.d70.s13|64-69|3-fold|drug
DDI-DrugBank.d70.s13|71-73|the|drug
DDI-DrugBank.d70.s13|75-82|systemic|drug
DDI-DrugBank.d70.s13|84-91|exposure|drug
DDI-DrugBank.d70.s13|93-93|[|drug
DDI-DrugBank.d70.s13|94-100|AUC0-30|drug
DDI-DrugBank.d70.s13|102-105|days|drug
DDI-DrugBank.d70.s13|106-106|]|drug
DDI-DrugBank.d70.s13|108-115|achieved|drug
DDI-DrugBank.d70.s13|117-118|in|drug
DDI-DrugBank.d70.s13|120-124|women|drug
DDI-DrugBank.d70.s13|125-125|.|drug
DDI-DrugBank.d70.s14|0-8|Pregnancy|drug
DDI-DrugBank.d70.s14|10-18|Pregnancy|drug
DDI-DrugBank.d70.s14|20-27|Category|drug
DDI-DrugBank.d70.s14|29-29|D|drug
DDI-DrugBank.d70.s14|30-30|:|drug
DDI-DrugBank.d70.s14|32-32|.|drug
DDI-DrugBank.d70.s15|0-1|In|drug
DDI-DrugBank.d70.s15|3-9|studies|drug
DDI-DrugBank.d70.s15|11-12|in|drug
DDI-DrugBank.d70.s15|14-19|female|drug
DDI-DrugBank.d70.s15|21-24|rats|drug
DDI-DrugBank.d70.s15|26-27|at|drug
DDI-DrugBank.d70.s15|29-33|doses|drug
DDI-DrugBank.d70.s15|37-40|0.01|drug
DDI-DrugBank.d70.s15|42-50|mg/kg/day|drug
DDI-DrugBank.d70.s15|52-52|(|drug
DDI-DrugBank.d70.s15|53-54|IM|drug
DDI-DrugBank.d70.s15|55-55|;|drug
DDI-DrugBank.d70.s16|0-12|approximately|drug
DDI-DrugBank.d70.s16|14-26|one-hundredth|drug
DDI-DrugBank.d70.s16|28-29|of|drug
DDI-DrugBank.d70.s16|31-33|the|drug
DDI-DrugBank.d70.s16|35-39|human|drug
DDI-DrugBank.d70.s16|41-51|recommended|drug
DDI-DrugBank.d70.s16|53-56|dose|drug
DDI-DrugBank.d70.s16|58-62|based|drug
DDI-DrugBank.d70.s16|64-65|on|drug
DDI-DrugBank.d70.s16|67-70|body|drug
DDI-DrugBank.d70.s16|72-78|surface|drug
DDI-DrugBank.d70.s16|80-83|area|drug
DDI-DrugBank.d70.s16|85-85|[|drug
DDI-DrugBank.d70.s16|86-88|BSA|drug
DDI-DrugBank.d70.s16|89-89|]|drug
DDI-DrugBank.d70.s16|90-90|)|drug
DDI-DrugBank.d70.s16|91-91|,|drug
DDI-DrugBank.d70.s16|93-103|fulvestrant|drug
DDI-DrugBank.d70.s16|105-110|caused|drug
DDI-DrugBank.d70.s16|112-112|a|drug
DDI-DrugBank.d70.s16|114-123|reversible|drug
DDI-DrugBank.d70.s16|125-133|reduction|drug
DDI-DrugBank.d70.s16|135-136|in|drug
DDI-DrugBank.d70.s16|138-143|female|drug
DDI-DrugBank.d70.s16|145-153|fertility|drug
DDI-DrugBank.d70.s16|154-154|,|drug
DDI-DrugBank.d70.s16|156-157|as|drug
DDI-DrugBank.d70.s16|159-162|well|drug
DDI-DrugBank.d70.s16|164-165|as|drug
DDI-DrugBank.d70.s16|167-173|effects|drug
DDI-DrugBank.d70.s16|175-176|on|drug
DDI-DrugBank.d70.s16|178-189|embryo/fetal|drug
DDI-DrugBank.d70.s16|191-201|development|drug
DDI-DrugBank.d70.s16|203-212|consistent|drug
DDI-DrugBank.d70.s16|214-217|with|drug
DDI-DrugBank.d70.s16|219-221|its|drug
DDI-DrugBank.d70.s16|223-237|anti-estrogenic|drug
DDI-DrugBank.d70.s16|239-246|activity|drug
DDI-DrugBank.d70.s16|247-247|.|drug
DDI-DrugBank.d70.s17|0-10|Fulvestrant|drug
DDI-DrugBank.d70.s17|12-17|caused|drug
DDI-DrugBank.d70.s17|19-20|an|drug
DDI-DrugBank.d70.s17|22-30|increased|drug
DDI-DrugBank.d70.s17|32-40|incidence|drug
DDI-DrugBank.d70.s17|42-43|of|drug
DDI-DrugBank.d70.s17|45-49|fetal|drug
DDI-DrugBank.d70.s17|51-63|abnormalities|drug
DDI-DrugBank.d70.s17|65-66|in|drug
DDI-DrugBank.d70.s17|68-71|rats|drug
DDI-DrugBank.d70.s17|73-73|(|drug
DDI-DrugBank.d70.s17|74-79|tarsal|drug
DDI-DrugBank.d70.s17|81-87|flexure|drug
DDI-DrugBank.d70.s17|89-90|of|drug
DDI-DrugBank.d70.s17|92-94|the|drug
DDI-DrugBank.d70.s17|96-99|hind|drug
DDI-DrugBank.d70.s17|101-103|paw|drug
DDI-DrugBank.d70.s17|105-106|at|drug
DDI-DrugBank.d70.s17|108-108|2|drug
DDI-DrugBank.d70.s17|110-118|mg/kg/day|drug
DDI-DrugBank.d70.s17|120-121|IM|drug
DDI-DrugBank.d70.s17|122-122|;|drug
DDI-DrugBank.d70.s18|0-4|twice|drug
DDI-DrugBank.d70.s18|6-8|the|drug
DDI-DrugBank.d70.s18|10-14|human|drug
DDI-DrugBank.d70.s18|16-19|dose|drug
DDI-DrugBank.d70.s18|21-22|on|drug
DDI-DrugBank.d70.s18|24-26|BSA|drug
DDI-DrugBank.d70.s18|27-27|)|drug
DDI-DrugBank.d70.s18|29-31|and|drug
DDI-DrugBank.d70.s18|33-48|non-ossification|drug
DDI-DrugBank.d70.s18|50-51|of|drug
DDI-DrugBank.d70.s18|53-55|the|drug
DDI-DrugBank.d70.s18|57-64|odontoid|drug
DDI-DrugBank.d70.s18|66-68|and|drug
DDI-DrugBank.d70.s18|70-76|ventral|drug
DDI-DrugBank.d70.s18|78-85|tubercle|drug
DDI-DrugBank.d70.s18|87-88|of|drug
DDI-DrugBank.d70.s18|90-92|the|drug
DDI-DrugBank.d70.s18|94-98|first|drug
DDI-DrugBank.d70.s18|100-107|cervical|drug
DDI-DrugBank.d70.s18|109-116|vertebra|drug
DDI-DrugBank.d70.s18|118-119|at|drug
DDI-DrugBank.d70.s18|121-125|doses|drug
DDI-DrugBank.d70.s18|129-131|0.1|drug
DDI-DrugBank.d70.s18|133-141|mg/kg/day|drug
DDI-DrugBank.d70.s18|143-144|IM|drug
DDI-DrugBank.d70.s18|146-146|(|drug
DDI-DrugBank.d70.s18|147-159|approximately|drug
DDI-DrugBank.d70.s18|161-169|one-tenth|drug
DDI-DrugBank.d70.s18|171-172|of|drug
DDI-DrugBank.d70.s18|174-176|the|drug
DDI-DrugBank.d70.s18|178-182|human|drug
DDI-DrugBank.d70.s18|184-187|dose|drug
DDI-DrugBank.d70.s18|189-190|on|drug
DDI-DrugBank.d70.s18|192-194|BSA|drug
DDI-DrugBank.d70.s18|195-195|)|drug
DDI-DrugBank.d70.s18|197-200|when|drug
DDI-DrugBank.d70.s18|202-213|administered|drug
DDI-DrugBank.d70.s18|215-220|during|drug
DDI-DrugBank.d70.s18|222-224|the|drug
DDI-DrugBank.d70.s18|226-231|period|drug
DDI-DrugBank.d70.s18|233-234|of|drug
DDI-DrugBank.d70.s18|236-248|organogenesis|drug
DDI-DrugBank.d70.s18|249-249|.|drug
DDI-DrugBank.d70.s19|0-6|Rabbits|drug
DDI-DrugBank.d70.s19|8-13|failed|drug
DDI-DrugBank.d70.s19|15-16|to|drug
DDI-DrugBank.d70.s19|18-25|maintain|drug
DDI-DrugBank.d70.s19|27-35|pregnancy|drug
DDI-DrugBank.d70.s19|37-40|when|drug
DDI-DrugBank.d70.s19|42-46|dosed|drug
DDI-DrugBank.d70.s19|48-51|with|drug
DDI-DrugBank.d70.s19|53-53|1|drug
DDI-DrugBank.d70.s19|55-63|mg/kg/day|drug
DDI-DrugBank.d70.s19|65-75|fulvestrant|drug
DDI-DrugBank.d70.s19|77-78|IM|drug
DDI-DrugBank.d70.s19|80-80|(|drug
DDI-DrugBank.d70.s19|81-85|twice|drug
DDI-DrugBank.d70.s19|87-89|the|drug
DDI-DrugBank.d70.s19|91-95|human|drug
DDI-DrugBank.d70.s19|97-100|dose|drug
DDI-DrugBank.d70.s19|102-103|on|drug
DDI-DrugBank.d70.s19|105-107|BSA|drug
DDI-DrugBank.d70.s19|108-108|)|drug
DDI-DrugBank.d70.s19|110-115|during|drug
DDI-DrugBank.d70.s19|117-119|the|drug
DDI-DrugBank.d70.s19|121-126|period|drug
DDI-DrugBank.d70.s19|128-129|of|drug
DDI-DrugBank.d70.s19|131-143|organogenesis|drug
DDI-DrugBank.d70.s19|144-144|.|drug
DDI-DrugBank.d70.s20|0-6|Further|drug
DDI-DrugBank.d70.s20|7-7|,|drug
DDI-DrugBank.d70.s20|9-10|in|drug
DDI-DrugBank.d70.s20|12-18|rabbits|drug
DDI-DrugBank.d70.s20|20-24|dosed|drug
DDI-DrugBank.d70.s20|26-27|at|drug
DDI-DrugBank.d70.s20|29-32|0.25|drug
DDI-DrugBank.d70.s20|34-42|mg/kg/day|drug
DDI-DrugBank.d70.s20|44-44|(|drug
DDI-DrugBank.d70.s20|45-49|about|drug
DDI-DrugBank.d70.s20|51-58|one-half|drug
DDI-DrugBank.d70.s20|60-62|the|drug
DDI-DrugBank.d70.s20|64-68|human|drug
DDI-DrugBank.d70.s20|70-73|dose|drug
DDI-DrugBank.d70.s20|75-76|on|drug
DDI-DrugBank.d70.s20|78-80|BSA|drug
DDI-DrugBank.d70.s20|81-81|)|drug
DDI-DrugBank.d70.s20|82-82|,|drug
DDI-DrugBank.d70.s20|84-92|increases|drug
DDI-DrugBank.d70.s20|94-95|in|drug
DDI-DrugBank.d70.s20|97-105|placental|drug
DDI-DrugBank.d70.s20|107-112|weight|drug
DDI-DrugBank.d70.s20|114-116|and|drug
DDI-DrugBank.d70.s20|118-134|post-implantation|drug
DDI-DrugBank.d70.s20|136-139|loss|drug
DDI-DrugBank.d70.s20|141-144|were|drug
DDI-DrugBank.d70.s20|146-153|observed|drug
DDI-DrugBank.d70.s20|155-157|but|drug
DDI-DrugBank.d70.s20|158-158|,|drug
DDI-DrugBank.d70.s20|160-164|there|drug
DDI-DrugBank.d70.s20|166-169|were|drug
DDI-DrugBank.d70.s20|171-172|no|drug
DDI-DrugBank.d70.s20|174-181|observed|drug
DDI-DrugBank.d70.s20|183-189|effects|drug
DDI-DrugBank.d70.s20|191-192|on|drug
DDI-DrugBank.d70.s20|194-198|fetal|drug
DDI-DrugBank.d70.s20|200-210|development|drug
DDI-DrugBank.d70.s20|211-211|.|drug
DDI-DrugBank.d70.s21|0-10|Fulvestrant|drug
DDI-DrugBank.d70.s21|12-14|was|drug
DDI-DrugBank.d70.s21|16-25|associated|drug
DDI-DrugBank.d70.s21|27-30|with|drug
DDI-DrugBank.d70.s21|32-33|an|drug
DDI-DrugBank.d70.s21|35-43|increased|drug
DDI-DrugBank.d70.s21|45-53|incidence|drug
DDI-DrugBank.d70.s21|55-56|of|drug
DDI-DrugBank.d70.s21|58-62|fetal|drug
DDI-DrugBank.d70.s21|64-73|variations|drug
DDI-DrugBank.d70.s21|75-76|in|drug
DDI-DrugBank.d70.s21|78-84|rabbits|drug
DDI-DrugBank.d70.s21|86-86|(|drug
DDI-DrugBank.d70.s21|87-95|backwards|drug
DDI-DrugBank.d70.s21|97-108|displacement|drug
DDI-DrugBank.d70.s21|110-111|of|drug
DDI-DrugBank.d70.s21|113-115|the|drug
DDI-DrugBank.d70.s21|117-122|pelvic|drug
DDI-DrugBank.d70.s21|124-129|girdle|drug
DDI-DrugBank.d70.s21|130-130|,|drug
DDI-DrugBank.d70.s21|132-134|and|drug
DDI-DrugBank.d70.s21|136-137|27|drug
DDI-DrugBank.d70.s21|139-148|pre-sacral|drug
DDI-DrugBank.d70.s21|150-158|vertebrae|drug
DDI-DrugBank.d70.s21|160-161|at|drug
DDI-DrugBank.d70.s21|163-166|0.25|drug
DDI-DrugBank.d70.s21|168-176|mg/kg/day|drug
DDI-DrugBank.d70.s21|178-179|IM|drug
DDI-DrugBank.d70.s21|180-180|;|drug
DDI-DrugBank.d70.s22|0-7|one-half|drug
DDI-DrugBank.d70.s22|9-11|the|drug
DDI-DrugBank.d70.s22|13-17|human|drug
DDI-DrugBank.d70.s22|19-22|dose|drug
DDI-DrugBank.d70.s22|24-25|on|drug
DDI-DrugBank.d70.s22|27-29|BSA|drug
DDI-DrugBank.d70.s22|30-30|)|drug
DDI-DrugBank.d70.s22|32-35|when|drug
DDI-DrugBank.d70.s22|37-48|administered|drug
DDI-DrugBank.d70.s22|50-55|during|drug
DDI-DrugBank.d70.s22|57-59|the|drug
DDI-DrugBank.d70.s22|61-66|period|drug
DDI-DrugBank.d70.s22|68-69|of|drug
DDI-DrugBank.d70.s22|71-83|organogenesis|drug
DDI-DrugBank.d70.s22|84-84|.|drug
DDI-DrugBank.d70.s23|0-6|Because|drug
DDI-DrugBank.d70.s23|8-16|pregnancy|drug
DDI-DrugBank.d70.s23|18-22|could|drug
DDI-DrugBank.d70.s23|24-26|not|drug
DDI-DrugBank.d70.s23|28-29|be|drug
DDI-DrugBank.d70.s23|31-40|maintained|drug
DDI-DrugBank.d70.s23|42-43|in|drug
DDI-DrugBank.d70.s23|45-47|the|drug
DDI-DrugBank.d70.s23|49-54|rabbit|drug
DDI-DrugBank.d70.s23|56-64|following|drug
DDI-DrugBank.d70.s23|66-70|doses|drug
DDI-DrugBank.d70.s23|72-73|of|drug
DDI-DrugBank.d70.s23|75-85|fulvestrant|drug
DDI-DrugBank.d70.s23|87-88|of|drug
DDI-DrugBank.d70.s23|90-90|1|drug
DDI-DrugBank.d70.s23|92-100|mg/kg/day|drug
DDI-DrugBank.d70.s23|102-104|and|drug
DDI-DrugBank.d70.s23|106-110|above|drug
DDI-DrugBank.d70.s23|111-111|,|drug
DDI-DrugBank.d70.s23|113-116|this|drug
DDI-DrugBank.d70.s23|118-122|study|drug
DDI-DrugBank.d70.s23|124-126|was|drug
DDI-DrugBank.d70.s23|128-137|inadequate|drug
DDI-DrugBank.d70.s23|139-140|to|drug
DDI-DrugBank.d70.s23|142-146|fully|drug
DDI-DrugBank.d70.s23|148-153|define|drug
DDI-DrugBank.d70.s23|155-157|the|drug
DDI-DrugBank.d70.s23|159-166|possible|drug
DDI-DrugBank.d70.s23|168-174|adverse|drug
DDI-DrugBank.d70.s23|176-182|effects|drug
DDI-DrugBank.d70.s23|184-185|on|drug
DDI-DrugBank.d70.s23|187-191|fetal|drug
DDI-DrugBank.d70.s23|193-203|development|drug
DDI-DrugBank.d70.s23|205-206|at|drug
DDI-DrugBank.d70.s23|208-217|clinically|drug
DDI-DrugBank.d70.s23|219-226|relevant|drug
DDI-DrugBank.d70.s23|228-236|exposures|drug
DDI-DrugBank.d70.s23|237-237|.|drug
DDI-DrugBank.d70.s24|0-6|Nursing|drug
DDI-DrugBank.d70.s24|8-14|Mothers|drug
DDI-DrugBank.d70.s24|16-26|Fulvestrant|drug
DDI-DrugBank.d70.s24|28-29|is|drug
DDI-DrugBank.d70.s24|31-35|found|drug
DDI-DrugBank.d70.s24|37-38|in|drug
DDI-DrugBank.d70.s24|40-42|rat|drug
DDI-DrugBank.d70.s24|44-47|milk|drug
DDI-DrugBank.d70.s24|49-50|at|drug
DDI-DrugBank.d70.s24|52-57|levels|drug
DDI-DrugBank.d70.s24|59-71|significantly|drug
DDI-DrugBank.d70.s24|73-78|higher|drug
DDI-DrugBank.d70.s24|80-80|(|drug
DDI-DrugBank.d70.s24|81-93|approximately|drug
DDI-DrugBank.d70.s24|95-101|12-fold|drug
DDI-DrugBank.d70.s24|102-102|)|drug
DDI-DrugBank.d70.s24|104-107|than|drug
DDI-DrugBank.d70.s24|109-114|plasma|drug
DDI-DrugBank.d70.s24|116-120|after|drug
DDI-DrugBank.d70.s24|122-135|administration|drug
DDI-DrugBank.d70.s24|137-138|of|drug
DDI-DrugBank.d70.s24|140-140|2|drug
DDI-DrugBank.d70.s24|142-146|mg/kg|drug
DDI-DrugBank.d70.s24|147-147|.|drug
DDI-DrugBank.d70.s25|0-3|Drug|drug
DDI-DrugBank.d70.s25|5-12|exposure|drug
DDI-DrugBank.d70.s25|14-15|in|drug
DDI-DrugBank.d70.s25|17-22|rodent|drug
DDI-DrugBank.d70.s25|24-27|pups|drug
DDI-DrugBank.d70.s25|29-32|from|drug
DDI-DrugBank.d70.s25|34-52|fulvestrant-treated|drug
DDI-DrugBank.d70.s25|54-62|lactating|drug
DDI-DrugBank.d70.s25|64-67|dams|drug
DDI-DrugBank.d70.s25|69-71|was|drug
DDI-DrugBank.d70.s25|73-81|estimated|drug
DDI-DrugBank.d70.s25|83-84|as|drug
DDI-DrugBank.d70.s25|86-87|10|drug
DDI-DrugBank.d70.s25|88-88|%|drug
DDI-DrugBank.d70.s25|90-91|of|drug
DDI-DrugBank.d70.s25|93-95|the|drug
DDI-DrugBank.d70.s25|97-108|administered|drug
DDI-DrugBank.d70.s25|110-113|dose|drug
DDI-DrugBank.d70.s25|114-114|.|drug
DDI-DrugBank.d70.s26|0-1|It|drug
DDI-DrugBank.d70.s26|3-4|is|drug
DDI-DrugBank.d70.s26|6-8|not|drug
DDI-DrugBank.d70.s26|10-14|known|drug
DDI-DrugBank.d70.s26|16-17|if|drug
DDI-DrugBank.d70.s26|19-29|fulvestrant|drug
DDI-DrugBank.d70.s26|31-32|is|drug
DDI-DrugBank.d70.s26|34-41|excreted|drug
DDI-DrugBank.d70.s26|43-44|in|drug
DDI-DrugBank.d70.s26|46-50|human|drug
DDI-DrugBank.d70.s26|52-55|milk|drug
DDI-DrugBank.d70.s26|56-56|.|drug
DDI-DrugBank.d70.s27|0-6|Because|drug
DDI-DrugBank.d70.s27|8-11|many|drug
DDI-DrugBank.d70.s27|13-17|drugs|drug
DDI-DrugBank.d70.s27|19-21|are|drug
DDI-DrugBank.d70.s27|23-30|excreted|drug
DDI-DrugBank.d70.s27|32-33|in|drug
DDI-DrugBank.d70.s27|35-39|human|drug
DDI-DrugBank.d70.s27|41-44|milk|drug
DDI-DrugBank.d70.s27|45-45|,|drug
DDI-DrugBank.d70.s27|47-49|and|drug
DDI-DrugBank.d70.s27|51-57|because|drug
DDI-DrugBank.d70.s27|59-60|of|drug
DDI-DrugBank.d70.s27|62-64|the|drug
DDI-DrugBank.d70.s27|66-74|potential|drug
DDI-DrugBank.d70.s27|76-78|for|drug
DDI-DrugBank.d70.s27|80-86|serious|drug
DDI-DrugBank.d70.s27|88-94|adverse|drug
DDI-DrugBank.d70.s27|96-104|reactions|drug
DDI-DrugBank.d70.s27|106-109|from|drug
DDI-DrugBank.d70.s27|111-118|FASLODEX|drug
DDI-DrugBank.d70.s27|120-121|in|drug
DDI-DrugBank.d70.s27|123-129|nursing|drug
DDI-DrugBank.d70.s27|131-137|infants|drug
DDI-DrugBank.d70.s27|138-138|,|drug
DDI-DrugBank.d70.s27|140-140|a|drug
DDI-DrugBank.d70.s27|142-149|decision|drug
DDI-DrugBank.d70.s27|151-156|should|drug
DDI-DrugBank.d70.s27|158-159|be|drug
DDI-DrugBank.d70.s27|161-164|made|drug
DDI-DrugBank.d70.s27|166-172|whether|drug
DDI-DrugBank.d70.s27|174-175|to|drug
DDI-DrugBank.d70.s27|177-187|discontinue|drug
DDI-DrugBank.d70.s27|189-195|nursing|drug
DDI-DrugBank.d70.s27|197-198|or|drug
DDI-DrugBank.d70.s27|200-201|to|drug
DDI-DrugBank.d70.s27|203-213|discontinue|drug
DDI-DrugBank.d70.s27|215-217|the|drug
DDI-DrugBank.d70.s27|219-222|drug|drug
DDI-DrugBank.d70.s27|224-229|taking|drug
DDI-DrugBank.d70.s27|231-234|into|drug
DDI-DrugBank.d70.s27|236-242|account|drug
DDI-DrugBank.d70.s27|244-246|the|drug
DDI-DrugBank.d70.s27|248-257|importance|drug
DDI-DrugBank.d70.s27|259-260|of|drug
DDI-DrugBank.d70.s27|262-264|the|drug
DDI-DrugBank.d70.s27|266-269|drug|drug
DDI-DrugBank.d70.s27|271-272|to|drug
DDI-DrugBank.d70.s27|274-276|the|drug
DDI-DrugBank.d70.s27|278-283|mother|drug
DDI-DrugBank.d70.s27|284-284|.|drug
DDI-DrugBank.d70.s28|0-8|Pediatric|drug
DDI-DrugBank.d70.s28|10-12|Use|drug
DDI-DrugBank.d70.s28|14-16|The|drug
DDI-DrugBank.d70.s28|18-23|safety|drug
DDI-DrugBank.d70.s28|25-27|and|drug
DDI-DrugBank.d70.s28|29-36|efficacy|drug
DDI-DrugBank.d70.s28|38-39|of|drug
DDI-DrugBank.d70.s28|41-48|FASLODEX|drug
DDI-DrugBank.d70.s28|50-51|in|drug
DDI-DrugBank.d70.s28|53-61|pediatric|drug
DDI-DrugBank.d70.s28|63-70|patients|drug
DDI-DrugBank.d70.s28|72-75|have|drug
DDI-DrugBank.d70.s28|77-79|not|drug
DDI-DrugBank.d70.s28|81-84|been|drug
DDI-DrugBank.d70.s28|86-96|established|drug
DDI-DrugBank.d70.s28|97-97|.|drug
DDI-DrugBank.d70.s29|0-8|Geriatric|drug
DDI-DrugBank.d70.s29|10-12|Use|drug
DDI-DrugBank.d70.s29|14-17|When|drug
DDI-DrugBank.d70.s29|19-23|tumor|drug
DDI-DrugBank.d70.s29|25-32|response|drug
DDI-DrugBank.d70.s29|34-36|was|drug
DDI-DrugBank.d70.s29|38-47|considered|drug
DDI-DrugBank.d70.s29|49-50|by|drug
DDI-DrugBank.d70.s29|52-54|age|drug
DDI-DrugBank.d70.s29|55-55|,|drug
DDI-DrugBank.d70.s29|57-65|objective|drug
DDI-DrugBank.d70.s29|67-75|responses|drug
DDI-DrugBank.d70.s29|77-80|were|drug
DDI-DrugBank.d70.s29|82-85|seen|drug
DDI-DrugBank.d70.s29|87-88|in|drug
DDI-DrugBank.d70.s29|90-91|24|drug
DDI-DrugBank.d70.s29|92-92|%|drug
DDI-DrugBank.d70.s29|94-96|and|drug
DDI-DrugBank.d70.s29|98-99|22|drug
DDI-DrugBank.d70.s29|100-100|%|drug
DDI-DrugBank.d70.s29|102-103|of|drug
DDI-DrugBank.d70.s29|105-112|patients|drug
DDI-DrugBank.d70.s29|114-118|under|drug
DDI-DrugBank.d70.s29|120-121|65|drug
DDI-DrugBank.d70.s29|123-127|years|drug
DDI-DrugBank.d70.s29|129-130|of|drug
DDI-DrugBank.d70.s29|132-134|age|drug
DDI-DrugBank.d70.s29|136-138|and|drug
DDI-DrugBank.d70.s29|140-141|in|drug
DDI-DrugBank.d70.s29|143-144|16|drug
DDI-DrugBank.d70.s29|145-145|%|drug
DDI-DrugBank.d70.s29|147-149|and|drug
DDI-DrugBank.d70.s29|151-152|11|drug
DDI-DrugBank.d70.s29|153-153|%|drug
DDI-DrugBank.d70.s29|155-156|of|drug
DDI-DrugBank.d70.s29|158-165|patients|drug
DDI-DrugBank.d70.s29|167-168|65|drug
DDI-DrugBank.d70.s29|170-174|years|drug
DDI-DrugBank.d70.s29|176-177|of|drug
DDI-DrugBank.d70.s29|179-181|age|drug
DDI-DrugBank.d70.s29|183-185|and|drug
DDI-DrugBank.d70.s29|187-191|older|drug
DDI-DrugBank.d70.s29|192-192|,|drug
DDI-DrugBank.d70.s29|194-196|who|drug
DDI-DrugBank.d70.s29|198-201|were|drug
DDI-DrugBank.d70.s29|203-209|treated|drug
DDI-DrugBank.d70.s29|211-214|with|drug
DDI-DrugBank.d70.s29|216-223|FASLODEX|drug
DDI-DrugBank.d70.s29|225-226|in|drug
DDI-DrugBank.d70.s29|228-230|the|drug
DDI-DrugBank.d70.s29|232-239|European|drug
DDI-DrugBank.d70.s29|241-243|and|drug
DDI-DrugBank.d70.s29|245-249|North|drug
DDI-DrugBank.d70.s29|251-258|American|drug
DDI-DrugBank.d70.s29|260-265|trials|drug
DDI-DrugBank.d70.s29|266-266|,|drug
DDI-DrugBank.d70.s29|268-279|respectively|drug
DDI-DrugBank.d70.s29|280-280|.|drug
DDI-DrugBank.d123.s0|0-3|Some|drug
DDI-DrugBank.d123.s0|5-14|quinolones|drug
DDI-DrugBank.d123.s0|15-15|,|drug
DDI-DrugBank.d123.s0|17-25|including|drug
DDI-DrugBank.d123.s0|27-39|ciprofloxacin|drug
DDI-DrugBank.d123.s0|40-40|,|drug
DDI-DrugBank.d123.s0|42-45|have|drug
DDI-DrugBank.d123.s0|47-50|also|drug
DDI-DrugBank.d123.s0|52-55|been|drug
DDI-DrugBank.d123.s0|57-61|shown|drug
DDI-DrugBank.d123.s0|63-64|to|drug
DDI-DrugBank.d123.s0|66-74|interfere|drug
DDI-DrugBank.d123.s0|76-79|with|drug
DDI-DrugBank.d123.s0|81-83|the|drug
DDI-DrugBank.d123.s0|85-94|metabolism|drug
DDI-DrugBank.d123.s0|96-97|of|drug
DDI-DrugBank.d123.s0|99-106|caffeine|drug
DDI-DrugBank.d123.s0|107-107|.|drug
DDI-DrugBank.d123.s1|0-3|This|drug
DDI-DrugBank.d123.s1|5-7|may|drug
DDI-DrugBank.d123.s1|9-12|lead|drug
DDI-DrugBank.d123.s1|14-15|to|drug
DDI-DrugBank.d123.s1|17-23|reduced|drug
DDI-DrugBank.d123.s1|25-33|clearance|drug
DDI-DrugBank.d123.s1|35-36|of|drug
DDI-DrugBank.d123.s1|38-45|caffeine|drug
DDI-DrugBank.d123.s1|47-49|and|drug
DDI-DrugBank.d123.s1|51-51|a|drug
DDI-DrugBank.d123.s1|53-64|prolongation|drug
DDI-DrugBank.d123.s1|66-67|of|drug
DDI-DrugBank.d123.s1|69-71|its|drug
DDI-DrugBank.d123.s1|73-77|serum|drug
DDI-DrugBank.d123.s1|79-87|half-life|drug
DDI-DrugBank.d123.s1|88-88|.|drug
DDI-DrugBank.d123.s2|0-3|Some|drug
DDI-DrugBank.d123.s2|5-14|quinolones|drug
DDI-DrugBank.d123.s2|15-15|,|drug
DDI-DrugBank.d123.s2|17-25|including|drug
DDI-DrugBank.d123.s2|27-39|ciprofloxacin|drug
DDI-DrugBank.d123.s2|40-40|,|drug
DDI-DrugBank.d123.s2|42-45|have|drug
DDI-DrugBank.d123.s2|47-50|been|drug
DDI-DrugBank.d123.s2|52-61|associated|drug
DDI-DrugBank.d123.s2|63-66|with|drug
DDI-DrugBank.d123.s2|68-76|transient|drug
DDI-DrugBank.d123.s2|78-87|elevations|drug
DDI-DrugBank.d123.s2|89-90|in|drug
DDI-DrugBank.d123.s2|92-96|serum|drug
DDI-DrugBank.d123.s2|98-107|creatinine|drug
DDI-DrugBank.d123.s2|109-110|in|drug
DDI-DrugBank.d123.s2|112-119|patients|drug
DDI-DrugBank.d123.s2|121-129|receiving|drug
DDI-DrugBank.d123.s2|131-142|cyclosporine|drug
DDI-DrugBank.d123.s2|144-156|concomitantly|drug
DDI-DrugBank.d123.s2|157-157|.|drug
DDI-DrugBank.d123.s3|0-8|Glyburide|drug
DDI-DrugBank.d123.s3|9-9|:|drug
DDI-DrugBank.d123.s3|11-13|The|drug
DDI-DrugBank.d123.s3|15-25|concomitant|drug
DDI-DrugBank.d123.s3|27-40|administration|drug
DDI-DrugBank.d123.s3|42-43|of|drug
DDI-DrugBank.d123.s3|45-57|ciprofloxacin|drug
DDI-DrugBank.d123.s3|59-62|with|drug
DDI-DrugBank.d123.s3|64-66|the|drug
DDI-DrugBank.d123.s3|68-79|sulfonylurea|drug
DDI-DrugBank.d123.s3|81-89|glyburide|drug
DDI-DrugBank.d123.s3|91-93|has|drug
DDI-DrugBank.d123.s3|94-94|,|drug
DDI-DrugBank.d123.s3|96-97|on|drug
DDI-DrugBank.d123.s3|99-102|rare|drug
DDI-DrugBank.d123.s3|104-112|occasions|drug
DDI-DrugBank.d123.s3|113-113|,|drug
DDI-DrugBank.d123.s3|115-122|resulted|drug
DDI-DrugBank.d123.s3|124-125|in|drug
DDI-DrugBank.d123.s3|127-132|severe|drug
DDI-DrugBank.d123.s3|134-145|hypoglycemia|drug
DDI-DrugBank.d123.s3|146-146|.|drug
DDI-DrugBank.d123.s4|0-8|Histamine|drug
DDI-DrugBank.d123.s4|10-20|H2-receptor|drug
DDI-DrugBank.d123.s4|22-32|antagonists|drug
DDI-DrugBank.d123.s4|33-33|:|drug
DDI-DrugBank.d123.s4|35-43|Histamine|drug
DDI-DrugBank.d123.s4|45-55|H2-receptor|drug
DDI-DrugBank.d123.s4|57-67|antagonists|drug
DDI-DrugBank.d123.s4|69-74|appear|drug
DDI-DrugBank.d123.s4|76-77|to|drug
DDI-DrugBank.d123.s4|79-82|have|drug
DDI-DrugBank.d123.s4|84-85|no|drug
DDI-DrugBank.d123.s4|87-97|significant|drug
DDI-DrugBank.d123.s4|99-104|effect|drug
DDI-DrugBank.d123.s4|106-107|on|drug
DDI-DrugBank.d123.s4|109-111|the|drug
DDI-DrugBank.d123.s4|113-127|bioavailability|drug
DDI-DrugBank.d123.s4|129-130|of|drug
DDI-DrugBank.d123.s4|132-144|ciprofloxacin|drug
DDI-DrugBank.d123.s4|145-145|.|drug
DDI-DrugBank.d123.s5|0-11|Methotrexate|drug
DDI-DrugBank.d123.s5|13-17|Renal|drug
DDI-DrugBank.d123.s5|19-25|tubular|drug
DDI-DrugBank.d123.s5|27-35|transport|drug
DDI-DrugBank.d123.s5|37-38|of|drug
DDI-DrugBank.d123.s5|40-51|methotrexate|drug
DDI-DrugBank.d123.s5|53-55|may|drug
DDI-DrugBank.d123.s5|57-58|be|drug
DDI-DrugBank.d123.s5|60-68|inhibited|drug
DDI-DrugBank.d123.s5|70-71|by|drug
DDI-DrugBank.d123.s5|73-83|concomitant|drug
DDI-DrugBank.d123.s5|85-98|administration|drug
DDI-DrugBank.d123.s5|100-101|of|drug
DDI-DrugBank.d123.s5|103-115|ciprofloxacin|drug
DDI-DrugBank.d123.s5|116-116|,|drug
DDI-DrugBank.d123.s5|118-128|potentially|drug
DDI-DrugBank.d123.s5|130-136|leading|drug
DDI-DrugBank.d123.s5|138-139|to|drug
DDI-DrugBank.d123.s5|141-149|increased|drug
DDI-DrugBank.d123.s5|151-156|plasma|drug
DDI-DrugBank.d123.s5|158-163|levels|drug
DDI-DrugBank.d123.s5|165-166|of|drug
DDI-DrugBank.d123.s5|168-179|methotrexate|drug
DDI-DrugBank.d123.s5|180-180|.|drug
DDI-DrugBank.d123.s6|0-3|This|drug
DDI-DrugBank.d123.s6|5-9|might|drug
DDI-DrugBank.d123.s6|11-18|increase|drug
DDI-DrugBank.d123.s6|20-22|the|drug
DDI-DrugBank.d123.s6|24-27|risk|drug
DDI-DrugBank.d123.s6|29-30|of|drug
DDI-DrugBank.d123.s6|32-43|methotrexate|drug
DDI-DrugBank.d123.s6|45-49|toxic|drug
DDI-DrugBank.d123.s6|51-59|reactions|drug
DDI-DrugBank.d123.s6|60-60|.|drug
DDI-DrugBank.d123.s7|0-8|Therefore|drug
DDI-DrugBank.d123.s7|9-9|,|drug
DDI-DrugBank.d123.s7|11-18|patients|drug
DDI-DrugBank.d123.s7|20-24|under|drug
DDI-DrugBank.d123.s7|26-37|methotrexate|drug
DDI-DrugBank.d123.s7|39-45|therapy|drug
DDI-DrugBank.d123.s7|47-52|should|drug
DDI-DrugBank.d123.s7|54-55|be|drug
DDI-DrugBank.d123.s7|57-65|carefully|drug
DDI-DrugBank.d123.s7|67-75|monitored|drug
DDI-DrugBank.d123.s7|77-80|when|drug
DDI-DrugBank.d123.s7|82-92|concomitant|drug
DDI-DrugBank.d123.s7|94-106|ciprofloxacin|drug
DDI-DrugBank.d123.s7|108-114|therapy|drug
DDI-DrugBank.d123.s7|116-117|is|drug
DDI-DrugBank.d123.s7|119-127|indicated|drug
DDI-DrugBank.d123.s7|128-128|.|drug
DDI-DrugBank.d123.s8|0-10|Multivalent|drug
DDI-DrugBank.d123.s8|12-28|Cation-Containing|drug
DDI-DrugBank.d123.s8|30-37|Products|drug
DDI-DrugBank.d123.s8|38-38|:|drug
DDI-DrugBank.d123.s8|40-49|Concurrent|drug
DDI-DrugBank.d123.s8|51-64|administration|drug
DDI-DrugBank.d123.s8|66-67|of|drug
DDI-DrugBank.d123.s8|69-69|a|drug
DDI-DrugBank.d123.s8|71-79|quinolone|drug
DDI-DrugBank.d123.s8|80-80|,|drug
DDI-DrugBank.d123.s8|82-90|including|drug
DDI-DrugBank.d123.s8|92-104|ciprofloxacin|drug
DDI-DrugBank.d123.s8|105-105|,|drug
DDI-DrugBank.d123.s8|107-110|with|drug
DDI-DrugBank.d123.s8|112-122|multivalent|drug
DDI-DrugBank.d123.s8|124-140|cation-containing|drug
DDI-DrugBank.d123.s8|142-149|products|drug
DDI-DrugBank.d123.s8|151-154|such|drug
DDI-DrugBank.d123.s8|156-157|as|drug
DDI-DrugBank.d123.s8|159-167|magnesium|drug
DDI-DrugBank.d123.s8|169-170|or|drug
DDI-DrugBank.d123.s8|172-179|aluminum|drug
DDI-DrugBank.d123.s8|181-188|antacids|drug
DDI-DrugBank.d123.s8|189-189|,|drug
DDI-DrugBank.d123.s8|191-200|sucralfate|drug
DDI-DrugBank.d123.s8|201-201|,|drug
DDI-DrugBank.d123.s8|203-207|VIDEX|drug
DDI-DrugBank.d123.s8|209-225|chewable/buffered|drug
DDI-DrugBank.d123.s8|227-233|tablets|drug
DDI-DrugBank.d123.s8|235-236|or|drug
DDI-DrugBank.d123.s8|238-246|pediatric|drug
DDI-DrugBank.d123.s8|248-253|powder|drug
DDI-DrugBank.d123.s8|254-254|,|drug
DDI-DrugBank.d123.s8|256-257|or|drug
DDI-DrugBank.d123.s8|259-266|products|drug
DDI-DrugBank.d123.s8|268-277|containing|drug
DDI-DrugBank.d123.s8|279-285|calcium|drug
DDI-DrugBank.d123.s8|286-286|,|drug
DDI-DrugBank.d123.s8|288-291|iron|drug
DDI-DrugBank.d123.s8|292-292|,|drug
DDI-DrugBank.d123.s8|294-295|or|drug
DDI-DrugBank.d123.s8|297-300|zinc|drug
DDI-DrugBank.d123.s8|302-304|may|drug
DDI-DrugBank.d123.s8|306-318|substantially|drug
DDI-DrugBank.d123.s8|320-327|decrease|drug
DDI-DrugBank.d123.s8|329-331|the|drug
DDI-DrugBank.d123.s8|333-342|absorption|drug
DDI-DrugBank.d123.s8|344-345|of|drug
DDI-DrugBank.d123.s8|347-359|ciprofloxacin|drug
DDI-DrugBank.d123.s8|360-360|,|drug
DDI-DrugBank.d123.s8|362-370|resulting|drug
DDI-DrugBank.d123.s8|372-373|in|drug
DDI-DrugBank.d123.s8|375-379|serum|drug
DDI-DrugBank.d123.s8|381-383|and|drug
DDI-DrugBank.d123.s8|385-389|urine|drug
DDI-DrugBank.d123.s8|391-396|levels|drug
DDI-DrugBank.d123.s8|398-409|considerably|drug
DDI-DrugBank.d123.s8|411-415|lower|drug
DDI-DrugBank.d123.s8|417-420|than|drug
DDI-DrugBank.d123.s8|422-428|desired|drug
DDI-DrugBank.d123.s8|429-429|.|drug
DDI-DrugBank.d123.s9|0-6|Proquin|drug
DDI-DrugBank.d123.s9|8-9|XR|drug
DDI-DrugBank.d123.s9|11-16|should|drug
DDI-DrugBank.d123.s9|18-19|be|drug
DDI-DrugBank.d123.s9|21-32|administered|drug
DDI-DrugBank.d123.s9|34-35|at|drug
DDI-DrugBank.d123.s9|37-41|least|drug
DDI-DrugBank.d123.s9|43-43|4|drug
DDI-DrugBank.d123.s9|45-49|hours|drug
DDI-DrugBank.d123.s9|51-56|before|drug
DDI-DrugBank.d123.s9|58-59|or|drug
DDI-DrugBank.d123.s9|61-61|2|drug
DDI-DrugBank.d123.s9|63-67|hours|drug
DDI-DrugBank.d123.s9|69-73|after|drug
DDI-DrugBank.d123.s9|75-79|these|drug
DDI-DrugBank.d123.s9|81-88|products|drug
DDI-DrugBank.d123.s9|89-89|.|drug
DDI-DrugBank.d123.s10|0-3|This|drug
DDI-DrugBank.d123.s10|5-8|time|drug
DDI-DrugBank.d123.s10|10-15|window|drug
DDI-DrugBank.d123.s10|17-18|is|drug
DDI-DrugBank.d123.s10|20-28|different|drug
DDI-DrugBank.d123.s10|30-33|than|drug
DDI-DrugBank.d123.s10|35-37|for|drug
DDI-DrugBank.d123.s10|39-43|other|drug
DDI-DrugBank.d123.s10|45-48|oral|drug
DDI-DrugBank.d123.s10|50-61|formulations|drug
DDI-DrugBank.d123.s10|63-64|of|drug
DDI-DrugBank.d123.s10|66-78|ciprofloxacin|drug
DDI-DrugBank.d123.s10|79-79|,|drug
DDI-DrugBank.d123.s10|81-85|which|drug
DDI-DrugBank.d123.s10|87-89|are|drug
DDI-DrugBank.d123.s10|91-97|usually|drug
DDI-DrugBank.d123.s10|99-110|administered|drug
DDI-DrugBank.d123.s10|112-112|2|drug
DDI-DrugBank.d123.s10|114-118|hours|drug
DDI-DrugBank.d123.s10|120-125|before|drug
DDI-DrugBank.d123.s10|127-128|or|drug
DDI-DrugBank.d123.s10|130-130|6|drug
DDI-DrugBank.d123.s10|132-136|hours|drug
DDI-DrugBank.d123.s10|138-142|after|drug
DDI-DrugBank.d123.s10|144-151|antacids|drug
DDI-DrugBank.d123.s10|152-152|.|drug
DDI-DrugBank.d123.s11|0-12|Non-steroidal|drug
DDI-DrugBank.d123.s11|14-30|anti-inflammatory|drug
DDI-DrugBank.d123.s11|32-36|drugs|drug
DDI-DrugBank.d123.s11|38-38|(|drug
DDI-DrugBank.d123.s11|39-41|but|drug
DDI-DrugBank.d123.s11|43-45|not|drug
DDI-DrugBank.d123.s11|47-53|aspirin|drug
DDI-DrugBank.d123.s11|54-54|)|drug
DDI-DrugBank.d123.s11|55-55|:|drug
DDI-DrugBank.d123.s11|57-61|These|drug
DDI-DrugBank.d123.s11|63-67|drugs|drug
DDI-DrugBank.d123.s11|69-70|in|drug
DDI-DrugBank.d123.s11|72-82|combination|drug
DDI-DrugBank.d123.s11|84-87|with|drug
DDI-DrugBank.d123.s11|89-92|very|drug
DDI-DrugBank.d123.s11|94-97|high|drug
DDI-DrugBank.d123.s11|99-103|doses|drug
DDI-DrugBank.d123.s11|105-106|of|drug
DDI-DrugBank.d123.s11|108-117|quinolones|drug
DDI-DrugBank.d123.s11|119-122|have|drug
DDI-DrugBank.d123.s11|124-127|been|drug
DDI-DrugBank.d123.s11|129-133|shown|drug
DDI-DrugBank.d123.s11|135-136|to|drug
DDI-DrugBank.d123.s11|138-144|provoke|drug
DDI-DrugBank.d123.s11|146-156|convulsions|drug
DDI-DrugBank.d123.s11|158-159|in|drug
DDI-DrugBank.d123.s11|161-172|pre-clinical|drug
DDI-DrugBank.d123.s11|174-180|studies|drug
DDI-DrugBank.d123.s11|181-181|.|drug
DDI-DrugBank.d123.s12|0-9|Omeprazole|drug
DDI-DrugBank.d123.s12|10-10|:|drug
DDI-DrugBank.d123.s12|12-14|The|drug
DDI-DrugBank.d123.s12|16-19|rate|drug
DDI-DrugBank.d123.s12|21-23|and|drug
DDI-DrugBank.d123.s12|25-30|extent|drug
DDI-DrugBank.d123.s12|32-33|of|drug
DDI-DrugBank.d123.s12|35-44|absorption|drug
DDI-DrugBank.d123.s12|46-47|of|drug
DDI-DrugBank.d123.s12|49-61|ciprofloxacin|drug
DDI-DrugBank.d123.s12|63-65|was|drug
DDI-DrugBank.d123.s12|67-79|bioequivalent|drug
DDI-DrugBank.d123.s12|81-84|when|drug
DDI-DrugBank.d123.s12|86-92|Proquin|drug
DDI-DrugBank.d123.s12|94-95|XR|drug
DDI-DrugBank.d123.s12|97-99|was|drug
DDI-DrugBank.d123.s12|101-105|given|drug
DDI-DrugBank.d123.s12|107-111|alone|drug
DDI-DrugBank.d123.s12|113-114|or|drug
DDI-DrugBank.d123.s12|116-119|when|drug
DDI-DrugBank.d123.s12|121-127|Proquin|drug
DDI-DrugBank.d123.s12|129-130|XR|drug
DDI-DrugBank.d123.s12|132-134|was|drug
DDI-DrugBank.d123.s12|136-140|given|drug
DDI-DrugBank.d123.s12|142-142|2|drug
DDI-DrugBank.d123.s12|144-148|hours|drug
DDI-DrugBank.d123.s12|150-154|after|drug
DDI-DrugBank.d123.s12|156-165|omeprazole|drug
DDI-DrugBank.d123.s12|167-168|at|drug
DDI-DrugBank.d123.s12|170-172|the|drug
DDI-DrugBank.d123.s12|174-177|dose|drug
DDI-DrugBank.d123.s12|179-182|that|drug
DDI-DrugBank.d123.s12|184-192|maximally|drug
DDI-DrugBank.d123.s12|194-203|suppresses|drug
DDI-DrugBank.d123.s12|205-211|gastric|drug
DDI-DrugBank.d123.s12|213-216|acid|drug
DDI-DrugBank.d123.s12|218-226|secretion|drug
DDI-DrugBank.d123.s12|227-227|.|drug
DDI-DrugBank.d123.s13|0-9|Omeprazole|drug
DDI-DrugBank.d123.s13|11-16|should|drug
DDI-DrugBank.d123.s13|18-19|be|drug
DDI-DrugBank.d123.s13|21-25|taken|drug
DDI-DrugBank.d123.s13|27-28|as|drug
DDI-DrugBank.d123.s13|30-37|directed|drug
DDI-DrugBank.d123.s13|39-41|and|drug
DDI-DrugBank.d123.s13|43-49|Proquin|drug
DDI-DrugBank.d123.s13|51-52|XR|drug
DDI-DrugBank.d123.s13|54-59|should|drug
DDI-DrugBank.d123.s13|61-62|be|drug
DDI-DrugBank.d123.s13|64-68|taken|drug
DDI-DrugBank.d123.s13|70-73|with|drug
DDI-DrugBank.d123.s13|75-75|a|drug
DDI-DrugBank.d123.s13|77-80|main|drug
DDI-DrugBank.d123.s13|82-85|meal|drug
DDI-DrugBank.d123.s13|87-88|of|drug
DDI-DrugBank.d123.s13|90-92|the|drug
DDI-DrugBank.d123.s13|94-96|day|drug
DDI-DrugBank.d123.s13|97-97|,|drug
DDI-DrugBank.d123.s13|99-108|preferably|drug
DDI-DrugBank.d123.s13|110-112|the|drug
DDI-DrugBank.d123.s13|114-120|evening|drug
DDI-DrugBank.d123.s13|122-127|meal|drug
DDI-DrugBank.d123.s14|0-8|Phenytoin|drug
DDI-DrugBank.d123.s14|9-9|:|drug
DDI-DrugBank.d123.s14|11-17|Altered|drug
DDI-DrugBank.d123.s14|19-23|serum|drug
DDI-DrugBank.d123.s14|25-30|levels|drug
DDI-DrugBank.d123.s14|32-33|of|drug
DDI-DrugBank.d123.s14|35-43|phenytoin|drug
DDI-DrugBank.d123.s14|45-45|(|drug
DDI-DrugBank.d123.s14|46-54|increased|drug
DDI-DrugBank.d123.s14|56-58|and|drug
DDI-DrugBank.d123.s14|60-68|decreased|drug
DDI-DrugBank.d123.s14|69-69|)|drug
DDI-DrugBank.d123.s14|71-74|have|drug
DDI-DrugBank.d123.s14|76-79|been|drug
DDI-DrugBank.d123.s14|81-88|reported|drug
DDI-DrugBank.d123.s14|90-91|in|drug
DDI-DrugBank.d123.s14|93-100|patients|drug
DDI-DrugBank.d123.s14|102-110|receiving|drug
DDI-DrugBank.d123.s14|112-122|concomitant|drug
DDI-DrugBank.d123.s14|124-136|ciprofloxacin|drug
DDI-DrugBank.d123.s14|137-137|.|drug
DDI-DrugBank.d123.s15|0-9|Probenecid|drug
DDI-DrugBank.d123.s15|10-10|:|drug
DDI-DrugBank.d123.s15|12-21|Probenecid|drug
DDI-DrugBank.d123.s15|23-32|interferes|drug
DDI-DrugBank.d123.s15|34-37|with|drug
DDI-DrugBank.d123.s15|39-43|renal|drug
DDI-DrugBank.d123.s15|45-51|tubular|drug
DDI-DrugBank.d123.s15|53-61|secretion|drug
DDI-DrugBank.d123.s15|63-64|of|drug
DDI-DrugBank.d123.s15|66-78|ciprofloxacin|drug
DDI-DrugBank.d123.s15|80-82|and|drug
DDI-DrugBank.d123.s15|84-91|produces|drug
DDI-DrugBank.d123.s15|93-94|an|drug
DDI-DrugBank.d123.s15|96-103|increase|drug
DDI-DrugBank.d123.s15|105-106|in|drug
DDI-DrugBank.d123.s15|108-110|the|drug
DDI-DrugBank.d123.s15|112-116|level|drug
DDI-DrugBank.d123.s15|118-119|of|drug
DDI-DrugBank.d123.s15|121-133|ciprofloxacin|drug
DDI-DrugBank.d123.s15|135-136|in|drug
DDI-DrugBank.d123.s15|138-142|serum|drug
DDI-DrugBank.d123.s15|143-143|.|drug
DDI-DrugBank.d123.s16|0-11|Theophylline|drug
DDI-DrugBank.d123.s16|12-12|:|drug
DDI-DrugBank.d123.s16|14-15|As|drug
DDI-DrugBank.d123.s16|17-20|with|drug
DDI-DrugBank.d123.s16|22-25|some|drug
DDI-DrugBank.d123.s16|27-31|other|drug
DDI-DrugBank.d123.s16|33-42|quinolones|drug
DDI-DrugBank.d123.s16|43-43|,|drug
DDI-DrugBank.d123.s16|45-54|concurrent|drug
DDI-DrugBank.d123.s16|56-69|administration|drug
DDI-DrugBank.d123.s16|71-72|of|drug
DDI-DrugBank.d123.s16|74-86|ciprofloxacin|drug
DDI-DrugBank.d123.s16|88-91|with|drug
DDI-DrugBank.d123.s16|93-104|theophylline|drug
DDI-DrugBank.d123.s16|106-108|may|drug
DDI-DrugBank.d123.s16|110-113|lead|drug
DDI-DrugBank.d123.s16|115-116|to|drug
DDI-DrugBank.d123.s16|118-125|elevated|drug
DDI-DrugBank.d123.s16|127-131|serum|drug
DDI-DrugBank.d123.s16|133-146|concentrations|drug
DDI-DrugBank.d123.s16|148-149|of|drug
DDI-DrugBank.d123.s16|151-162|theophylline|drug
DDI-DrugBank.d123.s16|164-166|and|drug
DDI-DrugBank.d123.s16|168-179|prolongation|drug
DDI-DrugBank.d123.s16|181-182|of|drug
DDI-DrugBank.d123.s16|184-186|its|drug
DDI-DrugBank.d123.s16|188-198|elimination|drug
DDI-DrugBank.d123.s16|200-208|half-life|drug
DDI-DrugBank.d123.s16|209-209|.|drug
DDI-DrugBank.d123.s17|0-3|This|drug
DDI-DrugBank.d123.s17|5-7|may|drug
DDI-DrugBank.d123.s17|9-14|result|drug
DDI-DrugBank.d123.s17|16-17|in|drug
DDI-DrugBank.d123.s17|19-27|increased|drug
DDI-DrugBank.d123.s17|29-32|risk|drug
DDI-DrugBank.d123.s17|34-35|of|drug
DDI-DrugBank.d123.s17|37-56|theophylline-related|drug
DDI-DrugBank.d123.s17|58-64|adverse|drug
DDI-DrugBank.d123.s17|66-74|reactions|drug
DDI-DrugBank.d123.s17|75-75|.|drug
DDI-DrugBank.d123.s18|0-1|If|drug
DDI-DrugBank.d123.s18|3-13|concomitant|drug
DDI-DrugBank.d123.s18|15-17|use|drug
DDI-DrugBank.d123.s18|19-21|can|drug
DDI-DrugBank.d123.s18|22-24|not|drug
DDI-DrugBank.d123.s18|26-27|be|drug
DDI-DrugBank.d123.s18|29-35|avoided|drug
DDI-DrugBank.d123.s18|36-36|,|drug
DDI-DrugBank.d123.s18|38-42|serum|drug
DDI-DrugBank.d123.s18|44-49|levels|drug
DDI-DrugBank.d123.s18|51-52|of|drug
DDI-DrugBank.d123.s18|54-65|theophylline|drug
DDI-DrugBank.d123.s18|67-72|should|drug
DDI-DrugBank.d123.s18|74-75|be|drug
DDI-DrugBank.d123.s18|77-85|monitored|drug
DDI-DrugBank.d123.s18|87-89|and|drug
DDI-DrugBank.d123.s18|91-96|dosage|drug
DDI-DrugBank.d123.s18|98-108|adjustments|drug
DDI-DrugBank.d123.s18|110-113|made|drug
DDI-DrugBank.d123.s18|115-116|as|drug
DDI-DrugBank.d123.s18|118-128|appropriate|drug
DDI-DrugBank.d123.s18|129-129|.|drug
DDI-DrugBank.d123.s19|0-7|Warfarin|drug
DDI-DrugBank.d123.s19|8-8|:|drug
DDI-DrugBank.d123.s19|10-19|Quinolones|drug
DDI-DrugBank.d123.s19|21-24|have|drug
DDI-DrugBank.d123.s19|26-29|been|drug
DDI-DrugBank.d123.s19|31-38|reported|drug
DDI-DrugBank.d123.s19|40-41|to|drug
DDI-DrugBank.d123.s19|43-49|enhance|drug
DDI-DrugBank.d123.s19|51-53|the|drug
DDI-DrugBank.d123.s19|55-61|effects|drug
DDI-DrugBank.d123.s19|63-64|of|drug
DDI-DrugBank.d123.s19|66-68|the|drug
DDI-DrugBank.d123.s19|70-73|oral|drug
DDI-DrugBank.d123.s19|75-87|anticoagulant|drug
DDI-DrugBank.d123.s19|89-96|warfarin|drug
DDI-DrugBank.d123.s19|98-99|or|drug
DDI-DrugBank.d123.s19|101-103|its|drug
DDI-DrugBank.d123.s19|105-115|derivatives|drug
DDI-DrugBank.d123.s19|116-116|.|drug
DDI-DrugBank.d123.s20|0-3|When|drug
DDI-DrugBank.d123.s20|5-9|these|drug
DDI-DrugBank.d123.s20|11-18|products|drug
DDI-DrugBank.d123.s20|20-22|are|drug
DDI-DrugBank.d123.s20|24-35|administered|drug
DDI-DrugBank.d123.s20|37-49|concomitantly|drug
DDI-DrugBank.d123.s20|50-50|,|drug
DDI-DrugBank.d123.s20|52-62|prothrombin|drug
DDI-DrugBank.d123.s20|64-67|time|drug
DDI-DrugBank.d123.s20|69-70|or|drug
DDI-DrugBank.d123.s20|72-76|other|drug
DDI-DrugBank.d123.s20|78-85|suitable|drug
DDI-DrugBank.d123.s20|87-97|coagulation|drug
DDI-DrugBank.d123.s20|99-103|tests|drug
DDI-DrugBank.d123.s20|105-110|should|drug
DDI-DrugBank.d123.s20|112-113|be|drug
DDI-DrugBank.d123.s20|115-123|monitored|drug
DDI-DrugBank.d123.s20|124-124|.|drug
DDI-DrugBank.d404.s0|0-11|Interactions|drug
DDI-DrugBank.d404.s0|13-15|for|drug
DDI-DrugBank.d404.s0|17-23|vitamin|drug
DDI-DrugBank.d404.s0|25-25|D|drug
DDI-DrugBank.d404.s0|27-35|analogues|drug
DDI-DrugBank.d404.s0|37-37|(|drug
DDI-DrugBank.d404.s0|38-44|Vitamin|drug
DDI-DrugBank.d404.s0|46-47|D2|drug
DDI-DrugBank.d404.s0|48-48|,|drug
DDI-DrugBank.d404.s0|50-56|Vitamin|drug
DDI-DrugBank.d404.s0|58-59|D3|drug
DDI-DrugBank.d404.s0|60-60|,|drug
DDI-DrugBank.d404.s0|62-71|Calcitriol|drug
DDI-DrugBank.d404.s0|72-72|,|drug
DDI-DrugBank.d404.s0|74-76|and|drug
DDI-DrugBank.d404.s0|78-86|Calcidiol|drug
DDI-DrugBank.d404.s0|87-87|)|drug
DDI-DrugBank.d404.s0|88-88|:|drug
DDI-DrugBank.d404.s0|90-103|Cholestyramine|drug
DDI-DrugBank.d404.s0|104-104|:|drug
DDI-DrugBank.d404.s0|106-119|Cholestyramine|drug
DDI-DrugBank.d404.s0|121-123|has|drug
DDI-DrugBank.d404.s0|125-128|been|drug
DDI-DrugBank.d404.s0|130-137|reported|drug
DDI-DrugBank.d404.s0|139-140|to|drug
DDI-DrugBank.d404.s0|142-147|reduce|drug
DDI-DrugBank.d404.s0|149-158|intestinal|drug
DDI-DrugBank.d404.s0|160-169|absorption|drug
DDI-DrugBank.d404.s0|171-172|of|drug
DDI-DrugBank.d404.s0|174-176|fat|drug
DDI-DrugBank.d404.s0|178-184|soluble|drug
DDI-DrugBank.d404.s0|186-193|vitamins|drug
DDI-DrugBank.d404.s0|194-194|;|drug
DDI-DrugBank.d404.s1|0-1|as|drug
DDI-DrugBank.d404.s1|3-6|such|drug
DDI-DrugBank.d404.s1|8-9|it|drug
DDI-DrugBank.d404.s1|11-13|may|drug
DDI-DrugBank.d404.s1|15-20|impair|drug
DDI-DrugBank.d404.s1|22-31|intestinal|drug
DDI-DrugBank.d404.s1|33-42|absorption|drug
DDI-DrugBank.d404.s1|44-45|of|drug
DDI-DrugBank.d404.s1|47-49|any|drug
DDI-DrugBank.d404.s1|51-52|of|drug
DDI-DrugBank.d404.s1|54-60|vitamin|drug
DDI-DrugBank.d404.s1|62-62|D|drug
DDI-DrugBank.d404.s1|63-63|.|drug
DDI-DrugBank.d404.s2|0-22|Phenytoin/Phenobarbital|drug
DDI-DrugBank.d404.s2|23-23|:|drug
DDI-DrugBank.d404.s2|25-27|The|drug
DDI-DrugBank.d404.s2|29-44|coadministration|drug
DDI-DrugBank.d404.s2|46-47|of|drug
DDI-DrugBank.d404.s2|49-57|phenytoin|drug
DDI-DrugBank.d404.s2|59-60|or|drug
DDI-DrugBank.d404.s2|62-74|phenobarbital|drug
DDI-DrugBank.d404.s2|76-79|will|drug
DDI-DrugBank.d404.s2|81-83|not|drug
DDI-DrugBank.d404.s2|85-90|affect|drug
DDI-DrugBank.d404.s2|92-97|plasma|drug
DDI-DrugBank.d404.s2|99-112|concentrations|drug
DDI-DrugBank.d404.s2|114-115|of|drug
DDI-DrugBank.d404.s2|117-123|vitamin|drug
DDI-DrugBank.d404.s2|125-125|D|drug
DDI-DrugBank.d404.s2|126-126|,|drug
DDI-DrugBank.d404.s2|128-130|but|drug
DDI-DrugBank.d404.s2|132-134|may|drug
DDI-DrugBank.d404.s2|136-141|reduce|drug
DDI-DrugBank.d404.s2|143-152|endogenous|drug
DDI-DrugBank.d404.s2|154-159|plasma|drug
DDI-DrugBank.d404.s2|161-166|levels|drug
DDI-DrugBank.d404.s2|168-169|of|drug
DDI-DrugBank.d404.s2|171-195|calcitriol/ergocalcitriol|drug
DDI-DrugBank.d404.s2|197-198|by|drug
DDI-DrugBank.d404.s2|200-211|accelerating|drug
DDI-DrugBank.d404.s2|213-222|metabolism|drug
DDI-DrugBank.d404.s2|223-223|.|drug
DDI-DrugBank.d404.s3|0-4|Since|drug
DDI-DrugBank.d404.s3|6-10|blood|drug
DDI-DrugBank.d404.s3|12-16|level|drug
DDI-DrugBank.d404.s3|18-19|of|drug
DDI-DrugBank.d404.s3|21-45|calcitriol/ergocalcitriol|drug
DDI-DrugBank.d404.s3|47-50|will|drug
DDI-DrugBank.d404.s3|52-53|be|drug
DDI-DrugBank.d404.s3|55-61|reduced|drug
DDI-DrugBank.d404.s3|62-62|,|drug
DDI-DrugBank.d404.s3|64-69|higher|drug
DDI-DrugBank.d404.s3|71-75|doses|drug
DDI-DrugBank.d404.s3|77-78|of|drug
DDI-DrugBank.d404.s3|80-88|Rocaltrol|drug
DDI-DrugBank.d404.s3|90-92|may|drug
DDI-DrugBank.d404.s3|94-95|be|drug
DDI-DrugBank.d404.s3|97-105|necessary|drug
DDI-DrugBank.d404.s3|107-108|if|drug
DDI-DrugBank.d404.s3|110-114|these|drug
DDI-DrugBank.d404.s3|116-120|drugs|drug
DDI-DrugBank.d404.s3|122-124|are|drug
DDI-DrugBank.d404.s3|126-137|administered|drug
DDI-DrugBank.d404.s3|139-152|simultaneously|drug
DDI-DrugBank.d404.s3|153-153|.|drug
DDI-DrugBank.d404.s4|0-8|Thiazides|drug
DDI-DrugBank.d404.s4|9-9|:|drug
DDI-DrugBank.d404.s4|11-19|Thiazides|drug
DDI-DrugBank.d404.s4|21-23|are|drug
DDI-DrugBank.d404.s4|25-29|known|drug
DDI-DrugBank.d404.s4|31-32|to|drug
DDI-DrugBank.d404.s4|34-39|induce|drug
DDI-DrugBank.d404.s4|41-53|hypercalcemia|drug
DDI-DrugBank.d404.s4|55-56|by|drug
DDI-DrugBank.d404.s4|58-60|the|drug
DDI-DrugBank.d404.s4|62-70|reduction|drug
DDI-DrugBank.d404.s4|72-73|of|drug
DDI-DrugBank.d404.s4|75-81|calcium|drug
DDI-DrugBank.d404.s4|83-91|excretion|drug
DDI-DrugBank.d404.s4|93-94|in|drug
DDI-DrugBank.d404.s4|96-100|urine|drug
DDI-DrugBank.d404.s4|101-101|.|drug
DDI-DrugBank.d404.s5|0-3|Some|drug
DDI-DrugBank.d404.s5|5-11|reports|drug
DDI-DrugBank.d404.s5|13-16|have|drug
DDI-DrugBank.d404.s5|18-22|shown|drug
DDI-DrugBank.d404.s5|24-27|that|drug
DDI-DrugBank.d404.s5|29-31|the|drug
DDI-DrugBank.d404.s5|33-43|concomitant|drug
DDI-DrugBank.d404.s5|45-58|administration|drug
DDI-DrugBank.d404.s5|60-61|of|drug
DDI-DrugBank.d404.s5|63-71|thiazides|drug
DDI-DrugBank.d404.s5|73-76|with|drug
DDI-DrugBank.d404.s5|78-84|vitamin|drug
DDI-DrugBank.d404.s5|86-86|D|drug
DDI-DrugBank.d404.s5|88-93|causes|drug
DDI-DrugBank.d404.s5|95-107|hypercalcemia|drug
DDI-DrugBank.d404.s5|108-108|.|drug
DDI-DrugBank.d404.s6|0-8|Therefore|drug
DDI-DrugBank.d404.s6|9-9|,|drug
DDI-DrugBank.d404.s6|11-20|precaution|drug
DDI-DrugBank.d404.s6|22-27|should|drug
DDI-DrugBank.d404.s6|29-30|be|drug
DDI-DrugBank.d404.s6|32-36|taken|drug
DDI-DrugBank.d404.s6|38-41|when|drug
DDI-DrugBank.d404.s6|43-58|coadministration|drug
DDI-DrugBank.d404.s6|60-61|is|drug
DDI-DrugBank.d404.s6|63-71|necessary|drug
DDI-DrugBank.d404.s6|72-72|.|drug
DDI-DrugBank.d404.s7|0-8|Digitalis|drug
DDI-DrugBank.d404.s7|9-9|:|drug
DDI-DrugBank.d404.s7|11-17|Vitamin|drug
DDI-DrugBank.d404.s7|19-19|D|drug
DDI-DrugBank.d404.s7|21-26|dosage|drug
DDI-DrugBank.d404.s7|28-31|must|drug
DDI-DrugBank.d404.s7|33-34|be|drug
DDI-DrugBank.d404.s7|36-45|determined|drug
DDI-DrugBank.d404.s7|47-50|with|drug
DDI-DrugBank.d404.s7|52-55|care|drug
DDI-DrugBank.d404.s7|57-58|in|drug
DDI-DrugBank.d404.s7|60-67|patients|drug
DDI-DrugBank.d404.s7|69-78|undergoing|drug
DDI-DrugBank.d404.s7|80-88|treatment|drug
DDI-DrugBank.d404.s7|90-93|with|drug
DDI-DrugBank.d404.s7|95-103|digitalis|drug
DDI-DrugBank.d404.s7|104-104|,|drug
DDI-DrugBank.d404.s7|106-107|as|drug
DDI-DrugBank.d404.s7|109-121|hypercalcemia|drug
DDI-DrugBank.d404.s7|123-124|in|drug
DDI-DrugBank.d404.s7|126-129|such|drug
DDI-DrugBank.d404.s7|131-138|patients|drug
DDI-DrugBank.d404.s7|140-142|may|drug
DDI-DrugBank.d404.s7|144-154|precipitate|drug
DDI-DrugBank.d404.s7|156-162|cardiac|drug
DDI-DrugBank.d404.s7|164-174|arrhythmias|drug
DDI-DrugBank.d404.s7|175-175|.|drug
DDI-DrugBank.d404.s8|0-11|Ketoconazole|drug
DDI-DrugBank.d404.s8|12-12|:|drug
DDI-DrugBank.d404.s8|14-25|Ketoconazole|drug
DDI-DrugBank.d404.s8|27-29|may|drug
DDI-DrugBank.d404.s8|31-37|inhibit|drug
DDI-DrugBank.d404.s8|39-42|both|drug
DDI-DrugBank.d404.s8|44-52|synthetic|drug
DDI-DrugBank.d404.s8|54-56|and|drug
DDI-DrugBank.d404.s8|58-66|catabolic|drug
DDI-DrugBank.d404.s8|68-74|enzymes|drug
DDI-DrugBank.d404.s8|76-77|of|drug
DDI-DrugBank.d404.s8|79-85|vitamin|drug
DDI-DrugBank.d404.s8|87-87|D|drug
DDI-DrugBank.d404.s8|88-88|.|drug
DDI-DrugBank.d404.s9|0-9|Reductions|drug
DDI-DrugBank.d404.s9|11-12|in|drug
DDI-DrugBank.d404.s9|14-18|serum|drug
DDI-DrugBank.d404.s9|20-29|endogenous|drug
DDI-DrugBank.d404.s9|31-37|vitamin|drug
DDI-DrugBank.d404.s9|39-39|D|drug
DDI-DrugBank.d404.s9|41-54|concentrations|drug
DDI-DrugBank.d404.s9|56-59|have|drug
DDI-DrugBank.d404.s9|61-64|been|drug
DDI-DrugBank.d404.s9|66-73|observed|drug
DDI-DrugBank.d404.s9|75-83|following|drug
DDI-DrugBank.d404.s9|85-87|the|drug
DDI-DrugBank.d404.s9|89-102|administration|drug
DDI-DrugBank.d404.s9|104-105|of|drug
DDI-DrugBank.d404.s9|107-109|300|drug
DDI-DrugBank.d404.s9|111-116|mg/day|drug
DDI-DrugBank.d404.s9|118-119|to|drug
DDI-DrugBank.d404.s9|121-124|1200|drug
DDI-DrugBank.d404.s9|126-131|mg/day|drug
DDI-DrugBank.d404.s9|133-144|ketoconazole|drug
DDI-DrugBank.d404.s9|146-148|for|drug
DDI-DrugBank.d404.s9|150-150|a|drug
DDI-DrugBank.d404.s9|152-155|week|drug
DDI-DrugBank.d404.s9|157-158|to|drug
DDI-DrugBank.d404.s9|160-166|healthy|drug
DDI-DrugBank.d404.s9|168-170|men|drug
DDI-DrugBank.d404.s9|171-171|.|drug
DDI-DrugBank.d404.s10|0-6|However|drug
DDI-DrugBank.d404.s10|7-7|,|drug
DDI-DrugBank.d404.s10|9-10|in|drug
DDI-DrugBank.d404.s10|12-15|vivo|drug
DDI-DrugBank.d404.s10|17-20|drug|drug
DDI-DrugBank.d404.s10|22-32|interaction|drug
DDI-DrugBank.d404.s10|34-40|studies|drug
DDI-DrugBank.d404.s10|42-43|of|drug
DDI-DrugBank.d404.s10|45-56|ketoconazole|drug
DDI-DrugBank.d404.s10|58-61|with|drug
DDI-DrugBank.d404.s10|63-69|vitamin|drug
DDI-DrugBank.d404.s10|71-71|D|drug
DDI-DrugBank.d404.s10|73-76|have|drug
DDI-DrugBank.d404.s10|78-80|not|drug
DDI-DrugBank.d404.s10|82-85|been|drug
DDI-DrugBank.d404.s10|87-98|investigated|drug
DDI-DrugBank.d404.s10|99-99|.|drug
DDI-DrugBank.d404.s11|0-14|Corticosteroids|drug
DDI-DrugBank.d404.s11|15-15|:|drug
DDI-DrugBank.d404.s11|17-17|A|drug
DDI-DrugBank.d404.s11|19-30|relationship|drug
DDI-DrugBank.d404.s11|32-33|of|drug
DDI-DrugBank.d404.s11|35-44|functional|drug
DDI-DrugBank.d404.s11|46-55|antagonism|drug
DDI-DrugBank.d404.s11|57-62|exists|drug
DDI-DrugBank.d404.s11|64-70|between|drug
DDI-DrugBank.d404.s11|72-78|vitamin|drug
DDI-DrugBank.d404.s11|80-80|D|drug
DDI-DrugBank.d404.s11|82-90|analogues|drug
DDI-DrugBank.d404.s11|91-91|,|drug
DDI-DrugBank.d404.s11|93-97|which|drug
DDI-DrugBank.d404.s11|99-105|promote|drug
DDI-DrugBank.d404.s11|107-113|calcium|drug
DDI-DrugBank.d404.s11|115-124|absorption|drug
DDI-DrugBank.d404.s11|125-125|,|drug
DDI-DrugBank.d404.s11|127-129|and|drug
DDI-DrugBank.d404.s11|131-145|corticosteroids|drug
DDI-DrugBank.d404.s11|146-146|,|drug
DDI-DrugBank.d404.s11|148-152|which|drug
DDI-DrugBank.d404.s11|154-160|inhibit|drug
DDI-DrugBank.d404.s11|162-168|calcium|drug
DDI-DrugBank.d404.s11|170-179|absorption|drug
DDI-DrugBank.d404.s11|180-180|.|drug
DDI-DrugBank.d404.s12|0-16|Phosphate-Binding|drug
DDI-DrugBank.d404.s12|18-23|Agents|drug
DDI-DrugBank.d404.s12|24-24|:|drug
DDI-DrugBank.d404.s12|26-30|Since|drug
DDI-DrugBank.d404.s12|32-38|vitamin|drug
DDI-DrugBank.d404.s12|40-40|D|drug
DDI-DrugBank.d404.s12|42-45|also|drug
DDI-DrugBank.d404.s12|47-49|has|drug
DDI-DrugBank.d404.s12|51-52|an|drug
DDI-DrugBank.d404.s12|54-59|effect|drug
DDI-DrugBank.d404.s12|61-62|on|drug
DDI-DrugBank.d404.s12|64-72|phosphate|drug
DDI-DrugBank.d404.s12|74-82|transport|drug
DDI-DrugBank.d404.s12|84-85|in|drug
DDI-DrugBank.d404.s12|87-89|the|drug
DDI-DrugBank.d404.s12|91-99|intestine|drug
DDI-DrugBank.d404.s12|100-100|,|drug
DDI-DrugBank.d404.s12|102-108|kidneys|drug
DDI-DrugBank.d404.s12|110-112|and|drug
DDI-DrugBank.d404.s12|114-118|bones|drug
DDI-DrugBank.d404.s12|119-119|,|drug
DDI-DrugBank.d404.s12|121-123|the|drug
DDI-DrugBank.d404.s12|125-130|dosage|drug
DDI-DrugBank.d404.s12|132-133|of|drug
DDI-DrugBank.d404.s12|135-151|phosphate-binding|drug
DDI-DrugBank.d404.s12|153-158|agents|drug
DDI-DrugBank.d404.s12|160-163|must|drug
DDI-DrugBank.d404.s12|165-166|be|drug
DDI-DrugBank.d404.s12|168-175|adjusted|drug
DDI-DrugBank.d404.s12|177-178|in|drug
DDI-DrugBank.d404.s12|180-189|accordance|drug
DDI-DrugBank.d404.s12|191-194|with|drug
DDI-DrugBank.d404.s12|196-198|the|drug
DDI-DrugBank.d404.s12|200-204|serum|drug
DDI-DrugBank.d404.s12|206-214|phosphate|drug
DDI-DrugBank.d404.s12|216-228|concentration|drug
DDI-DrugBank.d404.s12|229-229|.|drug
DDI-DrugBank.d404.s13|0-6|Vitamin|drug
DDI-DrugBank.d404.s13|8-8|D|drug
DDI-DrugBank.d404.s13|9-9|:|drug
DDI-DrugBank.d404.s13|11-13|The|drug
DDI-DrugBank.d404.s13|15-30|coadministration|drug
DDI-DrugBank.d404.s13|32-33|of|drug
DDI-DrugBank.d404.s13|35-37|any|drug
DDI-DrugBank.d404.s13|39-40|of|drug
DDI-DrugBank.d404.s13|42-44|the|drug
DDI-DrugBank.d404.s13|46-52|vitamin|drug
DDI-DrugBank.d404.s13|54-54|D|drug
DDI-DrugBank.d404.s13|56-64|analogues|drug
DDI-DrugBank.d404.s13|66-71|should|drug
DDI-DrugBank.d404.s13|73-74|be|drug
DDI-DrugBank.d404.s13|76-82|avoided|drug
DDI-DrugBank.d404.s13|84-85|as|drug
DDI-DrugBank.d404.s13|87-90|this|drug
DDI-DrugBank.d404.s13|92-96|could|drug
DDI-DrugBank.d404.s13|98-103|create|drug
DDI-DrugBank.d404.s13|105-112|possible|drug
DDI-DrugBank.d404.s13|114-121|additive|drug
DDI-DrugBank.d404.s13|123-129|effects|drug
DDI-DrugBank.d404.s13|131-133|and|drug
DDI-DrugBank.d404.s13|135-147|hypercalcemia|drug
DDI-DrugBank.d404.s13|148-148|.|drug
DDI-DrugBank.d404.s14|0-6|Calcium|drug
DDI-DrugBank.d404.s14|8-18|Supplements|drug
DDI-DrugBank.d404.s14|19-19|:|drug
DDI-DrugBank.d404.s14|21-32|Uncontrolled|drug
DDI-DrugBank.d404.s14|34-39|intake|drug
DDI-DrugBank.d404.s14|41-42|of|drug
DDI-DrugBank.d404.s14|44-53|additional|drug
DDI-DrugBank.d404.s14|55-72|calcium-containing|drug
DDI-DrugBank.d404.s14|74-85|preparations|drug
DDI-DrugBank.d404.s14|87-92|should|drug
DDI-DrugBank.d404.s14|94-95|be|drug
DDI-DrugBank.d404.s14|97-103|avoided|drug
DDI-DrugBank.d404.s14|104-104|.|drug
DDI-DrugBank.d404.s15|0-8|Magnesium|drug
DDI-DrugBank.d404.s15|9-9|:|drug
DDI-DrugBank.d404.s15|11-30|Magnesium-containing|drug
DDI-DrugBank.d404.s15|32-43|preparations|drug
DDI-DrugBank.d404.s15|45-45|(|drug
DDI-DrugBank.d404.s15|46-47|eg|drug
DDI-DrugBank.d404.s15|48-48|,|drug
DDI-DrugBank.d404.s15|50-57|antacids|drug
DDI-DrugBank.d404.s15|58-58|)|drug
DDI-DrugBank.d404.s15|60-62|may|drug
DDI-DrugBank.d404.s15|64-68|cause|drug
DDI-DrugBank.d404.s15|70-84|hypermagnesemia|drug
DDI-DrugBank.d404.s15|86-88|and|drug
DDI-DrugBank.d404.s15|90-95|should|drug
DDI-DrugBank.d404.s15|97-105|therefore|drug
DDI-DrugBank.d404.s15|107-109|not|drug
DDI-DrugBank.d404.s15|111-112|be|drug
DDI-DrugBank.d404.s15|114-118|taken|drug
DDI-DrugBank.d404.s15|120-125|during|drug
DDI-DrugBank.d404.s15|127-133|therapy|drug
DDI-DrugBank.d404.s15|135-138|with|drug
DDI-DrugBank.d404.s15|140-146|vitamin|drug
DDI-DrugBank.d404.s15|148-148|D|drug
DDI-DrugBank.d404.s15|150-151|by|drug
DDI-DrugBank.d404.s15|153-160|patients|drug
DDI-DrugBank.d404.s15|162-163|on|drug
DDI-DrugBank.d404.s15|165-171|chronic|drug
DDI-DrugBank.d404.s15|173-177|renal|drug
DDI-DrugBank.d404.s15|179-186|dialysis|drug
DDI-DrugBank.d404.s15|187-187|.|drug
DDI-DrugBank.d411.s0|0-2|The|drug
DDI-DrugBank.d411.s0|4-12|magnitude|drug
DDI-DrugBank.d411.s0|14-16|and|drug
DDI-DrugBank.d411.s0|18-25|relative|drug
DDI-DrugBank.d411.s0|27-36|importance|drug
DDI-DrugBank.d411.s0|38-39|of|drug
DDI-DrugBank.d411.s0|41-43|the|drug
DDI-DrugBank.d411.s0|45-51|effects|drug
DDI-DrugBank.d411.s0|53-57|noted|drug
DDI-DrugBank.d411.s0|59-63|below|drug
DDI-DrugBank.d411.s0|65-67|are|drug
DDI-DrugBank.d411.s0|69-74|likely|drug
DDI-DrugBank.d411.s0|76-77|to|drug
DDI-DrugBank.d411.s0|79-80|be|drug
DDI-DrugBank.d411.s0|82-88|patient|drug
DDI-DrugBank.d411.s0|90-97|specific|drug
DDI-DrugBank.d411.s0|99-101|and|drug
DDI-DrugBank.d411.s0|103-105|may|drug
DDI-DrugBank.d411.s0|107-110|vary|drug
DDI-DrugBank.d411.s0|112-113|by|drug
DDI-DrugBank.d411.s0|115-118|such|drug
DDI-DrugBank.d411.s0|120-126|factors|drug
DDI-DrugBank.d411.s0|128-129|as|drug
DDI-DrugBank.d411.s0|131-133|age|drug
DDI-DrugBank.d411.s0|134-134|,|drug
DDI-DrugBank.d411.s0|136-141|gender|drug
DDI-DrugBank.d411.s0|142-142|,|drug
DDI-DrugBank.d411.s0|144-147|race|drug
DDI-DrugBank.d411.s0|148-148|,|drug
DDI-DrugBank.d411.s0|150-161|intercurrent|drug
DDI-DrugBank.d411.s0|163-171|illnesses|drug
DDI-DrugBank.d411.s0|172-172|,|drug
DDI-DrugBank.d411.s0|174-177|dose|drug
DDI-DrugBank.d411.s0|179-180|of|drug
DDI-DrugBank.d411.s0|182-187|either|drug
DDI-DrugBank.d411.s0|189-193|agent|drug
DDI-DrugBank.d411.s0|194-194|,|drug
DDI-DrugBank.d411.s0|196-205|additional|drug
DDI-DrugBank.d411.s0|207-217|concomitant|drug
DDI-DrugBank.d411.s0|219-229|medications|drug
DDI-DrugBank.d411.s0|230-230|,|drug
DDI-DrugBank.d411.s0|232-234|and|drug
DDI-DrugBank.d411.s0|236-241|timing|drug
DDI-DrugBank.d411.s0|243-244|of|drug
DDI-DrugBank.d411.s0|246-249|drug|drug
DDI-DrugBank.d411.s0|251-264|administration|drug
DDI-DrugBank.d411.s0|265-265|.|drug
DDI-DrugBank.d411.s1|0-2|Any|drug
DDI-DrugBank.d411.s1|4-8|agent|drug
DDI-DrugBank.d411.s1|10-13|that|drug
DDI-DrugBank.d411.s1|15-20|alters|drug
DDI-DrugBank.d411.s1|22-28|thyroid|drug
DDI-DrugBank.d411.s1|30-36|hormone|drug
DDI-DrugBank.d411.s1|38-46|synthesis|drug
DDI-DrugBank.d411.s1|47-47|,|drug
DDI-DrugBank.d411.s1|49-57|secretion|drug
DDI-DrugBank.d411.s1|58-58|,|drug
DDI-DrugBank.d411.s1|60-71|distribution|drug
DDI-DrugBank.d411.s1|72-72|,|drug
DDI-DrugBank.d411.s1|74-79|effect|drug
DDI-DrugBank.d411.s1|81-82|on|drug
DDI-DrugBank.d411.s1|84-89|target|drug
DDI-DrugBank.d411.s1|91-97|tissues|drug
DDI-DrugBank.d411.s1|98-98|,|drug
DDI-DrugBank.d411.s1|100-109|metabolism|drug
DDI-DrugBank.d411.s1|110-110|,|drug
DDI-DrugBank.d411.s1|112-113|or|drug
DDI-DrugBank.d411.s1|115-125|elimination|drug
DDI-DrugBank.d411.s1|127-129|may|drug
DDI-DrugBank.d411.s1|131-135|alter|drug
DDI-DrugBank.d411.s1|137-139|the|drug
DDI-DrugBank.d411.s1|141-147|optimal|drug
DDI-DrugBank.d411.s1|149-159|therapeutic|drug
DDI-DrugBank.d411.s1|161-164|dose|drug
DDI-DrugBank.d411.s1|166-167|of|drug
DDI-DrugBank.d411.s1|169-181|levothyroxine|drug
DDI-DrugBank.d411.s1|183-188|sodium|drug
DDI-DrugBank.d411.s1|189-189|.|drug
DDI-DrugBank.d411.s2|0-12|Levothyroxine|drug
DDI-DrugBank.d411.s2|14-19|Sodium|drug
DDI-DrugBank.d411.s2|21-30|Absorption|drug
DDI-DrugBank.d411.s2|31-31|:|drug
DDI-DrugBank.d411.s2|33-35|The|drug
DDI-DrugBank.d411.s2|37-45|following|drug
DDI-DrugBank.d411.s2|47-52|agents|drug
DDI-DrugBank.d411.s2|54-56|may|drug
DDI-DrugBank.d411.s2|58-61|bind|drug
DDI-DrugBank.d411.s2|63-65|and|drug
DDI-DrugBank.d411.s2|67-74|decrease|drug
DDI-DrugBank.d411.s2|76-85|absorption|drug
DDI-DrugBank.d411.s2|87-88|of|drug
DDI-DrugBank.d411.s2|90-102|levothyroxine|drug
DDI-DrugBank.d411.s2|104-109|sodium|drug
DDI-DrugBank.d411.s2|111-114|from|drug
DDI-DrugBank.d411.s2|116-118|the|drug
DDI-DrugBank.d411.s2|120-135|gastrointestinal|drug
DDI-DrugBank.d411.s2|137-141|tract|drug
DDI-DrugBank.d411.s2|142-142|:|drug
DDI-DrugBank.d411.s2|144-151|aluminum|drug
DDI-DrugBank.d411.s2|153-160|hydoxide|drug
DDI-DrugBank.d411.s2|161-161|,|drug
DDI-DrugBank.d411.s2|163-176|cholestyramine|drug
DDI-DrugBank.d411.s2|178-182|resin|drug
DDI-DrugBank.d411.s2|183-183|,|drug
DDI-DrugBank.d411.s2|185-194|colestipol|drug
DDI-DrugBank.d411.s2|196-208|hydrochloride|drug
DDI-DrugBank.d411.s2|209-209|,|drug
DDI-DrugBank.d411.s2|211-217|ferrous|drug
DDI-DrugBank.d411.s2|219-225|sulfate|drug
DDI-DrugBank.d411.s2|226-226|,|drug
DDI-DrugBank.d411.s2|228-233|sodium|drug
DDI-DrugBank.d411.s2|235-245|polystyrene|drug
DDI-DrugBank.d411.s2|247-255|sulfonate|drug
DDI-DrugBank.d411.s2|256-256|,|drug
DDI-DrugBank.d411.s2|258-264|soybean|drug
DDI-DrugBank.d411.s2|266-270|flour|drug
DDI-DrugBank.d411.s2|272-272|(|drug
DDI-DrugBank.d411.s2|273-276|e.g.|drug
DDI-DrugBank.d411.s2|277-277|,|drug
DDI-DrugBank.d411.s2|279-284|infant|drug
DDI-DrugBank.d411.s2|286-292|formula|drug
DDI-DrugBank.d411.s2|293-293|)|drug
DDI-DrugBank.d411.s2|294-294|,|drug
DDI-DrugBank.d411.s2|296-305|sucralfate|drug
DDI-DrugBank.d411.s2|306-306|.|drug
DDI-DrugBank.d411.s3|0-6|Binding|drug
DDI-DrugBank.d411.s3|8-9|to|drug
DDI-DrugBank.d411.s3|11-15|Serum|drug
DDI-DrugBank.d411.s3|17-24|Proteins|drug
DDI-DrugBank.d411.s3|25-25|:|drug
DDI-DrugBank.d411.s3|27-29|The|drug
DDI-DrugBank.d411.s3|31-39|following|drug
DDI-DrugBank.d411.s3|41-46|agents|drug
DDI-DrugBank.d411.s3|48-50|may|drug
DDI-DrugBank.d411.s3|52-57|either|drug
DDI-DrugBank.d411.s3|59-65|inhibit|drug
DDI-DrugBank.d411.s3|67-79|levothyroxine|drug
DDI-DrugBank.d411.s3|81-86|sodium|drug
DDI-DrugBank.d411.s3|88-94|binding|drug
DDI-DrugBank.d411.s3|96-97|to|drug
DDI-DrugBank.d411.s3|99-103|serum|drug
DDI-DrugBank.d411.s3|105-112|proteins|drug
DDI-DrugBank.d411.s3|114-115|or|drug
DDI-DrugBank.d411.s3|117-121|alter|drug
DDI-DrugBank.d411.s3|123-125|the|drug
DDI-DrugBank.d411.s3|127-140|concentrations|drug
DDI-DrugBank.d411.s3|142-143|of|drug
DDI-DrugBank.d411.s3|145-149|serum|drug
DDI-DrugBank.d411.s3|151-157|binding|drug
DDI-DrugBank.d411.s3|159-166|proteins|drug
DDI-DrugBank.d411.s3|167-167|:|drug
DDI-DrugBank.d411.s3|169-177|androgens|drug
DDI-DrugBank.d411.s3|179-181|and|drug
DDI-DrugBank.d411.s3|183-189|related|drug
DDI-DrugBank.d411.s3|191-198|anabolic|drug
DDI-DrugBank.d411.s3|200-207|hormones|drug
DDI-DrugBank.d411.s3|208-208|,|drug
DDI-DrugBank.d411.s3|210-221|asparaginase|drug
DDI-DrugBank.d411.s3|222-222|,|drug
DDI-DrugBank.d411.s3|224-233|clofibrate|drug
DDI-DrugBank.d411.s3|234-234|,|drug
DDI-DrugBank.d411.s3|236-244|estrogens|drug
DDI-DrugBank.d411.s3|246-248|and|drug
DDI-DrugBank.d411.s3|250-268|estrogen-containing|drug
DDI-DrugBank.d411.s3|270-278|compounds|drug
DDI-DrugBank.d411.s3|279-279|,|drug
DDI-DrugBank.d411.s3|281-294|5-fluorouracil|drug
DDI-DrugBank.d411.s3|295-295|,|drug
DDI-DrugBank.d411.s3|297-306|furosemide|drug
DDI-DrugBank.d411.s3|307-307|,|drug
DDI-DrugBank.d411.s3|309-323|glucocorticoids|drug
DDI-DrugBank.d411.s3|324-324|,|drug
DDI-DrugBank.d411.s3|326-337|meclofenamic|drug
DDI-DrugBank.d411.s3|339-342|acid|drug
DDI-DrugBank.d411.s3|343-343|,|drug
DDI-DrugBank.d411.s3|345-353|mefenamic|drug
DDI-DrugBank.d411.s3|355-358|acid|drug
DDI-DrugBank.d411.s3|359-359|,|drug
DDI-DrugBank.d411.s3|361-369|methadone|drug
DDI-DrugBank.d411.s3|370-370|,|drug
DDI-DrugBank.d411.s3|372-383|perphenazine|drug
DDI-DrugBank.d411.s3|384-384|,|drug
DDI-DrugBank.d411.s3|386-399|phenylbutazone|drug
DDI-DrugBank.d411.s3|400-400|,|drug
DDI-DrugBank.d411.s3|402-410|phenytoin|drug
DDI-DrugBank.d411.s3|411-411|,|drug
DDI-DrugBank.d411.s3|413-423|salicylates|drug
DDI-DrugBank.d411.s3|424-424|,|drug
DDI-DrugBank.d411.s3|426-434|tamoxifen|drug
DDI-DrugBank.d411.s3|435-435|.|drug
DDI-DrugBank.d411.s4|0-6|Thyroid|drug
DDI-DrugBank.d411.s4|8-17|Physiology|drug
DDI-DrugBank.d411.s4|18-18|:|drug
DDI-DrugBank.d411.s4|20-22|The|drug
DDI-DrugBank.d411.s4|24-32|following|drug
DDI-DrugBank.d411.s4|34-39|agents|drug
DDI-DrugBank.d411.s4|41-43|may|drug
DDI-DrugBank.d411.s4|45-49|alter|drug
DDI-DrugBank.d411.s4|51-57|thyroid|drug
DDI-DrugBank.d411.s4|59-65|hormone|drug
DDI-DrugBank.d411.s4|67-68|or|drug
DDI-DrugBank.d411.s4|70-72|TSH|drug
DDI-DrugBank.d411.s4|74-79|levels|drug
DDI-DrugBank.d411.s4|80-80|,|drug
DDI-DrugBank.d411.s4|82-90|generally|drug
DDI-DrugBank.d411.s4|92-93|by|drug
DDI-DrugBank.d411.s4|95-101|effects|drug
DDI-DrugBank.d411.s4|103-104|on|drug
DDI-DrugBank.d411.s4|106-112|thyroid|drug
DDI-DrugBank.d411.s4|114-120|hormone|drug
DDI-DrugBank.d411.s4|122-130|synthesis|drug
DDI-DrugBank.d411.s4|131-131|,|drug
DDI-DrugBank.d411.s4|133-141|secretion|drug
DDI-DrugBank.d411.s4|142-142|,|drug
DDI-DrugBank.d411.s4|144-155|distribution|drug
DDI-DrugBank.d411.s4|156-156|,|drug
DDI-DrugBank.d411.s4|158-167|metabolism|drug
DDI-DrugBank.d411.s4|168-168|,|drug
DDI-DrugBank.d411.s4|170-176|hormone|drug
DDI-DrugBank.d411.s4|178-183|action|drug
DDI-DrugBank.d411.s4|184-184|,|drug
DDI-DrugBank.d411.s4|186-187|or|drug
DDI-DrugBank.d411.s4|189-199|elimination|drug
DDI-DrugBank.d411.s4|200-200|,|drug
DDI-DrugBank.d411.s4|202-203|or|drug
DDI-DrugBank.d411.s4|205-211|altered|drug
DDI-DrugBank.d411.s4|213-215|TSH|drug
DDI-DrugBank.d411.s4|217-225|secretion|drug
DDI-DrugBank.d411.s4|226-226|:|drug
DDI-DrugBank.d411.s4|228-244|aminoglutethimide|drug
DDI-DrugBank.d411.s4|245-245|,|drug
DDI-DrugBank.d411.s4|247-262|p-aminosalicylic|drug
DDI-DrugBank.d411.s4|264-267|acid|drug
DDI-DrugBank.d411.s4|268-268|,|drug
DDI-DrugBank.d411.s4|270-279|amiodarone|drug
DDI-DrugBank.d411.s4|280-280|,|drug
DDI-DrugBank.d411.s4|282-290|androgens|drug
DDI-DrugBank.d411.s4|292-294|and|drug
DDI-DrugBank.d411.s4|296-302|related|drug
DDI-DrugBank.d411.s4|304-311|anabolic|drug
DDI-DrugBank.d411.s4|313-320|hormones|drug
DDI-DrugBank.d411.s4|321-321|,|drug
DDI-DrugBank.d411.s4|323-329|complex|drug
DDI-DrugBank.d411.s4|331-336|anions|drug
DDI-DrugBank.d411.s4|338-338|(|drug
DDI-DrugBank.d411.s4|339-349|thiocyanate|drug
DDI-DrugBank.d411.s4|350-350|,|drug
DDI-DrugBank.d411.s4|352-362|perchlorate|drug
DDI-DrugBank.d411.s4|363-363|,|drug
DDI-DrugBank.d411.s4|365-377|pertechnetate|drug
DDI-DrugBank.d411.s4|378-378|)|drug
DDI-DrugBank.d411.s4|379-379|,|drug
DDI-DrugBank.d411.s4|381-391|antithyroid|drug
DDI-DrugBank.d411.s4|393-397|drugs|drug
DDI-DrugBank.d411.s4|398-398|,|drug
DDI-DrugBank.d411.s4|400-411|b-adrenergic|drug
DDI-DrugBank.d411.s4|413-420|blocking|drug
DDI-DrugBank.d411.s4|422-427|agents|drug
DDI-DrugBank.d411.s4|428-428|,|drug
DDI-DrugBank.d411.s4|430-442|carbamazepine|drug
DDI-DrugBank.d411.s4|443-443|,|drug
DDI-DrugBank.d411.s4|445-451|chloral|drug
DDI-DrugBank.d411.s4|453-459|hydrate|drug
DDI-DrugBank.d411.s4|460-460|,|drug
DDI-DrugBank.d411.s4|462-469|diazepam|drug
DDI-DrugBank.d411.s4|470-470|,|drug
DDI-DrugBank.d411.s4|472-479|dopamine|drug
DDI-DrugBank.d411.s4|481-483|and|drug
DDI-DrugBank.d411.s4|485-492|dopamine|drug
DDI-DrugBank.d411.s4|494-501|agonists|drug
DDI-DrugBank.d411.s4|502-502|,|drug
DDI-DrugBank.d411.s4|504-514|ethionamide|drug
DDI-DrugBank.d411.s4|515-515|,|drug
DDI-DrugBank.d411.s4|517-531|glucocorticoids|drug
DDI-DrugBank.d411.s4|532-532|,|drug
DDI-DrugBank.d411.s4|534-540|heparin|drug
DDI-DrugBank.d411.s4|541-541|,|drug
DDI-DrugBank.d411.s4|543-549|hepatic|drug
DDI-DrugBank.d411.s4|551-556|enzyme|drug
DDI-DrugBank.d411.s4|558-565|inducers|drug
DDI-DrugBank.d411.s4|566-566|,|drug
DDI-DrugBank.d411.s4|568-574|insulin|drug
DDI-DrugBank.d411.s4|575-575|,|drug
DDI-DrugBank.d411.s4|577-585|iodinated|drug
DDI-DrugBank.d411.s4|587-601|cholestographic|drug
DDI-DrugBank.d411.s4|603-608|agents|drug
DDI-DrugBank.d411.s4|609-609|,|drug
DDI-DrugBank.d411.s4|611-627|iodine-containing|drug
DDI-DrugBank.d411.s4|629-637|compounds|drug
DDI-DrugBank.d411.s4|638-638|,|drug
DDI-DrugBank.d411.s4|640-647|levodopa|drug
DDI-DrugBank.d411.s4|648-648|,|drug
DDI-DrugBank.d411.s4|650-659|lovastatin|drug
DDI-DrugBank.d411.s4|660-660|,|drug
DDI-DrugBank.d411.s4|662-668|lithium|drug
DDI-DrugBank.d411.s4|669-669|,|drug
DDI-DrugBank.d411.s4|671-686|6-mercaptopurine|drug
DDI-DrugBank.d411.s4|687-687|,|drug
DDI-DrugBank.d411.s4|689-702|metoclopramide|drug
DDI-DrugBank.d411.s4|703-703|,|drug
DDI-DrugBank.d411.s4|705-712|mitotane|drug
DDI-DrugBank.d411.s4|713-713|,|drug
DDI-DrugBank.d411.s4|715-727|nitroprusside|drug
DDI-DrugBank.d411.s4|728-728|,|drug
DDI-DrugBank.d411.s4|730-742|phenobarbital|drug
DDI-DrugBank.d411.s4|743-743|,|drug
DDI-DrugBank.d411.s4|745-753|phenytoin|drug
DDI-DrugBank.d411.s4|754-754|,|drug
DDI-DrugBank.d411.s4|756-765|resorcinol|drug
DDI-DrugBank.d411.s4|766-766|,|drug
DDI-DrugBank.d411.s4|768-775|rifampin|drug
DDI-DrugBank.d411.s4|776-776|,|drug
DDI-DrugBank.d411.s4|778-789|somatostatin|drug
DDI-DrugBank.d411.s4|791-797|analogs|drug
DDI-DrugBank.d411.s4|798-798|,|drug
DDI-DrugBank.d411.s4|800-811|sulfonamides|drug
DDI-DrugBank.d411.s4|812-812|,|drug
DDI-DrugBank.d411.s4|814-826|sulfonylureas|drug
DDI-DrugBank.d411.s4|827-827|,|drug
DDI-DrugBank.d411.s4|829-836|thiazide|drug
DDI-DrugBank.d411.s4|838-846|diuretics|drug
DDI-DrugBank.d411.s4|847-847|.|drug
DDI-DrugBank.d411.s5|0-15|Adrenocorticoids|drug
DDI-DrugBank.d411.s5|16-16|:|drug
DDI-DrugBank.d411.s5|18-26|Metabolic|drug
DDI-DrugBank.d411.s5|28-36|clearance|drug
DDI-DrugBank.d411.s5|38-39|of|drug
DDI-DrugBank.d411.s5|41-56|adrenocorticoids|drug
DDI-DrugBank.d411.s5|58-59|is|drug
DDI-DrugBank.d411.s5|61-69|decreased|drug
DDI-DrugBank.d411.s5|71-72|in|drug
DDI-DrugBank.d411.s5|74-84|hypothyroid|drug
DDI-DrugBank.d411.s5|86-93|patients|drug
DDI-DrugBank.d411.s5|95-97|and|drug
DDI-DrugBank.d411.s5|99-107|increased|drug
DDI-DrugBank.d411.s5|109-110|in|drug
DDI-DrugBank.d411.s5|112-123|hyperthyroid|drug
DDI-DrugBank.d411.s5|125-132|patients|drug
DDI-DrugBank.d411.s5|133-133|,|drug
DDI-DrugBank.d411.s5|135-137|and|drug
DDI-DrugBank.d411.s5|139-141|may|drug
DDI-DrugBank.d411.s5|143-151|therefore|drug
DDI-DrugBank.d411.s5|153-158|change|drug
DDI-DrugBank.d411.s5|160-163|with|drug
DDI-DrugBank.d411.s5|165-172|changing|drug
DDI-DrugBank.d411.s5|174-180|thyroid|drug
DDI-DrugBank.d411.s5|182-187|status|drug
DDI-DrugBank.d411.s5|188-188|.|drug
DDI-DrugBank.d411.s6|0-9|Amiodarone|drug
DDI-DrugBank.d411.s6|10-10|:|drug
DDI-DrugBank.d411.s6|12-21|Amiodarone|drug
DDI-DrugBank.d411.s6|23-29|therapy|drug
DDI-DrugBank.d411.s6|31-35|alone|drug
DDI-DrugBank.d411.s6|37-39|can|drug
DDI-DrugBank.d411.s6|41-45|cause|drug
DDI-DrugBank.d411.s6|47-60|hypothyroidism|drug
DDI-DrugBank.d411.s6|62-63|or|drug
DDI-DrugBank.d411.s6|65-79|hyperthyroidism|drug
DDI-DrugBank.d411.s6|80-80|.|drug
DDI-DrugBank.d411.s7|0-13|Anticoagulants|drug
DDI-DrugBank.d411.s7|15-15|(|drug
DDI-DrugBank.d411.s7|16-19|Oral|drug
DDI-DrugBank.d411.s7|20-20|)|drug
DDI-DrugBank.d411.s7|21-21|:|drug
DDI-DrugBank.d411.s7|23-25|The|drug
DDI-DrugBank.d411.s7|27-45|hypoprothrombinemic|drug
DDI-DrugBank.d411.s7|47-52|effect|drug
DDI-DrugBank.d411.s7|54-55|of|drug
DDI-DrugBank.d411.s7|57-70|anticoagulants|drug
DDI-DrugBank.d411.s7|72-74|may|drug
DDI-DrugBank.d411.s7|76-77|be|drug
DDI-DrugBank.d411.s7|79-89|potentiated|drug
DDI-DrugBank.d411.s7|90-90|,|drug
DDI-DrugBank.d411.s7|92-101|apparently|drug
DDI-DrugBank.d411.s7|103-104|by|drug
DDI-DrugBank.d411.s7|106-114|increased|drug
DDI-DrugBank.d411.s7|116-125|catabloism|drug
DDI-DrugBank.d411.s7|127-128|of|drug
DDI-DrugBank.d411.s7|130-136|vitamin|drug
DDI-DrugBank.d411.s7|138-148|K-dependent|drug
DDI-DrugBank.d411.s7|150-157|clotting|drug
DDI-DrugBank.d411.s7|159-165|factors|drug
DDI-DrugBank.d411.s7|166-166|.|drug
DDI-DrugBank.d411.s8|0-11|Antidiabetic|drug
DDI-DrugBank.d411.s8|13-18|Agents|drug
DDI-DrugBank.d411.s8|20-20|(|drug
DDI-DrugBank.d411.s8|21-27|Insulin|drug
DDI-DrugBank.d411.s8|28-28|,|drug
DDI-DrugBank.d411.s8|30-42|Sulfonylureas|drug
DDI-DrugBank.d411.s8|43-43|)|drug
DDI-DrugBank.d411.s8|44-44|:|drug
DDI-DrugBank.d411.s8|46-57|Requirements|drug
DDI-DrugBank.d411.s8|59-61|for|drug
DDI-DrugBank.d411.s8|63-69|insulin|drug
DDI-DrugBank.d411.s8|71-72|or|drug
DDI-DrugBank.d411.s8|74-77|oral|drug
DDI-DrugBank.d411.s8|79-90|antidiabetic|drug
DDI-DrugBank.d411.s8|92-97|agents|drug
DDI-DrugBank.d411.s8|99-101|may|drug
DDI-DrugBank.d411.s8|103-104|be|drug
DDI-DrugBank.d411.s8|106-112|reduced|drug
DDI-DrugBank.d411.s8|114-115|in|drug
DDI-DrugBank.d411.s8|117-127|hypothyroid|drug
DDI-DrugBank.d411.s8|129-136|patients|drug
DDI-DrugBank.d411.s8|138-141|with|drug
DDI-DrugBank.d411.s8|143-150|diabetes|drug
DDI-DrugBank.d411.s8|152-159|mellitus|drug
DDI-DrugBank.d411.s8|161-163|and|drug
DDI-DrugBank.d411.s8|165-167|may|drug
DDI-DrugBank.d411.s8|169-180|subsequently|drug
DDI-DrugBank.d411.s8|182-189|increase|drug
DDI-DrugBank.d411.s8|191-194|with|drug
DDI-DrugBank.d411.s8|196-198|the|drug
DDI-DrugBank.d411.s8|200-209|initiation|drug
DDI-DrugBank.d411.s8|211-212|of|drug
DDI-DrugBank.d411.s8|214-220|thyroid|drug
DDI-DrugBank.d411.s8|222-228|hormone|drug
DDI-DrugBank.d411.s8|230-240|replacement|drug
DDI-DrugBank.d411.s8|242-248|therapy|drug
DDI-DrugBank.d411.s8|249-249|.|drug
DDI-DrugBank.d411.s9|0-11|b-Adrenergic|drug
DDI-DrugBank.d411.s9|13-20|Blocking|drug
DDI-DrugBank.d411.s9|22-27|Agents|drug
DDI-DrugBank.d411.s9|28-28|:|drug
DDI-DrugBank.d411.s9|30-36|Actions|drug
DDI-DrugBank.d411.s9|38-39|of|drug
DDI-DrugBank.d411.s9|41-44|some|drug
DDI-DrugBank.d411.s9|46-47|of|drug
DDI-DrugBank.d411.s9|49-61|beta-blocking|drug
DDI-DrugBank.d411.s9|63-68|agents|drug
DDI-DrugBank.d411.s9|70-72|may|drug
DDI-DrugBank.d411.s9|74-75|be|drug
DDI-DrugBank.d411.s9|77-84|impaired|drug
DDI-DrugBank.d411.s9|86-89|when|drug
DDI-DrugBank.d411.s9|91-101|hypothyroid|drug
DDI-DrugBank.d411.s9|103-110|patients|drug
DDI-DrugBank.d411.s9|112-117|become|drug
DDI-DrugBank.d411.s9|119-127|euthyroid|drug
DDI-DrugBank.d411.s9|128-128|.|drug
DDI-DrugBank.d411.s10|0-8|Cytokines|drug
DDI-DrugBank.d411.s10|10-10|(|drug
DDI-DrugBank.d411.s10|11-20|interferon|drug
DDI-DrugBank.d411.s10|21-21|,|drug
DDI-DrugBank.d411.s10|23-33|interleukin|drug
DDI-DrugBank.d411.s10|34-34|)|drug
DDI-DrugBank.d411.s10|35-35|:|drug
DDI-DrugBank.d411.s10|37-45|Cytokines|drug
DDI-DrugBank.d411.s10|47-50|have|drug
DDI-DrugBank.d411.s10|52-55|been|drug
DDI-DrugBank.d411.s10|57-64|reported|drug
DDI-DrugBank.d411.s10|66-67|to|drug
DDI-DrugBank.d411.s10|69-74|induce|drug
DDI-DrugBank.d411.s10|76-79|both|drug
DDI-DrugBank.d411.s10|81-95|hyperthyroidism|drug
DDI-DrugBank.d411.s10|97-99|and|drug
DDI-DrugBank.d411.s10|101-114|hypothyroidism|drug
DDI-DrugBank.d411.s10|115-115|.|drug
DDI-DrugBank.d411.s11|0-8|Digitalis|drug
DDI-DrugBank.d411.s11|10-19|Glycosides|drug
DDI-DrugBank.d411.s11|20-20|:|drug
DDI-DrugBank.d411.s11|22-32|Therapeutic|drug
DDI-DrugBank.d411.s11|34-40|effects|drug
DDI-DrugBank.d411.s11|42-43|of|drug
DDI-DrugBank.d411.s11|45-53|digitalis|drug
DDI-DrugBank.d411.s11|55-64|glycosides|drug
DDI-DrugBank.d411.s11|66-68|may|drug
DDI-DrugBank.d411.s11|70-71|be|drug
DDI-DrugBank.d411.s11|73-79|reduced|drug
DDI-DrugBank.d411.s11|80-80|.|drug
DDI-DrugBank.d411.s12|0-4|Serum|drug
DDI-DrugBank.d411.s12|6-14|digitalis|drug
DDI-DrugBank.d411.s12|16-21|levels|drug
DDI-DrugBank.d411.s12|23-25|may|drug
DDI-DrugBank.d411.s12|27-28|be|drug
DDI-DrugBank.d411.s12|30-38|decreased|drug
DDI-DrugBank.d411.s12|40-41|in|drug
DDI-DrugBank.d411.s12|43-57|hyperthyroidism|drug
DDI-DrugBank.d411.s12|59-60|or|drug
DDI-DrugBank.d411.s12|62-65|when|drug
DDI-DrugBank.d411.s12|67-67|a|drug
DDI-DrugBank.d411.s12|69-79|hypothyroid|drug
DDI-DrugBank.d411.s12|81-87|patient|drug
DDI-DrugBank.d411.s12|89-95|becomes|drug
DDI-DrugBank.d411.s12|97-105|euthyroid|drug
DDI-DrugBank.d411.s12|106-106|.|drug
DDI-DrugBank.d411.s13|0-7|Ketamine|drug
DDI-DrugBank.d411.s13|8-8|:|drug
DDI-DrugBank.d411.s13|10-15|Marked|drug
DDI-DrugBank.d411.s13|17-28|hypertension|drug
DDI-DrugBank.d411.s13|30-32|and|drug
DDI-DrugBank.d411.s13|34-44|tachycardia|drug
DDI-DrugBank.d411.s13|46-49|have|drug
DDI-DrugBank.d411.s13|51-54|been|drug
DDI-DrugBank.d411.s13|56-63|reported|drug
DDI-DrugBank.d411.s13|65-66|in|drug
DDI-DrugBank.d411.s13|68-78|association|drug
DDI-DrugBank.d411.s13|80-83|with|drug
DDI-DrugBank.d411.s13|85-95|concomitant|drug
DDI-DrugBank.d411.s13|97-110|administration|drug
DDI-DrugBank.d411.s13|112-113|of|drug
DDI-DrugBank.d411.s13|115-127|levothyroxine|drug
DDI-DrugBank.d411.s13|129-134|sodium|drug
DDI-DrugBank.d411.s13|136-138|and|drug
DDI-DrugBank.d411.s13|140-147|ketamine|drug
DDI-DrugBank.d411.s13|148-148|.|drug
DDI-DrugBank.d411.s14|0-10|Maprotiline|drug
DDI-DrugBank.d411.s14|11-11|:|drug
DDI-DrugBank.d411.s14|13-16|Risk|drug
DDI-DrugBank.d411.s14|18-19|of|drug
DDI-DrugBank.d411.s14|21-27|cardiac|drug
DDI-DrugBank.d411.s14|29-39|arrhythmias|drug
DDI-DrugBank.d411.s14|41-43|may|drug
DDI-DrugBank.d411.s14|45-52|increase|drug
DDI-DrugBank.d411.s14|53-53|.|drug
DDI-DrugBank.d411.s15|0-5|Sodium|drug
DDI-DrugBank.d411.s15|7-12|Iodide|drug
DDI-DrugBank.d411.s15|14-14|(|drug
DDI-DrugBank.d411.s15|15-18|123I|drug
DDI-DrugBank.d411.s15|20-22|and|drug
DDI-DrugBank.d411.s15|24-27|131I|drug
DDI-DrugBank.d411.s15|28-28|)|drug
DDI-DrugBank.d411.s15|29-29|,|drug
DDI-DrugBank.d411.s15|31-36|Sodium|drug
DDI-DrugBank.d411.s15|38-50|Pertechnetate|drug
DDI-DrugBank.d411.s15|52-56|Tc99m|drug
DDI-DrugBank.d411.s15|57-57|:|drug
DDI-DrugBank.d411.s15|59-64|Uptake|drug
DDI-DrugBank.d411.s15|66-67|of|drug
DDI-DrugBank.d411.s15|69-80|radiolabeled|drug
DDI-DrugBank.d411.s15|82-85|ions|drug
DDI-DrugBank.d411.s15|87-89|may|drug
DDI-DrugBank.d411.s15|91-92|be|drug
DDI-DrugBank.d411.s15|94-102|decreased|drug
DDI-DrugBank.d411.s15|103-103|.|drug
DDI-DrugBank.d411.s16|0-18|Somatrem/Somatropin|drug
DDI-DrugBank.d411.s16|19-19|:|drug
DDI-DrugBank.d411.s16|21-29|Excessive|drug
DDI-DrugBank.d411.s16|31-40|concurrent|drug
DDI-DrugBank.d411.s16|42-44|use|drug
DDI-DrugBank.d411.s16|46-47|of|drug
DDI-DrugBank.d411.s16|49-55|thyroid|drug
DDI-DrugBank.d411.s16|57-63|hormone|drug
DDI-DrugBank.d411.s16|65-67|may|drug
DDI-DrugBank.d411.s16|69-78|accelerate|drug
DDI-DrugBank.d411.s16|80-89|epiphyseal|drug
DDI-DrugBank.d411.s16|91-97|closure|drug
DDI-DrugBank.d411.s16|98-98|.|drug
DDI-DrugBank.d411.s17|0-8|Untreated|drug
DDI-DrugBank.d411.s17|10-23|hypothyroidism|drug
DDI-DrugBank.d411.s17|25-27|may|drug
DDI-DrugBank.d411.s17|29-37|interfere|drug
DDI-DrugBank.d411.s17|39-42|with|drug
DDI-DrugBank.d411.s17|44-46|the|drug
DDI-DrugBank.d411.s17|48-53|growth|drug
DDI-DrugBank.d411.s17|55-62|response|drug
DDI-DrugBank.d411.s17|64-65|to|drug
DDI-DrugBank.d411.s17|67-74|somatrem|drug
DDI-DrugBank.d411.s17|76-77|or|drug
DDI-DrugBank.d411.s17|79-88|somatropin|drug
DDI-DrugBank.d411.s17|89-89|.|drug
DDI-DrugBank.d411.s18|0-11|Theophylline|drug
DDI-DrugBank.d411.s18|12-12|:|drug
DDI-DrugBank.d411.s18|14-25|Theophylline|drug
DDI-DrugBank.d411.s18|27-35|clearance|drug
DDI-DrugBank.d411.s18|37-39|may|drug
DDI-DrugBank.d411.s18|41-48|decrease|drug
DDI-DrugBank.d411.s18|50-51|in|drug
DDI-DrugBank.d411.s18|53-63|hypothyroid|drug
DDI-DrugBank.d411.s18|65-72|patients|drug
DDI-DrugBank.d411.s18|74-76|and|drug
DDI-DrugBank.d411.s18|78-83|return|drug
DDI-DrugBank.d411.s18|85-90|toward|drug
DDI-DrugBank.d411.s18|92-97|normal|drug
DDI-DrugBank.d411.s18|99-102|when|drug
DDI-DrugBank.d411.s18|104-104|a|drug
DDI-DrugBank.d411.s18|106-114|euthyroid|drug
DDI-DrugBank.d411.s18|116-120|state|drug
DDI-DrugBank.d411.s18|122-123|is|drug
DDI-DrugBank.d411.s18|125-132|achieved|drug
DDI-DrugBank.d411.s18|133-133|.|drug
DDI-DrugBank.d411.s19|0-8|Tricyclic|drug
DDI-DrugBank.d411.s19|10-24|Antidepressants|drug
DDI-DrugBank.d411.s19|25-25|:|drug
DDI-DrugBank.d411.s19|27-36|Concurrent|drug
DDI-DrugBank.d411.s19|38-40|use|drug
DDI-DrugBank.d411.s19|42-44|may|drug
DDI-DrugBank.d411.s19|46-53|increase|drug
DDI-DrugBank.d411.s19|55-57|the|drug
DDI-DrugBank.d411.s19|59-69|therapeutic|drug
DDI-DrugBank.d411.s19|71-73|and|drug
DDI-DrugBank.d411.s19|75-79|toxic|drug
DDI-DrugBank.d411.s19|81-87|effects|drug
DDI-DrugBank.d411.s19|89-90|of|drug
DDI-DrugBank.d411.s19|92-95|both|drug
DDI-DrugBank.d411.s19|97-101|drugs|drug
DDI-DrugBank.d411.s19|102-102|,|drug
DDI-DrugBank.d411.s19|104-111|possibly|drug
DDI-DrugBank.d411.s19|113-115|due|drug
DDI-DrugBank.d411.s19|117-118|to|drug
DDI-DrugBank.d411.s19|120-128|increased|drug
DDI-DrugBank.d411.s19|130-142|catecholamine|drug
DDI-DrugBank.d411.s19|144-154|sensitivity|drug
DDI-DrugBank.d411.s19|155-155|.|drug
DDI-DrugBank.d411.s20|0-4|Onset|drug
DDI-DrugBank.d411.s20|6-7|of|drug
DDI-DrugBank.d411.s20|9-14|action|drug
DDI-DrugBank.d411.s20|16-17|of|drug
DDI-DrugBank.d411.s20|19-28|tricyclics|drug
DDI-DrugBank.d411.s20|30-32|may|drug
DDI-DrugBank.d411.s20|34-35|be|drug
DDI-DrugBank.d411.s20|37-47|accelerated|drug
DDI-DrugBank.d411.s20|48-48|.|drug
DDI-DrugBank.d411.s21|0-14|Sympathomimetic|drug
DDI-DrugBank.d411.s21|16-21|Agents|drug
DDI-DrugBank.d411.s21|22-22|:|drug
DDI-DrugBank.d411.s21|24-31|Possible|drug
DDI-DrugBank.d411.s21|33-41|increased|drug
DDI-DrugBank.d411.s21|43-46|risk|drug
DDI-DrugBank.d411.s21|48-49|of|drug
DDI-DrugBank.d411.s21|51-58|coronary|drug
DDI-DrugBank.d411.s21|60-72|insufficiency|drug
DDI-DrugBank.d411.s21|74-75|in|drug
DDI-DrugBank.d411.s21|77-84|patients|drug
DDI-DrugBank.d411.s21|86-89|with|drug
DDI-DrugBank.d411.s21|91-98|coronary|drug
DDI-DrugBank.d411.s21|100-105|artery|drug
DDI-DrugBank.d411.s21|107-113|disease|drug
DDI-DrugBank.d411.s21|114-114|.|drug
DDI-DrugBank.d352.s0|0-11|Antidiabetic|drug
DDI-DrugBank.d352.s0|13-16|drug|drug
DDI-DrugBank.d352.s0|18-29|requirements|drug
DDI-DrugBank.d352.s0|31-31|(|drug
DDI-DrugBank.d352.s0|32-35|i.e.|drug
DDI-DrugBank.d352.s0|36-36|,|drug
DDI-DrugBank.d352.s0|38-44|insulin|drug
DDI-DrugBank.d352.s0|45-45|)|drug
DDI-DrugBank.d352.s0|47-49|may|drug
DDI-DrugBank.d352.s0|51-52|be|drug
DDI-DrugBank.d352.s0|54-60|altered|drug
DDI-DrugBank.d352.s0|61-61|.|drug
DDI-DrugBank.d352.s1|0-9|Concurrent|drug
DDI-DrugBank.d352.s1|11-13|use|drug
DDI-DrugBank.d352.s1|15-18|with|drug
DDI-DrugBank.d352.s1|20-26|general|drug
DDI-DrugBank.d352.s1|28-38|anesthetics|drug
DDI-DrugBank.d352.s1|40-42|may|drug
DDI-DrugBank.d352.s1|44-49|result|drug
DDI-DrugBank.d352.s1|51-52|in|drug
DDI-DrugBank.d352.s1|54-64|arrhythmias|drug
DDI-DrugBank.d352.s1|65-65|.|drug
DDI-DrugBank.d352.s2|0-2|The|drug
DDI-DrugBank.d352.s2|4-10|pressor|drug
DDI-DrugBank.d352.s2|12-18|effects|drug
DDI-DrugBank.d352.s2|20-21|of|drug
DDI-DrugBank.d352.s2|23-36|diethylpropion|drug
DDI-DrugBank.d352.s2|38-40|and|drug
DDI-DrugBank.d352.s2|42-46|those|drug
DDI-DrugBank.d352.s2|48-49|of|drug
DDI-DrugBank.d352.s2|51-55|other|drug
DDI-DrugBank.d352.s2|57-61|drugs|drug
DDI-DrugBank.d352.s2|63-65|may|drug
DDI-DrugBank.d352.s2|67-68|be|drug
DDI-DrugBank.d352.s2|70-77|additive|drug
DDI-DrugBank.d352.s2|79-82|when|drug
DDI-DrugBank.d352.s2|84-86|the|drug
DDI-DrugBank.d352.s2|88-92|drugs|drug
DDI-DrugBank.d352.s2|94-96|are|drug
DDI-DrugBank.d352.s2|98-101|used|drug
DDI-DrugBank.d352.s2|103-115|concomitantly|drug
DDI-DrugBank.d352.s2|116-116|;|drug
DDI-DrugBank.d352.s3|0-9|conversely|drug
DDI-DrugBank.d352.s3|10-10|,|drug
DDI-DrugBank.d352.s3|12-25|diethylpropion|drug
DDI-DrugBank.d352.s3|27-29|may|drug
DDI-DrugBank.d352.s3|31-39|interfere|drug
DDI-DrugBank.d352.s3|41-44|with|drug
DDI-DrugBank.d352.s3|46-61|antihypertensive|drug
DDI-DrugBank.d352.s3|63-67|drugs|drug
DDI-DrugBank.d352.s3|69-69|(|drug
DDI-DrugBank.d352.s3|70-73|i.e.|drug
DDI-DrugBank.d352.s3|74-74|,|drug
DDI-DrugBank.d352.s3|76-87|guanethidine|drug
DDI-DrugBank.d352.s3|88-88|,|drug
DDI-DrugBank.d352.s3|90-101|a-methyldopa|drug
DDI-DrugBank.d352.s3|102-102|)|drug
DDI-DrugBank.d352.s3|103-103|.|drug
DDI-DrugBank.d352.s4|0-9|Concurrent|drug
DDI-DrugBank.d352.s4|11-13|use|drug
DDI-DrugBank.d352.s4|15-16|of|drug
DDI-DrugBank.d352.s4|18-31|phenothiazines|drug
DDI-DrugBank.d352.s4|33-35|may|drug
DDI-DrugBank.d352.s4|37-46|antagonize|drug
DDI-DrugBank.d352.s4|48-50|the|drug
DDI-DrugBank.d352.s4|52-60|anorectic|drug
DDI-DrugBank.d352.s4|62-67|effect|drug
DDI-DrugBank.d352.s4|69-70|of|drug
DDI-DrugBank.d352.s4|72-85|diethylpropion|drug
DDI-DrugBank.d352.s4|86-86|.|drug
DDI-DrugBank.d732.s0|0-5|CHEMET|drug
DDI-DrugBank.d732.s0|7-8|is|drug
DDI-DrugBank.d732.s0|10-12|not|drug
DDI-DrugBank.d732.s0|14-18|known|drug
DDI-DrugBank.d732.s0|20-21|to|drug
DDI-DrugBank.d732.s0|23-30|interact|drug
DDI-DrugBank.d732.s0|32-35|with|drug
DDI-DrugBank.d732.s0|37-41|other|drug
DDI-DrugBank.d732.s0|43-47|drugs|drug
DDI-DrugBank.d732.s0|49-57|including|drug
DDI-DrugBank.d732.s0|59-62|iron|drug
DDI-DrugBank.d732.s0|64-74|supplements|drug
DDI-DrugBank.d732.s0|75-75|;|drug
DDI-DrugBank.d732.s1|0-11|interactions|drug
DDI-DrugBank.d732.s1|13-16|have|drug
DDI-DrugBank.d732.s1|18-20|not|drug
DDI-DrugBank.d732.s1|22-25|been|drug
DDI-DrugBank.d732.s1|27-40|systematically|drug
DDI-DrugBank.d732.s1|42-48|studied|drug
DDI-DrugBank.d732.s1|49-49|.|drug
DDI-DrugBank.d732.s2|0-10|Concomitant|drug
DDI-DrugBank.d732.s2|12-25|administration|drug
DDI-DrugBank.d732.s2|27-28|of|drug
DDI-DrugBank.d732.s2|30-35|CHEMET|drug
DDI-DrugBank.d732.s2|37-40|with|drug
DDI-DrugBank.d732.s2|42-46|other|drug
DDI-DrugBank.d732.s2|48-56|chelation|drug
DDI-DrugBank.d732.s2|58-64|therapy|drug
DDI-DrugBank.d732.s2|65-65|,|drug
DDI-DrugBank.d732.s2|67-70|such|drug
DDI-DrugBank.d732.s2|72-73|as|drug
DDI-DrugBank.d732.s2|75-78|CaNa|drug
DDI-DrugBank.d732.s2|80-80|2|drug
DDI-DrugBank.d732.s2|82-85|EDTA|drug
DDI-DrugBank.d732.s2|87-88|is|drug
DDI-DrugBank.d732.s2|90-92|not|drug
DDI-DrugBank.d732.s2|94-104|recommended|drug
DDI-DrugBank.d732.s2|105-105|.|drug
DDI-DrugBank.d732.s3|0-14|Drug/Laboratory|drug
DDI-DrugBank.d732.s3|16-20|Tests|drug
DDI-DrugBank.d732.s3|22-32|Interaction|drug
DDI-DrugBank.d732.s3|33-33|:|drug
DDI-DrugBank.d732.s3|35-42|Succimer|drug
DDI-DrugBank.d732.s3|44-46|may|drug
DDI-DrugBank.d732.s3|48-56|interfere|drug
DDI-DrugBank.d732.s3|58-61|with|drug
DDI-DrugBank.d732.s3|63-67|serum|drug
DDI-DrugBank.d732.s3|69-71|and|drug
DDI-DrugBank.d732.s3|73-79|urinary|drug
DDI-DrugBank.d732.s3|81-90|laboratory|drug
DDI-DrugBank.d732.s3|92-96|tests|drug
DDI-DrugBank.d732.s3|97-97|.|drug
DDI-DrugBank.d732.s4|0-1|In|drug
DDI-DrugBank.d732.s4|3-7|vitro|drug
DDI-DrugBank.d732.s4|9-15|studies|drug
DDI-DrugBank.d732.s4|17-20|have|drug
DDI-DrugBank.d732.s4|22-26|shown|drug
DDI-DrugBank.d732.s4|28-35|succimer|drug
DDI-DrugBank.d732.s4|37-38|to|drug
DDI-DrugBank.d732.s4|40-44|cause|drug
DDI-DrugBank.d732.s4|46-50|false|drug
DDI-DrugBank.d732.s4|52-59|positive|drug
DDI-DrugBank.d732.s4|61-67|results|drug
DDI-DrugBank.d732.s4|69-71|for|drug
DDI-DrugBank.d732.s4|73-79|ketones|drug
DDI-DrugBank.d732.s4|81-82|in|drug
DDI-DrugBank.d732.s4|84-88|urine|drug
DDI-DrugBank.d732.s4|90-94|using|drug
DDI-DrugBank.d732.s4|96-108|nitroprusside|drug
DDI-DrugBank.d732.s4|110-117|reagents|drug
DDI-DrugBank.d732.s4|119-122|such|drug
DDI-DrugBank.d732.s4|124-125|as|drug
DDI-DrugBank.d732.s4|127-134|Ketostix|drug
DDI-DrugBank.d732.s4|139-141|and|drug
DDI-DrugBank.d732.s4|143-149|falsely|drug
DDI-DrugBank.d732.s4|151-159|decreased|drug
DDI-DrugBank.d732.s4|161-172|measurements|drug
DDI-DrugBank.d732.s4|174-175|of|drug
DDI-DrugBank.d732.s4|177-181|serum|drug
DDI-DrugBank.d732.s4|183-186|uric|drug
DDI-DrugBank.d732.s4|188-191|acid|drug
DDI-DrugBank.d732.s4|193-195|and|drug
DDI-DrugBank.d732.s4|197-199|CPK|drug
DDI-DrugBank.d732.s4|200-200|.|drug
DDI-DrugBank.d703.s0|0-10|Interaction|drug
DDI-DrugBank.d703.s0|12-15|with|drug
DDI-DrugBank.d703.s0|17-21|Other|drug
DDI-DrugBank.d703.s0|23-29|Central|drug
DDI-DrugBank.d703.s0|31-37|Nervous|drug
DDI-DrugBank.d703.s0|39-44|System|drug
DDI-DrugBank.d703.s0|46-56|Depressants|drug
DDI-DrugBank.d703.s0|57-57|:|drug
DDI-DrugBank.d703.s0|59-68|MEPERIDINE|drug
DDI-DrugBank.d703.s0|70-75|SHOULD|drug
DDI-DrugBank.d703.s0|77-78|BE|drug
DDI-DrugBank.d703.s0|80-83|USED|drug
DDI-DrugBank.d703.s0|85-88|WITH|drug
DDI-DrugBank.d703.s0|90-94|GREAT|drug
DDI-DrugBank.d703.s0|96-102|CAUTION|drug
DDI-DrugBank.d703.s0|104-106|AND|drug
DDI-DrugBank.d703.s0|108-109|IN|drug
DDI-DrugBank.d703.s0|111-117|REDUCED|drug
DDI-DrugBank.d703.s0|119-124|DOSAGE|drug
DDI-DrugBank.d703.s0|126-127|IN|drug
DDI-DrugBank.d703.s0|129-136|PATIENTS|drug
DDI-DrugBank.d703.s0|138-140|WHO|drug
DDI-DrugBank.d703.s0|142-144|ARE|drug
DDI-DrugBank.d703.s0|146-157|CONCURRENTLY|drug
DDI-DrugBank.d703.s0|159-167|RECEIVING|drug
DDI-DrugBank.d703.s0|169-173|OTHER|drug
DDI-DrugBank.d703.s0|175-182|NARCOTIC|drug
DDI-DrugBank.d703.s0|184-193|ANALGESICS|drug
DDI-DrugBank.d703.s0|194-194|,|drug
DDI-DrugBank.d703.s0|196-202|GENERAL|drug
DDI-DrugBank.d703.s0|204-214|ANESTHETICS|drug
DDI-DrugBank.d703.s0|215-215|,|drug
DDI-DrugBank.d703.s0|217-230|PHENOTHIAZINES|drug
DDI-DrugBank.d703.s0|231-231|,|drug
DDI-DrugBank.d703.s0|233-237|OTHER|drug
DDI-DrugBank.d703.s0|239-251|TRANQUILIZERS|drug
DDI-DrugBank.d703.s0|252-252|,|drug
DDI-DrugBank.d703.s0|254-271|SEDATIVE-HYPNOTICS|drug
DDI-DrugBank.d703.s0|273-273|(|drug
DDI-DrugBank.d703.s0|274-282|INCLUDING|drug
DDI-DrugBank.d703.s0|284-295|BARBITURATES|drug
DDI-DrugBank.d703.s0|296-296|)|drug
DDI-DrugBank.d703.s0|297-297|,|drug
DDI-DrugBank.d703.s0|299-307|TRICYCLIC|drug
DDI-DrugBank.d703.s0|309-323|ANTIDEPRESSANTS|drug
DDI-DrugBank.d703.s0|325-327|AND|drug
DDI-DrugBank.d703.s0|329-333|OTHER|drug
DDI-DrugBank.d703.s0|335-337|CNS|drug
DDI-DrugBank.d703.s0|339-349|DEPRESSANTS|drug
DDI-DrugBank.d703.s0|351-351|(|drug
DDI-DrugBank.d703.s0|352-360|INCLUDING|drug
DDI-DrugBank.d703.s0|362-368|ALCOHOL|drug
DDI-DrugBank.d703.s0|369-369|)|drug
DDI-DrugBank.d703.s0|370-370|.|drug
DDI-DrugBank.d703.s1|0-10|RESPIRATORY|drug
DDI-DrugBank.d703.s1|12-21|DEPRESSION|drug
DDI-DrugBank.d703.s1|22-22|,|drug
DDI-DrugBank.d703.s1|24-34|HYPOTENSION|drug
DDI-DrugBank.d703.s1|35-35|,|drug
DDI-DrugBank.d703.s1|37-39|AND|drug
DDI-DrugBank.d703.s1|41-48|PROFOUND|drug
DDI-DrugBank.d703.s1|50-57|SEDATION|drug
DDI-DrugBank.d703.s1|59-60|OR|drug
DDI-DrugBank.d703.s1|62-65|COMA|drug
DDI-DrugBank.d703.s1|67-69|MAY|drug
DDI-DrugBank.d703.s1|71-76|RESULT|drug
DDI-DrugBank.d703.s1|77-77|.|drug
DDI-DrugBank.d363.s0|0-1|No|drug
DDI-DrugBank.d363.s0|3-12|clinically|drug
DDI-DrugBank.d363.s0|14-24|significant|drug
DDI-DrugBank.d363.s0|26-32|adverse|drug
DDI-DrugBank.d363.s0|34-45|interactions|drug
DDI-DrugBank.d363.s0|47-50|with|drug
DDI-DrugBank.d363.s0|52-59|commonly|drug
DDI-DrugBank.d363.s0|61-64|used|drug
DDI-DrugBank.d363.s0|66-78|preanesthetic|drug
DDI-DrugBank.d363.s0|80-84|drugs|drug
DDI-DrugBank.d363.s0|85-85|,|drug
DDI-DrugBank.d363.s0|87-88|or|drug
DDI-DrugBank.d363.s0|90-94|drugs|drug
DDI-DrugBank.d363.s0|96-99|used|drug
DDI-DrugBank.d363.s0|101-106|during|drug
DDI-DrugBank.d363.s0|108-117|anesthesia|drug
DDI-DrugBank.d363.s0|119-119|(|drug
DDI-DrugBank.d363.s0|120-125|muscle|drug
DDI-DrugBank.d363.s0|127-135|relaxants|drug
DDI-DrugBank.d363.s0|136-136|,|drug
DDI-DrugBank.d363.s0|138-148|intravenous|drug
DDI-DrugBank.d363.s0|150-155|agents|drug
DDI-DrugBank.d363.s0|156-156|,|drug
DDI-DrugBank.d363.s0|158-160|and|drug
DDI-DrugBank.d363.s0|162-166|local|drug
DDI-DrugBank.d363.s0|168-177|anesthetic|drug
DDI-DrugBank.d363.s0|179-184|agents|drug
DDI-DrugBank.d363.s0|185-185|)|drug
DDI-DrugBank.d363.s0|187-190|were|drug
DDI-DrugBank.d363.s0|192-199|reported|drug
DDI-DrugBank.d363.s0|201-202|in|drug
DDI-DrugBank.d363.s0|204-211|clinical|drug
DDI-DrugBank.d363.s0|213-218|trials|drug
DDI-DrugBank.d363.s0|219-219|.|drug
DDI-DrugBank.d363.s1|0-2|The|drug
DDI-DrugBank.d363.s1|4-9|effect|drug
DDI-DrugBank.d363.s1|11-12|of|drug
DDI-DrugBank.d363.s1|14-23|desflurane|drug
DDI-DrugBank.d363.s1|25-26|on|drug
DDI-DrugBank.d363.s1|28-30|the|drug
DDI-DrugBank.d363.s1|32-42|disposition|drug
DDI-DrugBank.d363.s1|44-45|of|drug
DDI-DrugBank.d363.s1|47-51|other|drug
DDI-DrugBank.d363.s1|53-57|drugs|drug
DDI-DrugBank.d363.s1|59-61|has|drug
DDI-DrugBank.d363.s1|63-65|not|drug
DDI-DrugBank.d363.s1|67-70|been|drug
DDI-DrugBank.d363.s1|72-81|determined|drug
DDI-DrugBank.d363.s1|82-82|.|drug
DDI-DrugBank.d363.s2|0-3|Like|drug
DDI-DrugBank.d363.s2|5-14|isoflurane|drug
DDI-DrugBank.d363.s2|15-15|,|drug
DDI-DrugBank.d363.s2|17-26|desflurane|drug
DDI-DrugBank.d363.s2|28-31|does|drug
DDI-DrugBank.d363.s2|33-35|not|drug
DDI-DrugBank.d363.s2|37-46|predispose|drug
DDI-DrugBank.d363.s2|48-49|to|drug
DDI-DrugBank.d363.s2|51-59|premature|drug
DDI-DrugBank.d363.s2|61-71|ventricular|drug
DDI-DrugBank.d363.s2|73-83|arrhythmias|drug
DDI-DrugBank.d363.s2|85-86|in|drug
DDI-DrugBank.d363.s2|88-90|the|drug
DDI-DrugBank.d363.s2|92-99|presence|drug
DDI-DrugBank.d363.s2|101-102|of|drug
DDI-DrugBank.d363.s2|104-114|exogenously|drug
DDI-DrugBank.d363.s2|116-122|infused|drug
DDI-DrugBank.d363.s2|124-134|epinephrine|drug
DDI-DrugBank.d363.s2|136-137|in|drug
DDI-DrugBank.d363.s2|139-143|swine|drug
DDI-DrugBank.d363.s2|144-144|.|drug
DDI-MedLine.d103.s0|0-8|Magnesium|drug
DDI-MedLine.d103.s0|10-12|and|drug
DDI-MedLine.d103.s0|14-25|therapeutics|drug
DDI-MedLine.d103.s0|26-26|.|drug
DDI-MedLine.d103.s1|0-2|Two|drug
DDI-MedLine.d103.s1|4-12|different|drug
DDI-MedLine.d103.s1|14-18|types|drug
DDI-MedLine.d103.s1|20-21|of|drug
DDI-MedLine.d103.s1|23-29|therapy|drug
DDI-MedLine.d103.s1|31-34|with|drug
DDI-MedLine.d103.s1|36-44|magnesium|drug
DDI-MedLine.d103.s1|46-48|are|drug
DDI-MedLine.d103.s1|50-53|used|drug
DDI-MedLine.d103.s1|54-54|:|drug
DDI-MedLine.d103.s1|56-68|physiological|drug
DDI-MedLine.d103.s1|70-73|oral|drug
DDI-MedLine.d103.s1|75-83|magnesium|drug
DDI-MedLine.d103.s1|85-99|supplementation|drug
DDI-MedLine.d103.s1|101-105|which|drug
DDI-MedLine.d103.s1|107-108|is|drug
DDI-MedLine.d103.s1|110-116|totally|drug
DDI-MedLine.d103.s1|118-123|atoxic|drug
DDI-MedLine.d103.s1|125-129|since|drug
DDI-MedLine.d103.s1|131-132|it|drug
DDI-MedLine.d103.s1|134-142|palliates|drug
DDI-MedLine.d103.s1|144-152|magnesium|drug
DDI-MedLine.d103.s1|154-165|deficiencies|drug
DDI-MedLine.d103.s1|167-168|by|drug
DDI-MedLine.d103.s1|170-175|simply|drug
DDI-MedLine.d103.s1|177-187|normalizing|drug
DDI-MedLine.d103.s1|189-191|the|drug
DDI-MedLine.d103.s1|193-201|magnesium|drug
DDI-MedLine.d103.s1|203-208|intake|drug
DDI-MedLine.d103.s1|210-212|and|drug
DDI-MedLine.d103.s1|214-228|pharmacological|drug
DDI-MedLine.d103.s1|230-238|magnesium|drug
DDI-MedLine.d103.s1|240-246|therapy|drug
DDI-MedLine.d103.s1|248-252|which|drug
DDI-MedLine.d103.s1|254-256|may|drug
DDI-MedLine.d103.s1|258-263|induce|drug
DDI-MedLine.d103.s1|265-272|toxicity|drug
DDI-MedLine.d103.s1|274-278|since|drug
DDI-MedLine.d103.s1|280-281|it|drug
DDI-MedLine.d103.s1|283-289|creates|drug
DDI-MedLine.d103.s1|291-300|iatrogenic|drug
DDI-MedLine.d103.s1|302-310|magnesium|drug
DDI-MedLine.d103.s1|312-319|overload|drug
DDI-MedLine.d103.s1|320-320|.|drug
DDI-MedLine.d103.s2|0-6|Primary|drug
DDI-MedLine.d103.s2|8-10|and|drug
DDI-MedLine.d103.s2|12-20|secondary|drug
DDI-MedLine.d103.s2|22-30|magnesium|drug
DDI-MedLine.d103.s2|32-43|deficiencies|drug
DDI-MedLine.d103.s2|45-54|constitute|drug
DDI-MedLine.d103.s2|56-58|the|drug
DDI-MedLine.d103.s2|60-63|sole|drug
DDI-MedLine.d103.s2|65-74|indication|drug
DDI-MedLine.d103.s2|76-77|of|drug
DDI-MedLine.d103.s2|79-91|physiological|drug
DDI-MedLine.d103.s2|93-96|oral|drug
DDI-MedLine.d103.s2|98-106|magnesium|drug
DDI-MedLine.d103.s2|108-114|therapy|drug
DDI-MedLine.d103.s2|115-115|.|drug
DDI-MedLine.d103.s3|0-1|It|drug
DDI-MedLine.d103.s3|3-4|is|drug
DDI-MedLine.d103.s3|6-14|therefore|drug
DDI-MedLine.d103.s3|16-24|necessary|drug
DDI-MedLine.d103.s3|26-27|to|drug
DDI-MedLine.d103.s3|29-30|be|drug
DDI-MedLine.d103.s3|32-35|well|drug
DDI-MedLine.d103.s3|37-46|acquainted|drug
DDI-MedLine.d103.s3|48-51|with|drug
DDI-MedLine.d103.s3|53-55|the|drug
DDI-MedLine.d103.s3|57-64|clinical|drug
DDI-MedLine.d103.s3|66-68|and|drug
DDI-MedLine.d103.s3|70-81|paraclinical|drug
DDI-MedLine.d103.s3|83-89|pattern|drug
DDI-MedLine.d103.s3|91-92|of|drug
DDI-MedLine.d103.s3|94-102|magnesium|drug
DDI-MedLine.d103.s3|104-110|deficit|drug
DDI-MedLine.d103.s3|112-114|and|drug
DDI-MedLine.d103.s3|116-117|to|drug
DDI-MedLine.d103.s3|119-130|discriminate|drug
DDI-MedLine.d103.s3|132-138|between|drug
DDI-MedLine.d103.s3|140-148|magnesium|drug
DDI-MedLine.d103.s3|150-159|deficiency|drug
DDI-MedLine.d103.s3|161-163|due|drug
DDI-MedLine.d103.s3|165-166|to|drug
DDI-MedLine.d103.s3|168-169|an|drug
DDI-MedLine.d103.s3|171-182|insufficient|drug
DDI-MedLine.d103.s3|184-192|magnesium|drug
DDI-MedLine.d103.s3|194-199|intake|drug
DDI-MedLine.d103.s3|201-205|which|drug
DDI-MedLine.d103.s3|207-210|only|drug
DDI-MedLine.d103.s3|212-219|requires|drug
DDI-MedLine.d103.s3|221-224|oral|drug
DDI-MedLine.d103.s3|226-238|physiological|drug
DDI-MedLine.d103.s3|240-254|supplementation|drug
DDI-MedLine.d103.s3|256-258|and|drug
DDI-MedLine.d103.s3|260-268|magnesium|drug
DDI-MedLine.d103.s3|270-278|depletion|drug
DDI-MedLine.d103.s3|280-286|related|drug
DDI-MedLine.d103.s3|288-289|to|drug
DDI-MedLine.d103.s3|291-291|a|drug
DDI-MedLine.d103.s3|293-305|dysregulation|drug
DDI-MedLine.d103.s3|307-308|of|drug
DDI-MedLine.d103.s3|310-312|the|drug
DDI-MedLine.d103.s3|314-320|control|drug
DDI-MedLine.d103.s3|322-331|mechanisms|drug
DDI-MedLine.d103.s3|333-334|of|drug
DDI-MedLine.d103.s3|336-344|magnesium|drug
DDI-MedLine.d103.s3|346-351|status|drug
DDI-MedLine.d103.s3|353-357|which|drug
DDI-MedLine.d103.s3|359-366|requires|drug
DDI-MedLine.d103.s3|368-371|more|drug
DDI-MedLine.d103.s3|373-374|or|drug
DDI-MedLine.d103.s3|376-379|less|drug
DDI-MedLine.d103.s3|381-388|specific|drug
DDI-MedLine.d103.s3|390-399|regulation|drug
DDI-MedLine.d103.s3|401-402|of|drug
DDI-MedLine.d103.s3|404-406|its|drug
DDI-MedLine.d103.s3|408-413|causal|drug
DDI-MedLine.d103.s3|415-427|dysregulation|drug
DDI-MedLine.d103.s3|428-428|.|drug
DDI-MedLine.d103.s4|0-12|Physiological|drug
DDI-MedLine.d103.s4|14-17|oral|drug
DDI-MedLine.d103.s4|19-27|magnesium|drug
DDI-MedLine.d103.s4|29-32|load|drug
DDI-MedLine.d103.s4|34-44|constitutes|drug
DDI-MedLine.d103.s4|46-48|the|drug
DDI-MedLine.d103.s4|50-53|best|drug
DDI-MedLine.d103.s4|55-58|tool|drug
DDI-MedLine.d103.s4|60-62|for|drug
DDI-MedLine.d103.s4|64-72|diagnosis|drug
DDI-MedLine.d103.s4|74-75|of|drug
DDI-MedLine.d103.s4|77-85|magnesium|drug
DDI-MedLine.d103.s4|87-96|deficiency|drug
DDI-MedLine.d103.s4|98-100|and|drug
DDI-MedLine.d103.s4|102-104|the|drug
DDI-MedLine.d103.s4|106-110|first|drug
DDI-MedLine.d103.s4|112-115|step|drug
DDI-MedLine.d103.s4|117-118|of|drug
DDI-MedLine.d103.s4|120-122|its|drug
DDI-MedLine.d103.s4|124-132|treatment|drug
DDI-MedLine.d103.s4|133-133|.|drug
DDI-MedLine.d103.s5|0-12|Physiological|drug
DDI-MedLine.d103.s5|14-17|oral|drug
DDI-MedLine.d103.s5|19-27|magnesium|drug
DDI-MedLine.d103.s5|29-43|supplementation|drug
DDI-MedLine.d103.s5|45-45|(|drug
DDI-MedLine.d103.s5|46-46|5|drug
DDI-MedLine.d103.s5|48-56|mg/kg/day|drug
DDI-MedLine.d103.s5|57-57|)|drug
DDI-MedLine.d103.s5|59-60|is|drug
DDI-MedLine.d103.s5|62-65|easy|drug
DDI-MedLine.d103.s5|67-69|and|drug
DDI-MedLine.d103.s5|71-73|can|drug
DDI-MedLine.d103.s5|75-76|be|drug
DDI-MedLine.d103.s5|78-84|carried|drug
DDI-MedLine.d103.s5|86-88|out|drug
DDI-MedLine.d103.s5|90-91|in|drug
DDI-MedLine.d103.s5|93-95|the|drug
DDI-MedLine.d103.s5|97-100|diet|drug
DDI-MedLine.d103.s5|102-103|or|drug
DDI-MedLine.d103.s5|105-108|with|drug
DDI-MedLine.d103.s5|110-118|magnesium|drug
DDI-MedLine.d103.s5|120-124|salts|drug
DDI-MedLine.d103.s5|125-125|,|drug
DDI-MedLine.d103.s5|127-130|with|drug
DDI-MedLine.d103.s5|132-142|practically|drug
DDI-MedLine.d103.s5|144-147|only|drug
DDI-MedLine.d103.s5|149-151|one|drug
DDI-MedLine.d103.s5|153-169|contra-indication|drug
DDI-MedLine.d103.s5|170-170|:|drug
DDI-MedLine.d103.s5|172-176|overt|drug
DDI-MedLine.d103.s5|178-182|renal|drug
DDI-MedLine.d103.s5|184-190|failure|drug
DDI-MedLine.d103.s5|191-191|.|drug
DDI-MedLine.d103.s6|0-7|Specific|drug
DDI-MedLine.d103.s6|9-11|and|drug
DDI-MedLine.d103.s6|13-21|aspecific|drug
DDI-MedLine.d103.s6|23-32|treatments|drug
DDI-MedLine.d103.s6|34-35|of|drug
DDI-MedLine.d103.s6|37-45|magnesium|drug
DDI-MedLine.d103.s6|47-55|depletion|drug
DDI-MedLine.d103.s6|57-59|are|drug
DDI-MedLine.d103.s6|61-66|tricky|drug
DDI-MedLine.d103.s6|68-72|using|drug
DDI-MedLine.d103.s6|74-76|for|drug
DDI-MedLine.d103.s6|78-84|example|drug
DDI-MedLine.d103.s6|86-94|magnesium|drug
DDI-MedLine.d103.s6|96-102|sparing|drug
DDI-MedLine.d103.s6|104-112|diuretics|drug
DDI-MedLine.d103.s6|113-113|,|drug
DDI-MedLine.d103.s6|115-129|pharmacological|drug
DDI-MedLine.d103.s6|131-135|doses|drug
DDI-MedLine.d103.s6|137-138|of|drug
DDI-MedLine.d103.s6|140-146|vitamin|drug
DDI-MedLine.d103.s6|148-149|B6|drug
DDI-MedLine.d103.s6|150-150|,|drug
DDI-MedLine.d103.s6|152-164|physiological|drug
DDI-MedLine.d103.s6|166-170|doses|drug
DDI-MedLine.d103.s6|172-173|of|drug
DDI-MedLine.d103.s6|175-181|vitamin|drug
DDI-MedLine.d103.s6|183-183|D|drug
DDI-MedLine.d103.s6|185-187|and|drug
DDI-MedLine.d103.s6|189-190|of|drug
DDI-MedLine.d103.s6|192-199|selenium|drug
DDI-MedLine.d103.s6|200-200|.|drug
DDI-MedLine.d103.s7|0-1|In|drug
DDI-MedLine.d103.s7|3-7|order|drug
DDI-MedLine.d103.s7|9-10|to|drug
DDI-MedLine.d103.s7|12-14|use|drug
DDI-MedLine.d103.s7|16-18|the|drug
DDI-MedLine.d103.s7|20-34|pharmacological|drug
DDI-MedLine.d103.s7|36-45|properties|drug
DDI-MedLine.d103.s7|47-48|of|drug
DDI-MedLine.d103.s7|50-56|induced|drug
DDI-MedLine.d103.s7|58-68|therapeutic|drug
DDI-MedLine.d103.s7|70-85|hypermagnesaemia|drug
DDI-MedLine.d103.s7|86-86|,|drug
DDI-MedLine.d103.s7|88-91|high|drug
DDI-MedLine.d103.s7|93-96|oral|drug
DDI-MedLine.d103.s7|98-102|doses|drug
DDI-MedLine.d103.s7|104-105|of|drug
DDI-MedLine.d103.s7|107-115|magnesium|drug
DDI-MedLine.d103.s7|117-117|(|drug
DDI-MedLine.d103.s7|118-118|>|drug
DDI-MedLine.d103.s7|120-121|10|drug
DDI-MedLine.d103.s7|123-131|mg/kg/day|drug
DDI-MedLine.d103.s7|132-132|)|drug
DDI-MedLine.d103.s7|134-136|are|drug
DDI-MedLine.d103.s7|138-146|advisable|drug
DDI-MedLine.d103.s7|148-150|for|drug
DDI-MedLine.d103.s7|152-158|chronic|drug
DDI-MedLine.d103.s7|160-170|indications|drug
DDI-MedLine.d103.s7|172-174|and|drug
DDI-MedLine.d103.s7|176-178|the|drug
DDI-MedLine.d103.s7|180-189|parenteral|drug
DDI-MedLine.d103.s7|191-195|route|drug
DDI-MedLine.d103.s7|197-198|is|drug
DDI-MedLine.d103.s7|200-207|suitable|drug
DDI-MedLine.d103.s7|209-211|for|drug
DDI-MedLine.d103.s7|213-217|acute|drug
DDI-MedLine.d103.s7|219-229|indications|drug
DDI-MedLine.d103.s7|230-230|.|drug
DDI-MedLine.d103.s8|0-4|There|drug
DDI-MedLine.d103.s8|6-8|are|drug
DDI-MedLine.d103.s8|10-10|3|drug
DDI-MedLine.d103.s8|12-16|types|drug
DDI-MedLine.d103.s8|18-19|of|drug
DDI-MedLine.d103.s8|21-31|indications|drug
DDI-MedLine.d103.s8|32-32|:|drug
DDI-MedLine.d103.s8|34-41|specific|drug
DDI-MedLine.d103.s8|43-43|(|drug
DDI-MedLine.d103.s8|44-46|for|drug
DDI-MedLine.d103.s8|48-50|the|drug
DDI-MedLine.d103.s8|52-60|treatment|drug
DDI-MedLine.d103.s8|62-63|of|drug
DDI-MedLine.d103.s8|65-68|some|drug
DDI-MedLine.d103.s8|70-74|forms|drug
DDI-MedLine.d103.s8|76-77|of|drug
DDI-MedLine.d103.s8|79-87|magnesium|drug
DDI-MedLine.d103.s8|89-95|deficit|drug
DDI-MedLine.d103.s8|97-100|i.e|drug
DDI-MedLine.d103.s8|102-106|.|drug
DDI-MedLine.d103.s8|107-107|acute|drug
DDI-MedLine.d103.s8|108-108|)|drug
DDI-MedLine.d103.s8|110-124|,|drug
DDI-MedLine.d103.s8|126-126|pharmacological|drug
DDI-MedLine.d103.s8|127-130|(|drug
DDI-MedLine.d103.s8|132-138|i.e|drug
DDI-MedLine.d103.s8|140-150|.|drug
DDI-MedLine.d103.s8|152-153|without|drug
DDI-MedLine.d103.s8|155-163|alterations|drug
DDI-MedLine.d103.s8|165-170|of|drug
DDI-MedLine.d103.s8|171-171|magnesium|drug
DDI-MedLine.d103.s8|173-175|status|drug
DDI-MedLine.d103.s8|177-181|)|drug
DDI-MedLine.d103.s8|182-183|and|drug
DDI-MedLine.d103.s8|184-198|mixed|drug
DDI-MedLine.d103.s8|200-202|--|drug
DDI-MedLine.d103.s8|204-218|pharmacological|drug
DDI-MedLine.d103.s8|219-220|and|drug
DDI-MedLine.d103.s8|221-221|aetiopathogenic|drug
DDI-MedLine.d103.s8|222-224|--|drug
DDI-MedLine.d103.s8|226-232|(|drug
DDI-MedLine.d103.s8|234-246|for|drug
DDI-MedLine.d103.s8|248-249|example|drug
DDI-MedLine.d103.s8|251-257|complications|drug
DDI-MedLine.d103.s8|259-268|of|drug
DDI-MedLine.d103.s8|269-269|chronic|drug
DDI-MedLine.d103.s8|270-270|alcoholism|drug
DDI-MedLine.d103.s9|0-4|Today|drug
DDI-MedLine.d103.s9|6-20|pharmacological|drug
DDI-MedLine.d103.s9|22-30|magnesium|drug
DDI-MedLine.d103.s9|32-38|therapy|drug
DDI-MedLine.d103.s9|40-45|mainly|drug
DDI-MedLine.d103.s9|47-54|concerns|drug
DDI-MedLine.d103.s9|56-58|the|drug
DDI-MedLine.d103.s9|60-70|obstetrical|drug
DDI-MedLine.d103.s9|71-71|,|drug
DDI-MedLine.d103.s9|73-85|cardiological|drug
DDI-MedLine.d103.s9|87-89|and|drug
DDI-MedLine.d103.s9|91-108|anaesthesiological|drug
DDI-MedLine.d103.s9|110-115|fields|drug
DDI-MedLine.d103.s9|116-116|.|drug
DDI-MedLine.d103.s10|0-2|The|drug
DDI-MedLine.d103.s10|4-7|main|drug
DDI-MedLine.d103.s10|9-19|indications|drug
DDI-MedLine.d103.s10|21-23|are|drug
DDI-MedLine.d103.s10|25-33|eclampsia|drug
DDI-MedLine.d103.s10|34-34|,|drug
DDI-MedLine.d103.s10|36-39|some|drug
DDI-MedLine.d103.s10|41-52|dysrhythmias|drug
DDI-MedLine.d103.s10|54-54|(|drug
DDI-MedLine.d103.s10|55-62|torsades|drug
DDI-MedLine.d103.s10|64-65|de|drug
DDI-MedLine.d103.s10|67-72|pointe|drug
DDI-MedLine.d103.s10|74-85|particularly|drug
DDI-MedLine.d103.s10|86-86|)|drug
DDI-MedLine.d103.s10|88-90|and|drug
DDI-MedLine.d103.s10|92-101|myocardial|drug
DDI-MedLine.d103.s10|103-112|ischaemias|drug
DDI-MedLine.d103.s10|113-113|.|drug
DDI-MedLine.d103.s11|0-2|But|drug
DDI-MedLine.d103.s11|4-5|it|drug
DDI-MedLine.d103.s11|7-8|is|drug
DDI-MedLine.d103.s11|10-12|now|drug
DDI-MedLine.d103.s11|14-22|difficult|drug
DDI-MedLine.d103.s11|24-25|to|drug
DDI-MedLine.d103.s11|27-33|situate|drug
DDI-MedLine.d103.s11|35-37|the|drug
DDI-MedLine.d103.s11|39-43|exact|drug
DDI-MedLine.d103.s11|45-49|place|drug
DDI-MedLine.d103.s11|51-52|of|drug
DDI-MedLine.d103.s11|54-56|the|drug
DDI-MedLine.d103.s11|58-72|pharmacological|drug
DDI-MedLine.d103.s11|74-84|indications|drug
DDI-MedLine.d103.s11|86-87|of|drug
DDI-MedLine.d103.s11|89-97|magnesium|drug
DDI-MedLine.d103.s11|98-98|.|drug
DDI-MedLine.d103.s12|0-8|Magnesium|drug
DDI-MedLine.d103.s12|10-18|infusions|drug
DDI-MedLine.d103.s12|20-22|can|drug
DDI-MedLine.d103.s12|24-27|only|drug
DDI-MedLine.d103.s12|29-30|be|drug
DDI-MedLine.d103.s12|32-40|envisaged|drug
DDI-MedLine.d103.s12|42-43|in|drug
DDI-MedLine.d103.s12|45-53|intensive|drug
DDI-MedLine.d103.s12|55-58|care|drug
DDI-MedLine.d103.s12|60-64|units|drug
DDI-MedLine.d103.s12|66-69|with|drug
DDI-MedLine.d103.s12|71-77|careful|drug
DDI-MedLine.d103.s12|79-88|monitoring|drug
DDI-MedLine.d103.s12|90-91|of|drug
DDI-MedLine.d103.s12|93-97|pulse|drug
DDI-MedLine.d103.s12|98-98|,|drug
DDI-MedLine.d103.s12|100-107|arterial|drug
DDI-MedLine.d103.s12|109-116|pressure|drug
DDI-MedLine.d103.s12|117-117|,|drug
DDI-MedLine.d103.s12|119-122|deep|drug
DDI-MedLine.d103.s12|124-129|tendon|drug
DDI-MedLine.d103.s12|131-138|reflexes|drug
DDI-MedLine.d103.s12|139-139|,|drug
DDI-MedLine.d103.s12|141-146|hourly|drug
DDI-MedLine.d103.s12|148-155|diuresis|drug
DDI-MedLine.d103.s12|156-156|,|drug
DDI-MedLine.d103.s12|158-174|electrocardiogram|drug
DDI-MedLine.d103.s12|176-178|and|drug
DDI-MedLine.d103.s12|180-190|respiratory|drug
DDI-MedLine.d103.s12|192-201|recordings|drug
DDI-MedLine.d103.s12|202-202|.|drug
DDI-MedLine.d103.s13|0-3|High|drug
DDI-MedLine.d103.s13|5-8|oral|drug
DDI-MedLine.d103.s13|10-18|magnesium|drug
DDI-MedLine.d103.s13|20-24|doses|drug
DDI-MedLine.d103.s13|26-32|besides|drug
DDI-MedLine.d103.s13|34-38|their|drug
DDI-MedLine.d103.s13|40-47|laxative|drug
DDI-MedLine.d103.s13|49-54|action|drug
DDI-MedLine.d103.s13|56-58|may|drug
DDI-MedLine.d103.s13|60-64|bring|drug
DDI-MedLine.d103.s13|66-71|latent|drug
DDI-MedLine.d103.s13|73-85|complications|drug
DDI-MedLine.d103.s13|87-91|which|drug
DDI-MedLine.d103.s13|93-95|may|drug
DDI-MedLine.d103.s13|97-102|reduce|drug
DDI-MedLine.d103.s13|104-111|lifespan|drug
DDI-MedLine.d103.s13|112-112|.|drug
DDI-MedLine.d103.s14|0-4|There|drug
DDI-MedLine.d103.s14|6-8|may|drug
DDI-MedLine.d103.s14|10-15|remain|drug
DDI-MedLine.d103.s14|17-20|some|drug
DDI-MedLine.d103.s14|22-32|indications|drug
DDI-MedLine.d103.s14|34-35|of|drug
DDI-MedLine.d103.s14|37-39|the|drug
DDI-MedLine.d103.s14|41-48|laxative|drug
DDI-MedLine.d103.s14|50-52|and|drug
DDI-MedLine.d103.s14|54-60|antacid|drug
DDI-MedLine.d103.s14|62-71|properties|drug
DDI-MedLine.d103.s14|73-74|of|drug
DDI-MedLine.d103.s14|76-78|non|drug
DDI-MedLine.d103.s14|80-86|soluble|drug
DDI-MedLine.d103.s14|88-96|magnesium|drug
DDI-MedLine.d103.s14|97-97|,|drug
DDI-MedLine.d103.s14|99-110|particularly|drug
DDI-MedLine.d103.s14|112-117|during|drug
DDI-MedLine.d103.s14|119-130|intermittent|drug
DDI-MedLine.d103.s14|132-144|haemodialysis|drug
DDI-MedLine.d103.s14|145-145|.|drug
DDI-MedLine.d103.s15|0-5|Lastly|drug
DDI-MedLine.d103.s15|7-11|local|drug
DDI-MedLine.d103.s15|13-15|use|drug
DDI-MedLine.d103.s15|17-18|of|drug
DDI-MedLine.d103.s15|20-22|the|drug
DDI-MedLine.d103.s15|24-36|mucocutaneous|drug
DDI-MedLine.d103.s15|38-40|and|drug
DDI-MedLine.d103.s15|42-55|cytoprotective|drug
DDI-MedLine.d103.s15|57-66|properties|drug
DDI-MedLine.d103.s15|68-69|of|drug
DDI-MedLine.d103.s15|71-79|magnesium|drug
DDI-MedLine.d103.s15|81-82|is|drug
DDI-MedLine.d103.s15|84-88|still|drug
DDI-MedLine.d103.s15|90-94|valid|drug
DDI-MedLine.d103.s15|95-95|,|drug
DDI-MedLine.d103.s15|97-98|in|drug
DDI-MedLine.d103.s15|100-111|cardioplegic|drug
DDI-MedLine.d103.s15|113-121|solutions|drug
DDI-MedLine.d103.s15|123-125|and|drug
DDI-MedLine.d103.s15|127-129|for|drug
DDI-MedLine.d103.s15|131-142|preservation|drug
DDI-MedLine.d103.s15|144-145|of|drug
DDI-MedLine.d103.s15|147-157|transplants|drug
DDI-MedLine.d103.s15|159-170|particularly|drug
DDI-MedLine.d103.s15|171-171|.|drug
DDI-DrugBank.d340.s0|0-9|Nelfinavir|drug
DDI-DrugBank.d340.s0|11-12|is|drug
DDI-DrugBank.d340.s0|14-15|an|drug
DDI-DrugBank.d340.s0|17-25|inhibitor|drug
DDI-DrugBank.d340.s0|27-28|of|drug
DDI-DrugBank.d340.s0|30-34|CYP3A|drug
DDI-DrugBank.d340.s0|36-36|(|drug
DDI-DrugBank.d340.s0|37-46|cytochrome|drug
DDI-DrugBank.d340.s0|48-51|P450|drug
DDI-DrugBank.d340.s0|53-54|3A|drug
DDI-DrugBank.d340.s0|55-55|)|drug
DDI-DrugBank.d340.s0|56-56|.|drug
DDI-DrugBank.d340.s1|0-15|Coadministration|drug
DDI-DrugBank.d340.s1|17-18|of|drug
DDI-DrugBank.d340.s1|20-27|VIRACEPT|drug
DDI-DrugBank.d340.s1|29-31|and|drug
DDI-DrugBank.d340.s1|33-37|drugs|drug
DDI-DrugBank.d340.s1|39-47|primarily|drug
DDI-DrugBank.d340.s1|49-59|metabolized|drug
DDI-DrugBank.d340.s1|61-62|by|drug
DDI-DrugBank.d340.s1|64-68|CYP3A|drug
DDI-DrugBank.d340.s1|70-70|(|drug
DDI-DrugBank.d340.s1|71-74|e.g.|drug
DDI-DrugBank.d340.s1|75-75|,|drug
DDI-DrugBank.d340.s1|77-91|dihydropyridine|drug
DDI-DrugBank.d340.s1|93-99|calcium|drug
DDI-DrugBank.d340.s1|101-107|channel|drug
DDI-DrugBank.d340.s1|109-116|blockers|drug
DDI-DrugBank.d340.s1|117-117|)|drug
DDI-DrugBank.d340.s1|119-121|may|drug
DDI-DrugBank.d340.s1|123-128|result|drug
DDI-DrugBank.d340.s1|130-131|in|drug
DDI-DrugBank.d340.s1|133-141|increased|drug
DDI-DrugBank.d340.s1|143-148|plasma|drug
DDI-DrugBank.d340.s1|150-163|concentrations|drug
DDI-DrugBank.d340.s1|165-166|of|drug
DDI-DrugBank.d340.s1|168-170|the|drug
DDI-DrugBank.d340.s1|172-176|other|drug
DDI-DrugBank.d340.s1|178-181|drug|drug
DDI-DrugBank.d340.s1|183-186|that|drug
DDI-DrugBank.d340.s1|188-192|could|drug
DDI-DrugBank.d340.s1|194-201|increase|drug
DDI-DrugBank.d340.s1|203-204|or|drug
DDI-DrugBank.d340.s1|206-212|prolong|drug
DDI-DrugBank.d340.s1|214-217|both|drug
DDI-DrugBank.d340.s1|219-221|its|drug
DDI-DrugBank.d340.s1|223-233|therapeutic|drug
DDI-DrugBank.d340.s1|235-237|and|drug
DDI-DrugBank.d340.s1|239-245|adverse|drug
DDI-DrugBank.d340.s1|247-253|effects|drug
DDI-DrugBank.d340.s1|254-254|.|drug
DDI-DrugBank.d340.s2|0-9|Nelfinavir|drug
DDI-DrugBank.d340.s2|11-12|is|drug
DDI-DrugBank.d340.s2|14-24|metabolized|drug
DDI-DrugBank.d340.s2|26-27|in|drug
DDI-DrugBank.d340.s2|29-33|proof|drug
DDI-DrugBank.d340.s2|35-36|by|drug
DDI-DrugBank.d340.s2|38-42|C.P.A|drug
DDI-DrugBank.d340.s2|43-43|.|drug
DDI-DrugBank.d340.s3|0-15|Coadministration|drug
DDI-DrugBank.d340.s3|17-18|of|drug
DDI-DrugBank.d340.s3|20-27|VIRACEPT|drug
DDI-DrugBank.d340.s3|29-31|and|drug
DDI-DrugBank.d340.s3|33-37|drugs|drug
DDI-DrugBank.d340.s3|39-42|that|drug
DDI-DrugBank.d340.s3|44-49|induce|drug
DDI-DrugBank.d340.s3|51-55|CYP3A|drug
DDI-DrugBank.d340.s3|57-59|may|drug
DDI-DrugBank.d340.s3|61-68|decrease|drug
DDI-DrugBank.d340.s3|70-79|nelfinavir|drug
DDI-DrugBank.d340.s3|81-86|plasma|drug
DDI-DrugBank.d340.s3|88-101|concentrations|drug
DDI-DrugBank.d340.s3|103-105|and|drug
DDI-DrugBank.d340.s3|107-112|reduce|drug
DDI-DrugBank.d340.s3|114-116|its|drug
DDI-DrugBank.d340.s3|118-128|therapeutic|drug
DDI-DrugBank.d340.s3|130-135|effect|drug
DDI-DrugBank.d340.s3|136-136|.|drug
DDI-DrugBank.d340.s4|0-15|Coadministration|drug
DDI-DrugBank.d340.s4|17-18|of|drug
DDI-DrugBank.d340.s4|20-27|VIRACEPT|drug
DDI-DrugBank.d340.s4|29-31|and|drug
DDI-DrugBank.d340.s4|33-37|drugs|drug
DDI-DrugBank.d340.s4|39-42|that|drug
DDI-DrugBank.d340.s4|44-50|inhibit|drug
DDI-DrugBank.d340.s4|52-56|CYP3A|drug
DDI-DrugBank.d340.s4|58-60|may|drug
DDI-DrugBank.d340.s4|62-69|increase|drug
DDI-DrugBank.d340.s4|71-80|nelfinavir|drug
DDI-DrugBank.d340.s4|82-87|plasma|drug
DDI-DrugBank.d340.s4|89-102|concentrations|drug
DDI-DrugBank.d340.s4|103-103|.|drug
DDI-DrugBank.d340.s5|0-4|Based|drug
DDI-DrugBank.d340.s5|6-7|on|drug
DDI-DrugBank.d340.s5|9-13|known|drug
DDI-DrugBank.d340.s5|15-23|metabolic|drug
DDI-DrugBank.d340.s5|25-32|profiles|drug
DDI-DrugBank.d340.s5|33-33|,|drug
DDI-DrugBank.d340.s5|35-44|clinically|drug
DDI-DrugBank.d340.s5|46-56|significant|drug
DDI-DrugBank.d340.s5|58-61|drug|drug
DDI-DrugBank.d340.s5|63-74|interactions|drug
DDI-DrugBank.d340.s5|76-78|are|drug
DDI-DrugBank.d340.s5|80-82|not|drug
DDI-DrugBank.d340.s5|84-91|expected|drug
DDI-DrugBank.d340.s5|93-99|between|drug
DDI-DrugBank.d340.s5|101-108|VIRACEPT|drug
DDI-DrugBank.d340.s5|110-112|and|drug
DDI-DrugBank.d340.s5|114-120|dapsone|drug
DDI-DrugBank.d340.s5|121-121|,|drug
DDI-DrugBank.d340.s5|123-151|trimethoprim/sulfamethoxazole|drug
DDI-DrugBank.d340.s5|152-152|,|drug
DDI-DrugBank.d340.s5|154-167|clarithromycin|drug
DDI-DrugBank.d340.s5|168-168|,|drug
DDI-DrugBank.d340.s5|170-181|erythromycin|drug
DDI-DrugBank.d340.s5|182-182|,|drug
DDI-DrugBank.d340.s5|184-195|itraconazole|drug
DDI-DrugBank.d340.s5|197-198|or|drug
DDI-DrugBank.d340.s5|200-210|fluconazole|drug
DDI-DrugBank.d340.s5|211-211|.|drug
DDI-DrugBank.d340.s6|0-4|Drugs|drug
DDI-DrugBank.d340.s6|6-9|That|drug
DDI-DrugBank.d340.s6|11-16|Should|drug
DDI-DrugBank.d340.s6|18-20|Not|drug
DDI-DrugBank.d340.s6|22-23|Be|drug
DDI-DrugBank.d340.s6|25-38|Coadministered|drug
DDI-DrugBank.d340.s6|40-43|With|drug
DDI-DrugBank.d340.s6|45-52|VIRACEPT|drug
DDI-DrugBank.d340.s6|54-68|Antiarrhythmics|drug
DDI-DrugBank.d340.s6|69-69|:|drug
DDI-DrugBank.d340.s6|71-80|amiodarone|drug
DDI-DrugBank.d340.s6|81-81|,|drug
DDI-DrugBank.d340.s6|83-91|quinidine|drug
DDI-DrugBank.d340.s6|93-106|Antihistamines|drug
DDI-DrugBank.d340.s6|107-107|:|drug
DDI-DrugBank.d340.s6|109-118|astemizole|drug
DDI-DrugBank.d340.s6|119-119|,|drug
DDI-DrugBank.d340.s6|121-131|terfenadine|drug
DDI-DrugBank.d340.s6|133-144|Antimigraine|drug
DDI-DrugBank.d340.s6|145-145|:|drug
DDI-DrugBank.d340.s6|147-151|ergot|drug
DDI-DrugBank.d340.s6|153-163|derivatives|drug
DDI-DrugBank.d340.s6|165-181|Antimycobacterial|drug
DDI-DrugBank.d340.s6|183-188|agents|drug
DDI-DrugBank.d340.s6|189-189|:|drug
DDI-DrugBank.d340.s6|191-198|rifampin|drug
DDI-DrugBank.d340.s6|200-214|Benzodiazepines|drug
DDI-DrugBank.d340.s6|216-224|midazolam|drug
DDI-DrugBank.d340.s6|225-225|,|drug
DDI-DrugBank.d340.s6|227-235|triazolam|drug
DDI-DrugBank.d340.s6|237-238|GI|drug
DDI-DrugBank.d340.s6|240-247|motility|drug
DDI-DrugBank.d340.s6|249-254|agents|drug
DDI-DrugBank.d340.s6|255-255|:|drug
DDI-DrugBank.d340.s6|257-265|cisapride|drug
DDI-DrugBank.d340.s7|0-4|Drugs|drug
DDI-DrugBank.d340.s7|6-10|Which|drug
DDI-DrugBank.d340.s7|12-18|Require|drug
DDI-DrugBank.d340.s7|20-20|a|drug
DDI-DrugBank.d340.s7|22-25|Dose|drug
DDI-DrugBank.d340.s7|27-35|Reduction|drug
DDI-DrugBank.d340.s7|37-40|When|drug
DDI-DrugBank.d340.s7|42-54|Coadminstered|drug
DDI-DrugBank.d340.s7|56-59|With|drug
DDI-DrugBank.d340.s7|61-68|VIRACEPT|drug
DDI-DrugBank.d340.s7|70-86|Antimycobacterial|drug
DDI-DrugBank.d340.s7|88-93|agents|drug
DDI-DrugBank.d340.s7|94-94|:|drug
DDI-DrugBank.d340.s7|96-104|rifabutin|drug
DDI-DrugBank.d340.s8|0-0|*|drug
DDI-DrugBank.d340.s8|2-5|This|drug
DDI-DrugBank.d340.s8|7-11|table|drug
DDI-DrugBank.d340.s8|13-14|is|drug
DDI-DrugBank.d340.s8|16-18|not|drug
DDI-DrugBank.d340.s8|20-22|all|drug
DDI-DrugBank.d340.s8|24-32|inclusive|drug
DDI-DrugBank.d340.s8|34-35|*|drug
DDI-DrugBank.d340.s8|37-44|*|drug
DDI-DrugBank.d340.s8|46-48|VIRACEPT|drug
DDI-DrugBank.d340.s8|50-52|may|drug
DDI-DrugBank.d340.s8|54-55|not|drug
DDI-DrugBank.d340.s8|57-65|be|drug
DDI-DrugBank.d340.s8|67-69|effective|drug
DDI-DrugBank.d340.s8|71-72|due|drug
DDI-DrugBank.d340.s8|74-82|to|drug
DDI-DrugBank.d340.s8|84-93|decreased|drug
DDI-DrugBank.d340.s8|95-100|nelfinavir|drug
DDI-DrugBank.d340.s8|102-115|plasma|drug
DDI-DrugBank.d340.s8|117-118|concentrations|drug
DDI-DrugBank.d340.s8|120-127|in|drug
DDI-DrugBank.d340.s8|129-134|patients|drug
DDI-DrugBank.d340.s8|136-140|taking|drug
DDI-DrugBank.d340.s8|142-147|these|drug
DDI-DrugBank.d340.s8|149-161|agents|drug
DDI-DrugBank.d340.s9|0-13|Antihistamines|drug
DDI-DrugBank.d340.s10|0-10|Terfenadine|drug
DDI-DrugBank.d340.s10|11-11|:|drug
DDI-DrugBank.d340.s10|13-26|Administration|drug
DDI-DrugBank.d340.s10|28-29|of|drug
DDI-DrugBank.d340.s10|31-41|terfenadine|drug
DDI-DrugBank.d340.s10|43-46|with|drug
DDI-DrugBank.d340.s10|48-55|VIRACEPT|drug
DDI-DrugBank.d340.s10|57-64|resulted|drug
DDI-DrugBank.d340.s10|66-67|in|drug
DDI-DrugBank.d340.s10|69-71|the|drug
DDI-DrugBank.d340.s10|73-82|appearance|drug
DDI-DrugBank.d340.s10|84-85|of|drug
DDI-DrugBank.d340.s10|87-95|unchanged|drug
DDI-DrugBank.d340.s10|97-107|terfenadine|drug
DDI-DrugBank.d340.s10|109-110|in|drug
DDI-DrugBank.d340.s10|112-117|plasma|drug
DDI-DrugBank.d340.s10|118-118|;|drug
DDI-DrugBank.d340.s11|0-8|therefore|drug
DDI-DrugBank.d340.s11|9-9|,|drug
DDI-DrugBank.d340.s11|11-18|VIRACEPT|drug
DDI-DrugBank.d340.s11|20-25|should|drug
DDI-DrugBank.d340.s11|27-29|not|drug
DDI-DrugBank.d340.s11|31-32|be|drug
DDI-DrugBank.d340.s11|34-45|administered|drug
DDI-DrugBank.d340.s11|47-58|concurrently|drug
DDI-DrugBank.d340.s11|60-63|with|drug
DDI-DrugBank.d340.s11|65-75|terfenadine|drug
DDI-DrugBank.d340.s11|77-83|because|drug
DDI-DrugBank.d340.s11|85-86|of|drug
DDI-DrugBank.d340.s11|88-90|the|drug
DDI-DrugBank.d340.s11|92-100|potential|drug
DDI-DrugBank.d340.s11|102-104|for|drug
DDI-DrugBank.d340.s11|106-112|serious|drug
DDI-DrugBank.d340.s11|114-119|and/or|drug
DDI-DrugBank.d340.s11|121-136|life-threatening|drug
DDI-DrugBank.d340.s11|138-144|cardiac|drug
DDI-DrugBank.d340.s11|146-156|arrhythmias|drug
DDI-DrugBank.d340.s11|157-157|.|drug
DDI-DrugBank.d340.s12|0-6|Because|drug
DDI-DrugBank.d340.s12|8-8|a|drug
DDI-DrugBank.d340.s12|10-16|similar|drug
DDI-DrugBank.d340.s12|18-28|interaction|drug
DDI-DrugBank.d340.s12|30-31|is|drug
DDI-DrugBank.d340.s12|33-38|likely|drug
DDI-DrugBank.d340.s12|39-39|,|drug
DDI-DrugBank.d340.s12|41-48|VIRACEPT|drug
DDI-DrugBank.d340.s12|50-55|should|drug
DDI-DrugBank.d340.s12|57-60|also|drug
DDI-DrugBank.d340.s12|62-64|not|drug
DDI-DrugBank.d340.s12|66-67|be|drug
DDI-DrugBank.d340.s12|69-80|administered|drug
DDI-DrugBank.d340.s12|82-93|concurrently|drug
DDI-DrugBank.d340.s12|95-98|with|drug
DDI-DrugBank.d340.s12|100-109|astemizole|drug
DDI-DrugBank.d340.s12|110-110|.|drug
DDI-DrugBank.d340.s13|0-7|Anti-HIV|drug
DDI-DrugBank.d340.s13|9-16|Protease|drug
DDI-DrugBank.d340.s13|18-27|Inhibitors|drug
DDI-DrugBank.d340.s14|0-8|Indinavir|drug
DDI-DrugBank.d340.s14|9-9|:|drug
DDI-DrugBank.d340.s14|11-26|Coadministration|drug
DDI-DrugBank.d340.s14|28-29|of|drug
DDI-DrugBank.d340.s14|31-39|indinavir|drug
DDI-DrugBank.d340.s14|41-44|with|drug
DDI-DrugBank.d340.s14|46-53|VIRACEPT|drug
DDI-DrugBank.d340.s14|55-62|resulted|drug
DDI-DrugBank.d340.s14|64-65|in|drug
DDI-DrugBank.d340.s14|67-68|an|drug
DDI-DrugBank.d340.s14|70-71|83|drug
DDI-DrugBank.d340.s14|72-72|%|drug
DDI-DrugBank.d340.s14|74-81|increase|drug
DDI-DrugBank.d340.s14|83-84|in|drug
DDI-DrugBank.d340.s14|86-95|nelfinavir|drug
DDI-DrugBank.d340.s14|97-102|plasma|drug
DDI-DrugBank.d340.s14|104-106|AUC|drug
DDI-DrugBank.d340.s14|108-110|and|drug
DDI-DrugBank.d340.s14|112-112|a|drug
DDI-DrugBank.d340.s14|114-115|51|drug
DDI-DrugBank.d340.s14|116-116|%|drug
DDI-DrugBank.d340.s14|118-125|increase|drug
DDI-DrugBank.d340.s14|127-128|in|drug
DDI-DrugBank.d340.s14|130-138|indinavir|drug
DDI-DrugBank.d340.s14|140-145|plasma|drug
DDI-DrugBank.d340.s14|147-149|A.C|drug
DDI-DrugBank.d340.s14|150-150|.|drug
DDI-DrugBank.d340.s15|0-8|Currently|drug
DDI-DrugBank.d340.s15|9-9|,|drug
DDI-DrugBank.d340.s15|11-15|there|drug
DDI-DrugBank.d340.s15|17-19|are|drug
DDI-DrugBank.d340.s15|21-22|no|drug
DDI-DrugBank.d340.s15|24-29|safety|drug
DDI-DrugBank.d340.s15|31-33|and|drug
DDI-DrugBank.d340.s15|35-42|efficacy|drug
DDI-DrugBank.d340.s15|44-47|data|drug
DDI-DrugBank.d340.s15|49-57|available|drug
DDI-DrugBank.d340.s15|59-62|from|drug
DDI-DrugBank.d340.s15|64-66|the|drug
DDI-DrugBank.d340.s15|68-70|use|drug
DDI-DrugBank.d340.s15|72-73|of|drug
DDI-DrugBank.d340.s15|75-78|this|drug
DDI-DrugBank.d340.s15|80-90|combination|drug
DDI-DrugBank.d340.s15|91-91|.|drug
DDI-DrugBank.d340.s16|0-8|Ritonavir|drug
DDI-DrugBank.d340.s16|9-9|:|drug
DDI-DrugBank.d340.s16|11-26|Coadministration|drug
DDI-DrugBank.d340.s16|28-29|of|drug
DDI-DrugBank.d340.s16|31-39|ritonavir|drug
DDI-DrugBank.d340.s16|41-44|with|drug
DDI-DrugBank.d340.s16|46-53|VIRACEPT|drug
DDI-DrugBank.d340.s16|55-62|resulted|drug
DDI-DrugBank.d340.s16|64-65|in|drug
DDI-DrugBank.d340.s16|67-67|a|drug
DDI-DrugBank.d340.s16|69-71|152|drug
DDI-DrugBank.d340.s16|72-72|%|drug
DDI-DrugBank.d340.s16|74-81|increase|drug
DDI-DrugBank.d340.s16|83-84|in|drug
DDI-DrugBank.d340.s16|86-95|nelfinavir|drug
DDI-DrugBank.d340.s16|97-102|plasma|drug
DDI-DrugBank.d340.s16|104-106|AUC|drug
DDI-DrugBank.d340.s16|108-110|and|drug
DDI-DrugBank.d340.s16|112-115|very|drug
DDI-DrugBank.d340.s16|117-122|little|drug
DDI-DrugBank.d340.s16|124-129|change|drug
DDI-DrugBank.d340.s16|131-132|in|drug
DDI-DrugBank.d340.s16|134-142|ritonavir|drug
DDI-DrugBank.d340.s16|144-149|plasma|drug
DDI-DrugBank.d340.s16|151-153|A.C|drug
DDI-DrugBank.d340.s16|154-154|.|drug
DDI-DrugBank.d340.s17|0-8|Currently|drug
DDI-DrugBank.d340.s17|9-9|,|drug
DDI-DrugBank.d340.s17|11-15|there|drug
DDI-DrugBank.d340.s17|17-19|are|drug
DDI-DrugBank.d340.s17|21-22|no|drug
DDI-DrugBank.d340.s17|24-29|safety|drug
DDI-DrugBank.d340.s17|31-33|and|drug
DDI-DrugBank.d340.s17|35-42|efficacy|drug
DDI-DrugBank.d340.s17|44-47|data|drug
DDI-DrugBank.d340.s17|49-57|available|drug
DDI-DrugBank.d340.s17|59-62|from|drug
DDI-DrugBank.d340.s17|64-66|the|drug
DDI-DrugBank.d340.s17|68-70|use|drug
DDI-DrugBank.d340.s17|72-73|of|drug
DDI-DrugBank.d340.s17|75-78|this|drug
DDI-DrugBank.d340.s17|80-90|combination|drug
DDI-DrugBank.d340.s17|91-91|.|drug
DDI-DrugBank.d340.s18|0-9|Saquinavir|drug
DDI-DrugBank.d340.s18|10-10|:|drug
DDI-DrugBank.d340.s18|12-27|Coadministration|drug
DDI-DrugBank.d340.s18|29-30|of|drug
DDI-DrugBank.d340.s18|32-41|saquinavir|drug
DDI-DrugBank.d340.s18|43-43|(|drug
DDI-DrugBank.d340.s18|44-48|using|drug
DDI-DrugBank.d340.s18|50-51|an|drug
DDI-DrugBank.d340.s18|53-64|experimental|drug
DDI-DrugBank.d340.s18|66-77|soft-gelatin|drug
DDI-DrugBank.d340.s18|79-85|capsule|drug
DDI-DrugBank.d340.s18|87-97|formulation|drug
DDI-DrugBank.d340.s18|99-100|of|drug
DDI-DrugBank.d340.s18|102-111|saquinavir|drug
DDI-DrugBank.d340.s18|113-118|1200mg|drug
DDI-DrugBank.d340.s18|119-119|)|drug
DDI-DrugBank.d340.s18|121-124|with|drug
DDI-DrugBank.d340.s18|126-133|VIRACEPT|drug
DDI-DrugBank.d340.s18|135-142|resulted|drug
DDI-DrugBank.d340.s18|144-145|in|drug
DDI-DrugBank.d340.s18|147-148|an|drug
DDI-DrugBank.d340.s18|150-151|18|drug
DDI-DrugBank.d340.s18|152-152|%|drug
DDI-DrugBank.d340.s18|154-161|increase|drug
DDI-DrugBank.d340.s18|163-164|in|drug
DDI-DrugBank.d340.s18|166-175|nelfinavir|drug
DDI-DrugBank.d340.s18|177-182|plasma|drug
DDI-DrugBank.d340.s18|184-186|AUC|drug
DDI-DrugBank.d340.s18|188-190|and|drug
DDI-DrugBank.d340.s18|192-192|a|drug
DDI-DrugBank.d340.s18|194-199|4-fold|drug
DDI-DrugBank.d340.s18|201-208|increase|drug
DDI-DrugBank.d340.s18|210-211|in|drug
DDI-DrugBank.d340.s18|213-222|saquinavir|drug
DDI-DrugBank.d340.s18|224-229|plasma|drug
DDI-DrugBank.d340.s18|231-233|A.C|drug
DDI-DrugBank.d340.s18|234-234|.|drug
DDI-DrugBank.d340.s19|0-1|If|drug
DDI-DrugBank.d340.s19|3-6|used|drug
DDI-DrugBank.d340.s19|8-9|in|drug
DDI-DrugBank.d340.s19|11-21|combination|drug
DDI-DrugBank.d340.s19|23-26|with|drug
DDI-DrugBank.d340.s19|28-37|saquinavir|drug
DDI-DrugBank.d340.s19|39-42|hard|drug
DDI-DrugBank.d340.s19|44-50|gelatin|drug
DDI-DrugBank.d340.s19|52-59|capsules|drug
DDI-DrugBank.d340.s19|61-62|at|drug
DDI-DrugBank.d340.s19|64-66|the|drug
DDI-DrugBank.d340.s19|68-78|recommended|drug
DDI-DrugBank.d340.s19|80-83|dose|drug
DDI-DrugBank.d340.s19|85-86|of|drug
DDI-DrugBank.d340.s19|88-90|600|drug
DDI-DrugBank.d340.s19|92-93|mg|drug
DDI-DrugBank.d340.s19|95-97|tid|drug
DDI-DrugBank.d340.s19|98-98|,|drug
DDI-DrugBank.d340.s19|100-101|no|drug
DDI-DrugBank.d340.s19|103-106|dose|drug
DDI-DrugBank.d340.s19|108-118|adjustments|drug
DDI-DrugBank.d340.s19|120-122|are|drug
DDI-DrugBank.d340.s19|124-129|needed|drug
DDI-DrugBank.d340.s19|130-130|.|drug
DDI-DrugBank.d340.s20|0-8|Currently|drug
DDI-DrugBank.d340.s20|9-9|,|drug
DDI-DrugBank.d340.s20|11-15|there|drug
DDI-DrugBank.d340.s20|17-19|are|drug
DDI-DrugBank.d340.s20|21-22|no|drug
DDI-DrugBank.d340.s20|24-29|safety|drug
DDI-DrugBank.d340.s20|31-33|and|drug
DDI-DrugBank.d340.s20|35-42|efficacy|drug
DDI-DrugBank.d340.s20|44-47|data|drug
DDI-DrugBank.d340.s20|49-57|available|drug
DDI-DrugBank.d340.s20|59-62|from|drug
DDI-DrugBank.d340.s20|64-66|the|drug
DDI-DrugBank.d340.s20|68-70|use|drug
DDI-DrugBank.d340.s20|72-73|of|drug
DDI-DrugBank.d340.s20|75-78|this|drug
DDI-DrugBank.d340.s20|80-90|combination|drug
DDI-DrugBank.d340.s20|91-91|.|drug
DDI-DrugBank.d340.s21|0-9|Antifungal|drug
DDI-DrugBank.d340.s21|11-16|Agents|drug
DDI-DrugBank.d340.s22|0-11|Ketoconazole|drug
DDI-DrugBank.d340.s22|12-12|:|drug
DDI-DrugBank.d340.s22|14-29|Coadministration|drug
DDI-DrugBank.d340.s22|31-32|of|drug
DDI-DrugBank.d340.s22|34-45|ketoconazole|drug
DDI-DrugBank.d340.s22|47-50|with|drug
DDI-DrugBank.d340.s22|52-59|VIRACEPT|drug
DDI-DrugBank.d340.s22|61-68|resulted|drug
DDI-DrugBank.d340.s22|70-71|in|drug
DDI-DrugBank.d340.s22|73-73|a|drug
DDI-DrugBank.d340.s22|75-76|35|drug
DDI-DrugBank.d340.s22|77-77|%|drug
DDI-DrugBank.d340.s22|79-86|increase|drug
DDI-DrugBank.d340.s22|88-89|in|drug
DDI-DrugBank.d340.s22|91-100|nelfinavir|drug
DDI-DrugBank.d340.s22|102-107|plasma|drug
DDI-DrugBank.d340.s22|109-111|A.C|drug
DDI-DrugBank.d340.s22|112-112|.|drug
DDI-DrugBank.d340.s23|0-3|This|drug
DDI-DrugBank.d340.s23|5-10|change|drug
DDI-DrugBank.d340.s23|12-14|was|drug
DDI-DrugBank.d340.s23|16-18|not|drug
DDI-DrugBank.d340.s23|20-29|considered|drug
DDI-DrugBank.d340.s23|31-40|clinically|drug
DDI-DrugBank.d340.s23|42-52|significant|drug
DDI-DrugBank.d340.s23|54-56|and|drug
DDI-DrugBank.d340.s23|58-59|no|drug
DDI-DrugBank.d340.s23|61-64|dose|drug
DDI-DrugBank.d340.s23|66-75|adjustment|drug
DDI-DrugBank.d340.s23|77-78|is|drug
DDI-DrugBank.d340.s23|80-85|needed|drug
DDI-DrugBank.d340.s23|87-90|when|drug
DDI-DrugBank.d340.s23|92-103|ketoconazole|drug
DDI-DrugBank.d340.s23|105-107|and|drug
DDI-DrugBank.d340.s23|109-116|VIRACEPT|drug
DDI-DrugBank.d340.s23|118-120|are|drug
DDI-DrugBank.d340.s23|122-135|coadministered|drug
DDI-DrugBank.d340.s23|136-136|.|drug
DDI-DrugBank.d340.s24|0-7|Anti-HIV|drug
DDI-DrugBank.d340.s24|9-15|Reverse|drug
DDI-DrugBank.d340.s24|17-29|Transcriptase|drug
DDI-DrugBank.d340.s24|31-40|Inhibitors|drug
DDI-DrugBank.d340.s25|0-9|Didanosine|drug
DDI-DrugBank.d340.s25|10-10|:|drug
DDI-DrugBank.d340.s25|12-13|It|drug
DDI-DrugBank.d340.s25|15-16|is|drug
DDI-DrugBank.d340.s25|18-28|recommended|drug
DDI-DrugBank.d340.s25|30-33|that|drug
DDI-DrugBank.d340.s25|35-44|didanosine|drug
DDI-DrugBank.d340.s25|46-47|be|drug
DDI-DrugBank.d340.s25|49-60|administered|drug
DDI-DrugBank.d340.s25|62-63|on|drug
DDI-DrugBank.d340.s25|65-66|an|drug
DDI-DrugBank.d340.s25|68-72|empty|drug
DDI-DrugBank.d340.s25|74-80|stomach|drug
DDI-DrugBank.d340.s25|81-81|;|drug
DDI-DrugBank.d340.s26|0-8|therefore|drug
DDI-DrugBank.d340.s26|9-9|,|drug
DDI-DrugBank.d340.s26|11-20|nelfinavir|drug
DDI-DrugBank.d340.s26|22-27|should|drug
DDI-DrugBank.d340.s26|29-30|be|drug
DDI-DrugBank.d340.s26|32-43|administered|drug
DDI-DrugBank.d340.s26|45-45|(|drug
DDI-DrugBank.d340.s26|46-49|with|drug
DDI-DrugBank.d340.s26|51-54|food|drug
DDI-DrugBank.d340.s26|55-55|)|drug
DDI-DrugBank.d340.s26|57-59|one|drug
DDI-DrugBank.d340.s26|61-64|hour|drug
DDI-DrugBank.d340.s26|66-70|after|drug
DDI-DrugBank.d340.s26|72-73|or|drug
DDI-DrugBank.d340.s26|75-78|more|drug
DDI-DrugBank.d340.s26|80-83|than|drug
DDI-DrugBank.d340.s26|85-87|two|drug
DDI-DrugBank.d340.s26|89-93|hours|drug
DDI-DrugBank.d340.s26|95-100|before|drug
DDI-DrugBank.d340.s26|102-111|didanosine|drug
DDI-DrugBank.d340.s26|112-112|.|drug
DDI-DrugBank.d340.s27|0-0|A|drug
DDI-DrugBank.d340.s27|2-5|dose|drug
DDI-DrugBank.d340.s27|7-16|adjustment|drug
DDI-DrugBank.d340.s27|18-19|is|drug
DDI-DrugBank.d340.s27|21-23|not|drug
DDI-DrugBank.d340.s27|25-30|needed|drug
DDI-DrugBank.d340.s27|32-35|when|drug
DDI-DrugBank.d340.s27|37-46|zidovudine|drug
DDI-DrugBank.d340.s27|48-49|is|drug
DDI-DrugBank.d340.s27|51-62|administered|drug
DDI-DrugBank.d340.s27|64-67|with|drug
DDI-DrugBank.d340.s27|69-76|VIRACEPT|drug
DDI-DrugBank.d340.s27|77-77|.|drug
DDI-DrugBank.d340.s28|0-5|Little|drug
DDI-DrugBank.d340.s28|7-8|or|drug
DDI-DrugBank.d340.s28|10-11|no|drug
DDI-DrugBank.d340.s28|13-18|change|drug
DDI-DrugBank.d340.s28|20-21|in|drug
DDI-DrugBank.d340.s28|23-25|the|drug
DDI-DrugBank.d340.s28|27-42|pharmacokinetics|drug
DDI-DrugBank.d340.s28|44-45|of|drug
DDI-DrugBank.d340.s28|47-52|either|drug
DDI-DrugBank.d340.s28|54-57|drug|drug
DDI-DrugBank.d340.s28|59-61|was|drug
DDI-DrugBank.d340.s28|63-70|observed|drug
DDI-DrugBank.d340.s28|72-75|when|drug
DDI-DrugBank.d340.s28|77-84|VIRACEPT|drug
DDI-DrugBank.d340.s28|86-88|was|drug
DDI-DrugBank.d340.s28|90-103|coadministered|drug
DDI-DrugBank.d340.s28|105-108|with|drug
DDI-DrugBank.d340.s28|110-119|lamivudine|drug
DDI-DrugBank.d340.s28|121-122|or|drug
DDI-DrugBank.d340.s28|124-132|stavudine|drug
DDI-DrugBank.d340.s28|133-133|.|drug
DDI-DrugBank.d340.s29|0-16|Antimycobacterial|drug
DDI-DrugBank.d340.s29|18-23|Agents|drug
DDI-DrugBank.d340.s30|0-8|Rifabutin|drug
DDI-DrugBank.d340.s30|9-9|:|drug
DDI-DrugBank.d340.s30|11-26|Coadministration|drug
DDI-DrugBank.d340.s30|28-29|of|drug
DDI-DrugBank.d340.s30|31-39|rifabutin|drug
DDI-DrugBank.d340.s30|41-43|and|drug
DDI-DrugBank.d340.s30|45-52|VIRACEPT|drug
DDI-DrugBank.d340.s30|54-61|resulted|drug
DDI-DrugBank.d340.s30|63-64|in|drug
DDI-DrugBank.d340.s30|66-66|a|drug
DDI-DrugBank.d340.s30|68-69|32|drug
DDI-DrugBank.d340.s30|70-70|%|drug
DDI-DrugBank.d340.s30|72-79|decrease|drug
DDI-DrugBank.d340.s30|81-82|in|drug
DDI-DrugBank.d340.s30|84-93|nelfinavir|drug
DDI-DrugBank.d340.s30|95-100|plasma|drug
DDI-DrugBank.d340.s30|102-104|AUC|drug
DDI-DrugBank.d340.s30|106-108|and|drug
DDI-DrugBank.d340.s30|110-110|a|drug
DDI-DrugBank.d340.s30|112-114|207|drug
DDI-DrugBank.d340.s30|115-115|%|drug
DDI-DrugBank.d340.s30|117-124|increase|drug
DDI-DrugBank.d340.s30|126-127|in|drug
DDI-DrugBank.d340.s30|129-137|rifabutin|drug
DDI-DrugBank.d340.s30|139-144|plasma|drug
DDI-DrugBank.d340.s30|146-148|A.C|drug
DDI-DrugBank.d340.s30|149-149|.|drug
DDI-DrugBank.d340.s31|0-1|It|drug
DDI-DrugBank.d340.s31|3-4|is|drug
DDI-DrugBank.d340.s31|6-16|recommended|drug
DDI-DrugBank.d340.s31|18-21|that|drug
DDI-DrugBank.d340.s31|23-25|the|drug
DDI-DrugBank.d340.s31|27-30|dose|drug
DDI-DrugBank.d340.s31|32-33|of|drug
DDI-DrugBank.d340.s31|35-43|rifabutin|drug
DDI-DrugBank.d340.s31|45-46|be|drug
DDI-DrugBank.d340.s31|48-54|reduced|drug
DDI-DrugBank.d340.s31|56-57|to|drug
DDI-DrugBank.d340.s31|59-66|one-half|drug
DDI-DrugBank.d340.s31|68-70|the|drug
DDI-DrugBank.d340.s31|72-76|usual|drug
DDI-DrugBank.d340.s31|78-81|dose|drug
DDI-DrugBank.d340.s31|83-86|when|drug
DDI-DrugBank.d340.s31|88-99|administered|drug
DDI-DrugBank.d340.s31|101-104|with|drug
DDI-DrugBank.d340.s31|106-113|VIRACEPT|drug
DDI-DrugBank.d340.s31|114-114|.|drug
DDI-DrugBank.d340.s32|0-7|Rifampin|drug
DDI-DrugBank.d340.s32|8-8|:|drug
DDI-DrugBank.d340.s32|10-25|Coadministration|drug
DDI-DrugBank.d340.s32|27-28|of|drug
DDI-DrugBank.d340.s32|30-37|rifampin|drug
DDI-DrugBank.d340.s32|39-41|and|drug
DDI-DrugBank.d340.s32|43-50|VIRACEPT|drug
DDI-DrugBank.d340.s32|52-59|resulted|drug
DDI-DrugBank.d340.s32|61-62|in|drug
DDI-DrugBank.d340.s32|64-65|an|drug
DDI-DrugBank.d340.s32|67-68|82|drug
DDI-DrugBank.d340.s32|69-69|%|drug
DDI-DrugBank.d340.s32|71-78|decrease|drug
DDI-DrugBank.d340.s32|80-81|in|drug
DDI-DrugBank.d340.s32|83-92|nelfinavir|drug
DDI-DrugBank.d340.s32|94-99|plasma|drug
DDI-DrugBank.d340.s32|101-103|A.C|drug
DDI-DrugBank.d340.s32|104-104|.|drug
DDI-DrugBank.d340.s33|0-7|VIRACEPT|drug
DDI-DrugBank.d340.s33|9-11|and|drug
DDI-DrugBank.d340.s33|13-20|rifampin|drug
DDI-DrugBank.d340.s33|22-27|should|drug
DDI-DrugBank.d340.s33|29-31|not|drug
DDI-DrugBank.d340.s33|33-34|be|drug
DDI-DrugBank.d340.s33|36-49|coadministered|drug
DDI-DrugBank.d340.s33|50-50|.|drug
DDI-DrugBank.d340.s34|0-3|Oral|drug
DDI-DrugBank.d340.s34|5-18|Contraceptives|drug
DDI-DrugBank.d340.s35|0-6|Ethinyl|drug
DDI-DrugBank.d340.s35|8-16|Estradiol|drug
DDI-DrugBank.d340.s35|18-20|and|drug
DDI-DrugBank.d340.s35|22-34|Norethindrone|drug
DDI-DrugBank.d340.s35|35-35|:|drug
DDI-DrugBank.d340.s35|37-52|Coadministration|drug
DDI-DrugBank.d340.s35|54-55|of|drug
DDI-DrugBank.d340.s35|57-64|VIRACEPT|drug
DDI-DrugBank.d340.s35|66-69|with|drug
DDI-DrugBank.d340.s35|71-78|OVCON-35|drug
DDI-DrugBank.d340.s35|80-87|resulted|drug
DDI-DrugBank.d340.s35|89-90|in|drug
DDI-DrugBank.d340.s35|92-92|a|drug
DDI-DrugBank.d340.s35|94-95|47|drug
DDI-DrugBank.d340.s35|96-96|%|drug
DDI-DrugBank.d340.s35|98-105|decrease|drug
DDI-DrugBank.d340.s35|107-108|in|drug
DDI-DrugBank.d340.s35|110-116|ethinyl|drug
DDI-DrugBank.d340.s35|118-126|estradiol|drug
DDI-DrugBank.d340.s35|128-130|and|drug
DDI-DrugBank.d340.s35|132-133|an|drug
DDI-DrugBank.d340.s35|135-136|18|drug
DDI-DrugBank.d340.s35|137-137|%|drug
DDI-DrugBank.d340.s35|139-146|decrease|drug
DDI-DrugBank.d340.s35|148-149|in|drug
DDI-DrugBank.d340.s35|151-163|norethindrone|drug
DDI-DrugBank.d340.s35|165-170|plasma|drug
DDI-DrugBank.d340.s35|172-185|concentrations|drug
DDI-DrugBank.d340.s35|186-186|.|drug
DDI-DrugBank.d340.s36|0-8|Alternate|drug
DDI-DrugBank.d340.s36|10-11|or|drug
DDI-DrugBank.d340.s36|13-22|additional|drug
DDI-DrugBank.d340.s36|24-36|contraceptive|drug
DDI-DrugBank.d340.s36|38-45|measures|drug
DDI-DrugBank.d340.s36|47-52|should|drug
DDI-DrugBank.d340.s36|54-55|be|drug
DDI-DrugBank.d340.s36|57-60|used|drug
DDI-DrugBank.d340.s36|62-67|during|drug
DDI-DrugBank.d340.s36|69-75|therapy|drug
DDI-DrugBank.d340.s36|77-80|with|drug
DDI-DrugBank.d340.s36|82-89|VIRACEPT|drug
DDI-DrugBank.d46.s0|0-3|When|drug
DDI-DrugBank.d46.s0|5-9|given|drug
DDI-DrugBank.d46.s0|11-22|concurrently|drug
DDI-DrugBank.d46.s0|24-26|the|drug
DDI-DrugBank.d46.s0|28-36|following|drug
DDI-DrugBank.d46.s0|38-42|drugs|drug
DDI-DrugBank.d46.s0|44-46|may|drug
DDI-DrugBank.d46.s0|48-55|interact|drug
DDI-DrugBank.d46.s0|57-60|with|drug
DDI-DrugBank.d46.s0|62-69|thiazide|drug
DDI-DrugBank.d46.s0|71-79|diuretics|drug
DDI-DrugBank.d46.s0|80-80|.|drug
DDI-DrugBank.d46.s1|0-0|-|drug
DDI-DrugBank.d46.s1|2-8|Alcohol|drug
DDI-DrugBank.d46.s1|9-9|,|drug
DDI-DrugBank.d46.s1|11-22|barbiturates|drug
DDI-DrugBank.d46.s1|23-23|,|drug
DDI-DrugBank.d46.s1|25-26|or|drug
DDI-DrugBank.d46.s1|28-36|narcotics|drug
DDI-DrugBank.d46.s1|37-37|:|drug
DDI-DrugBank.d46.s1|39-50|Potentiation|drug
DDI-DrugBank.d46.s1|52-53|of|drug
DDI-DrugBank.d46.s1|55-65|otthostatic|drug
DDI-DrugBank.d46.s1|67-77|hypotension|drug
DDI-DrugBank.d46.s1|79-81|may|drug
DDI-DrugBank.d46.s1|83-87|occur|drug
DDI-DrugBank.d46.s2|0-0|.|drug
DDI-DrugBank.d46.s3|0-0|-|drug
DDI-DrugBank.d46.s3|2-13|Antidiabetic|drug
DDI-DrugBank.d46.s3|15-19|drugs|drug
DDI-DrugBank.d46.s3|20-20|:|drug
DDI-DrugBank.d46.s3|22-22|(|drug
DDI-DrugBank.d46.s3|23-26|Oral|drug
DDI-DrugBank.d46.s3|28-33|agents|drug
DDI-DrugBank.d46.s3|35-37|and|drug
DDI-DrugBank.d46.s3|39-45|insulin|drug
DDI-DrugBank.d46.s3|46-46|)|drug
DDI-DrugBank.d46.s3|48-53|Dosage|drug
DDI-DrugBank.d46.s3|55-64|adjustment|drug
DDI-DrugBank.d46.s3|66-67|of|drug
DDI-DrugBank.d46.s3|69-71|the|drug
DDI-DrugBank.d46.s3|73-84|antidiabetic|drug
DDI-DrugBank.d46.s3|86-89|drug|drug
DDI-DrugBank.d46.s3|91-93|may|drug
DDI-DrugBank.d46.s3|95-96|be|drug
DDI-DrugBank.d46.s3|98-105|required|drug
DDI-DrugBank.d46.s4|0-0|.|drug
DDI-DrugBank.d46.s5|0-0|-|drug
DDI-DrugBank.d46.s5|2-6|Other|drug
DDI-DrugBank.d46.s5|8-23|antihypertensive|drug
DDI-DrugBank.d46.s5|25-29|drugs|drug
DDI-DrugBank.d46.s5|30-30|:|drug
DDI-DrugBank.d46.s5|32-39|Additive|drug
DDI-DrugBank.d46.s5|41-46|effect|drug
DDI-DrugBank.d46.s5|48-49|or|drug
DDI-DrugBank.d46.s5|51-62|potentiation|drug
DDI-DrugBank.d46.s6|0-0|.|drug
DDI-DrugBank.d46.s7|0-0|-|drug
DDI-DrugBank.d46.s7|2-15|Cholestyramine|drug
DDI-DrugBank.d46.s7|17-19|and|drug
DDI-DrugBank.d46.s7|21-30|colestipol|drug
DDI-DrugBank.d46.s7|32-37|resins|drug
DDI-DrugBank.d46.s7|38-38|:|drug
DDI-DrugBank.d46.s7|40-53|Cholestytamine|drug
DDI-DrugBank.d46.s7|55-57|and|drug
DDI-DrugBank.d46.s7|59-68|colestipol|drug
DDI-DrugBank.d46.s7|70-75|resins|drug
DDI-DrugBank.d46.s7|77-80|have|drug
DDI-DrugBank.d46.s7|82-84|the|drug
DDI-DrugBank.d46.s7|86-94|potential|drug
DDI-DrugBank.d46.s7|96-97|of|drug
DDI-DrugBank.d46.s7|99-105|binding|drug
DDI-DrugBank.d46.s7|107-114|thiazide|drug
DDI-DrugBank.d46.s7|116-124|diuretics|drug
DDI-DrugBank.d46.s7|126-128|and|drug
DDI-DrugBank.d46.s7|130-137|reducing|drug
DDI-DrugBank.d46.s7|139-146|diuretic|drug
DDI-DrugBank.d46.s7|148-157|absorption|drug
DDI-DrugBank.d46.s7|159-162|from|drug
DDI-DrugBank.d46.s7|164-166|the|drug
DDI-DrugBank.d46.s7|168-183|gastrointestinal|drug
DDI-DrugBank.d46.s7|185-189|tract|drug
DDI-DrugBank.d46.s8|0-0|.|drug
DDI-DrugBank.d46.s9|0-0|-|drug
DDI-DrugBank.d46.s9|2-16|Corticosteroids|drug
DDI-DrugBank.d46.s9|17-17|,|drug
DDI-DrugBank.d46.s9|19-22|ACTH|drug
DDI-DrugBank.d46.s9|23-23|:|drug
DDI-DrugBank.d46.s9|25-35|Intensified|drug
DDI-DrugBank.d46.s9|37-47|electrolyte|drug
DDI-DrugBank.d46.s9|49-57|depletion|drug
DDI-DrugBank.d46.s9|58-58|,|drug
DDI-DrugBank.d46.s9|60-71|particularly|drug
DDI-DrugBank.d46.s9|73-83|hypokalemia|drug
DDI-DrugBank.d46.s10|0-0|.|drug
DDI-DrugBank.d46.s11|0-0|-|drug
DDI-DrugBank.d46.s11|2-8|Pressor|drug
DDI-DrugBank.d46.s11|10-15|amines|drug
DDI-DrugBank.d46.s11|17-17|(|drug
DDI-DrugBank.d46.s11|18-21|e.g.|drug
DDI-DrugBank.d46.s11|22-22|,|drug
DDI-DrugBank.d46.s11|24-37|norepinephrine|drug
DDI-DrugBank.d46.s11|38-38|)|drug
DDI-DrugBank.d46.s11|39-39|:|drug
DDI-DrugBank.d46.s11|41-48|Possible|drug
DDI-DrugBank.d46.s11|50-58|decreased|drug
DDI-DrugBank.d46.s11|60-67|response|drug
DDI-DrugBank.d46.s11|69-70|to|drug
DDI-DrugBank.d46.s11|72-78|pressor|drug
DDI-DrugBank.d46.s11|80-85|amines|drug
DDI-DrugBank.d46.s11|87-89|but|drug
DDI-DrugBank.d46.s11|91-93|not|drug
DDI-DrugBank.d46.s11|95-104|sufficient|drug
DDI-DrugBank.d46.s11|106-107|to|drug
DDI-DrugBank.d46.s11|109-116|preclude|drug
DDI-DrugBank.d46.s11|118-122|their|drug
DDI-DrugBank.d46.s11|124-126|use|drug
DDI-DrugBank.d46.s12|0-0|.|drug
DDI-DrugBank.d46.s13|0-0|-|drug
DDI-DrugBank.d46.s13|2-9|Skeletal|drug
DDI-DrugBank.d46.s13|11-16|muscle|drug
DDI-DrugBank.d46.s13|18-26|relaxants|drug
DDI-DrugBank.d46.s13|27-27|,|drug
DDI-DrugBank.d46.s13|29-43|nondepolarizing|drug
DDI-DrugBank.d46.s13|45-45|(|drug
DDI-DrugBank.d46.s13|46-49|e.g.|drug
DDI-DrugBank.d46.s13|50-50|,|drug
DDI-DrugBank.d46.s13|52-63|tubocurarine|drug
DDI-DrugBank.d46.s13|64-64|)|drug
DDI-DrugBank.d46.s13|65-65|:|drug
DDI-DrugBank.d46.s13|67-74|Possible|drug
DDI-DrugBank.d46.s13|76-84|increased|drug
DDI-DrugBank.d46.s13|86-99|responsiveness|drug
DDI-DrugBank.d46.s13|101-102|to|drug
DDI-DrugBank.d46.s13|104-106|the|drug
DDI-DrugBank.d46.s13|108-113|muscle|drug
DDI-DrugBank.d46.s13|115-122|relaxant|drug
DDI-DrugBank.d46.s14|0-0|.|drug
DDI-DrugBank.d46.s15|0-0|-|drug
DDI-DrugBank.d46.s15|2-8|Lithium|drug
DDI-DrugBank.d46.s15|9-9|:|drug
DDI-DrugBank.d46.s15|11-19|Generally|drug
DDI-DrugBank.d46.s15|21-26|should|drug
DDI-DrugBank.d46.s15|28-30|not|drug
DDI-DrugBank.d46.s15|32-33|be|drug
DDI-DrugBank.d46.s15|35-39|given|drug
DDI-DrugBank.d46.s15|41-44|with|drug
DDI-DrugBank.d46.s15|46-54|diuretics|drug
DDI-DrugBank.d46.s15|55-55|.|drug
DDI-DrugBank.d46.s16|0-7|Diuretic|drug
DDI-DrugBank.d46.s16|9-14|agents|drug
DDI-DrugBank.d46.s16|16-21|reduce|drug
DDI-DrugBank.d46.s16|23-25|the|drug
DDI-DrugBank.d46.s16|27-31|renal|drug
DDI-DrugBank.d46.s16|33-41|clearance|drug
DDI-DrugBank.d46.s16|43-44|of|drug
DDI-DrugBank.d46.s16|46-52|lithium|drug
DDI-DrugBank.d46.s16|54-56|and|drug
DDI-DrugBank.d46.s16|58-60|add|drug
DDI-DrugBank.d46.s16|62-62|a|drug
DDI-DrugBank.d46.s16|64-67|high|drug
DDI-DrugBank.d46.s16|69-72|risk|drug
DDI-DrugBank.d46.s16|74-75|of|drug
DDI-DrugBank.d46.s16|77-83|lithium|drug
DDI-DrugBank.d46.s16|85-92|toxicity|drug
DDI-DrugBank.d46.s16|93-93|.|drug
DDI-DrugBank.d46.s17|0-4|Refer|drug
DDI-DrugBank.d46.s17|6-7|to|drug
DDI-DrugBank.d46.s17|9-11|the|drug
DDI-DrugBank.d46.s17|13-19|package|drug
DDI-DrugBank.d46.s17|21-26|insert|drug
DDI-DrugBank.d46.s17|28-30|for|drug
DDI-DrugBank.d46.s17|32-38|lithium|drug
DDI-DrugBank.d46.s17|40-51|preparations|drug
DDI-DrugBank.d46.s17|53-58|before|drug
DDI-DrugBank.d46.s17|60-62|use|drug
DDI-DrugBank.d46.s17|64-65|of|drug
DDI-DrugBank.d46.s17|67-70|such|drug
DDI-DrugBank.d46.s17|72-83|preparations|drug
DDI-DrugBank.d46.s17|85-88|with|drug
DDI-DrugBank.d46.s17|90-103|chlorothiazide|drug
DDI-DrugBank.d46.s18|0-0|.|drug
DDI-DrugBank.d46.s19|0-0|-|drug
DDI-DrugBank.d46.s19|2-14|Non-steroidal|drug
DDI-DrugBank.d46.s19|16-32|Anti-inflammatory|drug
DDI-DrugBank.d46.s19|34-38|Drugs|drug
DDI-DrugBank.d46.s19|39-39|:|drug
DDI-DrugBank.d46.s19|41-42|In|drug
DDI-DrugBank.d46.s19|44-47|some|drug
DDI-DrugBank.d46.s19|49-56|patients|drug
DDI-DrugBank.d46.s19|57-57|,|drug
DDI-DrugBank.d46.s19|59-61|the|drug
DDI-DrugBank.d46.s19|63-76|administration|drug
DDI-DrugBank.d46.s19|78-79|of|drug
DDI-DrugBank.d46.s19|81-81|a|drug
DDI-DrugBank.d46.s19|83-95|non-steroidal|drug
DDI-DrugBank.d46.s19|97-113|anti-inflammatory|drug
DDI-DrugBank.d46.s19|115-119|agent|drug
DDI-DrugBank.d46.s19|121-123|can|drug
DDI-DrugBank.d46.s19|125-130|reduce|drug
DDI-DrugBank.d46.s19|132-134|the|drug
DDI-DrugBank.d46.s19|136-143|diuretic|drug
DDI-DrugBank.d46.s19|144-144|,|drug
DDI-DrugBank.d46.s19|146-156|natriuretic|drug
DDI-DrugBank.d46.s19|157-157|,|drug
DDI-DrugBank.d46.s19|159-161|and|drug
DDI-DrugBank.d46.s19|163-178|antihypertensive|drug
DDI-DrugBank.d46.s19|180-186|effects|drug
DDI-DrugBank.d46.s19|188-189|of|drug
DDI-DrugBank.d46.s19|191-194|loop|drug
DDI-DrugBank.d46.s19|195-195|,|drug
DDI-DrugBank.d46.s19|197-213|potassium-sparing|drug
DDI-DrugBank.d46.s19|215-217|and|drug
DDI-DrugBank.d46.s19|219-226|thiazide|drug
DDI-DrugBank.d46.s19|228-236|diuretics|drug
DDI-DrugBank.d46.s19|237-237|.|drug
DDI-DrugBank.d46.s20|0-8|Therefore|drug
DDI-DrugBank.d46.s20|9-9|,|drug
DDI-DrugBank.d46.s20|11-14|when|drug
DDI-DrugBank.d46.s20|16-29|chlorothiazide|drug
DDI-DrugBank.d46.s20|31-33|and|drug
DDI-DrugBank.d46.s20|35-47|non-steroidal|drug
DDI-DrugBank.d46.s20|49-65|anti-inflammatory|drug
DDI-DrugBank.d46.s20|67-72|agents|drug
DDI-DrugBank.d46.s20|74-76|are|drug
DDI-DrugBank.d46.s20|78-81|used|drug
DDI-DrugBank.d46.s20|83-95|concomitantly|drug
DDI-DrugBank.d46.s20|96-96|,|drug
DDI-DrugBank.d46.s20|98-100|the|drug
DDI-DrugBank.d46.s20|102-108|patient|drug
DDI-DrugBank.d46.s20|110-115|should|drug
DDI-DrugBank.d46.s20|117-118|be|drug
DDI-DrugBank.d46.s20|120-127|observed|drug
DDI-DrugBank.d46.s20|129-135|closely|drug
DDI-DrugBank.d46.s20|137-138|to|drug
DDI-DrugBank.d46.s20|140-148|determine|drug
DDI-DrugBank.d46.s20|150-151|if|drug
DDI-DrugBank.d46.s20|153-155|the|drug
DDI-DrugBank.d46.s20|157-163|desired|drug
DDI-DrugBank.d46.s20|165-170|effect|drug
DDI-DrugBank.d46.s20|172-173|of|drug
DDI-DrugBank.d46.s20|175-177|the|drug
DDI-DrugBank.d46.s20|179-186|diuretic|drug
DDI-DrugBank.d46.s20|188-189|is|drug
DDI-DrugBank.d46.s20|191-198|obtained|drug
DDI-DrugBank.d46.s21|0-0|.|drug
DDI-DrugBank.d46.s22|0-0|-|drug
DDI-DrugBank.d46.s22|2-16|Drug/Laboratory|drug
DDI-DrugBank.d46.s22|18-21|Test|drug
DDI-DrugBank.d46.s22|23-34|Interactions|drug
DDI-DrugBank.d46.s22|35-35|:|drug
DDI-DrugBank.d46.s22|37-45|Thiazides|drug
DDI-DrugBank.d46.s22|47-52|should|drug
DDI-DrugBank.d46.s22|54-55|be|drug
DDI-DrugBank.d46.s22|57-68|discontinued|drug
DDI-DrugBank.d46.s22|70-75|before|drug
DDI-DrugBank.d46.s22|77-84|carrying|drug
DDI-DrugBank.d46.s22|86-88|out|drug
DDI-DrugBank.d46.s22|90-94|tests|drug
DDI-DrugBank.d46.s22|96-98|for|drug
DDI-DrugBank.d46.s22|100-110|parathyroid|drug
DDI-DrugBank.d46.s22|112-119|function|drug
DDI-DrugBank.d46.s22|120-120|.|drug
DDI-DrugBank.d119.s0|0-2|The|drug
DDI-DrugBank.d119.s0|4-12|following|drug
DDI-DrugBank.d119.s0|14-17|drug|drug
DDI-DrugBank.d119.s0|19-30|interactions|drug
DDI-DrugBank.d119.s0|32-35|have|drug
DDI-DrugBank.d119.s0|37-40|been|drug
DDI-DrugBank.d119.s0|42-49|reported|drug
DDI-DrugBank.d119.s0|51-54|with|drug
DDI-DrugBank.d119.s0|56-64|etomidate|drug
DDI-DrugBank.d119.s0|65-65|.|drug
DDI-DrugBank.d119.s1|0-3|Drug|drug
DDI-DrugBank.d119.s1|5-10|Effect|drug
DDI-DrugBank.d119.s2|0-9|Probenecid|drug
DDI-DrugBank.d119.s2|14-22|Prolonged|drug
DDI-DrugBank.d119.s2|24-29|action|drug
DDI-DrugBank.d119.s2|31-32|of|drug
DDI-DrugBank.d119.s2|34-42|etomidate|drug
DDI-DrugBank.d119.s3|0-8|Diazoxide|drug
DDI-DrugBank.d119.s3|13-23|Hypotension|drug
DDI-DrugBank.d119.s4|0-9|Zimelidine|drug
DDI-DrugBank.d119.s4|14-22|etomidate|drug
DDI-DrugBank.d119.s4|24-33|antagonism|drug
DDI-DrugBank.d119.s5|0-5|Opioid|drug
DDI-DrugBank.d119.s5|7-16|analgesics|drug
DDI-DrugBank.d119.s5|21-29|Decreased|drug
DDI-DrugBank.d119.s5|31-45|antinociceptive|drug
DDI-DrugBank.d119.s5|47-52|action|drug
DDI-DrugBank.d119.s6|0-12|Aminophylline|drug
DDI-DrugBank.d119.s6|18-26|Etomidate|drug
DDI-DrugBank.d119.s6|28-37|antagonism|drug
DDI-DrugBank.d119.s7|0-8|Midazolam|drug
DDI-DrugBank.d119.s7|13-21|Synergism|drug
DDI-DrugBank.d149.s0|0-7|Possible|drug
DDI-DrugBank.d149.s0|9-12|drug|drug
DDI-DrugBank.d149.s0|14-25|interactions|drug
DDI-DrugBank.d149.s0|27-28|of|drug
DDI-DrugBank.d149.s0|30-37|HUMORSOL|drug
DDI-DrugBank.d149.s0|39-42|with|drug
DDI-DrugBank.d149.s0|44-58|succinylcholine|drug
DDI-DrugBank.d149.s0|60-61|or|drug
DDI-DrugBank.d149.s0|63-66|with|drug
DDI-DrugBank.d149.s0|68-72|other|drug
DDI-DrugBank.d149.s0|74-91|anticholinesterase|drug
DDI-DrugBank.d149.s0|93-98|agents|drug
DDI-DrugBank.d149.s0|99-99|.|drug
DDI-MedLine.d11.s0|0-16|Immunosuppressive|drug
DDI-MedLine.d11.s0|18-22|drugs|drug
DDI-MedLine.d11.s0|24-26|and|drug
DDI-MedLine.d11.s0|28-32|their|drug
DDI-MedLine.d11.s0|34-46|complications|drug
DDI-MedLine.d11.s0|47-47|.|drug
DDI-MedLine.d11.s1|0-4|Drugs|drug
DDI-MedLine.d11.s1|6-9|that|drug
DDI-MedLine.d11.s1|11-18|suppress|drug
DDI-MedLine.d11.s1|20-22|the|drug
DDI-MedLine.d11.s1|24-29|immune|drug
DDI-MedLine.d11.s1|31-36|system|drug
DDI-MedLine.d11.s1|38-40|are|drug
DDI-MedLine.d11.s1|42-47|widely|drug
DDI-MedLine.d11.s1|49-52|used|drug
DDI-MedLine.d11.s1|53-53|.|drug
DDI-MedLine.d11.s2|0-3|They|drug
DDI-MedLine.d11.s2|5-7|are|drug
DDI-MedLine.d11.s2|9-12|part|drug
DDI-MedLine.d11.s2|14-15|of|drug
DDI-MedLine.d11.s2|17-19|the|drug
DDI-MedLine.d11.s2|21-29|treatment|drug
DDI-MedLine.d11.s2|31-32|of|drug
DDI-MedLine.d11.s2|34-41|patients|drug
DDI-MedLine.d11.s2|43-46|with|drug
DDI-MedLine.d11.s2|48-52|organ|drug
DDI-MedLine.d11.s2|54-64|transplants|drug
DDI-MedLine.d11.s2|65-65|,|drug
DDI-MedLine.d11.s2|67-76|malignancy|drug
DDI-MedLine.d11.s2|77-77|,|drug
DDI-MedLine.d11.s2|79-81|and|drug
DDI-MedLine.d11.s2|83-94|increasingly|drug
DDI-MedLine.d11.s2|96-100|those|drug
DDI-MedLine.d11.s2|102-105|with|drug
DDI-MedLine.d11.s2|107-116|conditions|drug
DDI-MedLine.d11.s2|118-121|such|drug
DDI-MedLine.d11.s2|123-124|as|drug
DDI-MedLine.d11.s2|126-134|psoriasis|drug
DDI-MedLine.d11.s2|135-135|,|drug
DDI-MedLine.d11.s2|137-146|rheumatoid|drug
DDI-MedLine.d11.s2|148-156|arthritis|drug
DDI-MedLine.d11.s2|157-157|,|drug
DDI-MedLine.d11.s2|159-161|and|drug
DDI-MedLine.d11.s2|163-167|liver|drug
DDI-MedLine.d11.s2|169-171|and|drug
DDI-MedLine.d11.s2|173-177|bowel|drug
DDI-MedLine.d11.s2|179-185|disease|drug
DDI-MedLine.d11.s2|187-188|in|drug
DDI-MedLine.d11.s2|190-194|which|drug
DDI-MedLine.d11.s2|196-207|inflammation|drug
DDI-MedLine.d11.s2|209-210|is|drug
DDI-MedLine.d11.s2|212-213|an|drug
DDI-MedLine.d11.s2|215-226|aetiological|drug
DDI-MedLine.d11.s2|228-233|factor|drug
DDI-MedLine.d11.s2|234-234|.|drug
DDI-MedLine.d11.s3|0-6|Because|drug
DDI-MedLine.d11.s3|8-9|of|drug
DDI-MedLine.d11.s3|11-13|the|drug
DDI-MedLine.d11.s3|15-24|broadening|drug
DDI-MedLine.d11.s3|26-36|indications|drug
DDI-MedLine.d11.s3|38-40|for|drug
DDI-MedLine.d11.s3|42-58|immunosuppressive|drug
DDI-MedLine.d11.s3|60-64|drugs|drug
DDI-MedLine.d11.s3|65-65|,|drug
DDI-MedLine.d11.s3|67-69|and|drug
DDI-MedLine.d11.s3|71-73|the|drug
DDI-MedLine.d11.s3|75-83|prolonged|drug
DDI-MedLine.d11.s3|85-92|survival|drug
DDI-MedLine.d11.s3|94-95|in|drug
DDI-MedLine.d11.s3|97-106|conditions|drug
DDI-MedLine.d11.s3|108-110|for|drug
DDI-MedLine.d11.s3|112-116|which|drug
DDI-MedLine.d11.s3|118-121|they|drug
DDI-MedLine.d11.s3|123-125|are|drug
DDI-MedLine.d11.s3|127-131|being|drug
DDI-MedLine.d11.s3|133-136|used|drug
DDI-MedLine.d11.s3|137-137|,|drug
DDI-MedLine.d11.s3|139-142|many|drug
DDI-MedLine.d11.s3|144-151|patients|drug
DDI-MedLine.d11.s3|153-154|on|drug
DDI-MedLine.d11.s3|156-172|immunosuppression|drug
DDI-MedLine.d11.s3|174-176|are|drug
DDI-MedLine.d11.s3|178-180|now|drug
DDI-MedLine.d11.s3|182-186|cared|drug
DDI-MedLine.d11.s3|188-190|for|drug
DDI-MedLine.d11.s3|192-193|in|drug
DDI-MedLine.d11.s3|195-197|the|drug
DDI-MedLine.d11.s3|199-207|community|drug
DDI-MedLine.d11.s3|209-210|or|drug
DDI-MedLine.d11.s3|212-215|seen|drug
DDI-MedLine.d11.s3|217-218|in|drug
DDI-MedLine.d11.s3|220-233|non-specialist|drug
DDI-MedLine.d11.s3|235-243|hospitals|drug
DDI-MedLine.d11.s3|244-244|,|drug
DDI-MedLine.d11.s3|246-252|usually|drug
DDI-MedLine.d11.s3|254-255|in|drug
DDI-MedLine.d11.s3|257-261|close|drug
DDI-MedLine.d11.s3|263-275|collaboration|drug
DDI-MedLine.d11.s3|277-280|with|drug
DDI-MedLine.d11.s3|282-282|a|drug
DDI-MedLine.d11.s3|284-293|specialist|drug
DDI-MedLine.d11.s3|294-294|.|drug
DDI-MedLine.d11.s4|0-3|This|drug
DDI-MedLine.d11.s4|5-11|article|drug
DDI-MedLine.d11.s4|13-17|looks|drug
DDI-MedLine.d11.s4|19-20|at|drug
DDI-MedLine.d11.s4|22-25|five|drug
DDI-MedLine.d11.s4|27-34|commonly|drug
DDI-MedLine.d11.s4|36-39|used|drug
DDI-MedLine.d11.s4|41-57|immunosuppressive|drug
DDI-MedLine.d11.s4|59-63|drugs|drug
DDI-MedLine.d11.s4|65-66|in|drug
DDI-MedLine.d11.s4|68-71|turn|drug
DDI-MedLine.d11.s4|73-73|(|drug
DDI-MedLine.d11.s4|74-88|corticosteroids|drug
DDI-MedLine.d11.s4|89-89|,|drug
DDI-MedLine.d11.s4|91-101|cyclosporin|drug
DDI-MedLine.d11.s4|102-102|,|drug
DDI-MedLine.d11.s4|104-115|azathioprine|drug
DDI-MedLine.d11.s4|116-116|,|drug
DDI-MedLine.d11.s4|118-129|methotrexate|drug
DDI-MedLine.d11.s4|130-130|,|drug
DDI-MedLine.d11.s4|132-147|cyclophosphamide|drug
DDI-MedLine.d11.s4|148-148|)|drug
DDI-MedLine.d11.s4|149-149|,|drug
DDI-MedLine.d11.s4|151-160|discussing|drug
DDI-MedLine.d11.s4|162-164|the|drug
DDI-MedLine.d11.s4|166-169|main|drug
DDI-MedLine.d11.s4|170-170|,|drug
DDI-MedLine.d11.s4|172-184|non-infection|drug
DDI-MedLine.d11.s4|185-185|,|drug
DDI-MedLine.d11.s4|187-194|unwanted|drug
DDI-MedLine.d11.s4|196-202|effects|drug
DDI-MedLine.d11.s4|203-203|,|drug
DDI-MedLine.d11.s4|205-208|ways|drug
DDI-MedLine.d11.s4|210-211|to|drug
DDI-MedLine.d11.s4|213-217|avoid|drug
DDI-MedLine.d11.s4|219-222|them|drug
DDI-MedLine.d11.s4|224-226|and|drug
DDI-MedLine.d11.s4|228-231|what|drug
DDI-MedLine.d11.s4|233-234|to|drug
DDI-MedLine.d11.s4|236-237|do|drug
DDI-MedLine.d11.s4|239-240|if|drug
DDI-MedLine.d11.s4|242-249|problems|drug
DDI-MedLine.d11.s4|251-255|arise|drug
DDI-MedLine.d11.s4|256-256|.|drug
DDI-MedLine.d11.s5|0-2|The|drug
DDI-MedLine.d11.s5|4-13|management|drug
DDI-MedLine.d11.s5|15-16|of|drug
DDI-MedLine.d11.s5|18-26|infection|drug
DDI-MedLine.d11.s5|28-29|is|drug
DDI-MedLine.d11.s5|31-35|dealt|drug
DDI-MedLine.d11.s5|37-40|with|drug
DDI-MedLine.d11.s5|42-43|as|drug
DDI-MedLine.d11.s5|45-45|a|drug
DDI-MedLine.d11.s5|47-54|separate|drug
DDI-MedLine.d11.s5|56-62|section|drug
DDI-MedLine.d11.s5|63-63|.|drug
DDI-DrugBank.d591.s0|0-10|Ropivacaine|drug
DDI-DrugBank.d591.s0|12-17|should|drug
DDI-DrugBank.d591.s0|19-20|be|drug
DDI-DrugBank.d591.s0|22-25|used|drug
DDI-DrugBank.d591.s0|27-30|with|drug
DDI-DrugBank.d591.s0|32-38|caution|drug
DDI-DrugBank.d591.s0|40-41|in|drug
DDI-DrugBank.d591.s0|43-50|patients|drug
DDI-DrugBank.d591.s0|52-60|receiving|drug
DDI-DrugBank.d591.s0|62-66|other|drug
DDI-DrugBank.d591.s0|68-72|local|drug
DDI-DrugBank.d591.s0|74-84|anesthetics|drug
DDI-DrugBank.d591.s0|86-87|or|drug
DDI-DrugBank.d591.s0|89-94|agents|drug
DDI-DrugBank.d591.s0|96-107|structurally|drug
DDI-DrugBank.d591.s0|109-115|related|drug
DDI-DrugBank.d591.s0|117-118|to|drug
DDI-DrugBank.d591.s0|120-129|amide-type|drug
DDI-DrugBank.d591.s0|131-135|local|drug
DDI-DrugBank.d591.s0|137-147|anesthetics|drug
DDI-DrugBank.d591.s0|148-148|,|drug
DDI-DrugBank.d591.s0|150-154|since|drug
DDI-DrugBank.d591.s0|156-158|the|drug
DDI-DrugBank.d591.s0|160-164|toxic|drug
DDI-DrugBank.d591.s0|166-172|effects|drug
DDI-DrugBank.d591.s0|174-175|of|drug
DDI-DrugBank.d591.s0|177-181|these|drug
DDI-DrugBank.d591.s0|183-187|drugs|drug
DDI-DrugBank.d591.s0|189-191|are|drug
DDI-DrugBank.d591.s0|193-200|additive|drug
DDI-DrugBank.d591.s0|201-201|.|drug
DDI-DrugBank.d591.s1|0-9|Cytochrome|drug
DDI-DrugBank.d591.s1|11-17|P4501A2|drug
DDI-DrugBank.d591.s1|19-20|is|drug
DDI-DrugBank.d591.s1|22-29|involved|drug
DDI-DrugBank.d591.s1|31-32|in|drug
DDI-DrugBank.d591.s1|34-36|the|drug
DDI-DrugBank.d591.s1|38-46|formation|drug
DDI-DrugBank.d591.s1|48-49|of|drug
DDI-DrugBank.d591.s1|51-59|3-hydroxy|drug
DDI-DrugBank.d591.s1|61-71|ropivacaine|drug
DDI-DrugBank.d591.s1|72-72|,|drug
DDI-DrugBank.d591.s1|74-76|the|drug
DDI-DrugBank.d591.s1|78-82|major|drug
DDI-DrugBank.d591.s1|84-93|metabolite|drug
DDI-DrugBank.d591.s1|94-94|.|drug
DDI-DrugBank.d591.s2|0-1|In|drug
DDI-DrugBank.d591.s2|3-6|vivo|drug
DDI-DrugBank.d591.s2|7-7|,|drug
DDI-DrugBank.d591.s2|9-11|the|drug
DDI-DrugBank.d591.s2|13-18|plasma|drug
DDI-DrugBank.d591.s2|20-28|clearance|drug
DDI-DrugBank.d591.s2|30-31|of|drug
DDI-DrugBank.d591.s2|33-43|ropivacaine|drug
DDI-DrugBank.d591.s2|45-47|was|drug
DDI-DrugBank.d591.s2|49-55|reduced|drug
DDI-DrugBank.d591.s2|57-58|by|drug
DDI-DrugBank.d591.s2|60-61|70|drug
DDI-DrugBank.d591.s2|62-62|%|drug
DDI-DrugBank.d591.s2|64-69|during|drug
DDI-DrugBank.d591.s2|71-86|coadministration|drug
DDI-DrugBank.d591.s2|88-89|of|drug
DDI-DrugBank.d591.s2|91-101|fluvoxamine|drug
DDI-DrugBank.d591.s2|103-103|(|drug
DDI-DrugBank.d591.s2|104-105|25|drug
DDI-DrugBank.d591.s2|107-108|mg|drug
DDI-DrugBank.d591.s2|110-112|bid|drug
DDI-DrugBank.d591.s2|114-116|for|drug
DDI-DrugBank.d591.s2|118-118|2|drug
DDI-DrugBank.d591.s2|120-123|days|drug
DDI-DrugBank.d591.s2|124-124|)|drug
DDI-DrugBank.d591.s2|125-125|,|drug
DDI-DrugBank.d591.s2|127-127|a|drug
DDI-DrugBank.d591.s2|129-137|selective|drug
DDI-DrugBank.d591.s2|139-141|and|drug
DDI-DrugBank.d591.s2|143-148|potent|drug
DDI-DrugBank.d591.s2|150-155|CYP1A2|drug
DDI-DrugBank.d591.s2|157-165|inhibitor|drug
DDI-DrugBank.d591.s2|166-166|.|drug
DDI-DrugBank.d591.s3|0-3|Thus|drug
DDI-DrugBank.d591.s3|5-10|strong|drug
DDI-DrugBank.d591.s3|12-21|inhibitors|drug
DDI-DrugBank.d591.s3|23-24|of|drug
DDI-DrugBank.d591.s3|26-35|cytochrome|drug
DDI-DrugBank.d591.s3|37-43|P4501A2|drug
DDI-DrugBank.d591.s3|44-44|,|drug
DDI-DrugBank.d591.s3|46-49|such|drug
DDI-DrugBank.d591.s3|51-52|as|drug
DDI-DrugBank.d591.s3|54-64|fluvoxamine|drug
DDI-DrugBank.d591.s3|65-65|,|drug
DDI-DrugBank.d591.s3|67-71|given|drug
DDI-DrugBank.d591.s3|73-85|concomitantly|drug
DDI-DrugBank.d591.s3|87-92|during|drug
DDI-DrugBank.d591.s3|94-107|administration|drug
DDI-DrugBank.d591.s3|109-110|of|drug
DDI-DrugBank.d591.s3|112-122|Ropivacaine|drug
DDI-DrugBank.d591.s3|123-123|,|drug
DDI-DrugBank.d591.s3|125-127|can|drug
DDI-DrugBank.d591.s3|129-136|interact|drug
DDI-DrugBank.d591.s3|138-141|with|drug
DDI-DrugBank.d591.s3|143-153|Ropivacaine|drug
DDI-DrugBank.d591.s3|155-161|leading|drug
DDI-DrugBank.d591.s3|163-164|to|drug
DDI-DrugBank.d591.s3|166-174|increased|drug
DDI-DrugBank.d591.s3|176-186|ropivacaine|drug
DDI-DrugBank.d591.s3|188-193|plasma|drug
DDI-DrugBank.d591.s3|195-200|levels|drug
DDI-DrugBank.d591.s3|201-201|.|drug
DDI-DrugBank.d591.s4|0-6|Caution|drug
DDI-DrugBank.d591.s4|8-13|should|drug
DDI-DrugBank.d591.s4|15-16|be|drug
DDI-DrugBank.d591.s4|18-26|exercised|drug
DDI-DrugBank.d591.s4|28-31|when|drug
DDI-DrugBank.d591.s4|33-38|CYP1A2|drug
DDI-DrugBank.d591.s4|40-49|inhibitors|drug
DDI-DrugBank.d591.s4|51-53|are|drug
DDI-DrugBank.d591.s4|55-68|coadministered|drug
DDI-DrugBank.d591.s4|69-69|.|drug
DDI-DrugBank.d591.s5|0-7|Possible|drug
DDI-DrugBank.d591.s5|9-20|interactions|drug
DDI-DrugBank.d591.s5|22-25|with|drug
DDI-DrugBank.d591.s5|27-31|drugs|drug
DDI-DrugBank.d591.s5|33-37|known|drug
DDI-DrugBank.d591.s5|39-40|to|drug
DDI-DrugBank.d591.s5|42-43|be|drug
DDI-DrugBank.d591.s5|45-55|metabolized|drug
DDI-DrugBank.d591.s5|57-58|by|drug
DDI-DrugBank.d591.s5|60-65|CYP1A2|drug
DDI-DrugBank.d591.s5|67-69|via|drug
DDI-DrugBank.d591.s5|71-81|competitive|drug
DDI-DrugBank.d591.s5|83-92|inhibition|drug
DDI-DrugBank.d591.s5|94-97|such|drug
DDI-DrugBank.d591.s5|99-100|as|drug
DDI-DrugBank.d591.s5|102-113|theophylline|drug
DDI-DrugBank.d591.s5|115-117|and|drug
DDI-DrugBank.d591.s5|119-128|imipramine|drug
DDI-DrugBank.d591.s5|130-132|may|drug
DDI-DrugBank.d591.s5|134-137|also|drug
DDI-DrugBank.d591.s5|139-143|occur|drug
DDI-DrugBank.d591.s5|144-144|.|drug
DDI-DrugBank.d591.s6|0-15|Coadministration|drug
DDI-DrugBank.d591.s6|17-18|of|drug
DDI-DrugBank.d591.s6|20-20|a|drug
DDI-DrugBank.d591.s6|22-30|selective|drug
DDI-DrugBank.d591.s6|32-34|and|drug
DDI-DrugBank.d591.s6|36-41|potent|drug
DDI-DrugBank.d591.s6|43-51|inhibitor|drug
DDI-DrugBank.d591.s6|53-54|of|drug
DDI-DrugBank.d591.s6|56-61|CYP3A4|drug
DDI-DrugBank.d591.s6|62-62|,|drug
DDI-DrugBank.d591.s6|64-75|ketoconazole|drug
DDI-DrugBank.d591.s6|77-77|(|drug
DDI-DrugBank.d591.s6|78-80|100|drug
DDI-DrugBank.d591.s6|82-83|mg|drug
DDI-DrugBank.d591.s6|85-87|bid|drug
DDI-DrugBank.d591.s6|89-91|for|drug
DDI-DrugBank.d591.s6|93-93|2|drug
DDI-DrugBank.d591.s6|95-98|days|drug
DDI-DrugBank.d591.s6|100-103|with|drug
DDI-DrugBank.d591.s6|105-115|ropivacaine|drug
DDI-DrugBank.d591.s6|117-124|infusion|drug
DDI-DrugBank.d591.s6|126-137|administered|drug
DDI-DrugBank.d591.s6|139-139|1|drug
DDI-DrugBank.d591.s6|141-144|hour|drug
DDI-DrugBank.d591.s6|146-150|after|drug
DDI-DrugBank.d591.s6|152-163|ketoconazole|drug
DDI-DrugBank.d591.s6|164-164|)|drug
DDI-DrugBank.d591.s6|166-171|caused|drug
DDI-DrugBank.d591.s6|173-173|a|drug
DDI-DrugBank.d591.s6|175-176|15|drug
DDI-DrugBank.d591.s6|177-177|%|drug
DDI-DrugBank.d591.s6|179-187|reduction|drug
DDI-DrugBank.d591.s6|189-190|in|drug
DDI-DrugBank.d591.s6|192-198|in-vivo|drug
DDI-DrugBank.d591.s6|200-205|plasma|drug
DDI-DrugBank.d591.s6|207-215|clearance|drug
DDI-DrugBank.d591.s6|217-218|of|drug
DDI-DrugBank.d591.s6|220-230|ropivacaine|drug
DDI-DrugBank.d591.s6|231-231|.|drug
DDI-DrugBank.d634.s0|0-13|Anticoagulants|drug
DDI-DrugBank.d634.s0|15-15|(|drug
DDI-DrugBank.d634.s0|16-19|oral|drug
DDI-DrugBank.d634.s0|20-20|)|drug
DDI-DrugBank.d634.s0|21-21|:|drug
DDI-DrugBank.d634.s0|23-25|The|drug
DDI-DrugBank.d634.s0|27-34|activity|drug
DDI-DrugBank.d634.s0|36-37|of|drug
DDI-DrugBank.d634.s0|39-42|oral|drug
DDI-DrugBank.d634.s0|44-57|anticoagulants|drug
DDI-DrugBank.d634.s0|59-61|may|drug
DDI-DrugBank.d634.s0|63-64|be|drug
DDI-DrugBank.d634.s0|66-76|potentiated|drug
DDI-DrugBank.d634.s0|78-79|by|drug
DDI-DrugBank.d634.s0|81-94|anti-vitamin-K|drug
DDI-DrugBank.d634.s0|96-103|activity|drug
DDI-DrugBank.d634.s0|105-114|attributed|drug
DDI-DrugBank.d634.s0|116-117|to|drug
DDI-DrugBank.d634.s0|119-129|methimazole|drug
DDI-DrugBank.d634.s0|130-130|.|drug
DDI-DrugBank.d634.s1|0-10|-adrenergic|drug
DDI-DrugBank.d634.s1|12-19|blocking|drug
DDI-DrugBank.d634.s1|21-26|agents|drug
DDI-DrugBank.d634.s1|27-27|:|drug
DDI-DrugBank.d634.s1|29-43|Hyperthyroidism|drug
DDI-DrugBank.d634.s1|45-47|may|drug
DDI-DrugBank.d634.s1|49-53|cause|drug
DDI-DrugBank.d634.s1|55-56|an|drug
DDI-DrugBank.d634.s1|58-66|increased|drug
DDI-DrugBank.d634.s1|68-76|clearance|drug
DDI-DrugBank.d634.s1|78-79|of|drug
DDI-DrugBank.d634.s1|81-84|beta|drug
DDI-DrugBank.d634.s1|86-90|ratio|drug
DDI-DrugBank.d634.s1|91-91|.|drug
DDI-DrugBank.d634.s2|0-0|A|drug
DDI-DrugBank.d634.s2|2-5|dose|drug
DDI-DrugBank.d634.s2|7-15|reduction|drug
DDI-DrugBank.d634.s2|17-18|of|drug
DDI-DrugBank.d634.s2|20-34|beta-adrenergic|drug
DDI-DrugBank.d634.s2|36-43|blockers|drug
DDI-DrugBank.d634.s2|45-47|may|drug
DDI-DrugBank.d634.s2|49-50|be|drug
DDI-DrugBank.d634.s2|52-57|needed|drug
DDI-DrugBank.d634.s2|59-62|when|drug
DDI-DrugBank.d634.s2|64-64|a|drug
DDI-DrugBank.d634.s2|66-77|hyperthyroid|drug
DDI-DrugBank.d634.s2|79-85|patient|drug
DDI-DrugBank.d634.s2|87-93|becomes|drug
DDI-DrugBank.d634.s2|95-103|euthyroid|drug
DDI-DrugBank.d634.s2|104-104|.|drug
DDI-DrugBank.d634.s3|0-8|Digitalis|drug
DDI-DrugBank.d634.s3|10-19|glycosides|drug
DDI-DrugBank.d634.s3|20-20|:|drug
DDI-DrugBank.d634.s3|22-26|Serum|drug
DDI-DrugBank.d634.s3|28-36|digitalis|drug
DDI-DrugBank.d634.s3|38-43|levels|drug
DDI-DrugBank.d634.s3|45-47|may|drug
DDI-DrugBank.d634.s3|49-50|be|drug
DDI-DrugBank.d634.s3|52-60|increased|drug
DDI-DrugBank.d634.s3|62-65|when|drug
DDI-DrugBank.d634.s3|67-78|hyperthyroid|drug
DDI-DrugBank.d634.s3|80-87|patients|drug
DDI-DrugBank.d634.s3|89-90|on|drug
DDI-DrugBank.d634.s3|92-92|a|drug
DDI-DrugBank.d634.s3|94-99|stable|drug
DDI-DrugBank.d634.s3|101-109|digitalis|drug
DDI-DrugBank.d634.s3|111-119|glycoside|drug
DDI-DrugBank.d634.s3|121-127|regimen|drug
DDI-DrugBank.d634.s3|129-134|become|drug
DDI-DrugBank.d634.s3|136-144|euthyroid|drug
DDI-DrugBank.d634.s3|145-145|;|drug
DDI-DrugBank.d634.s4|0-6|reduced|drug
DDI-DrugBank.d634.s4|8-13|dosage|drug
DDI-DrugBank.d634.s4|15-16|of|drug
DDI-DrugBank.d634.s4|18-26|digitalis|drug
DDI-DrugBank.d634.s4|28-37|glycosides|drug
DDI-DrugBank.d634.s4|39-41|may|drug
DDI-DrugBank.d634.s4|43-44|be|drug
DDI-DrugBank.d634.s4|46-53|required|drug
DDI-DrugBank.d634.s4|54-54|.|drug
DDI-DrugBank.d634.s5|0-11|Theophylline|drug
DDI-DrugBank.d634.s5|12-12|:|drug
DDI-DrugBank.d634.s5|14-25|Theophylline|drug
DDI-DrugBank.d634.s5|27-35|clearance|drug
DDI-DrugBank.d634.s5|37-39|may|drug
DDI-DrugBank.d634.s5|41-48|decrease|drug
DDI-DrugBank.d634.s5|50-53|when|drug
DDI-DrugBank.d634.s5|55-66|hyperthyroid|drug
DDI-DrugBank.d634.s5|68-75|patients|drug
DDI-DrugBank.d634.s5|77-78|on|drug
DDI-DrugBank.d634.s5|80-80|a|drug
DDI-DrugBank.d634.s5|82-87|stable|drug
DDI-DrugBank.d634.s5|89-100|theophylline|drug
DDI-DrugBank.d634.s5|102-108|regimen|drug
DDI-DrugBank.d634.s5|110-115|become|drug
DDI-DrugBank.d634.s5|117-125|euthyroid|drug
DDI-DrugBank.d634.s5|126-126|;|drug
DDI-DrugBank.d634.s6|0-0|a|drug
DDI-DrugBank.d634.s6|2-8|reduced|drug
DDI-DrugBank.d634.s6|10-13|dose|drug
DDI-DrugBank.d634.s6|15-16|of|drug
DDI-DrugBank.d634.s6|18-29|theophylline|drug
DDI-DrugBank.d634.s6|31-33|may|drug
DDI-DrugBank.d634.s6|35-36|be|drug
DDI-DrugBank.d634.s6|38-43|needed|drug
DDI-DrugBank.d634.s6|44-44|.|drug
DDI-DrugBank.d558.s0|0-14|Drug/Laboratory|drug
DDI-DrugBank.d558.s0|16-19|Test|drug
DDI-DrugBank.d558.s0|21-32|Interactions|drug
DDI-DrugBank.d558.s0|34-37|None|drug
DDI-DrugBank.d558.s0|39-43|known|drug
DDI-DrugBank.d558.s0|44-44|.|drug
DDI-DrugBank.d558.s1|0-8|Drug-Drug|drug
DDI-DrugBank.d558.s1|10-21|Interactions|drug
DDI-DrugBank.d558.s1|23-32|Cimetidine|drug
DDI-DrugBank.d558.s1|33-33|:|drug
DDI-DrugBank.d558.s1|35-45|Concomitant|drug
DDI-DrugBank.d558.s1|47-49|use|drug
DDI-DrugBank.d558.s1|51-52|of|drug
DDI-DrugBank.d558.s1|54-63|cimetidine|drug
DDI-DrugBank.d558.s1|65-66|is|drug
DDI-DrugBank.d558.s1|68-82|contraindicated|drug
DDI-DrugBank.d558.s1|83-83|.|drug
DDI-DrugBank.d558.s2|0-9|Cimetidine|drug
DDI-DrugBank.d558.s2|11-12|at|drug
DDI-DrugBank.d558.s2|14-16|400|drug
DDI-DrugBank.d558.s2|18-19|mg|drug
DDI-DrugBank.d558.s2|21-23|BID|drug
DDI-DrugBank.d558.s2|25-25|(|drug
DDI-DrugBank.d558.s2|26-28|the|drug
DDI-DrugBank.d558.s2|30-34|usual|drug
DDI-DrugBank.d558.s2|36-47|prescription|drug
DDI-DrugBank.d558.s2|49-52|dose|drug
DDI-DrugBank.d558.s2|53-53|)|drug
DDI-DrugBank.d558.s2|55-69|co-administered|drug
DDI-DrugBank.d558.s2|71-74|with|drug
DDI-DrugBank.d558.s2|76-82|TIKOSYN|drug
DDI-DrugBank.d558.s2|84-84|(|drug
DDI-DrugBank.d558.s2|85-87|500|drug
DDI-DrugBank.d558.s2|89-91|mcg|drug
DDI-DrugBank.d558.s2|93-95|BID|drug
DDI-DrugBank.d558.s2|96-96|)|drug
DDI-DrugBank.d558.s2|98-100|for|drug
DDI-DrugBank.d558.s2|102-102|7|drug
DDI-DrugBank.d558.s2|104-107|days|drug
DDI-DrugBank.d558.s2|109-111|has|drug
DDI-DrugBank.d558.s2|113-116|been|drug
DDI-DrugBank.d558.s2|118-122|shown|drug
DDI-DrugBank.d558.s2|124-125|to|drug
DDI-DrugBank.d558.s2|127-134|increase|drug
DDI-DrugBank.d558.s2|136-145|dofetilide|drug
DDI-DrugBank.d558.s2|147-152|plasma|drug
DDI-DrugBank.d558.s2|154-159|levels|drug
DDI-DrugBank.d558.s2|161-162|by|drug
DDI-DrugBank.d558.s2|164-165|58|drug
DDI-DrugBank.d558.s2|166-166|%|drug
DDI-DrugBank.d558.s2|167-167|.|drug
DDI-DrugBank.d558.s3|0-9|Cimetidine|drug
DDI-DrugBank.d558.s3|11-12|at|drug
DDI-DrugBank.d558.s3|14-18|doses|drug
DDI-DrugBank.d558.s3|20-21|of|drug
DDI-DrugBank.d558.s3|23-25|100|drug
DDI-DrugBank.d558.s3|27-28|mg|drug
DDI-DrugBank.d558.s3|30-32|BID|drug
DDI-DrugBank.d558.s3|34-34|(|drug
DDI-DrugBank.d558.s3|35-37|OTC|drug
DDI-DrugBank.d558.s3|39-42|dose|drug
DDI-DrugBank.d558.s3|43-43|)|drug
DDI-DrugBank.d558.s3|45-52|resulted|drug
DDI-DrugBank.d558.s3|54-55|in|drug
DDI-DrugBank.d558.s3|57-57|a|drug
DDI-DrugBank.d558.s3|59-60|13|drug
DDI-DrugBank.d558.s3|61-61|%|drug
DDI-DrugBank.d558.s3|63-70|increase|drug
DDI-DrugBank.d558.s3|72-73|in|drug
DDI-DrugBank.d558.s3|75-84|dofetilide|drug
DDI-DrugBank.d558.s3|86-91|plasma|drug
DDI-DrugBank.d558.s3|93-98|levels|drug
DDI-DrugBank.d558.s3|100-100|(|drug
DDI-DrugBank.d558.s3|101-103|500|drug
DDI-DrugBank.d558.s3|105-107|mcg|drug
DDI-DrugBank.d558.s3|109-114|single|drug
DDI-DrugBank.d558.s3|116-119|dose|drug
DDI-DrugBank.d558.s3|120-120|)|drug
DDI-DrugBank.d558.s3|121-121|.|drug
DDI-DrugBank.d558.s4|0-1|No|drug
DDI-DrugBank.d558.s4|3-9|studies|drug
DDI-DrugBank.d558.s4|11-14|have|drug
DDI-DrugBank.d558.s4|16-19|been|drug
DDI-DrugBank.d558.s4|21-29|conducted|drug
DDI-DrugBank.d558.s4|31-32|at|drug
DDI-DrugBank.d558.s4|34-45|intermediate|drug
DDI-DrugBank.d558.s4|47-51|doses|drug
DDI-DrugBank.d558.s4|53-54|of|drug
DDI-DrugBank.d558.s4|56-65|cimetidine|drug
DDI-DrugBank.d558.s4|66-66|.|drug
DDI-DrugBank.d558.s5|0-1|If|drug
DDI-DrugBank.d558.s5|3-3|a|drug
DDI-DrugBank.d558.s5|5-11|patient|drug
DDI-DrugBank.d558.s5|13-20|requires|drug
DDI-DrugBank.d558.s5|22-28|TIKOSYN|drug
DDI-DrugBank.d558.s5|30-32|and|drug
DDI-DrugBank.d558.s5|34-43|anti-ulcer|drug
DDI-DrugBank.d558.s5|45-51|therapy|drug
DDI-DrugBank.d558.s5|52-52|,|drug
DDI-DrugBank.d558.s5|54-55|it|drug
DDI-DrugBank.d558.s5|57-58|is|drug
DDI-DrugBank.d558.s5|60-68|suggested|drug
DDI-DrugBank.d558.s5|70-73|that|drug
DDI-DrugBank.d558.s5|75-84|omeprazole|drug
DDI-DrugBank.d558.s5|85-85|,|drug
DDI-DrugBank.d558.s5|87-96|ranitidine|drug
DDI-DrugBank.d558.s5|97-97|,|drug
DDI-DrugBank.d558.s5|99-100|or|drug
DDI-DrugBank.d558.s5|102-109|antacids|drug
DDI-DrugBank.d558.s5|111-111|(|drug
DDI-DrugBank.d558.s5|112-119|aluminum|drug
DDI-DrugBank.d558.s5|121-123|and|drug
DDI-DrugBank.d558.s5|125-133|magnesium|drug
DDI-DrugBank.d558.s5|135-144|hydroxides|drug
DDI-DrugBank.d558.s5|145-145|)|drug
DDI-DrugBank.d558.s5|147-148|be|drug
DDI-DrugBank.d558.s5|150-153|used|drug
DDI-DrugBank.d558.s5|155-156|as|drug
DDI-DrugBank.d558.s5|158-169|alternatives|drug
DDI-DrugBank.d558.s5|171-172|to|drug
DDI-DrugBank.d558.s5|174-183|cimetidine|drug
DDI-DrugBank.d558.s5|184-184|,|drug
DDI-DrugBank.d558.s5|186-187|as|drug
DDI-DrugBank.d558.s5|189-193|these|drug
DDI-DrugBank.d558.s5|195-200|agents|drug
DDI-DrugBank.d558.s5|202-205|have|drug
DDI-DrugBank.d558.s5|207-208|no|drug
DDI-DrugBank.d558.s5|210-215|effect|drug
DDI-DrugBank.d558.s5|217-218|on|drug
DDI-DrugBank.d558.s5|220-222|the|drug
DDI-DrugBank.d558.s5|224-238|pharmacokinetic|drug
DDI-DrugBank.d558.s5|240-246|profile|drug
DDI-DrugBank.d558.s5|248-249|of|drug
DDI-DrugBank.d558.s5|251-257|TIKOSYN|drug
DDI-DrugBank.d558.s5|258-258|.|drug
DDI-DrugBank.d558.s6|0-8|Verapamil|drug
DDI-DrugBank.d558.s6|9-9|:|drug
DDI-DrugBank.d558.s6|11-21|Concomitant|drug
DDI-DrugBank.d558.s6|23-25|use|drug
DDI-DrugBank.d558.s6|27-28|of|drug
DDI-DrugBank.d558.s6|30-38|verapamil|drug
DDI-DrugBank.d558.s6|40-41|is|drug
DDI-DrugBank.d558.s6|43-57|contraindicated|drug
DDI-DrugBank.d558.s6|58-58|.|drug
DDI-DrugBank.d558.s7|0-16|Co-administration|drug
DDI-DrugBank.d558.s7|18-19|of|drug
DDI-DrugBank.d558.s7|21-27|TIKOSYN|drug
DDI-DrugBank.d558.s7|29-32|with|drug
DDI-DrugBank.d558.s7|34-42|verapamil|drug
DDI-DrugBank.d558.s7|44-51|resulted|drug
DDI-DrugBank.d558.s7|53-54|in|drug
DDI-DrugBank.d558.s7|56-64|increases|drug
DDI-DrugBank.d558.s7|66-67|in|drug
DDI-DrugBank.d558.s7|69-78|dofetilide|drug
DDI-DrugBank.d558.s7|80-83|peak|drug
DDI-DrugBank.d558.s7|85-90|plasma|drug
DDI-DrugBank.d558.s7|92-97|levels|drug
DDI-DrugBank.d558.s7|99-100|of|drug
DDI-DrugBank.d558.s7|102-103|42|drug
DDI-DrugBank.d558.s7|104-104|%|drug
DDI-DrugBank.d558.s7|105-105|,|drug
DDI-DrugBank.d558.s7|107-114|although|drug
DDI-DrugBank.d558.s7|116-122|overall|drug
DDI-DrugBank.d558.s7|124-131|exposure|drug
DDI-DrugBank.d558.s7|133-134|to|drug
DDI-DrugBank.d558.s7|136-145|dofetilide|drug
DDI-DrugBank.d558.s7|147-149|was|drug
DDI-DrugBank.d558.s7|151-153|not|drug
DDI-DrugBank.d558.s7|155-167|significantly|drug
DDI-DrugBank.d558.s7|169-177|increased|drug
DDI-DrugBank.d558.s7|178-178|.|drug
DDI-DrugBank.d558.s8|0-1|In|drug
DDI-DrugBank.d558.s8|3-4|an|drug
DDI-DrugBank.d558.s8|6-13|analysis|drug
DDI-DrugBank.d558.s8|15-16|of|drug
DDI-DrugBank.d558.s8|18-20|the|drug
DDI-DrugBank.d558.s8|22-37|supraventricular|drug
DDI-DrugBank.d558.s8|39-48|arrhythmia|drug
DDI-DrugBank.d558.s8|50-52|and|drug
DDI-DrugBank.d558.s8|54-60|DIAMOND|drug
DDI-DrugBank.d558.s8|62-68|patient|drug
DDI-DrugBank.d558.s8|70-80|populations|drug
DDI-DrugBank.d558.s8|81-81|,|drug
DDI-DrugBank.d558.s8|83-85|the|drug
DDI-DrugBank.d558.s8|87-97|concomitant|drug
DDI-DrugBank.d558.s8|99-112|administration|drug
DDI-DrugBank.d558.s8|114-115|of|drug
DDI-DrugBank.d558.s8|117-125|verapamil|drug
DDI-DrugBank.d558.s8|127-130|with|drug
DDI-DrugBank.d558.s8|132-141|dofetilide|drug
DDI-DrugBank.d558.s8|143-145|was|drug
DDI-DrugBank.d558.s8|147-156|associated|drug
DDI-DrugBank.d558.s8|158-161|with|drug
DDI-DrugBank.d558.s8|163-163|a|drug
DDI-DrugBank.d558.s8|165-170|higher|drug
DDI-DrugBank.d558.s8|172-181|occurrence|drug
DDI-DrugBank.d558.s8|183-184|of|drug
DDI-DrugBank.d558.s8|186-192|torsade|drug
DDI-DrugBank.d558.s8|194-195|de|drug
DDI-DrugBank.d558.s8|197-203|pointes|drug
DDI-DrugBank.d558.s8|204-204|.|drug
DDI-DrugBank.d558.s9|0-11|Ketoconazole|drug
DDI-DrugBank.d558.s9|12-12|:|drug
DDI-DrugBank.d558.s9|14-24|Concomitant|drug
DDI-DrugBank.d558.s9|26-28|use|drug
DDI-DrugBank.d558.s9|30-31|of|drug
DDI-DrugBank.d558.s9|33-44|ketoconazole|drug
DDI-DrugBank.d558.s9|46-47|is|drug
DDI-DrugBank.d558.s9|49-63|contraindicated|drug
DDI-DrugBank.d558.s9|64-64|.|drug
DDI-DrugBank.d558.s10|0-11|Ketoconazole|drug
DDI-DrugBank.d558.s10|13-14|at|drug
DDI-DrugBank.d558.s10|16-18|400|drug
DDI-DrugBank.d558.s10|20-21|mg|drug
DDI-DrugBank.d558.s10|23-27|daily|drug
DDI-DrugBank.d558.s10|29-29|(|drug
DDI-DrugBank.d558.s10|30-32|the|drug
DDI-DrugBank.d558.s10|34-40|maximum|drug
DDI-DrugBank.d558.s10|42-49|approved|drug
DDI-DrugBank.d558.s10|51-62|prescription|drug
DDI-DrugBank.d558.s10|64-67|dose|drug
DDI-DrugBank.d558.s10|68-68|)|drug
DDI-DrugBank.d558.s10|70-84|co-administered|drug
DDI-DrugBank.d558.s10|86-89|with|drug
DDI-DrugBank.d558.s10|91-97|TIKOSYN|drug
DDI-DrugBank.d558.s10|99-99|(|drug
DDI-DrugBank.d558.s10|100-102|500|drug
DDI-DrugBank.d558.s10|104-106|mcg|drug
DDI-DrugBank.d558.s10|108-110|BID|drug
DDI-DrugBank.d558.s10|111-111|)|drug
DDI-DrugBank.d558.s10|113-115|for|drug
DDI-DrugBank.d558.s10|117-117|7|drug
DDI-DrugBank.d558.s10|119-122|days|drug
DDI-DrugBank.d558.s10|124-126|has|drug
DDI-DrugBank.d558.s10|128-131|been|drug
DDI-DrugBank.d558.s10|133-137|shown|drug
DDI-DrugBank.d558.s10|139-140|to|drug
DDI-DrugBank.d558.s10|142-149|increase|drug
DDI-DrugBank.d558.s10|151-160|dofetilide|drug
DDI-DrugBank.d558.s10|162-165|Cmax|drug
DDI-DrugBank.d558.s10|167-168|by|drug
DDI-DrugBank.d558.s10|170-171|53|drug
DDI-DrugBank.d558.s10|172-172|%|drug
DDI-DrugBank.d558.s10|174-175|in|drug
DDI-DrugBank.d558.s10|177-181|males|drug
DDI-DrugBank.d558.s10|183-185|and|drug
DDI-DrugBank.d558.s10|187-188|97|drug
DDI-DrugBank.d558.s10|189-189|%|drug
DDI-DrugBank.d558.s10|191-192|in|drug
DDI-DrugBank.d558.s10|194-200|females|drug
DDI-DrugBank.d558.s10|201-201|,|drug
DDI-DrugBank.d558.s10|203-205|and|drug
DDI-DrugBank.d558.s10|207-209|AUC|drug
DDI-DrugBank.d558.s10|211-212|by|drug
DDI-DrugBank.d558.s10|214-215|41|drug
DDI-DrugBank.d558.s10|216-216|%|drug
DDI-DrugBank.d558.s10|218-219|in|drug
DDI-DrugBank.d558.s10|221-225|males|drug
DDI-DrugBank.d558.s10|227-229|and|drug
DDI-DrugBank.d558.s10|231-232|69|drug
DDI-DrugBank.d558.s10|233-233|%|drug
DDI-DrugBank.d558.s10|235-236|in|drug
DDI-DrugBank.d558.s10|238-244|females|drug
DDI-DrugBank.d558.s10|245-245|.|drug
DDI-DrugBank.d558.s11|0-11|Trimethoprim|drug
DDI-DrugBank.d558.s11|13-17|Alone|drug
DDI-DrugBank.d558.s11|19-20|or|drug
DDI-DrugBank.d558.s11|22-23|in|drug
DDI-DrugBank.d558.s11|25-35|Combination|drug
DDI-DrugBank.d558.s11|37-40|with|drug
DDI-DrugBank.d558.s11|42-57|Sulfamethoxazole|drug
DDI-DrugBank.d558.s11|58-58|:|drug
DDI-DrugBank.d558.s11|60-70|Concomitant|drug
DDI-DrugBank.d558.s11|72-74|use|drug
DDI-DrugBank.d558.s11|76-77|of|drug
DDI-DrugBank.d558.s11|79-90|trimethoprim|drug
DDI-DrugBank.d558.s11|92-96|alone|drug
DDI-DrugBank.d558.s11|98-99|or|drug
DDI-DrugBank.d558.s11|101-102|in|drug
DDI-DrugBank.d558.s11|104-114|combination|drug
DDI-DrugBank.d558.s11|116-119|with|drug
DDI-DrugBank.d558.s11|121-136|sulfamethoxazole|drug
DDI-DrugBank.d558.s11|138-139|is|drug
DDI-DrugBank.d558.s11|141-155|contraindicated|drug
DDI-DrugBank.d558.s11|156-156|.|drug
DDI-DrugBank.d558.s12|0-18|Hydrochlorothiazide|drug
DDI-DrugBank.d558.s12|20-20|(|drug
DDI-DrugBank.d558.s12|21-24|HCTZ|drug
DDI-DrugBank.d558.s12|25-25|)|drug
DDI-DrugBank.d558.s12|27-31|Alone|drug
DDI-DrugBank.d558.s12|33-34|or|drug
DDI-DrugBank.d558.s12|36-37|in|drug
DDI-DrugBank.d558.s12|39-49|Combination|drug
DDI-DrugBank.d558.s12|51-54|with|drug
DDI-DrugBank.d558.s12|56-66|Triamterene|drug
DDI-DrugBank.d558.s12|67-67|:|drug
DDI-DrugBank.d558.s12|69-79|Concomitant|drug
DDI-DrugBank.d558.s12|81-83|use|drug
DDI-DrugBank.d558.s12|85-86|of|drug
DDI-DrugBank.d558.s12|88-91|HCTZ|drug
DDI-DrugBank.d558.s12|93-97|alone|drug
DDI-DrugBank.d558.s12|99-100|or|drug
DDI-DrugBank.d558.s12|102-103|in|drug
DDI-DrugBank.d558.s12|105-115|combination|drug
DDI-DrugBank.d558.s12|117-120|with|drug
DDI-DrugBank.d558.s12|122-132|triamterene|drug
DDI-DrugBank.d558.s12|134-135|is|drug
DDI-DrugBank.d558.s12|137-151|contraindicated|drug
DDI-DrugBank.d558.s12|152-152|.|drug
DDI-DrugBank.d558.s13|0-3|HCTZ|drug
DDI-DrugBank.d558.s13|5-6|50|drug
DDI-DrugBank.d558.s13|8-9|mg|drug
DDI-DrugBank.d558.s13|11-12|QD|drug
DDI-DrugBank.d558.s13|14-15|or|drug
DDI-DrugBank.d558.s13|17-32|HCTZ/triamterene|drug
DDI-DrugBank.d558.s13|34-39|50/100|drug
DDI-DrugBank.d558.s13|41-42|mg|drug
DDI-DrugBank.d558.s13|44-45|QD|drug
DDI-DrugBank.d558.s13|47-49|was|drug
DDI-DrugBank.d558.s13|51-65|co-administered|drug
DDI-DrugBank.d558.s13|67-70|with|drug
DDI-DrugBank.d558.s13|72-78|TIKOSYN|drug
DDI-DrugBank.d558.s13|80-80|(|drug
DDI-DrugBank.d558.s13|81-83|500|drug
DDI-DrugBank.d558.s13|85-87|mcg|drug
DDI-DrugBank.d558.s13|89-91|BID|drug
DDI-DrugBank.d558.s13|92-92|)|drug
DDI-DrugBank.d558.s13|94-96|for|drug
DDI-DrugBank.d558.s13|98-98|5|drug
DDI-DrugBank.d558.s13|100-103|days|drug
DDI-DrugBank.d558.s13|105-105|(|drug
DDI-DrugBank.d558.s13|106-114|following|drug
DDI-DrugBank.d558.s13|116-116|2|drug
DDI-DrugBank.d558.s13|118-121|days|drug
DDI-DrugBank.d558.s13|123-124|of|drug
DDI-DrugBank.d558.s13|126-133|diuretic|drug
DDI-DrugBank.d558.s13|135-137|use|drug
DDI-DrugBank.d558.s13|139-140|at|drug
DDI-DrugBank.d558.s13|142-145|half|drug
DDI-DrugBank.d558.s13|147-150|dose|drug
DDI-DrugBank.d558.s13|151-151|)|drug
DDI-DrugBank.d558.s13|152-152|.|drug
DDI-DrugBank.d558.s14|0-1|In|drug
DDI-DrugBank.d558.s14|3-10|patients|drug
DDI-DrugBank.d558.s14|12-20|receiving|drug
DDI-DrugBank.d558.s14|22-25|HCTZ|drug
DDI-DrugBank.d558.s14|27-31|alone|drug
DDI-DrugBank.d558.s14|32-32|,|drug
DDI-DrugBank.d558.s14|34-43|dofetilide|drug
DDI-DrugBank.d558.s14|45-47|AUC|drug
DDI-DrugBank.d558.s14|49-57|increased|drug
DDI-DrugBank.d558.s14|59-60|by|drug
DDI-DrugBank.d558.s14|62-63|27|drug
DDI-DrugBank.d558.s14|64-64|%|drug
DDI-DrugBank.d558.s14|66-68|and|drug
DDI-DrugBank.d558.s14|70-73|Cmax|drug
DDI-DrugBank.d558.s14|75-76|by|drug
DDI-DrugBank.d558.s14|78-79|21|drug
DDI-DrugBank.d558.s14|80-80|%|drug
DDI-DrugBank.d558.s14|81-81|.|drug
DDI-DrugBank.d558.s15|0-6|However|drug
DDI-DrugBank.d558.s15|7-7|,|drug
DDI-DrugBank.d558.s15|9-11|the|drug
DDI-DrugBank.d558.s15|13-27|pharmacodynamic|drug
DDI-DrugBank.d558.s15|29-34|effect|drug
DDI-DrugBank.d558.s15|36-44|increased|drug
DDI-DrugBank.d558.s15|46-47|by|drug
DDI-DrugBank.d558.s15|49-51|197|drug
DDI-DrugBank.d558.s15|52-52|%|drug
DDI-DrugBank.d558.s15|54-54|(|drug
DDI-DrugBank.d558.s15|55-57|QTc|drug
DDI-DrugBank.d558.s15|59-66|increase|drug
DDI-DrugBank.d558.s15|68-71|over|drug
DDI-DrugBank.d558.s15|73-76|time|drug
DDI-DrugBank.d558.s15|77-77|)|drug
DDI-DrugBank.d558.s15|79-81|and|drug
DDI-DrugBank.d558.s15|83-84|by|drug
DDI-DrugBank.d558.s15|86-87|95|drug
DDI-DrugBank.d558.s15|88-88|%|drug
DDI-DrugBank.d558.s15|90-90|(|drug
DDI-DrugBank.d558.s15|91-97|maximum|drug
DDI-DrugBank.d558.s15|99-101|QTc|drug
DDI-DrugBank.d558.s15|103-110|increase|drug
DDI-DrugBank.d558.s15|111-111|)|drug
DDI-DrugBank.d558.s15|112-112|.|drug
DDI-DrugBank.d558.s16|0-6|However|drug
DDI-DrugBank.d558.s16|7-7|,|drug
DDI-DrugBank.d558.s16|9-11|the|drug
DDI-DrugBank.d558.s16|13-27|pharmacodynamic|drug
DDI-DrugBank.d558.s16|29-34|effect|drug
DDI-DrugBank.d558.s16|36-44|increased|drug
DDI-DrugBank.d558.s16|46-47|by|drug
DDI-DrugBank.d558.s16|49-51|190|drug
DDI-DrugBank.d558.s16|52-52|%|drug
DDI-DrugBank.d558.s16|54-54|(|drug
DDI-DrugBank.d558.s16|55-57|QTc|drug
DDI-DrugBank.d558.s16|59-66|increase|drug
DDI-DrugBank.d558.s16|68-71|over|drug
DDI-DrugBank.d558.s16|73-76|time|drug
DDI-DrugBank.d558.s16|77-77|)|drug
DDI-DrugBank.d558.s16|79-81|and|drug
DDI-DrugBank.d558.s16|83-84|by|drug
DDI-DrugBank.d558.s16|86-87|84|drug
DDI-DrugBank.d558.s16|88-88|%|drug
DDI-DrugBank.d558.s16|90-90|(|drug
DDI-DrugBank.d558.s16|91-97|Maximum|drug
DDI-DrugBank.d558.s16|99-101|QTc|drug
DDI-DrugBank.d558.s16|103-110|increase|drug
DDI-DrugBank.d558.s16|111-111|)|drug
DDI-DrugBank.d558.s16|112-112|.|drug
DDI-DrugBank.d558.s17|0-2|The|drug
DDI-DrugBank.d558.s17|4-18|pharmacodynamic|drug
DDI-DrugBank.d558.s17|20-26|effects|drug
DDI-DrugBank.d558.s17|28-30|can|drug
DDI-DrugBank.d558.s17|32-33|be|drug
DDI-DrugBank.d558.s17|35-43|explained|drug
DDI-DrugBank.d558.s17|45-46|by|drug
DDI-DrugBank.d558.s17|48-48|a|drug
DDI-DrugBank.d558.s17|50-60|combination|drug
DDI-DrugBank.d558.s17|62-63|of|drug
DDI-DrugBank.d558.s17|65-67|the|drug
DDI-DrugBank.d558.s17|69-76|increase|drug
DDI-DrugBank.d558.s17|78-79|in|drug
DDI-DrugBank.d558.s17|81-90|dofetilide|drug
DDI-DrugBank.d558.s17|92-99|exposure|drug
DDI-DrugBank.d558.s17|101-103|and|drug
DDI-DrugBank.d558.s17|105-107|the|drug
DDI-DrugBank.d558.s17|109-118|reductions|drug
DDI-DrugBank.d558.s17|120-121|in|drug
DDI-DrugBank.d558.s17|123-127|serum|drug
DDI-DrugBank.d558.s17|129-137|potassium|drug
DDI-DrugBank.d558.s17|138-138|.|drug
DDI-DrugBank.d558.s18|0-1|In|drug
DDI-DrugBank.d558.s18|3-5|the|drug
DDI-DrugBank.d558.s18|7-13|DIAMOND|drug
DDI-DrugBank.d558.s18|15-20|trials|drug
DDI-DrugBank.d558.s18|21-21|,|drug
DDI-DrugBank.d558.s18|23-26|1252|drug
DDI-DrugBank.d558.s18|28-35|patients|drug
DDI-DrugBank.d558.s18|37-40|were|drug
DDI-DrugBank.d558.s18|42-48|treated|drug
DDI-DrugBank.d558.s18|50-53|with|drug
DDI-DrugBank.d558.s18|55-61|TIKOSYN|drug
DDI-DrugBank.d558.s18|63-65|and|drug
DDI-DrugBank.d558.s18|67-75|diuretics|drug
DDI-DrugBank.d558.s18|77-89|concomitantly|drug
DDI-DrugBank.d558.s18|91-92|of|drug
DDI-DrugBank.d558.s18|94-97|whom|drug
DDI-DrugBank.d558.s18|99-101|493|drug
DDI-DrugBank.d558.s18|103-106|died|drug
DDI-DrugBank.d558.s18|108-115|compared|drug
DDI-DrugBank.d558.s18|117-118|to|drug
DDI-DrugBank.d558.s18|120-122|508|drug
DDI-DrugBank.d558.s18|124-129|deaths|drug
DDI-DrugBank.d558.s18|131-135|among|drug
DDI-DrugBank.d558.s18|137-139|the|drug
DDI-DrugBank.d558.s18|141-144|1248|drug
DDI-DrugBank.d558.s18|146-153|patients|drug
DDI-DrugBank.d558.s18|155-163|receiving|drug
DDI-DrugBank.d558.s18|165-171|placebo|drug
DDI-DrugBank.d558.s18|173-175|and|drug
DDI-DrugBank.d558.s18|177-185|diuretics|drug
DDI-DrugBank.d558.s18|186-186|.|drug
DDI-DrugBank.d558.s19|0-1|Of|drug
DDI-DrugBank.d558.s19|3-5|the|drug
DDI-DrugBank.d558.s19|7-9|229|drug
DDI-DrugBank.d558.s19|11-18|patients|drug
DDI-DrugBank.d558.s19|20-22|who|drug
DDI-DrugBank.d558.s19|24-26|had|drug
DDI-DrugBank.d558.s19|28-36|potassium|drug
DDI-DrugBank.d558.s19|38-46|depleting|drug
DDI-DrugBank.d558.s19|48-56|diuretics|drug
DDI-DrugBank.d558.s19|58-62|added|drug
DDI-DrugBank.d558.s19|64-65|to|drug
DDI-DrugBank.d558.s19|67-71|their|drug
DDI-DrugBank.d558.s19|73-83|concomitant|drug
DDI-DrugBank.d558.s19|85-95|medications|drug
DDI-DrugBank.d558.s19|97-98|in|drug
DDI-DrugBank.d558.s19|100-102|the|drug
DDI-DrugBank.d558.s19|104-110|DIAMOND|drug
DDI-DrugBank.d558.s19|112-117|trials|drug
DDI-DrugBank.d558.s19|118-118|,|drug
DDI-DrugBank.d558.s19|120-122|the|drug
DDI-DrugBank.d558.s19|124-131|patients|drug
DDI-DrugBank.d558.s19|133-134|on|drug
DDI-DrugBank.d558.s19|136-142|TIKOSYN|drug
DDI-DrugBank.d558.s19|144-146|had|drug
DDI-DrugBank.d558.s19|148-148|a|drug
DDI-DrugBank.d558.s19|150-166|non-significantly|drug
DDI-DrugBank.d558.s19|168-174|reduced|drug
DDI-DrugBank.d558.s19|176-183|relative|drug
DDI-DrugBank.d558.s19|185-188|risk|drug
DDI-DrugBank.d558.s19|190-192|for|drug
DDI-DrugBank.d558.s19|194-198|death|drug
DDI-DrugBank.d558.s19|200-201|of|drug
DDI-DrugBank.d558.s19|203-206|0.68|drug
DDI-DrugBank.d558.s19|208-208|(|drug
DDI-DrugBank.d558.s19|209-210|95|drug
DDI-DrugBank.d558.s19|211-211|%|drug
DDI-DrugBank.d558.s19|213-214|CI|drug
DDI-DrugBank.d558.s19|216-220|0.376|drug
DDI-DrugBank.d558.s19|221-221|,|drug
DDI-DrugBank.d558.s19|223-227|1.230|drug
DDI-DrugBank.d558.s19|228-228|)|drug
DDI-DrugBank.d558.s19|229-229|.|drug
DDI-DrugBank.d558.s20|0-8|Potential|drug
DDI-DrugBank.d558.s20|10-13|Drug|drug
DDI-DrugBank.d558.s20|15-26|Interactions|drug
DDI-DrugBank.d558.s20|28-37|Dofetilide|drug
DDI-DrugBank.d558.s20|39-40|is|drug
DDI-DrugBank.d558.s20|42-51|eliminated|drug
DDI-DrugBank.d558.s20|53-54|in|drug
DDI-DrugBank.d558.s20|56-58|the|drug
DDI-DrugBank.d558.s20|60-65|kidney|drug
DDI-DrugBank.d558.s20|67-68|by|drug
DDI-DrugBank.d558.s20|70-77|cationic|drug
DDI-DrugBank.d558.s20|79-87|secretion|drug
DDI-DrugBank.d558.s20|88-88|.|drug
DDI-DrugBank.d558.s21|0-9|Inhibitors|drug
DDI-DrugBank.d558.s21|11-12|of|drug
DDI-DrugBank.d558.s21|14-18|renal|drug
DDI-DrugBank.d558.s21|20-27|cationic|drug
DDI-DrugBank.d558.s21|29-37|secretion|drug
DDI-DrugBank.d558.s21|39-41|are|drug
DDI-DrugBank.d558.s21|43-57|contraindicated|drug
DDI-DrugBank.d558.s21|59-62|with|drug
DDI-DrugBank.d558.s21|64-70|TIKOSYN|drug
DDI-DrugBank.d558.s21|71-71|.|drug
DDI-DrugBank.d558.s22|0-1|In|drug
DDI-DrugBank.d558.s22|3-10|addition|drug
DDI-DrugBank.d558.s22|11-11|,|drug
DDI-DrugBank.d558.s22|13-17|drugs|drug
DDI-DrugBank.d558.s22|19-22|that|drug
DDI-DrugBank.d558.s22|24-26|are|drug
DDI-DrugBank.d558.s22|28-35|actively|drug
DDI-DrugBank.d558.s22|37-44|secreted|drug
DDI-DrugBank.d558.s22|46-48|via|drug
DDI-DrugBank.d558.s22|50-53|this|drug
DDI-DrugBank.d558.s22|55-59|route|drug
DDI-DrugBank.d558.s22|61-61|(|drug
DDI-DrugBank.d558.s22|62-65|e.g.|drug
DDI-DrugBank.d558.s22|66-66|,|drug
DDI-DrugBank.d558.s22|68-78|triamterene|drug
DDI-DrugBank.d558.s22|79-79|,|drug
DDI-DrugBank.d558.s22|81-89|metformin|drug
DDI-DrugBank.d558.s22|91-93|and|drug
DDI-DrugBank.d558.s22|95-103|amiloride|drug
DDI-DrugBank.d558.s22|104-104|)|drug
DDI-DrugBank.d558.s22|106-111|should|drug
DDI-DrugBank.d558.s22|113-114|be|drug
DDI-DrugBank.d558.s22|116-130|co-administered|drug
DDI-DrugBank.d558.s22|132-135|with|drug
DDI-DrugBank.d558.s22|137-140|care|drug
DDI-DrugBank.d558.s22|142-143|as|drug
DDI-DrugBank.d558.s22|145-148|they|drug
DDI-DrugBank.d558.s22|150-154|might|drug
DDI-DrugBank.d558.s22|156-163|increase|drug
DDI-DrugBank.d558.s22|165-174|dofetilide|drug
DDI-DrugBank.d558.s22|176-181|levels|drug
DDI-DrugBank.d558.s22|182-182|.|drug
DDI-DrugBank.d558.s23|0-9|Dofetilide|drug
DDI-DrugBank.d558.s23|11-12|is|drug
DDI-DrugBank.d558.s23|14-24|metabolized|drug
DDI-DrugBank.d558.s23|26-27|to|drug
DDI-DrugBank.d558.s23|29-29|a|drug
DDI-DrugBank.d558.s23|31-35|small|drug
DDI-DrugBank.d558.s23|37-42|extent|drug
DDI-DrugBank.d558.s23|44-45|by|drug
DDI-DrugBank.d558.s23|47-49|the|drug
DDI-DrugBank.d558.s23|51-56|CYP3A4|drug
DDI-DrugBank.d558.s23|58-66|isoenzyme|drug
DDI-DrugBank.d558.s23|68-69|of|drug
DDI-DrugBank.d558.s23|71-73|the|drug
DDI-DrugBank.d558.s23|75-84|cytochrome|drug
DDI-DrugBank.d558.s23|86-89|P450|drug
DDI-DrugBank.d558.s23|91-96|system|drug
DDI-DrugBank.d558.s23|97-97|.|drug
DDI-DrugBank.d558.s24|0-9|Inhibitors|drug
DDI-DrugBank.d558.s24|11-12|of|drug
DDI-DrugBank.d558.s24|14-16|the|drug
DDI-DrugBank.d558.s24|18-23|CYP3A4|drug
DDI-DrugBank.d558.s24|25-33|isoenzyme|drug
DDI-DrugBank.d558.s24|35-39|could|drug
DDI-DrugBank.d558.s24|41-48|increase|drug
DDI-DrugBank.d558.s24|50-57|systemic|drug
DDI-DrugBank.d558.s24|59-68|dofetilide|drug
DDI-DrugBank.d558.s24|70-77|exposure|drug
DDI-DrugBank.d558.s24|78-78|.|drug
DDI-DrugBank.d558.s25|0-9|Inhibitors|drug
DDI-DrugBank.d558.s25|11-12|of|drug
DDI-DrugBank.d558.s25|14-17|this|drug
DDI-DrugBank.d558.s25|19-27|isoenzyme|drug
DDI-DrugBank.d558.s25|29-29|(|drug
DDI-DrugBank.d558.s25|30-33|e.g.|drug
DDI-DrugBank.d558.s25|34-34|,|drug
DDI-DrugBank.d558.s25|36-44|macrolide|drug
DDI-DrugBank.d558.s25|46-56|antibiotics|drug
DDI-DrugBank.d558.s25|57-57|,|drug
DDI-DrugBank.d558.s25|59-63|azole|drug
DDI-DrugBank.d558.s25|65-74|antifungal|drug
DDI-DrugBank.d558.s25|76-81|agents|drug
DDI-DrugBank.d558.s25|82-82|,|drug
DDI-DrugBank.d558.s25|84-91|protease|drug
DDI-DrugBank.d558.s25|93-102|inhibitors|drug
DDI-DrugBank.d558.s25|103-103|,|drug
DDI-DrugBank.d558.s25|105-113|serotonin|drug
DDI-DrugBank.d558.s25|115-122|reuptake|drug
DDI-DrugBank.d558.s25|124-133|inhibitors|drug
DDI-DrugBank.d558.s25|134-134|,|drug
DDI-DrugBank.d558.s25|136-145|amiodarone|drug
DDI-DrugBank.d558.s25|146-146|,|drug
DDI-DrugBank.d558.s25|148-159|cannabinoids|drug
DDI-DrugBank.d558.s25|160-160|,|drug
DDI-DrugBank.d558.s25|162-170|diltiazem|drug
DDI-DrugBank.d558.s25|171-171|,|drug
DDI-DrugBank.d558.s25|173-182|grapefruit|drug
DDI-DrugBank.d558.s25|184-188|juice|drug
DDI-DrugBank.d558.s25|189-189|,|drug
DDI-DrugBank.d558.s25|191-200|nefazadone|drug
DDI-DrugBank.d558.s25|201-201|,|drug
DDI-DrugBank.d558.s25|203-213|norfloxacin|drug
DDI-DrugBank.d558.s25|214-214|,|drug
DDI-DrugBank.d558.s25|216-222|quinine|drug
DDI-DrugBank.d558.s25|223-223|,|drug
DDI-DrugBank.d558.s25|225-235|zafirlukast|drug
DDI-DrugBank.d558.s25|236-236|)|drug
DDI-DrugBank.d558.s25|238-243|should|drug
DDI-DrugBank.d558.s25|245-246|be|drug
DDI-DrugBank.d558.s25|248-257|cautiously|drug
DDI-DrugBank.d558.s25|259-272|coadministered|drug
DDI-DrugBank.d558.s25|274-277|with|drug
DDI-DrugBank.d558.s25|279-285|TIKOSYN|drug
DDI-DrugBank.d558.s25|287-288|as|drug
DDI-DrugBank.d558.s25|290-293|they|drug
DDI-DrugBank.d558.s25|295-297|can|drug
DDI-DrugBank.d558.s25|299-309|potentially|drug
DDI-DrugBank.d558.s25|311-318|increase|drug
DDI-DrugBank.d558.s25|320-329|dofetilide|drug
DDI-DrugBank.d558.s25|331-336|levels|drug
DDI-DrugBank.d558.s25|337-337|.|drug
DDI-DrugBank.d558.s26|0-9|Dofetilide|drug
DDI-DrugBank.d558.s26|11-12|is|drug
DDI-DrugBank.d558.s26|14-16|not|drug
DDI-DrugBank.d558.s26|18-19|an|drug
DDI-DrugBank.d558.s26|21-29|inhibitor|drug
DDI-DrugBank.d558.s26|31-32|of|drug
DDI-DrugBank.d558.s26|34-39|CYP3A4|drug
DDI-DrugBank.d558.s26|41-43|nor|drug
DDI-DrugBank.d558.s26|45-46|of|drug
DDI-DrugBank.d558.s26|48-52|other|drug
DDI-DrugBank.d558.s26|54-63|cytochrome|drug
DDI-DrugBank.d558.s26|65-68|P450|drug
DDI-DrugBank.d558.s26|70-79|isoenzymes|drug
DDI-DrugBank.d558.s26|81-81|(|drug
DDI-DrugBank.d558.s26|82-85|e.g.|drug
DDI-DrugBank.d558.s26|86-86|,|drug
DDI-DrugBank.d558.s26|88-93|CYP2C9|drug
DDI-DrugBank.d558.s26|94-94|,|drug
DDI-DrugBank.d558.s26|96-101|CYP2D6|drug
DDI-DrugBank.d558.s26|102-102|)|drug
DDI-DrugBank.d558.s26|104-106|and|drug
DDI-DrugBank.d558.s26|108-109|is|drug
DDI-DrugBank.d558.s26|111-113|not|drug
DDI-DrugBank.d558.s26|115-122|expected|drug
DDI-DrugBank.d558.s26|124-125|to|drug
DDI-DrugBank.d558.s26|127-134|increase|drug
DDI-DrugBank.d558.s26|136-141|levels|drug
DDI-DrugBank.d558.s26|143-144|of|drug
DDI-DrugBank.d558.s26|146-150|drugs|drug
DDI-DrugBank.d558.s26|152-162|metabolized|drug
DDI-DrugBank.d558.s26|164-165|by|drug
DDI-DrugBank.d558.s26|167-172|CYP3A4|drug
DDI-DrugBank.d558.s26|173-173|.|drug
DDI-DrugBank.d558.s27|0-4|Other|drug
DDI-DrugBank.d558.s27|6-9|Drug|drug
DDI-DrugBank.d558.s27|11-21|Interaction|drug
DDI-DrugBank.d558.s27|23-33|Information|drug
DDI-DrugBank.d558.s27|35-41|Digoxin|drug
DDI-DrugBank.d558.s27|42-42|:|drug
DDI-DrugBank.d558.s27|44-50|Studies|drug
DDI-DrugBank.d558.s27|52-53|in|drug
DDI-DrugBank.d558.s27|55-61|healthy|drug
DDI-DrugBank.d558.s27|63-72|volunteers|drug
DDI-DrugBank.d558.s27|74-77|have|drug
DDI-DrugBank.d558.s27|79-83|shown|drug
DDI-DrugBank.d558.s27|85-88|that|drug
DDI-DrugBank.d558.s27|90-96|TIKOSYN|drug
DDI-DrugBank.d558.s27|98-101|does|drug
DDI-DrugBank.d558.s27|103-105|not|drug
DDI-DrugBank.d558.s27|107-112|affect|drug
DDI-DrugBank.d558.s27|114-116|the|drug
DDI-DrugBank.d558.s27|118-133|pharmacokinetics|drug
DDI-DrugBank.d558.s27|135-136|of|drug
DDI-DrugBank.d558.s27|138-144|digoxin|drug
DDI-DrugBank.d558.s27|145-145|.|drug
DDI-DrugBank.d558.s28|0-1|In|drug
DDI-DrugBank.d558.s28|3-10|patients|drug
DDI-DrugBank.d558.s28|11-11|,|drug
DDI-DrugBank.d558.s28|13-15|the|drug
DDI-DrugBank.d558.s28|17-27|concomitant|drug
DDI-DrugBank.d558.s28|29-42|administration|drug
DDI-DrugBank.d558.s28|44-45|of|drug
DDI-DrugBank.d558.s28|47-53|digoxin|drug
DDI-DrugBank.d558.s28|55-58|with|drug
DDI-DrugBank.d558.s28|60-69|dofetilide|drug
DDI-DrugBank.d558.s28|71-73|was|drug
DDI-DrugBank.d558.s28|75-84|associated|drug
DDI-DrugBank.d558.s28|86-89|with|drug
DDI-DrugBank.d558.s28|91-91|a|drug
DDI-DrugBank.d558.s28|93-98|higher|drug
DDI-DrugBank.d558.s28|100-109|occurrence|drug
DDI-DrugBank.d558.s28|111-112|of|drug
DDI-DrugBank.d558.s28|114-120|torsade|drug
DDI-DrugBank.d558.s28|122-123|de|drug
DDI-DrugBank.d558.s28|125-131|pointes|drug
DDI-DrugBank.d558.s28|132-132|.|drug
DDI-DrugBank.d558.s29|0-1|It|drug
DDI-DrugBank.d558.s29|3-4|is|drug
DDI-DrugBank.d558.s29|6-8|not|drug
DDI-DrugBank.d558.s29|10-14|clear|drug
DDI-DrugBank.d558.s29|16-22|whether|drug
DDI-DrugBank.d558.s29|24-27|this|drug
DDI-DrugBank.d558.s29|29-38|represents|drug
DDI-DrugBank.d558.s29|40-41|an|drug
DDI-DrugBank.d558.s29|43-53|interaction|drug
DDI-DrugBank.d558.s29|55-58|with|drug
DDI-DrugBank.d558.s29|60-66|TIKOSYN|drug
DDI-DrugBank.d558.s29|68-69|or|drug
DDI-DrugBank.d558.s29|71-73|the|drug
DDI-DrugBank.d558.s29|75-82|presence|drug
DDI-DrugBank.d558.s29|84-85|of|drug
DDI-DrugBank.d558.s29|87-90|more|drug
DDI-DrugBank.d558.s29|92-97|severe|drug
DDI-DrugBank.d558.s29|99-108|structural|drug
DDI-DrugBank.d558.s29|110-114|heart|drug
DDI-DrugBank.d558.s29|116-122|disease|drug
DDI-DrugBank.d558.s29|124-125|in|drug
DDI-DrugBank.d558.s29|127-134|patients|drug
DDI-DrugBank.d558.s29|136-137|on|drug
DDI-DrugBank.d558.s29|139-145|digoxin|drug
DDI-DrugBank.d558.s29|146-146|;|drug
DDI-DrugBank.d558.s30|0-9|structural|drug
DDI-DrugBank.d558.s30|11-15|heart|drug
DDI-DrugBank.d558.s30|17-23|disease|drug
DDI-DrugBank.d558.s30|25-26|is|drug
DDI-DrugBank.d558.s30|28-28|a|drug
DDI-DrugBank.d558.s30|30-34|known|drug
DDI-DrugBank.d558.s30|36-39|risk|drug
DDI-DrugBank.d558.s30|41-46|factor|drug
DDI-DrugBank.d558.s30|48-50|for|drug
DDI-DrugBank.d558.s30|52-61|arrhythmia|drug
DDI-DrugBank.d558.s30|62-62|.|drug
DDI-DrugBank.d558.s31|0-1|No|drug
DDI-DrugBank.d558.s31|3-10|increase|drug
DDI-DrugBank.d558.s31|12-13|in|drug
DDI-DrugBank.d558.s31|15-23|mortality|drug
DDI-DrugBank.d558.s31|25-27|was|drug
DDI-DrugBank.d558.s31|29-36|observed|drug
DDI-DrugBank.d558.s31|38-39|in|drug
DDI-DrugBank.d558.s31|41-48|patients|drug
DDI-DrugBank.d558.s31|50-55|taking|drug
DDI-DrugBank.d558.s31|57-63|digoxin|drug
DDI-DrugBank.d558.s31|65-66|as|drug
DDI-DrugBank.d558.s31|68-78|concomitant|drug
DDI-DrugBank.d558.s31|80-89|medication|drug
DDI-DrugBank.d558.s31|90-90|.|drug
DDI-DrugBank.d558.s32|0-4|Other|drug
DDI-DrugBank.d558.s32|6-10|Drugs|drug
DDI-DrugBank.d558.s32|11-11|:|drug
DDI-DrugBank.d558.s32|13-14|In|drug
DDI-DrugBank.d558.s32|16-22|healthy|drug
DDI-DrugBank.d558.s32|24-33|volunteers|drug
DDI-DrugBank.d558.s32|34-34|,|drug
DDI-DrugBank.d558.s32|36-45|amlodipine|drug
DDI-DrugBank.d558.s32|46-46|,|drug
DDI-DrugBank.d558.s32|48-56|phenytoin|drug
DDI-DrugBank.d558.s32|57-57|,|drug
DDI-DrugBank.d558.s32|59-67|glyburide|drug
DDI-DrugBank.d558.s32|68-68|,|drug
DDI-DrugBank.d558.s32|70-79|ranitidine|drug
DDI-DrugBank.d558.s32|80-80|,|drug
DDI-DrugBank.d558.s32|82-91|omeprazole|drug
DDI-DrugBank.d558.s32|92-92|,|drug
DDI-DrugBank.d558.s32|94-100|hormone|drug
DDI-DrugBank.d558.s32|102-112|replacement|drug
DDI-DrugBank.d558.s32|114-120|therapy|drug
DDI-DrugBank.d558.s32|122-122|(|drug
DDI-DrugBank.d558.s32|123-123|a|drug
DDI-DrugBank.d558.s32|125-135|combination|drug
DDI-DrugBank.d558.s32|137-138|of|drug
DDI-DrugBank.d558.s32|140-149|conjugated|drug
DDI-DrugBank.d558.s32|151-159|estrogens|drug
DDI-DrugBank.d558.s32|161-163|and|drug
DDI-DrugBank.d558.s32|165-183|medroxyprogesterone|drug
DDI-DrugBank.d558.s32|184-184|)|drug
DDI-DrugBank.d558.s32|185-185|,|drug
DDI-DrugBank.d558.s32|187-193|antacid|drug
DDI-DrugBank.d558.s32|195-195|(|drug
DDI-DrugBank.d558.s32|196-203|aluminum|drug
DDI-DrugBank.d558.s32|205-207|and|drug
DDI-DrugBank.d558.s32|209-217|magnesium|drug
DDI-DrugBank.d558.s32|219-228|hydroxides|drug
DDI-DrugBank.d558.s32|229-229|)|drug
DDI-DrugBank.d558.s32|231-233|and|drug
DDI-DrugBank.d558.s32|235-246|theophylline|drug
DDI-DrugBank.d558.s32|248-250|did|drug
DDI-DrugBank.d558.s32|252-254|not|drug
DDI-DrugBank.d558.s32|256-261|affect|drug
DDI-DrugBank.d558.s32|263-265|the|drug
DDI-DrugBank.d558.s32|267-282|pharmacokinetics|drug
DDI-DrugBank.d558.s32|284-285|of|drug
DDI-DrugBank.d558.s32|287-293|TIKOSYN|drug
DDI-DrugBank.d558.s32|294-294|.|drug
DDI-DrugBank.d558.s33|0-1|In|drug
DDI-DrugBank.d558.s33|3-10|addition|drug
DDI-DrugBank.d558.s33|11-11|,|drug
DDI-DrugBank.d558.s33|13-19|studies|drug
DDI-DrugBank.d558.s33|21-22|in|drug
DDI-DrugBank.d558.s33|24-30|healthy|drug
DDI-DrugBank.d558.s33|32-41|volunteers|drug
DDI-DrugBank.d558.s33|43-46|have|drug
DDI-DrugBank.d558.s33|48-52|shown|drug
DDI-DrugBank.d558.s33|54-57|that|drug
DDI-DrugBank.d558.s33|59-65|TIKOSYN|drug
DDI-DrugBank.d558.s33|67-70|does|drug
DDI-DrugBank.d558.s33|72-74|not|drug
DDI-DrugBank.d558.s33|76-81|affect|drug
DDI-DrugBank.d558.s33|83-85|the|drug
DDI-DrugBank.d558.s33|87-102|pharmacokinetics|drug
DDI-DrugBank.d558.s33|104-105|or|drug
DDI-DrugBank.d558.s33|107-122|pharmacodynamics|drug
DDI-DrugBank.d558.s33|124-125|of|drug
DDI-DrugBank.d558.s33|127-134|warfarin|drug
DDI-DrugBank.d558.s33|135-135|,|drug
DDI-DrugBank.d558.s33|137-138|or|drug
DDI-DrugBank.d558.s33|140-142|the|drug
DDI-DrugBank.d558.s33|144-159|pharmacokinetics|drug
DDI-DrugBank.d558.s33|161-162|of|drug
DDI-DrugBank.d558.s33|164-174|propranolol|drug
DDI-DrugBank.d558.s33|176-176|(|drug
DDI-DrugBank.d558.s33|177-178|40|drug
DDI-DrugBank.d558.s33|180-181|mg|drug
DDI-DrugBank.d558.s33|183-187|twice|drug
DDI-DrugBank.d558.s33|189-193|daily|drug
DDI-DrugBank.d558.s33|194-194|)|drug
DDI-DrugBank.d558.s33|195-195|,|drug
DDI-DrugBank.d558.s33|197-205|phenytoin|drug
DDI-DrugBank.d558.s33|206-206|,|drug
DDI-DrugBank.d558.s33|208-219|theophylline|drug
DDI-DrugBank.d558.s33|220-220|,|drug
DDI-DrugBank.d558.s33|222-223|or|drug
DDI-DrugBank.d558.s33|225-228|oral|drug
DDI-DrugBank.d558.s33|230-243|contraceptives|drug
DDI-DrugBank.d558.s33|244-244|.|drug
DDI-DrugBank.d558.s34|0-9|Population|drug
DDI-DrugBank.d558.s34|11-25|pharmacokinetic|drug
DDI-DrugBank.d558.s34|27-34|analyses|drug
DDI-DrugBank.d558.s34|36-39|were|drug
DDI-DrugBank.d558.s34|41-49|conducted|drug
DDI-DrugBank.d558.s34|51-52|on|drug
DDI-DrugBank.d558.s34|54-59|plasma|drug
DDI-DrugBank.d558.s34|61-73|concentration|drug
DDI-DrugBank.d558.s34|75-78|data|drug
DDI-DrugBank.d558.s34|80-83|from|drug
DDI-DrugBank.d558.s34|85-88|1445|drug
DDI-DrugBank.d558.s34|90-97|patients|drug
DDI-DrugBank.d558.s34|99-100|in|drug
DDI-DrugBank.d558.s34|102-109|clinical|drug
DDI-DrugBank.d558.s34|111-116|trials|drug
DDI-DrugBank.d558.s34|118-119|to|drug
DDI-DrugBank.d558.s34|121-127|examine|drug
DDI-DrugBank.d558.s34|129-131|the|drug
DDI-DrugBank.d558.s34|133-139|effects|drug
DDI-DrugBank.d558.s34|141-142|of|drug
DDI-DrugBank.d558.s34|144-154|concomitant|drug
DDI-DrugBank.d558.s34|156-166|medications|drug
DDI-DrugBank.d558.s34|168-169|on|drug
DDI-DrugBank.d558.s34|171-179|clearance|drug
DDI-DrugBank.d558.s34|181-182|or|drug
DDI-DrugBank.d558.s34|184-189|volume|drug
DDI-DrugBank.d558.s34|191-192|of|drug
DDI-DrugBank.d558.s34|194-205|distribution|drug
DDI-DrugBank.d558.s34|207-208|of|drug
DDI-DrugBank.d558.s34|210-219|dofetilide|drug
DDI-DrugBank.d558.s34|220-220|.|drug
DDI-DrugBank.d558.s35|0-10|Concomitant|drug
DDI-DrugBank.d558.s35|12-22|medications|drug
DDI-DrugBank.d558.s35|24-27|were|drug
DDI-DrugBank.d558.s35|29-35|grouped|drug
DDI-DrugBank.d558.s35|37-38|as|drug
DDI-DrugBank.d558.s35|40-42|ACE|drug
DDI-DrugBank.d558.s35|44-53|inhibitors|drug
DDI-DrugBank.d558.s35|54-54|,|drug
DDI-DrugBank.d558.s35|56-59|oral|drug
DDI-DrugBank.d558.s35|61-74|anticoagulants|drug
DDI-DrugBank.d558.s35|75-75|,|drug
DDI-DrugBank.d558.s35|77-83|calcium|drug
DDI-DrugBank.d558.s35|85-91|channel|drug
DDI-DrugBank.d558.s35|93-100|blockers|drug
DDI-DrugBank.d558.s35|101-101|,|drug
DDI-DrugBank.d558.s35|103-106|beta|drug
DDI-DrugBank.d558.s35|108-115|blockers|drug
DDI-DrugBank.d558.s35|116-116|,|drug
DDI-DrugBank.d558.s35|118-124|cardiac|drug
DDI-DrugBank.d558.s35|126-135|glycosides|drug
DDI-DrugBank.d558.s35|136-136|,|drug
DDI-DrugBank.d558.s35|138-145|inducers|drug
DDI-DrugBank.d558.s35|147-148|of|drug
DDI-DrugBank.d558.s35|150-155|CYP3A4|drug
DDI-DrugBank.d558.s35|156-156|,|drug
DDI-DrugBank.d558.s35|158-167|substrates|drug
DDI-DrugBank.d558.s35|169-171|and|drug
DDI-DrugBank.d558.s35|173-182|inhibitors|drug
DDI-DrugBank.d558.s35|184-185|of|drug
DDI-DrugBank.d558.s35|187-192|CYP3A4|drug
DDI-DrugBank.d558.s35|193-193|,|drug
DDI-DrugBank.d558.s35|195-204|substrates|drug
DDI-DrugBank.d558.s35|206-208|and|drug
DDI-DrugBank.d558.s35|210-219|inhibitors|drug
DDI-DrugBank.d558.s35|221-222|of|drug
DDI-DrugBank.d558.s35|224-237|P-glycoprotein|drug
DDI-DrugBank.d558.s35|238-238|,|drug
DDI-DrugBank.d558.s35|240-247|nitrates|drug
DDI-DrugBank.d558.s35|248-248|,|drug
DDI-DrugBank.d558.s35|250-263|sulphonylureas|drug
DDI-DrugBank.d558.s35|264-264|,|drug
DDI-DrugBank.d558.s35|266-269|loop|drug
DDI-DrugBank.d558.s35|271-279|diuretics|drug
DDI-DrugBank.d558.s35|280-280|,|drug
DDI-DrugBank.d558.s35|282-290|potassium|drug
DDI-DrugBank.d558.s35|292-298|sparing|drug
DDI-DrugBank.d558.s35|300-308|diuretics|drug
DDI-DrugBank.d558.s35|309-309|,|drug
DDI-DrugBank.d558.s35|311-318|thiazide|drug
DDI-DrugBank.d558.s35|320-328|diuretics|drug
DDI-DrugBank.d558.s35|329-329|,|drug
DDI-DrugBank.d558.s35|331-340|substrates|drug
DDI-DrugBank.d558.s35|342-344|and|drug
DDI-DrugBank.d558.s35|346-355|inhibitors|drug
DDI-DrugBank.d558.s35|357-358|of|drug
DDI-DrugBank.d558.s35|360-366|tubular|drug
DDI-DrugBank.d558.s35|368-374|organic|drug
DDI-DrugBank.d558.s35|376-381|cation|drug
DDI-DrugBank.d558.s35|383-391|transport|drug
DDI-DrugBank.d558.s35|392-392|,|drug
DDI-DrugBank.d558.s35|394-396|and|drug
DDI-DrugBank.d558.s35|398-411|QTc-prolonging|drug
DDI-DrugBank.d558.s35|413-417|drugs|drug
DDI-DrugBank.d558.s35|418-418|.|drug
DDI-DrugBank.d558.s36|0-10|Differences|drug
DDI-DrugBank.d558.s36|12-13|in|drug
DDI-DrugBank.d558.s36|15-23|clearance|drug
DDI-DrugBank.d558.s36|25-31|between|drug
DDI-DrugBank.d558.s36|33-40|patients|drug
DDI-DrugBank.d558.s36|42-43|on|drug
DDI-DrugBank.d558.s36|45-49|these|drug
DDI-DrugBank.d558.s36|51-61|medications|drug
DDI-DrugBank.d558.s36|63-63|(|drug
DDI-DrugBank.d558.s36|64-65|at|drug
DDI-DrugBank.d558.s36|67-69|any|drug
DDI-DrugBank.d558.s36|71-78|occasion|drug
DDI-DrugBank.d558.s36|80-81|in|drug
DDI-DrugBank.d558.s36|83-85|the|drug
DDI-DrugBank.d558.s36|87-91|study|drug
DDI-DrugBank.d558.s36|92-92|)|drug
DDI-DrugBank.d558.s36|94-96|and|drug
DDI-DrugBank.d558.s36|98-102|those|drug
DDI-DrugBank.d558.s36|104-106|off|drug
DDI-DrugBank.d558.s36|108-118|medications|drug
DDI-DrugBank.d558.s36|120-125|varied|drug
DDI-DrugBank.d558.s36|127-133|between|drug
DDI-DrugBank.d558.s36|135-137|-16|drug
DDI-DrugBank.d558.s36|138-138|%|drug
DDI-DrugBank.d558.s36|140-142|and|drug
DDI-DrugBank.d558.s36|144-145|+3|drug
DDI-DrugBank.d558.s36|146-146|%|drug
DDI-DrugBank.d558.s36|147-147|.|drug
DDI-DrugBank.d558.s37|0-2|The|drug
DDI-DrugBank.d558.s37|4-7|mean|drug
DDI-DrugBank.d558.s37|9-18|clearances|drug
DDI-DrugBank.d558.s37|20-21|of|drug
DDI-DrugBank.d558.s37|23-32|dofetilide|drug
DDI-DrugBank.d558.s37|34-37|were|drug
DDI-DrugBank.d558.s37|39-40|16|drug
DDI-DrugBank.d558.s37|41-41|%|drug
DDI-DrugBank.d558.s37|43-45|and|drug
DDI-DrugBank.d558.s37|47-48|15|drug
DDI-DrugBank.d558.s37|49-49|%|drug
DDI-DrugBank.d558.s37|51-55|lower|drug
DDI-DrugBank.d558.s37|57-58|in|drug
DDI-DrugBank.d558.s37|60-67|patients|drug
DDI-DrugBank.d558.s37|69-70|on|drug
DDI-DrugBank.d558.s37|72-79|thiazide|drug
DDI-DrugBank.d558.s37|81-89|diuretics|drug
DDI-DrugBank.d558.s37|91-93|and|drug
DDI-DrugBank.d558.s37|95-104|inhibitors|drug
DDI-DrugBank.d558.s37|106-107|of|drug
DDI-DrugBank.d558.s37|109-115|tubular|drug
DDI-DrugBank.d558.s37|117-123|organic|drug
DDI-DrugBank.d558.s37|125-130|cation|drug
DDI-DrugBank.d558.s37|132-140|transport|drug
DDI-DrugBank.d558.s37|141-141|,|drug
DDI-DrugBank.d558.s37|143-154|respectively|drug
DDI-DrugBank.d558.s37|155-155|.|drug
DDI-DrugBank.d16.s0|0-10|Prospective|drug
DDI-DrugBank.d16.s0|12-18|studies|drug
DDI-DrugBank.d16.s0|20-21|on|drug
DDI-DrugBank.d16.s0|23-25|the|drug
DDI-DrugBank.d16.s0|27-35|potential|drug
DDI-DrugBank.d16.s0|37-39|for|drug
DDI-DrugBank.d16.s0|41-51|hydroxyurea|drug
DDI-DrugBank.d16.s0|53-54|to|drug
DDI-DrugBank.d16.s0|56-63|interact|drug
DDI-DrugBank.d16.s0|65-68|with|drug
DDI-DrugBank.d16.s0|70-74|other|drug
DDI-DrugBank.d16.s0|76-80|drugs|drug
DDI-DrugBank.d16.s0|82-85|have|drug
DDI-DrugBank.d16.s0|87-89|not|drug
DDI-DrugBank.d16.s0|91-94|been|drug
DDI-DrugBank.d16.s0|96-104|performed|drug
DDI-DrugBank.d16.s0|105-105|.|drug
DDI-DrugBank.d16.s1|0-9|Concurrent|drug
DDI-DrugBank.d16.s1|11-13|use|drug
DDI-DrugBank.d16.s1|15-16|of|drug
DDI-DrugBank.d16.s1|18-28|hydroxyurea|drug
DDI-DrugBank.d16.s1|30-32|and|drug
DDI-DrugBank.d16.s1|34-38|other|drug
DDI-DrugBank.d16.s1|40-55|myelosuppressive|drug
DDI-DrugBank.d16.s1|57-62|agents|drug
DDI-DrugBank.d16.s1|64-65|or|drug
DDI-DrugBank.d16.s1|67-75|radiation|drug
DDI-DrugBank.d16.s1|77-83|therapy|drug
DDI-DrugBank.d16.s1|85-87|may|drug
DDI-DrugBank.d16.s1|89-96|increase|drug
DDI-DrugBank.d16.s1|98-100|the|drug
DDI-DrugBank.d16.s1|102-111|likelihood|drug
DDI-DrugBank.d16.s1|113-114|of|drug
DDI-DrugBank.d16.s1|116-119|bone|drug
DDI-DrugBank.d16.s1|121-126|marrow|drug
DDI-DrugBank.d16.s1|128-137|depression|drug
DDI-DrugBank.d16.s1|139-140|or|drug
DDI-DrugBank.d16.s1|142-146|other|drug
DDI-DrugBank.d16.s1|148-154|adverse|drug
DDI-DrugBank.d16.s1|156-161|events|drug
DDI-DrugBank.d16.s1|162-162|.|drug
DDI-DrugBank.d16.s2|0-4|Since|drug
DDI-DrugBank.d16.s2|6-16|hydroxyurea|drug
DDI-DrugBank.d16.s2|18-20|may|drug
DDI-DrugBank.d16.s2|22-26|raise|drug
DDI-DrugBank.d16.s2|28-30|the|drug
DDI-DrugBank.d16.s2|32-36|serum|drug
DDI-DrugBank.d16.s2|38-41|uric|drug
DDI-DrugBank.d16.s2|43-46|acid|drug
DDI-DrugBank.d16.s2|48-52|level|drug
DDI-DrugBank.d16.s2|53-53|,|drug
DDI-DrugBank.d16.s2|55-60|dosage|drug
DDI-DrugBank.d16.s2|62-71|adjustment|drug
DDI-DrugBank.d16.s2|73-74|of|drug
DDI-DrugBank.d16.s2|76-85|uricosuric|drug
DDI-DrugBank.d16.s2|87-96|medication|drug
DDI-DrugBank.d16.s2|98-100|may|drug
DDI-DrugBank.d16.s2|102-103|be|drug
DDI-DrugBank.d16.s2|105-113|necessary|drug
DDI-DrugBank.d16.s3|0-0|.|drug
DDI-DrugBank.d130.s0|0-9|Lincomycin|drug
DDI-DrugBank.d130.s0|11-13|has|drug
DDI-DrugBank.d130.s0|15-18|been|drug
DDI-DrugBank.d130.s0|20-24|shown|drug
DDI-DrugBank.d130.s0|26-27|to|drug
DDI-DrugBank.d130.s0|29-32|have|drug
DDI-DrugBank.d130.s0|34-46|neuromuscular|drug
DDI-DrugBank.d130.s0|48-55|blocking|drug
DDI-DrugBank.d130.s0|57-66|properties|drug
DDI-DrugBank.d130.s0|68-71|that|drug
DDI-DrugBank.d130.s0|73-75|may|drug
DDI-DrugBank.d130.s0|77-83|enhance|drug
DDI-DrugBank.d130.s0|85-87|the|drug
DDI-DrugBank.d130.s0|89-94|action|drug
DDI-DrugBank.d130.s0|96-97|of|drug
DDI-DrugBank.d130.s0|99-103|other|drug
DDI-DrugBank.d130.s0|105-117|neuromuscular|drug
DDI-DrugBank.d130.s0|119-126|blocking|drug
DDI-DrugBank.d130.s0|128-133|agents|drug
DDI-DrugBank.d130.s0|134-134|.|drug
DDI-DrugBank.d130.s1|0-8|Therefore|drug
DDI-DrugBank.d130.s1|9-9|,|drug
DDI-DrugBank.d130.s1|11-12|it|drug
DDI-DrugBank.d130.s1|14-19|should|drug
DDI-DrugBank.d130.s1|21-22|be|drug
DDI-DrugBank.d130.s1|24-27|used|drug
DDI-DrugBank.d130.s1|29-30|in|drug
DDI-DrugBank.d130.s1|32-38|caution|drug
DDI-DrugBank.d130.s1|40-41|in|drug
DDI-DrugBank.d130.s1|43-50|patients|drug
DDI-DrugBank.d130.s1|52-60|receiving|drug
DDI-DrugBank.d130.s1|62-65|such|drug
DDI-DrugBank.d130.s1|67-72|agents|drug
DDI-DrugBank.d130.s1|73-73|.|drug
DDI-DrugBank.d130.s2|0-9|Antagonism|drug
DDI-DrugBank.d130.s2|11-17|between|drug
DDI-DrugBank.d130.s2|19-28|lincomycin|drug
DDI-DrugBank.d130.s2|30-32|and|drug
DDI-DrugBank.d130.s2|34-45|erythromycin|drug
DDI-DrugBank.d130.s2|47-48|in|drug
DDI-DrugBank.d130.s2|50-54|vitro|drug
DDI-DrugBank.d130.s2|56-58|has|drug
DDI-DrugBank.d130.s2|60-63|been|drug
DDI-DrugBank.d130.s2|65-76|demonstrated|drug
DDI-DrugBank.d130.s2|77-77|.|drug
DDI-DrugBank.d130.s3|0-6|Because|drug
DDI-DrugBank.d130.s3|8-9|of|drug
DDI-DrugBank.d130.s3|11-18|possible|drug
DDI-DrugBank.d130.s3|20-27|clinical|drug
DDI-DrugBank.d130.s3|29-40|significance|drug
DDI-DrugBank.d130.s3|41-41|,|drug
DDI-DrugBank.d130.s3|43-45|the|drug
DDI-DrugBank.d130.s3|47-49|two|drug
DDI-DrugBank.d130.s3|51-55|drugs|drug
DDI-DrugBank.d130.s3|57-62|should|drug
DDI-DrugBank.d130.s3|64-66|not|drug
DDI-DrugBank.d130.s3|68-69|be|drug
DDI-DrugBank.d130.s3|71-82|administered|drug
DDI-DrugBank.d130.s3|84-95|concurrently|drug
DDI-DrugBank.d130.s3|96-96|.|drug
DDI-DrugBank.d504.s0|0-4|There|drug
DDI-DrugBank.d504.s0|6-9|have|drug
DDI-DrugBank.d504.s0|11-14|been|drug
DDI-DrugBank.d504.s0|16-19|rare|drug
DDI-DrugBank.d504.s0|21-27|reports|drug
DDI-DrugBank.d504.s0|29-30|of|drug
DDI-DrugBank.d504.s0|32-42|significant|drug
DDI-DrugBank.d504.s0|44-54|respiratory|drug
DDI-DrugBank.d504.s0|56-65|depression|drug
DDI-DrugBank.d504.s0|66-66|,|drug
DDI-DrugBank.d504.s0|68-73|stupor|drug
DDI-DrugBank.d504.s0|75-80|and/or|drug
DDI-DrugBank.d504.s0|82-92|hypotension|drug
DDI-DrugBank.d504.s0|94-97|with|drug
DDI-DrugBank.d504.s0|99-101|the|drug
DDI-DrugBank.d504.s0|103-113|concomitant|drug
DDI-DrugBank.d504.s0|115-117|use|drug
DDI-DrugBank.d504.s0|119-120|of|drug
DDI-DrugBank.d504.s0|122-129|loxapine|drug
DDI-DrugBank.d504.s0|131-133|and|drug
DDI-DrugBank.d504.s0|135-143|lorazepam|drug
DDI-DrugBank.d504.s0|144-144|.|drug
DDI-DrugBank.d504.s1|0-2|The|drug
DDI-DrugBank.d504.s1|4-7|risk|drug
DDI-DrugBank.d504.s1|9-10|of|drug
DDI-DrugBank.d504.s1|12-16|using|drug
DDI-DrugBank.d504.s1|18-25|loxapine|drug
DDI-DrugBank.d504.s1|27-28|in|drug
DDI-DrugBank.d504.s1|30-40|combination|drug
DDI-DrugBank.d504.s1|42-45|with|drug
DDI-DrugBank.d504.s1|47-56|CNS-active|drug
DDI-DrugBank.d504.s1|58-62|drugs|drug
DDI-DrugBank.d504.s1|64-66|has|drug
DDI-DrugBank.d504.s1|68-70|not|drug
DDI-DrugBank.d504.s1|72-75|been|drug
DDI-DrugBank.d504.s1|77-90|systematically|drug
DDI-DrugBank.d504.s1|92-100|evaluated|drug
DDI-DrugBank.d504.s1|101-101|.|drug
DDI-DrugBank.d504.s2|0-8|Therefore|drug
DDI-DrugBank.d504.s2|9-9|,|drug
DDI-DrugBank.d504.s2|11-17|caution|drug
DDI-DrugBank.d504.s2|19-20|is|drug
DDI-DrugBank.d504.s2|22-28|advised|drug
DDI-DrugBank.d504.s2|30-31|if|drug
DDI-DrugBank.d504.s2|33-35|the|drug
DDI-DrugBank.d504.s2|37-47|concomitant|drug
DDI-DrugBank.d504.s2|49-62|administration|drug
DDI-DrugBank.d504.s2|64-65|of|drug
DDI-DrugBank.d504.s2|67-74|loxapine|drug
DDI-DrugBank.d504.s2|76-78|and|drug
DDI-DrugBank.d504.s2|80-89|CNS-active|drug
DDI-DrugBank.d504.s2|91-95|drugs|drug
DDI-DrugBank.d504.s2|97-98|is|drug
DDI-DrugBank.d504.s2|100-107|required|drug
DDI-DrugBank.d504.s2|108-108|.|drug
DDI-DrugBank.d361.s0|0-10|Combination|drug
DDI-DrugBank.d361.s0|12-18|Therapy|drug
DDI-DrugBank.d361.s0|19-19|:|drug
DDI-DrugBank.d361.s0|21-23|Any|drug
DDI-DrugBank.d361.s0|25-28|form|drug
DDI-DrugBank.d361.s0|30-31|of|drug
DDI-DrugBank.d361.s0|33-39|therapy|drug
DDI-DrugBank.d361.s0|41-45|which|drug
DDI-DrugBank.d361.s0|47-50|adds|drug
DDI-DrugBank.d361.s0|52-53|to|drug
DDI-DrugBank.d361.s0|55-57|the|drug
DDI-DrugBank.d361.s0|59-64|stress|drug
DDI-DrugBank.d361.s0|66-67|of|drug
DDI-DrugBank.d361.s0|69-71|the|drug
DDI-DrugBank.d361.s0|73-79|patient|drug
DDI-DrugBank.d361.s0|80-80|,|drug
DDI-DrugBank.d361.s0|82-91|interferes|drug
DDI-DrugBank.d361.s0|93-96|with|drug
DDI-DrugBank.d361.s0|98-106|nutrition|drug
DDI-DrugBank.d361.s0|108-109|or|drug
DDI-DrugBank.d361.s0|111-119|depresses|drug
DDI-DrugBank.d361.s0|121-124|bone|drug
DDI-DrugBank.d361.s0|126-131|marrow|drug
DDI-DrugBank.d361.s0|133-140|function|drug
DDI-DrugBank.d361.s0|142-145|will|drug
DDI-DrugBank.d361.s0|147-154|increase|drug
DDI-DrugBank.d361.s0|156-158|the|drug
DDI-DrugBank.d361.s0|160-167|toxicity|drug
DDI-DrugBank.d361.s0|169-170|of|drug
DDI-DrugBank.d361.s0|172-182|Floxuridine|drug
DDI-DrugBank.d361.s0|183-183|.|drug
DDI-DrugBank.d138.s0|0-7|Although|drug
DDI-DrugBank.d138.s0|9-16|specific|drug
DDI-DrugBank.d138.s0|18-21|drug|drug
DDI-DrugBank.d138.s0|23-33|interaction|drug
DDI-DrugBank.d138.s0|35-41|studies|drug
DDI-DrugBank.d138.s0|43-46|have|drug
DDI-DrugBank.d138.s0|48-50|not|drug
DDI-DrugBank.d138.s0|52-55|been|drug
DDI-DrugBank.d138.s0|57-65|conducted|drug
DDI-DrugBank.d138.s0|67-70|with|drug
DDI-DrugBank.d138.s0|72-79|ALPHAGAN|drug
DDI-DrugBank.d138.s0|81-81|P|drug
DDI-DrugBank.d138.s0|82-82|,|drug
DDI-DrugBank.d138.s0|84-86|the|drug
DDI-DrugBank.d138.s0|88-98|possibility|drug
DDI-DrugBank.d138.s0|100-101|of|drug
DDI-DrugBank.d138.s0|103-104|an|drug
DDI-DrugBank.d138.s0|106-113|additive|drug
DDI-DrugBank.d138.s0|115-116|or|drug
DDI-DrugBank.d138.s0|118-129|potentiating|drug
DDI-DrugBank.d138.s0|131-136|effect|drug
DDI-DrugBank.d138.s0|138-141|with|drug
DDI-DrugBank.d138.s0|143-145|CNS|drug
DDI-DrugBank.d138.s0|147-157|depressants|drug
DDI-DrugBank.d138.s0|159-159|(|drug
DDI-DrugBank.d138.s0|160-166|alcohol|drug
DDI-DrugBank.d138.s0|167-167|,|drug
DDI-DrugBank.d138.s0|169-180|barbiturates|drug
DDI-DrugBank.d138.s0|181-181|,|drug
DDI-DrugBank.d138.s0|183-189|opiates|drug
DDI-DrugBank.d138.s0|190-190|,|drug
DDI-DrugBank.d138.s0|192-200|sedatives|drug
DDI-DrugBank.d138.s0|201-201|,|drug
DDI-DrugBank.d138.s0|203-204|or|drug
DDI-DrugBank.d138.s0|206-216|anesthetics|drug
DDI-DrugBank.d138.s0|217-217|)|drug
DDI-DrugBank.d138.s0|219-224|should|drug
DDI-DrugBank.d138.s0|226-227|be|drug
DDI-DrugBank.d138.s0|229-238|considered|drug
DDI-DrugBank.d138.s0|239-239|.|drug
DDI-DrugBank.d138.s1|0-13|Alpha-agonists|drug
DDI-DrugBank.d138.s1|14-14|,|drug
DDI-DrugBank.d138.s1|16-17|as|drug
DDI-DrugBank.d138.s1|19-19|a|drug
DDI-DrugBank.d138.s1|21-25|class|drug
DDI-DrugBank.d138.s1|26-26|,|drug
DDI-DrugBank.d138.s1|28-30|may|drug
DDI-DrugBank.d138.s1|32-37|reduce|drug
DDI-DrugBank.d138.s1|39-43|pulse|drug
DDI-DrugBank.d138.s1|45-47|and|drug
DDI-DrugBank.d138.s1|49-53|blood|drug
DDI-DrugBank.d138.s1|55-62|pressure|drug
DDI-DrugBank.d138.s1|63-63|.|drug
DDI-DrugBank.d138.s2|0-6|Caution|drug
DDI-DrugBank.d138.s2|8-9|in|drug
DDI-DrugBank.d138.s2|11-15|using|drug
DDI-DrugBank.d138.s2|17-27|concomitant|drug
DDI-DrugBank.d138.s2|29-33|drugs|drug
DDI-DrugBank.d138.s2|35-38|such|drug
DDI-DrugBank.d138.s2|40-41|as|drug
DDI-DrugBank.d138.s2|43-55|beta-blockers|drug
DDI-DrugBank.d138.s2|57-57|(|drug
DDI-DrugBank.d138.s2|58-67|ophthalmic|drug
DDI-DrugBank.d138.s2|69-71|and|drug
DDI-DrugBank.d138.s2|73-80|systemic|drug
DDI-DrugBank.d138.s2|81-81|)|drug
DDI-DrugBank.d138.s2|82-82|,|drug
DDI-DrugBank.d138.s2|84-101|anti-hypertensives|drug
DDI-DrugBank.d138.s2|103-108|and/or|drug
DDI-DrugBank.d138.s2|110-116|cardiac|drug
DDI-DrugBank.d138.s2|118-127|glycosides|drug
DDI-DrugBank.d138.s2|129-130|is|drug
DDI-DrugBank.d138.s2|132-138|advised|drug
DDI-DrugBank.d138.s2|139-139|.|drug
DDI-DrugBank.d138.s3|0-8|Tricyclic|drug
DDI-DrugBank.d138.s3|10-24|antidepressants|drug
DDI-DrugBank.d138.s3|26-29|have|drug
DDI-DrugBank.d138.s3|31-34|been|drug
DDI-DrugBank.d138.s3|36-43|reported|drug
DDI-DrugBank.d138.s3|45-46|to|drug
DDI-DrugBank.d138.s3|48-52|blunt|drug
DDI-DrugBank.d138.s3|54-56|the|drug
DDI-DrugBank.d138.s3|58-68|hypotensive|drug
DDI-DrugBank.d138.s3|70-75|effect|drug
DDI-DrugBank.d138.s3|77-78|of|drug
DDI-DrugBank.d138.s3|80-87|systemic|drug
DDI-DrugBank.d138.s3|89-100|clonidine.It|drug
DDI-DrugBank.d138.s3|102-103|is|drug
DDI-DrugBank.d138.s3|105-107|not|drug
DDI-DrugBank.d138.s3|109-113|known|drug
DDI-DrugBank.d138.s3|115-121|whether|drug
DDI-DrugBank.d138.s3|123-125|the|drug
DDI-DrugBank.d138.s3|127-136|concurrent|drug
DDI-DrugBank.d138.s3|138-140|use|drug
DDI-DrugBank.d138.s3|142-143|of|drug
DDI-DrugBank.d138.s3|145-149|these|drug
DDI-DrugBank.d138.s3|151-156|agents|drug
DDI-DrugBank.d138.s3|158-161|with|drug
DDI-DrugBank.d138.s3|163-170|ALPHAGAN|drug
DDI-DrugBank.d138.s3|172-172|P|drug
DDI-DrugBank.d138.s3|174-175|in|drug
DDI-DrugBank.d138.s3|177-182|humans|drug
DDI-DrugBank.d138.s3|184-186|can|drug
DDI-DrugBank.d138.s3|188-191|lead|drug
DDI-DrugBank.d138.s3|193-194|to|drug
DDI-DrugBank.d138.s3|196-204|resulting|drug
DDI-DrugBank.d138.s3|206-217|interference|drug
DDI-DrugBank.d138.s3|219-222|with|drug
DDI-DrugBank.d138.s3|224-226|the|drug
DDI-DrugBank.d138.s3|228-230|IOP|drug
DDI-DrugBank.d138.s3|232-239|lowering|drug
DDI-DrugBank.d138.s3|241-246|effect|drug
DDI-DrugBank.d138.s3|247-247|.|drug
DDI-DrugBank.d138.s4|0-1|No|drug
DDI-DrugBank.d138.s4|3-6|data|drug
DDI-DrugBank.d138.s4|8-9|on|drug
DDI-DrugBank.d138.s4|11-13|the|drug
DDI-DrugBank.d138.s4|15-19|level|drug
DDI-DrugBank.d138.s4|21-22|of|drug
DDI-DrugBank.d138.s4|24-34|circulating|drug
DDI-DrugBank.d138.s4|36-49|catecholamines|drug
DDI-DrugBank.d138.s4|51-55|after|drug
DDI-DrugBank.d138.s4|57-64|ALPHAGAN|drug
DDI-DrugBank.d138.s4|66-66|P|drug
DDI-DrugBank.d138.s4|68-81|administration|drug
DDI-DrugBank.d138.s4|83-85|are|drug
DDI-DrugBank.d138.s4|87-95|available|drug
DDI-DrugBank.d138.s4|96-96|.|drug
DDI-DrugBank.d138.s5|0-6|Caution|drug
DDI-DrugBank.d138.s5|7-7|,|drug
DDI-DrugBank.d138.s5|9-15|however|drug
DDI-DrugBank.d138.s5|16-16|,|drug
DDI-DrugBank.d138.s5|18-19|is|drug
DDI-DrugBank.d138.s5|21-27|advised|drug
DDI-DrugBank.d138.s5|29-30|in|drug
DDI-DrugBank.d138.s5|32-39|patients|drug
DDI-DrugBank.d138.s5|41-46|taking|drug
DDI-DrugBank.d138.s5|48-56|tricyclic|drug
DDI-DrugBank.d138.s5|58-72|antidepressants|drug
DDI-DrugBank.d138.s5|74-78|which|drug
DDI-DrugBank.d138.s5|80-82|can|drug
DDI-DrugBank.d138.s5|84-89|affect|drug
DDI-DrugBank.d138.s5|91-93|the|drug
DDI-DrugBank.d138.s5|95-104|metabolism|drug
DDI-DrugBank.d138.s5|106-108|and|drug
DDI-DrugBank.d138.s5|110-115|uptake|drug
DDI-DrugBank.d138.s5|117-118|of|drug
DDI-DrugBank.d138.s5|120-130|circulating|drug
DDI-DrugBank.d138.s5|132-137|amines|drug
DDI-DrugBank.d138.s5|138-138|.|drug
DDI-DrugBank.d553.s0|0-3|Drug|drug
DDI-DrugBank.d553.s0|5-14|Laboratory|drug
DDI-DrugBank.d553.s0|16-19|Test|drug
DDI-DrugBank.d553.s0|21-32|Interactions|drug
DDI-DrugBank.d553.s0|33-33|:|drug
DDI-DrugBank.d553.s0|35-46|Prolongation|drug
DDI-DrugBank.d553.s0|48-49|of|drug
DDI-DrugBank.d553.s0|51-53|the|drug
DDI-DrugBank.d553.s0|55-62|template|drug
DDI-DrugBank.d553.s0|64-71|bleeding|drug
DDI-DrugBank.d553.s0|73-76|time|drug
DDI-DrugBank.d553.s0|78-80|has|drug
DDI-DrugBank.d553.s0|82-85|been|drug
DDI-DrugBank.d553.s0|87-94|reported|drug
DDI-DrugBank.d553.s0|96-101|during|drug
DDI-DrugBank.d553.s0|103-112|continuous|drug
DDI-DrugBank.d553.s0|114-124|intravenous|drug
DDI-DrugBank.d553.s0|126-133|infusion|drug
DDI-DrugBank.d553.s0|135-136|of|drug
DDI-DrugBank.d553.s0|138-143|AMICAR|drug
DDI-DrugBank.d553.s0|145-146|at|drug
DDI-DrugBank.d553.s0|148-154|dosages|drug
DDI-DrugBank.d553.s0|156-164|exceeding|drug
DDI-DrugBank.d553.s0|166-167|24|drug
DDI-DrugBank.d553.s0|169-173|g/day|drug
DDI-DrugBank.d553.s0|174-174|.|drug
DDI-DrugBank.d553.s1|0-7|Platelet|drug
DDI-DrugBank.d553.s1|9-16|function|drug
DDI-DrugBank.d553.s1|18-24|studies|drug
DDI-DrugBank.d553.s1|26-27|in|drug
DDI-DrugBank.d553.s1|29-33|these|drug
DDI-DrugBank.d553.s1|35-42|patients|drug
DDI-DrugBank.d553.s1|44-47|have|drug
DDI-DrugBank.d553.s1|49-51|not|drug
DDI-DrugBank.d553.s1|53-64|demonstrated|drug
DDI-DrugBank.d553.s1|66-68|any|drug
DDI-DrugBank.d553.s1|70-80|significant|drug
DDI-DrugBank.d553.s1|82-89|platelet|drug
DDI-DrugBank.d553.s1|91-101|dysfunction|drug
DDI-DrugBank.d553.s1|102-102|.|drug
DDI-DrugBank.d553.s2|0-6|However|drug
DDI-DrugBank.d553.s2|7-7|,|drug
DDI-DrugBank.d553.s2|9-10|in|drug
DDI-DrugBank.d553.s2|12-16|vitro|drug
DDI-DrugBank.d553.s2|18-24|studies|drug
DDI-DrugBank.d553.s2|26-29|have|drug
DDI-DrugBank.d553.s2|31-35|shown|drug
DDI-DrugBank.d553.s2|37-40|that|drug
DDI-DrugBank.d553.s2|42-43|at|drug
DDI-DrugBank.d553.s2|45-48|high|drug
DDI-DrugBank.d553.s2|50-63|concentrations|drug
DDI-DrugBank.d553.s2|65-65|(|drug
DDI-DrugBank.d553.s2|66-68|7.4|drug
DDI-DrugBank.d553.s2|70-75|mMol/L|drug
DDI-DrugBank.d553.s2|77-78|or|drug
DDI-DrugBank.d553.s2|80-83|0.97|drug
DDI-DrugBank.d553.s2|85-89|mg/mL|drug
DDI-DrugBank.d553.s2|91-93|and|drug
DDI-DrugBank.d553.s2|95-101|greater|drug
DDI-DrugBank.d553.s2|102-102|)|drug
DDI-DrugBank.d553.s2|104-107|EACA|drug
DDI-DrugBank.d553.s2|109-116|inhibits|drug
DDI-DrugBank.d553.s2|118-120|ADP|drug
DDI-DrugBank.d553.s2|122-124|and|drug
DDI-DrugBank.d553.s2|126-141|collagen-induced|drug
DDI-DrugBank.d553.s2|143-150|platelet|drug
DDI-DrugBank.d553.s2|152-162|aggregation|drug
DDI-DrugBank.d553.s2|163-163|,|drug
DDI-DrugBank.d553.s2|165-167|the|drug
DDI-DrugBank.d553.s2|169-175|release|drug
DDI-DrugBank.d553.s2|177-178|of|drug
DDI-DrugBank.d553.s2|180-182|ATP|drug
DDI-DrugBank.d553.s2|184-186|and|drug
DDI-DrugBank.d553.s2|188-196|serotonin|drug
DDI-DrugBank.d553.s2|197-197|,|drug
DDI-DrugBank.d553.s2|199-201|and|drug
DDI-DrugBank.d553.s2|203-205|the|drug
DDI-DrugBank.d553.s2|207-213|binding|drug
DDI-DrugBank.d553.s2|215-216|of|drug
DDI-DrugBank.d553.s2|218-227|fibrinogen|drug
DDI-DrugBank.d553.s2|229-230|to|drug
DDI-DrugBank.d553.s2|232-234|the|drug
DDI-DrugBank.d553.s2|236-244|platelets|drug
DDI-DrugBank.d553.s2|246-247|in|drug
DDI-DrugBank.d553.s2|249-249|a|drug
DDI-DrugBank.d553.s2|251-272|concentration-response|drug
DDI-DrugBank.d553.s2|274-279|manner|drug
DDI-DrugBank.d553.s2|280-280|.|drug
DDI-DrugBank.d553.s3|0-8|Following|drug
DDI-DrugBank.d553.s3|10-10|a|drug
DDI-DrugBank.d553.s3|12-13|10|drug
DDI-DrugBank.d553.s3|15-15|g|drug
DDI-DrugBank.d553.s3|17-21|bolus|drug
DDI-DrugBank.d553.s3|23-24|of|drug
DDI-DrugBank.d553.s3|26-31|AMICAR|drug
DDI-DrugBank.d553.s3|32-32|,|drug
DDI-DrugBank.d553.s3|34-42|transient|drug
DDI-DrugBank.d553.s3|44-47|peak|drug
DDI-DrugBank.d553.s3|49-54|plasma|drug
DDI-DrugBank.d553.s3|56-69|concentrations|drug
DDI-DrugBank.d553.s3|71-72|of|drug
DDI-DrugBank.d553.s3|74-76|4.6|drug
DDI-DrugBank.d553.s3|78-83|mMol/L|drug
DDI-DrugBank.d553.s3|85-86|or|drug
DDI-DrugBank.d553.s3|88-91|0.60|drug
DDI-DrugBank.d553.s3|93-97|mg/mL|drug
DDI-DrugBank.d553.s3|99-102|have|drug
DDI-DrugBank.d553.s3|104-107|been|drug
DDI-DrugBank.d553.s3|109-116|obtained|drug
DDI-DrugBank.d553.s3|117-117|.|drug
DDI-DrugBank.d553.s4|0-2|The|drug
DDI-DrugBank.d553.s4|4-16|concentration|drug
DDI-DrugBank.d553.s4|18-19|of|drug
DDI-DrugBank.d553.s4|21-26|AMICAR|drug
DDI-DrugBank.d553.s4|28-36|necessary|drug
DDI-DrugBank.d553.s4|38-39|to|drug
DDI-DrugBank.d553.s4|41-48|maintain|drug
DDI-DrugBank.d553.s4|50-59|inhibition|drug
DDI-DrugBank.d553.s4|61-62|of|drug
DDI-DrugBank.d553.s4|64-75|fibrinolysis|drug
DDI-DrugBank.d553.s4|77-78|is|drug
DDI-DrugBank.d553.s4|80-83|0.99|drug
DDI-DrugBank.d553.s4|85-90|mMol/L|drug
DDI-DrugBank.d553.s4|92-93|or|drug
DDI-DrugBank.d553.s4|95-98|0.13|drug
DDI-DrugBank.d553.s4|100-104|mg/mL|drug
DDI-DrugBank.d553.s4|105-105|.|drug
DDI-DrugBank.d553.s5|0-13|Administration|drug
DDI-DrugBank.d553.s5|15-16|of|drug
DDI-DrugBank.d553.s5|18-18|a|drug
DDI-DrugBank.d553.s5|20-20|5|drug
DDI-DrugBank.d553.s5|22-22|g|drug
DDI-DrugBank.d553.s5|24-28|bolus|drug
DDI-DrugBank.d553.s5|30-37|followed|drug
DDI-DrugBank.d553.s5|39-40|by|drug
DDI-DrugBank.d553.s5|42-42|1|drug
DDI-DrugBank.d553.s5|44-45|to|drug
DDI-DrugBank.d553.s5|47-50|1.25|drug
DDI-DrugBank.d553.s5|52-55|g/hr|drug
DDI-DrugBank.d553.s5|57-62|should|drug
DDI-DrugBank.d553.s5|64-70|achieve|drug
DDI-DrugBank.d553.s5|72-74|and|drug
DDI-DrugBank.d553.s5|76-82|sustain|drug
DDI-DrugBank.d553.s5|84-89|plasma|drug
DDI-DrugBank.d553.s5|91-96|levels|drug
DDI-DrugBank.d553.s5|98-99|of|drug
DDI-DrugBank.d553.s5|101-104|0.13|drug
DDI-DrugBank.d553.s5|106-110|mg/mL|drug
DDI-DrugBank.d553.s5|111-111|.|drug
DDI-DrugBank.d553.s6|0-3|Thus|drug
DDI-DrugBank.d553.s6|4-4|,|drug
DDI-DrugBank.d553.s6|6-19|concentrations|drug
DDI-DrugBank.d553.s6|21-25|which|drug
DDI-DrugBank.d553.s6|27-30|have|drug
DDI-DrugBank.d553.s6|32-35|been|drug
DDI-DrugBank.d553.s6|37-44|obtained|drug
DDI-DrugBank.d553.s6|46-47|in|drug
DDI-DrugBank.d553.s6|49-52|vivo|drug
DDI-DrugBank.d553.s6|54-63|clinically|drug
DDI-DrugBank.d553.s6|65-66|in|drug
DDI-DrugBank.d553.s6|68-75|patients|drug
DDI-DrugBank.d553.s6|77-80|with|drug
DDI-DrugBank.d553.s6|82-87|normal|drug
DDI-DrugBank.d553.s6|89-93|renal|drug
DDI-DrugBank.d553.s6|95-102|function|drug
DDI-DrugBank.d553.s6|104-106|are|drug
DDI-DrugBank.d553.s6|108-119|considerably|drug
DDI-DrugBank.d553.s6|121-125|lower|drug
DDI-DrugBank.d553.s6|127-130|than|drug
DDI-DrugBank.d553.s6|132-134|the|drug
DDI-DrugBank.d553.s6|136-137|in|drug
DDI-DrugBank.d553.s6|139-143|vitro|drug
DDI-DrugBank.d553.s6|145-158|concentrations|drug
DDI-DrugBank.d553.s6|160-164|found|drug
DDI-DrugBank.d553.s6|166-167|to|drug
DDI-DrugBank.d553.s6|169-174|induce|drug
DDI-DrugBank.d553.s6|176-188|abnormalities|drug
DDI-DrugBank.d553.s6|190-191|in|drug
DDI-DrugBank.d553.s6|193-200|platelet|drug
DDI-DrugBank.d553.s6|202-209|function|drug
DDI-DrugBank.d553.s6|211-215|tests|drug
DDI-DrugBank.d553.s6|216-216|.|drug
DDI-DrugBank.d553.s7|0-6|However|drug
DDI-DrugBank.d553.s7|7-7|,|drug
DDI-DrugBank.d553.s7|9-14|higher|drug
DDI-DrugBank.d553.s7|16-21|plasma|drug
DDI-DrugBank.d553.s7|23-36|concentrations|drug
DDI-DrugBank.d553.s7|38-39|of|drug
DDI-DrugBank.d553.s7|41-46|AMICAR|drug
DDI-DrugBank.d553.s7|48-50|may|drug
DDI-DrugBank.d553.s7|52-56|occur|drug
DDI-DrugBank.d553.s7|58-59|in|drug
DDI-DrugBank.d553.s7|61-68|patients|drug
DDI-DrugBank.d553.s7|70-73|with|drug
DDI-DrugBank.d553.s7|75-80|severe|drug
DDI-DrugBank.d553.s7|82-86|renal|drug
DDI-DrugBank.d553.s7|88-94|failure|drug
DDI-DrugBank.d553.s7|95-95|.|drug
DDI-DrugBank.d194.s0|0-6|Caution|drug
DDI-DrugBank.d194.s0|8-13|should|drug
DDI-DrugBank.d194.s0|15-16|be|drug
DDI-DrugBank.d194.s0|18-26|exercised|drug
DDI-DrugBank.d194.s0|28-31|when|drug
DDI-DrugBank.d194.s0|33-45|administering|drug
DDI-DrugBank.d194.s0|47-55|ETOPOPHOS|drug
DDI-DrugBank.d194.s0|57-60|with|drug
DDI-DrugBank.d194.s0|62-66|drugs|drug
DDI-DrugBank.d194.s0|68-71|that|drug
DDI-DrugBank.d194.s0|73-75|are|drug
DDI-DrugBank.d194.s0|77-81|known|drug
DDI-DrugBank.d194.s0|83-84|to|drug
DDI-DrugBank.d194.s0|86-92|inhibit|drug
DDI-DrugBank.d194.s0|94-104|phosphatase|drug
DDI-DrugBank.d194.s0|106-115|activities|drug
DDI-DrugBank.d194.s0|117-117|(|drug
DDI-DrugBank.d194.s0|118-121|e.g.|drug
DDI-DrugBank.d194.s0|122-122|,|drug
DDI-DrugBank.d194.s0|124-133|levamisole|drug
DDI-DrugBank.d194.s0|135-147|hydrochloride|drug
DDI-DrugBank.d194.s0|148-148|)|drug
DDI-DrugBank.d194.s0|149-149|.|drug
DDI-DrugBank.d194.s1|0-8|High-dose|drug
DDI-DrugBank.d194.s1|10-20|cyclosporin|drug
DDI-DrugBank.d194.s1|22-22|A|drug
DDI-DrugBank.d194.s1|24-32|resulting|drug
DDI-DrugBank.d194.s1|34-35|in|drug
DDI-DrugBank.d194.s1|37-50|concentrations|drug
DDI-DrugBank.d194.s1|52-56|above|drug
DDI-DrugBank.d194.s1|58-61|2000|drug
DDI-DrugBank.d194.s1|63-67|ng/mL|drug
DDI-DrugBank.d194.s1|69-80|administered|drug
DDI-DrugBank.d194.s1|82-85|with|drug
DDI-DrugBank.d194.s1|87-90|oral|drug
DDI-DrugBank.d194.s1|92-100|etoposide|drug
DDI-DrugBank.d194.s1|102-104|has|drug
DDI-DrugBank.d194.s1|106-108|led|drug
DDI-DrugBank.d194.s1|110-111|to|drug
DDI-DrugBank.d194.s1|113-114|an|drug
DDI-DrugBank.d194.s1|116-117|80|drug
DDI-DrugBank.d194.s1|118-118|%|drug
DDI-DrugBank.d194.s1|120-127|increase|drug
DDI-DrugBank.d194.s1|129-130|in|drug
DDI-DrugBank.d194.s1|132-140|etoposide|drug
DDI-DrugBank.d194.s1|142-149|exposure|drug
DDI-DrugBank.d194.s1|151-154|with|drug
DDI-DrugBank.d194.s1|156-156|a|drug
DDI-DrugBank.d194.s1|158-159|38|drug
DDI-DrugBank.d194.s1|160-160|%|drug
DDI-DrugBank.d194.s1|162-169|decrease|drug
DDI-DrugBank.d194.s1|171-172|in|drug
DDI-DrugBank.d194.s1|174-178|total|drug
DDI-DrugBank.d194.s1|180-183|body|drug
DDI-DrugBank.d194.s1|185-193|clearance|drug
DDI-DrugBank.d194.s1|195-196|of|drug
DDI-DrugBank.d194.s1|198-206|etoposide|drug
DDI-DrugBank.d194.s1|208-215|compared|drug
DDI-DrugBank.d194.s1|217-218|to|drug
DDI-DrugBank.d194.s1|220-228|etoposide|drug
DDI-DrugBank.d194.s1|230-234|alone|drug
DDI-DrugBank.d194.s1|235-235|.|drug
DDI-DrugBank.d136.s0|0-6|Alcohol|drug
DDI-DrugBank.d136.s0|8-8|(|drug
DDI-DrugBank.d136.s0|9-17|increases|drug
DDI-DrugBank.d136.s0|19-33|bioavailability|drug
DDI-DrugBank.d136.s0|35-36|by|drug
DDI-DrugBank.d136.s0|38-39|50|drug
DDI-DrugBank.d136.s0|40-40|%|drug
DDI-DrugBank.d136.s0|41-41|)|drug
DDI-DrugBank.d136.s0|42-42|,|drug
DDI-DrugBank.d136.s0|44-53|cimetidine|drug
DDI-DrugBank.d136.s0|54-54|,|drug
DDI-DrugBank.d136.s0|56-58|and|drug
DDI-DrugBank.d136.s0|60-69|valproates|drug
DDI-DrugBank.d136.s0|70-70|.|drug
DDI-DrugBank.d293.s0|0-2|May|drug
DDI-DrugBank.d293.s0|4-11|interact|drug
DDI-DrugBank.d293.s0|13-16|with|drug
DDI-DrugBank.d293.s0|18-24|thyroid|drug
DDI-DrugBank.d293.s0|26-35|medication|drug
DDI-DrugBank.d293.s0|37-37|(|drug
DDI-DrugBank.d293.s0|38-41|e.g.|drug
DDI-DrugBank.d293.s0|42-42|,|drug
DDI-DrugBank.d293.s0|44-56|levothyroxine|drug
DDI-DrugBank.d293.s0|57-57|)|drug
DDI-DrugBank.d293.s0|58-58|,|drug
DDI-DrugBank.d293.s0|60-76|iodine-containing|drug
DDI-DrugBank.d293.s0|78-85|products|drug
DDI-DrugBank.d293.s0|86-86|,|drug
DDI-DrugBank.d293.s0|88-95|antacids|drug
DDI-DrugBank.d293.s0|96-96|,|drug
DDI-DrugBank.d293.s0|98-111|H2-antagonists|drug
DDI-DrugBank.d293.s0|113-113|(|drug
DDI-DrugBank.d293.s0|114-117|e.g.|drug
DDI-DrugBank.d293.s0|118-118|,|drug
DDI-DrugBank.d293.s0|120-129|famotidine|drug
DDI-DrugBank.d293.s0|130-130|,|drug
DDI-DrugBank.d293.s0|132-141|ranitidine|drug
DDI-DrugBank.d293.s0|142-142|)|drug
DDI-DrugBank.d293.s0|143-143|,|drug
DDI-DrugBank.d293.s0|145-147|and|drug
DDI-DrugBank.d293.s0|149-154|proton|drug
DDI-DrugBank.d293.s0|156-159|pump|drug
DDI-DrugBank.d293.s0|161-170|inhibitors|drug
DDI-DrugBank.d293.s0|172-172|(|drug
DDI-DrugBank.d293.s0|173-176|e.g.|drug
DDI-DrugBank.d293.s0|177-177|,|drug
DDI-DrugBank.d293.s0|179-190|lansoprazole|drug
DDI-DrugBank.d293.s0|191-191|,|drug
DDI-DrugBank.d293.s0|193-202|omeprazole|drug
DDI-DrugBank.d293.s0|203-203|)|drug
DDI-DrugBank.d293.s0|204-204|.|drug
DDI-DrugBank.d293.s1|0-3|This|drug
DDI-DrugBank.d293.s1|5-11|product|drug
DDI-DrugBank.d293.s1|13-15|can|drug
DDI-DrugBank.d293.s1|17-22|affect|drug
DDI-DrugBank.d293.s1|24-26|the|drug
DDI-DrugBank.d293.s1|28-34|results|drug
DDI-DrugBank.d293.s1|36-37|of|drug
DDI-DrugBank.d293.s1|39-45|certain|drug
DDI-DrugBank.d293.s1|47-49|lab|drug
DDI-DrugBank.d293.s1|51-55|tests|drug
DDI-DrugBank.d293.s1|56-56|.|drug
DDI-DrugBank.d485.s0|0-6|Ethinyl|drug
DDI-DrugBank.d485.s0|8-16|estradiol|drug
DDI-DrugBank.d485.s0|17-17|:|drug
DDI-DrugBank.d485.s0|19-27|Substrate|drug
DDI-DrugBank.d485.s0|29-30|of|drug
DDI-DrugBank.d485.s0|32-37|CYP3A4|drug
DDI-DrugBank.d485.s0|39-39|(|drug
DDI-DrugBank.d485.s0|40-44|major|drug
DDI-DrugBank.d485.s0|45-45|)|drug
DDI-DrugBank.d485.s0|46-46|,|drug
DDI-DrugBank.d485.s0|48-52|3A5-7|drug
DDI-DrugBank.d485.s0|54-54|(|drug
DDI-DrugBank.d485.s0|55-59|minor|drug
DDI-DrugBank.d485.s0|60-60|)|drug
DDI-DrugBank.d485.s0|61-61|;|drug
DDI-DrugBank.d485.s1|0-7|Inhibits|drug
DDI-DrugBank.d485.s1|9-14|CYP1A2|drug
DDI-DrugBank.d485.s1|16-16|(|drug
DDI-DrugBank.d485.s1|17-20|weak|drug
DDI-DrugBank.d485.s1|21-21|)|drug
DDI-DrugBank.d485.s1|22-22|,|drug
DDI-DrugBank.d485.s1|24-26|2B6|drug
DDI-DrugBank.d485.s1|28-28|(|drug
DDI-DrugBank.d485.s1|29-32|weak|drug
DDI-DrugBank.d485.s1|33-33|)|drug
DDI-DrugBank.d485.s1|34-34|,|drug
DDI-DrugBank.d485.s1|36-39|2C19|drug
DDI-DrugBank.d485.s1|41-41|(|drug
DDI-DrugBank.d485.s1|42-45|weak|drug
DDI-DrugBank.d485.s1|46-46|)|drug
DDI-DrugBank.d485.s1|47-47|,|drug
DDI-DrugBank.d485.s1|49-51|3A4|drug
DDI-DrugBank.d485.s1|53-53|(|drug
DDI-DrugBank.d485.s1|54-57|weak|drug
DDI-DrugBank.d485.s1|58-58|)|drug
DDI-DrugBank.d485.s1|59-59|.|drug
DDI-DrugBank.d485.s2|0-12|Acetaminophen|drug
DDI-DrugBank.d485.s2|13-13|:|drug
DDI-DrugBank.d485.s2|15-17|May|drug
DDI-DrugBank.d485.s2|19-26|increase|drug
DDI-DrugBank.d485.s2|28-33|plasma|drug
DDI-DrugBank.d485.s2|35-47|concentration|drug
DDI-DrugBank.d485.s2|49-50|of|drug
DDI-DrugBank.d485.s2|52-60|synthetic|drug
DDI-DrugBank.d485.s2|62-70|estrogens|drug
DDI-DrugBank.d485.s2|71-71|,|drug
DDI-DrugBank.d485.s2|73-80|possibly|drug
DDI-DrugBank.d485.s2|82-83|by|drug
DDI-DrugBank.d485.s2|85-94|inhibiting|drug
DDI-DrugBank.d485.s2|96-106|conjugation|drug
DDI-DrugBank.d485.s2|107-107|.|drug
DDI-DrugBank.d485.s3|0-10|Combination|drug
DDI-DrugBank.d485.s3|12-19|hormonal|drug
DDI-DrugBank.d485.s3|21-34|contraceptives|drug
DDI-DrugBank.d485.s3|36-38|may|drug
DDI-DrugBank.d485.s3|40-43|also|drug
DDI-DrugBank.d485.s3|45-52|decrease|drug
DDI-DrugBank.d485.s3|54-56|the|drug
DDI-DrugBank.d485.s3|58-63|plasma|drug
DDI-DrugBank.d485.s3|65-77|concentration|drug
DDI-DrugBank.d485.s3|79-80|of|drug
DDI-DrugBank.d485.s3|82-94|acetaminophen|drug
DDI-DrugBank.d485.s3|95-95|.|drug
DDI-DrugBank.d485.s4|0-8|Acitretin|drug
DDI-DrugBank.d485.s4|9-9|:|drug
DDI-DrugBank.d485.s4|11-20|Interferes|drug
DDI-DrugBank.d485.s4|22-25|with|drug
DDI-DrugBank.d485.s4|27-29|the|drug
DDI-DrugBank.d485.s4|31-43|contraceptive|drug
DDI-DrugBank.d485.s4|45-50|effect|drug
DDI-DrugBank.d485.s4|52-53|of|drug
DDI-DrugBank.d485.s4|55-64|microdosed|drug
DDI-DrugBank.d485.s4|66-85|progestin-containing|drug
DDI-DrugBank.d485.s4|87-94|minipill|drug
DDI-DrugBank.d485.s4|96-107|preparations|drug
DDI-DrugBank.d485.s4|108-108|.|drug
DDI-DrugBank.d485.s5|0-2|The|drug
DDI-DrugBank.d485.s5|4-9|effect|drug
DDI-DrugBank.d485.s5|11-12|on|drug
DDI-DrugBank.d485.s5|14-18|other|drug
DDI-DrugBank.d485.s5|20-33|progestational|drug
DDI-DrugBank.d485.s5|35-48|contraceptives|drug
DDI-DrugBank.d485.s5|50-50|(|drug
DDI-DrugBank.d485.s5|51-52|eg|drug
DDI-DrugBank.d485.s5|53-53|,|drug
DDI-DrugBank.d485.s5|55-62|implants|drug
DDI-DrugBank.d485.s5|63-63|,|drug
DDI-DrugBank.d485.s5|65-75|injectables|drug
DDI-DrugBank.d485.s5|76-76|)|drug
DDI-DrugBank.d485.s5|78-79|is|drug
DDI-DrugBank.d485.s5|81-87|unknown|drug
DDI-DrugBank.d485.s5|88-88|.|drug
DDI-DrugBank.d485.s6|0-16|Aminoglutethimide|drug
DDI-DrugBank.d485.s6|17-17|:|drug
DDI-DrugBank.d485.s6|19-21|May|drug
DDI-DrugBank.d485.s6|23-30|increase|drug
DDI-DrugBank.d485.s6|32-34|CYP|drug
DDI-DrugBank.d485.s6|36-45|metabolism|drug
DDI-DrugBank.d485.s6|47-48|of|drug
DDI-DrugBank.d485.s6|50-59|progestins|drug
DDI-DrugBank.d485.s6|61-67|leading|drug
DDI-DrugBank.d485.s6|69-70|to|drug
DDI-DrugBank.d485.s6|72-79|possible|drug
DDI-DrugBank.d485.s6|81-88|decrease|drug
DDI-DrugBank.d485.s6|90-91|in|drug
DDI-DrugBank.d485.s6|93-105|contraceptive|drug
DDI-DrugBank.d485.s6|107-119|effectiveness|drug
DDI-DrugBank.d485.s6|120-120|.|drug
DDI-DrugBank.d485.s7|0-2|Use|drug
DDI-DrugBank.d485.s7|4-5|of|drug
DDI-DrugBank.d485.s7|7-7|a|drug
DDI-DrugBank.d485.s7|9-19|nonhormonal|drug
DDI-DrugBank.d485.s7|21-33|contraceptive|drug
DDI-DrugBank.d485.s7|35-41|product|drug
DDI-DrugBank.d485.s7|43-44|is|drug
DDI-DrugBank.d485.s7|46-56|recommended|drug
DDI-DrugBank.d485.s7|57-57|.|drug
DDI-DrugBank.d485.s8|0-10|Antibiotics|drug
DDI-DrugBank.d485.s8|12-12|(|drug
DDI-DrugBank.d485.s8|13-22|ampicillin|drug
DDI-DrugBank.d485.s8|23-23|,|drug
DDI-DrugBank.d485.s8|25-36|tetracycline|drug
DDI-DrugBank.d485.s8|37-37|)|drug
DDI-DrugBank.d485.s8|38-38|:|drug
DDI-DrugBank.d485.s8|40-48|Pregnancy|drug
DDI-DrugBank.d485.s8|50-52|has|drug
DDI-DrugBank.d485.s8|54-57|been|drug
DDI-DrugBank.d485.s8|59-66|reported|drug
DDI-DrugBank.d485.s8|68-76|following|drug
DDI-DrugBank.d485.s8|78-88|concomitant|drug
DDI-DrugBank.d485.s8|90-92|use|drug
DDI-DrugBank.d485.s8|93-93|,|drug
DDI-DrugBank.d485.s8|95-101|however|drug
DDI-DrugBank.d485.s8|102-102|,|drug
DDI-DrugBank.d485.s8|104-118|pharmacokinetic|drug
DDI-DrugBank.d485.s8|120-126|studies|drug
DDI-DrugBank.d485.s8|128-131|have|drug
DDI-DrugBank.d485.s8|133-135|not|drug
DDI-DrugBank.d485.s8|137-141|shown|drug
DDI-DrugBank.d485.s8|143-152|consistent|drug
DDI-DrugBank.d485.s8|154-160|effects|drug
DDI-DrugBank.d485.s8|162-165|with|drug
DDI-DrugBank.d485.s8|167-171|these|drug
DDI-DrugBank.d485.s8|173-183|antibiotics|drug
DDI-DrugBank.d485.s8|185-186|on|drug
DDI-DrugBank.d485.s8|188-193|plasma|drug
DDI-DrugBank.d485.s8|195-208|concentrations|drug
DDI-DrugBank.d485.s8|210-211|of|drug
DDI-DrugBank.d485.s8|213-221|synthetic|drug
DDI-DrugBank.d485.s8|223-230|steroids|drug
DDI-DrugBank.d485.s8|231-231|.|drug
DDI-DrugBank.d485.s9|0-2|Use|drug
DDI-DrugBank.d485.s9|4-5|of|drug
DDI-DrugBank.d485.s9|7-7|a|drug
DDI-DrugBank.d485.s9|9-19|nonhormonal|drug
DDI-DrugBank.d485.s9|21-33|contraceptive|drug
DDI-DrugBank.d485.s9|35-41|product|drug
DDI-DrugBank.d485.s9|43-44|is|drug
DDI-DrugBank.d485.s9|46-56|recommended|drug
DDI-DrugBank.d485.s9|57-57|.|drug
DDI-DrugBank.d485.s10|0-13|Anticoagulants|drug
DDI-DrugBank.d485.s10|14-14|:|drug
DDI-DrugBank.d485.s10|16-26|Combination|drug
DDI-DrugBank.d485.s10|28-35|hormonal|drug
DDI-DrugBank.d485.s10|37-50|contraceptives|drug
DDI-DrugBank.d485.s10|52-54|may|drug
DDI-DrugBank.d485.s10|56-63|increase|drug
DDI-DrugBank.d485.s10|65-66|or|drug
DDI-DrugBank.d485.s10|68-75|decrease|drug
DDI-DrugBank.d485.s10|77-79|the|drug
DDI-DrugBank.d485.s10|81-87|effects|drug
DDI-DrugBank.d485.s10|89-90|of|drug
DDI-DrugBank.d485.s10|92-99|coumarin|drug
DDI-DrugBank.d485.s10|101-111|derivatives|drug
DDI-DrugBank.d485.s10|112-112|.|drug
DDI-DrugBank.d485.s11|0-10|Combination|drug
DDI-DrugBank.d485.s11|12-19|hormonal|drug
DDI-DrugBank.d485.s11|21-34|contraceptives|drug
DDI-DrugBank.d485.s11|36-38|may|drug
DDI-DrugBank.d485.s11|40-43|also|drug
DDI-DrugBank.d485.s11|45-52|increase|drug
DDI-DrugBank.d485.s11|54-57|risk|drug
DDI-DrugBank.d485.s11|59-60|of|drug
DDI-DrugBank.d485.s11|62-75|thromboembolic|drug
DDI-DrugBank.d485.s11|77-85|disorders|drug
DDI-DrugBank.d485.s11|86-86|.|drug
DDI-DrugBank.d485.s12|0-14|Anticonvulsants|drug
DDI-DrugBank.d485.s12|16-16|(|drug
DDI-DrugBank.d485.s12|17-29|carbamazepine|drug
DDI-DrugBank.d485.s12|30-30|,|drug
DDI-DrugBank.d485.s12|32-40|felbamate|drug
DDI-DrugBank.d485.s12|41-41|,|drug
DDI-DrugBank.d485.s12|43-55|phenobarbital|drug
DDI-DrugBank.d485.s12|56-56|,|drug
DDI-DrugBank.d485.s12|58-66|phenytoin|drug
DDI-DrugBank.d485.s12|67-67|,|drug
DDI-DrugBank.d485.s12|69-78|topiramate|drug
DDI-DrugBank.d485.s12|79-79|)|drug
DDI-DrugBank.d485.s12|80-80|:|drug
DDI-DrugBank.d485.s12|82-89|Increase|drug
DDI-DrugBank.d485.s12|91-93|the|drug
DDI-DrugBank.d485.s12|95-104|metabolism|drug
DDI-DrugBank.d485.s12|106-107|of|drug
DDI-DrugBank.d485.s12|109-115|ethinyl|drug
DDI-DrugBank.d485.s12|117-125|estradiol|drug
DDI-DrugBank.d485.s12|127-132|and/or|drug
DDI-DrugBank.d485.s12|134-137|some|drug
DDI-DrugBank.d485.s12|139-148|progestins|drug
DDI-DrugBank.d485.s12|149-149|,|drug
DDI-DrugBank.d485.s12|151-157|leading|drug
DDI-DrugBank.d485.s12|159-160|to|drug
DDI-DrugBank.d485.s12|162-169|possible|drug
DDI-DrugBank.d485.s12|171-178|decrease|drug
DDI-DrugBank.d485.s12|180-181|in|drug
DDI-DrugBank.d485.s12|183-195|contraceptive|drug
DDI-DrugBank.d485.s12|197-209|effectiveness|drug
DDI-DrugBank.d485.s12|210-210|.|drug
DDI-DrugBank.d485.s13|0-2|Use|drug
DDI-DrugBank.d485.s13|4-5|of|drug
DDI-DrugBank.d485.s13|7-7|a|drug
DDI-DrugBank.d485.s13|9-19|nonhormonal|drug
DDI-DrugBank.d485.s13|21-33|contraceptive|drug
DDI-DrugBank.d485.s13|35-41|product|drug
DDI-DrugBank.d485.s13|43-44|is|drug
DDI-DrugBank.d485.s13|46-56|recommended|drug
DDI-DrugBank.d485.s13|57-57|.|drug
DDI-DrugBank.d485.s14|0-7|Ascorbic|drug
DDI-DrugBank.d485.s14|9-12|acid|drug
DDI-DrugBank.d485.s14|13-13|:|drug
DDI-DrugBank.d485.s14|15-19|Doses|drug
DDI-DrugBank.d485.s14|21-22|of|drug
DDI-DrugBank.d485.s14|24-31|ascorbic|drug
DDI-DrugBank.d485.s14|33-36|acid|drug
DDI-DrugBank.d485.s14|38-38|(|drug
DDI-DrugBank.d485.s14|39-45|vitamin|drug
DDI-DrugBank.d485.s14|47-47|C|drug
DDI-DrugBank.d485.s14|48-48|)|drug
DDI-DrugBank.d485.s14|50-50|1|drug
DDI-DrugBank.d485.s14|52-56|g/day|drug
DDI-DrugBank.d485.s14|58-61|have|drug
DDI-DrugBank.d485.s14|63-66|been|drug
DDI-DrugBank.d485.s14|68-75|reported|drug
DDI-DrugBank.d485.s14|77-78|to|drug
DDI-DrugBank.d485.s14|80-87|increase|drug
DDI-DrugBank.d485.s14|89-94|plasma|drug
DDI-DrugBank.d485.s14|96-108|concentration|drug
DDI-DrugBank.d485.s14|110-111|of|drug
DDI-DrugBank.d485.s14|113-121|synthetic|drug
DDI-DrugBank.d485.s14|123-131|estrogens|drug
DDI-DrugBank.d485.s14|133-134|by|drug
DDI-DrugBank.d485.s14|136-138|~47|drug
DDI-DrugBank.d485.s14|139-139|%|drug
DDI-DrugBank.d485.s14|140-140|,|drug
DDI-DrugBank.d485.s14|142-149|possibly|drug
DDI-DrugBank.d485.s14|151-152|by|drug
DDI-DrugBank.d485.s14|154-163|inhibiting|drug
DDI-DrugBank.d485.s14|165-175|conjugation|drug
DDI-DrugBank.d485.s14|176-176|;|drug
DDI-DrugBank.d485.s15|0-7|clinical|drug
DDI-DrugBank.d485.s15|9-20|implications|drug
DDI-DrugBank.d485.s15|22-24|are|drug
DDI-DrugBank.d485.s15|26-32|unclear|drug
DDI-DrugBank.d485.s15|33-33|.|drug
DDI-DrugBank.d485.s16|0-11|Atorvastatin|drug
DDI-DrugBank.d485.s16|12-12|:|drug
DDI-DrugBank.d485.s16|14-25|Atorvastatin|drug
DDI-DrugBank.d485.s16|27-35|increases|drug
DDI-DrugBank.d485.s16|37-39|the|drug
DDI-DrugBank.d485.s16|41-43|AUC|drug
DDI-DrugBank.d485.s16|45-47|for|drug
DDI-DrugBank.d485.s16|49-61|norethindrone|drug
DDI-DrugBank.d485.s16|63-65|and|drug
DDI-DrugBank.d485.s16|67-73|ethinyl|drug
DDI-DrugBank.d485.s16|75-83|estradiol|drug
DDI-DrugBank.d485.s16|84-84|.|drug
DDI-DrugBank.d485.s17|0-14|Benzodiazepines|drug
DDI-DrugBank.d485.s17|15-15|:|drug
DDI-DrugBank.d485.s17|17-27|Combination|drug
DDI-DrugBank.d485.s17|29-36|hormonal|drug
DDI-DrugBank.d485.s17|38-51|contraceptives|drug
DDI-DrugBank.d485.s17|53-55|may|drug
DDI-DrugBank.d485.s17|57-64|decrease|drug
DDI-DrugBank.d485.s17|66-68|the|drug
DDI-DrugBank.d485.s17|70-78|clearance|drug
DDI-DrugBank.d485.s17|80-81|of|drug
DDI-DrugBank.d485.s17|83-86|some|drug
DDI-DrugBank.d485.s17|88-102|benzodiazepines|drug
DDI-DrugBank.d485.s17|104-104|(|drug
DDI-DrugBank.d485.s17|105-114|alprazolam|drug
DDI-DrugBank.d485.s17|115-115|,|drug
DDI-DrugBank.d485.s17|117-132|chlordiazepoxide|drug
DDI-DrugBank.d485.s17|133-133|,|drug
DDI-DrugBank.d485.s17|135-142|diazepam|drug
DDI-DrugBank.d485.s17|143-143|)|drug
DDI-DrugBank.d485.s17|145-147|and|drug
DDI-DrugBank.d485.s17|149-156|increase|drug
DDI-DrugBank.d485.s17|158-160|the|drug
DDI-DrugBank.d485.s17|162-170|clearance|drug
DDI-DrugBank.d485.s17|172-173|of|drug
DDI-DrugBank.d485.s17|175-180|others|drug
DDI-DrugBank.d485.s17|182-182|(|drug
DDI-DrugBank.d485.s17|183-191|lorazepam|drug
DDI-DrugBank.d485.s17|192-192|,|drug
DDI-DrugBank.d485.s17|194-201|oxazepam|drug
DDI-DrugBank.d485.s17|202-202|,|drug
DDI-DrugBank.d485.s17|204-212|temazepam|drug
DDI-DrugBank.d485.s17|213-213|)|drug
DDI-DrugBank.d485.s17|214-214|.|drug
DDI-DrugBank.d485.s18|0-8|Clofibric|drug
DDI-DrugBank.d485.s18|10-13|acid|drug
DDI-DrugBank.d485.s18|14-14|:|drug
DDI-DrugBank.d485.s18|16-26|Combination|drug
DDI-DrugBank.d485.s18|28-35|hormonal|drug
DDI-DrugBank.d485.s18|37-50|contraceptives|drug
DDI-DrugBank.d485.s18|52-54|may|drug
DDI-DrugBank.d485.s18|56-63|increase|drug
DDI-DrugBank.d485.s18|65-67|the|drug
DDI-DrugBank.d485.s18|69-77|clearance|drug
DDI-DrugBank.d485.s18|79-80|of|drug
DDI-DrugBank.d485.s18|82-90|clofibric|drug
DDI-DrugBank.d485.s18|92-95|acid|drug
DDI-DrugBank.d485.s18|96-96|.|drug
DDI-DrugBank.d485.s19|0-11|Cyclosporine|drug
DDI-DrugBank.d485.s19|12-12|:|drug
DDI-DrugBank.d485.s19|14-24|Combination|drug
DDI-DrugBank.d485.s19|26-33|hormonal|drug
DDI-DrugBank.d485.s19|35-48|contraceptives|drug
DDI-DrugBank.d485.s19|50-52|may|drug
DDI-DrugBank.d485.s19|54-60|inhibit|drug
DDI-DrugBank.d485.s19|62-64|the|drug
DDI-DrugBank.d485.s19|66-75|metabolism|drug
DDI-DrugBank.d485.s19|77-78|of|drug
DDI-DrugBank.d485.s19|80-91|cyclosporine|drug
DDI-DrugBank.d485.s19|92-92|,|drug
DDI-DrugBank.d485.s19|94-100|leading|drug
DDI-DrugBank.d485.s19|102-103|to|drug
DDI-DrugBank.d485.s19|105-113|increased|drug
DDI-DrugBank.d485.s19|115-120|plasma|drug
DDI-DrugBank.d485.s19|122-135|concentrations|drug
DDI-DrugBank.d485.s19|136-136|;|drug
DDI-DrugBank.d485.s20|0-6|monitor|drug
DDI-DrugBank.d485.s20|8-19|cyclosporine|drug
DDI-DrugBank.d485.s20|21-26|levels|drug
DDI-DrugBank.d485.s20|27-27|.|drug
DDI-DrugBank.d485.s21|0-5|CYP3A4|drug
DDI-DrugBank.d485.s21|7-14|inducers|drug
DDI-DrugBank.d485.s21|15-15|:|drug
DDI-DrugBank.d485.s21|17-22|CYP3A4|drug
DDI-DrugBank.d485.s21|24-31|inducers|drug
DDI-DrugBank.d485.s21|33-35|may|drug
DDI-DrugBank.d485.s21|37-44|decrease|drug
DDI-DrugBank.d485.s21|46-48|the|drug
DDI-DrugBank.d485.s21|50-63|levels/effects|drug
DDI-DrugBank.d485.s21|65-66|of|drug
DDI-DrugBank.d485.s21|68-74|ethinyl|drug
DDI-DrugBank.d485.s21|76-84|estradiol|drug
DDI-DrugBank.d485.s21|85-85|.|drug
DDI-DrugBank.d485.s22|0-6|Example|drug
DDI-DrugBank.d485.s22|8-15|inducers|drug
DDI-DrugBank.d485.s22|17-23|include|drug
DDI-DrugBank.d485.s22|25-41|aminoglutethimide|drug
DDI-DrugBank.d485.s22|42-42|,|drug
DDI-DrugBank.d485.s22|44-56|carbamazepine|drug
DDI-DrugBank.d485.s22|57-57|,|drug
DDI-DrugBank.d485.s22|59-67|nafcillin|drug
DDI-DrugBank.d485.s22|68-68|,|drug
DDI-DrugBank.d485.s22|70-79|nevirapine|drug
DDI-DrugBank.d485.s22|80-80|,|drug
DDI-DrugBank.d485.s22|82-94|phenobarbital|drug
DDI-DrugBank.d485.s22|95-95|,|drug
DDI-DrugBank.d485.s22|97-105|phenytoin|drug
DDI-DrugBank.d485.s22|106-106|,|drug
DDI-DrugBank.d485.s22|108-110|and|drug
DDI-DrugBank.d485.s22|112-121|rifamycins|drug
DDI-DrugBank.d485.s22|122-122|.|drug
DDI-DrugBank.d485.s23|0-11|Griseofulvin|drug
DDI-DrugBank.d485.s23|12-12|:|drug
DDI-DrugBank.d485.s23|14-25|Griseofulvin|drug
DDI-DrugBank.d485.s23|27-29|may|drug
DDI-DrugBank.d485.s23|31-36|induce|drug
DDI-DrugBank.d485.s23|38-40|the|drug
DDI-DrugBank.d485.s23|42-51|metabolism|drug
DDI-DrugBank.d485.s23|53-54|of|drug
DDI-DrugBank.d485.s23|56-66|combination|drug
DDI-DrugBank.d485.s23|68-75|hormonal|drug
DDI-DrugBank.d485.s23|77-90|contraceptives|drug
DDI-DrugBank.d485.s23|92-98|causing|drug
DDI-DrugBank.d485.s23|100-108|menstrual|drug
DDI-DrugBank.d485.s23|110-116|changes|drug
DDI-DrugBank.d485.s23|117-117|;|drug
DDI-DrugBank.d485.s24|0-10|pregnancies|drug
DDI-DrugBank.d485.s24|12-15|have|drug
DDI-DrugBank.d485.s24|17-20|been|drug
DDI-DrugBank.d485.s24|22-29|reported|drug
DDI-DrugBank.d485.s24|30-30|.|drug
DDI-DrugBank.d485.s25|0-2|Use|drug
DDI-DrugBank.d485.s25|4-5|of|drug
DDI-DrugBank.d485.s25|7-13|barrier|drug
DDI-DrugBank.d485.s25|15-18|form|drug
DDI-DrugBank.d485.s25|20-21|of|drug
DDI-DrugBank.d485.s25|23-35|contraception|drug
DDI-DrugBank.d485.s25|37-38|is|drug
DDI-DrugBank.d485.s25|40-48|suggested|drug
DDI-DrugBank.d485.s25|50-54|while|drug
DDI-DrugBank.d485.s25|56-57|on|drug
DDI-DrugBank.d485.s25|59-70|griseofulvin|drug
DDI-DrugBank.d485.s25|72-78|therapy|drug
DDI-DrugBank.d485.s25|79-79|.|drug
DDI-DrugBank.d485.s26|0-7|Morphine|drug
DDI-DrugBank.d485.s26|8-8|:|drug
DDI-DrugBank.d485.s26|10-20|Combination|drug
DDI-DrugBank.d485.s26|22-29|hormonal|drug
DDI-DrugBank.d485.s26|31-44|contraceptives|drug
DDI-DrugBank.d485.s26|46-48|may|drug
DDI-DrugBank.d485.s26|50-57|increase|drug
DDI-DrugBank.d485.s26|59-61|the|drug
DDI-DrugBank.d485.s26|63-71|clearance|drug
DDI-DrugBank.d485.s26|73-74|of|drug
DDI-DrugBank.d485.s26|76-83|morphine|drug
DDI-DrugBank.d485.s26|84-84|.|drug
DDI-DrugBank.d485.s27|0-13|Non-nucleoside|drug
DDI-DrugBank.d485.s27|15-21|reverse|drug
DDI-DrugBank.d485.s27|23-35|transcriptase|drug
DDI-DrugBank.d485.s27|37-46|inhibitors|drug
DDI-DrugBank.d485.s27|48-48|(|drug
DDI-DrugBank.d485.s27|49-54|NNRTIs|drug
DDI-DrugBank.d485.s27|55-55|)|drug
DDI-DrugBank.d485.s27|56-56|:|drug
DDI-DrugBank.d485.s27|58-67|Nevirapine|drug
DDI-DrugBank.d485.s27|69-71|may|drug
DDI-DrugBank.d485.s27|73-80|decrease|drug
DDI-DrugBank.d485.s27|82-87|plasma|drug
DDI-DrugBank.d485.s27|89-94|levels|drug
DDI-DrugBank.d485.s27|96-97|of|drug
DDI-DrugBank.d485.s27|99-109|combination|drug
DDI-DrugBank.d485.s27|111-118|hormonal|drug
DDI-DrugBank.d485.s27|120-133|contraceptives|drug
DDI-DrugBank.d485.s27|134-134|;|drug
DDI-DrugBank.d485.s28|0-2|use|drug
DDI-DrugBank.d485.s28|4-5|of|drug
DDI-DrugBank.d485.s28|7-7|a|drug
DDI-DrugBank.d485.s28|9-19|nonhormonal|drug
DDI-DrugBank.d485.s28|21-33|contraceptive|drug
DDI-DrugBank.d485.s28|35-41|product|drug
DDI-DrugBank.d485.s28|43-44|is|drug
DDI-DrugBank.d485.s28|46-56|recommended|drug
DDI-DrugBank.d485.s28|57-57|.|drug
DDI-DrugBank.d485.s29|0-1|No|drug
DDI-DrugBank.d485.s29|3-6|data|drug
DDI-DrugBank.d485.s29|8-10|for|drug
DDI-DrugBank.d485.s29|12-22|delavirdine|drug
DDI-DrugBank.d485.s29|23-23|;|drug
DDI-DrugBank.d485.s30|0-9|incomplete|drug
DDI-DrugBank.d485.s30|11-14|data|drug
DDI-DrugBank.d485.s30|16-18|for|drug
DDI-DrugBank.d485.s30|20-28|efavirenz|drug
DDI-DrugBank.d485.s30|29-29|.|drug
DDI-DrugBank.d485.s31|0-11|Prednisolone|drug
DDI-DrugBank.d485.s31|12-12|:|drug
DDI-DrugBank.d485.s31|14-20|Ethinyl|drug
DDI-DrugBank.d485.s31|22-30|estradiol|drug
DDI-DrugBank.d485.s31|32-34|may|drug
DDI-DrugBank.d485.s31|36-42|inhibit|drug
DDI-DrugBank.d485.s31|44-46|the|drug
DDI-DrugBank.d485.s31|48-57|metabolism|drug
DDI-DrugBank.d485.s31|59-60|of|drug
DDI-DrugBank.d485.s31|62-73|prednisolone|drug
DDI-DrugBank.d485.s31|74-74|,|drug
DDI-DrugBank.d485.s31|76-82|leading|drug
DDI-DrugBank.d485.s31|84-85|to|drug
DDI-DrugBank.d485.s31|87-95|increased|drug
DDI-DrugBank.d485.s31|97-102|plasma|drug
DDI-DrugBank.d485.s31|104-117|concentrations|drug
DDI-DrugBank.d485.s31|118-118|.|drug
DDI-DrugBank.d485.s32|0-7|Protease|drug
DDI-DrugBank.d485.s32|9-18|inhibitors|drug
DDI-DrugBank.d485.s32|19-19|:|drug
DDI-DrugBank.d485.s32|21-30|Amprenavir|drug
DDI-DrugBank.d485.s32|31-31|,|drug
DDI-DrugBank.d485.s32|33-41|lopinavir|drug
DDI-DrugBank.d485.s32|42-42|,|drug
DDI-DrugBank.d485.s32|44-53|nelfinavir|drug
DDI-DrugBank.d485.s32|54-54|,|drug
DDI-DrugBank.d485.s32|56-58|and|drug
DDI-DrugBank.d485.s32|60-68|ritonavir|drug
DDI-DrugBank.d485.s32|70-73|have|drug
DDI-DrugBank.d485.s32|75-78|been|drug
DDI-DrugBank.d485.s32|80-84|shown|drug
DDI-DrugBank.d485.s32|86-87|to|drug
DDI-DrugBank.d485.s32|89-96|decrease|drug
DDI-DrugBank.d485.s32|98-103|plasma|drug
DDI-DrugBank.d485.s32|105-110|levels|drug
DDI-DrugBank.d485.s32|112-113|of|drug
DDI-DrugBank.d485.s32|115-125|combination|drug
DDI-DrugBank.d485.s32|127-134|hormonal|drug
DDI-DrugBank.d485.s32|136-149|contraceptives|drug
DDI-DrugBank.d485.s32|150-150|;|drug
DDI-DrugBank.d485.s33|0-2|use|drug
DDI-DrugBank.d485.s33|4-5|of|drug
DDI-DrugBank.d485.s33|7-7|a|drug
DDI-DrugBank.d485.s33|9-19|nonhormonal|drug
DDI-DrugBank.d485.s33|21-33|contraceptive|drug
DDI-DrugBank.d485.s33|35-41|product|drug
DDI-DrugBank.d485.s33|43-44|is|drug
DDI-DrugBank.d485.s33|46-56|recommended|drug
DDI-DrugBank.d485.s33|57-57|.|drug
DDI-DrugBank.d485.s34|0-8|Indinavir|drug
DDI-DrugBank.d485.s34|10-12|has|drug
DDI-DrugBank.d485.s34|14-17|been|drug
DDI-DrugBank.d485.s34|19-23|shown|drug
DDI-DrugBank.d485.s34|25-26|to|drug
DDI-DrugBank.d485.s34|28-35|increase|drug
DDI-DrugBank.d485.s34|37-42|plasma|drug
DDI-DrugBank.d485.s34|44-49|levels|drug
DDI-DrugBank.d485.s34|51-52|of|drug
DDI-DrugBank.d485.s34|54-64|combination|drug
DDI-DrugBank.d485.s34|66-73|hormonal|drug
DDI-DrugBank.d485.s34|75-88|contraceptives|drug
DDI-DrugBank.d485.s34|89-89|.|drug
DDI-DrugBank.d485.s35|0-1|No|drug
DDI-DrugBank.d485.s35|3-6|data|drug
DDI-DrugBank.d485.s35|8-10|for|drug
DDI-DrugBank.d485.s35|12-21|saquinavir|drug
DDI-DrugBank.d485.s35|22-22|.|drug
DDI-DrugBank.d485.s36|0-7|Rifampin|drug
DDI-DrugBank.d485.s36|8-8|:|drug
DDI-DrugBank.d485.s36|10-17|Rifampin|drug
DDI-DrugBank.d485.s36|19-27|increases|drug
DDI-DrugBank.d485.s36|29-31|the|drug
DDI-DrugBank.d485.s36|33-42|metabolism|drug
DDI-DrugBank.d485.s36|44-45|of|drug
DDI-DrugBank.d485.s36|47-53|ethinyl|drug
DDI-DrugBank.d485.s36|55-63|estradiol|drug
DDI-DrugBank.d485.s36|65-67|and|drug
DDI-DrugBank.d485.s36|69-72|some|drug
DDI-DrugBank.d485.s36|74-83|progestins|drug
DDI-DrugBank.d485.s36|85-85|(|drug
DDI-DrugBank.d485.s36|86-98|norethindrone|drug
DDI-DrugBank.d485.s36|99-99|)|drug
DDI-DrugBank.d485.s36|101-109|resulting|drug
DDI-DrugBank.d485.s36|111-112|in|drug
DDI-DrugBank.d485.s36|114-122|decreased|drug
DDI-DrugBank.d485.s36|124-136|contraceptive|drug
DDI-DrugBank.d485.s36|138-150|effectiveness|drug
DDI-DrugBank.d485.s36|152-154|and|drug
DDI-DrugBank.d485.s36|156-164|increased|drug
DDI-DrugBank.d485.s36|166-174|menstrual|drug
DDI-DrugBank.d485.s36|176-189|irregularities|drug
DDI-DrugBank.d485.s36|190-190|.|drug
DDI-DrugBank.d485.s37|0-2|Use|drug
DDI-DrugBank.d485.s37|4-5|of|drug
DDI-DrugBank.d485.s37|7-7|a|drug
DDI-DrugBank.d485.s37|9-19|nonhormonal|drug
DDI-DrugBank.d485.s37|21-33|contraceptive|drug
DDI-DrugBank.d485.s37|35-41|product|drug
DDI-DrugBank.d485.s37|43-44|is|drug
DDI-DrugBank.d485.s37|46-56|recommended|drug
DDI-DrugBank.d485.s37|57-57|.|drug
DDI-DrugBank.d485.s38|0-8|Salicylic|drug
DDI-DrugBank.d485.s38|10-13|acid|drug
DDI-DrugBank.d485.s38|14-14|:|drug
DDI-DrugBank.d485.s38|16-26|Combination|drug
DDI-DrugBank.d485.s38|28-35|hormonal|drug
DDI-DrugBank.d485.s38|37-50|contraceptives|drug
DDI-DrugBank.d485.s38|52-54|may|drug
DDI-DrugBank.d485.s38|56-63|increase|drug
DDI-DrugBank.d485.s38|65-67|the|drug
DDI-DrugBank.d485.s38|69-77|clearance|drug
DDI-DrugBank.d485.s38|79-80|of|drug
DDI-DrugBank.d485.s38|82-90|salicylic|drug
DDI-DrugBank.d485.s38|92-95|acid|drug
DDI-DrugBank.d485.s38|96-96|.|drug
DDI-DrugBank.d485.s39|0-9|Selegiline|drug
DDI-DrugBank.d485.s39|10-10|:|drug
DDI-DrugBank.d485.s39|12-22|Combination|drug
DDI-DrugBank.d485.s39|24-31|hormonal|drug
DDI-DrugBank.d485.s39|33-46|contraceptives|drug
DDI-DrugBank.d485.s39|48-50|may|drug
DDI-DrugBank.d485.s39|52-59|increase|drug
DDI-DrugBank.d485.s39|61-63|the|drug
DDI-DrugBank.d485.s39|65-69|serum|drug
DDI-DrugBank.d485.s39|71-83|concentration|drug
DDI-DrugBank.d485.s39|85-86|of|drug
DDI-DrugBank.d485.s39|88-97|selegiline|drug
DDI-DrugBank.d485.s39|98-98|.|drug
DDI-DrugBank.d485.s40|0-11|Theophylline|drug
DDI-DrugBank.d485.s40|12-12|:|drug
DDI-DrugBank.d485.s40|14-20|Ethinyl|drug
DDI-DrugBank.d485.s40|22-30|estradiol|drug
DDI-DrugBank.d485.s40|32-34|may|drug
DDI-DrugBank.d485.s40|36-42|inhibit|drug
DDI-DrugBank.d485.s40|44-46|the|drug
DDI-DrugBank.d485.s40|48-57|metabolism|drug
DDI-DrugBank.d485.s40|59-60|of|drug
DDI-DrugBank.d485.s40|62-73|theophylline|drug
DDI-DrugBank.d485.s40|74-74|,|drug
DDI-DrugBank.d485.s40|76-82|leading|drug
DDI-DrugBank.d485.s40|84-85|to|drug
DDI-DrugBank.d485.s40|87-95|increased|drug
DDI-DrugBank.d485.s40|97-102|plasma|drug
DDI-DrugBank.d485.s40|104-117|concentrations|drug
DDI-DrugBank.d485.s40|118-118|.|drug
DDI-DrugBank.d485.s41|0-8|Tricyclic|drug
DDI-DrugBank.d485.s41|10-24|antidepressants|drug
DDI-DrugBank.d485.s41|26-26|(|drug
DDI-DrugBank.d485.s41|27-39|amitriptyline|drug
DDI-DrugBank.d485.s41|40-40|,|drug
DDI-DrugBank.d485.s41|42-51|imipramine|drug
DDI-DrugBank.d485.s41|52-52|,|drug
DDI-DrugBank.d485.s41|54-66|nortriptyline|drug
DDI-DrugBank.d485.s41|67-67|)|drug
DDI-DrugBank.d485.s41|68-68|:|drug
DDI-DrugBank.d485.s41|70-79|Metabolism|drug
DDI-DrugBank.d485.s41|81-83|may|drug
DDI-DrugBank.d485.s41|85-86|be|drug
DDI-DrugBank.d485.s41|88-96|inhibited|drug
DDI-DrugBank.d485.s41|98-99|by|drug
DDI-DrugBank.d485.s41|101-111|combination|drug
DDI-DrugBank.d485.s41|113-120|hormonal|drug
DDI-DrugBank.d485.s41|122-135|contraceptives|drug
DDI-DrugBank.d485.s41|136-136|,|drug
DDI-DrugBank.d485.s41|138-147|increasing|drug
DDI-DrugBank.d485.s41|149-154|plasma|drug
DDI-DrugBank.d485.s41|156-161|levels|drug
DDI-DrugBank.d485.s41|163-164|of|drug
DDI-DrugBank.d485.s41|166-179|antidepressant|drug
DDI-DrugBank.d485.s41|180-180|;|drug
DDI-DrugBank.d485.s42|0-2|use|drug
DDI-DrugBank.d485.s42|4-10|caution|drug
DDI-DrugBank.d485.s42|11-11|.|drug
DDI-DrugBank.d485.s43|0-6|ETHANOL|drug
DDI-DrugBank.d485.s43|8-8|/|drug
DDI-DrugBank.d485.s43|10-18|NUTRITION|drug
DDI-DrugBank.d485.s43|20-20|/|drug
DDI-DrugBank.d485.s43|22-25|HERB|drug
DDI-DrugBank.d485.s43|27-38|INTERACTIONS|drug
DDI-DrugBank.d485.s43|39-39|:|drug
DDI-DrugBank.d485.s43|41-44|Food|drug
DDI-DrugBank.d485.s43|45-45|:|drug
DDI-DrugBank.d485.s43|47-49|CNS|drug
DDI-DrugBank.d485.s43|51-57|effects|drug
DDI-DrugBank.d485.s43|59-60|of|drug
DDI-DrugBank.d485.s43|62-69|caffeine|drug
DDI-DrugBank.d485.s43|71-73|may|drug
DDI-DrugBank.d485.s43|75-76|be|drug
DDI-DrugBank.d485.s43|78-85|enhanced|drug
DDI-DrugBank.d485.s43|87-88|if|drug
DDI-DrugBank.d485.s43|90-100|combination|drug
DDI-DrugBank.d485.s43|102-109|hormonal|drug
DDI-DrugBank.d485.s43|111-124|contraceptives|drug
DDI-DrugBank.d485.s43|126-128|are|drug
DDI-DrugBank.d485.s43|130-133|used|drug
DDI-DrugBank.d485.s43|135-146|concurrently|drug
DDI-DrugBank.d485.s43|148-151|with|drug
DDI-DrugBank.d485.s43|153-160|caffeine|drug
DDI-DrugBank.d485.s43|161-161|.|drug
DDI-DrugBank.d485.s44|0-9|Grapefruit|drug
DDI-DrugBank.d485.s44|11-15|juice|drug
DDI-DrugBank.d485.s44|17-25|increases|drug
DDI-DrugBank.d485.s44|27-33|ethinyl|drug
DDI-DrugBank.d485.s44|35-43|estradiol|drug
DDI-DrugBank.d485.s44|45-58|concentrations|drug
DDI-DrugBank.d485.s44|60-62|and|drug
DDI-DrugBank.d485.s44|64-68|would|drug
DDI-DrugBank.d485.s44|70-71|be|drug
DDI-DrugBank.d485.s44|73-80|expected|drug
DDI-DrugBank.d485.s44|82-83|to|drug
DDI-DrugBank.d485.s44|85-92|increase|drug
DDI-DrugBank.d485.s44|94-105|progesterone|drug
DDI-DrugBank.d485.s44|107-111|serum|drug
DDI-DrugBank.d485.s44|113-118|levels|drug
DDI-DrugBank.d485.s44|120-121|as|drug
DDI-DrugBank.d485.s44|123-126|well|drug
DDI-DrugBank.d485.s44|127-127|;|drug
DDI-DrugBank.d485.s45|0-7|clinical|drug
DDI-DrugBank.d485.s45|9-20|implications|drug
DDI-DrugBank.d485.s45|22-24|are|drug
DDI-DrugBank.d485.s45|26-32|unclear|drug
DDI-DrugBank.d485.s45|33-33|.|drug
DDI-DrugBank.d485.s46|0-17|Herb/Nutraceutical|drug
DDI-DrugBank.d485.s46|18-18|:|drug
DDI-DrugBank.d485.s46|20-21|St|drug
DDI-DrugBank.d485.s46|23-27|Johns|drug
DDI-DrugBank.d485.s46|29-32|wort|drug
DDI-DrugBank.d485.s46|34-36|may|drug
DDI-DrugBank.d485.s46|38-45|decrease|drug
DDI-DrugBank.d485.s46|47-49|the|drug
DDI-DrugBank.d485.s46|51-63|effectiveness|drug
DDI-DrugBank.d485.s46|65-66|of|drug
DDI-DrugBank.d485.s46|68-78|combination|drug
DDI-DrugBank.d485.s46|80-87|hormonal|drug
DDI-DrugBank.d485.s46|89-102|contraceptives|drug
DDI-DrugBank.d485.s46|104-105|by|drug
DDI-DrugBank.d485.s46|107-114|inducing|drug
DDI-DrugBank.d485.s46|116-122|hepatic|drug
DDI-DrugBank.d485.s46|124-130|enzymes|drug
DDI-DrugBank.d485.s46|131-131|.|drug
DDI-DrugBank.d485.s47|0-4|Avoid|drug
DDI-DrugBank.d485.s47|6-9|dong|drug
DDI-DrugBank.d485.s47|11-14|quai|drug
DDI-DrugBank.d485.s47|16-18|and|drug
DDI-DrugBank.d485.s47|20-24|black|drug
DDI-DrugBank.d485.s47|26-31|cohosh|drug
DDI-DrugBank.d485.s47|33-33|(|drug
DDI-DrugBank.d485.s47|34-37|have|drug
DDI-DrugBank.d485.s47|39-46|estrogen|drug
DDI-DrugBank.d485.s47|48-55|activity|drug
DDI-DrugBank.d485.s47|56-56|)|drug
DDI-DrugBank.d485.s47|57-57|.|drug
DDI-DrugBank.d485.s48|0-4|Avoid|drug
DDI-DrugBank.d485.s48|6-8|saw|drug
DDI-DrugBank.d485.s48|10-17|palmetto|drug
DDI-DrugBank.d485.s48|18-18|,|drug
DDI-DrugBank.d485.s48|20-22|red|drug
DDI-DrugBank.d485.s48|24-29|clover|drug
DDI-DrugBank.d485.s48|30-30|,|drug
DDI-DrugBank.d485.s48|32-38|ginseng|drug
DDI-DrugBank.d485.s48|39-39|.|drug
DDI-DrugBank.d34.s0|0-7|Although|drug
DDI-DrugBank.d34.s0|9-17|acid-base|drug
DDI-DrugBank.d34.s0|19-21|and|drug
DDI-DrugBank.d34.s0|23-33|electrolyte|drug
DDI-DrugBank.d34.s0|35-46|disturbances|drug
DDI-DrugBank.d34.s0|48-51|were|drug
DDI-DrugBank.d34.s0|53-55|not|drug
DDI-DrugBank.d34.s0|57-64|reported|drug
DDI-DrugBank.d34.s0|66-67|in|drug
DDI-DrugBank.d34.s0|69-71|the|drug
DDI-DrugBank.d34.s0|73-80|clinical|drug
DDI-DrugBank.d34.s0|82-87|trials|drug
DDI-DrugBank.d34.s0|89-92|with|drug
DDI-DrugBank.d34.s0|94-104|dorzolamide|drug
DDI-DrugBank.d34.s0|105-105|,|drug
DDI-DrugBank.d34.s0|107-111|these|drug
DDI-DrugBank.d34.s0|113-124|disturbances|drug
DDI-DrugBank.d34.s0|126-129|have|drug
DDI-DrugBank.d34.s0|131-134|been|drug
DDI-DrugBank.d34.s0|136-143|reported|drug
DDI-DrugBank.d34.s0|145-148|with|drug
DDI-DrugBank.d34.s0|150-153|oral|drug
DDI-DrugBank.d34.s0|155-162|carbonic|drug
DDI-DrugBank.d34.s0|164-172|anhydrase|drug
DDI-DrugBank.d34.s0|174-183|inhibitors|drug
DDI-DrugBank.d34.s0|185-187|and|drug
DDI-DrugBank.d34.s0|189-192|have|drug
DDI-DrugBank.d34.s0|193-193|,|drug
DDI-DrugBank.d34.s0|195-196|in|drug
DDI-DrugBank.d34.s0|198-201|some|drug
DDI-DrugBank.d34.s0|203-211|instances|drug
DDI-DrugBank.d34.s0|212-212|,|drug
DDI-DrugBank.d34.s0|214-221|resulted|drug
DDI-DrugBank.d34.s0|223-224|in|drug
DDI-DrugBank.d34.s0|226-229|drug|drug
DDI-DrugBank.d34.s0|231-242|interactions|drug
DDI-DrugBank.d34.s0|244-244|(|drug
DDI-DrugBank.d34.s0|245-248|e.g.|drug
DDI-DrugBank.d34.s0|249-249|,|drug
DDI-DrugBank.d34.s0|251-258|toxicity|drug
DDI-DrugBank.d34.s0|260-269|associated|drug
DDI-DrugBank.d34.s0|271-274|with|drug
DDI-DrugBank.d34.s0|276-284|high-dose|drug
DDI-DrugBank.d34.s0|286-295|salicylate|drug
DDI-DrugBank.d34.s0|297-303|therapy|drug
DDI-DrugBank.d34.s0|304-304|)|drug
DDI-DrugBank.d34.s0|305-305|.|drug
DDI-DrugBank.d34.s1|0-8|Therefore|drug
DDI-DrugBank.d34.s1|9-9|,|drug
DDI-DrugBank.d34.s1|11-13|the|drug
DDI-DrugBank.d34.s1|15-23|potential|drug
DDI-DrugBank.d34.s1|25-27|for|drug
DDI-DrugBank.d34.s1|29-32|such|drug
DDI-DrugBank.d34.s1|34-37|drug|drug
DDI-DrugBank.d34.s1|39-50|interactions|drug
DDI-DrugBank.d34.s1|52-57|should|drug
DDI-DrugBank.d34.s1|59-60|be|drug
DDI-DrugBank.d34.s1|62-71|considered|drug
DDI-DrugBank.d34.s1|73-74|in|drug
DDI-DrugBank.d34.s1|76-83|patients|drug
DDI-DrugBank.d34.s1|85-93|receiving|drug
DDI-DrugBank.d34.s1|95-105|dorzolamide|drug
DDI-DrugBank.d34.s1|106-106|.|drug
DDI-DrugBank.d599.s0|0-8|Excessive|drug
DDI-DrugBank.d599.s0|10-23|glucocorticoid|drug
DDI-DrugBank.d599.s0|25-31|therapy|drug
DDI-DrugBank.d599.s0|33-36|will|drug
DDI-DrugBank.d599.s0|38-44|inhibit|drug
DDI-DrugBank.d599.s0|46-48|the|drug
DDI-DrugBank.d599.s0|50-65|growth-promoting|drug
DDI-DrugBank.d599.s0|67-72|effect|drug
DDI-DrugBank.d599.s0|74-75|of|drug
DDI-DrugBank.d599.s0|77-81|human|drug
DDI-DrugBank.d599.s0|83-84|GH|drug
DDI-DrugBank.d599.s0|85-85|.|drug
DDI-DrugBank.d599.s1|0-7|Patients|drug
DDI-DrugBank.d599.s1|9-12|with|drug
DDI-DrugBank.d599.s1|14-17|ACTH|drug
DDI-DrugBank.d599.s1|19-28|deficiency|drug
DDI-DrugBank.d599.s1|30-35|should|drug
DDI-DrugBank.d599.s1|37-40|have|drug
DDI-DrugBank.d599.s1|42-46|their|drug
DDI-DrugBank.d599.s1|48-73|glucocorticoid-replacement|drug
DDI-DrugBank.d599.s1|75-78|dose|drug
DDI-DrugBank.d599.s1|80-88|carefully|drug
DDI-DrugBank.d599.s1|90-97|adjusted|drug
DDI-DrugBank.d599.s1|99-100|to|drug
DDI-DrugBank.d599.s1|102-106|avoid|drug
DDI-DrugBank.d599.s1|108-109|an|drug
DDI-DrugBank.d599.s1|111-120|inhibitory|drug
DDI-DrugBank.d599.s1|122-127|effect|drug
DDI-DrugBank.d599.s1|129-130|on|drug
DDI-DrugBank.d599.s1|132-137|growth|drug
DDI-DrugBank.d599.s1|138-138|.|drug
DDI-DrugBank.d599.s2|0-2|The|drug
DDI-DrugBank.d599.s2|4-6|use|drug
DDI-DrugBank.d599.s2|8-9|of|drug
DDI-DrugBank.d599.s2|11-18|Nutropin|drug
DDI-DrugBank.d599.s2|20-21|in|drug
DDI-DrugBank.d599.s2|23-30|patients|drug
DDI-DrugBank.d599.s2|32-35|with|drug
DDI-DrugBank.d599.s2|37-43|chronic|drug
DDI-DrugBank.d599.s2|45-49|renal|drug
DDI-DrugBank.d599.s2|51-63|insufficiency|drug
DDI-DrugBank.d599.s2|65-73|receiving|drug
DDI-DrugBank.d599.s2|75-88|glucocorticoid|drug
DDI-DrugBank.d599.s2|90-96|therapy|drug
DDI-DrugBank.d599.s2|98-100|has|drug
DDI-DrugBank.d599.s2|102-104|not|drug
DDI-DrugBank.d599.s2|106-109|been|drug
DDI-DrugBank.d599.s2|111-119|evaluated|drug
DDI-DrugBank.d599.s2|120-120|.|drug
DDI-DrugBank.d599.s3|0-10|Concomitant|drug
DDI-DrugBank.d599.s3|12-25|glucocorticoid|drug
DDI-DrugBank.d599.s3|27-33|therapy|drug
DDI-DrugBank.d599.s3|35-37|may|drug
DDI-DrugBank.d599.s3|39-45|inhibit|drug
DDI-DrugBank.d599.s3|47-49|the|drug
DDI-DrugBank.d599.s3|51-66|growth-promoting|drug
DDI-DrugBank.d599.s3|68-73|effect|drug
DDI-DrugBank.d599.s3|75-76|of|drug
DDI-DrugBank.d599.s3|78-85|Nutropin|drug
DDI-DrugBank.d599.s3|86-86|.|drug
DDI-DrugBank.d599.s4|0-1|If|drug
DDI-DrugBank.d599.s4|3-16|glucocorticoid|drug
DDI-DrugBank.d599.s4|18-28|replacement|drug
DDI-DrugBank.d599.s4|30-31|is|drug
DDI-DrugBank.d599.s4|33-40|required|drug
DDI-DrugBank.d599.s4|41-41|,|drug
DDI-DrugBank.d599.s4|43-45|the|drug
DDI-DrugBank.d599.s4|47-60|glucocorticoid|drug
DDI-DrugBank.d599.s4|62-65|dose|drug
DDI-DrugBank.d599.s4|67-72|should|drug
DDI-DrugBank.d599.s4|74-75|be|drug
DDI-DrugBank.d599.s4|77-85|carefully|drug
DDI-DrugBank.d599.s4|87-94|adjusted|drug
DDI-DrugBank.d599.s4|95-95|.|drug
DDI-DrugBank.d599.s5|0-4|There|drug
DDI-DrugBank.d599.s5|6-8|was|drug
DDI-DrugBank.d599.s5|10-11|no|drug
DDI-DrugBank.d599.s5|13-20|evidence|drug
DDI-DrugBank.d599.s5|22-23|in|drug
DDI-DrugBank.d599.s5|25-27|the|drug
DDI-DrugBank.d599.s5|29-38|controlled|drug
DDI-DrugBank.d599.s5|40-46|studies|drug
DDI-DrugBank.d599.s5|48-49|of|drug
DDI-DrugBank.d599.s5|51-58|Nutropin|drug
DDI-DrugBank.d599.s5|62-62|s|drug
DDI-DrugBank.d599.s5|64-74|interaction|drug
DDI-DrugBank.d599.s5|76-79|with|drug
DDI-DrugBank.d599.s5|81-85|drugs|drug
DDI-DrugBank.d599.s5|87-94|commonly|drug
DDI-DrugBank.d599.s5|96-99|used|drug
DDI-DrugBank.d599.s5|101-102|in|drug
DDI-DrugBank.d599.s5|104-110|chronic|drug
DDI-DrugBank.d599.s5|112-116|renal|drug
DDI-DrugBank.d599.s5|118-130|insufficiency|drug
DDI-DrugBank.d599.s5|132-139|patients|drug
DDI-DrugBank.d599.s5|140-140|.|drug
DDI-DrugBank.d599.s6|0-6|Limited|drug
DDI-DrugBank.d599.s6|8-16|published|drug
DDI-DrugBank.d599.s6|18-21|data|drug
DDI-DrugBank.d599.s6|23-30|indicate|drug
DDI-DrugBank.d599.s6|32-35|that|drug
DDI-DrugBank.d599.s6|37-38|GH|drug
DDI-DrugBank.d599.s6|40-48|treatment|drug
DDI-DrugBank.d599.s6|50-58|increases|drug
DDI-DrugBank.d599.s6|60-69|cytochrome|drug
DDI-DrugBank.d599.s6|71-74|P450|drug
DDI-DrugBank.d599.s6|76-76|(|drug
DDI-DrugBank.d599.s6|77-81|CP450|drug
DDI-DrugBank.d599.s6|82-82|)|drug
DDI-DrugBank.d599.s6|84-91|mediated|drug
DDI-DrugBank.d599.s6|93-102|antipyrine|drug
DDI-DrugBank.d599.s6|104-112|clearance|drug
DDI-DrugBank.d599.s6|114-115|in|drug
DDI-DrugBank.d599.s6|117-119|man|drug
DDI-DrugBank.d599.s6|120-120|.|drug
DDI-DrugBank.d599.s7|0-4|These|drug
DDI-DrugBank.d599.s7|6-9|data|drug
DDI-DrugBank.d599.s7|11-17|suggest|drug
DDI-DrugBank.d599.s7|19-22|that|drug
DDI-DrugBank.d599.s7|24-25|GH|drug
DDI-DrugBank.d599.s7|27-40|administration|drug
DDI-DrugBank.d599.s7|42-44|may|drug
DDI-DrugBank.d599.s7|46-50|alter|drug
DDI-DrugBank.d599.s7|52-54|the|drug
DDI-DrugBank.d599.s7|56-64|clearance|drug
DDI-DrugBank.d599.s7|66-67|of|drug
DDI-DrugBank.d599.s7|69-77|compounds|drug
DDI-DrugBank.d599.s7|79-83|known|drug
DDI-DrugBank.d599.s7|85-86|to|drug
DDI-DrugBank.d599.s7|88-89|be|drug
DDI-DrugBank.d599.s7|91-101|metabolized|drug
DDI-DrugBank.d599.s7|103-104|by|drug
DDI-DrugBank.d599.s7|106-110|CP450|drug
DDI-DrugBank.d599.s7|112-116|liver|drug
DDI-DrugBank.d599.s7|118-124|enzymes|drug
DDI-DrugBank.d599.s7|126-126|(|drug
DDI-DrugBank.d599.s7|127-130|e.g.|drug
DDI-DrugBank.d599.s7|131-131|,|drug
DDI-DrugBank.d599.s7|133-147|corticosteroids|drug
DDI-DrugBank.d599.s7|148-148|,|drug
DDI-DrugBank.d599.s7|150-152|sex|drug
DDI-DrugBank.d599.s7|154-161|steroids|drug
DDI-DrugBank.d599.s7|162-162|,|drug
DDI-DrugBank.d599.s7|164-178|anticonvulsants|drug
DDI-DrugBank.d599.s7|179-179|,|drug
DDI-DrugBank.d599.s7|181-191|cyclosporin|drug
DDI-DrugBank.d599.s7|192-192|)|drug
DDI-DrugBank.d599.s7|193-193|.|drug
DDI-DrugBank.d599.s8|0-6|Careful|drug
DDI-DrugBank.d599.s8|8-17|monitoring|drug
DDI-DrugBank.d599.s8|19-20|is|drug
DDI-DrugBank.d599.s8|22-30|advisable|drug
DDI-DrugBank.d599.s8|32-35|when|drug
DDI-DrugBank.d599.s8|37-38|GH|drug
DDI-DrugBank.d599.s8|40-41|is|drug
DDI-DrugBank.d599.s8|43-54|administered|drug
DDI-DrugBank.d599.s8|56-57|in|drug
DDI-DrugBank.d599.s8|59-69|combination|drug
DDI-DrugBank.d599.s8|71-74|with|drug
DDI-DrugBank.d599.s8|76-80|other|drug
DDI-DrugBank.d599.s8|82-86|drugs|drug
DDI-DrugBank.d599.s8|88-92|known|drug
DDI-DrugBank.d599.s8|94-95|to|drug
DDI-DrugBank.d599.s8|97-98|be|drug
DDI-DrugBank.d599.s8|100-110|metabolized|drug
DDI-DrugBank.d599.s8|112-113|by|drug
DDI-DrugBank.d599.s8|115-119|CP450|drug
DDI-DrugBank.d599.s8|121-125|liver|drug
DDI-DrugBank.d599.s8|127-133|enzymes|drug
DDI-DrugBank.d599.s8|134-134|.|drug
DDI-DrugBank.d499.s0|0-2|The|drug
DDI-DrugBank.d499.s0|4-12|following|drug
DDI-DrugBank.d499.s0|14-17|drug|drug
DDI-DrugBank.d499.s0|19-30|interactions|drug
DDI-DrugBank.d499.s0|32-35|were|drug
DDI-DrugBank.d499.s0|37-43|studied|drug
DDI-DrugBank.d499.s0|45-48|with|drug
DDI-DrugBank.d499.s0|50-59|ketoprofen|drug
DDI-DrugBank.d499.s0|61-65|doses|drug
DDI-DrugBank.d499.s0|67-68|of|drug
DDI-DrugBank.d499.s0|70-72|200|drug
DDI-DrugBank.d499.s0|74-79|mg/day|drug
DDI-DrugBank.d499.s0|80-80|.|drug
DDI-DrugBank.d499.s1|0-2|The|drug
DDI-DrugBank.d499.s1|4-14|possibility|drug
DDI-DrugBank.d499.s1|16-17|of|drug
DDI-DrugBank.d499.s1|19-27|increased|drug
DDI-DrugBank.d499.s1|29-39|interaction|drug
DDI-DrugBank.d499.s1|41-46|should|drug
DDI-DrugBank.d499.s1|48-49|be|drug
DDI-DrugBank.d499.s1|51-54|kept|drug
DDI-DrugBank.d499.s1|56-57|in|drug
DDI-DrugBank.d499.s1|59-62|mind|drug
DDI-DrugBank.d499.s1|64-67|when|drug
DDI-DrugBank.d499.s1|69-74|Orudis|drug
DDI-DrugBank.d499.s1|76-80|doses|drug
DDI-DrugBank.d499.s1|82-88|greater|drug
DDI-DrugBank.d499.s1|90-93|than|drug
DDI-DrugBank.d499.s1|95-96|50|drug
DDI-DrugBank.d499.s1|98-99|mg|drug
DDI-DrugBank.d499.s1|101-102|as|drug
DDI-DrugBank.d499.s1|104-104|a|drug
DDI-DrugBank.d499.s1|106-111|single|drug
DDI-DrugBank.d499.s1|113-116|dose|drug
DDI-DrugBank.d499.s1|118-119|or|drug
DDI-DrugBank.d499.s1|121-123|200|drug
DDI-DrugBank.d499.s1|125-126|mg|drug
DDI-DrugBank.d499.s1|128-129|of|drug
DDI-DrugBank.d499.s1|131-140|ketoprofen|drug
DDI-DrugBank.d499.s1|142-144|per|drug
DDI-DrugBank.d499.s1|146-148|day|drug
DDI-DrugBank.d499.s1|150-152|are|drug
DDI-DrugBank.d499.s1|154-157|used|drug
DDI-DrugBank.d499.s1|159-171|concomitantly|drug
DDI-DrugBank.d499.s1|173-176|with|drug
DDI-DrugBank.d499.s1|178-183|highly|drug
DDI-DrugBank.d499.s1|185-189|bound|drug
DDI-DrugBank.d499.s1|191-195|drugs|drug
DDI-DrugBank.d499.s1|196-196|.|drug
DDI-DrugBank.d499.s2|0-0|1|drug
DDI-DrugBank.d499.s2|1-1|.|drug
DDI-DrugBank.d499.s3|0-7|Antacids|drug
DDI-DrugBank.d499.s3|8-8|:|drug
DDI-DrugBank.d499.s3|10-20|Concomitant|drug
DDI-DrugBank.d499.s3|22-35|administration|drug
DDI-DrugBank.d499.s3|37-38|of|drug
DDI-DrugBank.d499.s3|40-48|magnesium|drug
DDI-DrugBank.d499.s3|50-58|hydroxide|drug
DDI-DrugBank.d499.s3|60-62|and|drug
DDI-DrugBank.d499.s3|64-71|aluminum|drug
DDI-DrugBank.d499.s3|73-81|hydroxide|drug
DDI-DrugBank.d499.s3|83-86|does|drug
DDI-DrugBank.d499.s3|88-90|not|drug
DDI-DrugBank.d499.s3|92-100|interfere|drug
DDI-DrugBank.d499.s3|102-105|with|drug
DDI-DrugBank.d499.s3|107-109|the|drug
DDI-DrugBank.d499.s3|111-114|rate|drug
DDI-DrugBank.d499.s3|116-117|or|drug
DDI-DrugBank.d499.s3|119-124|extent|drug
DDI-DrugBank.d499.s3|126-127|of|drug
DDI-DrugBank.d499.s3|129-131|the|drug
DDI-DrugBank.d499.s3|133-142|absorption|drug
DDI-DrugBank.d499.s3|144-145|of|drug
DDI-DrugBank.d499.s3|147-156|ketoprofen|drug
DDI-DrugBank.d499.s3|158-169|administered|drug
DDI-DrugBank.d499.s3|171-172|as|drug
DDI-DrugBank.d499.s3|174-179|Orudis|drug
DDI-DrugBank.d499.s3|180-180|.|drug
DDI-DrugBank.d499.s4|0-0|2|drug
DDI-DrugBank.d499.s4|1-1|.|drug
DDI-DrugBank.d499.s5|0-6|Aspirin|drug
DDI-DrugBank.d499.s5|7-7|:|drug
DDI-DrugBank.d499.s5|9-18|Ketoprofen|drug
DDI-DrugBank.d499.s5|20-23|does|drug
DDI-DrugBank.d499.s5|25-27|not|drug
DDI-DrugBank.d499.s5|29-33|alter|drug
DDI-DrugBank.d499.s5|35-41|aspirin|drug
DDI-DrugBank.d499.s5|43-52|absorption|drug
DDI-DrugBank.d499.s5|53-53|;|drug
DDI-DrugBank.d499.s6|0-6|however|drug
DDI-DrugBank.d499.s6|7-7|,|drug
DDI-DrugBank.d499.s6|9-10|in|drug
DDI-DrugBank.d499.s6|12-12|a|drug
DDI-DrugBank.d499.s6|14-18|study|drug
DDI-DrugBank.d499.s6|20-21|of|drug
DDI-DrugBank.d499.s6|23-24|12|drug
DDI-DrugBank.d499.s6|26-31|normal|drug
DDI-DrugBank.d499.s6|33-40|subjects|drug
DDI-DrugBank.d499.s6|41-41|,|drug
DDI-DrugBank.d499.s6|43-52|concurrent|drug
DDI-DrugBank.d499.s6|54-67|administration|drug
DDI-DrugBank.d499.s6|69-70|of|drug
DDI-DrugBank.d499.s6|72-78|aspirin|drug
DDI-DrugBank.d499.s6|80-88|decreased|drug
DDI-DrugBank.d499.s6|90-99|ketoprofen|drug
DDI-DrugBank.d499.s6|101-107|protein|drug
DDI-DrugBank.d499.s6|109-115|binding|drug
DDI-DrugBank.d499.s6|117-119|and|drug
DDI-DrugBank.d499.s6|121-129|increased|drug
DDI-DrugBank.d499.s6|131-140|ketoprofen|drug
DDI-DrugBank.d499.s6|142-147|plasma|drug
DDI-DrugBank.d499.s6|149-157|clearance|drug
DDI-DrugBank.d499.s6|159-162|from|drug
DDI-DrugBank.d499.s6|164-167|0.07|drug
DDI-DrugBank.d499.s6|169-174|L/kg/h|drug
DDI-DrugBank.d499.s6|176-182|without|drug
DDI-DrugBank.d499.s6|184-190|aspirin|drug
DDI-DrugBank.d499.s6|192-193|to|drug
DDI-DrugBank.d499.s6|195-198|0.11|drug
DDI-DrugBank.d499.s6|200-205|L/kg/h|drug
DDI-DrugBank.d499.s6|207-210|with|drug
DDI-DrugBank.d499.s6|212-218|aspirin|drug
DDI-DrugBank.d499.s6|219-219|.|drug
DDI-DrugBank.d499.s7|0-2|The|drug
DDI-DrugBank.d499.s7|4-11|clinical|drug
DDI-DrugBank.d499.s7|13-24|significance|drug
DDI-DrugBank.d499.s7|26-27|of|drug
DDI-DrugBank.d499.s7|29-33|these|drug
DDI-DrugBank.d499.s7|35-41|changes|drug
DDI-DrugBank.d499.s7|43-45|has|drug
DDI-DrugBank.d499.s7|47-49|not|drug
DDI-DrugBank.d499.s7|51-54|been|drug
DDI-DrugBank.d499.s7|56-65|adequately|drug
DDI-DrugBank.d499.s7|67-73|studied|drug
DDI-DrugBank.d499.s7|74-74|.|drug
DDI-DrugBank.d499.s8|0-8|Therefore|drug
DDI-DrugBank.d499.s8|9-9|,|drug
DDI-DrugBank.d499.s8|11-20|concurrent|drug
DDI-DrugBank.d499.s8|22-24|use|drug
DDI-DrugBank.d499.s8|26-27|of|drug
DDI-DrugBank.d499.s8|29-35|aspirin|drug
DDI-DrugBank.d499.s8|37-39|and|drug
DDI-DrugBank.d499.s8|41-50|ketoprofen|drug
DDI-DrugBank.d499.s8|52-53|is|drug
DDI-DrugBank.d499.s8|55-57|not|drug
DDI-DrugBank.d499.s8|59-69|recommended|drug
DDI-DrugBank.d499.s8|70-70|.|drug
DDI-DrugBank.d499.s9|0-0|3|drug
DDI-DrugBank.d499.s9|1-1|.|drug
DDI-DrugBank.d499.s10|0-7|Diuretic|drug
DDI-DrugBank.d499.s10|8-8|:|drug
DDI-DrugBank.d499.s10|10-28|Hydrochlorothiazide|drug
DDI-DrugBank.d499.s10|29-29|,|drug
DDI-DrugBank.d499.s10|31-35|given|drug
DDI-DrugBank.d499.s10|37-49|concomitantly|drug
DDI-DrugBank.d499.s10|51-54|with|drug
DDI-DrugBank.d499.s10|56-65|ketoprofen|drug
DDI-DrugBank.d499.s10|66-66|,|drug
DDI-DrugBank.d499.s10|68-75|produces|drug
DDI-DrugBank.d499.s10|77-77|a|drug
DDI-DrugBank.d499.s10|79-87|reduction|drug
DDI-DrugBank.d499.s10|89-90|in|drug
DDI-DrugBank.d499.s10|92-98|urinary|drug
DDI-DrugBank.d499.s10|100-108|potassium|drug
DDI-DrugBank.d499.s10|110-112|and|drug
DDI-DrugBank.d499.s10|114-121|chloride|drug
DDI-DrugBank.d499.s10|123-131|excretion|drug
DDI-DrugBank.d499.s10|133-140|compared|drug
DDI-DrugBank.d499.s10|142-143|to|drug
DDI-DrugBank.d499.s10|145-163|hydrochlorothiazide|drug
DDI-DrugBank.d499.s10|165-169|alone|drug
DDI-DrugBank.d499.s10|170-170|.|drug
DDI-DrugBank.d499.s11|0-7|Patients|drug
DDI-DrugBank.d499.s11|9-14|taking|drug
DDI-DrugBank.d499.s11|16-24|diuretics|drug
DDI-DrugBank.d499.s11|26-28|are|drug
DDI-DrugBank.d499.s11|30-31|at|drug
DDI-DrugBank.d499.s11|33-33|a|drug
DDI-DrugBank.d499.s11|35-41|greater|drug
DDI-DrugBank.d499.s11|43-46|risk|drug
DDI-DrugBank.d499.s11|48-49|of|drug
DDI-DrugBank.d499.s11|51-60|developing|drug
DDI-DrugBank.d499.s11|62-66|renal|drug
DDI-DrugBank.d499.s11|68-74|failure|drug
DDI-DrugBank.d499.s11|76-84|secondary|drug
DDI-DrugBank.d499.s11|86-87|to|drug
DDI-DrugBank.d499.s11|89-89|a|drug
DDI-DrugBank.d499.s11|91-98|decrease|drug
DDI-DrugBank.d499.s11|100-101|in|drug
DDI-DrugBank.d499.s11|103-107|renal|drug
DDI-DrugBank.d499.s11|109-113|blood|drug
DDI-DrugBank.d499.s11|115-118|flow|drug
DDI-DrugBank.d499.s11|120-125|caused|drug
DDI-DrugBank.d499.s11|127-128|by|drug
DDI-DrugBank.d499.s11|130-142|prostaglandin|drug
DDI-DrugBank.d499.s11|144-153|inhibition|drug
DDI-DrugBank.d499.s11|154-154|.|drug
DDI-DrugBank.d499.s12|0-0|4|drug
DDI-DrugBank.d499.s12|1-1|.|drug
DDI-DrugBank.d499.s13|0-6|Digoxin|drug
DDI-DrugBank.d499.s13|7-7|:|drug
DDI-DrugBank.d499.s13|9-10|In|drug
DDI-DrugBank.d499.s13|12-12|a|drug
DDI-DrugBank.d499.s13|14-18|study|drug
DDI-DrugBank.d499.s13|20-21|in|drug
DDI-DrugBank.d499.s13|23-24|12|drug
DDI-DrugBank.d499.s13|26-33|patients|drug
DDI-DrugBank.d499.s13|35-38|with|drug
DDI-DrugBank.d499.s13|40-49|congestive|drug
DDI-DrugBank.d499.s13|51-55|heart|drug
DDI-DrugBank.d499.s13|57-63|failure|drug
DDI-DrugBank.d499.s13|65-69|where|drug
DDI-DrugBank.d499.s13|71-80|ketoprofen|drug
DDI-DrugBank.d499.s13|82-84|and|drug
DDI-DrugBank.d499.s13|86-92|digoxin|drug
DDI-DrugBank.d499.s13|94-97|were|drug
DDI-DrugBank.d499.s13|99-111|concomitantly|drug
DDI-DrugBank.d499.s13|113-124|administered|drug
DDI-DrugBank.d499.s13|125-125|,|drug
DDI-DrugBank.d499.s13|127-136|ketoprofen|drug
DDI-DrugBank.d499.s13|138-140|did|drug
DDI-DrugBank.d499.s13|142-144|not|drug
DDI-DrugBank.d499.s13|146-150|alter|drug
DDI-DrugBank.d499.s13|152-154|the|drug
DDI-DrugBank.d499.s13|156-160|serum|drug
DDI-DrugBank.d499.s13|162-167|levels|drug
DDI-DrugBank.d499.s13|169-170|of|drug
DDI-DrugBank.d499.s13|172-178|digoxin|drug
DDI-DrugBank.d499.s13|179-179|.|drug
DDI-DrugBank.d499.s14|0-0|5|drug
DDI-DrugBank.d499.s14|1-1|.|drug
DDI-DrugBank.d499.s15|0-7|Warfarin|drug
DDI-DrugBank.d499.s15|8-8|:|drug
DDI-DrugBank.d499.s15|10-11|In|drug
DDI-DrugBank.d499.s15|13-13|a|drug
DDI-DrugBank.d499.s15|15-24|short-term|drug
DDI-DrugBank.d499.s15|26-35|controlled|drug
DDI-DrugBank.d499.s15|37-41|study|drug
DDI-DrugBank.d499.s15|43-44|in|drug
DDI-DrugBank.d499.s15|46-47|14|drug
DDI-DrugBank.d499.s15|49-54|normal|drug
DDI-DrugBank.d499.s15|56-65|volunteers|drug
DDI-DrugBank.d499.s15|66-66|,|drug
DDI-DrugBank.d499.s15|68-77|ketoprofen|drug
DDI-DrugBank.d499.s15|79-81|did|drug
DDI-DrugBank.d499.s15|83-85|not|drug
DDI-DrugBank.d499.s15|87-99|significantly|drug
DDI-DrugBank.d499.s15|101-109|interfere|drug
DDI-DrugBank.d499.s15|111-114|with|drug
DDI-DrugBank.d499.s15|116-118|the|drug
DDI-DrugBank.d499.s15|120-125|effect|drug
DDI-DrugBank.d499.s15|127-128|of|drug
DDI-DrugBank.d499.s15|130-137|warfarin|drug
DDI-DrugBank.d499.s15|139-140|on|drug
DDI-DrugBank.d499.s15|142-152|prothrombin|drug
DDI-DrugBank.d499.s15|154-157|time|drug
DDI-DrugBank.d499.s15|158-158|.|drug
DDI-DrugBank.d499.s16|0-7|Bleeding|drug
DDI-DrugBank.d499.s16|9-12|from|drug
DDI-DrugBank.d499.s16|14-14|a|drug
DDI-DrugBank.d499.s16|16-21|number|drug
DDI-DrugBank.d499.s16|23-24|of|drug
DDI-DrugBank.d499.s16|26-30|sites|drug
DDI-DrugBank.d499.s16|32-34|may|drug
DDI-DrugBank.d499.s16|36-37|be|drug
DDI-DrugBank.d499.s16|39-39|a|drug
DDI-DrugBank.d499.s16|41-52|complication|drug
DDI-DrugBank.d499.s16|54-55|of|drug
DDI-DrugBank.d499.s16|57-64|warfarin|drug
DDI-DrugBank.d499.s16|66-74|treatment|drug
DDI-DrugBank.d499.s16|76-78|and|drug
DDI-DrugBank.d499.s16|80-81|GI|drug
DDI-DrugBank.d499.s16|83-90|bleeding|drug
DDI-DrugBank.d499.s16|92-92|a|drug
DDI-DrugBank.d499.s16|94-105|complication|drug
DDI-DrugBank.d499.s16|107-108|of|drug
DDI-DrugBank.d499.s16|110-119|ketoprofen|drug
DDI-DrugBank.d499.s16|121-129|treatment|drug
DDI-DrugBank.d499.s16|130-130|.|drug
DDI-DrugBank.d499.s17|0-6|Because|drug
DDI-DrugBank.d499.s17|8-21|prostaglandina|drug
DDI-DrugBank.d499.s17|23-26|play|drug
DDI-DrugBank.d499.s17|28-29|an|drug
DDI-DrugBank.d499.s17|31-39|important|drug
DDI-DrugBank.d499.s17|41-44|role|drug
DDI-DrugBank.d499.s17|46-47|in|drug
DDI-DrugBank.d499.s17|49-58|hemostasis|drug
DDI-DrugBank.d499.s17|60-62|and|drug
DDI-DrugBank.d499.s17|64-73|ketoprofen|drug
DDI-DrugBank.d499.s17|75-77|has|drug
DDI-DrugBank.d499.s17|79-80|an|drug
DDI-DrugBank.d499.s17|82-87|effect|drug
DDI-DrugBank.d499.s17|89-90|on|drug
DDI-DrugBank.d499.s17|92-99|platelet|drug
DDI-DrugBank.d499.s17|101-108|function|drug
DDI-DrugBank.d499.s17|110-111|as|drug
DDI-DrugBank.d499.s17|113-116|well|drug
DDI-DrugBank.d499.s17|117-117|,|drug
DDI-DrugBank.d499.s17|119-127|concurent|drug
DDI-DrugBank.d499.s17|129-135|therapy|drug
DDI-DrugBank.d499.s17|137-140|with|drug
DDI-DrugBank.d499.s17|142-151|ketoprofen|drug
DDI-DrugBank.d499.s17|153-155|and|drug
DDI-DrugBank.d499.s17|157-164|warfarin|drug
DDI-DrugBank.d499.s17|166-173|requires|drug
DDI-DrugBank.d499.s17|175-179|close|drug
DDI-DrugBank.d499.s17|181-190|monitoring|drug
DDI-DrugBank.d499.s17|192-193|of|drug
DDI-DrugBank.d499.s17|195-202|patients|drug
DDI-DrugBank.d499.s17|204-205|on|drug
DDI-DrugBank.d499.s17|207-210|both|drug
DDI-DrugBank.d499.s17|212-216|drugs|drug
DDI-DrugBank.d499.s17|217-217|.|drug
DDI-DrugBank.d499.s18|0-0|6|drug
DDI-DrugBank.d499.s18|1-1|.|drug
DDI-DrugBank.d499.s19|0-9|Probenecid|drug
DDI-DrugBank.d499.s19|10-10|:|drug
DDI-DrugBank.d499.s19|12-21|Probenecid|drug
DDI-DrugBank.d499.s19|23-31|increases|drug
DDI-DrugBank.d499.s19|33-36|both|drug
DDI-DrugBank.d499.s19|38-41|free|drug
DDI-DrugBank.d499.s19|43-45|and|drug
DDI-DrugBank.d499.s19|47-51|bound|drug
DDI-DrugBank.d499.s19|53-62|ketoprofen|drug
DDI-DrugBank.d499.s19|64-65|by|drug
DDI-DrugBank.d499.s19|67-74|reducing|drug
DDI-DrugBank.d499.s19|76-78|the|drug
DDI-DrugBank.d499.s19|80-85|plasma|drug
DDI-DrugBank.d499.s19|87-95|clearance|drug
DDI-DrugBank.d499.s19|97-98|of|drug
DDI-DrugBank.d499.s19|100-109|ketoprofen|drug
DDI-DrugBank.d499.s19|111-112|to|drug
DDI-DrugBank.d499.s19|114-118|about|drug
DDI-DrugBank.d499.s19|120-128|one-third|drug
DDI-DrugBank.d499.s19|129-129|,|drug
DDI-DrugBank.d499.s19|131-132|as|drug
DDI-DrugBank.d499.s19|134-137|well|drug
DDI-DrugBank.d499.s19|139-140|as|drug
DDI-DrugBank.d499.s19|142-151|decreasing|drug
DDI-DrugBank.d499.s19|153-155|its|drug
DDI-DrugBank.d499.s19|157-163|protein|drug
DDI-DrugBank.d499.s19|165-171|binding|drug
DDI-DrugBank.d499.s19|172-172|.|drug
DDI-DrugBank.d499.s20|0-8|Therefore|drug
DDI-DrugBank.d499.s20|9-9|,|drug
DDI-DrugBank.d499.s20|11-13|the|drug
DDI-DrugBank.d499.s20|15-25|combination|drug
DDI-DrugBank.d499.s20|27-28|of|drug
DDI-DrugBank.d499.s20|30-39|ketoprofen|drug
DDI-DrugBank.d499.s20|41-43|and|drug
DDI-DrugBank.d499.s20|45-54|probenecid|drug
DDI-DrugBank.d499.s20|56-57|is|drug
DDI-DrugBank.d499.s20|59-61|not|drug
DDI-DrugBank.d499.s20|63-73|recommended|drug
DDI-DrugBank.d499.s20|74-74|.|drug
DDI-DrugBank.d499.s21|0-0|7|drug
DDI-DrugBank.d499.s21|1-1|.|drug
DDI-DrugBank.d499.s22|0-11|Methotrexate|drug
DDI-DrugBank.d499.s22|12-12|:|drug
DDI-DrugBank.d499.s22|14-23|Ketoprofen|drug
DDI-DrugBank.d499.s22|24-24|,|drug
DDI-DrugBank.d499.s22|26-29|like|drug
DDI-DrugBank.d499.s22|31-35|other|drug
DDI-DrugBank.d499.s22|37-42|NSAIDs|drug
DDI-DrugBank.d499.s22|43-43|,|drug
DDI-DrugBank.d499.s22|45-47|may|drug
DDI-DrugBank.d499.s22|49-53|cause|drug
DDI-DrugBank.d499.s22|55-61|changes|drug
DDI-DrugBank.d499.s22|63-64|in|drug
DDI-DrugBank.d499.s22|66-68|the|drug
DDI-DrugBank.d499.s22|70-80|elimination|drug
DDI-DrugBank.d499.s22|82-83|of|drug
DDI-DrugBank.d499.s22|85-96|methotrexate|drug
DDI-DrugBank.d499.s22|98-104|leading|drug
DDI-DrugBank.d499.s22|106-107|to|drug
DDI-DrugBank.d499.s22|109-116|elevated|drug
DDI-DrugBank.d499.s22|118-122|serum|drug
DDI-DrugBank.d499.s22|124-129|levels|drug
DDI-DrugBank.d499.s22|131-132|of|drug
DDI-DrugBank.d499.s22|134-136|the|drug
DDI-DrugBank.d499.s22|138-141|drug|drug
DDI-DrugBank.d499.s22|143-145|and|drug
DDI-DrugBank.d499.s22|147-155|increased|drug
DDI-DrugBank.d499.s22|157-164|toxicity|drug
DDI-DrugBank.d499.s22|165-165|.|drug
DDI-DrugBank.d499.s23|0-0|8|drug
DDI-DrugBank.d499.s23|1-1|.|drug
DDI-DrugBank.d499.s24|0-6|Lithium|drug
DDI-DrugBank.d499.s24|7-7|:|drug
DDI-DrugBank.d499.s24|9-20|Nonsteroidal|drug
DDI-DrugBank.d499.s24|22-38|anti-inflammatory|drug
DDI-DrugBank.d499.s24|40-45|agents|drug
DDI-DrugBank.d499.s24|47-50|have|drug
DDI-DrugBank.d499.s24|52-55|been|drug
DDI-DrugBank.d499.s24|57-64|reported|drug
DDI-DrugBank.d499.s24|66-67|to|drug
DDI-DrugBank.d499.s24|69-76|increase|drug
DDI-DrugBank.d499.s24|78-88|steadystate|drug
DDI-DrugBank.d499.s24|90-95|plasma|drug
DDI-DrugBank.d499.s24|97-103|lithium|drug
DDI-DrugBank.d499.s24|105-110|levels|drug
DDI-DrugBank.d499.s24|111-111|.|drug
DDI-DrugBank.d499.s25|0-1|It|drug
DDI-DrugBank.d499.s25|3-4|is|drug
DDI-DrugBank.d499.s25|6-16|recommended|drug
DDI-DrugBank.d499.s25|18-21|that|drug
DDI-DrugBank.d499.s25|23-28|plasma|drug
DDI-DrugBank.d499.s25|30-36|lithium|drug
DDI-DrugBank.d499.s25|38-43|levels|drug
DDI-DrugBank.d499.s25|45-46|be|drug
DDI-DrugBank.d499.s25|48-56|monitored|drug
DDI-DrugBank.d499.s25|58-61|when|drug
DDI-DrugBank.d499.s25|63-72|ketoprofen|drug
DDI-DrugBank.d499.s25|74-75|is|drug
DDI-DrugBank.d499.s25|77-90|coadministered|drug
DDI-DrugBank.d499.s25|92-95|with|drug
DDI-DrugBank.d499.s25|97-103|lithium|drug
DDI-DrugBank.d499.s25|104-104|.|drug
DDI-DrugBank.d499.s26|0-14|DRUG/LABORATORY|drug
DDI-DrugBank.d499.s26|16-19|TEST|drug
DDI-DrugBank.d499.s26|21-32|INTERACTIONS|drug
DDI-DrugBank.d499.s26|33-33|:|drug
DDI-DrugBank.d499.s26|35-40|EFFECT|drug
DDI-DrugBank.d499.s26|42-43|ON|drug
DDI-DrugBank.d499.s26|45-49|BLOOD|drug
DDI-DrugBank.d499.s26|51-61|COAGULATION|drug
DDI-DrugBank.d499.s26|63-72|Ketoprofen|drug
DDI-DrugBank.d499.s26|74-82|decreases|drug
DDI-DrugBank.d499.s26|84-91|platelet|drug
DDI-DrugBank.d499.s26|93-100|adhesion|drug
DDI-DrugBank.d499.s26|102-104|and|drug
DDI-DrugBank.d499.s26|106-116|aggregation|drug
DDI-DrugBank.d499.s26|117-117|.|drug
DDI-DrugBank.d499.s27|0-8|Therefore|drug
DDI-DrugBank.d499.s27|9-9|,|drug
DDI-DrugBank.d499.s27|11-12|it|drug
DDI-DrugBank.d499.s27|14-16|can|drug
DDI-DrugBank.d499.s27|18-24|prolong|drug
DDI-DrugBank.d499.s27|26-33|bleeding|drug
DDI-DrugBank.d499.s27|35-38|time|drug
DDI-DrugBank.d499.s27|40-41|by|drug
DDI-DrugBank.d499.s27|43-55|approximately|drug
DDI-DrugBank.d499.s27|57-57|3|drug
DDI-DrugBank.d499.s27|59-60|to|drug
DDI-DrugBank.d499.s27|62-62|4|drug
DDI-DrugBank.d499.s27|64-70|minutes|drug
DDI-DrugBank.d499.s27|72-75|from|drug
DDI-DrugBank.d499.s27|77-84|baseline|drug
DDI-DrugBank.d499.s27|86-91|values|drug
DDI-DrugBank.d499.s27|92-92|.|drug
DDI-DrugBank.d499.s28|0-4|There|drug
DDI-DrugBank.d499.s28|6-7|is|drug
DDI-DrugBank.d499.s28|9-10|no|drug
DDI-DrugBank.d499.s28|12-22|significant|drug
DDI-DrugBank.d499.s28|24-29|change|drug
DDI-DrugBank.d499.s28|31-32|in|drug
DDI-DrugBank.d499.s28|34-41|platelet|drug
DDI-DrugBank.d499.s28|43-47|count|drug
DDI-DrugBank.d499.s28|48-48|,|drug
DDI-DrugBank.d499.s28|50-60|prothrombin|drug
DDI-DrugBank.d499.s28|62-65|time|drug
DDI-DrugBank.d499.s28|66-66|,|drug
DDI-DrugBank.d499.s28|68-74|partial|drug
DDI-DrugBank.d499.s28|76-89|thromboplastin|drug
DDI-DrugBank.d499.s28|91-94|time|drug
DDI-DrugBank.d499.s28|95-95|,|drug
DDI-DrugBank.d499.s28|97-98|or|drug
DDI-DrugBank.d499.s28|100-107|thrombin|drug
DDI-DrugBank.d499.s28|109-112|time|drug
DDI-DrugBank.d499.s28|113-113|.|drug
DDI-DrugBank.d602.s0|0-6|Caution|drug
DDI-DrugBank.d602.s0|8-9|is|drug
DDI-DrugBank.d602.s0|11-21|recommended|drug
DDI-DrugBank.d602.s0|23-26|when|drug
DDI-DrugBank.d602.s0|28-40|administering|drug
DDI-DrugBank.d602.s0|42-48|NEXAVAR|drug
DDI-DrugBank.d602.s0|50-53|with|drug
DDI-DrugBank.d602.s0|55-63|compounds|drug
DDI-DrugBank.d602.s0|65-68|that|drug
DDI-DrugBank.d602.s0|70-72|are|drug
DDI-DrugBank.d602.s0|74-95|metabolized/eliminated|drug
DDI-DrugBank.d602.s0|97-109|predominantly|drug
DDI-DrugBank.d602.s0|111-112|by|drug
DDI-DrugBank.d602.s0|114-116|the|drug
DDI-DrugBank.d602.s0|118-123|UGT1A1|drug
DDI-DrugBank.d602.s0|125-131|pathway|drug
DDI-DrugBank.d602.s0|133-133|(|drug
DDI-DrugBank.d602.s0|134-137|e.g|drug
DDI-DrugBank.d602.s0|139-148|.|drug
DDI-DrugBank.d602.s0|149-149|irinotecan|drug
DDI-DrugBank.d602.s0|150-150|)|drug
DDI-DrugBank.d602.s1|0-10|Concomitant|drug
DDI-DrugBank.d602.s1|12-20|treatment|drug
DDI-DrugBank.d602.s1|22-25|with|drug
DDI-DrugBank.d602.s1|27-33|NEXAVAR|drug
DDI-DrugBank.d602.s1|35-42|resulted|drug
DDI-DrugBank.d602.s1|44-45|in|drug
DDI-DrugBank.d602.s1|47-47|a|drug
DDI-DrugBank.d602.s1|49-50|21|drug
DDI-DrugBank.d602.s1|51-51|%|drug
DDI-DrugBank.d602.s1|53-60|increase|drug
DDI-DrugBank.d602.s1|62-63|in|drug
DDI-DrugBank.d602.s1|65-67|the|drug
DDI-DrugBank.d602.s1|69-71|AUC|drug
DDI-DrugBank.d602.s1|73-74|of|drug
DDI-DrugBank.d602.s1|76-86|doxorubicin|drug
DDI-DrugBank.d602.s1|87-87|.|drug
DDI-DrugBank.d602.s2|0-6|Caution|drug
DDI-DrugBank.d602.s2|8-9|is|drug
DDI-DrugBank.d602.s2|11-21|recommended|drug
DDI-DrugBank.d602.s2|23-26|when|drug
DDI-DrugBank.d602.s2|28-40|administering|drug
DDI-DrugBank.d602.s2|42-52|doxorubicin|drug
DDI-DrugBank.d602.s2|54-57|with|drug
DDI-DrugBank.d602.s2|59-65|NEXAVAR|drug
DDI-DrugBank.d602.s2|66-66|.|drug
DDI-DrugBank.d602.s3|0-8|Sorafenib|drug
DDI-DrugBank.d602.s3|10-17|inhibits|drug
DDI-DrugBank.d602.s3|19-24|CYP2B6|drug
DDI-DrugBank.d602.s3|26-28|and|drug
DDI-DrugBank.d602.s3|30-35|CYP2C8|drug
DDI-DrugBank.d602.s3|37-38|in|drug
DDI-DrugBank.d602.s3|40-44|vitro|drug
DDI-DrugBank.d602.s3|46-49|with|drug
DDI-DrugBank.d602.s3|51-52|Ki|drug
DDI-DrugBank.d602.s3|54-59|values|drug
DDI-DrugBank.d602.s3|61-62|of|drug
DDI-DrugBank.d602.s3|64-64|6|drug
DDI-DrugBank.d602.s3|66-68|and|drug
DDI-DrugBank.d602.s3|70-72|1-2|drug
DDI-DrugBank.d602.s3|74-74|?|drug
DDI-DrugBank.d602.s3|75-75|M|drug
DDI-DrugBank.d602.s3|76-76|,|drug
DDI-DrugBank.d602.s3|78-89|respectively|drug
DDI-DrugBank.d602.s3|90-90|.|drug
DDI-DrugBank.d602.s4|0-7|Systemic|drug
DDI-DrugBank.d602.s4|9-16|exposure|drug
DDI-DrugBank.d602.s4|18-19|to|drug
DDI-DrugBank.d602.s4|21-30|substrates|drug
DDI-DrugBank.d602.s4|32-33|of|drug
DDI-DrugBank.d602.s4|35-40|CYP2B6|drug
DDI-DrugBank.d602.s4|42-44|and|drug
DDI-DrugBank.d602.s4|46-51|CYP2C8|drug
DDI-DrugBank.d602.s4|53-54|is|drug
DDI-DrugBank.d602.s4|56-63|expected|drug
DDI-DrugBank.d602.s4|65-66|to|drug
DDI-DrugBank.d602.s4|68-75|increase|drug
DDI-DrugBank.d602.s4|77-80|when|drug
DDI-DrugBank.d602.s4|82-96|co-administered|drug
DDI-DrugBank.d602.s4|98-101|with|drug
DDI-DrugBank.d602.s4|103-109|NEXAVAR|drug
DDI-DrugBank.d602.s4|110-110|.|drug
DDI-DrugBank.d602.s5|0-6|Caution|drug
DDI-DrugBank.d602.s5|8-9|is|drug
DDI-DrugBank.d602.s5|11-21|recommended|drug
DDI-DrugBank.d602.s5|23-26|when|drug
DDI-DrugBank.d602.s5|28-40|administering|drug
DDI-DrugBank.d602.s5|42-51|substrates|drug
DDI-DrugBank.d602.s5|53-54|of|drug
DDI-DrugBank.d602.s5|56-61|CYP2B6|drug
DDI-DrugBank.d602.s5|63-65|and|drug
DDI-DrugBank.d602.s5|67-72|CYP2C8|drug
DDI-DrugBank.d602.s5|74-77|with|drug
DDI-DrugBank.d602.s5|79-85|NEXAVAR|drug
DDI-DrugBank.d602.s5|86-86|.|drug
DDI-DrugBank.d167.s0|0-10|Potentially|drug
DDI-DrugBank.d167.s0|12-16|fatal|drug
DDI-DrugBank.d167.s0|18-21|drug|drug
DDI-DrugBank.d167.s0|23-34|interactions|drug
DDI-DrugBank.d167.s0|36-38|may|drug
DDI-DrugBank.d167.s0|40-44|occur|drug
DDI-DrugBank.d167.s0|46-49|when|drug
DDI-DrugBank.d167.s0|51-64|coadministered|drug
DDI-DrugBank.d167.s0|66-69|with|drug
DDI-DrugBank.d167.s0|71-77|digoxin|drug
DDI-DrugBank.d167.s0|78-78|,|drug
DDI-DrugBank.d167.s0|80-81|as|drug
DDI-DrugBank.d167.s0|83-86|this|drug
DDI-DrugBank.d167.s0|88-90|may|drug
DDI-DrugBank.d167.s0|92-98|enhance|drug
DDI-DrugBank.d167.s0|100-113|cardiovascular|drug
DDI-DrugBank.d167.s0|115-124|depression|drug
DDI-DrugBank.d167.s0|126-128|and|drug
DDI-DrugBank.d167.s0|130-145|bradyarrhythmias|drug
DDI-DrugBank.d167.s0|147-149|may|drug
DDI-DrugBank.d167.s0|151-155|occur|drug
DDI-DrugBank.d167.s0|156-156|.|drug
DDI-DrugBank.d167.s1|0-18|Anticholinesterases|drug
DDI-DrugBank.d167.s1|20-20|(|drug
DDI-DrugBank.d167.s1|21-30|neostgmine|drug
DDI-DrugBank.d167.s1|31-31|,|drug
DDI-DrugBank.d167.s1|33-45|physostigmine|drug
DDI-DrugBank.d167.s1|46-46|)|drug
DDI-DrugBank.d167.s1|47-47|,|drug
DDI-DrugBank.d167.s1|49-58|lignocaine|drug
DDI-DrugBank.d167.s1|59-59|,|drug
DDI-DrugBank.d167.s1|61-67|quinine|drug
DDI-DrugBank.d167.s1|68-68|,|drug
DDI-DrugBank.d167.s1|70-81|procainamide|drug
DDI-DrugBank.d167.s1|83-85|can|drug
DDI-DrugBank.d167.s1|87-93|enhance|drug
DDI-DrugBank.d167.s1|95-102|toxicity|drug
DDI-DrugBank.d167.s1|104-106|and|drug
DDI-DrugBank.d167.s1|108-112|cause|drug
DDI-DrugBank.d167.s1|114-119|cardio|drug
DDI-DrugBank.d167.s1|121-131|respiratory|drug
DDI-DrugBank.d167.s1|133-142|depression|drug
DDI-DrugBank.d167.s1|143-143|.|drug
DDI-DrugBank.d167.s2|0-1|In|drug
DDI-DrugBank.d167.s2|3-10|addition|drug
DDI-DrugBank.d167.s2|11-11|,|drug
DDI-DrugBank.d167.s2|13-25|neuromuscular|drug
DDI-DrugBank.d167.s2|27-34|blocking|drug
DDI-DrugBank.d167.s2|36-41|action|drug
DDI-DrugBank.d167.s2|43-44|is|drug
DDI-DrugBank.d167.s2|46-53|enhanced|drug
DDI-DrugBank.d167.s2|55-56|by|drug
DDI-DrugBank.d167.s2|58-64|general|drug
DDI-DrugBank.d167.s2|66-76|anesthetics|drug
DDI-DrugBank.d167.s2|77-77|,|drug
DDI-DrugBank.d167.s2|79-83|local|drug
DDI-DrugBank.d167.s2|85-95|anesthetics|drug
DDI-DrugBank.d167.s2|97-100|like|drug
DDI-DrugBank.d167.s2|102-110|lidocaine|drug
DDI-DrugBank.d167.s2|111-111|,|drug
DDI-DrugBank.d167.s2|113-120|procaine|drug
DDI-DrugBank.d167.s2|121-121|,|drug
DDI-DrugBank.d167.s2|123-135|beta-blockers|drug
DDI-DrugBank.d167.s2|136-136|,|drug
DDI-DrugBank.d167.s2|138-151|metaclopramide|drug
DDI-DrugBank.d167.s2|152-152|,|drug
DDI-DrugBank.d167.s2|154-160|lithium|drug
DDI-DrugBank.d167.s2|162-170|carbonate|drug
DDI-DrugBank.d167.s2|171-171|,|drug
DDI-DrugBank.d167.s2|173-175|and|drug
DDI-DrugBank.d167.s2|177-187|terbutaline|drug
DDI-DrugBank.d167.s2|188-188|.|drug
DDI-MedLine.d113.s0|0-13|Acid-catalyzed|drug
DDI-MedLine.d113.s0|15-25|ethanolysis|drug
DDI-MedLine.d113.s0|27-28|of|drug
DDI-MedLine.d113.s0|30-38|temazepam|drug
DDI-MedLine.d113.s0|40-41|in|drug
DDI-MedLine.d113.s0|43-51|anhydrous|drug
DDI-MedLine.d113.s0|53-55|and|drug
DDI-MedLine.d113.s0|57-63|aqueous|drug
DDI-MedLine.d113.s0|65-71|ethanol|drug
DDI-MedLine.d113.s0|73-81|solutions|drug
DDI-MedLine.d113.s0|82-82|.|drug
DDI-MedLine.d113.s1|0-2|The|drug
DDI-MedLine.d113.s1|4-18|benzodiazepines|drug
DDI-MedLine.d113.s1|20-22|are|drug
DDI-MedLine.d113.s1|24-24|a|drug
DDI-MedLine.d113.s1|26-31|family|drug
DDI-MedLine.d113.s1|33-34|of|drug
DDI-MedLine.d113.s1|36-45|anxiolytic|drug
DDI-MedLine.d113.s1|47-49|and|drug
DDI-MedLine.d113.s1|51-58|hypnotic|drug
DDI-MedLine.d113.s1|60-64|drugs|drug
DDI-MedLine.d113.s1|65-65|.|drug
DDI-MedLine.d113.s2|0-3|When|drug
DDI-MedLine.d113.s2|5-9|taken|drug
DDI-MedLine.d113.s2|11-22|concurrently|drug
DDI-MedLine.d113.s2|24-27|with|drug
DDI-MedLine.d113.s2|29-35|ethanol|drug
DDI-MedLine.d113.s2|36-36|,|drug
DDI-MedLine.d113.s2|38-38|a|drug
DDI-MedLine.d113.s2|40-54|pharmacological|drug
DDI-MedLine.d113.s2|56-66|interaction|drug
DDI-MedLine.d113.s2|68-70|may|drug
DDI-MedLine.d113.s2|72-76|occur|drug
DDI-MedLine.d113.s2|77-77|,|drug
DDI-MedLine.d113.s2|79-90|potentiating|drug
DDI-MedLine.d113.s2|92-94|the|drug
DDI-MedLine.d113.s2|96-102|central|drug
DDI-MedLine.d113.s2|104-110|nervous|drug
DDI-MedLine.d113.s2|112-117|system|drug
DDI-MedLine.d113.s2|119-128|depression|drug
DDI-MedLine.d113.s2|130-137|produced|drug
DDI-MedLine.d113.s2|139-140|by|drug
DDI-MedLine.d113.s2|142-147|either|drug
DDI-MedLine.d113.s2|149-152|drug|drug
DDI-MedLine.d113.s2|153-153|.|drug
DDI-MedLine.d113.s3|0-1|In|drug
DDI-MedLine.d113.s3|3-10|addition|drug
DDI-MedLine.d113.s3|12-13|to|drug
DDI-MedLine.d113.s3|15-18|this|drug
DDI-MedLine.d113.s3|20-34|pharmacological|drug
DDI-MedLine.d113.s3|36-46|interaction|drug
DDI-MedLine.d113.s3|47-47|,|drug
DDI-MedLine.d113.s3|49-52|this|drug
DDI-MedLine.d113.s3|54-59|report|drug
DDI-MedLine.d113.s3|61-69|describes|drug
DDI-MedLine.d113.s3|71-71|a|drug
DDI-MedLine.d113.s3|73-77|novel|drug
DDI-MedLine.d113.s3|79-86|chemical|drug
DDI-MedLine.d113.s3|88-95|reaction|drug
DDI-MedLine.d113.s3|97-103|between|drug
DDI-MedLine.d113.s3|105-113|temazepam|drug
DDI-MedLine.d113.s3|115-115|(|drug
DDI-MedLine.d113.s3|116-116|a|drug
DDI-MedLine.d113.s3|118-131|benzodiazepine|drug
DDI-MedLine.d113.s3|132-132|)|drug
DDI-MedLine.d113.s3|134-136|and|drug
DDI-MedLine.d113.s3|138-144|ethanol|drug
DDI-MedLine.d113.s3|146-150|under|drug
DDI-MedLine.d113.s3|152-157|acidic|drug
DDI-MedLine.d113.s3|159-168|conditions|drug
DDI-MedLine.d113.s3|170-176|similar|drug
DDI-MedLine.d113.s3|178-179|to|drug
DDI-MedLine.d113.s3|181-185|those|drug
DDI-MedLine.d113.s3|187-191|found|drug
DDI-MedLine.d113.s3|193-194|in|drug
DDI-MedLine.d113.s3|196-199|vivo|drug
DDI-MedLine.d113.s3|200-200|,|drug
DDI-MedLine.d113.s3|202-210|resulting|drug
DDI-MedLine.d113.s3|212-213|in|drug
DDI-MedLine.d113.s3|215-215|a|drug
DDI-MedLine.d113.s3|217-229|3-ethoxylated|drug
DDI-MedLine.d113.s3|231-237|product|drug
DDI-MedLine.d113.s3|238-238|.|drug
DDI-MedLine.d113.s4|0-6|Optimal|drug
DDI-MedLine.d113.s4|8-17|conditions|drug
DDI-MedLine.d113.s4|18-18|,|drug
DDI-MedLine.d113.s4|20-27|kinetics|drug
DDI-MedLine.d113.s4|28-28|,|drug
DDI-MedLine.d113.s4|30-40|equilibrium|drug
DDI-MedLine.d113.s4|41-41|,|drug
DDI-MedLine.d113.s4|43-45|and|drug
DDI-MedLine.d113.s4|47-49|the|drug
DDI-MedLine.d113.s4|51-59|mechanism|drug
DDI-MedLine.d113.s4|61-62|of|drug
DDI-MedLine.d113.s4|64-67|this|drug
DDI-MedLine.d113.s4|69-82|acid-catalyzed|drug
DDI-MedLine.d113.s4|84-94|ethanolysis|drug
DDI-MedLine.d113.s4|96-98|are|drug
DDI-MedLine.d113.s4|100-107|reported|drug
DDI-MedLine.d113.s4|108-108|.|drug
DDI-MedLine.d113.s5|0-2|The|drug
DDI-MedLine.d113.s5|4-10|results|drug
DDI-MedLine.d113.s5|12-16|raise|drug
DDI-MedLine.d113.s5|18-20|the|drug
DDI-MedLine.d113.s5|22-32|possibility|drug
DDI-MedLine.d113.s5|34-37|that|drug
DDI-MedLine.d113.s5|39-41|the|drug
DDI-MedLine.d113.s5|43-53|ethanolysis|drug
DDI-MedLine.d113.s5|55-62|reaction|drug
DDI-MedLine.d113.s5|64-66|may|drug
DDI-MedLine.d113.s5|68-72|occur|drug
DDI-MedLine.d113.s5|74-75|in|drug
DDI-MedLine.d113.s5|77-79|the|drug
DDI-MedLine.d113.s5|81-87|stomach|drug
DDI-MedLine.d113.s5|89-90|of|drug
DDI-MedLine.d113.s5|92-97|people|drug
DDI-MedLine.d113.s5|99-101|who|drug
DDI-MedLine.d113.s5|103-109|consume|drug
DDI-MedLine.d113.s5|111-117|alcohol|drug
DDI-MedLine.d113.s5|119-121|and|drug
DDI-MedLine.d113.s5|123-150|3-hydroxy-1,4-benzodiazepine|drug
DDI-MedLine.d113.s5|152-153|on|drug
DDI-MedLine.d113.s5|155-155|a|drug
DDI-MedLine.d113.s5|157-163|regular|drug
DDI-MedLine.d113.s5|165-169|basis|drug
DDI-MedLine.d113.s5|170-170|.|drug
DDI-MedLine.d113.s6|0-2|The|drug
DDI-MedLine.d113.s6|4-17|acid-catalyzed|drug
DDI-MedLine.d113.s6|19-30|ethanol-drug|drug
DDI-MedLine.d113.s6|32-39|reaction|drug
DDI-MedLine.d113.s6|41-42|is|drug
DDI-MedLine.d113.s6|44-44|a|drug
DDI-MedLine.d113.s6|46-55|relatively|drug
DDI-MedLine.d113.s6|57-66|unexplored|drug
DDI-MedLine.d113.s6|68-71|area|drug
DDI-MedLine.d113.s6|73-75|and|drug
DDI-MedLine.d113.s6|77-79|may|drug
DDI-MedLine.d113.s6|81-85|alter|drug
DDI-MedLine.d113.s6|87-89|the|drug
DDI-MedLine.d113.s6|91-105|pharmacological|drug
DDI-MedLine.d113.s6|107-112|action|drug
DDI-MedLine.d113.s6|114-115|of|drug
DDI-MedLine.d113.s6|117-120|some|drug
DDI-MedLine.d113.s6|122-126|drugs|drug
DDI-MedLine.d113.s6|127-127|.|drug
DDI-DrugBank.d103.s0|0-11|Short-Acting|drug
DDI-DrugBank.d103.s0|13-26|beta2-agonists|drug
DDI-DrugBank.d103.s0|27-27|:|drug
DDI-DrugBank.d103.s0|29-35|Aerosol|drug
DDI-DrugBank.d103.s0|37-51|bronchodilators|drug
DDI-DrugBank.d103.s0|53-54|of|drug
DDI-DrugBank.d103.s0|56-58|the|drug
DDI-DrugBank.d103.s0|60-71|short-acting|drug
DDI-DrugBank.d103.s0|73-82|adrenergic|drug
DDI-DrugBank.d103.s0|84-92|stimulant|drug
DDI-DrugBank.d103.s0|94-97|type|drug
DDI-DrugBank.d103.s0|99-101|may|drug
DDI-DrugBank.d103.s0|103-104|be|drug
DDI-DrugBank.d103.s0|106-109|used|drug
DDI-DrugBank.d103.s0|111-113|for|drug
DDI-DrugBank.d103.s0|115-120|relief|drug
DDI-DrugBank.d103.s0|122-123|of|drug
DDI-DrugBank.d103.s0|125-136|breakthrough|drug
DDI-DrugBank.d103.s0|138-145|symptoms|drug
DDI-DrugBank.d103.s0|147-151|while|drug
DDI-DrugBank.d103.s0|153-157|using|drug
DDI-DrugBank.d103.s0|159-168|formoterol|drug
DDI-DrugBank.d103.s0|169-169|.|drug
DDI-DrugBank.d103.s1|0-6|However|drug
DDI-DrugBank.d103.s1|7-7|,|drug
DDI-DrugBank.d103.s1|9-18|increasing|drug
DDI-DrugBank.d103.s1|20-22|use|drug
DDI-DrugBank.d103.s1|24-25|of|drug
DDI-DrugBank.d103.s1|27-30|such|drug
DDI-DrugBank.d103.s1|32-43|preparations|drug
DDI-DrugBank.d103.s1|45-46|to|drug
DDI-DrugBank.d103.s1|48-54|control|drug
DDI-DrugBank.d103.s1|56-63|symptoms|drug
DDI-DrugBank.d103.s1|65-73|indicates|drug
DDI-DrugBank.d103.s1|75-87|deterioration|drug
DDI-DrugBank.d103.s1|89-90|of|drug
DDI-DrugBank.d103.s1|92-97|asthma|drug
DDI-DrugBank.d103.s1|99-105|control|drug
DDI-DrugBank.d103.s1|107-109|and|drug
DDI-DrugBank.d103.s1|111-113|the|drug
DDI-DrugBank.d103.s1|115-118|need|drug
DDI-DrugBank.d103.s1|120-121|to|drug
DDI-DrugBank.d103.s1|123-130|reassess|drug
DDI-DrugBank.d103.s1|132-134|the|drug
DDI-DrugBank.d103.s1|136-142|patient|drug
DDI-DrugBank.d103.s1|144-144|s|drug
DDI-DrugBank.d103.s1|146-152|therapy|drug
DDI-DrugBank.d103.s1|153-153|.|drug
DDI-DrugBank.d103.s2|0-10|Concomitant|drug
DDI-DrugBank.d103.s2|12-25|administration|drug
DDI-DrugBank.d103.s2|27-28|of|drug
DDI-DrugBank.d103.s2|30-34|other|drug
DDI-DrugBank.d103.s2|36-50|sympathomimetic|drug
DDI-DrugBank.d103.s2|52-57|agents|drug
DDI-DrugBank.d103.s2|59-61|may|drug
DDI-DrugBank.d103.s2|63-72|potentiate|drug
DDI-DrugBank.d103.s2|74-76|the|drug
DDI-DrugBank.d103.s2|78-88|undesirable|drug
DDI-DrugBank.d103.s2|90-96|effects|drug
DDI-DrugBank.d103.s2|98-99|of|drug
DDI-DrugBank.d103.s2|101-107|FORADIL|drug
DDI-DrugBank.d103.s2|108-108|.|drug
DDI-DrugBank.d103.s3|0-8|Monoamine|drug
DDI-DrugBank.d103.s3|10-16|Oxidase|drug
DDI-DrugBank.d103.s3|18-27|Inhibitors|drug
DDI-DrugBank.d103.s3|29-31|and|drug
DDI-DrugBank.d103.s3|33-41|Tricyclic|drug
DDI-DrugBank.d103.s3|43-57|Antidepressants|drug
DDI-DrugBank.d103.s3|58-58|:|drug
DDI-DrugBank.d103.s3|60-66|FORADIL|drug
DDI-DrugBank.d103.s3|68-73|should|drug
DDI-DrugBank.d103.s3|75-76|be|drug
DDI-DrugBank.d103.s3|78-89|administered|drug
DDI-DrugBank.d103.s3|91-94|with|drug
DDI-DrugBank.d103.s3|96-102|extreme|drug
DDI-DrugBank.d103.s3|104-110|caution|drug
DDI-DrugBank.d103.s3|112-113|in|drug
DDI-DrugBank.d103.s3|115-122|patients|drug
DDI-DrugBank.d103.s3|124-128|being|drug
DDI-DrugBank.d103.s3|130-136|treated|drug
DDI-DrugBank.d103.s3|138-141|with|drug
DDI-DrugBank.d103.s3|143-151|monoamine|drug
DDI-DrugBank.d103.s3|153-159|oxidase|drug
DDI-DrugBank.d103.s3|161-170|inhibitors|drug
DDI-DrugBank.d103.s3|172-173|or|drug
DDI-DrugBank.d103.s3|175-183|tricyclic|drug
DDI-DrugBank.d103.s3|185-199|antidepressants|drug
DDI-DrugBank.d103.s3|201-207|because|drug
DDI-DrugBank.d103.s3|209-211|the|drug
DDI-DrugBank.d103.s3|213-218|action|drug
DDI-DrugBank.d103.s3|220-221|of|drug
DDI-DrugBank.d103.s3|223-232|formoterol|drug
DDI-DrugBank.d103.s3|234-235|on|drug
DDI-DrugBank.d103.s3|237-239|the|drug
DDI-DrugBank.d103.s3|241-254|cardiovascular|drug
DDI-DrugBank.d103.s3|256-261|system|drug
DDI-DrugBank.d103.s3|263-265|may|drug
DDI-DrugBank.d103.s3|267-268|be|drug
DDI-DrugBank.d103.s3|270-280|potentiated|drug
DDI-DrugBank.d103.s3|282-283|by|drug
DDI-DrugBank.d103.s3|285-289|these|drug
DDI-DrugBank.d103.s3|291-296|agents|drug
DDI-DrugBank.d103.s3|297-297|.|drug
DDI-DrugBank.d103.s4|0-14|Corticosteroids|drug
DDI-DrugBank.d103.s4|15-15|,|drug
DDI-DrugBank.d103.s4|17-31|Methylxanthines|drug
DDI-DrugBank.d103.s4|33-35|and|drug
DDI-DrugBank.d103.s4|37-45|Diuretics|drug
DDI-DrugBank.d103.s4|46-46|:|drug
DDI-DrugBank.d103.s4|48-58|Concomitant|drug
DDI-DrugBank.d103.s4|60-68|treatment|drug
DDI-DrugBank.d103.s4|70-73|with|drug
DDI-DrugBank.d103.s4|75-82|xanthine|drug
DDI-DrugBank.d103.s4|84-94|derivatives|drug
DDI-DrugBank.d103.s4|95-95|,|drug
DDI-DrugBank.d103.s4|97-104|steroids|drug
DDI-DrugBank.d103.s4|105-105|,|drug
DDI-DrugBank.d103.s4|107-108|or|drug
DDI-DrugBank.d103.s4|110-118|diuretics|drug
DDI-DrugBank.d103.s4|120-122|may|drug
DDI-DrugBank.d103.s4|124-133|potentiate|drug
DDI-DrugBank.d103.s4|135-135|a|drug
DDI-DrugBank.d103.s4|137-144|possible|drug
DDI-DrugBank.d103.s4|146-156|hypokalemic|drug
DDI-DrugBank.d103.s4|158-163|effect|drug
DDI-DrugBank.d103.s4|165-166|of|drug
DDI-DrugBank.d103.s4|169-182|beta2-agonists|drug
DDI-DrugBank.d103.s4|183-183|.|drug
DDI-DrugBank.d103.s5|0-10|Hypokalemia|drug
DDI-DrugBank.d103.s5|12-14|may|drug
DDI-DrugBank.d103.s5|16-23|increase|drug
DDI-DrugBank.d103.s5|25-38|susceptibility|drug
DDI-DrugBank.d103.s5|40-41|to|drug
DDI-DrugBank.d103.s5|43-49|cardiac|drug
DDI-DrugBank.d103.s5|51-61|arrhythmias|drug
DDI-DrugBank.d103.s5|63-64|in|drug
DDI-DrugBank.d103.s5|66-73|patients|drug
DDI-DrugBank.d103.s5|75-81|treated|drug
DDI-DrugBank.d103.s5|83-86|with|drug
DDI-DrugBank.d103.s5|88-96|digitalis|drug
DDI-DrugBank.d103.s5|97-97|.|drug
DDI-DrugBank.d103.s6|0-10|-adrenergic|drug
DDI-DrugBank.d103.s6|12-19|Blockers|drug
DDI-DrugBank.d103.s6|20-20|:|drug
DDI-DrugBank.d103.s6|23-33|-adrenergic|drug
DDI-DrugBank.d103.s6|35-42|blockers|drug
DDI-DrugBank.d103.s6|44-46|may|drug
DDI-DrugBank.d103.s6|48-53|weaken|drug
DDI-DrugBank.d103.s6|55-56|or|drug
DDI-DrugBank.d103.s6|58-67|antagonise|drug
DDI-DrugBank.d103.s6|69-71|the|drug
DDI-DrugBank.d103.s6|73-78|effect|drug
DDI-DrugBank.d103.s6|80-81|of|drug
DDI-DrugBank.d103.s6|83-89|FORADIL|drug
DDI-DrugBank.d103.s6|90-90|.|drug
DDI-DrugBank.d103.s7|0-8|Therefore|drug
DDI-DrugBank.d103.s7|10-16|FORADIL|drug
DDI-DrugBank.d103.s7|18-23|should|drug
DDI-DrugBank.d103.s7|25-27|not|drug
DDI-DrugBank.d103.s7|29-30|be|drug
DDI-DrugBank.d103.s7|32-36|given|drug
DDI-DrugBank.d103.s7|38-45|together|drug
DDI-DrugBank.d103.s7|47-50|with|drug
DDI-DrugBank.d103.s7|53-63|-adrenergic|drug
DDI-DrugBank.d103.s7|65-72|blockers|drug
DDI-DrugBank.d103.s7|74-74|(|drug
DDI-DrugBank.d103.s7|75-83|including|drug
DDI-DrugBank.d103.s7|85-87|eye|drug
DDI-DrugBank.d103.s7|89-93|drops|drug
DDI-DrugBank.d103.s7|94-94|)|drug
DDI-DrugBank.d103.s7|96-101|unless|drug
DDI-DrugBank.d103.s7|103-107|there|drug
DDI-DrugBank.d103.s7|109-111|are|drug
DDI-DrugBank.d103.s7|113-122|compelling|drug
DDI-DrugBank.d103.s7|124-130|reasons|drug
DDI-DrugBank.d103.s7|132-134|for|drug
DDI-DrugBank.d103.s7|136-140|their|drug
DDI-DrugBank.d103.s7|142-144|use|drug
DDI-DrugBank.d103.s7|145-145|.|drug
DDI-DrugBank.d103.s8|0-4|Other|drug
DDI-DrugBank.d103.s8|6-10|Drugs|drug
DDI-DrugBank.d103.s8|11-11|:|drug
DDI-DrugBank.d103.s8|12-16|Drugs|drug
DDI-DrugBank.d103.s8|18-21|such|drug
DDI-DrugBank.d103.s8|23-24|as|drug
DDI-DrugBank.d103.s8|26-34|quinidine|drug
DDI-DrugBank.d103.s8|35-35|,|drug
DDI-DrugBank.d103.s8|37-48|disopyramide|drug
DDI-DrugBank.d103.s8|49-49|,|drug
DDI-DrugBank.d103.s8|51-62|procainamide|drug
DDI-DrugBank.d103.s8|63-63|,|drug
DDI-DrugBank.d103.s8|65-78|phenothiazines|drug
DDI-DrugBank.d103.s8|79-79|,|drug
DDI-DrugBank.d103.s8|81-94|antihistamines|drug
DDI-DrugBank.d103.s8|95-95|,|drug
DDI-DrugBank.d103.s8|97-99|and|drug
DDI-DrugBank.d103.s8|101-109|tricyclic|drug
DDI-DrugBank.d103.s8|111-125|antidepressants|drug
DDI-DrugBank.d103.s8|127-129|may|drug
DDI-DrugBank.d103.s8|131-132|be|drug
DDI-DrugBank.d103.s8|134-143|associated|drug
DDI-DrugBank.d103.s8|145-148|with|drug
DDI-DrugBank.d103.s8|150-160|QT-interval|drug
DDI-DrugBank.d103.s8|162-173|prolongation|drug
DDI-DrugBank.d103.s8|175-177|and|drug
DDI-DrugBank.d103.s8|179-180|an|drug
DDI-DrugBank.d103.s8|182-190|increased|drug
DDI-DrugBank.d103.s8|192-195|risk|drug
DDI-DrugBank.d103.s8|197-198|of|drug
DDI-DrugBank.d103.s8|200-210|ventricular|drug
DDI-DrugBank.d103.s8|212-221|arrhythmia|drug
DDI-DrugBank.d103.s8|222-222|.|drug
DDI-DrugBank.d103.s9|0-10|INFORMATION|drug
DDI-DrugBank.d103.s9|12-13|TO|drug
DDI-DrugBank.d103.s9|15-16|BE|drug
DDI-DrugBank.d103.s9|18-25|PROVIDED|drug
DDI-DrugBank.d103.s9|27-28|TO|drug
DDI-DrugBank.d103.s9|30-32|THE|drug
DDI-DrugBank.d103.s9|34-40|PATIENT|drug
DDI-DrugBank.d103.s9|42-43|OR|drug
DDI-DrugBank.d103.s9|45-52|GUARDIAN|drug
DDI-DrugBank.d103.s9|54-56|See|drug
DDI-DrugBank.d103.s9|58-68|illustrated|drug
DDI-DrugBank.d103.s9|70-80|Information|drug
DDI-DrugBank.d103.s9|82-84|For|drug
DDI-DrugBank.d103.s9|86-88|The|drug
DDI-DrugBank.d103.s9|90-96|Patient|drug
DDI-DrugBank.d103.s9|98-99|or|drug
DDI-DrugBank.d103.s9|101-108|Guardian|drug
DDI-DrugBank.d103.s9|110-116|section|drug
DDI-DrugBank.d103.s9|117-117|.|drug
DDI-DrugBank.d103.s10|0-1|It|drug
DDI-DrugBank.d103.s10|3-4|is|drug
DDI-DrugBank.d103.s10|6-14|important|drug
DDI-DrugBank.d103.s10|16-19|that|drug
DDI-DrugBank.d103.s10|21-28|patients|drug
DDI-DrugBank.d103.s10|30-39|understand|drug
DDI-DrugBank.d103.s10|41-43|how|drug
DDI-DrugBank.d103.s10|45-46|to|drug
DDI-DrugBank.d103.s10|48-50|use|drug
DDI-DrugBank.d103.s10|52-58|FORADIL|drug
DDI-DrugBank.d103.s10|61-61|(|drug
DDI-DrugBank.d103.s10|62-71|formoterol|drug
DDI-DrugBank.d103.s10|73-80|fumarate|drug
DDI-DrugBank.d103.s10|81-81|)|drug
DDI-DrugBank.d103.s10|83-90|capsules|drug
DDI-DrugBank.d103.s10|92-95|with|drug
DDI-DrugBank.d103.s10|97-99|the|drug
DDI-DrugBank.d103.s10|101-108|supplied|drug
DDI-DrugBank.d103.s10|110-120|AerolizerTM|drug
DDI-DrugBank.d103.s10|122-131|inhalation|drug
DDI-DrugBank.d103.s10|133-138|device|drug
DDI-DrugBank.d103.s10|140-142|and|drug
DDI-DrugBank.d103.s10|144-146|how|drug
DDI-DrugBank.d103.s10|148-149|it|drug
DDI-DrugBank.d103.s10|151-156|should|drug
DDI-DrugBank.d103.s10|158-159|be|drug
DDI-DrugBank.d103.s10|161-164|used|drug
DDI-DrugBank.d103.s10|166-167|in|drug
DDI-DrugBank.d103.s10|169-176|relation|drug
DDI-DrugBank.d103.s10|178-179|to|drug
DDI-DrugBank.d103.s10|181-185|other|drug
DDI-DrugBank.d103.s10|187-192|asthma|drug
DDI-DrugBank.d103.s10|194-195|or|drug
DDI-DrugBank.d103.s10|197-200|COPD|drug
DDI-DrugBank.d103.s10|202-212|medications|drug
DDI-DrugBank.d103.s10|214-217|they|drug
DDI-DrugBank.d103.s10|219-221|are|drug
DDI-DrugBank.d103.s10|223-228|taking|drug
DDI-DrugBank.d103.s10|229-229|.|drug
DDI-DrugBank.d103.s11|0-17|Patients/Guardians|drug
DDI-DrugBank.d103.s11|19-24|should|drug
DDI-DrugBank.d103.s11|26-27|be|drug
DDI-DrugBank.d103.s11|29-33|given|drug
DDI-DrugBank.d103.s11|35-37|the|drug
DDI-DrugBank.d103.s11|39-47|following|drug
DDI-DrugBank.d103.s11|49-59|information|drug
DDI-DrugBank.d103.s11|60-60|:|drug
DDI-DrugBank.d103.s11|62-62|i|drug
DDI-DrugBank.d103.s11|63-63|.|drug
DDI-DrugBank.d103.s12|0-2|The|drug
DDI-DrugBank.d103.s12|4-14|recommended|drug
DDI-DrugBank.d103.s12|16-21|dosage|drug
DDI-DrugBank.d103.s12|23-23|(|drug
DDI-DrugBank.d103.s12|24-26|one|drug
DDI-DrugBank.d103.s12|28-29|or|drug
DDI-DrugBank.d103.s12|31-33|two|drug
DDI-DrugBank.d103.s12|35-42|capsules|drug
DDI-DrugBank.d103.s12|44-48|twice|drug
DDI-DrugBank.d103.s12|50-54|daily|drug
DDI-DrugBank.d103.s12|55-55|,|drug
DDI-DrugBank.d103.s12|57-63|morning|drug
DDI-DrugBank.d103.s12|65-67|and|drug
DDI-DrugBank.d103.s12|69-75|evening|drug
DDI-DrugBank.d103.s12|76-76|)|drug
DDI-DrugBank.d103.s12|78-83|should|drug
DDI-DrugBank.d103.s12|85-87|not|drug
DDI-DrugBank.d103.s12|89-90|be|drug
DDI-DrugBank.d103.s12|92-99|exceeded|drug
DDI-DrugBank.d103.s12|100-100|.|drug
DDI-DrugBank.d103.s13|0-1|ii|drug
DDI-DrugBank.d103.s13|2-2|.|drug
DDI-DrugBank.d103.s14|0-6|FORADIL|drug
DDI-DrugBank.d103.s14|8-9|is|drug
DDI-DrugBank.d103.s14|11-13|not|drug
DDI-DrugBank.d103.s14|15-19|meant|drug
DDI-DrugBank.d103.s14|21-22|to|drug
DDI-DrugBank.d103.s14|24-30|relieve|drug
DDI-DrugBank.d103.s14|32-36|acute|drug
DDI-DrugBank.d103.s14|38-43|asthma|drug
DDI-DrugBank.d103.s14|45-46|or|drug
DDI-DrugBank.d103.s14|48-51|COPD|drug
DDI-DrugBank.d103.s14|53-60|symptoms|drug
DDI-DrugBank.d103.s14|62-64|and|drug
DDI-DrugBank.d103.s14|66-70|extra|drug
DDI-DrugBank.d103.s14|72-76|doses|drug
DDI-DrugBank.d103.s14|78-83|should|drug
DDI-DrugBank.d103.s14|85-87|not|drug
DDI-DrugBank.d103.s14|89-90|be|drug
DDI-DrugBank.d103.s14|92-95|used|drug
DDI-DrugBank.d103.s14|97-99|for|drug
DDI-DrugBank.d103.s14|101-104|that|drug
DDI-DrugBank.d103.s14|106-112|purpose|drug
DDI-DrugBank.d103.s14|113-113|.|drug
DDI-DrugBank.d103.s15|0-4|Acute|drug
DDI-DrugBank.d103.s15|6-13|symptoms|drug
DDI-DrugBank.d103.s15|15-20|should|drug
DDI-DrugBank.d103.s15|22-23|be|drug
DDI-DrugBank.d103.s15|25-31|treated|drug
DDI-DrugBank.d103.s15|33-36|with|drug
DDI-DrugBank.d103.s15|38-38|a|drug
DDI-DrugBank.d103.s15|40-51|short-acting|drug
DDI-DrugBank.d103.s15|52-52|,|drug
DDI-DrugBank.d103.s15|54-60|inhaled|drug
DDI-DrugBank.d103.s15|63-75|beta2-agonist|drug
DDI-DrugBank.d103.s15|77-80|such|drug
DDI-DrugBank.d103.s15|82-83|as|drug
DDI-DrugBank.d103.s15|85-94|salbutamol|drug
DDI-DrugBank.d103.s15|96-96|(|drug
DDI-DrugBank.d103.s15|97-99|the|drug
DDI-DrugBank.d103.s15|101-109|physician|drug
DDI-DrugBank.d103.s15|111-116|should|drug
DDI-DrugBank.d103.s15|118-124|provide|drug
DDI-DrugBank.d103.s15|126-128|the|drug
DDI-DrugBank.d103.s15|130-136|patient|drug
DDI-DrugBank.d103.s15|138-141|with|drug
DDI-DrugBank.d103.s15|143-146|such|drug
DDI-DrugBank.d103.s15|148-157|medication|drug
DDI-DrugBank.d103.s15|159-161|and|drug
DDI-DrugBank.d103.s15|163-170|instruct|drug
DDI-DrugBank.d103.s15|172-174|the|drug
DDI-DrugBank.d103.s15|176-182|patient|drug
DDI-DrugBank.d103.s15|184-185|in|drug
DDI-DrugBank.d103.s15|187-189|how|drug
DDI-DrugBank.d103.s15|191-192|it|drug
DDI-DrugBank.d103.s15|194-199|should|drug
DDI-DrugBank.d103.s15|201-202|be|drug
DDI-DrugBank.d103.s15|204-207|used|drug
DDI-DrugBank.d103.s15|208-208|)|drug
DDI-DrugBank.d103.s15|209-209|.|drug
DDI-DrugBank.d103.s16|0-2|iii|drug
DDI-DrugBank.d103.s16|3-3|.|drug
DDI-DrugBank.d103.s17|0-2|The|drug
DDI-DrugBank.d103.s17|4-12|physician|drug
DDI-DrugBank.d103.s17|14-19|should|drug
DDI-DrugBank.d103.s17|21-22|be|drug
DDI-DrugBank.d103.s17|24-31|notified|drug
DDI-DrugBank.d103.s17|33-43|immediately|drug
DDI-DrugBank.d103.s17|45-46|if|drug
DDI-DrugBank.d103.s17|48-50|any|drug
DDI-DrugBank.d103.s17|52-53|of|drug
DDI-DrugBank.d103.s17|55-57|the|drug
DDI-DrugBank.d103.s17|59-67|following|drug
DDI-DrugBank.d103.s17|69-78|situations|drug
DDI-DrugBank.d103.s17|80-84|occur|drug
DDI-DrugBank.d103.s17|85-85|,|drug
DDI-DrugBank.d103.s17|87-91|which|drug
DDI-DrugBank.d103.s17|93-95|may|drug
DDI-DrugBank.d103.s17|97-98|be|drug
DDI-DrugBank.d103.s17|100-100|a|drug
DDI-DrugBank.d103.s17|102-105|sign|drug
DDI-DrugBank.d103.s17|107-108|of|drug
DDI-DrugBank.d103.s17|110-118|seriously|drug
DDI-DrugBank.d103.s17|120-128|worsening|drug
DDI-DrugBank.d103.s17|130-135|asthma|drug
DDI-DrugBank.d103.s17|136-136|:|drug
DDI-DrugBank.d103.s17|140-148|Decreased|drug
DDI-DrugBank.d103.s17|150-162|effectiveness|drug
DDI-DrugBank.d103.s17|164-165|of|drug
DDI-DrugBank.d103.s17|167-178|short-acting|drug
DDI-DrugBank.d103.s17|179-179|,|drug
DDI-DrugBank.d103.s17|181-187|inhaled|drug
DDI-DrugBank.d103.s17|189-202|beta2-agonists|drug
DDI-DrugBank.d103.s17|203-203|;|drug
DDI-DrugBank.d103.s18|0-3|Need|drug
DDI-DrugBank.d103.s18|5-7|for|drug
DDI-DrugBank.d103.s18|9-12|more|drug
DDI-DrugBank.d103.s18|14-24|inhalations|drug
DDI-DrugBank.d103.s18|26-29|than|drug
DDI-DrugBank.d103.s18|31-35|usual|drug
DDI-DrugBank.d103.s18|37-38|of|drug
DDI-DrugBank.d103.s18|40-51|short-acting|drug
DDI-DrugBank.d103.s18|52-52|,|drug
DDI-DrugBank.d103.s18|54-60|inhaled|drug
DDI-DrugBank.d103.s18|62-75|beta2-agonists|drug
DDI-DrugBank.d103.s18|76-76|.|drug
DDI-DrugBank.d103.s19|0-1|iv|drug
DDI-DrugBank.d103.s19|2-2|.|drug
DDI-DrugBank.d103.s20|0-6|FORADIL|drug
DDI-DrugBank.d103.s20|8-13|should|drug
DDI-DrugBank.d103.s20|15-17|not|drug
DDI-DrugBank.d103.s20|19-20|be|drug
DDI-DrugBank.d103.s20|22-25|used|drug
DDI-DrugBank.d103.s20|27-28|as|drug
DDI-DrugBank.d103.s20|30-30|a|drug
DDI-DrugBank.d103.s20|32-41|substitute|drug
DDI-DrugBank.d103.s20|43-45|for|drug
DDI-DrugBank.d103.s20|47-50|oral|drug
DDI-DrugBank.d103.s20|52-53|or|drug
DDI-DrugBank.d103.s20|55-61|inhaled|drug
DDI-DrugBank.d103.s20|63-77|corticosteroids|drug
DDI-DrugBank.d103.s20|78-78|.|drug
DDI-DrugBank.d103.s21|0-2|The|drug
DDI-DrugBank.d103.s21|4-9|dosage|drug
DDI-DrugBank.d103.s21|11-12|of|drug
DDI-DrugBank.d103.s21|14-18|these|drug
DDI-DrugBank.d103.s21|20-30|medications|drug
DDI-DrugBank.d103.s21|32-37|should|drug
DDI-DrugBank.d103.s21|39-41|not|drug
DDI-DrugBank.d103.s21|43-44|be|drug
DDI-DrugBank.d103.s21|46-52|changed|drug
DDI-DrugBank.d103.s21|54-56|and|drug
DDI-DrugBank.d103.s21|58-61|they|drug
DDI-DrugBank.d103.s21|63-68|should|drug
DDI-DrugBank.d103.s21|70-72|not|drug
DDI-DrugBank.d103.s21|74-75|be|drug
DDI-DrugBank.d103.s21|77-83|stopped|drug
DDI-DrugBank.d103.s21|85-91|without|drug
DDI-DrugBank.d103.s21|93-102|consulting|drug
DDI-DrugBank.d103.s21|104-106|the|drug
DDI-DrugBank.d103.s21|108-116|physician|drug
DDI-DrugBank.d103.s21|117-117|,|drug
DDI-DrugBank.d103.s21|119-122|even|drug
DDI-DrugBank.d103.s21|124-125|if|drug
DDI-DrugBank.d103.s21|127-129|the|drug
DDI-DrugBank.d103.s21|131-137|patient|drug
DDI-DrugBank.d103.s21|139-143|feels|drug
DDI-DrugBank.d103.s21|145-150|better|drug
DDI-DrugBank.d103.s21|152-156|after|drug
DDI-DrugBank.d103.s21|158-167|initiating|drug
DDI-DrugBank.d103.s21|169-177|treatment|drug
DDI-DrugBank.d103.s21|179-182|with|drug
DDI-DrugBank.d103.s21|184-190|FORADIL|drug
DDI-DrugBank.d103.s21|191-191|.|drug
DDI-DrugBank.d103.s22|0-1|v.|drug
DDI-DrugBank.d103.s22|3-10|Patients|drug
DDI-DrugBank.d103.s22|12-17|should|drug
DDI-DrugBank.d103.s22|19-20|be|drug
DDI-DrugBank.d103.s22|22-30|cautioned|drug
DDI-DrugBank.d103.s22|32-40|regarding|drug
DDI-DrugBank.d103.s22|42-50|potential|drug
DDI-DrugBank.d103.s22|52-58|adverse|drug
DDI-DrugBank.d103.s22|60-73|cardiovascular|drug
DDI-DrugBank.d103.s22|75-81|effects|drug
DDI-DrugBank.d103.s22|82-82|,|drug
DDI-DrugBank.d103.s22|84-87|such|drug
DDI-DrugBank.d103.s22|89-90|as|drug
DDI-DrugBank.d103.s22|92-103|palpitations|drug
DDI-DrugBank.d103.s22|105-106|or|drug
DDI-DrugBank.d103.s22|108-112|chest|drug
DDI-DrugBank.d103.s22|114-117|pain|drug
DDI-DrugBank.d103.s22|118-118|.|drug
DDI-DrugBank.d103.s23|0-1|vi|drug
DDI-DrugBank.d103.s23|2-2|.|drug
DDI-DrugBank.d103.s24|0-1|In|drug
DDI-DrugBank.d103.s24|3-10|patients|drug
DDI-DrugBank.d103.s24|12-20|receiving|drug
DDI-DrugBank.d103.s24|22-28|FORADIL|drug
DDI-DrugBank.d103.s24|29-29|,|drug
DDI-DrugBank.d103.s24|31-35|other|drug
DDI-DrugBank.d103.s24|37-43|inhaled|drug
DDI-DrugBank.d103.s24|45-55|medications|drug
DDI-DrugBank.d103.s24|57-62|should|drug
DDI-DrugBank.d103.s24|64-65|be|drug
DDI-DrugBank.d103.s24|67-70|used|drug
DDI-DrugBank.d103.s24|72-75|only|drug
DDI-DrugBank.d103.s24|77-78|as|drug
DDI-DrugBank.d103.s24|80-87|directed|drug
DDI-DrugBank.d103.s24|89-90|by|drug
DDI-DrugBank.d103.s24|92-94|the|drug
DDI-DrugBank.d103.s24|96-104|physician|drug
DDI-DrugBank.d103.s24|105-105|.|drug
DDI-DrugBank.d103.s25|0-2|vii|drug
DDI-DrugBank.d103.s25|3-3|.|drug
DDI-DrugBank.d103.s26|0-8|Guardians|drug
DDI-DrugBank.d103.s26|10-11|of|drug
DDI-DrugBank.d103.s26|13-20|children|drug
DDI-DrugBank.d103.s26|22-24|who|drug
DDI-DrugBank.d103.s26|26-29|have|drug
DDI-DrugBank.d103.s26|31-34|been|drug
DDI-DrugBank.d103.s26|36-45|prescribed|drug
DDI-DrugBank.d103.s26|47-53|FORADIL|drug
DDI-DrugBank.d103.s26|55-60|should|drug
DDI-DrugBank.d103.s26|62-63|be|drug
DDI-DrugBank.d103.s26|65-71|alerted|drug
DDI-DrugBank.d103.s26|73-74|to|drug
DDI-DrugBank.d103.s26|76-78|the|drug
DDI-DrugBank.d103.s26|80-86|general|drug
DDI-DrugBank.d103.s26|88-94|concern|drug
DDI-DrugBank.d103.s26|96-104|regarding|drug
DDI-DrugBank.d103.s26|106-111|asthma|drug
DDI-DrugBank.d103.s26|113-119|therapy|drug
DDI-DrugBank.d103.s26|121-130|compliance|drug
DDI-DrugBank.d103.s26|131-131|,|drug
DDI-DrugBank.d103.s26|133-142|especially|drug
DDI-DrugBank.d103.s26|144-150|neglect|drug
DDI-DrugBank.d103.s26|152-153|of|drug
DDI-DrugBank.d103.s26|155-171|anti-inflammatory|drug
DDI-DrugBank.d103.s26|173-179|therapy|drug
DDI-DrugBank.d103.s26|181-183|and|drug
DDI-DrugBank.d103.s26|185-191|overuse|drug
DDI-DrugBank.d103.s26|193-194|of|drug
DDI-DrugBank.d103.s26|196-207|short-acting|drug
DDI-DrugBank.d103.s26|210-223|beta2-agonists|drug
DDI-DrugBank.d103.s26|224-224|.|drug
DDI-DrugBank.d597.s0|0-2|ACE|drug
DDI-DrugBank.d597.s0|4-13|inhibitors|drug
DDI-DrugBank.d597.s0|15-21|Reports|drug
DDI-DrugBank.d597.s0|23-29|suggest|drug
DDI-DrugBank.d597.s0|31-34|that|drug
DDI-DrugBank.d597.s0|36-41|NSAIDs|drug
DDI-DrugBank.d597.s0|43-45|may|drug
DDI-DrugBank.d597.s0|47-54|diminish|drug
DDI-DrugBank.d597.s0|56-58|the|drug
DDI-DrugBank.d597.s0|60-75|antihypertensive|drug
DDI-DrugBank.d597.s0|77-82|effect|drug
DDI-DrugBank.d597.s0|84-85|of|drug
DDI-DrugBank.d597.s0|87-108|angiotensin-converting|drug
DDI-DrugBank.d597.s0|110-115|enzyme|drug
DDI-DrugBank.d597.s0|117-117|(|drug
DDI-DrugBank.d597.s0|118-120|ACE|drug
DDI-DrugBank.d597.s0|121-121|)|drug
DDI-DrugBank.d597.s0|123-132|inhibitors|drug
DDI-DrugBank.d597.s0|133-133|.|drug
DDI-DrugBank.d597.s1|0-3|This|drug
DDI-DrugBank.d597.s1|5-15|interaction|drug
DDI-DrugBank.d597.s1|17-22|should|drug
DDI-DrugBank.d597.s1|24-25|be|drug
DDI-DrugBank.d597.s1|27-31|given|drug
DDI-DrugBank.d597.s1|33-45|consideration|drug
DDI-DrugBank.d597.s1|47-48|in|drug
DDI-DrugBank.d597.s1|50-57|patients|drug
DDI-DrugBank.d597.s1|59-64|taking|drug
DDI-DrugBank.d597.s1|66-71|NSAIDs|drug
DDI-DrugBank.d597.s1|73-85|concomitantly|drug
DDI-DrugBank.d597.s1|87-90|with|drug
DDI-DrugBank.d597.s1|92-94|ACE|drug
DDI-DrugBank.d597.s1|96-105|inhibitors|drug
DDI-DrugBank.d597.s1|106-106|.|drug
DDI-DrugBank.d597.s2|0-6|Aspirin|drug
DDI-DrugBank.d597.s2|7-7|:|drug
DDI-DrugBank.d597.s2|9-19|Concomitant|drug
DDI-DrugBank.d597.s2|21-34|administration|drug
DDI-DrugBank.d597.s2|36-37|of|drug
DDI-DrugBank.d597.s2|39-45|aspirin|drug
DDI-DrugBank.d597.s2|47-47|(|drug
DDI-DrugBank.d597.s2|48-51|1000|drug
DDI-DrugBank.d597.s2|53-54|mg|drug
DDI-DrugBank.d597.s2|56-58|TID|drug
DDI-DrugBank.d597.s2|59-59|)|drug
DDI-DrugBank.d597.s2|61-62|to|drug
DDI-DrugBank.d597.s2|64-70|healthy|drug
DDI-DrugBank.d597.s2|72-81|volunteers|drug
DDI-DrugBank.d597.s2|83-88|tended|drug
DDI-DrugBank.d597.s2|90-91|to|drug
DDI-DrugBank.d597.s2|93-100|increase|drug
DDI-DrugBank.d597.s2|102-104|the|drug
DDI-DrugBank.d597.s2|106-108|AUC|drug
DDI-DrugBank.d597.s2|110-110|(|drug
DDI-DrugBank.d597.s2|111-112|10|drug
DDI-DrugBank.d597.s2|113-113|%|drug
DDI-DrugBank.d597.s2|114-114|)|drug
DDI-DrugBank.d597.s2|116-118|and|drug
DDI-DrugBank.d597.s2|120-123|Cmax|drug
DDI-DrugBank.d597.s2|125-125|(|drug
DDI-DrugBank.d597.s2|126-127|24|drug
DDI-DrugBank.d597.s2|128-128|%|drug
DDI-DrugBank.d597.s2|129-129|)|drug
DDI-DrugBank.d597.s2|131-132|of|drug
DDI-DrugBank.d597.s2|134-142|meloxicam|drug
DDI-DrugBank.d597.s2|143-143|.|drug
DDI-DrugBank.d597.s3|0-2|The|drug
DDI-DrugBank.d597.s3|4-11|clinical|drug
DDI-DrugBank.d597.s3|13-24|significance|drug
DDI-DrugBank.d597.s3|26-27|of|drug
DDI-DrugBank.d597.s3|29-32|this|drug
DDI-DrugBank.d597.s3|34-44|interaction|drug
DDI-DrugBank.d597.s3|46-47|is|drug
DDI-DrugBank.d597.s3|49-51|not|drug
DDI-DrugBank.d597.s3|53-57|known|drug
DDI-DrugBank.d597.s3|58-58|;|drug
DDI-DrugBank.d597.s4|0-6|however|drug
DDI-DrugBank.d597.s4|7-7|,|drug
DDI-DrugBank.d597.s4|9-10|as|drug
DDI-DrugBank.d597.s4|12-15|with|drug
DDI-DrugBank.d597.s4|17-21|other|drug
DDI-DrugBank.d597.s4|23-28|NSAIDs|drug
DDI-DrugBank.d597.s4|29-29|,|drug
DDI-DrugBank.d597.s4|31-41|concomitant|drug
DDI-DrugBank.d597.s4|43-56|administration|drug
DDI-DrugBank.d597.s4|58-59|of|drug
DDI-DrugBank.d597.s4|61-69|meloxicam|drug
DDI-DrugBank.d597.s4|71-73|and|drug
DDI-DrugBank.d597.s4|75-81|aspirin|drug
DDI-DrugBank.d597.s4|83-84|is|drug
DDI-DrugBank.d597.s4|86-88|not|drug
DDI-DrugBank.d597.s4|90-98|generally|drug
DDI-DrugBank.d597.s4|100-110|recommended|drug
DDI-DrugBank.d597.s4|112-118|because|drug
DDI-DrugBank.d597.s4|120-121|of|drug
DDI-DrugBank.d597.s4|123-125|the|drug
DDI-DrugBank.d597.s4|127-135|potential|drug
DDI-DrugBank.d597.s4|137-139|for|drug
DDI-DrugBank.d597.s4|141-149|increased|drug
DDI-DrugBank.d597.s4|151-157|adverse|drug
DDI-DrugBank.d597.s4|159-165|effects|drug
DDI-DrugBank.d597.s4|166-166|.|drug
DDI-DrugBank.d597.s5|0-10|Concomitant|drug
DDI-DrugBank.d597.s5|12-25|administration|drug
DDI-DrugBank.d597.s5|27-28|of|drug
DDI-DrugBank.d597.s5|30-37|low-dose|drug
DDI-DrugBank.d597.s5|39-45|aspirin|drug
DDI-DrugBank.d597.s5|47-50|with|drug
DDI-DrugBank.d597.s5|52-56|MOBIC|drug
DDI-DrugBank.d597.s5|58-60|may|drug
DDI-DrugBank.d597.s5|62-67|result|drug
DDI-DrugBank.d597.s5|69-70|in|drug
DDI-DrugBank.d597.s5|72-73|an|drug
DDI-DrugBank.d597.s5|75-83|increased|drug
DDI-DrugBank.d597.s5|85-88|rate|drug
DDI-DrugBank.d597.s5|90-91|of|drug
DDI-DrugBank.d597.s5|93-94|GI|drug
DDI-DrugBank.d597.s5|96-105|ulceration|drug
DDI-DrugBank.d597.s5|107-108|or|drug
DDI-DrugBank.d597.s5|110-114|other|drug
DDI-DrugBank.d597.s5|116-128|complications|drug
DDI-DrugBank.d597.s5|129-129|,|drug
DDI-DrugBank.d597.s5|131-138|compared|drug
DDI-DrugBank.d597.s5|140-141|to|drug
DDI-DrugBank.d597.s5|143-145|use|drug
DDI-DrugBank.d597.s5|147-148|of|drug
DDI-DrugBank.d597.s5|150-154|MOBIC|drug
DDI-DrugBank.d597.s5|156-160|alone|drug
DDI-DrugBank.d597.s5|161-161|.|drug
DDI-DrugBank.d597.s6|0-4|MOBIC|drug
DDI-DrugBank.d597.s6|6-7|is|drug
DDI-DrugBank.d597.s6|9-11|not|drug
DDI-DrugBank.d597.s6|13-13|a|drug
DDI-DrugBank.d597.s6|15-24|substitute|drug
DDI-DrugBank.d597.s6|26-28|for|drug
DDI-DrugBank.d597.s6|30-36|aspirin|drug
DDI-DrugBank.d597.s6|38-40|for|drug
DDI-DrugBank.d597.s6|42-55|cardiovascular|drug
DDI-DrugBank.d597.s6|57-67|prophylaxis|drug
DDI-DrugBank.d597.s6|68-68|.|drug
DDI-DrugBank.d597.s7|0-13|Cholestyramine|drug
DDI-DrugBank.d597.s7|14-14|:|drug
DDI-DrugBank.d597.s7|16-27|Pretreatment|drug
DDI-DrugBank.d597.s7|29-31|for|drug
DDI-DrugBank.d597.s7|33-36|four|drug
DDI-DrugBank.d597.s7|38-41|days|drug
DDI-DrugBank.d597.s7|43-46|with|drug
DDI-DrugBank.d597.s7|48-61|cholestyramine|drug
DDI-DrugBank.d597.s7|63-75|significantly|drug
DDI-DrugBank.d597.s7|77-85|increased|drug
DDI-DrugBank.d597.s7|87-89|the|drug
DDI-DrugBank.d597.s7|91-99|clearance|drug
DDI-DrugBank.d597.s7|101-102|of|drug
DDI-DrugBank.d597.s7|104-112|meloxicam|drug
DDI-DrugBank.d597.s7|114-115|by|drug
DDI-DrugBank.d597.s7|117-118|50|drug
DDI-DrugBank.d597.s7|119-119|%|drug
DDI-DrugBank.d597.s7|120-120|.|drug
DDI-DrugBank.d597.s8|0-3|This|drug
DDI-DrugBank.d597.s8|5-12|resulted|drug
DDI-DrugBank.d597.s8|14-15|in|drug
DDI-DrugBank.d597.s8|17-17|a|drug
DDI-DrugBank.d597.s8|19-26|decrease|drug
DDI-DrugBank.d597.s8|28-29|in|drug
DDI-DrugBank.d597.s8|31-34|t1/2|drug
DDI-DrugBank.d597.s8|35-35|,|drug
DDI-DrugBank.d597.s8|37-40|from|drug
DDI-DrugBank.d597.s8|42-45|19.2|drug
DDI-DrugBank.d597.s8|47-51|hours|drug
DDI-DrugBank.d597.s8|53-54|to|drug
DDI-DrugBank.d597.s8|56-59|12.5|drug
DDI-DrugBank.d597.s8|61-65|hours|drug
DDI-DrugBank.d597.s8|66-66|,|drug
DDI-DrugBank.d597.s8|68-70|and|drug
DDI-DrugBank.d597.s8|72-72|a|drug
DDI-DrugBank.d597.s8|74-75|35|drug
DDI-DrugBank.d597.s8|76-76|%|drug
DDI-DrugBank.d597.s8|78-86|reduction|drug
DDI-DrugBank.d597.s8|88-89|in|drug
DDI-DrugBank.d597.s8|91-93|AUC|drug
DDI-DrugBank.d597.s8|94-94|.|drug
DDI-DrugBank.d597.s9|0-3|This|drug
DDI-DrugBank.d597.s9|5-12|suggests|drug
DDI-DrugBank.d597.s9|14-16|the|drug
DDI-DrugBank.d597.s9|18-26|existence|drug
DDI-DrugBank.d597.s9|28-29|of|drug
DDI-DrugBank.d597.s9|31-31|a|drug
DDI-DrugBank.d597.s9|33-45|recirculation|drug
DDI-DrugBank.d597.s9|47-53|pathway|drug
DDI-DrugBank.d597.s9|55-57|for|drug
DDI-DrugBank.d597.s9|59-67|meloxicam|drug
DDI-DrugBank.d597.s9|69-70|in|drug
DDI-DrugBank.d597.s9|72-74|the|drug
DDI-DrugBank.d597.s9|76-91|gastrointestinal|drug
DDI-DrugBank.d597.s9|93-97|tract|drug
DDI-DrugBank.d597.s9|98-98|.|drug
DDI-DrugBank.d597.s10|0-2|The|drug
DDI-DrugBank.d597.s10|4-11|clinical|drug
DDI-DrugBank.d597.s10|13-21|relevance|drug
DDI-DrugBank.d597.s10|23-24|of|drug
DDI-DrugBank.d597.s10|26-29|this|drug
DDI-DrugBank.d597.s10|31-41|interaction|drug
DDI-DrugBank.d597.s10|43-45|has|drug
DDI-DrugBank.d597.s10|47-49|not|drug
DDI-DrugBank.d597.s10|51-54|been|drug
DDI-DrugBank.d597.s10|56-66|established|drug
DDI-DrugBank.d597.s10|67-67|.|drug
DDI-DrugBank.d597.s11|0-9|Cimetidine|drug
DDI-DrugBank.d597.s11|10-10|:|drug
DDI-DrugBank.d597.s11|12-22|Concomitant|drug
DDI-DrugBank.d597.s11|24-37|administration|drug
DDI-DrugBank.d597.s11|39-40|of|drug
DDI-DrugBank.d597.s11|42-44|200|drug
DDI-DrugBank.d597.s11|46-47|mg|drug
DDI-DrugBank.d597.s11|49-58|cimetidine|drug
DDI-DrugBank.d597.s11|60-62|QID|drug
DDI-DrugBank.d597.s11|64-66|did|drug
DDI-DrugBank.d597.s11|68-70|not|drug
DDI-DrugBank.d597.s11|72-76|alter|drug
DDI-DrugBank.d597.s11|78-80|the|drug
DDI-DrugBank.d597.s11|82-92|single-dose|drug
DDI-DrugBank.d597.s11|94-109|pharmacokinetics|drug
DDI-DrugBank.d597.s11|111-112|of|drug
DDI-DrugBank.d597.s11|114-115|30|drug
DDI-DrugBank.d597.s11|117-118|mg|drug
DDI-DrugBank.d597.s11|120-128|meloxicam|drug
DDI-DrugBank.d597.s11|129-129|.|drug
DDI-DrugBank.d597.s12|0-6|Digoxin|drug
DDI-DrugBank.d597.s12|7-7|:|drug
DDI-DrugBank.d597.s12|9-17|Meloxicam|drug
DDI-DrugBank.d597.s12|19-20|15|drug
DDI-DrugBank.d597.s12|22-23|mg|drug
DDI-DrugBank.d597.s12|25-28|once|drug
DDI-DrugBank.d597.s12|30-34|daily|drug
DDI-DrugBank.d597.s12|36-38|for|drug
DDI-DrugBank.d597.s12|40-40|7|drug
DDI-DrugBank.d597.s12|42-45|days|drug
DDI-DrugBank.d597.s12|47-49|did|drug
DDI-DrugBank.d597.s12|51-53|not|drug
DDI-DrugBank.d597.s12|55-59|alter|drug
DDI-DrugBank.d597.s12|61-63|the|drug
DDI-DrugBank.d597.s12|65-70|plasma|drug
DDI-DrugBank.d597.s12|72-84|concentration|drug
DDI-DrugBank.d597.s12|86-92|profile|drug
DDI-DrugBank.d597.s12|94-95|of|drug
DDI-DrugBank.d597.s12|97-103|digoxin|drug
DDI-DrugBank.d597.s12|105-109|after|drug
DDI-DrugBank.d597.s12|111-125|b-acetyldigoxin|drug
DDI-DrugBank.d597.s12|127-140|administration|drug
DDI-DrugBank.d597.s12|142-144|for|drug
DDI-DrugBank.d597.s12|146-146|7|drug
DDI-DrugBank.d597.s12|148-151|days|drug
DDI-DrugBank.d597.s12|153-154|at|drug
DDI-DrugBank.d597.s12|156-163|clinical|drug
DDI-DrugBank.d597.s12|165-169|doses|drug
DDI-DrugBank.d597.s12|170-170|.|drug
DDI-DrugBank.d597.s13|0-1|In|drug
DDI-DrugBank.d597.s13|3-7|vitro|drug
DDI-DrugBank.d597.s13|9-15|testing|drug
DDI-DrugBank.d597.s13|17-21|found|drug
DDI-DrugBank.d597.s13|23-24|no|drug
DDI-DrugBank.d597.s13|26-32|protein|drug
DDI-DrugBank.d597.s13|34-40|binding|drug
DDI-DrugBank.d597.s13|42-45|drug|drug
DDI-DrugBank.d597.s13|47-57|interaction|drug
DDI-DrugBank.d597.s13|59-65|between|drug
DDI-DrugBank.d597.s13|67-73|digoxin|drug
DDI-DrugBank.d597.s13|75-77|and|drug
DDI-DrugBank.d597.s13|79-87|meloxicam|drug
DDI-DrugBank.d597.s13|88-88|.|drug
DDI-DrugBank.d597.s14|0-9|Furosemide|drug
DDI-DrugBank.d597.s14|10-10|:|drug
DDI-DrugBank.d597.s14|12-19|Clinical|drug
DDI-DrugBank.d597.s14|21-27|studies|drug
DDI-DrugBank.d597.s14|28-28|,|drug
DDI-DrugBank.d597.s14|30-31|as|drug
DDI-DrugBank.d597.s14|33-36|well|drug
DDI-DrugBank.d597.s14|38-39|as|drug
DDI-DrugBank.d597.s14|41-54|post-marketing|drug
DDI-DrugBank.d597.s14|56-67|observations|drug
DDI-DrugBank.d597.s14|68-68|,|drug
DDI-DrugBank.d597.s14|70-73|have|drug
DDI-DrugBank.d597.s14|75-79|shown|drug
DDI-DrugBank.d597.s14|81-84|that|drug
DDI-DrugBank.d597.s14|86-91|NSAIDs|drug
DDI-DrugBank.d597.s14|93-95|can|drug
DDI-DrugBank.d597.s14|97-102|reduce|drug
DDI-DrugBank.d597.s14|104-106|the|drug
DDI-DrugBank.d597.s14|108-118|natriuretic|drug
DDI-DrugBank.d597.s14|120-125|effect|drug
DDI-DrugBank.d597.s14|127-128|of|drug
DDI-DrugBank.d597.s14|130-139|furosemide|drug
DDI-DrugBank.d597.s14|141-143|and|drug
DDI-DrugBank.d597.s14|145-152|thiazide|drug
DDI-DrugBank.d597.s14|154-162|diuretics|drug
DDI-DrugBank.d597.s14|164-165|in|drug
DDI-DrugBank.d597.s14|167-170|some|drug
DDI-DrugBank.d597.s14|172-179|patients|drug
DDI-DrugBank.d597.s14|180-180|.|drug
DDI-DrugBank.d597.s15|0-3|This|drug
DDI-DrugBank.d597.s15|5-10|effect|drug
DDI-DrugBank.d597.s15|12-14|has|drug
DDI-DrugBank.d597.s15|16-19|been|drug
DDI-DrugBank.d597.s15|21-30|attributed|drug
DDI-DrugBank.d597.s15|32-33|to|drug
DDI-DrugBank.d597.s15|35-44|inhibition|drug
DDI-DrugBank.d597.s15|46-47|of|drug
DDI-DrugBank.d597.s15|49-53|renal|drug
DDI-DrugBank.d597.s15|55-67|prostaglandin|drug
DDI-DrugBank.d597.s15|69-77|synthesis|drug
DDI-DrugBank.d597.s15|78-78|.|drug
DDI-DrugBank.d597.s16|0-6|Studies|drug
DDI-DrugBank.d597.s16|8-11|with|drug
DDI-DrugBank.d597.s16|13-22|furosemide|drug
DDI-DrugBank.d597.s16|24-29|agents|drug
DDI-DrugBank.d597.s16|31-33|and|drug
DDI-DrugBank.d597.s16|35-43|meloxicam|drug
DDI-DrugBank.d597.s16|45-48|have|drug
DDI-DrugBank.d597.s16|50-52|not|drug
DDI-DrugBank.d597.s16|54-65|demonstrated|drug
DDI-DrugBank.d597.s16|67-67|a|drug
DDI-DrugBank.d597.s16|69-77|reduction|drug
DDI-DrugBank.d597.s16|79-80|in|drug
DDI-DrugBank.d597.s16|82-92|natriuretic|drug
DDI-DrugBank.d597.s16|94-99|effect|drug
DDI-DrugBank.d597.s16|100-100|.|drug
DDI-DrugBank.d597.s17|0-9|Furosemide|drug
DDI-DrugBank.d597.s17|10-10|:|drug
DDI-DrugBank.d597.s17|12-17|single|drug
DDI-DrugBank.d597.s17|19-21|and|drug
DDI-DrugBank.d597.s17|23-30|multiple|drug
DDI-DrugBank.d597.s17|32-35|dose|drug
DDI-DrugBank.d597.s17|37-52|pharmacodynamics|drug
DDI-DrugBank.d597.s17|54-56|and|drug
DDI-DrugBank.d597.s17|58-73|pharmacokinetics|drug
DDI-DrugBank.d597.s17|75-77|are|drug
DDI-DrugBank.d597.s17|79-81|not|drug
DDI-DrugBank.d597.s17|83-90|affected|drug
DDI-DrugBank.d597.s17|92-93|by|drug
DDI-DrugBank.d597.s17|95-102|multiple|drug
DDI-DrugBank.d597.s17|104-108|doses|drug
DDI-DrugBank.d597.s17|110-111|of|drug
DDI-DrugBank.d597.s17|113-121|meloxicam|drug
DDI-DrugBank.d597.s17|122-122|.|drug
DDI-DrugBank.d597.s18|0-11|Nevertheless|drug
DDI-DrugBank.d597.s18|12-12|,|drug
DDI-DrugBank.d597.s18|14-19|during|drug
DDI-DrugBank.d597.s18|21-31|concomitant|drug
DDI-DrugBank.d597.s18|33-39|therapy|drug
DDI-DrugBank.d597.s18|41-44|with|drug
DDI-DrugBank.d597.s18|46-55|furosemide|drug
DDI-DrugBank.d597.s18|57-59|and|drug
DDI-DrugBank.d597.s18|61-65|MOBIC|drug
DDI-DrugBank.d597.s18|66-66|,|drug
DDI-DrugBank.d597.s18|68-75|patients|drug
DDI-DrugBank.d597.s18|77-82|should|drug
DDI-DrugBank.d597.s18|84-85|be|drug
DDI-DrugBank.d597.s18|87-94|observed|drug
DDI-DrugBank.d597.s18|96-102|closely|drug
DDI-DrugBank.d597.s18|104-106|for|drug
DDI-DrugBank.d597.s18|108-112|signs|drug
DDI-DrugBank.d597.s18|114-115|of|drug
DDI-DrugBank.d597.s18|117-125|declining|drug
DDI-DrugBank.d597.s18|127-131|renal|drug
DDI-DrugBank.d597.s18|133-140|function|drug
DDI-DrugBank.d597.s18|141-141|,|drug
DDI-DrugBank.d597.s18|143-144|as|drug
DDI-DrugBank.d597.s18|146-149|well|drug
DDI-DrugBank.d597.s18|151-152|as|drug
DDI-DrugBank.d597.s18|154-155|to|drug
DDI-DrugBank.d597.s18|157-162|assure|drug
DDI-DrugBank.d597.s18|164-171|diuretic|drug
DDI-DrugBank.d597.s18|173-180|efficacy|drug
DDI-DrugBank.d597.s18|181-181|.|drug
DDI-DrugBank.d597.s19|0-6|Lithium|drug
DDI-DrugBank.d597.s19|7-7|:|drug
DDI-DrugBank.d597.s19|9-10|In|drug
DDI-DrugBank.d597.s19|12-19|clinical|drug
DDI-DrugBank.d597.s19|21-26|trials|drug
DDI-DrugBank.d597.s19|27-27|,|drug
DDI-DrugBank.d597.s19|29-34|NSAIDs|drug
DDI-DrugBank.d597.s19|36-39|have|drug
DDI-DrugBank.d597.s19|41-48|produced|drug
DDI-DrugBank.d597.s19|50-51|an|drug
DDI-DrugBank.d597.s19|53-61|elevation|drug
DDI-DrugBank.d597.s19|63-64|of|drug
DDI-DrugBank.d597.s19|66-71|plasma|drug
DDI-DrugBank.d597.s19|73-79|lithium|drug
DDI-DrugBank.d597.s19|81-86|levels|drug
DDI-DrugBank.d597.s19|88-90|and|drug
DDI-DrugBank.d597.s19|92-92|a|drug
DDI-DrugBank.d597.s19|94-102|reduction|drug
DDI-DrugBank.d597.s19|104-105|in|drug
DDI-DrugBank.d597.s19|107-111|renal|drug
DDI-DrugBank.d597.s19|113-119|lithium|drug
DDI-DrugBank.d597.s19|121-129|clearance|drug
DDI-DrugBank.d597.s19|130-130|.|drug
DDI-DrugBank.d597.s20|0-1|In|drug
DDI-DrugBank.d597.s20|3-3|a|drug
DDI-DrugBank.d597.s20|5-9|study|drug
DDI-DrugBank.d597.s20|11-19|conducted|drug
DDI-DrugBank.d597.s20|21-22|in|drug
DDI-DrugBank.d597.s20|24-30|healthy|drug
DDI-DrugBank.d597.s20|32-39|subjects|drug
DDI-DrugBank.d597.s20|40-40|,|drug
DDI-DrugBank.d597.s20|42-45|mean|drug
DDI-DrugBank.d597.s20|47-54|pre-dose|drug
DDI-DrugBank.d597.s20|56-62|lithium|drug
DDI-DrugBank.d597.s20|64-76|concentration|drug
DDI-DrugBank.d597.s20|78-80|and|drug
DDI-DrugBank.d597.s20|82-84|AUC|drug
DDI-DrugBank.d597.s20|86-89|were|drug
DDI-DrugBank.d597.s20|91-99|increased|drug
DDI-DrugBank.d597.s20|101-102|by|drug
DDI-DrugBank.d597.s20|104-105|21|drug
DDI-DrugBank.d597.s20|106-106|%|drug
DDI-DrugBank.d597.s20|108-109|in|drug
DDI-DrugBank.d597.s20|111-118|subjects|drug
DDI-DrugBank.d597.s20|120-128|receiving|drug
DDI-DrugBank.d597.s20|130-136|lithium|drug
DDI-DrugBank.d597.s20|138-142|doses|drug
DDI-DrugBank.d597.s20|144-150|ranging|drug
DDI-DrugBank.d597.s20|152-155|from|drug
DDI-DrugBank.d597.s20|157-159|804|drug
DDI-DrugBank.d597.s20|161-162|to|drug
DDI-DrugBank.d597.s20|164-167|1072|drug
DDI-DrugBank.d597.s20|169-170|mg|drug
DDI-DrugBank.d597.s20|172-174|BID|drug
DDI-DrugBank.d597.s20|176-179|with|drug
DDI-DrugBank.d597.s20|181-189|meloxicam|drug
DDI-DrugBank.d597.s20|191-192|15|drug
DDI-DrugBank.d597.s20|194-195|mg|drug
DDI-DrugBank.d597.s20|197-198|QD|drug
DDI-DrugBank.d597.s20|200-201|as|drug
DDI-DrugBank.d597.s20|203-210|compared|drug
DDI-DrugBank.d597.s20|212-213|to|drug
DDI-DrugBank.d597.s20|215-222|subjects|drug
DDI-DrugBank.d597.s20|224-232|receiving|drug
DDI-DrugBank.d597.s20|234-240|lithium|drug
DDI-DrugBank.d597.s20|242-246|alone|drug
DDI-DrugBank.d597.s20|247-247|.|drug
DDI-DrugBank.d597.s21|0-4|These|drug
DDI-DrugBank.d597.s21|6-12|effects|drug
DDI-DrugBank.d597.s21|14-17|have|drug
DDI-DrugBank.d597.s21|19-22|been|drug
DDI-DrugBank.d597.s21|24-33|attributed|drug
DDI-DrugBank.d597.s21|35-36|to|drug
DDI-DrugBank.d597.s21|38-47|inhibition|drug
DDI-DrugBank.d597.s21|49-50|of|drug
DDI-DrugBank.d597.s21|52-56|renal|drug
DDI-DrugBank.d597.s21|58-70|prostaglandin|drug
DDI-DrugBank.d597.s21|72-80|synthesis|drug
DDI-DrugBank.d597.s21|82-83|by|drug
DDI-DrugBank.d597.s21|85-89|MOBIC|drug
DDI-DrugBank.d597.s21|90-90|.|drug
DDI-DrugBank.d597.s22|0-7|Patients|drug
DDI-DrugBank.d597.s22|9-10|on|drug
DDI-DrugBank.d597.s22|12-18|lithium|drug
DDI-DrugBank.d597.s22|20-28|treatment|drug
DDI-DrugBank.d597.s22|30-35|should|drug
DDI-DrugBank.d597.s22|37-38|be|drug
DDI-DrugBank.d597.s22|40-46|closely|drug
DDI-DrugBank.d597.s22|48-56|monitored|drug
DDI-DrugBank.d597.s22|58-61|when|drug
DDI-DrugBank.d597.s22|63-67|MOBIC|drug
DDI-DrugBank.d597.s22|69-70|is|drug
DDI-DrugBank.d597.s22|72-81|introduced|drug
DDI-DrugBank.d597.s22|83-84|or|drug
DDI-DrugBank.d597.s22|86-94|withdrawn|drug
DDI-DrugBank.d597.s22|95-95|.|drug
DDI-DrugBank.d597.s23|0-11|Methotrexate|drug
DDI-DrugBank.d597.s23|12-12|:|drug
DDI-DrugBank.d597.s23|14-14|A|drug
DDI-DrugBank.d597.s23|16-20|study|drug
DDI-DrugBank.d597.s23|22-23|in|drug
DDI-DrugBank.d597.s23|25-26|13|drug
DDI-DrugBank.d597.s23|28-37|rheumatoid|drug
DDI-DrugBank.d597.s23|39-47|arthritis|drug
DDI-DrugBank.d597.s23|49-49|(|drug
DDI-DrugBank.d597.s23|50-51|RA|drug
DDI-DrugBank.d597.s23|52-52|)|drug
DDI-DrugBank.d597.s23|54-61|patients|drug
DDI-DrugBank.d597.s23|63-71|evaluated|drug
DDI-DrugBank.d597.s23|73-75|the|drug
DDI-DrugBank.d597.s23|77-83|effects|drug
DDI-DrugBank.d597.s23|85-86|of|drug
DDI-DrugBank.d597.s23|88-95|multiple|drug
DDI-DrugBank.d597.s23|97-101|doses|drug
DDI-DrugBank.d597.s23|103-104|of|drug
DDI-DrugBank.d597.s23|106-114|meloxicam|drug
DDI-DrugBank.d597.s23|116-117|on|drug
DDI-DrugBank.d597.s23|119-121|the|drug
DDI-DrugBank.d597.s23|123-138|pharmacokinetics|drug
DDI-DrugBank.d597.s23|140-141|of|drug
DDI-DrugBank.d597.s23|143-154|methotrexate|drug
DDI-DrugBank.d597.s23|156-160|taken|drug
DDI-DrugBank.d597.s23|162-165|once|drug
DDI-DrugBank.d597.s23|167-172|weekly|drug
DDI-DrugBank.d597.s23|173-173|.|drug
DDI-DrugBank.d597.s24|0-8|Meloxicam|drug
DDI-DrugBank.d597.s24|10-12|did|drug
DDI-DrugBank.d597.s24|14-16|not|drug
DDI-DrugBank.d597.s24|18-21|have|drug
DDI-DrugBank.d597.s24|23-23|a|drug
DDI-DrugBank.d597.s24|25-35|significant|drug
DDI-DrugBank.d597.s24|37-42|effect|drug
DDI-DrugBank.d597.s24|44-45|on|drug
DDI-DrugBank.d597.s24|47-49|the|drug
DDI-DrugBank.d597.s24|51-66|pharmacokinetics|drug
DDI-DrugBank.d597.s24|68-69|of|drug
DDI-DrugBank.d597.s24|71-76|single|drug
DDI-DrugBank.d597.s24|78-82|doses|drug
DDI-DrugBank.d597.s24|84-85|of|drug
DDI-DrugBank.d597.s24|87-98|methotrexate|drug
DDI-DrugBank.d597.s24|99-99|.|drug
DDI-DrugBank.d597.s25|0-1|In|drug
DDI-DrugBank.d597.s25|3-7|vitro|drug
DDI-DrugBank.d597.s25|8-8|,|drug
DDI-DrugBank.d597.s25|10-21|methotrexate|drug
DDI-DrugBank.d597.s25|23-25|did|drug
DDI-DrugBank.d597.s25|27-29|not|drug
DDI-DrugBank.d597.s25|31-38|displace|drug
DDI-DrugBank.d597.s25|40-48|meloxicam|drug
DDI-DrugBank.d597.s25|50-53|from|drug
DDI-DrugBank.d597.s25|55-57|its|drug
DDI-DrugBank.d597.s25|59-63|human|drug
DDI-DrugBank.d597.s25|65-69|serum|drug
DDI-DrugBank.d597.s25|71-77|binding|drug
DDI-DrugBank.d597.s25|79-83|sites|drug
DDI-DrugBank.d597.s25|84-84|.|drug
DDI-DrugBank.d597.s26|0-7|Warfarin|drug
DDI-DrugBank.d597.s26|8-8|:|drug
DDI-DrugBank.d597.s26|10-22|Anticoagulant|drug
DDI-DrugBank.d597.s26|24-31|activity|drug
DDI-DrugBank.d597.s26|33-38|should|drug
DDI-DrugBank.d597.s26|40-41|be|drug
DDI-DrugBank.d597.s26|43-51|monitored|drug
DDI-DrugBank.d597.s26|52-52|,|drug
DDI-DrugBank.d597.s26|54-65|particularly|drug
DDI-DrugBank.d597.s26|67-68|in|drug
DDI-DrugBank.d597.s26|70-72|the|drug
DDI-DrugBank.d597.s26|74-78|first|drug
DDI-DrugBank.d597.s26|80-82|few|drug
DDI-DrugBank.d597.s26|84-87|days|drug
DDI-DrugBank.d597.s26|89-93|after|drug
DDI-DrugBank.d597.s26|95-104|initiating|drug
DDI-DrugBank.d597.s26|106-107|or|drug
DDI-DrugBank.d597.s26|109-116|changing|drug
DDI-DrugBank.d597.s26|118-122|MOBIC|drug
DDI-DrugBank.d597.s26|124-130|therapy|drug
DDI-DrugBank.d597.s26|132-133|in|drug
DDI-DrugBank.d597.s26|135-142|patients|drug
DDI-DrugBank.d597.s26|144-152|receiving|drug
DDI-DrugBank.d597.s26|154-161|warfarin|drug
DDI-DrugBank.d597.s26|163-164|or|drug
DDI-DrugBank.d597.s26|166-172|similar|drug
DDI-DrugBank.d597.s26|174-179|agents|drug
DDI-DrugBank.d597.s26|180-180|,|drug
DDI-DrugBank.d597.s26|182-186|since|drug
DDI-DrugBank.d597.s26|188-192|these|drug
DDI-DrugBank.d597.s26|194-201|patients|drug
DDI-DrugBank.d597.s26|203-205|are|drug
DDI-DrugBank.d597.s26|207-208|at|drug
DDI-DrugBank.d597.s26|210-211|an|drug
DDI-DrugBank.d597.s26|213-221|increased|drug
DDI-DrugBank.d597.s26|223-226|risk|drug
DDI-DrugBank.d597.s26|228-229|of|drug
DDI-DrugBank.d597.s26|231-238|bleeding|drug
DDI-DrugBank.d597.s26|239-239|.|drug
DDI-DrugBank.d597.s27|0-2|The|drug
DDI-DrugBank.d597.s27|4-9|effect|drug
DDI-DrugBank.d597.s27|11-12|of|drug
DDI-DrugBank.d597.s27|14-22|meloxicam|drug
DDI-DrugBank.d597.s27|24-25|on|drug
DDI-DrugBank.d597.s27|27-29|the|drug
DDI-DrugBank.d597.s27|31-43|anticoagulant|drug
DDI-DrugBank.d597.s27|45-50|effect|drug
DDI-DrugBank.d597.s27|52-53|of|drug
DDI-DrugBank.d597.s27|55-62|warfarin|drug
DDI-DrugBank.d597.s27|64-66|was|drug
DDI-DrugBank.d597.s27|68-74|studied|drug
DDI-DrugBank.d597.s27|76-77|in|drug
DDI-DrugBank.d597.s27|79-79|a|drug
DDI-DrugBank.d597.s27|81-85|group|drug
DDI-DrugBank.d597.s27|87-88|of|drug
DDI-DrugBank.d597.s27|90-96|healthy|drug
DDI-DrugBank.d597.s27|98-105|subjects|drug
DDI-DrugBank.d597.s27|107-115|receiving|drug
DDI-DrugBank.d597.s27|117-121|daily|drug
DDI-DrugBank.d597.s27|123-127|doses|drug
DDI-DrugBank.d597.s27|129-130|of|drug
DDI-DrugBank.d597.s27|132-139|warfarin|drug
DDI-DrugBank.d597.s27|141-144|that|drug
DDI-DrugBank.d597.s27|146-153|produced|drug
DDI-DrugBank.d597.s27|155-156|an|drug
DDI-DrugBank.d597.s27|158-160|INR|drug
DDI-DrugBank.d597.s27|162-162|(|drug
DDI-DrugBank.d597.s27|163-175|International|drug
DDI-DrugBank.d597.s27|177-186|Normalized|drug
DDI-DrugBank.d597.s27|188-192|Ratio|drug
DDI-DrugBank.d597.s27|193-193|)|drug
DDI-DrugBank.d597.s27|195-201|between|drug
DDI-DrugBank.d597.s27|203-205|1.2|drug
DDI-DrugBank.d597.s27|207-209|and|drug
DDI-DrugBank.d597.s27|211-213|1.8|drug
DDI-DrugBank.d597.s27|214-214|.|drug
DDI-DrugBank.d597.s28|0-1|In|drug
DDI-DrugBank.d597.s28|3-7|these|drug
DDI-DrugBank.d597.s28|9-16|subjects|drug
DDI-DrugBank.d597.s28|17-17|,|drug
DDI-DrugBank.d597.s28|19-27|meloxicam|drug
DDI-DrugBank.d597.s28|29-31|did|drug
DDI-DrugBank.d597.s28|33-35|not|drug
DDI-DrugBank.d597.s28|37-41|alter|drug
DDI-DrugBank.d597.s28|43-50|warfarin|drug
DDI-DrugBank.d597.s28|52-67|pharmacokinetics|drug
DDI-DrugBank.d597.s28|69-71|and|drug
DDI-DrugBank.d597.s28|73-75|the|drug
DDI-DrugBank.d597.s28|77-83|average|drug
DDI-DrugBank.d597.s28|85-97|anticoagulant|drug
DDI-DrugBank.d597.s28|99-104|effect|drug
DDI-DrugBank.d597.s28|106-107|of|drug
DDI-DrugBank.d597.s28|109-116|warfarin|drug
DDI-DrugBank.d597.s28|118-119|as|drug
DDI-DrugBank.d597.s28|121-130|determined|drug
DDI-DrugBank.d597.s28|132-133|by|drug
DDI-DrugBank.d597.s28|135-145|prothrombin|drug
DDI-DrugBank.d597.s28|147-150|time|drug
DDI-DrugBank.d597.s28|151-151|.|drug
DDI-DrugBank.d597.s29|0-6|However|drug
DDI-DrugBank.d597.s29|7-7|,|drug
DDI-DrugBank.d597.s29|9-11|one|drug
DDI-DrugBank.d597.s29|13-19|subject|drug
DDI-DrugBank.d597.s29|21-26|showed|drug
DDI-DrugBank.d597.s29|28-29|an|drug
DDI-DrugBank.d597.s29|31-38|increase|drug
DDI-DrugBank.d597.s29|40-41|in|drug
DDI-DrugBank.d597.s29|43-45|INR|drug
DDI-DrugBank.d597.s29|47-50|from|drug
DDI-DrugBank.d597.s29|52-54|1.5|drug
DDI-DrugBank.d597.s29|56-57|to|drug
DDI-DrugBank.d597.s29|59-61|2.1|drug
DDI-DrugBank.d597.s29|62-62|.|drug
DDI-DrugBank.d597.s30|0-6|Caution|drug
DDI-DrugBank.d597.s30|8-13|should|drug
DDI-DrugBank.d597.s30|15-16|be|drug
DDI-DrugBank.d597.s30|18-21|used|drug
DDI-DrugBank.d597.s30|23-26|when|drug
DDI-DrugBank.d597.s30|28-40|administering|drug
DDI-DrugBank.d597.s30|42-46|MOBIC|drug
DDI-DrugBank.d597.s30|48-51|with|drug
DDI-DrugBank.d597.s30|53-60|warfarin|drug
DDI-DrugBank.d597.s30|62-66|since|drug
DDI-DrugBank.d597.s30|68-75|patients|drug
DDI-DrugBank.d597.s30|77-78|on|drug
DDI-DrugBank.d597.s30|80-87|warfarin|drug
DDI-DrugBank.d597.s30|89-91|may|drug
DDI-DrugBank.d597.s30|93-102|experience|drug
DDI-DrugBank.d597.s30|104-110|changes|drug
DDI-DrugBank.d597.s30|112-113|in|drug
DDI-DrugBank.d597.s30|115-117|INR|drug
DDI-DrugBank.d597.s30|119-121|and|drug
DDI-DrugBank.d597.s30|123-124|an|drug
DDI-DrugBank.d597.s30|126-134|increased|drug
DDI-DrugBank.d597.s30|136-139|risk|drug
DDI-DrugBank.d597.s30|141-142|of|drug
DDI-DrugBank.d597.s30|144-151|bleeding|drug
DDI-DrugBank.d597.s30|153-165|complications|drug
DDI-DrugBank.d597.s30|167-170|when|drug
DDI-DrugBank.d597.s30|172-172|a|drug
DDI-DrugBank.d597.s30|174-176|new|drug
DDI-DrugBank.d597.s30|178-187|medication|drug
DDI-DrugBank.d597.s30|189-190|is|drug
DDI-DrugBank.d597.s30|192-201|introduced|drug
DDI-DrugBank.d597.s30|202-202|.|drug
DDI-MedLine.d201.s0|0-8|Antitumor|drug
DDI-MedLine.d201.s0|10-16|effects|drug
DDI-MedLine.d201.s0|18-19|of|drug
DDI-MedLine.d201.s0|21-26|CRM197|drug
DDI-MedLine.d201.s0|27-27|,|drug
DDI-MedLine.d201.s0|29-29|a|drug
DDI-MedLine.d201.s0|31-38|specific|drug
DDI-MedLine.d201.s0|40-48|inhibitor|drug
DDI-MedLine.d201.s0|50-51|of|drug
DDI-MedLine.d201.s0|53-58|HB-EGF|drug
DDI-MedLine.d201.s0|59-59|,|drug
DDI-MedLine.d201.s0|61-62|in|drug
DDI-MedLine.d201.s0|64-69|T-cell|drug
DDI-MedLine.d201.s0|71-75|acute|drug
DDI-MedLine.d201.s0|77-89|lymphoblastic|drug
DDI-MedLine.d201.s0|91-98|leukemia|drug
DDI-MedLine.d201.s0|99-99|.|drug
DDI-MedLine.d201.s1|0-2|The|drug
DDI-MedLine.d201.s1|4-14|therapeutic|drug
DDI-MedLine.d201.s1|16-22|outcome|drug
DDI-MedLine.d201.s1|24-26|for|drug
DDI-MedLine.d201.s1|28-33|T-cell|drug
DDI-MedLine.d201.s1|35-39|acute|drug
DDI-MedLine.d201.s1|41-53|lymphoblastic|drug
DDI-MedLine.d201.s1|55-62|leukemia|drug
DDI-MedLine.d201.s1|64-64|(|drug
DDI-MedLine.d201.s1|65-69|T-ALL|drug
DDI-MedLine.d201.s1|70-70|)|drug
DDI-MedLine.d201.s1|72-78|remains|drug
DDI-MedLine.d201.s1|80-83|poor|drug
DDI-MedLine.d201.s1|84-84|;|drug
DDI-MedLine.d201.s2|0-3|thus|drug
DDI-MedLine.d201.s2|4-4|,|drug
DDI-MedLine.d201.s2|6-10|novel|drug
DDI-MedLine.d201.s2|11-11|,|drug
DDI-MedLine.d201.s2|13-20|targeted|drug
DDI-MedLine.d201.s2|22-30|therapies|drug
DDI-MedLine.d201.s2|32-34|are|drug
DDI-MedLine.d201.s2|36-43|urgently|drug
DDI-MedLine.d201.s2|45-50|needed|drug
DDI-MedLine.d201.s2|51-51|.|drug
DDI-MedLine.d201.s3|0-7|Recently|drug
DDI-MedLine.d201.s3|8-8|,|drug
DDI-MedLine.d201.s3|10-11|we|drug
DDI-MedLine.d201.s3|13-18|showed|drug
DDI-MedLine.d201.s3|20-23|that|drug
DDI-MedLine.d201.s3|25-39|heparin-binding|drug
DDI-MedLine.d201.s3|41-49|epidermal|drug
DDI-MedLine.d201.s3|51-56|growth|drug
DDI-MedLine.d201.s3|58-68|factor-like|drug
DDI-MedLine.d201.s3|70-75|growth|drug
DDI-MedLine.d201.s3|77-82|factor|drug
DDI-MedLine.d201.s3|84-84|(|drug
DDI-MedLine.d201.s3|85-90|HB-EGF|drug
DDI-MedLine.d201.s3|91-91|)|drug
DDI-MedLine.d201.s3|92-92|,|drug
DDI-MedLine.d201.s3|94-94|a|drug
DDI-MedLine.d201.s3|96-101|member|drug
DDI-MedLine.d201.s3|103-104|of|drug
DDI-MedLine.d201.s3|106-108|the|drug
DDI-MedLine.d201.s3|110-112|EGF|drug
DDI-MedLine.d201.s3|114-119|family|drug
DDI-MedLine.d201.s3|120-120|,|drug
DDI-MedLine.d201.s3|122-123|is|drug
DDI-MedLine.d201.s3|125-125|a|drug
DDI-MedLine.d201.s3|127-135|promising|drug
DDI-MedLine.d201.s3|137-142|target|drug
DDI-MedLine.d201.s3|144-146|for|drug
DDI-MedLine.d201.s3|148-150|the|drug
DDI-MedLine.d201.s3|152-160|treatment|drug
DDI-MedLine.d201.s3|162-163|of|drug
DDI-MedLine.d201.s3|165-171|various|drug
DDI-MedLine.d201.s3|173-177|types|drug
DDI-MedLine.d201.s3|179-180|of|drug
DDI-MedLine.d201.s3|182-187|cancer|drug
DDI-MedLine.d201.s3|188-188|.|drug
DDI-MedLine.d201.s4|0-2|The|drug
DDI-MedLine.d201.s4|4-6|aim|drug
DDI-MedLine.d201.s4|8-9|of|drug
DDI-MedLine.d201.s4|11-13|the|drug
DDI-MedLine.d201.s4|15-21|present|drug
DDI-MedLine.d201.s4|23-27|study|drug
DDI-MedLine.d201.s4|29-31|was|drug
DDI-MedLine.d201.s4|33-34|to|drug
DDI-MedLine.d201.s4|36-46|investigate|drug
DDI-MedLine.d201.s4|48-54|whether|drug
DDI-MedLine.d201.s4|56-61|HB-EGF|drug
DDI-MedLine.d201.s4|63-64|is|drug
DDI-MedLine.d201.s4|66-66|a|drug
DDI-MedLine.d201.s4|68-78|therapeutic|drug
DDI-MedLine.d201.s4|80-85|target|drug
DDI-MedLine.d201.s4|87-89|for|drug
DDI-MedLine.d201.s4|91-95|T-ALL|drug
DDI-MedLine.d201.s4|96-96|,|drug
DDI-MedLine.d201.s4|98-100|and|drug
DDI-MedLine.d201.s4|102-103|to|drug
DDI-MedLine.d201.s4|105-111|further|drug
DDI-MedLine.d201.s4|113-121|elucidate|drug
DDI-MedLine.d201.s4|123-125|the|drug
DDI-MedLine.d201.s4|127-135|antitumor|drug
DDI-MedLine.d201.s4|137-143|effects|drug
DDI-MedLine.d201.s4|145-146|of|drug
DDI-MedLine.d201.s4|148-148|a|drug
DDI-MedLine.d201.s4|150-157|specific|drug
DDI-MedLine.d201.s4|159-167|inhibitor|drug
DDI-MedLine.d201.s4|169-170|of|drug
DDI-MedLine.d201.s4|172-177|HB-EGF|drug
DDI-MedLine.d201.s4|178-178|,|drug
DDI-MedLine.d201.s4|180-193|cross-reacting|drug
DDI-MedLine.d201.s4|195-202|material|drug
DDI-MedLine.d201.s4|204-206|197|drug
DDI-MedLine.d201.s4|208-208|(|drug
DDI-MedLine.d201.s4|209-214|CRM197|drug
DDI-MedLine.d201.s4|215-215|)|drug
DDI-MedLine.d201.s4|216-216|.|drug
DDI-MedLine.d201.s5|0-1|We|drug
DDI-MedLine.d201.s5|3-12|elucidated|drug
DDI-MedLine.d201.s5|14-16|the|drug
DDI-MedLine.d201.s5|18-27|expression|drug
DDI-MedLine.d201.s5|29-30|of|drug
DDI-MedLine.d201.s5|32-37|HB-EGF|drug
DDI-MedLine.d201.s5|39-40|in|drug
DDI-MedLine.d201.s5|42-46|T-ALL|drug
DDI-MedLine.d201.s5|48-51|cell|drug
DDI-MedLine.d201.s5|53-57|lines|drug
DDI-MedLine.d201.s5|58-58|,|drug
DDI-MedLine.d201.s5|60-62|and|drug
DDI-MedLine.d201.s5|64-72|evaluated|drug
DDI-MedLine.d201.s5|74-76|the|drug
DDI-MedLine.d201.s5|78-83|effect|drug
DDI-MedLine.d201.s5|85-86|of|drug
DDI-MedLine.d201.s5|88-93|CRM197|drug
DDI-MedLine.d201.s5|95-96|on|drug
DDI-MedLine.d201.s5|98-102|these|drug
DDI-MedLine.d201.s5|104-108|cells|drug
DDI-MedLine.d201.s5|110-114|alone|drug
DDI-MedLine.d201.s5|116-117|or|drug
DDI-MedLine.d201.s5|119-120|in|drug
DDI-MedLine.d201.s5|122-132|combination|drug
DDI-MedLine.d201.s5|134-137|with|drug
DDI-MedLine.d201.s5|139-148|anticancer|drug
DDI-MedLine.d201.s5|150-154|agent|drug
DDI-MedLine.d201.s5|155-155|.|drug
DDI-MedLine.d201.s6|0-2|The|drug
DDI-MedLine.d201.s6|4-13|expression|drug
DDI-MedLine.d201.s6|15-16|of|drug
DDI-MedLine.d201.s6|18-21|EGFR|drug
DDI-MedLine.d201.s6|23-25|and|drug
DDI-MedLine.d201.s6|27-30|EGFR|drug
DDI-MedLine.d201.s6|32-38|ligands|drug
DDI-MedLine.d201.s6|40-42|was|drug
DDI-MedLine.d201.s6|44-53|determined|drug
DDI-MedLine.d201.s6|55-56|by|drug
DDI-MedLine.d201.s6|58-61|flow|drug
DDI-MedLine.d201.s6|63-71|cytometry|drug
DDI-MedLine.d201.s6|72-72|,|drug
DDI-MedLine.d201.s6|74-79|RT-PCR|drug
DDI-MedLine.d201.s6|81-83|and|drug
DDI-MedLine.d201.s6|85-93|real-time|drug
DDI-MedLine.d201.s6|95-106|quantitative|drug
DDI-MedLine.d201.s6|108-110|PCR|drug
DDI-MedLine.d201.s6|111-111|.|drug
DDI-MedLine.d201.s7|0-8|Induction|drug
DDI-MedLine.d201.s7|10-11|of|drug
DDI-MedLine.d201.s7|13-21|apoptosis|drug
DDI-MedLine.d201.s7|23-25|was|drug
DDI-MedLine.d201.s7|27-34|assessed|drug
DDI-MedLine.d201.s7|36-37|by|drug
DDI-MedLine.d201.s7|39-43|TUNEL|drug
DDI-MedLine.d201.s7|45-49|assay|drug
DDI-MedLine.d201.s7|50-50|.|drug
DDI-MedLine.d201.s8|0-5|HB-EGF|drug
DDI-MedLine.d201.s8|7-9|was|drug
DDI-MedLine.d201.s8|11-18|strongly|drug
DDI-MedLine.d201.s8|20-28|expressed|drug
DDI-MedLine.d201.s8|30-31|by|drug
DDI-MedLine.d201.s8|33-37|T-ALL|drug
DDI-MedLine.d201.s8|39-42|cell|drug
DDI-MedLine.d201.s8|44-48|lines|drug
DDI-MedLine.d201.s8|49-49|,|drug
DDI-MedLine.d201.s8|51-53|and|drug
DDI-MedLine.d201.s8|55-57|the|drug
DDI-MedLine.d201.s8|59-68|expression|drug
DDI-MedLine.d201.s8|70-71|of|drug
DDI-MedLine.d201.s8|73-76|both|drug
DDI-MedLine.d201.s8|78-83|HB-EGF|drug
DDI-MedLine.d201.s8|85-87|and|drug
DDI-MedLine.d201.s8|89-92|EGFR|drug
DDI-MedLine.d201.s8|94-96|was|drug
DDI-MedLine.d201.s8|98-105|enhanced|drug
DDI-MedLine.d201.s8|107-108|by|drug
DDI-MedLine.d201.s8|110-120|doxorubicin|drug
DDI-MedLine.d201.s8|121-121|.|drug
DDI-MedLine.d201.s9|0-5|CRM197|drug
DDI-MedLine.d201.s9|7-13|induced|drug
DDI-MedLine.d201.s9|15-23|apoptosis|drug
DDI-MedLine.d201.s9|24-24|,|drug
DDI-MedLine.d201.s9|26-28|and|drug
DDI-MedLine.d201.s9|30-40|furthermore|drug
DDI-MedLine.d201.s9|41-41|,|drug
DDI-MedLine.d201.s9|43-45|the|drug
DDI-MedLine.d201.s9|47-57|combination|drug
DDI-MedLine.d201.s9|59-60|of|drug
DDI-MedLine.d201.s9|62-67|CRM197|drug
DDI-MedLine.d201.s9|69-72|plus|drug
DDI-MedLine.d201.s9|74-84|doxorubicin|drug
DDI-MedLine.d201.s9|86-93|enhanced|drug
DDI-MedLine.d201.s9|95-106|cytotoxicity|drug
DDI-MedLine.d201.s9|108-109|in|drug
DDI-MedLine.d201.s9|111-111|a|drug
DDI-MedLine.d201.s9|113-117|T-ALL|drug
DDI-MedLine.d201.s9|119-122|cell|drug
DDI-MedLine.d201.s9|124-127|line|drug
DDI-MedLine.d201.s9|128-128|.|drug
DDI-MedLine.d201.s10|0-4|These|drug
DDI-MedLine.d201.s10|6-12|results|drug
DDI-MedLine.d201.s10|14-20|suggest|drug
DDI-MedLine.d201.s10|22-25|that|drug
DDI-MedLine.d201.s10|27-32|HB-EGF|drug
DDI-MedLine.d201.s10|34-35|is|drug
DDI-MedLine.d201.s10|37-37|a|drug
DDI-MedLine.d201.s10|39-47|promising|drug
DDI-MedLine.d201.s10|49-59|therapeutic|drug
DDI-MedLine.d201.s10|61-66|target|drug
DDI-MedLine.d201.s10|68-70|for|drug
DDI-MedLine.d201.s10|72-76|T-ALL|drug
DDI-MedLine.d201.s10|77-77|.|drug
DDI-DrugBank.d71.s0|0-9|Lamivudine|drug
DDI-DrugBank.d71.s0|11-12|is|drug
DDI-DrugBank.d71.s0|14-26|predominantly|drug
DDI-DrugBank.d71.s0|28-37|eliminated|drug
DDI-DrugBank.d71.s0|39-40|in|drug
DDI-DrugBank.d71.s0|42-44|the|drug
DDI-DrugBank.d71.s0|46-50|urine|drug
DDI-DrugBank.d71.s0|52-53|by|drug
DDI-DrugBank.d71.s0|55-60|active|drug
DDI-DrugBank.d71.s0|62-68|organic|drug
DDI-DrugBank.d71.s0|70-77|cationic|drug
DDI-DrugBank.d71.s0|79-87|secretion|drug
DDI-DrugBank.d71.s0|88-88|.|drug
DDI-DrugBank.d71.s1|0-2|The|drug
DDI-DrugBank.d71.s1|4-14|possibility|drug
DDI-DrugBank.d71.s1|16-17|of|drug
DDI-DrugBank.d71.s1|19-30|interactions|drug
DDI-DrugBank.d71.s1|32-35|with|drug
DDI-DrugBank.d71.s1|37-41|other|drug
DDI-DrugBank.d71.s1|43-47|drugs|drug
DDI-DrugBank.d71.s1|49-60|administered|drug
DDI-DrugBank.d71.s1|62-73|concurrently|drug
DDI-DrugBank.d71.s1|75-80|should|drug
DDI-DrugBank.d71.s1|82-83|be|drug
DDI-DrugBank.d71.s1|85-94|considered|drug
DDI-DrugBank.d71.s1|95-95|,|drug
DDI-DrugBank.d71.s1|97-108|particularly|drug
DDI-DrugBank.d71.s1|110-113|when|drug
DDI-DrugBank.d71.s1|115-119|their|drug
DDI-DrugBank.d71.s1|121-124|main|drug
DDI-DrugBank.d71.s1|126-130|route|drug
DDI-DrugBank.d71.s1|132-133|of|drug
DDI-DrugBank.d71.s1|135-145|elimination|drug
DDI-DrugBank.d71.s1|147-148|is|drug
DDI-DrugBank.d71.s1|150-155|active|drug
DDI-DrugBank.d71.s1|157-161|renal|drug
DDI-DrugBank.d71.s1|163-171|secretion|drug
DDI-DrugBank.d71.s1|173-175|via|drug
DDI-DrugBank.d71.s1|177-179|the|drug
DDI-DrugBank.d71.s1|181-187|organic|drug
DDI-DrugBank.d71.s1|189-196|cationic|drug
DDI-DrugBank.d71.s1|198-206|transport|drug
DDI-DrugBank.d71.s1|208-213|system|drug
DDI-DrugBank.d71.s1|215-215|(|drug
DDI-DrugBank.d71.s1|216-219|e.g.|drug
DDI-DrugBank.d71.s1|220-220|,|drug
DDI-DrugBank.d71.s1|222-233|trimethoprim|drug
DDI-DrugBank.d71.s1|234-234|)|drug
DDI-DrugBank.d71.s1|235-235|.|drug
DDI-DrugBank.d71.s2|0-1|No|drug
DDI-DrugBank.d71.s2|3-8|change|drug
DDI-DrugBank.d71.s2|10-11|in|drug
DDI-DrugBank.d71.s2|13-16|dose|drug
DDI-DrugBank.d71.s2|18-19|of|drug
DDI-DrugBank.d71.s2|21-26|either|drug
DDI-DrugBank.d71.s2|28-31|drug|drug
DDI-DrugBank.d71.s2|33-34|is|drug
DDI-DrugBank.d71.s2|36-46|recommended|drug
DDI-DrugBank.d71.s2|47-47|.|drug
DDI-DrugBank.d71.s3|0-4|There|drug
DDI-DrugBank.d71.s3|6-7|is|drug
DDI-DrugBank.d71.s3|9-10|no|drug
DDI-DrugBank.d71.s3|12-22|information|drug
DDI-DrugBank.d71.s3|24-32|regarding|drug
DDI-DrugBank.d71.s3|34-36|the|drug
DDI-DrugBank.d71.s3|38-43|effect|drug
DDI-DrugBank.d71.s3|45-46|on|drug
DDI-DrugBank.d71.s3|48-57|lamivudine|drug
DDI-DrugBank.d71.s3|59-74|pharmacokinetics|drug
DDI-DrugBank.d71.s3|76-77|of|drug
DDI-DrugBank.d71.s3|79-84|higher|drug
DDI-DrugBank.d71.s3|86-90|doses|drug
DDI-DrugBank.d71.s3|92-93|of|drug
DDI-DrugBank.d71.s3|95-101|TMP/SMX|drug
DDI-DrugBank.d71.s3|103-106|such|drug
DDI-DrugBank.d71.s3|108-109|as|drug
DDI-DrugBank.d71.s3|111-115|those|drug
DDI-DrugBank.d71.s3|117-120|used|drug
DDI-DrugBank.d71.s3|122-123|to|drug
DDI-DrugBank.d71.s3|125-129|treat|drug
DDI-DrugBank.d71.s3|131-142|Pneumocystis|drug
DDI-DrugBank.d71.s3|144-150|carinii|drug
DDI-DrugBank.d71.s3|152-160|pneumonia|drug
DDI-DrugBank.d71.s3|161-161|.|drug
DDI-DrugBank.d71.s4|0-1|No|drug
DDI-DrugBank.d71.s4|3-6|data|drug
DDI-DrugBank.d71.s4|8-10|are|drug
DDI-DrugBank.d71.s4|12-20|available|drug
DDI-DrugBank.d71.s4|22-30|regarding|drug
DDI-DrugBank.d71.s4|32-43|interactions|drug
DDI-DrugBank.d71.s4|45-48|with|drug
DDI-DrugBank.d71.s4|50-54|other|drug
DDI-DrugBank.d71.s4|56-60|drugs|drug
DDI-DrugBank.d71.s4|62-65|that|drug
DDI-DrugBank.d71.s4|67-70|have|drug
DDI-DrugBank.d71.s4|72-76|renal|drug
DDI-DrugBank.d71.s4|78-86|clearance|drug
DDI-DrugBank.d71.s4|88-97|mechanisms|drug
DDI-DrugBank.d71.s4|99-105|similar|drug
DDI-DrugBank.d71.s4|107-108|to|drug
DDI-DrugBank.d71.s4|110-113|that|drug
DDI-DrugBank.d71.s4|115-116|of|drug
DDI-DrugBank.d71.s4|118-127|lamivudine|drug
DDI-DrugBank.d71.s4|128-128|.|drug
DDI-DrugBank.d71.s5|0-9|Lamivudine|drug
DDI-DrugBank.d71.s5|11-13|and|drug
DDI-DrugBank.d71.s5|15-25|zalcitabine|drug
DDI-DrugBank.d71.s5|27-29|may|drug
DDI-DrugBank.d71.s5|31-37|inhibit|drug
DDI-DrugBank.d71.s5|39-41|the|drug
DDI-DrugBank.d71.s5|43-55|intracellular|drug
DDI-DrugBank.d71.s5|57-71|phosphorylation|drug
DDI-DrugBank.d71.s5|73-74|of|drug
DDI-DrugBank.d71.s5|76-78|one|drug
DDI-DrugBank.d71.s5|80-86|another|drug
DDI-DrugBank.d71.s5|87-87|.|drug
DDI-DrugBank.d71.s6|0-8|Therefore|drug
DDI-DrugBank.d71.s6|9-9|,|drug
DDI-DrugBank.d71.s6|11-13|use|drug
DDI-DrugBank.d71.s6|15-16|of|drug
DDI-DrugBank.d71.s6|18-27|lamivudine|drug
DDI-DrugBank.d71.s6|29-30|in|drug
DDI-DrugBank.d71.s6|32-42|combination|drug
DDI-DrugBank.d71.s6|44-47|with|drug
DDI-DrugBank.d71.s6|49-59|zalcitabine|drug
DDI-DrugBank.d71.s6|61-62|is|drug
DDI-DrugBank.d71.s6|64-66|not|drug
DDI-DrugBank.d71.s6|68-78|recommended|drug
DDI-DrugBank.d71.s7|0-0|.|drug
DDI-DrugBank.d743.s0|0-11|Ketoconazole|drug
DDI-DrugBank.d743.s0|12-12|:|drug
DDI-DrugBank.d743.s0|14-24|Spontaneous|drug
DDI-DrugBank.d743.s0|26-32|adverse|drug
DDI-DrugBank.d743.s0|34-41|reaction|drug
DDI-DrugBank.d743.s0|43-49|reports|drug
DDI-DrugBank.d743.s0|51-52|of|drug
DDI-DrugBank.d743.s0|54-61|patients|drug
DDI-DrugBank.d743.s0|63-68|taking|drug
DDI-DrugBank.d743.s0|70-80|concomitant|drug
DDI-DrugBank.d743.s0|82-93|ketoconazole|drug
DDI-DrugBank.d743.s0|95-98|with|drug
DDI-DrugBank.d743.s0|100-110|recommended|drug
DDI-DrugBank.d743.s0|112-116|doses|drug
DDI-DrugBank.d743.s0|118-119|of|drug
DDI-DrugBank.d743.s0|121-131|terfenadine|drug
DDI-DrugBank.d743.s0|133-143|demonstrate|drug
DDI-DrugBank.d743.s0|145-146|QT|drug
DDI-DrugBank.d743.s0|148-155|interval|drug
DDI-DrugBank.d743.s0|157-168|prolongation|drug
DDI-DrugBank.d743.s0|170-172|and|drug
DDI-DrugBank.d743.s0|174-177|rare|drug
DDI-DrugBank.d743.s0|179-185|serious|drug
DDI-DrugBank.d743.s0|187-193|cardiac|drug
DDI-DrugBank.d743.s0|195-200|events|drug
DDI-DrugBank.d743.s0|201-201|,|drug
DDI-DrugBank.d743.s0|203-205|e.g|drug
DDI-DrugBank.d743.s0|206-206|.|drug
DDI-DrugBank.d743.s1|0-4|death|drug
DDI-DrugBank.d743.s1|5-5|,|drug
DDI-DrugBank.d743.s1|7-13|cardiac|drug
DDI-DrugBank.d743.s1|15-20|arrest|drug
DDI-DrugBank.d743.s1|21-21|,|drug
DDI-DrugBank.d743.s1|23-25|and|drug
DDI-DrugBank.d743.s1|27-37|ventricular|drug
DDI-DrugBank.d743.s1|39-48|arrhythmia|drug
DDI-DrugBank.d743.s1|50-58|including|drug
DDI-DrugBank.d743.s1|60-67|torsades|drug
DDI-DrugBank.d743.s1|69-70|de|drug
DDI-DrugBank.d743.s1|72-78|pointes|drug
DDI-DrugBank.d743.s1|79-79|.|drug
DDI-DrugBank.d743.s2|0-14|Pharmacokinetic|drug
DDI-DrugBank.d743.s2|16-19|data|drug
DDI-DrugBank.d743.s2|21-28|indicate|drug
DDI-DrugBank.d743.s2|30-33|that|drug
DDI-DrugBank.d743.s2|35-46|ketoconazole|drug
DDI-DrugBank.d743.s2|48-55|markedly|drug
DDI-DrugBank.d743.s2|57-64|inhibits|drug
DDI-DrugBank.d743.s2|66-68|the|drug
DDI-DrugBank.d743.s2|70-79|metabolism|drug
DDI-DrugBank.d743.s2|81-82|of|drug
DDI-DrugBank.d743.s2|84-94|terfenadine|drug
DDI-DrugBank.d743.s2|95-95|,|drug
DDI-DrugBank.d743.s2|97-105|resulting|drug
DDI-DrugBank.d743.s2|107-108|in|drug
DDI-DrugBank.d743.s2|110-117|elevated|drug
DDI-DrugBank.d743.s2|119-124|plasma|drug
DDI-DrugBank.d743.s2|126-136|terfenadine|drug
DDI-DrugBank.d743.s2|138-143|levels|drug
DDI-DrugBank.d743.s2|144-144|.|drug
DDI-DrugBank.d743.s3|0-7|Presence|drug
DDI-DrugBank.d743.s3|9-10|of|drug
DDI-DrugBank.d743.s3|12-20|unchanged|drug
DDI-DrugBank.d743.s3|22-32|terfenadine|drug
DDI-DrugBank.d743.s3|34-35|is|drug
DDI-DrugBank.d743.s3|37-46|associated|drug
DDI-DrugBank.d743.s3|48-51|with|drug
DDI-DrugBank.d743.s3|53-65|statistically|drug
DDI-DrugBank.d743.s3|67-77|significant|drug
DDI-DrugBank.d743.s3|79-90|prolongation|drug
DDI-DrugBank.d743.s3|92-93|of|drug
DDI-DrugBank.d743.s3|95-97|the|drug
DDI-DrugBank.d743.s3|99-100|QT|drug
DDI-DrugBank.d743.s3|102-104|and|drug
DDI-DrugBank.d743.s3|106-108|QTc|drug
DDI-DrugBank.d743.s3|110-118|intervals|drug
DDI-DrugBank.d743.s3|119-119|.|drug
DDI-DrugBank.d743.s4|0-10|Concomitant|drug
DDI-DrugBank.d743.s4|12-25|administration|drug
DDI-DrugBank.d743.s4|27-28|of|drug
DDI-DrugBank.d743.s4|30-41|ketoconazole|drug
DDI-DrugBank.d743.s4|43-45|and|drug
DDI-DrugBank.d743.s4|47-57|terfenadine|drug
DDI-DrugBank.d743.s4|59-60|is|drug
DDI-DrugBank.d743.s4|62-76|contraindicated|drug
DDI-DrugBank.d743.s4|77-77|.|drug
DDI-DrugBank.d743.s5|0-11|Itraconazole|drug
DDI-DrugBank.d743.s5|12-12|:|drug
DDI-DrugBank.d743.s5|14-21|Torsades|drug
DDI-DrugBank.d743.s5|23-24|de|drug
DDI-DrugBank.d743.s5|26-32|pointes|drug
DDI-DrugBank.d743.s5|34-36|and|drug
DDI-DrugBank.d743.s5|38-45|elevated|drug
DDI-DrugBank.d743.s5|47-52|parent|drug
DDI-DrugBank.d743.s5|54-64|terfenadine|drug
DDI-DrugBank.d743.s5|66-71|levels|drug
DDI-DrugBank.d743.s5|73-76|have|drug
DDI-DrugBank.d743.s5|78-81|been|drug
DDI-DrugBank.d743.s5|83-90|reported|drug
DDI-DrugBank.d743.s5|92-97|during|drug
DDI-DrugBank.d743.s5|99-109|concomitant|drug
DDI-DrugBank.d743.s5|111-113|use|drug
DDI-DrugBank.d743.s5|115-116|of|drug
DDI-DrugBank.d743.s5|118-128|terfenadine|drug
DDI-DrugBank.d743.s5|130-132|and|drug
DDI-DrugBank.d743.s5|134-145|itraconazole|drug
DDI-DrugBank.d743.s5|147-148|in|drug
DDI-DrugBank.d743.s5|150-157|clinical|drug
DDI-DrugBank.d743.s5|159-164|trials|drug
DDI-DrugBank.d743.s5|166-167|of|drug
DDI-DrugBank.d743.s5|169-180|itraconazole|drug
DDI-DrugBank.d743.s5|182-184|and|drug
DDI-DrugBank.d743.s5|186-189|from|drug
DDI-DrugBank.d743.s5|191-197|foreign|drug
DDI-DrugBank.d743.s5|199-212|post-marketing|drug
DDI-DrugBank.d743.s5|214-220|sources|drug
DDI-DrugBank.d743.s5|221-221|.|drug
DDI-DrugBank.d743.s6|0-2|One|drug
DDI-DrugBank.d743.s6|4-8|death|drug
DDI-DrugBank.d743.s6|10-12|has|drug
DDI-DrugBank.d743.s6|14-17|also|drug
DDI-DrugBank.d743.s6|19-22|been|drug
DDI-DrugBank.d743.s6|24-31|reported|drug
DDI-DrugBank.d743.s6|33-36|from|drug
DDI-DrugBank.d743.s6|38-44|foreign|drug
DDI-DrugBank.d743.s6|46-50|post-|drug
DDI-DrugBank.d743.s6|52-60|marketing|drug
DDI-DrugBank.d743.s6|62-68|sources|drug
DDI-DrugBank.d743.s6|69-69|.|drug
DDI-DrugBank.d743.s7|0-10|Concomitant|drug
DDI-DrugBank.d743.s7|12-25|administration|drug
DDI-DrugBank.d743.s7|27-28|of|drug
DDI-DrugBank.d743.s7|30-41|itraconazole|drug
DDI-DrugBank.d743.s7|43-45|and|drug
DDI-DrugBank.d743.s7|47-57|terfenadine|drug
DDI-DrugBank.d743.s7|59-60|is|drug
DDI-DrugBank.d743.s7|62-76|contraindicated|drug
DDI-DrugBank.d743.s7|77-77|.|drug
DDI-DrugBank.d743.s8|0-2|Due|drug
DDI-DrugBank.d743.s8|4-5|to|drug
DDI-DrugBank.d743.s8|7-9|the|drug
DDI-DrugBank.d743.s8|11-18|chemical|drug
DDI-DrugBank.d743.s8|20-29|similarity|drug
DDI-DrugBank.d743.s8|31-32|of|drug
DDI-DrugBank.d743.s8|34-38|other|drug
DDI-DrugBank.d743.s8|40-49|azole-type|drug
DDI-DrugBank.d743.s8|51-60|antifungal|drug
DDI-DrugBank.d743.s8|62-67|agents|drug
DDI-DrugBank.d743.s8|69-69|(|drug
DDI-DrugBank.d743.s8|70-78|including|drug
DDI-DrugBank.d743.s8|80-90|fluconazole|drug
DDI-DrugBank.d743.s8|91-91|,|drug
DDI-DrugBank.d743.s8|93-105|metronidazole|drug
DDI-DrugBank.d743.s8|106-106|,|drug
DDI-DrugBank.d743.s8|108-110|and|drug
DDI-DrugBank.d743.s8|112-121|miconazole|drug
DDI-DrugBank.d743.s8|122-122|)|drug
DDI-DrugBank.d743.s8|124-125|to|drug
DDI-DrugBank.d743.s8|127-138|ketoconazole|drug
DDI-DrugBank.d743.s8|139-139|,|drug
DDI-DrugBank.d743.s8|141-143|and|drug
DDI-DrugBank.d743.s8|145-156|itraconazole|drug
DDI-DrugBank.d743.s8|157-157|,|drug
DDI-DrugBank.d743.s8|159-169|concomitant|drug
DDI-DrugBank.d743.s8|171-173|use|drug
DDI-DrugBank.d743.s8|175-176|of|drug
DDI-DrugBank.d743.s8|178-182|these|drug
DDI-DrugBank.d743.s8|184-191|products|drug
DDI-DrugBank.d743.s8|193-196|with|drug
DDI-DrugBank.d743.s8|198-208|terfenadine|drug
DDI-DrugBank.d743.s8|210-211|is|drug
DDI-DrugBank.d743.s8|213-215|not|drug
DDI-DrugBank.d743.s8|217-227|recommended|drug
DDI-DrugBank.d743.s8|229-235|pending|drug
DDI-DrugBank.d743.s8|237-240|full|drug
DDI-DrugBank.d743.s8|242-252|examination|drug
DDI-DrugBank.d743.s8|254-255|of|drug
DDI-DrugBank.d743.s8|257-265|potential|drug
DDI-DrugBank.d743.s8|267-278|interactions|drug
DDI-DrugBank.d743.s8|279-279|.|drug
DDI-DrugBank.d743.s9|0-9|Macrolides|drug
DDI-DrugBank.d743.s9|10-10|:|drug
DDI-DrugBank.d743.s9|12-19|Clinical|drug
DDI-DrugBank.d743.s9|21-24|drug|drug
DDI-DrugBank.d743.s9|26-36|interaction|drug
DDI-DrugBank.d743.s9|38-44|studies|drug
DDI-DrugBank.d743.s9|46-53|indicate|drug
DDI-DrugBank.d743.s9|55-58|that|drug
DDI-DrugBank.d743.s9|60-71|erythromycin|drug
DDI-DrugBank.d743.s9|73-75|and|drug
DDI-DrugBank.d743.s9|77-90|clarithromycin|drug
DDI-DrugBank.d743.s9|92-94|can|drug
DDI-DrugBank.d743.s9|96-100|exert|drug
DDI-DrugBank.d743.s9|102-103|an|drug
DDI-DrugBank.d743.s9|105-110|effect|drug
DDI-DrugBank.d743.s9|112-113|on|drug
DDI-DrugBank.d743.s9|115-125|terfenadine|drug
DDI-DrugBank.d743.s9|127-136|metabolism|drug
DDI-DrugBank.d743.s9|138-139|by|drug
DDI-DrugBank.d743.s9|141-141|a|drug
DDI-DrugBank.d743.s9|143-151|mechanism|drug
DDI-DrugBank.d743.s9|153-157|which|drug
DDI-DrugBank.d743.s9|159-161|may|drug
DDI-DrugBank.d743.s9|163-164|be|drug
DDI-DrugBank.d743.s9|166-172|similar|drug
DDI-DrugBank.d743.s9|174-175|to|drug
DDI-DrugBank.d743.s9|177-180|that|drug
DDI-DrugBank.d743.s9|182-183|of|drug
DDI-DrugBank.d743.s9|185-196|ketoconazole|drug
DDI-DrugBank.d743.s9|197-197|,|drug
DDI-DrugBank.d743.s9|199-201|but|drug
DDI-DrugBank.d743.s9|203-204|to|drug
DDI-DrugBank.d743.s9|206-206|a|drug
DDI-DrugBank.d743.s9|208-213|lesser|drug
DDI-DrugBank.d743.s9|215-220|extent|drug
DDI-DrugBank.d743.s9|221-221|.|drug
DDI-DrugBank.d743.s10|0-7|Although|drug
DDI-DrugBank.d743.s10|9-20|erythromycin|drug
DDI-DrugBank.d743.s10|22-31|measurably|drug
DDI-DrugBank.d743.s10|33-41|decreases|drug
DDI-DrugBank.d743.s10|43-45|the|drug
DDI-DrugBank.d743.s10|47-55|clearance|drug
DDI-DrugBank.d743.s10|57-58|of|drug
DDI-DrugBank.d743.s10|60-62|the|drug
DDI-DrugBank.d743.s10|64-74|terfenadine|drug
DDI-DrugBank.d743.s10|76-79|acid|drug
DDI-DrugBank.d743.s10|81-90|metabolite|drug
DDI-DrugBank.d743.s10|91-91|,|drug
DDI-DrugBank.d743.s10|93-95|its|drug
DDI-DrugBank.d743.s10|97-105|influence|drug
DDI-DrugBank.d743.s10|107-108|on|drug
DDI-DrugBank.d743.s10|110-120|terfenadine|drug
DDI-DrugBank.d743.s10|122-127|plasma|drug
DDI-DrugBank.d743.s10|129-134|levels|drug
DDI-DrugBank.d743.s10|136-137|is|drug
DDI-DrugBank.d743.s10|139-143|still|drug
DDI-DrugBank.d743.s10|145-149|under|drug
DDI-DrugBank.d743.s10|151-163|investigation|drug
DDI-DrugBank.d743.s10|164-164|.|drug
DDI-DrugBank.d743.s11|0-0|A|drug
DDI-DrugBank.d743.s11|2-4|few|drug
DDI-DrugBank.d743.s11|6-16|spontaneous|drug
DDI-DrugBank.d743.s11|18-25|accounts|drug
DDI-DrugBank.d743.s11|27-28|of|drug
DDI-DrugBank.d743.s11|30-31|QT|drug
DDI-DrugBank.d743.s11|33-40|interval|drug
DDI-DrugBank.d743.s11|42-53|prolongation|drug
DDI-DrugBank.d743.s11|55-58|with|drug
DDI-DrugBank.d743.s11|60-70|ventricular|drug
DDI-DrugBank.d743.s11|72-81|arrhythmia|drug
DDI-DrugBank.d743.s11|83-91|including|drug
DDI-DrugBank.d743.s11|93-100|torsades|drug
DDI-DrugBank.d743.s11|102-103|de|drug
DDI-DrugBank.d743.s11|105-111|pointes|drug
DDI-DrugBank.d743.s11|112-112|,|drug
DDI-DrugBank.d743.s11|114-117|have|drug
DDI-DrugBank.d743.s11|119-122|been|drug
DDI-DrugBank.d743.s11|124-131|reported|drug
DDI-DrugBank.d743.s11|133-134|in|drug
DDI-DrugBank.d743.s11|136-143|patients|drug
DDI-DrugBank.d743.s11|145-153|receiving|drug
DDI-DrugBank.d743.s11|155-166|erythromycin|drug
DDI-DrugBank.d743.s11|168-169|or|drug
DDI-DrugBank.d743.s11|171-184|troleandomycin|drug
DDI-DrugBank.d743.s11|185-185|.|drug
DDI-DrugBank.d743.s12|0-10|Concomitant|drug
DDI-DrugBank.d743.s12|12-25|administration|drug
DDI-DrugBank.d743.s12|27-28|of|drug
DDI-DrugBank.d743.s12|30-40|terfenadine|drug
DDI-DrugBank.d743.s12|42-45|with|drug
DDI-DrugBank.d743.s12|47-60|clarithromycin|drug
DDI-DrugBank.d743.s12|61-61|,|drug
DDI-DrugBank.d743.s12|63-74|erythromycin|drug
DDI-DrugBank.d743.s12|75-75|,|drug
DDI-DrugBank.d743.s12|77-78|or|drug
DDI-DrugBank.d743.s12|80-93|troleandomycin|drug
DDI-DrugBank.d743.s12|95-96|is|drug
DDI-DrugBank.d743.s12|98-112|contraindicated|drug
DDI-DrugBank.d743.s12|113-113|:|drug
DDI-DrugBank.d743.s12|115-121|Pending|drug
DDI-DrugBank.d743.s12|123-126|full|drug
DDI-DrugBank.d743.s12|128-143|characterization|drug
DDI-DrugBank.d743.s12|145-146|of|drug
DDI-DrugBank.d743.s12|148-156|potential|drug
DDI-DrugBank.d743.s12|158-169|interactions|drug
DDI-DrugBank.d743.s12|170-170|,|drug
DDI-DrugBank.d743.s12|172-182|concomitant|drug
DDI-DrugBank.d743.s12|184-197|administration|drug
DDI-DrugBank.d743.s12|199-200|of|drug
DDI-DrugBank.d743.s12|202-212|terfenadine|drug
DDI-DrugBank.d743.s12|214-217|with|drug
DDI-DrugBank.d743.s12|219-223|other|drug
DDI-DrugBank.d743.s12|225-233|macrolide|drug
DDI-DrugBank.d743.s12|235-245|antibiotics|drug
DDI-DrugBank.d743.s12|246-246|,|drug
DDI-DrugBank.d743.s12|248-256|including|drug
DDI-DrugBank.d743.s12|258-269|azithromycin|drug
DDI-DrugBank.d743.s12|270-270|,|drug
DDI-DrugBank.d743.s12|272-273|is|drug
DDI-DrugBank.d743.s12|275-277|not|drug
DDI-DrugBank.d743.s12|279-289|recommended|drug
DDI-DrugBank.d743.s12|290-290|.|drug
DDI-DrugBank.d743.s13|0-6|Studies|drug
DDI-DrugBank.d743.s13|8-9|to|drug
DDI-DrugBank.d743.s13|11-18|evaluate|drug
DDI-DrugBank.d743.s13|20-28|potential|drug
DDI-DrugBank.d743.s13|30-41|interactions|drug
DDI-DrugBank.d743.s13|43-44|of|drug
DDI-DrugBank.d743.s13|46-56|terfenadine|drug
DDI-DrugBank.d743.s13|58-61|with|drug
DDI-DrugBank.d743.s13|63-74|azithromycin|drug
DDI-DrugBank.d743.s13|76-78|are|drug
DDI-DrugBank.d743.s13|80-81|in|drug
DDI-DrugBank.d743.s13|83-90|progress|drug
DDI-DrugBank.d743.s13|91-91|.|drug
DDI-DrugBank.d229.s0|0-3|Drug|drug
DDI-DrugBank.d229.s0|5-15|Interaction|drug
DDI-DrugBank.d229.s0|17-22|During|drug
DDI-DrugBank.d229.s0|24-32|Pregnancy|drug
DDI-DrugBank.d229.s0|33-33|:|drug
DDI-DrugBank.d229.s0|35-42|Cromolyn|drug
DDI-DrugBank.d229.s0|44-49|sodium|drug
DDI-DrugBank.d229.s0|51-53|and|drug
DDI-DrugBank.d229.s0|55-67|isoproterenol|drug
DDI-DrugBank.d229.s0|69-72|were|drug
DDI-DrugBank.d229.s0|74-80|studied|drug
DDI-DrugBank.d229.s0|82-90|following|drug
DDI-DrugBank.d229.s0|92-103|subcutaneous|drug
DDI-DrugBank.d229.s0|105-114|injections|drug
DDI-DrugBank.d229.s0|116-117|in|drug
DDI-DrugBank.d229.s0|119-126|pregnant|drug
DDI-DrugBank.d229.s0|128-131|mice|drug
DDI-DrugBank.d229.s0|132-132|.|drug
DDI-DrugBank.d229.s1|0-7|Cromolyn|drug
DDI-DrugBank.d229.s1|9-14|sodium|drug
DDI-DrugBank.d229.s1|16-20|alone|drug
DDI-DrugBank.d229.s1|22-23|in|drug
DDI-DrugBank.d229.s1|25-29|doses|drug
DDI-DrugBank.d229.s1|31-32|up|drug
DDI-DrugBank.d229.s1|34-35|to|drug
DDI-DrugBank.d229.s1|37-39|540|drug
DDI-DrugBank.d229.s1|41-49|mg/kg/day|drug
DDI-DrugBank.d229.s1|51-51|(|drug
DDI-DrugBank.d229.s1|52-64|approximately|drug
DDI-DrugBank.d229.s1|66-68|340|drug
DDI-DrugBank.d229.s1|70-74|times|drug
DDI-DrugBank.d229.s1|76-78|the|drug
DDI-DrugBank.d229.s1|80-86|maximum|drug
DDI-DrugBank.d229.s1|88-98|recommended|drug
DDI-DrugBank.d229.s1|100-104|daily|drug
DDI-DrugBank.d229.s1|106-115|inhalation|drug
DDI-DrugBank.d229.s1|117-120|dose|drug
DDI-DrugBank.d229.s1|122-123|in|drug
DDI-DrugBank.d229.s1|125-130|adults|drug
DDI-DrugBank.d229.s1|132-133|on|drug
DDI-DrugBank.d229.s1|135-135|a|drug
DDI-DrugBank.d229.s1|137-141|mg/m2|drug
DDI-DrugBank.d229.s1|143-147|basis|drug
DDI-DrugBank.d229.s1|148-148|)|drug
DDI-DrugBank.d229.s1|150-152|did|drug
DDI-DrugBank.d229.s1|154-156|not|drug
DDI-DrugBank.d229.s1|158-162|cause|drug
DDI-DrugBank.d229.s1|164-174|significant|drug
DDI-DrugBank.d229.s1|176-184|increases|drug
DDI-DrugBank.d229.s1|186-187|in|drug
DDI-DrugBank.d229.s1|189-199|resorptions|drug
DDI-DrugBank.d229.s1|201-202|or|drug
DDI-DrugBank.d229.s1|204-208|major|drug
DDI-DrugBank.d229.s1|210-222|malformations|drug
DDI-DrugBank.d229.s1|223-223|.|drug
DDI-DrugBank.d229.s2|0-12|Isoproterenol|drug
DDI-DrugBank.d229.s2|14-18|alone|drug
DDI-DrugBank.d229.s2|20-21|at|drug
DDI-DrugBank.d229.s2|23-23|a|drug
DDI-DrugBank.d229.s2|25-28|dose|drug
DDI-DrugBank.d229.s2|30-31|of|drug
DDI-DrugBank.d229.s2|33-35|2.7|drug
DDI-DrugBank.d229.s2|37-45|mg/kg/day|drug
DDI-DrugBank.d229.s2|47-47|(|drug
DDI-DrugBank.d229.s2|48-60|approximately|drug
DDI-DrugBank.d229.s2|62-62|7|drug
DDI-DrugBank.d229.s2|64-68|times|drug
DDI-DrugBank.d229.s2|70-72|the|drug
DDI-DrugBank.d229.s2|74-80|maximum|drug
DDI-DrugBank.d229.s2|82-92|recommended|drug
DDI-DrugBank.d229.s2|94-98|daily|drug
DDI-DrugBank.d229.s2|100-109|inhalation|drug
DDI-DrugBank.d229.s2|111-114|dose|drug
DDI-DrugBank.d229.s2|116-117|in|drug
DDI-DrugBank.d229.s2|119-124|adults|drug
DDI-DrugBank.d229.s2|126-127|on|drug
DDI-DrugBank.d229.s2|129-129|a|drug
DDI-DrugBank.d229.s2|131-135|mg/m2|drug
DDI-DrugBank.d229.s2|137-141|basis|drug
DDI-DrugBank.d229.s2|142-142|)|drug
DDI-DrugBank.d229.s2|144-152|increased|drug
DDI-DrugBank.d229.s2|154-157|both|drug
DDI-DrugBank.d229.s2|159-169|resorptions|drug
DDI-DrugBank.d229.s2|171-173|and|drug
DDI-DrugBank.d229.s2|175-187|malformations|drug
DDI-DrugBank.d229.s2|188-188|.|drug
DDI-DrugBank.d229.s3|0-2|The|drug
DDI-DrugBank.d229.s3|4-11|addition|drug
DDI-DrugBank.d229.s3|13-14|of|drug
DDI-DrugBank.d229.s3|16-18|540|drug
DDI-DrugBank.d229.s3|20-28|mg/kg/day|drug
DDI-DrugBank.d229.s3|30-31|of|drug
DDI-DrugBank.d229.s3|33-40|cromolyn|drug
DDI-DrugBank.d229.s3|42-47|sodium|drug
DDI-DrugBank.d229.s3|49-49|(|drug
DDI-DrugBank.d229.s3|50-62|approximately|drug
DDI-DrugBank.d229.s3|64-66|340|drug
DDI-DrugBank.d229.s3|68-72|times|drug
DDI-DrugBank.d229.s3|74-76|the|drug
DDI-DrugBank.d229.s3|78-84|maximum|drug
DDI-DrugBank.d229.s3|86-96|recommended|drug
DDI-DrugBank.d229.s3|98-102|daily|drug
DDI-DrugBank.d229.s3|104-113|inhalation|drug
DDI-DrugBank.d229.s3|115-118|dose|drug
DDI-DrugBank.d229.s3|120-121|in|drug
DDI-DrugBank.d229.s3|123-128|adults|drug
DDI-DrugBank.d229.s3|130-131|on|drug
DDI-DrugBank.d229.s3|133-133|a|drug
DDI-DrugBank.d229.s3|135-139|mg/m2|drug
DDI-DrugBank.d229.s3|141-145|basis|drug
DDI-DrugBank.d229.s3|146-146|)|drug
DDI-DrugBank.d229.s3|148-149|to|drug
DDI-DrugBank.d229.s3|151-153|2.7|drug
DDI-DrugBank.d229.s3|155-163|mg/kg/day|drug
DDI-DrugBank.d229.s3|165-166|of|drug
DDI-DrugBank.d229.s3|168-180|isoproterenol|drug
DDI-DrugBank.d229.s3|182-182|(|drug
DDI-DrugBank.d229.s3|183-195|approximately|drug
DDI-DrugBank.d229.s3|197-197|7|drug
DDI-DrugBank.d229.s3|199-203|times|drug
DDI-DrugBank.d229.s3|205-207|the|drug
DDI-DrugBank.d229.s3|209-215|maximum|drug
DDI-DrugBank.d229.s3|217-227|recommended|drug
DDI-DrugBank.d229.s3|229-233|daily|drug
DDI-DrugBank.d229.s3|235-244|inhalation|drug
DDI-DrugBank.d229.s3|246-249|dose|drug
DDI-DrugBank.d229.s3|251-252|in|drug
DDI-DrugBank.d229.s3|254-259|adults|drug
DDI-DrugBank.d229.s3|261-262|on|drug
DDI-DrugBank.d229.s3|264-264|a|drug
DDI-DrugBank.d229.s3|266-270|mg/m2|drug
DDI-DrugBank.d229.s3|272-276|basis|drug
DDI-DrugBank.d229.s3|277-277|)|drug
DDI-DrugBank.d229.s3|279-285|appears|drug
DDI-DrugBank.d229.s3|287-288|to|drug
DDI-DrugBank.d229.s3|290-293|have|drug
DDI-DrugBank.d229.s3|295-303|increased|drug
DDI-DrugBank.d229.s3|305-307|the|drug
DDI-DrugBank.d229.s3|309-317|incidence|drug
DDI-DrugBank.d229.s3|319-320|of|drug
DDI-DrugBank.d229.s3|322-325|both|drug
DDI-DrugBank.d229.s3|327-337|resorptions|drug
DDI-DrugBank.d229.s3|339-341|and|drug
DDI-DrugBank.d229.s3|343-355|malformations|drug
DDI-DrugBank.d229.s3|356-356|.|drug
DDI-DrugBank.d524.s0|0-8|Albuterol|drug
DDI-DrugBank.d524.s0|9-9|,|drug
DDI-DrugBank.d524.s0|11-24|Antihistamines|drug
DDI-DrugBank.d524.s0|25-25|,|drug
DDI-DrugBank.d524.s0|27-38|antidiabetic|drug
DDI-DrugBank.d524.s0|40-44|drugs|drug
DDI-DrugBank.d524.s0|45-45|,|drug
DDI-DrugBank.d524.s0|47-55|diuretics|drug
DDI-DrugBank.d524.s0|56-56|,|drug
DDI-DrugBank.d524.s0|58-66|digitalis|drug
DDI-DrugBank.d524.s0|67-67|.|drug
DDI-MedLine.d14.s0|0-0|[|drug
DDI-MedLine.d14.s0|1-1|A|drug
DDI-MedLine.d14.s0|3-17|pharmacological|drug
DDI-MedLine.d14.s0|19-26|analysis|drug
DDI-MedLine.d14.s0|28-29|of|drug
DDI-MedLine.d14.s0|31-33|the|drug
DDI-MedLine.d14.s0|35-40|effect|drug
DDI-MedLine.d14.s0|42-43|of|drug
DDI-MedLine.d14.s0|45-55|angiotensin|drug
DDI-MedLine.d14.s0|57-58|on|drug
DDI-MedLine.d14.s0|60-69|stimulated|drug
DDI-MedLine.d14.s0|71-77|gastric|drug
DDI-MedLine.d14.s0|79-87|secretion|drug
DDI-MedLine.d14.s0|88-88|]|drug
DDI-MedLine.d14.s0|91-97|Chronic|drug
DDI-MedLine.d14.s0|99-109|experiments|drug
DDI-MedLine.d14.s0|111-112|on|drug
DDI-MedLine.d14.s0|114-117|dogs|drug
DDI-MedLine.d14.s0|119-122|with|drug
DDI-MedLine.d14.s0|124-130|gastric|drug
DDI-MedLine.d14.s0|132-139|fistulas|drug
DDI-MedLine.d14.s0|141-144|were|drug
DDI-MedLine.d14.s0|146-152|carried|drug
DDI-MedLine.d14.s0|154-156|out|drug
DDI-MedLine.d14.s0|158-159|to|drug
DDI-MedLine.d14.s0|161-165|study|drug
DDI-MedLine.d14.s0|167-169|the|drug
DDI-MedLine.d14.s0|171-179|influence|drug
DDI-MedLine.d14.s0|181-182|of|drug
DDI-MedLine.d14.s0|184-194|angiotensin|drug
DDI-MedLine.d14.s0|196-196|1|drug
DDI-MedLine.d14.s0|198-200|and|drug
DDI-MedLine.d14.s0|202-212|angiotensin|drug
DDI-MedLine.d14.s0|214-214|2|drug
DDI-MedLine.d14.s0|216-217|on|drug
DDI-MedLine.d14.s0|219-231|pentagastrin-|drug
DDI-MedLine.d14.s0|233-235|and|drug
DDI-MedLine.d14.s0|237-253|histamine-induced|drug
DDI-MedLine.d14.s0|255-261|gastric|drug
DDI-MedLine.d14.s0|263-266|acid|drug
DDI-MedLine.d14.s0|268-276|secretion|drug
DDI-MedLine.d14.s0|277-277|.|drug
DDI-MedLine.d14.s1|0-1|It|drug
DDI-MedLine.d14.s1|3-5|was|drug
DDI-MedLine.d14.s1|7-17|established|drug
DDI-MedLine.d14.s1|19-22|that|drug
DDI-MedLine.d14.s1|24-27|both|drug
DDI-MedLine.d14.s1|29-40|angiotensins|drug
DDI-MedLine.d14.s1|42-50|inhibited|drug
DDI-MedLine.d14.s1|52-58|gastric|drug
DDI-MedLine.d14.s1|60-63|acid|drug
DDI-MedLine.d14.s1|65-73|secretion|drug
DDI-MedLine.d14.s1|75-84|stimulated|drug
DDI-MedLine.d14.s1|86-87|by|drug
DDI-MedLine.d14.s1|89-100|pentagastrin|drug
DDI-MedLine.d14.s1|102-104|but|drug
DDI-MedLine.d14.s1|106-108|not|drug
DDI-MedLine.d14.s1|110-111|by|drug
DDI-MedLine.d14.s1|113-121|histamine|drug
DDI-MedLine.d14.s1|122-122|.|drug
DDI-MedLine.d14.s2|0-10|Comparative|drug
DDI-MedLine.d14.s2|12-19|analysis|drug
DDI-MedLine.d14.s2|21-22|of|drug
DDI-MedLine.d14.s2|24-26|the|drug
DDI-MedLine.d14.s2|28-34|effects|drug
DDI-MedLine.d14.s2|36-37|of|drug
DDI-MedLine.d14.s2|39-49|stimulation|drug
DDI-MedLine.d14.s2|51-53|and|drug
DDI-MedLine.d14.s2|55-64|inhibition|drug
DDI-MedLine.d14.s2|66-67|of|drug
DDI-MedLine.d14.s2|69-76|cholino-|drug
DDI-MedLine.d14.s2|78-80|and|drug
DDI-MedLine.d14.s2|82-96|adrenoreceptors|drug
DDI-MedLine.d14.s2|98-99|on|drug
DDI-MedLine.d14.s2|101-104|this|drug
DDI-MedLine.d14.s2|106-115|inhibitory|drug
DDI-MedLine.d14.s2|117-122|action|drug
DDI-MedLine.d14.s2|124-125|of|drug
DDI-MedLine.d14.s2|127-138|angiotensins|drug
DDI-MedLine.d14.s2|140-148|suggested|drug
DDI-MedLine.d14.s2|150-152|the|drug
DDI-MedLine.d14.s2|154-162|mediation|drug
DDI-MedLine.d14.s2|164-165|of|drug
DDI-MedLine.d14.s2|167-177|angiotensin|drug
DDI-MedLine.d14.s2|179-187|influence|drug
DDI-MedLine.d14.s2|189-195|through|drug
DDI-MedLine.d14.s2|197-199|the|drug
DDI-MedLine.d14.s2|201-210|modulation|drug
DDI-MedLine.d14.s2|212-213|of|drug
DDI-MedLine.d14.s2|215-225|cholinergic|drug
DDI-MedLine.d14.s2|227-235|reactions|drug
DDI-MedLine.d14.s2|237-238|of|drug
DDI-MedLine.d14.s2|240-247|parietal|drug
DDI-MedLine.d14.s2|249-253|cells|drug
DDI-MedLine.d14.s2|255-256|in|drug
DDI-MedLine.d14.s2|258-260|the|drug
DDI-MedLine.d14.s2|262-268|stomach|drug
DDI-MedLine.d14.s2|269-269|.|drug
DDI-DrugBank.d450.s0|0-18|Potassium-depleting|drug
DDI-DrugBank.d450.s0|20-28|diuretics|drug
DDI-DrugBank.d450.s0|30-32|are|drug
DDI-DrugBank.d450.s0|34-34|a|drug
DDI-DrugBank.d450.s0|36-40|major|drug
DDI-DrugBank.d450.s0|42-53|contributing|drug
DDI-DrugBank.d450.s0|55-60|factor|drug
DDI-DrugBank.d450.s0|62-63|to|drug
DDI-DrugBank.d450.s0|65-73|digitalis|drug
DDI-DrugBank.d450.s0|75-82|toxicity|drug
DDI-DrugBank.d450.s0|83-83|.|drug
DDI-DrugBank.d450.s1|0-6|Calcium|drug
DDI-DrugBank.d450.s1|7-7|,|drug
DDI-DrugBank.d450.s1|9-20|particularly|drug
DDI-DrugBank.d450.s1|22-23|if|drug
DDI-DrugBank.d450.s1|25-36|administered|drug
DDI-DrugBank.d450.s1|38-44|rapidly|drug
DDI-DrugBank.d450.s1|46-47|by|drug
DDI-DrugBank.d450.s1|49-51|the|drug
DDI-DrugBank.d450.s1|53-63|intravenous|drug
DDI-DrugBank.d450.s1|65-69|route|drug
DDI-DrugBank.d450.s1|70-70|,|drug
DDI-DrugBank.d450.s1|72-74|may|drug
DDI-DrugBank.d450.s1|76-82|produce|drug
DDI-DrugBank.d450.s1|84-90|serious|drug
DDI-DrugBank.d450.s1|92-102|arrhythmias|drug
DDI-DrugBank.d450.s1|104-105|in|drug
DDI-DrugBank.d450.s1|107-117|digitalized|drug
DDI-DrugBank.d450.s1|119-126|patients|drug
DDI-DrugBank.d450.s1|127-127|.|drug
DDI-DrugBank.d450.s2|0-8|Quinidine|drug
DDI-DrugBank.d450.s2|9-9|,|drug
DDI-DrugBank.d450.s2|11-19|verapamil|drug
DDI-DrugBank.d450.s2|20-20|,|drug
DDI-DrugBank.d450.s2|22-31|amiodarone|drug
DDI-DrugBank.d450.s2|32-32|,|drug
DDI-DrugBank.d450.s2|34-44|propafenone|drug
DDI-DrugBank.d450.s2|45-45|,|drug
DDI-DrugBank.d450.s2|47-58|indomethacin|drug
DDI-DrugBank.d450.s2|59-59|,|drug
DDI-DrugBank.d450.s2|61-72|itraconazole|drug
DDI-DrugBank.d450.s2|73-73|,|drug
DDI-DrugBank.d450.s2|75-84|alprazolam|drug
DDI-DrugBank.d450.s2|85-85|,|drug
DDI-DrugBank.d450.s2|87-89|and|drug
DDI-DrugBank.d450.s2|91-104|spironolactone|drug
DDI-DrugBank.d450.s2|106-110|raise|drug
DDI-DrugBank.d450.s2|112-114|the|drug
DDI-DrugBank.d450.s2|116-120|serum|drug
DDI-DrugBank.d450.s2|122-128|digoxin|drug
DDI-DrugBank.d450.s2|130-142|concentration|drug
DDI-DrugBank.d450.s2|144-146|due|drug
DDI-DrugBank.d450.s2|148-149|to|drug
DDI-DrugBank.d450.s2|151-151|a|drug
DDI-DrugBank.d450.s2|153-161|reduction|drug
DDI-DrugBank.d450.s2|163-164|in|drug
DDI-DrugBank.d450.s2|166-174|clearance|drug
DDI-DrugBank.d450.s2|176-181|and/or|drug
DDI-DrugBank.d450.s2|183-184|in|drug
DDI-DrugBank.d450.s2|186-191|volume|drug
DDI-DrugBank.d450.s2|193-194|of|drug
DDI-DrugBank.d450.s2|196-207|distribution|drug
DDI-DrugBank.d450.s2|209-210|of|drug
DDI-DrugBank.d450.s2|212-214|the|drug
DDI-DrugBank.d450.s2|216-219|drug|drug
DDI-DrugBank.d450.s2|220-220|,|drug
DDI-DrugBank.d450.s2|222-225|with|drug
DDI-DrugBank.d450.s2|227-229|the|drug
DDI-DrugBank.d450.s2|231-241|implication|drug
DDI-DrugBank.d450.s2|243-246|that|drug
DDI-DrugBank.d450.s2|248-256|digitalis|drug
DDI-DrugBank.d450.s2|258-269|intoxication|drug
DDI-DrugBank.d450.s2|271-273|may|drug
DDI-DrugBank.d450.s2|275-280|result|drug
DDI-DrugBank.d450.s2|281-281|.|drug
DDI-DrugBank.d450.s3|0-11|Erythromycin|drug
DDI-DrugBank.d450.s3|13-15|and|drug
DDI-DrugBank.d450.s3|17-30|clarithromycin|drug
DDI-DrugBank.d450.s3|32-32|(|drug
DDI-DrugBank.d450.s3|33-35|and|drug
DDI-DrugBank.d450.s3|37-44|possibly|drug
DDI-DrugBank.d450.s3|46-50|other|drug
DDI-DrugBank.d450.s3|52-60|macrolide|drug
DDI-DrugBank.d450.s3|62-72|antibiotics|drug
DDI-DrugBank.d450.s3|73-73|)|drug
DDI-DrugBank.d450.s3|75-77|and|drug
DDI-DrugBank.d450.s3|79-90|tetracycline|drug
DDI-DrugBank.d450.s3|92-94|may|drug
DDI-DrugBank.d450.s3|96-103|increase|drug
DDI-DrugBank.d450.s3|105-111|digoxin|drug
DDI-DrugBank.d450.s3|113-122|absorption|drug
DDI-DrugBank.d450.s3|124-125|in|drug
DDI-DrugBank.d450.s3|127-134|patients|drug
DDI-DrugBank.d450.s3|136-138|who|drug
DDI-DrugBank.d450.s3|140-149|inactivate|drug
DDI-DrugBank.d450.s3|151-157|digoxin|drug
DDI-DrugBank.d450.s3|159-160|by|drug
DDI-DrugBank.d450.s3|162-170|bacterial|drug
DDI-DrugBank.d450.s3|172-181|metabolism|drug
DDI-DrugBank.d450.s3|183-184|in|drug
DDI-DrugBank.d450.s3|186-188|the|drug
DDI-DrugBank.d450.s3|190-194|lower|drug
DDI-DrugBank.d450.s3|196-204|intestine|drug
DDI-DrugBank.d450.s3|205-205|,|drug
DDI-DrugBank.d450.s3|207-208|so|drug
DDI-DrugBank.d450.s3|210-213|that|drug
DDI-DrugBank.d450.s3|215-223|digitalis|drug
DDI-DrugBank.d450.s3|225-236|intoxication|drug
DDI-DrugBank.d450.s3|238-240|may|drug
DDI-DrugBank.d450.s3|242-247|result|drug
DDI-DrugBank.d450.s3|248-248|.|drug
DDI-DrugBank.d450.s4|0-2|The|drug
DDI-DrugBank.d450.s4|4-7|risk|drug
DDI-DrugBank.d450.s4|9-10|of|drug
DDI-DrugBank.d450.s4|12-15|this|drug
DDI-DrugBank.d450.s4|17-27|interaction|drug
DDI-DrugBank.d450.s4|29-31|may|drug
DDI-DrugBank.d450.s4|33-34|be|drug
DDI-DrugBank.d450.s4|36-42|reduced|drug
DDI-DrugBank.d450.s4|44-45|if|drug
DDI-DrugBank.d450.s4|47-53|digoxin|drug
DDI-DrugBank.d450.s4|55-56|is|drug
DDI-DrugBank.d450.s4|58-62|given|drug
DDI-DrugBank.d450.s4|64-65|as|drug
DDI-DrugBank.d450.s4|67-74|capsules|drug
DDI-DrugBank.d450.s4|75-75|.|drug
DDI-DrugBank.d450.s5|0-12|Propantheline|drug
DDI-DrugBank.d450.s5|14-16|and|drug
DDI-DrugBank.d450.s5|18-30|diphenoxylate|drug
DDI-DrugBank.d450.s5|31-31|,|drug
DDI-DrugBank.d450.s5|33-34|by|drug
DDI-DrugBank.d450.s5|36-45|decreasing|drug
DDI-DrugBank.d450.s5|47-49|gut|drug
DDI-DrugBank.d450.s5|51-58|motility|drug
DDI-DrugBank.d450.s5|59-59|,|drug
DDI-DrugBank.d450.s5|61-63|may|drug
DDI-DrugBank.d450.s5|65-72|increase|drug
DDI-DrugBank.d450.s5|74-80|digoxin|drug
DDI-DrugBank.d450.s5|82-91|absorption|drug
DDI-DrugBank.d450.s5|92-92|.|drug
DDI-DrugBank.d450.s6|0-7|Antacids|drug
DDI-DrugBank.d450.s6|8-8|,|drug
DDI-DrugBank.d450.s6|10-22|kaolin-pectin|drug
DDI-DrugBank.d450.s6|23-23|,|drug
DDI-DrugBank.d450.s6|25-37|sulfasalazine|drug
DDI-DrugBank.d450.s6|38-38|,|drug
DDI-DrugBank.d450.s6|40-47|neomycin|drug
DDI-DrugBank.d450.s6|48-48|,|drug
DDI-DrugBank.d450.s6|50-63|cholestyramine|drug
DDI-DrugBank.d450.s6|64-64|,|drug
DDI-DrugBank.d450.s6|66-72|certain|drug
DDI-DrugBank.d450.s6|74-83|anticancer|drug
DDI-DrugBank.d450.s6|85-89|drugs|drug
DDI-DrugBank.d450.s6|90-90|,|drug
DDI-DrugBank.d450.s6|92-94|and|drug
DDI-DrugBank.d450.s6|96-109|metoclopramide|drug
DDI-DrugBank.d450.s6|111-113|may|drug
DDI-DrugBank.d450.s6|115-123|interfere|drug
DDI-DrugBank.d450.s6|125-128|with|drug
DDI-DrugBank.d450.s6|130-139|intestinal|drug
DDI-DrugBank.d450.s6|141-147|digoxin|drug
DDI-DrugBank.d450.s6|149-158|absorption|drug
DDI-DrugBank.d450.s6|159-159|,|drug
DDI-DrugBank.d450.s6|161-169|resulting|drug
DDI-DrugBank.d450.s6|171-172|in|drug
DDI-DrugBank.d450.s6|174-185|unexpectedly|drug
DDI-DrugBank.d450.s6|187-189|low|drug
DDI-DrugBank.d450.s6|191-195|serum|drug
DDI-DrugBank.d450.s6|197-210|concentrations|drug
DDI-DrugBank.d450.s6|211-211|.|drug
DDI-DrugBank.d450.s7|0-7|Rifampin|drug
DDI-DrugBank.d450.s7|9-11|may|drug
DDI-DrugBank.d450.s7|13-20|decrease|drug
DDI-DrugBank.d450.s7|22-26|serum|drug
DDI-DrugBank.d450.s7|28-34|digoxin|drug
DDI-DrugBank.d450.s7|36-48|concentration|drug
DDI-DrugBank.d450.s7|49-49|,|drug
DDI-DrugBank.d450.s7|51-60|especially|drug
DDI-DrugBank.d450.s7|62-63|in|drug
DDI-DrugBank.d450.s7|65-72|patients|drug
DDI-DrugBank.d450.s7|74-77|with|drug
DDI-DrugBank.d450.s7|79-83|renal|drug
DDI-DrugBank.d450.s7|85-95|dysfunction|drug
DDI-DrugBank.d450.s7|96-96|,|drug
DDI-DrugBank.d450.s7|98-99|by|drug
DDI-DrugBank.d450.s7|101-110|increasing|drug
DDI-DrugBank.d450.s7|112-114|the|drug
DDI-DrugBank.d450.s7|116-124|non-renal|drug
DDI-DrugBank.d450.s7|126-134|clearance|drug
DDI-DrugBank.d450.s7|136-137|of|drug
DDI-DrugBank.d450.s7|139-145|digoxin|drug
DDI-DrugBank.d450.s7|146-146|.|drug
DDI-DrugBank.d450.s8|0-4|There|drug
DDI-DrugBank.d450.s8|6-9|have|drug
DDI-DrugBank.d450.s8|11-14|been|drug
DDI-DrugBank.d450.s8|16-27|inconsistent|drug
DDI-DrugBank.d450.s8|29-35|reports|drug
DDI-DrugBank.d450.s8|37-45|regarding|drug
DDI-DrugBank.d450.s8|47-49|the|drug
DDI-DrugBank.d450.s8|51-57|effects|drug
DDI-DrugBank.d450.s8|59-60|of|drug
DDI-DrugBank.d450.s8|62-66|other|drug
DDI-DrugBank.d450.s8|68-72|drugs|drug
DDI-DrugBank.d450.s8|74-74|(|drug
DDI-DrugBank.d450.s8|75-78|e.g.|drug
DDI-DrugBank.d450.s8|79-79|,|drug
DDI-DrugBank.d450.s8|81-87|quinine|drug
DDI-DrugBank.d450.s8|88-88|,|drug
DDI-DrugBank.d450.s8|90-102|penicillamine|drug
DDI-DrugBank.d450.s8|103-103|)|drug
DDI-DrugBank.d450.s8|105-106|on|drug
DDI-DrugBank.d450.s8|108-112|serum|drug
DDI-DrugBank.d450.s8|114-120|digoxin|drug
DDI-DrugBank.d450.s8|122-134|concentration|drug
DDI-DrugBank.d450.s8|135-135|.|drug
DDI-DrugBank.d450.s9|0-6|Thyroid|drug
DDI-DrugBank.d450.s9|8-21|administration|drug
DDI-DrugBank.d450.s9|23-24|to|drug
DDI-DrugBank.d450.s9|26-26|a|drug
DDI-DrugBank.d450.s9|28-38|digitalized|drug
DDI-DrugBank.d450.s9|39-39|,|drug
DDI-DrugBank.d450.s9|41-51|hypothyroid|drug
DDI-DrugBank.d450.s9|53-59|patient|drug
DDI-DrugBank.d450.s9|61-63|may|drug
DDI-DrugBank.d450.s9|65-72|increase|drug
DDI-DrugBank.d450.s9|74-76|the|drug
DDI-DrugBank.d450.s9|78-81|dose|drug
DDI-DrugBank.d450.s9|83-93|requirement|drug
DDI-DrugBank.d450.s9|95-96|of|drug
DDI-DrugBank.d450.s9|98-104|digoxin|drug
DDI-DrugBank.d450.s9|105-105|.|drug
DDI-DrugBank.d450.s10|0-10|Concomitant|drug
DDI-DrugBank.d450.s10|12-14|use|drug
DDI-DrugBank.d450.s10|16-17|of|drug
DDI-DrugBank.d450.s10|19-25|digoxin|drug
DDI-DrugBank.d450.s10|27-29|and|drug
DDI-DrugBank.d450.s10|31-46|sympathomimetics|drug
DDI-DrugBank.d450.s10|48-56|increases|drug
DDI-DrugBank.d450.s10|58-60|the|drug
DDI-DrugBank.d450.s10|62-65|risk|drug
DDI-DrugBank.d450.s10|67-68|of|drug
DDI-DrugBank.d450.s10|70-76|cardiac|drug
DDI-DrugBank.d450.s10|78-88|arrhythmias|drug
DDI-DrugBank.d450.s10|89-89|.|drug
DDI-DrugBank.d450.s11|0-14|Succinylcholine|drug
DDI-DrugBank.d450.s11|16-18|may|drug
DDI-DrugBank.d450.s11|20-24|cause|drug
DDI-DrugBank.d450.s11|26-26|a|drug
DDI-DrugBank.d450.s11|28-33|sudden|drug
DDI-DrugBank.d450.s11|35-43|extrusion|drug
DDI-DrugBank.d450.s11|45-46|of|drug
DDI-DrugBank.d450.s11|48-56|potassium|drug
DDI-DrugBank.d450.s11|58-61|from|drug
DDI-DrugBank.d450.s11|63-68|muscle|drug
DDI-DrugBank.d450.s11|70-74|cells|drug
DDI-DrugBank.d450.s11|75-75|,|drug
DDI-DrugBank.d450.s11|77-79|and|drug
DDI-DrugBank.d450.s11|81-83|may|drug
DDI-DrugBank.d450.s11|85-91|thereby|drug
DDI-DrugBank.d450.s11|93-97|cause|drug
DDI-DrugBank.d450.s11|99-109|arrhythmias|drug
DDI-DrugBank.d450.s11|111-112|in|drug
DDI-DrugBank.d450.s11|114-124|digitalized|drug
DDI-DrugBank.d450.s11|126-133|patients|drug
DDI-DrugBank.d450.s11|134-134|.|drug
DDI-DrugBank.d450.s12|0-7|Although|drug
DDI-DrugBank.d450.s12|9-23|beta-adrenergic|drug
DDI-DrugBank.d450.s12|25-32|blockers|drug
DDI-DrugBank.d450.s12|34-35|or|drug
DDI-DrugBank.d450.s12|37-43|calcium|drug
DDI-DrugBank.d450.s12|45-51|channel|drug
DDI-DrugBank.d450.s12|53-60|blockers|drug
DDI-DrugBank.d450.s12|62-64|and|drug
DDI-DrugBank.d450.s12|66-72|digoxin|drug
DDI-DrugBank.d450.s12|74-76|may|drug
DDI-DrugBank.d450.s12|78-79|be|drug
DDI-DrugBank.d450.s12|81-86|useful|drug
DDI-DrugBank.d450.s12|88-89|in|drug
DDI-DrugBank.d450.s12|91-101|combination|drug
DDI-DrugBank.d450.s12|103-104|to|drug
DDI-DrugBank.d450.s12|106-112|control|drug
DDI-DrugBank.d450.s12|114-119|atrial|drug
DDI-DrugBank.d450.s12|121-132|fibrillation|drug
DDI-DrugBank.d450.s12|133-133|,|drug
DDI-DrugBank.d450.s12|135-139|their|drug
DDI-DrugBank.d450.s12|141-148|additive|drug
DDI-DrugBank.d450.s12|150-156|effects|drug
DDI-DrugBank.d450.s12|158-159|on|drug
DDI-DrugBank.d450.s12|161-162|AV|drug
DDI-DrugBank.d450.s12|164-167|node|drug
DDI-DrugBank.d450.s12|169-178|conduction|drug
DDI-DrugBank.d450.s12|180-182|can|drug
DDI-DrugBank.d450.s12|184-189|result|drug
DDI-DrugBank.d450.s12|191-192|in|drug
DDI-DrugBank.d450.s12|194-201|advanced|drug
DDI-DrugBank.d450.s12|203-204|or|drug
DDI-DrugBank.d450.s12|206-213|complete|drug
DDI-DrugBank.d450.s12|215-219|heart|drug
DDI-DrugBank.d450.s12|221-225|block|drug
DDI-DrugBank.d450.s12|226-226|.|drug
DDI-DrugBank.d450.s13|0-2|Due|drug
DDI-DrugBank.d450.s13|4-5|to|drug
DDI-DrugBank.d450.s13|7-9|the|drug
DDI-DrugBank.d450.s13|11-22|considerable|drug
DDI-DrugBank.d450.s13|24-34|variability|drug
DDI-DrugBank.d450.s13|36-37|of|drug
DDI-DrugBank.d450.s13|39-43|these|drug
DDI-DrugBank.d450.s13|45-56|interactions|drug
DDI-DrugBank.d450.s13|57-57|,|drug
DDI-DrugBank.d450.s13|59-61|the|drug
DDI-DrugBank.d450.s13|63-68|dosage|drug
DDI-DrugBank.d450.s13|70-71|of|drug
DDI-DrugBank.d450.s13|73-79|digoxin|drug
DDI-DrugBank.d450.s13|81-86|should|drug
DDI-DrugBank.d450.s13|88-89|be|drug
DDI-DrugBank.d450.s13|91-104|individualized|drug
DDI-DrugBank.d450.s13|106-109|when|drug
DDI-DrugBank.d450.s13|111-118|patients|drug
DDI-DrugBank.d450.s13|120-126|receive|drug
DDI-DrugBank.d450.s13|128-132|these|drug
DDI-DrugBank.d450.s13|134-144|medications|drug
DDI-DrugBank.d450.s13|146-157|concurrently|drug
DDI-DrugBank.d450.s13|158-158|.|drug
DDI-DrugBank.d450.s14|0-10|Furthermore|drug
DDI-DrugBank.d450.s14|11-11|,|drug
DDI-DrugBank.d450.s14|13-19|caution|drug
DDI-DrugBank.d450.s14|21-26|should|drug
DDI-DrugBank.d450.s14|28-29|be|drug
DDI-DrugBank.d450.s14|31-39|exercised|drug
DDI-DrugBank.d450.s14|41-44|when|drug
DDI-DrugBank.d450.s14|46-54|combining|drug
DDI-DrugBank.d450.s14|56-62|digoxin|drug
DDI-DrugBank.d450.s14|64-67|with|drug
DDI-DrugBank.d450.s14|69-71|any|drug
DDI-DrugBank.d450.s14|73-76|drug|drug
DDI-DrugBank.d450.s14|78-81|that|drug
DDI-DrugBank.d450.s14|83-85|may|drug
DDI-DrugBank.d450.s14|87-91|cause|drug
DDI-DrugBank.d450.s14|93-93|a|drug
DDI-DrugBank.d450.s14|95-105|significant|drug
DDI-DrugBank.d450.s14|107-119|deterioration|drug
DDI-DrugBank.d450.s14|121-122|in|drug
DDI-DrugBank.d450.s14|124-128|renal|drug
DDI-DrugBank.d450.s14|130-137|function|drug
DDI-DrugBank.d450.s14|138-138|,|drug
DDI-DrugBank.d450.s14|140-144|since|drug
DDI-DrugBank.d450.s14|146-146|a|drug
DDI-DrugBank.d450.s14|148-154|decline|drug
DDI-DrugBank.d450.s14|156-157|in|drug
DDI-DrugBank.d450.s14|159-168|glomerular|drug
DDI-DrugBank.d450.s14|170-179|filtration|drug
DDI-DrugBank.d450.s14|181-182|or|drug
DDI-DrugBank.d450.s14|184-190|tubular|drug
DDI-DrugBank.d450.s14|192-200|secretion|drug
DDI-DrugBank.d450.s14|202-204|may|drug
DDI-DrugBank.d450.s14|206-211|impair|drug
DDI-DrugBank.d450.s14|213-215|the|drug
DDI-DrugBank.d450.s14|217-225|excretion|drug
DDI-DrugBank.d450.s14|227-228|of|drug
DDI-DrugBank.d450.s14|230-236|digoxin|drug
DDI-DrugBank.d450.s14|237-237|.|drug
DDI-MedLine.d108.s0|0-13|Administration|drug
DDI-MedLine.d108.s0|15-16|of|drug
DDI-MedLine.d108.s0|18-24|lithium|drug
DDI-MedLine.d108.s0|26-36|prophylaxis|drug
DDI-MedLine.d108.s0|37-37|.|drug
DDI-MedLine.d108.s1|0-9|Successful|drug
DDI-MedLine.d108.s1|11-21|prophylaxis|drug
DDI-MedLine.d108.s1|23-24|of|drug
DDI-MedLine.d108.s1|26-41|manic-depressive|drug
DDI-MedLine.d108.s1|43-50|disorder|drug
DDI-MedLine.d108.s1|52-59|requires|drug
DDI-MedLine.d108.s1|61-64|more|drug
DDI-MedLine.d108.s1|66-69|than|drug
DDI-MedLine.d108.s1|71-73|the|drug
DDI-MedLine.d108.s1|75-86|prescription|drug
DDI-MedLine.d108.s1|88-89|of|drug
DDI-MedLine.d108.s1|91-97|lithium|drug
DDI-MedLine.d108.s1|99-107|carbonate|drug
DDI-MedLine.d108.s1|108-108|.|drug
DDI-MedLine.d108.s2|0-2|The|drug
DDI-MedLine.d108.s2|4-17|administrative|drug
DDI-MedLine.d108.s2|19-30|arrangements|drug
DDI-MedLine.d108.s2|32-33|in|drug
DDI-MedLine.d108.s2|35-36|an|drug
DDI-MedLine.d108.s2|38-41|area|drug
DDI-MedLine.d108.s2|43-44|of|drug
DDI-MedLine.d108.s2|46-53|Scotland|drug
DDI-MedLine.d108.s2|55-58|were|drug
DDI-MedLine.d108.s2|60-70|accompanied|drug
DDI-MedLine.d108.s2|72-73|by|drug
DDI-MedLine.d108.s2|75-75|a|drug
DDI-MedLine.d108.s2|77-79|300|drug
DDI-MedLine.d108.s2|80-80|%|drug
DDI-MedLine.d108.s2|82-89|increase|drug
DDI-MedLine.d108.s2|91-92|in|drug
DDI-MedLine.d108.s2|94-96|the|drug
DDI-MedLine.d108.s2|98-106|frequency|drug
DDI-MedLine.d108.s2|108-109|of|drug
DDI-MedLine.d108.s2|111-120|admissions|drug
DDI-MedLine.d108.s2|122-124|for|drug
DDI-MedLine.d108.s2|126-130|mania|drug
DDI-MedLine.d108.s2|131-131|,|drug
DDI-MedLine.d108.s2|133-139|whereas|drug
DDI-MedLine.d108.s2|141-142|in|drug
DDI-MedLine.d108.s2|144-145|an|drug
DDI-MedLine.d108.s2|147-150|area|drug
DDI-MedLine.d108.s2|152-153|of|drug
DDI-MedLine.d108.s2|155-157|the|drug
DDI-MedLine.d108.s2|159-162|West|drug
DDI-MedLine.d108.s2|164-171|Midlands|drug
DDI-MedLine.d108.s2|172-172|,|drug
DDI-MedLine.d108.s2|174-174|a|drug
DDI-MedLine.d108.s2|176-180|large|drug
DDI-MedLine.d108.s2|182-189|decrease|drug
DDI-MedLine.d108.s2|191-193|was|drug
DDI-MedLine.d108.s2|195-202|achieved|drug
DDI-MedLine.d108.s2|203-203|.|drug
DDI-DrugBank.d143.s0|0-9|Amiodarone|drug
DDI-DrugBank.d143.s0|11-12|is|drug
DDI-DrugBank.d143.s0|14-24|metabolized|drug
DDI-DrugBank.d143.s0|26-27|to|drug
DDI-DrugBank.d143.s0|29-46|desethylamiodarone|drug
DDI-DrugBank.d143.s0|48-49|by|drug
DDI-DrugBank.d143.s0|51-53|the|drug
DDI-DrugBank.d143.s0|55-64|cytochrome|drug
DDI-DrugBank.d143.s0|66-69|P450|drug
DDI-DrugBank.d143.s0|71-71|(|drug
DDI-DrugBank.d143.s0|72-77|CYP450|drug
DDI-DrugBank.d143.s0|78-78|)|drug
DDI-DrugBank.d143.s0|80-85|enzyme|drug
DDI-DrugBank.d143.s0|87-91|group|drug
DDI-DrugBank.d143.s0|92-92|,|drug
DDI-DrugBank.d143.s0|94-105|specifically|drug
DDI-DrugBank.d143.s0|107-117|cytochromes|drug
DDI-DrugBank.d143.s0|119-122|P450|drug
DDI-DrugBank.d143.s0|124-126|3A4|drug
DDI-DrugBank.d143.s0|128-128|(|drug
DDI-DrugBank.d143.s0|129-134|CYP3A4|drug
DDI-DrugBank.d143.s0|135-135|)|drug
DDI-DrugBank.d143.s0|137-139|and|drug
DDI-DrugBank.d143.s0|141-146|CYP2C8|drug
DDI-DrugBank.d143.s0|147-147|.|drug
DDI-DrugBank.d143.s1|0-2|The|drug
DDI-DrugBank.d143.s1|4-9|CYP3A4|drug
DDI-DrugBank.d143.s1|11-19|isoenzyme|drug
DDI-DrugBank.d143.s1|21-22|is|drug
DDI-DrugBank.d143.s1|24-30|present|drug
DDI-DrugBank.d143.s1|32-33|in|drug
DDI-DrugBank.d143.s1|35-38|both|drug
DDI-DrugBank.d143.s1|40-42|the|drug
DDI-DrugBank.d143.s1|44-48|liver|drug
DDI-DrugBank.d143.s1|50-52|and|drug
DDI-DrugBank.d143.s1|54-63|intestines|drug
DDI-DrugBank.d143.s1|64-64|.|drug
DDI-DrugBank.d143.s2|0-9|Amiodarone|drug
DDI-DrugBank.d143.s2|11-12|is|drug
DDI-DrugBank.d143.s2|14-17|also|drug
DDI-DrugBank.d143.s2|19-23|known|drug
DDI-DrugBank.d143.s2|25-26|to|drug
DDI-DrugBank.d143.s2|28-29|be|drug
DDI-DrugBank.d143.s2|31-32|an|drug
DDI-DrugBank.d143.s2|34-42|inhibitor|drug
DDI-DrugBank.d143.s2|44-45|of|drug
DDI-DrugBank.d143.s2|47-52|CYP3A4|drug
DDI-DrugBank.d143.s2|53-53|.|drug
DDI-DrugBank.d143.s3|0-8|Therefore|drug
DDI-DrugBank.d143.s3|9-9|,|drug
DDI-DrugBank.d143.s3|11-20|amiodarone|drug
DDI-DrugBank.d143.s3|22-24|has|drug
DDI-DrugBank.d143.s3|26-28|the|drug
DDI-DrugBank.d143.s3|30-38|potential|drug
DDI-DrugBank.d143.s3|40-42|for|drug
DDI-DrugBank.d143.s3|44-55|interactions|drug
DDI-DrugBank.d143.s3|57-60|with|drug
DDI-DrugBank.d143.s3|62-66|drugs|drug
DDI-DrugBank.d143.s3|68-69|or|drug
DDI-DrugBank.d143.s3|71-80|substances|drug
DDI-DrugBank.d143.s3|82-85|that|drug
DDI-DrugBank.d143.s3|87-89|may|drug
DDI-DrugBank.d143.s3|91-92|be|drug
DDI-DrugBank.d143.s3|94-103|substrates|drug
DDI-DrugBank.d143.s3|104-104|,|drug
DDI-DrugBank.d143.s3|106-115|inhibitors|drug
DDI-DrugBank.d143.s3|117-118|or|drug
DDI-DrugBank.d143.s3|120-127|inducers|drug
DDI-DrugBank.d143.s3|129-130|of|drug
DDI-DrugBank.d143.s3|132-137|CYP3A4|drug
DDI-DrugBank.d143.s3|138-138|.|drug
DDI-DrugBank.d143.s4|0-4|While|drug
DDI-DrugBank.d143.s4|6-9|only|drug
DDI-DrugBank.d143.s4|11-11|a|drug
DDI-DrugBank.d143.s4|13-19|limited|drug
DDI-DrugBank.d143.s4|21-26|number|drug
DDI-DrugBank.d143.s4|28-29|of|drug
DDI-DrugBank.d143.s4|31-32|in|drug
DDI-DrugBank.d143.s4|34-37|vivo|drug
DDI-DrugBank.d143.s4|39-47|drug-drug|drug
DDI-DrugBank.d143.s4|49-60|interactions|drug
DDI-DrugBank.d143.s4|62-65|with|drug
DDI-DrugBank.d143.s4|67-76|amiodarone|drug
DDI-DrugBank.d143.s4|78-81|have|drug
DDI-DrugBank.d143.s4|83-86|been|drug
DDI-DrugBank.d143.s4|88-95|reported|drug
DDI-DrugBank.d143.s4|96-96|,|drug
DDI-DrugBank.d143.s4|98-104|chiefly|drug
DDI-DrugBank.d143.s4|106-109|with|drug
DDI-DrugBank.d143.s4|111-113|the|drug
DDI-DrugBank.d143.s4|115-118|oral|drug
DDI-DrugBank.d143.s4|120-130|formulation|drug
DDI-DrugBank.d143.s4|131-131|,|drug
DDI-DrugBank.d143.s4|133-135|the|drug
DDI-DrugBank.d143.s4|137-145|potential|drug
DDI-DrugBank.d143.s4|147-149|for|drug
DDI-DrugBank.d143.s4|151-155|other|drug
DDI-DrugBank.d143.s4|157-168|interactions|drug
DDI-DrugBank.d143.s4|170-175|should|drug
DDI-DrugBank.d143.s4|177-178|be|drug
DDI-DrugBank.d143.s4|180-190|anticipated|drug
DDI-DrugBank.d143.s4|191-191|.|drug
DDI-DrugBank.d143.s5|0-3|This|drug
DDI-DrugBank.d143.s5|5-6|is|drug
DDI-DrugBank.d143.s5|8-17|especially|drug
DDI-DrugBank.d143.s5|19-27|important|drug
DDI-DrugBank.d143.s5|29-31|for|drug
DDI-DrugBank.d143.s5|33-37|drugs|drug
DDI-DrugBank.d143.s5|39-48|associated|drug
DDI-DrugBank.d143.s5|50-53|with|drug
DDI-DrugBank.d143.s5|55-61|serious|drug
DDI-DrugBank.d143.s5|63-70|toxicity|drug
DDI-DrugBank.d143.s5|71-71|,|drug
DDI-DrugBank.d143.s5|73-76|such|drug
DDI-DrugBank.d143.s5|78-79|as|drug
DDI-DrugBank.d143.s5|81-85|other|drug
DDI-DrugBank.d143.s5|87-101|antiarrhythmics|drug
DDI-DrugBank.d143.s5|102-102|.|drug
DDI-DrugBank.d143.s6|0-1|If|drug
DDI-DrugBank.d143.s6|3-6|such|drug
DDI-DrugBank.d143.s6|8-12|drugs|drug
DDI-DrugBank.d143.s6|14-16|are|drug
DDI-DrugBank.d143.s6|18-23|needed|drug
DDI-DrugBank.d143.s6|24-24|,|drug
DDI-DrugBank.d143.s6|26-30|their|drug
DDI-DrugBank.d143.s6|32-35|dose|drug
DDI-DrugBank.d143.s6|37-42|should|drug
DDI-DrugBank.d143.s6|44-45|be|drug
DDI-DrugBank.d143.s6|47-56|reassessed|drug
DDI-DrugBank.d143.s6|58-60|and|drug
DDI-DrugBank.d143.s6|61-61|,|drug
DDI-DrugBank.d143.s6|63-67|where|drug
DDI-DrugBank.d143.s6|69-79|appropriate|drug
DDI-DrugBank.d143.s6|80-80|,|drug
DDI-DrugBank.d143.s6|82-87|plasma|drug
DDI-DrugBank.d143.s6|89-101|concentration|drug
DDI-DrugBank.d143.s6|103-110|measured|drug
DDI-DrugBank.d143.s6|111-111|.|drug
DDI-DrugBank.d143.s7|0-1|In|drug
DDI-DrugBank.d143.s7|3-6|view|drug
DDI-DrugBank.d143.s7|8-9|of|drug
DDI-DrugBank.d143.s7|11-13|the|drug
DDI-DrugBank.d143.s7|15-18|long|drug
DDI-DrugBank.d143.s7|20-22|and|drug
DDI-DrugBank.d143.s7|24-31|variable|drug
DDI-DrugBank.d143.s7|33-41|half-life|drug
DDI-DrugBank.d143.s7|43-44|of|drug
DDI-DrugBank.d143.s7|46-55|amiodarone|drug
DDI-DrugBank.d143.s7|56-56|,|drug
DDI-DrugBank.d143.s7|58-66|potential|drug
DDI-DrugBank.d143.s7|68-70|for|drug
DDI-DrugBank.d143.s7|72-75|drug|drug
DDI-DrugBank.d143.s7|77-88|interactions|drug
DDI-DrugBank.d143.s7|90-95|exists|drug
DDI-DrugBank.d143.s7|97-99|not|drug
DDI-DrugBank.d143.s7|101-104|only|drug
DDI-DrugBank.d143.s7|106-109|with|drug
DDI-DrugBank.d143.s7|111-121|concomitant|drug
DDI-DrugBank.d143.s7|123-132|medication|drug
DDI-DrugBank.d143.s7|134-136|but|drug
DDI-DrugBank.d143.s7|138-141|also|drug
DDI-DrugBank.d143.s7|143-146|with|drug
DDI-DrugBank.d143.s7|148-152|drugs|drug
DDI-DrugBank.d143.s7|154-165|administered|drug
DDI-DrugBank.d143.s7|167-171|after|drug
DDI-DrugBank.d143.s7|173-187|discontinuation|drug
DDI-DrugBank.d143.s7|189-190|of|drug
DDI-DrugBank.d143.s7|192-201|amiodarone|drug
DDI-DrugBank.d143.s7|202-202|.|drug
DDI-DrugBank.d143.s8|0-4|Since|drug
DDI-DrugBank.d143.s8|6-15|amiodarone|drug
DDI-DrugBank.d143.s8|17-18|is|drug
DDI-DrugBank.d143.s8|20-20|a|drug
DDI-DrugBank.d143.s8|22-30|substrate|drug
DDI-DrugBank.d143.s8|32-34|for|drug
DDI-DrugBank.d143.s8|36-41|CYP3A4|drug
DDI-DrugBank.d143.s8|43-45|and|drug
DDI-DrugBank.d143.s8|47-52|CYP2C8|drug
DDI-DrugBank.d143.s8|53-53|,|drug
DDI-DrugBank.d143.s8|55-70|drugs/substances|drug
DDI-DrugBank.d143.s8|72-75|that|drug
DDI-DrugBank.d143.s8|77-83|inhibit|drug
DDI-DrugBank.d143.s8|85-89|these|drug
DDI-DrugBank.d143.s8|91-100|isoenzymes|drug
DDI-DrugBank.d143.s8|102-104|may|drug
DDI-DrugBank.d143.s8|106-113|decrease|drug
DDI-DrugBank.d143.s8|115-117|the|drug
DDI-DrugBank.d143.s8|119-128|metabolism|drug
DDI-DrugBank.d143.s8|130-132|and|drug
DDI-DrugBank.d143.s8|134-141|increase|drug
DDI-DrugBank.d143.s8|143-147|serum|drug
DDI-DrugBank.d143.s8|149-161|concentration|drug
DDI-DrugBank.d143.s8|163-164|of|drug
DDI-DrugBank.d143.s8|166-175|amiodarone|drug
DDI-DrugBank.d143.s8|176-176|.|drug
DDI-DrugBank.d143.s9|0-7|Reported|drug
DDI-DrugBank.d143.s9|9-16|examples|drug
DDI-DrugBank.d143.s9|18-24|include|drug
DDI-DrugBank.d143.s9|26-28|the|drug
DDI-DrugBank.d143.s9|30-38|following|drug
DDI-DrugBank.d143.s9|39-39|:|drug
DDI-DrugBank.d143.s9|41-48|Protease|drug
DDI-DrugBank.d143.s9|50-59|Inhibitors|drug
DDI-DrugBank.d143.s9|60-60|:|drug
DDI-DrugBank.d143.s9|62-69|Protease|drug
DDI-DrugBank.d143.s9|71-80|inhibitors|drug
DDI-DrugBank.d143.s9|82-84|are|drug
DDI-DrugBank.d143.s9|86-90|known|drug
DDI-DrugBank.d143.s9|92-93|to|drug
DDI-DrugBank.d143.s9|95-101|inhibit|drug
DDI-DrugBank.d143.s9|103-108|CYP3A4|drug
DDI-DrugBank.d143.s9|110-111|to|drug
DDI-DrugBank.d143.s9|113-119|varying|drug
DDI-DrugBank.d143.s9|121-127|degrees|drug
DDI-DrugBank.d143.s9|128-128|.|drug
DDI-DrugBank.d143.s10|0-0|A|drug
DDI-DrugBank.d143.s10|2-5|case|drug
DDI-DrugBank.d143.s10|7-12|report|drug
DDI-DrugBank.d143.s10|14-15|of|drug
DDI-DrugBank.d143.s10|17-19|one|drug
DDI-DrugBank.d143.s10|21-27|patient|drug
DDI-DrugBank.d143.s10|29-34|taking|drug
DDI-DrugBank.d143.s10|36-45|amiodarone|drug
DDI-DrugBank.d143.s10|47-49|200|drug
DDI-DrugBank.d143.s10|51-52|mg|drug
DDI-DrugBank.d143.s10|54-56|and|drug
DDI-DrugBank.d143.s10|58-66|indinavir|drug
DDI-DrugBank.d143.s10|68-70|800|drug
DDI-DrugBank.d143.s10|72-73|mg|drug
DDI-DrugBank.d143.s10|75-79|three|drug
DDI-DrugBank.d143.s10|81-85|times|drug
DDI-DrugBank.d143.s10|87-87|a|drug
DDI-DrugBank.d143.s10|89-91|day|drug
DDI-DrugBank.d143.s10|93-100|resulted|drug
DDI-DrugBank.d143.s10|102-103|in|drug
DDI-DrugBank.d143.s10|105-113|increases|drug
DDI-DrugBank.d143.s10|115-116|in|drug
DDI-DrugBank.d143.s10|118-127|amiodarone|drug
DDI-DrugBank.d143.s10|129-142|concentrations|drug
DDI-DrugBank.d143.s10|144-147|from|drug
DDI-DrugBank.d143.s10|149-151|0.9|drug
DDI-DrugBank.d143.s10|153-156|mg/L|drug
DDI-DrugBank.d143.s10|158-159|to|drug
DDI-DrugBank.d143.s10|161-163|1.3|drug
DDI-DrugBank.d143.s10|165-168|mg/L|drug
DDI-DrugBank.d143.s10|169-169|.|drug
DDI-DrugBank.d143.s11|0-2|DEA|drug
DDI-DrugBank.d143.s11|4-17|concentrations|drug
DDI-DrugBank.d143.s11|19-22|were|drug
DDI-DrugBank.d143.s11|24-26|not|drug
DDI-DrugBank.d143.s11|28-35|affected|drug
DDI-DrugBank.d143.s11|36-36|.|drug
DDI-DrugBank.d143.s12|0-4|There|drug
DDI-DrugBank.d143.s12|6-8|was|drug
DDI-DrugBank.d143.s12|10-11|no|drug
DDI-DrugBank.d143.s12|13-20|evidence|drug
DDI-DrugBank.d143.s12|22-23|of|drug
DDI-DrugBank.d143.s12|25-32|toxicity|drug
DDI-DrugBank.d143.s12|33-33|.|drug
DDI-DrugBank.d143.s13|0-9|Monitoring|drug
DDI-DrugBank.d143.s13|11-13|for|drug
DDI-DrugBank.d143.s13|15-24|amiodarone|drug
DDI-DrugBank.d143.s13|26-33|toxicity|drug
DDI-DrugBank.d143.s13|35-37|and|drug
DDI-DrugBank.d143.s13|39-44|serial|drug
DDI-DrugBank.d143.s13|46-56|measurement|drug
DDI-DrugBank.d143.s13|58-59|of|drug
DDI-DrugBank.d143.s13|61-70|amiodarone|drug
DDI-DrugBank.d143.s13|72-76|serum|drug
DDI-DrugBank.d143.s13|78-90|concentration|drug
DDI-DrugBank.d143.s13|92-97|during|drug
DDI-DrugBank.d143.s13|99-109|concomitant|drug
DDI-DrugBank.d143.s13|111-118|protease|drug
DDI-DrugBank.d143.s13|120-128|inhibitor|drug
DDI-DrugBank.d143.s13|130-136|therapy|drug
DDI-DrugBank.d143.s13|138-143|should|drug
DDI-DrugBank.d143.s13|145-146|be|drug
DDI-DrugBank.d143.s13|148-157|considered|drug
DDI-DrugBank.d143.s13|158-158|.|drug
DDI-DrugBank.d143.s14|0-8|Histamine|drug
DDI-DrugBank.d143.s14|10-11|H2|drug
DDI-DrugBank.d143.s14|13-23|antagonists|drug
DDI-DrugBank.d143.s14|24-24|:|drug
DDI-DrugBank.d143.s14|26-35|Cimetidine|drug
DDI-DrugBank.d143.s14|37-44|inhibits|drug
DDI-DrugBank.d143.s14|46-51|CYP3A4|drug
DDI-DrugBank.d143.s14|53-55|and|drug
DDI-DrugBank.d143.s14|57-59|can|drug
DDI-DrugBank.d143.s14|61-68|increase|drug
DDI-DrugBank.d143.s14|70-74|serum|drug
DDI-DrugBank.d143.s14|76-85|amiodarone|drug
DDI-DrugBank.d143.s14|87-92|levels|drug
DDI-DrugBank.d143.s14|93-93|.|drug
DDI-DrugBank.d143.s15|0-4|Other|drug
DDI-DrugBank.d143.s15|6-15|substances|drug
DDI-DrugBank.d143.s15|16-16|:|drug
DDI-DrugBank.d143.s15|18-27|Grapefruit|drug
DDI-DrugBank.d143.s15|29-33|juice|drug
DDI-DrugBank.d143.s15|35-39|given|drug
DDI-DrugBank.d143.s15|41-42|to|drug
DDI-DrugBank.d143.s15|44-50|healthy|drug
DDI-DrugBank.d143.s15|52-61|volunteers|drug
DDI-DrugBank.d143.s15|63-71|increased|drug
DDI-DrugBank.d143.s15|73-82|amiodarone|drug
DDI-DrugBank.d143.s15|84-86|AUC|drug
DDI-DrugBank.d143.s15|88-89|by|drug
DDI-DrugBank.d143.s15|91-92|50|drug
DDI-DrugBank.d143.s15|93-93|%|drug
DDI-DrugBank.d143.s15|95-97|and|drug
DDI-DrugBank.d143.s15|99-102|Cmax|drug
DDI-DrugBank.d143.s15|104-105|by|drug
DDI-DrugBank.d143.s15|107-108|84|drug
DDI-DrugBank.d143.s15|109-109|%|drug
DDI-DrugBank.d143.s15|110-110|,|drug
DDI-DrugBank.d143.s15|112-120|resulting|drug
DDI-DrugBank.d143.s15|122-123|in|drug
DDI-DrugBank.d143.s15|125-133|increased|drug
DDI-DrugBank.d143.s15|135-140|plasma|drug
DDI-DrugBank.d143.s15|142-147|levels|drug
DDI-DrugBank.d143.s15|149-150|of|drug
DDI-DrugBank.d143.s15|152-161|amiodarone|drug
DDI-DrugBank.d143.s15|162-162|.|drug
DDI-DrugBank.d143.s16|0-9|Grapefruit|drug
DDI-DrugBank.d143.s16|11-15|juice|drug
DDI-DrugBank.d143.s16|17-22|should|drug
DDI-DrugBank.d143.s16|24-26|not|drug
DDI-DrugBank.d143.s16|28-29|be|drug
DDI-DrugBank.d143.s16|31-35|taken|drug
DDI-DrugBank.d143.s16|37-42|during|drug
DDI-DrugBank.d143.s16|44-52|treatment|drug
DDI-DrugBank.d143.s16|54-57|with|drug
DDI-DrugBank.d143.s16|59-62|oral|drug
DDI-DrugBank.d143.s16|64-73|amiodarone|drug
DDI-DrugBank.d143.s16|74-74|.|drug
DDI-DrugBank.d143.s17|0-3|This|drug
DDI-DrugBank.d143.s17|5-15|information|drug
DDI-DrugBank.d143.s17|17-22|should|drug
DDI-DrugBank.d143.s17|24-25|be|drug
DDI-DrugBank.d143.s17|27-36|considered|drug
DDI-DrugBank.d143.s17|38-41|when|drug
DDI-DrugBank.d143.s17|43-50|changing|drug
DDI-DrugBank.d143.s17|52-55|from|drug
DDI-DrugBank.d143.s17|57-67|intravenous|drug
DDI-DrugBank.d143.s17|69-78|amiodarone|drug
DDI-DrugBank.d143.s17|80-81|to|drug
DDI-DrugBank.d143.s17|83-86|oral|drug
DDI-DrugBank.d143.s17|88-97|amiodarone|drug
DDI-DrugBank.d143.s17|99-99|.|drug
DDI-DrugBank.d143.s18|0-9|Amiodarone|drug
DDI-DrugBank.d143.s18|11-13|may|drug
DDI-DrugBank.d143.s18|15-22|suppress|drug
DDI-DrugBank.d143.s18|24-30|certain|drug
DDI-DrugBank.d143.s18|32-37|CYP450|drug
DDI-DrugBank.d143.s18|39-45|enzymes|drug
DDI-DrugBank.d143.s18|46-46|,|drug
DDI-DrugBank.d143.s18|48-56|including|drug
DDI-DrugBank.d143.s18|58-63|CYP1A2|drug
DDI-DrugBank.d143.s18|64-64|,|drug
DDI-DrugBank.d143.s18|66-71|CYP2C9|drug
DDI-DrugBank.d143.s18|72-72|,|drug
DDI-DrugBank.d143.s18|74-79|CYP2D6|drug
DDI-DrugBank.d143.s18|80-80|,|drug
DDI-DrugBank.d143.s18|82-84|and|drug
DDI-DrugBank.d143.s18|86-91|CYP3A4|drug
DDI-DrugBank.d143.s18|92-92|.|drug
DDI-DrugBank.d143.s19|0-3|This|drug
DDI-DrugBank.d143.s19|5-14|inhibition|drug
DDI-DrugBank.d143.s19|16-18|can|drug
DDI-DrugBank.d143.s19|20-25|result|drug
DDI-DrugBank.d143.s19|27-28|in|drug
DDI-DrugBank.d143.s19|30-41|unexpectedly|drug
DDI-DrugBank.d143.s19|43-46|high|drug
DDI-DrugBank.d143.s19|48-53|plasma|drug
DDI-DrugBank.d143.s19|55-60|levels|drug
DDI-DrugBank.d143.s19|62-63|of|drug
DDI-DrugBank.d143.s19|65-69|other|drug
DDI-DrugBank.d143.s19|71-75|drugs|drug
DDI-DrugBank.d143.s19|77-81|which|drug
DDI-DrugBank.d143.s19|83-85|are|drug
DDI-DrugBank.d143.s19|87-97|metabolized|drug
DDI-DrugBank.d143.s19|99-100|by|drug
DDI-DrugBank.d143.s19|102-106|those|drug
DDI-DrugBank.d143.s19|108-113|CYP450|drug
DDI-DrugBank.d143.s19|115-121|enzymes|drug
DDI-DrugBank.d143.s19|122-122|.|drug
DDI-DrugBank.d143.s20|0-7|Reported|drug
DDI-DrugBank.d143.s20|9-16|examples|drug
DDI-DrugBank.d143.s20|18-19|of|drug
DDI-DrugBank.d143.s20|21-24|this|drug
DDI-DrugBank.d143.s20|26-36|interaction|drug
DDI-DrugBank.d143.s20|38-44|include|drug
DDI-DrugBank.d143.s20|46-48|the|drug
DDI-DrugBank.d143.s20|50-58|following|drug
DDI-DrugBank.d143.s20|59-59|:|drug
DDI-DrugBank.d143.s20|61-78|Immunosuppressives|drug
DDI-DrugBank.d143.s20|79-79|:|drug
DDI-DrugBank.d143.s20|81-92|Cyclosporine|drug
DDI-DrugBank.d143.s20|94-94|(|drug
DDI-DrugBank.d143.s20|95-100|CYP3A4|drug
DDI-DrugBank.d143.s20|102-110|substrate|drug
DDI-DrugBank.d143.s20|111-111|)|drug
DDI-DrugBank.d143.s20|113-124|administered|drug
DDI-DrugBank.d143.s20|126-127|in|drug
DDI-DrugBank.d143.s20|129-139|combination|drug
DDI-DrugBank.d143.s20|141-144|with|drug
DDI-DrugBank.d143.s20|146-149|oral|drug
DDI-DrugBank.d143.s20|151-160|amiodarone|drug
DDI-DrugBank.d143.s20|162-164|has|drug
DDI-DrugBank.d143.s20|166-169|been|drug
DDI-DrugBank.d143.s20|171-178|reported|drug
DDI-DrugBank.d143.s20|180-181|to|drug
DDI-DrugBank.d143.s20|183-189|produce|drug
DDI-DrugBank.d143.s20|191-202|persistently|drug
DDI-DrugBank.d143.s20|204-211|elevated|drug
DDI-DrugBank.d143.s20|213-218|plasma|drug
DDI-DrugBank.d143.s20|220-233|concentrations|drug
DDI-DrugBank.d143.s20|235-236|of|drug
DDI-DrugBank.d143.s20|238-249|cyclosporine|drug
DDI-DrugBank.d143.s20|251-259|resulting|drug
DDI-DrugBank.d143.s20|261-262|in|drug
DDI-DrugBank.d143.s20|264-271|elevated|drug
DDI-DrugBank.d143.s20|273-282|creatinine|drug
DDI-DrugBank.d143.s20|283-283|,|drug
DDI-DrugBank.d143.s20|285-291|despite|drug
DDI-DrugBank.d143.s20|293-301|reduction|drug
DDI-DrugBank.d143.s20|303-304|in|drug
DDI-DrugBank.d143.s20|306-309|dose|drug
DDI-DrugBank.d143.s20|311-312|of|drug
DDI-DrugBank.d143.s20|314-325|cyclosporine|drug
DDI-DrugBank.d143.s20|326-326|.|drug
DDI-DrugBank.d143.s21|0-6|HMG-CoA|drug
DDI-DrugBank.d143.s21|8-16|Reductase|drug
DDI-DrugBank.d143.s21|18-27|Inhibitors|drug
DDI-DrugBank.d143.s21|28-28|:|drug
DDI-DrugBank.d143.s21|30-40|Simvastatin|drug
DDI-DrugBank.d143.s21|42-42|(|drug
DDI-DrugBank.d143.s21|43-48|CYP3A4|drug
DDI-DrugBank.d143.s21|50-58|substrate|drug
DDI-DrugBank.d143.s21|59-59|)|drug
DDI-DrugBank.d143.s21|61-62|in|drug
DDI-DrugBank.d143.s21|64-74|combination|drug
DDI-DrugBank.d143.s21|76-79|with|drug
DDI-DrugBank.d143.s21|81-90|amiodarone|drug
DDI-DrugBank.d143.s21|92-94|has|drug
DDI-DrugBank.d143.s21|96-99|been|drug
DDI-DrugBank.d143.s21|101-110|associated|drug
DDI-DrugBank.d143.s21|112-115|with|drug
DDI-DrugBank.d143.s21|117-123|reports|drug
DDI-DrugBank.d143.s21|125-126|of|drug
DDI-DrugBank.d143.s21|128-150|myopathy/rhabdomyolysis|drug
DDI-DrugBank.d143.s21|151-151|.|drug
DDI-DrugBank.d143.s22|0-14|Cardiovasculars|drug
DDI-DrugBank.d143.s22|15-15|:|drug
DDI-DrugBank.d143.s22|17-23|Cardiac|drug
DDI-DrugBank.d143.s22|25-34|glycosides|drug
DDI-DrugBank.d143.s22|35-35|:|drug
DDI-DrugBank.d143.s22|37-38|In|drug
DDI-DrugBank.d143.s22|40-47|patients|drug
DDI-DrugBank.d143.s22|49-57|receiving|drug
DDI-DrugBank.d143.s22|59-65|digoxin|drug
DDI-DrugBank.d143.s22|67-73|therapy|drug
DDI-DrugBank.d143.s22|74-74|,|drug
DDI-DrugBank.d143.s22|76-89|administration|drug
DDI-DrugBank.d143.s22|91-92|of|drug
DDI-DrugBank.d143.s22|94-97|oral|drug
DDI-DrugBank.d143.s22|99-108|amiodarone|drug
DDI-DrugBank.d143.s22|110-118|regularly|drug
DDI-DrugBank.d143.s22|120-126|results|drug
DDI-DrugBank.d143.s22|128-129|in|drug
DDI-DrugBank.d143.s22|131-132|an|drug
DDI-DrugBank.d143.s22|134-141|increase|drug
DDI-DrugBank.d143.s22|143-144|in|drug
DDI-DrugBank.d143.s22|146-150|serum|drug
DDI-DrugBank.d143.s22|152-158|digoxin|drug
DDI-DrugBank.d143.s22|160-172|concentration|drug
DDI-DrugBank.d143.s22|174-177|that|drug
DDI-DrugBank.d143.s22|179-181|may|drug
DDI-DrugBank.d143.s22|183-187|reach|drug
DDI-DrugBank.d143.s22|189-193|toxic|drug
DDI-DrugBank.d143.s22|195-200|levels|drug
DDI-DrugBank.d143.s22|202-205|with|drug
DDI-DrugBank.d143.s22|207-215|resultant|drug
DDI-DrugBank.d143.s22|217-224|clinical|drug
DDI-DrugBank.d143.s22|226-233|toxicity|drug
DDI-DrugBank.d143.s22|234-234|.|drug
DDI-DrugBank.d143.s23|0-9|Amiodarone|drug
DDI-DrugBank.d143.s23|11-15|taken|drug
DDI-DrugBank.d143.s23|17-29|concomitantly|drug
DDI-DrugBank.d143.s23|31-34|with|drug
DDI-DrugBank.d143.s23|36-42|digoxin|drug
DDI-DrugBank.d143.s23|44-52|increases|drug
DDI-DrugBank.d143.s23|54-56|the|drug
DDI-DrugBank.d143.s23|58-62|serum|drug
DDI-DrugBank.d143.s23|64-70|digoxin|drug
DDI-DrugBank.d143.s23|72-84|concentration|drug
DDI-DrugBank.d143.s23|86-87|by|drug
DDI-DrugBank.d143.s23|89-90|70|drug
DDI-DrugBank.d143.s23|91-91|%|drug
DDI-DrugBank.d143.s23|93-97|after|drug
DDI-DrugBank.d143.s23|99-101|one|drug
DDI-DrugBank.d143.s23|103-105|day|drug
DDI-DrugBank.d143.s23|106-106|.|drug
DDI-DrugBank.d143.s24|0-1|On|drug
DDI-DrugBank.d143.s24|3-16|administration|drug
DDI-DrugBank.d143.s24|18-19|of|drug
DDI-DrugBank.d143.s24|21-24|oral|drug
DDI-DrugBank.d143.s24|26-35|amiodarone|drug
DDI-DrugBank.d143.s24|36-36|,|drug
DDI-DrugBank.d143.s24|38-40|the|drug
DDI-DrugBank.d143.s24|42-45|need|drug
DDI-DrugBank.d143.s24|47-49|for|drug
DDI-DrugBank.d143.s24|51-59|digitalis|drug
DDI-DrugBank.d143.s24|61-67|therapy|drug
DDI-DrugBank.d143.s24|69-74|should|drug
DDI-DrugBank.d143.s24|76-77|be|drug
DDI-DrugBank.d143.s24|79-86|reviewed|drug
DDI-DrugBank.d143.s24|88-90|and|drug
DDI-DrugBank.d143.s24|92-94|the|drug
DDI-DrugBank.d143.s24|96-99|dose|drug
DDI-DrugBank.d143.s24|101-107|reduced|drug
DDI-DrugBank.d143.s24|109-110|by|drug
DDI-DrugBank.d143.s24|112-124|approximately|drug
DDI-DrugBank.d143.s24|126-127|50|drug
DDI-DrugBank.d143.s24|128-128|%|drug
DDI-DrugBank.d143.s24|130-131|or|drug
DDI-DrugBank.d143.s24|133-144|discontinued|drug
DDI-DrugBank.d143.s24|145-145|.|drug
DDI-DrugBank.d143.s25|0-1|If|drug
DDI-DrugBank.d143.s25|3-11|digitalis|drug
DDI-DrugBank.d143.s25|13-21|treatment|drug
DDI-DrugBank.d143.s25|23-24|is|drug
DDI-DrugBank.d143.s25|26-34|continued|drug
DDI-DrugBank.d143.s25|35-35|,|drug
DDI-DrugBank.d143.s25|37-41|serum|drug
DDI-DrugBank.d143.s25|43-48|levels|drug
DDI-DrugBank.d143.s25|50-55|should|drug
DDI-DrugBank.d143.s25|57-58|be|drug
DDI-DrugBank.d143.s25|60-66|closely|drug
DDI-DrugBank.d143.s25|68-76|monitored|drug
DDI-DrugBank.d143.s25|78-80|and|drug
DDI-DrugBank.d143.s25|82-89|patients|drug
DDI-DrugBank.d143.s25|91-98|observed|drug
DDI-DrugBank.d143.s25|100-102|for|drug
DDI-DrugBank.d143.s25|104-111|clinical|drug
DDI-DrugBank.d143.s25|113-120|evidence|drug
DDI-DrugBank.d143.s25|122-123|of|drug
DDI-DrugBank.d143.s25|125-132|toxicity|drug
DDI-DrugBank.d143.s25|133-133|.|drug
DDI-DrugBank.d143.s26|0-4|These|drug
DDI-DrugBank.d143.s26|6-16|precautions|drug
DDI-DrugBank.d143.s26|18-25|probably|drug
DDI-DrugBank.d143.s26|27-32|should|drug
DDI-DrugBank.d143.s26|34-38|apply|drug
DDI-DrugBank.d143.s26|40-41|to|drug
DDI-DrugBank.d143.s26|43-51|digitoxin|drug
DDI-DrugBank.d143.s26|53-66|administration|drug
DDI-DrugBank.d143.s26|68-69|as|drug
DDI-DrugBank.d143.s26|71-74|well|drug
DDI-DrugBank.d143.s26|75-75|.|drug
DDI-DrugBank.d143.s27|0-14|Antiarrhythmics|drug
DDI-DrugBank.d143.s27|15-15|:|drug
DDI-DrugBank.d143.s27|17-21|Other|drug
DDI-DrugBank.d143.s27|23-36|antiarrhythmic|drug
DDI-DrugBank.d143.s27|38-42|drugs|drug
DDI-DrugBank.d143.s27|43-43|,|drug
DDI-DrugBank.d143.s27|45-48|such|drug
DDI-DrugBank.d143.s27|50-51|as|drug
DDI-DrugBank.d143.s27|53-61|quinidine|drug
DDI-DrugBank.d143.s27|62-62|,|drug
DDI-DrugBank.d143.s27|64-75|procainamide|drug
DDI-DrugBank.d143.s27|76-76|,|drug
DDI-DrugBank.d143.s27|78-89|disopyramide|drug
DDI-DrugBank.d143.s27|90-90|,|drug
DDI-DrugBank.d143.s27|92-94|and|drug
DDI-DrugBank.d143.s27|96-104|phenytoin|drug
DDI-DrugBank.d143.s27|105-105|,|drug
DDI-DrugBank.d143.s27|107-110|have|drug
DDI-DrugBank.d143.s27|112-115|been|drug
DDI-DrugBank.d143.s27|117-120|used|drug
DDI-DrugBank.d143.s27|122-133|concurrently|drug
DDI-DrugBank.d143.s27|135-138|with|drug
DDI-DrugBank.d143.s27|140-149|amiodarone|drug
DDI-DrugBank.d143.s27|150-150|.|drug
DDI-DrugBank.d143.s28|0-4|There|drug
DDI-DrugBank.d143.s28|6-9|have|drug
DDI-DrugBank.d143.s28|11-14|been|drug
DDI-DrugBank.d143.s28|16-19|case|drug
DDI-DrugBank.d143.s28|21-27|reports|drug
DDI-DrugBank.d143.s28|29-30|of|drug
DDI-DrugBank.d143.s28|32-40|increased|drug
DDI-DrugBank.d143.s28|42-53|steady-state|drug
DDI-DrugBank.d143.s28|55-60|levels|drug
DDI-DrugBank.d143.s28|62-63|of|drug
DDI-DrugBank.d143.s28|65-73|quinidine|drug
DDI-DrugBank.d143.s28|74-74|,|drug
DDI-DrugBank.d143.s28|76-87|procainamide|drug
DDI-DrugBank.d143.s28|88-88|,|drug
DDI-DrugBank.d143.s28|90-92|and|drug
DDI-DrugBank.d143.s28|94-102|phenytoin|drug
DDI-DrugBank.d143.s28|104-109|during|drug
DDI-DrugBank.d143.s28|111-121|concomitant|drug
DDI-DrugBank.d143.s28|123-129|therapy|drug
DDI-DrugBank.d143.s28|131-134|with|drug
DDI-DrugBank.d143.s28|136-145|amiodarone|drug
DDI-DrugBank.d143.s28|146-146|.|drug
DDI-DrugBank.d143.s29|0-8|Phenytoin|drug
DDI-DrugBank.d143.s29|10-18|decreases|drug
DDI-DrugBank.d143.s29|20-24|serum|drug
DDI-DrugBank.d143.s29|26-35|amiodarone|drug
DDI-DrugBank.d143.s29|37-42|levels|drug
DDI-DrugBank.d143.s29|43-43|.|drug
DDI-DrugBank.d143.s30|0-9|Amiodarone|drug
DDI-DrugBank.d143.s30|11-15|taken|drug
DDI-DrugBank.d143.s30|17-29|concomitantly|drug
DDI-DrugBank.d143.s30|31-34|with|drug
DDI-DrugBank.d143.s30|36-44|quinidine|drug
DDI-DrugBank.d143.s30|46-54|increases|drug
DDI-DrugBank.d143.s30|56-64|quinidine|drug
DDI-DrugBank.d143.s30|66-70|serum|drug
DDI-DrugBank.d143.s30|72-84|concentration|drug
DDI-DrugBank.d143.s30|86-87|by|drug
DDI-DrugBank.d143.s30|89-90|33|drug
DDI-DrugBank.d143.s30|91-91|%|drug
DDI-DrugBank.d143.s30|93-97|after|drug
DDI-DrugBank.d143.s30|99-101|two|drug
DDI-DrugBank.d143.s30|103-106|days|drug
DDI-DrugBank.d143.s30|107-107|.|drug
DDI-DrugBank.d143.s31|0-9|Amiodarone|drug
DDI-DrugBank.d143.s31|11-15|taken|drug
DDI-DrugBank.d143.s31|17-29|concomitantly|drug
DDI-DrugBank.d143.s31|31-34|with|drug
DDI-DrugBank.d143.s31|36-47|procainamide|drug
DDI-DrugBank.d143.s31|49-51|for|drug
DDI-DrugBank.d143.s31|53-56|less|drug
DDI-DrugBank.d143.s31|58-61|than|drug
DDI-DrugBank.d143.s31|63-67|seven|drug
DDI-DrugBank.d143.s31|69-72|days|drug
DDI-DrugBank.d143.s31|74-82|increases|drug
DDI-DrugBank.d143.s31|84-89|plasma|drug
DDI-DrugBank.d143.s31|91-104|concentrations|drug
DDI-DrugBank.d143.s31|106-107|of|drug
DDI-DrugBank.d143.s31|109-120|procainamide|drug
DDI-DrugBank.d143.s31|122-124|and|drug
DDI-DrugBank.d143.s31|126-133|n-acetyl|drug
DDI-DrugBank.d143.s31|135-146|procainamide|drug
DDI-DrugBank.d143.s31|148-149|by|drug
DDI-DrugBank.d143.s31|151-152|55|drug
DDI-DrugBank.d143.s31|153-153|%|drug
DDI-DrugBank.d143.s31|155-157|and|drug
DDI-DrugBank.d143.s31|159-160|33|drug
DDI-DrugBank.d143.s31|161-161|%|drug
DDI-DrugBank.d143.s31|162-162|,|drug
DDI-DrugBank.d143.s31|164-175|respectively|drug
DDI-DrugBank.d143.s31|176-176|.|drug
DDI-DrugBank.d143.s32|0-8|Quinidine|drug
DDI-DrugBank.d143.s32|10-12|and|drug
DDI-DrugBank.d143.s32|14-25|procainamide|drug
DDI-DrugBank.d143.s32|27-31|doses|drug
DDI-DrugBank.d143.s32|33-38|should|drug
DDI-DrugBank.d143.s32|40-41|be|drug
DDI-DrugBank.d143.s32|43-49|reduced|drug
DDI-DrugBank.d143.s32|51-52|by|drug
DDI-DrugBank.d143.s32|54-62|one-third|drug
DDI-DrugBank.d143.s32|64-67|when|drug
DDI-DrugBank.d143.s32|69-74|either|drug
DDI-DrugBank.d143.s32|76-77|is|drug
DDI-DrugBank.d143.s32|79-90|administered|drug
DDI-DrugBank.d143.s32|92-95|with|drug
DDI-DrugBank.d143.s32|97-106|amiodarone|drug
DDI-DrugBank.d143.s32|107-107|.|drug
DDI-DrugBank.d143.s33|0-5|Plasma|drug
DDI-DrugBank.d143.s33|7-12|levels|drug
DDI-DrugBank.d143.s33|14-15|of|drug
DDI-DrugBank.d143.s33|17-26|flecainide|drug
DDI-DrugBank.d143.s33|28-31|have|drug
DDI-DrugBank.d143.s33|33-36|been|drug
DDI-DrugBank.d143.s33|38-45|reported|drug
DDI-DrugBank.d143.s33|47-48|to|drug
DDI-DrugBank.d143.s33|50-57|increase|drug
DDI-DrugBank.d143.s33|59-60|in|drug
DDI-DrugBank.d143.s33|62-64|the|drug
DDI-DrugBank.d143.s33|66-73|presence|drug
DDI-DrugBank.d143.s33|75-76|of|drug
DDI-DrugBank.d143.s33|78-81|oral|drug
DDI-DrugBank.d143.s33|83-92|amiodarone|drug
DDI-DrugBank.d143.s33|93-93|;|drug
DDI-DrugBank.d143.s34|0-6|because|drug
DDI-DrugBank.d143.s34|8-9|of|drug
DDI-DrugBank.d143.s34|11-14|this|drug
DDI-DrugBank.d143.s34|15-15|,|drug
DDI-DrugBank.d143.s34|17-19|the|drug
DDI-DrugBank.d143.s34|21-26|dosage|drug
DDI-DrugBank.d143.s34|28-29|of|drug
DDI-DrugBank.d143.s34|31-40|flecainide|drug
DDI-DrugBank.d143.s34|42-47|should|drug
DDI-DrugBank.d143.s34|49-50|be|drug
DDI-DrugBank.d143.s34|52-59|adjusted|drug
DDI-DrugBank.d143.s34|61-64|when|drug
DDI-DrugBank.d143.s34|66-70|these|drug
DDI-DrugBank.d143.s34|72-76|drugs|drug
DDI-DrugBank.d143.s34|78-80|are|drug
DDI-DrugBank.d143.s34|82-93|administered|drug
DDI-DrugBank.d143.s34|95-107|concomitantly|drug
DDI-DrugBank.d143.s34|108-108|.|drug
DDI-DrugBank.d143.s35|0-1|In|drug
DDI-DrugBank.d143.s35|3-9|general|drug
DDI-DrugBank.d143.s35|10-10|,|drug
DDI-DrugBank.d143.s35|12-14|any|drug
DDI-DrugBank.d143.s35|16-20|added|drug
DDI-DrugBank.d143.s35|22-35|antiarrhythmic|drug
DDI-DrugBank.d143.s35|37-40|drug|drug
DDI-DrugBank.d143.s35|42-47|should|drug
DDI-DrugBank.d143.s35|49-50|be|drug
DDI-DrugBank.d143.s35|52-60|initiated|drug
DDI-DrugBank.d143.s35|62-63|at|drug
DDI-DrugBank.d143.s35|65-65|a|drug
DDI-DrugBank.d143.s35|67-71|lower|drug
DDI-DrugBank.d143.s35|73-76|than|drug
DDI-DrugBank.d143.s35|78-82|usual|drug
DDI-DrugBank.d143.s35|84-87|dose|drug
DDI-DrugBank.d143.s35|89-92|with|drug
DDI-DrugBank.d143.s35|94-100|careful|drug
DDI-DrugBank.d143.s35|102-111|monitoring|drug
DDI-DrugBank.d143.s35|112-112|.|drug
DDI-DrugBank.d143.s36|0-10|Combination|drug
DDI-DrugBank.d143.s36|12-13|of|drug
DDI-DrugBank.d143.s36|15-24|amiodarone|drug
DDI-DrugBank.d143.s36|26-29|with|drug
DDI-DrugBank.d143.s36|31-35|other|drug
DDI-DrugBank.d143.s36|37-50|antiarrhythmic|drug
DDI-DrugBank.d143.s36|52-58|therapy|drug
DDI-DrugBank.d143.s36|60-65|should|drug
DDI-DrugBank.d143.s36|67-68|be|drug
DDI-DrugBank.d143.s36|70-77|reserved|drug
DDI-DrugBank.d143.s36|79-81|for|drug
DDI-DrugBank.d143.s36|83-90|patients|drug
DDI-DrugBank.d143.s36|92-95|with|drug
DDI-DrugBank.d143.s36|97-112|life-threatening|drug
DDI-DrugBank.d143.s36|114-124|ventricular|drug
DDI-DrugBank.d143.s36|126-136|arrhythmias|drug
DDI-DrugBank.d143.s36|138-140|who|drug
DDI-DrugBank.d143.s36|142-144|are|drug
DDI-DrugBank.d143.s36|146-157|incompletely|drug
DDI-DrugBank.d143.s36|159-168|responsive|drug
DDI-DrugBank.d143.s36|170-171|to|drug
DDI-DrugBank.d143.s36|173-173|a|drug
DDI-DrugBank.d143.s36|175-180|single|drug
DDI-DrugBank.d143.s36|182-186|agent|drug
DDI-DrugBank.d143.s36|188-189|or|drug
DDI-DrugBank.d143.s36|191-202|incompletely|drug
DDI-DrugBank.d143.s36|204-213|responsive|drug
DDI-DrugBank.d143.s36|215-216|to|drug
DDI-DrugBank.d143.s36|218-227|amiodarone|drug
DDI-DrugBank.d143.s36|228-228|.|drug
DDI-DrugBank.d143.s37|0-5|During|drug
DDI-DrugBank.d143.s37|7-14|transfer|drug
DDI-DrugBank.d143.s37|16-17|to|drug
DDI-DrugBank.d143.s37|19-22|oral|drug
DDI-DrugBank.d143.s37|24-33|amiodarone|drug
DDI-DrugBank.d143.s37|34-34|,|drug
DDI-DrugBank.d143.s37|36-38|the|drug
DDI-DrugBank.d143.s37|40-43|dose|drug
DDI-DrugBank.d143.s37|45-50|levels|drug
DDI-DrugBank.d143.s37|52-53|of|drug
DDI-DrugBank.d143.s37|55-64|previously|drug
DDI-DrugBank.d143.s37|66-77|administered|drug
DDI-DrugBank.d143.s37|79-84|agents|drug
DDI-DrugBank.d143.s37|86-91|should|drug
DDI-DrugBank.d143.s37|93-94|be|drug
DDI-DrugBank.d143.s37|96-102|reduced|drug
DDI-DrugBank.d143.s37|104-105|by|drug
DDI-DrugBank.d143.s37|107-108|30|drug
DDI-DrugBank.d143.s37|110-111|to|drug
DDI-DrugBank.d143.s37|113-114|50|drug
DDI-DrugBank.d143.s37|115-115|%|drug
DDI-DrugBank.d143.s37|117-123|several|drug
DDI-DrugBank.d143.s37|125-128|days|drug
DDI-DrugBank.d143.s37|130-134|after|drug
DDI-DrugBank.d143.s37|136-138|the|drug
DDI-DrugBank.d143.s37|140-147|addition|drug
DDI-DrugBank.d143.s37|149-150|of|drug
DDI-DrugBank.d143.s37|152-155|oral|drug
DDI-DrugBank.d143.s37|157-166|amiodarone|drug
DDI-DrugBank.d143.s37|167-167|.|drug
DDI-DrugBank.d143.s38|0-2|The|drug
DDI-DrugBank.d143.s38|4-12|continued|drug
DDI-DrugBank.d143.s38|14-17|need|drug
DDI-DrugBank.d143.s38|19-21|for|drug
DDI-DrugBank.d143.s38|23-25|the|drug
DDI-DrugBank.d143.s38|27-31|other|drug
DDI-DrugBank.d143.s38|33-46|antiarrhythmic|drug
DDI-DrugBank.d143.s38|48-52|agent|drug
DDI-DrugBank.d143.s38|54-59|should|drug
DDI-DrugBank.d143.s38|61-62|be|drug
DDI-DrugBank.d143.s38|64-71|reviewed|drug
DDI-DrugBank.d143.s38|73-77|after|drug
DDI-DrugBank.d143.s38|79-81|the|drug
DDI-DrugBank.d143.s38|83-89|effects|drug
DDI-DrugBank.d143.s38|91-92|of|drug
DDI-DrugBank.d143.s38|94-103|amiodarone|drug
DDI-DrugBank.d143.s38|105-108|have|drug
DDI-DrugBank.d143.s38|110-113|been|drug
DDI-DrugBank.d143.s38|115-125|established|drug
DDI-DrugBank.d143.s38|126-126|,|drug
DDI-DrugBank.d143.s38|128-130|and|drug
DDI-DrugBank.d143.s38|132-146|discontinuation|drug
DDI-DrugBank.d143.s38|148-157|ordinarily|drug
DDI-DrugBank.d143.s38|159-164|should|drug
DDI-DrugBank.d143.s38|166-167|be|drug
DDI-DrugBank.d143.s38|169-177|attempted|drug
DDI-DrugBank.d143.s38|178-178|.|drug
DDI-DrugBank.d143.s39|0-1|If|drug
DDI-DrugBank.d143.s39|3-5|the|drug
DDI-DrugBank.d143.s39|7-15|treatment|drug
DDI-DrugBank.d143.s39|17-18|is|drug
DDI-DrugBank.d143.s39|20-28|continued|drug
DDI-DrugBank.d143.s39|29-29|,|drug
DDI-DrugBank.d143.s39|31-35|these|drug
DDI-DrugBank.d143.s39|37-44|patients|drug
DDI-DrugBank.d143.s39|46-51|should|drug
DDI-DrugBank.d143.s39|53-54|be|drug
DDI-DrugBank.d143.s39|56-67|particularly|drug
DDI-DrugBank.d143.s39|69-77|carefully|drug
DDI-DrugBank.d143.s39|79-87|monitored|drug
DDI-DrugBank.d143.s39|89-91|for|drug
DDI-DrugBank.d143.s39|93-99|adverse|drug
DDI-DrugBank.d143.s39|101-107|effects|drug
DDI-DrugBank.d143.s39|108-108|,|drug
DDI-DrugBank.d143.s39|110-119|especially|drug
DDI-DrugBank.d143.s39|121-130|conduction|drug
DDI-DrugBank.d143.s39|132-143|disturbances|drug
DDI-DrugBank.d143.s39|145-147|and|drug
DDI-DrugBank.d143.s39|149-160|exacerbation|drug
DDI-DrugBank.d143.s39|162-163|of|drug
DDI-DrugBank.d143.s39|165-180|tachyarrhythmias|drug
DDI-DrugBank.d143.s39|181-181|,|drug
DDI-DrugBank.d143.s39|183-184|as|drug
DDI-DrugBank.d143.s39|186-195|amiodarone|drug
DDI-DrugBank.d143.s39|197-198|is|drug
DDI-DrugBank.d143.s39|200-208|continued|drug
DDI-DrugBank.d143.s39|209-209|.|drug
DDI-DrugBank.d143.s40|0-1|In|drug
DDI-DrugBank.d143.s40|3-20|amiodarone-treated|drug
DDI-DrugBank.d143.s40|22-29|patients|drug
DDI-DrugBank.d143.s40|31-33|who|drug
DDI-DrugBank.d143.s40|35-41|require|drug
DDI-DrugBank.d143.s40|43-52|additional|drug
DDI-DrugBank.d143.s40|54-67|antiarrhythmic|drug
DDI-DrugBank.d143.s40|69-75|therapy|drug
DDI-DrugBank.d143.s40|76-76|,|drug
DDI-DrugBank.d143.s40|78-80|the|drug
DDI-DrugBank.d143.s40|82-88|initial|drug
DDI-DrugBank.d143.s40|90-93|dose|drug
DDI-DrugBank.d143.s40|95-96|of|drug
DDI-DrugBank.d143.s40|98-101|such|drug
DDI-DrugBank.d143.s40|103-108|agents|drug
DDI-DrugBank.d143.s40|110-115|should|drug
DDI-DrugBank.d143.s40|117-118|be|drug
DDI-DrugBank.d143.s40|120-132|approximately|drug
DDI-DrugBank.d143.s40|134-137|half|drug
DDI-DrugBank.d143.s40|139-140|of|drug
DDI-DrugBank.d143.s40|142-144|the|drug
DDI-DrugBank.d143.s40|146-150|usual|drug
DDI-DrugBank.d143.s40|152-162|recommended|drug
DDI-DrugBank.d143.s40|164-167|dose|drug
DDI-DrugBank.d143.s40|168-168|.|drug
DDI-DrugBank.d143.s41|0-16|Antihypertensives|drug
DDI-DrugBank.d143.s41|17-17|:|drug
DDI-DrugBank.d143.s41|19-28|Amiodarone|drug
DDI-DrugBank.d143.s41|30-35|should|drug
DDI-DrugBank.d143.s41|37-38|be|drug
DDI-DrugBank.d143.s41|40-43|used|drug
DDI-DrugBank.d143.s41|45-48|with|drug
DDI-DrugBank.d143.s41|50-56|caution|drug
DDI-DrugBank.d143.s41|58-59|in|drug
DDI-DrugBank.d143.s41|61-68|patients|drug
DDI-DrugBank.d143.s41|70-78|receiving|drug
DDI-DrugBank.d143.s41|81-89|-receptor|drug
DDI-DrugBank.d143.s41|91-98|blocking|drug
DDI-DrugBank.d143.s41|100-105|agents|drug
DDI-DrugBank.d143.s41|107-107|(|drug
DDI-DrugBank.d143.s41|108-111|e.g.|drug
DDI-DrugBank.d143.s41|112-112|,|drug
DDI-DrugBank.d143.s41|114-124|propranolol|drug
DDI-DrugBank.d143.s41|125-125|,|drug
DDI-DrugBank.d143.s41|127-127|a|drug
DDI-DrugBank.d143.s41|129-134|CYP3A4|drug
DDI-DrugBank.d143.s41|136-144|inhibitor|drug
DDI-DrugBank.d143.s41|145-145|)|drug
DDI-DrugBank.d143.s41|147-148|or|drug
DDI-DrugBank.d143.s41|150-156|calcium|drug
DDI-DrugBank.d143.s41|158-164|channel|drug
DDI-DrugBank.d143.s41|166-176|antagonists|drug
DDI-DrugBank.d143.s41|178-178|(|drug
DDI-DrugBank.d143.s41|179-182|e.g.|drug
DDI-DrugBank.d143.s41|183-183|,|drug
DDI-DrugBank.d143.s41|185-193|verapamil|drug
DDI-DrugBank.d143.s41|194-194|,|drug
DDI-DrugBank.d143.s41|196-196|a|drug
DDI-DrugBank.d143.s41|198-203|CYP3A4|drug
DDI-DrugBank.d143.s41|205-213|substrate|drug
DDI-DrugBank.d143.s41|214-214|,|drug
DDI-DrugBank.d143.s41|216-218|and|drug
DDI-DrugBank.d143.s41|220-228|diltiazem|drug
DDI-DrugBank.d143.s41|229-229|,|drug
DDI-DrugBank.d143.s41|231-231|a|drug
DDI-DrugBank.d143.s41|233-238|CYP3A4|drug
DDI-DrugBank.d143.s41|240-248|inhibitor|drug
DDI-DrugBank.d143.s41|249-249|)|drug
DDI-DrugBank.d143.s41|251-257|because|drug
DDI-DrugBank.d143.s41|259-260|of|drug
DDI-DrugBank.d143.s41|262-264|the|drug
DDI-DrugBank.d143.s41|266-273|possible|drug
DDI-DrugBank.d143.s41|275-286|potentiation|drug
DDI-DrugBank.d143.s41|288-289|of|drug
DDI-DrugBank.d143.s41|291-301|bradycardia|drug
DDI-DrugBank.d143.s41|302-302|,|drug
DDI-DrugBank.d143.s41|304-308|sinus|drug
DDI-DrugBank.d143.s41|310-315|arrest|drug
DDI-DrugBank.d143.s41|316-316|,|drug
DDI-DrugBank.d143.s41|318-320|and|drug
DDI-DrugBank.d143.s41|322-323|AV|drug
DDI-DrugBank.d143.s41|325-329|block|drug
DDI-DrugBank.d143.s41|330-330|;|drug
DDI-DrugBank.d143.s42|0-1|if|drug
DDI-DrugBank.d143.s42|3-11|necessary|drug
DDI-DrugBank.d143.s42|12-12|,|drug
DDI-DrugBank.d143.s42|14-23|amiodarone|drug
DDI-DrugBank.d143.s42|25-27|can|drug
DDI-DrugBank.d143.s42|29-36|continue|drug
DDI-DrugBank.d143.s42|38-39|to|drug
DDI-DrugBank.d143.s42|41-42|be|drug
DDI-DrugBank.d143.s42|44-47|used|drug
DDI-DrugBank.d143.s42|49-53|after|drug
DDI-DrugBank.d143.s42|55-63|insertion|drug
DDI-DrugBank.d143.s42|65-66|of|drug
DDI-DrugBank.d143.s42|68-68|a|drug
DDI-DrugBank.d143.s42|70-78|pacemaker|drug
DDI-DrugBank.d143.s42|80-81|in|drug
DDI-DrugBank.d143.s42|83-90|patients|drug
DDI-DrugBank.d143.s42|92-95|with|drug
DDI-DrugBank.d143.s42|97-102|severe|drug
DDI-DrugBank.d143.s42|104-114|bradycardia|drug
DDI-DrugBank.d143.s42|116-117|or|drug
DDI-DrugBank.d143.s42|119-123|sinus|drug
DDI-DrugBank.d143.s42|125-130|arrest|drug
DDI-DrugBank.d143.s42|131-131|.|drug
DDI-DrugBank.d143.s43|0-13|Anticoagulants|drug
DDI-DrugBank.d143.s43|14-14|:|drug
DDI-DrugBank.d143.s43|16-27|Potentiation|drug
DDI-DrugBank.d143.s43|29-30|of|drug
DDI-DrugBank.d143.s43|32-44|warfarin-type|drug
DDI-DrugBank.d143.s43|46-46|(|drug
DDI-DrugBank.d143.s43|47-52|CYP2C9|drug
DDI-DrugBank.d143.s43|54-56|and|drug
DDI-DrugBank.d143.s43|58-63|CYP3A4|drug
DDI-DrugBank.d143.s43|65-73|substrate|drug
DDI-DrugBank.d143.s43|74-74|)|drug
DDI-DrugBank.d143.s43|76-88|anticoagulant|drug
DDI-DrugBank.d143.s43|90-97|response|drug
DDI-DrugBank.d143.s43|99-100|is|drug
DDI-DrugBank.d143.s43|102-107|almost|drug
DDI-DrugBank.d143.s43|109-114|always|drug
DDI-DrugBank.d143.s43|116-119|seen|drug
DDI-DrugBank.d143.s43|121-122|in|drug
DDI-DrugBank.d143.s43|124-131|patients|drug
DDI-DrugBank.d143.s43|133-141|receiving|drug
DDI-DrugBank.d143.s43|143-152|amiodarone|drug
DDI-DrugBank.d143.s43|154-156|and|drug
DDI-DrugBank.d143.s43|158-160|can|drug
DDI-DrugBank.d143.s43|162-167|result|drug
DDI-DrugBank.d143.s43|169-170|in|drug
DDI-DrugBank.d143.s43|172-178|serious|drug
DDI-DrugBank.d143.s43|180-181|or|drug
DDI-DrugBank.d143.s43|183-187|fatal|drug
DDI-DrugBank.d143.s43|189-196|bleeding|drug
DDI-DrugBank.d143.s43|197-197|.|drug
DDI-DrugBank.d143.s44|0-4|Since|drug
DDI-DrugBank.d143.s44|6-8|the|drug
DDI-DrugBank.d143.s44|10-20|concomitant|drug
DDI-DrugBank.d143.s44|22-35|administration|drug
DDI-DrugBank.d143.s44|37-38|of|drug
DDI-DrugBank.d143.s44|40-47|warfarin|drug
DDI-DrugBank.d143.s44|49-52|with|drug
DDI-DrugBank.d143.s44|54-63|amiodarone|drug
DDI-DrugBank.d143.s44|65-73|increases|drug
DDI-DrugBank.d143.s44|75-77|the|drug
DDI-DrugBank.d143.s44|79-89|prothrombin|drug
DDI-DrugBank.d143.s44|91-94|time|drug
DDI-DrugBank.d143.s44|96-97|by|drug
DDI-DrugBank.d143.s44|99-101|100|drug
DDI-DrugBank.d143.s44|102-102|%|drug
DDI-DrugBank.d143.s44|104-108|after|drug
DDI-DrugBank.d143.s44|110-110|3|drug
DDI-DrugBank.d143.s44|112-113|to|drug
DDI-DrugBank.d143.s44|115-115|4|drug
DDI-DrugBank.d143.s44|117-120|days|drug
DDI-DrugBank.d143.s44|121-121|,|drug
DDI-DrugBank.d143.s44|123-125|the|drug
DDI-DrugBank.d143.s44|127-130|dose|drug
DDI-DrugBank.d143.s44|132-133|of|drug
DDI-DrugBank.d143.s44|135-137|the|drug
DDI-DrugBank.d143.s44|139-151|anticoagulant|drug
DDI-DrugBank.d143.s44|153-158|should|drug
DDI-DrugBank.d143.s44|160-161|be|drug
DDI-DrugBank.d143.s44|163-169|reduced|drug
DDI-DrugBank.d143.s44|171-172|by|drug
DDI-DrugBank.d143.s44|174-182|one-third|drug
DDI-DrugBank.d143.s44|184-185|to|drug
DDI-DrugBank.d143.s44|187-194|one-half|drug
DDI-DrugBank.d143.s44|195-195|,|drug
DDI-DrugBank.d143.s44|197-199|and|drug
DDI-DrugBank.d143.s44|201-211|prothrombin|drug
DDI-DrugBank.d143.s44|213-217|times|drug
DDI-DrugBank.d143.s44|219-224|should|drug
DDI-DrugBank.d143.s44|226-227|be|drug
DDI-DrugBank.d143.s44|229-237|monitored|drug
DDI-DrugBank.d143.s44|239-245|closely|drug
DDI-DrugBank.d143.s44|246-246|.|drug
DDI-DrugBank.d143.s45|0-3|Some|drug
DDI-DrugBank.d143.s45|5-20|drugs/substances|drug
DDI-DrugBank.d143.s45|22-24|are|drug
DDI-DrugBank.d143.s45|26-30|known|drug
DDI-DrugBank.d143.s45|32-33|to|drug
DDI-DrugBank.d143.s45|35-44|accelerate|drug
DDI-DrugBank.d143.s45|46-48|the|drug
DDI-DrugBank.d143.s45|50-59|metabolism|drug
DDI-DrugBank.d143.s45|61-62|of|drug
DDI-DrugBank.d143.s45|64-73|amiodarone|drug
DDI-DrugBank.d143.s45|75-76|by|drug
DDI-DrugBank.d143.s45|78-88|stimulating|drug
DDI-DrugBank.d143.s45|90-92|the|drug
DDI-DrugBank.d143.s45|94-102|synthesis|drug
DDI-DrugBank.d143.s45|104-105|of|drug
DDI-DrugBank.d143.s45|107-112|CYP3A4|drug
DDI-DrugBank.d143.s45|114-114|(|drug
DDI-DrugBank.d143.s45|115-120|enzyme|drug
DDI-DrugBank.d143.s45|122-130|induction|drug
DDI-DrugBank.d143.s45|131-131|)|drug
DDI-DrugBank.d143.s45|132-132|.|drug
DDI-DrugBank.d143.s46|0-3|This|drug
DDI-DrugBank.d143.s46|5-7|may|drug
DDI-DrugBank.d143.s46|9-12|lead|drug
DDI-DrugBank.d143.s46|14-15|to|drug
DDI-DrugBank.d143.s46|17-19|low|drug
DDI-DrugBank.d143.s46|21-30|amiodarone|drug
DDI-DrugBank.d143.s46|32-36|serum|drug
DDI-DrugBank.d143.s46|38-43|levels|drug
DDI-DrugBank.d143.s46|45-47|and|drug
DDI-DrugBank.d143.s46|49-57|potential|drug
DDI-DrugBank.d143.s46|59-66|decrease|drug
DDI-DrugBank.d143.s46|68-69|in|drug
DDI-DrugBank.d143.s46|71-78|efficacy|drug
DDI-DrugBank.d143.s46|79-79|.|drug
DDI-DrugBank.d143.s47|0-7|Reported|drug
DDI-DrugBank.d143.s47|9-16|examples|drug
DDI-DrugBank.d143.s47|18-19|of|drug
DDI-DrugBank.d143.s47|21-24|this|drug
DDI-DrugBank.d143.s47|26-36|interaction|drug
DDI-DrugBank.d143.s47|38-44|include|drug
DDI-DrugBank.d143.s47|46-48|the|drug
DDI-DrugBank.d143.s47|50-58|following|drug
DDI-DrugBank.d143.s47|59-59|:|drug
DDI-DrugBank.d143.s47|61-71|Antibiotics|drug
DDI-DrugBank.d143.s47|72-72|:|drug
DDI-DrugBank.d143.s47|74-81|Rifampin|drug
DDI-DrugBank.d143.s47|83-84|is|drug
DDI-DrugBank.d143.s47|86-86|a|drug
DDI-DrugBank.d143.s47|88-93|potent|drug
DDI-DrugBank.d143.s47|95-101|inducer|drug
DDI-DrugBank.d143.s47|103-104|of|drug
DDI-DrugBank.d143.s47|106-111|CYP3A4|drug
DDI-DrugBank.d143.s47|112-112|.|drug
DDI-DrugBank.d143.s48|0-13|Administration|drug
DDI-DrugBank.d143.s48|15-16|of|drug
DDI-DrugBank.d143.s48|18-25|rifampin|drug
DDI-DrugBank.d143.s48|27-39|concomitantly|drug
DDI-DrugBank.d143.s48|41-44|with|drug
DDI-DrugBank.d143.s48|46-49|oral|drug
DDI-DrugBank.d143.s48|51-60|amiodarone|drug
DDI-DrugBank.d143.s48|62-64|has|drug
DDI-DrugBank.d143.s48|66-69|been|drug
DDI-DrugBank.d143.s48|71-75|shown|drug
DDI-DrugBank.d143.s48|77-78|to|drug
DDI-DrugBank.d143.s48|80-85|result|drug
DDI-DrugBank.d143.s48|87-88|in|drug
DDI-DrugBank.d143.s48|90-98|decreases|drug
DDI-DrugBank.d143.s48|100-101|in|drug
DDI-DrugBank.d143.s48|103-107|serum|drug
DDI-DrugBank.d143.s48|109-122|concentrations|drug
DDI-DrugBank.d143.s48|124-125|of|drug
DDI-DrugBank.d143.s48|127-136|amiodarone|drug
DDI-DrugBank.d143.s48|138-140|and|drug
DDI-DrugBank.d143.s48|142-159|desethylamiodarone|drug
DDI-DrugBank.d143.s48|160-160|.|drug
DDI-DrugBank.d143.s49|0-4|Other|drug
DDI-DrugBank.d143.s49|6-15|substances|drug
DDI-DrugBank.d143.s49|16-16|,|drug
DDI-DrugBank.d143.s49|18-26|including|drug
DDI-DrugBank.d143.s49|28-33|herbal|drug
DDI-DrugBank.d143.s49|35-46|preparations|drug
DDI-DrugBank.d143.s49|47-47|:|drug
DDI-DrugBank.d143.s49|49-51|St.|drug
DDI-DrugBank.d143.s49|53-56|John|drug
DDI-DrugBank.d143.s49|58-58|s|drug
DDI-DrugBank.d143.s49|60-63|Wort|drug
DDI-DrugBank.d143.s49|65-65|(|drug
DDI-DrugBank.d143.s49|66-74|Hypericum|drug
DDI-DrugBank.d143.s49|76-85|perforatum|drug
DDI-DrugBank.d143.s49|86-86|)|drug
DDI-DrugBank.d143.s49|88-94|induces|drug
DDI-DrugBank.d143.s49|96-101|CYP3A4|drug
DDI-DrugBank.d143.s49|102-102|.|drug
DDI-DrugBank.d143.s50|0-4|Since|drug
DDI-DrugBank.d143.s50|6-15|amiodarone|drug
DDI-DrugBank.d143.s50|17-18|is|drug
DDI-DrugBank.d143.s50|20-20|a|drug
DDI-DrugBank.d143.s50|22-30|substrate|drug
DDI-DrugBank.d143.s50|32-34|for|drug
DDI-DrugBank.d143.s50|36-41|CYP3A4|drug
DDI-DrugBank.d143.s50|42-42|,|drug
DDI-DrugBank.d143.s50|44-48|there|drug
DDI-DrugBank.d143.s50|50-51|is|drug
DDI-DrugBank.d143.s50|53-55|the|drug
DDI-DrugBank.d143.s50|57-65|potential|drug
DDI-DrugBank.d143.s50|67-70|that|drug
DDI-DrugBank.d143.s50|72-74|the|drug
DDI-DrugBank.d143.s50|76-78|use|drug
DDI-DrugBank.d143.s50|80-81|of|drug
DDI-DrugBank.d143.s50|83-85|St.|drug
DDI-DrugBank.d143.s50|87-90|John|drug
DDI-DrugBank.d143.s50|92-92|s|drug
DDI-DrugBank.d143.s50|94-97|Wort|drug
DDI-DrugBank.d143.s50|99-100|in|drug
DDI-DrugBank.d143.s50|102-109|patients|drug
DDI-DrugBank.d143.s50|111-119|receiving|drug
DDI-DrugBank.d143.s50|121-130|amiodarone|drug
DDI-DrugBank.d143.s50|132-136|could|drug
DDI-DrugBank.d143.s50|138-143|result|drug
DDI-DrugBank.d143.s50|145-146|in|drug
DDI-DrugBank.d143.s50|148-154|reduced|drug
DDI-DrugBank.d143.s50|156-165|amiodarone|drug
DDI-DrugBank.d143.s50|167-172|levels|drug
DDI-DrugBank.d143.s50|173-173|.|drug
DDI-DrugBank.d143.s51|0-4|Other|drug
DDI-DrugBank.d143.s51|6-13|reported|drug
DDI-DrugBank.d143.s51|15-26|interactions|drug
DDI-DrugBank.d143.s51|28-31|with|drug
DDI-DrugBank.d143.s51|33-42|amiodarone|drug
DDI-DrugBank.d143.s51|43-43|:|drug
DDI-DrugBank.d143.s51|45-52|Fentanyl|drug
DDI-DrugBank.d143.s51|54-54|(|drug
DDI-DrugBank.d143.s51|55-60|CYP3A4|drug
DDI-DrugBank.d143.s51|62-70|substrate|drug
DDI-DrugBank.d143.s51|71-71|)|drug
DDI-DrugBank.d143.s51|73-74|in|drug
DDI-DrugBank.d143.s51|76-86|combination|drug
DDI-DrugBank.d143.s51|88-91|with|drug
DDI-DrugBank.d143.s51|93-102|amiodarone|drug
DDI-DrugBank.d143.s51|104-106|may|drug
DDI-DrugBank.d143.s51|108-112|cause|drug
DDI-DrugBank.d143.s51|114-124|hypotension|drug
DDI-DrugBank.d143.s51|125-125|,|drug
DDI-DrugBank.d143.s51|127-137|bradycardia|drug
DDI-DrugBank.d143.s51|138-138|,|drug
DDI-DrugBank.d143.s51|140-142|and|drug
DDI-DrugBank.d143.s51|144-152|decreased|drug
DDI-DrugBank.d143.s51|154-160|cardiac|drug
DDI-DrugBank.d143.s51|162-167|output|drug
DDI-DrugBank.d143.s51|168-168|.|drug
DDI-DrugBank.d143.s52|0-4|Sinus|drug
DDI-DrugBank.d143.s52|6-16|bradycardia|drug
DDI-DrugBank.d143.s52|18-20|has|drug
DDI-DrugBank.d143.s52|22-25|been|drug
DDI-DrugBank.d143.s52|27-34|reported|drug
DDI-DrugBank.d143.s52|36-39|with|drug
DDI-DrugBank.d143.s52|41-44|oral|drug
DDI-DrugBank.d143.s52|46-55|amiodarone|drug
DDI-DrugBank.d143.s52|57-58|in|drug
DDI-DrugBank.d143.s52|60-70|combination|drug
DDI-DrugBank.d143.s52|72-75|with|drug
DDI-DrugBank.d143.s52|77-85|lidocaine|drug
DDI-DrugBank.d143.s52|87-87|(|drug
DDI-DrugBank.d143.s52|88-93|CYP3A4|drug
DDI-DrugBank.d143.s52|95-103|substrate|drug
DDI-DrugBank.d143.s52|104-104|)|drug
DDI-DrugBank.d143.s52|106-110|given|drug
DDI-DrugBank.d143.s52|112-114|for|drug
DDI-DrugBank.d143.s52|116-120|local|drug
DDI-DrugBank.d143.s52|122-131|anesthesia|drug
DDI-DrugBank.d143.s52|132-132|.|drug
DDI-DrugBank.d143.s53|0-6|Seizure|drug
DDI-DrugBank.d143.s53|7-7|,|drug
DDI-DrugBank.d143.s53|9-18|associated|drug
DDI-DrugBank.d143.s53|20-23|with|drug
DDI-DrugBank.d143.s53|25-33|increased|drug
DDI-DrugBank.d143.s53|35-43|lidocaine|drug
DDI-DrugBank.d143.s53|45-58|concentrations|drug
DDI-DrugBank.d143.s53|59-59|,|drug
DDI-DrugBank.d143.s53|61-63|has|drug
DDI-DrugBank.d143.s53|65-68|been|drug
DDI-DrugBank.d143.s53|70-77|reported|drug
DDI-DrugBank.d143.s53|79-82|with|drug
DDI-DrugBank.d143.s53|84-94|concomitant|drug
DDI-DrugBank.d143.s53|96-109|administration|drug
DDI-DrugBank.d143.s53|111-112|of|drug
DDI-DrugBank.d143.s53|114-124|intravenous|drug
DDI-DrugBank.d143.s53|126-135|amiodarone|drug
DDI-DrugBank.d143.s53|136-136|.|drug
DDI-DrugBank.d143.s54|0-15|Dextromethorphan|drug
DDI-DrugBank.d143.s54|17-18|is|drug
DDI-DrugBank.d143.s54|20-20|a|drug
DDI-DrugBank.d143.s54|22-30|substrate|drug
DDI-DrugBank.d143.s54|32-34|for|drug
DDI-DrugBank.d143.s54|36-39|both|drug
DDI-DrugBank.d143.s54|41-46|CYP2D6|drug
DDI-DrugBank.d143.s54|48-50|and|drug
DDI-DrugBank.d143.s54|52-57|CYP3A4|drug
DDI-DrugBank.d143.s54|58-58|.|drug
DDI-DrugBank.d143.s55|0-9|Amiodarone|drug
DDI-DrugBank.d143.s55|11-18|inhibits|drug
DDI-DrugBank.d143.s55|20-25|CYP2D6|drug
DDI-DrugBank.d143.s55|26-26|.|drug
DDI-DrugBank.d143.s56|0-13|Cholestyramine|drug
DDI-DrugBank.d143.s56|15-23|increases|drug
DDI-DrugBank.d143.s56|25-37|enterohepatic|drug
DDI-DrugBank.d143.s56|39-49|elimination|drug
DDI-DrugBank.d143.s56|51-52|of|drug
DDI-DrugBank.d143.s56|54-63|amiodarone|drug
DDI-DrugBank.d143.s56|65-67|and|drug
DDI-DrugBank.d143.s56|69-71|may|drug
DDI-DrugBank.d143.s56|73-78|reduce|drug
DDI-DrugBank.d143.s56|80-82|its|drug
DDI-DrugBank.d143.s56|84-88|serum|drug
DDI-DrugBank.d143.s56|90-95|levels|drug
DDI-DrugBank.d143.s56|97-99|and|drug
DDI-DrugBank.d143.s56|101-104|t1/2|drug
DDI-DrugBank.d143.s56|105-105|.|drug
DDI-DrugBank.d143.s57|0-11|Disopyramide|drug
DDI-DrugBank.d143.s57|13-21|increases|drug
DDI-DrugBank.d143.s57|23-24|QT|drug
DDI-DrugBank.d143.s57|26-37|prolongation|drug
DDI-DrugBank.d143.s57|39-43|which|drug
DDI-DrugBank.d143.s57|45-49|could|drug
DDI-DrugBank.d143.s57|51-55|cause|drug
DDI-DrugBank.d143.s57|57-66|arrhythmia|drug
DDI-DrugBank.d143.s57|67-67|.|drug
DDI-DrugBank.d143.s58|0-15|Fluoroquinolones|drug
DDI-DrugBank.d143.s58|16-16|,|drug
DDI-DrugBank.d143.s58|18-26|macrolide|drug
DDI-DrugBank.d143.s58|28-38|antibiotics|drug
DDI-DrugBank.d143.s58|39-39|,|drug
DDI-DrugBank.d143.s58|41-43|and|drug
DDI-DrugBank.d143.s58|45-50|azoles|drug
DDI-DrugBank.d143.s58|52-54|are|drug
DDI-DrugBank.d143.s58|56-60|known|drug
DDI-DrugBank.d143.s58|62-63|to|drug
DDI-DrugBank.d143.s58|65-69|cause|drug
DDI-DrugBank.d143.s58|71-73|QTc|drug
DDI-DrugBank.d143.s58|75-86|prolongation|drug
DDI-DrugBank.d143.s58|87-87|.|drug
DDI-DrugBank.d143.s59|0-4|There|drug
DDI-DrugBank.d143.s59|6-9|have|drug
DDI-DrugBank.d143.s59|11-14|been|drug
DDI-DrugBank.d143.s59|16-22|reports|drug
DDI-DrugBank.d143.s59|24-25|of|drug
DDI-DrugBank.d143.s59|27-29|QTc|drug
DDI-DrugBank.d143.s59|31-42|prolongation|drug
DDI-DrugBank.d143.s59|43-43|,|drug
DDI-DrugBank.d143.s59|45-48|with|drug
DDI-DrugBank.d143.s59|50-51|or|drug
DDI-DrugBank.d143.s59|53-59|without|drug
DDI-DrugBank.d143.s59|61-63|TdP|drug
DDI-DrugBank.d143.s59|64-64|,|drug
DDI-DrugBank.d143.s59|66-67|in|drug
DDI-DrugBank.d143.s59|69-76|patients|drug
DDI-DrugBank.d143.s59|78-83|taking|drug
DDI-DrugBank.d143.s59|85-94|amiodarone|drug
DDI-DrugBank.d143.s59|96-99|when|drug
DDI-DrugBank.d143.s59|101-116|fluoroquinolones|drug
DDI-DrugBank.d143.s59|117-117|,|drug
DDI-DrugBank.d143.s59|119-127|macrolide|drug
DDI-DrugBank.d143.s59|129-139|antibiotics|drug
DDI-DrugBank.d143.s59|140-140|,|drug
DDI-DrugBank.d143.s59|142-143|or|drug
DDI-DrugBank.d143.s59|145-150|azoles|drug
DDI-DrugBank.d143.s59|152-155|were|drug
DDI-DrugBank.d143.s59|157-168|administered|drug
DDI-DrugBank.d143.s59|170-182|concomitantly|drug
DDI-DrugBank.d143.s59|183-183|.|drug
DDI-DrugBank.d143.s60|0-10|Hemodynamic|drug
DDI-DrugBank.d143.s60|12-14|and|drug
DDI-DrugBank.d143.s60|16-33|electrophysiologic|drug
DDI-DrugBank.d143.s60|35-46|interactions|drug
DDI-DrugBank.d143.s60|48-51|have|drug
DDI-DrugBank.d143.s60|53-56|also|drug
DDI-DrugBank.d143.s60|58-61|been|drug
DDI-DrugBank.d143.s60|63-70|observed|drug
DDI-DrugBank.d143.s60|72-76|after|drug
DDI-DrugBank.d143.s60|78-88|concomitant|drug
DDI-DrugBank.d143.s60|90-103|administration|drug
DDI-DrugBank.d143.s60|105-108|with|drug
DDI-DrugBank.d143.s60|110-120|propranolol|drug
DDI-DrugBank.d143.s60|121-121|,|drug
DDI-DrugBank.d143.s60|123-131|diltiazem|drug
DDI-DrugBank.d143.s60|132-132|,|drug
DDI-DrugBank.d143.s60|134-136|and|drug
DDI-DrugBank.d143.s60|138-146|verapamil|drug
DDI-DrugBank.d143.s60|147-147|.|drug
DDI-DrugBank.d143.s61|0-7|Volatile|drug
DDI-DrugBank.d143.s61|9-18|Anesthetic|drug
DDI-DrugBank.d143.s61|20-25|Agents|drug
DDI-DrugBank.d143.s61|26-26|:|drug
DDI-DrugBank.d143.s61|27-27|.|drug
DDI-DrugBank.d143.s62|0-1|In|drug
DDI-DrugBank.d143.s62|3-10|addition|drug
DDI-DrugBank.d143.s62|12-13|to|drug
DDI-DrugBank.d143.s62|15-17|the|drug
DDI-DrugBank.d143.s62|19-30|interactions|drug
DDI-DrugBank.d143.s62|32-36|noted|drug
DDI-DrugBank.d143.s62|38-42|above|drug
DDI-DrugBank.d143.s62|43-43|,|drug
DDI-DrugBank.d143.s62|45-51|chronic|drug
DDI-DrugBank.d143.s62|53-53|(|drug
DDI-DrugBank.d143.s62|56-56|2|drug
DDI-DrugBank.d143.s62|58-62|weeks|drug
DDI-DrugBank.d143.s62|63-63|)|drug
DDI-DrugBank.d143.s62|65-68|oral|drug
DDI-DrugBank.d143.s62|70-78|Cordarone|drug
DDI-DrugBank.d143.s62|80-93|administration|drug
DDI-DrugBank.d143.s62|95-101|impairs|drug
DDI-DrugBank.d143.s62|103-112|metabolism|drug
DDI-DrugBank.d143.s62|114-115|of|drug
DDI-DrugBank.d143.s62|117-125|phenytoin|drug
DDI-DrugBank.d143.s62|126-126|,|drug
DDI-DrugBank.d143.s62|128-143|dextromethorphan|drug
DDI-DrugBank.d143.s62|144-144|,|drug
DDI-DrugBank.d143.s62|146-148|and|drug
DDI-DrugBank.d143.s62|150-161|methotrexate|drug
DDI-DrugBank.d143.s62|162-162|.|drug
DDI-DrugBank.d143.s63|0-10|Electrolyte|drug
DDI-DrugBank.d143.s63|12-23|Disturbances|drug
DDI-DrugBank.d143.s63|25-32|Patients|drug
DDI-DrugBank.d143.s63|34-37|with|drug
DDI-DrugBank.d143.s63|39-49|hypokalemia|drug
DDI-DrugBank.d143.s63|51-52|or|drug
DDI-DrugBank.d143.s63|54-67|hypomagnesemia|drug
DDI-DrugBank.d143.s63|69-74|should|drug
DDI-DrugBank.d143.s63|76-79|have|drug
DDI-DrugBank.d143.s63|81-83|the|drug
DDI-DrugBank.d143.s63|85-93|condition|drug
DDI-DrugBank.d143.s63|95-103|corrected|drug
DDI-DrugBank.d143.s63|105-112|whenever|drug
DDI-DrugBank.d143.s63|114-121|possible|drug
DDI-DrugBank.d143.s63|123-128|before|drug
DDI-DrugBank.d143.s63|130-134|being|drug
DDI-DrugBank.d143.s63|136-142|treated|drug
DDI-DrugBank.d143.s63|144-147|with|drug
DDI-DrugBank.d143.s63|149-157|Cordarone|drug
DDI-DrugBank.d143.s63|159-162|I.V.|drug
DDI-DrugBank.d143.s63|163-163|,|drug
DDI-DrugBank.d143.s63|165-166|as|drug
DDI-DrugBank.d143.s63|168-172|these|drug
DDI-DrugBank.d143.s63|174-182|disorders|drug
DDI-DrugBank.d143.s63|184-186|can|drug
DDI-DrugBank.d143.s63|188-197|exaggerate|drug
DDI-DrugBank.d143.s63|199-201|the|drug
DDI-DrugBank.d143.s63|203-208|degree|drug
DDI-DrugBank.d143.s63|210-211|of|drug
DDI-DrugBank.d143.s63|213-215|QTc|drug
DDI-DrugBank.d143.s63|217-228|prolongation|drug
DDI-DrugBank.d143.s63|230-232|and|drug
DDI-DrugBank.d143.s63|234-241|increase|drug
DDI-DrugBank.d143.s63|243-245|the|drug
DDI-DrugBank.d143.s63|247-255|potential|drug
DDI-DrugBank.d143.s63|257-259|for|drug
DDI-DrugBank.d143.s63|261-263|TdP|drug
DDI-DrugBank.d143.s63|264-264|.|drug
DDI-DrugBank.d143.s64|0-6|Special|drug
DDI-DrugBank.d143.s64|8-16|attention|drug
DDI-DrugBank.d143.s64|18-23|should|drug
DDI-DrugBank.d143.s64|25-26|be|drug
DDI-DrugBank.d143.s64|28-32|given|drug
DDI-DrugBank.d143.s64|34-35|to|drug
DDI-DrugBank.d143.s64|37-47|electrolyte|drug
DDI-DrugBank.d143.s64|49-51|and|drug
DDI-DrugBank.d143.s64|53-61|acid-base|drug
DDI-DrugBank.d143.s64|63-69|balance|drug
DDI-DrugBank.d143.s64|71-72|in|drug
DDI-DrugBank.d143.s64|74-81|patients|drug
DDI-DrugBank.d143.s64|83-94|experiencing|drug
DDI-DrugBank.d143.s64|96-101|severe|drug
DDI-DrugBank.d143.s64|103-104|or|drug
DDI-DrugBank.d143.s64|106-114|prolonged|drug
DDI-DrugBank.d143.s64|116-123|diarrhea|drug
DDI-DrugBank.d143.s64|125-126|or|drug
DDI-DrugBank.d143.s64|128-129|in|drug
DDI-DrugBank.d143.s64|131-138|patients|drug
DDI-DrugBank.d143.s64|140-148|receiving|drug
DDI-DrugBank.d143.s64|150-160|concomitant|drug
DDI-DrugBank.d143.s64|162-170|diuretics|drug
DDI-DrugBank.d143.s64|171-171|.|drug
DDI-DrugBank.d263.s0|0-9|Zidovudine|drug
DDI-DrugBank.d263.s0|10-10|:|drug
DDI-DrugBank.d263.s0|12-16|There|drug
DDI-DrugBank.d263.s0|18-19|is|drug
DDI-DrugBank.d263.s0|21-22|no|drug
DDI-DrugBank.d263.s0|24-34|significant|drug
DDI-DrugBank.d263.s0|36-50|pharmacokinetic|drug
DDI-DrugBank.d263.s0|52-62|interaction|drug
DDI-DrugBank.d263.s0|64-70|between|drug
DDI-DrugBank.d263.s0|72-74|ZDV|drug
DDI-DrugBank.d263.s0|76-78|and|drug
DDI-DrugBank.d263.s0|80-90|zalcitabine|drug
DDI-DrugBank.d263.s0|92-96|which|drug
DDI-DrugBank.d263.s0|98-100|has|drug
DDI-DrugBank.d263.s0|102-105|been|drug
DDI-DrugBank.d263.s0|107-115|confirmed|drug
DDI-DrugBank.d263.s0|117-126|clinically|drug
DDI-DrugBank.d263.s0|127-127|.|drug
DDI-DrugBank.d263.s1|0-10|Zalcitabine|drug
DDI-DrugBank.d263.s1|12-15|also|drug
DDI-DrugBank.d263.s1|17-19|has|drug
DDI-DrugBank.d263.s1|21-22|no|drug
DDI-DrugBank.d263.s1|24-34|significant|drug
DDI-DrugBank.d263.s1|36-41|effect|drug
DDI-DrugBank.d263.s1|43-44|on|drug
DDI-DrugBank.d263.s1|46-48|the|drug
DDI-DrugBank.d263.s1|50-62|intracellular|drug
DDI-DrugBank.d263.s1|64-78|phosphorylation|drug
DDI-DrugBank.d263.s1|80-81|of|drug
DDI-DrugBank.d263.s1|83-85|ZDV|drug
DDI-DrugBank.d263.s1|86-86|,|drug
DDI-DrugBank.d263.s1|88-89|as|drug
DDI-DrugBank.d263.s1|91-95|shown|drug
DDI-DrugBank.d263.s1|97-98|in|drug
DDI-DrugBank.d263.s1|100-104|vitro|drug
DDI-DrugBank.d263.s1|106-107|in|drug
DDI-DrugBank.d263.s1|109-118|peripheral|drug
DDI-DrugBank.d263.s1|120-124|blood|drug
DDI-DrugBank.d263.s1|126-136|mononuclear|drug
DDI-DrugBank.d263.s1|138-142|cells|drug
DDI-DrugBank.d263.s1|144-145|or|drug
DDI-DrugBank.d263.s1|147-148|in|drug
DDI-DrugBank.d263.s1|150-152|two|drug
DDI-DrugBank.d263.s1|154-158|other|drug
DDI-DrugBank.d263.s1|160-163|cell|drug
DDI-DrugBank.d263.s1|165-169|lines|drug
DDI-DrugBank.d263.s1|171-171|(|drug
DDI-DrugBank.d263.s1|172-175|U937|drug
DDI-DrugBank.d263.s1|177-179|and|drug
DDI-DrugBank.d263.s1|181-186|Molt-4|drug
DDI-DrugBank.d263.s1|187-187|)|drug
DDI-DrugBank.d263.s1|188-188|.|drug
DDI-DrugBank.d263.s2|0-1|In|drug
DDI-DrugBank.d263.s2|3-5|the|drug
DDI-DrugBank.d263.s2|7-10|same|drug
DDI-DrugBank.d263.s2|12-16|study|drug
DDI-DrugBank.d263.s2|18-19|it|drug
DDI-DrugBank.d263.s2|21-23|was|drug
DDI-DrugBank.d263.s2|25-29|shown|drug
DDI-DrugBank.d263.s2|31-34|that|drug
DDI-DrugBank.d263.s2|36-45|didanosine|drug
DDI-DrugBank.d263.s2|47-49|and|drug
DDI-DrugBank.d263.s2|51-59|stavudine|drug
DDI-DrugBank.d263.s2|61-63|had|drug
DDI-DrugBank.d263.s2|65-66|no|drug
DDI-DrugBank.d263.s2|68-78|significant|drug
DDI-DrugBank.d263.s2|80-85|effect|drug
DDI-DrugBank.d263.s2|87-88|on|drug
DDI-DrugBank.d263.s2|90-92|the|drug
DDI-DrugBank.d263.s2|94-106|intracellular|drug
DDI-DrugBank.d263.s2|108-122|phosphorylation|drug
DDI-DrugBank.d263.s2|124-125|of|drug
DDI-DrugBank.d263.s2|127-137|zalcitabine|drug
DDI-DrugBank.d263.s2|139-140|in|drug
DDI-DrugBank.d263.s2|142-151|peripheral|drug
DDI-DrugBank.d263.s2|153-157|blood|drug
DDI-DrugBank.d263.s2|159-169|mononuclear|drug
DDI-DrugBank.d263.s2|171-175|cells|drug
DDI-DrugBank.d263.s2|176-176|.|drug
DDI-DrugBank.d263.s3|0-9|Lamivudine|drug
DDI-DrugBank.d263.s3|10-10|:|drug
DDI-DrugBank.d263.s3|12-13|In|drug
DDI-DrugBank.d263.s3|15-19|vitro|drug
DDI-DrugBank.d263.s3|21-27|studies|drug
DDI-DrugBank.d263.s3|29-30|in|drug
DDI-DrugBank.d263.s3|32-41|peripheral|drug
DDI-DrugBank.d263.s3|43-47|blood|drug
DDI-DrugBank.d263.s3|49-59|mononuclear|drug
DDI-DrugBank.d263.s3|61-65|cells|drug
DDI-DrugBank.d263.s3|66-66|,|drug
DDI-DrugBank.d263.s3|68-71|U937|drug
DDI-DrugBank.d263.s3|73-75|and|drug
DDI-DrugBank.d263.s3|77-82|Molt-4|drug
DDI-DrugBank.d263.s3|84-88|cells|drug
DDI-DrugBank.d263.s3|90-97|revealed|drug
DDI-DrugBank.d263.s3|99-102|that|drug
DDI-DrugBank.d263.s3|104-113|lamivudine|drug
DDI-DrugBank.d263.s3|115-127|significantly|drug
DDI-DrugBank.d263.s3|129-137|inhibited|drug
DDI-DrugBank.d263.s3|139-149|zalcitabine|drug
DDI-DrugBank.d263.s3|151-165|phosphorylation|drug
DDI-DrugBank.d263.s3|167-168|in|drug
DDI-DrugBank.d263.s3|170-170|a|drug
DDI-DrugBank.d263.s3|172-175|dose|drug
DDI-DrugBank.d263.s3|177-185|dependent|drug
DDI-DrugBank.d263.s3|187-192|manner|drug
DDI-DrugBank.d263.s3|193-193|.|drug
DDI-DrugBank.d263.s4|0-6|Effects|drug
DDI-DrugBank.d263.s4|8-11|were|drug
DDI-DrugBank.d263.s4|13-19|already|drug
DDI-DrugBank.d263.s4|21-24|seen|drug
DDI-DrugBank.d263.s4|26-29|with|drug
DDI-DrugBank.d263.s4|31-35|doses|drug
DDI-DrugBank.d263.s4|37-49|corresponding|drug
DDI-DrugBank.d263.s4|51-52|to|drug
DDI-DrugBank.d263.s4|54-61|relevant|drug
DDI-DrugBank.d263.s4|63-68|plasma|drug
DDI-DrugBank.d263.s4|70-75|levels|drug
DDI-DrugBank.d263.s4|77-78|in|drug
DDI-DrugBank.d263.s4|80-85|humans|drug
DDI-DrugBank.d263.s4|86-86|,|drug
DDI-DrugBank.d263.s4|88-90|and|drug
DDI-DrugBank.d263.s4|92-94|the|drug
DDI-DrugBank.d263.s4|96-108|intracellular|drug
DDI-DrugBank.d263.s4|110-124|phosphorylation|drug
DDI-DrugBank.d263.s4|126-127|of|drug
DDI-DrugBank.d263.s4|129-139|zalcitabine|drug
DDI-DrugBank.d263.s4|141-142|to|drug
DDI-DrugBank.d263.s4|144-146|its|drug
DDI-DrugBank.d263.s4|148-152|three|drug
DDI-DrugBank.d263.s4|154-164|metabolites|drug
DDI-DrugBank.d263.s4|166-166|(|drug
DDI-DrugBank.d263.s4|167-175|including|drug
DDI-DrugBank.d263.s4|177-179|the|drug
DDI-DrugBank.d263.s4|181-186|active|drug
DDI-DrugBank.d263.s4|188-198|zalcitabine|drug
DDI-DrugBank.d263.s4|200-211|triphosphate|drug
DDI-DrugBank.d263.s4|213-222|metabolite|drug
DDI-DrugBank.d263.s4|223-223|)|drug
DDI-DrugBank.d263.s4|225-227|was|drug
DDI-DrugBank.d263.s4|229-241|significantly|drug
DDI-DrugBank.d263.s4|243-251|inhibited|drug
DDI-DrugBank.d263.s4|252-252|.|drug
DDI-DrugBank.d263.s5|0-10|Zalcitabine|drug
DDI-DrugBank.d263.s5|12-20|inhibited|drug
DDI-DrugBank.d263.s5|22-31|lamivudine|drug
DDI-DrugBank.d263.s5|33-47|phosphorylation|drug
DDI-DrugBank.d263.s5|49-50|at|drug
DDI-DrugBank.d263.s5|52-55|high|drug
DDI-DrugBank.d263.s5|57-69|concentration|drug
DDI-DrugBank.d263.s5|71-76|ratios|drug
DDI-DrugBank.d263.s5|78-78|(|drug
DDI-DrugBank.d263.s5|79-80|10|drug
DDI-DrugBank.d263.s5|82-84|and|drug
DDI-DrugBank.d263.s5|86-88|100|drug
DDI-DrugBank.d263.s5|89-89|)|drug
DDI-DrugBank.d263.s5|90-90|;|drug
DDI-DrugBank.d263.s6|0-6|however|drug
DDI-DrugBank.d263.s6|7-7|,|drug
DDI-DrugBank.d263.s6|9-10|it|drug
DDI-DrugBank.d263.s6|12-13|is|drug
DDI-DrugBank.d263.s6|15-24|considered|drug
DDI-DrugBank.d263.s6|26-27|to|drug
DDI-DrugBank.d263.s6|29-30|be|drug
DDI-DrugBank.d263.s6|32-39|unlikely|drug
DDI-DrugBank.d263.s6|41-44|that|drug
DDI-DrugBank.d263.s6|46-49|this|drug
DDI-DrugBank.d263.s6|51-58|decrease|drug
DDI-DrugBank.d263.s6|60-61|of|drug
DDI-DrugBank.d263.s6|63-76|phosphorylated|drug
DDI-DrugBank.d263.s6|78-87|lamivudine|drug
DDI-DrugBank.d263.s6|89-101|concentration|drug
DDI-DrugBank.d263.s6|103-104|is|drug
DDI-DrugBank.d263.s6|106-107|of|drug
DDI-DrugBank.d263.s6|109-116|clinical|drug
DDI-DrugBank.d263.s6|118-129|significance|drug
DDI-DrugBank.d263.s6|130-130|,|drug
DDI-DrugBank.d263.s6|132-133|as|drug
DDI-DrugBank.d263.s6|135-144|lamivudine|drug
DDI-DrugBank.d263.s6|146-147|is|drug
DDI-DrugBank.d263.s6|149-149|a|drug
DDI-DrugBank.d263.s6|151-154|more|drug
DDI-DrugBank.d263.s6|156-164|efficient|drug
DDI-DrugBank.d263.s6|166-174|substrate|drug
DDI-DrugBank.d263.s6|176-178|for|drug
DDI-DrugBank.d263.s6|180-192|deoxycytidine|drug
DDI-DrugBank.d263.s6|194-199|kinase|drug
DDI-DrugBank.d263.s6|201-204|than|drug
DDI-DrugBank.d263.s6|206-216|zalcitabine|drug
DDI-DrugBank.d263.s6|217-217|.|drug
DDI-DrugBank.d263.s7|0-4|These|drug
DDI-DrugBank.d263.s7|6-7|in|drug
DDI-DrugBank.d263.s7|9-13|vitro|drug
DDI-DrugBank.d263.s7|15-21|studies|drug
DDI-DrugBank.d263.s7|23-29|suggest|drug
DDI-DrugBank.d263.s7|31-34|that|drug
DDI-DrugBank.d263.s7|36-46|concomitant|drug
DDI-DrugBank.d263.s7|48-61|administration|drug
DDI-DrugBank.d263.s7|63-64|of|drug
DDI-DrugBank.d263.s7|66-76|zalcitabine|drug
DDI-DrugBank.d263.s7|78-80|and|drug
DDI-DrugBank.d263.s7|82-91|lamivudine|drug
DDI-DrugBank.d263.s7|93-94|in|drug
DDI-DrugBank.d263.s7|96-101|humans|drug
DDI-DrugBank.d263.s7|103-105|may|drug
DDI-DrugBank.d263.s7|107-112|result|drug
DDI-DrugBank.d263.s7|114-115|in|drug
DDI-DrugBank.d263.s7|117-131|sub-therapeutic|drug
DDI-DrugBank.d263.s7|133-146|concentrations|drug
DDI-DrugBank.d263.s7|148-149|of|drug
DDI-DrugBank.d263.s7|151-156|active|drug
DDI-DrugBank.d263.s7|158-171|phosphorylated|drug
DDI-DrugBank.d263.s7|173-183|zalcitabine|drug
DDI-DrugBank.d263.s7|184-184|,|drug
DDI-DrugBank.d263.s7|186-190|which|drug
DDI-DrugBank.d263.s7|192-194|may|drug
DDI-DrugBank.d263.s7|196-199|lead|drug
DDI-DrugBank.d263.s7|201-202|to|drug
DDI-DrugBank.d263.s7|204-204|a|drug
DDI-DrugBank.d263.s7|206-214|decreased|drug
DDI-DrugBank.d263.s7|216-229|antiretroviral|drug
DDI-DrugBank.d263.s7|231-236|effect|drug
DDI-DrugBank.d263.s7|238-239|of|drug
DDI-DrugBank.d263.s7|241-251|zalcitabine|drug
DDI-DrugBank.d263.s7|252-252|.|drug
DDI-DrugBank.d263.s8|0-1|It|drug
DDI-DrugBank.d263.s8|3-4|is|drug
DDI-DrugBank.d263.s8|6-12|unknown|drug
DDI-DrugBank.d263.s8|14-16|how|drug
DDI-DrugBank.d263.s8|18-20|the|drug
DDI-DrugBank.d263.s8|22-27|effect|drug
DDI-DrugBank.d263.s8|29-32|seen|drug
DDI-DrugBank.d263.s8|34-35|in|drug
DDI-DrugBank.d263.s8|37-41|these|drug
DDI-DrugBank.d263.s8|43-44|in|drug
DDI-DrugBank.d263.s8|46-50|vitro|drug
DDI-DrugBank.d263.s8|52-58|studies|drug
DDI-DrugBank.d263.s8|60-69|translates|drug
DDI-DrugBank.d263.s8|71-74|into|drug
DDI-DrugBank.d263.s8|76-83|clinical|drug
DDI-DrugBank.d263.s8|85-96|consequences|drug
DDI-DrugBank.d263.s8|97-97|.|drug
DDI-DrugBank.d263.s9|0-10|Concomitant|drug
DDI-DrugBank.d263.s9|12-14|use|drug
DDI-DrugBank.d263.s9|16-17|of|drug
DDI-DrugBank.d263.s9|19-29|zalcitabine|drug
DDI-DrugBank.d263.s9|31-33|and|drug
DDI-DrugBank.d263.s9|35-44|lamivudine|drug
DDI-DrugBank.d263.s9|46-47|is|drug
DDI-DrugBank.d263.s9|49-51|not|drug
DDI-DrugBank.d263.s9|53-63|recommended|drug
DDI-DrugBank.d263.s9|64-64|.|drug
DDI-DrugBank.d263.s10|0-9|Saquinavir|drug
DDI-DrugBank.d263.s10|10-10|:|drug
DDI-DrugBank.d263.s10|12-14|The|drug
DDI-DrugBank.d263.s10|16-26|combination|drug
DDI-DrugBank.d263.s10|28-29|of|drug
DDI-DrugBank.d263.s10|31-35|HIVID|drug
DDI-DrugBank.d263.s10|36-36|,|drug
DDI-DrugBank.d263.s10|38-47|saquinavir|drug
DDI-DrugBank.d263.s10|48-48|,|drug
DDI-DrugBank.d263.s10|50-52|and|drug
DDI-DrugBank.d263.s10|54-56|ZDV|drug
DDI-DrugBank.d263.s10|58-60|has|drug
DDI-DrugBank.d263.s10|62-65|been|drug
DDI-DrugBank.d263.s10|67-73|studied|drug
DDI-DrugBank.d263.s10|75-75|(|drug
DDI-DrugBank.d263.s10|76-77|as|drug
DDI-DrugBank.d263.s10|79-84|triple|drug
DDI-DrugBank.d263.s10|86-96|combination|drug
DDI-DrugBank.d263.s10|97-97|)|drug
DDI-DrugBank.d263.s10|99-100|in|drug
DDI-DrugBank.d263.s10|102-107|adults|drug
DDI-DrugBank.d263.s10|108-108|.|drug
DDI-DrugBank.d263.s11|0-14|Pharmacokinetic|drug
DDI-DrugBank.d263.s11|16-19|data|drug
DDI-DrugBank.d263.s11|21-27|suggest|drug
DDI-DrugBank.d263.s11|29-32|that|drug
DDI-DrugBank.d263.s11|34-43|absorption|drug
DDI-DrugBank.d263.s11|44-44|,|drug
DDI-DrugBank.d263.s11|46-55|metabolism|drug
DDI-DrugBank.d263.s11|56-56|,|drug
DDI-DrugBank.d263.s11|58-60|and|drug
DDI-DrugBank.d263.s11|62-72|elimination|drug
DDI-DrugBank.d263.s11|74-75|of|drug
DDI-DrugBank.d263.s11|77-80|each|drug
DDI-DrugBank.d263.s11|82-83|of|drug
DDI-DrugBank.d263.s11|85-89|these|drug
DDI-DrugBank.d263.s11|91-95|drugs|drug
DDI-DrugBank.d263.s11|97-99|are|drug
DDI-DrugBank.d263.s11|101-109|unchanged|drug
DDI-DrugBank.d263.s11|111-114|when|drug
DDI-DrugBank.d263.s11|116-119|they|drug
DDI-DrugBank.d263.s11|121-123|are|drug
DDI-DrugBank.d263.s11|125-128|used|drug
DDI-DrugBank.d263.s11|130-137|together|drug
DDI-DrugBank.d263.s11|138-138|.|drug
DDI-DrugBank.d263.s12|0-4|Drugs|drug
DDI-DrugBank.d263.s12|6-15|Associated|drug
DDI-DrugBank.d263.s12|17-20|With|drug
DDI-DrugBank.d263.s12|22-31|Peripheral|drug
DDI-DrugBank.d263.s12|33-42|Neuropathy|drug
DDI-DrugBank.d263.s12|43-43|:|drug
DDI-DrugBank.d263.s12|45-47|The|drug
DDI-DrugBank.d263.s12|49-59|concomitant|drug
DDI-DrugBank.d263.s12|61-63|use|drug
DDI-DrugBank.d263.s12|65-66|of|drug
DDI-DrugBank.d263.s12|68-72|HIVID|drug
DDI-DrugBank.d263.s12|74-77|with|drug
DDI-DrugBank.d263.s12|79-83|drugs|drug
DDI-DrugBank.d263.s12|85-88|that|drug
DDI-DrugBank.d263.s12|90-93|have|drug
DDI-DrugBank.d263.s12|95-97|the|drug
DDI-DrugBank.d263.s12|99-107|potential|drug
DDI-DrugBank.d263.s12|109-110|to|drug
DDI-DrugBank.d263.s12|112-116|cause|drug
DDI-DrugBank.d263.s12|118-127|peripheral|drug
DDI-DrugBank.d263.s12|129-138|neuropathy|drug
DDI-DrugBank.d263.s12|140-145|should|drug
DDI-DrugBank.d263.s12|147-148|be|drug
DDI-DrugBank.d263.s12|150-156|avoided|drug
DDI-DrugBank.d263.s12|158-162|where|drug
DDI-DrugBank.d263.s12|164-171|possible|drug
DDI-DrugBank.d263.s12|172-172|.|drug
DDI-DrugBank.d263.s13|0-4|Drugs|drug
DDI-DrugBank.d263.s13|6-9|that|drug
DDI-DrugBank.d263.s13|11-14|have|drug
DDI-DrugBank.d263.s13|16-19|been|drug
DDI-DrugBank.d263.s13|21-30|associated|drug
DDI-DrugBank.d263.s13|32-35|with|drug
DDI-DrugBank.d263.s13|37-46|peripheral|drug
DDI-DrugBank.d263.s13|48-57|neuropathy|drug
DDI-DrugBank.d263.s13|59-65|include|drug
DDI-DrugBank.d263.s13|67-80|antiretroviral|drug
DDI-DrugBank.d263.s13|82-91|nucleoside|drug
DDI-DrugBank.d263.s13|93-101|analogues|drug
DDI-DrugBank.d263.s13|102-102|,|drug
DDI-DrugBank.d263.s13|104-118|chloramphenicol|drug
DDI-DrugBank.d263.s13|119-119|,|drug
DDI-DrugBank.d263.s13|121-129|cisplatin|drug
DDI-DrugBank.d263.s13|130-130|,|drug
DDI-DrugBank.d263.s13|132-138|dapsone|drug
DDI-DrugBank.d263.s13|139-139|,|drug
DDI-DrugBank.d263.s13|141-150|disulfiram|drug
DDI-DrugBank.d263.s13|151-151|,|drug
DDI-DrugBank.d263.s13|153-163|ethionamide|drug
DDI-DrugBank.d263.s13|164-164|,|drug
DDI-DrugBank.d263.s13|166-177|glutethimide|drug
DDI-DrugBank.d263.s13|178-178|,|drug
DDI-DrugBank.d263.s13|180-183|gold|drug
DDI-DrugBank.d263.s13|184-184|,|drug
DDI-DrugBank.d263.s13|186-196|hydralazine|drug
DDI-DrugBank.d263.s13|197-197|,|drug
DDI-DrugBank.d263.s13|199-208|iodoquinol|drug
DDI-DrugBank.d263.s13|209-209|,|drug
DDI-DrugBank.d263.s13|211-219|isoniazid|drug
DDI-DrugBank.d263.s13|220-220|,|drug
DDI-DrugBank.d263.s13|222-234|metronidazole|drug
DDI-DrugBank.d263.s13|235-235|,|drug
DDI-DrugBank.d263.s13|237-250|nitrofurantoin|drug
DDI-DrugBank.d263.s13|251-251|,|drug
DDI-DrugBank.d263.s13|253-261|phenytoin|drug
DDI-DrugBank.d263.s13|262-262|,|drug
DDI-DrugBank.d263.s13|264-272|ribavirin|drug
DDI-DrugBank.d263.s13|273-273|,|drug
DDI-DrugBank.d263.s13|275-277|and|drug
DDI-DrugBank.d263.s13|279-289|vincristine|drug
DDI-DrugBank.d263.s13|290-290|.|drug
DDI-DrugBank.d263.s14|0-10|Concomitant|drug
DDI-DrugBank.d263.s14|12-14|use|drug
DDI-DrugBank.d263.s14|16-17|of|drug
DDI-DrugBank.d263.s14|19-23|HIVID|drug
DDI-DrugBank.d263.s14|25-28|with|drug
DDI-DrugBank.d263.s14|30-39|didanosine|drug
DDI-DrugBank.d263.s14|41-42|is|drug
DDI-DrugBank.d263.s14|44-46|not|drug
DDI-DrugBank.d263.s14|48-58|recommended|drug
DDI-DrugBank.d263.s14|59-59|.|drug
DDI-DrugBank.d263.s15|0-10|Intravenous|drug
DDI-DrugBank.d263.s15|12-22|Pentamidine|drug
DDI-DrugBank.d263.s15|23-23|:|drug
DDI-DrugBank.d263.s15|25-33|Treatment|drug
DDI-DrugBank.d263.s15|35-38|with|drug
DDI-DrugBank.d263.s15|40-44|HIVID|drug
DDI-DrugBank.d263.s15|46-51|should|drug
DDI-DrugBank.d263.s15|53-54|be|drug
DDI-DrugBank.d263.s15|56-66|interrupted|drug
DDI-DrugBank.d263.s15|68-71|when|drug
DDI-DrugBank.d263.s15|73-75|the|drug
DDI-DrugBank.d263.s15|77-79|use|drug
DDI-DrugBank.d263.s15|81-82|of|drug
DDI-DrugBank.d263.s15|84-84|a|drug
DDI-DrugBank.d263.s15|86-89|drug|drug
DDI-DrugBank.d263.s15|91-94|that|drug
DDI-DrugBank.d263.s15|96-98|has|drug
DDI-DrugBank.d263.s15|100-102|the|drug
DDI-DrugBank.d263.s15|104-112|potential|drug
DDI-DrugBank.d263.s15|114-115|to|drug
DDI-DrugBank.d263.s15|117-121|cause|drug
DDI-DrugBank.d263.s15|123-134|pancreatitis|drug
DDI-DrugBank.d263.s15|136-137|is|drug
DDI-DrugBank.d263.s15|139-146|required|drug
DDI-DrugBank.d263.s15|147-147|.|drug
DDI-DrugBank.d263.s16|0-4|Death|drug
DDI-DrugBank.d263.s16|6-8|due|drug
DDI-DrugBank.d263.s16|10-11|to|drug
DDI-DrugBank.d263.s16|13-21|fulminant|drug
DDI-DrugBank.d263.s16|23-34|pancreatitis|drug
DDI-DrugBank.d263.s16|36-43|possibly|drug
DDI-DrugBank.d263.s16|45-51|related|drug
DDI-DrugBank.d263.s16|53-54|to|drug
DDI-DrugBank.d263.s16|56-66|intravenous|drug
DDI-DrugBank.d263.s16|68-78|pentamidine|drug
DDI-DrugBank.d263.s16|80-82|and|drug
DDI-DrugBank.d263.s16|84-88|HIVID|drug
DDI-DrugBank.d263.s16|90-92|has|drug
DDI-DrugBank.d263.s16|94-97|been|drug
DDI-DrugBank.d263.s16|99-106|reported|drug
DDI-DrugBank.d263.s16|107-107|.|drug
DDI-DrugBank.d263.s17|0-1|If|drug
DDI-DrugBank.d263.s17|3-13|intravenous|drug
DDI-DrugBank.d263.s17|15-25|pentamidine|drug
DDI-DrugBank.d263.s17|27-28|is|drug
DDI-DrugBank.d263.s17|30-37|required|drug
DDI-DrugBank.d263.s17|39-40|to|drug
DDI-DrugBank.d263.s17|42-46|treat|drug
DDI-DrugBank.d263.s17|48-59|Pneumocystis|drug
DDI-DrugBank.d263.s17|61-67|carinii|drug
DDI-DrugBank.d263.s17|69-77|pneumonia|drug
DDI-DrugBank.d263.s17|78-78|,|drug
DDI-DrugBank.d263.s17|80-88|treatment|drug
DDI-DrugBank.d263.s17|90-93|with|drug
DDI-DrugBank.d263.s17|95-99|HIVID|drug
DDI-DrugBank.d263.s17|101-106|should|drug
DDI-DrugBank.d263.s17|108-109|be|drug
DDI-DrugBank.d263.s17|111-121|interrupted|drug
DDI-DrugBank.d263.s17|122-122|.|drug
DDI-DrugBank.d263.s18|0-11|Amphotericin|drug
DDI-DrugBank.d263.s18|12-12|,|drug
DDI-DrugBank.d263.s18|14-22|Foscarnet|drug
DDI-DrugBank.d263.s18|23-23|,|drug
DDI-DrugBank.d263.s18|25-27|and|drug
DDI-DrugBank.d263.s18|29-43|Aminoglycosides|drug
DDI-DrugBank.d263.s18|44-44|:|drug
DDI-DrugBank.d263.s18|46-50|Drugs|drug
DDI-DrugBank.d263.s18|52-55|such|drug
DDI-DrugBank.d263.s18|57-58|as|drug
DDI-DrugBank.d263.s18|60-71|amphotericin|drug
DDI-DrugBank.d263.s18|72-72|,|drug
DDI-DrugBank.d263.s18|74-82|foscarnet|drug
DDI-DrugBank.d263.s18|83-83|,|drug
DDI-DrugBank.d263.s18|85-87|and|drug
DDI-DrugBank.d263.s18|89-103|aminoglycosides|drug
DDI-DrugBank.d263.s18|105-107|may|drug
DDI-DrugBank.d263.s18|109-116|increase|drug
DDI-DrugBank.d263.s18|118-120|the|drug
DDI-DrugBank.d263.s18|122-125|risk|drug
DDI-DrugBank.d263.s18|127-128|of|drug
DDI-DrugBank.d263.s18|130-139|developing|drug
DDI-DrugBank.d263.s18|141-150|peripheral|drug
DDI-DrugBank.d263.s18|152-161|neuropathy|drug
DDI-DrugBank.d263.s18|163-164|or|drug
DDI-DrugBank.d263.s18|166-170|other|drug
DDI-DrugBank.d263.s18|172-187|HIVID-associated|drug
DDI-DrugBank.d263.s18|189-195|adverse|drug
DDI-DrugBank.d263.s18|197-202|events|drug
DDI-DrugBank.d263.s18|204-205|by|drug
DDI-DrugBank.d263.s18|207-217|interfering|drug
DDI-DrugBank.d263.s18|219-222|with|drug
DDI-DrugBank.d263.s18|224-226|the|drug
DDI-DrugBank.d263.s18|228-232|renal|drug
DDI-DrugBank.d263.s18|234-242|clearance|drug
DDI-DrugBank.d263.s18|244-245|of|drug
DDI-DrugBank.d263.s18|247-257|zalcitabine|drug
DDI-DrugBank.d263.s18|259-259|(|drug
DDI-DrugBank.d263.s18|260-266|thereby|drug
DDI-DrugBank.d263.s18|268-274|raising|drug
DDI-DrugBank.d263.s18|276-283|systemic|drug
DDI-DrugBank.d263.s18|285-292|exposure|drug
DDI-DrugBank.d263.s18|293-293|)|drug
DDI-DrugBank.d263.s18|294-294|.|drug
DDI-DrugBank.d263.s19|0-7|Patients|drug
DDI-DrugBank.d263.s19|9-11|who|drug
DDI-DrugBank.d263.s19|13-19|require|drug
DDI-DrugBank.d263.s19|21-23|the|drug
DDI-DrugBank.d263.s19|25-27|use|drug
DDI-DrugBank.d263.s19|29-30|of|drug
DDI-DrugBank.d263.s19|32-34|one|drug
DDI-DrugBank.d263.s19|36-37|of|drug
DDI-DrugBank.d263.s19|39-43|these|drug
DDI-DrugBank.d263.s19|45-49|drugs|drug
DDI-DrugBank.d263.s19|51-54|with|drug
DDI-DrugBank.d263.s19|56-60|HIVID|drug
DDI-DrugBank.d263.s19|62-67|should|drug
DDI-DrugBank.d263.s19|69-72|have|drug
DDI-DrugBank.d263.s19|74-81|frequent|drug
DDI-DrugBank.d263.s19|83-90|clinical|drug
DDI-DrugBank.d263.s19|92-94|and|drug
DDI-DrugBank.d263.s19|96-105|laboratory|drug
DDI-DrugBank.d263.s19|107-116|monitoring|drug
DDI-DrugBank.d263.s19|118-121|with|drug
DDI-DrugBank.d263.s19|123-128|dosage|drug
DDI-DrugBank.d263.s19|130-139|adjustment|drug
DDI-DrugBank.d263.s19|141-143|for|drug
DDI-DrugBank.d263.s19|145-147|any|drug
DDI-DrugBank.d263.s19|149-159|significant|drug
DDI-DrugBank.d263.s19|161-166|change|drug
DDI-DrugBank.d263.s19|168-169|in|drug
DDI-DrugBank.d263.s19|171-175|renal|drug
DDI-DrugBank.d263.s19|177-184|function|drug
DDI-DrugBank.d263.s19|185-185|.|drug
DDI-DrugBank.d263.s20|0-9|Probenecid|drug
DDI-DrugBank.d263.s20|11-12|or|drug
DDI-DrugBank.d263.s20|14-23|Cimetidine|drug
DDI-DrugBank.d263.s20|24-24|:|drug
DDI-DrugBank.d263.s20|26-36|Concomitant|drug
DDI-DrugBank.d263.s20|38-51|administration|drug
DDI-DrugBank.d263.s20|53-54|of|drug
DDI-DrugBank.d263.s20|56-65|probenecid|drug
DDI-DrugBank.d263.s20|67-68|or|drug
DDI-DrugBank.d263.s20|70-79|cimetidine|drug
DDI-DrugBank.d263.s20|81-89|decreases|drug
DDI-DrugBank.d263.s20|91-93|the|drug
DDI-DrugBank.d263.s20|95-105|elimination|drug
DDI-DrugBank.d263.s20|107-108|of|drug
DDI-DrugBank.d263.s20|110-120|zalcitabine|drug
DDI-DrugBank.d263.s20|121-121|,|drug
DDI-DrugBank.d263.s20|123-126|most|drug
DDI-DrugBank.d263.s20|128-133|likely|drug
DDI-DrugBank.d263.s20|135-136|by|drug
DDI-DrugBank.d263.s20|138-147|inhibition|drug
DDI-DrugBank.d263.s20|149-150|of|drug
DDI-DrugBank.d263.s20|152-156|renal|drug
DDI-DrugBank.d263.s20|158-164|tubular|drug
DDI-DrugBank.d263.s20|166-174|secretion|drug
DDI-DrugBank.d263.s20|176-177|of|drug
DDI-DrugBank.d263.s20|179-189|zalcitabine|drug
DDI-DrugBank.d263.s20|190-190|.|drug
DDI-DrugBank.d263.s21|0-7|Patients|drug
DDI-DrugBank.d263.s21|9-17|receiving|drug
DDI-DrugBank.d263.s21|19-23|these|drug
DDI-DrugBank.d263.s21|25-29|drugs|drug
DDI-DrugBank.d263.s21|31-32|in|drug
DDI-DrugBank.d263.s21|34-44|combination|drug
DDI-DrugBank.d263.s21|46-49|with|drug
DDI-DrugBank.d263.s21|51-61|zalcitabine|drug
DDI-DrugBank.d263.s21|63-68|should|drug
DDI-DrugBank.d263.s21|70-71|be|drug
DDI-DrugBank.d263.s21|73-81|monitored|drug
DDI-DrugBank.d263.s21|83-85|for|drug
DDI-DrugBank.d263.s21|87-91|signs|drug
DDI-DrugBank.d263.s21|93-94|of|drug
DDI-DrugBank.d263.s21|96-103|toxicity|drug
DDI-DrugBank.d263.s21|105-107|and|drug
DDI-DrugBank.d263.s21|109-111|the|drug
DDI-DrugBank.d263.s21|113-116|dose|drug
DDI-DrugBank.d263.s21|118-119|of|drug
DDI-DrugBank.d263.s21|121-131|zalcitabine|drug
DDI-DrugBank.d263.s21|133-139|reduced|drug
DDI-DrugBank.d263.s21|141-142|if|drug
DDI-DrugBank.d263.s21|144-152|warranted|drug
DDI-DrugBank.d263.s21|153-153|.|drug
DDI-DrugBank.d263.s22|0-28|Magnesium/Aluminum-containing|drug
DDI-DrugBank.d263.s22|30-36|Antacid|drug
DDI-DrugBank.d263.s22|38-45|Products|drug
DDI-DrugBank.d263.s22|46-46|:|drug
DDI-DrugBank.d263.s22|48-57|Absorption|drug
DDI-DrugBank.d263.s22|59-60|of|drug
DDI-DrugBank.d263.s22|62-72|zalcitabine|drug
DDI-DrugBank.d263.s22|74-75|is|drug
DDI-DrugBank.d263.s22|77-86|moderately|drug
DDI-DrugBank.d263.s22|88-94|reduced|drug
DDI-DrugBank.d263.s22|96-96|(|drug
DDI-DrugBank.d263.s22|97-109|approximately|drug
DDI-DrugBank.d263.s22|111-112|25|drug
DDI-DrugBank.d263.s22|113-113|%|drug
DDI-DrugBank.d263.s22|114-114|)|drug
DDI-DrugBank.d263.s22|116-119|when|drug
DDI-DrugBank.d263.s22|121-134|coadministered|drug
DDI-DrugBank.d263.s22|136-139|with|drug
DDI-DrugBank.d263.s22|141-169|magnesium/aluminum-containing|drug
DDI-DrugBank.d263.s22|171-177|antacid|drug
DDI-DrugBank.d263.s22|179-186|products|drug
DDI-DrugBank.d263.s22|187-187|.|drug
DDI-DrugBank.d263.s23|0-2|The|drug
DDI-DrugBank.d263.s23|4-11|clinical|drug
DDI-DrugBank.d263.s23|13-24|significance|drug
DDI-DrugBank.d263.s23|26-27|of|drug
DDI-DrugBank.d263.s23|29-32|this|drug
DDI-DrugBank.d263.s23|34-42|reduction|drug
DDI-DrugBank.d263.s23|44-45|is|drug
DDI-DrugBank.d263.s23|47-49|not|drug
DDI-DrugBank.d263.s23|51-55|known|drug
DDI-DrugBank.d263.s23|56-56|,|drug
DDI-DrugBank.d263.s23|58-62|hence|drug
DDI-DrugBank.d263.s23|64-74|zalcitabine|drug
DDI-DrugBank.d263.s23|76-77|is|drug
DDI-DrugBank.d263.s23|79-81|not|drug
DDI-DrugBank.d263.s23|83-93|recommended|drug
DDI-DrugBank.d263.s23|95-96|to|drug
DDI-DrugBank.d263.s23|98-99|be|drug
DDI-DrugBank.d263.s23|101-108|ingested|drug
DDI-DrugBank.d263.s23|110-123|simultaneously|drug
DDI-DrugBank.d263.s23|125-128|with|drug
DDI-DrugBank.d263.s23|130-158|magnesium/aluminum-containing|drug
DDI-DrugBank.d263.s23|160-167|antacids|drug
DDI-DrugBank.d263.s23|168-168|.|drug
DDI-DrugBank.d263.s24|0-13|Metoclopramide|drug
DDI-DrugBank.d263.s24|14-14|:|drug
DDI-DrugBank.d263.s24|16-30|Bioavailability|drug
DDI-DrugBank.d263.s24|32-33|is|drug
DDI-DrugBank.d263.s24|35-40|mildly|drug
DDI-DrugBank.d263.s24|42-48|reduced|drug
DDI-DrugBank.d263.s24|50-50|(|drug
DDI-DrugBank.d263.s24|51-63|approximately|drug
DDI-DrugBank.d263.s24|65-66|10|drug
DDI-DrugBank.d263.s24|67-67|%|drug
DDI-DrugBank.d263.s24|68-68|)|drug
DDI-DrugBank.d263.s24|70-73|when|drug
DDI-DrugBank.d263.s24|75-85|zalcitabine|drug
DDI-DrugBank.d263.s24|87-89|and|drug
DDI-DrugBank.d263.s24|91-104|metoclopramide|drug
DDI-DrugBank.d263.s24|106-108|are|drug
DDI-DrugBank.d263.s24|110-123|coadministered|drug
DDI-DrugBank.d263.s24|124-124|.|drug
DDI-DrugBank.d263.s25|0-10|Doxorubicin|drug
DDI-DrugBank.d263.s25|11-11|:|drug
DDI-DrugBank.d263.s25|13-23|Doxorubicin|drug
DDI-DrugBank.d263.s25|25-30|caused|drug
DDI-DrugBank.d263.s25|32-32|a|drug
DDI-DrugBank.d263.s25|34-41|decrease|drug
DDI-DrugBank.d263.s25|43-44|in|drug
DDI-DrugBank.d263.s25|46-56|zalcitabine|drug
DDI-DrugBank.d263.s25|58-72|phosphorylation|drug
DDI-DrugBank.d263.s25|74-74|(|drug
DDI-DrugBank.d263.s25|76-77|50|drug
DDI-DrugBank.d263.s25|78-78|%|drug
DDI-DrugBank.d263.s25|80-89|inhibition|drug
DDI-DrugBank.d263.s25|91-92|of|drug
DDI-DrugBank.d263.s25|94-98|total|drug
DDI-DrugBank.d263.s25|100-108|phosphate|drug
DDI-DrugBank.d263.s25|110-118|formation|drug
DDI-DrugBank.d263.s25|119-119|)|drug
DDI-DrugBank.d263.s25|121-122|in|drug
DDI-DrugBank.d263.s25|124-132|U937/Molt|drug
DDI-DrugBank.d263.s25|134-134|4|drug
DDI-DrugBank.d263.s25|136-140|cells|drug
DDI-DrugBank.d263.s25|141-141|.|drug
DDI-DrugBank.d263.s26|0-7|Although|drug
DDI-DrugBank.d263.s26|9-13|there|drug
DDI-DrugBank.d263.s26|15-17|may|drug
DDI-DrugBank.d263.s26|19-20|be|drug
DDI-DrugBank.d263.s26|22-30|decreased|drug
DDI-DrugBank.d263.s26|32-42|zalcitabine|drug
DDI-DrugBank.d263.s26|44-51|activity|drug
DDI-DrugBank.d263.s26|53-59|because|drug
DDI-DrugBank.d263.s26|61-62|of|drug
DDI-DrugBank.d263.s26|64-71|lessened|drug
DDI-DrugBank.d263.s26|73-78|active|drug
DDI-DrugBank.d263.s26|80-89|metabolite|drug
DDI-DrugBank.d263.s26|91-99|formation|drug
DDI-DrugBank.d263.s26|100-100|,|drug
DDI-DrugBank.d263.s26|102-104|the|drug
DDI-DrugBank.d263.s26|106-113|clinical|drug
DDI-DrugBank.d263.s26|115-123|relevance|drug
DDI-DrugBank.d263.s26|125-126|of|drug
DDI-DrugBank.d263.s26|128-132|these|drug
DDI-DrugBank.d263.s26|134-135|in|drug
DDI-DrugBank.d263.s26|137-141|vitro|drug
DDI-DrugBank.d263.s26|143-149|results|drug
DDI-DrugBank.d263.s26|151-153|are|drug
DDI-DrugBank.d263.s26|155-157|not|drug
DDI-DrugBank.d263.s26|159-163|known|drug
DDI-DrugBank.d263.s26|164-164|.|drug
DDI-DrugBank.d488.s0|0-3|Drug|drug
DDI-DrugBank.d488.s0|5-16|Interactions|drug
DDI-DrugBank.d488.s0|17-17|:|drug
DDI-DrugBank.d488.s0|19-20|a|drug
DDI-DrugBank.d488.s0|22-26|.|drug
DDI-DrugBank.d488.s0|28-36|Drugs|drug
DDI-DrugBank.d488.s0|38-44|Enhancing|drug
DDI-DrugBank.d488.s0|46-51|Heparin|drug
DDI-DrugBank.d488.s0|52-52|Effect|drug
DDI-DrugBank.d488.s0|54-57|:|drug
DDI-DrugBank.d488.s0|59-72|Oral|drug
DDI-DrugBank.d488.s0|73-73|anticoagulants|drug
DDI-DrugBank.d488.s0|75-81|:|drug
DDI-DrugBank.d488.s0|83-88|Heparin|drug
DDI-DrugBank.d488.s0|90-92|sodium|drug
DDI-DrugBank.d488.s0|94-100|may|drug
DDI-DrugBank.d488.s0|102-104|prolong|drug
DDI-DrugBank.d488.s0|106-114|the|drug
DDI-DrugBank.d488.s0|116-126|one-stage|drug
DDI-DrugBank.d488.s0|128-131|prothrombin|drug
DDI-DrugBank.d488.s0|132-132|time|drug
DDI-DrugBank.d488.s1|0-8|Therefore|drug
DDI-DrugBank.d488.s1|9-9|,|drug
DDI-DrugBank.d488.s1|11-14|when|drug
DDI-DrugBank.d488.s1|16-22|heparin|drug
DDI-DrugBank.d488.s1|24-29|sodium|drug
DDI-DrugBank.d488.s1|31-32|is|drug
DDI-DrugBank.d488.s1|34-38|given|drug
DDI-DrugBank.d488.s1|40-43|with|drug
DDI-DrugBank.d488.s1|45-53|dicumarol|drug
DDI-DrugBank.d488.s1|55-56|or|drug
DDI-DrugBank.d488.s1|58-65|warfarin|drug
DDI-DrugBank.d488.s1|67-72|sodium|drug
DDI-DrugBank.d488.s1|73-73|,|drug
DDI-DrugBank.d488.s1|75-75|a|drug
DDI-DrugBank.d488.s1|77-82|period|drug
DDI-DrugBank.d488.s1|84-85|of|drug
DDI-DrugBank.d488.s1|87-88|at|drug
DDI-DrugBank.d488.s1|90-94|least|drug
DDI-DrugBank.d488.s1|96-96|5|drug
DDI-DrugBank.d488.s1|98-102|hours|drug
DDI-DrugBank.d488.s1|104-108|after|drug
DDI-DrugBank.d488.s1|110-112|the|drug
DDI-DrugBank.d488.s1|114-117|last|drug
DDI-DrugBank.d488.s1|119-129|intravenous|drug
DDI-DrugBank.d488.s1|131-134|dose|drug
DDI-DrugBank.d488.s1|136-137|or|drug
DDI-DrugBank.d488.s1|139-140|24|drug
DDI-DrugBank.d488.s1|142-146|hours|drug
DDI-DrugBank.d488.s1|148-152|after|drug
DDI-DrugBank.d488.s1|154-156|the|drug
DDI-DrugBank.d488.s1|158-161|last|drug
DDI-DrugBank.d488.s1|163-174|subcutaneous|drug
DDI-DrugBank.d488.s1|176-179|dose|drug
DDI-DrugBank.d488.s1|181-186|should|drug
DDI-DrugBank.d488.s1|188-193|elapse|drug
DDI-DrugBank.d488.s1|195-200|before|drug
DDI-DrugBank.d488.s1|202-206|blood|drug
DDI-DrugBank.d488.s1|208-209|is|drug
DDI-DrugBank.d488.s1|211-215|drawn|drug
DDI-DrugBank.d488.s1|217-218|if|drug
DDI-DrugBank.d488.s1|220-220|a|drug
DDI-DrugBank.d488.s1|222-226|valid|drug
DDI-DrugBank.d488.s1|228-238|prothrombin|drug
DDI-DrugBank.d488.s1|240-243|time|drug
DDI-DrugBank.d488.s1|245-246|is|drug
DDI-DrugBank.d488.s1|248-249|to|drug
DDI-DrugBank.d488.s1|251-252|be|drug
DDI-DrugBank.d488.s1|254-261|obtained|drug
DDI-DrugBank.d488.s1|262-262|.|drug
DDI-DrugBank.d488.s2|0-7|Platelet|drug
DDI-DrugBank.d488.s2|9-18|inhibitors|drug
DDI-DrugBank.d488.s2|19-19|:|drug
DDI-DrugBank.d488.s2|21-25|Drugs|drug
DDI-DrugBank.d488.s2|27-30|such|drug
DDI-DrugBank.d488.s2|32-33|as|drug
DDI-DrugBank.d488.s2|35-49|acetylsalicylic|drug
DDI-DrugBank.d488.s2|51-54|acid|drug
DDI-DrugBank.d488.s2|55-55|,|drug
DDI-DrugBank.d488.s2|57-63|dextran|drug
DDI-DrugBank.d488.s2|64-64|,|drug
DDI-DrugBank.d488.s2|66-79|phenylbutazone|drug
DDI-DrugBank.d488.s2|80-80|,|drug
DDI-DrugBank.d488.s2|82-90|ibuprofen|drug
DDI-DrugBank.d488.s2|91-91|,|drug
DDI-DrugBank.d488.s2|93-104|indomethacin|drug
DDI-DrugBank.d488.s2|105-105|,|drug
DDI-DrugBank.d488.s2|107-118|dipyridamole|drug
DDI-DrugBank.d488.s2|119-119|,|drug
DDI-DrugBank.d488.s2|121-138|hydroxychloroquine|drug
DDI-DrugBank.d488.s2|140-142|and|drug
DDI-DrugBank.d488.s2|144-149|others|drug
DDI-DrugBank.d488.s2|151-154|that|drug
DDI-DrugBank.d488.s2|156-164|interfere|drug
DDI-DrugBank.d488.s2|166-169|with|drug
DDI-DrugBank.d488.s2|171-190|platelet-aggregation|drug
DDI-DrugBank.d488.s2|192-200|reactions|drug
DDI-DrugBank.d488.s2|202-202|(|drug
DDI-DrugBank.d488.s2|203-205|the|drug
DDI-DrugBank.d488.s2|207-210|main|drug
DDI-DrugBank.d488.s2|212-221|hemostatic|drug
DDI-DrugBank.d488.s2|223-229|defense|drug
DDI-DrugBank.d488.s2|231-232|of|drug
DDI-DrugBank.d488.s2|234-244|heparinized|drug
DDI-DrugBank.d488.s2|246-253|patients|drug
DDI-DrugBank.d488.s2|254-254|)|drug
DDI-DrugBank.d488.s2|256-258|may|drug
DDI-DrugBank.d488.s2|260-265|induce|drug
DDI-DrugBank.d488.s2|267-274|bleeding|drug
DDI-DrugBank.d488.s2|276-278|and|drug
DDI-DrugBank.d488.s2|280-285|should|drug
DDI-DrugBank.d488.s2|287-288|be|drug
DDI-DrugBank.d488.s2|290-293|used|drug
DDI-DrugBank.d488.s2|295-298|with|drug
DDI-DrugBank.d488.s2|300-306|caution|drug
DDI-DrugBank.d488.s2|308-309|in|drug
DDI-DrugBank.d488.s2|311-318|patients|drug
DDI-DrugBank.d488.s2|320-328|receiving|drug
DDI-DrugBank.d488.s2|330-336|heparin|drug
DDI-DrugBank.d488.s2|338-343|sodium|drug
DDI-DrugBank.d488.s2|344-344|.|drug
DDI-DrugBank.d488.s3|0-2|The|drug
DDI-DrugBank.d488.s3|4-16|anticoagulant|drug
DDI-DrugBank.d488.s3|18-23|effect|drug
DDI-DrugBank.d488.s3|25-26|of|drug
DDI-DrugBank.d488.s3|28-34|heparin|drug
DDI-DrugBank.d488.s3|36-37|is|drug
DDI-DrugBank.d488.s3|39-46|enhanced|drug
DDI-DrugBank.d488.s3|48-49|by|drug
DDI-DrugBank.d488.s3|51-60|concurrent|drug
DDI-DrugBank.d488.s3|62-70|treatment|drug
DDI-DrugBank.d488.s3|72-75|with|drug
DDI-DrugBank.d488.s3|77-88|antithrombin|drug
DDI-DrugBank.d488.s3|90-92|III|drug
DDI-DrugBank.d488.s3|94-94|(|drug
DDI-DrugBank.d488.s3|95-99|human|drug
DDI-DrugBank.d488.s3|100-100|)|drug
DDI-DrugBank.d488.s3|102-103|in|drug
DDI-DrugBank.d488.s3|105-112|patients|drug
DDI-DrugBank.d488.s3|114-117|with|drug
DDI-DrugBank.d488.s3|119-128|hereditary|drug
DDI-DrugBank.d488.s3|130-141|antithrombin|drug
DDI-DrugBank.d488.s3|143-145|III|drug
DDI-DrugBank.d488.s3|147-156|deficiency|drug
DDI-DrugBank.d488.s3|157-157|.|drug
DDI-DrugBank.d488.s4|0-3|Thus|drug
DDI-DrugBank.d488.s4|5-6|in|drug
DDI-DrugBank.d488.s4|8-12|order|drug
DDI-DrugBank.d488.s4|14-15|to|drug
DDI-DrugBank.d488.s4|17-21|avoid|drug
DDI-DrugBank.d488.s4|23-30|bleeding|drug
DDI-DrugBank.d488.s4|31-31|,|drug
DDI-DrugBank.d488.s4|33-39|reduced|drug
DDI-DrugBank.d488.s4|41-46|dosage|drug
DDI-DrugBank.d488.s4|48-49|of|drug
DDI-DrugBank.d488.s4|51-57|heparin|drug
DDI-DrugBank.d488.s4|59-60|is|drug
DDI-DrugBank.d488.s4|62-72|recommended|drug
DDI-DrugBank.d488.s4|74-79|during|drug
DDI-DrugBank.d488.s4|81-89|treatment|drug
DDI-DrugBank.d488.s4|91-94|with|drug
DDI-DrugBank.d488.s4|96-107|antithrombin|drug
DDI-DrugBank.d488.s4|109-111|III|drug
DDI-DrugBank.d488.s4|113-113|(|drug
DDI-DrugBank.d488.s4|114-118|human|drug
DDI-DrugBank.d488.s4|119-119|)|drug
DDI-DrugBank.d488.s4|120-120|.|drug
DDI-DrugBank.d488.s5|0-0|b|drug
DDI-DrugBank.d488.s5|1-1|.|drug
DDI-DrugBank.d488.s6|0-4|Drugs|drug
DDI-DrugBank.d488.s6|6-15|Decreasing|drug
DDI-DrugBank.d488.s6|17-23|Heparin|drug
DDI-DrugBank.d488.s6|25-30|Effect|drug
DDI-DrugBank.d488.s6|31-31|:|drug
DDI-DrugBank.d488.s6|33-41|Digitalis|drug
DDI-DrugBank.d488.s6|42-42|,|drug
DDI-DrugBank.d488.s6|44-56|tetracyclines|drug
DDI-DrugBank.d488.s6|57-57|,|drug
DDI-DrugBank.d488.s6|59-66|nicotine|drug
DDI-DrugBank.d488.s6|67-67|,|drug
DDI-DrugBank.d488.s6|69-70|or|drug
DDI-DrugBank.d488.s6|72-85|antihistamines|drug
DDI-DrugBank.d488.s6|87-89|may|drug
DDI-DrugBank.d488.s6|91-99|partially|drug
DDI-DrugBank.d488.s6|101-110|counteract|drug
DDI-DrugBank.d488.s6|112-114|the|drug
DDI-DrugBank.d488.s6|116-128|anticoagulant|drug
DDI-DrugBank.d488.s6|130-135|action|drug
DDI-DrugBank.d488.s6|137-138|of|drug
DDI-DrugBank.d488.s6|140-146|heparin|drug
DDI-DrugBank.d488.s6|148-153|sodium|drug
DDI-DrugBank.d488.s6|154-154|.|drug
DDI-DrugBank.d488.s7|0-6|Heparin|drug
DDI-DrugBank.d488.s7|8-13|Sodium|drug
DDI-DrugBank.d488.s7|15-23|Injection|drug
DDI-DrugBank.d488.s7|25-30|should|drug
DDI-DrugBank.d488.s7|32-34|not|drug
DDI-DrugBank.d488.s7|36-37|be|drug
DDI-DrugBank.d488.s7|39-43|mixed|drug
DDI-DrugBank.d488.s7|45-48|with|drug
DDI-DrugBank.d488.s7|50-60|doxorubicin|drug
DDI-DrugBank.d488.s7|61-61|,|drug
DDI-DrugBank.d488.s7|63-72|droperidol|drug
DDI-DrugBank.d488.s7|73-73|,|drug
DDI-DrugBank.d488.s7|75-87|ciprofloxacin|drug
DDI-DrugBank.d488.s7|88-88|,|drug
DDI-DrugBank.d488.s7|90-91|or|drug
DDI-DrugBank.d488.s7|93-104|mitoxantrone|drug
DDI-DrugBank.d488.s7|105-105|,|drug
DDI-DrugBank.d488.s7|107-111|since|drug
DDI-DrugBank.d488.s7|113-114|it|drug
DDI-DrugBank.d488.s7|116-118|has|drug
DDI-DrugBank.d488.s7|120-123|been|drug
DDI-DrugBank.d488.s7|125-132|reported|drug
DDI-DrugBank.d488.s7|134-137|that|drug
DDI-DrugBank.d488.s7|139-143|these|drug
DDI-DrugBank.d488.s7|145-149|drugs|drug
DDI-DrugBank.d488.s7|151-153|are|drug
DDI-DrugBank.d488.s7|155-166|incompatible|drug
DDI-DrugBank.d488.s7|168-171|with|drug
DDI-DrugBank.d488.s7|173-179|heparin|drug
DDI-DrugBank.d488.s7|181-183|and|drug
DDI-DrugBank.d488.s7|185-185|a|drug
DDI-DrugBank.d488.s7|187-197|precipitate|drug
DDI-DrugBank.d488.s7|199-201|may|drug
DDI-DrugBank.d488.s7|203-206|form|drug
DDI-DrugBank.d488.s7|207-207|.|drug
DDI-DrugBank.d488.s8|0-4|Drug/|drug
DDI-DrugBank.d488.s8|6-15|Laboratory|drug
DDI-DrugBank.d488.s8|17-21|Tests|drug
DDI-DrugBank.d488.s8|23-34|Interactions|drug
DDI-DrugBank.d488.s8|36-59|Hyperaminotransferasemia|drug
DDI-DrugBank.d488.s8|60-60|:|drug
DDI-DrugBank.d488.s8|62-72|Significant|drug
DDI-DrugBank.d488.s8|74-83|elevations|drug
DDI-DrugBank.d488.s8|85-86|of|drug
DDI-DrugBank.d488.s8|88-103|aminotransferase|drug
DDI-DrugBank.d488.s8|105-105|(|drug
DDI-DrugBank.d488.s8|106-109|SGOT|drug
DDI-DrugBank.d488.s8|111-111|[|drug
DDI-DrugBank.d488.s8|112-116|S-AST|drug
DDI-DrugBank.d488.s8|117-117|]|drug
DDI-DrugBank.d488.s8|119-121|and|drug
DDI-DrugBank.d488.s8|123-126|SGPT|drug
DDI-DrugBank.d488.s8|128-128|[|drug
DDI-DrugBank.d488.s8|129-133|S-ALT|drug
DDI-DrugBank.d488.s8|134-134|]|drug
DDI-DrugBank.d488.s8|135-135|)|drug
DDI-DrugBank.d488.s8|137-142|levels|drug
DDI-DrugBank.d488.s8|144-147|have|drug
DDI-DrugBank.d488.s8|149-156|occurred|drug
DDI-DrugBank.d488.s8|158-159|in|drug
DDI-DrugBank.d488.s8|161-161|a|drug
DDI-DrugBank.d488.s8|163-166|high|drug
DDI-DrugBank.d488.s8|168-177|percentage|drug
DDI-DrugBank.d488.s8|179-180|of|drug
DDI-DrugBank.d488.s8|182-189|patients|drug
DDI-DrugBank.d488.s8|191-191|(|drug
DDI-DrugBank.d488.s8|192-194|and|drug
DDI-DrugBank.d488.s8|196-202|healthy|drug
DDI-DrugBank.d488.s8|204-211|subjects|drug
DDI-DrugBank.d488.s8|212-212|)|drug
DDI-DrugBank.d488.s8|214-216|who|drug
DDI-DrugBank.d488.s8|218-221|have|drug
DDI-DrugBank.d488.s8|223-230|received|drug
DDI-DrugBank.d488.s8|232-238|heparin|drug
DDI-DrugBank.d488.s8|240-245|sodium|drug
DDI-DrugBank.d488.s8|246-246|.|drug
DDI-DrugBank.d488.s9|0-4|Since|drug
DDI-DrugBank.d488.s9|6-21|aminotransferase|drug
DDI-DrugBank.d488.s9|23-36|determinations|drug
DDI-DrugBank.d488.s9|38-40|are|drug
DDI-DrugBank.d488.s9|42-50|important|drug
DDI-DrugBank.d488.s9|52-53|in|drug
DDI-DrugBank.d488.s9|55-57|the|drug
DDI-DrugBank.d488.s9|59-70|differential|drug
DDI-DrugBank.d488.s9|72-80|diagnosis|drug
DDI-DrugBank.d488.s9|82-83|of|drug
DDI-DrugBank.d488.s9|85-94|myocardial|drug
DDI-DrugBank.d488.s9|96-105|infarction|drug
DDI-DrugBank.d488.s9|106-106|,|drug
DDI-DrugBank.d488.s9|108-112|liver|drug
DDI-DrugBank.d488.s9|114-120|disease|drug
DDI-DrugBank.d488.s9|122-124|and|drug
DDI-DrugBank.d488.s9|126-134|pulmonary|drug
DDI-DrugBank.d488.s9|136-141|emboli|drug
DDI-DrugBank.d488.s9|142-142|,|drug
DDI-DrugBank.d488.s9|144-148|rises|drug
DDI-DrugBank.d488.s9|150-153|that|drug
DDI-DrugBank.d488.s9|155-159|might|drug
DDI-DrugBank.d488.s9|161-162|be|drug
DDI-DrugBank.d488.s9|164-169|caused|drug
DDI-DrugBank.d488.s9|171-172|by|drug
DDI-DrugBank.d488.s9|174-178|drugs|drug
DDI-DrugBank.d488.s9|180-180|(|drug
DDI-DrugBank.d488.s9|181-187|heparin|drug
DDI-DrugBank.d488.s9|189-194|sodium|drug
DDI-DrugBank.d488.s9|195-195|)|drug
DDI-DrugBank.d488.s9|197-202|should|drug
DDI-DrugBank.d488.s9|204-205|be|drug
DDI-DrugBank.d488.s9|207-217|interpreted|drug
DDI-DrugBank.d488.s9|219-222|with|drug
DDI-DrugBank.d488.s9|224-230|caution|drug
DDI-DrugBank.d488.s9|231-231|.|drug
DDI-DrugBank.d758.s0|0-2|The|drug
DDI-DrugBank.d758.s0|4-6|CNS|drug
DDI-DrugBank.d758.s0|8-17|depressant|drug
DDI-DrugBank.d758.s0|19-25|effects|drug
DDI-DrugBank.d758.s0|27-28|of|drug
DDI-DrugBank.d758.s0|30-38|oxycodone|drug
DDI-DrugBank.d758.s0|40-52|hydrochloride|drug
DDI-DrugBank.d758.s0|54-56|may|drug
DDI-DrugBank.d758.s0|58-59|be|drug
DDI-DrugBank.d758.s0|61-68|additive|drug
DDI-DrugBank.d758.s0|70-73|with|drug
DDI-DrugBank.d758.s0|75-78|that|drug
DDI-DrugBank.d758.s0|80-81|of|drug
DDI-DrugBank.d758.s0|83-87|other|drug
DDI-DrugBank.d758.s0|89-91|CNS|drug
DDI-DrugBank.d758.s0|93-105|depressants|drug
DDI-DrugBank.d172.s0|0-6|General|drug
DDI-DrugBank.d172.s0|7-7|:|drug
DDI-DrugBank.d172.s0|9-19|Significant|drug
DDI-DrugBank.d172.s0|21-32|interactions|drug
DDI-DrugBank.d172.s0|34-36|may|drug
DDI-DrugBank.d172.s0|38-42|occur|drug
DDI-DrugBank.d172.s0|44-47|when|drug
DDI-DrugBank.d172.s0|49-57|celecoxib|drug
DDI-DrugBank.d172.s0|59-60|is|drug
DDI-DrugBank.d172.s0|62-73|administered|drug
DDI-DrugBank.d172.s0|75-82|together|drug
DDI-DrugBank.d172.s0|84-87|with|drug
DDI-DrugBank.d172.s0|89-93|drugs|drug
DDI-DrugBank.d172.s0|95-98|that|drug
DDI-DrugBank.d172.s0|100-106|inhibit|drug
DDI-DrugBank.d172.s0|108-111|P450|drug
DDI-DrugBank.d172.s0|113-115|2C9|drug
DDI-DrugBank.d172.s0|116-116|.|drug
DDI-DrugBank.d172.s1|0-8|Celecoxib|drug
DDI-DrugBank.d172.s1|10-19|metabolism|drug
DDI-DrugBank.d172.s1|21-22|is|drug
DDI-DrugBank.d172.s1|24-36|predominantly|drug
DDI-DrugBank.d172.s1|38-45|mediated|drug
DDI-DrugBank.d172.s1|47-49|via|drug
DDI-DrugBank.d172.s1|51-60|cytochrome|drug
DDI-DrugBank.d172.s1|62-65|P450|drug
DDI-DrugBank.d172.s1|67-69|2C9|drug
DDI-DrugBank.d172.s1|71-72|in|drug
DDI-DrugBank.d172.s1|74-76|the|drug
DDI-DrugBank.d172.s1|78-82|liver|drug
DDI-DrugBank.d172.s1|83-83|.|drug
DDI-DrugBank.d172.s2|0-16|Co-administration|drug
DDI-DrugBank.d172.s2|18-19|of|drug
DDI-DrugBank.d172.s2|21-29|celecoxib|drug
DDI-DrugBank.d172.s2|31-34|with|drug
DDI-DrugBank.d172.s2|36-40|drugs|drug
DDI-DrugBank.d172.s2|42-45|that|drug
DDI-DrugBank.d172.s2|47-49|are|drug
DDI-DrugBank.d172.s2|51-55|known|drug
DDI-DrugBank.d172.s2|57-58|to|drug
DDI-DrugBank.d172.s2|60-66|inhibit|drug
DDI-DrugBank.d172.s2|68-70|2C9|drug
DDI-DrugBank.d172.s2|72-77|should|drug
DDI-DrugBank.d172.s2|79-80|be|drug
DDI-DrugBank.d172.s2|82-85|done|drug
DDI-DrugBank.d172.s2|87-90|with|drug
DDI-DrugBank.d172.s2|92-98|caution|drug
DDI-DrugBank.d172.s2|99-99|.|drug
DDI-DrugBank.d172.s3|0-1|In|drug
DDI-DrugBank.d172.s3|3-7|vitro|drug
DDI-DrugBank.d172.s3|9-15|studies|drug
DDI-DrugBank.d172.s3|17-24|indicate|drug
DDI-DrugBank.d172.s3|26-29|that|drug
DDI-DrugBank.d172.s3|31-39|celecoxib|drug
DDI-DrugBank.d172.s3|41-42|is|drug
DDI-DrugBank.d172.s3|44-46|not|drug
DDI-DrugBank.d172.s3|48-49|an|drug
DDI-DrugBank.d172.s3|51-59|inhibitor|drug
DDI-DrugBank.d172.s3|61-62|of|drug
DDI-DrugBank.d172.s3|64-73|cytochrome|drug
DDI-DrugBank.d172.s3|75-78|P450|drug
DDI-DrugBank.d172.s3|80-82|2C9|drug
DDI-DrugBank.d172.s3|83-83|,|drug
DDI-DrugBank.d172.s3|85-88|2C19|drug
DDI-DrugBank.d172.s3|90-91|or|drug
DDI-DrugBank.d172.s3|93-95|3A4|drug
DDI-DrugBank.d172.s3|96-96|.|drug
DDI-DrugBank.d172.s4|0-1|In|drug
DDI-DrugBank.d172.s4|3-7|vitro|drug
DDI-DrugBank.d172.s4|9-15|studies|drug
DDI-DrugBank.d172.s4|17-20|also|drug
DDI-DrugBank.d172.s4|22-29|indicate|drug
DDI-DrugBank.d172.s4|31-34|that|drug
DDI-DrugBank.d172.s4|36-44|celecoxib|drug
DDI-DrugBank.d172.s4|45-45|,|drug
DDI-DrugBank.d172.s4|47-54|although|drug
DDI-DrugBank.d172.s4|56-58|not|drug
DDI-DrugBank.d172.s4|60-60|a|drug
DDI-DrugBank.d172.s4|62-70|substrate|drug
DDI-DrugBank.d172.s4|71-71|,|drug
DDI-DrugBank.d172.s4|73-74|is|drug
DDI-DrugBank.d172.s4|76-77|an|drug
DDI-DrugBank.d172.s4|79-87|inhibitor|drug
DDI-DrugBank.d172.s4|89-90|of|drug
DDI-DrugBank.d172.s4|92-101|cytochrome|drug
DDI-DrugBank.d172.s4|103-106|P450|drug
DDI-DrugBank.d172.s4|108-110|2D6|drug
DDI-DrugBank.d172.s4|111-111|.|drug
DDI-DrugBank.d172.s5|0-8|Therefore|drug
DDI-DrugBank.d172.s5|9-9|,|drug
DDI-DrugBank.d172.s5|11-15|there|drug
DDI-DrugBank.d172.s5|17-18|is|drug
DDI-DrugBank.d172.s5|20-20|a|drug
DDI-DrugBank.d172.s5|22-30|potential|drug
DDI-DrugBank.d172.s5|32-34|for|drug
DDI-DrugBank.d172.s5|36-37|an|drug
DDI-DrugBank.d172.s5|39-40|in|drug
DDI-DrugBank.d172.s5|42-45|vivo|drug
DDI-DrugBank.d172.s5|47-50|drug|drug
DDI-DrugBank.d172.s5|52-62|interaction|drug
DDI-DrugBank.d172.s5|64-67|with|drug
DDI-DrugBank.d172.s5|69-73|drugs|drug
DDI-DrugBank.d172.s5|75-78|that|drug
DDI-DrugBank.d172.s5|80-82|are|drug
DDI-DrugBank.d172.s5|84-94|metabolized|drug
DDI-DrugBank.d172.s5|96-97|by|drug
DDI-DrugBank.d172.s5|99-102|P450|drug
DDI-DrugBank.d172.s5|104-106|2D6|drug
DDI-DrugBank.d172.s5|107-107|.|drug
DDI-DrugBank.d172.s6|0-7|Clinical|drug
DDI-DrugBank.d172.s6|9-15|studies|drug
DDI-DrugBank.d172.s6|17-20|with|drug
DDI-DrugBank.d172.s6|22-30|celecoxib|drug
DDI-DrugBank.d172.s6|32-35|have|drug
DDI-DrugBank.d172.s6|37-46|identified|drug
DDI-DrugBank.d172.s6|48-58|potentially|drug
DDI-DrugBank.d172.s6|60-70|significant|drug
DDI-DrugBank.d172.s6|72-83|interactions|drug
DDI-DrugBank.d172.s6|85-88|with|drug
DDI-DrugBank.d172.s6|90-100|fluconazole|drug
DDI-DrugBank.d172.s6|102-104|and|drug
DDI-DrugBank.d172.s6|106-112|lithium|drug
DDI-DrugBank.d172.s6|113-113|.|drug
DDI-DrugBank.d172.s7|0-9|Experience|drug
DDI-DrugBank.d172.s7|11-14|with|drug
DDI-DrugBank.d172.s7|16-27|nonsteroidal|drug
DDI-DrugBank.d172.s7|29-45|anti-inflammatory|drug
DDI-DrugBank.d172.s7|47-51|drugs|drug
DDI-DrugBank.d172.s7|53-53|(|drug
DDI-DrugBank.d172.s7|54-59|NSAIDs|drug
DDI-DrugBank.d172.s7|60-60|)|drug
DDI-DrugBank.d172.s7|62-69|suggests|drug
DDI-DrugBank.d172.s7|71-73|the|drug
DDI-DrugBank.d172.s7|75-83|potential|drug
DDI-DrugBank.d172.s7|85-87|for|drug
DDI-DrugBank.d172.s7|89-100|interactions|drug
DDI-DrugBank.d172.s7|102-105|with|drug
DDI-DrugBank.d172.s7|107-116|furosemide|drug
DDI-DrugBank.d172.s7|118-120|and|drug
DDI-DrugBank.d172.s7|122-124|ACE|drug
DDI-DrugBank.d172.s7|126-135|inhibitors|drug
DDI-DrugBank.d172.s7|136-136|.|drug
DDI-DrugBank.d172.s8|0-2|The|drug
DDI-DrugBank.d172.s8|4-10|effects|drug
DDI-DrugBank.d172.s8|12-20|celecoxib|drug
DDI-DrugBank.d172.s8|22-23|on|drug
DDI-DrugBank.d172.s8|25-27|the|drug
DDI-DrugBank.d172.s8|29-44|pharmacokinetics|drug
DDI-DrugBank.d172.s8|46-51|and/or|drug
DDI-DrugBank.d172.s8|53-68|pharmacodynamics|drug
DDI-DrugBank.d172.s8|70-71|of|drug
DDI-DrugBank.d172.s8|73-81|glyburide|drug
DDI-DrugBank.d172.s8|82-82|,|drug
DDI-DrugBank.d172.s8|84-95|ketoconazole|drug
DDI-DrugBank.d172.s8|96-96|,|drug
DDI-DrugBank.d172.s8|98-109|methotrexate|drug
DDI-DrugBank.d172.s8|110-110|,|drug
DDI-DrugBank.d172.s8|112-120|phenytoin|drug
DDI-DrugBank.d172.s8|121-121|,|drug
DDI-DrugBank.d172.s8|123-133|tolbutamide|drug
DDI-DrugBank.d172.s8|134-134|,|drug
DDI-DrugBank.d172.s8|136-138|and|drug
DDI-DrugBank.d172.s8|140-147|warfarin|drug
DDI-DrugBank.d172.s8|149-152|have|drug
DDI-DrugBank.d172.s8|154-157|been|drug
DDI-DrugBank.d172.s8|159-165|studied|drug
DDI-DrugBank.d172.s8|167-168|in|drug
DDI-DrugBank.d172.s8|170-173|vivo|drug
DDI-DrugBank.d172.s8|175-177|and|drug
DDI-DrugBank.d172.s8|179-188|clinically|drug
DDI-DrugBank.d172.s8|190-198|important|drug
DDI-DrugBank.d172.s8|200-211|interactions|drug
DDI-DrugBank.d172.s8|213-216|have|drug
DDI-DrugBank.d172.s8|218-220|not|drug
DDI-DrugBank.d172.s8|222-225|been|drug
DDI-DrugBank.d172.s8|227-231|found|drug
DDI-DrugBank.d172.s8|232-232|.|drug
DDI-DrugBank.d172.s9|0-2|ACE|drug
DDI-DrugBank.d172.s9|4-13|inhibitors|drug
DDI-DrugBank.d172.s9|14-14|:|drug
DDI-DrugBank.d172.s9|16-22|Reports|drug
DDI-DrugBank.d172.s9|24-30|suggest|drug
DDI-DrugBank.d172.s9|32-35|that|drug
DDI-DrugBank.d172.s9|37-42|NSAIDs|drug
DDI-DrugBank.d172.s9|44-46|may|drug
DDI-DrugBank.d172.s9|48-55|diminish|drug
DDI-DrugBank.d172.s9|57-59|the|drug
DDI-DrugBank.d172.s9|61-76|antihypertensive|drug
DDI-DrugBank.d172.s9|78-83|effect|drug
DDI-DrugBank.d172.s9|85-86|of|drug
DDI-DrugBank.d172.s9|88-98|Angiotensin|drug
DDI-DrugBank.d172.s9|100-109|Converting|drug
DDI-DrugBank.d172.s9|111-116|Enzyme|drug
DDI-DrugBank.d172.s9|118-118|(|drug
DDI-DrugBank.d172.s9|119-121|ACE|drug
DDI-DrugBank.d172.s9|122-122|)|drug
DDI-DrugBank.d172.s9|124-133|inhibitors|drug
DDI-DrugBank.d172.s9|134-134|.|drug
DDI-DrugBank.d172.s10|0-3|This|drug
DDI-DrugBank.d172.s10|5-15|interaction|drug
DDI-DrugBank.d172.s10|17-22|should|drug
DDI-DrugBank.d172.s10|24-25|be|drug
DDI-DrugBank.d172.s10|27-31|given|drug
DDI-DrugBank.d172.s10|33-45|consideration|drug
DDI-DrugBank.d172.s10|47-48|in|drug
DDI-DrugBank.d172.s10|50-57|patients|drug
DDI-DrugBank.d172.s10|59-64|taking|drug
DDI-DrugBank.d172.s10|66-73|CELEBREX|drug
DDI-DrugBank.d172.s10|75-87|concomitantly|drug
DDI-DrugBank.d172.s10|89-92|with|drug
DDI-DrugBank.d172.s10|94-107|ACE-inhibitors|drug
DDI-DrugBank.d172.s10|108-108|.|drug
DDI-DrugBank.d172.s11|0-9|Furosemide|drug
DDI-DrugBank.d172.s11|10-10|:|drug
DDI-DrugBank.d172.s11|12-19|Clinical|drug
DDI-DrugBank.d172.s11|21-27|studies|drug
DDI-DrugBank.d172.s11|28-28|,|drug
DDI-DrugBank.d172.s11|30-31|as|drug
DDI-DrugBank.d172.s11|33-36|well|drug
DDI-DrugBank.d172.s11|38-39|as|drug
DDI-DrugBank.d172.s11|41-44|post|drug
DDI-DrugBank.d172.s11|46-54|marketing|drug
DDI-DrugBank.d172.s11|56-67|observations|drug
DDI-DrugBank.d172.s11|68-68|,|drug
DDI-DrugBank.d172.s11|70-73|have|drug
DDI-DrugBank.d172.s11|75-79|shown|drug
DDI-DrugBank.d172.s11|81-84|that|drug
DDI-DrugBank.d172.s11|86-91|NSAIDs|drug
DDI-DrugBank.d172.s11|93-95|can|drug
DDI-DrugBank.d172.s11|97-102|reduce|drug
DDI-DrugBank.d172.s11|104-106|the|drug
DDI-DrugBank.d172.s11|108-118|natriuretic|drug
DDI-DrugBank.d172.s11|120-125|effect|drug
DDI-DrugBank.d172.s11|127-128|of|drug
DDI-DrugBank.d172.s11|130-139|furosemide|drug
DDI-DrugBank.d172.s11|141-143|and|drug
DDI-DrugBank.d172.s11|145-153|thiazides|drug
DDI-DrugBank.d172.s11|155-156|in|drug
DDI-DrugBank.d172.s11|158-161|some|drug
DDI-DrugBank.d172.s11|163-170|patients|drug
DDI-DrugBank.d172.s11|171-171|.|drug
DDI-DrugBank.d172.s12|0-3|This|drug
DDI-DrugBank.d172.s12|5-12|response|drug
DDI-DrugBank.d172.s12|14-16|has|drug
DDI-DrugBank.d172.s12|18-21|been|drug
DDI-DrugBank.d172.s12|23-32|attributed|drug
DDI-DrugBank.d172.s12|34-35|to|drug
DDI-DrugBank.d172.s12|37-46|inhibition|drug
DDI-DrugBank.d172.s12|48-49|of|drug
DDI-DrugBank.d172.s12|51-55|renal|drug
DDI-DrugBank.d172.s12|57-69|prostaglandin|drug
DDI-DrugBank.d172.s12|71-79|synthesis|drug
DDI-DrugBank.d172.s12|80-80|.|drug
DDI-DrugBank.d172.s13|0-6|Aspirin|drug
DDI-DrugBank.d172.s13|7-7|:|drug
DDI-DrugBank.d172.s13|9-16|CELEBREX|drug
DDI-DrugBank.d172.s13|18-20|can|drug
DDI-DrugBank.d172.s13|22-23|be|drug
DDI-DrugBank.d172.s13|25-28|used|drug
DDI-DrugBank.d172.s13|30-33|with|drug
DDI-DrugBank.d172.s13|35-37|low|drug
DDI-DrugBank.d172.s13|39-42|dose|drug
DDI-DrugBank.d172.s13|44-50|aspirin|drug
DDI-DrugBank.d172.s13|51-51|.|drug
DDI-DrugBank.d172.s14|0-6|However|drug
DDI-DrugBank.d172.s14|7-7|,|drug
DDI-DrugBank.d172.s14|9-19|concomitant|drug
DDI-DrugBank.d172.s14|21-34|administration|drug
DDI-DrugBank.d172.s14|36-37|of|drug
DDI-DrugBank.d172.s14|39-45|aspirin|drug
DDI-DrugBank.d172.s14|47-50|with|drug
DDI-DrugBank.d172.s14|52-59|CELEBREX|drug
DDI-DrugBank.d172.s14|61-63|may|drug
DDI-DrugBank.d172.s14|65-70|result|drug
DDI-DrugBank.d172.s14|72-73|in|drug
DDI-DrugBank.d172.s14|75-76|an|drug
DDI-DrugBank.d172.s14|78-86|increased|drug
DDI-DrugBank.d172.s14|88-91|rate|drug
DDI-DrugBank.d172.s14|93-94|of|drug
DDI-DrugBank.d172.s14|96-97|GI|drug
DDI-DrugBank.d172.s14|99-108|ulceration|drug
DDI-DrugBank.d172.s14|110-111|or|drug
DDI-DrugBank.d172.s14|113-117|other|drug
DDI-DrugBank.d172.s14|119-131|complications|drug
DDI-DrugBank.d172.s14|132-132|,|drug
DDI-DrugBank.d172.s14|134-141|compared|drug
DDI-DrugBank.d172.s14|143-144|to|drug
DDI-DrugBank.d172.s14|146-148|use|drug
DDI-DrugBank.d172.s14|150-151|of|drug
DDI-DrugBank.d172.s14|153-160|CELEBREX|drug
DDI-DrugBank.d172.s14|162-166|alone|drug
DDI-DrugBank.d172.s14|167-167|.|drug
DDI-DrugBank.d172.s15|0-6|Because|drug
DDI-DrugBank.d172.s15|8-9|of|drug
DDI-DrugBank.d172.s15|11-13|its|drug
DDI-DrugBank.d172.s15|15-18|lack|drug
DDI-DrugBank.d172.s15|20-21|of|drug
DDI-DrugBank.d172.s15|23-30|platelet|drug
DDI-DrugBank.d172.s15|32-38|effects|drug
DDI-DrugBank.d172.s15|39-39|,|drug
DDI-DrugBank.d172.s15|41-48|CELEBREX|drug
DDI-DrugBank.d172.s15|50-51|is|drug
DDI-DrugBank.d172.s15|53-55|not|drug
DDI-DrugBank.d172.s15|57-57|a|drug
DDI-DrugBank.d172.s15|59-68|substitute|drug
DDI-DrugBank.d172.s15|70-72|for|drug
DDI-DrugBank.d172.s15|74-80|aspirin|drug
DDI-DrugBank.d172.s15|82-84|for|drug
DDI-DrugBank.d172.s15|86-99|cardiovascular|drug
DDI-DrugBank.d172.s15|101-111|prophylaxis|drug
DDI-DrugBank.d172.s15|112-112|.|drug
DDI-DrugBank.d172.s16|0-10|Fluconazole|drug
DDI-DrugBank.d172.s16|11-11|:|drug
DDI-DrugBank.d172.s16|13-23|Concomitant|drug
DDI-DrugBank.d172.s16|25-38|administration|drug
DDI-DrugBank.d172.s16|40-41|of|drug
DDI-DrugBank.d172.s16|43-53|fluconazole|drug
DDI-DrugBank.d172.s16|55-56|at|drug
DDI-DrugBank.d172.s16|58-60|200|drug
DDI-DrugBank.d172.s16|62-63|mg|drug
DDI-DrugBank.d172.s16|65-66|QD|drug
DDI-DrugBank.d172.s16|68-75|resulted|drug
DDI-DrugBank.d172.s16|77-78|in|drug
DDI-DrugBank.d172.s16|80-80|a|drug
DDI-DrugBank.d172.s16|82-89|two-fold|drug
DDI-DrugBank.d172.s16|91-98|increase|drug
DDI-DrugBank.d172.s16|100-101|in|drug
DDI-DrugBank.d172.s16|103-111|celecoxib|drug
DDI-DrugBank.d172.s16|113-118|plasma|drug
DDI-DrugBank.d172.s16|120-132|concentration|drug
DDI-DrugBank.d172.s16|133-133|.|drug
DDI-DrugBank.d172.s17|0-3|This|drug
DDI-DrugBank.d172.s17|5-12|increase|drug
DDI-DrugBank.d172.s17|14-15|is|drug
DDI-DrugBank.d172.s17|17-19|due|drug
DDI-DrugBank.d172.s17|21-22|to|drug
DDI-DrugBank.d172.s17|24-26|the|drug
DDI-DrugBank.d172.s17|28-37|inhibition|drug
DDI-DrugBank.d172.s17|39-40|of|drug
DDI-DrugBank.d172.s17|42-50|celecoxib|drug
DDI-DrugBank.d172.s17|52-61|metabolism|drug
DDI-DrugBank.d172.s17|63-65|via|drug
DDI-DrugBank.d172.s17|67-70|P450|drug
DDI-DrugBank.d172.s17|72-74|2C9|drug
DDI-DrugBank.d172.s17|76-77|by|drug
DDI-DrugBank.d172.s17|79-89|fluconazole|drug
DDI-DrugBank.d172.s17|91-91|(|drug
DDI-DrugBank.d172.s17|92-94|see|drug
DDI-DrugBank.d172.s17|96-103|CLINICAL|drug
DDI-DrugBank.d172.s17|105-116|PHARMACOLOGY|drug
DDI-DrugBank.d172.s17|118-118|-|drug
DDI-DrugBank.d172.s17|120-135|Pharmacokinetics|drug
DDI-DrugBank.d172.s17|136-136|:|drug
DDI-DrugBank.d172.s17|138-147|Metabolism|drug
DDI-DrugBank.d172.s17|148-148|)|drug
DDI-DrugBank.d172.s17|149-149|.|drug
DDI-DrugBank.d172.s18|0-7|CELEBREX|drug
DDI-DrugBank.d172.s18|9-14|should|drug
DDI-DrugBank.d172.s18|16-17|be|drug
DDI-DrugBank.d172.s18|19-28|introduced|drug
DDI-DrugBank.d172.s18|30-31|at|drug
DDI-DrugBank.d172.s18|33-35|the|drug
DDI-DrugBank.d172.s18|37-42|lowest|drug
DDI-DrugBank.d172.s18|44-54|recommended|drug
DDI-DrugBank.d172.s18|56-59|dose|drug
DDI-DrugBank.d172.s18|61-62|in|drug
DDI-DrugBank.d172.s18|64-71|patients|drug
DDI-DrugBank.d172.s18|73-81|receiving|drug
DDI-DrugBank.d172.s18|83-93|fluconazole|drug
DDI-DrugBank.d172.s18|94-94|.|drug
DDI-DrugBank.d172.s19|0-6|Lithium|drug
DDI-DrugBank.d172.s19|7-7|:|drug
DDI-DrugBank.d172.s19|9-10|In|drug
DDI-DrugBank.d172.s19|12-12|a|drug
DDI-DrugBank.d172.s19|14-18|study|drug
DDI-DrugBank.d172.s19|20-28|conducted|drug
DDI-DrugBank.d172.s19|30-31|in|drug
DDI-DrugBank.d172.s19|33-39|healthy|drug
DDI-DrugBank.d172.s19|41-48|subjects|drug
DDI-DrugBank.d172.s19|49-49|,|drug
DDI-DrugBank.d172.s19|51-54|mean|drug
DDI-DrugBank.d172.s19|56-67|steady-state|drug
DDI-DrugBank.d172.s19|69-75|lithium|drug
DDI-DrugBank.d172.s19|77-82|plasma|drug
DDI-DrugBank.d172.s19|84-89|levels|drug
DDI-DrugBank.d172.s19|91-99|increased|drug
DDI-DrugBank.d172.s19|101-113|approximately|drug
DDI-DrugBank.d172.s19|115-116|17|drug
DDI-DrugBank.d172.s19|117-117|%|drug
DDI-DrugBank.d172.s19|119-120|in|drug
DDI-DrugBank.d172.s19|122-129|subjects|drug
DDI-DrugBank.d172.s19|131-139|receiving|drug
DDI-DrugBank.d172.s19|141-147|lithium|drug
DDI-DrugBank.d172.s19|149-151|450|drug
DDI-DrugBank.d172.s19|153-154|mg|drug
DDI-DrugBank.d172.s19|156-158|BID|drug
DDI-DrugBank.d172.s19|160-163|with|drug
DDI-DrugBank.d172.s19|165-172|CELEBREX|drug
DDI-DrugBank.d172.s19|174-176|200|drug
DDI-DrugBank.d172.s19|178-179|mg|drug
DDI-DrugBank.d172.s19|181-183|BID|drug
DDI-DrugBank.d172.s19|185-186|as|drug
DDI-DrugBank.d172.s19|188-195|compared|drug
DDI-DrugBank.d172.s19|197-198|to|drug
DDI-DrugBank.d172.s19|200-207|subjects|drug
DDI-DrugBank.d172.s19|209-217|receiving|drug
DDI-DrugBank.d172.s19|219-225|lithium|drug
DDI-DrugBank.d172.s19|227-231|alone|drug
DDI-DrugBank.d172.s19|232-232|.|drug
DDI-DrugBank.d172.s20|0-7|Patients|drug
DDI-DrugBank.d172.s20|9-10|on|drug
DDI-DrugBank.d172.s20|12-18|lithium|drug
DDI-DrugBank.d172.s20|20-28|treatment|drug
DDI-DrugBank.d172.s20|30-35|should|drug
DDI-DrugBank.d172.s20|37-38|be|drug
DDI-DrugBank.d172.s20|40-46|closely|drug
DDI-DrugBank.d172.s20|48-56|monitored|drug
DDI-DrugBank.d172.s20|58-61|when|drug
DDI-DrugBank.d172.s20|63-70|CELEBREX|drug
DDI-DrugBank.d172.s20|72-73|is|drug
DDI-DrugBank.d172.s20|75-84|introduced|drug
DDI-DrugBank.d172.s20|86-87|or|drug
DDI-DrugBank.d172.s20|89-97|withdrawn|drug
DDI-DrugBank.d172.s20|98-98|.|drug
DDI-DrugBank.d172.s21|0-11|Methotrexate|drug
DDI-DrugBank.d172.s21|12-12|:|drug
DDI-DrugBank.d172.s21|14-15|In|drug
DDI-DrugBank.d172.s21|17-18|an|drug
DDI-DrugBank.d172.s21|20-30|interaction|drug
DDI-DrugBank.d172.s21|32-36|study|drug
DDI-DrugBank.d172.s21|38-39|of|drug
DDI-DrugBank.d172.s21|41-50|rheumatoid|drug
DDI-DrugBank.d172.s21|52-60|arthritis|drug
DDI-DrugBank.d172.s21|62-69|patients|drug
DDI-DrugBank.d172.s21|71-76|taking|drug
DDI-DrugBank.d172.s21|78-89|methotrexate|drug
DDI-DrugBank.d172.s21|90-90|,|drug
DDI-DrugBank.d172.s21|92-99|CELEBREX|drug
DDI-DrugBank.d172.s21|101-103|did|drug
DDI-DrugBank.d172.s21|105-107|not|drug
DDI-DrugBank.d172.s21|109-112|have|drug
DDI-DrugBank.d172.s21|114-114|a|drug
DDI-DrugBank.d172.s21|116-126|significant|drug
DDI-DrugBank.d172.s21|128-133|effect|drug
DDI-DrugBank.d172.s21|135-136|on|drug
DDI-DrugBank.d172.s21|138-140|the|drug
DDI-DrugBank.d172.s21|142-157|pharmacokinetics|drug
DDI-DrugBank.d172.s21|159-160|of|drug
DDI-DrugBank.d172.s21|162-173|methotrexate|drug
DDI-DrugBank.d172.s21|174-174|.|drug
DDI-DrugBank.d172.s22|0-7|Warfarin|drug
DDI-DrugBank.d172.s22|8-8|:|drug
DDI-DrugBank.d172.s22|10-12|The|drug
DDI-DrugBank.d172.s22|14-19|effect|drug
DDI-DrugBank.d172.s22|21-22|of|drug
DDI-DrugBank.d172.s22|24-32|celecoxib|drug
DDI-DrugBank.d172.s22|34-35|on|drug
DDI-DrugBank.d172.s22|37-39|the|drug
DDI-DrugBank.d172.s22|41-54|anti-coagulant|drug
DDI-DrugBank.d172.s22|56-61|effect|drug
DDI-DrugBank.d172.s22|63-64|of|drug
DDI-DrugBank.d172.s22|66-73|warfarin|drug
DDI-DrugBank.d172.s22|75-77|was|drug
DDI-DrugBank.d172.s22|79-85|studied|drug
DDI-DrugBank.d172.s22|87-88|in|drug
DDI-DrugBank.d172.s22|90-90|a|drug
DDI-DrugBank.d172.s22|92-96|group|drug
DDI-DrugBank.d172.s22|98-99|of|drug
DDI-DrugBank.d172.s22|101-107|healthy|drug
DDI-DrugBank.d172.s22|109-116|subjects|drug
DDI-DrugBank.d172.s22|118-126|receiving|drug
DDI-DrugBank.d172.s22|128-132|daily|drug
DDI-DrugBank.d172.s22|134-138|doses|drug
DDI-DrugBank.d172.s22|140-141|of|drug
DDI-DrugBank.d172.s22|143-145|2-5|drug
DDI-DrugBank.d172.s22|147-148|mg|drug
DDI-DrugBank.d172.s22|150-151|of|drug
DDI-DrugBank.d172.s22|153-160|warfarin|drug
DDI-DrugBank.d172.s22|161-161|.|drug
DDI-DrugBank.d172.s23|0-1|In|drug
DDI-DrugBank.d172.s23|3-7|these|drug
DDI-DrugBank.d172.s23|9-16|subjects|drug
DDI-DrugBank.d172.s23|17-17|,|drug
DDI-DrugBank.d172.s23|19-27|celecoxib|drug
DDI-DrugBank.d172.s23|29-31|did|drug
DDI-DrugBank.d172.s23|33-35|not|drug
DDI-DrugBank.d172.s23|37-41|alter|drug
DDI-DrugBank.d172.s23|43-45|the|drug
DDI-DrugBank.d172.s23|47-59|anticoagulant|drug
DDI-DrugBank.d172.s23|61-66|effect|drug
DDI-DrugBank.d172.s23|68-69|of|drug
DDI-DrugBank.d172.s23|71-78|warfarin|drug
DDI-DrugBank.d172.s23|80-81|as|drug
DDI-DrugBank.d172.s23|83-92|determined|drug
DDI-DrugBank.d172.s23|94-95|by|drug
DDI-DrugBank.d172.s23|97-107|prothrombin|drug
DDI-DrugBank.d172.s23|109-112|time|drug
DDI-DrugBank.d172.s23|113-113|.|drug
DDI-DrugBank.d172.s24|0-6|However|drug
DDI-DrugBank.d172.s24|7-7|,|drug
DDI-DrugBank.d172.s24|9-15|caution|drug
DDI-DrugBank.d172.s24|17-22|should|drug
DDI-DrugBank.d172.s24|24-25|be|drug
DDI-DrugBank.d172.s24|27-30|used|drug
DDI-DrugBank.d172.s24|32-35|when|drug
DDI-DrugBank.d172.s24|37-49|administering|drug
DDI-DrugBank.d172.s24|51-58|CELEBREX|drug
DDI-DrugBank.d172.s24|60-63|with|drug
DDI-DrugBank.d172.s24|65-72|warfarin|drug
DDI-DrugBank.d172.s24|74-78|since|drug
DDI-DrugBank.d172.s24|80-84|these|drug
DDI-DrugBank.d172.s24|86-93|patients|drug
DDI-DrugBank.d172.s24|95-97|are|drug
DDI-DrugBank.d172.s24|99-100|at|drug
DDI-DrugBank.d172.s24|102-110|increased|drug
DDI-DrugBank.d172.s24|112-115|risk|drug
DDI-DrugBank.d172.s24|117-118|of|drug
DDI-DrugBank.d172.s24|120-127|bleeding|drug
DDI-DrugBank.d172.s24|129-141|complications|drug
DDI-DrugBank.d172.s24|142-142|.|drug
DDI-MedLine.d115.s0|0-10|Concomitant|drug
DDI-MedLine.d115.s0|12-27|cyclophosphamide|drug
DDI-MedLine.d115.s0|28-28|,|drug
DDI-MedLine.d115.s0|30-40|doxorubicin|drug
DDI-MedLine.d115.s0|41-41|,|drug
DDI-MedLine.d115.s0|43-53|vincristine|drug
DDI-MedLine.d115.s0|54-54|,|drug
DDI-MedLine.d115.s0|56-58|and|drug
DDI-MedLine.d115.s0|60-69|prednisone|drug
DDI-MedLine.d115.s0|71-82|chemotherapy|drug
DDI-MedLine.d115.s0|84-87|plus|drug
DDI-MedLine.d115.s0|89-94|highly|drug
DDI-MedLine.d115.s0|96-101|active|drug
DDI-MedLine.d115.s0|103-116|antiretroviral|drug
DDI-MedLine.d115.s0|118-124|therapy|drug
DDI-MedLine.d115.s0|126-127|in|drug
DDI-MedLine.d115.s0|129-136|patients|drug
DDI-MedLine.d115.s0|138-141|with|drug
DDI-MedLine.d115.s0|143-147|human|drug
DDI-MedLine.d115.s0|149-164|immunodeficiency|drug
DDI-MedLine.d115.s0|166-178|virus-related|drug
DDI-MedLine.d115.s0|179-179|,|drug
DDI-MedLine.d115.s0|181-191|non-Hodgkin|drug
DDI-MedLine.d115.s0|193-200|lymphoma|drug
DDI-MedLine.d115.s0|201-201|.|drug
DDI-MedLine.d115.s1|0-9|BACKGROUND|drug
DDI-MedLine.d115.s1|10-10|:|drug
DDI-MedLine.d115.s1|12-14|The|drug
DDI-MedLine.d115.s1|16-26|feasibility|drug
DDI-MedLine.d115.s1|28-30|and|drug
DDI-MedLine.d115.s1|32-39|efficacy|drug
DDI-MedLine.d115.s1|41-42|of|drug
DDI-MedLine.d115.s1|44-54|concomitant|drug
DDI-MedLine.d115.s1|56-67|chemotherapy|drug
DDI-MedLine.d115.s1|69-71|and|drug
DDI-MedLine.d115.s1|73-78|highly|drug
DDI-MedLine.d115.s1|80-85|active|drug
DDI-MedLine.d115.s1|87-100|antiretroviral|drug
DDI-MedLine.d115.s1|102-108|therapy|drug
DDI-MedLine.d115.s1|110-110|(|drug
DDI-MedLine.d115.s1|111-115|HAART|drug
DDI-MedLine.d115.s1|116-116|)|drug
DDI-MedLine.d115.s1|118-119|is|drug
DDI-MedLine.d115.s1|121-125|still|drug
DDI-MedLine.d115.s1|127-133|unknown|drug
DDI-MedLine.d115.s1|135-136|in|drug
DDI-MedLine.d115.s1|138-145|patients|drug
DDI-MedLine.d115.s1|147-150|with|drug
DDI-MedLine.d115.s1|152-156|human|drug
DDI-MedLine.d115.s1|158-173|immunodeficiency|drug
DDI-MedLine.d115.s1|175-179|virus|drug
DDI-MedLine.d115.s1|181-181|(|drug
DDI-MedLine.d115.s1|182-184|HIV|drug
DDI-MedLine.d115.s1|185-185|)|drug
DDI-MedLine.d115.s1|186-193|-related|drug
DDI-MedLine.d115.s1|195-206|malignancies|drug
DDI-MedLine.d115.s1|207-207|.|drug
DDI-MedLine.d115.s2|0-1|To|drug
DDI-MedLine.d115.s2|3-10|evaluate|drug
DDI-MedLine.d115.s2|12-14|the|drug
DDI-MedLine.d115.s2|16-21|impact|drug
DDI-MedLine.d115.s2|23-24|of|drug
DDI-MedLine.d115.s2|26-37|chemotherapy|drug
DDI-MedLine.d115.s2|39-42|plus|drug
DDI-MedLine.d115.s2|44-48|HAART|drug
DDI-MedLine.d115.s2|50-51|on|drug
DDI-MedLine.d115.s2|53-55|the|drug
DDI-MedLine.d115.s2|57-64|clinical|drug
DDI-MedLine.d115.s2|66-71|course|drug
DDI-MedLine.d115.s2|73-74|of|drug
DDI-MedLine.d115.s2|76-83|patients|drug
DDI-MedLine.d115.s2|85-88|with|drug
DDI-MedLine.d115.s2|90-100|HIV-related|drug
DDI-MedLine.d115.s2|101-101|,|drug
DDI-MedLine.d115.s2|103-110|systemic|drug
DDI-MedLine.d115.s2|111-111|,|drug
DDI-MedLine.d115.s2|113-123|non-Hodgkin|drug
DDI-MedLine.d115.s2|125-132|lymphoma|drug
DDI-MedLine.d115.s2|134-134|(|drug
DDI-MedLine.d115.s2|135-141|HIV-NHL|drug
DDI-MedLine.d115.s2|142-142|)|drug
DDI-MedLine.d115.s2|143-143|,|drug
DDI-MedLine.d115.s2|145-147|the|drug
DDI-MedLine.d115.s2|149-155|authors|drug
DDI-MedLine.d115.s2|157-164|compared|drug
DDI-MedLine.d115.s2|166-180|retrospectively|drug
DDI-MedLine.d115.s2|182-182|a|drug
DDI-MedLine.d115.s2|184-188|group|drug
DDI-MedLine.d115.s2|190-191|of|drug
DDI-MedLine.d115.s2|193-194|24|drug
DDI-MedLine.d115.s2|196-203|patients|drug
DDI-MedLine.d115.s2|205-208|with|drug
DDI-MedLine.d115.s2|210-216|HIV-NHL|drug
DDI-MedLine.d115.s2|218-220|who|drug
DDI-MedLine.d115.s2|222-225|were|drug
DDI-MedLine.d115.s2|227-233|treated|drug
DDI-MedLine.d115.s2|235-238|with|drug
DDI-MedLine.d115.s2|240-242|the|drug
DDI-MedLine.d115.s2|244-259|cyclophosphamide|drug
DDI-MedLine.d115.s2|260-260|,|drug
DDI-MedLine.d115.s2|262-272|doxorubicin|drug
DDI-MedLine.d115.s2|273-273|,|drug
DDI-MedLine.d115.s2|275-285|vincristine|drug
DDI-MedLine.d115.s2|286-286|,|drug
DDI-MedLine.d115.s2|288-290|and|drug
DDI-MedLine.d115.s2|292-301|prednisone|drug
DDI-MedLine.d115.s2|303-303|(|drug
DDI-MedLine.d115.s2|304-307|CHOP|drug
DDI-MedLine.d115.s2|308-308|)|drug
DDI-MedLine.d115.s2|310-321|chemotherapy|drug
DDI-MedLine.d115.s2|323-329|regimen|drug
DDI-MedLine.d115.s2|331-334|plus|drug
DDI-MedLine.d115.s2|336-340|HAART|drug
DDI-MedLine.d115.s2|342-345|with|drug
DDI-MedLine.d115.s2|347-347|a|drug
DDI-MedLine.d115.s2|349-353|group|drug
DDI-MedLine.d115.s2|355-356|of|drug
DDI-MedLine.d115.s2|358-359|80|drug
DDI-MedLine.d115.s2|361-368|patients|drug
DDI-MedLine.d115.s2|370-372|who|drug
DDI-MedLine.d115.s2|374-377|were|drug
DDI-MedLine.d115.s2|379-385|treated|drug
DDI-MedLine.d115.s2|387-390|with|drug
DDI-MedLine.d115.s2|392-395|CHOP|drug
DDI-MedLine.d115.s2|397-408|chemotherapy|drug
DDI-MedLine.d115.s2|410-411|or|drug
DDI-MedLine.d115.s2|413-413|a|drug
DDI-MedLine.d115.s2|415-423|CHOP-like|drug
DDI-MedLine.d115.s2|425-431|regimen|drug
DDI-MedLine.d115.s2|433-433|(|drug
DDI-MedLine.d115.s2|434-437|i.e.|drug
DDI-MedLine.d115.s2|438-438|,|drug
DDI-MedLine.d115.s2|440-455|cyclophosphamide|drug
DDI-MedLine.d115.s2|456-456|,|drug
DDI-MedLine.d115.s2|458-468|doxorubicin|drug
DDI-MedLine.d115.s2|469-469|,|drug
DDI-MedLine.d115.s2|471-480|teniposide|drug
DDI-MedLine.d115.s2|481-481|,|drug
DDI-MedLine.d115.s2|483-485|and|drug
DDI-MedLine.d115.s2|487-496|prednisone|drug
DDI-MedLine.d115.s2|498-501|with|drug
DDI-MedLine.d115.s2|503-513|vincristine|drug
DDI-MedLine.d115.s2|515-518|plus|drug
DDI-MedLine.d115.s2|520-528|bleomycin|drug
DDI-MedLine.d115.s2|529-529|)|drug
DDI-MedLine.d115.s2|531-537|without|drug
DDI-MedLine.d115.s2|539-547|receiving|drug
DDI-MedLine.d115.s2|549-562|antiretroviral|drug
DDI-MedLine.d115.s2|564-570|therapy|drug
DDI-MedLine.d115.s2|571-571|.|drug
DDI-MedLine.d115.s3|0-6|METHODS|drug
DDI-MedLine.d115.s3|7-7|:|drug
DDI-MedLine.d115.s3|9-11|All|drug
DDI-MedLine.d115.s3|13-20|patients|drug
DDI-MedLine.d115.s3|22-25|were|drug
DDI-MedLine.d115.s3|27-34|enrolled|drug
DDI-MedLine.d115.s3|36-37|in|drug
DDI-MedLine.d115.s3|39-41|two|drug
DDI-MedLine.d115.s3|43-52|sequential|drug
DDI-MedLine.d115.s3|54-59|trials|drug
DDI-MedLine.d115.s3|61-69|performed|drug
DDI-MedLine.d115.s3|71-72|at|drug
DDI-MedLine.d115.s3|74-76|the|drug
DDI-MedLine.d115.s3|78-83|Aviano|drug
DDI-MedLine.d115.s3|85-90|Cancer|drug
DDI-MedLine.d115.s3|92-97|Center|drug
DDI-MedLine.d115.s3|98-98|,|drug
DDI-MedLine.d115.s3|100-104|Italy|drug
DDI-MedLine.d115.s3|105-105|,|drug
DDI-MedLine.d115.s3|107-110|from|drug
DDI-MedLine.d115.s3|112-116|April|drug
DDI-MedLine.d115.s3|118-121|1988|drug
DDI-MedLine.d115.s3|123-124|to|drug
DDI-MedLine.d115.s3|126-133|December|drug
DDI-MedLine.d115.s3|135-138|1998|drug
DDI-MedLine.d115.s3|139-139|.|drug
DDI-MedLine.d115.s4|0-4|HAART|drug
DDI-MedLine.d115.s4|6-8|was|drug
DDI-MedLine.d115.s4|10-17|included|drug
DDI-MedLine.d115.s4|19-22|with|drug
DDI-MedLine.d115.s4|24-34|combination|drug
DDI-MedLine.d115.s4|36-42|therapy|drug
DDI-MedLine.d115.s4|44-47|from|drug
DDI-MedLine.d115.s4|49-55|January|drug
DDI-MedLine.d115.s4|57-60|1997|drug
DDI-MedLine.d115.s4|61-61|.|drug
DDI-MedLine.d115.s5|0-13|Antiretroviral|drug
DDI-MedLine.d115.s5|15-22|regimens|drug
DDI-MedLine.d115.s5|24-32|consisted|drug
DDI-MedLine.d115.s5|34-35|of|drug
DDI-MedLine.d115.s5|37-39|two|drug
DDI-MedLine.d115.s5|41-47|reverse|drug
DDI-MedLine.d115.s5|49-61|transcriptase|drug
DDI-MedLine.d115.s5|63-72|inhibitors|drug
DDI-MedLine.d115.s5|74-76|and|drug
DDI-MedLine.d115.s5|78-80|one|drug
DDI-MedLine.d115.s5|82-89|protease|drug
DDI-MedLine.d115.s5|91-99|inhibitor|drug
DDI-MedLine.d115.s5|100-100|.|drug
DDI-MedLine.d115.s6|0-6|RESULTS|drug
DDI-MedLine.d115.s6|7-7|:|drug
DDI-MedLine.d115.s6|9-11|The|drug
DDI-MedLine.d115.s6|13-15|two|drug
DDI-MedLine.d115.s6|17-25|treatment|drug
DDI-MedLine.d115.s6|27-32|groups|drug
DDI-MedLine.d115.s6|34-37|were|drug
DDI-MedLine.d115.s6|39-42|well|drug
DDI-MedLine.d115.s6|44-50|matched|drug
DDI-MedLine.d115.s6|52-55|with|drug
DDI-MedLine.d115.s6|57-62|regard|drug
DDI-MedLine.d115.s6|64-65|to|drug
DDI-MedLine.d115.s6|67-73|patient|drug
DDI-MedLine.d115.s6|75-86|demographics|drug
DDI-MedLine.d115.s6|87-87|,|drug
DDI-MedLine.d115.s6|89-91|NHL|drug
DDI-MedLine.d115.s6|93-107|characteristics|drug
DDI-MedLine.d115.s6|108-108|,|drug
DDI-MedLine.d115.s6|110-112|HIV|drug
DDI-MedLine.d115.s6|114-119|status|drug
DDI-MedLine.d115.s6|120-120|,|drug
DDI-MedLine.d115.s6|122-124|and|drug
DDI-MedLine.d115.s6|126-134|treatment|drug
DDI-MedLine.d115.s6|135-135|,|drug
DDI-MedLine.d115.s6|137-140|i.e.|drug
DDI-MedLine.d115.s6|141-141|,|drug
DDI-MedLine.d115.s6|143-145|the|drug
DDI-MedLine.d115.s6|147-152|number|drug
DDI-MedLine.d115.s6|154-155|of|drug
DDI-MedLine.d115.s6|157-162|cycles|drug
DDI-MedLine.d115.s6|164-166|and|drug
DDI-MedLine.d115.s6|168-179|chemotherapy|drug
DDI-MedLine.d115.s6|181-184|dose|drug
DDI-MedLine.d115.s6|185-185|.|drug
DDI-MedLine.d115.s7|0-2|The|drug
DDI-MedLine.d115.s7|4-11|response|drug
DDI-MedLine.d115.s7|13-17|rates|drug
DDI-MedLine.d115.s7|19-22|were|drug
DDI-MedLine.d115.s7|24-30|similar|drug
DDI-MedLine.d115.s7|32-38|between|drug
DDI-MedLine.d115.s7|40-42|the|drug
DDI-MedLine.d115.s7|44-46|two|drug
DDI-MedLine.d115.s7|48-53|groups|drug
DDI-MedLine.d115.s7|54-54|.|drug
DDI-MedLine.d115.s8|0-5|Severe|drug
DDI-MedLine.d115.s8|7-12|anemia|drug
DDI-MedLine.d115.s8|14-14|(|drug
DDI-MedLine.d115.s8|15-19|Grade|drug
DDI-MedLine.d115.s8|21-23|3-4|drug
DDI-MedLine.d115.s8|25-33|according|drug
DDI-MedLine.d115.s8|35-36|to|drug
DDI-MedLine.d115.s8|38-40|the|drug
DDI-MedLine.d115.s8|42-46|World|drug
DDI-MedLine.d115.s8|48-53|Health|drug
DDI-MedLine.d115.s8|55-66|Organization|drug
DDI-MedLine.d115.s8|68-75|criteria|drug
DDI-MedLine.d115.s8|76-76|)|drug
DDI-MedLine.d115.s8|78-80|was|drug
DDI-MedLine.d115.s8|82-94|significantly|drug
DDI-MedLine.d115.s8|96-102|greater|drug
DDI-MedLine.d115.s8|104-105|in|drug
DDI-MedLine.d115.s8|107-109|the|drug
DDI-MedLine.d115.s8|111-118|patients|drug
DDI-MedLine.d115.s8|120-122|who|drug
DDI-MedLine.d115.s8|124-131|received|drug
DDI-MedLine.d115.s8|133-142|CHOP-HAART|drug
DDI-MedLine.d115.s8|144-151|compared|drug
DDI-MedLine.d115.s8|153-156|with|drug
DDI-MedLine.d115.s8|158-160|the|drug
DDI-MedLine.d115.s8|162-169|patients|drug
DDI-MedLine.d115.s8|171-173|who|drug
DDI-MedLine.d115.s8|175-182|received|drug
DDI-MedLine.d115.s8|184-187|CHOP|drug
DDI-MedLine.d115.s8|189-193|alone|drug
DDI-MedLine.d115.s8|195-195|(|drug
DDI-MedLine.d115.s8|196-197|33|drug
DDI-MedLine.d115.s8|198-198|%|drug
DDI-MedLine.d115.s8|200-202|vs.|drug
DDI-MedLine.d115.s8|204-204|7|drug
DDI-MedLine.d115.s8|205-205|%|drug
DDI-MedLine.d115.s8|206-206|,|drug
DDI-MedLine.d115.s8|208-219|respectively|drug
DDI-MedLine.d115.s8|220-220|;|drug
DDI-MedLine.d115.s8|222-222|P|drug
DDI-MedLine.d115.s8|224-224|=|drug
DDI-MedLine.d115.s8|226-230|0.001|drug
DDI-MedLine.d115.s8|231-231|)|drug
DDI-MedLine.d115.s8|232-232|.|drug
DDI-MedLine.d115.s9|0-9|Leukopenia|drug
DDI-MedLine.d115.s9|11-13|was|drug
DDI-MedLine.d115.s9|15-21|similar|drug
DDI-MedLine.d115.s9|23-29|between|drug
DDI-MedLine.d115.s9|31-33|the|drug
DDI-MedLine.d115.s9|35-37|two|drug
DDI-MedLine.d115.s9|39-44|groups|drug
DDI-MedLine.d115.s9|45-45|,|drug
DDI-MedLine.d115.s9|47-49|but|drug
DDI-MedLine.d115.s9|51-56|colony|drug
DDI-MedLine.d115.s9|58-68|stimulating|drug
DDI-MedLine.d115.s9|70-75|factor|drug
DDI-MedLine.d115.s9|77-83|support|drug
DDI-MedLine.d115.s9|85-87|was|drug
DDI-MedLine.d115.s9|89-101|significantly|drug
DDI-MedLine.d115.s9|103-109|greater|drug
DDI-MedLine.d115.s9|111-112|in|drug
DDI-MedLine.d115.s9|114-116|the|drug
DDI-MedLine.d115.s9|118-127|CHOP-HAART|drug
DDI-MedLine.d115.s9|129-133|group|drug
DDI-MedLine.d115.s9|135-138|than|drug
DDI-MedLine.d115.s9|140-141|in|drug
DDI-MedLine.d115.s9|143-145|the|drug
DDI-MedLine.d115.s9|147-153|control|drug
DDI-MedLine.d115.s9|155-159|group|drug
DDI-MedLine.d115.s9|161-161|(|drug
DDI-MedLine.d115.s9|162-163|92|drug
DDI-MedLine.d115.s9|164-164|%|drug
DDI-MedLine.d115.s9|166-168|vs.|drug
DDI-MedLine.d115.s9|170-171|66|drug
DDI-MedLine.d115.s9|172-172|%|drug
DDI-MedLine.d115.s9|173-173|,|drug
DDI-MedLine.d115.s9|175-186|respectively|drug
DDI-MedLine.d115.s9|187-187|;|drug
DDI-MedLine.d115.s9|189-189|P|drug
DDI-MedLine.d115.s9|191-191|=|drug
DDI-MedLine.d115.s9|193-196|0.03|drug
DDI-MedLine.d115.s9|197-197|)|drug
DDI-MedLine.d115.s9|198-198|.|drug
DDI-MedLine.d115.s10|0-8|Seventeen|drug
DDI-MedLine.d115.s10|10-16|percent|drug
DDI-MedLine.d115.s10|18-19|of|drug
DDI-MedLine.d115.s10|21-30|CHOP-HAART|drug
DDI-MedLine.d115.s10|32-39|patients|drug
DDI-MedLine.d115.s10|41-49|developed|drug
DDI-MedLine.d115.s10|51-56|severe|drug
DDI-MedLine.d115.s10|58-66|autonomic|drug
DDI-MedLine.d115.s10|68-80|neurotoxicity|drug
DDI-MedLine.d115.s10|81-81|,|drug
DDI-MedLine.d115.s10|83-89|whereas|drug
DDI-MedLine.d115.s10|91-94|none|drug
DDI-MedLine.d115.s10|96-97|of|drug
DDI-MedLine.d115.s10|99-101|the|drug
DDI-MedLine.d115.s10|103-106|CHOP|drug
DDI-MedLine.d115.s10|108-115|patients|drug
DDI-MedLine.d115.s10|117-125|developed|drug
DDI-MedLine.d115.s10|127-139|neurotoxicity|drug
DDI-MedLine.d115.s10|141-141|(|drug
DDI-MedLine.d115.s10|142-142|P|drug
DDI-MedLine.d115.s10|144-144|=|drug
DDI-MedLine.d115.s10|146-150|0.002|drug
DDI-MedLine.d115.s10|151-151|)|drug
DDI-MedLine.d115.s10|152-152|.|drug
DDI-MedLine.d115.s11|0-1|At|drug
DDI-MedLine.d115.s11|3-9|similar|drug
DDI-MedLine.d115.s11|11-16|median|drug
DDI-MedLine.d115.s11|18-26|follow-up|drug
DDI-MedLine.d115.s11|27-27|,|drug
DDI-MedLine.d115.s11|29-41|opportunistic|drug
DDI-MedLine.d115.s11|43-51|infection|drug
DDI-MedLine.d115.s11|53-53|(|drug
DDI-MedLine.d115.s11|54-55|OI|drug
DDI-MedLine.d115.s11|56-56|)|drug
DDI-MedLine.d115.s11|58-62|rates|drug
DDI-MedLine.d115.s11|64-66|and|drug
DDI-MedLine.d115.s11|68-76|mortality|drug
DDI-MedLine.d115.s11|78-81|were|drug
DDI-MedLine.d115.s11|83-95|significantly|drug
DDI-MedLine.d115.s11|97-101|lower|drug
DDI-MedLine.d115.s11|103-104|in|drug
DDI-MedLine.d115.s11|106-108|the|drug
DDI-MedLine.d115.s11|110-119|CHOP-HAART|drug
DDI-MedLine.d115.s11|121-128|patients|drug
DDI-MedLine.d115.s11|130-133|than|drug
DDI-MedLine.d115.s11|135-136|in|drug
DDI-MedLine.d115.s11|138-140|the|drug
DDI-MedLine.d115.s11|142-145|CHOP|drug
DDI-MedLine.d115.s11|147-154|patients|drug
DDI-MedLine.d115.s11|156-156|(|drug
DDI-MedLine.d115.s11|157-158|18|drug
DDI-MedLine.d115.s11|159-159|%|drug
DDI-MedLine.d115.s11|161-163|vs.|drug
DDI-MedLine.d115.s11|165-166|52|drug
DDI-MedLine.d115.s11|167-167|%|drug
DDI-MedLine.d115.s11|168-168|,|drug
DDI-MedLine.d115.s11|170-181|respectively|drug
DDI-MedLine.d115.s11|182-182|;|drug
DDI-MedLine.d115.s11|184-184|P|drug
DDI-MedLine.d115.s11|186-186|=|drug
DDI-MedLine.d115.s11|188-191|0.05|drug
DDI-MedLine.d115.s11|192-192|;|drug
DDI-MedLine.d115.s11|194-196|and|drug
DDI-MedLine.d115.s11|198-199|38|drug
DDI-MedLine.d115.s11|200-200|%|drug
DDI-MedLine.d115.s11|202-204|vs.|drug
DDI-MedLine.d115.s11|206-207|85|drug
DDI-MedLine.d115.s11|208-208|%|drug
DDI-MedLine.d115.s11|209-209|,|drug
DDI-MedLine.d115.s11|211-222|respectively|drug
DDI-MedLine.d115.s11|223-223|;|drug
DDI-MedLine.d115.s11|225-225|P|drug
DDI-MedLine.d115.s11|227-227|=|drug
DDI-MedLine.d115.s11|229-233|0.001|drug
DDI-MedLine.d115.s11|234-234|)|drug
DDI-MedLine.d115.s11|235-235|.|drug
DDI-MedLine.d115.s12|0-2|The|drug
DDI-MedLine.d115.s12|4-9|median|drug
DDI-MedLine.d115.s12|11-18|survival|drug
DDI-MedLine.d115.s12|20-22|for|drug
DDI-MedLine.d115.s12|24-33|CHOP-HAART|drug
DDI-MedLine.d115.s12|35-42|patients|drug
DDI-MedLine.d115.s12|44-46|was|drug
DDI-MedLine.d115.s12|48-50|not|drug
DDI-MedLine.d115.s12|52-58|reached|drug
DDI-MedLine.d115.s12|59-59|,|drug
DDI-MedLine.d115.s12|61-67|whereas|drug
DDI-MedLine.d115.s12|69-71|the|drug
DDI-MedLine.d115.s12|73-78|medial|drug
DDI-MedLine.d115.s12|80-87|survival|drug
DDI-MedLine.d115.s12|89-90|of|drug
DDI-MedLine.d115.s12|92-95|CHOP|drug
DDI-MedLine.d115.s12|97-104|patients|drug
DDI-MedLine.d115.s12|106-108|was|drug
DDI-MedLine.d115.s12|110-110|7|drug
DDI-MedLine.d115.s12|112-117|months|drug
DDI-MedLine.d115.s12|119-119|(|drug
DDI-MedLine.d115.s12|120-120|P|drug
DDI-MedLine.d115.s12|122-122|=|drug
DDI-MedLine.d115.s12|124-127|0.03|drug
DDI-MedLine.d115.s12|128-128|)|drug
DDI-MedLine.d115.s12|129-129|.|drug
DDI-MedLine.d115.s13|0-10|CONCLUSIONS|drug
DDI-MedLine.d115.s13|11-11|:|drug
DDI-MedLine.d115.s13|13-15|The|drug
DDI-MedLine.d115.s13|17-27|combination|drug
DDI-MedLine.d115.s13|29-30|of|drug
DDI-MedLine.d115.s13|32-35|CHOP|drug
DDI-MedLine.d115.s13|37-40|plus|drug
DDI-MedLine.d115.s13|42-46|HAART|drug
DDI-MedLine.d115.s13|48-49|is|drug
DDI-MedLine.d115.s13|51-58|feasible|drug
DDI-MedLine.d115.s13|60-62|and|drug
DDI-MedLine.d115.s13|64-66|may|drug
DDI-MedLine.d115.s13|68-73|reduce|drug
DDI-MedLine.d115.s13|75-77|the|drug
DDI-MedLine.d115.s13|79-87|morbidity|drug
DDI-MedLine.d115.s13|89-92|from|drug
DDI-MedLine.d115.s13|94-96|OIs|drug
DDI-MedLine.d115.s13|98-99|in|drug
DDI-MedLine.d115.s13|101-107|HIV-NHL|drug
DDI-MedLine.d115.s13|109-116|patients|drug
DDI-MedLine.d115.s13|117-117|.|drug
DDI-MedLine.d115.s14|0-6|However|drug
DDI-MedLine.d115.s14|7-7|,|drug
DDI-MedLine.d115.s14|9-15|careful|drug
DDI-MedLine.d115.s14|17-25|attention|drug
DDI-MedLine.d115.s14|27-30|must|drug
DDI-MedLine.d115.s14|32-33|be|drug
DDI-MedLine.d115.s14|35-42|directed|drug
DDI-MedLine.d115.s14|44-45|to|drug
DDI-MedLine.d115.s14|47-51|cross|drug
DDI-MedLine.d115.s14|53-60|toxicity|drug
DDI-MedLine.d115.s14|62-64|and|drug
DDI-MedLine.d115.s14|66-73|possible|drug
DDI-MedLine.d115.s14|75-89|pharmacokinetic|drug
DDI-MedLine.d115.s14|91-102|interactions|drug
DDI-MedLine.d115.s14|104-110|between|drug
DDI-MedLine.d115.s14|112-125|antiretroviral|drug
DDI-MedLine.d115.s14|127-129|and|drug
DDI-MedLine.d115.s14|131-144|antineoplastic|drug
DDI-MedLine.d115.s14|146-150|drugs|drug
DDI-MedLine.d115.s14|151-151|.|drug
DDI-MedLine.d115.s15|0-2|The|drug
DDI-MedLine.d115.s15|4-9|impact|drug
DDI-MedLine.d115.s15|11-12|of|drug
DDI-MedLine.d115.s15|14-16|the|drug
DDI-MedLine.d115.s15|18-25|combined|drug
DDI-MedLine.d115.s15|27-38|chemotherapy|drug
DDI-MedLine.d115.s15|40-43|plus|drug
DDI-MedLine.d115.s15|45-49|HAART|drug
DDI-MedLine.d115.s15|51-59|treatment|drug
DDI-MedLine.d115.s15|61-62|on|drug
DDI-MedLine.d115.s15|64-70|patient|drug
DDI-MedLine.d115.s15|72-79|survival|drug
DDI-MedLine.d115.s15|81-85|needs|drug
DDI-MedLine.d115.s15|87-94|urgently|drug
DDI-MedLine.d115.s15|96-97|to|drug
DDI-MedLine.d115.s15|99-100|be|drug
DDI-MedLine.d115.s15|102-110|evaluated|drug
DDI-MedLine.d115.s15|112-113|in|drug
DDI-MedLine.d115.s15|115-125|prospective|drug
DDI-MedLine.d115.s15|127-133|studies|drug
DDI-MedLine.d115.s15|134-134|.|drug
DDI-DrugBank.d526.s0|0-3|When|drug
DDI-DrugBank.d526.s0|5-16|administered|drug
DDI-DrugBank.d526.s0|18-29|concurrently|drug
DDI-DrugBank.d526.s0|30-30|,|drug
DDI-DrugBank.d526.s0|32-34|the|drug
DDI-DrugBank.d526.s0|36-44|following|drug
DDI-DrugBank.d526.s0|46-50|drugs|drug
DDI-DrugBank.d526.s0|52-54|may|drug
DDI-DrugBank.d526.s0|56-63|interact|drug
DDI-DrugBank.d526.s0|65-68|with|drug
DDI-DrugBank.d526.s0|70-76|adrenal|drug
DDI-DrugBank.d526.s0|78-92|corticosteroids|drug
DDI-DrugBank.d526.s0|93-93|.|drug
DDI-DrugBank.d526.s1|0-11|Amphotericin|drug
DDI-DrugBank.d526.s1|13-13|B|drug
DDI-DrugBank.d526.s1|15-16|or|drug
DDI-DrugBank.d526.s1|18-36|potassium-depleting|drug
DDI-DrugBank.d526.s1|38-46|diuretics|drug
DDI-DrugBank.d526.s1|48-48|(|drug
DDI-DrugBank.d526.s1|49-65|benzothiadiazines|drug
DDI-DrugBank.d526.s1|67-69|and|drug
DDI-DrugBank.d526.s1|71-77|related|drug
DDI-DrugBank.d526.s1|79-83|drugs|drug
DDI-DrugBank.d526.s1|84-84|,|drug
DDI-DrugBank.d526.s1|86-95|ethacrynic|drug
DDI-DrugBank.d526.s1|97-100|acid|drug
DDI-DrugBank.d526.s1|102-104|and|drug
DDI-DrugBank.d526.s1|106-115|furosemide|drug
DDI-DrugBank.d526.s1|116-116|)|drug
DDI-DrugBank.d526.s1|118-125|enhanced|drug
DDI-DrugBank.d526.s1|127-137|hypokalemia|drug
DDI-DrugBank.d526.s1|138-138|.|drug
DDI-DrugBank.d526.s2|0-4|Check|drug
DDI-DrugBank.d526.s2|6-10|serum|drug
DDI-DrugBank.d526.s2|12-20|potassium|drug
DDI-DrugBank.d526.s2|22-27|levels|drug
DDI-DrugBank.d526.s2|29-30|at|drug
DDI-DrugBank.d526.s2|32-39|frequent|drug
DDI-DrugBank.d526.s2|41-49|intervals|drug
DDI-DrugBank.d526.s2|50-50|;|drug
DDI-DrugBank.d526.s3|0-2|use|drug
DDI-DrugBank.d526.s3|4-12|potassium|drug
DDI-DrugBank.d526.s3|14-24|supplements|drug
DDI-DrugBank.d526.s3|26-27|if|drug
DDI-DrugBank.d526.s3|29-37|necessary|drug
DDI-DrugBank.d526.s3|39-39|.|drug
DDI-DrugBank.d526.s4|0-8|Digitalis|drug
DDI-DrugBank.d526.s4|10-19|glycosides|drug
DDI-DrugBank.d526.s4|21-28|enhanced|drug
DDI-DrugBank.d526.s4|30-40|possibility|drug
DDI-DrugBank.d526.s4|42-43|of|drug
DDI-DrugBank.d526.s4|45-55|arrhythmias|drug
DDI-DrugBank.d526.s4|57-58|or|drug
DDI-DrugBank.d526.s4|60-68|digitalis|drug
DDI-DrugBank.d526.s4|70-77|toxicity|drug
DDI-DrugBank.d526.s4|79-88|associated|drug
DDI-DrugBank.d526.s4|90-93|with|drug
DDI-DrugBank.d526.s4|95-105|hypokalemia|drug
DDI-DrugBank.d526.s4|106-106|.|drug
DDI-DrugBank.d526.s5|0-6|Monitor|drug
DDI-DrugBank.d526.s5|8-12|serum|drug
DDI-DrugBank.d526.s5|14-22|potassium|drug
DDI-DrugBank.d526.s5|24-29|levels|drug
DDI-DrugBank.d526.s5|30-30|;|drug
DDI-DrugBank.d526.s6|0-2|use|drug
DDI-DrugBank.d526.s6|4-12|potassium|drug
DDI-DrugBank.d526.s6|14-24|supplements|drug
DDI-DrugBank.d526.s6|26-27|if|drug
DDI-DrugBank.d526.s6|29-37|necessary|drug
DDI-DrugBank.d526.s6|38-38|.|drug
DDI-DrugBank.d526.s7|0-3|Oral|drug
DDI-DrugBank.d526.s7|5-18|anticoagulants|drug
DDI-DrugBank.d526.s7|20-28|decreased|drug
DDI-DrugBank.d526.s7|30-40|prothrombin|drug
DDI-DrugBank.d526.s7|42-45|time|drug
DDI-DrugBank.d526.s7|47-54|response|drug
DDI-DrugBank.d526.s7|55-55|.|drug
DDI-DrugBank.d526.s8|0-6|Monitor|drug
DDI-DrugBank.d526.s8|8-18|prothrombin|drug
DDI-DrugBank.d526.s8|20-25|levels|drug
DDI-DrugBank.d526.s8|27-29|and|drug
DDI-DrugBank.d526.s8|31-36|adjust|drug
DDI-DrugBank.d526.s8|38-50|anticoagulant|drug
DDI-DrugBank.d526.s8|52-57|dosage|drug
DDI-DrugBank.d526.s8|59-69|accordingly|drug
DDI-DrugBank.d526.s8|70-70|.|drug
DDI-DrugBank.d526.s9|0-11|Antidiabetic|drug
DDI-DrugBank.d526.s9|13-17|drugs|drug
DDI-DrugBank.d526.s9|19-19|(|drug
DDI-DrugBank.d526.s9|20-23|oral|drug
DDI-DrugBank.d526.s9|25-30|agents|drug
DDI-DrugBank.d526.s9|32-34|and|drug
DDI-DrugBank.d526.s9|36-42|insulin|drug
DDI-DrugBank.d526.s9|43-43|)|drug
DDI-DrugBank.d526.s9|45-54|diminished|drug
DDI-DrugBank.d526.s9|56-67|antidiabetic|drug
DDI-DrugBank.d526.s9|69-74|effect|drug
DDI-DrugBank.d526.s9|75-75|.|drug
DDI-DrugBank.d526.s10|0-6|Monitor|drug
DDI-DrugBank.d526.s10|8-10|for|drug
DDI-DrugBank.d526.s10|12-19|symptoms|drug
DDI-DrugBank.d526.s10|21-22|of|drug
DDI-DrugBank.d526.s10|24-36|hyperglycemia|drug
DDI-DrugBank.d526.s10|37-37|;|drug
DDI-DrugBank.d526.s11|0-5|adjust|drug
DDI-DrugBank.d526.s11|7-12|dosage|drug
DDI-DrugBank.d526.s11|14-15|of|drug
DDI-DrugBank.d526.s11|17-28|antidiabetic|drug
DDI-DrugBank.d526.s11|30-33|drug|drug
DDI-DrugBank.d526.s11|35-40|upward|drug
DDI-DrugBank.d526.s11|42-43|if|drug
DDI-DrugBank.d526.s11|45-53|necessary|drug
DDI-DrugBank.d526.s11|54-54|.|drug
DDI-DrugBank.d526.s12|0-6|Aspirin|drug
DDI-DrugBank.d526.s12|8-16|increased|drug
DDI-DrugBank.d526.s12|18-28|ulcerogenic|drug
DDI-DrugBank.d526.s12|30-35|effect|drug
DDI-DrugBank.d526.s12|36-36|;|drug
DDI-DrugBank.d526.s13|0-8|decreased|drug
DDI-DrugBank.d526.s13|10-22|pharmacologic|drug
DDI-DrugBank.d526.s13|24-29|effect|drug
DDI-DrugBank.d526.s13|31-32|of|drug
DDI-DrugBank.d526.s13|34-40|aspirin|drug
DDI-DrugBank.d526.s13|41-41|.|drug
DDI-DrugBank.d526.s14|0-5|Rarely|drug
DDI-DrugBank.d526.s14|7-16|salicylate|drug
DDI-DrugBank.d526.s14|18-25|toxicity|drug
DDI-DrugBank.d526.s14|27-29|may|drug
DDI-DrugBank.d526.s14|31-35|occur|drug
DDI-DrugBank.d526.s14|37-38|in|drug
DDI-DrugBank.d526.s14|40-47|patients|drug
DDI-DrugBank.d526.s14|49-51|who|drug
DDI-DrugBank.d526.s14|53-63|discontinue|drug
DDI-DrugBank.d526.s14|65-72|steroids|drug
DDI-DrugBank.d526.s14|74-78|after|drug
DDI-DrugBank.d526.s14|80-89|concurrent|drug
DDI-DrugBank.d526.s14|91-99|high-dose|drug
DDI-DrugBank.d526.s14|101-107|aspirin|drug
DDI-DrugBank.d526.s14|109-115|therapy|drug
DDI-DrugBank.d526.s14|116-116|.|drug
DDI-DrugBank.d526.s15|0-6|Monitor|drug
DDI-DrugBank.d526.s15|8-17|salicylate|drug
DDI-DrugBank.d526.s15|19-24|levels|drug
DDI-DrugBank.d526.s15|26-27|or|drug
DDI-DrugBank.d526.s15|29-31|the|drug
DDI-DrugBank.d526.s15|33-43|therapeutic|drug
DDI-DrugBank.d526.s15|45-50|effect|drug
DDI-DrugBank.d526.s15|52-54|for|drug
DDI-DrugBank.d526.s15|56-60|which|drug
DDI-DrugBank.d526.s15|62-68|aspirin|drug
DDI-DrugBank.d526.s15|70-71|is|drug
DDI-DrugBank.d526.s15|73-77|given|drug
DDI-DrugBank.d526.s15|78-78|;|drug
DDI-DrugBank.d526.s16|0-5|adjust|drug
DDI-DrugBank.d526.s16|7-16|salicylate|drug
DDI-DrugBank.d526.s16|18-23|dosage|drug
DDI-DrugBank.d526.s16|25-35|accordingly|drug
DDI-DrugBank.d526.s16|37-38|if|drug
DDI-DrugBank.d526.s16|40-45|effect|drug
DDI-DrugBank.d526.s16|47-48|is|drug
DDI-DrugBank.d526.s16|50-56|altered|drug
DDI-DrugBank.d526.s16|57-57|.|drug
DDI-DrugBank.d526.s17|0-11|Barbiturates|drug
DDI-DrugBank.d526.s17|12-12|,|drug
DDI-DrugBank.d526.s17|14-22|phenytoin|drug
DDI-DrugBank.d526.s17|23-23|,|drug
DDI-DrugBank.d526.s17|25-26|or|drug
DDI-DrugBank.d526.s17|28-35|rifampin|drug
DDI-DrugBank.d526.s17|37-45|increased|drug
DDI-DrugBank.d526.s17|47-55|metabolic|drug
DDI-DrugBank.d526.s17|57-65|clearance|drug
DDI-DrugBank.d526.s17|67-68|of|drug
DDI-DrugBank.d526.s17|70-84|fludrocortisone|drug
DDI-DrugBank.d526.s17|86-92|acetate|drug
DDI-DrugBank.d526.s17|94-100|because|drug
DDI-DrugBank.d526.s17|102-103|of|drug
DDI-DrugBank.d526.s17|105-107|the|drug
DDI-DrugBank.d526.s17|109-117|induction|drug
DDI-DrugBank.d526.s17|119-120|of|drug
DDI-DrugBank.d526.s17|122-128|hepatic|drug
DDI-DrugBank.d526.s17|130-136|enzymes|drug
DDI-DrugBank.d526.s17|137-137|.|drug
DDI-DrugBank.d526.s18|0-6|Observe|drug
DDI-DrugBank.d526.s18|8-10|the|drug
DDI-DrugBank.d526.s18|12-18|patient|drug
DDI-DrugBank.d526.s18|20-22|for|drug
DDI-DrugBank.d526.s18|24-31|possible|drug
DDI-DrugBank.d526.s18|33-42|diminished|drug
DDI-DrugBank.d526.s18|44-49|effect|drug
DDI-DrugBank.d526.s18|51-52|of|drug
DDI-DrugBank.d526.s18|54-60|steroid|drug
DDI-DrugBank.d526.s18|62-64|and|drug
DDI-DrugBank.d526.s18|66-73|increase|drug
DDI-DrugBank.d526.s18|75-77|the|drug
DDI-DrugBank.d526.s18|79-85|steroid|drug
DDI-DrugBank.d526.s18|87-92|dosage|drug
DDI-DrugBank.d526.s18|94-104|accordingly|drug
DDI-DrugBank.d526.s18|105-105|.|drug
DDI-DrugBank.d526.s19|0-7|Anabolic|drug
DDI-DrugBank.d526.s19|9-16|steroids|drug
DDI-DrugBank.d526.s19|18-18|(|drug
DDI-DrugBank.d526.s19|19-30|particularly|drug
DDI-DrugBank.d526.s19|32-35|C-17|drug
DDI-DrugBank.d526.s19|37-45|alkylated|drug
DDI-DrugBank.d526.s19|47-55|androgens|drug
DDI-DrugBank.d526.s19|57-60|such|drug
DDI-DrugBank.d526.s19|62-63|as|drug
DDI-DrugBank.d526.s19|65-76|oxymetholone|drug
DDI-DrugBank.d526.s19|77-77|,|drug
DDI-DrugBank.d526.s19|79-96|methandrostenolone|drug
DDI-DrugBank.d526.s19|97-97|,|drug
DDI-DrugBank.d526.s19|99-113|norethandrolone|drug
DDI-DrugBank.d526.s19|114-114|,|drug
DDI-DrugBank.d526.s19|116-118|and|drug
DDI-DrugBank.d526.s19|120-126|similar|drug
DDI-DrugBank.d526.s19|128-136|compounds|drug
DDI-DrugBank.d526.s19|137-137|)|drug
DDI-DrugBank.d526.s19|139-146|enhanced|drug
DDI-DrugBank.d526.s19|148-155|tendency|drug
DDI-DrugBank.d526.s19|157-162|toward|drug
DDI-DrugBank.d526.s19|164-168|edema|drug
DDI-DrugBank.d526.s19|169-169|.|drug
DDI-DrugBank.d526.s20|0-2|Use|drug
DDI-DrugBank.d526.s20|4-10|caution|drug
DDI-DrugBank.d526.s20|12-15|when|drug
DDI-DrugBank.d526.s20|17-22|giving|drug
DDI-DrugBank.d526.s20|24-28|these|drug
DDI-DrugBank.d526.s20|30-34|drugs|drug
DDI-DrugBank.d526.s20|36-43|together|drug
DDI-DrugBank.d526.s20|44-44|,|drug
DDI-DrugBank.d526.s20|46-55|especially|drug
DDI-DrugBank.d526.s20|57-58|in|drug
DDI-DrugBank.d526.s20|60-67|patients|drug
DDI-DrugBank.d526.s20|69-72|with|drug
DDI-DrugBank.d526.s20|74-80|hepatic|drug
DDI-DrugBank.d526.s20|82-83|or|drug
DDI-DrugBank.d526.s20|85-91|cardiac|drug
DDI-DrugBank.d526.s20|93-99|disease|drug
DDI-DrugBank.d526.s20|100-100|.|drug
DDI-DrugBank.d526.s21|0-7|Vaccines|drug
DDI-DrugBank.d526.s21|9-20|neurological|drug
DDI-DrugBank.d526.s21|22-34|complications|drug
DDI-DrugBank.d526.s21|36-38|and|drug
DDI-DrugBank.d526.s21|40-43|lack|drug
DDI-DrugBank.d526.s21|45-46|of|drug
DDI-DrugBank.d526.s21|48-55|antibody|drug
DDI-DrugBank.d526.s21|57-64|response|drug
DDI-DrugBank.d526.s21|66-66|.|drug
DDI-DrugBank.d526.s22|0-7|Estrogen|drug
DDI-DrugBank.d526.s22|9-17|increased|drug
DDI-DrugBank.d526.s22|19-24|levels|drug
DDI-DrugBank.d526.s22|26-27|of|drug
DDI-DrugBank.d526.s22|29-50|corticosteroid-binding|drug
DDI-DrugBank.d526.s22|52-59|globulin|drug
DDI-DrugBank.d526.s22|60-60|,|drug
DDI-DrugBank.d526.s22|62-68|thereby|drug
DDI-DrugBank.d526.s22|70-79|increasing|drug
DDI-DrugBank.d526.s22|81-83|the|drug
DDI-DrugBank.d526.s22|85-89|bound|drug
DDI-DrugBank.d526.s22|91-91|(|drug
DDI-DrugBank.d526.s22|92-99|inactive|drug
DDI-DrugBank.d526.s22|100-100|)|drug
DDI-DrugBank.d526.s22|102-109|fraction|drug
DDI-DrugBank.d526.s22|110-110|;|drug
DDI-DrugBank.d526.s23|0-3|this|drug
DDI-DrugBank.d526.s23|5-10|effect|drug
DDI-DrugBank.d526.s23|12-13|is|drug
DDI-DrugBank.d526.s23|15-16|at|drug
DDI-DrugBank.d526.s23|18-22|least|drug
DDI-DrugBank.d526.s23|24-31|balanced|drug
DDI-DrugBank.d526.s23|33-34|by|drug
DDI-DrugBank.d526.s23|36-44|decreased|drug
DDI-DrugBank.d526.s23|46-55|metabolism|drug
DDI-DrugBank.d526.s23|57-58|of|drug
DDI-DrugBank.d526.s23|60-74|corticosteroids|drug
DDI-DrugBank.d526.s23|75-75|.|drug
DDI-DrugBank.d526.s24|0-3|When|drug
DDI-DrugBank.d526.s24|5-12|estrogen|drug
DDI-DrugBank.d526.s24|14-20|therapy|drug
DDI-DrugBank.d526.s24|22-23|is|drug
DDI-DrugBank.d526.s24|25-33|initiated|drug
DDI-DrugBank.d526.s24|34-34|,|drug
DDI-DrugBank.d526.s24|36-36|a|drug
DDI-DrugBank.d526.s24|38-46|reduction|drug
DDI-DrugBank.d526.s24|48-49|in|drug
DDI-DrugBank.d526.s24|51-64|corticosteroid|drug
DDI-DrugBank.d526.s24|66-71|dosage|drug
DDI-DrugBank.d526.s24|73-75|may|drug
DDI-DrugBank.d526.s24|77-78|be|drug
DDI-DrugBank.d526.s24|80-87|required|drug
DDI-DrugBank.d526.s24|88-88|,|drug
DDI-DrugBank.d526.s24|90-92|and|drug
DDI-DrugBank.d526.s24|94-102|increased|drug
DDI-DrugBank.d526.s24|104-110|amounts|drug
DDI-DrugBank.d526.s24|112-114|may|drug
DDI-DrugBank.d526.s24|116-117|be|drug
DDI-DrugBank.d526.s24|119-126|required|drug
DDI-DrugBank.d526.s24|128-131|when|drug
DDI-DrugBank.d526.s24|133-140|estrogen|drug
DDI-DrugBank.d526.s24|142-143|is|drug
DDI-DrugBank.d526.s24|145-154|terminated|drug
DDI-DrugBank.d526.s24|155-155|.|drug
DDI-DrugBank.d526.s25|0-14|Drug/Laboratory|drug
DDI-DrugBank.d526.s25|16-19|Test|drug
DDI-DrugBank.d526.s25|21-32|Interactions|drug
DDI-DrugBank.d526.s25|34-48|Corticosteroids|drug
DDI-DrugBank.d526.s25|50-52|may|drug
DDI-DrugBank.d526.s25|54-59|affect|drug
DDI-DrugBank.d526.s25|61-63|the|drug
DDI-DrugBank.d526.s25|65-84|nitrobluetetrazolium|drug
DDI-DrugBank.d526.s25|86-89|test|drug
DDI-DrugBank.d526.s25|91-93|for|drug
DDI-DrugBank.d526.s25|95-103|bacterial|drug
DDI-DrugBank.d526.s25|105-113|infection|drug
DDI-DrugBank.d526.s25|115-117|and|drug
DDI-DrugBank.d526.s25|119-125|produce|drug
DDI-DrugBank.d526.s25|127-140|false-negative|drug
DDI-DrugBank.d526.s25|142-148|results|drug
DDI-DrugBank.d526.s26|0-0|.|drug
DDI-DrugBank.d710.s0|0-9|Cimetidine|drug
DDI-DrugBank.d710.s0|10-10|:|drug
DDI-DrugBank.d710.s0|12-14|The|drug
DDI-DrugBank.d710.s0|16-22|effects|drug
DDI-DrugBank.d710.s0|24-25|of|drug
DDI-DrugBank.d710.s0|27-33|chronic|drug
DDI-DrugBank.d710.s0|35-44|cimetidine|drug
DDI-DrugBank.d710.s0|46-48|use|drug
DDI-DrugBank.d710.s0|50-51|on|drug
DDI-DrugBank.d710.s0|53-55|the|drug
DDI-DrugBank.d710.s0|57-66|metabolism|drug
DDI-DrugBank.d710.s0|68-69|of|drug
DDI-DrugBank.d710.s0|71-81|rimantadine|drug
DDI-DrugBank.d710.s0|83-85|are|drug
DDI-DrugBank.d710.s0|87-89|not|drug
DDI-DrugBank.d710.s0|91-95|known|drug
DDI-DrugBank.d710.s0|96-96|.|drug
DDI-DrugBank.d710.s1|0-3|When|drug
DDI-DrugBank.d710.s1|5-5|a|drug
DDI-DrugBank.d710.s1|7-12|single|drug
DDI-DrugBank.d710.s1|14-16|100|drug
DDI-DrugBank.d710.s1|18-19|mg|drug
DDI-DrugBank.d710.s1|21-24|dose|drug
DDI-DrugBank.d710.s1|26-27|of|drug
DDI-DrugBank.d710.s1|29-39|rimantadine|drug
DDI-DrugBank.d710.s1|41-43|HCl|drug
DDI-DrugBank.d710.s1|45-47|was|drug
DDI-DrugBank.d710.s1|49-60|administered|drug
DDI-DrugBank.d710.s1|62-64|one|drug
DDI-DrugBank.d710.s1|66-69|hour|drug
DDI-DrugBank.d710.s1|71-75|after|drug
DDI-DrugBank.d710.s1|77-79|the|drug
DDI-DrugBank.d710.s1|81-90|initiation|drug
DDI-DrugBank.d710.s1|92-93|of|drug
DDI-DrugBank.d710.s1|95-104|Cimetidine|drug
DDI-DrugBank.d710.s1|106-106|(|drug
DDI-DrugBank.d710.s1|107-109|300|drug
DDI-DrugBank.d710.s1|111-112|mg|drug
DDI-DrugBank.d710.s1|114-117|four|drug
DDI-DrugBank.d710.s1|119-123|times|drug
DDI-DrugBank.d710.s1|125-125|a|drug
DDI-DrugBank.d710.s1|127-129|day|drug
DDI-DrugBank.d710.s1|130-130|)|drug
DDI-DrugBank.d710.s1|131-131|,|drug
DDI-DrugBank.d710.s1|133-135|the|drug
DDI-DrugBank.d710.s1|137-144|apparent|drug
DDI-DrugBank.d710.s1|146-150|total|drug
DDI-DrugBank.d710.s1|152-162|rimantadine|drug
DDI-DrugBank.d710.s1|164-172|clearance|drug
DDI-DrugBank.d710.s1|174-175|of|drug
DDI-DrugBank.d710.s1|177-180|this|drug
DDI-DrugBank.d710.s1|182-187|single|drug
DDI-DrugBank.d710.s1|189-192|dose|drug
DDI-DrugBank.d710.s1|194-195|in|drug
DDI-DrugBank.d710.s1|197-202|normal|drug
DDI-DrugBank.d710.s1|204-210|healthy|drug
DDI-DrugBank.d710.s1|212-217|adults|drug
DDI-DrugBank.d710.s1|219-221|was|drug
DDI-DrugBank.d710.s1|223-229|reduced|drug
DDI-DrugBank.d710.s1|231-232|by|drug
DDI-DrugBank.d710.s1|234-235|18|drug
DDI-DrugBank.d710.s1|236-236|%|drug
DDI-DrugBank.d710.s1|238-238|(|drug
DDI-DrugBank.d710.s1|239-246|compared|drug
DDI-DrugBank.d710.s1|248-249|to|drug
DDI-DrugBank.d710.s1|251-253|the|drug
DDI-DrugBank.d710.s1|255-262|apparent|drug
DDI-DrugBank.d710.s1|264-268|total|drug
DDI-DrugBank.d710.s1|270-280|rimantadine|drug
DDI-DrugBank.d710.s1|282-290|clearance|drug
DDI-DrugBank.d710.s1|292-293|in|drug
DDI-DrugBank.d710.s1|295-297|the|drug
DDI-DrugBank.d710.s1|299-302|same|drug
DDI-DrugBank.d710.s1|304-311|subjects|drug
DDI-DrugBank.d710.s1|313-314|in|drug
DDI-DrugBank.d710.s1|316-318|the|drug
DDI-DrugBank.d710.s1|320-326|absence|drug
DDI-DrugBank.d710.s1|328-329|of|drug
DDI-DrugBank.d710.s1|331-340|cimetidine|drug
DDI-DrugBank.d710.s1|341-341|)|drug
DDI-DrugBank.d710.s1|342-342|.|drug
DDI-DrugBank.d710.s2|0-12|Acetaminophen|drug
DDI-DrugBank.d710.s2|13-13|:|drug
DDI-DrugBank.d710.s2|15-25|Rimantadine|drug
DDI-DrugBank.d710.s2|27-29|HCl|drug
DDI-DrugBank.d710.s2|30-30|,|drug
DDI-DrugBank.d710.s2|32-34|100|drug
DDI-DrugBank.d710.s2|36-37|mg|drug
DDI-DrugBank.d710.s2|38-38|,|drug
DDI-DrugBank.d710.s2|40-42|was|drug
DDI-DrugBank.d710.s2|44-48|given|drug
DDI-DrugBank.d710.s2|50-54|twice|drug
DDI-DrugBank.d710.s2|56-60|daily|drug
DDI-DrugBank.d710.s2|62-64|for|drug
DDI-DrugBank.d710.s2|66-67|13|drug
DDI-DrugBank.d710.s2|69-72|days|drug
DDI-DrugBank.d710.s2|74-75|to|drug
DDI-DrugBank.d710.s2|77-78|12|drug
DDI-DrugBank.d710.s2|80-86|healthy|drug
DDI-DrugBank.d710.s2|88-97|volunteers|drug
DDI-DrugBank.d710.s2|98-98|.|drug
DDI-DrugBank.d710.s3|0-1|On|drug
DDI-DrugBank.d710.s3|3-5|day|drug
DDI-DrugBank.d710.s3|7-8|11|drug
DDI-DrugBank.d710.s3|9-9|,|drug
DDI-DrugBank.d710.s3|11-23|acetaminophen|drug
DDI-DrugBank.d710.s3|25-25|(|drug
DDI-DrugBank.d710.s3|26-28|650|drug
DDI-DrugBank.d710.s3|30-31|mg|drug
DDI-DrugBank.d710.s3|33-36|four|drug
DDI-DrugBank.d710.s3|38-42|times|drug
DDI-DrugBank.d710.s3|44-48|daily|drug
DDI-DrugBank.d710.s3|49-49|)|drug
DDI-DrugBank.d710.s3|51-53|was|drug
DDI-DrugBank.d710.s3|55-61|started|drug
DDI-DrugBank.d710.s3|63-65|and|drug
DDI-DrugBank.d710.s3|67-75|continued|drug
DDI-DrugBank.d710.s3|77-79|for|drug
DDI-DrugBank.d710.s3|81-81|8|drug
DDI-DrugBank.d710.s3|83-86|days|drug
DDI-DrugBank.d710.s3|87-87|.|drug
DDI-DrugBank.d710.s4|0-2|The|drug
DDI-DrugBank.d710.s4|4-19|pharmacokinetics|drug
DDI-DrugBank.d710.s4|21-22|of|drug
DDI-DrugBank.d710.s4|24-34|rimantadine|drug
DDI-DrugBank.d710.s4|36-39|were|drug
DDI-DrugBank.d710.s4|41-48|assessed|drug
DDI-DrugBank.d710.s4|50-51|on|drug
DDI-DrugBank.d710.s4|53-56|days|drug
DDI-DrugBank.d710.s4|58-59|11|drug
DDI-DrugBank.d710.s4|61-63|and|drug
DDI-DrugBank.d710.s4|65-66|13|drug
DDI-DrugBank.d710.s4|67-67|.|drug
DDI-DrugBank.d710.s5|0-15|Coadministration|drug
DDI-DrugBank.d710.s5|17-20|with|drug
DDI-DrugBank.d710.s5|22-34|acetaminophen|drug
DDI-DrugBank.d710.s5|36-42|reduced|drug
DDI-DrugBank.d710.s5|44-46|the|drug
DDI-DrugBank.d710.s5|48-51|peak|drug
DDI-DrugBank.d710.s5|53-65|concentration|drug
DDI-DrugBank.d710.s5|67-69|and|drug
DDI-DrugBank.d710.s5|71-73|AUC|drug
DDI-DrugBank.d710.s5|75-80|values|drug
DDI-DrugBank.d710.s5|82-84|for|drug
DDI-DrugBank.d710.s5|86-96|rimantadine|drug
DDI-DrugBank.d710.s5|98-99|by|drug
DDI-DrugBank.d710.s5|101-113|approximately|drug
DDI-DrugBank.d710.s5|115-116|11|drug
DDI-DrugBank.d710.s5|117-117|%|drug
DDI-DrugBank.d710.s5|118-118|.|drug
DDI-DrugBank.d710.s6|0-6|Aspirin|drug
DDI-DrugBank.d710.s6|7-7|:|drug
DDI-DrugBank.d710.s6|9-19|Rimantadine|drug
DDI-DrugBank.d710.s6|21-23|HCl|drug
DDI-DrugBank.d710.s6|24-24|,|drug
DDI-DrugBank.d710.s6|26-28|100|drug
DDI-DrugBank.d710.s6|30-31|mg|drug
DDI-DrugBank.d710.s6|32-32|,|drug
DDI-DrugBank.d710.s6|34-36|was|drug
DDI-DrugBank.d710.s6|38-42|given|drug
DDI-DrugBank.d710.s6|44-48|twice|drug
DDI-DrugBank.d710.s6|50-54|daily|drug
DDI-DrugBank.d710.s6|56-58|fro|drug
DDI-DrugBank.d710.s6|60-61|13|drug
DDI-DrugBank.d710.s6|63-66|days|drug
DDI-DrugBank.d710.s6|68-69|to|drug
DDI-DrugBank.d710.s6|71-72|12|drug
DDI-DrugBank.d710.s6|74-80|healthy|drug
DDI-DrugBank.d710.s6|82-91|volunteers|drug
DDI-DrugBank.d710.s6|92-92|.|drug
DDI-DrugBank.d710.s7|0-1|On|drug
DDI-DrugBank.d710.s7|3-5|day|drug
DDI-DrugBank.d710.s7|7-8|11|drug
DDI-DrugBank.d710.s7|9-9|,|drug
DDI-DrugBank.d710.s7|11-17|aspirin|drug
DDI-DrugBank.d710.s7|19-19|(|drug
DDI-DrugBank.d710.s7|20-22|650|drug
DDI-DrugBank.d710.s7|24-25|mg|drug
DDI-DrugBank.d710.s7|26-26|,|drug
DDI-DrugBank.d710.s7|28-31|four|drug
DDI-DrugBank.d710.s7|33-37|times|drug
DDI-DrugBank.d710.s7|39-43|daily|drug
DDI-DrugBank.d710.s7|44-44|)|drug
DDI-DrugBank.d710.s7|46-48|was|drug
DDI-DrugBank.d710.s7|50-56|started|drug
DDI-DrugBank.d710.s7|58-60|and|drug
DDI-DrugBank.d710.s7|62-70|continued|drug
DDI-DrugBank.d710.s7|72-74|for|drug
DDI-DrugBank.d710.s7|76-76|8|drug
DDI-DrugBank.d710.s7|78-81|days|drug
DDI-DrugBank.d710.s7|82-82|.|drug
DDI-DrugBank.d710.s8|0-2|The|drug
DDI-DrugBank.d710.s8|4-19|pharmacokinetics|drug
DDI-DrugBank.d710.s8|21-22|of|drug
DDI-DrugBank.d710.s8|24-34|rimantadine|drug
DDI-DrugBank.d710.s8|36-39|were|drug
DDI-DrugBank.d710.s8|41-48|assessed|drug
DDI-DrugBank.d710.s8|50-51|on|drug
DDI-DrugBank.d710.s8|53-56|days|drug
DDI-DrugBank.d710.s8|58-59|11|drug
DDI-DrugBank.d710.s8|61-63|and|drug
DDI-DrugBank.d710.s8|65-66|13|drug
DDI-DrugBank.d710.s8|67-67|.|drug
DDI-DrugBank.d710.s9|0-3|Peak|drug
DDI-DrugBank.d710.s9|5-10|plasma|drug
DDI-DrugBank.d710.s9|12-25|concentrations|drug
DDI-DrugBank.d710.s9|27-29|and|drug
DDI-DrugBank.d710.s9|31-33|AUC|drug
DDI-DrugBank.d710.s9|35-36|of|drug
DDI-DrugBank.d710.s9|38-48|rimantadine|drug
DDI-DrugBank.d710.s9|50-53|were|drug
DDI-DrugBank.d710.s9|55-61|reduced|drug
DDI-DrugBank.d710.s9|63-75|approximately|drug
DDI-DrugBank.d710.s9|77-78|10|drug
DDI-DrugBank.d710.s9|79-79|%|drug
DDI-DrugBank.d710.s9|81-82|in|drug
DDI-DrugBank.d710.s9|84-86|the|drug
DDI-DrugBank.d710.s9|88-95|presence|drug
DDI-DrugBank.d710.s9|97-98|of|drug
DDI-DrugBank.d710.s9|100-106|aspirin|drug
DDI-DrugBank.d710.s9|107-107|.|drug
DDI-DrugBank.d557.s0|0-14|Drug/Laboratory|drug
DDI-DrugBank.d557.s0|16-19|Test|drug
DDI-DrugBank.d557.s0|21-32|Interactions|drug
DDI-DrugBank.d557.s0|34-41|Positive|drug
DDI-DrugBank.d557.s0|43-48|direct|drug
DDI-DrugBank.d557.s0|50-55|Coombs|drug
DDI-DrugBank.d557.s0|58-62|tests|drug
DDI-DrugBank.d557.s0|64-67|have|drug
DDI-DrugBank.d557.s0|69-72|been|drug
DDI-DrugBank.d557.s0|74-81|reported|drug
DDI-DrugBank.d557.s0|83-88|during|drug
DDI-DrugBank.d557.s0|90-98|treatment|drug
DDI-DrugBank.d557.s0|100-103|with|drug
DDI-DrugBank.d557.s0|105-107|the|drug
DDI-DrugBank.d557.s0|109-121|cephalosporin|drug
DDI-DrugBank.d557.s0|123-133|antibiotics|drug
DDI-DrugBank.d557.s0|134-134|.|drug
DDI-DrugBank.d557.s1|0-1|In|drug
DDI-DrugBank.d557.s1|3-13|hematologic|drug
DDI-DrugBank.d557.s1|15-21|studies|drug
DDI-DrugBank.d557.s1|23-24|or|drug
DDI-DrugBank.d557.s1|26-27|in|drug
DDI-DrugBank.d557.s1|29-39|transfusion|drug
DDI-DrugBank.d557.s1|41-54|cross-matching|drug
DDI-DrugBank.d557.s1|56-65|procedures|drug
DDI-DrugBank.d557.s1|67-70|when|drug
DDI-DrugBank.d557.s1|72-84|anti-globulin|drug
DDI-DrugBank.d557.s1|86-90|tests|drug
DDI-DrugBank.d557.s1|92-94|are|drug
DDI-DrugBank.d557.s1|96-104|performed|drug
DDI-DrugBank.d557.s1|106-107|on|drug
DDI-DrugBank.d557.s1|109-111|the|drug
DDI-DrugBank.d557.s1|113-117|minor|drug
DDI-DrugBank.d557.s1|119-122|side|drug
DDI-DrugBank.d557.s1|124-125|or|drug
DDI-DrugBank.d557.s1|127-128|in|drug
DDI-DrugBank.d557.s1|130-135|Coombs|drug
DDI-DrugBank.d557.s1|138-144|testing|drug
DDI-DrugBank.d557.s1|146-147|of|drug
DDI-DrugBank.d557.s1|149-156|newborns|drug
DDI-DrugBank.d557.s1|158-162|whose|drug
DDI-DrugBank.d557.s1|164-170|mothers|drug
DDI-DrugBank.d557.s1|172-175|have|drug
DDI-DrugBank.d557.s1|177-184|received|drug
DDI-DrugBank.d557.s1|186-198|cephalosporin|drug
DDI-DrugBank.d557.s1|200-210|antibiotics|drug
DDI-DrugBank.d557.s1|212-217|before|drug
DDI-DrugBank.d557.s1|219-229|parturition|drug
DDI-DrugBank.d557.s1|230-230|,|drug
DDI-DrugBank.d557.s1|232-233|it|drug
DDI-DrugBank.d557.s1|235-240|should|drug
DDI-DrugBank.d557.s1|242-243|be|drug
DDI-DrugBank.d557.s1|245-254|recognized|drug
DDI-DrugBank.d557.s1|256-259|that|drug
DDI-DrugBank.d557.s1|261-261|a|drug
DDI-DrugBank.d557.s1|263-270|positive|drug
DDI-DrugBank.d557.s1|272-277|Coombs|drug
DDI-DrugBank.d557.s1|280-283|test|drug
DDI-DrugBank.d557.s1|285-287|may|drug
DDI-DrugBank.d557.s1|289-290|be|drug
DDI-DrugBank.d557.s1|292-294|due|drug
DDI-DrugBank.d557.s1|296-297|to|drug
DDI-DrugBank.d557.s1|299-301|the|drug
DDI-DrugBank.d557.s1|303-306|drug|drug
DDI-DrugBank.d557.s1|307-307|.|drug
DDI-DrugBank.d55.s0|0-12|Isoproterenol|drug
DDI-DrugBank.d55.s0|14-26|hydrochloride|drug
DDI-DrugBank.d55.s0|28-36|injection|drug
DDI-DrugBank.d55.s0|38-40|and|drug
DDI-DrugBank.d55.s0|42-52|epinephrine|drug
DDI-DrugBank.d55.s0|54-59|should|drug
DDI-DrugBank.d55.s0|61-63|not|drug
DDI-DrugBank.d55.s0|65-66|be|drug
DDI-DrugBank.d55.s0|68-79|administered|drug
DDI-DrugBank.d55.s0|81-94|simultaneously|drug
DDI-DrugBank.d55.s0|96-102|because|drug
DDI-DrugBank.d55.s0|104-107|both|drug
DDI-DrugBank.d55.s0|109-113|drugs|drug
DDI-DrugBank.d55.s0|115-117|are|drug
DDI-DrugBank.d55.s0|119-124|direct|drug
DDI-DrugBank.d55.s0|126-132|cardiac|drug
DDI-DrugBank.d55.s0|134-143|stimulants|drug
DDI-DrugBank.d55.s0|145-147|and|drug
DDI-DrugBank.d55.s0|149-153|their|drug
DDI-DrugBank.d55.s0|155-162|combined|drug
DDI-DrugBank.d55.s0|164-170|effects|drug
DDI-DrugBank.d55.s0|172-174|may|drug
DDI-DrugBank.d55.s0|176-181|induce|drug
DDI-DrugBank.d55.s0|183-189|serious|drug
DDI-DrugBank.d55.s0|191-201|arrhythmias|drug
DDI-DrugBank.d55.s0|202-202|.|drug
DDI-DrugBank.d55.s1|0-2|The|drug
DDI-DrugBank.d55.s1|4-8|drugs|drug
DDI-DrugBank.d55.s1|10-12|may|drug
DDI-DrugBank.d55.s1|13-13|,|drug
DDI-DrugBank.d55.s1|15-21|however|drug
DDI-DrugBank.d55.s1|22-22|,|drug
DDI-DrugBank.d55.s1|24-25|be|drug
DDI-DrugBank.d55.s1|27-38|administered|drug
DDI-DrugBank.d55.s1|40-50|alternately|drug
DDI-DrugBank.d55.s1|52-59|provided|drug
DDI-DrugBank.d55.s1|61-61|a|drug
DDI-DrugBank.d55.s1|63-68|proper|drug
DDI-DrugBank.d55.s1|70-77|interval|drug
DDI-DrugBank.d55.s1|79-81|has|drug
DDI-DrugBank.d55.s1|83-89|elapsed|drug
DDI-DrugBank.d55.s1|91-97|between|drug
DDI-DrugBank.d55.s1|99-103|doses|drug
DDI-DrugBank.d55.s1|104-104|.|drug
DDI-DrugBank.d55.s2|0-6|ISUPREL|drug
DDI-DrugBank.d55.s2|8-13|should|drug
DDI-DrugBank.d55.s2|15-16|be|drug
DDI-DrugBank.d55.s2|18-21|used|drug
DDI-DrugBank.d55.s2|23-26|with|drug
DDI-DrugBank.d55.s2|28-34|caution|drug
DDI-DrugBank.d55.s2|35-35|,|drug
DDI-DrugBank.d55.s2|37-38|if|drug
DDI-DrugBank.d55.s2|40-41|at|drug
DDI-DrugBank.d55.s2|43-45|all|drug
DDI-DrugBank.d55.s2|46-46|,|drug
DDI-DrugBank.d55.s2|48-51|when|drug
DDI-DrugBank.d55.s2|53-58|potent|drug
DDI-DrugBank.d55.s2|60-71|inhalational|drug
DDI-DrugBank.d55.s2|73-83|anesthetics|drug
DDI-DrugBank.d55.s2|85-88|such|drug
DDI-DrugBank.d55.s2|90-91|as|drug
DDI-DrugBank.d55.s2|93-101|halothane|drug
DDI-DrugBank.d55.s2|103-105|are|drug
DDI-DrugBank.d55.s2|107-114|employed|drug
DDI-DrugBank.d55.s2|116-122|because|drug
DDI-DrugBank.d55.s2|124-125|of|drug
DDI-DrugBank.d55.s2|127-135|potential|drug
DDI-DrugBank.d55.s2|137-138|to|drug
DDI-DrugBank.d55.s2|140-148|sensitize|drug
DDI-DrugBank.d55.s2|150-152|the|drug
DDI-DrugBank.d55.s2|154-163|myocardium|drug
DDI-DrugBank.d55.s2|165-166|to|drug
DDI-DrugBank.d55.s2|168-174|effects|drug
DDI-DrugBank.d55.s2|176-177|of|drug
DDI-DrugBank.d55.s2|179-193|sympathomimetic|drug
DDI-DrugBank.d55.s2|195-200|amines|drug
DDI-DrugBank.d55.s2|201-201|.|drug
DDI-MedLine.d141.s0|0-7|Toxicity|drug
DDI-MedLine.d141.s0|9-10|of|drug
DDI-MedLine.d141.s0|12-18|cadmium|drug
DDI-MedLine.d141.s0|20-22|and|drug
DDI-MedLine.d141.s0|24-27|zinc|drug
DDI-MedLine.d141.s0|29-30|to|drug
DDI-MedLine.d141.s0|32-41|encystment|drug
DDI-MedLine.d141.s0|43-45|and|drug
DDI-MedLine.d141.s0|47-48|in|drug
DDI-MedLine.d141.s0|50-54|vitro|drug
DDI-MedLine.d141.s0|56-65|excystment|drug
DDI-MedLine.d141.s0|67-68|of|drug
DDI-MedLine.d141.s0|70-78|Parorchis|drug
DDI-MedLine.d141.s0|80-87|acanthus|drug
DDI-MedLine.d141.s0|89-89|(|drug
DDI-MedLine.d141.s0|90-96|Digenea|drug
DDI-MedLine.d141.s0|97-97|:|drug
DDI-MedLine.d141.s0|99-114|Philophthalmidae|drug
DDI-MedLine.d141.s0|115-115|)|drug
DDI-MedLine.d141.s0|116-116|.|drug
DDI-MedLine.d141.s1|0-2|The|drug
DDI-MedLine.d141.s1|4-11|toxicity|drug
DDI-MedLine.d141.s1|13-14|of|drug
DDI-MedLine.d141.s1|16-22|cadmium|drug
DDI-MedLine.d141.s1|23-23|,|drug
DDI-MedLine.d141.s1|25-28|zinc|drug
DDI-MedLine.d141.s1|30-32|and|drug
DDI-MedLine.d141.s1|34-45|cadmium/zinc|drug
DDI-MedLine.d141.s1|47-54|mixtures|drug
DDI-MedLine.d141.s1|56-57|at|drug
DDI-MedLine.d141.s1|59-72|concentrations|drug
DDI-MedLine.d141.s1|74-80|ranging|drug
DDI-MedLine.d141.s1|82-85|from|drug
DDI-MedLine.d141.s1|87-90|1000|drug
DDI-MedLine.d141.s1|92-93|to|drug
DDI-MedLine.d141.s1|95-99|50000|drug
DDI-MedLine.d141.s1|101-108|microg/l|drug
DDI-MedLine.d141.s1|110-113|were|drug
DDI-MedLine.d141.s1|115-126|investigated|drug
DDI-MedLine.d141.s1|128-134|against|drug
DDI-MedLine.d141.s1|136-144|cercariae|drug
DDI-MedLine.d141.s1|146-148|and|drug
DDI-MedLine.d141.s1|150-162|metacercariae|drug
DDI-MedLine.d141.s1|164-165|of|drug
DDI-MedLine.d141.s1|167-175|Parorchis|drug
DDI-MedLine.d141.s1|177-184|acanthus|drug
DDI-MedLine.d141.s1|186-193|obtained|drug
DDI-MedLine.d141.s1|195-198|from|drug
DDI-MedLine.d141.s1|200-202|the|drug
DDI-MedLine.d141.s1|204-206|dog|drug
DDI-MedLine.d141.s1|208-212|whelk|drug
DDI-MedLine.d141.s1|214-220|Nucella|drug
DDI-MedLine.d141.s1|222-229|lapillus|drug
DDI-MedLine.d141.s1|230-230|.|drug
DDI-MedLine.d141.s2|0-8|Cercarial|drug
DDI-MedLine.d141.s2|10-19|encystment|drug
DDI-MedLine.d141.s2|21-22|at|drug
DDI-MedLine.d141.s2|24-37|concentrations|drug
DDI-MedLine.d141.s2|39-40|of|drug
DDI-MedLine.d141.s2|42-46|25000|drug
DDI-MedLine.d141.s2|48-55|microg/l|drug
DDI-MedLine.d141.s2|57-58|or|drug
DDI-MedLine.d141.s2|60-65|higher|drug
DDI-MedLine.d141.s2|67-69|was|drug
DDI-MedLine.d141.s2|71-83|significantly|drug
DDI-MedLine.d141.s2|85-92|impaired|drug
DDI-MedLine.d141.s2|94-95|by|drug
DDI-MedLine.d141.s2|97-99|all|drug
DDI-MedLine.d141.s2|101-104|test|drug
DDI-MedLine.d141.s2|106-111|metals|drug
DDI-MedLine.d141.s2|112-112|;|drug
DDI-MedLine.d141.s3|0-6|however|drug
DDI-MedLine.d141.s3|7-7|,|drug
DDI-MedLine.d141.s3|9-10|at|drug
DDI-MedLine.d141.s3|12-16|lower|drug
DDI-MedLine.d141.s3|18-31|concentrations|drug
DDI-MedLine.d141.s3|33-36|only|drug
DDI-MedLine.d141.s3|38-41|zinc|drug
DDI-MedLine.d141.s3|43-54|demonstrated|drug
DDI-MedLine.d141.s3|56-63|toxicity|drug
DDI-MedLine.d141.s3|64-64|.|drug
DDI-MedLine.d141.s4|0-7|Mixtures|drug
DDI-MedLine.d141.s4|9-10|of|drug
DDI-MedLine.d141.s4|12-18|cadmium|drug
DDI-MedLine.d141.s4|20-22|and|drug
DDI-MedLine.d141.s4|24-27|zinc|drug
DDI-MedLine.d141.s4|29-31|had|drug
DDI-MedLine.d141.s4|33-33|a|drug
DDI-MedLine.d141.s4|35-45|synergistic|drug
DDI-MedLine.d141.s4|47-52|effect|drug
DDI-MedLine.d141.s4|54-61|compared|drug
DDI-MedLine.d141.s4|63-66|with|drug
DDI-MedLine.d141.s4|68-73|single|drug
DDI-MedLine.d141.s4|75-79|metal|drug
DDI-MedLine.d141.s4|81-88|toxicity|drug
DDI-MedLine.d141.s4|90-92|but|drug
DDI-MedLine.d141.s4|94-97|only|drug
DDI-MedLine.d141.s4|99-100|at|drug
DDI-MedLine.d141.s4|102-106|50000|drug
DDI-MedLine.d141.s4|108-115|microg/l|drug
DDI-MedLine.d141.s4|116-116|.|drug
DDI-MedLine.d141.s5|0-9|Excystment|drug
DDI-MedLine.d141.s5|11-12|in|drug
DDI-MedLine.d141.s5|14-18|vitro|drug
DDI-MedLine.d141.s5|20-22|was|drug
DDI-MedLine.d141.s5|24-27|only|drug
DDI-MedLine.d141.s5|29-41|significantly|drug
DDI-MedLine.d141.s5|43-50|affected|drug
DDI-MedLine.d141.s5|52-53|by|drug
DDI-MedLine.d141.s5|55-63|cercariae|drug
DDI-MedLine.d141.s5|65-71|exposed|drug
DDI-MedLine.d141.s5|73-74|to|drug
DDI-MedLine.d141.s5|76-87|cadmium/zinc|drug
DDI-MedLine.d141.s5|89-96|mixtures|drug
DDI-MedLine.d141.s5|98-103|whilst|drug
DDI-MedLine.d141.s5|105-113|encysting|drug
DDI-MedLine.d141.s5|114-114|.|drug
DDI-MedLine.d141.s6|0-10|Twenty-four|drug
DDI-MedLine.d141.s6|12-12|h|drug
DDI-MedLine.d141.s6|14-22|exposures|drug
DDI-MedLine.d141.s6|24-25|of|drug
DDI-MedLine.d141.s6|27-31|fully|drug
DDI-MedLine.d141.s6|33-38|formed|drug
DDI-MedLine.d141.s6|40-44|cysts|drug
DDI-MedLine.d141.s6|46-48|had|drug
DDI-MedLine.d141.s6|50-51|no|drug
DDI-MedLine.d141.s6|53-58|effect|drug
DDI-MedLine.d141.s6|60-61|on|drug
DDI-MedLine.d141.s6|63-72|excystment|drug
DDI-MedLine.d141.s6|74-75|in|drug
DDI-MedLine.d141.s6|77-81|vitro|drug
DDI-MedLine.d141.s6|82-82|.|drug
DDI-MedLine.d141.s7|0-6|Effects|drug
DDI-MedLine.d141.s7|8-9|on|drug
DDI-MedLine.d141.s7|11-12|in|drug
DDI-MedLine.d141.s7|14-18|vitro|drug
DDI-MedLine.d141.s7|20-29|excystment|drug
DDI-MedLine.d141.s7|31-35|rates|drug
DDI-MedLine.d141.s7|37-40|over|drug
DDI-MedLine.d141.s7|42-42|a|drug
DDI-MedLine.d141.s7|44-44|2|drug
DDI-MedLine.d141.s7|46-46|h|drug
DDI-MedLine.d141.s7|48-53|period|drug
DDI-MedLine.d141.s7|55-66|demonstrated|drug
DDI-MedLine.d141.s7|68-77|widespread|drug
DDI-MedLine.d141.s7|79-85|effects|drug
DDI-MedLine.d141.s7|87-89|for|drug
DDI-MedLine.d141.s7|91-107|cercariae-exposed|drug
DDI-MedLine.d141.s7|109-109|P|drug
DDI-MedLine.d141.s7|110-110|.|drug
DDI-MedLine.d141.s8|0-7|acanthus|drug
DDI-MedLine.d141.s8|8-8|.|drug
DDI-MedLine.d141.s9|0-1|No|drug
DDI-MedLine.d141.s9|3-9|effects|drug
DDI-MedLine.d141.s9|11-14|were|drug
DDI-MedLine.d141.s9|16-22|evident|drug
DDI-MedLine.d141.s9|24-25|on|drug
DDI-MedLine.d141.s9|27-36|excystment|drug
DDI-MedLine.d141.s9|38-42|rates|drug
DDI-MedLine.d141.s9|44-45|of|drug
DDI-MedLine.d141.s9|47-58|cyst-exposed|drug
DDI-MedLine.d141.s9|60-68|parasites|drug
DDI-MedLine.d141.s9|69-69|.|drug
DDI-DrugBank.d321.s0|0-12|Dexamethasone|drug
DDI-DrugBank.d321.s0|13-13|:|drug
DDI-DrugBank.d321.s0|15-26|Steady-state|drug
DDI-DrugBank.d321.s0|28-33|trough|drug
DDI-DrugBank.d321.s0|35-48|concentrations|drug
DDI-DrugBank.d321.s0|50-51|of|drug
DDI-DrugBank.d321.s0|53-63|albendazole|drug
DDI-DrugBank.d321.s0|65-73|sulfoxide|drug
DDI-DrugBank.d321.s0|75-78|were|drug
DDI-DrugBank.d321.s0|80-84|about|drug
DDI-DrugBank.d321.s0|86-87|56|drug
DDI-DrugBank.d321.s0|88-88|%|drug
DDI-DrugBank.d321.s0|90-95|higher|drug
DDI-DrugBank.d321.s0|97-100|when|drug
DDI-DrugBank.d321.s0|102-102|8|drug
DDI-DrugBank.d321.s0|104-105|mg|drug
DDI-DrugBank.d321.s0|107-119|dexamethasone|drug
DDI-DrugBank.d321.s0|121-123|was|drug
DDI-DrugBank.d321.s0|125-138|coadministered|drug
DDI-DrugBank.d321.s0|140-143|with|drug
DDI-DrugBank.d321.s0|145-148|each|drug
DDI-DrugBank.d321.s0|150-153|dose|drug
DDI-DrugBank.d321.s0|155-156|of|drug
DDI-DrugBank.d321.s0|158-168|albendazole|drug
DDI-DrugBank.d321.s0|170-170|(|drug
DDI-DrugBank.d321.s0|171-172|15|drug
DDI-DrugBank.d321.s0|174-182|mg/kg/day|drug
DDI-DrugBank.d321.s0|183-183|)|drug
DDI-DrugBank.d321.s0|185-186|in|drug
DDI-DrugBank.d321.s0|188-192|eight|drug
DDI-DrugBank.d321.s0|194-211|neurocysticercosis|drug
DDI-DrugBank.d321.s0|213-220|patients|drug
DDI-DrugBank.d321.s0|221-221|.|drug
DDI-DrugBank.d321.s1|0-11|Praziquantel|drug
DDI-DrugBank.d321.s1|12-12|:|drug
DDI-DrugBank.d321.s1|14-15|In|drug
DDI-DrugBank.d321.s1|17-19|the|drug
DDI-DrugBank.d321.s1|21-23|fed|drug
DDI-DrugBank.d321.s1|25-29|state|drug
DDI-DrugBank.d321.s1|30-30|,|drug
DDI-DrugBank.d321.s1|32-43|praziquantel|drug
DDI-DrugBank.d321.s1|45-45|(|drug
DDI-DrugBank.d321.s1|46-47|40|drug
DDI-DrugBank.d321.s1|49-53|mg/kg|drug
DDI-DrugBank.d321.s1|54-54|)|drug
DDI-DrugBank.d321.s1|56-64|increased|drug
DDI-DrugBank.d321.s1|66-69|mean|drug
DDI-DrugBank.d321.s1|71-77|maximum|drug
DDI-DrugBank.d321.s1|79-84|plasma|drug
DDI-DrugBank.d321.s1|86-98|concentration|drug
DDI-DrugBank.d321.s1|100-102|and|drug
DDI-DrugBank.d321.s1|104-107|area|drug
DDI-DrugBank.d321.s1|109-113|under|drug
DDI-DrugBank.d321.s1|115-117|the|drug
DDI-DrugBank.d321.s1|119-123|curve|drug
DDI-DrugBank.d321.s1|125-126|of|drug
DDI-DrugBank.d321.s1|128-138|albendazole|drug
DDI-DrugBank.d321.s1|140-148|sulfoxide|drug
DDI-DrugBank.d321.s1|150-151|by|drug
DDI-DrugBank.d321.s1|153-157|about|drug
DDI-DrugBank.d321.s1|159-160|50|drug
DDI-DrugBank.d321.s1|161-161|%|drug
DDI-DrugBank.d321.s1|163-164|in|drug
DDI-DrugBank.d321.s1|166-172|healthy|drug
DDI-DrugBank.d321.s1|174-181|subjects|drug
DDI-DrugBank.d321.s1|183-183|(|drug
DDI-DrugBank.d321.s1|184-187|n=10|drug
DDI-DrugBank.d321.s1|188-188|)|drug
DDI-DrugBank.d321.s1|190-197|compared|drug
DDI-DrugBank.d321.s1|199-202|with|drug
DDI-DrugBank.d321.s1|204-204|a|drug
DDI-DrugBank.d321.s1|206-213|separate|drug
DDI-DrugBank.d321.s1|215-219|group|drug
DDI-DrugBank.d321.s1|221-222|of|drug
DDI-DrugBank.d321.s1|224-231|subjects|drug
DDI-DrugBank.d321.s1|233-233|(|drug
DDI-DrugBank.d321.s1|234-236|n=6|drug
DDI-DrugBank.d321.s1|237-237|)|drug
DDI-DrugBank.d321.s1|239-243|given|drug
DDI-DrugBank.d321.s1|245-255|albendazole|drug
DDI-DrugBank.d321.s1|257-261|alone|drug
DDI-DrugBank.d321.s1|262-262|.|drug
DDI-DrugBank.d321.s2|0-3|Mean|drug
DDI-DrugBank.d321.s2|5-5|T|drug
DDI-DrugBank.d321.s2|7-9|max|drug
DDI-DrugBank.d321.s2|11-13|and|drug
DDI-DrugBank.d321.s2|15-18|mean|drug
DDI-DrugBank.d321.s2|20-25|plasma|drug
DDI-DrugBank.d321.s2|27-37|elimination|drug
DDI-DrugBank.d321.s2|39-47|half-life|drug
DDI-DrugBank.d321.s2|49-50|of|drug
DDI-DrugBank.d321.s2|52-62|albendazole|drug
DDI-DrugBank.d321.s2|64-72|sulfoxide|drug
DDI-DrugBank.d321.s2|74-77|were|drug
DDI-DrugBank.d321.s2|79-87|unchanged|drug
DDI-DrugBank.d321.s2|88-88|.|drug
DDI-DrugBank.d321.s3|0-2|The|drug
DDI-DrugBank.d321.s3|4-19|pharmacokinetics|drug
DDI-DrugBank.d321.s3|21-22|of|drug
DDI-DrugBank.d321.s3|24-35|praziquantel|drug
DDI-DrugBank.d321.s3|37-40|were|drug
DDI-DrugBank.d321.s3|42-50|unchanged|drug
DDI-DrugBank.d321.s3|52-60|following|drug
DDI-DrugBank.d321.s3|62-77|coadministration|drug
DDI-DrugBank.d321.s3|79-82|with|drug
DDI-DrugBank.d321.s3|84-94|albendazole|drug
DDI-DrugBank.d321.s3|96-96|(|drug
DDI-DrugBank.d321.s3|97-99|400|drug
DDI-DrugBank.d321.s3|101-102|mg|drug
DDI-DrugBank.d321.s3|103-103|)|drug
DDI-DrugBank.d321.s3|104-104|.|drug
DDI-DrugBank.d321.s4|0-9|Cimetidine|drug
DDI-DrugBank.d321.s4|10-10|:|drug
DDI-DrugBank.d321.s4|12-22|Albendazole|drug
DDI-DrugBank.d321.s4|24-32|sulfoxide|drug
DDI-DrugBank.d321.s4|34-47|concentrations|drug
DDI-DrugBank.d321.s4|49-50|in|drug
DDI-DrugBank.d321.s4|52-55|bile|drug
DDI-DrugBank.d321.s4|57-59|and|drug
DDI-DrugBank.d321.s4|61-66|cystic|drug
DDI-DrugBank.d321.s4|68-72|fluid|drug
DDI-DrugBank.d321.s4|74-77|were|drug
DDI-DrugBank.d321.s4|79-87|increased|drug
DDI-DrugBank.d321.s4|89-89|(|drug
DDI-DrugBank.d321.s4|90-94|about|drug
DDI-DrugBank.d321.s4|96-101|2-fold|drug
DDI-DrugBank.d321.s4|102-102|)|drug
DDI-DrugBank.d321.s4|104-105|in|drug
DDI-DrugBank.d321.s4|107-113|hydatid|drug
DDI-DrugBank.d321.s4|115-118|cyst|drug
DDI-DrugBank.d321.s4|120-127|patients|drug
DDI-DrugBank.d321.s4|129-135|treated|drug
DDI-DrugBank.d321.s4|137-140|with|drug
DDI-DrugBank.d321.s4|142-151|cimetidine|drug
DDI-DrugBank.d321.s4|153-153|(|drug
DDI-DrugBank.d321.s4|154-155|10|drug
DDI-DrugBank.d321.s4|157-165|mg/kg/day|drug
DDI-DrugBank.d321.s4|166-166|)|drug
DDI-DrugBank.d321.s4|168-168|(|drug
DDI-DrugBank.d321.s4|169-171|n=7|drug
DDI-DrugBank.d321.s4|172-172|)|drug
DDI-DrugBank.d321.s4|174-181|compared|drug
DDI-DrugBank.d321.s4|183-186|with|drug
DDI-DrugBank.d321.s4|188-198|albendazole|drug
DDI-DrugBank.d321.s4|200-200|(|drug
DDI-DrugBank.d321.s4|201-202|20|drug
DDI-DrugBank.d321.s4|204-212|mg/kg/day|drug
DDI-DrugBank.d321.s4|213-213|)|drug
DDI-DrugBank.d321.s4|215-219|alone|drug
DDI-DrugBank.d321.s4|221-221|(|drug
DDI-DrugBank.d321.s4|222-225|n=12|drug
DDI-DrugBank.d321.s4|226-226|)|drug
DDI-DrugBank.d321.s4|227-227|.|drug
DDI-DrugBank.d321.s5|0-10|Albendazole|drug
DDI-DrugBank.d321.s5|12-20|sulfoxide|drug
DDI-DrugBank.d321.s5|22-27|plasma|drug
DDI-DrugBank.d321.s5|29-42|concentrations|drug
DDI-DrugBank.d321.s5|44-47|were|drug
DDI-DrugBank.d321.s5|49-57|unchanged|drug
DDI-DrugBank.d321.s5|59-59|4|drug
DDI-DrugBank.d321.s5|61-65|hours|drug
DDI-DrugBank.d321.s5|67-71|after|drug
DDI-DrugBank.d321.s5|73-78|dosing|drug
DDI-DrugBank.d321.s5|79-79|.|drug
DDI-DrugBank.d321.s6|0-11|Theophylline|drug
DDI-DrugBank.d321.s6|12-12|:|drug
DDI-DrugBank.d321.s6|14-16|The|drug
DDI-DrugBank.d321.s6|18-33|pharmacokinetics|drug
DDI-DrugBank.d321.s6|35-36|of|drug
DDI-DrugBank.d321.s6|38-49|theophylline|drug
DDI-DrugBank.d321.s6|51-51|(|drug
DDI-DrugBank.d321.s6|52-64|aminophylline|drug
DDI-DrugBank.d321.s6|66-68|5.8|drug
DDI-DrugBank.d321.s6|70-74|mg/kg|drug
DDI-DrugBank.d321.s6|76-82|infused|drug
DDI-DrugBank.d321.s6|84-87|over|drug
DDI-DrugBank.d321.s6|89-90|20|drug
DDI-DrugBank.d321.s6|92-98|minutes|drug
DDI-DrugBank.d321.s6|99-99|)|drug
DDI-DrugBank.d321.s6|101-104|were|drug
DDI-DrugBank.d321.s6|106-114|unchanged|drug
DDI-DrugBank.d321.s6|116-124|following|drug
DDI-DrugBank.d321.s6|126-126|a|drug
DDI-DrugBank.d321.s6|128-133|single|drug
DDI-DrugBank.d321.s6|135-138|oral|drug
DDI-DrugBank.d321.s6|140-143|dose|drug
DDI-DrugBank.d321.s6|145-146|of|drug
DDI-DrugBank.d321.s6|148-158|albendazole|drug
DDI-DrugBank.d321.s6|160-160|(|drug
DDI-DrugBank.d321.s6|161-163|400|drug
DDI-DrugBank.d321.s6|165-166|mg|drug
DDI-DrugBank.d321.s6|167-167|)|drug
DDI-DrugBank.d321.s6|169-170|in|drug
DDI-DrugBank.d321.s6|172-172|6|drug
DDI-DrugBank.d321.s6|174-180|healthy|drug
DDI-DrugBank.d321.s6|182-189|subjects|drug
DDI-DrugBank.d321.s6|190-190|.|drug
DDI-DrugBank.d161.s0|0-1|No|drug
DDI-DrugBank.d161.s0|3-10|specific|drug
DDI-DrugBank.d161.s0|12-15|drug|drug
DDI-DrugBank.d161.s0|17-27|interaction|drug
DDI-DrugBank.d161.s0|29-35|studies|drug
DDI-DrugBank.d161.s0|37-40|have|drug
DDI-DrugBank.d161.s0|42-45|been|drug
DDI-DrugBank.d161.s0|47-55|conducted|drug
DDI-DrugBank.d161.s0|56-56|.|drug
DDI-DrugBank.d161.s1|0-2|For|drug
DDI-DrugBank.d161.s1|4-14|information|drug
DDI-DrugBank.d161.s1|16-17|on|drug
DDI-DrugBank.d161.s1|19-21|the|drug
DDI-DrugBank.d161.s1|23-38|pharmacokinetics|drug
DDI-DrugBank.d161.s1|40-41|of|drug
DDI-DrugBank.d161.s1|43-48|Gemzar|drug
DDI-DrugBank.d161.s1|50-52|and|drug
DDI-DrugBank.d161.s1|54-62|cisplatin|drug
DDI-DrugBank.d161.s1|64-65|in|drug
DDI-DrugBank.d161.s1|67-77|combination|drug
DDI-DrugBank.d161.s1|78-78|,|drug
DDI-DrugBank.d161.s1|80-82|see|drug
DDI-DrugBank.d161.s1|84-87|Drug|drug
DDI-DrugBank.d161.s1|89-100|Interactions|drug
DDI-DrugBank.d161.s1|102-106|under|drug
DDI-DrugBank.d161.s1|108-115|CLINICAL|drug
DDI-DrugBank.d161.s1|117-128|PHARMACOLOGY|drug
DDI-DrugBank.d161.s1|130-136|section|drug
DDI-DrugBank.d161.s1|137-137|.|drug
DDI-DrugBank.d279.s0|0-2|The|drug
DDI-DrugBank.d279.s0|4-10|adverse|drug
DDI-DrugBank.d279.s0|12-18|effects|drug
DDI-DrugBank.d279.s0|20-21|of|drug
DDI-DrugBank.d279.s0|23-31|CAMPTOSAR|drug
DDI-DrugBank.d279.s0|32-32|,|drug
DDI-DrugBank.d279.s0|34-37|such|drug
DDI-DrugBank.d279.s0|39-40|as|drug
DDI-DrugBank.d279.s0|42-57|myelosuppression|drug
DDI-DrugBank.d279.s0|59-61|and|drug
DDI-DrugBank.d279.s0|63-70|diarrhea|drug
DDI-DrugBank.d279.s0|71-71|,|drug
DDI-DrugBank.d279.s0|73-77|would|drug
DDI-DrugBank.d279.s0|79-80|be|drug
DDI-DrugBank.d279.s0|82-89|expected|drug
DDI-DrugBank.d279.s0|91-92|to|drug
DDI-DrugBank.d279.s0|94-95|be|drug
DDI-DrugBank.d279.s0|97-107|exacerbated|drug
DDI-DrugBank.d279.s0|109-110|by|drug
DDI-DrugBank.d279.s0|112-116|other|drug
DDI-DrugBank.d279.s0|118-131|antineoplastic|drug
DDI-DrugBank.d279.s0|133-138|agents|drug
DDI-DrugBank.d279.s0|140-145|having|drug
DDI-DrugBank.d279.s0|147-153|similar|drug
DDI-DrugBank.d279.s0|155-161|adverse|drug
DDI-DrugBank.d279.s0|163-169|effects|drug
DDI-DrugBank.d279.s0|170-170|.|drug
DDI-DrugBank.d279.s1|0-7|Patients|drug
DDI-DrugBank.d279.s1|9-11|who|drug
DDI-DrugBank.d279.s1|13-16|have|drug
DDI-DrugBank.d279.s1|18-27|previously|drug
DDI-DrugBank.d279.s1|29-36|received|drug
DDI-DrugBank.d279.s1|38-44|pelvic/|drug
DDI-DrugBank.d279.s1|46-54|abdominal|drug
DDI-DrugBank.d279.s1|56-66|irradiation|drug
DDI-DrugBank.d279.s1|68-70|are|drug
DDI-DrugBank.d279.s1|72-73|at|drug
DDI-DrugBank.d279.s1|75-83|increased|drug
DDI-DrugBank.d279.s1|85-88|risk|drug
DDI-DrugBank.d279.s1|90-91|of|drug
DDI-DrugBank.d279.s1|93-98|severe|drug
DDI-DrugBank.d279.s1|100-115|myelosuppression|drug
DDI-DrugBank.d279.s1|117-125|following|drug
DDI-DrugBank.d279.s1|127-129|the|drug
DDI-DrugBank.d279.s1|131-144|administration|drug
DDI-DrugBank.d279.s1|146-147|of|drug
DDI-DrugBank.d279.s1|149-157|CAMPTOSAR|drug
DDI-DrugBank.d279.s1|158-158|.|drug
DDI-DrugBank.d279.s2|0-2|The|drug
DDI-DrugBank.d279.s2|4-13|concurrent|drug
DDI-DrugBank.d279.s2|15-28|administration|drug
DDI-DrugBank.d279.s2|30-31|of|drug
DDI-DrugBank.d279.s2|33-41|CAMPTOSAR|drug
DDI-DrugBank.d279.s2|43-46|with|drug
DDI-DrugBank.d279.s2|48-58|irradiation|drug
DDI-DrugBank.d279.s2|60-62|has|drug
DDI-DrugBank.d279.s2|64-66|not|drug
DDI-DrugBank.d279.s2|68-71|been|drug
DDI-DrugBank.d279.s2|73-82|adequately|drug
DDI-DrugBank.d279.s2|84-90|studied|drug
DDI-DrugBank.d279.s2|92-94|and|drug
DDI-DrugBank.d279.s2|96-97|is|drug
DDI-DrugBank.d279.s2|99-101|not|drug
DDI-DrugBank.d279.s2|103-113|recommended|drug
DDI-DrugBank.d279.s2|114-114|.|drug
DDI-DrugBank.d279.s3|0-14|Lymphocytopenia|drug
DDI-DrugBank.d279.s3|16-18|has|drug
DDI-DrugBank.d279.s3|20-23|been|drug
DDI-DrugBank.d279.s3|25-32|reported|drug
DDI-DrugBank.d279.s3|34-35|in|drug
DDI-DrugBank.d279.s3|37-44|patients|drug
DDI-DrugBank.d279.s3|46-54|receiving|drug
DDI-DrugBank.d279.s3|56-64|CAMPTOSAR|drug
DDI-DrugBank.d279.s3|65-65|,|drug
DDI-DrugBank.d279.s3|67-69|and|drug
DDI-DrugBank.d279.s3|71-72|it|drug
DDI-DrugBank.d279.s3|74-75|is|drug
DDI-DrugBank.d279.s3|77-84|possible|drug
DDI-DrugBank.d279.s3|86-89|that|drug
DDI-DrugBank.d279.s3|91-93|the|drug
DDI-DrugBank.d279.s3|95-108|administration|drug
DDI-DrugBank.d279.s3|110-111|of|drug
DDI-DrugBank.d279.s3|113-125|dexamethasone|drug
DDI-DrugBank.d279.s3|127-128|as|drug
DDI-DrugBank.d279.s3|130-139|antiemetic|drug
DDI-DrugBank.d279.s3|141-151|prophylaxis|drug
DDI-DrugBank.d279.s3|153-155|may|drug
DDI-DrugBank.d279.s3|157-160|have|drug
DDI-DrugBank.d279.s3|162-169|enhanced|drug
DDI-DrugBank.d279.s3|171-173|the|drug
DDI-DrugBank.d279.s3|175-184|likelihood|drug
DDI-DrugBank.d279.s3|186-187|of|drug
DDI-DrugBank.d279.s3|189-192|this|drug
DDI-DrugBank.d279.s3|194-199|effect|drug
DDI-DrugBank.d279.s3|200-200|.|drug
DDI-DrugBank.d279.s4|0-6|However|drug
DDI-DrugBank.d279.s4|7-7|,|drug
DDI-DrugBank.d279.s4|9-15|serious|drug
DDI-DrugBank.d279.s4|17-29|opportunistic|drug
DDI-DrugBank.d279.s4|31-40|infections|drug
DDI-DrugBank.d279.s4|42-45|have|drug
DDI-DrugBank.d279.s4|47-49|not|drug
DDI-DrugBank.d279.s4|51-54|been|drug
DDI-DrugBank.d279.s4|56-63|observed|drug
DDI-DrugBank.d279.s4|64-64|,|drug
DDI-DrugBank.d279.s4|66-68|and|drug
DDI-DrugBank.d279.s4|70-71|no|drug
DDI-DrugBank.d279.s4|73-85|complications|drug
DDI-DrugBank.d279.s4|87-90|have|drug
DDI-DrugBank.d279.s4|92-103|specifically|drug
DDI-DrugBank.d279.s4|105-108|been|drug
DDI-DrugBank.d279.s4|110-119|attributed|drug
DDI-DrugBank.d279.s4|121-122|to|drug
DDI-DrugBank.d279.s4|124-138|lymphocytopenia|drug
DDI-DrugBank.d279.s4|139-139|.|drug
DDI-DrugBank.d279.s5|0-12|Hyperglycemia|drug
DDI-DrugBank.d279.s5|14-16|has|drug
DDI-DrugBank.d279.s5|18-21|also|drug
DDI-DrugBank.d279.s5|23-26|been|drug
DDI-DrugBank.d279.s5|28-35|reported|drug
DDI-DrugBank.d279.s5|37-38|in|drug
DDI-DrugBank.d279.s5|40-47|patients|drug
DDI-DrugBank.d279.s5|49-57|receiving|drug
DDI-DrugBank.d279.s5|59-67|CAMPTOSAR|drug
DDI-DrugBank.d279.s5|68-68|.|drug
DDI-DrugBank.d279.s6|0-6|Usually|drug
DDI-DrugBank.d279.s6|7-7|,|drug
DDI-DrugBank.d279.s6|9-12|this|drug
DDI-DrugBank.d279.s6|14-16|has|drug
DDI-DrugBank.d279.s6|18-21|been|drug
DDI-DrugBank.d279.s6|23-30|observed|drug
DDI-DrugBank.d279.s6|32-33|in|drug
DDI-DrugBank.d279.s6|35-42|patients|drug
DDI-DrugBank.d279.s6|44-47|with|drug
DDI-DrugBank.d279.s6|49-49|a|drug
DDI-DrugBank.d279.s6|51-57|history|drug
DDI-DrugBank.d279.s6|59-60|of|drug
DDI-DrugBank.d279.s6|62-69|diabetes|drug
DDI-DrugBank.d279.s6|71-78|mellitus|drug
DDI-DrugBank.d279.s6|80-81|or|drug
DDI-DrugBank.d279.s6|83-90|evidence|drug
DDI-DrugBank.d279.s6|92-93|of|drug
DDI-DrugBank.d279.s6|95-101|glucose|drug
DDI-DrugBank.d279.s6|103-113|intolerance|drug
DDI-DrugBank.d279.s6|115-119|prior|drug
DDI-DrugBank.d279.s6|121-122|to|drug
DDI-DrugBank.d279.s6|124-137|administration|drug
DDI-DrugBank.d279.s6|139-140|of|drug
DDI-DrugBank.d279.s6|142-150|CAMPTOSAR|drug
DDI-DrugBank.d279.s6|151-151|.|drug
DDI-DrugBank.d279.s7|0-1|It|drug
DDI-DrugBank.d279.s7|3-4|is|drug
DDI-DrugBank.d279.s7|6-13|probable|drug
DDI-DrugBank.d279.s7|15-18|that|drug
DDI-DrugBank.d279.s7|20-32|dexamethasone|drug
DDI-DrugBank.d279.s7|33-33|,|drug
DDI-DrugBank.d279.s7|35-39|given|drug
DDI-DrugBank.d279.s7|41-42|as|drug
DDI-DrugBank.d279.s7|44-53|antiemetic|drug
DDI-DrugBank.d279.s7|55-65|prophylaxis|drug
DDI-DrugBank.d279.s7|66-66|,|drug
DDI-DrugBank.d279.s7|68-78|contributed|drug
DDI-DrugBank.d279.s7|80-81|to|drug
DDI-DrugBank.d279.s7|83-95|hyperglycemia|drug
DDI-DrugBank.d279.s7|97-98|in|drug
DDI-DrugBank.d279.s7|100-103|some|drug
DDI-DrugBank.d279.s7|105-112|patients|drug
DDI-DrugBank.d279.s7|113-113|.|drug
DDI-DrugBank.d279.s8|0-2|The|drug
DDI-DrugBank.d279.s8|4-12|incidence|drug
DDI-DrugBank.d279.s8|14-15|of|drug
DDI-DrugBank.d279.s8|17-25|akathisia|drug
DDI-DrugBank.d279.s8|27-28|in|drug
DDI-DrugBank.d279.s8|30-37|clinical|drug
DDI-DrugBank.d279.s8|39-44|trials|drug
DDI-DrugBank.d279.s8|46-47|of|drug
DDI-DrugBank.d279.s8|49-51|the|drug
DDI-DrugBank.d279.s8|53-58|weekly|drug
DDI-DrugBank.d279.s8|60-65|dosage|drug
DDI-DrugBank.d279.s8|67-74|schedule|drug
DDI-DrugBank.d279.s8|76-78|was|drug
DDI-DrugBank.d279.s8|80-86|greater|drug
DDI-DrugBank.d279.s8|88-88|(|drug
DDI-DrugBank.d279.s8|89-91|8.5|drug
DDI-DrugBank.d279.s8|92-92|%|drug
DDI-DrugBank.d279.s8|93-93|,|drug
DDI-DrugBank.d279.s8|95-98|4/47|drug
DDI-DrugBank.d279.s8|100-107|patients|drug
DDI-DrugBank.d279.s8|108-108|)|drug
DDI-DrugBank.d279.s8|110-113|when|drug
DDI-DrugBank.d279.s8|115-130|prochlorperazine|drug
DDI-DrugBank.d279.s8|132-134|was|drug
DDI-DrugBank.d279.s8|136-147|administered|drug
DDI-DrugBank.d279.s8|149-150|on|drug
DDI-DrugBank.d279.s8|152-154|the|drug
DDI-DrugBank.d279.s8|156-159|same|drug
DDI-DrugBank.d279.s8|161-163|day|drug
DDI-DrugBank.d279.s8|165-166|as|drug
DDI-DrugBank.d279.s8|168-176|CAMPTOSAR|drug
DDI-DrugBank.d279.s8|178-181|than|drug
DDI-DrugBank.d279.s8|183-186|when|drug
DDI-DrugBank.d279.s8|188-192|these|drug
DDI-DrugBank.d279.s8|194-198|drugs|drug
DDI-DrugBank.d279.s8|200-203|were|drug
DDI-DrugBank.d279.s8|205-209|given|drug
DDI-DrugBank.d279.s8|211-212|on|drug
DDI-DrugBank.d279.s8|214-221|separate|drug
DDI-DrugBank.d279.s8|223-226|days|drug
DDI-DrugBank.d279.s8|228-228|(|drug
DDI-DrugBank.d279.s8|229-231|1.3|drug
DDI-DrugBank.d279.s8|232-232|%|drug
DDI-DrugBank.d279.s8|233-233|,|drug
DDI-DrugBank.d279.s8|235-238|1/80|drug
DDI-DrugBank.d279.s8|240-247|patients|drug
DDI-DrugBank.d279.s8|248-248|)|drug
DDI-DrugBank.d279.s8|249-249|.|drug
DDI-DrugBank.d279.s9|0-2|The|drug
DDI-DrugBank.d279.s9|4-6|8.5|drug
DDI-DrugBank.d279.s9|7-7|%|drug
DDI-DrugBank.d279.s9|9-17|incidence|drug
DDI-DrugBank.d279.s9|19-20|of|drug
DDI-DrugBank.d279.s9|22-30|akathisia|drug
DDI-DrugBank.d279.s9|31-31|,|drug
DDI-DrugBank.d279.s9|33-39|however|drug
DDI-DrugBank.d279.s9|40-40|,|drug
DDI-DrugBank.d279.s9|42-43|is|drug
DDI-DrugBank.d279.s9|45-50|within|drug
DDI-DrugBank.d279.s9|52-54|the|drug
DDI-DrugBank.d279.s9|56-60|range|drug
DDI-DrugBank.d279.s9|62-69|reported|drug
DDI-DrugBank.d279.s9|71-73|for|drug
DDI-DrugBank.d279.s9|75-77|use|drug
DDI-DrugBank.d279.s9|79-80|of|drug
DDI-DrugBank.d279.s9|82-97|prochlorperazine|drug
DDI-DrugBank.d279.s9|99-102|when|drug
DDI-DrugBank.d279.s9|104-108|given|drug
DDI-DrugBank.d279.s9|110-111|as|drug
DDI-DrugBank.d279.s9|113-113|a|drug
DDI-DrugBank.d279.s9|115-127|premedication|drug
DDI-DrugBank.d279.s9|129-131|for|drug
DDI-DrugBank.d279.s9|133-137|other|drug
DDI-DrugBank.d279.s9|139-152|chemotherapies|drug
DDI-DrugBank.d279.s9|153-153|.|drug
DDI-DrugBank.d279.s10|0-1|It|drug
DDI-DrugBank.d279.s10|3-7|would|drug
DDI-DrugBank.d279.s10|9-10|be|drug
DDI-DrugBank.d279.s10|12-19|expected|drug
DDI-DrugBank.d279.s10|21-24|that|drug
DDI-DrugBank.d279.s10|26-33|laxative|drug
DDI-DrugBank.d279.s10|35-37|use|drug
DDI-DrugBank.d279.s10|39-44|during|drug
DDI-DrugBank.d279.s10|46-52|therapy|drug
DDI-DrugBank.d279.s10|54-57|with|drug
DDI-DrugBank.d279.s10|59-67|CAMPTOSAR|drug
DDI-DrugBank.d279.s10|69-73|would|drug
DDI-DrugBank.d279.s10|75-80|worsen|drug
DDI-DrugBank.d279.s10|82-84|the|drug
DDI-DrugBank.d279.s10|86-94|incidence|drug
DDI-DrugBank.d279.s10|96-97|or|drug
DDI-DrugBank.d279.s10|99-106|severity|drug
DDI-DrugBank.d279.s10|108-109|of|drug
DDI-DrugBank.d279.s10|111-118|diarrhea|drug
DDI-DrugBank.d279.s10|119-119|,|drug
DDI-DrugBank.d279.s10|121-123|but|drug
DDI-DrugBank.d279.s10|125-128|this|drug
DDI-DrugBank.d279.s10|130-132|has|drug
DDI-DrugBank.d279.s10|134-136|not|drug
DDI-DrugBank.d279.s10|138-141|been|drug
DDI-DrugBank.d279.s10|143-149|studied|drug
DDI-DrugBank.d279.s10|150-150|.|drug
DDI-DrugBank.d279.s11|0-1|In|drug
DDI-DrugBank.d279.s11|3-6|view|drug
DDI-DrugBank.d279.s11|8-9|of|drug
DDI-DrugBank.d279.s11|11-13|the|drug
DDI-DrugBank.d279.s11|15-23|potential|drug
DDI-DrugBank.d279.s11|25-28|risk|drug
DDI-DrugBank.d279.s11|30-31|of|drug
DDI-DrugBank.d279.s11|33-43|dehydration|drug
DDI-DrugBank.d279.s11|45-53|secondary|drug
DDI-DrugBank.d279.s11|55-56|to|drug
DDI-DrugBank.d279.s11|58-65|vomiting|drug
DDI-DrugBank.d279.s11|67-72|and/or|drug
DDI-DrugBank.d279.s11|74-81|diarrhea|drug
DDI-DrugBank.d279.s11|83-89|induced|drug
DDI-DrugBank.d279.s11|91-92|by|drug
DDI-DrugBank.d279.s11|94-102|CAMPTOSAR|drug
DDI-DrugBank.d279.s11|103-103|,|drug
DDI-DrugBank.d279.s11|105-107|the|drug
DDI-DrugBank.d279.s11|109-117|physician|drug
DDI-DrugBank.d279.s11|119-121|may|drug
DDI-DrugBank.d279.s11|123-126|wish|drug
DDI-DrugBank.d279.s11|128-129|to|drug
DDI-DrugBank.d279.s11|131-138|withhold|drug
DDI-DrugBank.d279.s11|140-148|diuretics|drug
DDI-DrugBank.d279.s11|150-155|during|drug
DDI-DrugBank.d279.s11|157-162|dosing|drug
DDI-DrugBank.d279.s11|164-167|with|drug
DDI-DrugBank.d279.s11|169-177|CAMPTOSAR|drug
DDI-DrugBank.d279.s11|179-181|and|drug
DDI-DrugBank.d279.s11|182-182|,|drug
DDI-DrugBank.d279.s11|184-192|certainly|drug
DDI-DrugBank.d279.s11|193-193|,|drug
DDI-DrugBank.d279.s11|195-200|during|drug
DDI-DrugBank.d279.s11|202-208|periods|drug
DDI-DrugBank.d279.s11|210-211|of|drug
DDI-DrugBank.d279.s11|213-218|active|drug
DDI-DrugBank.d279.s11|220-227|vomiting|drug
DDI-DrugBank.d279.s11|229-230|or|drug
DDI-DrugBank.d279.s11|232-239|diarrhea|drug
DDI-DrugBank.d279.s11|240-240|.|drug
DDI-DrugBank.d279.s12|0-14|Drug-Laboratory|drug
DDI-DrugBank.d279.s12|16-19|Test|drug
DDI-DrugBank.d279.s12|21-32|Interactions|drug
DDI-DrugBank.d279.s12|34-38|There|drug
DDI-DrugBank.d279.s12|40-42|are|drug
DDI-DrugBank.d279.s12|44-45|no|drug
DDI-DrugBank.d279.s12|47-51|known|drug
DDI-DrugBank.d279.s12|53-64|interactions|drug
DDI-DrugBank.d279.s12|66-72|between|drug
DDI-DrugBank.d279.s12|74-82|CAMPTOSAR|drug
DDI-DrugBank.d279.s12|84-86|and|drug
DDI-DrugBank.d279.s12|88-97|laboratory|drug
DDI-DrugBank.d279.s12|99-103|tests|drug
DDI-DrugBank.d279.s12|104-104|.|drug
DDI-DrugBank.d585.s0|0-2|The|drug
DDI-DrugBank.d585.s0|4-12|following|drug
DDI-DrugBank.d585.s0|14-19|agents|drug
DDI-DrugBank.d585.s0|21-23|may|drug
DDI-DrugBank.d585.s0|25-32|increase|drug
DDI-DrugBank.d585.s0|34-40|certain|drug
DDI-DrugBank.d585.s0|42-48|actions|drug
DDI-DrugBank.d585.s0|50-51|or|drug
DDI-DrugBank.d585.s0|53-56|side|drug
DDI-DrugBank.d585.s0|58-64|effects|drug
DDI-DrugBank.d585.s0|66-67|of|drug
DDI-DrugBank.d585.s0|69-83|anticholinergic|drug
DDI-DrugBank.d585.s0|85-89|drugs|drug
DDI-DrugBank.d585.s0|90-90|:|drug
DDI-DrugBank.d585.s0|92-101|amantadine|drug
DDI-DrugBank.d585.s0|102-102|,|drug
DDI-DrugBank.d585.s0|104-117|antiarrhythmic|drug
DDI-DrugBank.d585.s0|119-124|agents|drug
DDI-DrugBank.d585.s0|126-127|of|drug
DDI-DrugBank.d585.s0|129-133|class|drug
DDI-DrugBank.d585.s0|135-135|I|drug
DDI-DrugBank.d585.s0|137-137|(|drug
DDI-DrugBank.d585.s0|138-141|e.g.|drug
DDI-DrugBank.d585.s0|142-142|,|drug
DDI-DrugBank.d585.s0|144-152|quinidine|drug
DDI-DrugBank.d585.s0|153-153|)|drug
DDI-DrugBank.d585.s0|154-154|,|drug
DDI-DrugBank.d585.s0|156-169|antihistamines|drug
DDI-DrugBank.d585.s0|170-170|,|drug
DDI-DrugBank.d585.s0|172-184|antipsychotic|drug
DDI-DrugBank.d585.s0|186-191|agents|drug
DDI-DrugBank.d585.s0|193-193|(|drug
DDI-DrugBank.d585.s0|194-197|e.g.|drug
DDI-DrugBank.d585.s0|198-198|,|drug
DDI-DrugBank.d585.s0|200-213|phenothiazines|drug
DDI-DrugBank.d585.s0|214-214|)|drug
DDI-DrugBank.d585.s0|215-215|,|drug
DDI-DrugBank.d585.s0|217-231|benzodiazepines|drug
DDI-DrugBank.d585.s0|232-232|,|drug
DDI-DrugBank.d585.s0|234-236|MAO|drug
DDI-DrugBank.d585.s0|238-247|inhibitors|drug
DDI-DrugBank.d585.s0|248-248|,|drug
DDI-DrugBank.d585.s0|250-257|narcotic|drug
DDI-DrugBank.d585.s0|259-268|analgesics|drug
DDI-DrugBank.d585.s0|270-270|(|drug
DDI-DrugBank.d585.s0|271-274|e.g.|drug
DDI-DrugBank.d585.s0|275-275|,|drug
DDI-DrugBank.d585.s0|277-286|meperidine|drug
DDI-DrugBank.d585.s0|287-287|)|drug
DDI-DrugBank.d585.s0|288-288|,|drug
DDI-DrugBank.d585.s0|290-297|nitrates|drug
DDI-DrugBank.d585.s0|299-301|and|drug
DDI-DrugBank.d585.s0|303-310|nitrites|drug
DDI-DrugBank.d585.s0|311-311|,|drug
DDI-DrugBank.d585.s0|313-327|sympathomimetic|drug
DDI-DrugBank.d585.s0|329-334|agents|drug
DDI-DrugBank.d585.s0|335-335|,|drug
DDI-DrugBank.d585.s0|337-345|tricyclic|drug
DDI-DrugBank.d585.s0|347-361|antidepressants|drug
DDI-DrugBank.d585.s0|362-362|,|drug
DDI-DrugBank.d585.s0|364-366|and|drug
DDI-DrugBank.d585.s0|368-372|other|drug
DDI-DrugBank.d585.s0|374-378|drugs|drug
DDI-DrugBank.d585.s0|380-385|having|drug
DDI-DrugBank.d585.s0|387-401|anticholinergic|drug
DDI-DrugBank.d585.s0|403-410|activity|drug
DDI-DrugBank.d585.s0|411-411|.|drug
DDI-DrugBank.d585.s1|0-15|Anticholinergics|drug
DDI-DrugBank.d585.s1|17-26|antagonize|drug
DDI-DrugBank.d585.s1|28-30|the|drug
DDI-DrugBank.d585.s1|32-38|effects|drug
DDI-DrugBank.d585.s1|40-41|of|drug
DDI-DrugBank.d585.s1|43-54|antiglaucoma|drug
DDI-DrugBank.d585.s1|56-61|agents|drug
DDI-DrugBank.d585.s1|62-62|.|drug
DDI-DrugBank.d585.s2|0-14|Anticholinergic|drug
DDI-DrugBank.d585.s2|16-20|drugs|drug
DDI-DrugBank.d585.s2|22-23|in|drug
DDI-DrugBank.d585.s2|25-27|the|drug
DDI-DrugBank.d585.s2|29-36|presence|drug
DDI-DrugBank.d585.s2|38-39|of|drug
DDI-DrugBank.d585.s2|41-49|increased|drug
DDI-DrugBank.d585.s2|51-61|intraocular|drug
DDI-DrugBank.d585.s2|63-70|pressure|drug
DDI-DrugBank.d585.s2|72-74|may|drug
DDI-DrugBank.d585.s2|76-77|be|drug
DDI-DrugBank.d585.s2|79-87|hazardous|drug
DDI-DrugBank.d585.s2|89-92|when|drug
DDI-DrugBank.d585.s2|94-98|taken|drug
DDI-DrugBank.d585.s2|100-111|concurrently|drug
DDI-DrugBank.d585.s2|113-116|with|drug
DDI-DrugBank.d585.s2|118-123|agents|drug
DDI-DrugBank.d585.s2|125-128|such|drug
DDI-DrugBank.d585.s2|130-131|as|drug
DDI-DrugBank.d585.s2|133-147|corticosteroids|drug
DDI-DrugBank.d585.s2|148-148|.|drug
DDI-DrugBank.d585.s3|0-14|Anticholinergic|drug
DDI-DrugBank.d585.s3|16-21|agents|drug
DDI-DrugBank.d585.s3|23-25|may|drug
DDI-DrugBank.d585.s3|27-32|affect|drug
DDI-DrugBank.d585.s3|34-49|gastrointestinal|drug
DDI-DrugBank.d585.s3|51-60|absorption|drug
DDI-DrugBank.d585.s3|62-63|of|drug
DDI-DrugBank.d585.s3|65-71|various|drug
DDI-DrugBank.d585.s3|73-77|drugs|drug
DDI-DrugBank.d585.s3|78-78|,|drug
DDI-DrugBank.d585.s3|80-83|such|drug
DDI-DrugBank.d585.s3|85-86|as|drug
DDI-DrugBank.d585.s3|88-93|slowly|drug
DDI-DrugBank.d585.s3|95-104|dissolving|drug
DDI-DrugBank.d585.s3|106-111|dosage|drug
DDI-DrugBank.d585.s3|113-117|forms|drug
DDI-DrugBank.d585.s3|119-120|of|drug
DDI-DrugBank.d585.s3|122-128|digoxin|drug
DDI-DrugBank.d585.s3|129-129|;|drug
DDI-DrugBank.d585.s4|0-8|increased|drug
DDI-DrugBank.d585.s4|10-14|serum|drug
DDI-DrugBank.d585.s4|16-22|digoxin|drug
DDI-DrugBank.d585.s4|24-37|concentrations|drug
DDI-DrugBank.d585.s4|39-41|may|drug
DDI-DrugBank.d585.s4|43-48|result|drug
DDI-DrugBank.d585.s4|49-49|.|drug
DDI-DrugBank.d585.s5|0-14|Anticholinergic|drug
DDI-DrugBank.d585.s5|16-20|drugs|drug
DDI-DrugBank.d585.s5|22-24|may|drug
DDI-DrugBank.d585.s5|26-35|antagonize|drug
DDI-DrugBank.d585.s5|37-39|the|drug
DDI-DrugBank.d585.s5|41-47|effects|drug
DDI-DrugBank.d585.s5|49-50|of|drug
DDI-DrugBank.d585.s5|52-56|drugs|drug
DDI-DrugBank.d585.s5|58-61|that|drug
DDI-DrugBank.d585.s5|63-67|alter|drug
DDI-DrugBank.d585.s5|69-84|gastrointestinal|drug
DDI-DrugBank.d585.s5|86-93|motility|drug
DDI-DrugBank.d585.s5|94-94|,|drug
DDI-DrugBank.d585.s5|96-99|such|drug
DDI-DrugBank.d585.s5|101-102|as|drug
DDI-DrugBank.d585.s5|104-117|metoclopramide|drug
DDI-DrugBank.d585.s5|118-118|.|drug
DDI-DrugBank.d585.s6|0-6|Because|drug
DDI-DrugBank.d585.s6|8-15|antacids|drug
DDI-DrugBank.d585.s6|17-19|may|drug
DDI-DrugBank.d585.s6|21-29|interfere|drug
DDI-DrugBank.d585.s6|31-34|with|drug
DDI-DrugBank.d585.s6|36-38|the|drug
DDI-DrugBank.d585.s6|40-49|absorption|drug
DDI-DrugBank.d585.s6|51-52|of|drug
DDI-DrugBank.d585.s6|54-68|anticholinergic|drug
DDI-DrugBank.d585.s6|70-75|agents|drug
DDI-DrugBank.d585.s6|76-76|,|drug
DDI-DrugBank.d585.s6|78-89|simultaneous|drug
DDI-DrugBank.d585.s6|91-93|use|drug
DDI-DrugBank.d585.s6|95-96|of|drug
DDI-DrugBank.d585.s6|98-102|these|drug
DDI-DrugBank.d585.s6|104-108|drugs|drug
DDI-DrugBank.d585.s6|110-115|should|drug
DDI-DrugBank.d585.s6|117-118|be|drug
DDI-DrugBank.d585.s6|120-126|avoided|drug
DDI-DrugBank.d585.s6|127-127|.|drug
DDI-DrugBank.d585.s7|0-2|The|drug
DDI-DrugBank.d585.s7|4-13|inhibiting|drug
DDI-DrugBank.d585.s7|15-21|effects|drug
DDI-DrugBank.d585.s7|23-24|of|drug
DDI-DrugBank.d585.s7|26-40|anticholinergic|drug
DDI-DrugBank.d585.s7|42-46|drugs|drug
DDI-DrugBank.d585.s7|48-49|on|drug
DDI-DrugBank.d585.s7|51-57|gastric|drug
DDI-DrugBank.d585.s7|59-70|hydrochloric|drug
DDI-DrugBank.d585.s7|72-75|acid|drug
DDI-DrugBank.d585.s7|77-85|secretion|drug
DDI-DrugBank.d585.s7|87-89|are|drug
DDI-DrugBank.d585.s7|91-101|antagonized|drug
DDI-DrugBank.d585.s7|103-104|by|drug
DDI-DrugBank.d585.s7|106-111|agents|drug
DDI-DrugBank.d585.s7|113-116|used|drug
DDI-DrugBank.d585.s7|118-119|to|drug
DDI-DrugBank.d585.s7|121-125|treat|drug
DDI-DrugBank.d585.s7|127-138|achlorhydria|drug
DDI-DrugBank.d585.s7|140-142|and|drug
DDI-DrugBank.d585.s7|144-148|those|drug
DDI-DrugBank.d585.s7|150-153|used|drug
DDI-DrugBank.d585.s7|155-156|to|drug
DDI-DrugBank.d585.s7|158-161|test|drug
DDI-DrugBank.d585.s7|163-169|gastric|drug
DDI-DrugBank.d585.s7|171-179|secretion|drug
DDI-DrugBank.d585.s7|180-180|.|drug
DDI-MedLine.d49.s0|0-10|Interaction|drug
DDI-MedLine.d49.s0|12-13|of|drug
DDI-MedLine.d49.s0|15-25|clindamycin|drug
DDI-MedLine.d49.s0|27-29|and|drug
DDI-MedLine.d49.s0|31-40|gentamicin|drug
DDI-MedLine.d49.s0|42-43|in|drug
DDI-MedLine.d49.s0|45-49|vitro|drug
DDI-MedLine.d49.s0|50-50|.|drug
DDI-MedLine.d49.s1|0-2|The|drug
DDI-MedLine.d49.s1|4-10|minimal|drug
DDI-MedLine.d49.s1|12-21|inhibitory|drug
DDI-MedLine.d49.s1|23-36|concentrations|drug
DDI-MedLine.d49.s1|38-39|of|drug
DDI-MedLine.d49.s1|41-51|clindamycin|drug
DDI-MedLine.d49.s1|53-55|and|drug
DDI-MedLine.d49.s1|57-66|gentamicin|drug
DDI-MedLine.d49.s1|68-72|alone|drug
DDI-MedLine.d49.s1|74-76|and|drug
DDI-MedLine.d49.s1|78-79|in|drug
DDI-MedLine.d49.s1|81-92|combinations|drug
DDI-MedLine.d49.s1|94-97|were|drug
DDI-MedLine.d49.s1|99-108|determined|drug
DDI-MedLine.d49.s1|110-111|by|drug
DDI-MedLine.d49.s1|113-113|a|drug
DDI-MedLine.d49.s1|115-127|microdilution|drug
DDI-MedLine.d49.s1|129-134|method|drug
DDI-MedLine.d49.s1|136-138|for|drug
DDI-MedLine.d49.s1|140-142|163|drug
DDI-MedLine.d49.s1|144-150|aerobic|drug
DDI-MedLine.d49.s1|151-151|,|drug
DDI-MedLine.d49.s1|153-163|facultative|drug
DDI-MedLine.d49.s1|164-164|,|drug
DDI-MedLine.d49.s1|166-168|and|drug
DDI-MedLine.d49.s1|170-178|anaerobic|drug
DDI-MedLine.d49.s1|180-187|clinical|drug
DDI-MedLine.d49.s1|189-196|isolates|drug
DDI-MedLine.d49.s1|197-197|.|drug
DDI-MedLine.d49.s2|0-2|All|drug
DDI-MedLine.d49.s2|4-5|77|drug
DDI-MedLine.d49.s2|7-13|strains|drug
DDI-MedLine.d49.s2|15-16|of|drug
DDI-MedLine.d49.s2|18-31|Staphylococcus|drug
DDI-MedLine.d49.s2|33-38|aureus|drug
DDI-MedLine.d49.s2|39-39|,|drug
DDI-MedLine.d49.s2|41-51|Diplococcus|drug
DDI-MedLine.d49.s2|53-62|pneumoniae|drug
DDI-MedLine.d49.s2|63-63|,|drug
DDI-MedLine.d49.s2|65-77|Streptococcus|drug
DDI-MedLine.d49.s2|79-86|pyogenes|drug
DDI-MedLine.d49.s2|87-87|,|drug
DDI-MedLine.d49.s2|89-91|and|drug
DDI-MedLine.d49.s2|93-101|anaerobic|drug
DDI-MedLine.d49.s2|103-110|bacteria|drug
DDI-MedLine.d49.s2|112-112|(|drug
DDI-MedLine.d49.s2|113-118|except|drug
DDI-MedLine.d49.s2|120-122|for|drug
DDI-MedLine.d49.s2|124-128|three|drug
DDI-MedLine.d49.s2|130-136|strains|drug
DDI-MedLine.d49.s2|138-139|of|drug
DDI-MedLine.d49.s2|141-151|Clostridium|drug
DDI-MedLine.d49.s2|152-152|)|drug
DDI-MedLine.d49.s2|154-157|were|drug
DDI-MedLine.d49.s2|159-167|inhibited|drug
DDI-MedLine.d49.s2|169-170|by|drug
DDI-MedLine.d49.s2|172-174|1.6|drug
DDI-MedLine.d49.s2|176-178|mug|drug
DDI-MedLine.d49.s2|180-181|or|drug
DDI-MedLine.d49.s2|183-186|less|drug
DDI-MedLine.d49.s2|188-189|of|drug
DDI-MedLine.d49.s2|191-201|clindamycin|drug
DDI-MedLine.d49.s2|203-205|per|drug
DDI-MedLine.d49.s2|207-208|ml|drug
DDI-MedLine.d49.s2|209-209|.|drug
DDI-MedLine.d49.s3|0-9|Gentamicin|drug
DDI-MedLine.d49.s3|11-13|did|drug
DDI-MedLine.d49.s3|15-17|not|drug
DDI-MedLine.d49.s3|19-27|interfere|drug
DDI-MedLine.d49.s3|29-32|with|drug
DDI-MedLine.d49.s3|34-36|the|drug
DDI-MedLine.d49.s3|38-45|activity|drug
DDI-MedLine.d49.s3|47-48|of|drug
DDI-MedLine.d49.s3|50-60|clindamycin|drug
DDI-MedLine.d49.s3|62-67|within|drug
DDI-MedLine.d49.s3|69-71|the|drug
DDI-MedLine.d49.s3|73-77|range|drug
DDI-MedLine.d49.s3|79-80|of|drug
DDI-MedLine.d49.s3|82-95|concentrations|drug
DDI-MedLine.d49.s3|97-102|tested|drug
DDI-MedLine.d49.s3|104-104|(|drug
DDI-MedLine.d49.s3|105-107|0.1|drug
DDI-MedLine.d49.s3|109-110|to|drug
DDI-MedLine.d49.s3|112-114|100|drug
DDI-MedLine.d49.s3|116-121|mug/ml|drug
DDI-MedLine.d49.s3|122-122|)|drug
DDI-MedLine.d49.s3|123-123|;|drug
DDI-MedLine.d49.s4|0-2|for|drug
DDI-MedLine.d49.s4|4-7|some|drug
DDI-MedLine.d49.s4|9-15|strains|drug
DDI-MedLine.d49.s4|17-28|combinations|drug
DDI-MedLine.d49.s4|30-33|were|drug
DDI-MedLine.d49.s4|35-45|synergistic|drug
DDI-MedLine.d49.s4|46-46|.|drug
DDI-MedLine.d49.s5|0-8|Sixty-two|drug
DDI-MedLine.d49.s5|10-10|(|drug
DDI-MedLine.d49.s5|11-12|94|drug
DDI-MedLine.d49.s5|13-13|%|drug
DDI-MedLine.d49.s5|14-14|)|drug
DDI-MedLine.d49.s5|16-17|of|drug
DDI-MedLine.d49.s5|19-20|66|drug
DDI-MedLine.d49.s5|22-28|strains|drug
DDI-MedLine.d49.s5|30-31|of|drug
DDI-MedLine.d49.s5|33-50|Enterobacteriaceae|drug
DDI-MedLine.d49.s5|52-54|and|drug
DDI-MedLine.d49.s5|56-66|Pseudomonas|drug
DDI-MedLine.d49.s5|68-77|aeruginosa|drug
DDI-MedLine.d49.s5|79-82|were|drug
DDI-MedLine.d49.s5|84-92|inhibited|drug
DDI-MedLine.d49.s5|94-95|by|drug
DDI-MedLine.d49.s5|97-99|6.2|drug
DDI-MedLine.d49.s5|101-103|mug|drug
DDI-MedLine.d49.s5|105-106|or|drug
DDI-MedLine.d49.s5|108-111|less|drug
DDI-MedLine.d49.s5|113-114|of|drug
DDI-MedLine.d49.s5|116-125|gentamicin|drug
DDI-MedLine.d49.s5|127-129|per|drug
DDI-MedLine.d49.s5|131-132|ml|drug
DDI-MedLine.d49.s5|133-133|.|drug
DDI-MedLine.d49.s6|0-11|Combinations|drug
DDI-MedLine.d49.s6|13-14|of|drug
DDI-MedLine.d49.s6|16-26|clindamycin|drug
DDI-MedLine.d49.s6|28-30|and|drug
DDI-MedLine.d49.s6|32-41|gentamicin|drug
DDI-MedLine.d49.s6|43-46|were|drug
DDI-MedLine.d49.s6|48-58|indifferent|drug
DDI-MedLine.d49.s6|60-62|for|drug
DDI-MedLine.d49.s6|64-65|29|drug
DDI-MedLine.d49.s6|67-73|strains|drug
DDI-MedLine.d49.s6|75-77|and|drug
DDI-MedLine.d49.s6|79-89|synergistic|drug
DDI-MedLine.d49.s6|91-93|for|drug
DDI-MedLine.d49.s6|95-96|33|drug
DDI-MedLine.d49.s6|98-104|strains|drug
DDI-MedLine.d49.s6|105-105|.|drug
DDI-MedLine.d49.s7|0-2|All|drug
DDI-MedLine.d49.s7|4-5|20|drug
DDI-MedLine.d49.s7|7-13|strains|drug
DDI-MedLine.d49.s7|15-16|of|drug
DDI-MedLine.d49.s7|18-29|enterococcus|drug
DDI-MedLine.d49.s7|30-30|,|drug
DDI-MedLine.d49.s7|32-36|three|drug
DDI-MedLine.d49.s7|38-44|strains|drug
DDI-MedLine.d49.s7|46-47|of|drug
DDI-MedLine.d49.s7|49-59|Clostridium|drug
DDI-MedLine.d49.s7|60-60|,|drug
DDI-MedLine.d49.s7|62-66|three|drug
DDI-MedLine.d49.s7|68-74|strains|drug
DDI-MedLine.d49.s7|76-77|of|drug
DDI-MedLine.d49.s7|79-89|Escherichia|drug
DDI-MedLine.d49.s7|91-94|coli|drug
DDI-MedLine.d49.s7|95-95|,|drug
DDI-MedLine.d49.s7|97-99|and|drug
DDI-MedLine.d49.s7|101-103|one|drug
DDI-MedLine.d49.s7|105-110|strain|drug
DDI-MedLine.d49.s7|112-113|of|drug
DDI-MedLine.d49.s7|115-121|Proteus|drug
DDI-MedLine.d49.s7|123-130|rettgeri|drug
DDI-MedLine.d49.s7|132-135|were|drug
DDI-MedLine.d49.s7|137-145|resistant|drug
DDI-MedLine.d49.s7|147-148|to|drug
DDI-MedLine.d49.s7|150-153|both|drug
DDI-MedLine.d49.s7|155-165|clindamycin|drug
DDI-MedLine.d49.s7|167-167|(|drug
DDI-MedLine.d49.s7|168-174|minimal|drug
DDI-MedLine.d49.s7|176-185|inhibitory|drug
DDI-MedLine.d49.s7|187-199|concentration|drug
DDI-MedLine.d49.s7|201-207|greater|drug
DDI-MedLine.d49.s7|209-212|than|drug
DDI-MedLine.d49.s7|214-216|3.1|drug
DDI-MedLine.d49.s7|218-223|mug/ml|drug
DDI-MedLine.d49.s7|224-224|)|drug
DDI-MedLine.d49.s7|226-228|and|drug
DDI-MedLine.d49.s7|230-239|gentamicin|drug
DDI-MedLine.d49.s7|241-241|(|drug
DDI-MedLine.d49.s7|242-248|minimal|drug
DDI-MedLine.d49.s7|250-259|inhibitory|drug
DDI-MedLine.d49.s7|261-273|concentration|drug
DDI-MedLine.d49.s7|275-281|greater|drug
DDI-MedLine.d49.s7|283-286|than|drug
DDI-MedLine.d49.s7|288-290|6.2|drug
DDI-MedLine.d49.s7|292-297|mug/ml|drug
DDI-MedLine.d49.s7|298-298|)|drug
DDI-MedLine.d49.s7|299-299|.|drug
DDI-MedLine.d49.s8|0-11|Combinations|drug
DDI-MedLine.d49.s8|13-14|of|drug
DDI-MedLine.d49.s8|16-26|clindamycin|drug
DDI-MedLine.d49.s8|28-30|and|drug
DDI-MedLine.d49.s8|32-41|gentamicin|drug
DDI-MedLine.d49.s8|43-46|were|drug
DDI-MedLine.d49.s8|48-58|indifferent|drug
DDI-MedLine.d49.s8|60-62|for|drug
DDI-MedLine.d49.s8|64-65|16|drug
DDI-MedLine.d49.s8|67-69|and|drug
DDI-MedLine.d49.s8|71-81|synergistic|drug
DDI-MedLine.d49.s8|83-85|for|drug
DDI-MedLine.d49.s8|87-88|11|drug
DDI-MedLine.d49.s8|90-91|of|drug
DDI-MedLine.d49.s8|93-95|the|drug
DDI-MedLine.d49.s8|97-105|resistant|drug
DDI-MedLine.d49.s8|107-113|strains|drug
DDI-MedLine.d49.s8|114-114|.|drug
DDI-MedLine.d49.s9|0-5|Except|drug
DDI-MedLine.d49.s9|7-9|for|drug
DDI-MedLine.d49.s9|11-31|clindamycin-sensitive|drug
DDI-MedLine.d49.s9|33-40|isolates|drug
DDI-MedLine.d49.s9|41-41|,|drug
DDI-MedLine.d49.s9|43-49|synergy|drug
DDI-MedLine.d49.s9|51-53|was|drug
DDI-MedLine.d49.s9|55-61|usually|drug
DDI-MedLine.d49.s9|63-70|observed|drug
DDI-MedLine.d49.s9|72-75|only|drug
DDI-MedLine.d49.s9|77-78|at|drug
DDI-MedLine.d49.s9|80-93|concentrations|drug
DDI-MedLine.d49.s9|95-96|of|drug
DDI-MedLine.d49.s9|98-100|one|drug
DDI-MedLine.d49.s9|102-103|or|drug
DDI-MedLine.d49.s9|105-108|both|drug
DDI-MedLine.d49.s9|110-114|drugs|drug
DDI-MedLine.d49.s9|116-120|which|drug
DDI-MedLine.d49.s9|122-124|are|drug
DDI-MedLine.d49.s9|126-128|not|drug
DDI-MedLine.d49.s9|130-136|readily|drug
DDI-MedLine.d49.s9|138-147|obtainable|drug
DDI-MedLine.d49.s9|149-150|in|drug
DDI-MedLine.d49.s9|152-155|vivo|drug
DDI-MedLine.d49.s9|156-156|.|drug
DDI-MedLine.d49.s10|0-9|Antagonism|drug
DDI-MedLine.d49.s10|11-13|was|drug
DDI-MedLine.d49.s10|15-19|never|drug
DDI-MedLine.d49.s10|21-28|observed|drug
DDI-MedLine.d49.s10|29-29|.|drug
DDI-DrugBank.d195.s0|0-10|Anastrozole|drug
DDI-DrugBank.d195.s0|12-20|inhibited|drug
DDI-DrugBank.d195.s0|22-23|in|drug
DDI-DrugBank.d195.s0|25-29|vitro|drug
DDI-DrugBank.d195.s0|31-39|metabolic|drug
DDI-DrugBank.d195.s0|41-49|reactions|drug
DDI-DrugBank.d195.s0|51-59|catalyzed|drug
DDI-DrugBank.d195.s0|61-62|by|drug
DDI-DrugBank.d195.s0|64-74|cytochromes|drug
DDI-DrugBank.d195.s0|76-79|P450|drug
DDI-DrugBank.d195.s0|81-83|1A2|drug
DDI-DrugBank.d195.s0|84-84|,|drug
DDI-DrugBank.d195.s0|86-90|2C8/9|drug
DDI-DrugBank.d195.s0|91-91|,|drug
DDI-DrugBank.d195.s0|93-95|and|drug
DDI-DrugBank.d195.s0|97-99|3A4|drug
DDI-DrugBank.d195.s0|101-103|but|drug
DDI-DrugBank.d195.s0|105-108|only|drug
DDI-DrugBank.d195.s0|110-111|at|drug
DDI-DrugBank.d195.s0|113-122|relatively|drug
DDI-DrugBank.d195.s0|124-127|high|drug
DDI-DrugBank.d195.s0|129-142|concentrations|drug
DDI-DrugBank.d195.s0|143-143|.|drug
DDI-DrugBank.d195.s1|0-10|Anastrozole|drug
DDI-DrugBank.d195.s1|12-14|did|drug
DDI-DrugBank.d195.s1|16-18|not|drug
DDI-DrugBank.d195.s1|20-26|inhibit|drug
DDI-DrugBank.d195.s1|28-31|P450|drug
DDI-DrugBank.d195.s1|33-35|2A6|drug
DDI-DrugBank.d195.s1|37-38|or|drug
DDI-DrugBank.d195.s1|40-42|the|drug
DDI-DrugBank.d195.s1|44-54|polymorphic|drug
DDI-DrugBank.d195.s1|56-59|P450|drug
DDI-DrugBank.d195.s1|61-63|2D6|drug
DDI-DrugBank.d195.s1|65-66|in|drug
DDI-DrugBank.d195.s1|68-72|human|drug
DDI-DrugBank.d195.s1|74-78|liver|drug
DDI-DrugBank.d195.s1|80-89|microsomes|drug
DDI-DrugBank.d195.s1|90-90|.|drug
DDI-DrugBank.d195.s2|0-10|Anastrozole|drug
DDI-DrugBank.d195.s2|12-14|did|drug
DDI-DrugBank.d195.s2|16-18|not|drug
DDI-DrugBank.d195.s2|20-24|alter|drug
DDI-DrugBank.d195.s2|26-28|the|drug
DDI-DrugBank.d195.s2|30-45|pharmacokinetics|drug
DDI-DrugBank.d195.s2|47-48|of|drug
DDI-DrugBank.d195.s2|50-59|antipyrine|drug
DDI-DrugBank.d195.s2|60-60|.|drug
DDI-DrugBank.d195.s3|0-7|Although|drug
DDI-DrugBank.d195.s3|9-13|there|drug
DDI-DrugBank.d195.s3|15-18|have|drug
DDI-DrugBank.d195.s3|20-23|been|drug
DDI-DrugBank.d195.s3|25-26|no|drug
DDI-DrugBank.d195.s3|28-33|formal|drug
DDI-DrugBank.d195.s3|35-45|interaction|drug
DDI-DrugBank.d195.s3|47-53|studies|drug
DDI-DrugBank.d195.s3|55-59|other|drug
DDI-DrugBank.d195.s3|61-64|than|drug
DDI-DrugBank.d195.s3|66-69|with|drug
DDI-DrugBank.d195.s3|71-80|antipyrine|drug
DDI-DrugBank.d195.s3|81-81|,|drug
DDI-DrugBank.d195.s3|83-87|based|drug
DDI-DrugBank.d195.s3|89-90|on|drug
DDI-DrugBank.d195.s3|92-96|these|drug
DDI-DrugBank.d195.s3|98-99|in|drug
DDI-DrugBank.d195.s3|101-104|vivo|drug
DDI-DrugBank.d195.s3|106-108|and|drug
DDI-DrugBank.d195.s3|110-111|in|drug
DDI-DrugBank.d195.s3|113-117|vitro|drug
DDI-DrugBank.d195.s3|119-125|studies|drug
DDI-DrugBank.d195.s3|126-126|,|drug
DDI-DrugBank.d195.s3|128-129|it|drug
DDI-DrugBank.d195.s3|131-132|is|drug
DDI-DrugBank.d195.s3|134-141|unlikely|drug
DDI-DrugBank.d195.s3|143-146|that|drug
DDI-DrugBank.d195.s3|148-164|co-administration|drug
DDI-DrugBank.d195.s3|166-167|of|drug
DDI-DrugBank.d195.s3|169-169|a|drug
DDI-DrugBank.d195.s3|171-171|1|drug
DDI-DrugBank.d195.s3|173-174|mg|drug
DDI-DrugBank.d195.s3|176-179|dose|drug
DDI-DrugBank.d195.s3|181-182|of|drug
DDI-DrugBank.d195.s3|184-191|ARIMIDEX|drug
DDI-DrugBank.d195.s3|193-196|with|drug
DDI-DrugBank.d195.s3|198-202|other|drug
DDI-DrugBank.d195.s3|204-208|drugs|drug
DDI-DrugBank.d195.s3|210-213|will|drug
DDI-DrugBank.d195.s3|215-220|result|drug
DDI-DrugBank.d195.s3|222-223|in|drug
DDI-DrugBank.d195.s3|225-234|clinically|drug
DDI-DrugBank.d195.s3|236-246|significant|drug
DDI-DrugBank.d195.s3|248-251|drug|drug
DDI-DrugBank.d195.s3|253-262|inhibition|drug
DDI-DrugBank.d195.s3|264-265|of|drug
DDI-DrugBank.d195.s3|267-276|cytochrome|drug
DDI-DrugBank.d195.s3|278-290|P450-mediated|drug
DDI-DrugBank.d195.s3|292-301|metabolism|drug
DDI-DrugBank.d195.s3|303-304|of|drug
DDI-DrugBank.d195.s3|306-308|the|drug
DDI-DrugBank.d195.s3|310-314|other|drug
DDI-DrugBank.d195.s3|316-320|drugs|drug
DDI-DrugBank.d195.s3|321-321|.|drug
DDI-DrugBank.d195.s4|0-1|An|drug
DDI-DrugBank.d195.s4|3-13|interaction|drug
DDI-DrugBank.d195.s4|15-19|study|drug
DDI-DrugBank.d195.s4|21-24|with|drug
DDI-DrugBank.d195.s4|26-33|warfarin|drug
DDI-DrugBank.d195.s4|35-40|showed|drug
DDI-DrugBank.d195.s4|42-43|no|drug
DDI-DrugBank.d195.s4|45-54|clinically|drug
DDI-DrugBank.d195.s4|56-66|significant|drug
DDI-DrugBank.d195.s4|68-73|effect|drug
DDI-DrugBank.d195.s4|75-76|of|drug
DDI-DrugBank.d195.s4|78-88|anastrozole|drug
DDI-DrugBank.d195.s4|90-91|on|drug
DDI-DrugBank.d195.s4|93-100|warfarin|drug
DDI-DrugBank.d195.s4|102-117|pharmacokinetics|drug
DDI-DrugBank.d195.s4|119-120|or|drug
DDI-DrugBank.d195.s4|122-134|anticoagulant|drug
DDI-DrugBank.d195.s4|136-143|activity|drug
DDI-DrugBank.d195.s4|144-144|.|drug
DDI-DrugBank.d195.s5|0-1|At|drug
DDI-DrugBank.d195.s5|3-3|a|drug
DDI-DrugBank.d195.s5|5-10|median|drug
DDI-DrugBank.d195.s5|12-20|follow-up|drug
DDI-DrugBank.d195.s5|22-23|of|drug
DDI-DrugBank.d195.s5|25-26|33|drug
DDI-DrugBank.d195.s5|28-33|months|drug
DDI-DrugBank.d195.s5|34-34|,|drug
DDI-DrugBank.d195.s5|36-38|the|drug
DDI-DrugBank.d195.s5|40-50|combination|drug
DDI-DrugBank.d195.s5|52-53|of|drug
DDI-DrugBank.d195.s5|55-62|ARIMIDEX|drug
DDI-DrugBank.d195.s5|64-66|and|drug
DDI-DrugBank.d195.s5|68-76|tamoxifen|drug
DDI-DrugBank.d195.s5|78-80|did|drug
DDI-DrugBank.d195.s5|82-84|not|drug
DDI-DrugBank.d195.s5|86-96|demonstrate|drug
DDI-DrugBank.d195.s5|98-100|any|drug
DDI-DrugBank.d195.s5|102-109|efficacy|drug
DDI-DrugBank.d195.s5|111-117|benefit|drug
DDI-DrugBank.d195.s5|119-122|when|drug
DDI-DrugBank.d195.s5|124-131|compared|drug
DDI-DrugBank.d195.s5|133-136|with|drug
DDI-DrugBank.d195.s5|138-146|tamoxifen|drug
DDI-DrugBank.d195.s5|148-149|in|drug
DDI-DrugBank.d195.s5|151-153|all|drug
DDI-DrugBank.d195.s5|155-162|patients|drug
DDI-DrugBank.d195.s5|164-165|as|drug
DDI-DrugBank.d195.s5|167-170|well|drug
DDI-DrugBank.d195.s5|172-173|as|drug
DDI-DrugBank.d195.s5|175-176|in|drug
DDI-DrugBank.d195.s5|178-180|the|drug
DDI-DrugBank.d195.s5|182-188|hormone|drug
DDI-DrugBank.d195.s5|190-206|receptor-positive|drug
DDI-DrugBank.d195.s5|208-220|subpopulation|drug
DDI-DrugBank.d195.s5|221-221|.|drug
DDI-DrugBank.d195.s6|0-3|This|drug
DDI-DrugBank.d195.s6|5-13|treatment|drug
DDI-DrugBank.d195.s6|15-17|arm|drug
DDI-DrugBank.d195.s6|19-21|was|drug
DDI-DrugBank.d195.s6|23-34|discontinued|drug
DDI-DrugBank.d195.s6|36-39|from|drug
DDI-DrugBank.d195.s6|41-43|the|drug
DDI-DrugBank.d195.s6|45-49|trial|drug
DDI-DrugBank.d195.s6|50-50|.|drug
DDI-DrugBank.d195.s7|0-4|Based|drug
DDI-DrugBank.d195.s7|6-7|on|drug
DDI-DrugBank.d195.s7|9-16|clinical|drug
DDI-DrugBank.d195.s7|18-20|and|drug
DDI-DrugBank.d195.s7|22-36|pharmacokinetic|drug
DDI-DrugBank.d195.s7|38-44|results|drug
DDI-DrugBank.d195.s7|46-49|from|drug
DDI-DrugBank.d195.s7|51-53|the|drug
DDI-DrugBank.d195.s7|55-58|ATAC|drug
DDI-DrugBank.d195.s7|60-64|trial|drug
DDI-DrugBank.d195.s7|65-65|,|drug
DDI-DrugBank.d195.s7|67-75|tamoxifen|drug
DDI-DrugBank.d195.s7|77-82|should|drug
DDI-DrugBank.d195.s7|84-86|not|drug
DDI-DrugBank.d195.s7|88-89|be|drug
DDI-DrugBank.d195.s7|91-102|administered|drug
DDI-DrugBank.d195.s7|104-107|with|drug
DDI-DrugBank.d195.s7|109-119|anastrozole|drug
DDI-DrugBank.d195.s7|121-121|(|drug
DDI-DrugBank.d195.s7|122-124|see|drug
DDI-DrugBank.d195.s7|126-133|CLINICAL|drug
DDI-DrugBank.d195.s7|135-146|PHARMACOLOGY|drug
DDI-DrugBank.d195.s7|150-153|Drug|drug
DDI-DrugBank.d195.s7|155-166|Interactions|drug
DDI-DrugBank.d195.s7|168-170|and|drug
DDI-DrugBank.d195.s7|172-179|CLINICAL|drug
DDI-DrugBank.d195.s7|181-192|PHARMACOLOGY|drug
DDI-DrugBank.d195.s7|194-194|-|drug
DDI-DrugBank.d195.s7|196-203|Clinical|drug
DDI-DrugBank.d195.s7|205-211|Studies|drug
DDI-DrugBank.d195.s7|213-213|-|drug
DDI-DrugBank.d195.s7|215-222|Adjuvant|drug
DDI-DrugBank.d195.s7|224-232|Treatment|drug
DDI-DrugBank.d195.s7|234-235|of|drug
DDI-DrugBank.d195.s7|237-242|Breast|drug
DDI-DrugBank.d195.s7|244-249|Cancer|drug
DDI-DrugBank.d195.s7|251-252|in|drug
DDI-DrugBank.d195.s7|254-267|Postmenopausal|drug
DDI-DrugBank.d195.s7|269-273|Women|drug
DDI-DrugBank.d195.s7|275-285|subsections|drug
DDI-DrugBank.d195.s7|286-286|)|drug
DDI-DrugBank.d195.s7|287-287|.|drug
DDI-DrugBank.d195.s8|0-16|Co-administration|drug
DDI-DrugBank.d195.s8|18-19|of|drug
DDI-DrugBank.d195.s8|21-31|anastrozole|drug
DDI-DrugBank.d195.s8|33-35|and|drug
DDI-DrugBank.d195.s8|37-45|tamoxifen|drug
DDI-DrugBank.d195.s8|47-54|resulted|drug
DDI-DrugBank.d195.s8|56-57|in|drug
DDI-DrugBank.d195.s8|59-59|a|drug
DDI-DrugBank.d195.s8|61-69|reduction|drug
DDI-DrugBank.d195.s8|71-72|of|drug
DDI-DrugBank.d195.s8|74-84|anastrozole|drug
DDI-DrugBank.d195.s8|86-91|plasma|drug
DDI-DrugBank.d195.s8|93-98|levels|drug
DDI-DrugBank.d195.s8|100-101|by|drug
DDI-DrugBank.d195.s8|103-104|27|drug
DDI-DrugBank.d195.s8|105-105|%|drug
DDI-DrugBank.d195.s8|107-114|compared|drug
DDI-DrugBank.d195.s8|116-119|with|drug
DDI-DrugBank.d195.s8|121-125|those|drug
DDI-DrugBank.d195.s8|127-134|achieved|drug
DDI-DrugBank.d195.s8|136-139|with|drug
DDI-DrugBank.d195.s8|141-151|anastrozole|drug
DDI-DrugBank.d195.s8|153-157|alone|drug
DDI-DrugBank.d195.s8|158-158|.|drug
DDI-DrugBank.d195.s9|0-18|Estrogen-containing|drug
DDI-DrugBank.d195.s9|20-28|therapies|drug
DDI-DrugBank.d195.s9|30-35|should|drug
DDI-DrugBank.d195.s9|37-39|not|drug
DDI-DrugBank.d195.s9|41-42|be|drug
DDI-DrugBank.d195.s9|44-47|used|drug
DDI-DrugBank.d195.s9|49-52|with|drug
DDI-DrugBank.d195.s9|54-61|ARIMIDEX|drug
DDI-DrugBank.d195.s9|63-64|as|drug
DDI-DrugBank.d195.s9|66-69|they|drug
DDI-DrugBank.d195.s9|71-73|may|drug
DDI-DrugBank.d195.s9|75-82|diminish|drug
DDI-DrugBank.d195.s9|84-86|its|drug
DDI-DrugBank.d195.s9|88-100|pharmacologic|drug
DDI-DrugBank.d195.s9|102-107|action|drug
DDI-DrugBank.d195.s9|108-108|.|drug
DDI-DrugBank.d195.s10|0-14|Drug/Laboratory|drug
DDI-DrugBank.d195.s10|16-19|Test|drug
DDI-DrugBank.d195.s10|21-32|Interactions|drug
DDI-DrugBank.d195.s10|34-35|No|drug
DDI-DrugBank.d195.s10|37-46|clinically|drug
DDI-DrugBank.d195.s10|48-58|significant|drug
DDI-DrugBank.d195.s10|60-66|changes|drug
DDI-DrugBank.d195.s10|68-69|in|drug
DDI-DrugBank.d195.s10|71-73|the|drug
DDI-DrugBank.d195.s10|75-81|results|drug
DDI-DrugBank.d195.s10|83-84|of|drug
DDI-DrugBank.d195.s10|86-93|clinical|drug
DDI-DrugBank.d195.s10|95-104|laboratory|drug
DDI-DrugBank.d195.s10|106-110|tests|drug
DDI-DrugBank.d195.s10|112-115|have|drug
DDI-DrugBank.d195.s10|117-120|been|drug
DDI-DrugBank.d195.s10|122-129|observed|drug
DDI-DrugBank.d195.s11|0-0|.|drug
DDI-DrugBank.d412.s0|0-1|In|drug
DDI-DrugBank.d412.s0|3-5|one|drug
DDI-DrugBank.d412.s0|7-12|survey|drug
DDI-DrugBank.d412.s0|13-13|,|drug
DDI-DrugBank.d412.s0|15-17|2.3|drug
DDI-DrugBank.d412.s0|18-18|%|drug
DDI-DrugBank.d412.s0|20-21|of|drug
DDI-DrugBank.d412.s0|23-30|patients|drug
DDI-DrugBank.d412.s0|32-37|taking|drug
DDI-DrugBank.d412.s0|39-47|labetalol|drug
DDI-DrugBank.d412.s0|49-51|HCl|drug
DDI-DrugBank.d412.s0|53-54|in|drug
DDI-DrugBank.d412.s0|56-66|combination|drug
DDI-DrugBank.d412.s0|68-71|with|drug
DDI-DrugBank.d412.s0|73-81|tricyclic|drug
DDI-DrugBank.d412.s0|83-97|antidepressants|drug
DDI-DrugBank.d412.s0|99-109|experienced|drug
DDI-DrugBank.d412.s0|111-116|tremor|drug
DDI-DrugBank.d412.s0|117-117|,|drug
DDI-DrugBank.d412.s0|119-120|as|drug
DDI-DrugBank.d412.s0|122-129|compared|drug
DDI-DrugBank.d412.s0|131-132|to|drug
DDI-DrugBank.d412.s0|134-136|0.7|drug
DDI-DrugBank.d412.s0|137-137|%|drug
DDI-DrugBank.d412.s0|139-146|reported|drug
DDI-DrugBank.d412.s0|148-149|to|drug
DDI-DrugBank.d412.s0|151-155|occur|drug
DDI-DrugBank.d412.s0|157-160|with|drug
DDI-DrugBank.d412.s0|162-170|labetalol|drug
DDI-DrugBank.d412.s0|172-174|HCl|drug
DDI-DrugBank.d412.s0|176-180|alone|drug
DDI-DrugBank.d412.s0|181-181|.|drug
DDI-DrugBank.d412.s1|0-2|The|drug
DDI-DrugBank.d412.s1|4-15|contribution|drug
DDI-DrugBank.d412.s1|17-18|of|drug
DDI-DrugBank.d412.s1|20-23|each|drug
DDI-DrugBank.d412.s1|25-26|of|drug
DDI-DrugBank.d412.s1|28-30|the|drug
DDI-DrugBank.d412.s1|32-41|treatments|drug
DDI-DrugBank.d412.s1|43-44|to|drug
DDI-DrugBank.d412.s1|46-49|this|drug
DDI-DrugBank.d412.s1|51-57|adverse|drug
DDI-DrugBank.d412.s1|59-66|reaction|drug
DDI-DrugBank.d412.s1|68-69|is|drug
DDI-DrugBank.d412.s1|71-77|unknown|drug
DDI-DrugBank.d412.s1|79-81|but|drug
DDI-DrugBank.d412.s1|83-85|the|drug
DDI-DrugBank.d412.s1|87-97|possibility|drug
DDI-DrugBank.d412.s1|99-100|of|drug
DDI-DrugBank.d412.s1|102-102|a|drug
DDI-DrugBank.d412.s1|104-107|drug|drug
DDI-DrugBank.d412.s1|109-119|interaction|drug
DDI-DrugBank.d412.s1|121-123|can|drug
DDI-DrugBank.d412.s1|124-126|not|drug
DDI-DrugBank.d412.s1|128-129|be|drug
DDI-DrugBank.d412.s1|131-138|excluded|drug
DDI-DrugBank.d412.s1|139-139|.|drug
DDI-DrugBank.d412.s2|0-4|Drugs|drug
DDI-DrugBank.d412.s2|6-15|possessing|drug
DDI-DrugBank.d412.s2|17-29|beta-blocking|drug
DDI-DrugBank.d412.s2|31-40|properties|drug
DDI-DrugBank.d412.s2|42-44|can|drug
DDI-DrugBank.d412.s2|46-50|blunt|drug
DDI-DrugBank.d412.s2|52-54|the|drug
DDI-DrugBank.d412.s2|56-69|bronchodilator|drug
DDI-DrugBank.d412.s2|71-76|effect|drug
DDI-DrugBank.d412.s2|78-79|of|drug
DDI-DrugBank.d412.s2|81-93|beta-receptor|drug
DDI-DrugBank.d412.s2|95-101|agonist|drug
DDI-DrugBank.d412.s2|103-107|drugs|drug
DDI-DrugBank.d412.s2|109-110|in|drug
DDI-DrugBank.d412.s2|112-119|patients|drug
DDI-DrugBank.d412.s2|121-124|with|drug
DDI-DrugBank.d412.s2|126-137|bronchospasm|drug
DDI-DrugBank.d412.s2|138-138|;|drug
DDI-DrugBank.d412.s3|0-8|therefore|drug
DDI-DrugBank.d412.s3|9-9|,|drug
DDI-DrugBank.d412.s3|11-15|doses|drug
DDI-DrugBank.d412.s3|17-23|greater|drug
DDI-DrugBank.d412.s3|25-28|than|drug
DDI-DrugBank.d412.s3|30-32|the|drug
DDI-DrugBank.d412.s3|34-39|normal|drug
DDI-DrugBank.d412.s3|41-53|antiasthmatic|drug
DDI-DrugBank.d412.s3|55-58|dose|drug
DDI-DrugBank.d412.s3|60-61|of|drug
DDI-DrugBank.d412.s3|63-74|beta-agonist|drug
DDI-DrugBank.d412.s3|76-89|bronchodilator|drug
DDI-DrugBank.d412.s3|91-95|drugs|drug
DDI-DrugBank.d412.s3|97-99|may|drug
DDI-DrugBank.d412.s3|101-102|be|drug
DDI-DrugBank.d412.s3|104-111|required|drug
DDI-DrugBank.d412.s3|112-112|.|drug
DDI-DrugBank.d412.s4|0-9|Cimetidine|drug
DDI-DrugBank.d412.s4|11-13|has|drug
DDI-DrugBank.d412.s4|15-18|been|drug
DDI-DrugBank.d412.s4|20-24|shown|drug
DDI-DrugBank.d412.s4|26-27|to|drug
DDI-DrugBank.d412.s4|29-36|increase|drug
DDI-DrugBank.d412.s4|38-40|the|drug
DDI-DrugBank.d412.s4|42-56|bioavailability|drug
DDI-DrugBank.d412.s4|58-59|of|drug
DDI-DrugBank.d412.s4|61-69|labetalol|drug
DDI-DrugBank.d412.s4|71-73|HCl|drug
DDI-DrugBank.d412.s4|74-74|.|drug
DDI-DrugBank.d412.s5|0-4|Since|drug
DDI-DrugBank.d412.s5|6-9|this|drug
DDI-DrugBank.d412.s5|11-15|could|drug
DDI-DrugBank.d412.s5|17-18|be|drug
DDI-DrugBank.d412.s5|20-28|explained|drug
DDI-DrugBank.d412.s5|30-35|either|drug
DDI-DrugBank.d412.s5|37-38|by|drug
DDI-DrugBank.d412.s5|40-47|enhanced|drug
DDI-DrugBank.d412.s5|49-58|absorption|drug
DDI-DrugBank.d412.s5|60-61|or|drug
DDI-DrugBank.d412.s5|63-64|by|drug
DDI-DrugBank.d412.s5|66-67|an|drug
DDI-DrugBank.d412.s5|69-78|alteration|drug
DDI-DrugBank.d412.s5|80-81|of|drug
DDI-DrugBank.d412.s5|83-89|hepatic|drug
DDI-DrugBank.d412.s5|91-100|metabolism|drug
DDI-DrugBank.d412.s5|102-103|of|drug
DDI-DrugBank.d412.s5|105-113|labetalol|drug
DDI-DrugBank.d412.s5|115-117|HCl|drug
DDI-DrugBank.d412.s5|118-118|,|drug
DDI-DrugBank.d412.s5|120-126|special|drug
DDI-DrugBank.d412.s5|128-131|care|drug
DDI-DrugBank.d412.s5|133-138|should|drug
DDI-DrugBank.d412.s5|140-141|be|drug
DDI-DrugBank.d412.s5|143-146|used|drug
DDI-DrugBank.d412.s5|148-149|in|drug
DDI-DrugBank.d412.s5|151-162|establishing|drug
DDI-DrugBank.d412.s5|164-166|the|drug
DDI-DrugBank.d412.s5|168-171|dose|drug
DDI-DrugBank.d412.s5|173-180|required|drug
DDI-DrugBank.d412.s5|182-184|for|drug
DDI-DrugBank.d412.s5|186-190|blood|drug
DDI-DrugBank.d412.s5|192-199|pressure|drug
DDI-DrugBank.d412.s5|201-207|control|drug
DDI-DrugBank.d412.s5|209-210|in|drug
DDI-DrugBank.d412.s5|212-215|such|drug
DDI-DrugBank.d412.s5|217-224|patients|drug
DDI-DrugBank.d412.s5|225-225|.|drug
DDI-DrugBank.d412.s6|0-8|Synergism|drug
DDI-DrugBank.d412.s6|10-12|has|drug
DDI-DrugBank.d412.s6|14-17|been|drug
DDI-DrugBank.d412.s6|19-23|shown|drug
DDI-DrugBank.d412.s6|25-31|between|drug
DDI-DrugBank.d412.s6|33-41|halothane|drug
DDI-DrugBank.d412.s6|43-52|anesthesia|drug
DDI-DrugBank.d412.s6|54-56|and|drug
DDI-DrugBank.d412.s6|58-70|intravenously|drug
DDI-DrugBank.d412.s6|72-83|administered|drug
DDI-DrugBank.d412.s6|85-93|labetalol|drug
DDI-DrugBank.d412.s6|95-97|HCl|drug
DDI-DrugBank.d412.s6|98-98|.|drug
DDI-DrugBank.d412.s7|0-5|During|drug
DDI-DrugBank.d412.s7|7-16|controlled|drug
DDI-DrugBank.d412.s7|18-28|hypotensive|drug
DDI-DrugBank.d412.s7|30-39|anesthesia|drug
DDI-DrugBank.d412.s7|41-45|using|drug
DDI-DrugBank.d412.s7|47-55|labetalol|drug
DDI-DrugBank.d412.s7|57-59|HCl|drug
DDI-DrugBank.d412.s7|61-62|in|drug
DDI-DrugBank.d412.s7|64-74|association|drug
DDI-DrugBank.d412.s7|76-79|with|drug
DDI-DrugBank.d412.s7|81-89|halothane|drug
DDI-DrugBank.d412.s7|90-90|,|drug
DDI-DrugBank.d412.s7|92-95|high|drug
DDI-DrugBank.d412.s7|97-110|concentrations|drug
DDI-DrugBank.d412.s7|112-112|(|drug
DDI-DrugBank.d412.s7|113-113|3|drug
DDI-DrugBank.d412.s7|114-114|%|drug
DDI-DrugBank.d412.s7|116-117|or|drug
DDI-DrugBank.d412.s7|119-123|above|drug
DDI-DrugBank.d412.s7|124-124|)|drug
DDI-DrugBank.d412.s7|126-127|of|drug
DDI-DrugBank.d412.s7|129-137|halothane|drug
DDI-DrugBank.d412.s7|139-144|should|drug
DDI-DrugBank.d412.s7|146-148|not|drug
DDI-DrugBank.d412.s7|150-151|be|drug
DDI-DrugBank.d412.s7|153-156|used|drug
DDI-DrugBank.d412.s7|158-164|because|drug
DDI-DrugBank.d412.s7|166-168|the|drug
DDI-DrugBank.d412.s7|170-175|degree|drug
DDI-DrugBank.d412.s7|177-178|of|drug
DDI-DrugBank.d412.s7|180-190|hypotension|drug
DDI-DrugBank.d412.s7|192-195|will|drug
DDI-DrugBank.d412.s7|197-198|be|drug
DDI-DrugBank.d412.s7|200-208|increased|drug
DDI-DrugBank.d412.s7|210-212|and|drug
DDI-DrugBank.d412.s7|214-220|because|drug
DDI-DrugBank.d412.s7|222-223|of|drug
DDI-DrugBank.d412.s7|225-227|the|drug
DDI-DrugBank.d412.s7|229-239|possibility|drug
DDI-DrugBank.d412.s7|241-242|of|drug
DDI-DrugBank.d412.s7|244-244|a|drug
DDI-DrugBank.d412.s7|246-250|large|drug
DDI-DrugBank.d412.s7|252-260|reduction|drug
DDI-DrugBank.d412.s7|262-263|in|drug
DDI-DrugBank.d412.s7|265-271|cardiac|drug
DDI-DrugBank.d412.s7|273-278|output|drug
DDI-DrugBank.d412.s7|280-282|and|drug
DDI-DrugBank.d412.s7|284-285|an|drug
DDI-DrugBank.d412.s7|287-294|increase|drug
DDI-DrugBank.d412.s7|296-297|in|drug
DDI-DrugBank.d412.s7|299-305|central|drug
DDI-DrugBank.d412.s7|307-312|venous|drug
DDI-DrugBank.d412.s7|314-321|pressure|drug
DDI-DrugBank.d412.s7|322-322|.|drug
DDI-DrugBank.d412.s8|0-2|The|drug
DDI-DrugBank.d412.s8|4-19|anesthesiologist|drug
DDI-DrugBank.d412.s8|21-26|should|drug
DDI-DrugBank.d412.s8|28-29|be|drug
DDI-DrugBank.d412.s8|31-38|informed|drug
DDI-DrugBank.d412.s8|40-43|when|drug
DDI-DrugBank.d412.s8|45-45|a|drug
DDI-DrugBank.d412.s8|47-53|patient|drug
DDI-DrugBank.d412.s8|55-56|is|drug
DDI-DrugBank.d412.s8|58-66|receiving|drug
DDI-DrugBank.d412.s8|68-76|labetalol|drug
DDI-DrugBank.d412.s8|78-80|HCl|drug
DDI-DrugBank.d412.s8|81-81|.|drug
DDI-DrugBank.d412.s9|0-8|Labetalol|drug
DDI-DrugBank.d412.s9|10-12|HCl|drug
DDI-DrugBank.d412.s9|14-19|blunts|drug
DDI-DrugBank.d412.s9|21-23|the|drug
DDI-DrugBank.d412.s9|25-30|reflex|drug
DDI-DrugBank.d412.s9|32-42|tachycardia|drug
DDI-DrugBank.d412.s9|44-51|produced|drug
DDI-DrugBank.d412.s9|53-54|by|drug
DDI-DrugBank.d412.s9|56-68|nitroglycerin|drug
DDI-DrugBank.d412.s9|70-76|without|drug
DDI-DrugBank.d412.s9|78-87|preventing|drug
DDI-DrugBank.d412.s9|89-91|its|drug
DDI-DrugBank.d412.s9|93-103|hypotensive|drug
DDI-DrugBank.d412.s9|105-110|effect|drug
DDI-DrugBank.d412.s9|111-111|.|drug
DDI-DrugBank.d412.s10|0-1|If|drug
DDI-DrugBank.d412.s10|3-11|labetalol|drug
DDI-DrugBank.d412.s10|13-15|HCl|drug
DDI-DrugBank.d412.s10|17-18|is|drug
DDI-DrugBank.d412.s10|20-23|used|drug
DDI-DrugBank.d412.s10|25-28|with|drug
DDI-DrugBank.d412.s10|30-42|nitroglycerin|drug
DDI-DrugBank.d412.s10|44-45|in|drug
DDI-DrugBank.d412.s10|47-54|patients|drug
DDI-DrugBank.d412.s10|56-59|with|drug
DDI-DrugBank.d412.s10|61-66|angina|drug
DDI-DrugBank.d412.s10|68-75|pectoris|drug
DDI-DrugBank.d412.s10|76-76|,|drug
DDI-DrugBank.d412.s10|78-87|additional|drug
DDI-DrugBank.d412.s10|89-104|antihypertensive|drug
DDI-DrugBank.d412.s10|106-112|effects|drug
DDI-DrugBank.d412.s10|114-116|may|drug
DDI-DrugBank.d412.s10|118-122|occur|drug
DDI-DrugBank.d412.s10|123-123|.|drug
DDI-DrugBank.d412.s11|0-3|Care|drug
DDI-DrugBank.d412.s11|5-10|should|drug
DDI-DrugBank.d412.s11|12-13|be|drug
DDI-DrugBank.d412.s11|15-19|taken|drug
DDI-DrugBank.d412.s11|21-22|if|drug
DDI-DrugBank.d412.s11|24-32|labetalol|drug
DDI-DrugBank.d412.s11|34-35|is|drug
DDI-DrugBank.d412.s11|37-40|used|drug
DDI-DrugBank.d412.s11|42-54|concomitantly|drug
DDI-DrugBank.d412.s11|56-59|with|drug
DDI-DrugBank.d412.s11|61-67|calcium|drug
DDI-DrugBank.d412.s11|69-79|antagonists|drug
DDI-DrugBank.d412.s11|81-82|of|drug
DDI-DrugBank.d412.s11|84-86|the|drug
DDI-DrugBank.d412.s11|88-96|verapamil|drug
DDI-DrugBank.d412.s11|98-101|type|drug
DDI-DrugBank.d412.s11|102-102|.|drug
DDI-DrugBank.d412.s12|0-3|Risk|drug
DDI-DrugBank.d412.s12|5-6|of|drug
DDI-DrugBank.d412.s12|8-19|Anaphylactic|drug
DDI-DrugBank.d412.s12|21-28|Reaction|drug
DDI-DrugBank.d412.s12|30-34|While|drug
DDI-DrugBank.d412.s12|36-41|taking|drug
DDI-DrugBank.d412.s12|43-55|beta-blockers|drug
DDI-DrugBank.d412.s12|56-56|,|drug
DDI-DrugBank.d412.s12|58-65|patients|drug
DDI-DrugBank.d412.s12|67-70|with|drug
DDI-DrugBank.d412.s12|72-72|a|drug
DDI-DrugBank.d412.s12|74-80|history|drug
DDI-DrugBank.d412.s12|82-83|of|drug
DDI-DrugBank.d412.s12|85-90|severe|drug
DDI-DrugBank.d412.s12|92-103|anaphylactic|drug
DDI-DrugBank.d412.s12|105-112|reaction|drug
DDI-DrugBank.d412.s12|114-115|to|drug
DDI-DrugBank.d412.s12|117-117|a|drug
DDI-DrugBank.d412.s12|119-125|variety|drug
DDI-DrugBank.d412.s12|127-128|of|drug
DDI-DrugBank.d412.s12|130-138|allergens|drug
DDI-DrugBank.d412.s12|140-142|may|drug
DDI-DrugBank.d412.s12|144-145|be|drug
DDI-DrugBank.d412.s12|147-150|more|drug
DDI-DrugBank.d412.s12|152-159|reactive|drug
DDI-DrugBank.d412.s12|161-162|to|drug
DDI-DrugBank.d412.s12|164-171|repeated|drug
DDI-DrugBank.d412.s12|173-181|challenge|drug
DDI-DrugBank.d412.s12|182-182|,|drug
DDI-DrugBank.d412.s12|184-189|either|drug
DDI-DrugBank.d412.s12|191-200|accidental|drug
DDI-DrugBank.d412.s12|201-201|,|drug
DDI-DrugBank.d412.s12|203-212|diagnostic|drug
DDI-DrugBank.d412.s12|213-213|,|drug
DDI-DrugBank.d412.s12|215-216|or|drug
DDI-DrugBank.d412.s12|218-228|therapeutic|drug
DDI-DrugBank.d412.s12|229-229|.|drug
DDI-DrugBank.d412.s13|0-3|Such|drug
DDI-DrugBank.d412.s13|5-12|patients|drug
DDI-DrugBank.d412.s13|14-16|may|drug
DDI-DrugBank.d412.s13|18-19|be|drug
DDI-DrugBank.d412.s13|21-32|unresponsive|drug
DDI-DrugBank.d412.s13|34-35|to|drug
DDI-DrugBank.d412.s13|37-39|the|drug
DDI-DrugBank.d412.s13|41-45|usual|drug
DDI-DrugBank.d412.s13|47-51|doses|drug
DDI-DrugBank.d412.s13|53-54|of|drug
DDI-DrugBank.d412.s13|56-66|epinephrine|drug
DDI-DrugBank.d412.s13|68-71|used|drug
DDI-DrugBank.d412.s13|73-74|to|drug
DDI-DrugBank.d412.s13|76-80|treat|drug
DDI-DrugBank.d412.s13|82-89|allergic|drug
DDI-DrugBank.d412.s13|91-98|reaction|drug
DDI-DrugBank.d412.s13|99-99|.|drug
DDI-DrugBank.d412.s14|0-14|Drug/Laboratory|drug
DDI-DrugBank.d412.s14|16-19|Test|drug
DDI-DrugBank.d412.s14|21-32|Interactions|drug
DDI-DrugBank.d412.s14|34-36|The|drug
DDI-DrugBank.d412.s14|38-45|presence|drug
DDI-DrugBank.d412.s14|47-48|of|drug
DDI-DrugBank.d412.s14|50-58|labetalol|drug
DDI-DrugBank.d412.s14|60-70|metabolites|drug
DDI-DrugBank.d412.s14|72-73|in|drug
DDI-DrugBank.d412.s14|75-77|the|drug
DDI-DrugBank.d412.s14|79-83|urine|drug
DDI-DrugBank.d412.s14|85-87|may|drug
DDI-DrugBank.d412.s14|89-94|result|drug
DDI-DrugBank.d412.s14|96-97|in|drug
DDI-DrugBank.d412.s14|99-105|falsely|drug
DDI-DrugBank.d412.s14|107-114|elevated|drug
DDI-DrugBank.d412.s14|116-121|levels|drug
DDI-DrugBank.d412.s14|123-124|of|drug
DDI-DrugBank.d412.s14|126-132|urinary|drug
DDI-DrugBank.d412.s14|134-147|catecholamines|drug
DDI-DrugBank.d412.s14|148-148|,|drug
DDI-DrugBank.d412.s14|150-161|metanephrine|drug
DDI-DrugBank.d412.s14|162-162|,|drug
DDI-DrugBank.d412.s14|164-178|normetanephrine|drug
DDI-DrugBank.d412.s14|180-182|and|drug
DDI-DrugBank.d412.s14|184-199|vanillylmandelic|drug
DDI-DrugBank.d412.s14|201-204|acid|drug
DDI-DrugBank.d412.s14|206-209|when|drug
DDI-DrugBank.d412.s14|211-218|measured|drug
DDI-DrugBank.d412.s14|220-221|by|drug
DDI-DrugBank.d412.s14|223-234|fluorimetric|drug
DDI-DrugBank.d412.s14|236-237|or|drug
DDI-DrugBank.d412.s14|239-249|photometric|drug
DDI-DrugBank.d412.s14|251-257|methods|drug
DDI-DrugBank.d412.s14|258-258|.|drug
DDI-DrugBank.d412.s15|0-1|In|drug
DDI-DrugBank.d412.s15|3-11|screening|drug
DDI-DrugBank.d412.s15|13-20|patients|drug
DDI-DrugBank.d412.s15|22-30|suspected|drug
DDI-DrugBank.d412.s15|32-33|of|drug
DDI-DrugBank.d412.s15|35-40|having|drug
DDI-DrugBank.d412.s15|42-42|a|drug
DDI-DrugBank.d412.s15|44-59|pheochromocytoma|drug
DDI-DrugBank.d412.s15|61-63|and|drug
DDI-DrugBank.d412.s15|65-69|being|drug
DDI-DrugBank.d412.s15|71-77|treated|drug
DDI-DrugBank.d412.s15|79-82|with|drug
DDI-DrugBank.d412.s15|84-92|labetalol|drug
DDI-DrugBank.d412.s15|94-96|HCl|drug
DDI-DrugBank.d412.s15|97-97|,|drug
DDI-DrugBank.d412.s15|99-99|a|drug
DDI-DrugBank.d412.s15|101-108|specific|drug
DDI-DrugBank.d412.s15|110-115|method|drug
DDI-DrugBank.d412.s15|116-116|,|drug
DDI-DrugBank.d412.s15|118-121|such|drug
DDI-DrugBank.d412.s15|123-124|as|drug
DDI-DrugBank.d412.s15|126-126|a|drug
DDI-DrugBank.d412.s15|128-131|high|drug
DDI-DrugBank.d412.s15|133-143|performance|drug
DDI-DrugBank.d412.s15|145-150|liquid|drug
DDI-DrugBank.d412.s15|152-166|chromatographic|drug
DDI-DrugBank.d412.s15|168-172|assay|drug
DDI-DrugBank.d412.s15|174-177|with|drug
DDI-DrugBank.d412.s15|179-183|solid|drug
DDI-DrugBank.d412.s15|185-189|phase|drug
DDI-DrugBank.d412.s15|191-200|extraction|drug
DDI-DrugBank.d412.s15|202-202|(|drug
DDI-DrugBank.d412.s15|203-206|e.g.|drug
DDI-DrugBank.d412.s15|207-207|,|drug
DDI-DrugBank.d412.s15|209-209|J|drug
DDI-DrugBank.d412.s15|211-220|Chromatogr|drug
DDI-DrugBank.d412.s15|222-233|385:241,1987|drug
DDI-DrugBank.d412.s15|234-234|)|drug
DDI-DrugBank.d412.s15|236-241|should|drug
DDI-DrugBank.d412.s15|243-244|be|drug
DDI-DrugBank.d412.s15|246-253|employed|drug
DDI-DrugBank.d412.s15|255-256|in|drug
DDI-DrugBank.d412.s15|258-268|determining|drug
DDI-DrugBank.d412.s15|270-275|levels|drug
DDI-DrugBank.d412.s15|277-278|of|drug
DDI-DrugBank.d412.s15|280-293|catecholamines|drug
DDI-DrugBank.d412.s15|294-294|.|drug
DDI-DrugBank.d412.s16|0-8|Labetalol|drug
DDI-DrugBank.d412.s16|10-12|HCl|drug
DDI-DrugBank.d412.s16|14-16|has|drug
DDI-DrugBank.d412.s16|18-21|also|drug
DDI-DrugBank.d412.s16|23-26|been|drug
DDI-DrugBank.d412.s16|28-35|reported|drug
DDI-DrugBank.d412.s16|37-38|to|drug
DDI-DrugBank.d412.s16|40-46|produce|drug
DDI-DrugBank.d412.s16|48-48|a|drug
DDI-DrugBank.d412.s16|50-54|false|drug
DDI-DrugBank.d412.s16|56-63|positive|drug
DDI-DrugBank.d412.s16|65-68|test|drug
DDI-DrugBank.d412.s16|70-72|for|drug
DDI-DrugBank.d412.s16|74-84|amphetamine|drug
DDI-DrugBank.d412.s16|86-89|when|drug
DDI-DrugBank.d412.s16|91-99|screening|drug
DDI-DrugBank.d412.s16|101-105|urine|drug
DDI-DrugBank.d412.s16|107-109|for|drug
DDI-DrugBank.d412.s16|111-113|the|drug
DDI-DrugBank.d412.s16|115-122|presence|drug
DDI-DrugBank.d412.s16|124-125|of|drug
DDI-DrugBank.d412.s16|127-131|drugs|drug
DDI-DrugBank.d412.s16|133-137|using|drug
DDI-DrugBank.d412.s16|139-141|the|drug
DDI-DrugBank.d412.s16|143-154|commercially|drug
DDI-DrugBank.d412.s16|156-164|available|drug
DDI-DrugBank.d412.s16|166-170|assay|drug
DDI-DrugBank.d412.s16|172-178|methods|drug
DDI-DrugBank.d412.s16|180-187|Toxi-Lab|drug
DDI-DrugBank.d412.s16|189-189|A|drug
DDI-DrugBank.d412.s16|192-192|(|drug
DDI-DrugBank.d412.s16|193-202|thin-layer|drug
DDI-DrugBank.d412.s16|204-218|chromatographic|drug
DDI-DrugBank.d412.s16|220-224|assay|drug
DDI-DrugBank.d412.s16|225-225|)|drug
DDI-DrugBank.d412.s16|227-229|and|drug
DDI-DrugBank.d412.s16|231-241|Emit-d.a.u|drug
DDI-DrugBank.d412.s16|244-244|.|drug
DDI-DrugBank.d412.s16|245-258|(|drug
DDI-DrugBank.d412.s16|260-264|radioenzymatic|drug
DDI-DrugBank.d412.s16|265-265|assay|drug
DDI-DrugBank.d412.s16|266-266|)|drug
DDI-DrugBank.d412.s17|0-3|When|drug
DDI-DrugBank.d412.s17|5-12|patients|drug
DDI-DrugBank.d412.s17|14-18|being|drug
DDI-DrugBank.d412.s17|20-26|treated|drug
DDI-DrugBank.d412.s17|28-31|with|drug
DDI-DrugBank.d412.s17|33-41|labetalol|drug
DDI-DrugBank.d412.s17|43-46|have|drug
DDI-DrugBank.d412.s17|48-48|a|drug
DDI-DrugBank.d412.s17|50-57|positive|drug
DDI-DrugBank.d412.s17|59-63|urine|drug
DDI-DrugBank.d412.s17|65-68|test|drug
DDI-DrugBank.d412.s17|70-72|for|drug
DDI-DrugBank.d412.s17|74-84|amphetamine|drug
DDI-DrugBank.d412.s17|86-90|using|drug
DDI-DrugBank.d412.s17|92-96|these|drug
DDI-DrugBank.d412.s17|98-107|techniques|drug
DDI-DrugBank.d412.s17|109-120|confirmation|drug
DDI-DrugBank.d412.s17|122-127|should|drug
DDI-DrugBank.d412.s17|129-130|be|drug
DDI-DrugBank.d412.s17|132-135|made|drug
DDI-DrugBank.d412.s17|137-138|by|drug
DDI-DrugBank.d412.s17|140-144|using|drug
DDI-DrugBank.d412.s17|146-149|more|drug
DDI-DrugBank.d412.s17|151-158|specific|drug
DDI-DrugBank.d412.s17|160-166|methods|drug
DDI-DrugBank.d412.s17|168-171|such|drug
DDI-DrugBank.d412.s17|173-174|as|drug
DDI-DrugBank.d412.s17|176-176|a|drug
DDI-DrugBank.d412.s17|178-180|gas|drug
DDI-DrugBank.d412.s17|182-201|chromatographic-mass|drug
DDI-DrugBank.d412.s17|203-214|spectrometer|drug
DDI-DrugBank.d412.s17|216-224|technique|drug
DDI-DrugBank.d412.s17|225-225|.|drug
